Citrus Sinensis ID: 014079

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-
Protein Sequence
MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPNCSPGGPAACRVR
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHcccccccccccccccEEEEEEEcccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccEEccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccEcccccEEEEEEEcccccccccHHHHHHHHHHHHccccccEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHcccccEEEEcccHccEEEcccccccHcHcccccccccccccEEEEEEccccccccHHHHHccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHccccHHHHccHHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEcc
Coil and Loop (DISEMBL)
MGNCGTREESAVVSTVQVQQLHmlssslpvkperkhnrsisdlsdpstprnledsrkNAVLYTHVIAFSLFELETITKSfrsdyilgeggfgtvykGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVnflgqlrhpnlVKLIGycceddhrLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFlhnaerpviyrdfktsnilldsdytaklsdfglakagpqgdethvstrvmgtygyaapeyvmtghltarsDVYSFGVVLLELLTgrksvdktrpskeqslvdwarpklndkrKMLQIidprlenqYSVRAAQKACSLAYYClsqnpkarplmsdvvetleplqcandggneissSLTANLVVAAGgatnafamggipgyrtrprfsnnvgpgsscrspnpncspggpaacrvr
Flexible Loop (DISEMBL)
mgncgtreesaVVSTVQVQQLHmlssslpvkperkhnrsisdlsdpstprnLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGlakagpqgdethvsTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLtgrksvdktrpskeqslvdwarpklndkrKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVgpgsscrspnpncspggpaacrvr
Low Complexity Region (SEG)
MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVgpgsscrspnpncspgGPAACRVR
Disordered region (IsUnstruct)
**********************************************************AVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG***DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG*****************W*********KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYR*********************************
Disordered Region (DISOPRED)
******************************************************************AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP************************************************************************
Disordered Region (DISEMBL)
**************TVQVQQLHMLSSSLPVK**********************DSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS**********SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSN**************************
Disordered Region (DISPRO)
**************************************************************THVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC*********************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPNCSPGGPAACRVR
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	431	2.2.26 [Sep-21-2011]
Q8GXZ3	410	Serine/threonine-protein	yes	no	0.951	1.0	0.812	0.0
Q9FM85	408	Probable receptor-like pr	no	no	0.830	0.877	0.606	1e-127
Q9LFP7	493	Probable receptor-like pr	no	no	0.770	0.673	0.609	1e-118
Q9SRH7	490	Receptor-like serine/thre	no	no	0.807	0.710	0.596	1e-117
P46573	412	Protein kinase APK1B, chl	no	no	0.698	0.730	0.640	1e-114
P43293	389	Probable serine/threonine	no	no	0.700	0.776	0.628	1e-113
Q06548	410	Protein kinase APK1A, chl	no	no	0.700	0.736	0.634	1e-111
O49840	426	Protein kinase 2B, chloro	no	no	0.696	0.704	0.627	1e-109
Q8H186	389	Probable receptor-like pr	no	no	0.693	0.768	0.629	1e-108
O48814	395	Serine/threonine-protein	no	no	0.693	0.756	0.618	1e-107

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  698 bits (1802), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 350/431 (81%), Positives = 368/431 (85%), Gaps = 21/431 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAV 60
           MGNCGTR+E+AV +     Q               H+RS+SDLSDPSTPR  +DSR   +
Sbjct: 1   MGNCGTRDEAAVFTPQAQAQQLQKK----------HSRSVSDLSDPSTPRFRDDSR-TPI 49

Query: 61  LYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
            Y  VI F+LFELETITKSFR DYILGEGGFGTVYKGYID+N+RVGLKSLPVAVKVLNKE
Sbjct: 50  SYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNKE 109

Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPL 180
           GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM RGSLENHLFRK T PL
Sbjct: 110 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAPL 169

Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE 240
           SW+ RMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE
Sbjct: 170 SWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE 229

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD 300
           THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE+LTGRKSVDKTRPSKEQ+LVD
Sbjct: 230 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLVD 289

Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           WARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL
Sbjct: 290 WARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 349

Query: 361 QCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPNC 420
           QC  D          A +  A   A  AFAMGG+P YR   RF+ NVGPG+ CRSPNPN 
Sbjct: 350 QCTGD----------ALIPCATTTAGAAFAMGGVPDYRMHRRFAKNVGPGAICRSPNPNY 399

Query: 421 SPGGPAACRVR 431
           SPGGPAACRVR
Sbjct: 400 SPGGPAACRVR 410

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9FM85|Y5564_ARATH Probable receptor-like protein kinase At5g56460 OS=Arabidopsis thaliana GN=At5g56460 PE=1 SV=1

 Score =  456 bits (1173), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 225/371 (60%), Positives = 285/371 (76%), Gaps = 13/371 (3%)

Query: 1   MGNCGTREESA---VVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRK 57
           MGNC  R E     V +  + +     S ++    E KH + +  L  PS P+ +ED R+
Sbjct: 1   MGNCWCRFEPLNHRVSANAKSESPKEQSPTV----EDKHIKEVQKL--PSNPKEVEDLRR 54

Query: 58  NAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENV--RVGLKSLPVAVK 115
           ++     +IAF+  EL+ IT +FR D +LG GGFG+VYKG+I E++  +   + LPVAVK
Sbjct: 55  DSAA-NPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVK 113

Query: 116 VLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
           V + +   QGHREWL EV FLGQL HPNLVKLIGYCCED+HR+L+YE+M RGS+EN+LF 
Sbjct: 114 VHDGDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFS 173

Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           +  +PLSWA RM IAFGAAKGLAFLH A++PVIYRDFKTSNILLD DY AKLSDFGLAK 
Sbjct: 174 RVLLPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKD 233

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
           GP GD++HVSTR+MGTYGYAAPEY+MTGHLT  SDVYSFGVVLLELLTGRKS+DK+RP++
Sbjct: 234 GPVGDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTR 293

Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
           EQ+L+DWA P L +K+K+L I+DP++  +Y V+A QKA  LAY+CL++NPKARPLM D+V
Sbjct: 294 EQNLIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIV 353

Query: 355 ETLEPLQCAND 365
           ++LEPLQ   +
Sbjct: 354 DSLEPLQATEE 364

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  427 bits (1097), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 209/343 (60%), Positives = 260/343 (75%), Gaps = 11/343 (3%)

Query: 33  ERKHNRSISDLSDPSTPRNLEDSRKNAVLY------THVIAFSLFELETITKSFRSDYIL 86
           E+ +++ +  +S  +T  N E S    V+       +H+  F+  +L+  T++FR + +L
Sbjct: 89  EKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLL 148

Query: 87  GEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           GEGGFG V+KG+I+EN    +K    L VAVK LN +GLQGH+EWL E+NFLG L HPNL
Sbjct: 149 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNL 208

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-A 202
           VKL+GYC EDD RLLVYEFM RGSLENHLFR+ ++PL W+ RM IA GAAKGL+FLH  A
Sbjct: 209 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIALGAAKGLSFLHEEA 267

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            +PVIYRDFKTSNILLD+DY AKLSDFGLAK  P   +THVSTRVMGTYGYAAPEYVMTG
Sbjct: 268 LKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 327

Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
           HLT++SDVYSFGVVLLE+LTGR+S+DK RP+ E +LV+WARP L DKR+  +++DPRLE 
Sbjct: 328 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEG 387

Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
            +S++ AQK   LA  CLS++PK RP MSDVVE L+PL    D
Sbjct: 388 HFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKD 430

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  421 bits (1083), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 213/357 (59%), Positives = 263/357 (73%), Gaps = 9/357 (2%)

Query: 13  VSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFE 72
            STV  Q   + S+  PV P      + +  S  STP   E+      +Y+H+  FS  +
Sbjct: 73  TSTVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELN----IYSHLKKFSFID 128

Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQGHREWL 129
           L+  T++FR + +LGEGGFG V+KG+++EN    +K    L VAVK LN +GLQGH+EWL
Sbjct: 129 LKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWL 188

Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
            E+N+LG L HPNLVKL+GYC EDD RLLVYEFM RGSLENHLFR+ ++PL W+ RM IA
Sbjct: 189 AEINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRR-SLPLPWSIRMKIA 247

Query: 190 FGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
            GAAKGL+FLH  A +PVIYRDFKTSNILLD +Y AKLSDFGLAK  P   +THVSTRVM
Sbjct: 248 LGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVM 307

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
           GTYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGR+S+DK RP+ E +LV+WARP L D
Sbjct: 308 GTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLD 367

Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
           KR+  +++DPRLE  +SV+ AQK   LA  CLS++ K RP MS+VVE L+PL    D
Sbjct: 368 KRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKD 424

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  412 bits (1060), Expect = e-114,   Method: Compositional matrix adjust.
 Identities = 196/306 (64%), Positives = 241/306 (78%), Gaps = 5/306 (1%)

Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQ 123
           +F+  EL+  T++FR D +LGEGGFG+V+KG+IDE      K    + +AVK LN++G Q
Sbjct: 56  SFTFAELKAATRNFRPDSVLGEGGFGSVFKGWIDEQTLTASKPGTGVVIAVKKLNQDGWQ 115

Query: 124 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--PLS 181
           GH+EWL EVN+LGQ  HPNLVKLIGYC ED+HRLLVYEFM RGSLENHLFR+ +   PLS
Sbjct: 116 GHQEWLAEVNYLGQFSHPNLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGSYFQPLS 175

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
           W  R+ +A GAAKGLAFLHNAE  VIYRDFKTSNILLDS+Y AKLSDFGLAK GP GD++
Sbjct: 176 WTLRLKVALGAAKGLAFLHNAETSVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPTGDKS 235

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW 301
           HVSTR+MGTYGYAAPEY+ TGHLT +SDVYS+GVVLLE+L+GR++VDK RP  EQ LV+W
Sbjct: 236 HVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVDKNRPPGEQKLVEW 295

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
           ARP L +KRK+ ++ID RL++QYS+  A K  +LA  CL+   K RP M++VV  LE +Q
Sbjct: 296 ARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRPNMNEVVSHLEHIQ 355

Query: 362 CANDGG 367
             N+ G
Sbjct: 356 TLNEAG 361

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  409 bits (1052), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 193/307 (62%), Positives = 243/307 (79%), Gaps = 5/307 (1%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQG 124
           FSL EL++ T++FR D ++GEGGFG V+KG+IDE+     K    + +AVK LN+EG QG
Sbjct: 56  FSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPGTGIVIAVKRLNQEGFQG 115

Query: 125 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--PLSW 182
           HREWL E+N+LGQL HPNLVKLIGYC E++HRLLVYEFM RGSLENHLFR+ T   PLSW
Sbjct: 116 HREWLAEINYLGQLDHPNLVKLIGYCLEEEHRLLVYEFMTRGSLENHLFRRGTFYQPLSW 175

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
            TR+ +A GAA+GLAFLHNA+  VIYRDFK SNILLDS+Y AKLSDFGLA+ GP GD +H
Sbjct: 176 NTRVRMALGAARGLAFLHNAQPQVIYRDFKASNILLDSNYNAKLSDFGLARDGPMGDNSH 235

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
           VSTRVMGT GYAAPEY+ TGHL+ +SDVYSFGVVLLELL+GR+++DK +P  E +LVDWA
Sbjct: 236 VSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQPVGEHNLVDWA 295

Query: 303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC 362
           RP L +KR++L+++DPRL+ QYS+  A K   LA  C+S + K+RP M+++V+T+E L  
Sbjct: 296 RPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMNEIVKTMEELHI 355

Query: 363 ANDGGNE 369
             +   E
Sbjct: 356 QKEASKE 362

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  401 bits (1030), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 196/309 (63%), Positives = 242/309 (78%), Gaps = 7/309 (2%)

Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQ 123
           +FS  EL++ T++FR D +LGEGGFG V+KG+IDE      +    L +AVK LN++G Q
Sbjct: 55  SFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPGTGLVIAVKKLNQDGWQ 114

Query: 124 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--PLS 181
           GH+EWL EVN+LGQ  H +LVKLIGYC ED+HRLLVYEFM RGSLENHLFR+     PLS
Sbjct: 115 GHQEWLAEVNYLGQFSHRHLVKLIGYCLEDEHRLLVYEFMPRGSLENHLFRRGLYFQPLS 174

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
           W  R+ +A GAAKGLAFLH++E  VIYRDFKTSNILLDS+Y AKLSDFGLAK GP GD++
Sbjct: 175 WKLRLKVALGAAKGLAFLHSSETRVIYRDFKTSNILLDSEYNAKLSDFGLAKDGPIGDKS 234

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW 301
           HVSTRVMGT+GYAAPEY+ TGHLT +SDVYSFGVVLLELL+GR++VDK RPS E++LV+W
Sbjct: 235 HVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNRPSGERNLVEW 294

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
           A+P L +KRK+ ++ID RL++QYS+  A K  +L+  CL+   K RP MS+VV  LE +Q
Sbjct: 295 AKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMSEVVSHLEHIQ 354

Query: 362 CAND--GGN 368
             N   GGN
Sbjct: 355 SLNAAIGGN 363

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49840|APK2B_ARATH Protein kinase 2B, chloroplastic OS=Arabidopsis thaliana GN=APK2B PE=1 SV=1

 Score =  396 bits (1018), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 190/303 (62%), Positives = 233/303 (76%), Gaps = 3/303 (0%)

Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQ 123
           AF+  EL+  T++FR D +LGEGGFG V+KG+ID       K    + VAVK L  EG Q
Sbjct: 70  AFTFNELKNATRNFRPDSLLGEGGFGYVFKGWIDGTTLTASKPGSGIVVAVKKLKTEGYQ 129

Query: 124 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA 183
           GH+EWLTEVN+LGQL HPNLVKL+GYC E ++RLLVYEFM +GSLENHLFR+   PL+WA
Sbjct: 130 GHKEWLTEVNYLGQLSHPNLVKLVGYCVEGENRLLVYEFMPKGSLENHLFRRGAQPLTWA 189

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
            RM +A GAAKGL FLH+A+  VIYRDFK +NILLD+++ +KLSDFGLAKAGP GD+THV
Sbjct: 190 IRMKVAIGAAKGLTFLHDAKSQVIYRDFKAANILLDAEFNSKLSDFGLAKAGPTGDKTHV 249

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
           ST+VMGT+GYAAPEYV TG LTA+SDVYSFGVVLLELL+GR++VDK++   EQSLVDWA 
Sbjct: 250 STQVMGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELLSGRRAVDKSKVGMEQSLVDWAT 309

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA 363
           P L DKRK+ +I+D RL  QY  + A  A SLA  CL+ + K RP MS+V+  L+ L+  
Sbjct: 310 PYLGDKRKLFRIMDTRLGGQYPQKGAYTAASLALQCLNPDAKLRPKMSEVLAKLDQLEST 369

Query: 364 NDG 366
             G
Sbjct: 370 KPG 372

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  391 bits (1004), Expect = e-108,   Method: Compositional matrix adjust.
 Identities = 192/305 (62%), Positives = 230/305 (75%), Gaps = 6/305 (1%)

Query: 63  THVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKS---LPVAVKVLNK 119
           T V +FS  EL+  T++FRSD ++GEGGFG V++G++DE      KS   L +AVK LN 
Sbjct: 44  TTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKSSSGLVIAVKRLNP 103

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF---RKA 176
           +G QGHREWLTE+N+LGQL HPNLVKLIGYC ED+ RLLVYEFM +GSLENHLF    K 
Sbjct: 104 DGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEQRLLVYEFMHKGSLENHLFANGNKD 163

Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
             PLSW  R+ +A  AAKGLAFLH+    VIYRD K SNILLDSD+ AKLSDFGLA+ GP
Sbjct: 164 FKPLSWILRIKVALDAAKGLAFLHSDPVKVIYRDIKASNILLDSDFNAKLSDFGLARDGP 223

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
            G++++VSTRVMGT+GYAAPEYV TGHL ARSDVYSFGVVLLELL GR+++D  RP+KEQ
Sbjct: 224 MGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELLCGRQALDHNRPAKEQ 283

Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
           +LVDWARP L  +RK+L I+D RL +QY    A +  S+A  CLS  PK+RP M  VV  
Sbjct: 284 NLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLSFEPKSRPTMDQVVRA 343

Query: 357 LEPLQ 361
           L  LQ
Sbjct: 344 LVQLQ 348

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  389 bits (998), Expect = e-107,   Method: Compositional matrix adjust.
 Identities = 188/304 (61%), Positives = 232/304 (76%), Gaps = 5/304 (1%)

Query: 63  THVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNK 119
           T V +F+  EL+  T++FR D ++GEGGFG V+KG++DE+     K    L +AVK LN+
Sbjct: 50  TPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPGTGLVIAVKKLNQ 109

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV- 178
           EG QGHREWLTE+N+LGQL HPNLVKLIGYC ED+HRLLVYEFM +GSLENHLFR+    
Sbjct: 110 EGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDEHRLLVYEFMQKGSLENHLFRRGAYF 169

Query: 179 -PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 237
            PL W  R+ +A  AAKGLAFLH+    VIYRD K SNILLD+DY AKLSDFGLA+ GP 
Sbjct: 170 KPLPWFLRVNVALDAAKGLAFLHSDPVKVIYRDIKASNILLDADYNAKLSDFGLARDGPM 229

Query: 238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS 297
           GD ++VSTRVMGTYGYAAPEY+ +GHL ARSDVYSFGV+LLE+L+G++++D  RP+KE++
Sbjct: 230 GDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILSGKRALDHNRPAKEEN 289

Query: 298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
           LVDWARP L  KRK+L I+D RL+ QY    A +  S+A  CLS  PK+RP M  VV  L
Sbjct: 290 LVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSFEPKSRPTMDQVVRAL 349

Query: 358 EPLQ 361
           + LQ
Sbjct: 350 QQLQ 353

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	431
224139430	423	predicted protein [Populus trichocarpa]	0.972	0.990	0.885	0.0
224069820	414	predicted protein [Populus trichocarpa]	0.958	0.997	0.893	0.0
255557899	534	Protein kinase APK1B, chloroplast precur	0.983	0.794	0.873	0.0
225439055	432	PREDICTED: serine/threonine-protein kina	0.988	0.986	0.864	0.0
449439785	426	PREDICTED: serine/threonine-protein kina	0.969	0.981	0.858	0.0
449497148	426	PREDICTED: LOW QUALITY PROTEIN: serine/t	0.969	0.981	0.856	0.0
239056195	412	ATP binding / serine-threonine kinase [V	0.953	0.997	0.847	0.0
239056175	422	ATP binding / kinase/ protein kinase/ pr	0.965	0.985	0.842	0.0
356532117	432	PREDICTED: serine/threonine-protein kina	0.981	0.979	0.822	0.0
357506811	437	Protein kinase 2B [Medicago truncatula]	0.986	0.972	0.821	0.0

>gi|224139430|ref|XP_002323108.1| predicted protein [Populus trichocarpa] gi|222867738|gb|EEF04869.1| predicted protein [Populus trichocarpa]

 Score =  787 bits (2032), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/435 (88%), Positives = 402/435 (92%), Gaps = 16/435 (3%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVK---PERKHNRSISDLSDP-STPRNLEDSR 56
           MGNCGTREESAV        LH+LSSS  +K    ++KH RSISDLSDP STPRN EDSR
Sbjct: 1   MGNCGTREESAV--------LHILSSSTSIKNGQSDKKHTRSISDLSDPTSTPRNFEDSR 52

Query: 57  KNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           KNA+LYTHVIAF+L+ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKS+PVAVKV
Sbjct: 53  KNALLYTHVIAFTLYELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSIPVAVKV 112

Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA 176
           LN+EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA
Sbjct: 113 LNREGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA 172

Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
           TVPLSWATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP
Sbjct: 173 TVPLSWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 232

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
           QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ
Sbjct: 233 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 292

Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
           SLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET
Sbjct: 293 SLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 352

Query: 357 LEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSP 416
           LEPLQC+NDG N +SSS   +L     G+ +AFAMGG+P YR R RF+NNV PGSSCRSP
Sbjct: 353 LEPLQCSNDGANGVSSS---SLTPTLTGSASAFAMGGVPDYRMR-RFTNNVVPGSSCRSP 408

Query: 417 NPNCSPGGPAACRVR 431
           NPNCSPGGPAACRVR
Sbjct: 409 NPNCSPGGPAACRVR 423

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224069820|ref|XP_002326422.1| predicted protein [Populus trichocarpa] gi|222833615|gb|EEE72092.1| predicted protein [Populus trichocarpa]

 Score =  782 bits (2019), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 386/432 (89%), Positives = 398/432 (92%), Gaps = 19/432 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDP-STPRNLEDSRKNA 59
           MGNCGTREESAVVST Q          L    ++KH+RS+SDLSDP STPRN EDSRKNA
Sbjct: 1   MGNCGTREESAVVSTAQ---------GLISLLDKKHSRSVSDLSDPTSTPRNFEDSRKNA 51

Query: 60  VLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK 119
           +LYTHVIAF+L+ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK
Sbjct: 52  LLYTHVIAFTLYELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK 111

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 179
           EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP
Sbjct: 112 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 171

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSWATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD
Sbjct: 172 LSWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 231

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV
Sbjct: 232 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 291

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           DWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP
Sbjct: 292 DWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 351

Query: 360 LQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPN 419
           LQC+     E+SSSLT  L    GGA  AFAMGG+P YR R RF+NNVGPGSSCRSPNPN
Sbjct: 352 LQCS-----EVSSSLTPALT---GGAV-AFAMGGVPDYRMRHRFTNNVGPGSSCRSPNPN 402

Query: 420 CSPGGPAACRVR 431
           CSPGGPAACRVR
Sbjct: 403 CSPGGPAACRVR 414

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255557899|ref|XP_002519978.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223540742|gb|EEF42302.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  776 bits (2004), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 380/435 (87%), Positives = 397/435 (91%), Gaps = 11/435 (2%)

Query: 1   MGNCGTREESAVVSTVQVQQ-LHMLSSSLPVK---PERKHNRSISDLSDP-STPRNLEDS 55
           MGNCGTREE+AVVS  QVQQ LH + SS  VK   PE+KH+RSISDLSDP STPRN EDS
Sbjct: 1   MGNCGTREEAAVVSNAQVQQQLHHMLSSSSVKNGLPEKKHSRSISDLSDPTSTPRNFEDS 60

Query: 56  RKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVK 115
           RKNAVLYTHVIAF+L+ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVK
Sbjct: 61  RKNAVLYTHVIAFTLYELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVK 120

Query: 116 VLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK 175
           VLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK
Sbjct: 121 VLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK 180

Query: 176 ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG 235
           ATVPL WATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG
Sbjct: 181 ATVPLPWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG 240

Query: 236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE 295
           PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE
Sbjct: 241 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE 300

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           QSLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE
Sbjct: 301 QSLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 360

Query: 356 TLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRS 415
           TLEPLQC+NDG  E++ + T      A           +P YR R RF+NNVGPG++CRS
Sbjct: 361 TLEPLQCSNDGATEVTFTPTLAGGAGAFAMGG------VPDYRMRRRFANNVGPGANCRS 414

Query: 416 PNPNCSPGGPAACRV 430
           PNP+CSPGGPAACR+
Sbjct: 415 PNPSCSPGGPAACRL 429

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225439055|ref|XP_002265437.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Vitis vinifera]

 Score =  765 bits (1976), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 378/437 (86%), Positives = 399/437 (91%), Gaps = 11/437 (2%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPE-----RKHNRSISDLSDP-STPRNLED 54
           MGNCG+ E++ VVS  QVQQLH+LSS L VK       +KH+RS+SDLSD  STPRNL+D
Sbjct: 1   MGNCGSTEDNPVVSHAQVQQLHILSS-LSVKDAAPNCGKKHSRSVSDLSDHHSTPRNLDD 59

Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 114
           S KN++LYTHVIAF+LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV
Sbjct: 60  SGKNSLLYTHVIAFTLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 119

Query: 115 KVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
           KVLNKEG QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR
Sbjct: 120 KVLNKEGFQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 179

Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           KATVPLSWATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA
Sbjct: 180 KATVPLSWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 239

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
           GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK
Sbjct: 240 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 299

Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
           EQSLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV
Sbjct: 300 EQSLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 359

Query: 355 ETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCR 414
           ETLEPLQ ++ G +E+SSS T NL V +GG    FA  G+  YR + RF+N VG G+ CR
Sbjct: 360 ETLEPLQDSSGGTSEVSSS-TKNLSVGSGG---PFAKAGMSDYRMQHRFANKVGAGAVCR 415

Query: 415 SPNPNCSPGGPAACRVR 431
           SPNPNCSPGGPAACRVR
Sbjct: 416 SPNPNCSPGGPAACRVR 432

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449439785|ref|XP_004137666.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Cucumis sativus]

 Score =  764 bits (1972), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 377/439 (85%), Positives = 387/439 (88%), Gaps = 21/439 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERK--------HNRSISDLSDPSTPRNL 52
           MGNCGTREESAVVS  QVQQLH  SSSL VK            HNRSISDLSDPSTPRNL
Sbjct: 1   MGNCGTREESAVVSNAQVQQLHT-SSSLAVKNANNNATDKRHIHNRSISDLSDPSTPRNL 59

Query: 53  EDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 112
           ED RKN+VLYTHVIAF+L+ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV
Sbjct: 60  EDFRKNSVLYTHVIAFTLYELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 119

Query: 113 AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL 172
           AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL
Sbjct: 120 AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL 179

Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
           FRK TVPL WA RMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA
Sbjct: 180 FRKTTVPLPWARRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 239

Query: 233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP 292
           KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKT+P
Sbjct: 240 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTKP 299

Query: 293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSD 352
           SKEQ+LVDWARPKLNDKRK+LQIIDPRLE+QYS+RAAQKACSLAYYCLSQNPKARPLMSD
Sbjct: 300 SKEQNLVDWARPKLNDKRKLLQIIDPRLESQYSIRAAQKACSLAYYCLSQNPKARPLMSD 359

Query: 353 VVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSS 412
           VVETLEPLQ  ND    I  S   N           F  GG+P YR R RF NNVG G+S
Sbjct: 360 VVETLEPLQSGNDA---IEYSSMGN---------TPFVRGGVPDYRMRQRFINNVGSGAS 407

Query: 413 CRSPNPNCSPGGPAACRVR 431
           CRSPNPNCSP GPAACRVR
Sbjct: 408 CRSPNPNCSPNGPAACRVR 426

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449497148|ref|XP_004160326.1| PREDICTED: LOW QUALITY PROTEIN: serine/threonine-protein kinase At5g01020-like [Cucumis sativus]

 Score =  761 bits (1965), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/439 (85%), Positives = 386/439 (87%), Gaps = 21/439 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERK--------HNRSISDLSDPSTPRNL 52
           MGNCGTREESAVVS  QVQQLH  SSSL VK            HNRSISDLSDPSTPRNL
Sbjct: 1   MGNCGTREESAVVSNAQVQQLHT-SSSLAVKNANNNATDKRHIHNRSISDLSDPSTPRNL 59

Query: 53  EDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 112
           ED RKN+VLYTHVIAF+L+ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV
Sbjct: 60  EDFRKNSVLYTHVIAFTLYELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 119

Query: 113 AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL 172
           AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL
Sbjct: 120 AVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL 179

Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
           FRK TVPL WA RMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA
Sbjct: 180 FRKTTVPLPWARRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 239

Query: 233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP 292
           KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKT+P
Sbjct: 240 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTKP 299

Query: 293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSD 352
           SKEQ+LVDWARPKLNDKRK+LQIIDPRLE+QYS+RAAQKACSLAYYCLSQNPKARPLMSD
Sbjct: 300 SKEQNLVDWARPKLNDKRKLLQIIDPRLESQYSIRAAQKACSLAYYCLSQNPKARPLMSD 359

Query: 353 VVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSS 412
           VVETLEPLQ  ND    I  S   N           F  G +P YR R RF NNVG G+S
Sbjct: 360 VVETLEPLQSGNDA---IEYSSMGN---------TPFVRGXVPDYRMRQRFINNVGSGAS 407

Query: 413 CRSPNPNCSPGGPAACRVR 431
           CRSPNPNCSP GPAACRVR
Sbjct: 408 CRSPNPNCSPNGPAACRVR 426

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|239056195|emb|CAQ58633.1| ATP binding / serine-threonine kinase [Vitis vinifera]

 Score =  743 bits (1917), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 366/432 (84%), Positives = 386/432 (89%), Gaps = 21/432 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDP-STPRNLEDSRKNA 59
           MGNCG+ E++ VVS  Q                 KH+RS+SDLSD  STPRNL+DS KN+
Sbjct: 1   MGNCGSTEDNPVVSHAQ----------------EKHSRSVSDLSDHHSTPRNLDDSGKNS 44

Query: 60  VLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK 119
           +LYTHVIAF+LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK
Sbjct: 45  LLYTHVIAFTLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK 104

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 179
           EG QGHREWLTEVNFLGQLRHPNLVKLIG+CCEDDHRLLVYEFMFRGSLENHLFRKATVP
Sbjct: 105 EGFQGHREWLTEVNFLGQLRHPNLVKLIGHCCEDDHRLLVYEFMFRGSLENHLFRKATVP 164

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSWATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD
Sbjct: 165 LSWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 224

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV
Sbjct: 225 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 284

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           DWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP
Sbjct: 285 DWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 344

Query: 360 LQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPN 419
           LQ ++ G +E+SSS T NL V +GG    FA  G+  YR + RF+N VG G+ CRSPNPN
Sbjct: 345 LQDSSGGTSEVSSS-TKNLSVGSGG---PFAKAGMSDYRMQHRFANKVGAGAVCRSPNPN 400

Query: 420 CSPGGPAACRVR 431
           CSPGGPAACRVR
Sbjct: 401 CSPGGPAACRVR 412

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|239056175|emb|CAQ58609.1| ATP binding / kinase/ protein kinase/ protein serine/threonine kinase/ protein-tyrosine kinase [Vitis vinifera]

 Score =  738 bits (1905), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/437 (84%), Positives = 389/437 (89%), Gaps = 21/437 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPE-----RKHNRSISDLSDP-STPRNLED 54
           MGNCG+ E++ VVS  QVQQLH+LSS L VK       +KH+RS+SDLSD  STPRNL+D
Sbjct: 1   MGNCGSTEDNPVVSHAQVQQLHILSS-LSVKDAAPNCGKKHSRSVSDLSDHHSTPRNLDD 59

Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 114
           S KN++LYTHVIAF+LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV
Sbjct: 60  SGKNSLLYTHVIAFTLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 119

Query: 115 KVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
           KVLNKEG QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR
Sbjct: 120 KVLNKEGFQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 179

Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           KATVPLSWATRMMIA GAAKGLAFLHNAERPVIYRD          DYTAKLSDFGLAKA
Sbjct: 180 KATVPLSWATRMMIALGAAKGLAFLHNAERPVIYRD----------DYTAKLSDFGLAKA 229

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
           GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK
Sbjct: 230 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 289

Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
           EQSLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV
Sbjct: 290 EQSLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 349

Query: 355 ETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCR 414
           ETLEPLQ ++ G +E+SSS T NL V +GG    FA  G+  YR + RF+N VG G+ CR
Sbjct: 350 ETLEPLQDSSGGTSEVSSS-TKNLSVGSGG---PFAKAGMSDYRMQHRFANKVGAGAVCR 405

Query: 415 SPNPNCSPGGPAACRVR 431
           SPNPNCSPGGPAACRVR
Sbjct: 406 SPNPNCSPGGPAACRVR 422

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356532117|ref|XP_003534620.1| PREDICTED: serine/threonine-protein kinase At5g01020-like [Glycine max]

 Score =  726 bits (1874), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/440 (82%), Positives = 384/440 (87%), Gaps = 17/440 (3%)

Query: 1   MGNCGTREESAVVSTVQV-QQLHMLSS-SLPVKPERKH------NRSISDLSDP-STPRN 51
           MGNCG+REESAVVS  QV QQLH  +S     + ++KH      +   SDLS+  STPR 
Sbjct: 1   MGNCGSREESAVVSKAQVVQQLHHATSLGASARTDKKHAHRHNLSECASDLSESCSTPRG 60

Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
             ++  N +LYTHVIAF+L+ELETITKSFR+DYILGEGGFGTVYKGYIDENVRVGLKSLP
Sbjct: 61  --NNSSNTLLYTHVIAFTLYELETITKSFRADYILGEGGFGTVYKGYIDENVRVGLKSLP 118

Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH 171
           VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH
Sbjct: 119 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH 178

Query: 172 LFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 231
           LFRKATVPLSWATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL
Sbjct: 179 LFRKATVPLSWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 238

Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR 291
           AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR
Sbjct: 239 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR 298

Query: 292 PSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 351
           P KEQSLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS
Sbjct: 299 PGKEQSLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 358

Query: 352 DVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGS 411
           DVVETLEPLQ ++ G  E+S      L  +  G+   FAM  I   R R +FSNNVGPG+
Sbjct: 359 DVVETLEPLQSSSVGPGEVS------LSGSNSGSAGPFAMNKISDCRMRHKFSNNVGPGA 412

Query: 412 SCRSPNPNCSPGGPAACRVR 431
           +CRSPNPNCSPGGPA  RVR
Sbjct: 413 TCRSPNPNCSPGGPATLRVR 432

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357506811|ref|XP_003623694.1| Protein kinase 2B [Medicago truncatula] gi|355498709|gb|AES79912.1| Protein kinase 2B [Medicago truncatula]

 Score =  719 bits (1856), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 364/443 (82%), Positives = 387/443 (87%), Gaps = 18/443 (4%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLS---SSLPVKPERKHNR-------SISDLSDP-STP 49
           MGNCGTREESAVVS  QVQ L   +   +SL    ERK++        S SDLS+  STP
Sbjct: 1   MGNCGTREESAVVSNAQVQHLPAGARNQTSLSGTGERKNSSLRHHLTDSASDLSETCSTP 60

Query: 50  RNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKS 109
           R    +  N +LYTHVIAF+L+ELETITKSFR+DYILGEGGFGTVYKGYIDENVRVGLKS
Sbjct: 61  RWNNANNNNTLLYTHVIAFTLYELETITKSFRADYILGEGGFGTVYKGYIDENVRVGLKS 120

Query: 110 LPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           LPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE
Sbjct: 121 LPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 180

Query: 170 NHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF 229
           NHLFRKATVPL+WATRMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF
Sbjct: 181 NHLFRKATVPLTWATRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF 240

Query: 230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK 289
           GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK
Sbjct: 241 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK 300

Query: 290 TRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL 349
           TRP KEQSLVDWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL
Sbjct: 301 TRPGKEQSLVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL 360

Query: 350 MSDVVETLEPLQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGP 409
           MSDVVETLEPLQ ++ G +E+S S + +       ++  FAM  I  YR R +FSNNVGP
Sbjct: 361 MSDVVETLEPLQSSSVGADEVSLSGSNSG------SSGPFAMNKISDYRMRHKFSNNVGP 414

Query: 410 GSSCRSPNPNCSPGG-PAACRVR 431
           G++CRSPNPNCSPGG PAA RVR
Sbjct: 415 GATCRSPNPNCSPGGAPAALRVR 437

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	431
TAIR|locus:2150019	410	AT5G01020 [Arabidopsis thalian	0.948	0.997	0.789	3.2e-175
TAIR|locus:2064712	462	RIPK "RPM1-induced protein kin	0.774	0.722	0.689	6.2e-117
TAIR|locus:2161093	408	AT5G56460 [Arabidopsis thalian	0.837	0.884	0.608	2.7e-116
TAIR|locus:2060167	442	AT2G07180 [Arabidopsis thalian	0.761	0.742	0.653	2.4e-115
TAIR|locus:2157101	494	AT5G35580 [Arabidopsis thalian	0.754	0.657	0.664	2.6e-111
TAIR|locus:2057770	424	ARSK1 "root-specific kinase 1"	0.749	0.761	0.637	2.3e-110
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.742	0.754	0.636	1e-109
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.883	0.777	0.559	3.9e-108
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.770	0.673	0.609	8.1e-108
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.751	0.715	0.624	1.4e-105

TAIR|locus:2150019 AT5G01020 [Arabidopsis thaliana (taxid:3702)]

 Score = 1702 (604.2 bits), Expect = 3.2e-175, P = 3.2e-175
 Identities = 341/432 (78%), Positives = 360/432 (83%)

Query:     1 MGNCGTREESAVVST-VQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNA 59
             MGNCGTR+E+AV +   Q QQL           ++KH+RS+SDLSDPSTPR  +DSR   
Sbjct:     1 MGNCGTRDEAAVFTPQAQAQQL-----------QKKHSRSVSDLSDPSTPRFRDDSR-TP 48

Query:    60 VLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK 119
             + Y  VI F+LFELETITKSFR DYILGEGGFGTVYKGYID+N+RVGLKSLPVAVKVLNK
Sbjct:    49 ISYAQVIPFTLFELETITKSFRPDYILGEGGFGTVYKGYIDDNLRVGLKSLPVAVKVLNK 108

Query:   120 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 179
             EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM RGSLENHLFRK T P
Sbjct:   109 EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMLRGSLENHLFRKTTAP 168

Query:   180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
             LSW+ RMMIA GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD
Sbjct:   169 LSWSRRMMIALGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 228

Query:   240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
             ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE+LTGRKSVDKTRPSKEQ+LV
Sbjct:   229 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQNLV 288

Query:   300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
             DWARPKLNDKRK+LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP
Sbjct:   289 DWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 348

Query:   360 LQCANDGGNEISSSLTANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVXXXXXXXXXXXX 419
             LQC  D       +L       AG A   FAMGG+P YR   RF+ NV            
Sbjct:   349 LQCTGD-------ALIPCATTTAGAA---FAMGGVPDYRMHRRFAKNVGPGAICRSPNPN 398

Query:   420 XXXXGPAACRVR 431
                 GPAACRVR
Sbjct:   399 YSPGGPAACRVR 410

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000394 "RNA splicing, via endonucleolytic cleavage and ligation" evidence=RCA

GO:0009086 "methionine biosynthetic process" evidence=RCA

GO:0032880 "regulation of protein localization" evidence=RCA

TAIR|locus:2064712 RIPK "RPM1-induced protein kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 1152 (410.6 bits), Expect = 6.2e-117, P = 6.2e-117
 Identities = 233/338 (68%), Positives = 266/338 (78%)

Query:    30 VKPERKHNR-SISDLSDPSTPRNLED-SRKNAVLYTHVIAFSLFELETITKSFRSDYILG 87
             +K +    R SI D+S+PS+    ED S   A    HV  F+L EL+ IT+SF S   LG
Sbjct:    37 IKKQSSFQRLSILDMSNPSSNTLSEDLSISLAGSDLHV--FTLAELKVITQSFSSTNFLG 94

Query:    88 EGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLI 147
             EGGFG V+KG+ID+ +R GLK+ PVAVK+L+ EGLQGHREWLTEV FLGQL+H NLVKLI
Sbjct:    95 EGGFGPVHKGFIDDKLRPGLKAQPVAVKLLDLEGLQGHREWLTEVMFLGQLKHKNLVKLI 154

Query:   148 GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVI 207
             GYCCE++HR LVYEFM RGSLEN LFR+ +  L W+TRM IA GAA GL FLH AE PVI
Sbjct:   155 GYCCEEEHRTLVYEFMPRGSLENQLFRRYSASLPWSTRMKIAHGAATGLQFLHEAENPVI 214

Query:   208 YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTAR 267
             YRDFK SNILLDSDYTAKLSDFGLAK GP+GD+THVSTRVMGT GYAAPEY+MTGHLTAR
Sbjct:   215 YRDFKASNILLDSDYTAKLSDFGLAKDGPEGDDTHVSTRVMGTQGYAAPEYIMTGHLTAR 274

Query:   268 SDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVR 327
             SDVYSFGVVLLELLTGR+SVDK R S+EQ+LVDWARP LND RK+ +I+DPRLE QYS  
Sbjct:   275 SDVYSFGVVLLELLTGRRSVDKKRSSREQNLVDWARPMLNDPRKLSRIMDPRLEGQYSET 334

Query:   328 AAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
              A+KA +LAY CLS  PK RP MS VV  L  L+  ND
Sbjct:   335 GARKAATLAYQCLSHRPKNRPCMSAVVSILNDLKDYND 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042742 "defense response to bacterium" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006499 "N-terminal protein myristoylation" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2161093 AT5G56460 [Arabidopsis thaliana (taxid:3702)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 224/368 (60%), Positives = 280/368 (76%)

Query:     1 MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAV 60
             MGNC  R E          +        P   E KH + +  L  PS P+ +ED R+++ 
Sbjct:     1 MGNCWCRFEPLNHRVSANAKSESPKEQSPTV-EDKHIKEVQKL--PSNPKEVEDLRRDSA 57

Query:    61 LYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENV--RVGLKSLPVAVKVLN 118
                 +IAF+  EL+ IT +FR D +LG GGFG+VYKG+I E++  +   + LPVAVKV +
Sbjct:    58 A-NPLIAFTYEELKNITSNFRQDRVLGGGGFGSVYKGFIKEDLGDQEVPEPLPVAVKVHD 116

Query:   119 KEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT 177
              +   QGHREWL EV FLGQL HPNLVKLIGYCCED+HR+L+YE+M RGS+EN+LF +  
Sbjct:   117 GDNSFQGHREWLAEVIFLGQLSHPNLVKLIGYCCEDNHRVLIYEYMARGSVENNLFSRVL 176

Query:   178 VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 237
             +PLSWA RM IAFGAAKGLAFLH A++PVIYRDFKTSNILLD DY AKLSDFGLAK GP 
Sbjct:   177 LPLSWAIRMKIAFGAAKGLAFLHEAKKPVIYRDFKTSNILLDMDYNAKLSDFGLAKDGPV 236

Query:   238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS 297
             GD++HVSTR+MGTYGYAAPEY+MTGHLT  SDVYSFGVVLLELLTGRKS+DK+RP++EQ+
Sbjct:   237 GDKSHVSTRIMGTYGYAAPEYIMTGHLTPGSDVYSFGVVLLELLTGRKSLDKSRPTREQN 296

Query:   298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             L+DWA P L +K+K+L I+DP++  +Y V+A QKA  LAY+CL++NPKARPLM D+V++L
Sbjct:   297 LIDWALPLLKEKKKVLNIVDPKMNCEYPVKAVQKAAMLAYHCLNRNPKARPLMRDIVDSL 356

Query:   358 EPLQCAND 365
             EPLQ   +
Sbjct:   357 EPLQATEE 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2060167 AT2G07180 [Arabidopsis thaliana (taxid:3702)]

 Score = 1137 (405.3 bits), Expect = 2.4e-115, P = 2.4e-115
 Identities = 215/329 (65%), Positives = 255/329 (77%)

Query:    46 PSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRV 105
             P  P+N++D + N   Y +V  F+  E++  TK FR DYILGEGGFG VYKG IDE+VRV
Sbjct:    57 PLAPKNIKDLQSNPG-YENVDIFTYEEMKIATKQFRPDYILGEGGFGVVYKGVIDESVRV 115

Query:   106 GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFR 165
             G KS  VA+K LN EG QG REWL EVN+LGQL HPNLVKLIGYCCEDDHRLLVYE+M  
Sbjct:   116 GFKSTKVAIKELNPEGFQGDREWLAEVNYLGQLSHPNLVKLIGYCCEDDHRLLVYEYMAM 175

Query:   166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
             GSLE HLFR+    L+W  RM IA  AAKGLAFLH AER +IYRD KT+NILLD  Y AK
Sbjct:   176 GSLEKHLFRRVGCTLTWTKRMKIALDAAKGLAFLHGAERSIIYRDLKTANILLDEGYNAK 235

Query:   226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK 285
             LSDFGLAK GP+GD+THVSTRVMGTYGYAAPEYVMTGHLT+RSDVY FGV+LLE+L G++
Sbjct:   236 LSDFGLAKDGPRGDQTHVSTRVMGTYGYAAPEYVMTGHLTSRSDVYGFGVLLLEMLLGKR 295

Query:   286 SVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 345
             ++DK+R  +E +LV+WARP LN  +K+L+IIDPR++ QY  +A  K   LAY CLSQNPK
Sbjct:   296 AMDKSRACREHNLVEWARPLLNHNKKLLRIIDPRMDGQYGTKALMKVAGLAYQCLSQNPK 355

Query:   346 ARPLMSDVVETLEPLQCANDGGNEISSSL 374
              RPLM+ VVE LE L+   D   E+ ++L
Sbjct:   356 GRPLMNHVVEVLETLKDDGDAQEEVMTNL 384

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2157101 AT5G35580 [Arabidopsis thaliana (taxid:3702)]

 Score = 1099 (391.9 bits), Expect = 2.6e-111, P = 2.6e-111
 Identities = 218/328 (66%), Positives = 262/328 (79%)

Query:    39 SISDLSDPSTPRNLED-SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKG 97
             SI D+S+PS+    ED S   A    HV  F+  EL  IT+SF S   LGEGGFG V+KG
Sbjct:    36 SILDISNPSSTTLSEDLSISLAGSDLHV--FTQAELRVITQSFSSSNFLGEGGFGPVHKG 93

Query:    98 YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL 157
             +ID+ +R GLK+ PVAVK+L+ +GLQGHRE++TEV  LG+L+HPNLVKLIGYCCE+ HRL
Sbjct:    94 FIDDKLRPGLKAQPVAVKLLDLDGLQGHREFMTEVMCLGKLKHPNLVKLIGYCCEEAHRL 153

Query:   158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
             LVYEFM RGSLE+ LFR+ ++PL W TR+ IA+ AAKGL FLH AE+P+IYRDFK SNIL
Sbjct:   154 LVYEFMPRGSLESQLFRRCSLPLPWTTRLNIAYEAAKGLQFLHEAEKPIIYRDFKASNIL 213

Query:   218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVL 277
             LDSDYTAKLSDFGLAK GPQGD+THVSTRVMGT GYAAPEY+MTGHLTA+SDVYSFGVVL
Sbjct:   214 LDSDYTAKLSDFGLAKDGPQGDDTHVSTRVMGTQGYAAPEYIMTGHLTAKSDVYSFGVVL 273

Query:   278 LELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAY 337
             LELLTGRKSVD  R S++++LV+WARP LND RK+ +I+DPRLE+QYS   A+KA +LAY
Sbjct:   274 LELLTGRKSVDIARSSRKETLVEWARPMLNDARKLGRIMDPRLEDQYSETGARKAATLAY 333

Query:   338 YCLSQNPKARPLMSDVVETLEPLQCAND 365
              CL   PK RP +S VV  L+ ++   D
Sbjct:   334 QCLRYRPKTRPDISTVVSVLQDIKDYKD 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2057770 ARSK1 "root-specific kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
 Identities = 206/323 (63%), Positives = 257/323 (79%)

Query:    39 SISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGY 98
             S+SD+SDPS+P ++ D   ++     +  F+L EL  IT +F    +LGEGGFG VYKG+
Sbjct:    47 SLSDISDPSSPMSVMDDLSHSFTSQKLRLFTLSELRVITHNFSRSNMLGEGGFGPVYKGF 106

Query:    99 IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL 158
             ID+ V+ G+++ PVAVK L+  G QGHREWL E+ FLGQL + +LVKLIG+CCE++ R+L
Sbjct:   107 IDDKVKPGIEAQPVAVKALDLHGHQGHREWLAEILFLGQLSNKHLVKLIGFCCEEEQRVL 166

Query:   159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL 218
             VYE+M RGSLEN LFR+ ++ ++W  RM IA GAAKGLAFLH AE+PVIYRDFKTSNILL
Sbjct:   167 VYEYMPRGSLENQLFRRNSLAMAWGIRMKIALGAAKGLAFLHEAEKPVIYRDFKTSNILL 226

Query:   219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 278
             DSDY AKLSDFGLAK GP+G+ THV+TRVMGT GYAAPEY+MTGHLT  +DVYSFGVVLL
Sbjct:   227 DSDYNAKLSDFGLAKDGPEGEHTHVTTRVMGTQGYAAPEYIMTGHLTTMNDVYSFGVVLL 286

Query:   279 ELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY 338
             EL+TG++S+D TR  +EQSLV+WARP L D+RK+ +IIDPRL NQ+   AAQ A SLAY 
Sbjct:   287 ELITGKRSMDNTRTRREQSLVEWARPMLRDQRKLERIIDPRLANQHKTEAAQVAASLAYK 346

Query:   339 CLSQNPKARPLMSDVVETLEPLQ 361
             CLSQ+PK RP M +VV+ LE +Q
Sbjct:   347 CLSQHPKYRPTMCEVVKVLESIQ 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0048765 "root hair cell differentiation" evidence=RCA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 1084 (386.6 bits), Expect = 1.0e-109, P = 1.0e-109
 Identities = 205/322 (63%), Positives = 257/322 (79%)

Query:    39 SISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGY 98
             S +DLS  S+ R  ED  +   L   ++ F + EL+ IT+SF  +Y+LGEGGFG VYKGY
Sbjct:    60 SFADLSRSSSARINEDLAQT--LGADLVDFQMCELKMITQSFSGNYLLGEGGFGKVYKGY 117

Query:    99 IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL 158
             +D+ +R  LK+ PVAVK+L+ EGLQGHREWL+EV FLGQL+HPNLVKLIGYCCE++ R+L
Sbjct:   118 VDDYLRQSLKAQPVAVKLLDIEGLQGHREWLSEVIFLGQLKHPNLVKLIGYCCEEEERVL 177

Query:   159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL 218
             +YEFM RGSLENHLFR+ ++ L WATR+ IA  AAKGLAFLH+ E P+IYRDFKTSNILL
Sbjct:   178 IYEFMPRGSLENHLFRRISLSLPWATRLKIAVAAAKGLAFLHDLESPIIYRDFKTSNILL 237

Query:   219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 278
             DSD+TAKLSDFGLAK GP+G ++HV+TRVMGTYGYAAPEYV TGHLT +SDVYS+GVVLL
Sbjct:   238 DSDFTAKLSDFGLAKMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLTTKSDVYSYGVVLL 297

Query:   279 ELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY 338
             ELLTGR++ +K+RP  +Q+++DW++P L   R++  ++DPRL  QYSV+AA+    LA  
Sbjct:   298 ELLTGRRATEKSRPKNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYSVKAAKDTALLALQ 357

Query:   339 CLSQNPKARPLMSDVVETLEPL 360
             C+S NPK RP M  VVE LE L
Sbjct:   358 CVSPNPKDRPKMLAVVEALESL 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 1069 (381.4 bits), Expect = 3.9e-108, P = 3.9e-108
 Identities = 221/395 (55%), Positives = 278/395 (70%)

Query:    14 STVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFEL 73
             STV  Q   + S+  PV P      + +  S  STP   E+      +Y+H+  FS  +L
Sbjct:    74 STVGSQSAIVQSNDQPVGPVSSTTTTSNAESSLSTPIISEELN----IYSHLKKFSFIDL 129

Query:    74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQGHREWLT 130
             +  T++FR + +LGEGGFG V+KG+++EN    +K    L VAVK LN +GLQGH+EWL 
Sbjct:   130 KLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLA 189

Query:   131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
             E+N+LG L HPNLVKL+GYC EDD RLLVYEFM RGSLENHLFR++ +PL W+ RM IA 
Sbjct:   190 EINYLGNLLHPNLVKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIAL 248

Query:   191 GAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
             GAAKGL+FLH  A +PVIYRDFKTSNILLD +Y AKLSDFGLAK  P   +THVSTRVMG
Sbjct:   249 GAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMG 308

Query:   250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
             TYGYAAPEYVMTGHLT++SDVYSFGVVLLE+LTGR+S+DK RP+ E +LV+WARP L DK
Sbjct:   309 TYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDK 368

Query:   310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND--GG 367
             R+  +++DPRLE  +SV+ AQK   LA  CLS++ K RP MS+VVE L+PL    D    
Sbjct:   369 RRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVLKPLPHLKDMASA 428

Query:   368 NEISSSLTANLVVAAGGATNAFAMG---GIPGYRT 399
             +    ++ A  + A  G+ +    G   G P +RT
Sbjct:   429 SYYFQTMQAERLKAGSGSGSGRGFGSRNGQPVFRT 463

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 1066 (380.3 bits), Expect = 8.1e-108, P = 8.1e-108
 Identities = 209/343 (60%), Positives = 260/343 (75%)

Query:    33 ERKHNRSISDLSDPSTPRNLEDSRKNAVLY------THVIAFSLFELETITKSFRSDYIL 86
             E+ +++ +  +S  +T  N E S    V+       +H+  F+  +L+  T++FR + +L
Sbjct:    89 EKSNDQPVGQVSSTTTTSNAESSSSTPVISEELNISSHLRKFTFNDLKLSTRNFRPESLL 148

Query:    87 GEGGFGTVYKGYIDENVRVGLK---SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
             GEGGFG V+KG+I+EN    +K    L VAVK LN +GLQGH+EWL E+NFLG L HPNL
Sbjct:   149 GEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNL 208

Query:   144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-A 202
             VKL+GYC EDD RLLVYEFM RGSLENHLFR++ +PL W+ RM IA GAAKGL+FLH  A
Sbjct:   209 VKLVGYCIEDDQRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLHEEA 267

Query:   203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
              +PVIYRDFKTSNILLD+DY AKLSDFGLAK  P   +THVSTRVMGTYGYAAPEYVMTG
Sbjct:   268 LKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYVMTG 327

Query:   263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
             HLT++SDVYSFGVVLLE+LTGR+S+DK RP+ E +LV+WARP L DKR+  +++DPRLE 
Sbjct:   328 HLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPRLEG 387

Query:   323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
              +S++ AQK   LA  CLS++PK RP MSDVVE L+PL    D
Sbjct:   388 HFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEALKPLPHLKD 430

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 1045 (372.9 bits), Expect = 1.4e-105, P = 1.4e-105
 Identities = 206/330 (62%), Positives = 253/330 (76%)

Query:    62 YTHVIAFSLF-ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK---SLPVAVKVL 117
             Y+  +   +F +L+  T++FR + +LGEGGFG V+KG+I+EN    +K    L VAVK L
Sbjct:    84 YSSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPGTGLTVAVKTL 143

Query:   118 NKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT 177
             N +GLQGH+EWL E+NFLG L HP+LVKL+GYC E+D RLLVYEFM RGSLENHLFR+ T
Sbjct:   144 NPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEEDQRLLVYEFMPRGSLENHLFRR-T 202

Query:   178 VPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
             +PL W+ RM IA GAAKGLAFLH  AE+PVIYRDFKTSNILLD +Y AKLSDFGLAK  P
Sbjct:   203 LPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAP 262

Query:   237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
                ++HVSTRVMGTYGYAAPEYVMTGHLT +SDVYSFGVVLLE+LTGR+SVDK+RP+ EQ
Sbjct:   263 DEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSRPNGEQ 322

Query:   297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
             +LV+W RP L DK++  +++DPRLE  YS++ AQKA  +A  CL+++ KARP MS+VVE 
Sbjct:   323 NLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMSEVVEA 382

Query:   357 LEPLQCANDGGNEISSSLTANLVVAAGGAT 386
             L+PL    D  +  SS  T   V   G  T
Sbjct:   383 LKPLPNLKDFASSSSSFQTMQPVAKNGVRT 412

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8GXZ3	Y5102_ARATH	2, ., 7, ., 1, 1, ., 1	0.8120	0.9512	1.0	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.994
3rd Layer	2.7.11	0.998

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	431
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-55
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-54
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-53
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-53
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-52
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-51
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	3e-50
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-38
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-36
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-35
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-32
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	8e-32
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-31
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-30
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	9e-30
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-29
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-29
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	9e-28
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-27
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-27
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-27
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-26
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	4e-26
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	7e-26
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-25
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-25
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	3e-25
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-25
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	5e-25
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-25
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-25
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-24
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-24
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-24
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-24
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-24
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	1e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	8e-23
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	9e-23
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-22
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-22
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-22
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-22
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-22
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	5e-22
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-22
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-22
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-22
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	9e-22
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-21
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-21
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-21
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-21
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	6e-21
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	7e-21
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-21
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-20
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	3e-20
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-20
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	5e-20
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-20
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	8e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-19
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-19
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-19
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-19
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-19
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-19
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-18
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-18
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-18
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	4e-18
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-18
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-18
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-18
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	8e-18
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-18
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-17
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-17
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-17
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-17
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	5e-17
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	7e-17
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	8e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	8e-17
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-16
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	2e-16
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-16
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-16
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-16
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-16
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-16
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	6e-16
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-16
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-16
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	8e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-16
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-15
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	2e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	2e-15
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-15
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	4e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	4e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-15
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	6e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-15
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-14
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-14
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-14
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	5e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-14
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	9e-14
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-13
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-13
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-13
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-13
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-13
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-13
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	7e-13
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	9e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-12
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-12
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-12
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-12
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-12
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-12
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-12
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-12
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-12
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-12
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-12
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	9e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-11
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-11
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	4e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	5e-11
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-11
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	6e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	6e-11
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-11
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-11
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	8e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	9e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-11
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	9e-11
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-10
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-10
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	5e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	5e-10
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	6e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-10
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-10
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	9e-10
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-09
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-09
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	6e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	6e-09
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	6e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	6e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	7e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	8e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-07
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-07
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-06
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-05
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-05
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	4e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-05
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	5e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	0.001
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.001
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	0.002
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	0.003
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	0.004

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  182 bits (465), Expect = 5e-55
 Identities = 90/277 (32%), Positives = 132/277 (47%), Gaps = 32/277 (11%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHP 141
            LG G FGTVYK         V       AVK+L K     +  +    E+  L +L HP
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIV-------AVKILKKRSEKSKKDQTARREIRILRRLSHP 58

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           N+V+LI    + DH  LV E+   G L ++L R    PLS      IA    +GL +LH 
Sbjct: 59  NIVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILRGLEYLH- 115

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               +I+RD K  NILLD +   K++DFGLAK   +     ++T V GT  Y APE ++ 
Sbjct: 116 -SNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFV-GTPWYMAPEVLLG 172

Query: 262 G-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
           G     + DV+S GV+L ELLTG+                     L+  + + +I+ P L
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK-------------PPFSGENILDQLQLIRRILGPPL 219

Query: 321 E--NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           E         +++A  L   CL+++P  RP   ++++
Sbjct: 220 EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  179 bits (457), Expect = 2e-54
 Identities = 82/275 (29%), Positives = 120/275 (43%), Gaps = 63/275 (22%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LGEGGFGTVY     +  +       VA+K++ KE      E  L E+  L +L HPN+V
Sbjct: 1   LGEGGFGTVYLARDKKTGK------KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIV 54

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL G   +++H  LV E+   GSL++ L       LS    + I     +GL +LH    
Sbjct: 55  KLYGVFEDENHLYLVMEYCEGGSLKDLLKEN-EGKLSEDEILRILLQILEGLEYLH--SN 111

Query: 205 PVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TG 262
            +I+RD K  NILLDSD    KL+DFGL+K             ++GT  Y APE ++  G
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSL--LKTIVGTPAYMAPEVLLGKG 169

Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
           + + +SD++S GV+L EL                                          
Sbjct: 170 YYSEKSDIWSLGVILYEL------------------------------------------ 187

Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
                   +   L    L ++P+ RP   +++E L
Sbjct: 188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  177 bits (451), Expect = 6e-53
 Identities = 85/279 (30%), Positives = 133/279 (47%), Gaps = 32/279 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
            LGEG FG VYKG +    +   K + VAVK L ++   Q   E+L E   + +L HPN+
Sbjct: 6   KLGEGAFGEVYKGTLKG--KGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL+G C E++  ++V E+M  G L ++L +     LS +  +  A   A+G+ +L    
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLE--S 121

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +  I+RD    N L+  +   K+SDFGL++     D   V         + APE +  G 
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGG-KLPIRWMAPESLKEGK 180

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            T++SDV+SFGV+L E+ T  +      P    S  +     L    ++     P+  N 
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEE-----PYPGMSNAE-VLEYLKKGYRL-----PKPPN- 228

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETL 357
                    C    Y     C +++P+ RP  S++VE L
Sbjct: 229 ---------CPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  176 bits (450), Expect = 9e-53
 Identities = 87/279 (31%), Positives = 133/279 (47%), Gaps = 33/279 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
            LGEG FG VYKG +      G K + VAVK L ++   Q   E+L E   + +L HPN+
Sbjct: 6   KLGEGAFGEVYKGKLKGKG--GKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL+G C E++   +V E+M  G L ++L RK    LS +  +  A   A+G+ +L    
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYL-RKNRPKLSLSDLLSFALQIARGMEYLE--S 120

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +  I+RD    N L+  +   K+SDFGL++     D             + APE +  G 
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGG-KLPIRWMAPESLKEGK 179

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            T++SDV+SFGV+L E+ T  +      P    S  +     L +  ++     P+  N 
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLEYLKNGYRL-----PQPPN- 227

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETL 357
                    C    Y     C +++P+ RP  S++VE L
Sbjct: 228 ---------CPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  175 bits (446), Expect = 4e-52
 Identities = 85/284 (29%), Positives = 130/284 (45%), Gaps = 44/284 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG VYKG +            VAVK L +    +   E+L E + + +L HPN+V
Sbjct: 7   LGEGAFGEVYKGTL--KGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L+G C + +   +V E+M  G L + L RK    L+    + +A   AKG+ +L    +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFL-RKHGEKLTLKDLLQMALQIAKGMEYLE--SK 121

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST------RVMGTYGYAAPEY 258
             ++RD    N L+  +   K+SDFGL++   + D            + M      APE 
Sbjct: 122 NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------APES 175

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
           +  G  T++SDV+SFGV+L E+ T  +      P    S  +     L D  ++     P
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQ-----PYPGMSNEE-VLELLEDGYRL-----P 224

Query: 319 RLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETL 357
           R EN          C    Y     C + +P+ RP  S++VE L
Sbjct: 225 RPEN----------CPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  172 bits (438), Expect = 4e-51
 Identities = 83/273 (30%), Positives = 126/273 (46%), Gaps = 44/273 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNL 143
            LGEG FG VY      + + G     VA+KV+ K+ ++  RE  L E+  L +L+HPN+
Sbjct: 6   KLGEGSFGKVYLAR---DKKTGKL---VAIKVIKKKKIKKDRERILREIKILKKLKHPNI 59

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM--IAFGAAKGLAFLHN 201
           V+L     ++D   LV E+   G L + L ++  +    A   +  I       L +LH 
Sbjct: 60  VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQIL----SALEYLH- 114

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             + +++RD K  NILLD D   KL+DFGLA+   Q D     T  +GT  Y APE ++ 
Sbjct: 115 -SKGIVHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLG 170

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII----- 316
                  D++S GV+L ELLTG+       P        +  P  +   ++ + I     
Sbjct: 171 KGYGKAVDIWSLGVILYELLTGK------PP--------F--PGDDQLLELFKKIGKPKP 214

Query: 317 -DPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
             P  E   S     +A  L    L ++P+ R 
Sbjct: 215 PFPPPEWDIS----PEAKDLIRKLLVKDPEKRL 243

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (433), Expect = 3e-50
 Identities = 89/294 (30%), Positives = 132/294 (44%), Gaps = 53/294 (18%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
            LGEG FG VYKG +        K+  VAVK L ++  +  R ++L E   + +L HPN+
Sbjct: 2   KLGEGAFGEVYKGKLKGK---DGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNV 58

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP--------LSWATRMMIAFGAAKG 195
           V+L+G C E++   LV E+M  G L ++L RK+           LS    +  A   AKG
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYL-RKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST------RVMG 249
           + +L    +  ++RD    N L+  D   K+SDFGL++     D     T      R M 
Sbjct: 118 MEYLA--SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWM- 174

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
                APE +  G  T++SDV+SFGV+L E+ T   +     P    S  +     L   
Sbjct: 175 -----APESLKDGIFTSKSDVWSFGVLLWEIFTLGAT-----PYPGLSNEE-VLEYLRKG 223

Query: 310 RKMLQIIDPRLENQYSVRAAQKACS-----LAYYCLSQNPKARPLMSDVVETLE 358
            ++ +   P              C      L   C   +P+ RP  S++VE LE
Sbjct: 224 YRLPK---PEY------------CPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  137 bits (347), Expect = 9e-38
 Identities = 67/203 (33%), Positives = 102/203 (50%), Gaps = 20/203 (9%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+GGFG VYK               VA+KV+  E  +   + + E+  L + +HPN+VK
Sbjct: 8   IGKGGFGEVYKARHKRT------GKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAF---GAAKGLAFLHN 201
             G   + D   +V EF   GSL++ L     T+  S      IA+      KGL +LH+
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-----IAYVCKELLKGLEYLHS 116

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               +I+RD K +NILL SD   KL DFGL+    Q  +T     ++GT  + APE +  
Sbjct: 117 NG--IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVING 171

Query: 262 GHLTARSDVYSFGVVLLELLTGR 284
                ++D++S G+  +EL  G+
Sbjct: 172 KPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  134 bits (339), Expect = 2e-36
 Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 14/208 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG FG V     D           VAVK LN  G + HR ++  E+  L  L H N+V
Sbjct: 12  LGEGHFGKVELCRYDPLG--DNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 145 KLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           K  G  CE        L+ E++  GSL ++L ++    ++    ++ +    KG+ +L +
Sbjct: 70  KYKG-VCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLKRLLLFSSQICKGMDYLGS 127

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST--RVMGTYGYAAPEYV 259
             +  I+RD    NIL++S+   K+SDFGLAK  P+  + +          + Y APE +
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY-APECL 184

Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKS 286
            T   ++ SDV+SFGV L EL T G  S
Sbjct: 185 RTSKFSSASDVWSFGVTLYELFTYGDPS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  131 bits (332), Expect = 2e-35
 Identities = 62/207 (29%), Positives = 101/207 (48%), Gaps = 20/207 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWL-TEVNFLGQLRHPN 142
           +LG G FG+VY     +   +      +AVK +      +   E L  E+  L  L+HPN
Sbjct: 7   LLGRGSFGSVYLALDKDTGEL------MAVKSVELSGDSEEELEALEREIRILSSLQHPN 60

Query: 143 LVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWA---TRMMIAFGAAKGLA 197
           +V+  G     E +   +  E++  GSL + L +   +P       TR ++     +GLA
Sbjct: 61  IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQIL-----EGLA 115

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +LH     +++RD K +NIL+DSD   KL+DFG AK     +    +  V GT  + APE
Sbjct: 116 YLH--SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTGR 284
            +        +D++S G  ++E+ TG+
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGK 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 1e-32
 Identities = 67/202 (33%), Positives = 108/202 (53%), Gaps = 21/202 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG V  G        G K   VAVK L K+     + +L E + +  LRHPNLV+
Sbjct: 14  IGKGEFGDVMLG-----DYRGQK---VAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQ 64

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G   + +   +V E+M +GSL ++L  +    ++ A ++  A    +G+ +L   E+ 
Sbjct: 65  LLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLE--EKN 122

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYVMTGH 263
            ++RD    N+L+  D  AK+SDFGLAK   QG ++       G     + APE +    
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDS-------GKLPVKWTAPEALREKK 175

Query: 264 LTARSDVYSFGVVLLELLT-GR 284
            + +SDV+SFG++L E+ + GR
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (312), Expect = 6e-32
 Identities = 89/292 (30%), Positives = 128/292 (43%), Gaps = 33/292 (11%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFL 135
           S+R    LGEG FG VY                VA+KVL K+     +E    L E+  L
Sbjct: 1   SYRILRKLGEGSFGEVYLAR---------DRKLVALKVLAKKLESKSKEVERFLREIQIL 51

Query: 136 GQLRHP-NLVKLIGYCCEDDHRLLVYEFMFRGSLE---NHLFRKATVPLSWATRMMIAFG 191
             L HP N+VKL  +  ++    LV E++  GSLE     + RK  +  S A  ++    
Sbjct: 52  ASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI- 110

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYT-AKLSDFGLAKAGPQGDET----HVSTR 246
               L +LH   + +I+RD K  NILLD D    KL DFGLAK  P    T     + + 
Sbjct: 111 -LSALEYLH--SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST 167

Query: 247 VMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
            +GT GY APE ++     + ++ SD++S G+ L ELLTG    +  + S   S      
Sbjct: 168 SVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQT-LKI 226

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                   +   + P      S  A+     L    L+++PK R   S  + 
Sbjct: 227 ILELPTPSLASPLSPSNPELISKAAS----DLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 8e-32
 Identities = 70/203 (34%), Positives = 108/203 (53%), Gaps = 16/203 (7%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           ++G G FG VYKG ++           VA+K ++ E +  +  +  + E++ L  L+HPN
Sbjct: 7   LIGRGAFGVVYKG-LNLE-----TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +VK IG     D   ++ E+   GSL   + +    P S     +  +   +GLA+LH  
Sbjct: 61  IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV--YQVLQGLAYLH-- 116

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV-MT 261
           E+ VI+RD K +NIL   D   KL+DFG+A      D +     V+GT  + APE + M+
Sbjct: 117 EQGVIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMS 174

Query: 262 GHLTARSDVYSFGVVLLELLTGR 284
           G  TA SD++S G  ++ELLTG 
Sbjct: 175 GASTA-SDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  120 bits (304), Expect = 1e-31
 Identities = 88/283 (31%), Positives = 128/283 (45%), Gaps = 41/283 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLV 144
           LG+G FG V +G   E    G K +PVAVK L  + L     ++L E   +  L H NL+
Sbjct: 3   LGDGSFGVVRRG---EWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI 59

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L G        ++V E    GSL + L + A      +T    A   A G+ +L    +
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE--SK 116

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST---RVMGTYGYAAPEYVMT 261
             I+RD    NILL SD   K+ DFGL +A PQ ++ +V     +V   + + APE + T
Sbjct: 117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV--PFAWCAPESLRT 174

Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +  SDV+ FGV L E+ T G +               WA   L+   ++L+ ID   
Sbjct: 175 RTFSHASDVWMFGVTLWEMFTYGEEP--------------WA--GLSG-SQILKKIDKEG 217

Query: 321 ENQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETL 357
           E     R  + +AC    Y     C + NP  RP  + + E L
Sbjct: 218 E-----RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  120 bits (303), Expect = 2e-31
 Identities = 75/206 (36%), Positives = 103/206 (50%), Gaps = 23/206 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG+G FG V        VR        A+KVL K+ +   +E    LTE N L ++ HP 
Sbjct: 1   LGKGSFGKVLL------VRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPF 54

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           +VKL  Y  + + +L LV E+   G L +HL ++       A      F AA+    L +
Sbjct: 55  IVKLH-YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA-----RFYAAEIVLALEY 108

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+    +IYRD K  NILLD+D   KL+DFGLAK          +T   GT  Y APE 
Sbjct: 109 LHS--LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR-TNTFC-GTPEYLAPEV 164

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           ++        D +S GV+L E+LTG+
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  116 bits (292), Expect = 7e-30
 Identities = 63/205 (30%), Positives = 104/205 (50%), Gaps = 11/205 (5%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           + F  +  LG G FG V++G       +    + VA+K+L  + L   +++  EV  L +
Sbjct: 6   EEFTLERKLGSGYFGEVWEG-------LWKNRVRVAIKILKSDDLLKQQDFQKEVQALKR 58

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRH +L+ L   C   +   ++ E M +GSL   L       L  A+ + +A   A+G+A
Sbjct: 59  LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +L   E+  I+RD    NIL+  D   K++DFGLA+   +        ++   Y + APE
Sbjct: 119 YLE--EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPE 174

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
               G  + +SDV+SFG++L E+ T
Sbjct: 175 AASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  116 bits (292), Expect = 9e-30
 Identities = 66/223 (29%), Positives = 115/223 (51%), Gaps = 20/223 (8%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPN 142
           +LG G FGTVYKG  I E  +V    +PVA+KVL +E   + ++E L E   +  + HP+
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKV---KIPVAIKVLREETSPKANKEILDEAYVMASVDHPH 70

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT-----VPLSWATRMMIAFGAAKGLA 197
           +V+L+G C       L+ + M  G L +++            L+W  ++      AKG++
Sbjct: 71  VVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMS 123

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +L   E+ +++RD    N+L+ +    K++DFGLAK     ++ + +        + A E
Sbjct: 124 YLE--EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV 299
            ++    T +SDV+S+GV + EL+T G K  +     +   L+
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  114 bits (288), Expect = 3e-29
 Identities = 73/287 (25%), Positives = 113/287 (39%), Gaps = 61/287 (21%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           +G+G FG VY       VR         +K ++   +      + L EV  L +L HPN+
Sbjct: 8   IGKGSFGKVYL------VRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLS------WATRMMIAFGAAKG 195
           +K      E     +V E+   G L   +   +K   P        W  ++ +A      
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA------ 115

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L +LH   R +++RD K  NI L S+   KL DFG++K           T V GT  Y +
Sbjct: 116 LKYLH--SRKILHRDIKPQNIFLTSNGLVKLGDFGISKV-LSSTVDLAKTVV-GTPYYLS 171

Query: 256 PE------YVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
           PE      Y        +SD++S G VL EL T +   +         L           
Sbjct: 172 PELCQNKPY------NYKSDIWSLGCVLYELCTLKHPFEGE---NLLEL----------- 211

Query: 310 RKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
              L+I+    P + +QYS         L    L ++P+ RP ++ +
Sbjct: 212 --ALKILKGQYPPIPSQYSSELRN----LVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  114 bits (287), Expect = 5e-29
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 12/206 (5%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G     V  G     VA+K +N+      R E+L E + + +    ++V
Sbjct: 14  LGQGSFGMVYEGLAK-GVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVV 72

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--------FRKATVPLSWATRMMIAFGAAKGL 196
           +L+G        L+V E M +G L+++L              P +    + +A   A G+
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGM 132

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L  A +  ++RD    N ++  D T K+ DFG+ +   + D      + +    + AP
Sbjct: 133 AYL--AAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E +  G  T +SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  112 bits (283), Expect = 1e-28
 Identities = 62/206 (30%), Positives = 107/206 (51%), Gaps = 21/206 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW--LTEVNFLGQLRHPN 142
           ++G G FG V +G +    +   K + VA+K L K G    +    LTE + +GQ  HPN
Sbjct: 11  VIGGGEFGEVCRGRLKLPGK---KEIDVAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPN 66

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L G   +    +++ E+M  GSL+  L R+     +    + +  G A G+ +L  +
Sbjct: 67  IIRLEGVVTKSRPVMIITEYMENGSLDKFL-RENDGKFTVGQLVGMLRGIASGMKYL--S 123

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG------YAAP 256
           E   ++RD    NIL++S+   K+SDFGL++     + T+       T G      + AP
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYT------TKGGKIPIRWTAP 177

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E +     T+ SDV+SFG+V+ E+++
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 69/209 (33%), Positives = 104/209 (49%), Gaps = 16/209 (7%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S + +  LG G FG V+ G  +        +  VAVK L K G      +L E   + +L
Sbjct: 7   SLKLERKLGAGQFGEVWMGTWN-------GTTKVAVKTL-KPGTMSPEAFLQEAQIMKKL 58

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           RH  LV+L   C E++   +V E+M +GSL + L       L     + +A   A+G+A+
Sbjct: 59  RHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAP 256
           L    R  I+RD    NIL+  +   K++DFGLA+   + DE       +      + AP
Sbjct: 119 LE--SRNYIHRDLAARNILVGENLVCKIADFGLARL-IEDDEYTAREGAKF--PIKWTAP 173

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GR 284
           E    G  T +SDV+SFG++L E++T GR
Sbjct: 174 EAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (278), Expect = 9e-28
 Identities = 87/283 (30%), Positives = 135/283 (47%), Gaps = 25/283 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LGEG FG V     D     G   + VAVK L +E  Q +   W  E+N L  L H N+V
Sbjct: 12  LGEGHFGKVSLYCYDPA-NDGTGEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 145 KLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           K  G CC +       L+ E++  GSL ++L +     L+ A  ++ A    +G+A+LH+
Sbjct: 70  KYKG-CCSEQGGKGLQLIMEYVPLGSLRDYLPKHK---LNLAQLLLFAQQICEGMAYLHS 125

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVM 260
             +  I+RD    N+LLD+D   K+ DFGLAKA P+G E + V         + A E + 
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
               +  SDV+SFGV L ELLT      ++ P K + ++   + ++     ++++I+  L
Sbjct: 184 ENKFSYASDVWSFGVTLYELLT-HCDSKQSPPKKFEEMIGPKQGQMT----VVRLIE-LL 237

Query: 321 ENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLE 358
           E    +   +  C    Y     C     K RP    ++  L+
Sbjct: 238 ERGMRLPCPKN-CPQEVYILMKNCWETEAKFRPTFRSLIPILK 279

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 2e-27
 Identities = 69/207 (33%), Positives = 113/207 (54%), Gaps = 26/207 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLV 144
           LG G FG+V KG     +    K + VAVK L +E +  G +E+L E + + QL HP +V
Sbjct: 3   LGHGNFGSVVKGVY---LMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIV 59

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLS----WATRMMIAFGAAKGLAFLH 200
           +LIG  C+ +  +LV E    G L  +L ++  +P+S     A ++      A G+A+L 
Sbjct: 60  RLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLE 112

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG-----YAA 255
              +  ++RD    N+LL + + AK+SDFG+++A   G + + +T    T G     + A
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT 282
           PE +  G  +++SDV+S+GV L E  +
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  114 bits (287), Expect = 3e-27
 Identities = 89/291 (30%), Positives = 139/291 (47%), Gaps = 27/291 (9%)

Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT 130
             +  I  S + + ++  G  G  YKG          KS+   ++ + KE    +    +
Sbjct: 683 ITINDILSSLKEENVISRGKKGASYKG----------KSIKNGMQFVVKEINDVNSIPSS 732

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E+  +G+L+HPN+VKLIG C  +    L++E++   +L   L       LSW  R  IA 
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAI 787

Query: 191 GAAKGLAFLHNAERP-VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           G AK L FLH    P V+  +     I++D      L    L+  G         T+   
Sbjct: 788 GIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR---LSLPGL----LCTDTKCFI 840

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
           +  Y APE   T  +T +SD+Y FG++L+ELLTG+   D        S+V+WAR   +D 
Sbjct: 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDC 899

Query: 310 RKMLQIIDPRLENQYSVRAAQ--KACSLAYYCLSQNPKARPLMSDVVETLE 358
             +   IDP +    SV   +  +  +LA +C + +P ARP  +DV++TLE
Sbjct: 900 H-LDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949

Length = 968

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  108 bits (273), Expect = 3e-27
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 41/272 (15%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG+G  G VYK  +        LK + V      ++ L      L E+  L     P +V
Sbjct: 9   LGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQL------LRELKTLRSCESPYVV 62

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP---LSWATRMMIAFGAAKGLAFLHN 201
           K  G   ++    +V E+M  GSL + L +   +P   L++  R ++     KGL +LH 
Sbjct: 63  KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQIL-----KGLDYLHT 117

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            +R +I+RD K SN+L++S    K++DFG++K      +   +T V GT  Y +PE +  
Sbjct: 118 -KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC-NTFV-GTVTYMSPERIQG 174

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII----D 317
              +  +D++S G+ LLE   G+       P        +         +++Q I     
Sbjct: 175 ESYSYAADIWSLGLTLLECALGK------FPFLPPGQPSFF--------ELMQAICDGPP 220

Query: 318 PRL-ENQYSVRAAQKACSLAYYCLSQNPKARP 348
           P L   ++S     +       CL ++PK RP
Sbjct: 221 PSLPAEEFS----PEFRDFISACLQKDPKKRP 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  108 bits (271), Expect = 4e-27
 Identities = 63/198 (31%), Positives = 98/198 (49%), Gaps = 9/198 (4%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG VYKG +  N  V +K+    +    K      R++L E   L Q  HPN+VK
Sbjct: 3   IGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLK------RKFLQEAEILKQYDHPNIVK 56

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           LIG C +     +V E +  GSL   L RK    L+    + ++  AA G+ +L +  + 
Sbjct: 57  LIGVCVQKQPIYIVMELVPGGSLLTFL-RKKKNRLTVKKLLQMSLDAAAGMEYLES--KN 113

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  +   K+SDFG+++    G  T           + APE +  G  T
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 266 ARSDVYSFGVVLLELLTG 283
           + SDV+S+G++L E  + 
Sbjct: 174 SESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 68/211 (32%), Positives = 95/211 (45%), Gaps = 18/211 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           LGEG FG V+ G          K L VAVK L KE       +++  E   L   +H N+
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKEL-VAVKTL-KETASNDARKDFEREAELLTNFQHENI 70

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL------------FRKATVPLSWATRMMIAFG 191
           VK  G C E D  ++V+E+M  G L   L                   L+ +  + IA  
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A G+ +L  A +  ++RD  T N L+  D   K+ DFG+++     D   V    M   
Sbjct: 131 IASGMVYL--ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE +M    T  SDV+SFGVVL E+ T
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 25/207 (12%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           +GEG +G VYK         V +K      K+  +   +G  +  L E+  L +L HPN+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIK------KIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLEN--HLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +KL+          LV+EFM      +   L +     L  +      +   +GLAF H+
Sbjct: 61  IKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHS 116

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETH-VSTRVMGTYGYAAPEY 258
               +++RD K  N+L++++   KL+DFGLA+    P    TH V TR      Y APE 
Sbjct: 117 HG--ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTR-----WYRAPEL 169

Query: 259 VMT-GHLTARSDVYSFGVVLLELLTGR 284
           ++     +   D++S G +  ELL+ R
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  106 bits (267), Expect = 4e-26
 Identities = 75/277 (27%), Positives = 120/277 (43%), Gaps = 55/277 (19%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-----NKEGLQGHREWLTEVNFLGQLRH 140
           +GEG  G VYK     +   G +   VA+K +     NKE +      + E+  +   +H
Sbjct: 27  IGEGASGEVYKAT---DRATGKE---VAIKKMRLRKQNKELI------INEILIMKDCKH 74

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA---KGLA 197
           PN+V         D   +V E+M  GSL + +  +  V +       IA+      +GL 
Sbjct: 75  PNIVDYYDSYLVGDELWVVMEYMDGGSLTD-IITQNFVRM---NEPQIAYVCREVLQGLE 130

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +LH+  + VI+RD K+ NILL  D + KL+DFG A    +      S  V+GT  + APE
Sbjct: 131 YLHS--QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGTPYWMAPE 186

Query: 258 YVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK--RKMLQ 314
            V+       + D++S G++ +E+  G        P           P L +   R +  
Sbjct: 187 -VIKRKDYGPKVDIWSLGIMCIEMAEG-------EP-----------PYLREPPLRALFL 227

Query: 315 IID---PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
           I     P L+N      + +       CL ++P+ RP
Sbjct: 228 ITTKGIPPLKNPEKW--SPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  105 bits (264), Expect = 5e-26
 Identities = 68/209 (32%), Positives = 103/209 (49%), Gaps = 13/209 (6%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNL 143
            LG G FG VY+G   + +  G   + VAVK L K    Q  +E+L E + +    HPN+
Sbjct: 2   FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNI 61

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVP---LSWATRMMIAFGAAKGLAF 198
           VKL+G C  ++ + ++ E M  G L ++L   R        L+    + I    AKG  +
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 199 LHNAERPVIYRDFKTSNILL-----DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           L       I+RD    N L+     D+D   K+ DFGLA+   + D        +    +
Sbjct: 122 LEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE ++ G  T +SDV+SFGV++ E+LT
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  105 bits (263), Expect = 7e-26
 Identities = 64/201 (31%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++G  +          PVAVK L K G    +++L E   + +LRHP L++
Sbjct: 14  LGAGQFGEVWEGLWNNTT-------PVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQ 65

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L   C  ++   +V E M  GSL  +L   A   L     + +A   A G+A+L    + 
Sbjct: 66  LYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE--AQN 123

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD-ETHVSTRVMGTYGYAAPEYVMTGHL 264
            I+RD    N+L+  +   K++DFGLA+   +   E     +      + APE  +    
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF--PIKWTAPEAALYNRF 181

Query: 265 TARSDVYSFGVVLLELLT-GR 284
           + +SDV+SFG++L E++T GR
Sbjct: 182 SIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  104 bits (262), Expect = 2e-25
 Identities = 62/210 (29%), Positives = 101/210 (48%), Gaps = 18/210 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG VYKG +       L +  VA+K L +    +  +E+  E   +  L+HPN+V
Sbjct: 13  LGEGAFGKVYKGEL-TGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--------------PLSWATRMMIAF 190
            L+G C ++    +++E++  G L   L R +                 L  +  + IA 
Sbjct: 72  CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             A G+ +L  +    ++RD    N L+    T K+SDFGL++     D   V ++ +  
Sbjct: 132 QIAAGMEYL--SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLEL 280
             +  PE ++ G  T  SD++SFGVVL E+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (258), Expect = 3e-25
 Identities = 77/272 (28%), Positives = 133/272 (48%), Gaps = 28/272 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY  E  +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTI--------REGAMSEEDFIEEAQVMMKLSHPKLVQ 63

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      S  T + +     +G+A+L ++   
Sbjct: 64  LYGVCTERSPICLVFEFMEHGCLSDYL-RAQRGKFSQETLLGMCLDVCEGMAYLESSN-- 120

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +++PE       +
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRF-VLDDQYTSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K+  + R + E  +V+     +N   ++ +   PRL     
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYENRSNSE--VVE----TINAGFRLYK---PRL----- 225

Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+Q    L  +C  + P+ RP  S ++  L
Sbjct: 226 --ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (261), Expect = 3e-25
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 31/211 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRH 140
            LGEG +G VYK   D+          VA+K +     +EG+      L E++ L +L+H
Sbjct: 6   KLGEGTYGVVYKA-RDKK-----TGEIVALKKIRLDNEEEGIP--STALREISLLKELKH 57

Query: 141 PNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           PN+VKL+     +    LV+E+     +  L+         PLS      I +   +GLA
Sbjct: 58  PNIVKLLDVIHTERKLYLVFEYCDMDLKKYLDKR-----PGPLSPNLIKSIMYQLLRGLA 112

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDE-THVSTRVMGTYGYAA 255
           + H     +++RD K  NIL++ D   KL+DFGLA+A G      TH    V+ T  Y A
Sbjct: 113 YCH--SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH---EVV-TLWYRA 166

Query: 256 PEYVM--TGHLTARSDVYSFGVVLLELLTGR 284
           PE ++    + TA  D++S G +  E++TG+
Sbjct: 167 PEILLGSKHYSTA-VDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  103 bits (258), Expect = 3e-25
 Identities = 65/200 (32%), Positives = 106/200 (53%), Gaps = 13/200 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+HP LV+
Sbjct: 14  LGAGQFGEVWMGYYNGHTKVAIKSL--------KQGSMSPEAFLAEANLMKQLQHPRLVR 65

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++    ++ E+M  GSL + L     + L+    + +A   A+G+AF+    + 
Sbjct: 66  LYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE--RKN 122

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+      K++DFGLA+   + +E            + APE +  G  T
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 181

Query: 266 ARSDVYSFGVVLLELLT-GR 284
            +SDV+SFG++L E++T GR
Sbjct: 182 IKSDVWSFGILLTEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  103 bits (260), Expect = 5e-25
 Identities = 68/213 (31%), Positives = 102/213 (47%), Gaps = 34/213 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN----KEGLQG-HREWLTEVNFLGQLRH 140
           LGEG +  VYK    E  R+      VA+K +     KE   G +   L E+  L +L+H
Sbjct: 8   LGEGTYAVVYKARDKETGRI------VAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA-----TRMMIAFGAAKG 195
           PN++ L+       +  LV+EFM    LE  + +  ++ L+ A       M +     +G
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFM-ETDLE-KVIKDKSIVLTPADIKSYMLMTL-----RG 114

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETH-VSTRVMGTYG 252
           L +LH+    +++RD K +N+L+ SD   KL+DFGLA+    P    TH V TR      
Sbjct: 115 LEYLHS--NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW----- 167

Query: 253 YAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           Y APE +    H     D++S G +  ELL   
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  103 bits (258), Expect = 6e-25
 Identities = 61/226 (26%), Positives = 97/226 (42%), Gaps = 40/226 (17%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQL-RH 140
           I+GEG F TV      E       +   A+K+L+K  L   +       E   L +L  H
Sbjct: 8   IIGEGSFSTVVLAKEKET------NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA---KGL 196
           P ++KL  Y  +D+  L  V E+   G L  ++ +  ++           F AA     L
Sbjct: 62  PGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR-----FYAAEILLAL 115

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---------AGPQGDETHVSTR- 246
            +LH+  + +I+RD K  NILLD D   K++DFG AK         +         S   
Sbjct: 116 EYLHS--KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 247 --------VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
                    +GT  Y +PE +        SD+++ G ++ ++LTG+
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  102 bits (255), Expect = 8e-25
 Identities = 67/205 (32%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNK-EGLQGHREWLTEVNFLGQLRHPN 142
           ++G+G FG VY G  ID +     + +  AVK LN+   L+   ++L E   +    HPN
Sbjct: 2   VIGKGHFGCVYHGTLIDSDG----QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPN 57

Query: 143 LVKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFL 199
           ++ L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP---TVKDLIGFGLQVAKGMEYL 114

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAPE 257
             A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E
Sbjct: 115 --ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALE 172

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
            + T   T +SDV+SFGV+L EL+T
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  102 bits (257), Expect = 1e-24
 Identities = 70/219 (31%), Positives = 106/219 (48%), Gaps = 26/219 (11%)

Query: 86  LGEGGFGTVY-------KGYID----ENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVN 133
           LGEG FG V+       + + +    EN       L VAVKVL  +     R ++L EV 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVL-VAVKVLRPDASDNAREDFLKEVK 71

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV----------PLSWA 183
            L +L  PN+ +L+G C  D    ++ E+M  G L N   +K              LS++
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHVAETSGLACNSKSLSFS 130

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
           T + +A   A G+ +L       ++RD  T N L+  +YT K++DFG+++     D   V
Sbjct: 131 TLLYMATQIASGMRYL--ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             R      + A E V+ G  T +SDV++FGV L E+LT
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  101 bits (254), Expect = 2e-24
 Identities = 82/306 (26%), Positives = 130/306 (42%), Gaps = 52/306 (16%)

Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLP----VAVKVLNKEGLQGH-REWLTEVNFLGQ 137
              LGEG FG V K          LK       VAVK+L +       R+ L+E N L Q
Sbjct: 5   GKTLGEGEFGKVVKATAFR-----LKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQ 59

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL----------------------FRK 175
           + HP+++KL G C +D   LL+ E+   GSL + L                         
Sbjct: 60  VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119

Query: 176 ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG 235
               L+    +  A+  ++G+ +L  AE  +++RD    N+L+      K+SDFGL++  
Sbjct: 120 DERALTMGDLISFAWQISRGMQYL--AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDV 177

Query: 236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSK 294
            + D     ++      + A E +     T +SDV+SFGV+L E++T G        P +
Sbjct: 178 YEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
             +L       L    +M      R EN      +++  +L   C  Q P  RP  +D+ 
Sbjct: 238 LFNL-------LKTGYRM-----ERPEN-----CSEEMYNLMLTCWKQEPDKRPTFADIS 280

Query: 355 ETLEPL 360
           + LE +
Sbjct: 281 KELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  100 bits (252), Expect = 3e-24
 Identities = 86/284 (30%), Positives = 119/284 (41%), Gaps = 45/284 (15%)

Query: 82  SDYIL----GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLG 136
            DY L    G G    VY      N         VA+K ++ E  Q    E   EV  + 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEK------VAIKRIDLEKCQTSVDELRKEVQAMS 54

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF---GAA 193
           Q  HPN+VK        D   LV  ++  GSL      K++ P       +IA       
Sbjct: 55  QCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL--LDIMKSSYPRGGLDEAIIATVLKEVL 112

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ-GDETH-VSTRVMGTY 251
           KGL +LH+  +  I+RD K  NILL  D + K++DFG++ +    GD T  V    +GT 
Sbjct: 113 KGLEYLHSNGQ--IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTP 170

Query: 252 GYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
            + APE VM        ++D++SFG+  +EL TG     K  P K   L+          
Sbjct: 171 CWMAPE-VMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLM---------- 217

Query: 310 RKMLQIIDPRLENQYSVRAAQKACSLAY-----YCLSQNPKARP 348
              LQ   P LE      A  K  S ++      CL ++P  RP
Sbjct: 218 -LTLQNDPPSLETG----ADYKKYSKSFRKMISLCLQKDPSKRP 256

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  100 bits (251), Expect = 4e-24
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 15/208 (7%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLG 136
           + F     LGEG +G+VYK    E  +V      VA+KV+  +E LQ   E + E++ L 
Sbjct: 3   EVFDILEKLGEGSYGSVYKAIHKETGQV------VAIKVVPVEEDLQ---EIIKEISILK 53

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           Q   P +VK  G   ++    +V E+   GS+ + + +     L+      I +   KGL
Sbjct: 54  QCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSV-SDIMKITNKTLTEEEIAAILYQTLKGL 112

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +LH+     I+RD K  NILL+ +  AKL+DFG+  +G   D       V+GT  + AP
Sbjct: 113 EYLHS--NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAP 168

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGR 284
           E +       ++D++S G+  +E+  G+
Sbjct: 169 EVIQEIGYNNKADIWSLGITAIEMAEGK 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  100 bits (250), Expect = 4e-24
 Identities = 67/271 (24%), Positives = 117/271 (43%), Gaps = 29/271 (10%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQ 137
           F     +G+G FG V+K     + RV       A+K ++   +      E + E   L +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRV------YAMKQIDLSKMNRREREEAIDEARVLAK 55

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           L    +++      +     +V E+   G L   L  +   PL              GLA
Sbjct: 56  LDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA 115

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
            LH+  + +++RD K+ N+ LD+    K+ D G+AK     D T+ +  ++GT  Y +PE
Sbjct: 116 HLHS--KKILHRDIKSLNLFLDAYDNVKIGDLGVAKL--LSDNTNFANTIVGTPYYLSPE 171

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
                    +SDV++ GVVL E  TG+   D    + + +L+           K+++ + 
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDA---NNQGALI----------LKIIRGVF 218

Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
           P +   YS    Q+   L   CL+++ + RP
Sbjct: 219 PPVSQMYS----QQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 99.8 bits (249), Expect = 6e-24
 Identities = 62/209 (29%), Positives = 107/209 (51%), Gaps = 27/209 (12%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG+VY+G  +D+     +K + +A     + G +  ++   E+  L +L+HPN+V
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADD--GQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP---LSWATRMMIAFGAAKGLAFLHN 201
           + +G   E+D+  +  E +  GSL   L +  + P   +   TR ++      GL +LH+
Sbjct: 66  QYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQIL-----LGLEYLHD 120

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-----GTYGYAAP 256
             R  ++RD K +NIL+D++   KL+DFG+AK         V          G+  + AP
Sbjct: 121 --RNTVHRDIKGANILVDTNGVVKLADFGMAK--------QVVEFSFAKSFKGSPYWMAP 170

Query: 257 EYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           E +   G     +D++S G  +LE+ TG+
Sbjct: 171 EVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score =  100 bits (249), Expect = 1e-23
 Identities = 81/297 (27%), Positives = 139/297 (46%), Gaps = 40/297 (13%)

Query: 86  LGEGGFGTVYKGYIDE-----------NVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVN 133
           LGEG FG V+   +             NVR G + L VAVK+L  +  +  R ++L EV 
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKG-RPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE-----NHLFRKAT----------- 177
            L +L+ PN+++L+G C ++D   ++ E+M  G L      +HL  K             
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 178 -VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
              +S+++ + +A   A G+ +L  +    ++RD  T N L+  + T K++DFG+++   
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL--SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
            GD   +  R +    + A E ++ G  T  SDV++FGV L E+L   K       + EQ
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQ 249

Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
            +++ A     D+ + + +  P           Q    L   C S++ + RP  SD+
Sbjct: 250 -VIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 99.5 bits (248), Expect = 1e-23
 Identities = 65/214 (30%), Positives = 105/214 (49%), Gaps = 25/214 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ILGEG FG+V +G + ++    LK   VAVK +  +    + E   +L+E   +    HP
Sbjct: 6   ILGEGEFGSVMEGQLSQDDGSQLK---VAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHP 61

Query: 142 NLVKLIGYCCEDDHR------LLVYEFMFRGSLENHLF--RKATVPLSWATRMMIAFGA- 192
           N++KLIG C E          +++  FM  G L + L   R   +P     + ++ F   
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121

Query: 193 -AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD---ETHVSTRVM 248
            A G+ +L N  R  I+RD    N +L  D T  ++DFGL+K    GD   +  ++   +
Sbjct: 122 IALGMEYLSN--RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 179

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
               + A E +     T++SDV++FGV + E+ T
Sbjct: 180 ---KWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.9 bits (244), Expect = 2e-23
 Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 28/272 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ G            + VA+K++ +EG     +++ E   + +L HPNLV+
Sbjct: 12  LGSGQFGVVHLGK-------WRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQ 63

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C +     +V E+M  G L N+L  +    L     + +     + + +L      
Sbjct: 64  LYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK-LGTEWLLDMCSDVCEAMEYLE--SNG 120

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  D   K+SDFGLA+     D+   S        +A PE       +
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARY-VLDDQYTSSQGTKFPVKWAPPEVFDYSRFS 179

Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   +   + E          +       ++  P+L     
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKMPYERFSNSEV---------VESVSAGYRLYRPKL----- 225

Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A  +  ++ Y C  + P+ RP    ++  L
Sbjct: 226 --APTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 96.6 bits (241), Expect = 8e-23
 Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 38/222 (17%)

Query: 81  RSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVNFLGQ 137
           R + I G G FG VY    +D    +      +AVK +       +  +E   E+  L  
Sbjct: 4   RGNKI-GGGTFGKVYTAVNLDTG-EL------MAVKEIRIQDNDPKTIKEIADEMKVLEL 55

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA--KG 195
           L+HPNLVK  G     +   +  E+   G+LE  L     +       ++  +     +G
Sbjct: 56  LKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDE----HVIRVYTLQLLEG 111

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--------AGPQGDETHVSTRV 247
           LA+LH     +++RD K +NI LD +   KL DFG A          G +          
Sbjct: 112 LAYLH--SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSL------ 163

Query: 248 MGTYGYAAPEYV----MTGHLTARSDVYSFGVVLLELLTGRK 285
            GT  Y APE +      GH  A +D++S G V+LE+ TG++
Sbjct: 164 AGTPAYMAPEVITGGKGKGHGRA-ADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 96.6 bits (241), Expect = 9e-23
 Identities = 61/209 (29%), Positives = 88/209 (42%), Gaps = 16/209 (7%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---GLQGHREWLTEVNFLG 136
           F    ++G+G FG V        V+        A+K +NK+        R  L E   L 
Sbjct: 2   FELLRVIGKGAFGKVCI------VQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ 55

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           +L HP LV L     ++++  LV + +  G L  HL +K  V  S              L
Sbjct: 56  ELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLAL 113

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +LH   + +I+RD K  NILLD      ++DF +A        T   T   GT GY AP
Sbjct: 114 EYLH--SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT---TSTSGTPGYMAP 168

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRK 285
           E +     +   D +S GV   E L G++
Sbjct: 169 EVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 64/213 (30%), Positives = 110/213 (51%), Gaps = 19/213 (8%)

Query: 77  TKSFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNF 134
               R   +LG G FGTV+KG +I E   +    +PVA+K + ++ G Q  +E    +  
Sbjct: 6   ETELRKLKLLGSGVFGTVHKGIWIPEGDSI---KIPVAIKTIQDRSGRQTFQEITDHMLA 62

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVP---LSWATRMMIA 189
           +G L H  +V+L+G C     +L V +    GSL +H+   R +  P   L+W  ++   
Sbjct: 63  MGSLDHAYIVRLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI--- 118

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              AKG+ +L   E  +++R+    NILL SD   +++DFG+A      D+ +  +    
Sbjct: 119 ---AKGMYYLE--EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              + A E ++ G  T +SDV+S+GV + E+++
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 96.6 bits (240), Expect = 1e-22
 Identities = 67/211 (31%), Positives = 110/211 (52%), Gaps = 15/211 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G FG V KG      ++  K + VA+KVL  E  +  R E + E   + QL +P +V
Sbjct: 3   LGSGNFGCVKKGVY----KMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIV 58

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           ++IG  CE +  +LV E    G L   L  +K  + +S    +M     + G+ +L    
Sbjct: 59  RMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELM--HQVSMGMKYLE--G 113

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYVMT 261
           +  ++RD    N+LL + + AK+SDFGL+KA    D+++   R  G +   + APE +  
Sbjct: 114 KNFVHRDLAARNVLLVNQHYAKISDFGLSKA-LGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTR 291
              ++RSDV+S+G+ + E  + G+K   K +
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMK 203

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 96.2 bits (239), Expect = 1e-22
 Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 23/208 (11%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           I+GEG FG V +G Y  +  +V +K++   V           + +L E   + +L H NL
Sbjct: 13  IIGEGEFGAVLQGEYTGQ--KVAVKNIKCDVTA---------QAFLEETAVMTKLHHKNL 61

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L+G    +    +V E M +G+L N L  +    +S    +  +   A+G+ +L +  
Sbjct: 62  VRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES-- 118

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG-DETHVSTRVMGTYGYAAPEYVMTG 262
           + +++RD    NIL+  D  AK+SDFGLA+ G  G D + +  +      + APE +   
Sbjct: 119 KKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK------WTAPEALKHK 172

Query: 263 HLTARSDVYSFGVVLLELLT-GRKSVDK 289
             +++SDV+S+GV+L E+ + GR    K
Sbjct: 173 KFSSKSDVWSYGVLLWEVFSYGRAPYPK 200

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.2 bits (240), Expect = 1e-22
 Identities = 75/279 (26%), Positives = 116/279 (41%), Gaps = 54/279 (19%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN---KEGLQGHREWLTEVNFLGQLRHPN 142
           LG G  G V K      V        +AVK +     E +Q  ++ L E++ L +   P 
Sbjct: 9   LGAGNSGVVSK------VLHRPTGKIMAVKTIRLEINEAIQ--KQILRELDILHKCNSPY 60

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHN 201
           +V   G    +    +  E+M  GSL+  L   +  +P     +  IA    KGL +LH 
Sbjct: 61  IVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGK--IAVAVLKGLTYLHE 118

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM--------GTYGY 253
            +  +I+RD K SNIL++S    KL DFG            VS +++        GT  Y
Sbjct: 119 -KHKIIHRDVKPSNILVNSRGQIKLCDFG------------VSGQLVNSLAKTFVGTSSY 165

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
            APE +     + +SD++S G+ L+EL TGR                   P       + 
Sbjct: 166 MAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPP-----------ENDPPDGIFELLQ 214

Query: 314 QIID---PRLEN-QYSVRAAQKACSLAYYCLSQNPKARP 348
            I++   PRL + ++S             CL ++P+ RP
Sbjct: 215 YIVNEPPPRLPSGKFS----PDFQDFVNLCLIKDPRERP 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 96.9 bits (241), Expect = 1e-22
 Identities = 80/297 (26%), Positives = 145/297 (48%), Gaps = 40/297 (13%)

Query: 86  LGEGGFGTVY-------KGYIDENVRVGLKS---LPVAVKVLNKEGLQGHR-EWLTEVNF 134
           LGEG FG V+       + ++D++  + +     + VAVK+L ++  +  R ++L E+  
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKI 72

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVP-LSWATR 185
           + +L+ PN+++L+  C   D   ++ E+M  G L   L R        KA V  +S++T 
Sbjct: 73  MSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTL 132

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
           + +A   A G+ +L +     ++RD  T N L+  +YT K++DFG+++    GD   +  
Sbjct: 133 IFMATQIASGMKYLSSLN--FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQG 190

Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK 305
           R +    + + E ++ G  T  SDV++FGV L E+LT  K    ++ S EQ +++     
Sbjct: 191 RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-VIENTGEF 249

Query: 306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETL 357
             D+ + + +  P L            C  + Y     C  +N K RP   ++  TL
Sbjct: 250 FRDQGRQVYLPKPAL------------CPDSLYKLMLSCWRRNAKERPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 96.8 bits (242), Expect = 1e-22
 Identities = 71/209 (33%), Positives = 101/209 (48%), Gaps = 34/209 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHPN 142
           LG G FG V        VR        A+K+L+K  +   ++    L E   L  +RHP 
Sbjct: 9   LGTGSFGRVML------VRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           LV L G   +DD  L LV E++  G L +HL +    P   A      F AA+    L +
Sbjct: 63  LVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVAR-----FYAAQVVLALEY 116

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  ++YRD K  N+LLDSD   K++DFG AK         V  R     GT  Y A
Sbjct: 117 LHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYTLCGTPEYLA 166

Query: 256 PEYVM-TGHLTARSDVYSFGVVLLELLTG 283
           PE ++  G+  A  D ++ G+++ E+L G
Sbjct: 167 PEIILSKGYGKA-VDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 71/230 (30%), Positives = 117/230 (50%), Gaps = 21/230 (9%)

Query: 86  LGEGGFGTVYKGYID---ENVRVGL-----KSLPVAVKVLNKEGLQGHR-EWLTEVNFLG 136
           LGEG FG V+    +   E +  G      + + VAVK+L  +  +  R ++L E+  + 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------FRKAT-VP-LSWATRM 186
           +L++PN+++L+G C  DD   ++ E+M  G L   L        F  A  +P +S A  +
Sbjct: 73  RLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLL 132

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            +A   A G+ +L  A    ++RD  T N L+ + YT K++DFG+++    GD   +  R
Sbjct: 133 YMAVQIASGMKYL--ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
            +    + A E ++ G  T  SDV++FGV L E+ T  K    +  S EQ
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 95.8 bits (238), Expect = 2e-22
 Identities = 76/281 (27%), Positives = 137/281 (48%), Gaps = 30/281 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           ++G G FG V++G +      G K + VA+K L     +  R ++L+E + +GQ  H N+
Sbjct: 12  VIGAGEFGEVFRGILKMP---GRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNI 68

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           ++L G   +    +++ E+M  G+L+ +L R      S    + +  G A G+ +L  ++
Sbjct: 69  IRLEGVVTKFKPAMIITEYMENGALDKYL-RDHDGEFSSYQLVGMLRGIAAGMKYL--SD 125

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVMGTYGYAAPEYVM 260
              ++RD    NIL++S+   K+SDFGL++     P+G  T    ++     + APE + 
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI--PIRWTAPEAIA 183

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID-PR 319
               T+ SDV+SFG+V+ E+++  +     RP  + S  +  +  +ND  ++   +D P 
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGE-----RPYWDMSNHEVMK-AINDGFRLPAPMDCPS 237

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
              Q           L   C  Q+   RP   D+V  L+ L
Sbjct: 238 AVYQ-----------LMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 95.2 bits (237), Expect = 4e-22
 Identities = 80/302 (26%), Positives = 123/302 (40%), Gaps = 38/302 (12%)

Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK---EGLQ 123
           AF    L+ IT        LG G FG V+          G     V VK L K   E LQ
Sbjct: 1   AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEG-GETLVLVKALQKTKDENLQ 52

Query: 124 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF-------RKA 176
              E+  E++   +L H N+V+L+G C E +   ++ E+   G L+  L        +  
Sbjct: 53  --SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLK 110

Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
             PLS   ++ +    A G+  L NA    ++RD    N L+ S    K+S   L+K   
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLLSLSKD-V 167

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
              E +     +    + APE V     + +SDV+SFGV++ E+ T            E 
Sbjct: 168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT----------QGEL 217

Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
                    L+D+  + ++   +LE         +   L   C + NPK RP  S++V  
Sbjct: 218 PF-----YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272

Query: 357 LE 358
           L 
Sbjct: 273 LG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 62/205 (30%), Positives = 98/205 (47%), Gaps = 21/205 (10%)

Query: 89  GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPNLVK 145
           G +G V+        +        A+KV+ K  +       + LTE + L Q + P +VK
Sbjct: 4   GAYGRVFL------AKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 146 LIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           L  Y  +    L LV E++  G L + L    ++    A R+ IA      L +LH+   
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA-RIYIA-EIVLALEYLHSNG- 113

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS------TRVMGTYGYAAPEY 258
            +I+RD K  NIL+DS+   KL+DFGL+K G    + +++       R++GT  Y APE 
Sbjct: 114 -IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEV 172

Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           ++    +   D +S G +L E L G
Sbjct: 173 ILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 94.8 bits (236), Expect = 5e-22
 Identities = 60/200 (30%), Positives = 101/200 (50%), Gaps = 13/200 (6%)

Query: 85  ILGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHP 141
            +GEG FG VY+G Y+  EN ++      VAVK          RE +L E   + Q  HP
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKI-----AVAVKTCKNCTSPSVREKFLQEAYIMRQFDHP 67

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           ++VKLIG    ++   +V E    G L ++L       L  A+ ++ ++  +  LA+L +
Sbjct: 68  HIVKLIG-VITENPVWIVMELAPLGELRSYLQVNKY-SLDLASLILYSYQLSTALAYLES 125

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N+L+ S    KL DFGL++   + +  + +++      + APE +  
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSRY-LEDESYYKASKGKLPIKWMAPESINF 182

Query: 262 GHLTARSDVYSFGVVLLELL 281
              T+ SDV+ FGV + E+L
Sbjct: 183 RRFTSASDVWMFGVCMWEIL 202

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 94.8 bits (236), Expect = 7e-22
 Identities = 58/206 (28%), Positives = 88/206 (42%), Gaps = 19/206 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNL 143
            LGEG  G+V K  +     +       A+K +         ++ L E+      + P +
Sbjct: 8   RLGEGAGGSVTKCRLKNTGMI------FALKTITTDPNPDLQKQILRELEINKSCKSPYI 61

Query: 144 VKLIGYCCEDDHRLL--VYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAFL 199
           VK  G   ++    +    E+   GSL++     +K    +       IA    KGL++L
Sbjct: 62  VKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETHVSTRVMGTYGYAAPEY 258
           H   R +I+RD K SNILL      KL DFG++ +       T       GT  Y APE 
Sbjct: 122 H--SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT-----GTSFYMAPER 174

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +     +  SDV+S G+ LLE+   R
Sbjct: 175 IQGKPYSITSDVWSLGLTLLEVAQNR 200

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 77/222 (34%), Positives = 104/222 (46%), Gaps = 32/222 (14%)

Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW- 128
           LF  +   K F     +G G FG VY         V      VA+K ++  G Q + +W 
Sbjct: 7   LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEV------VAIKKMSYSGKQSNEKWQ 60

Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGS----LENHLFRKATVPLSW 182
             + EV FL QLRHPN ++  G    +    LV E+   GS    LE H  +K   PL  
Sbjct: 61  DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVH--KK---PLQE 114

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDET 241
                I  GA +GLA+LH+ ER  I+RD K  NILL    T KL+DFG A    P     
Sbjct: 115 VEIAAICHGALQGLAYLHSHER--IHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167

Query: 242 HVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLEL 280
             +   +GT  + APE ++    G    + DV+S G+  +EL
Sbjct: 168 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 94.2 bits (234), Expect = 8e-22
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 12/203 (5%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           ++G G FG V +G +      G + + VA+K L K G      R++L+E + +GQ  HPN
Sbjct: 11  VIGAGEFGEVCRGRLKL---PGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 66

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++ L G   +    +++ EFM  G+L++ L R+     +    + +  G A G+ +L  +
Sbjct: 67  IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--S 123

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG---TYGYAAPEYV 259
           E   ++RD    NIL++S+   K+SDFGL++           T  +G      + APE +
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAI 183

Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
                T+ SDV+S+G+V+ E+++
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMS 206

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 94.3 bits (234), Expect = 9e-22
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 17/211 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L    L   +++  E   L  L+H ++VK
Sbjct: 13  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLF--------------RKATVPLSWATRMMIAFG 191
             G C + D  ++V+E+M  G L   L               R+A   L  +  + IA  
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A G+ +L  A +  ++RD  T N L+ ++   K+ DFG+++     D   V    M   
Sbjct: 132 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE +M    T  SDV+SFGV+L E+ T
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 94.1 bits (234), Expect = 9e-22
 Identities = 60/218 (27%), Positives = 99/218 (45%), Gaps = 24/218 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V++      +        VAVK+L +E       ++  E   + +  HPN+V
Sbjct: 13  IGQGAFGRVFQARA-PGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIV 71

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT--------------------VPLSWAT 184
           KL+G C       L++E+M  G L   L  ++                     +PLS   
Sbjct: 72  KLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTE 131

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
           ++ IA   A G+A+L  +ER  ++RD  T N L+  +   K++DFGL++     D    S
Sbjct: 132 QLCIAKQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                   +  PE +     T  SDV+++GVVL E+ +
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.8 bits (233), Expect = 1e-21
 Identities = 59/206 (28%), Positives = 105/206 (50%), Gaps = 14/206 (6%)

Query: 81  RSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           R+D      LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + 
Sbjct: 5   RTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMK 57

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           +++HPNLV+L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  +
Sbjct: 58  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +L   ++  I+RD    N L+  ++  K++DFGL++    GD             + AP
Sbjct: 118 EYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAP 174

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E +     + +SDV++FGV+L E+ T
Sbjct: 175 ESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 94.8 bits (236), Expect = 1e-21
 Identities = 70/209 (33%), Positives = 98/209 (46%), Gaps = 26/209 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW-LTEVNFLGQL-RH 140
           +LG+G FG V    +     +       AVKVL K+ +      E  +TE   L    +H
Sbjct: 2   VLGKGSFGKVLLAELKGTDEL------YAVKVLKKDVILQDDDVECTMTEKRVLALAGKH 55

Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           P L +L  + C    D    V E++  G L  H+ R        A      F AA+   G
Sbjct: 56  PFLTQL--HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRAR-----FYAAEIVLG 108

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH  ER +IYRD K  N+LLDS+   K++DFG+ K G  G  T  ++   GT  Y A
Sbjct: 109 LQFLH--ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVT--TSTFCGTPDYIA 164

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           PE +         D ++ GV+L E+L G+
Sbjct: 165 PEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 93.5 bits (232), Expect = 1e-21
 Identities = 78/289 (26%), Positives = 124/289 (42%), Gaps = 48/289 (16%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           K  +    +G+G FG V  G          +   VAVK +  +     + +L E + + Q
Sbjct: 6   KELKLLQTIGKGEFGDVMLG--------DYRGNKVAVKCIKNDATA--QAFLAEASVMTQ 55

Query: 138 LRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           LRH NLV+L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + +
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAA 255
            +L       ++RD    N+L+  D  AK+SDFGL K A    D   +  +      + A
Sbjct: 116 EYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTA 167

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           PE +     + +SDV+SFG++L E+ + GR              V + R  L D      
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD------ 207

Query: 315 IIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLE 358
            + PR+E  Y + A    C    Y     C   +   RP    + E LE
Sbjct: 208 -VVPRVEKGYKMDAPD-GCPPVVYDVMKQCWHLDAATRPSFLQLREQLE 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 94.0 bits (233), Expect = 1e-21
 Identities = 72/220 (32%), Positives = 119/220 (54%), Gaps = 23/220 (10%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPN 142
           +LG G FGTVYKG ++ E   V    +PVA+K+LN+  G + + E++ E   +  + HP+
Sbjct: 14  VLGSGAFGTVYKGIWVPEGETV---KIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 70

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGAAKGLA 197
           LV+L+G C     +L V + M  G L +++        + + L+W  ++      AKG+ 
Sbjct: 71  LVRLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMM 123

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGYAAP 256
           +L   ER +++RD    N+L+ S    K++DFGLA+   +GDE   +         + A 
Sbjct: 124 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARL-LEGDEKEYNADGGKMPIKWMAL 180

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE 295
           E +     T +SDV+S+GV + EL+T G K  D   P++E
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTRE 219

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 26/210 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN----KEGLQGHREWLTEVNFLGQLRH 140
            +GEG +G VYK     N + G     VA+K +     KEG       + E+  L +LRH
Sbjct: 6   QIGEGTYGQVYKA---RNKKTGEL---VALKKIRMENEKEGFP--ITAIREIKLLQKLRH 57

Query: 141 PNLVKLIGYCCEDDHR--LLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V+L             +V+E+M     G L++   +     +    + ++     +G
Sbjct: 58  PNIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL-----EG 112

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L +LH+    +++RD K SNIL+++D   KL+DFGLA+       +   T  + T  Y  
Sbjct: 113 LQYLHS--NGILHRDIKGSNILINNDGVLKLADFGLARP-YTKRNSADYTNRVITLWYRP 169

Query: 256 PEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           PE ++         D++S G +L EL  G+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 93.5 bits (232), Expect = 2e-21
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 18/211 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L +      +++  E   L  L+H ++V+
Sbjct: 13  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFR--------------KATVPLSWATRMMIAFG 191
             G C E    L+V+E+M  G L N   R               A   L+    + IA  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A G+ +L  A    ++RD  T N L+      K+ DFG+++     D   V  R M   
Sbjct: 131 IASGMVYL--ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPI 188

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE ++    T  SD++SFGVVL E+ T
Sbjct: 189 RWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 65/207 (31%), Positives = 98/207 (47%), Gaps = 19/207 (9%)

Query: 85  ILGEGGFGTVYK----GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL- 138
            LG G FG V +    G    +       + VAVK+L        RE L +E+  +  L 
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDA-----VMKVAVKMLKPTAHSSEREALMSELKIMSHLG 96

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
            H N+V L+G C      L++ E+   G L N L RK    L+    +  ++  AKG+AF
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV---STRVMGTYGYAA 255
           L  A +  I+RD    N+LL      K+ DFGLA+     D  +V   + R+     + A
Sbjct: 157 L--ASKNCIHRDLAARNVLLTHGKIVKICDFGLAR-DIMNDSNYVVKGNARL--PVKWMA 211

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT 282
           PE +     T  SDV+S+G++L E+ +
Sbjct: 212 PESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 42/281 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKS----LPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           +LG+G FG V+KG + +   V +K+    LP  +K+          ++L+E   L Q  H
Sbjct: 2   LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI----------KFLSEARILKQYDH 51

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           PN+VKLIG C +     +V E +  G   + L RK    L     +  A  AA G+A+L 
Sbjct: 52  PNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL-RKKKDELKTKQLVKFALDAAAGMAYLE 110

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +  +  I+RD    N L+  +   K+SDFG+++    G  +    + +    + APE + 
Sbjct: 111 S--KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI-PIKWTAPEALN 167

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
            G  ++ SDV+S+G++L E                 SL     P + +++   Q+     
Sbjct: 168 YGRYSSESDVWSYGILLWETF---------------SLGVCPYPGMTNQQAREQV----- 207

Query: 321 ENQYSVRAAQKACSLAY----YCLSQNPKARPLMSDVVETL 357
           E  Y +   QK     Y     C    P+ RP  S++ + L
Sbjct: 208 EKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKEL 248

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 91.9 bits (229), Expect = 3e-21
 Identities = 70/205 (34%), Positives = 96/205 (46%), Gaps = 22/205 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-----GLQGHREWLTEVNFLGQLRH 140
           LG GGFG V        V+V  K+   A+K + K      G Q H    +E   L +  H
Sbjct: 1   LGVGGFGRVEL------VKVKSKNRTFALKCVKKRHIVETGQQEH--IFSEKEILEECNH 52

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P +VKL     +  +  ++ E+   G L   L  +      +  R  IA        +LH
Sbjct: 53  PFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-EYTARFYIAC-VVLAFEYLH 110

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           N  R +IYRD K  N+LLDS+   KL DFG AK    G +T       GT  Y APE ++
Sbjct: 111 N--RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT---FCGTPEYVAPEIIL 165

Query: 261 T-GHLTARSDVYSFGVVLLELLTGR 284
             G+  +  D +S G++L ELLTGR
Sbjct: 166 NKGYDFS-VDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 92.2 bits (229), Expect = 4e-21
 Identities = 62/203 (30%), Positives = 86/203 (42%), Gaps = 16/203 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPN 142
           LG+GGFG V         +V       A K L+K+ L   +G +  L E   L ++    
Sbjct: 1   LGKGGFGEVCA------CQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF 54

Query: 143 LVKLIGYCCED-DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +V L  Y  E  D   LV   M  G L+ H++         A  +  A     GL  LH 
Sbjct: 55  IVSL-AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             R ++YRD K  N+LLD     ++SD GLA     G +        GT GY APE +  
Sbjct: 114 --RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA---GTPGYMAPEVLQG 168

Query: 262 GHLTARSDVYSFGVVLLELLTGR 284
                  D ++ G  L E++ GR
Sbjct: 169 EVYDFSVDWFALGCTLYEMIAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.7 bits (228), Expect = 5e-21
 Identities = 76/279 (27%), Positives = 131/279 (46%), Gaps = 33/279 (11%)

Query: 85  ILGEGGFG--TVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRH 140
           +LG+G FG  T+Y+   D+++        V  K +N   L  +  R+ L E+  L  L+H
Sbjct: 7   VLGKGAFGEATLYRRTEDDSL--------VVWKEVNLTRLSEKERRDALNEIVILSLLQH 58

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           PN++    +  +D+  L+  E+   G+L + + R+          +   F     ++++H
Sbjct: 59  PNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            A   +++RD KT NI L      KL DFG++K    G E  ++  V+GT  Y +PE   
Sbjct: 119 KAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKI--LGSEYSMAETVVGTPYYMSPELCQ 174

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
                 +SD+++ G VL ELLT +++ D T P     LV           K++Q     +
Sbjct: 175 GVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---LVV----------KIVQGNYTPV 221

Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
            + YS     +  SL +  L Q+P+ RP   +V++    
Sbjct: 222 VSVYS----SELISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 91.5 bits (227), Expect = 6e-21
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 32/272 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           +LG+G +GTVY G  ++   + +K   V +   N    +   E L  EV+ L  L+H N+
Sbjct: 7   VLGKGAYGTVYCGLTNQGQLIAVKQ--VELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNI 64

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP---LSWATRMMIAFGAAKGLAFLH 200
           V+ +G C +D+   +  EF+  GS+ + L R   +P       T+ ++      G+A+LH
Sbjct: 65  VQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQIL-----DGVAYLH 119

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK----AGPQGDETHVSTRVMGTYGYAAP 256
           N    V++RD K +N++L  +   KL DFG A+     G  G  +++   + GT  + AP
Sbjct: 120 N--NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +       +SD++S G  + E+ TG+  +           +   R  +          
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM---------- 227

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
            PRL + +S  A          CL+++   RP
Sbjct: 228 -PRLPDSFSAAAI----DFVTSCLTRDQHERP 254

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 91.2 bits (226), Expect = 7e-21
 Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 15/199 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +K+L        K G    + +L E N +  L+H  LV+
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTL--------KPGTMSVQAFLEEANLMKTLQHDKLVR 65

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFLHNAE 203
           L     +++   ++ E+M +GSL +  F K+          +I F A  A+G+A++    
Sbjct: 66  LYAVVTKEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIE--R 121

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +  I+RD + +N+L+      K++DFGLA+   + +E            + APE +  G 
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGS 180

Query: 264 LTARSDVYSFGVVLLELLT 282
            T +SDV+SFG++L E++T
Sbjct: 181 FTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 91.3 bits (226), Expect = 8e-21
 Identities = 68/212 (32%), Positives = 104/212 (49%), Gaps = 13/212 (6%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R D  LG+G FG V+ G  +   +V +K+L        K G      +L E  
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL--------KPGTMMPEAFLQEAQ 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV L     E+    +V EFM +GSL + L       L     + +A   A
Sbjct: 54  IMKKLRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIA 112

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       I+RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 113 DGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKW 169

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT-GR 284
            APE  + G  T +SDV+SFG++L EL+T GR
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG  G V+K    E    V LK + +       EG   + + L E+  L   +HP +V
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALR----RLEGGIPN-QALREIKALQACQHPYVV 62

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA-----TRMMIAFGAAKGLAFL 199
           KL+         +LV E+M    L   L R    PL  A      RM++     KG+A++
Sbjct: 63  KLLDVFPHGSGFVLVMEYMPS-DLSEVL-RDEERPLPEAQVKSYMRMLL-----KGVAYM 115

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     +++RD K +N+L+ +D   K++DFGLA+   + +    S +V  T  Y APE +
Sbjct: 116 HANG--IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPE-L 171

Query: 260 MTG--HLTARSDVYSFGVVLLELLTGR 284
           + G        D+++ G +  ELL G 
Sbjct: 172 LYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.0 bits (226), Expect = 1e-20
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 12/206 (5%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G            L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 14  LGHGAFGEVYEGLY-RGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIV 72

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATV---PLSWATRMMIAFGAAKGLAFL 199
           +LIG   E   R ++ E M  G L++ L   R        L+    +  A   AKG  +L
Sbjct: 73  RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132

Query: 200 HNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK++DFG+A+   +        R M    +  P
Sbjct: 133 E--ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPP 190

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  + G  T+++DV+SFGV+L E+ +
Sbjct: 191 EAFLDGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 66/212 (31%), Positives = 105/212 (49%), Gaps = 13/212 (6%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 54  VMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 112

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 113 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 169

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT-GR 284
            APE  + G  T +SDV+SFG++L EL T GR
Sbjct: 170 TAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 90.0 bits (223), Expect = 2e-20
 Identities = 64/210 (30%), Positives = 111/210 (52%), Gaps = 20/210 (9%)

Query: 81  RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL 138
           + + ++G G FG V  G +      G + +PVA+K L K G   +  R++L+E + +GQ 
Sbjct: 7   KIEKVIGAGEFGEVCSGRLKLP---GKREIPVAIKTL-KAGYTEKQRRDFLSEASIMGQF 62

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
            HPN++ L G   +    ++V E+M  GSL+  L RK     +    + +  G A G+ +
Sbjct: 63  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL-RKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG------ 252
           L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR     G      
Sbjct: 122 L--SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGKIPIR 174

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 175 WTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 89.6 bits (222), Expect = 3e-20
 Identities = 68/200 (34%), Positives = 103/200 (51%), Gaps = 18/200 (9%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FGTV KG     ++   K   VAVK+L    N   L+   E L E N + QL +P
Sbjct: 3   LGSGNFGTVKKGMY--KMKKSEK--TVAVKILKNDNNDPALKD--ELLREANVMQQLDNP 56

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L   L +   V     T ++     + G+ +L  
Sbjct: 57  YIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTEKNITELV--HQVSMGMKYLE- 112

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA    DE +   +  G +   + APE +
Sbjct: 113 -ETNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LGADENYYKAKTHGKWPVKWYAPECM 170

Query: 260 MTGHLTARSDVYSFGVVLLE 279
                +++SDV+SFGV++ E
Sbjct: 171 NYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 79/277 (28%), Positives = 122/277 (44%), Gaps = 56/277 (20%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           +G+G FG VYK       +V      VA+KV++ E  +   E +  E+ FL Q R P + 
Sbjct: 9   IGKGSFGEVYKAIDKRTNQV------VAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF---GAAKGLAFLHN 201
           K  G   +     ++ E+   GS    L +   +         IAF       GL +LH 
Sbjct: 63  KYYGSFLKGSKLWIIMEYCGGGSCL-DLLKPGKLD-----ETYIAFILREVLLGLEYLHE 116

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR---VMGTYGYAAPEY 258
            E   I+RD K +NILL  +   KL+DFG++     G  T   ++    +GT  + APE 
Sbjct: 117 -EG-KIHRDIKAANILLSEEGDVKLADFGVS-----GQLTSTMSKRNTFVGTPFWMAPEV 169

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM--LQII 316
           +       ++D++S G+  +EL  G                    P L+D   M  L +I
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKG-------------------EPPLSDLHPMRVLFLI 210

Query: 317 D----PRLE-NQYSVRAAQKACSLAYYCLSQNPKARP 348
                P LE N++S +  +   SL   CL+++PK RP
Sbjct: 211 PKNNPPSLEGNKFS-KPFKDFVSL---CLNKDPKERP 243

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 88.8 bits (220), Expect = 4e-20
 Identities = 71/281 (25%), Positives = 134/281 (47%), Gaps = 44/281 (15%)

Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   + +L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMKLSHE 59

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     +V E+M  G L N+L R+       +  + +     +G+A+L +
Sbjct: 60  KLVQLYGVCTKQRPIYIVTEYMSNGCLLNYL-REHGKRFQPSQLLEMCKDVCEGMAYLES 118

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPEY 258
            +   I+RD    N L+D     K+SDFGL++     D+ + S+  +G+     ++ PE 
Sbjct: 119 KQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDDEYTSS--VGSKFPVRWSPPEV 172

Query: 259 VMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
           ++    +++SDV++FGV++ E+ + G+   ++   S+    V           + L++  
Sbjct: 173 LLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS----------QGLRLYR 222

Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P L       A++K  ++ Y C  +  + RP    ++ ++E
Sbjct: 223 PHL-------ASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 89.4 bits (221), Expect = 5e-20
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L        +++  E   L  L+H ++VK
Sbjct: 13  LGEGAFGKVFLAEC-YNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-------------LSWATRMMIAFGA 192
             G C E D  ++V+E+M  G L    F +A  P             L+ +  + IA   
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNK--FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++     D   V    M    
Sbjct: 130 AAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 187

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +  PE +M    T  SDV+S GVVL E+ T
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 6e-20
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 16/204 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    ++   GL +   A K++  E  +   +++ E++ L + +HPN+V 
Sbjct: 13  LGDGAFGKVYKA---QHKETGLFA---AAKIIQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L      ++   ++ EF   G+L++ +  +    L+      +     + L FLH+    
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDS-IMLELERGLTEPQIRYVCRQMLEALNFLHS--HK 123

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD K  NILL  D   KL+DFG++       +   +   +GT  + APE V      
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVACETFK 181

Query: 266 -----ARSDVYSFGVVLLELLTGR 284
                 ++D++S G+ L+EL    
Sbjct: 182 DNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 88.1 bits (218), Expect = 8e-20
 Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 13/200 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ G  + N +V +K+L        K G      +L E   + +LRH  LV+
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTL--------KPGTMSPESFLEEAQIMKKLRHDKLVQ 65

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     E+    +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 66  LYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 122

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD +++NIL+      K++DFGLA+   + +E            + APE  + G  T
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 266 ARSDVYSFGVVLLELLT-GR 284
            +SDV+SFG++L EL+T GR
Sbjct: 182 IKSDVWSFGILLTELVTKGR 201

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 88.7 bits (220), Expect = 8e-20
 Identities = 60/201 (29%), Positives = 104/201 (51%), Gaps = 16/201 (7%)

Query: 86  LGEGGFGTVYK-GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG G  G+V K  +I     +  K     V +  K  ++  ++ L E+  + + R P +V
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKV----VHIGAKSSVR--KQILRELQIMHECRSPYIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    +++  +  EFM  GSL+  +++K   P+       IA    +GL +L+N  R
Sbjct: 67  SFYGAFLNENNICMCMEFMDCGSLDR-IYKKGG-PIPVEILGKIAVAVVEGLTYLYNVHR 124

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVMTGH 263
            +++RD K SNIL++S    KL DFG++     G+  + ++   +GT  Y +PE +  G 
Sbjct: 125 -IMHRDIKPSNILVNSRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPERIQGGK 178

Query: 264 LTARSDVYSFGVVLLELLTGR 284
            T +SDV+S G+ ++EL  G+
Sbjct: 179 YTVKSDVWSLGISIIELALGK 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 73/288 (25%), Positives = 111/288 (38%), Gaps = 44/288 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL--NKEGLQGHREWLTEVNFLGQLRHPNL 143
           +GEG +G V K        +      VA+K    +++     +  L EV  L QLRH N+
Sbjct: 9   VGEGAYGVVLKCRNKATGEI------VAIKKFKESEDDEDVKKTALREVKVLRQLRHENI 62

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V L           LV+E++ R  LE  L   +   L         +   + +A+ H+  
Sbjct: 63  VNLKEAFRRKGRLYLVFEYVERTLLE--LLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE----YV 259
             +I+RD K  NIL+      KL DFG A+A      + ++  V  T  Y APE      
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDT 177

Query: 260 MTGHLTARSDVYSFGVVLLELLTGR------KSVDK---------TRPSKEQSLVDWARP 304
             G      DV++ G ++ ELL G         +D+           P   Q L   + P
Sbjct: 178 NYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFS-SNP 233

Query: 305 KLNDKRKMLQIIDPR----LENQYSVRAAQKACSLAYYCLSQNPKARP 348
           +           +P     LE +Y  + +  A      CL  +PK R 
Sbjct: 234 RFAGVA----FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 76/288 (26%), Positives = 134/288 (46%), Gaps = 40/288 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G    ++  G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 14  LGQGSFGMVYEG-NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW--------ATRMMIAFGA--AK 194
           +L+G   +    L+V E M  G L+++L  ++  P +           + MI   A  A 
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYL--RSLRPEAENNPGRPPPTLQEMIQMAAEIAD 130

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + 
Sbjct: 131 GMAYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 188

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE +  G  T  SD++SFGVVL E+                SL +     L++++ +  
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKF 233

Query: 315 IID----PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           ++D     + +N       ++   L   C   NPK RP   ++V  L+
Sbjct: 234 VMDGGYLDQPDN-----CPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 88.9 bits (220), Expect = 1e-19
 Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 24/202 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           +G G FG VY         V      VAVK ++  G Q + +W   + EV FL QL+HPN
Sbjct: 29  IGHGSFGAVYFATNSHTNEV------VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
            ++  G   ++    LV E+   GS  + L      PL       I  GA +GLA+LH+ 
Sbjct: 83  TIEYKGCYLKEHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAITHGALQGLAYLHS- 139

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
              +I+RD K  NILL      KL+DFG A K+ P       +   +GT  + APE ++ 
Sbjct: 140 -HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP-------ANSFVGTPYWMAPEVILA 191

Query: 262 ---GHLTARSDVYSFGVVLLEL 280
              G    + DV+S G+  +EL
Sbjct: 192 MDEGQYDGKVDVWSLGITCIEL 213

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 87.8 bits (217), Expect = 1e-19
 Identities = 63/206 (30%), Positives = 104/206 (50%), Gaps = 12/206 (5%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G I + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 14  LGQGSFGMVYEG-IAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKAT------VPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L   R          P S    + +A   A G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 133 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E +  G  T  SDV+SFGVVL E+ T
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 87.5 bits (217), Expect = 2e-19
 Identities = 92/294 (31%), Positives = 136/294 (46%), Gaps = 39/294 (13%)

Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEV------VAVKKLQHSTAEHLRDFEREIEILKSLQHD 65

Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   LV E++  GSL ++L +K    L     ++ A    KG+ +L
Sbjct: 66  NIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYL-QKHRERLDHRKLLLYASQICKGMEYL 124

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG---TYGYAAP 256
               +  ++RD  T NIL++S+   K+ DFGL K  PQ  E +   R  G    + Y AP
Sbjct: 125 --GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYK-VREPGESPIFWY-AP 180

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR-PSKEQSLVDWARPKLNDKRK---M 312
           E +     +  SDV+SFGVVL EL T     DK+  P  E     + R   NDK+    +
Sbjct: 181 ESLTESKFSVASDVWSFGVVLYELFT---YSDKSCSPPAE-----FMRMMGNDKQGQMIV 232

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
             +I+  L+N   +  A   C    Y     C + +P  RP  S++   +E ++
Sbjct: 233 YHLIE-LLKNNGRL-PAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 80/296 (27%), Positives = 123/296 (41%), Gaps = 55/296 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FG V  G        G+    V VK L       E L     +L EV    +L H
Sbjct: 3   IGNGWFGKVLLG----EAHRGMSKARVVVKELRASATPDEQLL----FLQEVQPYRELNH 54

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----AFGAAKGL 196
           PN+++ +G C E    LLV EF   G L+N+L R     ++   +  +    A   A GL
Sbjct: 55  PNVLQCLGQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGL 113

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +LH A+   I+ D    N  L +D + K+ D+GLA      D             + AP
Sbjct: 114 LWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAP 171

Query: 257 EYV-------MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
           E V       +    T +S+++S GV + EL T        +P           P L+D+
Sbjct: 172 ELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT-----AADQPY----------PDLSDE 216

Query: 310 RKMLQII--------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
           + + Q++         P+L+ +YS R  +    +  +C    P+ RP   +V E L
Sbjct: 217 QVLKQVVREQDIKLPKPQLDLKYSDRWYE----VMQFCWLD-PETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 73/203 (35%), Positives = 99/203 (48%), Gaps = 13/203 (6%)

Query: 86  LGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           LGEG FG V     D E    G +   VAVK L  E    H   L  E+  L  L H N+
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 144 VKLIGYCCEDDHR--LLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLH 200
           VK  G C ED      L+ EF+  GSL+ +L R K  + L    ++  A    KG+ +L 
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK--QQLKYAVQICKGMDYL- 125

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYV 259
              R  ++RD    N+L++S++  K+ DFGL KA     E + V   +     + APE +
Sbjct: 126 -GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
           +       SDV+SFGV L ELLT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 87.2 bits (217), Expect = 2e-19
 Identities = 81/299 (27%), Positives = 124/299 (41%), Gaps = 69/299 (23%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK------EGLQGHREWLTEVNFLGQL- 138
           LG+G FG+VY     E   +      VA+K + K      E +      L EV  L +L 
Sbjct: 7   LGDGTFGSVYLARNKETGEL------VAIKKMKKKFYSWEECMN-----LREVKSLRKLN 55

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF----RKATVPLSWATRMMIAFGAAK 194
            HPN+VKL     E+D    V+E+M     E +L+     +   P S +    I +   +
Sbjct: 56  EHPNIVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQ 110

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH--------VSTR 246
           GLA +H       +RD K  N+L+      K++DFGLA+      E          VSTR
Sbjct: 111 GLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAR------EIRSRPPYTDYVSTR 162

Query: 247 VMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT------GRKSVDKT--------R 291
                 Y APE ++ +   ++  D+++ G ++ EL T      G   +D+          
Sbjct: 163 -----WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217

Query: 292 PSKEQSLVDWAR-PKL-NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
           P+K+    DW    KL +          P   +Q    A+ +A  L    L  +PK RP
Sbjct: 218 PTKQ----DWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP 272

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.1 bits (213), Expect = 4e-19
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 30/273 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ G     ++V +K++         EG     +++ E   + +L HP LV+
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAI--------NEGAMSEEDFIEEAKVMMKLSHPKLVQ 63

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER- 204
           L G C +     +V EFM  G L N+L R+    LS    + +     +G+ +L   ER 
Sbjct: 64  LYGVCTQQKPLYIVTEFMENGCLLNYL-RQRQGKLSKDMLLSMCQDVCEGMEYL---ERN 119

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD    N L+ S    K+SDFG+ +     DE   S+       ++ PE       
Sbjct: 120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRY-VLDDEYTSSSGAKFPVKWSPPEVFNFSKY 178

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
           +++SDV+SFGV++ E+ T  K      P +++S  +         R    +  P+L    
Sbjct: 179 SSKSDVWSFGVLMWEVFTEGK-----MPFEKKSNYEVVEMISRGFR----LYRPKL---- 225

Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
              A+     + Y C  + P+ RP  ++++  +
Sbjct: 226 ---ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 87.7 bits (218), Expect = 4e-19
 Identities = 71/235 (30%), Positives = 96/235 (40%), Gaps = 52/235 (22%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGH-REWLTEVNFLGQLRHP 141
           ++G G FG V+       VR        A+KVL K  +  +        E + L     P
Sbjct: 8   VIGRGAFGEVWL------VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSP 61

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGL 196
            +VKL  Y  +D+  L LV E+M  G L N L RK   P   A      +++A  +   L
Sbjct: 62  WIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET--------------- 241
            F+H        RD K  NIL+D+D   KL+DFGL K   +  +                
Sbjct: 121 GFIH--------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDN 172

Query: 242 -------HVSTRVM-----GTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTG 283
                  H   RV      GT  Y APE V+ G       D +S GV+L E+L G
Sbjct: 173 VLVRRRDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 86.6 bits (214), Expect = 6e-19
 Identities = 70/231 (30%), Positives = 115/231 (49%), Gaps = 27/231 (11%)

Query: 80  FRSDYILGEGGFGTVYKGYID---ENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFL 135
           F+   +LG G FGTVYKG      E V++     PVA+K L +    + ++E L E   +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKI-----PVAIKELREATSPKANKEILDEAYVM 63

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPLSWATRMMIAF 190
             + +P++ +L+G C     +L + + M  G L     E+     +   L+W  ++    
Sbjct: 64  ASVDNPHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI---- 118

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMG 249
             AKG+ +L   ER +++RD    N+L+ +    K++DFGLAK  G    E H     + 
Sbjct: 119 --AKGMNYLE--ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV- 173

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV 299
              + A E ++    T +SDV+S+GV + EL+T G K  D   P+ E S +
Sbjct: 174 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSI 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 85.5 bits (211), Expect = 9e-19
 Identities = 76/287 (26%), Positives = 132/287 (45%), Gaps = 38/287 (13%)

Query: 86  LGEGGFGTVYKGYIDEN---VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           LGEG FG+V +G ++++   ++V +K++ +A+   ++       ++L+E   + +  HPN
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSE-----MEDFLSEAVCMKEFDHPN 61

Query: 143 LVKLIGYCCEDDHR------LLVYEFMFRGSLENHLF--RKATVPLSWATRMMIAFGA-- 192
           +++LIG C +          +++  FM  G L + L   R    P    T+M++ F    
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           A G+ +L  + +  I+RD    N +L+ +    ++DFGL+K    GD             
Sbjct: 122 ASGMEYL--SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVK 179

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS-LVDWARPKLNDKRK 311
           + A E +     T +SDV+SFGV + E+ T  ++     P  E S + D+    L    +
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQT---PYPGVENSEIYDY----LRQGNR 232

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           + Q  D  L+  Y         SL   C   NPK RP    +   LE
Sbjct: 233 LKQPPDC-LDGLY---------SLMSSCWLLNPKDRPSFETLRCELE 269

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 85.3 bits (211), Expect = 1e-18
 Identities = 68/212 (32%), Positives = 108/212 (50%), Gaps = 25/212 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVK----VLNKEGLQGH--REWLTEVNFLGQL 138
            LG G F + Y+     +V+ G  +L +AVK    V N    Q         E+  + +L
Sbjct: 7   QLGTGAFSSCYQA---RDVKTG--TL-MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
            HP++++++G  CED H  L  E+M  GS+ +HL  K       A  +       +GL++
Sbjct: 61  NHPHIIRMLGATCEDSHFNLFVEWMAGGSV-SHLLSKYG-AFKEAVIINYTEQLLRGLSY 118

Query: 199 LHNAERPVIYRDFKTSNILLDSD-YTAKLSDFG----LAKAGPQGDETHVSTRVMGTYGY 253
           LH  E  +I+RD K +N+L+DS     +++DFG    LA  G    E     +++GT  +
Sbjct: 119 LH--ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE--FQGQLLGTIAF 174

Query: 254 AAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
            APE V+ G    RS DV+S G V++E+ T +
Sbjct: 175 MAPE-VLRGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 74/271 (27%), Positives = 121/271 (44%), Gaps = 31/271 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ E  +   E +  E+  L Q   P + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +D    ++ E++  GS  + L      PL       I     KGL +LH+ ++
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+  AG   D        +GT  + APE +     
Sbjct: 123 --IHRDIKAANVLLSEHGEVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G     +  P K   L+    PK N          P LE  Y
Sbjct: 179 DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI----PKNN---------PPTLEGNY 225

Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL++ P  RP   ++++
Sbjct: 226 S----KPLKEFVEACLNKEPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 73/287 (25%), Positives = 134/287 (46%), Gaps = 42/287 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV--LNKEGLQGHREWL--------TEVNF 134
           ++G+G +G VY      NV  G     +AVK   L       H            +E+  
Sbjct: 8   LIGKGTYGRVYLAL---NVTTGEM---MAVKQVELPATIAGRHDSRQKDMVKALRSEIET 61

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP---LSWATRMMIAFG 191
           L  L H N+V+ +G+   +++  +  E++  GS+ + L          + + T  ++   
Sbjct: 62  LKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVL--- 118

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             +GLA+LH+  + +++RD K  N+L+D+D   K+SDFG++K      +   +  + G+ 
Sbjct: 119 --EGLAYLHS--KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174

Query: 252 GYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRP-SKEQSLVDWARPKLND 308
            + APE + +     +A+ D++S G V+LE+  GR      RP S E+++   A  KL +
Sbjct: 175 FWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR------RPWSDEEAIA--AMFKLGN 226

Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           KR       P +    S+  +  A      C + NP  RP   ++++
Sbjct: 227 KRSA-----PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 63/203 (31%), Positives = 102/203 (50%), Gaps = 14/203 (6%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +LG+G FG VY  Y +D    + +K +P      + E  +       E+  L  L+H  +
Sbjct: 9   LLGQGAFGRVYLCYDVDTGRELAVKQVPF--DPDSPETKKEVNALECEIQLLKNLQHERI 66

Query: 144 VKLIGYCCEDDHRLLVY-EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           V+  G C  DD  L ++ E+M  GS+++ L  KA   L+            +G+ +LH+ 
Sbjct: 67  VQYYG-CLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEYVM 260
              +++RD K +NIL DS    KL DFG +K         T + + V GT  + +PE V+
Sbjct: 124 M--IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKS-VTGTPYWMSPE-VI 179

Query: 261 TGHLTAR-SDVYSFGVVLLELLT 282
           +G    R +DV+S G  ++E+LT
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 84.2 bits (208), Expect = 2e-18
 Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 12/212 (5%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEV 132
           E   KS + + ILG G FG + +G +    +   + LPVA+  L        R  +L E 
Sbjct: 1   ELDNKSIKIERILGTGRFGELCRGCLKLPSK---RELPVAIHTLRAGCSDKQRRGFLAEA 57

Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
             LGQ  H N+V+L G     +  ++V E+M  G+L++ L RK    L     M +  G 
Sbjct: 58  LTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFL-RKHEGQLVAGQLMGMLPGL 116

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           A G+ +L  +E   +++      +L++SD   K+S F       +     + T + G   
Sbjct: 117 ASGMKYL--SEMGYVHKGLAAHKVLVNSDLVCKISGFR---RLQEDKSEAIYTTMSGKSP 171

Query: 253 --YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             +AAPE +   H ++ SDV+SFG+V+ E+++
Sbjct: 172 VLWAAPEAIQYHHFSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 70/275 (25%), Positives = 122/275 (44%), Gaps = 39/275 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHRE-WLTEVNFLGQLRHPNL 143
           LG+G +G+VYK      V+    +   A+K ++   + Q  RE  + E+  L  + HPN+
Sbjct: 8   LGKGSYGSVYK------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 144 VKLIGY--CCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMM--IAFGAAKGLAF 198
              I Y     D ++L +V E+   G L   + ++         + +  I     +GL  
Sbjct: 62  ---ISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQA 118

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH  E+ +++RD K++NILL ++   K+ D G++K   +     ++   +GT  Y APE 
Sbjct: 119 LH--EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEV 172

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
                 + +SD++S G +L E+ T         P + +S+ D     L  K +  +   P
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAP------PFEARSMQD-----LRYKVQRGKY--P 219

Query: 319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
            +   YS +  Q         L   PK RP    +
Sbjct: 220 PIPPIYS-QDLQNFIR---SMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 66/202 (32%), Positives = 94/202 (46%), Gaps = 24/202 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           +G G FG VY      N  V      VA+K ++  G Q + +W   + EV FL +LRHPN
Sbjct: 23  IGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
            ++  G    +    LV E+   GS  + L      PL       +  GA +GLA+LH+ 
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMT 261
              +I+RD K  NILL      KL DFG A    P       +   +GT  + APE ++ 
Sbjct: 135 N--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------ANXFVGTPYWMAPEVILA 185

Query: 262 ---GHLTARSDVYSFGVVLLEL 280
              G    + DV+S G+  +EL
Sbjct: 186 MDEGQYDGKVDVWSLGITCIEL 207

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 83.7 bits (207), Expect = 4e-18
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 28/211 (13%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +LG+G +G VY    +   VR+ +K +P      +   +Q   E   E+     L+H N+
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPER----DSRYVQPLHE---EIALHSYLKHRNI 67

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA--KGLAFLHN 201
           V+ +G   E+    +  E +  GSL   L R    PL    + +I +     +GL +LH 
Sbjct: 68  VQYLGSDSENGFFKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIIFYTKQILEGLKYLH- 125

Query: 202 AERPVIYRDFKTSNILLDSDYTA--KLSDFG----LAKAGPQGDETHVSTRVMGTYGYAA 255
            +  +++RD K  N+L+++ Y+   K+SDFG    LA   P       +    GT  Y A
Sbjct: 126 -DNQIVHRDIKGDNVLVNT-YSGVVKISDFGTSKRLAGINP------CTETFTGTLQYMA 177

Query: 256 PEYVMTGH--LTARSDVYSFGVVLLELLTGR 284
           PE +  G     A +D++S G  ++E+ TG+
Sbjct: 178 PEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 31/270 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQL-RH 140
           ++G G +  V    + +  R+       A+KV+ KE +    +  W+ TE +   Q   H
Sbjct: 2   VIGRGSYAKVLLVRLKKTERI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 55

Query: 141 PNLVKLIGYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      + A   LA  
Sbjct: 56  PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLALN 110

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T  ++   GT  Y APE +
Sbjct: 111 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 168

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D ++ GV++ E++ GR   D    S          P  N +  + Q+I   
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN--------PDQNTEDYLFQVI--- 217

Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKAR 347
           LE Q  +    + KA S+    L+++PK R
Sbjct: 218 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 67/216 (31%), Positives = 111/216 (51%), Gaps = 21/216 (9%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S + +  LG G FG V+    +++ +V +K++        K G      +L E N
Sbjct: 2   EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--------KPGSMSVEAFLAEAN 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFG 191
            +  L+H  LVKL     ++    ++ EFM +GSL + L        PL      +I F 
Sbjct: 54  VMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFS 108

Query: 192 A--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           A  A+G+AF+   +R  I+RD + +NIL+ +    K++DFGLA+   + +E         
Sbjct: 109 AQIAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKF 165

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GR 284
              + APE +  G  T +SDV+SFG++L+E++T GR
Sbjct: 166 PIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 83.5 bits (206), Expect = 7e-18
 Identities = 65/217 (29%), Positives = 116/217 (53%), Gaps = 31/217 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V K  I ++   GL+ +  A+K + +   +  HR++  E+  L +L  HPN
Sbjct: 14  VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV-------------PLSWATRMMIA 189
           ++ L+G C    +  L  E+   G+L + L RK+ V               + +++ ++ 
Sbjct: 70  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 128

Query: 190 FGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           F A  A+G+ +L  +++  I+RD    NIL+  +Y AK++DFGL++    G E +V  + 
Sbjct: 129 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 181

Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T  SDV+S+GV+L E+++
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 62/222 (27%), Positives = 98/222 (44%), Gaps = 41/222 (18%)

Query: 84  YILGEGGFGTVYKGYIDENVRVGLKS--LPVAVKVLNKEGLQGH-REWLT-EVNFLGQLR 139
             +G+G FGTV K        V  KS    +  K ++   +    ++ L  EVN L +L+
Sbjct: 6   ETIGKGSFGTVRK--------VRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK 57

Query: 140 HPNLVKLIGYCCEDDHRL---------LVYEFMFRGSLENHLFRKAT-----VPLSWATR 185
           HPN+V+          R+         +V E+   G L   L +K       +   +  R
Sbjct: 58  HPNIVRYY-------DRIIDRSNQTLYIVMEYCEGGDLAQ-LIQKCKKERKYIEEEFIWR 109

Query: 186 MMIAFGAAKGLAFLHNAERP---VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
           ++     A  L   HN   P   V++RD K +NI LD++   KL DFGLAK    G ++ 
Sbjct: 110 ILTQLLLA--LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK--ILGHDSS 165

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
            +   +GT  Y +PE +       +SD++S G ++ EL    
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALS 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 82.3 bits (204), Expect = 8e-18
 Identities = 80/275 (29%), Positives = 124/275 (45%), Gaps = 45/275 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G +G VYK       R       VA+KV+  E          E++ L + RHPN+V 
Sbjct: 11  IGSGTYGDVYKA------RDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF---GAAKGLAFLHNA 202
             G     D   +V E+   GSL++ +++    PLS    + IA+      KGLA+LH  
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS---ELQIAYVCRETLKGLAYLH-- 118

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYAAPEYV- 259
           E   I+RD K +NILL  D   KL+DFG++    Q   T ++ R   +GT  + APE   
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVSA---QLTAT-IAKRKSFIGTPYWMAPEVAA 174

Query: 260 --MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV---DWARPKLNDKRK-ML 313
               G    + D+++ G+  +EL   +  +    P +   L+   ++  PKL DK K   
Sbjct: 175 VERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSP 234

Query: 314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
              D        ++           CL+++PK RP
Sbjct: 235 VFHD-------FIKK----------CLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 82.9 bits (205), Expect = 8e-18
 Identities = 63/204 (30%), Positives = 105/204 (51%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNLV 144
           LGEG + TVYKG      R       VA+K ++ +  +G     + E++ + +L+H N+V
Sbjct: 8   LGEGTYATVYKG------RNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 145 KLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +L      ++  +LV+E+M    +  ++ H  R A   L   T     +   KG+AF H 
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFCH- 117

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            E  V++RD K  N+L++     KL+DFGLA+A      T  +  V  T  Y AP+ ++ 
Sbjct: 118 -ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV--TLWYRAPDVLLG 174

Query: 262 GHLTARS-DVYSFGVVLLELLTGR 284
               + S D++S G ++ E++TGR
Sbjct: 175 SRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 77/281 (27%), Positives = 120/281 (42%), Gaps = 50/281 (17%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-------KEGLQGHREWLTEV 132
           ++   ++G G +G VY+G      RV      VA+K++N          +Q       EV
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRV------VALKIINLDTPDDDVSDIQ------REV 50

Query: 133 NFLGQLRH---PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
             L QLR    PN+ K  G       RL ++ E+   GS+   L +    P++     +I
Sbjct: 51  ALLSQLRQSQPPNITKYYG-SYLKGPRLWIIMEYAEGGSVRT-LMKAG--PIAEKYISVI 106

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
                  L ++H     VI+RD K +NIL+ +    KL DFG+A A    + +  ST V 
Sbjct: 107 IREVLVALKYIHKV--GVIHRDIKAANILVTNTGNVKLCDFGVA-ALLNQNSSKRSTFV- 162

Query: 249 GTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
           GT  + APE +  G     ++D++S G+ + E+ TG          +   L+  ++P   
Sbjct: 163 GTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--- 219

Query: 308 DKRKMLQIIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKAR 347
                     PRLE N YS     +       CL + PK R
Sbjct: 220 ----------PRLEDNGYS--KLLR--EFVAACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 60/220 (27%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLP-------VAVKVLNK-EGLQGHREWLTEVNFLGQ 137
           LGE  FG +YKG++          LP       VA+K L      Q   E+  E + + +
Sbjct: 13  LGECAFGKIYKGHL---------YLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAE 63

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA-------------TV--PLSW 182
           L HPN+V L+G   ++    +++E++ +G L   L  ++             TV   L  
Sbjct: 64  LHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH 123

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
              + IA   A G+ +L  +    +++D    NIL+      K+SD GL++     D   
Sbjct: 124 GDFLHIAIQIAAGMEYL--SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           V  + +    +  PE +M G  ++ SD++SFGVVL E+ +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 64/217 (29%), Positives = 113/217 (52%), Gaps = 31/217 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V +  I ++   GLK +  A+K+L +   +  HR++  E+  L +L  HPN
Sbjct: 9   VIGEGNFGQVIRAMIKKD---GLK-MNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPN 64

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV---------------PLSWATRMM 187
           ++ L+G C    +  +  E+   G+L + L RK+ V                L+    + 
Sbjct: 65  IINLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQ 123

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            A   A G+ +L  +E+  I+RD    N+L+  +  +K++DFGL++    G+E +V  + 
Sbjct: 124 FASDVATGMQYL--SEKQFIHRDLAARNVLVGENLASKIADFGLSR----GEEVYVK-KT 176

Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T +SDV+SFGV+L E+++
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 71/218 (32%), Positives = 103/218 (47%), Gaps = 24/218 (11%)

Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW- 128
           LF  E   K F     +G G FG VY      +VR    +  VA+K ++  G Q + +W 
Sbjct: 17  LFFKEDPEKLFTDLREIGHGSFGAVY---FARDVRT---NEVVAIKKMSYSGKQSNEKWQ 70

Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             + EV FL +++HPN ++  G    +    LV E+   GS  + L      PL      
Sbjct: 71  DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIA 128

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVST 245
            I  GA +GLA+LH+    +I+RD K  NILL      KL+DFG A  A P       + 
Sbjct: 129 AITHGALQGLAYLHS--HNMIHRDIKAGNILLTEPGQVKLADFGSASIASP-------AN 179

Query: 246 RVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLEL 280
             +GT  + APE ++    G    + DV+S G+  +EL
Sbjct: 180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 217

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 31/271 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           +G+G FG VYKG  +    V      VA+K+++ E  +   E +  E+  L Q   P + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +  G   +     ++ E++  GS  + L      PL       I     KGL +LH+  +
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+  AG   D        +GT  + APE +     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 178

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
             ++D++S G+  +EL  G        P +   L+    P             P LE QY
Sbjct: 179 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQY 225

Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL+++P+ RP   ++++
Sbjct: 226 S----KPFKEFVEACLNKDPRFRPTAKELLK 252

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 81/274 (29%), Positives = 130/274 (47%), Gaps = 41/274 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQLR-H 140
           ++G G +  V    + +N ++       A+KV+ KE +    +  W+ TE +   Q   +
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQI------YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSN 55

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GL 196
           P LV L   C +   RL LV E++  G L  H+ R+  +P   A      F AA+    L
Sbjct: 56  PFLVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYAAEICIAL 109

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            FLH  ER +IYRD K  N+LLD+D   KL+D+G+ K G    +T  ++   GT  Y AP
Sbjct: 110 NFLH--ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--TSTFCGTPNYIAP 165

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +         D ++ GV++ E++ GR   D          +    P +N +  + Q+I
Sbjct: 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFD----------IITDNPDMNTEDYLFQVI 215

Query: 317 --DP-RLENQYSVRAAQKACSLAYYCLSQNPKAR 347
              P R+    SV+A+     +    L+++PK R
Sbjct: 216 LEKPIRIPRFLSVKAS----HVLKGFLNKDPKER 245

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 81.1 bits (200), Expect = 3e-17
 Identities = 77/268 (28%), Positives = 113/268 (42%), Gaps = 33/268 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPN 142
           LG+GGFG V        V+V       A K L+K+ L+   G +  L E   L ++  P 
Sbjct: 1   LGKGGFGEVCA------VQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPF 54

Query: 143 LVKLIGYCCEDD-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +V L  Y  E   H  LV   M  G L+ H++      L      +I + A      LH 
Sbjct: 55  IVNL-AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLE--MERVIHYSAQITCGILHL 111

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               ++YRD K  N+LLD     +LSD GLA     G      T+  GT GY APE +  
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI---TQRAGTNGYMAPEILKE 168

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVD--KTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
              +   D ++ G  + E++ GR      K + +KE    +  R  L D+ K        
Sbjct: 169 EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKE----ELKRRTLEDEVK-------- 216

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKAR 347
            E+Q     ++  C L    L++ P+ R
Sbjct: 217 FEHQNFTEESKDICRLF---LAKKPEDR 241

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 82.2 bits (203), Expect = 3e-17
 Identities = 81/247 (32%), Positives = 120/247 (48%), Gaps = 35/247 (14%)

Query: 113 AVKVLNKEGLQGHRE--WL-TEVN-FLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGS 167
           A+KV+ KE +    +  W+ TE + F     HP LV L   C + + RL  V EF+  G 
Sbjct: 24  AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHS-CFQTESRLFFVIEFVSGGD 82

Query: 168 LENHLFRKATVPLSWATRMMIAFGAAK---GLAFLHNAERPVIYRDFKTSNILLDSDYTA 224
           L  H+ R+  +P   A      F +A+    L FLH  ER +IYRD K  N+LLD++   
Sbjct: 83  LMFHMQRQRKLPEEHAR-----FYSAEISLALNFLH--ERGIIYRDLKLDNVLLDAEGHI 135

Query: 225 KLSDFGLAKAGPQ-GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           KL+D+G+ K G + GD T  ST   GT  Y APE +         D ++ GV++ E++ G
Sbjct: 136 KLTDYGMCKEGIRPGDTT--ST-FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 192

Query: 284 RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII---DPRLENQYSVRAAQKACSLAYYCL 340
           R   D    S          P  N +  + Q+I     R+    SV+A+    S+    L
Sbjct: 193 RSPFDIVGMSDN--------PDQNTEDYLFQVILEKQIRIPRSLSVKAS----SVLKGFL 240

Query: 341 SQNPKAR 347
           +++PK R
Sbjct: 241 NKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.2 bits (200), Expect = 3e-17
 Identities = 81/273 (29%), Positives = 121/273 (44%), Gaps = 30/273 (10%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFL 135
           +FR   +LG+GGFG V    +    ++       A K L K+ ++   G    L E   L
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGESMALNEKQIL 54

Query: 136 GQLRHPNLVKLIGYCCE-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            ++    +V L  Y  E  D   LV   M  G L+ H++            +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICC 113

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL  LH  ER ++YRD K  NILLD     ++SD GLA   P+G    +  RV GT GY 
Sbjct: 114 GLEDLHQ-ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT--IKGRV-GTVGYM 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE V     T   D ++ G +L E++ G            QS     + K+  KR+ ++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMIAG------------QSPFQQRKKKI--KREEVE 214

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
            +   ++ +YS + +  A SL    L ++PK R
Sbjct: 215 RLVKEVQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 80.9 bits (199), Expect = 3e-17
 Identities = 64/217 (29%), Positives = 115/217 (52%), Gaps = 31/217 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V K  I ++   GL+ +  A+K + +   +  HR++  E+  L +L  HPN
Sbjct: 2   VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV-------------PLSWATRMMIA 189
           ++ L+G C    +  L  E+   G+L + L RK+ V               + +++ ++ 
Sbjct: 58  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 116

Query: 190 FG--AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           F    A+G+ +L  +++  I+RD    NIL+  +Y AK++DFGL++    G E +V  + 
Sbjct: 117 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 169

Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T  SDV+S+GV+L E+++
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 81.4 bits (201), Expect = 5e-17
 Identities = 69/206 (33%), Positives = 96/206 (46%), Gaps = 22/206 (10%)

Query: 85  ILGEGGFGTVY--KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-L 138
           ++G+G FG V   K   D            AVKVL K+ +   +E    + E N L + +
Sbjct: 2   VIGKGSFGKVLLAKHKADGKF--------YAVKVLQKKAILKKKEQKHIMAERNVLLKNV 53

Query: 139 RHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           +HP LV L  Y  +   +L  V +++  G L  HL R+ + P   A     A   A  L 
Sbjct: 54  KHPFLVGL-HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRAR--FYAAEIASALG 110

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +LH     +IYRD K  NILLDS     L+DFGL K G +  +T  ++   GT  Y APE
Sbjct: 111 YLH--SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT--TSTFCGTPEYLAPE 166

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTG 283
            +         D +  G VL E+L G
Sbjct: 167 VLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 89/303 (29%), Positives = 125/303 (41%), Gaps = 78/303 (25%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVK--VLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +GEG +G V+K    E  ++      VA+K  V +++     +  L E+  L QL+HPNL
Sbjct: 9   IGEGSYGVVFKCRNRETGQI------VAIKKFVESEDDPVIKKIALREIRMLKQLKHPNL 62

Query: 144 VKLI-------------GYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           V LI              YC   DH +L   E   RG +  HL +K      W T     
Sbjct: 63  VNLIEVFRRKRKLHLVFEYC---DHTVLNELEKNPRG-VPEHLIKKII----WQT----- 109

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDET-HVSTR 246
               + + F H  +   I+RD K  NIL+      KL DFG A+   GP  D T +V+TR
Sbjct: 110 ---LQAVNFCH--KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR 164

Query: 247 VMGTYGYAAPEYVMTGHLTARS--DVYSFGVVLLELLTG----------------RKSVD 288
                 Y APE ++ G        DV++ G V  ELLTG                RK++ 
Sbjct: 165 -----WYRAPE-LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG 218

Query: 289 KTRPSKEQSLVDWARPKLNDKRKMLQIIDPR----LENQYSVRAAQKACSLAYYCLSQNP 344
              P  +Q          N   K L I +P     LE+++    +  A S    CL  +P
Sbjct: 219 DLIPRHQQIF------STNQFFKGLSIPEPETREPLESKFP-NISSPALSFLKGCLQMDP 271

Query: 345 KAR 347
             R
Sbjct: 272 TER 274

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 80.7 bits (200), Expect = 7e-17
 Identities = 67/218 (30%), Positives = 103/218 (47%), Gaps = 38/218 (17%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPN 142
            +G G +G V       + R G K   VA+K ++   + L   +  L E+  L  LRH N
Sbjct: 7   PIGSGAYGVVCSAV---DKRTGRK---VAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60

Query: 143 LVKLI------GYCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAA 193
           ++ L+           +D  + +V E M     E  L +  K+  PL+        +   
Sbjct: 61  IIGLLDILRPPSPEDFND--VYIVTELM-----ETDLHKVIKSPQPLTDDHIQYFLYQIL 113

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDET-----HVSTRV 247
           +GL +LH+A   VI+RD K SNIL++S+   K+ DFGLA+   P  DE      +V TR 
Sbjct: 114 RGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 248 MGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
                Y APE +++    T   D++S G +  ELLT +
Sbjct: 172 -----YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 80.1 bits (198), Expect = 8e-17
 Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 21/205 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL--NKEGLQGHREWLTEVNFLGQLRHPN 142
           ++GEG +G V K    E  ++      VA+K    +++     +  + E+  L QLRH N
Sbjct: 8   LVGEGSYGMVMKCKHKETGQI------VAIKKFLESEDDKMVKKIAMREIRMLKQLRHEN 61

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           LV LI          LV+EF+    L++    K    L  +      F   +G+ F H+ 
Sbjct: 62  LVNLIEVFRRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQILRGIEFCHSH 119

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDET-HVSTRVMGTYGYAAPEYV 259
              +I+RD K  NIL+      KL DFG A+  A P    T +V+TR      Y APE +
Sbjct: 120 N--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATR-----WYRAPELL 172

Query: 260 MTGHLTARS-DVYSFGVVLLELLTG 283
           +      R+ D+++ G ++ E+LTG
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 79.3 bits (195), Expect = 8e-17
 Identities = 62/198 (31%), Positives = 95/198 (47%), Gaps = 16/198 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           +G G FG V+ G      R+   + PVAVK   +E L      ++L E   L Q  HPN+
Sbjct: 3   IGRGNFGEVFSG------RLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNI 55

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+LIG C +     +V E +  G     L R     L     + +   AA G+ +L +  
Sbjct: 56  VRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGPRLKVKELIQMVENAAAGMEYLES-- 112

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT--YGYAAPEYVMT 261
           +  I+RD    N L+      K+SDFG+++   + D  + ST  M      + APE +  
Sbjct: 113 KHCIHRDLAARNCLVTEKNVLKISDFGMSRE--EEDGVYASTGGMKQIPVKWTAPEALNY 170

Query: 262 GHLTARSDVYSFGVVLLE 279
           G  ++ SDV+SFG++L E
Sbjct: 171 GRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 79.1 bits (195), Expect = 1e-16
 Identities = 56/216 (25%), Positives = 100/216 (46%), Gaps = 32/216 (14%)

Query: 85  ILGEGGFGTVY--KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW--LTEVNFLGQLRH 140
           ++G G FG V+  +   D+ +        V +K +  E +          E   L  L H
Sbjct: 7   VVGRGAFGIVHLCRRKADQKL--------VIIKQIPVEQMTKDERLAAQNECQVLKLLSH 58

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLE-------NHLFRKATVPLSWATRMMIAFGAA 193
           PN+++      ED   ++V E+   G+L        N L  + T+ L +  ++++A    
Sbjct: 59  PNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTI-LHFFVQILLA---- 113

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             L  +H   + +++RD KT NILLD      K+ DFG++K      ++   T V+GT  
Sbjct: 114 --LHHVHT--KLILHRDLKTQNILLDKHKMVVKIGDFGISKI--LSSKSKAYT-VVGTPC 166

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVD 288
           Y +PE         +SD+++ G VL EL + +++ +
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 65/221 (29%), Positives = 111/221 (50%), Gaps = 25/221 (11%)

Query: 85  ILGEGGFGTVYKGYI---DENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRH 140
           +LG G FGTVYKG      ENV++     PVA+KVL +    + ++E L E   +  +  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKI-----PVAIKVLRENTSPKANKEILDEAYVMAGVGS 68

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGAAKG 195
           P + +L+G C     +L V + M  G L +++        +   L+W  ++      AKG
Sbjct: 69  PYVCRLLGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           +++L      +++RD    N+L+ S    K++DFGLA+     +  + +        + A
Sbjct: 122 MSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 179

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE 295
            E ++    T +SDV+S+GV + EL+T G K  D   P++E
Sbjct: 180 LESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 79.8 bits (197), Expect = 2e-16
 Identities = 51/151 (33%), Positives = 72/151 (47%), Gaps = 16/151 (10%)

Query: 139 RHPNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK-- 194
            HP L  L  +C     +H   V E++  G L  H+        + A      F AA+  
Sbjct: 54  EHPFLTHL--FCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARAR-----FYAAEII 106

Query: 195 -GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            GL FLH   + +IYRD K  N+LLD D   K++DFG+ K    G+    ++   GT  Y
Sbjct: 107 CGLQFLHK--KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK--ASTFCGTPDY 162

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
            APE +         D +SFGV+L E+L G+
Sbjct: 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 80/297 (26%), Positives = 135/297 (45%), Gaps = 45/297 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ILG G  GTVYK Y     R+      +AVKV+  +  ++  ++ ++E+  L +   P +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRI------LAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           +   G    ++   +  EFM  GSL+  ++RK  +P     R  IA    KGL +L + +
Sbjct: 62  IGFYGAFFVENRISICTEFMDGGSLD--VYRK--IPEHVLGR--IAVAVVKGLTYLWSLK 115

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             +++RD K SN+L+++    KL DFG++          ++   +GT  Y APE +    
Sbjct: 116 --ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQ 169

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKE--------QSLVDWARPKLNDKRKMLQI 315
               SDV+S G+  +EL  GR    + + ++         Q +VD   P L         
Sbjct: 170 YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV------- 222

Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISS 372
                  Q+S    +K       C+ + PK RP   ++++    +Q  NDG  E+ S
Sbjct: 223 ------GQFS----EKFVHFITQCMRKQPKERPAPENLMDHPFIVQ-YNDGNAEVVS 268

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 79.4 bits (196), Expect = 2e-16
 Identities = 61/216 (28%), Positives = 103/216 (47%), Gaps = 23/216 (10%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQL-RH 140
            LGEG FG V K   +  +     ++  VAVK+L K+        + ++E+  +  + +H
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPN--ETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKH 75

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRM 186
            N++ L+G C ++    +V E+   G+L + L               R     L+    +
Sbjct: 76  KNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
             A+  A+G+ FL  A +  I+RD    N+L+  D+  K++DFGLA+     D    +T 
Sbjct: 136 SFAYQVARGMEFL--ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTN 193

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV+L E+ T
Sbjct: 194 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 75/292 (25%), Positives = 127/292 (43%), Gaps = 59/292 (20%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLP---VAVKVLN----------KEGLQGHREWLTEV 132
           LG G FG VYK        V  K+     +A+K +N          +E  +   + ++EV
Sbjct: 8   LGSGAFGCVYK--------VRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEV 59

Query: 133 NFLG-QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF----RKATVPLS--WA-- 183
             +  QLRHPN+V+      E+D   +V + +    L  H      +K        W   
Sbjct: 60  TIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIF 119

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
            +M++A      L +LH  E+ +++RD   +NI+L  D    ++DFGLAK   Q      
Sbjct: 120 VQMVLA------LRYLHK-EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESK 169

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
            T V+GT  Y+ PE V       ++DV++FG +L ++ T +       P    +++  A 
Sbjct: 170 LTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP------PFYSTNMLSLAT 223

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
             +          +P  E  YS    +    +   CL+ + +ARP   D+++
Sbjct: 224 KIVEAV------YEPLPEGMYS----EDVTDVITSCLTPDAEARP---DIIQ 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 59/176 (33%), Positives = 88/176 (50%), Gaps = 43/176 (24%)

Query: 131 EVNFLGQLR-HPNLVKLIG-YCCEDDHRL-LVYEFM--------FRGSLEN-HLFRKATV 178
           E+ FL +L  HPN+VKL+     E+D  + LV+E+M            LE+ H       
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILEDVH------- 108

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
                 +  I +   K L ++H+    VI+RD K SNILL+SD   KL+DFGLA++  + 
Sbjct: 109 ------KRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160

Query: 239 DETH--------VSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           +E          V+TR      Y APE ++ G    T   D++S G +L E+L G+
Sbjct: 161 EENPENPVLTDYVATR-----WYRAPE-ILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 79.6 bits (196), Expect = 2e-16
 Identities = 70/208 (33%), Positives = 100/208 (48%), Gaps = 26/208 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLR-H 140
           +LG+G FG V    + E+ R+       AVKVL K+ +    +    +TE   L   R H
Sbjct: 2   VLGKGSFGKVMLARLKESGRL------YAVKVLKKDVILQDDDVECTMTEKRILSLARNH 55

Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           P L +L  YCC    D    V EF+  G L  H+ +      + A      F AA+    
Sbjct: 56  PFLTQL--YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-----FYAAEITSA 108

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH  ++ +IYRD K  N+LLD +   KL+DFG+ K G    +T  ++   GT  Y A
Sbjct: 109 LMFLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIA 164

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +         D ++ GV+L E+L G
Sbjct: 165 PEILQEMLYGPSVDWWAMGVLLYEMLCG 192

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 27/205 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNLV 144
           +GEG  G V    I  +   G +   VAVK ++    Q  RE L  EV  +   +HPN+V
Sbjct: 27  IGEGSTGIVC---IATDKSTGRQ---VAVKKMDLRK-QQRRELLFNEVVIMRDYQHPNIV 79

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAFGAAKGLAF 198
           ++       D   +V EF+  G+L +         +   TRM       +     K L+F
Sbjct: 80  EMYSSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIATVCLAVLKALSF 130

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH   + VI+RD K+ +ILL SD   KLSDFG         E      ++GT  + APE 
Sbjct: 131 LHA--QGVIHRDIKSDSILLTSDGRVKLSDFGF--CAQVSKEVPRRKSLVGTPYWMAPEV 186

Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           +         D++S G++++E++ G
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 57/200 (28%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    E        +  A KV++ +  +   +++ E++ L    HPN+VK
Sbjct: 13  LGDGAFGKVYKAQNKET------GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+     +++  ++ EF   G+++  +  +   PL+     ++     + L +LH  E  
Sbjct: 67  LLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTEPQIRVVCKQTLEALNYLH--ENK 123

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           +I+RD K  NIL   D   KL+DFG++    +  +   S   +GT  + APE VM     
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSK 181

Query: 266 AR-----SDVYSFGVVLLEL 280
            R     +DV+S G+ L+E+
Sbjct: 182 DRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 81.4 bits (201), Expect = 2e-16
 Identities = 53/188 (28%), Positives = 89/188 (47%), Gaps = 16/188 (8%)

Query: 112 VAVKVLNKEGLQGHRE---WLTEVNFLGQLRHPNLVKLIGY-CCEDDHRLLVYEFMFRGS 167
           VA+K+L  +  +   +   +  E     +L HPN+V L+            V+E++   +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 168 LENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTA 224
           L   L     +P     R+M+       LA  HN  + +++RD K  NI++        A
Sbjct: 66  LREVLAADGALPAGETGRLMLQ--VLDALACAHN--QGIVHRDLKPQNIMVSQTGVRPHA 121

Query: 225 KLSDFGLAKAGP---QGDETHVS--TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 279
           K+ DFG+    P     D   ++  T V+GT  Y APE +    +T  SD+Y++G++ LE
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181

Query: 280 LLTGRKSV 287
            LTG++ V
Sbjct: 182 CLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 70/210 (33%), Positives = 98/210 (46%), Gaps = 23/210 (10%)

Query: 85  ILGEGGFGTVY----KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           +LG G +G V+     G  D      +K L  A  ++ K     H    TE   L  +R 
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKA-TIVQKAKTAEHT--RTERQVLEAVRR 63

Query: 141 -PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
            P LV L  Y  + D +L L+ +++  G L  HL+++     S   R+ IA      LA 
Sbjct: 64  CPFLVTL-HYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES-EVRVYIA---EIVLAL 118

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAP 256
            H  +  +IYRD K  NILLDS+    L+DFGL+K     + +  +      GT  Y AP
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAY---SFCGTIEYMAP 175

Query: 257 EYVMT---GHLTARSDVYSFGVVLLELLTG 283
           E +     GH  A  D +S GV+  ELLTG
Sbjct: 176 EVIRGGSGGHDKA-VDWWSLGVLTFELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.0 bits (192), Expect = 3e-16
 Identities = 63/214 (29%), Positives = 103/214 (48%), Gaps = 25/214 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVK--VLNKEGLQG---HREWLT----EVNFL 135
           ++G G FG+VY G    N   G     +AVK   L           R  L     E+  L
Sbjct: 7   LIGSGSFGSVYLGM---NASSGEL---MAVKQVELPSVSASSKDRKRSMLDALAREIALL 60

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            +L+H N+V+ +G   + DH  +  E++  GS+   L        +     +      KG
Sbjct: 61  KELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI--LKG 118

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-----VMGT 250
           L +LHN  R +I+RD K +NIL+D+    K+SDFG++K   + +     T      + G+
Sbjct: 119 LNYLHN--RGIIHRDIKGANILVDNKGGIKISDFGISKK-LEANSLSTKTNGARPSLQGS 175

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
             + APE V     T ++D++S G +++E+LTG+
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 59/209 (28%), Positives = 100/209 (47%), Gaps = 27/209 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-----LTEVNFLGQLRH 140
           +GEG +G VYKG    N + G       +  + K  L+   E      + E++ L +L+H
Sbjct: 8   IGEGTYGVVYKG---RNKKTG------QIVAMKKIRLESEEEGVPSTAIREISLLKELQH 58

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA----FGAAKGL 196
           PN+V L     ++    L++EF+    L+ +L    ++P        +     +   +G+
Sbjct: 59  PNIVCLQDVLMQESRLYLIFEFL-SMDLKKYL---DSLPKGQYMDAELVKSYLYQILQGI 114

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            F H   R V++RD K  N+L+D+    KL+DFGLA+A   G    V T  + T  Y AP
Sbjct: 115 LFCH--SRRVLHRDLKPQNLLIDNKGVIKLADFGLARA--FGIPVRVYTHEVVTLWYRAP 170

Query: 257 EYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           E ++     +   D++S G +  E+ T +
Sbjct: 171 EVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 78.3 bits (193), Expect = 4e-16
 Identities = 69/204 (33%), Positives = 102/204 (50%), Gaps = 17/204 (8%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--EVNFLGQLRHPN 142
           +LG+G FG V+   +   +         A+KVL K  L+      T  E + L ++ HP 
Sbjct: 3   VLGQGSFGKVF---LVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPF 59

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK-GLAFLH 200
           +VKL  Y  + + +L L+ +F+  G L   L ++        T   + F  A+  LA  H
Sbjct: 60  IVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLAELALALDH 113

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV- 259
                +IYRD K  NILLD +   KL+DFGL+K     ++   S    GT  Y APE V 
Sbjct: 114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEVVN 171

Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
             GH  + +D +SFGV++ E+LTG
Sbjct: 172 RRGHTQS-ADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 37/219 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNL 143
           ++GEG +G VYK     + + G     VA+K+++        E   E N L +   HPN+
Sbjct: 13  VIGEGTYGKVYKA---RHKKTGQL---VAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNI 65

Query: 144 VKLIG------YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAF---G 191
               G          DD   LV E    GS+ + L +          R+    IA+    
Sbjct: 66  ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGL---RKKGKRLKEEWIAYILRE 121

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMG 249
             +GLA+LH  E  VI+RD K  NILL  +   KL DFG++    Q D T +  R   +G
Sbjct: 122 TLRGLAYLH--ENKVIHRDIKGQNILLTKNAEVKLVDFGVSA---QLDST-LGRRNTFIG 175

Query: 250 TYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTG 283
           T  + APE +           ARSDV+S G+  +EL  G
Sbjct: 176 TPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADG 214

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 80/296 (27%), Positives = 125/296 (42%), Gaps = 42/296 (14%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFL 135
           +FR   +LG+GGFG V    +    ++       A K L K+ ++   G    L E   L
Sbjct: 1   TFRQYRVLGKGGFGEVCACQVRATGKM------YACKRLEKKRIKKRKGESMALNEKQIL 54

Query: 136 GQLRHPNLVKLIGYCCE-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            ++    +V L  Y  E  D   LV   M  G L+ H++            +  A     
Sbjct: 55  EKVNSQFVVNL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILC 113

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL  LH      +YRD K  NILLD     ++SD GLA   P+G+   +  RV GT GY 
Sbjct: 114 GLEDLH--RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES--IRGRV-GTVGYM 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE +     T   D +  G ++ E++ G+      +   ++  VD         R++L+
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD---------RRVLE 219

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEI 370
                 E  YS + +++A S+    L+++PK R            L C  +G  E+
Sbjct: 220 T-----EEVYSAKFSEEAKSICKMLLTKDPKQR------------LGCQEEGAGEV 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 28/214 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V         R G   L  A+K+L K+ +    +    + E   L     P
Sbjct: 7   VLGKGSFGKVMLAE-----RKGTDEL-YAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAK---G 195
             +  +  C +   RL  V E++  G L  H+    K   P +        F AA+   G
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHA-------VFYAAEIAIG 113

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYA 254
           L FLH+  + +IYRD K  N++LD++   K++DFG+ K    G +T   TR   GT  Y 
Sbjct: 114 LFFLHS--KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT---TRTFCGTPDYI 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVD 288
           APE +         D ++FGV+L E+L G+   D
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 77.7 bits (191), Expect = 6e-16
 Identities = 54/148 (36%), Positives = 74/148 (50%), Gaps = 12/148 (8%)

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GL 196
           +P L  L       +H   V EF+  G L  H+  K    L  AT     F AA+   GL
Sbjct: 55  NPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRAT-----FYAAEIVCGL 109

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            FLH+  + +IYRD K  N++LD D   K++DFG+ K    GD    ++   GT  Y AP
Sbjct: 110 QFLHS--KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR--ASTFCGTPDYIAP 165

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGR 284
           E +     T   D +SFGV+L E+L G+
Sbjct: 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 65/219 (29%), Positives = 97/219 (44%), Gaps = 45/219 (20%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPN 142
            +GEG +G VY+         V LK     V++ N ++G+      L E+  L  LRHPN
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKK----VRMDNERDGIPISS--LREITLLLNLRHPN 67

Query: 143 LVKL---------------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           +V+L               + YC +D   LL          +N        P S +    
Sbjct: 68  IVELKEVVVGKHLDSIFLVMEYCEQDLASLL----------DN-----MPTPFSESQVKC 112

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           +     +GL +LH  E  +I+RD K SN+LL      K++DFGLA+    G      T  
Sbjct: 113 LMLQLLRGLQYLH--ENFIIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPMTPK 168

Query: 248 MGTYGYAAPEYV--MTGHLTARSDVYSFGVVLLELLTGR 284
           + T  Y APE +   T + TA  D+++ G +L ELL  +
Sbjct: 169 VVTLWYRAPELLLGCTTYTTA-IDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 77.9 bits (192), Expect = 7e-16
 Identities = 72/226 (31%), Positives = 108/226 (47%), Gaps = 38/226 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLP---VAVKVLNKEGL------QGHREWLTEVNFL 135
           +LG+GG+G V++      VR    +      A+KVL K  +        H +   E N L
Sbjct: 3   VLGKGGYGKVFQ------VRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERNIL 54

Query: 136 GQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
             ++HP +V LI Y  +   +L L+ E++  G L  HL R+      +       + +  
Sbjct: 55  EAVKHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGI----FMEDTACFYLSEI 109

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGY 253
            LA  H  ++ +IYRD K  NILLD+    KL+DFGL K        TH      GT  Y
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT---FCGTIEY 166

Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTG---------RKSVDK 289
            APE +M +GH  A  D +S G ++ ++LTG         +K++DK
Sbjct: 167 MAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 76.9 bits (189), Expect = 8e-16
 Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 21/212 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           +LG+G FG+V +  +        K   VAVK+L  +        E+L E   + +  HPN
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQK---VAVKMLKADIFSSSDIEEFLREAACMKEFDHPN 62

Query: 143 LVKLIGYCCEDDHR------LLVYEFMFRGSLENHLFRKA------TVPLSWATRMMIAF 190
           ++KLIG       +      +++  FM  G L   L          T+PL    R MI  
Sbjct: 63  VIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             A G+ +L +  +  I+RD    N +L+ + T  ++DFGL+K    GD           
Sbjct: 123 --ASGMEYLSS--KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP 178

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             + A E +     T  SDV++FGV + E++T
Sbjct: 179 VKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 9e-16
 Identities = 64/219 (29%), Positives = 106/219 (48%), Gaps = 29/219 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 26  LGEGCFGQVVMAEA-----IGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 80

Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +    VP   LS+ 
Sbjct: 81  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFK 140

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 141 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 198

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 62/216 (28%), Positives = 107/216 (49%), Gaps = 23/216 (10%)

Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     K + VAVK+L  +   +   + ++E+  +  + +H
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPN--KPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKH 77

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           F    +P   L++   +
Sbjct: 78  KNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
             A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    +T 
Sbjct: 138 SCAYQVARGMEYL--ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV+L E+ T
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG +G VYK        V      VA+K +      EG+      + E++ L +L HP
Sbjct: 8   IGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTA--IREISLLKELNHP 59

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           N+VKL+     ++   LV+EF+ +  L+  +       +         F   +GLAF H 
Sbjct: 60  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH- 117

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM- 260
           + R V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y APE ++ 
Sbjct: 118 SHR-VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
             + +   D++S G +  E++T R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 73/224 (32%), Positives = 96/224 (42%), Gaps = 47/224 (20%)

Query: 80  FRSDYILGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNK---------EGLQGHR 126
           FR   +LG G FG V    YK                A+K L K         E L   +
Sbjct: 1   FRCLAVLGRGHFGKVLLAEYKK----------TGELYAIKALKKGDIIARDEVESLMCEK 50

Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWAT 184
                 N     RHP LV L  + C   +DH   V E+   G L  H+           +
Sbjct: 51  RIFETAN---SERHPFLVNL--FACFQTEDHVCFVMEYAAGGDLMMHIHTDVF------S 99

Query: 185 RMMIAFGAAK---GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP-QGDE 240
                F AA    GL +LH  E  ++YRD K  N+LLD++   K++DFGL K G   GD 
Sbjct: 100 EPRAVFYAACVVLGLQYLH--ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR 157

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
           T  ST   GT  + APE V+T     R+ D +  GV++ E+L G
Sbjct: 158 T--ST-FCGTPEFLAPE-VLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 33/211 (15%)

Query: 85  ILGEGGFGTVY--KGYIDEN----VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
            +GEG FG +Y  K   D        + L  +PV  K  +K+          EV  L ++
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKK----------EVILLAKM 56

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP------LSWATRMMIAFGA 192
           +HPN+V       E+    +V E+   G L   + R+  V       LSW  ++      
Sbjct: 57  KHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI------ 110

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           + GL  +H  +R +++RD K+ NI L  +   AKL DFG+A+     D   ++   +GT 
Sbjct: 111 SLGLKHIH--DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTP 166

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            Y +PE         ++D++S G VL EL T
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 53/176 (30%), Positives = 82/176 (46%), Gaps = 16/176 (9%)

Query: 113 AVKVLNKEGLQGHREWLTEV-----NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGS 167
           A+KVL K  +    + +T V       + Q   P + KL       D+  LV E++  G 
Sbjct: 25  AIKVLKKSDMIAKNQ-VTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGD 83

Query: 168 LENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS 227
             + +     +P  WA +  IA     G+  LH  +R +I+RD K  N+L+D     KL+
Sbjct: 84  CASLIKTLGGLPEDWA-KQYIA-EVVLGVEDLH--QRGIIHRDIKPENLLIDQTGHLKLT 139

Query: 228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           DFGL++ G        + + +GT  Y APE ++       SD +S G V+ E L G
Sbjct: 140 DFGLSRNG------LENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFG 189

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 71/208 (34%), Positives = 93/208 (44%), Gaps = 25/208 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    LTE   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHP 55

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+         R    +GA     L +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSED-RARF---YGAEIVSALGY 110

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG-PQGDETHVSTRVMGTYGYAAPE 257
           LH     V+YRD K  N++LD D   K++DFGL K G   G          GT  Y APE
Sbjct: 111 LH--SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATM---KTFCGTPEYLAPE 165

Query: 258 YVMTGHLTARS-DVYSFGVVLLELLTGR 284
            V+  +   R+ D +  GVV+ E++ GR
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 40/215 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-----LTEVNFLGQLRH 140
           +GEG +G VYK        +      VA+K   K  L+   E      + E++ L +L H
Sbjct: 7   IGEGTYGVVYKARDKLTGEI------VALK---KIRLETEDEGVPSTAIREISLLKELNH 57

Query: 141 PNLVKL--IGYCCEDDHRL-LVYEFMFRGSLENHLFRK--ATVPLSWATRMMIA---FGA 192
           PN+V+L  + +    +++L LV+EF+      +   +K   + PL+     +I    +  
Sbjct: 58  PNIVRLLDVVHS---ENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQL 108

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-G-PQGDETHVSTRVMGT 250
            +G+A+ H+    V++RD K  N+L+D +   KL+DFGLA+A G P    TH    V+ T
Sbjct: 109 LQGIAYCHS--HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH---EVV-T 162

Query: 251 YGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
             Y APE ++     +   D++S G +  E++  R
Sbjct: 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.8 bits (186), Expect = 2e-15
 Identities = 82/273 (30%), Positives = 119/273 (43%), Gaps = 30/273 (10%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFL 135
           +FR   +LG+GGFG V        VR   K    A K L K+ ++   G    L E   L
Sbjct: 1   TFRHYRVLGKGGFGEVCAC----QVRATGKMY--ACKKLEKKRIKKRKGEAMALNEKRIL 54

Query: 136 GQLRHPNLVKLIGYCCE-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            ++    +V L  Y  E  D   LV   M  G L+ H++            +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCC 113

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL  L   ER ++YRD K  NILLD     ++SD GLA   P+G+   V  RV GT GY 
Sbjct: 114 GLEDLQR-ER-IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRV-GTVGYM 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE +     T   D +  G ++ E++ G+    K +   ++  VD  R    D      
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD--RRVKED------ 220

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
                 + +YS + ++ A S+    L++NPK R
Sbjct: 221 ------QEEYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 75.8 bits (186), Expect = 3e-15
 Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 26/209 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG-QLRH 140
           +LG+G FG V+   +    +        A+K L K+ +    +    + E   L     H
Sbjct: 2   MLGKGSFGKVFLAELKGTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 55

Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           P L  L  YC     ++   V E++  G L  H+       L  AT     F AA+   G
Sbjct: 56  PFLTHL--YCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRAT-----FYAAEIICG 108

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH+  + ++YRD K  NILLD+D   K++DFG+ K    GD    +    GT  Y A
Sbjct: 109 LQFLHS--KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK--TCTFCGTPDYIA 164

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           PE ++        D +SFGV+L E+L G+
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 86  LGEGGFGTVYK--GYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHP 141
           LGEG FG V +   Y  +  R   +++ VAVK+L      +   + ++E+  +  + +H 
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPD-QTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHK 78

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMM 187
           N++ L+G C ++    ++ E+  +G+L   L               +     LS+   + 
Sbjct: 79  NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            A+  A+G+ +L    R  I+RD    N+L+  D   K++DFGLA+     D    ++  
Sbjct: 139 CAYQVARGMEYL--ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + APE +     T +SDV+SFG+++ E+ T
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 24/204 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    +N   G  +    ++  ++E L+   +++ E+  L    HP +VK
Sbjct: 20  LGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELE---DYMVEIEILATCNHPYIVK 73

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLEN---HLFRKATVP-LSWATRMMIAFGAAKGLAFLHN 201
           L+G    D    ++ EF   G+++     L R  T P +    R M+     + L +LH+
Sbjct: 74  LLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHS 128

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            +  +I+RD K  N+LL  D   KL+DFG++    +  +   S   +GT  + APE VM 
Sbjct: 129 MK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS--FIGTPYWMAPEVVMC 184

Query: 262 GHLTA-----RSDVYSFGVVLLEL 280
             +       ++D++S G+ L+E+
Sbjct: 185 ETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 70/206 (33%), Positives = 93/206 (45%), Gaps = 21/206 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 55

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 56  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 110

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G   D   + T   GT  Y APE 
Sbjct: 111 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKT-FCGTPEYLAPEV 166

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 74.4 bits (183), Expect = 6e-15
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 28/219 (12%)

Query: 80  FRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVL--NKEGLQGHREWLTEVNFLG 136
                +L EG FG ++ G  IDE      K   V VK +  +   +Q     L E   L 
Sbjct: 8   VTLSDLLQEGTFGRIFYGILIDEK---PGKEEEVFVKTVKDHASEIQVTL-LLQESCLLY 63

Query: 137 QLRHPNLVKLIGYCCED-DHRLLVYEFMFRGSLENHL----FRKATVPLSWATRMMIAFG 191
            L H N++ ++  C ED +   ++Y +M  G+L+  L      +A  P + +T+ ++   
Sbjct: 64  GLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMA 123

Query: 192 A--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQ-----GDETHV 243
              A G+++LH   R VI++D    N ++D +   K++D  L++   P      GD  + 
Sbjct: 124 IQIACGMSYLHK--RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENR 181

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             + M      A E ++    ++ SDV+SFGV+L EL+T
Sbjct: 182 PVKWM------ALESLVNKEYSSASDVWSFGVLLWELMT 214

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 50/198 (25%), Positives = 91/198 (45%), Gaps = 11/198 (5%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G F  VYK   + +   V LK     V++      +  ++ L E++ L QL HPN++
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKK----VQIFEMMDAKARQDCLKEIDLLKQLDHPNVI 65

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           K +    E++   +V E    G L   +  F+K    +   T           L  +H  
Sbjct: 66  KYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMH-- 123

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + +++RD K +N+ + +    KL D GL +      +T  +  ++GT  Y +PE +   
Sbjct: 124 SKRIMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 263 HLTARSDVYSFGVVLLEL 280
               +SD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 70/204 (34%), Positives = 93/204 (45%), Gaps = 18/204 (8%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVN-FLGQLRH 140
           ++G+G FG V         +  L     AVKVL K+ +   +E    + E N  L  ++H
Sbjct: 2   VIGKGSFGKVLLA------KRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKH 55

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P LV L       +    V +F+  G L  HL R+ + P   A R   A   A  L +LH
Sbjct: 56  PFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRA-RFYAA-EIASALGYLH 113

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG-PQGDETHVSTRVMGTYGYAAPEYV 259
           +    ++YRD K  NILLDS     L+DFGL K G  Q D T   T   GT  Y APE +
Sbjct: 114 SIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTT---TTFCGTPEYLAPEVI 168

Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
                    D +  G VL E+L G
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 74.3 bits (182), Expect = 1e-14
 Identities = 69/206 (33%), Positives = 94/206 (45%), Gaps = 20/206 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 55

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 56  FLTAL-KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDY 110

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH +E+ V+YRD K  N++LD D   K++DFGL K G +   T  +    GT  Y APE 
Sbjct: 111 LH-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEV 167

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGR 193

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 70/230 (30%), Positives = 105/230 (45%), Gaps = 45/230 (19%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL--NKEGLQGHR 126
           SL ELE + +       +G G  GTVYK      V         A+KV+  N E     R
Sbjct: 72  SLSELERVNR-------IGSGAGGTVYK------VIHRPTGRLYALKVIYGNHED-TVRR 117

Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCED--DHR---LLVYEFMFRGSLENHLFRKATVPLS 181
           +   E+  L  + HPN+VK     C D  DH     ++ EFM  GSLE            
Sbjct: 118 QICREIEILRDVNHPNVVK-----CHDMFDHNGEIQVLLEFMDGGSLEGTHI-------- 164

Query: 182 WATRMM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
              + +  +A     G+A+LH   R +++RD K SN+L++S    K++DFG+++   Q  
Sbjct: 165 ADEQFLADVARQILSGIAYLH--RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTAR-----SDVYSFGVVLLELLTGR 284
           +   S+  +GT  Y +PE + T            D++S GV +LE   GR
Sbjct: 223 DPCNSS--VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 83/296 (28%), Positives = 125/296 (42%), Gaps = 42/296 (14%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFL 135
           +FR   +LG+GGFG V        VR   K    A K L K+ ++   G    L E   L
Sbjct: 1   TFRHYRVLGKGGFGEVCAC----QVRATGKMY--ACKKLEKKRIKKRKGEAMALNEKQIL 54

Query: 136 GQLRHPNLVKLIGYCCE-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            ++    +V L  Y  E  D   LV   M  G L+ H++            +  A     
Sbjct: 55  EKVNSRFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITC 113

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL  LH  ER ++YRD K  NILLD     ++SD GLA   P+G+   +  RV GT GY 
Sbjct: 114 GLEDLHR-ER-IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET--IRGRV-GTVGYM 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE V     T   D +  G ++ E++ G+    + +   ++  V+  R    D      
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVE--RRVKED------ 220

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEI 370
                 + +YS + ++ A S+    L+++P  R            L C  +G  E+
Sbjct: 221 ------QEEYSEKFSEAARSICRQLLTKDPGFR------------LGCRGEGAEEV 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 70/224 (31%), Positives = 98/224 (43%), Gaps = 40/224 (17%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLN---KEGLQGHREWLTEVNFLGQLRHP 141
           LGEG FG VYK   I     V LK      K+L    K+G       L E+  L +L+HP
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALK------KILMHNEKDGF--PITALREIKILKKLKHP 67

Query: 142 NLVKLIGYCCE--DDH---RLLVYEFMF------RGSLENHLFRKATVPLSWATRMMIAF 190
           N+V LI    E  D     R  VY           G LEN   +   +  S     M+  
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK---LTESQIKCYMLQL 124

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---------AGPQGDET 241
              +G+ +LH  E  +++RD K +NIL+D+    K++DFGLA+          G  G  T
Sbjct: 125 --LEGINYLH--ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGT 180

Query: 242 HVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
              T ++ T  Y  PE ++     T   D++  G V  E+ T R
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 66/208 (31%), Positives = 98/208 (47%), Gaps = 26/208 (12%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---H 140
            +GEG +GTVYK   ++    V LK + V    L++EG+      L E+  L QL    H
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVP---LSEEGIP--LSTLREIALLKQLESFEH 60

Query: 141 PNLVKLIGYC--CEDDHRL---LVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGA 192
           PN+V+L+  C     D  L   LV+E +       L      K  +P      +M     
Sbjct: 61  PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKC--PKPGLPPETIKDLM--RQL 116

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
            +G+ FLH + R +++RD K  NIL+ SD   K++DFGLA+           T V+ T  
Sbjct: 117 LRGVDFLH-SHR-IVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTLW 171

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLEL 280
           Y APE ++        D++S G +  EL
Sbjct: 172 YRAPEVLLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 63/209 (30%), Positives = 99/209 (47%), Gaps = 34/209 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-------KEGLQGHREWLTEVNFLGQL 138
           +G G FG V+       VR  +     A+KV+        K+    H     E   L ++
Sbjct: 9   VGTGTFGRVHL------VRDRISEHYYALKVMAIPEVIRLKQEQHVH----NEKRVLKEV 58

Query: 139 RHPNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            HP +++L  +  E D R L  + E++  G L ++L  + +   S +T +  A      L
Sbjct: 59  SHPFIIRL--FWTEHDQRFLYMLMEYVPGGELFSYL--RNSGRFSNSTGLFYASEIVCAL 114

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAA 255
            +LH+ E  ++YRD K  NILLD +   KL+DFG AK      +    T  + GT  Y A
Sbjct: 115 EYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAK------KLRDRTWTLCGTPEYLA 166

Query: 256 PEYVM-TGHLTARSDVYSFGVVLLELLTG 283
           PE +   GH  A  D ++ G+++ E+L G
Sbjct: 167 PEVIQSKGHNKA-VDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGE  FG VYKG++      G ++  VA+K L +K       E+  E     +L+HPN+V
Sbjct: 13  LGEDRFGKVYKGHL-FGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA------------TV--PLSWATRMMIAF 190
            L+G   ++    +++ +     L   L  ++            TV   L  A  + I  
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             A G+ FL  +   V+++D  T N+L+      K+SD GL +     D   +    +  
Sbjct: 132 QIAAGMEFL--SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             + +PE +M G  +  SD++S+GVVL E+ +
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.9 bits (182), Expect = 2e-14
 Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 34/212 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G V   +   + + G K   VA+K L++  +     +    E+  L  + H N+
Sbjct: 23  VGSGAYGQVCSAF---DTKTGRK---VAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENV 76

Query: 144 VKLIGYCCEDDHR------LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+                LV   M  G+  N++ +     LS      + +   +GL 
Sbjct: 77  IGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVK--CQKLSDDHIQFLVYQILRGLK 132

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE---THVSTRVMGTYGYA 254
           ++H+A   +I+RD K SNI ++ D   K+ DFGLA+     D+    +V+TR      Y 
Sbjct: 133 YIHSAG--IIHRDLKPSNIAVNEDCELKILDFGLAR---HTDDEMTGYVATR-----WYR 182

Query: 255 APEYVMT--GHLTARSDVYSFGVVLLELLTGR 284
           APE +M    H     D++S G ++ ELLTG+
Sbjct: 183 APE-IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 69/271 (25%), Positives = 120/271 (44%), Gaps = 31/271 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ E  +   E +  E+  L Q   P + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +     ++ E++  GS  + L          AT +       KGL +LH+ ++
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+  AG   D        +GT  + APE +     
Sbjct: 123 --IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 178

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G        P +   L+    PK N          P L  ++
Sbjct: 179 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI----PKNN---------PPTLTGEF 225

Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL+++P  RP   ++++
Sbjct: 226 SKPFKE----FIDACLNKDPSFRPTAKELLK 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 73.3 bits (180), Expect = 2e-14
 Identities = 59/183 (32%), Positives = 94/183 (51%), Gaps = 28/183 (15%)

Query: 112 VAVKVLNKEGLQGHRE---WLTEVNFLGQLRHPNLVKLI-GYCCEDDHRL-LVYEFMFRG 166
            A+K L K  +   ++      E + L +L HP +V ++  +  +D++R+  + EF+  G
Sbjct: 46  YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF--QDENRVYFLLEFVVGG 103

Query: 167 SLENHLFRKA-----TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD 221
            L  HL RKA      V   +   +++AF       +LH+ +  +IYRD K  N+LLD+ 
Sbjct: 104 ELFTHL-RKAGRFPNDVAKFYHAELVLAF------EYLHSKD--IIYRDLKPENLLLDNK 154

Query: 222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLEL 280
              K++DFG AK  P  D T     + GT  Y APE + + GH  A  D ++ GV+L E 
Sbjct: 155 GHVKVTDFGFAKKVP--DRTFT---LCGTPEYLAPEVIQSKGHGKA-VDWWTMGVLLYEF 208

Query: 281 LTG 283
           + G
Sbjct: 209 IAG 211

Length = 329

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 63/210 (30%), Positives = 95/210 (45%), Gaps = 35/210 (16%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHP 141
           LG G FG V    Y +E+        PVA+K   K  +   ++     +E   L  + HP
Sbjct: 38  LGTGSFGRVILATYKNEDFP------PVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLS----WATRMMIAFGAAKGLA 197
             V L G   ++ +  LV EF+  G     L R    P      +A ++++ F   + L 
Sbjct: 92  FCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR---VMGTYGYA 254
                   ++YRD K  N+LLD D   K++DFG AK         V TR   + GT  Y 
Sbjct: 152 --------IVYRDLKPENLLLDKDGFIKMTDFGFAKV--------VDTRTYTLCGTPEYI 195

Query: 255 APEYVMT-GHLTARSDVYSFGVVLLELLTG 283
           APE ++  GH  A +D ++ G+ + E+L G
Sbjct: 196 APEILLNVGHGKA-ADWWTLGIFIYEILVG 224

Length = 340

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.2 bits (179), Expect = 3e-14
 Identities = 69/206 (33%), Positives = 94/206 (45%), Gaps = 21/206 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    LTE   L   RHP
Sbjct: 2   LLGKGTFGKVIL------VREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHP 55

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E++  G L  HL R+        TR    +GA     L +
Sbjct: 56  FLTSL-KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED-RTRF---YGAEIVSALDY 110

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+ +  ++YRD K  N++LD D   K++DFGL K G     T  +    GT  Y APE 
Sbjct: 111 LHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKT--FCGTPEYLAPEV 166

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 56/216 (25%), Positives = 105/216 (48%), Gaps = 23/216 (10%)

Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 80

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L               R     +++   +
Sbjct: 81  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 141 SCTYQVARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 67/221 (30%), Positives = 103/221 (46%), Gaps = 40/221 (18%)

Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLN-KEGLQGHREWLT---EVNFLGQLR 139
            +GEG +G VYK    D    V LK     V++ N KEG       +T   E+  L QL 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKK----VRLDNEKEGFP-----ITAIREIKILRQLN 64

Query: 140 HPNLVKLIGYCCEDDHRL----------LVYEFM---FRGSLENHL--FRKATVPLSWAT 184
           H N+V L     +    L          LV+E+M     G LE+ L  F +  +  S+  
Sbjct: 65  HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIK-SFMK 123

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
           +++      +GL + H   +  ++RD K SNILL++    KL+DFGLA+     +    +
Sbjct: 124 QLL------EGLNYCHK--KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175

Query: 245 TRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
            +V+ T  Y  PE ++       + DV+S G +L EL T +
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 71.8 bits (176), Expect = 4e-14
 Identities = 69/283 (24%), Positives = 122/283 (43%), Gaps = 51/283 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVG----LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG FG   K  + ++   G    +K + ++ K+  KE  +  +E    V  L  ++HP
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIKEINIS-KMSPKEREESRKE----VAVLSNMKHP 59

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP------LSWATRMMIAFGAAKG 195
           N+V+      E+ +  +V ++   G L   +  +  V       L W  ++         
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQIC-------- 111

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           LA  H  +R +++RD K+ NI L  D T KL DFG+A+         ++   +GT  Y +
Sbjct: 112 LALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPYYLS 169

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE         +SD+++ G VL E+ T + + +                  N K  +L+I
Sbjct: 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----------------NMKNLVLKI 213

Query: 316 ID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           I    P + + YS         L      +NP+ RP ++ ++E
Sbjct: 214 IRGSYPPVSSHYSYDLRNLVSQL----FKRNPRDRPSVNSILE 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 15/207 (7%)

Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +FR +  +G G F  VY+   + + V V LK     V++ +    +   + + E++ L Q
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLKQ 58

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKAT--VPLSWATRMMIAFGAA 193
           L HPN++K      ED+   +V E    G L   +  F+K    +P     +  +   +A
Sbjct: 59  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L  +H+  R V++RD K +N+ + +    KL D GL +      +T  +  ++GT  Y
Sbjct: 119 --LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLEL 280
            +PE +       +SD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 72.3 bits (177), Expect = 5e-14
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG + TV+KG      R  L    VA+K +  E  +G     + EV+ L  L+H N+V
Sbjct: 14  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L      D    LV+E++ +  L+ ++     + +S     +  +   +GLA+ H   R
Sbjct: 68  TLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNI-MSMHNVKIFLYQILRGLAYCH--RR 123

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y  P+ ++ +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSSE 181

Query: 264 LTARSDVYSFGVVLLELLTGR 284
            + + D++  G +  E+ +GR
Sbjct: 182 YSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 65/209 (31%), Positives = 92/209 (44%), Gaps = 26/209 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLR-H 140
           +LG+G FG V    +     V       A+KVL K+ +    +    +TE   L     H
Sbjct: 2   VLGKGSFGKVMLAELKGTDEV------YAIKVLKKDVILQDDDVDCTMTEKRILALAAKH 55

Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           P L  L  +CC    D    V E++  G L   + R        +      F AA+    
Sbjct: 56  PFLTAL--HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRS-----RFYAAEVTLA 108

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH     VIYRD K  NILLD++   KL+DFG+ K G     T  +T   GT  Y A
Sbjct: 109 LMFLH--RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT--TTTFCGTPDYIA 164

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           PE +         D ++ GV++ E++ G+
Sbjct: 165 PEILQELEYGPSVDWWALGVLMYEMMAGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 63/215 (29%), Positives = 88/215 (40%), Gaps = 46/215 (21%)

Query: 86  LGEGGFGTVY---KGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLR 139
           +G+GG+G V+   K    E          VA+K + K  L      R  LTE + L   +
Sbjct: 9   VGQGGYGQVFLAKKKDTGE---------IVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59

Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFM----FR------GSLENHLFRKATVPLSWATRMMI 188
              LVKL+ Y  +DD  L L  E++    FR      G L     R       +   M  
Sbjct: 60  SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHAR------FYMAEMFE 112

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           A  A   L ++H        RD K  N L+D+    KL+DFGL+K          +  V+
Sbjct: 113 AVDALHELGYIH--------RDLKPENFLIDASGHIKLTDFGLSKGI-----VTYANSVV 159

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           G+  Y APE +         D +S G +L E L G
Sbjct: 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 77/281 (27%), Positives = 125/281 (44%), Gaps = 42/281 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA+K +N +        + E+  + + +HPN+V 
Sbjct: 27  IGQGASGTVYTAI---DVATGQE---VAIKQMNLQQQPKKELIINEILVMRENKHPNIVN 80

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA------KGLAFL 199
            +      D   +V E++  GSL +         +   T M     AA      + L FL
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTD---------VVTETCMDEGQIAAVCRECLQALEFL 131

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEY 258
           H+    VI+RD K+ NILL  D + KL+DFG  A+  P   E    + ++GT  + APE 
Sbjct: 132 HS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEV 186

Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKMLQI-- 315
           V       + D++S G++ +E++ G        P +   L+     P+L +  K+  I  
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR 246

Query: 316 --IDPRLENQYSVRAAQKACSLAYYCLSQNP---KARPLMS 351
             ++  LE     R + K        L Q+P    A+PL S
Sbjct: 247 DFLNRCLEMDVEKRGSAKE-------LLQHPFLKIAKPLSS 280

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 70.7 bits (173), Expect = 9e-14
 Identities = 68/209 (32%), Positives = 94/209 (44%), Gaps = 21/209 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G G FG V  G     V  G     V VK L     +Q   ++L E      L+H NL+
Sbjct: 3   IGNGWFGKVILG----EVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKA---TVPLSWATRMMIAFGAAKGLAFL 199
           + +G C E    LLV EF   G L+ +L   RKA   T   +   RM  A   A GL  L
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRM--ACEIALGLLHL 116

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +   I+ D    N LL +D T K+ D+GL+    + D      ++     + APE V
Sbjct: 117 H--KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Query: 260 --MTGHL-----TARSDVYSFGVVLLELL 281
             + G+L     T  S+V+S GV + EL 
Sbjct: 175 DEVHGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 67/235 (28%), Positives = 110/235 (46%), Gaps = 16/235 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V K      V+     L +A K+++ E     R + + E+  L +   P +V
Sbjct: 13  LGAGNGGVVTK------VQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L     +P     ++ IA    +GLA+L    +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIA--VLRGLAYLREKHQ 124

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   D   ++   +GT  Y +PE +   H 
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 179

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
           + +SD++S G+ L+EL  GR  +    P  ++    + RP ++ +      I PR
Sbjct: 180 SVQSDIWSMGLSLVELAIGRYPIPP--PDAKELEAIFGRPVVDGEEGEPHSISPR 232

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 7/156 (4%)

Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           + E+  L +   P +V   G    D    +  E M  GSL+  L +   +P +   ++ I
Sbjct: 47  IRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISI 106

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           A    +GL +L   +  +++RD K SNIL++S    KL DFG++  G   D   ++   +
Sbjct: 107 A--VLRGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFV 159

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           GT  Y +PE +   H T +SD++S G+ L+E+  GR
Sbjct: 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 70.9 bits (173), Expect = 1e-13
 Identities = 63/232 (27%), Positives = 111/232 (47%), Gaps = 16/232 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTV+      +V  G +   VA+K +N +        + E+  + +L++PN+V 
Sbjct: 27  IGQGASGTVFTA---IDVATGQE---VAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +  A    +     + L FLH  +  
Sbjct: 81  FLDSFLVGDELFVVMEYLAGGSLTDVVTETC---MDEAQIAAVCRECLQALEFLHANQ-- 135

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ N+LL  D + KL+DFG  A+  P+  ++  ST V GT  + APE V     
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKMLQI 315
             + D++S G++ +E++ G        P +   L+     P+L +  K+  I
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPI 244

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 71.1 bits (174), Expect = 1e-13
 Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 16/206 (7%)

Query: 85  ILGEGGFGTVY----KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           +LG G +G V+        D      +K L  A  ++ K     H    TE N L  +R 
Sbjct: 7   VLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAA-LVQKAKTVEHTR--TERNVLEHVRQ 63

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
              +  + Y  + + +L L+ +++  G +  HL+++     +++   +  +     LA  
Sbjct: 64  SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD----NFSEDEVRFYSGEIILALE 119

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +  ++YRD K  NILLDS+    L+DFGL+K     +E   +    GT  Y APE +
Sbjct: 120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLS-EEKERTYSFCGTIEYMAPEII 178

Query: 260 --MTGHLTARSDVYSFGVVLLELLTG 283
               GH  A  D +S G+++ ELLTG
Sbjct: 179 RGKGGHGKA-VDWWSLGILIFELLTG 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)

Query: 85  ILGEGGFGTVY-----KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           +LG G +G V+      G+ D      +K L  A  V   +  +  R   TE   L  +R
Sbjct: 7   VLGTGAYGKVFLVRKVSGH-DSGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIR 62

Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
               +  + Y  + D +L L+ +++  G L  HL ++      +  + +  +     LA 
Sbjct: 63  QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE----RFKEQEVQIYSGEIVLAL 118

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H  +  +IYRD K  NILLDS+    L+DFGL+K   + DE   +    GT  Y AP+ 
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE-DEVERAYSFCGTIEYMAPDI 177

Query: 259 VM---TGHLTARSDVYSFGVVLLELLTG 283
           V     GH  A  D +S GV++ ELLTG
Sbjct: 178 VRGGDGGHDKA-VDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 59/201 (29%), Positives = 101/201 (50%), Gaps = 14/201 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG + TV+KG      R  L    VA+K +  E  +G     + EV+ L  L+H N+V
Sbjct: 13  LGEGTYATVFKG------RSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L      +    LV+E++    L+ +L     + +S     +  F   +GL++ H  +R
Sbjct: 67  TLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNL-MSMHNVKIFMFQLLRGLSYCH--KR 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            +++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y  P+ ++ +  
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV--TLWYRPPDVLLGSTE 180

Query: 264 LTARSDVYSFGVVLLELLTGR 284
            +   D++  G +L E+ TGR
Sbjct: 181 YSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 65/227 (28%), Positives = 104/227 (45%), Gaps = 32/227 (14%)

Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVK----VLNKEGLQGHREWLTEVNFLGQ 137
           LG+G +G V         +E          VA+K    V +K+ L   +  L E+  L  
Sbjct: 8   LGQGAYGIVCSARNAETSEEE--------TVAIKKITNVFSKKILA--KRALRELKLLRH 57

Query: 138 LR-HPNLVKLIGYCCEDD---HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            R H N+  L           + L +YE +    L  H   ++  PL+ A      +   
Sbjct: 58  FRGHKNITCLYDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQPLTDAHFQSFIYQIL 115

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---AGPQGDETHVSTRVMGT 250
            GL ++H+A   V++RD K  N+L+++D   K+ DFGLA+     P  +   + T  + T
Sbjct: 116 CGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVAT 172

Query: 251 YGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
             Y APE +++     ++ DV+S G +L ELL GRK V K +   +Q
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFKGKDYVDQ 218

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 69.6 bits (170), Expect = 4e-13
 Identities = 68/206 (33%), Positives = 95/206 (46%), Gaps = 22/206 (10%)

Query: 85  ILGEGGFGTVY--KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVN-FLGQL 138
           ++G+G FG V   K   D +          AVKVL K+ +   +E    + E N  L  L
Sbjct: 2   VIGKGSFGKVLLAKRKSDGSF--------YAVKVLQKKTILKKKEQNHIMAERNVLLKNL 53

Query: 139 RHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           +HP LV L  Y  +   +L  V +++  G L  HL R+             A   A  + 
Sbjct: 54  KHPFLVGL-HYSFQTAEKLYFVLDYVNGGELFFHLQRERC--FLEPRARFYAAEVASAIG 110

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +LH+    +IYRD K  NILLDS     L+DFGL K G + +ET  ++   GT  Y APE
Sbjct: 111 YLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET--TSTFCGTPEYLAPE 166

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTG 283
            +         D +  G VL E+L G
Sbjct: 167 VLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 79/293 (26%), Positives = 121/293 (41%), Gaps = 56/293 (19%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHP 141
           I+G GGFG VY        R        A+K L+K+ +   QG    L E   L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 142 N--LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           +   +  + Y      +L  + + M  G L  HL +         +   + F AA+   G
Sbjct: 55  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEAEMRFYAAEIILG 109

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA----KAGPQGDETHVSTRVMGTY 251
           L  +HN  R V+YRD K +NILLD     ++SD GLA    K  P     H S   +GT+
Sbjct: 110 LEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTH 159

Query: 252 GYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
           GY APE +  G    + +D +S G +L +LL G  S  +   +K++  +D          
Sbjct: 160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH-SPFRQHKTKDKHEID---------- 208

Query: 311 KMLQIIDPRLENQYSVRA-------AQKACSLAYYCL---SQNPKARPLMSDV 353
           +M   +   L + +S           Q+  +    CL   +Q  K  P    +
Sbjct: 209 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 79  SFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +F+ +  +G G F  VY+   + +   V LK     V++      +  ++ + E++ L Q
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKK----VQIFEMMDAKARQDCVKEIDLLKQ 58

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKAT--VPLSWATRMMIAFGAA 193
           L HPN++K +    ED+   +V E    G L   +  F+K    +P     R +  +   
Sbjct: 59  LNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP----ERTVWKYFVQ 114

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
              A  H   R V++RD K +N+ + +    KL D GL +      +T  +  ++GT  Y
Sbjct: 115 LCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 172

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLEL 280
            +PE +       +SD++S G +L E+
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 68.6 bits (167), Expect = 7e-13
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 16/232 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 136

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P   E    + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKMLQI 315
             + D++S G++ +E++ G        P +   L+     P+L +  K+  I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 36/270 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G +G VYK     NV  G  +   A+KV+  E  +       E+  +   +H N+V 
Sbjct: 17  IGSGTYGDVYKA---RNVNTGELA---AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
             G     D   +  EF   GSL++      T PLS +    ++    +GL +LH+  + 
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQD--IYHVTGPLSESQIAYVSRETLQGLYYLHSKGK- 127

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYGYAAPEYVMT--- 261
            ++RD K +NILL  +   KL+DFG++    Q   T    +  +GT  + APE       
Sbjct: 128 -MHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWMAPEVAAVERK 183

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV---DWARPKLNDKRKMLQIIDP 318
           G      D+++ G+  +EL   +  +    P +   L+   ++  PKL DK K       
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF-- 241

Query: 319 RLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                + V+ A          L++NPK RP
Sbjct: 242 ----HHFVKMA----------LTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 68.5 bits (167), Expect = 1e-12
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V+K      V      L +A K+++ E     R + + E+  L +   P +V
Sbjct: 13  LGAGNGGVVFK------VSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     ++ IA    KGL +L    +
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 124

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   D   ++   +GT  Y +PE +   H 
Sbjct: 125 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 179

Query: 265 TARSDVYSFGVVLLELLTGR 284
           + +SD++S G+ L+E+  GR
Sbjct: 180 SVQSDIWSMGLSLVEMAIGR 199

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 28/221 (12%)

Query: 86  LGEGGFGTVYKGYIDENVR--VGLKSLPV------AVKVLNKEGLQG-HREWLTEVNFLG 136
           LGEG +G V K   D      V +K + +        K     G+ G H   L E+  + 
Sbjct: 17  LGEGTYGKVEK-AYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           +++H N++ L+    E D   LV + M    L+  + RK  + L+ +    I      GL
Sbjct: 76  EIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQILNGL 132

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-------AGPQGDETHVSTRVMG 249
             LH      ++RD   +NI ++S    K++DFGLA+       +     +  +  R   
Sbjct: 133 NVLHK--WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190

Query: 250 TYG-----YAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           T       Y APE +M       + D++S G +  ELLTG+
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG + TVYKG      R  L    VA+K +  E  +G     + EV+ L  L+H N+V
Sbjct: 14  LGEGTYATVYKG------RSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 67

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L      +    LV+E++ +  L+ +L       ++     +  F   +GL + H   R
Sbjct: 68  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNS-INMHNVKLFLFQLLRGLNYCH--RR 123

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y  P+ ++ +  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV--TLWYRPPDILLGSTD 181

Query: 264 LTARSDVYSFGVVLLELLTGR 284
            + + D++  G +  E+ TGR
Sbjct: 182 YSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 67.9 bits (166), Expect = 1e-12
 Identities = 53/206 (25%), Positives = 99/206 (48%), Gaps = 21/206 (10%)

Query: 86  LGEGGFGTVYKG---YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           +GEG +G VYK      +E +   LK +      L +E        + E++ L +++H N
Sbjct: 10  IGEGTYGVVYKARDRVTNETI--ALKKIR-----LEQEDEGVPSTAIREISLLKEMQHGN 62

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF--GAAKGLAFLH 200
           +V+L      +    LV+E++    L+      ++   +   R++  +     +G+A+ H
Sbjct: 63  IVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCH 119

Query: 201 NAERPVIYRDFKTSNILLD-SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +    V++RD K  N+L+D      KL+DFGLA+A   G      T  + T  Y APE +
Sbjct: 120 S--HRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPEIL 175

Query: 260 M-TGHLTARSDVYSFGVVLLELLTGR 284
           + + H +   D++S G +  E++  +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 59/218 (27%), Positives = 105/218 (48%), Gaps = 14/218 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLV 144
           LGEG + TVYKG    N ++      VA+KV++ +  +G     + E + L  L+H N+V
Sbjct: 13  LGEGSYATVYKGISRINGQL------VALKVISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L       +    V+E+M    L  ++ +       +  R+ + F   +GLA++H   +
Sbjct: 67  LLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFM-FQLLRGLAYIHG--Q 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            +++RD K  N+L+      KL+DFGLA+A     +T+ S  V  T  Y  P+ ++    
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV--TLWYRPPDVLLGATD 180

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW 301
            ++  D++  G + +E+L G+ +        EQ    W
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW 218

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 33/210 (15%)

Query: 88  EGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLT---EVNFLGQLRH 140
           EG +G VY+    +   +      VA+K L     KEG       +T   E+N L +L+H
Sbjct: 15  EGTYGVVYRARDKKTGEI------VALKKLKMEKEKEGFP-----ITSLREINILLKLQH 63

Query: 141 PNLVKL--IGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V +  +      D   +V E++    +  +E         P   +    +      G
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSG 118

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           +A LH  +  +++RD KTSN+LL++    K+ DFGLA+    G      T+++ T  Y A
Sbjct: 119 VAHLH--DNWILHRDLKTSNLLLNNRGILKICDFGLAR--EYGSPLKPYTQLVVTLWYRA 174

Query: 256 PEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           PE ++     +   D++S G +  ELLT +
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 66/228 (28%), Positives = 107/228 (46%), Gaps = 32/228 (14%)

Query: 86  LGEGGFGTVYKGYI----DENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQL 138
           LG+G F  +YKG +    D ++    + + V +KVL       HR    +    + + QL
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLG----SDHRDSLAFFETASLMSQL 58

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLA 197
            H +LVKL G C  D++ ++V E++  G L+  L R K  V L W  ++ +A   A  L 
Sbjct: 59  SHKHLVKLYGVCVRDEN-IMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALH 115

Query: 198 FLHNAERPVIYRDFKTSNILL-----DSDYT--AKLSDFGLAKAGPQGDETHVSTRVMGT 250
           +L   ++ +++ +    NIL+     +  Y    KLSD G+       +E     RV   
Sbjct: 116 YLE--DKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREE-----RVERI 168

Query: 251 YGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
             + APE +  G   LT  +D +SFG  LLE+ +  +    T  S E+
Sbjct: 169 -PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           +G G +GTVYK         V LKS+ V     N++GL     RE +  +  L    HPN
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQT---NEDGLPLSTVRE-VALLKRLEAFDHPN 63

Query: 143 LVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFRKAT--VPLSWATRMMIAFGAAKG 195
           +V+L+  C       +    LV+E + +  L  +L +     +P      +M  F   +G
Sbjct: 64  IVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQF--LRG 120

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS-TRVMGTYGYA 254
           L FLH     +++RD K  NIL+ S    KL+DFGLA+         ++ T V+ T  Y 
Sbjct: 121 LDFLHA--NCIVHRDLKPENILVTSGGQVKLADFGLARIY----SCQMALTPVVVTLWYR 174

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELL 281
           APE ++        D++S G +  E+ 
Sbjct: 175 APEVLLQSTYATPVDMWSVGCIFAEMF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)

Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +++  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 19  RTYLDNFIKIGEGSTGIVCIATVKSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 72

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 123

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              K L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 124 AVLKALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKSLVGT 179

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  K 
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPKL 236

Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 237 KNLHKVSPSLK 247

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 35/93 (37%), Positives = 58/93 (62%), Gaps = 4/93 (4%)

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYG 252
           +GL ++H+A   V++RD K SN+LL+++   K+ DFGLA+ A P+ D T   T  + T  
Sbjct: 117 RGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174

Query: 253 YAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           Y APE ++      ++ D++S G +L E+L+ R
Sbjct: 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 66.7 bits (162), Expect = 3e-12
 Identities = 58/215 (26%), Positives = 103/215 (47%), Gaps = 15/215 (6%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      ++  G +   VA+K +N +        + E+  + + ++PN+V 
Sbjct: 27  IGQGASGTVYTAI---DIATGQE---VAIKQMNLQQQPKKELIINEILVMRENKNPNIVN 80

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 81  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALDFLHSNQ-- 135

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P+  ++  ST V GT  + APE V     
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 192

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
             + D++S G++ +E++ G        P +   L+
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI 227

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 78/292 (26%), Positives = 122/292 (41%), Gaps = 44/292 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPN 142
           ++G+G +G V       +   G K   VA+K +N   E +      L E+  L  LRHP+
Sbjct: 7   VIGKGSYGVVCSAI---DTHTGEK---VAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60

Query: 143 LVKLIGYCCEDDHR-----LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           +V++         R      +V+E M     + H   KA   L+        +   + L 
Sbjct: 61  IVEIKHIMLPPSRREFKDIYVVFELM---ESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS-TRVMGTYGYAAP 256
           ++H A   V +RD K  NIL ++D   K+ DFGLA+       T +  T  + T  Y AP
Sbjct: 118 YIHTAN--VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 257 EYVMT--GHLTARSDVYSFGVVLLELLTGR-----KSVDKT---------RPSKEQSLVD 300
           E   +     T   D++S G +  E+LTG+     K+V             PS E   + 
Sbjct: 176 ELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPET--IS 233

Query: 301 WARPKLNDK-RKMLQIIDPRLENQYSVR---AAQKACSLAYYCLSQNPKARP 348
             R   N+K R+ L  +  +    +S +   A   A  L    L+ +PK RP
Sbjct: 234 RVR---NEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 11/234 (4%)

Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH 171
           VAVK ++    Q       EV  +    H N+V +       D   +V EF+  G+L + 
Sbjct: 50  VAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDI 109

Query: 172 LFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 231
           +          AT   +     + L++LHN  + VI+RD K+ +ILL SD   KLSDFG 
Sbjct: 110 VTHTRMNEEQIAT---VCLSVLRALSYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF 164

Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR 291
                +  E      ++GT  + APE +         D++S G++++E++ G        
Sbjct: 165 CAQVSK--EVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222

Query: 292 PSKE-QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNP 344
           P +  + + D   P++ D  K+  ++   L+       +Q+A +     L Q+P
Sbjct: 223 PLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQE---LLQHP 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 66.6 bits (162), Expect = 3e-12
 Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V         R G   L  A+K+L K+ +    +    + E   L     P
Sbjct: 7   VLGKGSFGKVMLAE-----RKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
             +  +  C +   RL  V E++  G L  H+ +        A  +  A   + GL FLH
Sbjct: 61  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQA--VFYAAEISVGLFFLH 118

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYV 259
              R +IYRD K  N++LDS+   K++DFG+ K   +     V+TR   GT  Y APE +
Sbjct: 119 --RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK---EHMVDGVTTRTFCGTPDYIAPEII 173

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVD 288
                    D +++GV+L E+L G+   D
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 64/210 (30%), Positives = 91/210 (43%), Gaps = 29/210 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRH- 140
           I+G GGFG VY        R        A+K L+K+ +   QG    L E   L  +   
Sbjct: 1   IIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 54

Query: 141 --PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
             P +V +       D    + + M  G L  HL +       ++ + M  +     L  
Sbjct: 55  DCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV----FSEKEMRFYATEIILGL 110

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA----KAGPQGDETHVSTRVMGTYGYA 254
            H   R V+YRD K +NILLD     ++SD GLA    K  P     H S   +GT+GY 
Sbjct: 111 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VGTHGYM 162

Query: 255 APEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           APE +  G    + +D +S G +L +LL G
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 47/158 (29%), Positives = 68/158 (43%), Gaps = 20/158 (12%)

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP----LSWATRMMIAFGAAKGL 196
           PN+V L  Y   +D   LV +    G L +H+ +   +P      WA  M++A  A    
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA---- 100

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG-LAKAGPQGDETHVSTRVMGTYGYAA 255
             LH     ++ RD   +NILLD     +L+ F   ++     D   V         Y A
Sbjct: 101 --LH--REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------YCA 150

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS 293
           PE       T   D +S G +L ELLTG K++ +  PS
Sbjct: 151 PEVGGISEETEACDWWSLGAILFELLTG-KTLVECHPS 187

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 59/189 (31%), Positives = 84/189 (44%), Gaps = 31/189 (16%)

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
           PL+    +  +F  A+G+ FL  A R  I+RD    NILL  +   K+ DFGLA+     
Sbjct: 170 PLTMEDLICYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 226

Query: 239 DETHV---STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE 295
           D  +V   S R+     + APE +     T +SDV+SFGV+L E+               
Sbjct: 227 DPDYVRKGSARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF-------------- 270

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAY----YCLSQNPKARPLMS 351
            SL     P +    +  Q    RL++   +RA + A    Y     C   +PK RP  S
Sbjct: 271 -SLGASPYPGVQINEEFCQ----RLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFS 325

Query: 352 DVVETLEPL 360
            +VE L  L
Sbjct: 326 ALVEILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 65.5 bits (160), Expect = 6e-12
 Identities = 64/212 (30%), Positives = 93/212 (43%), Gaps = 32/212 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRH- 140
           +G G  G VYK      +R       +AVK +    NKE     +  L +++ +    H 
Sbjct: 23  IGSGTCGQVYK------MRFKKTGHVMAVKQMRRTGNKEEN---KRILMDLDVV-LKSHD 72

Query: 141 -PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
            P +VK  GY   D    +  E M   +  + L ++   P+       +     K L +L
Sbjct: 73  CPYIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYL 130

Query: 200 ---HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              H     VI+RD K SNILLD+    KL DFG+  +G   D +   TR  G   Y AP
Sbjct: 131 KEKHG----VIHRDVKPSNILLDASGNVKLCDFGI--SGRLVD-SKAKTRSAGCAAYMAP 183

Query: 257 EYV----MTGHLTARSDVYSFGVVLLELLTGR 284
           E +           R+DV+S G+ L+EL TG+
Sbjct: 184 ERIDPPDPNPKYDIRADVWSLGISLVELATGQ 215

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 65.1 bits (159), Expect = 7e-12
 Identities = 48/167 (28%), Positives = 76/167 (45%), Gaps = 27/167 (16%)

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           IA    K L +LH ++  VI+RD K SN+L++ +   KL DFG++       ++   T  
Sbjct: 108 IAVSIVKALEYLH-SKLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTID 163

Query: 248 MGTYGYAAPEYV----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ--SLVDW 301
            G   Y APE +           +SDV+S G+ ++EL TGR   D  +   +Q   +V+ 
Sbjct: 164 AGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE 223

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
             P+L  ++   +  D    N+               CL +N K RP
Sbjct: 224 PSPQLPAEKFSPEFQD--FVNK---------------CLKKNYKERP 253

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 65.1 bits (158), Expect = 8e-12
 Identities = 60/210 (28%), Positives = 102/210 (48%), Gaps = 10/210 (4%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           ++R   +LG+G FG VY  Y D +    L +  V     + E  +       E+  L  L
Sbjct: 3   NWRRGKLLGQGAFGRVYLCY-DVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 139 RHPNLVKLIGYCCED--DHRLLVY-EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           +H  +V+  G C  D  +  L ++ E+M  GS+++ L  KA   L+ +          +G
Sbjct: 62  QHERIVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQL--KAYGALTESVTRKYTRQILEG 118

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYGYA 254
           +++LH+    +++RD K +NIL DS    KL DFG +K       +    R V GT  + 
Sbjct: 119 MSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWM 176

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           +PE +       ++DV+S G  ++E+LT +
Sbjct: 177 SPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 52/222 (23%), Positives = 90/222 (40%), Gaps = 45/222 (20%)

Query: 87  GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-----EVNFLGQLRHP 141
           G G +G VYK                A+K    +G +     ++     E+  L +L+H 
Sbjct: 9   GRGTYGRVYKAKRKNGKD----GKEYAIKKF--KGDKEQYTGISQSACREIALLRELKHE 62

Query: 142 NLVKLIGYCCEDDHRL--LVYEFMFRGSLENHLF-------RKATVPLSWATRMMIAFGA 192
           N+V L+    E   +   L++++      E+ L+       +   V +  +    + +  
Sbjct: 63  NVVSLVEVFLEHADKSVYLLFDYA-----EHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI 117

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAKLSDFGLA-------KAGPQGDET 241
             G+ +LH     V++RD K +NIL+  +       K+ D GLA       K     D  
Sbjct: 118 LNGVHYLH--SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLD-- 173

Query: 242 HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
                V+ T  Y APE ++   H T   D+++ G +  ELLT
Sbjct: 174 ----PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 58/189 (30%), Positives = 86/189 (45%), Gaps = 30/189 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPN 142
            +G+G FG V+K    +  + V LK     V + N KEG       L E+  L  L+H N
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKK----VLMENEKEGFP--ITALREIKILQLLKHEN 72

Query: 143 LVKLIGYC-----CEDDHR---LLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFG 191
           +V LI  C       + ++    LV+EF      G L N   +     LS   ++M    
Sbjct: 73  VVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKML- 128

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ---GDETHVSTRVM 248
              GL ++H  +  +++RD K +NIL+  D   KL+DFGLA+A            + RV+
Sbjct: 129 -LNGLYYIHRNK--ILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV 185

Query: 249 GTYGYAAPE 257
            T  Y  PE
Sbjct: 186 -TLWYRPPE 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 66/202 (32%), Positives = 91/202 (45%), Gaps = 17/202 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHPN 142
           +G+G FG V +    +  R+       A+K + K  +    E    L E   L Q+  P 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRI------YALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPF 54

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +V L       +   LV  F+  G L +HL R+    LS A      F  A+ L  L N 
Sbjct: 55  IVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRAR-----FYTAELLCALENL 109

Query: 203 -ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            +  VIYRD K  NILLD      L DFGL K   + D+   +    GT  Y APE ++ 
Sbjct: 110 HKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK--TNTFCGTPEYLAPELLLG 167

Query: 262 GHLTARSDVYSFGVVLLELLTG 283
              T   D ++ GV+L E+LTG
Sbjct: 168 HGYTKAVDWWTLGVLLYEMLTG 189

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 21/206 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFL---GQLR 139
           +G+G FG VY+    +  R+       A+KVL+K+ +   +E    + E N L       
Sbjct: 1   IGKGTFGQVYQVRKKDTRRI------YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDE 54

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
            P +V L      D    LV ++M  G L  HL ++       A +  IA      LA  
Sbjct: 55  SPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRA-KFYIA---ELVLALE 110

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +  ++YRD K  NILLD+     L DFGL+KA    ++T  +    GT  Y APE +
Sbjct: 111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT--TNTFCGTTEYLAPEVL 168

Query: 260 M--TGHLTARSDVYSFGVVLLELLTG 283
           +   G+ T   D +S GV++ E+  G
Sbjct: 169 LDEKGY-TKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 65/203 (32%), Positives = 92/203 (45%), Gaps = 16/203 (7%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVN-FLGQLRH 140
           ++G+G FG V         R   +    AVKVL K+ +   +E    ++E N  L  ++H
Sbjct: 2   VIGKGSFGKVLLA------RHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 55

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P LV L       D    V +++  G L  HL R+    L    R   A   A  L +LH
Sbjct: 56  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAA-EIASALGYLH 113

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +    ++YRD K  NILLDS     L+DFGL K   + + T  ++   GT  Y APE + 
Sbjct: 114 SLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT--TSTFCGTPEYLAPEVLH 169

Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D +  G VL E+L G
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 62/218 (28%), Positives = 94/218 (43%), Gaps = 51/218 (23%)

Query: 86  LGEGGFGTVYKGYIDE--NVRVGLKSL--PVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           +G G FG V     D+     V +K +  P +  VL K   + +RE    +  L  LRH 
Sbjct: 18  VGMGAFGLVCSAR-DQLTGQNVAIKKIMKPFSTPVLAK---RTYRE----LKLLKHLRHE 69

Query: 142 NLVKL----------IGYCCE----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           N++ L          I +  E    D HRLL                  + PL       
Sbjct: 70  NIISLSDIFISPLEDIYFVTELLGTDLHRLL-----------------TSRPLEKQFIQY 112

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
             +   +GL ++H+A   V++RD K SNIL++ +   K+ DFGLA+        +VSTR 
Sbjct: 113 FLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY 170

Query: 248 MGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGR 284
                Y APE ++T        D++S G +  E+L G+
Sbjct: 171 -----YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 25  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78

Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 79  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 134

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 135 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 187

Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 70/242 (28%), Positives = 100/242 (41%), Gaps = 48/242 (19%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG----HREWLTEVN 133
           K F+   +LG+G  G V+       VR+       A+KVL+K+ +       R  LTE  
Sbjct: 1   KHFKKIKLLGKGDVGRVFL------VRLKGTGKLFALKVLDKKEMIKRNKVKRV-LTEQE 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L  L HP L  L      + +  LV ++   G L   L ++   P    +  +  F AA
Sbjct: 54  ILATLDHPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQ--PGKCLSEEVARFYAA 110

Query: 194 K---GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-----------AGPQG- 238
           +    L +LH     ++YRD K  NILL       LSDF L+K           A  +G 
Sbjct: 111 EVLLALEYLHL--LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168

Query: 239 ---------DETHV---STRVM---GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT 282
                     ET     S R     GT  Y APE +   GH  +  D ++ G++L E+L 
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLY 227

Query: 283 GR 284
           G 
Sbjct: 228 GT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 64.7 bits (158), Expect = 2e-11
 Identities = 54/188 (28%), Positives = 88/188 (46%), Gaps = 24/188 (12%)

Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR------LLVYEFM 163
           VA+K +    +     +  L E+  L  L H N++ +        HR       +VYE M
Sbjct: 33  VAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELM 91

Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
                + H   +++  LS        +   +GL ++H+A   V++RD K SN+LL+++  
Sbjct: 92  ---DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCD 146

Query: 224 AKLSDFGLAKAGPQGDE---THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLE 279
            K+ DFGLA+   +  +    +V TR      Y APE ++     T   DV+S G +  E
Sbjct: 147 LKICDFGLARTTSEKGDFMTEYVVTR-----WYRAPELLLNCSEYTTAIDVWSVGCIFAE 201

Query: 280 LLTGRKSV 287
           LL GRK +
Sbjct: 202 LL-GRKPL 208

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 39/210 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG +GTV+K    E   +      VA+K +    + EG+      L E+  L +L+H 
Sbjct: 8   IGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSA--LREICLLKELKHK 59

Query: 142 NLVKLIGYCCEDDHRLLVYEFM----------FRGSLENHLFRKATVPLSWATRMMIAFG 191
           N+V+L      D    LV+E+             G ++  + +     L           
Sbjct: 60  NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQL----------- 108

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGLAF H     V++RD K  N+L++ +   KL+DFGLA+A   G      +  + T 
Sbjct: 109 -LKGLAFCH--SHNVLHRDLKPQNLLINKNGELKLADFGLARA--FGIPVRCYSAEVVTL 163

Query: 252 GYAAPEYVMTGHLTARS-DVYSFGVVLLEL 280
            Y  P+ +    L + S D++S G +  EL
Sbjct: 164 WYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 73/228 (32%), Positives = 99/228 (43%), Gaps = 36/228 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLV 144
           +G+G +G VYK     N + G  +   AVK+L+        E   E N L  L  HPN+V
Sbjct: 30  IGKGTYGKVYKV---TNKKDGSLA---AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVV 82

Query: 145 KLIGYCCEDDHRL-----LVYEFMFRGS---LENHLFRKATVPLSWATRMMIAFGAAKGL 196
           K  G   + D  +     LV E    GS   L   L       L  A    I +GA  GL
Sbjct: 83  KFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ-RLDEAMISYILYGALLGL 141

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV-----MGTY 251
             LHN    +I+RD K +NILL ++   KL DFG++           STR+     +GT 
Sbjct: 142 QHLHNNR--IIHRDVKGNNILLTTEGGVKLVDFGVSA-------QLTSTRLRRNTSVGTP 192

Query: 252 GYAAPEYVMTGH-----LTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
            + APE +           AR DV+S G+  +EL  G   +    P K
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 34/92 (36%), Positives = 56/92 (60%), Gaps = 4/92 (4%)

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GL +LH+A   +++RD K  N+L++S+   K+ DFGLA+     +  H++  V+  Y Y
Sbjct: 114 RGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-Y 170

Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE +M + H T+  D++S G +  ELL  R
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 63.2 bits (154), Expect = 4e-11
 Identities = 75/289 (25%), Positives = 116/289 (40%), Gaps = 51/289 (17%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVK-----VLNKEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTV K     +  +      +AVK     V  KE     +  L +++ + +   
Sbjct: 12  IGRGAFGTVNKMLHKPSGTI------MAVKRIRSTVDEKE----QKRLLMDLDVVMRSSD 61

Query: 141 -PNLVKLIGYCCEDDHRLLVYEFMFRGSLEN-----HLFRKATVPLSWATRMM--IAFGA 192
            P +VK  G    +    +  E M   SL+      +   K+ +P      ++  IA   
Sbjct: 62  CPYIVKFYGALFREGDCWICMELM-DISLDKFYKYVYEVLKSVIP----EEILGKIAVAT 116

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
            K L +L   E  +I+RD K SNILLD +   KL DFG++    Q  ++   TR  G   
Sbjct: 117 VKALNYLKE-ELKIIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRP 172

Query: 253 YAAPEYVMTGHLTA---RSDVYSFGVVLLELLTGRKSVDKTRPSKEQ--SLVDWARPKLN 307
           Y APE +          RSDV+S G+ L E+ TG+    K     +Q   +V    P L 
Sbjct: 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL- 231

Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
                        E ++S             CL ++   RP   +++E 
Sbjct: 232 ---------SNSEEREFSPSFVN----FINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 30/208 (14%)

Query: 86  LGEGGFGTVY-----KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           LG+G FGTVY     K   +E ++V LK +PV  ++   E +Q +     E   L +L H
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKV-LKEIPVG-ELNPNETVQAN----QEAQLLSKLDH 61

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLS------WATRMMIAFGA 192
           P +VK      E D   ++ E+     L+  L   +     LS      W  ++++    
Sbjct: 62  PAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL---- 117

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             G+ ++H  +R +++RD K  NI L ++   K+ DFG+++         ++T   GT  
Sbjct: 118 --GVHYMH--QRRILHRDLKAKNIFLKNNLL-KIGDFGVSRL--LMGSCDLATTFTGTPY 170

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLEL 280
           Y +PE +      ++SD++S G +L E+
Sbjct: 171 YMSPEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 68/292 (23%), Positives = 124/292 (42%), Gaps = 39/292 (13%)

Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S   +YI +GEG  G V       + R       VAVK+++    Q       EV  + 
Sbjct: 20  RSLLENYIKIGEGSTGIVCIAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMR 73

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
             +H N+V++       +   ++ EF+  G+L + +   +   L+      +     + L
Sbjct: 74  DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQTRLNEEQIATVCESVLQAL 130

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG----LAKAGPQGDETHVSTRVMGTYG 252
            +LH+  + VI+RD K+ +ILL  D   KLSDFG    ++K  P+         ++GT  
Sbjct: 131 CYLHS--QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKSLVGTPY 182

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP-SKEQSLVDWARPKLNDKRK 311
           + APE +         D++S G++++E++ G        P    + L D   PKL +  K
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA 363
           +  ++   LE                  L++ P+ R    ++++    LQ  
Sbjct: 243 ISPVLRDFLERM----------------LTREPQERATAQELLDHPFLLQTG 278

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 62.8 bits (153), Expect = 6e-11
 Identities = 62/220 (28%), Positives = 100/220 (45%), Gaps = 28/220 (12%)

Query: 86  LGEGGFGTVYKGY--IDENVRVGLKSLPVAVKVLNKEGLQGHREW-----LTEVNFLGQL 138
           LGEG + TVYKG   +   +        VA+K +  E    H E      + E + L  L
Sbjct: 13  LGEGSYATVYKGRSKLTGQL--------VALKEIRLE----HEEGAPFTAIREASLLKDL 60

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           +H N+V L           LV+E++    L+ ++       LS     +  F   +GLA+
Sbjct: 61  KHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGG-LSMHNVRLFLFQLLRGLAY 118

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H  +R V++RD K  N+L+      KL+DFGLA+A     +T+ +  V  T  Y  P+ 
Sbjct: 119 CH--QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVV--TLWYRPPD- 173

Query: 259 VMTG--HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
           V+ G    +   D++  G +  E+ TGR     +   ++Q
Sbjct: 174 VLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ 213

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 57/208 (27%), Positives = 89/208 (42%), Gaps = 29/208 (13%)

Query: 85  ILGEGGFG-TVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           ++GEG FG  +   +++ + +  +K + +       E  +       E   L +++HPN+
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSR------KEAVLLAKMKHPNI 60

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSL-------ENHLFRKATVPLSWATRMMIAFGAAKGL 196
           V        D H  +V E+   G L          LF + T+ L W  +M         L
Sbjct: 61  VAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMC--------L 111

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYA 254
              H  E+ V++RD K+ NI L  +   KL DFG A+    P     +  T V GT  Y 
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---AYACTYV-GTPYYV 167

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT 282
            PE         +SD++S G +L EL T
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCT 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 74/267 (27%), Positives = 118/267 (44%), Gaps = 35/267 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNL 143
           ++G G +G VYKG    +V+ G  +   A+KV++  G +   E   E+N L +   H N+
Sbjct: 13  LVGNGTYGQVYKG---RHVKTGQLA---AIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 65

Query: 144 VKLIGYCCE------DDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKG 195
               G   +      DD   LV EF   GS+ + +   +  T+   W     I     +G
Sbjct: 66  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRG 123

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGY 253
           L+ LH  +  VI+RD K  N+LL  +   KL DFG++    Q D T V  R   +GT  +
Sbjct: 124 LSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYW 177

Query: 254 AAPEYVMTGH-----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLN 307
            APE +            +SD++S G+  +E+  G   +    P +   L+     P+L 
Sbjct: 178 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLK 237

Query: 308 DK---RKMLQIIDPRLENQYSVRAAQK 331
            K   +K    I+  L   +S R   +
Sbjct: 238 SKKWSKKFQSFIESCLVKNHSQRPTTE 264

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 62.2 bits (151), Expect = 6e-11
 Identities = 71/260 (27%), Positives = 110/260 (42%), Gaps = 39/260 (15%)

Query: 86  LGEGGFGTVYKG--YIDENV-RVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           +G G FG V     Y D  V RV +K L            +   E+L + +    L+HPN
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANA------SSKEQNEFLQQGDPYRILQHPN 56

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL------FRKATVPLSWATRMMIAFGAAKGL 196
           +++ +G C E    LLV+E+   G L+++L       R + + L    RM  A   A G+
Sbjct: 57  ILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL--LQRM--ACEIAAGV 112

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
             +H  +   ++ D    N  L SD T K+ D+G+  +  + D             + AP
Sbjct: 113 THMH--KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAP 170

Query: 257 EYV-------MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND- 308
           E V       +T   T  S+V++ GV L EL          +P    S     R  LN  
Sbjct: 171 ELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA-----QPYSHLS----DREVLNHV 221

Query: 309 -KRKMLQIIDPRLENQYSVR 327
            K + +++  P+LE  YS R
Sbjct: 222 IKDQQVKLFKPQLELPYSER 241

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 59/209 (28%), Positives = 101/209 (48%), Gaps = 12/209 (5%)

Query: 79  SFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           ++R   +LG G FG VY  Y  D    + +K +P      ++E  +       E+  L  
Sbjct: 3   NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPD--SQETSKEVNALECEIQLLKN 60

Query: 138 LRHPNLVKLIGYCCED--DHRLLVY-EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           LRH  +V+  G C  D  + +L ++ E+M  GS+++ L  KA   L+            +
Sbjct: 61  LRHDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQL--KAYGALTENVTRRYTRQILQ 117

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYGY 253
           G+++LH+    +++RD K +NIL DS    KL DFG +K       +    + V GT  +
Sbjct: 118 GVSYLHS--NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYW 175

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +PE +       ++DV+S    ++E+LT
Sbjct: 176 MSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.8 bits (150), Expect = 8e-11
 Identities = 54/204 (26%), Positives = 94/204 (46%), Gaps = 11/204 (5%)

Query: 86  LGEGGFGTVYKGYIDENVRVG-LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG+G F  ++KG   E    G L    V +KVL+K        +    + + QL H +LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 145 KLIGYC-CEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNA 202
              G C C D+  ++V E++  GSL+ +L + K  + +SW  ++ +A   A  L FL   
Sbjct: 63  LNYGVCVCGDES-IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLE-- 117

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT--YGYAAPEYVM 260
           ++ + + +    N+LL  +   K  +    K    G    V  + +      +  PE + 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIE 177

Query: 261 TG-HLTARSDVYSFGVVLLELLTG 283
              +L+  +D +SFG  L E+ +G
Sbjct: 178 NPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 59/205 (28%), Positives = 89/205 (43%), Gaps = 17/205 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPN 142
           LG+GGFG V    +    ++       A K LNK+ L   +G+   + E   L ++ H  
Sbjct: 1   LGKGGFGEVSACQMRATGKL------YACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSR 53

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA--KGLAFL 199
            +  + Y  +    L LV   M  G L  H++        +       + A    GL  L
Sbjct: 54  FIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +R +IYRD K  N+LLD+D   ++SD GLA     G     +    GT G+ APE +
Sbjct: 114 H--QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELL 169

Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D ++ GV L E++  R
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 61/209 (29%), Positives = 96/209 (45%), Gaps = 18/209 (8%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V         R G   L  A+K+L K+ +    +    + E   L     P
Sbjct: 7   VLGKGSFGKVMLAE-----RKGTDEL-YAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
             +  +  C +   RL  V E++  G L   + +        A  +  A   A GL FLH
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHA--VFYAAEIAIGLFFLH 118

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYV 259
           +  + +IYRD K  N++LDS+   K++DFG+ K   +     V+T+   GT  Y APE +
Sbjct: 119 S--KGIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGTPDYIAPEII 173

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVD 288
                    D ++FGV+L E+L G+   +
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 61.9 bits (150), Expect = 9e-11
 Identities = 82/300 (27%), Positives = 119/300 (39%), Gaps = 66/300 (22%)

Query: 86  LGEGGFGTVYKGYIDEN--VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---H 140
           +GEG +G V+K    +N    V LK + V      +EG+      + EV  L  L    H
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG---EEGMP--LSTIREVAVLRHLETFEH 63

Query: 141 PNLVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAA 193
           PN+V+L   C       +    LV+E + +  L  +L +  +  VP      MM      
Sbjct: 64  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL--L 120

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GL FLH+    V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y
Sbjct: 121 RGLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWY 175

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTR--------PSKEQSLV 299
            APE ++        D++S G +  E      L  G   VD+          P +E    
Sbjct: 176 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE---- 231

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQK-----------ACSLAYYCLSQNPKARP 348
           DW R           +  PR    +  ++AQ               L   CL+ NP  R 
Sbjct: 232 DWPR----------DVALPR--QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 53/200 (26%), Positives = 97/200 (48%), Gaps = 14/200 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG + TVYKG    N ++      VA+KV+  +  +G     + E + L  L+H N+V
Sbjct: 13  LGEGSYATVYKGKSKVNGKL------VALKVIRLQEEEGTPFTAIREASLLKGLKHANIV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L       +   LV+E++     +     K    L      +  F   +GL+++H  +R
Sbjct: 67  LLHDIIHTKETLTLVFEYVHTDLCQ--YMDKHPGGLHPENVKLFLFQLLRGLSYIH--QR 122

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            +++RD K  N+L+      KL+DFGLA+A  +   +H  +  + T  Y  P+ ++ +  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPPDVLLGSTE 180

Query: 264 LTARSDVYSFGVVLLELLTG 283
            +   D++  G + +E++ G
Sbjct: 181 YSTCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 63/231 (27%), Positives = 95/231 (41%), Gaps = 37/231 (16%)

Query: 74  ETITKSFR------SDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ 123
           E I +  R       DY    ++G G FG V      + VR        A+K+L+K  + 
Sbjct: 29  EKIVRKIRKLQMKAEDYDVVKVIGRGAFGEV------QLVRHKSSQKVYAMKLLSKFEMI 82

Query: 124 GHRE---WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPL 180
              +   +  E + +     P +V+L     +D +  +V E+M  G L N L     VP 
Sbjct: 83  KRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPE 141

Query: 181 SWA----TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
            WA      +++A  A   +  +H        RD K  N+LLD     KL+DFG      
Sbjct: 142 KWAKFYTAEVVLALDAIHSMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMD 193

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYSFGVVLLELLTG 283
           +       T V GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 194 ETGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.6 bits (152), Expect = 2e-10
 Identities = 35/93 (37%), Positives = 50/93 (53%)

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           LA  H   + +I+RD K++NILL S+   KL DFG +K         V     GT  Y A
Sbjct: 154 LAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA 213

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVD 288
           PE       + ++D++S GV+L ELLT ++  D
Sbjct: 214 PEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 75/261 (28%), Positives = 112/261 (42%), Gaps = 31/261 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNL 143
           ++G G +G VYKG    +V+ G  +   A+KV++    +   E   E+N L +   H N+
Sbjct: 23  VVGNGTYGQVYKG---RHVKTGQLA---AIKVMDVTEDE-EEEIKLEINMLKKYSHHRNI 75

Query: 144 VKLIGYCCE------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
               G   +      DD   LV EF   GS+ + +       L       I     +GLA
Sbjct: 76  ATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLA 135

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYAA 255
            LH     VI+RD K  N+LL  +   KL DFG++    Q D T V  R   +GT  + A
Sbjct: 136 HLH--AHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRRNTFIGTPYWMA 189

Query: 256 PEYVMTGH-----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDK 309
           PE +            RSD++S G+  +E+  G   +    P +   L+     PKL  K
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSK 249

Query: 310 ---RKMLQIIDPRLENQYSVR 327
              +K +  I+  L   Y  R
Sbjct: 250 KWSKKFIDFIEGCLVKNYLSR 270

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 72/285 (25%), Positives = 119/285 (41%), Gaps = 38/285 (13%)

Query: 74  ETITKSFRSDYIL----GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
           + + ++ + DY L    G G +G VYK     N+  G  +   AVK++  E         
Sbjct: 1   DILRRNPQHDYELIQRVGSGTYGDVYKA---RNLHTGELA---AVKIIKLEPGDDFSLIQ 54

Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
            E+  + + +H N+V   G     +   +  E+   GSL++      T PLS      + 
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQD--IYHVTGPLSELQIAYVC 112

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
               +GLA+LH+  +  ++RD K +NILL  +   KL+DFG+A           S   +G
Sbjct: 113 RETLQGLAYLHS--KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS--FIG 168

Query: 250 TYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV---DWAR 303
           T  + APE       G      D+++ G+  +EL   +  +    P +   L+   ++  
Sbjct: 169 TPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQP 228

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
           PKL DK K          N   +             L++NPK RP
Sbjct: 229 PKLKDKTKW----SSTFHNFVKI------------SLTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)

Query: 111 PVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN 170
           PV +K+    G +G    L E   L  + HP+++++           +V    +   L  
Sbjct: 93  PVVLKI----GQKGTT--LIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP-HYSSDLYT 145

Query: 171 HLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG 230
           +L +++  PL     ++I     +GL +LH A+R +I+RD KT NI ++      + D G
Sbjct: 146 YLTKRSR-PLPIDQALIIEKQILEGLRYLH-AQR-IIHRDVKTENIFINDVDQVCIGDLG 202

Query: 231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKT 290
            A+  P      +   + GT    APE +      +++D++S G+VL E+L    ++ + 
Sbjct: 203 AAQF-PVVAPAFLG--LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259

Query: 291 RPSKEQSLVDWARPKLNDKRKMLQI 315
            PS  +  V      L      L++
Sbjct: 260 PPSTPEEYVKSCHSHLLKIISTLKV 284

Length = 357

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 49/180 (27%), Positives = 76/180 (42%), Gaps = 18/180 (10%)

Query: 111 PVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL--LVYEFM--FRG 166
            V VK +      G      E++ L  + H  ++ LI       +R    V   M  ++ 
Sbjct: 121 KVIVKAVTGGKTPG-----REIDILKTISHRAIINLI-----HAYRWKSTVCMVMPKYKC 170

Query: 167 SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL 226
            L  ++ R   +PL     + I     + LA+LH   R +I+RD KT NI LD    A L
Sbjct: 171 DLFTYVDRSGPLPLE--QAITIQRRLLEALAYLH--GRGIIHRDVKTENIFLDEPENAVL 226

Query: 227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS 286
            DFG A       +T       GT    +PE +      A++D++S G+VL E+     +
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286

Length = 392

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 31/231 (13%)

Query: 66  IAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH 125
            A  + +L    + F    ++G G FG V      + VR        A+K+L+K  +   
Sbjct: 31  AAEKITKLRMKAEDFDVIKVIGRGAFGEV------QLVRHKSSKQVYAMKLLSKFEMIKR 84

Query: 126 RE----WLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPL 180
            +    W  E + +       +V+L  Y  +DD  L +V E+M  G L N L     +P 
Sbjct: 85  SDSAFFW-EERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPE 141

Query: 181 SWA----TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
            WA      +++A  A   + F+H        RD K  N+LLD     KL+DFG      
Sbjct: 142 KWARFYTAEVVLALDAIHSMGFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMD 193

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYSFGVVLLELLTG 283
                   T V GT  Y +PE + +    G+     D +S GV L E+L G
Sbjct: 194 ANGMVRCDTAV-GTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 4e-10
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 35/235 (14%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-- 119
           Y   +  +++E+    +  +    +G G +GTV       + R G K   VA+K L +  
Sbjct: 2   YRQEVNKTIWEVPDRYRDLKQ---VGSGAYGTVCSAL---DRRTGAK---VAIKKLYRPF 52

Query: 120 -EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR------LLVYEFMFR--GSLEN 170
              L   R +  E+  L  ++H N++ L+     D          LV  FM    G L  
Sbjct: 53  QSELFAKRAY-RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK 111

Query: 171 HLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG 230
           H        LS      + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFG
Sbjct: 112 H------EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCELKILDFG 163

Query: 231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
           LA+        +V TR      Y APE ++   H T   D++S G ++ E+LTG+
Sbjct: 164 LARQTDSEMTGYVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 60.8 bits (148), Expect = 4e-10
 Identities = 58/227 (25%), Positives = 100/227 (44%), Gaps = 30/227 (13%)

Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENV--RVGLKSLPVAVKVLNKEGLQGHREW 128
           F++ +    ++    +G G +G V    ID     +V +K +P A  V         +  
Sbjct: 1   FDVGS---RYKPIENIGSGAYGVVCSA-IDTRSGKKVAIKKIPHAFDVP-----TLAKRT 51

Query: 129 LTEVNFLGQLRHPNLVKL--IGYCCEDD--HRLLVYEFMFRGSLENHLFR--KATVPLSW 182
           L E+  L   +H N++ +  I      D     +V + M     E+ L     +  PL+ 
Sbjct: 52  LRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-----ESDLHHIIHSDQPLTE 106

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
                  +   +GL ++H+A   VI+RD K SN+L++ D   ++ DFG+A+        H
Sbjct: 107 EHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEH 164

Query: 243 --VSTRVMGTYGYAAPE--YVMTGHLTARSDVYSFGVVLLELLTGRK 285
               T  + T  Y APE    +  + TA  D++S G +  E+L GR+
Sbjct: 165 KYFMTEYVATRWYRAPELLLSLPEYTTA-IDMWSVGCIFAEML-GRR 209

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 24/207 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   Y   + R+  K   VAVK L++  + L   R    E+  L  ++H N+
Sbjct: 23  VGSGAYGSVCSAY---DTRLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 144 VKLI-----GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           + L+         E+ + + +   +    L N +  +    LS      + +   +GL +
Sbjct: 77  IGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQK---LSDEHVQFLIYQLLRGLKY 133

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           +H+A   +I+RD K SN+ ++ D   ++ DFGLA+        +V+TR      Y APE 
Sbjct: 134 IHSAG--IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATR-----WYRAPEI 186

Query: 259 VMTG-HLTARSDVYSFGVVLLELLTGR 284
           ++   H     D++S G ++ ELL G+
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 60.3 bits (146), Expect = 5e-10
 Identities = 57/222 (25%), Positives = 99/222 (44%), Gaps = 35/222 (15%)

Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENV--RVGLKSL--PVAVKVLNKEGLQGHREWLTE 131
           + + + S   +G G +G+V    ID+    +V +K L  P   ++  K   +       E
Sbjct: 13  LPERYTSLKQVGSGAYGSVCSA-IDKRTGEKVAIKKLSRPFQSEIFAKRAYR-------E 64

Query: 132 VNFLGQLRHPNLVKL--------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA 183
           +  L  ++H N++ L         G   +D +  LV  +M        L +    PLS  
Sbjct: 65  LTLLKHMQHENVIGLLDVFTSAVSGDEFQDFY--LVMPYMQ-----TDLQKIMGHPLSED 117

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
               + +    GL ++H+A   +I+RD K  N+ ++ D   K+ DFGLA+        +V
Sbjct: 118 KVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV 175

Query: 244 STRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
            TR      Y APE ++   H     D++S G ++ E+LTG+
Sbjct: 176 VTR-----WYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.9 bits (145), Expect = 5e-10
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 43/276 (15%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG+G +G+VYK  +    V + +K + +    L++       + + E++ L +   P +V
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLE---LDESKF---NQIIMELDILHKAVSPYIV 62

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLEN-HLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
              G    +    +  E+M  GSL+  +    AT  +       I +   KGL FL   E
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE-E 121

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD-ETHVSTRVMGTYGYAAPEYVMTG 262
             +I+RD K +N+L++ +   KL DFG++     G+    ++   +G   Y APE + +G
Sbjct: 122 HNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIKSG 176

Query: 263 HLTAR------SDVYSFGVVLLELLTGR----KSVDKTRPSKEQSLVDWARPKLNDKRKM 312
                      SDV+S G+ +LE+  GR            ++  ++VD   P        
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD-GDP-------- 227

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                P L + YS   AQ   +    CL++ P  RP
Sbjct: 228 -----PTLPSGYS-DDAQDFVAK---CLNKIPNRRP 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 33/209 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR------ 139
           +GEG F  V K    ++ + G      A+K + K     H + L +VN L +++      
Sbjct: 7   IGEGTFSEVLKA---QSRKTGKY---YAIKCMKK-----HFKSLEQVNNLREIQALRRLS 55

Query: 140 -HPNLVKLIGYCCEDDH-RL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            HPN+++LI    +    RL LV+E M     E  L +    PL         +   K L
Sbjct: 56  PHPNILRLIEVLFDRKTGRLALVFELMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSL 113

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYA 254
             +H     + +RD K  NIL+  D   KL+DFG  +          ++STR      Y 
Sbjct: 114 DHMH--RNGIFHRDIKPENILIK-DDILKLADFGSCRGIYSKPPYTEYISTR-----WYR 165

Query: 255 APEYVMT-GHLTARSDVYSFGVVLLELLT 282
           APE ++T G+   + D+++ G V  E+L+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 59.8 bits (145), Expect = 7e-10
 Identities = 54/229 (23%), Positives = 96/229 (41%), Gaps = 35/229 (15%)

Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
           +   +     LG G  G V+   +D +         VAVK +     Q  +  L E+  +
Sbjct: 3   LGSRYMDLRPLGCGSNGLVFSA-VDSDCD-----KRVAVKKIVLTDPQSVKHALREIKII 56

Query: 136 GQLRHPNLVKLIGYCCEDDHRL--------------LVYEFM---FRGSLENHLFRKATV 178
            +L H N+VK+          L              +V E+M       LE         
Sbjct: 57  RRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQG------- 109

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAK-AGP 236
           PLS     +  +   +GL ++H+A   V++RD K +N+ +++ D   K+ DFGLA+   P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTEDLVLKIGDFGLARIVDP 167

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
                   +  + T  Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 59.0 bits (143), Expect = 9e-10
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 16/161 (9%)

Query: 131 EVNFLGQLRHPNLVKLIGY---CCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRM 186
           E+  L ++   N++K+ G+     +D  RL L+ E+  RG L   L ++    LS+ T++
Sbjct: 68  EIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD--LSFKTKL 125

Query: 187 MIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
            +A    KGL  L+    +P  Y++  + + L+  +Y  K+   GL K        +V+ 
Sbjct: 126 DMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183

Query: 246 RVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGR 284
            V     Y + + +       T + D+YS GVVL E+ TG+
Sbjct: 184 MV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 9e-10
 Identities = 54/190 (28%), Positives = 77/190 (40%), Gaps = 25/190 (13%)

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
            L+    +  +F  AKG+ FL  A R  I+RD    NILL  +   K+ DFGLA+   + 
Sbjct: 175 VLTLEDLICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232

Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
            +            + APE +     T +SDV+SFGV+L E+                SL
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SL 277

Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVV 354
                P +    +  +    RL+    +RA        Y     C    P  RP  S++V
Sbjct: 278 GASPYPGVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333

Query: 355 ETLEPLQCAN 364
           E L  L  AN
Sbjct: 334 EHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 60.0 bits (145), Expect = 1e-09
 Identities = 64/234 (27%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMM 187
           +E++ L    H  +VK       DD  LL+ E+   G L   + +  K  +P       +
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           + +     L  +H+  R +++RD K++NI L      KL DFG +K         V++  
Sbjct: 174 LFYQIVLALDEVHS--RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSF 231

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
            GT  Y APE       + ++D++S GV+L ELLT        RP K  S          
Sbjct: 232 CGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH------RPFKGPS---------- 275

Query: 308 DKRKMLQIIDPRLENQYS-----VRAAQKACSLAYYCLSQNPKARPLMSDVVET 356
            +R+++Q +   L  +Y      V +  KA  L    LS+NP  RP    ++ T
Sbjct: 276 -QREIMQQV---LYGKYDPFPCPVSSGMKA--LLDPLLSKNPALRPTTQQLLHT 323

Length = 478

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 58/193 (30%), Positives = 84/193 (43%), Gaps = 31/193 (16%)

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
           PL+    +  +F  A+G+ FL  A R  I+RD    NILL  +   K+ DFGLA+     
Sbjct: 169 PLTLEDLISYSFQVARGMEFL--ASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYK 225

Query: 239 DETHV---STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE 295
           D  +V     R+     + APE +     T +SDV+SFGV+L E+               
Sbjct: 226 DPDYVRKGDARL--PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIF-------------- 269

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMS 351
            SL     P +    +  +    RL+    +RA + A    Y     C   NP+ RP  S
Sbjct: 270 -SLGASPYPGVQIDEEFCR----RLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFS 324

Query: 352 DVVETLEPLQCAN 364
           ++VE L  L   N
Sbjct: 325 ELVEILGDLLQEN 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 59/250 (23%), Positives = 98/250 (39%), Gaps = 57/250 (22%)

Query: 85  ILGEGGFGTVYKGYIDE--NVRVGLKSLPVAVKVLNKEGLQG----HREWLTEVNFLGQL 138
           ++G+GG G VY  Y D   + RV LK +        +E L       + +L E      L
Sbjct: 9   LIGKGGMGEVYLAY-DPVCSRRVALKKI--------REDLSENPLLKKRFLREAKIAADL 59

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFM--FRGSLENHLFR----KATVP------LSWATRM 186
            HP +V +   C + D    VY  M    G     L +    K ++        S    +
Sbjct: 60  IHPGIVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL 116

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST- 245
            I       + ++H+  + V++RD K  NILL       + D+G A      +E  +   
Sbjct: 117 SIFHKICATIEYVHS--KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174

Query: 246 ---------------RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-------- 282
                          +++GT  Y APE ++    +  +D+Y+ GV+L ++LT        
Sbjct: 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRK 234

Query: 283 -GRKSVDKTR 291
            GRK   +  
Sbjct: 235 KGRKISYRDV 244

Length = 932

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V      + VR        A+K+L+K  +    +   +  E + +     P
Sbjct: 50  VIGRGAFGEV------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 103

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGL 196
            +V+L  Y  +DD  L +V E+M  G L N L     VP  WA      +++A  A   +
Sbjct: 104 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 161

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            F+H        RD K  N+LLD     KL+DFG      +       T V GT  Y +P
Sbjct: 162 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 212

Query: 257 EYVMT----GHLTARSDVYSFGVVLLELLTG 283
           E + +    G+     D +S GV L E+L G
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 5/90 (5%)

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++  V+  Y Y 
Sbjct: 130 GIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YR 184

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           APE ++        D++S G ++ E++ G 
Sbjct: 185 APEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 57/212 (26%), Positives = 98/212 (46%), Gaps = 14/212 (6%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFL 135
           ++R   +LG+G FG VY  Y   +   G + L V     + E  +  +E      E+  L
Sbjct: 3   NWRLGKLLGQGAFGRVYLCY---DADTG-RELAVKQVQFDPESPETSKEVNALECEIQLL 58

Query: 136 GQLRHPNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
             L H  +V+  G   +   R L    E M  GS+++ L  K+   L+            
Sbjct: 59  KNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL--KSYGALTENVTRKYTRQIL 116

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYG 252
           +G+++LH+    +++RD K +NIL DS    KL DFG +K       +    + V GT  
Sbjct: 117 EGVSYLHS--NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           + +PE +       ++D++S G  ++E+LT +
Sbjct: 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 11/201 (5%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-LTEVNFLGQLRHPNL 143
           ++GEG +G V K    E      K +    K  + E  +  +E  L E+  L  L+  N+
Sbjct: 8   VVGEGAYGVVLKCRHKET-----KEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENI 62

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L           LV+E++ +  LE  L            R  I +   K + + H  +
Sbjct: 63  VELKEAFRRRGKLYLVFEYVEKNMLE-LLEEMPNGVPPEKVRSYI-YQLIKAIHWCHKND 120

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             +++RD K  N+L+  +   KL DFG A+   +G   +  T  + T  Y +PE ++   
Sbjct: 121 --IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY-TEYVATRWYRSPELLLGAP 177

Query: 264 LTARSDVYSFGVVLLELLTGR 284
                D++S G +L EL  G+
Sbjct: 178 YGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 67/222 (30%), Positives = 97/222 (43%), Gaps = 24/222 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLV 144
           +G+G +G V+K     N + G K+   AVK+L+        E   E N L  L  HPN+V
Sbjct: 26  IGKGTYGKVFKVL---NKKNGSKA---AVKILDPIH-DIDEEIEAEYNILKALSDHPNVV 78

Query: 145 KLIG-YCCED----DHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLA 197
           K  G Y  +D    D   LV E    GS+ + +  F K    +       I   A  GL 
Sbjct: 79  KFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQ 138

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
            LH  +   I+RD K +NILL ++   KL DFG+  +             +GT  + APE
Sbjct: 139 HLHVNK--TIHRDVKGNNILLTTEGGVKLVDFGV--SAQLTSTRLRRNTSVGTPFWMAPE 194

Query: 258 YV-----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
            +     +     AR DV+S G+  +EL  G   +    P +
Sbjct: 195 VIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR 236

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 56.7 bits (137), Expect = 6e-09
 Identities = 54/213 (25%), Positives = 95/213 (44%), Gaps = 26/213 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVG-LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH-PN 142
            +GEG +G VYK     +   G L +L      +++EG+      L E++ L  L     
Sbjct: 8   KIGEGTYGKVYKA---RDKNTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSESIY 62

Query: 143 LVKLIGYCCEDDHR-----LLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +V+L+     ++        LV+E++    +  ++++  R    PL   T     +   K
Sbjct: 63  IVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSN-GRGPGRPLPAKTIKSFMYQLLK 121

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAG--PQGDETHVSTRVMGTY 251
           G+A  H  +  V++RD K  N+L+D      K++D GL +A   P    TH     + T 
Sbjct: 122 GVAHCH--KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTH----EIVTL 175

Query: 252 GYAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
            Y APE ++   H +   D++S G +  E+   
Sbjct: 176 WYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)

Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 66

Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 121

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 122 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 177

Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 178 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 56.6 bits (136), Expect = 1e-08
 Identities = 64/240 (26%), Positives = 113/240 (47%), Gaps = 52/240 (21%)

Query: 77  TKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
            KS++   I+G G FG VY+   ID + +V +K      KVL     + +RE L   N  
Sbjct: 65  NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIK------KVLQDPQYK-NRELLIMKN-- 115

Query: 136 GQLRHPNLVKLIGY----CCEDDHRLL------------VYEFMFRGSLENHLFRKATVP 179
             L H N++ L  Y    C + + + +            V+++M   +  NH      +P
Sbjct: 116 --LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNH-----ALP 168

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAK--AGP 236
           L      + ++   + LA++H+  + + +RD K  N+L+D + +T KL DFG AK     
Sbjct: 169 LFLVK--LYSYQLCRALAYIHS--KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAG 224

Query: 237 QGDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLE------LLTGRKSVDK 289
           Q   +++ +R      Y APE ++   + T   D++S G ++ E      + +G+ SVD+
Sbjct: 225 QRSVSYICSRF-----YRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQ 279

Length = 440

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 37/112 (33%), Positives = 56/112 (50%), Gaps = 10/112 (8%)

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
           PL     +  +   A+G+ FL  A +  I+RD    N+LL     AK+ DFGLA+     
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFL--ASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-DIMN 264

Query: 239 DETHVSTRVMGT----YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS 286
           D  +V   V G       + APE +     T +SDV+S+G++L E+ +  KS
Sbjct: 265 DSNYV---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKS 313

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 63/237 (26%), Positives = 107/237 (45%), Gaps = 27/237 (11%)

Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 114
           S +++  Y+  +A S F   T+ K ++    +G G  G V   +   +  +G+    VAV
Sbjct: 1   SEEDSQFYSVQVADSTF---TVLKRYQQLKPIGSGAQGIVCAAF---DTVLGI---NVAV 51

Query: 115 KVLNKE-GLQGH-REWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRG 166
           K L++    Q H +    E+  L  + H N++ L+          E     LV E M   
Sbjct: 52  KKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM--- 108

Query: 167 SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL 226
             + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K+
Sbjct: 109 --DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI 164

Query: 227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            DFGLA+         + T  + T  Y APE ++        D++S G ++ EL+ G
Sbjct: 165 LDFGLART---ACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 62/218 (28%), Positives = 96/218 (44%), Gaps = 32/218 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEV----NFLGQLRH 140
           ++  G +G VY       VR        A+K +NK+ L   R  + +V    + L    +
Sbjct: 8   LISNGAYGAVYL------VRHKETRQRFAMKKINKQNLI-LRNQIQQVFVERDILTFAEN 60

Query: 141 PNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           P +V +  +C  +  R L  V E++  G     L     +P+  A RM  A      L +
Sbjct: 61  PFVVSM--FCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA-RMYFA-ETVLALEY 116

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-------STR----- 246
           LHN    +++RD K  N+L+ S    KL+DFGL+K G     T++        TR     
Sbjct: 117 LHN--YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 247 -VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            V GT  Y APE ++        D ++ G++L E L G
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 43/225 (19%)

Query: 82  SDYILGE----GGFGTVYKGYIDENVRVGLK--SLPVAVKVLNKEGLQGHREWLTEVNFL 135
              ++G+         + K +   N  V +K  +L    K   K  LQ       E+   
Sbjct: 2   LLTLIGKCFEDLMIVHLAK-HKPTNTLVAVKKINLDSCSKEDLKL-LQQ------EIITS 53

Query: 136 GQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            QL+HPN++         D  L +V   M  GS E+ L       L       I      
Sbjct: 54  RQLQHPNILP-YVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLN 112

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF----GLAKAG---------PQGDET 241
            L ++H+  +  I+R  K S+ILL  D    LS       + K G         P+    
Sbjct: 113 ALDYIHS--KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK 170

Query: 242 HVSTRVMGTYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTG 283
           ++         + +PE +   + G+   +SD+YS G+   EL  G
Sbjct: 171 NLP--------WLSPEVLQQNLQGY-NEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 5/153 (3%)

Query: 131 EVNFLGQLRHPNLVKLI-GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           E   L QL+HPN+V     +  ED    +V  F   G L + L  +    L     +   
Sbjct: 49  EAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWF 108

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A  L +LH  E+ +++RD KT N+ L      K+ D G+A+     ++  +++ ++G
Sbjct: 109 VQIAMALQYLH--EKHILHRDLKTQNVFLTRTNIIKVGDLGIARV--LENQCDMASTLIG 164

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           T  Y +PE         +SDV++ G  + E+ T
Sbjct: 165 TPYYMSPELFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 53.9 bits (130), Expect = 6e-08
 Identities = 62/252 (24%), Positives = 91/252 (36%), Gaps = 63/252 (25%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-----EGLQGH----REW 128
             F S  ++G G FG V        V+        A+K L K     +    H    R+ 
Sbjct: 1   DDFESIKVIGRGAFGEV------RLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDI 54

Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           L E +      +P +VKL  Y  +D++ L L+ E++  G +   L +K T      TR  
Sbjct: 55  LAEAD------NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEE-ETRFY 106

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-------------- 233
           IA      +  +H      I+RD K  N+LLD+    KLSDFGL                
Sbjct: 107 IA-ETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRIL 163

Query: 234 ---AGPQGDETHVSTR-------------------VMGTYGYAAPEYVMTGHLTARSDVY 271
                    +                          +GT  Y APE  +        D +
Sbjct: 164 SHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWW 223

Query: 272 SFGVVLLELLTG 283
           S GV++ E+L G
Sbjct: 224 SLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 37/233 (15%)

Query: 86  LGEGGFGTVYKG---YIDENVRVGL---KSLPVAVKVLNKEGLQGHRE----WLTEVNFL 135
           LG G    +Y G   Y D++   G    K + V +KVL+      HR+    +    + +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDP----SHRDISLAFFETASMM 58

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            Q+ H ++V L G C  D   ++V EF+  G L+  + RK+   L+   +  +A   A  
Sbjct: 59  RQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQLASA 117

Query: 196 LAFLHNAERPVIYRDFKTSNILL-----DSDYTA--KLSDFGLAKAGPQGDETHVSTR-- 246
           L++L   ++ +++ +  T NILL     D +     KLSD G+           V +R  
Sbjct: 118 LSYLE--DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP--------ITVLSRQE 167

Query: 247 VMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLEL-LTGRKSV-DKTRPSKEQ 296
            +    + APE V  + +L+  +D +SFG  L E+   G   + DKT   KE+
Sbjct: 168 CVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER 220

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 59/242 (24%), Positives = 106/242 (43%), Gaps = 29/242 (11%)

Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLK 108
           +  S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   
Sbjct: 1   MSRSKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL 57

Query: 109 SLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEF 162
           S P   +   K   +       E+  +  + H N++ L+          E     +V E 
Sbjct: 58  SRPFQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY 222
           M     + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD 
Sbjct: 111 M-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDC 163

Query: 223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           T K+ DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ 
Sbjct: 164 TLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIK 220

Query: 283 GR 284
           G 
Sbjct: 221 GG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 34/204 (16%)

Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
             ++N L    +  L+    +   +  A+G+ FL  A +  ++RD    N+LL      K
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFL--ASKNCVHRDLAARNVLLAQGKIVK 277

Query: 226 LSDFGLAKAGPQGDETHVST-RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           + DFGLA+     D  +VS         + APE +     T  SDV+S+G++L E+ +  
Sbjct: 278 ICDFGLAR-DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLG 336

Query: 285 KS------VDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY 338
            +      VD T  +K +S    A+P                       A Q+   +   
Sbjct: 337 GTPYPGMIVDSTFYNKIKSGYRMAKPD---------------------HATQEVYDIMVK 375

Query: 339 CLSQNPKARPL---MSDVVETLEP 359
           C +  P+ RP    +SD+VE+L P
Sbjct: 376 CWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 61/247 (24%), Positives = 93/247 (37%), Gaps = 56/247 (22%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNF 134
           + F S  ++G G FG V      +   V    +     +L KE    ++  R+ L E + 
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADS 60

Query: 135 LGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLS----WATRMMIA 189
           L       +VK+  Y  +D   L L+ EF+  G +   L +K T+       +    ++A
Sbjct: 61  LW------VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLA 113

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET-------- 241
             +   L F+H        RD K  N+LLDS    KLSDFGL     +   T        
Sbjct: 114 IDSIHQLGFIH--------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNH 165

Query: 242 -------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVV 276
                                     ++   +GT  Y APE  M        D +S GV+
Sbjct: 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVI 225

Query: 277 LLELLTG 283
           + E+L G
Sbjct: 226 MYEMLIG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 2/94 (2%)

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           ++  AKG++FL  A +  I+RD    NILL      K+ DFGLA+         V     
Sbjct: 220 SYQVAKGMSFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNAR 277

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
               + APE +     T  SDV+S+G++L E+ +
Sbjct: 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 63/242 (26%), Positives = 91/242 (37%), Gaps = 50/242 (20%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           F S  ++G G FG V      +   +    +     +L KE +   R    E + L +  
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR---AERDILVEAD 59

Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLS----WATRMMIAFGAAK 194
              +VK+  Y  +D   L L+ EF+  G +   L +K T+       +    ++A  A  
Sbjct: 60  GAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---------------GPQGD 239
            L F+H        RD K  N+LLD+    KLSDFGL                   P  D
Sbjct: 119 QLGFIH--------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSD 170

Query: 240 ------------ETHVSTR------VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
                       ET    R       +GT  Y APE  M        D +S GV++ E+L
Sbjct: 171 FSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Query: 282 TG 283
            G
Sbjct: 231 IG 232

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 61/248 (24%), Positives = 100/248 (40%), Gaps = 37/248 (14%)

Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           TE + L  + HP++++L G    +    L+    ++  L  +L  K  + +     + I 
Sbjct: 132 TEAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNIAI--CDILAIE 188

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
               + + +LH     +I+RD K  NI ++      L DFG A   P     +      G
Sbjct: 189 RSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS------VDKTRPSKEQSLVDWAR 303
           T    APE +         D++S G+VL E+ T   S      +D    S  Q       
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI------ 299

Query: 304 PKLNDKRKMLQ----IIDPR--LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-- 355
            KL  +R         ID +  L+  Y +  A+K+        S+ P +RPL +++ E  
Sbjct: 300 -KLIIRRSGTHPNEFPIDAQANLDEIY-IGLAKKS--------SRKPGSRPLWTNLYELP 349

Query: 356 -TLEPLQC 362
             LE L C
Sbjct: 350 IDLEYLIC 357

Length = 391

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 4/104 (3%)

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LS+   +  ++  A G+ FL  A +  ++RD    N+L+      K+ DFGLA+     D
Sbjct: 236 LSYMDLVGFSYQVANGMEFL--ASKNCVHRDLAARNVLICEGKLVKICDFGLAR-DIMRD 292

Query: 240 ETHVST-RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             ++S         + APE +     T  SDV+SFG++L E+ T
Sbjct: 293 SNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.0 bits (112), Expect = 2e-06
 Identities = 34/146 (23%), Positives = 52/146 (35%), Gaps = 14/146 (9%)

Query: 94  VYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLV-KLIGYCC 151
           +  G  +    +G K     +K+         RE   EV  L  L      V K++    
Sbjct: 6   LKGGLTNRVYLLGTKDEDYVLKINPSREKGADRE--REVAILQLLARKGLPVPKVLASGE 63

Query: 152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPV-IYRD 210
            D    L+ E+     +E     +    +S   +  IA   A+ LA LH     V  + D
Sbjct: 64  SDGWSYLLMEW-----IEGETLDE----VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGD 114

Query: 211 FKTSNILLDSDYTAKLSDFGLAKAGP 236
               NIL+D      + D+  A  GP
Sbjct: 115 LHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 69/261 (26%), Positives = 105/261 (40%), Gaps = 55/261 (21%)

Query: 86  LGEGGFGTVY-KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G G FG V     +D N    +K+L  A  VL +     H +   E + L +  +  +V
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKA-DVLMRNQA-AHVK--AERDILAEADNEWVV 64

Query: 145 KLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           KL  Y  +D   L  V +++  G + + L R        A R  IA      +  +H   
Sbjct: 65  KLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA-RFYIA-ELTCAIESVHKMG 121

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGL---------AKAGPQGDETHVS---------- 244
              I+RD K  NIL+D D   KL+DFGL         +K   +GD               
Sbjct: 122 --FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSE 179

Query: 245 -----------------TRVM-----GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELL 281
                             R +     GT  Y APE ++ TG+ T   D +S GV+L E+L
Sbjct: 180 IDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEML 238

Query: 282 TGRKSVDKTRPSKEQ-SLVDW 301
            G+       P++ Q  +++W
Sbjct: 239 VGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 47.9 bits (114), Expect = 5e-06
 Identities = 66/258 (25%), Positives = 104/258 (40%), Gaps = 29/258 (11%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNF 134
           K F    ++G G FG V      + VR        A+KV+ K  L        +  E + 
Sbjct: 1   KDFDVKSLVGRGHFGEV------QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDI 54

Query: 135 LGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           L     P + +L  Y  +D   L LV E+   G L + L  +           M  F  A
Sbjct: 55  LSISNSPWIPQLQ-YAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFD---EDMAQFYLA 109

Query: 194 KGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           + +  +H+  +   ++RD K  N+L+D     KL+DFG A A    ++   S   +GT  
Sbjct: 110 ELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA-ARLTANKMVNSKLPVGTPD 168

Query: 253 YAAPEY--VMTGHLTARSDV----YSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
           Y APE    M G       V    +S GV+  E++ GR       P  E +        +
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRS------PFHEGTSAKTYNNIM 222

Query: 307 NDKRKMLQIIDPRLENQY 324
           N +R +    DP++ + +
Sbjct: 223 NFQRFLKFPEDPKVSSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.4 bits (112), Expect = 1e-05
 Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 31/167 (18%)

Query: 131 EVNFLGQLRHPNLVKL--------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           E+  LG+L H N++K+          Y     +   +Y FM+  +     F     PL  
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEA-----FDWKDRPLLK 267

Query: 183 ATR-MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
            TR +M     A  + ++H+  + +I+RD K  NI L+ D    L DFG A         
Sbjct: 268 QTRAIMKQLLCA--VEYIHD--KKLIHRDIKLENIFLNCDGKIVLGDFGTAM-------P 316

Query: 242 HVSTRVMGTYGYA------APEYVMTGHLTARSDVYSFGVVLLELLT 282
               R    YG+       +PE +        +D++S G++LL++L+
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 61/246 (24%), Positives = 99/246 (40%), Gaps = 68/246 (27%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLP--VAVKVLNK-EGLQ----------------GH 125
           ++G G FG V          V +K+     A+K+LNK E L+                G 
Sbjct: 8   VIGRGAFGEV--------AVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD 59

Query: 126 REWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWA- 183
           R W+T +++  Q              ++++  LV ++   G L   L + +  +P   A 
Sbjct: 60  RRWITNLHYAFQ--------------DENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMAR 105

Query: 184 ---TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG-LAKAGPQGD 239
                M++A  +   L ++H        RD K  N+LLD +   +L+DFG   +    G 
Sbjct: 106 FYLAEMVLAIDSVHQLGYVH--------RDIKPDNVLLDKNGHIRLADFGSCLRLLADG- 156

Query: 240 ETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
            T  S   +GT  Y +PE +       G      D +S GV + E+L G        P  
Sbjct: 157 -TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYG------ETPFY 209

Query: 295 EQSLVD 300
            +SLV+
Sbjct: 210 AESLVE 215

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 64/250 (25%), Positives = 101/250 (40%), Gaps = 52/250 (20%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-EGLQ----------------GHRE 127
           ++G G FG V    +    +V       A+K+LNK E L+                G  +
Sbjct: 8   VIGRGAFGEVAVVKLKNADKV------FAMKILNKWEMLKRAETACFREERDVLVNGDNQ 61

Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           W+T +++  Q  + NL  ++ Y    D  LL     F   L   + R       +   M+
Sbjct: 62  WITTLHYAFQDEN-NLYLVMDYYVGGD--LLTLLSKFEDRLPEDMAR------FYLAEMV 112

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           IA  +   L ++H        RD K  NIL+D +   +L+DFG      + D T  S+  
Sbjct: 113 IAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFGSCLKLME-DGTVQSSVA 163

Query: 248 MGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
           +GT  Y +PE +       G      D +S GV + E+L G        P   +SLV+  
Sbjct: 164 VGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGET------PFYAESLVETY 217

Query: 303 RPKLNDKRKM 312
              +N K + 
Sbjct: 218 GKIMNHKERF 227

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 60/243 (24%), Positives = 99/243 (40%), Gaps = 62/243 (25%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-EGLQ----------------GHRE 127
           ++G G FG V    +    R+       A+K+LNK E L+                G  +
Sbjct: 8   VIGRGAFGEVAVVKMKHTERI------YAMKILNKWEMLKRAETACFREERNVLVNGDCQ 61

Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWA--- 183
           W+T +++  Q              ++++  LV ++   G L   L + +  +P   A   
Sbjct: 62  WITTLHYAFQ--------------DENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 184 -TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
              M++A  +   L ++H        RD K  N+LLD +   +L+DFG      Q D T 
Sbjct: 108 IAEMVLAIHSIHQLHYVH--------RDIKPDNVLLDMNGHIRLADFGSCLKMNQ-DGTV 158

Query: 243 VSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS 297
            S+  +GT  Y +PE +       G      D +S GV + E+L G        P   +S
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGET------PFYAES 212

Query: 298 LVD 300
           LV+
Sbjct: 213 LVE 215

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 62/267 (23%), Positives = 104/267 (38%), Gaps = 63/267 (23%)

Query: 86  LGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG V     +D +    +K+L     VLN+  +  H +   E + L +  +  +V
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKK-DVLNRNQV-AHVK--AERDILAEADNEWVV 64

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGLAFLH 200
           KL     + D+   V +++  G + + L R    P   A      + +A  +   + F+H
Sbjct: 65  KLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGL---------AKAGPQGDETH--------- 242
                   RD K  NIL+D D   KL+DFGL         +K   +G             
Sbjct: 125 --------RDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 243 ---------------------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGV 275
                                      ++  ++GT  Y APE ++    T   D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 276 VLLELLTGRKSVDKTRPSKEQ-SLVDW 301
           +L E+L G+       P++ Q  +++W
Sbjct: 237 ILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 45.0 bits (106), Expect = 4e-05
 Identities = 50/160 (31%), Positives = 74/160 (46%), Gaps = 21/160 (13%)

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP--LSWATRMMIAFGAAKG 195
            RHPN++             ++  FM  GS  N L  K   P  +S A    I FGA +G
Sbjct: 56  FRHPNIMTSWTVFTTGSWLWVISPFMAYGS-ANSLL-KTYFPEGMSEALIGNILFGALRG 113

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD----FGLAKAGPQG----DETHVSTRV 247
           L +LH  +   I+R+ K S+IL+  D    LS     + L + G +     D    ST V
Sbjct: 114 LNYLH--QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV 171

Query: 248 MGTYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTGR 284
           +    + +PE +   + G+   +SD+YS G+   EL TGR
Sbjct: 172 LP---WLSPELLRQDLYGY-NVKSDIYSVGITACELATGR 207

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 65/254 (25%), Positives = 117/254 (46%), Gaps = 45/254 (17%)

Query: 108 KSLPVAVKVLNKEGLQGHRE----WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM 163
           + L V +KVL+      HR+    +    + + Q+ H +L  + G C      ++V EF+
Sbjct: 43  RELRVVLKVLDPS----HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFV 98

Query: 164 FRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--- 219
             G L+  L + K  VP++W  ++ +A   A  L++L +  + +++ +    NILL    
Sbjct: 99  EHGPLDVCLRKEKGRVPVAW--KITVAQQLASALSYLED--KNLVHGNVCAKNILLARLG 154

Query: 220 -SDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFG 274
            ++ T+   KLSD G++      +E     RV     + APE V  G  L+  +D +SFG
Sbjct: 155 LAEGTSPFIKLSDPGVSFTALSREE-----RV-ERIPWIAPECVPGGNSLSTAADKWSFG 208

Query: 275 VVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACS 334
             LLE+       D   P KE++  +  + +  +K+  L   +P         + ++  +
Sbjct: 209 TTLLEI-----CFDGEVPLKERTPSE--KERFYEKKHRLP--EP---------SCKELAT 250

Query: 335 LAYYCLSQNPKARP 348
           L   CL+  P  RP
Sbjct: 251 LISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 45.1 bits (106), Expect = 4e-05
 Identities = 53/215 (24%), Positives = 94/215 (43%), Gaps = 30/215 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G +G VYK    +    G      A+K +   G+        E+  L +L+HPN++ 
Sbjct: 9   VGRGTYGHVYKAKRKD----GKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62

Query: 146 LIG-YCCEDDHRL-LVYEFMFRGSLENHLFRKAT----VPLSWATRMM--IAFGAAKGLA 197
           L   +    D ++ L++++          F +A+     P+     M+  + +    G+ 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYT----AKLSDFGLAK-----AGPQGDETHVSTRVM 248
           +LH     V++RD K +NIL+  +       K++D G A+       P  D   V     
Sbjct: 123 YLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV--- 177

Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
            T+ Y APE ++   H T   D+++ G +  ELLT
Sbjct: 178 -TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 60/269 (22%), Positives = 100/269 (37%), Gaps = 67/269 (24%)

Query: 86  LGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPN 142
           LG G FG V     +D      +K+L     +L  +   ++  R+ L E +      +  
Sbjct: 9   LGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD------NEW 62

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGLAF 198
           +V+L     + D+   V +++  G + + L R    P   A      +  A  +   + F
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL---------AKAGPQGDETH------- 242
           +H        RD K  NIL+D D   KL+DFGL         +K    GD          
Sbjct: 123 IH--------RDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFS 174

Query: 243 -----------------------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSF 273
                                        ++  ++GT  Y APE ++    T   D +S 
Sbjct: 175 NEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 234

Query: 274 GVVLLELLTGRKSVDKTRPSKEQ-SLVDW 301
           GV+L E+L G+       P + Q  +++W
Sbjct: 235 GVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 55/219 (25%), Positives = 92/219 (42%), Gaps = 38/219 (17%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G +G VYK       + G      A+K +   G+        E+  L +L+HPN++ 
Sbjct: 9   VGRGTYGHVYKA----KRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62

Query: 146 LIG-YCCEDDHRL-LVYEF----------MFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           L   +    D ++ L++++            R S  N    K  V L       + +   
Sbjct: 63  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN----KKPVQLPRGMVKSLLYQIL 118

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYT----AKLSDFGLAK-----AGPQGDETHVS 244
            G+ +LH     V++RD K +NIL+  +       K++D G A+       P  D   V 
Sbjct: 119 DGIHYLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVV 176

Query: 245 TRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
                T+ Y APE ++   H T   D+++ G +  ELLT
Sbjct: 177 V----TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 46/159 (28%), Positives = 70/159 (44%), Gaps = 19/159 (11%)

Query: 80  FRSDYILGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           F +  ++G+G FG V      D      +K+L +  ++  K+ L   +    E + L + 
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTL-LKSEMFKKDQLAHVK---AERDVLAES 58

Query: 139 RHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKAT----VPLSWATRMMIAFGAA 193
             P +V L  Y  +D   L L+ EF+  G L   L +  T    V   +    ++A  A 
Sbjct: 59  DSPWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAV 117

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
             L F+H        RD K  NIL+D     KLSDFGL+
Sbjct: 118 HKLGFIH--------RDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 35/98 (35%), Positives = 45/98 (45%), Gaps = 11/98 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGL----KSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL- 138
            LG G FG V      E    GL      L VAVK+L        RE L +E+  L  L 
Sbjct: 45  TLGAGAFGKVV-----EATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLG 99

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA 176
           +H N+V L+G C      L++ E+   G L N L +KA
Sbjct: 100 QHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKA 137

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 17/150 (11%)

Query: 89  GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLRHPNLVK 145
           G FG VY G    N ++       AVKV+ K  +       +   E + L   + P +V 
Sbjct: 15  GAFGKVYLGRKKNNSKL------YAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVH 68

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLEN--HLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           L       ++  LV E++  G +++  H++      ++      I+   A  L +LH   
Sbjct: 69  LYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA---VKYIS-EVALALDYLH--R 122

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
             +I+RD K  N+L+ ++   KL+DFGL+K
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.001
 Identities = 51/188 (27%), Positives = 86/188 (45%), Gaps = 33/188 (17%)

Query: 131 EVNFLGQLRHPNLVKLIG-YCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLSWATRM 186
           EVN + +L+H N+V+ I  +  + + +L ++ EF   G L  ++ +  K    +     +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 187 MIAFGAAKGLAFLH------NAERPVIYRDFKTSNILLDSDY-----------------T 223
            I       LA+ H      N ER V++RD K  NI L +                    
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGER-VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPI 180

Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYSFGVVLLELL 281
           AK+ DFGL+K    G E+   + V GT  Y +PE ++  T     +SD+++ G ++ EL 
Sbjct: 181 AKIGDFGLSKN--IGIESMAHSCV-GTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 282 TGRKSVDK 289
           +G+    K
Sbjct: 238 SGKTPFHK 245

Length = 1021

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 39.8 bits (94), Expect = 0.001
 Identities = 41/163 (25%), Positives = 60/163 (36%), Gaps = 47/163 (28%)

Query: 140 HPNLVKLIGYCCE-DDHRLLV---------YEFM-FRGSLENHLFRKATVPLSWATRMMI 188
           +PN +KL  Y        +L+         ++ +   G L     +K            I
Sbjct: 68  NPNFIKLY-YSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK------------I 114

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK-----LSDFGLAKAGPQGDETHV 243
                + L  LH     +I+ D K  N+L    Y        L D+GL K         +
Sbjct: 115 IRQLVEALNDLHKHN--IIHNDIKLENVL----YDRAKDRIYLCDYGLCK--------II 160

Query: 244 STRVM--GTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
            T     GT  Y +PE +  GH    S D ++ GV+  ELLTG
Sbjct: 161 GTPSCYDGTLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 42/155 (27%), Positives = 64/155 (41%), Gaps = 16/155 (10%)

Query: 131 EVNFLGQLRHPNLVKLI------GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWAT 184
           E   L +L HP ++ L+      G  C      LV    +R  L  +L  +   PL  A 
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTC------LVLP-KYRSDLYTYLGARLR-PLGLAQ 261

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
              +A      + ++H     +I+RD KT N+L++      L DFG A        T   
Sbjct: 262 VTAVARQLLSAIDYIHG--EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFH 319

Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 279
             + GT    APE +     T   D++S G+V+ E
Sbjct: 320 YGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 47/170 (27%), Positives = 75/170 (44%), Gaps = 24/170 (14%)

Query: 132 VNFL-GQLR------HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWAT 184
           V FL G+L       HPN+V        D+   +V  FM  GS ++ +       +S   
Sbjct: 43  VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELA 102

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKL-SDFGLAKAGPQGDE 240
              I  G  K L ++H+     ++R  K S+IL+  D   Y + L S+  +   G +   
Sbjct: 103 IAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV 160

Query: 241 TH----VSTRVMGTYGYAAPEYVMTGHLT---ARSDVYSFGVVLLELLTG 283
            H     S +V+    + +PE V+  +L    A+SD+YS G+   EL  G
Sbjct: 161 VHDFPKYSVKVLP---WLSPE-VLQQNLQGYDAKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 32/119 (26%), Positives = 50/119 (42%), Gaps = 16/119 (13%)

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
           P S      I F     L + H  E  +++ D K  NIL+++  T    D    +A P  
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFH-TELHLMHTDLKPENILMETSDTV--VDPVTNRALPPD 283

Query: 239 -------------DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
                        DE H  T ++ T  Y +PE V+       +D++S G ++ EL TG+
Sbjct: 284 PCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342

Length = 467

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 39.2 bits (91), Expect = 0.004
 Identities = 32/96 (33%), Positives = 48/96 (50%), Gaps = 11/96 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGL-KSLPV---AVKVLNKEGLQGHREWL-TEVNFLGQL- 138
           ILG G FG V +G        GL +S PV   AVK+L        ++ L +E+  +  L 
Sbjct: 44  ILGSGAFGKVVEG-----TAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLG 98

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
            H N+V L+G C +     ++ E+ F G L N+L +
Sbjct: 99  PHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	431
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.87
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.86
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.85
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.84
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
smart00090	237	RIO RIO-like kinase.	99.79
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.76
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.7
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.62
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.55
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.45
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.44
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.43
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.38
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.35
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.35
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.18
COG4248	637	Uncharacterized protein with protein kinase and he	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.06
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.01
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.89
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.82
PRK09902	216	hypothetical protein; Provisional	98.81
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.67
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.63
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.54
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.5
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.48
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.46
PF01636	239	APH: Phosphotransferase enzyme family This family	98.44
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.32
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.26
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.22
PLN02876	822	acyl-CoA dehydrogenase	98.21
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.0
PRK10593	297	hypothetical protein; Provisional	98.0
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.99
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.97
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.91
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.91
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.81
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.79
PRK05231	319	homoserine kinase; Provisional	97.74
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.61
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.5
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.48
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.38
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.08
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.01
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.0
PLN02236	344	choline kinase	96.98
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.95
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.81
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.78
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.69
KOG2270	520	consensus Serine/threonine protein kinase involved	96.68
PLN02756	418	S-methyl-5-thioribose kinase	96.68
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.58
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.32
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.25
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	96.24
PRK06148	1013	hypothetical protein; Provisional	96.18
PRK12396	409	5-methylribose kinase; Reviewed	96.07
PRK11768	325	serine/threonine protein kinase; Provisional	95.73
COG2334	331	Putative homoserine kinase type II (protein kinase	95.72
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.16
PTZ00384	383	choline kinase; Provisional	95.06

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-53  Score=410.29  Aligned_cols=290  Identities=58%  Similarity=0.959  Sum_probs=251.1

Q ss_pred             cccccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce
Q 014079           64 HVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL  143 (431)
Q Consensus        64 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni  143 (431)
                      ....|++.++...|++|....+||+|+||.||+|...++.       .||||.+.........+|.+|+.+|.+++|||+
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~-------~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nl  133 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGT-------VVAVKRLSSNSGQGEREFLNEVEILSRLRHPNL  133 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCC-------EEEEEEecCCCCcchhHHHHHHHHHhcCCCcCc
Confidence            5677999999999999999999999999999999998863       399998776543214569999999999999999


Q ss_pred             eeeecEEEeCC-eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC-CCeeeccCCCCCEEECCC
Q 014079          144 VKLIGYCCEDD-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE-RPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       144 v~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivHrDlkp~NILl~~~  221 (431)
                      |+|+|||.+.+ ..+||+|||++|+|.++|+.....+++|..++.|+.++|+||+|||... ++|||||||++|||||++
T Consensus       134 v~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~  213 (361)
T KOG1187|consen  134 VKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED  213 (361)
T ss_pred             ccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC
Confidence            99999999999 5999999999999999998765448899999999999999999999843 379999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      +++||+|||+|+..+.. .....+...||.+|+|||++..+..+.|+|||||||+|.||++|+.+.+...+.....++.|
T Consensus       214 ~~aKlsDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w  292 (361)
T KOG1187|consen  214 FNAKLSDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW  292 (361)
T ss_pred             CCEEccCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence            99999999999775542 11111111799999999999999999999999999999999999999987766666678999


Q ss_pred             hhhhhhccchhhhhcCcccc-CcccH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          302 ARPKLNDKRKMLQIIDPRLE-NQYSV-RAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ..+.+... .+.+++|+.+. ..+.. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       293 ~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  293 AKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             HHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            87777765 88899999987 56554 677889999999999999999999999999965543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-53  Score=386.39  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=210.7

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe-eE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH-RL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~  157 (431)
                      .+..+.||+|..|+||++.++.+.+.      +|+|++.... ....+++.+|+++++.++|||||.+||.|..... ..
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk~t~~i------~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is  154 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHKPTGKI------YALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS  154 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEcCCCeE------EEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence            34456799999999999999988776      9999995442 3456789999999999999999999999999994 99


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      |+||||.+|+|++++...+  .+++...-.++.++++||.|||.. ++||||||||+||||+..|.+||||||.++.+..
T Consensus       155 I~mEYMDgGSLd~~~k~~g--~i~E~~L~~ia~~VL~GL~YLh~~-~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn  231 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKRVG--RIPEPVLGKIARAVLRGLSYLHEE-RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN  231 (364)
T ss_pred             eehhhcCCCCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhc-cCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence            9999999999999997664  478889999999999999999952 4499999999999999999999999999987644


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .    ...+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||....+...           .-...+..+++
T Consensus       232 S----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~-----------~~~~Ll~~Iv~  296 (364)
T KOG0581|consen  232 S----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYL-----------DIFELLCAIVD  296 (364)
T ss_pred             h----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCC-----------CHHHHHHHHhc
Confidence            3    44568899999999999999999999999999999999999999976411111           01112233333


Q ss_pred             ccccCcccH-HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSV-RAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~-~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ... ..++. .+++++++|+..||++||.+||++.|+++|=
T Consensus       297 ~pp-P~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  297 EPP-PRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             CCC-CCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            222 22333 4789999999999999999999999999874

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-53  Score=391.09  Aligned_cols=257  Identities=27%  Similarity=0.418  Sum_probs=213.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-------HHHHHHHHHHHhcCCCCceeee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-------HREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      +.+.+.|.+.+.||+|+||.|-+|+.+.+++.      ||||++++.....       .....+|++||++|+|||||++
T Consensus       168 ks~~d~yii~~~LGsGafg~Vkla~e~~tgk~------vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~  241 (475)
T KOG0615|consen  168 KSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQ------VAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRI  241 (475)
T ss_pred             chhcceeEeeeeecCCceeEEEEEEEcccCcE------EEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEE
Confidence            34667899999999999999999999988776      9999998753322       2335699999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---Cc
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YT  223 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~  223 (431)
                      +++|...+..||||||++||.|.+.+..++.  +.+..-..+++|++.|+.|||+.|  |+||||||+|||++.+   ..
T Consensus       242 ~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--l~ed~~K~~f~Qll~avkYLH~~G--I~HRDiKPeNILl~~~~e~~l  317 (475)
T KOG0615|consen  242 KDFFEVPDSSYMVLEYVEGGELFDKVVANKY--LREDLGKLLFKQLLTAVKYLHSQG--IIHRDIKPENILLSNDAEDCL  317 (475)
T ss_pred             eeeeecCCceEEEEEEecCccHHHHHHhccc--cccchhHHHHHHHHHHHHHHHHcC--cccccCCcceEEeccCCcceE
Confidence            9999999999999999999999999988765  566666789999999999999977  9999999999999766   78


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCccccccCCC---CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL---TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      +||+|||+|+...   ....+.+.||||.|.|||++.++.+   ..++|||||||+||-+|+|.+||........     
T Consensus       318 lKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s-----  389 (475)
T KOG0615|consen  318 LKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS-----  389 (475)
T ss_pred             EEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc-----
Confidence            9999999999854   3446678999999999999987643   3478999999999999999999987543221     


Q ss_pred             hhhhhhhccchhhhhcCcccc--CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          301 WARPKLNDKRKMLQIIDPRLE--NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                -..++...++.  .....+.+++..+||.+||..||++|||+.|+++|-+
T Consensus       390 ----------l~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  390 ----------LKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             ----------HHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence                      11122222221  2345678899999999999999999999999998744

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.7e-52  Score=400.42  Aligned_cols=250  Identities=28%  Similarity=0.465  Sum_probs=213.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+|...++||+|||+.||.+.+.+++..      ||+|++.+...   ...+.+.+|++|.++|+|||||+++++|++.+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~------~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~   91 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEV------VAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSN   91 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcE------EEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCC
Confidence            5689999999999999999999666655      99999987533   34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      +.|||+|+|..++|..+++++.  ++++..+..++.||+.||.|||+++  |||||||..|+||+++.++||+|||||..
T Consensus        92 nVYivLELC~~~sL~el~Krrk--~ltEpEary~l~QIv~GlkYLH~~~--IiHRDLKLGNlfL~~~~~VKIgDFGLAt~  167 (592)
T KOG0575|consen   92 NVYIVLELCHRGSLMELLKRRK--PLTEPEARYFLRQIVEGLKYLHSLG--IIHRDLKLGNLFLNENMNVKIGDFGLATQ  167 (592)
T ss_pred             ceEEEEEecCCccHHHHHHhcC--CCCcHHHHHHHHHHHHHHHHHHhcC--ceecccchhheeecCcCcEEecccceeee
Confidence            9999999999999999997544  6899999999999999999999977  99999999999999999999999999988


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      +.....  ...+.||||.|.|||++....++..+||||+||+||.||.|++||+...-....              ....
T Consensus       168 le~~~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety--------------~~Ik  231 (592)
T KOG0575|consen  168 LEYDGE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETY--------------NKIK  231 (592)
T ss_pred             ecCccc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHH--------------HHHH
Confidence            764433  234689999999999999999999999999999999999999999865311111              1111


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .-+    ..++...+.++.+||..+|+.||.+|||+.+|+.+=
T Consensus       232 ~~~----Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~  270 (592)
T KOG0575|consen  232 LNE----YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHP  270 (592)
T ss_pred             hcC----cccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCH
Confidence            111    123446678899999999999999999999999763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=394.16  Aligned_cols=260  Identities=34%  Similarity=0.543  Sum_probs=215.3

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh--HHHHHHHHHHHhcCCCCceeeeecEEEeCC-eeEE
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNLVKLIGYCCEDD-HRLL  158 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~l  158 (431)
                      +.+.||.|+||+||+|.+.....       ||+|++.......  .++|.+|+.+|.+++|||||+++|++.+.. .+++
T Consensus        45 ~~~~iG~G~~g~V~~~~~~g~~~-------vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   45 IEEVLGSGSFGTVYKGKWRGTDV-------VAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             hhhhcccCCceeEEEEEeCCcee-------EEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence            44459999999999999987532       8999988754322  458999999999999999999999999887 7999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCccCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQ  237 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~~~~~  237 (431)
                      ||||+++|+|.++++......+++..++.++.||++||.|||+.++ ||||||||+||||+.++ ++||+|||+++....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~-iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP-IIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-eeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9999999999999988545679999999999999999999998554 99999999999999998 999999999987543


Q ss_pred             CCCcceeecccCCccccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..  ...+...||+.|||||++.  ...|+.|+||||||+++|||+||+.||....+...                ...+
T Consensus       197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~----------------~~~v  258 (362)
T KOG0192|consen  197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQV----------------ASAV  258 (362)
T ss_pred             cc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHH----------------HHHH
Confidence            22  2233367999999999999  56999999999999999999999999988654111                1111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                      +....+...+..+...+..|+.+||+.||.+||++.+|+..|+.+.......
T Consensus       259 ~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~  310 (362)
T KOG0192|consen  259 VVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSA  310 (362)
T ss_pred             HhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhccc
Confidence            2222233334446788999999999999999999999999999887655543

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=378.94  Aligned_cols=250  Identities=29%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..+|...+.||+|+||+||+|+++....      .||||.+.+..  .+..+.+..|+.+|+.++|||||.+++++.+++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~------~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~   82 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGT------EVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDD   82 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCc------eEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCC
Confidence            3568888889999999999999987654      49999998773  345566789999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC------CcEEEec
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD------YTAKLSD  228 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~------~~~kl~D  228 (431)
                      .+|||||||.||+|.++|++++  .+++.....++.||+.||++||+.+  ||||||||.||||+..      -.+||+|
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~~~--~l~e~t~r~Fm~QLA~alq~L~~~~--IiHRDLKPQNiLLs~~~~~~~~~~LKIAD  158 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRRRG--RLPEATARHFMQQLASALQFLHENN--IIHRDLKPQNILLSTTARNDTSPVLKIAD  158 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCcceEEeccCCCCCCCceEEecc
Confidence            9999999999999999998876  4888999999999999999999866  9999999999999765      5689999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ||+|+.+..+.   ...+.||+|.|||||++..++|+.|+|+||+|++||+|++|+.||......+....+.       .
T Consensus       159 FGfAR~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~-------k  228 (429)
T KOG0595|consen  159 FGFARFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK-------K  228 (429)
T ss_pred             cchhhhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh-------c
Confidence            99999876433   4456899999999999999999999999999999999999999998655433221111       0


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV  354 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil  354 (431)
                      .        ..+....+...+..+.+|+...|..+|.+|-++.+-.
T Consensus       229 ~--------~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  229 G--------NEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             c--------ccccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            1        1111122223334445666666666666666555544

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=376.38  Aligned_cols=251  Identities=28%  Similarity=0.413  Sum_probs=209.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .+.|++.++||+|+||+||.++.+++.+.      ||+|++++..+.   ..+...+|..||.+++||+||+++..|++.
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~ki------YAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~   97 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKI------YAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTE   97 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCce------eehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccC
Confidence            35689999999999999999999987766      999999887543   345678999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|||+||+.||.|..+|.+.+.  +++..+..++.+|+.||.|||+.+  ||||||||+|||||.+|+++|+|||+++
T Consensus        98 ~kLylVld~~~GGeLf~hL~~eg~--F~E~~arfYlaEi~lAL~~LH~~g--IiyRDlKPENILLd~~GHi~LtDFgL~k  173 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQREGR--FSEDRARFYLAEIVLALGYLHSKG--IIYRDLKPENILLDEQGHIKLTDFGLCK  173 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHhcCC--cchhHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHeeecCCCcEEEeccccch
Confidence            999999999999999999987664  788888899999999999999877  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ....+.|||+.|||||++.+..|+..+|+||||+++|||++|.+||..........                
T Consensus       174 ~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~----------------  235 (357)
T KOG0598|consen  174 EDLKDG--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD----------------  235 (357)
T ss_pred             hcccCC--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH----------------
Confidence            643322  23345899999999999999999999999999999999999999997754222111                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP----t~~eil~~  356 (431)
                      .+...+ ....+...+.++++++..+|..||++|.    ++.+|..|
T Consensus       236 ~I~~~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  236 KILKGK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             HHhcCc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence            111111 1122333567889999999999999995    56665543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-52  Score=362.56  Aligned_cols=256  Identities=23%  Similarity=0.331  Sum_probs=207.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeec-EEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIG-YCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~  154 (431)
                      ..|+++++||.|+||.||++....++..      +|.|.+.-...  ....++..|+.+|++|+|||||++++ .|.++.
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l------~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~   92 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKL------VALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDN   92 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcch------hhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccc
Confidence            3477888999999999999998766554      88888775433  34567899999999999999999999 454444


Q ss_pred             e-eEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCC--CeeeccCCCCCEEECCCCcEEEecc
Q 014079          155 H-RLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAER--PVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       155 ~-~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~--~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                      . ++||||||.+|+|...++.  +....+++..++.++.|++.||.++|+.-+  -|+||||||.||+|+.+|.+||+||
T Consensus        93 evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDf  172 (375)
T KOG0591|consen   93 EVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDF  172 (375)
T ss_pred             hhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccc
Confidence            4 8999999999999999965  445568999999999999999999998323  3999999999999999999999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |+++.+...  .......+|||+||+||.+.+..|+.|+||||+||++|||+.-+.||.+..-.                
T Consensus       173 GL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~----------------  234 (375)
T KOG0591|consen  173 GLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL----------------  234 (375)
T ss_pred             hhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH----------------
Confidence            999986543  33445688999999999999999999999999999999999999999875211                


Q ss_pred             chhhhhcCccccCccc-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYS-VRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                       .+.+.+...--...+ ...+.++..+|..|+..||+.||+...++..+.
T Consensus       235 -~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  235 -SLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             -HHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence             111122111111223 567889999999999999999998655555443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=385.76  Aligned_cols=257  Identities=30%  Similarity=0.474  Sum_probs=221.5

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +...+.||+|-||.||+|.++...+       ||+|.++... ...+.|.+|+++|++|+|+|||+++++|..++.+|||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~-------vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIV  279 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTK-------VAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIV  279 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCc-------ccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEE
Confidence            3455679999999999999987654       8888887653 3456788999999999999999999999998899999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||||+.|+|.++|....+..+.....+.++.||++||+||++++  +|||||..+||||+++..+||+|||||+...+. 
T Consensus       280 tE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~--~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-  356 (468)
T KOG0197|consen  280 TEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN--YIHRDLAARNILVDEDLVVKISDFGLARLIGDD-  356 (468)
T ss_pred             EEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC--ccchhhhhhheeeccCceEEEcccccccccCCC-
Confidence            99999999999998866777999999999999999999999977  999999999999999999999999999954333 


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      .........-...|.|||.+..+.|+.|||||||||+||||+| |+.|+.+..                 ..++.+.++.
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms-----------------n~ev~~~le~  419 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS-----------------NEEVLELLER  419 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC-----------------HHHHHHHHhc
Confidence            3333333345667999999999999999999999999999999 999987754                 2344555666


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      ..+...+..++.++++++..||+.+|++|||++.+...|+.+....
T Consensus       420 GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  420 GYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             cCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            6666777889999999999999999999999999999999877654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=374.71  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=212.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---HHHHHHHHHHHhcC-CCCceeeeecEEE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQL-RHPNLVKLIGYCC  151 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~  151 (431)
                      -.++|..++.||.|+|++|++|+.+...+.      ||||++.+..+-.   .+-...|-.+|.+| .||.|++|+..|.
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~ke------YAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQ  144 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKE------YAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQ  144 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCce------eeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEee
Confidence            346799999999999999999999887654      9999998765422   23355788889999 7999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      ++..+|+|+||+++|+|.++|.+.+  .+++.....++.+|+.||+|||++|  ||||||||+|||||.+|+++|+|||.
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K~G--sfde~caR~YAAeIldAleylH~~G--IIHRDlKPENILLd~dmhikITDFGs  220 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKKYG--SFDETCARFYAAEILDALEYLHSNG--IIHRDLKPENILLDKDGHIKITDFGS  220 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHHhC--cchHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeEcCCCcEEEeeccc
Confidence            9999999999999999999998875  4888888999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCc---------ce--eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          232 AKAGPQGDET---------HV--STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       232 a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      |+.+......         ..  ...++||..|.+||+|..+..+..+|||+||||||.|+.|++||.+..+...     
T Consensus       221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyli-----  295 (604)
T KOG0592|consen  221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLI-----  295 (604)
T ss_pred             cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHH-----
Confidence            9876543222         11  1448899999999999999999999999999999999999999987643221     


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                                 +.++++  +.-.++...++.+.+|+++.|..||.+|+|..+|.+|.
T Consensus       296 -----------FqkI~~--l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  296 -----------FQKIQA--LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             -----------HHHHHH--hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                       112221  22334445558889999999999999999999998763

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-49  Score=351.89  Aligned_cols=266  Identities=24%  Similarity=0.291  Sum_probs=208.3

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhH-HHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .|+.+.++|+|+||+||+|++++++++      ||||.+..... ... +-.++|+++|++|+|+|+|.++.+|.....+
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqI------VAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrkl   76 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQI------VAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKL   76 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccE------EEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhccee
Confidence            577778899999999999999998876      99998865532 222 4468999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +||+|||+..-|.+ |.+.. ..++...+..+++|++.|+.|+|+++  +|||||||+||||+.+|.+||||||+|+.+.
T Consensus        77 hLVFE~~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n--~IHRDIKPENILit~~gvvKLCDFGFAR~L~  152 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHKNN--CIHRDIKPENILITQNGVVKLCDFGFARTLS  152 (396)
T ss_pred             EEEeeecchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcC--eecccCChhheEEecCCcEEeccchhhHhhc
Confidence            99999996655554 44433 34788999999999999999999977  9999999999999999999999999999875


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc-c-----
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND-K-----  309 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~-----  309 (431)
                      .  .....+..+.|.+|+|||++.+ ..|...+||||+||++.||++|.+-|.+..+......+......+.. .     
T Consensus       153 ~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~  230 (396)
T KOG0593|consen  153 A--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS  230 (396)
T ss_pred             C--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence            3  2223456778999999999988 68999999999999999999999999887766554443322111110 0     


Q ss_pred             --chhhhhcCcc--ccCcc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 --RKMLQIIDPR--LENQY---SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 --~~~~~~~~~~--~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ..+..+.-|.  -....   -...+.-+.+|++.||+.||.+|++.++++.|
T Consensus       231 ~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  231 SNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             cCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence              1111111111  11111   12345688999999999999999999999864

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1e-48  Score=362.86  Aligned_cols=258  Identities=28%  Similarity=0.412  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--e
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--H  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~  155 (431)
                      .+|...+.||+|+||.||++.+.+++..      .|||.+........+.+.+|+.+|.+|+|||||+++|......  .
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~------~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~   90 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGEL------MAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDE   90 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcc------eeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCee
Confidence            3466778899999999999999875443      8999887664344566889999999999999999999755444  6


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~  234 (431)
                      ++++|||+++|+|.+++.+.++ .+++..+..+..|+++||.|||+++  ||||||||+||||+. ++.+||+|||+++.
T Consensus        91 ~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g--~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~  167 (313)
T KOG0198|consen   91 YNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKG--IVHCDIKPANILLDPSNGDVKLADFGLAKK  167 (313)
T ss_pred             eEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCcccceEEEeCCCCeEEeccCccccc
Confidence            8999999999999999998876 7999999999999999999999866  999999999999999 79999999999987


Q ss_pred             CCC-CCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQ-GDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ... ...........||+.|||||++..+. ...++|||||||++.||+||+.||.....  .             ...+
T Consensus       168 ~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~--~-------------~~~~  232 (313)
T KOG0198|consen  168 LESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE--E-------------AEAL  232 (313)
T ss_pred             cccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc--h-------------HHHH
Confidence            553 11112233467999999999998643 33599999999999999999999976300  0             0111


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      ..+........++...+.++.+|+.+|+..||++|||+.++++|.-.
T Consensus       233 ~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  233 LLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             HHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            11211112224555677899999999999999999999999988653

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-48  Score=372.98  Aligned_cols=251  Identities=24%  Similarity=0.362  Sum_probs=215.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ..|...+.||+|+.|.||.|........      ||||.+........+-+++|+.+|+..+|+|||.+++.|...+.+|
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~------VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLW  346 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQE------VAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELW  346 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCce------EEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeE
Confidence            4688888999999999999998776554      9999998876666677899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +|||||+||+|.|.+...   .+++.++..++++++.||+|||..+  |+|||||.+|||++.+|.+||+|||++..+..
T Consensus       347 VVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~g--IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  347 VVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARG--IIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             EEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcc--eeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999998554   3889999999999999999999866  99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...  ...+.+|||+|||||++....|++|.||||||++++||+.|++||-...+.....++.             .  +
T Consensus       422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa-------------~--n  484 (550)
T KOG0578|consen  422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA-------------T--N  484 (550)
T ss_pred             ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh-------------h--c
Confidence            433  3345789999999999999999999999999999999999999997655443332221             1  1


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+...+..+.+|+.+||+.|+++|+++.|||+|
T Consensus       485 g~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  485 GTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            122233456678899999999999999999999999986

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-48  Score=340.97  Aligned_cols=237  Identities=27%  Similarity=0.379  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||.|+||.|.+++.+.++.+      +|+|++++....   ..+...+|..+|+.+.||+++++++.|.+.+
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~y------YAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~  117 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNY------YAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNS  117 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCce------eehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCC
Confidence            4577888999999999999999988776      999999987554   3455778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+||||||++||.|..++++.+  .+++.....++.||+.||+|||+.+  |++|||||+|||||.+|.+||+|||+|+.
T Consensus       118 ~lymvmeyv~GGElFS~Lrk~~--rF~e~~arFYAAeivlAleylH~~~--iiYRDLKPENiLlD~~G~iKitDFGFAK~  193 (355)
T KOG0616|consen  118 NLYMVMEYVPGGELFSYLRKSG--RFSEPHARFYAAEIVLALEYLHSLD--IIYRDLKPENLLLDQNGHIKITDFGFAKR  193 (355)
T ss_pred             eEEEEEeccCCccHHHHHHhcC--CCCchhHHHHHHHHHHHHHHHHhcC--eeeccCChHHeeeccCCcEEEEeccceEE
Confidence            9999999999999999997755  4788899999999999999999877  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     .-+.||||.|+|||++....|+.++|+|||||++|||+.|.+||....+.....                +
T Consensus       194 v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~----------------K  252 (355)
T KOG0616|consen  194 VSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYE----------------K  252 (355)
T ss_pred             ecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHH----------------H
Confidence            5432     345899999999999999999999999999999999999999998776532211                2


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR  347 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  347 (431)
                      ++...+  .++...+.++.+|+..+|+.|-.+|
T Consensus       253 I~~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  253 ILEGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             HHhCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            222221  2455667889999999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-47  Score=354.57  Aligned_cols=264  Identities=28%  Similarity=0.363  Sum_probs=216.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-HHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .+.|++.++||.|..++||+|+......+      ||||+++-+.... ...+.+|+..|+.++||||++++..|..++.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~------VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~   98 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEV------VAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSE   98 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCE------EEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecce
Confidence            36789999999999999999998776665      9999998876654 4778899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+||.||.+|++.+++...-...+++..+..|++++++||.|||.+|  .||||||+.||||+.+|.+||+|||.+..+
T Consensus        99 LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G--~IHRdvKAgnILi~~dG~VkLadFgvsa~l  176 (516)
T KOG0582|consen   99 LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG--HIHRDVKAGNILIDSDGTVKLADFGVSASL  176 (516)
T ss_pred             eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC--ceecccccccEEEcCCCcEEEcCceeeeee
Confidence            999999999999999998876667999999999999999999999877  999999999999999999999999987654


Q ss_pred             CCCC-Cccee-ecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          236 PQGD-ETHVS-TRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       236 ~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      .... ..... .+..||++|||||++..  ..|+.|+||||||++..||.+|..||....+.+.....-...|.      
T Consensus       177 ~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp------  250 (516)
T KOG0582|consen  177 FDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPP------  250 (516)
T ss_pred             cccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCC------
Confidence            3332 22222 56789999999999654  47999999999999999999999999987665533221111100      


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...  ...+..+........+.+++..||++||.+|||+++++++
T Consensus       251 ~~~--t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  251 TLL--TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             Ccc--cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            000  1111222233455689999999999999999999999965

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=9.8e-48  Score=364.75  Aligned_cols=247  Identities=30%  Similarity=0.445  Sum_probs=213.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|.+.+.||+|+||.||+|+.+.+.++      ||+|.+.+...  ++.+.+.+|++|++.|+|||||.++++|+...+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~------vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~   75 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQV------VAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAH   75 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeE------EEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccce
Confidence            4688889999999999999999888776      99999987654  345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+|.||+.| +|..+|...+  .++++.+..++.+++.||.|||+++  |+|||+||.|||++.+|++|+||||+|+.+
T Consensus        76 ~~vVte~a~g-~L~~il~~d~--~lpEe~v~~~a~~LVsaL~yLhs~r--ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   76 LWVVTEYAVG-DLFTILEQDG--KLPEEQVRAIAYDLVSALYYLHSNR--ILHRDMKPQNILLEKGGTLKLCDFGLARAM  150 (808)
T ss_pred             EEEEehhhhh-hHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHhcC--cccccCCcceeeecCCCceeechhhhhhhc
Confidence            9999999966 9999997765  4888999999999999999999977  999999999999999999999999999986


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh-
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ-  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  314 (431)
                      ..  .+...+.+.|||.|||||++.++.|+..+|+|||||++|||+.|++||-...-                 ..+.+ 
T Consensus       151 ~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si-----------------~~Lv~~  211 (808)
T KOG0597|consen  151 ST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSI-----------------TQLVKS  211 (808)
T ss_pred             cc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHH-----------------HHHHHH
Confidence            54  45566778899999999999999999999999999999999999999954311                 11111 


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +...  ...++...+..+..|+...|.+||.+|.+..+++.|
T Consensus       212 I~~d--~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  212 ILKD--PVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HhcC--CCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            1111  112345778899999999999999999999999865

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.6e-47  Score=361.54  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=207.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.++++||+|+||.||+|+.++++++      +|+|++++...-   ..+....|-.+|....+|+||+||..|++.+
T Consensus       141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~i------yAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~  214 (550)
T KOG0605|consen  141 DDFELLKVIGKGAFGEVRLARKKDTGEI------YAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKE  214 (550)
T ss_pred             ccchhheeeccccceeEEEEEEccCCcE------EeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCC
Confidence            5799999999999999999999999887      999999987543   3456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ++||||||++||++..+|.+.+  .|++.....++.+++.|+..||+.|  +|||||||+|+|||..|++||+||||+.-
T Consensus       215 ~LYLiMEylPGGD~mTLL~~~~--~L~e~~arfYiaE~vlAI~~iH~~g--yIHRDIKPdNlLiD~~GHiKLSDFGLs~g  290 (550)
T KOG0605|consen  215 YLYLIMEYLPGGDMMTLLMRKD--TLTEDWARFYIAETVLAIESIHQLG--YIHRDIKPDNLLIDAKGHIKLSDFGLSTG  290 (550)
T ss_pred             eeEEEEEecCCccHHHHHHhcC--cCchHHHHHHHHHHHHHHHHHHHcC--cccccCChhheeecCCCCEeeccccccch
Confidence            9999999999999999998766  4788888889999999999999877  99999999999999999999999999842


Q ss_pred             CCC----------------------CCCcc----e-------------------eecccCCccccCccccccCCCCcchh
Q 014079          235 GPQ----------------------GDETH----V-------------------STRVMGTYGYAAPEYVMTGHLTARSD  269 (431)
Q Consensus       235 ~~~----------------------~~~~~----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~D  269 (431)
                      +..                      .+...    .                   ....+|||.|+|||++.+..|+..+|
T Consensus       291 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  291 LDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             hhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence            111                      00000    0                   01257999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC
Q 014079          270 VYSFGVVLLELLTGRKSVDKTRPSKEQ-SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP  348 (431)
Q Consensus       270 iwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  348 (431)
                      +||||||+||||.|.+||....+...- .++.|.               ..+........+.++.+||.+||. ||++|.
T Consensus       371 wWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr---------------~~l~fP~~~~~s~eA~DLI~rll~-d~~~RL  434 (550)
T KOG0605|consen  371 WWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWR---------------ETLKFPEEVDLSDEAKDLITRLLC-DPENRL  434 (550)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh---------------hhccCCCcCcccHHHHHHHHHHhc-CHHHhc
Confidence            999999999999999999887664432 122221               112222223445899999999999 999997


Q ss_pred             C---HHHHHHH
Q 014079          349 L---MSDVVET  356 (431)
Q Consensus       349 t---~~eil~~  356 (431)
                      -   +.||-+|
T Consensus       435 G~~G~~EIK~H  445 (550)
T KOG0605|consen  435 GSKGAEEIKKH  445 (550)
T ss_pred             CcccHHHHhcC
Confidence            4   6677654

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-48  Score=361.52  Aligned_cols=269  Identities=26%  Similarity=0.351  Sum_probs=216.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHH-HHHHHHHHHhcCC-CCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLR-HPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~-~~~~E~~~l~~l~-h~niv~l~~~~~~~  153 (431)
                      +-++|.+.+.||.|+||.||+|+.......      ||||.+++......+ .-++|++.|++|+ |||||+|.+++.+.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~------VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~   81 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGEL------VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDN   81 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCce------eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence            457889999999999999999998887665      999998876443222 2368999999999 99999999999998


Q ss_pred             C-eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          154 D-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       154 ~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      + .+|+||||| ..+|.+++..+ ..++++..+..|++||++||+|+|.+|  +.||||||+|||+..+..+||+|||+|
T Consensus        82 ~~~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~G--fFHRDlKPENiLi~~~~~iKiaDFGLA  157 (538)
T KOG0661|consen   82 DRILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHG--FFHRDLKPENILISGNDVIKIADFGLA  157 (538)
T ss_pred             CceEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcC--cccccCChhheEecccceeEecccccc
Confidence            8 999999999 78999999887 668999999999999999999999877  999999999999998889999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hh---h
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PK---L  306 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~---~  306 (431)
                      |......   ..+..+.|.+|+|||++. .+.|+.+.||||+|||++|+.+-++-|.+....+....+....  |.   +
T Consensus       158 Rev~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~  234 (538)
T KOG0661|consen  158 REVRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW  234 (538)
T ss_pred             cccccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence            9864433   345678999999999876 5789999999999999999999999998876554433322111  11   1


Q ss_pred             hccchhhhhcCccccC-------cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          307 NDKRKMLQIIDPRLEN-------QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .....+...++-.+..       .+-..++.++.+||.+||.+||.+|||+.|++++-
T Consensus       235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence            1112222222222211       11223678999999999999999999999999864

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-47  Score=330.78  Aligned_cols=266  Identities=29%  Similarity=0.377  Sum_probs=211.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh--HHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .+|...++||+|.||.||+|++..+++.      ||||.++.....+  ....++|++.|+.++|+||+.++|+|...+.
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~------VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~   75 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKR------VAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSN   75 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcE------EEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCc
Confidence            4678888999999999999999887665      9999987764432  3457899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +.||+||+ ..+|+..+..+. ..+....+..++.++++||+|||.+.  |+||||||.|+||+++|.+||+|||+|+.+
T Consensus        76 l~lVfEfm-~tdLe~vIkd~~-i~l~pa~iK~y~~m~LkGl~y~H~~~--IlHRDlKPnNLLis~~g~lKiADFGLAr~f  151 (318)
T KOG0659|consen   76 LSLVFEFM-PTDLEVVIKDKN-IILSPADIKSYMLMTLKGLAYCHSKW--ILHRDLKPNNLLISSDGQLKIADFGLARFF  151 (318)
T ss_pred             eEEEEEec-cccHHHHhcccc-cccCHHHHHHHHHHHHHHHHHHHhhh--hhcccCCccceEEcCCCcEEeecccchhcc
Confidence            99999999 679999887654 47899999999999999999999877  999999999999999999999999999987


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--h------hhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--A------RPKL  306 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~------~~~~  306 (431)
                      .......  +..+-|.+|+|||++.| ..|+..+||||.|||+.||+-|.+-|.+..+.+....+-.  .      +|.+
T Consensus       152 ~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~  229 (318)
T KOG0659|consen  152 GSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEM  229 (318)
T ss_pred             CCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccc
Confidence            6554433  22367999999998876 4799999999999999999999888877665544332211  1      1111


Q ss_pred             hccchhhhh---cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQI---IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+..++   -.+.+. ..-..++.++.+|+..||..||.+|+++.|++++
T Consensus       230 ~~lpdY~~~~~~P~~~~~-~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  230 TSLPDYVKIQQFPKPPLN-NLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             cccccHHHHhcCCCCccc-cccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            111111111   111111 1333456778999999999999999999999976

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=362.09  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=208.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC----c-hhHHHHHHHHHHHhcCC-CCceeeeec
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG----L-QGHREWLTEVNFLGQLR-HPNLVKLIG  148 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~-~~~~~~~~E~~~l~~l~-h~niv~l~~  148 (431)
                      .....|.+.+.||+|+||.|++|.+..++.      .||+|++++..    . ...+.+.+|+.+++.++ ||||+++++
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~------~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~e   87 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGE------KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLE   87 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCC------eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEE
Confidence            345789999999999999999998876553      49999887741    1 12345568999999999 999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEe
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLS  227 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~  227 (431)
                      ++.....+|+||||+.||+|.+++...+  ++.+.....++.|++.|++|||+.+  |+||||||+|||++.+ +++||+
T Consensus        88 v~~t~~~~~ivmEy~~gGdL~~~i~~~g--~l~E~~ar~~F~Qlisav~y~H~~g--i~HRDLK~ENilld~~~~~~Kl~  163 (370)
T KOG0583|consen   88 VFATPTKIYIVMEYCSGGDLFDYIVNKG--RLKEDEARKYFRQLISAVAYCHSRG--IVHRDLKPENILLDGNEGNLKLS  163 (370)
T ss_pred             EEecCCeEEEEEEecCCccHHHHHHHcC--CCChHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEecCCCCCEEEe
Confidence            9999999999999999999999998843  5778888999999999999999876  9999999999999999 999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCC-CC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH-LT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |||++....  .......+.+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+.........        
T Consensus       164 DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~--------  233 (370)
T KOG0583|consen  164 DFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR--------  233 (370)
T ss_pred             ccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH--------
Confidence            999998864  2223455689999999999999877 86 67999999999999999999998733211110        


Q ss_pred             hhccchhhhhcCccccCcccHHH-HHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRA-AQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                              .+....+  .++... +.++.+|+.+||..||.+|+|+.+|+.+=+
T Consensus       234 --------ki~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w  277 (370)
T KOG0583|consen  234 --------KIRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPW  277 (370)
T ss_pred             --------HHhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChh
Confidence                    1111111  122223 688999999999999999999999995533

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-47  Score=380.69  Aligned_cols=265  Identities=29%  Similarity=0.474  Sum_probs=222.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      .+..+.||+|+||+||+|...+... ....+.||||.++..... ...+|.+|+++|..|+|||||+|+|+|.+++.++|
T Consensus       488 i~~~~eLGegaFGkVf~a~~~~l~p-~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M  566 (774)
T KOG1026|consen  488 IVFKEELGEGAFGKVFLAEAYGLLP-GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM  566 (774)
T ss_pred             eeehhhhcCchhhhhhhhhccCCCC-CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence            3455679999999999998755332 223445999999887655 67889999999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhC--------CCC----CcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          159 VYEFMFRGSLENHLFRK--------ATV----PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~--------~~~----~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      |+|||..|+|.++|...        .+.    +++..+.+.|+.|||.||+||-++.  +|||||..+|+||+++..|||
T Consensus       567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~--FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH--FVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc--ccccchhhhhceeccceEEEe
Confidence            99999999999999642        122    3889999999999999999999877  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+++.....+.......-.-..+||+||.+..++||.+||||||||+|||+++ |+.||.+....+           
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E-----------  713 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE-----------  713 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH-----------
Confidence            99999998777777665545556779999999999999999999999999999999 999998754322           


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                            +.+.+..+-.-+.+..++.++++|+..||+.+|.+||+++||-..|.......
T Consensus       714 ------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  714 ------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                  22222222224556778899999999999999999999999999998765543

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.8e-46  Score=360.40  Aligned_cols=267  Identities=28%  Similarity=0.432  Sum_probs=204.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED-  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  153 (431)
                      .++|++.++||+|+||.||+|.+..... ......||+|++..... .....+.+|+.+|..+ +||||+++++++... 
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDK-KSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCC-cccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            3578999999999999999998632111 01223499999875432 3345688999999999 899999999988764 


Q ss_pred             CeeEEEEEecCCCChHHhhhhCC---------------------------------------------------------
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKA---------------------------------------------------------  176 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  176 (431)
                      +.+++||||+++|+|.+++....                                                         
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence            45789999999999999986532                                                         


Q ss_pred             ---CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccc
Q 014079          177 ---TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY  253 (431)
Q Consensus       177 ---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y  253 (431)
                         ..++.+...+.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...............+++.|
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y  242 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW  242 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence               134778888999999999999999866  999999999999999999999999999865332222122234567889


Q ss_pred             cCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHH
Q 014079          254 AAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKA  332 (431)
Q Consensus       254 ~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (431)
                      +|||++.+..++.++|||||||++|||++ |..||........  ..              ..+........+...+..+
T Consensus       243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~~--------------~~~~~~~~~~~~~~~~~~l  306 (338)
T cd05102         243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--FC--------------QRLKDGTRMRAPENATPEI  306 (338)
T ss_pred             cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--HH--------------HHHhcCCCCCCCCCCCHHH
Confidence            99999999999999999999999999997 9999976432111  00              0000000011122345678


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          333 CSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       333 ~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         307 YRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999997654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=349.59  Aligned_cols=270  Identities=27%  Similarity=0.330  Sum_probs=216.3

Q ss_pred             cccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--------------hHHHHHHH
Q 014079           66 IAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--------------GHREWLTE  131 (431)
Q Consensus        66 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------~~~~~~~E  131 (431)
                      ..+...+.....++|++.+.||+|.||.|-+|++...+++      ||||++.+....              ..+...+|
T Consensus        85 ~~~~~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l------~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~E  158 (576)
T KOG0585|consen   85 VRYDDDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKL------YAIKILPKKELRRQYGFPRQPAMKLMPIEKVRRE  158 (576)
T ss_pred             eeecCcccceehhheehhhhhcCCccceEEEEeecCCCcE------EEEEeechhhhhhhcccccccccccCcHHHHHHH
Confidence            3444455556678899999999999999999999877665      999999775331              13467899


Q ss_pred             HHHHhcCCCCceeeeecEEEe--CCeeEEEEEecCCCChHHhhhhCCCCC-cCHHHHHHHHHHHHHHHHHhHhCCCCeee
Q 014079          132 VNFLGQLRHPNLVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFRKATVP-LSWATRMMIAFGAAKGLAFLHNAERPVIY  208 (431)
Q Consensus       132 ~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~-~~~~~~~~i~~~i~~~l~~LH~~~~~ivH  208 (431)
                      +.||++|+|||||+|+.+..+  .+.+|||+|||..|.+...-.   ..+ +.+.+.+.++.+++.||+|||.++  |||
T Consensus       159 IailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p~---d~~els~~~Ar~ylrDvv~GLEYLH~Qg--iiH  233 (576)
T KOG0585|consen  159 IAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCPP---DKPELSEQQARKYLRDVVLGLEYLHYQG--IIH  233 (576)
T ss_pred             HHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccCCC---CcccccHHHHHHHHHHHHHHHHHHHhcC--eec
Confidence            999999999999999999876  468899999999888765432   223 889999999999999999999977  999


Q ss_pred             ccCCCCCEEECCCCcEEEecccCCccCCCCC---CcceeecccCCccccCccccccCC----CCcchhhHHHHHHHHHHH
Q 014079          209 RDFKTSNILLDSDYTAKLSDFGLAKAGPQGD---ETHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYSFGVVLLELL  281 (431)
Q Consensus       209 rDlkp~NILl~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell  281 (431)
                      |||||+|+||+++|++||+|||.+.....+.   .........|||.|+|||...++.    .+.+.||||+||+||+|+
T Consensus       234 RDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCll  313 (576)
T KOG0585|consen  234 RDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLL  313 (576)
T ss_pred             cccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhh
Confidence            9999999999999999999999997653321   112233467999999999887633    345799999999999999


Q ss_pred             hCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          282 TGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       282 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      .|+.||.+....                ....++++..+......+...++.+||++||++||++|.+..+|..|..-..
T Consensus       314 fG~~PF~~~~~~----------------~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  314 FGQLPFFDDFEL----------------ELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             hccCCcccchHH----------------HHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            999999765321                1223445555554444566789999999999999999999999999987554


Q ss_pred             h
Q 014079          362 C  362 (431)
Q Consensus       362 ~  362 (431)
                      .
T Consensus       378 ~  378 (576)
T KOG0585|consen  378 D  378 (576)
T ss_pred             C
Confidence            4

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-46  Score=360.25  Aligned_cols=268  Identities=28%  Similarity=0.412  Sum_probs=214.2

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeec
Q 014079           71 FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        71 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      .+++.....+.+...||+|.||+||+|.|.+.         ||||+++.+..  ...+.|.+|+.++++-+|.||+-+.|
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG  455 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMG  455 (678)
T ss_pred             cccccCHHHhhccceeccccccceeecccccc---------eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeeh
Confidence            34444455677888999999999999999876         99999987654  34577999999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      +|..... .||..+|+|.+|+.+|+... ..+.....+.|+.|+++||.|||..+  |||||||..||+|.++++|||+|
T Consensus       456 ~~~~p~~-AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~--IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  456 ACMNPPL-AIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKN--IIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             hhcCCce-eeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhh--hhhhhccccceEEccCCcEEEec
Confidence            9988877 99999999999999998765 36889999999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      ||++.....-..........|...|||||+++   ..+|++.+||||||+++|||++|..||...........+..    
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGr----  607 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGR----  607 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecc----
Confidence            99997533222222223345788999999986   35799999999999999999999999984322221111110    


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                         ...+.+      .......+++++.+|+..||..++++||.+.+|+..|+.+....
T Consensus       608 ---G~l~pd------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~  657 (678)
T KOG0193|consen  608 ---GYLMPD------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSL  657 (678)
T ss_pred             ---cccCcc------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcc
Confidence               000000      01123456789999999999999999999999999998877653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=355.60  Aligned_cols=250  Identities=26%  Similarity=0.404  Sum_probs=211.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-HHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..|+..++||+|+||.||+|.+..+.+.      ||+|++..+...+ .+++.+|+.+|.+++++||.++|+.|..+..+
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~------vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~L   86 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKV------VAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKL   86 (467)
T ss_pred             cccccchhccccccceeeeeeeccccce------EEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccH
Confidence            3466778999999999999999888776      9999998875543 56788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      |++||||.||++.+++....  .+.+..+..++.+++.||.|||..+  .+|||||+.|||+..+|.+||+|||++..+.
T Consensus        87 wiiMey~~gGsv~~lL~~~~--~~~E~~i~~ilre~l~~l~ylH~~~--kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   87 WIIMEYCGGGSVLDLLKSGN--ILDEFEIAVILREVLKGLDYLHSEK--KIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHHHHhcCcchhhhhccCC--CCccceeeeehHHHHHHhhhhhhcc--eecccccccceeEeccCcEEEEecceeeeee
Confidence            99999999999999996644  3467777778999999999999877  9999999999999999999999999998765


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .....  ..+++|||.|||||++.+..|+.|+||||||++.+||.+|.+|+....+.....++.             +-.
T Consensus       163 ~~~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------k~~  227 (467)
T KOG0201|consen  163 NTVKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------KSA  227 (467)
T ss_pred             chhhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------CCC
Confidence            44332  256889999999999999899999999999999999999999998877644332221             111


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      -|.+    ...++..+.+|+..||++||+.||++.++++|
T Consensus       228 PP~L----~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPRL----DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCcc----ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            1222    22556789999999999999999999999965

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-46  Score=354.57  Aligned_cols=267  Identities=27%  Similarity=0.339  Sum_probs=208.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      +.|+..++||+|+||.||+|++..++++      ||+|.+..+..  ....-..+||.||++|+||||++|.+...+.  
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgki------vALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~  190 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKI------VALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS  190 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcE------EEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC
Confidence            4577778899999999999999988776      99998877652  3445678999999999999999999999877  


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..+|||+||| .-+|.-++.. ....+++.++..++.||+.||+|+|+.+  |+|||||.+|||||.+|.+||+|||||+
T Consensus       191 ~siYlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~g--vlHRDIK~SNiLidn~G~LKiaDFGLAr  266 (560)
T KOG0600|consen  191 GSIYLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRG--VLHRDIKGSNILIDNNGVLKIADFGLAR  266 (560)
T ss_pred             ceEEEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcC--eeeccccccceEEcCCCCEEecccccee
Confidence            6899999999 5678877754 3456899999999999999999999866  9999999999999999999999999999


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhccc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDKR  310 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~  310 (431)
                      ++...... ..+..+-|.+|+|||++.|. .|+.++|+||.||||.||+.|++.|.+.......+.+-..  .|......
T Consensus       267 ~y~~~~~~-~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~  345 (560)
T KOG0600|consen  267 FYTPSGSA-PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP  345 (560)
T ss_pred             eccCCCCc-ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence            76554433 24556789999999999875 7999999999999999999999999887655443332111  01100000


Q ss_pred             --hhh--hhcCc------cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 --KML--QIIDP------RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 --~~~--~~~~~------~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .+.  ..+.+      .+.+ .....+....+|+..+|..||.+|.|+.++++.
T Consensus       346 ~~kLP~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  346 VSKLPHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             cccCCcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence              111  01111      1111 112345678899999999999999999999854

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-46  Score=362.06  Aligned_cols=243  Identities=29%  Similarity=0.433  Sum_probs=204.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCC-CCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLR-HPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  152 (431)
                      .++|++.++||+|+||+|+++..+.+.++      +|||++++..+   .+.+....|.+|+.... ||.++.++..|+.
T Consensus       367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~------yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT  440 (694)
T KOG0694|consen  367 LDDFRLLAVLGRGSFGKVLLAELKGTNEY------YAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT  440 (694)
T ss_pred             ccceEEEEEeccCcCceEEEEEEcCCCcE------EEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc
Confidence            36799999999999999999999988776      99999998755   34556778988888775 9999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+++|+||||+.||++..+.+   ...+++.....++..++.||.|||+++  |||||||.+|||||.+|++||+|||++
T Consensus       441 ~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~--IIYRDlKLdNiLLD~eGh~kiADFGlc  515 (694)
T KOG0694|consen  441 KEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENG--IIYRDLKLDNLLLDTEGHVKIADFGLC  515 (694)
T ss_pred             CCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcC--ceeeecchhheEEcccCcEEecccccc
Confidence            999999999999999544442   235899999999999999999999977  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +......  ....++||||.|||||++.+..|+.++|+|||||+|||||.|+.||.+.+....                .
T Consensus       516 Ke~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~----------------F  577 (694)
T KOG0694|consen  516 KEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV----------------F  577 (694)
T ss_pred             cccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH----------------H
Confidence            8754222  245679999999999999999999999999999999999999999987543221                1


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~  350 (431)
                      ..++..  ...++...+.++.++++++|.+||++|.-+
T Consensus       578 dsI~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  578 DSIVND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHhcC--CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            112211  123456677899999999999999999855

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.4e-46  Score=341.28  Aligned_cols=255  Identities=27%  Similarity=0.346  Sum_probs=214.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH---HHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~---~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|+..+.||.|.-|+||++.+++....      +|+|++.+......   .+...|-+||..++||.++.||..|+.+.
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~------fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~  150 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCL------FAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDK  150 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCce------EEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccc
Confidence            4467778899999999999999887654      99999998865443   45667999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+|||||+||+|..+++++....+++..+..++.+++.||+|||..|  ||+|||||+||||.++|++.|+||.|+..
T Consensus       151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG--ivYRDLKPENILvredGHIMLsDFDLS~~  228 (459)
T KOG0610|consen  151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG--IVYRDLKPENILVREDGHIMLSDFDLSLR  228 (459)
T ss_pred             eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc--eeeccCCcceeEEecCCcEEeeecccccc
Confidence            9999999999999999999998889999999999999999999999988  99999999999999999999999998742


Q ss_pred             CCC---------------------------------CCCc---------------------ceeecccCCccccCccccc
Q 014079          235 GPQ---------------------------------GDET---------------------HVSTRVMGTYGYAAPEYVM  260 (431)
Q Consensus       235 ~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE~~~  260 (431)
                      ...                                 ....                     .....++||-.|+|||++.
T Consensus       229 ~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~  308 (459)
T KOG0610|consen  229 CPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIR  308 (459)
T ss_pred             CCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeee
Confidence            210                                 0000                     0112367999999999999


Q ss_pred             cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhh
Q 014079          261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCL  340 (431)
Q Consensus       261 ~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  340 (431)
                      +...+.++|+|+|||++||||.|..||.+....                ..+..++...+.-......+..+.|||+++|
T Consensus       309 G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~----------------~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LL  372 (459)
T KOG0610|consen  309 GEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNK----------------ETLRNIVGQPLKFPEEPEVSSAAKDLIRKLL  372 (459)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCcCCCCch----------------hhHHHHhcCCCcCCCCCcchhHHHHHHHHHh
Confidence            999999999999999999999999999886432                2344444444433333466789999999999


Q ss_pred             hcCCCCCCC----HHHHHHH
Q 014079          341 SQNPKARPL----MSDVVET  356 (431)
Q Consensus       341 ~~dP~~RPt----~~eil~~  356 (431)
                      .+||.+|..    +.||-+|
T Consensus       373 vKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  373 VKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             ccChhhhhccccchHHhhcC
Confidence            999999998    8888765

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-46  Score=361.21  Aligned_cols=248  Identities=26%  Similarity=0.359  Sum_probs=208.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-c--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-L--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      -|++++.||.|+-|.|-+|++..+++.      +|||++.+.. .  .....+.+|+-||+.+.||||+++|+++++..+
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGql------aaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQL------AAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccce------eEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            367888999999999999998877664      9999997762 2  223457899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+|+||++||.|++++.+++.  +++.....++.||+.|+.|+|..+  |+||||||+|+|||..+++||+|||+|..-
T Consensus        87 lylvlEyv~gGELFdylv~kG~--l~e~eaa~ff~QIi~gv~yCH~~~--icHRDLKpENlLLd~~~nIKIADFGMAsLe  162 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGP--LPEREAAHFFRQILDGVSYCHAFN--ICHRDLKPENLLLDVKNNIKIADFGMASLE  162 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHhhhc--ceeccCCchhhhhhcccCEeeeccceeecc
Confidence            9999999999999999988764  777888889999999999999977  999999999999999999999999999863


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .   ......+-||+|.|.|||++.+..|. .++||||.|||||.||+|+.||++.....                 +..
T Consensus       163 ~---~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~-----------------LLl  222 (786)
T KOG0588|consen  163 V---PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV-----------------LLL  222 (786)
T ss_pred             c---CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH-----------------HHH
Confidence            2   23355668999999999999999985 58999999999999999999998643211                 111


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+.. -..+.+...+.++.+||++||..||++|.|++||++|-
T Consensus       223 KV~~-G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  223 KVQR-GVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHHc-CcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence            1111 01123455678999999999999999999999999875

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=339.93  Aligned_cols=270  Identities=25%  Similarity=0.318  Sum_probs=213.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcc--ccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+...|...+.||.|+||.|+.+.++.++..      ||+|.+.  .......++..+|+++|+.++|+||+.+++++..
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~------VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p   92 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEK------VAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRP   92 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCE------eehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccc
Confidence            3556677788999999999999999887653      9999887  3444567888999999999999999999999875


Q ss_pred             -----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 -----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           -+..|+|+|+| +.+|...+..+.  .++......+++|+++||.|+|+.+  |+||||||.|+|++.+..+||+
T Consensus        93 ~~~~~f~DvYiV~elM-etDL~~iik~~~--~L~d~H~q~f~YQiLrgLKyiHSAn--ViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   93 PSRDKFNDVYLVFELM-ETDLHQIIKSQQ--DLTDDHAQYFLYQILRGLKYIHSAN--VIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             ccccccceeEEehhHH-hhHHHHHHHcCc--cccHHHHHHHHHHHHHhcchhhccc--ccccccchhheeeccCCCEEec
Confidence                 35679999999 889999996644  4899999999999999999999988  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+|+...........+..+-|.+|.|||++. ...|+.+.||||+|||+.||++|+.-|.+........++....+..
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP  247 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP  247 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence            999999875443344456678899999999876 5689999999999999999999999998876654433332211111


Q ss_pred             hccchhhhhc-----------CccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQII-----------DPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~-----------~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ....+..+-           .......   .-......+.+|+.+||..||.+|+|++|.+.|
T Consensus       248 -~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  248 -SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             -CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence             011111110           0000011   112456789999999999999999999999987

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=354.79  Aligned_cols=238  Identities=28%  Similarity=0.453  Sum_probs=201.7

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ++-||.|+.|.||+|+.++.        .||||.++.-.       ..+|+.|++|+|+||+.+.|+|...-.+||||||
T Consensus       129 LeWlGSGaQGAVF~Grl~ne--------tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf  193 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLHNE--------TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF  193 (904)
T ss_pred             hhhhccCcccceeeeeccCc--------eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence            34599999999999998764        38998764321       2588899999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      |..|-|.+.|+..  .++.......|..+|+.||.|||.++  |||||||.-||||..+..+||+|||-++.....   .
T Consensus       194 Ca~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hK--IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---S  266 (904)
T KOG4721|consen  194 CAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHK--IIHRDLKSPNILISYDDVVKISDFGTSKELSDK---S  266 (904)
T ss_pred             cccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhh--HhhhccCCCceEeeccceEEeccccchHhhhhh---h
Confidence            9999999999654  45788888899999999999999988  999999999999999999999999999875443   1


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ....++||..|||||++.+.+.++|+|||||||||||||||..||.+.....    +            +...-...+.-
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssA----I------------IwGVGsNsL~L  330 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSA----I------------IWGVGSNSLHL  330 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhe----e------------EEeccCCcccc
Confidence            2334789999999999999999999999999999999999999997653221    1            11122233444


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ..+..+++.|.-|+++||+-.|..||++.+|+.||+
T Consensus       331 pvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hld  366 (904)
T KOG4721|consen  331 PVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLD  366 (904)
T ss_pred             cCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHh
Confidence            566778899999999999999999999999999986

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.6e-45  Score=343.76  Aligned_cols=253  Identities=28%  Similarity=0.423  Sum_probs=204.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|+..+.||+|+||.||+|.+..++..      ||+|.+.+....   ....+.+|+.++++++|+||+++++++.+.+.
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~   74 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCce------EEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCe
Confidence            377888999999999999998766543      999988764322   23457789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nill~~~~~~kl~Dfg~~~~~  152 (285)
T cd05631          75 LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER--IVYRDLKPENILLDDRGHIRISDLGLAVQI  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeCCCcEEc
Confidence            999999999999998887655556899999999999999999999866  999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....   ......||..|+|||++.+..++.++|||||||++|||++|+.||.............             ..
T Consensus       153 ~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~-------------~~  216 (285)
T cd05631         153 PEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD-------------RR  216 (285)
T ss_pred             CCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH-------------HH
Confidence            3322   1234579999999999999999999999999999999999999998654321111110             00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      + ......++...+.++.+|+.+||+.||.+||+     +.+++++
T Consensus       217 ~-~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         217 V-KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             h-hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            0 00011223344578889999999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-46  Score=319.84  Aligned_cols=251  Identities=27%  Similarity=0.396  Sum_probs=213.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|.||.||+|+.+.+..+      ||+|++.+..+.   ...++.+|++|-..|+||||+++|++|.+..
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~I------valKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~   95 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFI------VALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSK   95 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcE------EEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccc
Confidence            5688999999999999999999888766      999999887542   3466889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..||++||..+|+|...|.......+++.....+..|++.||.|+|..+  ||||||||+|+|++..+.+||+|||.+..
T Consensus        96 riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~--VIhRdiKpenlLlg~~~~lkiAdfGwsV~  173 (281)
T KOG0580|consen   96 RIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  173 (281)
T ss_pred             eeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC--cccCCCCHHHhccCCCCCeeccCCCceee
Confidence            9999999999999999998666667888889999999999999999755  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .+..    ...+.|||..|.+||...+..++..+|+|++|++.||++.|.+||.........                ..
T Consensus       174 ~p~~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY----------------kr  233 (281)
T KOG0580|consen  174 APSN----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY----------------KR  233 (281)
T ss_pred             cCCC----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH----------------HH
Confidence            4422    234589999999999999999999999999999999999999999875421111                01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      +.  ..+-.++...+..+.+||.+||.++|.+|.+..|++++-.
T Consensus       234 I~--k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpw  275 (281)
T KOG0580|consen  234 IR--KVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPW  275 (281)
T ss_pred             HH--HccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHH
Confidence            11  0111233456678899999999999999999999998754

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=361.85  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=216.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecE-EEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGY-CCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~---  152 (431)
                      .++++.+.|.+|||+.||+|.+..+..      .||+|++-..+....+.+.+|+.+|++|+ |+|||.++|. ...   
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~------~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~  110 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGK------KYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS  110 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCc------eeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence            567888999999999999999987642      49999877766677788899999999998 9999999993 221   


Q ss_pred             ---CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          153 ---DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       153 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                         .-+++|.||||.||.|-|++..+....|++..++.|+.++++|+++||....+|||||||-+||||+.+|..|||||
T Consensus       111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence               12568999999999999999876666699999999999999999999999999999999999999999999999999


Q ss_pred             cCCccCCCCC-Ccce------eecccCCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          230 GLAKAGPQGD-ETHV------STRVMGTYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       230 G~a~~~~~~~-~~~~------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      |.+......- ....      .-...-|+-|+|||++   .+...++|+|||+|||+||-|+....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9986422211 1100      0013468999999987   477899999999999999999999999986532       


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                                   ..|++..+........+..+.+||+.||+.||.+||++.+++..+-.++....
T Consensus       264 -------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 -------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             -------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                         24455555444456788999999999999999999999999999987765533

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-44  Score=343.45  Aligned_cols=269  Identities=26%  Similarity=0.433  Sum_probs=205.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCcee----------ccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRV----------GLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      ++|++.+.||+|+||.||+|.+.++...          ......||+|++..... ....++.+|+++|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            5788999999999999999987553211          11233599999876532 234578899999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCC-----------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeec
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKA-----------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYR  209 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHr  209 (431)
                      ++++.+.+..++||||+.+++|.+++....                 ...+++...+.++.|++.||.|||+.+  |+||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--ivH~  162 (304)
T cd05096          85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN--FVHR  162 (304)
T ss_pred             EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--cccc
Confidence            999999999999999999999999885432                 123677888999999999999999876  9999


Q ss_pred             cCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCC
Q 014079          210 DFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT--GRKSV  287 (431)
Q Consensus       210 Dlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf  287 (431)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999986544333222333456889999999998999999999999999999987  56777


Q ss_pred             CCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ........   ...........       ........+..++..+.+|+.+||+.||++|||+.+|.+.|+
T Consensus       243 ~~~~~~~~---~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         243 GELTDEQV---IENAGEFFRDQ-------GRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CcCCHHHH---HHHHHHHhhhc-------cccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            65432211   11100000000       000000111234568899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-45  Score=336.71  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=212.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHH---HHHHHHHHHhcCCCCceeeeecEEE
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      .+..+|++.+.||+|.||.|-+|+....++.      ||||.|+++.+.+..   .+.+|++||..|+||||+.+|.+|+
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~------VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFE  123 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGRE------VAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFE  123 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcE------eehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhc
Confidence            3556788999999999999999998665554      999999988766544   4678999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      ..+.+.|||||..+|.|.|++.+.+  .+++.....++.||+.|+.|+|.++  ++|||||.+|||||.++++||+|||+
T Consensus       124 NkdKIvivMEYaS~GeLYDYiSer~--~LsErEaRhfFRQIvSAVhYCHknr--VvHRDLKLENILLD~N~NiKIADFGL  199 (668)
T KOG0611|consen  124 NKDKIVIVMEYASGGELYDYISERG--SLSEREARHFFRQIVSAVHYCHKNR--VVHRDLKLENILLDQNNNIKIADFGL  199 (668)
T ss_pred             CCceEEEEEEecCCccHHHHHHHhc--cccHHHHHHHHHHHHHHHHHHhhcc--ceecccchhheeecCCCCeeeeccch
Confidence            9999999999999999999997765  4888899999999999999999866  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      +..+...   ....++||+|-|.+||++.+.+|. +.+|.|||||+||.|+.|..||++.+-.                .
T Consensus       200 SNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk----------------~  260 (668)
T KOG0611|consen  200 SNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK----------------R  260 (668)
T ss_pred             hhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH----------------H
Confidence            9875433   345678999999999999999885 6799999999999999999999875321                1


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      -+.++-.....   .++.+..+.-||++||-.||++|.|+.+|..|.+
T Consensus       261 lvrQIs~GaYr---EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  261 LVRQISRGAYR---EPETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHHhhccccc---CCCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            11222222111   1123356678999999999999999999998875

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.4e-44  Score=353.96  Aligned_cols=264  Identities=26%  Similarity=0.415  Sum_probs=204.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..... ......||+|+++... ......+.+|+.+|..+ +||||++++++|.+.+
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecccc-CccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            3468889999999999999997532111 1123359999987543 23445688999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC----------------------------------------------------------
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA----------------------------------------------------------  176 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  176 (431)
                      ..++||||+++|+|.+++....                                                          
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            9999999999999999886432                                                          


Q ss_pred             ---------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          177 ---------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       177 ---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                                     ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN--CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                           124678889999999999999999866  999999999999999999999999999865433222


Q ss_pred             ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||........  .              .+.+....
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~--~--------------~~~~~~~~  334 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK--F--------------YKMIKEGY  334 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH--H--------------HHHHHhCc
Confidence            22222345678999999999999999999999999999998 8889865432110  0              11111111


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      ....+...+.++.+|+.+||+.||++||++.+|++.|++
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            111112234678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.2e-44  Score=353.97  Aligned_cols=265  Identities=26%  Similarity=0.404  Sum_probs=206.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+...+.. .....||+|+++.... .....+.+|+.+++.+ +|+|||+++++|...+.
T Consensus        38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~  116 (374)
T cd05106          38 DNLQFGKTLGAGAFGKVVEATAFGLGKE-DNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP  116 (374)
T ss_pred             HHceehheecCCCcccEEEEEEecCCcc-cccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence            4688999999999999999987543221 1223599999976533 3345688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC-----------------------------------------------------------
Q 014079          156 RLLVYEFMFRGSLENHLFRKA-----------------------------------------------------------  176 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~-----------------------------------------------------------  176 (431)
                      .++||||+.+|+|.+++....                                                           
T Consensus       117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (374)
T cd05106         117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD  196 (374)
T ss_pred             eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence            999999999999999885421                                                           


Q ss_pred             ---------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecc
Q 014079          177 ---------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV  247 (431)
Q Consensus       177 ---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  247 (431)
                               ..++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..............
T Consensus       197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g--iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~  274 (374)
T cd05106         197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN--CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA  274 (374)
T ss_pred             ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence                     124678888999999999999999866  999999999999999999999999999765433222222233


Q ss_pred             cCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccH
Q 014079          248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSV  326 (431)
Q Consensus       248 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (431)
                      .++..|+|||++.+..++.++|||||||++|||++ |+.||........                +...+........+.
T Consensus       275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----------------~~~~~~~~~~~~~~~  338 (374)
T cd05106         275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----------------FYKMVKRGYQMSRPD  338 (374)
T ss_pred             CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----------------HHHHHHcccCccCCC
Confidence            45678999999999999999999999999999997 9999976432111                111111111111112


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          327 RAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       327 ~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      ..+.++.+++.+||+.||.+|||+.+|++.|+++.
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            23478899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2e-45  Score=349.20  Aligned_cols=252  Identities=26%  Similarity=0.362  Sum_probs=215.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|...+.||+|+||.+++++.+....      .|++|.+.-...  ...+...+|+.++++++|||||.+.+.|.+++.
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~------~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~   77 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDK------LYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQ   77 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCc------eEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCc
Confidence            468888999999999999998876654      399998876543  333467899999999999999999999999888


Q ss_pred             -eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          156 -RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       156 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                       ++|||+||+||+|.+.|.+..+.-+++..++.++.|++.|+.|||+..  |+|||||+.|||++.++.++|+|||+|+.
T Consensus        78 ~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~--iLHRDlK~~Nifltk~~~VkLgDfGlaK~  155 (426)
T KOG0589|consen   78 LLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR--VLHRDLKCANIFLTKDKKVKLGDFGLAKI  155 (426)
T ss_pred             eEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh--hhcccchhhhhhccccCceeecchhhhhh
Confidence             899999999999999999888788999999999999999999999755  99999999999999999999999999998


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      +....  .....+.||+.||+||++.+.+|..|+|||||||++|||++-+++|.......                 +..
T Consensus       156 l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~-----------------Li~  216 (426)
T KOG0589|consen  156 LNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE-----------------LIL  216 (426)
T ss_pred             cCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH-----------------HHH
Confidence            76544  23456789999999999999999999999999999999999999998753211                 111


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      -+.+......+...+.++..+++.||..+|..||++.+++.+
T Consensus       217 ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  217 KINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            112222344566778899999999999999999999999976

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4.1e-44  Score=345.11  Aligned_cols=267  Identities=23%  Similarity=0.316  Sum_probs=206.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||++.+..++..      +|+|++..... .....+.+|+++|++++||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLI------MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcE------EEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            36789999999999999999998876543      89998876532 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.++|+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~-~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  154 (331)
T cd06649          78 ISICMEHMDGGSLDQVLKEAK--RIPEEILGKVSIAVLRGLAYLREK-HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (331)
T ss_pred             EEEEeecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHhhc-CCEEcCCCChhhEEEcCCCcEEEccCcccccc
Confidence            999999999999999997644  478888999999999999999973 23999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc-------
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND-------  308 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  308 (431)
                      ....    .....||+.|+|||++.+..++.++|||||||++|||++|+.||..............  +....       
T Consensus       155 ~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~~  228 (331)
T cd06649         155 IDSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR--PVVDGEEGEPHS  228 (331)
T ss_pred             cccc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc--cccccccCCccc
Confidence            3321    2335699999999999999999999999999999999999999965432211100000  00000       


Q ss_pred             ------------------------cchhhh-hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          309 ------------------------KRKMLQ-IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       309 ------------------------~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                              ...+.. +.............+.++.+|+.+||++||++|||+.+|+++..
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         229 ISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                    000000 00000011111234578999999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6e-44  Score=336.32  Aligned_cols=246  Identities=21%  Similarity=0.327  Sum_probs=198.1

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---HHHHHHHHHHHhcCCCCceeeeecEEEe----CCee
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPNLVKLIGYCCE----DDHR  156 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  156 (431)
                      ..||+|++|.||+|.+.+.        .||+|.++......   .+.+.+|+.+|++++||||+++++++.+    ....
T Consensus        26 ~~i~~g~~~~v~~~~~~~~--------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~   97 (283)
T PHA02988         26 VLIKENDQNSIYKGIFNNK--------EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRL   97 (283)
T ss_pred             eEEeeCCceEEEEEEECCE--------EEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCce
Confidence            4799999999999988432        49999987653322   4567799999999999999999999877    3568


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++||||+.+|+|.+++....  .+++...+.++.+++.||.|||+. +  ++||||||+|||++.++.+||+|||+++..
T Consensus        98 ~lv~Ey~~~g~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~~--~~Hrdlkp~nill~~~~~~kl~dfg~~~~~  173 (283)
T PHA02988         98 SLILEYCTRGYLREVLDKEK--DLSFKTKLDMAIDCCKGLYNLYKYTN--KPYKNLTSVSFLVTENYKLKIICHGLEKIL  173 (283)
T ss_pred             EEEEEeCCCCcHHHHHhhCC--CCChhHHHHHHHHHHHHHHHHHhcCC--CCCCcCChhhEEECCCCcEEEcccchHhhh
Confidence            99999999999999997643  578889999999999999999973 5  889999999999999999999999998864


Q ss_pred             CCCCCcceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ....     ....|+..|+|||++.+  ..++.++|||||||++|||++|+.||..........                
T Consensus       174 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~----------------  232 (283)
T PHA02988        174 SSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYD----------------  232 (283)
T ss_pred             cccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHH----------------
Confidence            3321     12468899999999876  689999999999999999999999997653211110                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .++........+..++..+.+++.+||+.||++|||+.++++.|+.++.
T Consensus       233 ~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        233 LIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             HHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            0111111112222456789999999999999999999999999988753

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-44  Score=347.39  Aligned_cols=243  Identities=29%  Similarity=0.379  Sum_probs=197.6

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      ++||+|+||.||++.+..++..      ||+|++++...   .....+.+|+.++++++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKY------YAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEE
Confidence            3699999999999998766543      99999876432   23356788999999999999999999999999999999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~-  149 (323)
T cd05571          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALGYLHSCD--VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-  149 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC-
Confidence            9999999999987644  5788899999999999999999876  9999999999999999999999999987532211 


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........                .+.... 
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~~-  211 (323)
T cd05571         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----------------LILMEE-  211 (323)
T ss_pred             -CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH----------------HHHcCC-
Confidence             12234579999999999999999999999999999999999999997543211100                000000 


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                       ..++...+.++.+|+.+||+.||++||     ++.+++++
T Consensus       212 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         212 -IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -CCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence             112233457888999999999999999     79999865

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=6.1e-44  Score=336.11  Aligned_cols=262  Identities=28%  Similarity=0.493  Sum_probs=209.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|++.+.||+|+||.||+|.+..... ......|++|.+..... .....+.+|+.++.+++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE-RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC-CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            357888999999999999998765431 11223489998875533 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          157 LLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      +++|||+++++|.+++.....              ..+++...+.++.|++.||.|||+.+  ++|+||||+|||++.++
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH--FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccccceEEEcCCC
Confidence            999999999999999976422              35788889999999999999999866  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  301 (431)
                      .++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+......      
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~------  235 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEV------  235 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHH------
Confidence            999999999986544333223334567889999999998999999999999999999998 9999976432211      


Q ss_pred             hhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                                 ...+........+..++.++.+|+.+||+.||.+||++.+|+++|+.
T Consensus       236 -----------~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         236 -----------IEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             -----------HHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                       11111111112234556889999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-44  Score=360.45  Aligned_cols=253  Identities=23%  Similarity=0.306  Sum_probs=204.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCC-ceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .|.+.+.||+|+||.||+|....+ ..      .|++|.+..........+.+|+.+|+.++|||||++++++...+..|
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~------~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~  141 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKE------KVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLL  141 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCe------EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEE
Confidence            388899999999999999987654 33      37888776555444556778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          158 LVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      |||||+++|+|.+++..  ....++++.....++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~~~~~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK--MMHRDLKSANIFLMPTGIIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCcCHHhEEECCCCcEEEEeCcCceec
Confidence            99999999999998854  23456888999999999999999999866  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............+||+.|+|||++.+..++.++|||||||++|||++|+.||........                +..+
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~----------------~~~~  283 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREI----------------MQQV  283 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH----------------HHHH
Confidence            443332233456799999999999999999999999999999999999999965422110                0011


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.... ...+...+.++.++|.+||+.||++||++.+++.+
T Consensus       284 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        284 LYGKY-DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             HhCCC-CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            11000 11222345788999999999999999999999754

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=341.89  Aligned_cols=247  Identities=24%  Similarity=0.312  Sum_probs=202.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++.....   .....+.+|+.++++++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   74 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHY------YALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQR   74 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCE------EEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCC
Confidence            3688899999999999999998765543      99999865432   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .+++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~NIli~~~~~~kl~Dfg~~~~  150 (291)
T cd05612          75 FLYMLMEYVPGGELFSYLRNSG--RFSNSTGLFYASEIVCALEYLHSKE--IVYRDLKPENILLDKEGHIKLTDFGFAKK  150 (291)
T ss_pred             eEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEEecCcchh
Confidence            9999999999999999997654  5788888999999999999999866  99999999999999999999999999886


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....     ....||+.|+|||++.+..++.++|||||||++|+|++|+.||..........                .
T Consensus       151 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----------------~  209 (291)
T cd05612         151 LRDRT-----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYE----------------K  209 (291)
T ss_pred             ccCCc-----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence            53221     23569999999999999999999999999999999999999997643211110                0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~L  357 (431)
                      +.....  .++...+..+.+|+.+||+.||.+||+     +.+++++-
T Consensus       210 i~~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         210 ILAGKL--EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             HHhCCc--CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            111000  112233567889999999999999995     88888663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.3e-44  Score=337.95  Aligned_cols=268  Identities=22%  Similarity=0.291  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEI------VAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGK   74 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcE------EEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCE
Confidence            4688999999999999999999876554      99998875432  234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||++++.|..+...  ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~  150 (287)
T cd07848          75 LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKND--IVHRDIKPENLLISHNDVLKLCDFGFARNL  150 (287)
T ss_pred             EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeeccCcccc
Confidence            9999999988777655433  235788899999999999999999866  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc-------
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND-------  308 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------  308 (431)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+......+..       
T Consensus       151 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07848         151 SEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY  229 (287)
T ss_pred             cccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence            432221 122356899999999999989999999999999999999999999765432211111110000000       


Q ss_pred             -cchhhhhcCcc------ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 -KRKMLQIIDPR------LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 -~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .........+.      .........+..+.+|+.+||+.||++|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence             00000000000      0001112245689999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-44  Score=347.42  Aligned_cols=246  Identities=26%  Similarity=0.376  Sum_probs=201.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++.+...   .....+.+|+.+|++++||||+++++++.+.+
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   91 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGE------YYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDEN   91 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCC
Confidence            568889999999999999999877654      399999876432   23456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+.+++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~~~~  167 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRKAG--RFPNDVAKFYHAELVLAFEYLHSKD--IIYRDLKPENLLLDNKGHVKVTDFGFAKK  167 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEECCCCCEEEeeccCceE
Confidence            9999999999999999997654  4778888889999999999999876  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....     ....||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..
T Consensus       168 ~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~----------------~~  226 (329)
T PTZ00263        168 VPDRT-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIY----------------EK  226 (329)
T ss_pred             cCCCc-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHH----------------HH
Confidence            53322     2357999999999999999999999999999999999999999754321110                01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      +....+  .++...+..+.+|+.+||+.||.+||+     +.+++.|
T Consensus       227 i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        227 ILAGRL--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HhcCCc--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            111111  111223467889999999999999996     6888766

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-44  Score=346.95  Aligned_cols=255  Identities=24%  Similarity=0.310  Sum_probs=205.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++.+...   .....+.+|+.++..++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~   74 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGE------IVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDE   74 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCC
Confidence            368899999999999999999876554      399999876532   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+++++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~  150 (333)
T cd05600          75 YLYLAMEYVPGGDFRTLLNNLG--VLSEDHARFYMAEMFEAVDALHELG--YIHRDLKPENFLIDASGHIKLTDFGLSKG  150 (333)
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEEEeCcCCcc
Confidence            9999999999999999996644  4788888999999999999999876  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...     ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+..       ..   .
T Consensus       151 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~-------~~---~  215 (333)
T cd05600         151 IVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKY-------WK---E  215 (333)
T ss_pred             ccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHh-------cc---c
Confidence            433     22346799999999999999999999999999999999999999976543221110000       00   0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+............+.++.+|+.+||..+|.+||++.+++.+-
T Consensus       216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             cccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            0000000000123457889999999999999999999999873

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=369.86  Aligned_cols=269  Identities=28%  Similarity=0.444  Sum_probs=221.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .-...+.||+|.||.||.|...+...... .+.||+|.+.+. ......+|++|..+|+.++|||||+++|++.+....+
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~-~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~  771 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVS-PIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL  771 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCcc-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence            34566789999999999999865432222 456999998876 3456678999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhC-----CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          158 LVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~-----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      |++|||+||+|..+|...     ....+.....+.++.|||+|+.||++.+  +|||||..+|+||++...+||+|||+|
T Consensus       772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~--fvHRDLAaRNCLL~~~r~VKIaDFGlA  849 (1025)
T KOG1095|consen  772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH--FVHRDLAARNCLLDERRVVKIADFGLA  849 (1025)
T ss_pred             EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC--CcCcchhhhheeecccCcEEEcccchh
Confidence            999999999999999764     2345888999999999999999999876  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      +.+...+.........-...|||||.+..+.|+.|+|||||||+|||+++ |..||.........               
T Consensus       850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~---------------  914 (1025)
T KOG1095|consen  850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL---------------  914 (1025)
T ss_pred             HhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH---------------
Confidence            96555554443333334568999999999999999999999999999999 99999876433221               


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                       ...+... +-+.+..+++.+++|+.+||+.+|++||++..|++.+..+.....+.
T Consensus       915 -~~~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  915 -LDVLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             -HHHHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence             1112222 33456678899999999999999999999999999888776655543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-44  Score=349.51  Aligned_cols=266  Identities=29%  Similarity=0.472  Sum_probs=214.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc---CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+-.+.++||+|+||.||+|........  ....||+|..+..   ......+|.+|+++|++++|||||++||++..+.
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~--~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGF--KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCc--eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            3445568999999999999998654321  1112899988753   2355678999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+++|||+|.||+|.++|..... .++...++.++.+.+.||+|||+.+  +|||||-.+|+|++.++.+||+|||+++.
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~--~IHRDIAARNcL~~~~~~vKISDFGLs~~  311 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKN--CIHRDIAARNCLYSKKGVVKISDFGLSRA  311 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCC--CcchhHhHHHheecCCCeEEeCccccccC
Confidence            99999999999999999988765 5899999999999999999999877  99999999999999999999999999987


Q ss_pred             CCCCCCcceee-cccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQGDETHVST-RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ...   ..... ...-...|+|||.+..+.|+.++|||||||++||+++ |..||.+......                .
T Consensus       312 ~~~---~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v----------------~  372 (474)
T KOG0194|consen  312 GSQ---YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV----------------K  372 (474)
T ss_pred             Ccc---eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHH----------------H
Confidence            431   11111 1124568999999999999999999999999999999 8889987643211                1


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                      ..++....+...+...+.++..++.+||..||++||+|.++.+.|+.+.......
T Consensus       373 ~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  373 AKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             HHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence            1121223333444456678889999999999999999999999999887665543

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-43  Score=330.41  Aligned_cols=259  Identities=24%  Similarity=0.404  Sum_probs=204.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.++....   ....||+|.++.... .....+.+|+.++++++||||+++++++..++..
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   81 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSK---RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM   81 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCC---ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence            468889999999999999998753221   233599999876532 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++++|||.+....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~--iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          82 MIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999999987643 35889999999999999999999866  9999999999999999999999999876532


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......++..|+|||++.+..++.++|||||||++||+++ |..||........   ..              .
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~---~~--------------~  220 (266)
T cd05064         159 SEAIY-TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV---IK--------------A  220 (266)
T ss_pred             ccchh-cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH---HH--------------H
Confidence            21111 1112345678999999999999999999999999999875 9999976532211   00              0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +........+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            011111112234557889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.2e-43  Score=338.79  Aligned_cols=243  Identities=29%  Similarity=0.382  Sum_probs=196.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      +.||+|+||.||++.+..++..      ||+|++.....   .....+.+|+++++.++||||++++++|...+..|+||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~   74 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   74 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEE
Confidence            4699999999999998765543      99999876422   23455778999999999999999999999999999999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.......
T Consensus        75 E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          75 EYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             eCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            9999999999886654  5788999999999999999999866  99999999999999999999999999875322211


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||..........                .+.....
T Consensus       151 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----------------~~~~~~~  212 (323)
T cd05595         151 --TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------LILMEEI  212 (323)
T ss_pred             --ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------HHhcCCC
Confidence              1233579999999999999999999999999999999999999997543211110                0010000


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                        .++...+.++.+|+.+||+.||.+||     ++.+++++
T Consensus       213 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         213 --RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             --CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence              11223457888999999999999998     88898875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.9e-44  Score=323.24  Aligned_cols=266  Identities=24%  Similarity=0.304  Sum_probs=206.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEe--CC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCE--DD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  154 (431)
                      .|+....|++|+||.||+|+++.+..+      ||+|.++-+...  .--.-++|+.+|.+++|||||.+-.+.+-  -+
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eI------VALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d  150 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEI------VALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD  150 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCccee------EEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence            466677899999999999999988876      999998765321  12335799999999999999999988764  35


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+||||||| .-+|..++.... .++....+..+..|+++|++|||.+.  |+|||||++|+|++..|.+||+|||+|+.
T Consensus       151 ~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~w--ilHRDLK~SNLLm~~~G~lKiaDFGLAR~  226 (419)
T KOG0663|consen  151 KIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNW--ILHRDLKTSNLLLSHKGILKIADFGLARE  226 (419)
T ss_pred             eeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhce--eEecccchhheeeccCCcEEecccchhhh
Confidence            689999999 568988887655 57889999999999999999999877  99999999999999999999999999998


Q ss_pred             CCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--------hhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--------ARPK  305 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~~~  305 (431)
                      +....  ...+..+-|.+|+|||++.+. .|+.+.|+||+|||+.||+++++-|.+.......+.+-.        .+|.
T Consensus       227 ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg  304 (419)
T KOG0663|consen  227 YGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG  304 (419)
T ss_pred             hcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence            75542  234567789999999998875 699999999999999999999999988766544332211        0111


Q ss_pred             hhccchhh-----hhcCccccCcccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKML-----QIIDPRLENQYSVR-AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~-----~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.......     +..-..++..+... .++..++|+..+|..||.+|.|+.+.|++
T Consensus       305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            11111000     00001122222222 55788899999999999999999999876

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.5e-43  Score=348.08  Aligned_cols=266  Identities=24%  Similarity=0.405  Sum_probs=207.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  154 (431)
                      .++|++.++||+|+||.||+|.+...... .....||+|++..... ...+.+.+|+++|+++. ||||+++++++.+.+
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~-~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRS-QPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCC-CCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            46788999999999999999987532211 1123499999975433 23456889999999996 999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC----------------------------------------------------------
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA----------------------------------------------------------  176 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------  176 (431)
                      ..||||||+++|+|.+++....                                                          
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            9999999999999999886421                                                          


Q ss_pred             ------------------------------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          177 ------------------------------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       177 ------------------------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                                                          ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dikp~Nill~~  272 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN--CVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHhEEEeC
Confidence                                                124677888899999999999999866  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  299 (431)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||........    
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~----  348 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST----  348 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH----
Confidence            99999999999986543322222223457788999999999999999999999999999997 9999875422110    


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                                  +...+........+...+.++.+++.+||+.||++||++.+|.+.|+.+.
T Consensus       349 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         349 ------------FYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             ------------HHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence                        00001111111122344578899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.5e-44  Score=335.91  Aligned_cols=267  Identities=23%  Similarity=0.332  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||.|+||.||+|.+..++.      .||+|+++.... .....+.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   78 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCL   78 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCC------EEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeE
Confidence            458889999999999999999876554      399998875432 2234677899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        79 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~  154 (288)
T cd07871          79 TLVFEYLD-SDLKQYLDNCG-NLMSMHNVKIFMFQLLRGLSYCHKRK--ILHRDLKPQNLLINEKGELKLADFGLARAKS  154 (288)
T ss_pred             EEEEeCCC-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence            99999996 58998886543 34788888999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--------hhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--------RPKLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--------~~~~~  307 (431)
                      ....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+...        .+.+.
T Consensus       155 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07871         155 VPTK--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT  232 (288)
T ss_pred             CCCc--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence            2221  1233568999999998875 56899999999999999999999999765433222111100        00000


Q ss_pred             ccchhhhhcCccccC----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLEN----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..........+....    ......+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            011111111111000    0011234678899999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-44  Score=311.51  Aligned_cols=265  Identities=26%  Similarity=0.359  Sum_probs=212.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      .++|++.+.||+|||+.||++..-.+...      ||+|++.-...++.+..++|++..++++||||++++++...+.  
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~------YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHL------YALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccc------hhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            47899999999999999999986655544      9999988777777888999999999999999999999876544  


Q ss_pred             ---eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                         ..||+++|...|+|.+.+.+.  ++..+++...+.|+.++++||++||....+..||||||.|||+.+.+.++|.||
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~  173 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL  173 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence               489999999999999998763  344689999999999999999999998888999999999999999999999999


Q ss_pred             cCCccCCCCCCcce-------eecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          230 GLAKAGPQGDETHV-------STRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       230 G~a~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      |.+....-.-....       ......|..|+|||++.   +...++++|||||||+||+|+.|..||+.... .+..+.
T Consensus       174 GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSla  252 (302)
T KOG2345|consen  174 GSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLA  252 (302)
T ss_pred             cCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEE
Confidence            99876432211110       11235788999999886   34678899999999999999999999976433 111111


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                                   ..+.++.+........++.+.+|+++||+.||.+||++.+++.+++.+.
T Consensus       253 -------------LAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  253 -------------LAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             -------------EeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                         1112222222222236788999999999999999999999999998764

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.2e-43  Score=340.16  Aligned_cols=268  Identities=23%  Similarity=0.332  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||++.+..+...      +|+|++..... .....+.+|++++++++|+||++++++|.+.+.
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   77 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLI------MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   77 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcE------EEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCE
Confidence            36799999999999999999998765543      88898765422 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+++|.+++....  .+++.....++.+++.||.|||+. .+|+|+||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~-~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~  154 (333)
T cd06650          78 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREK-HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL  154 (333)
T ss_pred             EEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhc-CCEEecCCChhhEEEcCCCCEEEeeCCcchhh
Confidence            999999999999999997644  478888889999999999999963 23999999999999999999999999998754


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh------hh----hh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW------AR----PK  305 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------~~----~~  305 (431)
                      ...    ......||..|+|||++.+..++.++|||||||++|+|++|+.||..............      ..    +.
T Consensus       155 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (333)
T cd06650         155 IDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR  230 (333)
T ss_pred             hhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence            322    12235689999999999998999999999999999999999999975432211100000      00    00


Q ss_pred             hhc--------------c---chhhhh-cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          306 LND--------------K---RKMLQI-IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       306 ~~~--------------~---~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...              .   ..+... .............+.++.+|+.+||++||++|||+.|++.+-
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence            000              0   000000 000000000012346789999999999999999999998763

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=7.2e-44  Score=331.50  Aligned_cols=255  Identities=35%  Similarity=0.560  Sum_probs=197.4

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      +.+.||.|.||.||+|.+...  ...+...|+||+++.... ...+.+.+|++++++++||||+++++++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~--~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQK--DNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEEST--TTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcc--cCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccc
Confidence            456899999999999999831  112344699999965432 34678999999999999999999999999888899999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ||+++|+|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+++|||++.++.+||+|||++........
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~--iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN--IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT--EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccc
Confidence            9999999999998875667999999999999999999999866  99999999999999999999999999987633333


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      ........+...|+|||.+.+..++.++||||||+++|||++ |+.||.......   ..              ..+...
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~---~~--------------~~~~~~  221 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE---II--------------EKLKQG  221 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH---HH--------------HHHHTT
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cc--------------cccccc
Confidence            222333457788999999999999999999999999999999 788886642211   10              001111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .....+..++..+.+++.+||..||++||++.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            11112223457788999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=3.1e-43  Score=327.84  Aligned_cols=256  Identities=25%  Similarity=0.419  Sum_probs=207.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ..|.+.+.||+|+||.||+|.+.+....      |++|.+..+. ....++.+|+++++.++|+||+++++++...+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~------~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCce------EEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            3577888999999999999998765443      9999887553 34567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+|||+++++.+||+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~  156 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  156 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence            9999999999999997765566899999999999999999999866  99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|+|||.+.+..++.++|||||||++|||++ |..||........                 ...+
T Consensus       157 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-----------------~~~~  218 (263)
T cd05052         157 DTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YELL  218 (263)
T ss_pred             ceee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHHH
Confidence            3221 1112334668999999999999999999999999999998 9999875432111                 0111


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ........+...+..+.+++.+||+.||++||++.++++.|+.+
T Consensus       219 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         219 EKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence            11111122233457889999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.1e-43  Score=331.57  Aligned_cols=266  Identities=27%  Similarity=0.419  Sum_probs=209.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|.+.+.||+|+||.||++....... ......+++|.+..........+.+|+.++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~-~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCC-CCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            468889999999999999998643211 0122348999887765455667899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC-----------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          158 LVYEFMFRGSLENHLFRKA-----------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      +||||+++++|.+++....           ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~--i~H~dlkp~Nili~~~~~~kl  161 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKI  161 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCcEEe
Confidence            9999999999999986432           234899999999999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||.........   .     
T Consensus       162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~---~-----  233 (288)
T cd05093         162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI---E-----  233 (288)
T ss_pred             ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH---H-----
Confidence            99999986543322222223446788999999999999999999999999999998 89998654321110   0     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                              .+..... ...+...+.++.+|+.+||+.||.+|||+.+++..|+++...
T Consensus       234 --------~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         234 --------CITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --------HHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence                    0000000 011112346789999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-43  Score=341.00  Aligned_cols=255  Identities=29%  Similarity=0.330  Sum_probs=217.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCC-CCceeeeecE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLR-HPNLVKLIGY  149 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~-h~niv~l~~~  149 (431)
                      ..+...|.+.+.||.|.||.||++..+.++.      .+|+|++.+....   ....+.+|+.+|+++. |||||.++++
T Consensus        31 ~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~------~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~  104 (382)
T KOG0032|consen   31 EDIKEKYELGRELGRGQFGVVYLCREKSTGK------EVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDA  104 (382)
T ss_pred             ccccccEEehhhhCCCCceEEEEEEecCCCc------eeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            4456778899999999999999999988654      4999999887553   3457889999999999 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC----CcEE
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD----YTAK  225 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~----~~~k  225 (431)
                      |++.+.+++|||++.||.|.+.+...   .+++.....++.|++.++.|||+.+  |+||||||+|+|+...    +.+|
T Consensus       105 ~e~~~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~g--vvHrDlKpEN~L~~~~~~~~~~ik  179 (382)
T KOG0032|consen  105 FEDPDSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLG--VVHRDLKPENLLLASKDEGSGRIK  179 (382)
T ss_pred             EEcCCeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCC--ceeccCCHHHeeeccccCCCCcEE
Confidence            99999999999999999999999877   2899999999999999999999977  9999999999999543    5799


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      ++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|..||.+........        
T Consensus       180 ~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~--------  248 (382)
T KOG0032|consen  180 LIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL--------  248 (382)
T ss_pred             EeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH--------
Confidence            999999998654   334567899999999999999999999999999999999999999998765332221        


Q ss_pred             hhccchhhhhc--CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          306 LNDKRKMLQII--DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       306 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                              .+.  +..+..+.....+..+.++++.||..||.+|+|+.++++|-+
T Consensus       249 --------~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  249 --------AILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             --------HHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence                    111  113344455667889999999999999999999999999844

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1e-43  Score=341.74  Aligned_cols=243  Identities=28%  Similarity=0.379  Sum_probs=197.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      ++||+|+||.||++.+..++..      ||+|++.+...   .....+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   74 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKY------YAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVM   74 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEE
Confidence            3699999999999998776543      99999876422   23456788999999999999999999999999999999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ||+++++|.+++....  .+++.....++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++...... 
T Consensus        75 Ey~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-  149 (328)
T cd05593          75 EYVNGGELFFHLSRER--VFSEDRTRFYGAEIVSALDYLHSGK--IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-  149 (328)
T ss_pred             eCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-
Confidence            9999999999886643  5788999999999999999999866  9999999999999999999999999987532211 


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                       ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||...........                +...  
T Consensus       150 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~----------------~~~~--  210 (328)
T cd05593         150 -ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----------------ILME--  210 (328)
T ss_pred             -cccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHH----------------hccC--
Confidence             122346799999999999999999999999999999999999999975432111000                0000  


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      ...++...+.++.+|+.+||+.||.+|+     ++.+++++
T Consensus       211 ~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            0012223456788999999999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.7e-43  Score=331.10  Aligned_cols=261  Identities=28%  Similarity=0.430  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|.+.+.||+|+||.||+|.+.+... ......||+|.++..... ....+.+|+++|+.++|+||+++++++......
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEP-ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccC-cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457788899999999999998754311 012235999998765443 446788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCC------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          157 LLVYEFMFRGSLENHLFRKA------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ++||||+++++|.+++...+            ...+++.....++.|++.||.|||+.+  ++||||||+|||++.++.+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH--FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eeccccccceEEEcCCCeE
Confidence            99999999999999996542            234788889999999999999999866  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      +|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........   ...  
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~---~~~--  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV---IEC--  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHH---HHH--
Confidence            9999999876433222222233456788999999999999999999999999999998 9999865432211   110  


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                 +. .......+...+..+.+++.+||+.||++||++.||++.|+
T Consensus       237 -----------~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 -----------IT-QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -----------HH-cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence                       00 01111112234578899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.7e-43  Score=337.28  Aligned_cols=264  Identities=23%  Similarity=0.364  Sum_probs=206.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|++.+.||+|+||.||+|.+..+...  ....||+|+++.... ....++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~   83 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCc--cceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cc
Confidence            4688999999999999999987654331  123489999875432 3456788999999999999999999998764 57


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+.+|+|.+++.... ..+++...+.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcC--eeccccchhheEecCCCcEEEcccccccccc
Confidence            89999999999999997653 34788889999999999999999866  9999999999999999999999999998765


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.+......                 ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-----------------~~~  223 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-----------------SSI  223 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-----------------HHH
Confidence            4333222222345678999999999999999999999999999998 9999976432111                 011


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      +........+..++..+.+++.+||..||.+||++.+++..|..+....
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         224 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence            1111111111223457889999999999999999999999998776443

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=4.8e-43  Score=331.60  Aligned_cols=266  Identities=26%  Similarity=0.419  Sum_probs=211.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .+|.+.+.||+|+||.||+|.+..... ......+++|.+..........+.+|+.++++++|+||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSP-TKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCC-CCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            357788899999999999998644211 1122348899987766555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc
Q 014079          158 LVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~  223 (431)
                      +||||+++++|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH--FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccCcceEEEccCCc
Confidence            9999999999999996532              124788999999999999999999866  999999999999999999


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  302 (431)
                      ++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |+.||........   ..  
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~---~~--  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEV---IE--  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--
Confidence            99999999976543332222233557889999999999999999999999999999999 9999865432111   00  


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                  .+............+..+.+++.+||+.||++||++.+|++.|+.+...
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 ------------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             ------------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence                        0000111111223456789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-43  Score=342.85  Aligned_cols=247  Identities=25%  Similarity=0.338  Sum_probs=201.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||+|.+.....     ..||+|++.+...   .....+.+|+.+++.++||||+++++++.+.+
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~  104 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDF-----PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES  104 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCC-----eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence            458888999999999999998765431     1499998865422   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+.+|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       105 ~~~lv~Ey~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        105 YLYLVLEFVIGGEFFTFLRRNK--RFPNDVGCFYAAQIVLIFEYLQSLN--IVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            9999999999999999997654  4788889999999999999999876  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+.....                .
T Consensus       181 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----------------~  239 (340)
T PTZ00426        181 VDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQ----------------K  239 (340)
T ss_pred             cCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHH----------------H
Confidence            5322     123579999999999999999999999999999999999999997643221110                0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +....  ..++...+..+.+++++||+.||++|+     ++.+++++
T Consensus       240 i~~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        240 ILEGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HhcCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            11110  011223346778999999999999995     89998876

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=338.88  Aligned_cols=241  Identities=28%  Similarity=0.360  Sum_probs=194.7

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||+|+||.||+|.+..++..      ||+|++.+..   ......+.+|+.+|++++||||+++++++.+.+..|+||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   74 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRI------YALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAF   74 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcC
Confidence            79999999999998776543      9999987542   23345678899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++......  .
T Consensus        75 ~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~  148 (312)
T cd05585          75 INGGELFHHLQREG--RFDLSRARFYTAELLCALENLHKFN--VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--D  148 (312)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--C
Confidence            99999999997654  4788899999999999999999866  9999999999999999999999999987532221  1


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                ...+....  .
T Consensus       149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~----------------~~~~~~~~--~  210 (312)
T cd05585         149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM----------------YRKILQEP--L  210 (312)
T ss_pred             ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH----------------HHHHHcCC--C
Confidence            22346799999999999999999999999999999999999999975422110                00111111  1


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPL---MSDVVET  356 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt---~~eil~~  356 (431)
                      .++...+..+.+|+.+||+.||.+||+   +.+++.+
T Consensus       211 ~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         211 RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence            122334578889999999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=3.5e-43  Score=339.20  Aligned_cols=266  Identities=27%  Similarity=0.412  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC-C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED-D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  154 (431)
                      ++|++.+.||+|+||.||+|.+.+.... .....||+|+++.... .....+.+|+.++.++ +|+||+++++++... .
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~-~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKS-ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccc-cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            5789999999999999999976442211 1223599999875432 2345678899999999 799999999988654 5


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC---------------------------------------------------------
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT---------------------------------------------------------  177 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  177 (431)
                      .++++|||+++++|.+++.....                                                         
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            67899999999999998864321                                                         


Q ss_pred             --CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccC
Q 014079          178 --VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA  255 (431)
Q Consensus       178 --~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a  255 (431)
                        .++++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++...............++..|+|
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~--ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a  243 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  243 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence              25788999999999999999999866  99999999999999999999999999987543322222223456778999


Q ss_pred             ccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHH
Q 014079          256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACS  334 (431)
Q Consensus       256 PE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (431)
                      ||++.+..++.++|||||||++|||++ |..||........                +...+........+...+.++.+
T Consensus       244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~  307 (337)
T cd05054         244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE----------------FCRRLKEGTRMRAPEYATPEIYS  307 (337)
T ss_pred             cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH----------------HHHHHhccCCCCCCccCCHHHHH
Confidence            999999999999999999999999998 9999975432110                00011001111112234567899


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          335 LAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       335 li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ++.+||+.+|++||++.||+++|+.+..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.1e-43  Score=328.42  Aligned_cols=256  Identities=29%  Similarity=0.478  Sum_probs=210.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..+|++.+.||.|+||.||+|.+.++.       .+++|++..........+.+|+.+++.++|+||+++++++.+.+..
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~-------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   77 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKNRV-------RVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPV   77 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecCCC-------cEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCe
Confidence            356888899999999999999987733       3899998877655567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~  155 (261)
T cd05148          78 YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN--SIHRDLAARNILVGEDLVCKVADFGLARLIK  155 (261)
T ss_pred             EEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccCcceEEEcCCceEEEccccchhhcC
Confidence            99999999999999998766667899999999999999999999866  9999999999999999999999999997654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....  .....++..|+|||++.+..++.++||||||+++|+|++ |+.||........   ..              .
T Consensus       156 ~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~---~~--------------~  216 (261)
T cd05148         156 EDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEV---YD--------------Q  216 (261)
T ss_pred             Ccccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH--------------H
Confidence            32211  123346778999999998899999999999999999998 8999965432111   11              0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +........+..++..+.+++.+||+.||.+|||+.+|++.|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         217 ITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             HHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            111111122234457888999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=2.9e-43  Score=332.77  Aligned_cols=267  Identities=25%  Similarity=0.333  Sum_probs=196.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcC-CceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcC---CCCceeeeecEEE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL---RHPNLVKLIGYCC  151 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~  151 (431)
                      ++|++.+.||+|+||.||+|.+.. ++.      .||+|+++....  .....+.+|+.+++.+   +||||+++++++.
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~   74 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGR------FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT   74 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCe------EEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEe
Confidence            468999999999999999998753 233      389998765422  1223455677776655   6999999999985


Q ss_pred             -----eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          152 -----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       152 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                           ....+++||||+. ++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||
T Consensus        75 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--iiH~dlkp~Nil~~~~~~~kl  151 (290)
T cd07862          75 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIKL  151 (290)
T ss_pred             cccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEcCCCCEEE
Confidence                 3456899999995 69999997765556899999999999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P  304 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~  304 (431)
                      +|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+....  +
T Consensus       152 ~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~  228 (290)
T cd07862         152 ADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP  228 (290)
T ss_pred             ccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999999764332   12234568999999999999999999999999999999999999998754322211110000  0


Q ss_pred             hhhccchhh----hhcCccc---cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKRKML----QIIDPRL---ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .........    .......   ........+..+.+|+.+||+.||++|||+.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         229 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            000000000    0000000   001112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.9e-43  Score=326.01  Aligned_cols=255  Identities=25%  Similarity=0.411  Sum_probs=205.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+.++.       .|++|.+.... ...+.+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~-------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNST-------KVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCc-------eEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            56888999999999999999876543       38999876543 23567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ++|||+++++|.+++.......+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.++|+|||++.....
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  155 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN--YIHRDLRAANVLVSESLMCKIADFGLARVIED  155 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEecCCCcEEECCCccceecCC
Confidence            9999999999999997765566888999999999999999999866  99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........   ...          +... 
T Consensus       156 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~---~~~----------~~~~-  220 (261)
T cd05072         156 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDV---MSA----------LQRG-  220 (261)
T ss_pred             Ccee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHH---HHH----------HHcC-
Confidence            2211 1122346778999999998899999999999999999998 9999965432111   100          0000 


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                         .........+.++.+++.+||+.+|++||++.++++.|+++
T Consensus       221 ---~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 ---YRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence               00111122446788999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3e-43  Score=355.08  Aligned_cols=257  Identities=25%  Similarity=0.327  Sum_probs=205.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ...++|++.+.||+|+||+||+|.+..++.      .||+|++.....  .....+.+|+.++..++|+||+++++.+..
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~  102 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGE------PFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAK  102 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCC------EEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceec
Confidence            345689999999999999999999876544      399999876533  334567889999999999999999887754


Q ss_pred             CC--------eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          153 DD--------HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       153 ~~--------~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      .+        .+++||||+++|+|.+++...  ...++++..+..++.|++.||.|||+.+  |+||||||+|||++.++
T Consensus       103 ~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~--IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        103 KDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH--MIHRDIKSANILLCSNG  180 (496)
T ss_pred             ccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEeCCC
Confidence            32        368999999999999998653  2346889999999999999999999866  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      .+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..   
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~---~~---  254 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---VM---  254 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH---HH---
Confidence            999999999986543333333345679999999999999999999999999999999999999997542111   00   


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                ...+... ....+...+.++.+++.+||+.||.+||++.+++.+
T Consensus       255 ----------~~~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        255 ----------HKTLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------HHHhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                      0011100 111223445788999999999999999999999875

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-43  Score=325.29  Aligned_cols=260  Identities=25%  Similarity=0.449  Sum_probs=206.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+.....   ....|++|+++.... ....++.+|+.++++++||||+++++++.+.+..
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGK---KEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV   80 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCC---CcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence            568899999999999999999865321   123499999876533 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||+++...
T Consensus        81 ~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          81 MIITEYMENGSLDKFLRENDG-KFTVGQLVGMLRGIASGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEEEcCCCCCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999999976543 6889999999999999999999866  9999999999999999999999999998764


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ..              .
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~---~~--------------~  220 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV---IK--------------A  220 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH---HH--------------H
Confidence            2222212222345678999999998999999999999999999998 9999965432111   00              0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +........+..++..+.+++.+||+.+|++||++.+|+++|+.+
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            000001111223456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.6e-43  Score=345.92  Aligned_cols=254  Identities=24%  Similarity=0.316  Sum_probs=198.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|+..+.||+|+||+||+|.+..+...      ||+|++.+...   .....+.+|+.++++++|+||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~   75 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHAL------YAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCE
Confidence            578889999999999999998776543      99999876432   234567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+||||+++|+|.+++.+..  .+++..+..++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++..
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDlKp~Nili~~~~~~kL~DFGl~~~~  151 (381)
T cd05626          76 LYFVMDYIPGGDMMSLLIRME--VFPEVLARFYIAELTLAIESVHKMG--FIHRDIKPDNILIDLDGHIKLTDFGLCTGF  151 (381)
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence            999999999999999997654  4788888889999999999999866  999999999999999999999999997532


Q ss_pred             CCCCC---------------------------------------------cceeecccCCccccCccccccCCCCcchhh
Q 014079          236 PQGDE---------------------------------------------THVSTRVMGTYGYAAPEYVMTGHLTARSDV  270 (431)
Q Consensus       236 ~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  270 (431)
                      .....                                             .......+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         152 RWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence            11000                                             001123579999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHH--hhhcCCCCCC
Q 014079          271 YSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY--CLSQNPKARP  348 (431)
Q Consensus       271 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RP  348 (431)
                      |||||++|||++|+.||...........+             .. ....+........+.++.+|+.+  |+..++..||
T Consensus       232 wSlG~il~elltG~~Pf~~~~~~~~~~~i-------------~~-~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~  297 (381)
T cd05626         232 WSVGVILFEMLVGQPPFLAPTPTETQLKV-------------IN-WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN  297 (381)
T ss_pred             eehhhHHHHHHhCCCCCcCCCHHHHHHHH-------------Hc-cccccCCCCCCCCCHHHHHHHHHHccCcccccCCC
Confidence            99999999999999999765432111000             00 00001111111245678889988  4455666699


Q ss_pred             CHHHHHHH
Q 014079          349 LMSDVVET  356 (431)
Q Consensus       349 t~~eil~~  356 (431)
                      ++.+++.|
T Consensus       298 ~~~~~l~h  305 (381)
T cd05626         298 GADDIKAH  305 (381)
T ss_pred             CHHHHhcC
Confidence            99999976

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=4e-43  Score=329.67  Aligned_cols=263  Identities=25%  Similarity=0.423  Sum_probs=204.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+++|++.+.||+|+||.||+|.+..... ......||+|.+..... ....++.+|+.+++.++|+||+++++++.+..
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCC-CCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45779999999999999999998754211 11223599998865432 33456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ..++||||+++++|.+++....        ...+.+..++.++.|++.||.|||+.+  ++|+||||+|||++.++.++|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--~vH~dlkp~Nil~~~~~~~~l  160 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKI  160 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCcchheEEEcCCCCEEE
Confidence            9999999999999999986532        124577888899999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||...........       
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~-------  233 (277)
T cd05062         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF-------  233 (277)
T ss_pred             CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-------
Confidence            99999876543322222222346788999999999999999999999999999999 7889865432111100       


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                               +..... ...+...+..+.+++.+||+.||++|||+.|+++.|+
T Consensus       234 ---------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         234 ---------VMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             ---------HHcCCc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence                     000000 0112234467899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4e-43  Score=339.11  Aligned_cols=267  Identities=25%  Similarity=0.396  Sum_probs=197.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      +|++.+.||+|+||.||+|.+..++.      .||+|.+...  .......+.+|+.+++.++||||+++++++....  
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   74 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGE------KVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRR   74 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCC------EEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCC
Confidence            48888999999999999999876554      3999988643  2233456889999999999999999999886432  


Q ss_pred             ---eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                         ..|+||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~~~~kL~Dfg~  149 (338)
T cd07859          75 EFKDIYVVFELM-ESDLHQVIKAND--DLTPEHHQFFLYQLLRALKYIHTAN--VFHRDLKPKNILANADCKLKICDFGL  149 (338)
T ss_pred             CCceEEEEEecC-CCCHHHHHHhcc--cCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEccCcc
Confidence               479999999 578999886544  4788999999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCc-ceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h--
Q 014079          232 AKAGPQGDET-HVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P--  304 (431)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~--  304 (431)
                      ++........ .......||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+....  +  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  229 (338)
T cd07859         150 ARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSP  229 (338)
T ss_pred             ccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            9764322211 12234579999999998876  678999999999999999999999997654322111110000  0  


Q ss_pred             ----hhhc--cchhhhhcCccccCccc---HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 ----KLND--KRKMLQIIDPRLENQYS---VRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ----~~~~--~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                          .+..  .......+.........   ...+..+.+++.+||+.||++|||+.|++++
T Consensus       230 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         230 ETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                0000  00000001000000000   1234577899999999999999999999976

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=5.4e-43  Score=340.33  Aligned_cols=249  Identities=27%  Similarity=0.339  Sum_probs=193.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .|+..+.||+|+||.||+|.+..+++      .||+|++..... .....+.+|+++++.++|+||+++++++.+.+.++
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  148 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGR------LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ  148 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCC------EEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence            35566789999999999999876544      399999865432 23456889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+..      ...+..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus       149 lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~  220 (353)
T PLN00034        149 VLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRRH--IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ  220 (353)
T ss_pred             EEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence            999999999987643      2456677889999999999999876  99999999999999999999999999986533


Q ss_pred             CCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ...  ......||..|+|||++..     ...+.++|||||||++|||++|+.||.............            
T Consensus       221 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~------------  286 (353)
T PLN00034        221 TMD--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC------------  286 (353)
T ss_pred             ccc--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH------------
Confidence            211  1233579999999998743     234568999999999999999999997432211111000            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       .+. ...........+.++.+||.+||+.||++|||+.||+++-
T Consensus       287 -~~~-~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp  329 (353)
T PLN00034        287 -AIC-MSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHP  329 (353)
T ss_pred             -HHh-ccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             000 0001112233457889999999999999999999999873

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.9e-44  Score=345.14  Aligned_cols=255  Identities=26%  Similarity=0.321  Sum_probs=204.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||+|.+..++.      .||+|++.+...   .....+.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ------VYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEE   74 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCC------EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCC
Confidence            368899999999999999999876544      399999876432   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~g--iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~  150 (350)
T cd05573          75 HLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLG--FIHRDIKPDNILIDADGHIKLADFGLCKK  150 (350)
T ss_pred             eEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEeecCCCCcc
Confidence            999999999999999999776  35888899999999999999999866  99999999999999999999999999976


Q ss_pred             CCCCC---------------------------CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          235 GPQGD---------------------------ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       235 ~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      .....                           .........||+.|+|||++.+..++.++|||||||++|||++|+.||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf  230 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF  230 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCC
Confidence            54332                           001122356999999999999999999999999999999999999999


Q ss_pred             CCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHH
Q 014079          288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-MSDVVETL  357 (431)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~eil~~L  357 (431)
                      ...........             +.... ..+........+.++.+||.+||. ||.+||+ +.+++.+.
T Consensus       231 ~~~~~~~~~~~-------------i~~~~-~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         231 YSDTLQETYNK-------------IINWK-ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             CCCCHHHHHHH-------------HhccC-CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            76542211100             00000 011111111145788899999997 9999999 99999863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-43  Score=342.78  Aligned_cols=262  Identities=19%  Similarity=0.238  Sum_probs=198.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .+|.+.+.||+|+||.||+|.+..+.+.      ||+|....      ..+.+|+++|++++||||++++++|......+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~------vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~  159 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEH------VVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC  159 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCE------EEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence            5799999999999999999999876554      89996543      34678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +|||++ +++|.+++....  .+++..++.++.|++.||.|||+.+  ||||||||+|||++.++.+||+|||+++....
T Consensus       160 lv~e~~-~~~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~ylH~~~--IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~  234 (391)
T PHA03212        160 LILPRY-KTDLYCYLAAKR--NIAICDILAIERSVLRAIQYLHENR--IIHRDIKAENIFINHPGDVCLGDFGAACFPVD  234 (391)
T ss_pred             EEEecC-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence            999999 578988886643  4788889999999999999999876  99999999999999999999999999975322


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc----hhhhhhh------h-hh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ----SLVDWAR------P-KL  306 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~~~~~------~-~~  306 (431)
                      ... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........    ..+....      + ..
T Consensus       235 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~  313 (391)
T PHA03212        235 INA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF  313 (391)
T ss_pred             ccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence            211 1223467999999999999999999999999999999999999887543221110    0000000      0 00


Q ss_pred             --hccchhhhhc---------CccccCc--ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          307 --NDKRKMLQII---------DPRLENQ--YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       307 --~~~~~~~~~~---------~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                        .....+....         .+.....  .....+.++.+|+.+||+.||++|||+.|++++-
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp  377 (391)
T PHA03212        314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFA  377 (391)
T ss_pred             CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcCh
Confidence              0000000000         0000000  0123456889999999999999999999999753

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=345.47  Aligned_cols=270  Identities=24%  Similarity=0.308  Sum_probs=211.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-C-----Cceeee
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-H-----PNLVKL  146 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l  146 (431)
                      -+.+..+|.++++||+|+||.|.+|.+..+++.      ||||++++.. ....+...|+.+|..|+ |     -|+|++
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~------VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm  253 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEI------VAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRM  253 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcE------EEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEe
Confidence            344555789999999999999999999988765      9999998763 44566678999999997 4     489999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC--CcE
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD--YTA  224 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~--~~~  224 (431)
                      +|+|...+++|||+|.+ ..+|.++|+.+...+++...+..++.||+.||.+||..+  |||+||||+||||...  ..+
T Consensus       254 ~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~--IIHcDLKPENILL~~~~r~~v  330 (586)
T KOG0667|consen  254 LDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG--IIHCDLKPENILLKDPKRSRI  330 (586)
T ss_pred             eeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCChhheeeccCCcCce
Confidence            99999999999999998 889999999998889999999999999999999999877  9999999999999653  479


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--  302 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--  302 (431)
                      ||+|||.|........     +.+-+..|+|||++.|.+|+.+.||||||||+.||++|.+-|.+.........+...  
T Consensus       331 KVIDFGSSc~~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG  405 (586)
T KOG0667|consen  331 KVIDFGSSCFESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLG  405 (586)
T ss_pred             eEEecccccccCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhC
Confidence            9999999987433222     456788899999999999999999999999999999998888776544322111000  


Q ss_pred             -------------hhhhhc---------cch-----------------hhhhcCc----cccCcccHHHHHHHHHHHHHh
Q 014079          303 -------------RPKLND---------KRK-----------------MLQIIDP----RLENQYSVRAAQKACSLAYYC  339 (431)
Q Consensus       303 -------------~~~~~~---------~~~-----------------~~~~~~~----~~~~~~~~~~~~~~~~li~~c  339 (431)
                                   ......         ...                 ..+...+    .+...........+.+|+++|
T Consensus       406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~  485 (586)
T KOG0667|consen  406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC  485 (586)
T ss_pred             CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence                         000000         000                 0000001    000111223456889999999


Q ss_pred             hhcCCCCCCCHHHHHHHH
Q 014079          340 LSQNPKARPLMSDVVETL  357 (431)
Q Consensus       340 l~~dP~~RPt~~eil~~L  357 (431)
                      |++||.+|+|..+.++|-
T Consensus       486 L~~dP~~R~tp~qal~Hp  503 (586)
T KOG0667|consen  486 LEWDPAERITPAQALNHP  503 (586)
T ss_pred             hccCchhcCCHHHHhcCc
Confidence            999999999999999874

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.4e-43  Score=332.25  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=198.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||+|++..... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   77 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGK------LVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCC------EEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCe
Confidence            3679999999999999999999876544      399999875432 223456789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+ +++|.+++.... ..++...+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  153 (303)
T cd07869          78 LTLVFEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRY--ILHRDLKPQNLLISDTGELKLADFGLARAK  153 (303)
T ss_pred             EEEEEECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECCCCcceec
Confidence            99999999 578888776543 35788888999999999999999876  999999999999999999999999998754


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhh--hhhhhhccc-
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-SLVDW--ARPKLNDKR-  310 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~--~~~~~~~~~-  310 (431)
                      .....  ......||+.|+|||++.+ ..++.++|||||||++|||++|..||......... .....  ..+...... 
T Consensus       154 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (303)
T cd07869         154 SVPSH--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG  231 (303)
T ss_pred             cCCCc--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence            32211  1233568999999998875 45889999999999999999999999865332111 00000  000000000 


Q ss_pred             --hhhhhcCccc----cCccc-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 --KMLQIIDPRL----ENQYS-----VRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 --~~~~~~~~~~----~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .........+    .....     ...+..+.+|+.+||+.||++|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence              0000000000    00000     0123578899999999999999999999975

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-43  Score=330.42  Aligned_cols=253  Identities=27%  Similarity=0.398  Sum_probs=203.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +|++.++||+|+||.||++.+..+..      .||+|.+......   ....+.+|+.+++.++||||+++++++.+++.
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGK------MYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCc------eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCe
Confidence            47888999999999999999876544      3999998764322   23456789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05605          75 LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER--IVYRDLKPENILLDDYGHIRISDLGLAVEI  152 (285)
T ss_pred             EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHEEECCCCCEEEeeCCCceec
Confidence            999999999999999887655556899999999999999999999876  999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....   .....|++.|+|||++.+..++.++|||||||++|||++|+.||...........             +...
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~-------------~~~~  216 (285)
T cd05605         153 PEGET---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE-------------VERR  216 (285)
T ss_pred             CCCCc---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHH-------------HHHH
Confidence            33221   1235689999999999999999999999999999999999999976432111100             0011


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +.. ....++...+..+.+|+.+||+.||.+||     ++.+++.+
T Consensus       217 ~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         217 VKE-DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             hhh-cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            100 11122334567889999999999999999     88888766

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-42  Score=323.37  Aligned_cols=256  Identities=27%  Similarity=0.432  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+..+.       .||+|.++... ....++.+|+.++++++|+||+++++++...+..
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-------~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTT-------PVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPI   76 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCe-------EEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCe
Confidence            356888999999999999999876542       38999887654 2356788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++....
T Consensus        77 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~  154 (261)
T cd05068          77 YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN--YIHRDLAARNVLVGENNICKVADFGLARVIK  154 (261)
T ss_pred             eeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence            99999999999999997765556899999999999999999999866  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... .......+..|+|||++.+..++.++||||||+++|||++ |+.||..........                 .
T Consensus       155 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-----------------~  216 (261)
T cd05068         155 EDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQ-----------------Q  216 (261)
T ss_pred             CCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH-----------------H
Confidence            22111 1111223457999999999999999999999999999999 999997543211110                 0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +........+...+..+.+++.+||+.||.+||++.+|+..|+.+
T Consensus       217 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         217 VDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            011111111223457889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-43  Score=344.70  Aligned_cols=254  Identities=23%  Similarity=0.319  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++.....   .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~   74 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHI------YAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDEN   74 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCC
Confidence            4688999999999999999998776543      99999876432   23345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~  150 (364)
T cd05599          75 YLYLIMEYLPGGDMMTLLMKKD--TFTEEETRFYIAETILAIDSIHKLG--YIHRDIKPDNLLLDAKGHIKLSDFGLCTG  150 (364)
T ss_pred             eEEEEECCCCCcHHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEeeccccee
Confidence            9999999999999999997654  4888999999999999999999876  99999999999999999999999999875


Q ss_pred             CCCCCCcc------------------------------------eeecccCCccccCccccccCCCCcchhhHHHHHHHH
Q 014079          235 GPQGDETH------------------------------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL  278 (431)
Q Consensus       235 ~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  278 (431)
                      ........                                    .....+||+.|+|||++.+..++.++|||||||++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~  230 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMY  230 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHH
Confidence            42211000                                    011246999999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHH
Q 014079          279 ELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL---MSDVVE  355 (431)
Q Consensus       279 ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~eil~  355 (431)
                      ||++|..||...........+             ... ...+........+.++.+||.+||. +|.+|++   +.+++.
T Consensus       231 el~~G~~Pf~~~~~~~~~~~i-------------~~~-~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~  295 (364)
T cd05599         231 EMLVGYPPFCSDNPQETYRKI-------------INW-KETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS  295 (364)
T ss_pred             HhhcCCCCCCCCCHHHHHHHH-------------HcC-CCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence            999999999765422111000             000 0001000111235678899999997 9999998   888887


Q ss_pred             H
Q 014079          356 T  356 (431)
Q Consensus       356 ~  356 (431)
                      +
T Consensus       296 h  296 (364)
T cd05599         296 H  296 (364)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-44  Score=343.08  Aligned_cols=247  Identities=32%  Similarity=0.454  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|.-++.||.|+||.||.|++..+..+      ||||.+...+..   ...+++.|++.|+++.|||+|.+-++|..+.
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~ev------VAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~   99 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH   99 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccce------eeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc
Confidence            3466677899999999999999888776      999988765443   3467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..||||||| -|+-.|++.-.. .|+.+..+..|+.+.+.||+|||+++  .||||||..|||+++.|.+||+|||.|..
T Consensus       100 TaWLVMEYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~--~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  100 TAWLVMEYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--RIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             hHHHHHHHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhh--HHhhhccccceEecCCCeeeeccccchhh
Confidence            999999999 677777775443 36889999999999999999999988  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ...      ...++|||+|||||++.   .+.|+-++||||||++..||...++|.-........             ..
T Consensus       176 ~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL-------------YH  236 (948)
T KOG0577|consen  176 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL-------------YH  236 (948)
T ss_pred             cCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH-------------HH
Confidence            433      23478999999999986   578999999999999999999999998664332211             11


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.+.-.|.+.   ..+.+..|+.|+..||++-|.+|||.++++.|
T Consensus       237 IAQNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  237 IAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHhcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            2222222222   45677899999999999999999999999865

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.1e-42  Score=327.59  Aligned_cols=261  Identities=26%  Similarity=0.424  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..|++.+.||+|+||.||+|.+......  ....+++|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~--~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   82 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMD--HAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV   82 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCC--CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence            3577888999999999999986322110  123489998875432 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCC---------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          157 LLVYEFMFRGSLENHLFRKA---------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      |+||||+.+++|.+++....               ...+++...+.++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~nili~~~  160 (283)
T cd05090          83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF--FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC--eehhccccceEEEcCC
Confidence            99999999999999985432               224778888999999999999999866  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........    
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~----  236 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI----  236 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH----
Confidence            9999999999986543332222333456778999999988899999999999999999998 99998654321111    


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                                   +.+........+..++..+.+++.+||+.||++||++.+|+++|..
T Consensus       237 -------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 -------------EMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence                         1110000011122344678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.4e-43  Score=341.55  Aligned_cols=255  Identities=25%  Similarity=0.318  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.+..++..      ||+|++.+...   .....+.+|+.++.+++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~   74 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHV------YAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKL   74 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCE------EEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            3688899999999999999998766543      99999876432   22345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g--ivHrDlKp~NILi~~~~~vkL~DFGla~~  150 (363)
T cd05628          75 NLYLIMEFLPGGDMMTLLMKKD--TLTEEETQFYIAETVLAIDSIHQLG--FIHRDIKPDNLLLDSKGHVKLSDFGLCTG  150 (363)
T ss_pred             eEEEEEcCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCCEEEeeccCccc
Confidence            9999999999999999997654  5788999999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 014079          235 GPQGDET---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL  281 (431)
Q Consensus       235 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  281 (431)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell  230 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHH
Confidence            4321100                                 0112357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhh--cCCCCCCCHHHHHHH
Q 014079          282 TGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLS--QNPKARPLMSDVVET  356 (431)
Q Consensus       282 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~dP~~RPt~~eil~~  356 (431)
                      +|+.||...........+             ... ...+........+.++.+++.+++.  .++..||++.||+++
T Consensus       231 ~G~~Pf~~~~~~~~~~~i-------------~~~-~~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         231 IGYPPFCSETPQETYKKV-------------MNW-KETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             hCCCCCCCCCHHHHHHHH-------------HcC-cCcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            999999765432111000             000 0000000011234677788887554  233456899999976

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-43  Score=339.77  Aligned_cols=244  Identities=29%  Similarity=0.375  Sum_probs=196.4

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      +.||+|+||.||++.+..++..      ||+|++.+...   .....+.+|+++++.++||||+++++++...+..|+||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~   74 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRY------YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM   74 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEE
Confidence            3699999999999998765543      99999876432   23456778999999999999999999999999999999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||+++++|.+++....  .+++..+..++.||+.||.|||+ .+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 E~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~lH~~~~--ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          75 EYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG  150 (325)
T ss_pred             eCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC
Confidence            9999999999886644  57889999999999999999996 45  9999999999999999999999999987532211


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+                ....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i----------------~~~~  212 (325)
T cd05594         151 --ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI----------------LMEE  212 (325)
T ss_pred             --cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH----------------hcCC
Confidence              1123457999999999999999999999999999999999999999764321111100                0000


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETL  357 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L  357 (431)
                        ..++...+.++.+|+.+||+.||++|+     ++.+++++-
T Consensus       213 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~  253 (325)
T cd05594         213 --IRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK  253 (325)
T ss_pred             --CCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence              011223456788999999999999996     899998763

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1.8e-42  Score=327.45  Aligned_cols=264  Identities=27%  Similarity=0.433  Sum_probs=206.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|++.+.||+|+||.||+|.+...... .....+++|.+..... .....+.+|+.+++.++||||+++++.+...+..+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGR-AGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCC-CcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence            477888999999999999987532111 0112488888876532 33467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhC----------------------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCC
Q 014079          158 LVYEFMFRGSLENHLFRK----------------------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSN  215 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~----------------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~N  215 (431)
                      +||||+.+++|.+++...                      ...++++..++.++.|++.||.|||+.+  |+||||||+|
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--ivH~dikp~n  157 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK--LVHRDLAARN  157 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC--eehhhhhhhe
Confidence            999999999999987542                      1235788899999999999999999866  9999999999


Q ss_pred             EEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcc
Q 014079          216 ILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSK  294 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~  294 (431)
                      ||++.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |..||....+..
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            9999999999999999976433322111223346778999999988899999999999999999998 999996543221


Q ss_pred             cchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .                 .+.+........+...+.++.+++.+||+.||++||++.++++.|+++..
T Consensus       238 ~-----------------~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 L-----------------FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             H-----------------HHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            1                 11111111111222345688899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-44  Score=341.45  Aligned_cols=250  Identities=25%  Similarity=0.420  Sum_probs=206.9

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |.+...||.|+||.||+|..++....      .|.|+|........++++-|+.||..++||+||+|++.|...+.+||+
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~l------AAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLL------AAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhh------hhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence            45556799999999999998876543      677888877777788999999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      .|||.||-...++..-+ .++.+..+..+++|++.||.|||+.+  |||||||..|||++-+|.++|+|||.+.....  
T Consensus       108 iEFC~GGAVDaimlEL~-r~LtE~QIqvvc~q~ldALn~LHs~~--iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--  182 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELG-RVLTEDQIQVVCYQVLDALNWLHSQN--IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--  182 (1187)
T ss_pred             EeecCCchHhHHHHHhc-cccchHHHHHHHHHHHHHHHHHhhcc--hhhhhccccceEEEecCcEeeecccccccchh--
Confidence            99999999888776654 46999999999999999999999977  99999999999999999999999999865322  


Q ss_pred             CcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          240 ETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .......++|||+|||||+..     ..+|++++||||||++|.||..+.+|.....+.                +.+..
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----------------RVllK  246 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----------------RVLLK  246 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----------------HHHHH
Confidence            122334589999999999875     468999999999999999999999998765432                22222


Q ss_pred             hcCcccc-CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +-....+ -..+...+..|.+|+.+||.+||..||++.+|++|
T Consensus       247 iaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  247 IAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            2211111 11244567889999999999999999999999976

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=313.65  Aligned_cols=253  Identities=25%  Similarity=0.324  Sum_probs=205.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.+.|.+.++||+|.|+.||++....++.      .+|+|+++....  .+.+++.+|++|-+.|+|||||++.+.+.+.
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~------~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~   82 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGL------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   82 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchH------HHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhccc
Confidence            45678888899999999999998876554      377777764422  3567788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEeccc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFG  230 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG  230 (431)
                      +..|||+|+|.|++|..-|..+  .-.++...--...||+++|.|+|..+  |||||+||+|+|+..   .--+||+|||
T Consensus        83 ~~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~--IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   83 SFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNG--IVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             ceeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcC--ceeccCChhheeeeeccCCCceeecccc
Confidence            9999999999999998766544  23567777778999999999999866  999999999999954   3469999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      +|..+..   ........|||.|||||++...+|+..+|||+-||+||-|+.|.+||.+......               
T Consensus       159 vAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl---------------  220 (355)
T KOG0033|consen  159 LAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL---------------  220 (355)
T ss_pred             eEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH---------------
Confidence            9988762   2234567899999999999999999999999999999999999999987432111               


Q ss_pred             hhhhhc--CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          311 KMLQII--DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       311 ~~~~~~--~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       ..+++  +-..........++++.+|+++||..||.+|.|+.|.+.|-
T Consensus       221 -ye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  221 -YEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             -HHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCc
Confidence             11111  11223334456678999999999999999999999998664

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.7e-42  Score=325.42  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|.+.+.||+|+||.||+|.+...... .....|++|.+..... .....+.+|+.+++.++|+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGD-AVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCC-CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35688899999999999999998652100 0122489998875432 234568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC-----CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC---cEEEe
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT-----VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLS  227 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~---~~kl~  227 (431)
                      .++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++   .+||+
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH--FIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchheEEEeccCCCcceEec
Confidence            9999999999999999866432     25889999999999999999999876  99999999999998754   69999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++................+..|+|||++.+..++.++|||||||++|||++ |..||.........          
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~----------  231 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM----------  231 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----------
Confidence            9999987533222111112234568999999999999999999999999999997 99999764332111          


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                             ..+........+...+..+.+++.+||+.||++||++.+|+++|.
T Consensus       232 -------~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         232 -------EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -------HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                   111111111122334568889999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=6.6e-43  Score=335.73  Aligned_cols=246  Identities=28%  Similarity=0.424  Sum_probs=194.5

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHH---hcCCCCceeeeecEEEeC
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFL---GQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~  153 (431)
                      |++.+.||+|+||.||+|.+..++.      .||+|++++...   ...+.+.+|++++   +.++||||+++++++.+.
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~   74 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGE------LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE   74 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC
Confidence            6778899999999999999876554      399999875432   2234556666554   567899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..|+||||+++++|..++..   ..+++...+.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        75 ~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~--ivHrdlkp~Nill~~~~~~kL~Dfg~~~  149 (324)
T cd05589          75 DHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK  149 (324)
T ss_pred             CEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecCCCHHHeEECCCCcEEeCcccCCc
Confidence            999999999999999988854   25889999999999999999999876  9999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........                
T Consensus       150 ~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~----------------  211 (324)
T cd05589         150 EGMGFG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD----------------  211 (324)
T ss_pred             cCCCCC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence            532221  12234679999999999999999999999999999999999999997643211100                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      .+.....  .++...+..+.+++.+||+.||.+||     ++.+++++
T Consensus       212 ~i~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         212 SIVNDEV--RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHhCCC--CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            0111000  11223456788999999999999999     56677654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.5e-43  Score=319.25  Aligned_cols=267  Identities=24%  Similarity=0.312  Sum_probs=203.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCc-eeeeecEEEeCC-
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPN-LVKLIGYCCEDD-  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-  154 (431)
                      .|...++||+|+||+||+|+...+++.      ||+|.++-+...  --....+|+.+|+.|+|+| ||++++++...+ 
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~------VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~   85 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKF------VALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN   85 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCE------EEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc
Confidence            345556799999999999999877654      999998765431  2244679999999999999 999999999887 


Q ss_pred             -----eeEEEEEecCCCChHHhhhhCCC--CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          155 -----HRLLVYEFMFRGSLENHLFRKAT--VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       155 -----~~~lv~e~~~~gsL~~~l~~~~~--~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           .+++|+||+ ..+|..++.....  ..++...+..+++||+.||+|||+++  |+||||||.||||+++|.+||+
T Consensus        86 ~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~--IlHRDLKPQNlLi~~~G~lKla  162 (323)
T KOG0594|consen   86 HRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG--ILHRDLKPQNLLISSSGVLKLA  162 (323)
T ss_pred             ccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCcceEEECCCCcEeee
Confidence                 789999999 7899999977543  35677889999999999999999877  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--hhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--ARP  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~  304 (431)
                      |||+|+...-..  ...+..++|.+|+|||++.+. .|+...||||+|||+.||++++.-|.+.........+-.  ..|
T Consensus       163 DFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  163 DFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             ccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            999999654222  224557899999999999876 799999999999999999999999988765332211111  011


Q ss_pred             hhhccchhhhhcCcc--c-----cCcccH---HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKRKMLQIIDPR--L-----ENQYSV---RAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~--~-----~~~~~~---~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+....+-.  +     ...+..   .......+++.+||+.+|.+|.|++.++.|
T Consensus       241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111111111100  0     001111   112478899999999999999999999987

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2e-42  Score=329.03  Aligned_cols=265  Identities=25%  Similarity=0.394  Sum_probs=207.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|.+.+.||+|+||.||++.+...... .....||+|+++.... .....+.+|+.+++++ +|+||+++++++...+
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKS-DAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCC-CceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            45789999999999999999986432110 1123499998876532 3345688999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||+++.
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eehhhhccceEEEcCCCeEEECCCccccc
Confidence            9999999999999999997655445899999999999999999999866  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ..............++..|+|||++.+..++.++|||||||++|||++ |..||........                ..
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----------------~~  254 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----------------FY  254 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----------------HH
Confidence            543322212223446788999999999999999999999999999998 9999865432111                00


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ..+........+...+.++.+++.+||+.+|++|||+.++++.|+++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         255 KLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            11111111111122346889999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-42  Score=329.19  Aligned_cols=265  Identities=26%  Similarity=0.404  Sum_probs=208.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||++.+..... ......+++|.+..... ....++.+|+.+++++ +|+||+++++++...+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~   89 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDN-PNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG   89 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCC-CCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence            3568888999999999999998764321 11223589998876432 3345688999999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhC--------------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          155 HRLLVYEFMFRGSLENHLFRK--------------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      ..+++|||+++++|.+++...              ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.
T Consensus        90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~Nil~~~  167 (293)
T cd05053          90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK--CIHRDLAARNVLVTE  167 (293)
T ss_pred             CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--ccccccceeeEEEcC
Confidence            999999999999999998642              2346889999999999999999999866  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  299 (431)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........   
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~---  244 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF---  244 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHH---
Confidence            99999999999987544332222222345678999999999999999999999999999998 99998654321111   


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                                    +.+........+...+..+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus       245 --------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         245 --------------KLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --------------HHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                          111111111122234568889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-43  Score=344.40  Aligned_cols=255  Identities=22%  Similarity=0.279  Sum_probs=197.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||++.+..++..      ||+|++.+...   .....+.+|++++++++||||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   74 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI------YAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQ   74 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCE------EEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCC
Confidence            3688899999999999999998776554      99998865422   23356788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~kl~DfGla~~  150 (377)
T cd05629          75 YLYLIMEFLPGGDLMTMLIKYD--TFSEDVTRFYMAECVLAIEAVHKLG--FIHRDIKPDNILIDRGGHIKLSDFGLSTG  150 (377)
T ss_pred             eeEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEEeecccccc
Confidence            9999999999999999997643  4788888889999999999999876  99999999999999999999999999863


Q ss_pred             CCCCCCc---------------------------------------------ceeecccCCccccCccccccCCCCcchh
Q 014079          235 GPQGDET---------------------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSD  269 (431)
Q Consensus       235 ~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~D  269 (431)
                      .......                                             ......+||+.|+|||++.+..++.++|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  230 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD  230 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCcee
Confidence            2110000                                             0001246999999999999999999999


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCC--
Q 014079          270 VYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR--  347 (431)
Q Consensus       270 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R--  347 (431)
                      ||||||++|||++|..||...........             +... ...+........+.++.+|+.+||. +|.+|  
T Consensus       231 iwSlGvil~elltG~~Pf~~~~~~~~~~~-------------i~~~-~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~  295 (377)
T cd05629         231 WWSLGAIMFECLIGWPPFCSENSHETYRK-------------IINW-RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG  295 (377)
T ss_pred             eEecchhhhhhhcCCCCCCCCCHHHHHHH-------------HHcc-CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCC
Confidence            99999999999999999976432111000             0000 0000000011234678899999998 67665  


Q ss_pred             -CCHHHHHHHH
Q 014079          348 -PLMSDVVETL  357 (431)
Q Consensus       348 -Pt~~eil~~L  357 (431)
                       +++.+++.+-
T Consensus       296 r~~~~~~l~hp  306 (377)
T cd05629         296 RGGAHEIKSHP  306 (377)
T ss_pred             CCCHHHHhcCC
Confidence             5999998764

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=322.56  Aligned_cols=249  Identities=26%  Similarity=0.382  Sum_probs=212.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |.+..+||+|+||.||+|.+++.+.+      +|+|.+..+  .+..++..|+.||++++.|+||++||.|.....+|+|
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v------~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV  106 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHV------LAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV  106 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcE------EEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence            44566799999999999999988776      999988766  4678899999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||||..|+..|.+..+. .++.+..+..++...++||+|||...  -||||||..|||++.+|..||+|||.+..+.+  
T Consensus       107 MEYCGAGSiSDI~R~R~-K~L~E~EIs~iL~~TLKGL~YLH~~~--KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--  181 (502)
T KOG0574|consen  107 MEYCGAGSISDIMRARR-KPLSEQEISAVLRDTLKGLQYLHDLK--KIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--  181 (502)
T ss_pred             hhhcCCCcHHHHHHHhc-CCccHHHHHHHHHHHHhHHHHHHHHH--HHHhhcccccEEEcccchhhhhhccccchhhh--
Confidence            99999999999986654 47999999999999999999999877  79999999999999999999999999976433  


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      ......+++|||.|||||++..-.|+.++||||||++..||..|++||.+..+......+.               .++.
T Consensus       182 TMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP---------------T~PP  246 (502)
T KOG0574|consen  182 TMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP---------------TKPP  246 (502)
T ss_pred             hHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc---------------CCCC
Confidence            2223456899999999999999999999999999999999999999998765433221111               1222


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+...+.++-+|++.||-++|++|-|+.++++|
T Consensus       247 PTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  247 PTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             CCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            2223456678899999999999999999999999876

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.9e-42  Score=321.17  Aligned_cols=251  Identities=25%  Similarity=0.431  Sum_probs=199.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.+.||+|+||.||++.++++.       .+++|.+.... ....++.+|+.+|+.++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~-------~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQI-------KVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLY   75 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCc-------eEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEE
Confidence            35778889999999999999876542       38999876543 23467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||+++....
T Consensus        76 iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05114          76 IVTEFMENGCLLNYLRQRQG-KLSKDMLLSMCQDVCEGMEYLERNS--FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhCcc-CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcceEEEcCCCeEEECCCCCccccCC
Confidence            99999999999999875433 5788999999999999999999866  99999999999999999999999999876433


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|+|||++.+..++.++||||||+++|||++ |+.||...........+                .
T Consensus       153 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----------------~  215 (256)
T cd05114         153 DEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----------------S  215 (256)
T ss_pred             Ccee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------------H
Confidence            2211 1122345678999999998899999999999999999999 89999764322111100                0


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      . ......+...+..+.+++.+||+.||.+||++.++++.|
T Consensus       216 ~-~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         216 R-GFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             C-CCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            0 000001112346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.5e-43  Score=344.53  Aligned_cols=253  Identities=23%  Similarity=0.288  Sum_probs=197.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|+..+.||+|+||.||+|.+..++..      ||+|++.+...   .....+.+|+.++++++|+||+++++++.+.+.
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~   75 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKAL------YAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDN   75 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCE------EEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCE
Confidence            578889999999999999998776554      99999876432   234567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+||||+++|+|.+++.+..  .+++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~al~~lH~~~--ivHrDlKp~NILl~~~g~~kL~DFGla~~~  151 (382)
T cd05625          76 LYFVMDYIPGGDMMSLLIRMG--IFPEDLARFYIAELTCAVESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (382)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence            999999999999999997654  4788888889999999999999876  999999999999999999999999997532


Q ss_pred             CCCC---------------------------------------------CcceeecccCCccccCccccccCCCCcchhh
Q 014079          236 PQGD---------------------------------------------ETHVSTRVMGTYGYAAPEYVMTGHLTARSDV  270 (431)
Q Consensus       236 ~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  270 (431)
                      ....                                             ........+||+.|+|||++.+..++.++||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence            1000                                             0001123579999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-
Q 014079          271 YSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-  349 (431)
Q Consensus       271 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-  349 (431)
                      |||||++|||++|+.||....+......+.             . ....+........+.++.+++.+|+ .+|.+|++ 
T Consensus       232 wSlGvil~elltG~~Pf~~~~~~~~~~~i~-------------~-~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~  296 (382)
T cd05625         232 WSVGVILYEMLVGQPPFLAQTPLETQMKVI-------------N-WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK  296 (382)
T ss_pred             EechHHHHHHHhCCCCCCCCCHHHHHHHHH-------------c-cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC
Confidence            999999999999999997654321111000             0 0001111111234567788888876 59999997 


Q ss_pred             --HHHHHHH
Q 014079          350 --MSDVVET  356 (431)
Q Consensus       350 --~~eil~~  356 (431)
                        +.+++.|
T Consensus       297 ~~~~ei~~h  305 (382)
T cd05625         297 NGADEIKAH  305 (382)
T ss_pred             CCHHHHhcC
Confidence              8888765

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.9e-43  Score=335.20  Aligned_cols=248  Identities=27%  Similarity=0.392  Sum_probs=197.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCC-CceeeeecEEEeCC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRH-PNLVKLIGYCCEDD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  154 (431)
                      +|++.+.||+|+||.||+|.+..+..      .||+|++.+...   .....+..|++++..+.| ++|+++++++.+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDE------LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD   74 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCC
Confidence            47888999999999999999877654      399999876422   234567789999999976 46889999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~~~~  150 (324)
T cd05587          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDAEGHIKIADFGMCKE  150 (324)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEEcCCCCEEEeecCccee
Confidence            9999999999999999986654  4788889999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~----------------~~  212 (324)
T cd05587         151 NIFGGK--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF----------------QS  212 (324)
T ss_pred             cCCCCC--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence            322211  223467999999999999999999999999999999999999999764321110                00


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      +....  ..++...+.++.+++.+||+.||.+|++.     .+++++
T Consensus       213 i~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         213 IMEHN--VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHcCC--CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11100  11222345678899999999999999976     566544

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.1e-42  Score=324.10  Aligned_cols=262  Identities=24%  Similarity=0.363  Sum_probs=203.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +.|++.+.||+|+||.||+|.+..++..  ....+++|.+..... ....++..|+.++.++.||||+++++++. ....
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~   83 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDS--IKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASL   83 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCc--eeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCcc
Confidence            4578888999999999999998654321  112378888765432 23356778888999999999999999875 4567


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++++||+++|+|.+++.... ..+++...+.++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          84 QLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHR--MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            89999999999999997643 35889999999999999999999866  9999999999999999999999999998654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............++..|+|||++.++.++.++|||||||++|||++ |..||.+..........                
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~----------------  224 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL----------------  224 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----------------
Confidence            4333222334557788999999999999999999999999999998 99999765332111111                


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                       ........+..+...+.+++.+||..||.+|||+.|+++.|..+..
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         225 -EKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             -HCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence             0000000111133567889999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2e-42  Score=329.89  Aligned_cols=268  Identities=24%  Similarity=0.390  Sum_probs=208.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .++|.+.+.||+|+||.||++.+..... .......+|+|++.... .....++.+|+.+++.+ +|+||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            3578999999999999999998754221 11122359999987653 23445688899999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +..|+||||+.+++|.+++.....              ..+++..++.++.|++.||+|||+.+  ++||||||+|||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~  174 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT  174 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHHheEEc
Confidence            999999999999999999976421              24788899999999999999999866  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......    
T Consensus       175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~----  250 (307)
T cd05098         175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  250 (307)
T ss_pred             CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHH----
Confidence            999999999999876543222111222335578999999999999999999999999999998 888886532111    


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                   +...+........+...+.++.+++.+||..+|.+||++.++++.|+.+...
T Consensus       251 -------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~  302 (307)
T cd05098         251 -------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL  302 (307)
T ss_pred             -------------HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence                         1111111111122234457888999999999999999999999999987655

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7e-43  Score=335.39  Aligned_cols=246  Identities=29%  Similarity=0.403  Sum_probs=195.6

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||++....+..   .+..||+|++.+...    .....+.+|+.+|+.++||||+++++++..++..|+|
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~---~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv   78 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGAD---TGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLI   78 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCC---CCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEE
Confidence            579999999999998753221   233599999876432    2234567899999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+.+++|.+++....  .+.+.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          79 LEYLSGGELFMHLEREG--IFMEDTACFYLSEISLALEHLHQQG--IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             EeCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            99999999999997654  4677888889999999999999876  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........                +..+....
T Consensus       155 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~----------------~~~~~~~~  216 (323)
T cd05584         155 T--VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKT----------------IDKILKGK  216 (323)
T ss_pred             C--cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHH----------------HHHHHcCC
Confidence            1  22345799999999999998999999999999999999999999976432111                11111111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      .  ..+...+..+.+|+.+||+.||++||     ++.+++.+
T Consensus       217 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 L--NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            1  12223456788999999999999999     78888875

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=7.2e-43  Score=334.22  Aligned_cols=243  Identities=27%  Similarity=0.414  Sum_probs=191.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhc-CCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQ-LRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||+|.+..+...      ||+|+++....   .....+..|..++.. ++||||+++++++...+..++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv   74 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEF------FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            3699999999999998776543      99999876422   223445567777765 4799999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~gg~L~~~~~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~  150 (316)
T cd05592          75 MEYLNGGDLMFHIQSSG--RFDEARARFYAAEIICGLQFLHKKG--IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE  150 (316)
T ss_pred             EcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC
Confidence            99999999999987644  4788888999999999999999866  9999999999999999999999999997543222


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||..........                .+... 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~----------------~i~~~-  211 (316)
T cd05592         151 --GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFD----------------SILND-  211 (316)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHHcC-
Confidence              22234679999999999999999999999999999999999999997643211100                00000 


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMS-DVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-eil~~  356 (431)
                       ...++...+.++.+|+.+||+.||.+||++. +++++
T Consensus       212 -~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 -RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             -CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence             0111223456788999999999999999875 55543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-42  Score=327.28  Aligned_cols=261  Identities=25%  Similarity=0.384  Sum_probs=204.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .|++.+.||+|+||.||+|.+..+.. ......||+|+++..... ....+.+|+.++..++||||+++++++.+.+..+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP-GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC-CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            36677889999999999998765321 112335999998765432 2356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc
Q 014079          158 LVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~  223 (431)
                      +++||+.+++|.+++....              ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH--VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhheEecCCCc
Confidence            9999999999999985321              234788888999999999999999866  999999999999999999


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  302 (431)
                      +||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.......   ...  
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~---~~~--  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VIE--  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH---HHH--
Confidence            99999999886544333222233456789999999998999999999999999999998 888886543211   110  


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                                 .+.+. .....+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       238 -----------~i~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 -----------MIRNR-QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             -----------HHHcC-CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence                       01111 1111233456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-42  Score=319.49  Aligned_cols=249  Identities=26%  Similarity=0.423  Sum_probs=196.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +.||+|+||.||+|.+..+..      .+|+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNT------PVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMEL   74 (252)
T ss_pred             CccCcccCccEEEEEEecCCc------eEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEee
Confidence            369999999999999876544      399998765432 3345688999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++..........
T Consensus        75 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  151 (252)
T cd05084          75 VQGGDFLTFLRTEG-PRLKVKELIQMVENAAAGMEYLESKH--CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS  151 (252)
T ss_pred             ccCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEEcCCCcEEECccccCcccccccccc
Confidence            99999999986543 35789999999999999999999866  9999999999999999999999999987643321111


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                      ......++..|+|||.+.++.++.++|||||||++|||++ |..||.........                 ..+.....
T Consensus       152 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~-----------------~~~~~~~~  214 (252)
T cd05084         152 TGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTR-----------------EAIEQGVR  214 (252)
T ss_pred             cCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHH-----------------HHHHcCCC
Confidence            1111223457999999999999999999999999999998 88888654321110                 01111111


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...+...+..+.+++.+||+.||++|||+.+|++.|.
T Consensus       215 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         215 LPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1222334578899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.3e-42  Score=325.11  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|...+.||+|+||.||++....... ......+++|.+..........+.+|+++++.++|+||+++++++.+.+..+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCC-CCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            457788899999999999997543211 1122348999887665555677899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCC-------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          158 LVYEFMFRGSLENHLFRKAT-------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~-------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ++|||+++++|.+++.....             ..+++..++.++.|++.||+|||+.+  ++||||||+|||+++++.+
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH--FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC--eecccccHhhEEEcCCCCE
Confidence            99999999999999875432             24788999999999999999999866  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      +|+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||..........      
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------  235 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIE------  235 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHH------
Confidence            9999999876433222222223345788999999999999999999999999999998 899986543211110      


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                .... ......+..++..+.+++.+||+.||.+||++.+|++.|+
T Consensus       236 ----------~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         236 ----------CITQ-GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             ----------HHHc-CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence                      0000 0001112234567889999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-43  Score=339.51  Aligned_cols=245  Identities=26%  Similarity=0.413  Sum_probs=206.2

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecC
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMF  164 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  164 (431)
                      +||+|.||+||.|++.+++..      +|||-+.........-+..|+.+.++|+|.|||+++|.+.+++.+-|.||-++
T Consensus       582 VLGKGTYG~VYA~RD~~tqvr------IaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVP  655 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVR------IAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVP  655 (1226)
T ss_pred             EeecCceeEEEeeccccceeE------EEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCC
Confidence            699999999999999987654      89999887766666778899999999999999999999999999999999999


Q ss_pred             CCChHHhhhhCCCCCc--CHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCccCCCCCCc
Q 014079          165 RGSLENHLFRKATVPL--SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       165 ~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      ||+|.+++..+.+ |+  .+...-.+..||++||.|||...  |||||||-+||||+. .|.+||+|||-++.+..  -.
T Consensus       656 GGSLSsLLrskWG-PlKDNEstm~fYtkQILeGLkYLHen~--IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--in  730 (1226)
T KOG4279|consen  656 GGSLSSLLRSKWG-PLKDNESTMNFYTKQILEGLKYLHENK--IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--IN  730 (1226)
T ss_pred             CCcHHHHHHhccC-CCccchhHHHHHHHHHHHHhhhhhhcc--eeeccccCCcEEEeeccceEEecccccchhhcc--CC
Confidence            9999999977654 55  77888889999999999999877  999999999999987 58999999999886532  22


Q ss_pred             ceeecccCCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          242 HVSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      ....++.||.-|||||++..+  .|..++|||||||++.||.||++||........               .+.+.---.
T Consensus       731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA---------------AMFkVGmyK  795 (1226)
T KOG4279|consen  731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA---------------AMFKVGMYK  795 (1226)
T ss_pred             ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH---------------hhhhhccee
Confidence            344567899999999999865  588999999999999999999999976543221               112211112


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      .....+.+.+.++..||.+|+.+||.+||++.++++
T Consensus       796 vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  796 VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            234556788899999999999999999999999985

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-43  Score=344.70  Aligned_cols=253  Identities=23%  Similarity=0.279  Sum_probs=198.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|++.+.||+|+||.||+|.+..+++.      ||+|++.+...   .....+.+|+.+|++++|+||+++++.+.+.+.
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~   75 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNAL------YAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDN   75 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCE------EEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCE
Confidence            688999999999999999998776543      99999875432   223557789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+||||+++|+|.+++....  .+++.....++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        76 ~~lv~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~ikL~DFG~a~~~  151 (376)
T cd05598          76 LYFVMDYIPGGDMMSLLIRLG--IFEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGF  151 (376)
T ss_pred             EEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence            999999999999999997654  4778888889999999999999876  999999999999999999999999997532


Q ss_pred             CCCC-----------------------------------------CcceeecccCCccccCccccccCCCCcchhhHHHH
Q 014079          236 PQGD-----------------------------------------ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFG  274 (431)
Q Consensus       236 ~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG  274 (431)
                      ....                                         ........+||+.|+|||++.+..++.++||||||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  231 (376)
T cd05598         152 RWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  231 (376)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecc
Confidence            1000                                         00011235799999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC---CHH
Q 014079          275 VVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP---LMS  351 (431)
Q Consensus       275 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---t~~  351 (431)
                      |++|||++|+.||....+......+.       .       ....+........+.++.++|.+|+ .+|.+|+   ++.
T Consensus       232 vilyell~G~~Pf~~~~~~~~~~~i~-------~-------~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~  296 (376)
T cd05598         232 VILYEMLVGQPPFLADTPAETQLKVI-------N-------WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGAD  296 (376)
T ss_pred             ceeeehhhCCCCCCCCCHHHHHHHHh-------c-------cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHH
Confidence            99999999999997654322111000       0       0000111111123467788998876 5999999   899


Q ss_pred             HHHHH
Q 014079          352 DVVET  356 (431)
Q Consensus       352 eil~~  356 (431)
                      +++.+
T Consensus       297 ell~h  301 (376)
T cd05598         297 EIKAH  301 (376)
T ss_pred             HHhCC
Confidence            99877

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.4e-43  Score=341.07  Aligned_cols=253  Identities=22%  Similarity=0.258  Sum_probs=201.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||++.+..++..      ||+|++.+...   .....+.+|+.+++.++||||+++++++.+.
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~  115 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQV------YAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD  115 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            45789999999999999999998776554      99999875422   2234567899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..|+||||+++|+|.+++...   .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~kL~DfG~~~  190 (370)
T cd05596         116 KYLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  190 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEcCCCCEEEEecccee
Confidence            9999999999999999988653   3677888889999999999999866  9999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ....... ......+||+.|+|||++.+.    .++.++|||||||++|||++|+.||........              
T Consensus       191 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--------------  255 (370)
T cd05596         191 KMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT--------------  255 (370)
T ss_pred             eccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH--------------
Confidence            6533221 112345799999999998653    488999999999999999999999976532111              


Q ss_pred             chhhhhcCc--cccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 014079          310 RKMLQIIDP--RLENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETL  357 (431)
Q Consensus       310 ~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L  357 (431)
                        ...+++.  .+........+.++.+|+.+||+.+|.+  |+++.+++.+-
T Consensus       256 --~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~  305 (370)
T cd05596         256 --YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHP  305 (370)
T ss_pred             --HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCc
Confidence              0111111  0111111134578899999999999998  99999999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-42  Score=321.82  Aligned_cols=259  Identities=29%  Similarity=0.461  Sum_probs=202.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe--
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH--  155 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--  155 (431)
                      |.+.+.||+|+||.||+|.+..+..   ....||+|+++....  .....+.+|+.+++.++|+||+++++++.....  
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   77 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDG---SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQ   77 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCC---CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccc
Confidence            5678899999999999998765321   123499999875432  334578899999999999999999998876554  


Q ss_pred             ----eEEEEEecCCCChHHhhhhC----CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          156 ----RLLVYEFMFRGSLENHLFRK----ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       156 ----~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                          .+++|||+++++|.+++...    ....+++...+.++.|++.||.|||+.+  ++||||||+||++++++.+||+
T Consensus        78 ~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  155 (273)
T cd05035          78 KIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN--FIHRDLAARNCMLREDMTVCVA  155 (273)
T ss_pred             cCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchheEEECCCCeEEEC
Confidence                79999999999999988542    2235788999999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+     
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~~~~-----  227 (273)
T cd05035         156 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---IYDY-----  227 (273)
T ss_pred             CccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH-----
Confidence            9999986544332222222345678999999988899999999999999999999 888886543211   1110     


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                               +........+...+..+.+++.+||+.||.+||++.++++.|+++
T Consensus       228 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         228 ---------LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ---------HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                     000011112234457889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=8.1e-43  Score=334.44  Aligned_cols=243  Identities=29%  Similarity=0.427  Sum_probs=193.9

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||+|.+..+...      ||+|++.+...   .....+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv   74 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRL------YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFV   74 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCE------EEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEE
Confidence            3699999999999998776543      99999876422   2345567888888876 699999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~Ey~~~g~L~~~i~~~~--~l~~~~~~~~~~ql~~~L~~lH~~~--ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~  150 (320)
T cd05590          75 MEFVNGGDLMFHIQKSR--RFDEARARFYAAEITSALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG  150 (320)
T ss_pred             EcCCCCchHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC
Confidence            99999999999886654  4788899999999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~----------------~~i~~~~  212 (320)
T cd05590         151 --KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLF----------------EAILNDE  212 (320)
T ss_pred             --CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH----------------HHHhcCC
Confidence              1223467999999999999999999999999999999999999999764321110                0011100


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLM------SDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~eil~~  356 (431)
                      .  ..+...+.++.+|+.+||+.||.+||++      .+++.+
T Consensus       213 ~--~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 V--VYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             C--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence            0  1122245678899999999999999998      556544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.3e-42  Score=339.56  Aligned_cols=265  Identities=23%  Similarity=0.386  Sum_probs=205.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCC-CCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  155 (431)
                      ++|.+.+.||+|+||.||+|.+..... ......||+|+++..... ....+.+|+++|.++. |||||++++++...+.
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~-~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLSH-SQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCCC-CCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457788899999999999999764211 112345999999765322 2346889999999997 9999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC----------------------------------------------------------
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT----------------------------------------------------------  177 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------------------  177 (431)
                      .++||||+.+|+|.+++.+...                                                          
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            9999999999999999865321                                                          


Q ss_pred             --------------------------------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          178 --------------------------------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       178 --------------------------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                                                            ..+++...+.++.|++.||.|||+.+  |+||||||+|||++
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrdlkp~NiLl~  273 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN--CVHRDLAARNVLIC  273 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--cCcccCCcceEEEe
Confidence                                                  13566778889999999999999865  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |+.||........   
T Consensus       274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~---  350 (401)
T cd05107         274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ---  350 (401)
T ss_pred             CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH---
Confidence            999999999999976433222111223457889999999998899999999999999999998 8899865432111   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                                   ....+........+...+.++.+|+.+||+.+|.+||++.+|++.|+.+.
T Consensus       351 -------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         351 -------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             -------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                         00111111111122234578899999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=5.9e-42  Score=319.75  Aligned_cols=259  Identities=23%  Similarity=0.342  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+..      .||+|.+....   ......+.+|+.+++.++||||+++++++.+.+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   75 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRK------PVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDN   75 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCC------EEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECC
Confidence            468899999999999999999876544      38999775432   233456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..++|+||+++++|.+++..  .....+++...+.++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~nil~~~~~~~~l~d~g~~  153 (267)
T cd08228          76 ELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCCHHHEEEcCCCCEEECccccc
Confidence            99999999999999988853  22345788889999999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........  ......|++.|+|||.+.+..++.++||||||+++|||++|+.||........ ...             
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~-~~~-------------  217 (267)
T cd08228         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-SLC-------------  217 (267)
T ss_pred             eeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHH-HHH-------------
Confidence            76543221  12235688999999999988899999999999999999999999865322110 000             


Q ss_pred             hhhcC-ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          313 LQIID-PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       313 ~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                       ..+. ...........+..+.+++.+||+.+|.+||++.+|++.|++++
T Consensus       218 -~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         218 -QKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             -HHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence             0010 01111112345578899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-43  Score=332.33  Aligned_cols=261  Identities=27%  Similarity=0.438  Sum_probs=217.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH-HHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +...+.++||+|.||.|.++.....       ..||+|.++....... .+|.+|+++|.+|+|||||.++++|..++.+
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeveg~-------lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVEGP-------LKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hheehhhhhcCcccceeEEEEecCc-------eEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            4567788999999999999987653       2499999988765544 7899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+|||++|+|.+++..+....+.......|+.||+.||+||.+.+  +|||||.+.|+|++.++++||+|||+++.+.
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n--fVHrd~a~rNcLv~~e~~iKiadfgmsR~ly  688 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN--FVHRDLATRNCLVDGEFTIKIADFGMSRNLY  688 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc--hhhccccccceeecCcccEEecCcccccccc
Confidence            99999999999999998875433456667789999999999999987  9999999999999999999999999999888


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT--GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .++......+.+-..+|||+|.+.-++++.++|+|+||+++||+++  ...||........-   .          ....
T Consensus       689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vv---e----------n~~~  755 (807)
T KOG1094|consen  689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVV---E----------NAGE  755 (807)
T ss_pred             cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHH---H----------hhhh
Confidence            8888777777778889999999999999999999999999999876  67888765432211   1          1111


Q ss_pred             hcCcc---ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          315 IIDPR---LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       315 ~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +++..   .....+.-++..+++++.+||..|-++||+++++..+|.+.
T Consensus       756 ~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  756 FFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            11111   11123455778999999999999999999999999988754

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3e-42  Score=323.82  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=196.4

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||+|+||.||++....++..      ||+|.+......   ....+..|++++++++||||+++++++.+....++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~------~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKM------YACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSL   74 (277)
T ss_pred             CCCCCceEEEEEEEccCCcE------EEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEec
Confidence            79999999999998765543      999988654322   223456799999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      ++|++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.......   
T Consensus        75 ~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---  149 (277)
T cd05607          75 MNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD--IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---  149 (277)
T ss_pred             CCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---
Confidence            99999999987766667899999999999999999999866  9999999999999999999999999987654322   


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ......|+..|+|||++.+..++.++|||||||++|||++|+.||...........+            ...........
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~------------~~~~~~~~~~~  217 (277)
T cd05607         150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEEL------------KRRTLEDEVKF  217 (277)
T ss_pred             eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHH------------HHHhhcccccc
Confidence            223356899999999999989999999999999999999999999754321111000            00011111100


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       .....+.++.+|+.+||+.||++||++.|+++.+
T Consensus       218 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         218 -EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             -ccccCCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence             0113456789999999999999999997766444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1.2e-42  Score=335.02  Aligned_cols=256  Identities=29%  Similarity=0.365  Sum_probs=198.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCC-CCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLR-HPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  153 (431)
                      +|++.+.||+|+||.||++....+..   .+..||+|++.+...    ...+.+.+|+.+++.++ |+||+++++++...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHD---TGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE   77 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCC---CCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC
Confidence            47889999999999999998743211   233599999875422    22345778999999994 99999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+++||||+++|+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        78 ~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          78 AKLHLILDYVSGGEMFTHLYQRD--NFSEDEVRFYSGEIILALEHLHKLG--IVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            99999999999999999987654  4788889999999999999999866  9999999999999999999999999997


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........ ......||+.|+|||++.+. .++.++|||||||++|||++|+.||..............         .+
T Consensus       154 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~---------~~  223 (332)
T cd05614         154 EFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR---------RI  223 (332)
T ss_pred             cccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHH---------HH
Confidence            64332221 12235799999999998865 478899999999999999999999975432211111100         00


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      . ..++.    .+...+..+.+++.+||+.||++||     ++.+++++
T Consensus       224 ~-~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         224 L-KCDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             h-cCCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            0 01111    2223456788999999999999999     77788866

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=4.1e-42  Score=327.30  Aligned_cols=268  Identities=22%  Similarity=0.378  Sum_probs=208.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCc-eeccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENV-RVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      ..+|.+.+.||+|+||.||+|.+.... ........|++|.+.... .....++.+|+.+++.+ +||||+++++++...
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   93 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   93 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence            466888899999999999999753211 011122358999887542 23456788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +..++||||+.+++|.+++....              ...+++..++.++.|++.||.|||+.+  |+||||||+|||++
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nili~  171 (304)
T cd05101          94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK--CIHRDLAARNVLVT  171 (304)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC--eeecccccceEEEc
Confidence            99999999999999999997642              134678888999999999999999866  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||........   
T Consensus       172 ~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---  248 (304)
T cd05101         172 ENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  248 (304)
T ss_pred             CCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---
Confidence            999999999999987544332222223446778999999999899999999999999999998 7888865421110   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                    ...+........+..++..+.+++.+||..+|.+||++.++++.|.++...
T Consensus       249 --------------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         249 --------------FKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             --------------HHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence                          001111111111223457889999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.3e-43  Score=337.94  Aligned_cols=254  Identities=23%  Similarity=0.256  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||++.+..++..      ||+|++++...   .....+.+|+.+++.++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~   74 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDI------YAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKD   74 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCC
Confidence            4688999999999999999998766543      99999876532   23455778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.+.. ..+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~--i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~  151 (330)
T cd05601          75 NLYLVMEYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMG--YVHRDIKPENVLIDRTGHIKLADFGSAAR  151 (330)
T ss_pred             eEEEEECCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEcccCchHheEECCCCCEEeccCCCCeE
Confidence            9999999999999999997652 35888999999999999999999866  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ....... ......||+.|+|||++.      +..++.++|||||||++|||++|+.||...........          
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~----------  220 (330)
T cd05601         152 LTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNN----------  220 (330)
T ss_pred             CCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHH----------
Confidence            5433221 223357999999999986      45688999999999999999999999976432211100          


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         +... ...+........+..+.+|+..||. ||.+||++.+++.+
T Consensus       221 ---i~~~-~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         221 ---IMNF-QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ---HHcC-CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence               0000 0000001111245678899999998 99999999999865

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-42  Score=334.05  Aligned_cols=243  Identities=28%  Similarity=0.400  Sum_probs=194.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||+|.+..++.      .||+|++.+...   .....+..|.+++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv   74 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDE------VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFV   74 (321)
T ss_pred             CccccCCCeEEEEEEECCCCC------EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEE
Confidence            369999999999999876544      399999876422   2334567888888866 799999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.......
T Consensus        75 ~E~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~  150 (321)
T cd05591          75 MEYVNGGDLMFQIQRSR--KFDEPRSRFYAAEVTLALMFLHRHG--VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG  150 (321)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeecccceecccCC
Confidence            99999999999886654  4788888999999999999999876  9999999999999999999999999987533222


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~----------------~~i~~~~  212 (321)
T cd05591         151 V--TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLF----------------ESILHDD  212 (321)
T ss_pred             c--cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHH----------------HHHHcCC
Confidence            1  223457999999999999999999999999999999999999999765321110                0111100


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCC-------CHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARP-------LMSDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-------t~~eil~~  356 (431)
                      .  ..+...+.++.+++.+||+.||++||       ++.+++++
T Consensus       213 ~--~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 V--LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             C--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            0  11122346788999999999999999       77888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.3e-42  Score=345.25  Aligned_cols=267  Identities=22%  Similarity=0.348  Sum_probs=194.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC------CCceeeee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR------HPNLVKLI  147 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~  147 (431)
                      +...++|++.++||+|+||+||+|.+......      ||||+++... ....++..|+.+++.++      |.++++++
T Consensus       125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~------vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~  197 (467)
T PTZ00284        125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEY------CAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQ  197 (467)
T ss_pred             ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeE------EEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeE
Confidence            34467899999999999999999998766544      9999986532 22334455666666664      45689999


Q ss_pred             cEEEeC-CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCC---
Q 014079          148 GYCCED-DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDY---  222 (431)
Q Consensus       148 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~---  222 (431)
                      ++|... .++|+|||++ +++|.+++.+..  .+++..+..++.||+.||.|||+ .+  ||||||||+|||++.++   
T Consensus       198 ~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~yLH~~~g--IiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        198 RYFQNETGHMCIVMPKY-GPCLLDWIMKHG--PFSHRHLAQIIFQTGVALDYFHTELH--LMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EEEEcCCceEEEEEecc-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhcCC--eecCCCCHHHEEEecCCccc
Confidence            988764 5788999988 889999887653  58889999999999999999997 35  99999999999998765   


Q ss_pred             -------------cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          223 -------------TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       223 -------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                                   .+||+|||++.....     .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence                         499999998764221     12346799999999999999999999999999999999999999987


Q ss_pred             CCCcccchhhhhhhhhhhc----------cchhhhh---cCccccC----------cc-cHHHHHHHHHHHHHhhhcCCC
Q 014079          290 TRPSKEQSLVDWARPKLND----------KRKMLQI---IDPRLEN----------QY-SVRAAQKACSLAYYCLSQNPK  345 (431)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~---~~~~~~~----------~~-~~~~~~~~~~li~~cl~~dP~  345 (431)
                      .........+......+..          ...+...   +.+....          .. .......+.+||.+||++||+
T Consensus       348 ~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~  427 (467)
T PTZ00284        348 HDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ  427 (467)
T ss_pred             CChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChh
Confidence            5433222111111000000          0000000   0000000          00 011235688999999999999


Q ss_pred             CCCCHHHHHHHH
Q 014079          346 ARPLMSDVVETL  357 (431)
Q Consensus       346 ~RPt~~eil~~L  357 (431)
                      +|||+.|+++|=
T Consensus       428 ~R~ta~e~L~Hp  439 (467)
T PTZ00284        428 KRLNARQMTTHP  439 (467)
T ss_pred             hCCCHHHHhcCc
Confidence            999999999863

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2.6e-42  Score=324.72  Aligned_cols=247  Identities=26%  Similarity=0.374  Sum_probs=196.1

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||+|+||+||++.+..+++.      ||+|.+.+....   ....+..|+++++.++|+||+++++++......++||||
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKL------YACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTI   74 (280)
T ss_pred             CCCCCceeEEEEEEccCCcE------EEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeC
Confidence            79999999999998765543      999998754322   234567899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          163 MFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       163 ~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      +++|+|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++........
T Consensus        75 ~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  152 (280)
T cd05608          75 MNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR--IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS  152 (280)
T ss_pred             CCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc
Confidence            9999999887542  3346889999999999999999999866  99999999999999999999999999876543322


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                        ......||+.|+|||++.+..++.++|||||||++|||++|+.||............            ...+.... 
T Consensus       153 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~------------~~~~~~~~-  217 (280)
T cd05608         153 --KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKEL------------KQRILNDS-  217 (280)
T ss_pred             --cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHH------------HHhhcccC-
Confidence              123357999999999999999999999999999999999999999764322111000            00111111 


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                       ..++...+..+.+++.+||+.||++||     ++++++.+
T Consensus       218 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         218 -VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             -CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence             112234557888999999999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.4e-42  Score=333.32  Aligned_cols=248  Identities=25%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      +|.+.+.||+|+||.||+|.+..+...      ||+|++.+...   .....+..|..++..+ +|++|+++++++.+.+
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDEL------YAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMD   74 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCC
Confidence            478889999999999999998776543      99999876432   2234566788888777 5899999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~E~~~~g~L~~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kL~DfG~~~~  150 (323)
T cd05616          75 RLYFVMEYVNGGDLMYQIQQVG--RFKEPHAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEecCCCHHHeEECCCCcEEEccCCCcee
Confidence            9999999999999999986654  4788899999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..
T Consensus       151 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~----------------~~  212 (323)
T cd05616         151 NMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELF----------------QS  212 (323)
T ss_pred             cCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence            32211  1223467999999999999999999999999999999999999999764321110                01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      +....  ..++...+.++.+++.+||+.||.+|++.     .+++++
T Consensus       213 i~~~~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         213 IMEHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHhCC--CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence            11111  11223345788899999999999999985     566543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=6.1e-42  Score=319.07  Aligned_cols=254  Identities=27%  Similarity=0.428  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .+|++.+.||+|+||.||+|.+.++.       .|++|.+..... ....+.+|+.+++.++|+||+++++++. .+..+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~-------~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   76 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCc-------eEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcE
Confidence            56899999999999999999876543       289999876432 3457889999999999999999999874 45689


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++....
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~  154 (262)
T cd05071          77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED  154 (262)
T ss_pred             EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence            9999999999999997654456788999999999999999999866  99999999999999999999999999976543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|+|||++.+..++.++|||||||++|||++ |..||...........                 +
T Consensus       155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~-----------------~  216 (262)
T cd05071         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-----------------V  216 (262)
T ss_pred             cccc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH-----------------H
Confidence            3221 1122346778999999988899999999999999999999 8888865432111100                 0


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ............+..+.+++.+||+.||++||++.++++.|+..
T Consensus       217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         217 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            00001112234557788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.2e-42  Score=319.04  Aligned_cols=252  Identities=25%  Similarity=0.432  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||++.+.+..       .+|+|.+..... ....+.+|+.++++++||||+++++++.+.+..+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~-------~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   75 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQY-------DVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIY   75 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCC-------cEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcE
Confidence            35778889999999999999876532       389998875543 3467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.+++|.+++..... .+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.+||+|||+++....
T Consensus        76 lv~e~~~~~~l~~~i~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~  152 (256)
T cd05113          76 IVTEYMSNGCLLNYLREHGK-RFQPSQLLEMCKDVCEGMAYLESKQ--FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEEEcCCCCcHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence            99999999999999876443 6899999999999999999999866  99999999999999999999999999876533


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|++||++.+..++.++|||||||++|+|++ |..||.........   .             .+.
T Consensus       153 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~---~-------------~~~  215 (256)
T cd05113         153 DEYT-SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETV---E-------------KVS  215 (256)
T ss_pred             Ccee-ecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHH---H-------------HHh
Confidence            2211 1112345678999999988889999999999999999998 99998654321110   0             000


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      . ......+...+..+.+++.+||+.||.+||++.+|+..|+
T Consensus       216 ~-~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         216 Q-GLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             c-CCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0 0000111123478899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.4e-42  Score=338.87  Aligned_cols=253  Identities=23%  Similarity=0.281  Sum_probs=200.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||++.+..+...      ||+|++.+...   .....+.+|+.+++.++||||+++++++.++
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKV------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD  115 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC
Confidence            46799999999999999999999876554      99999865322   2334577899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..|+||||+++|+|.+++...   .+++.....++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       116 ~~~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~--IvHrDLKp~NILl~~~~~~kL~DFG~a~  190 (370)
T cd05621         116 KYLYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMG--LIHRDVKPDNMLLDKHGHLKLADFGTCM  190 (370)
T ss_pred             CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEEecccce
Confidence            9999999999999999998543   4788888899999999999999866  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ....... ......+||+.|+|||++.+.    .++.++|||||||++|||++|+.||........              
T Consensus       191 ~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~--------------  255 (370)
T cd05621         191 KMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT--------------  255 (370)
T ss_pred             ecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH--------------
Confidence            6533221 112346799999999998754    378899999999999999999999976432111              


Q ss_pred             chhhhhcCcc--ccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 014079          310 RKMLQIIDPR--LENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETL  357 (431)
Q Consensus       310 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L  357 (431)
                        ...+++..  +........+..+.+++..||..++.+  |+++.++++|-
T Consensus       256 --~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp  305 (370)
T cd05621         256 --YSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHP  305 (370)
T ss_pred             --HHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCc
Confidence              11111111  111111234577889999999865544  88999999873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=6e-42  Score=317.46  Aligned_cols=251  Identities=25%  Similarity=0.370  Sum_probs=205.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|.+.+.||+|+||.||+|.+..++..      |++|.+....  ......+.+|+++++.++||||+++++++.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~------~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRV------YAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKL   74 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcE------EEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEE
Confidence            377788999999999999998766543      8999876542  23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.......+++..++.++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~--i~h~dl~~~nili~~~~~~~l~df~~~~~~~  152 (256)
T cd08529          75 NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK--ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS  152 (256)
T ss_pred             EEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEeCCCCEEEcccccceecc
Confidence            99999999999999998765567899999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...             .+.
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~-------------~~~  214 (256)
T cd08529         153 DNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---LIL-------------KII  214 (256)
T ss_pred             Cccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHH-------------HHH
Confidence            3321  1233568899999999999999999999999999999999999997543111   000             011


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      . ..........+..+.+++.+||+.+|++||++.+++++
T Consensus       215 ~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         215 R-GVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             c-CCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            1 01111222445788999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.7e-42  Score=333.37  Aligned_cols=250  Identities=27%  Similarity=0.408  Sum_probs=194.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+..++..      ||+|++++...   .....+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEE
Confidence            4699999999999998776543      99999876422   2334567888888776 799999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~E~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            99999999998886543  5788999999999999999999876  9999999999999999999999999987532211


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc--chhhhhhhhhhhccchhhhhcC
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE--QSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  .....+..         ..+..
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~i~~  219 (329)
T cd05618         151 D--TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------QVILE  219 (329)
T ss_pred             C--ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH---------HHHhc
Confidence            1  12346799999999999999999999999999999999999999964321111  00000000         00111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPL------MSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt------~~eil~~  356 (431)
                      ..  ..++...+..+.+|+.+||+.||.+||+      +.++++|
T Consensus       220 ~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            11  1123334567889999999999999998      4677655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-42  Score=323.13  Aligned_cols=262  Identities=26%  Similarity=0.415  Sum_probs=206.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..... ......|++|.+..... .....+.+|+.+++.++|+||+++++++.....
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK-GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC-CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3578889999999999999998865331 11223599999875532 334568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC--------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          156 RLLVYEFMFRGSLENHLFRKA--------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      .++||||+++++|.+++....        ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK--FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccChheEEEcCCCCEEEC
Confidence            999999999999999986532        223678889999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||...........        
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~--------  233 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF--------  233 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHH--------
Confidence            9999876543332222233457889999999988899999999999999999998 9999965432211110        


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                               +........+...+..+.+++.+||+.+|++|||+.+++..|+
T Consensus       234 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         234 ---------VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             ---------HhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                     0000011112223578899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-42  Score=333.52  Aligned_cols=250  Identities=27%  Similarity=0.407  Sum_probs=195.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||++.+..++..      ||+|++++...   .....+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv   74 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRI------YAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFV   74 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEE
Confidence            4699999999999998776543      99999976432   2334577899999988 699999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  150 (329)
T cd05588          75 IEFVSGGDLMFHMQRQR--KLPEEHARFYSAEISLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG  150 (329)
T ss_pred             EeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEECcCccccccccCC
Confidence            99999999999886543  5889999999999999999999866  9999999999999999999999999987532211


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc--cchhhhhhhhhhhccchhhhhcC
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK--EQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  ......+..         ..+..
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~~~~  219 (329)
T cd05588         151 --DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF---------QVILE  219 (329)
T ss_pred             --CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHH---------HHHHc
Confidence              12234679999999999999999999999999999999999999997432211  000000000         00111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCC------HHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPL------MSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt------~~eil~~  356 (431)
                      ...  ..+...+.++.+++.+||+.||.+|++      +.+++++
T Consensus       220 ~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 KQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            111  122234567889999999999999997      6677755

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-42  Score=318.62  Aligned_cols=250  Identities=26%  Similarity=0.422  Sum_probs=199.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      +|++.+.||+|+||.||++.+..+.       .+++|++.+... ....+.+|+.++++++|+||+++++++...+..++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~-------~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   76 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKI-------DVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFI   76 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCc-------cEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEE
Confidence            4778889999999999999876432       389998865432 34568889999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ||||+++++|.+++..... .+++..++.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++.....
T Consensus        77 v~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~  153 (256)
T cd05059          77 VTEYMANGCLLNYLRERKG-KLGTEWLLDMCSDVCEAMEYLESNG--FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDD  153 (256)
T ss_pred             EEecCCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHHCC--cccccccHhhEEECCCCcEEECCcccceecccc
Confidence            9999999999999976543 5889999999999999999999866  999999999999999999999999998765332


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.........   .          .+.    
T Consensus       154 ~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---~----------~~~----  215 (256)
T cd05059         154 QYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV---E----------SVS----  215 (256)
T ss_pred             ccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHH---H----------HHH----
Confidence            111 1111224557999999999999999999999999999999 89999754321110   0          000    


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .......+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            0011111223457899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.3e-42  Score=324.90  Aligned_cols=253  Identities=29%  Similarity=0.451  Sum_probs=202.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|+..+.||+|+||.||++.+..+.+.      ||+|.+......   ....+.+|+.++++++|+||+.+++.+.+.+.
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDA   74 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCce------EEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCE
Confidence            367788999999999999999876554      999988654322   23456789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~  152 (285)
T cd05630          75 LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER--IVYRDLKPENILLDDHGHIRISDLGLAVHV  152 (285)
T ss_pred             EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHEEECCCCCEEEeeccceeec
Confidence            999999999999999987665556899999999999999999999866  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....   .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.............             ..
T Consensus       153 ~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~-------------~~  216 (285)
T cd05630         153 PEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------RL  216 (285)
T ss_pred             CCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHH-------------hh
Confidence            33221   123469999999999999999999999999999999999999997643211110000             00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      .. .....+....+.++.+|+.+||+.||++|||     +.|++++
T Consensus       217 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         217 VK-EVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             hh-hhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence            00 0011122234567889999999999999999     8888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-42  Score=325.33  Aligned_cols=269  Identities=27%  Similarity=0.417  Sum_probs=208.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceec----------cccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVG----------LKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~----------~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      ++|++.+.||+|+||.||+|.+.......          .....|++|++..... .....+.+|++++++++||||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~   84 (296)
T cd05051           5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL   84 (296)
T ss_pred             hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence            57889999999999999999876543211          1234589999876543 345678899999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCC---------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEE
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKA---------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL  217 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NIL  217 (431)
                      ++++...+..++||||+.+++|.+++....         ...+++..++.++.|++.||.|||+.+  |+|+||||+||+
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~--i~H~dlkp~Nil  162 (296)
T cd05051          85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN--FVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC--ccccccchhcee
Confidence            999999999999999999999999986643         125789999999999999999999866  999999999999


Q ss_pred             ECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCccc
Q 014079          218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT--GRKSVDKTRPSKE  295 (431)
Q Consensus       218 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~  295 (431)
                      ++.++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            99999999999999986544333233334567889999999998899999999999999999998  6778865432111


Q ss_pred             chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         .....       ..............+...+.++.+++.+||+.||.+|||+.+|++.|+
T Consensus       243 ---~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         243 ---IENAG-------HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             ---HHHHH-------hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence               11000       000000001111112234468999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-43  Score=327.77  Aligned_cols=251  Identities=24%  Similarity=0.357  Sum_probs=213.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH--HHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      |..-|.+.+.||+|.|.+|-+|++.-++.      .||||++++....+.  ..+++|++.|+.++|||||++|.+...+
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGe------kVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ   89 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGE------KVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ   89 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccc------eeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc
Confidence            44567788899999999999987754444      499999998866544  4588999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a  232 (431)
                      ..+|||+|+-.+|+|+|+|.+... .+.+....+++.||+.|+.|+|+..  +|||||||+||++.+ -|-+||.|||++
T Consensus        90 TKlyLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLH--VVHRDLKPENVVFFEKlGlVKLTDFGFS  166 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLH--VVHRDLKPENVVFFEKLGLVKLTDFGFS  166 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhh--hhcccCCcceeEEeeecCceEeeecccc
Confidence            999999999999999999987654 4888999999999999999999988  999999999988755 589999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ..+..+.   ..++.||+..|-|||++.+..|+. ++||||||||||.|++|+.||....+.+                .
T Consensus       167 Nkf~PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE----------------T  227 (864)
T KOG4717|consen  167 NKFQPGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE----------------T  227 (864)
T ss_pred             ccCCCcc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh----------------h
Confidence            8765554   345689999999999999999975 7999999999999999999998764332                3


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +-.++|-..  ..+...+.++++||..||..||.+|.+.+||..+
T Consensus       228 LTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  228 LTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence            333444332  3567788999999999999999999999999854

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.7e-41  Score=330.05  Aligned_cols=261  Identities=21%  Similarity=0.290  Sum_probs=193.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..+|++.+.||+|+||.||+|.+.....      .||+|+.....      ...|+.++++++|+||+++++++.+....
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~valK~~~~~~------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  132 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPD------PVVLKIGQKGT------TLIEAMLLQNVNHPSVIRMKDTLVSGAIT  132 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCc------eEEEEeCCccc------cHHHHHHHHhCCCCCCcChhheEEeCCee
Confidence            3579999999999999999999876644      38999765432      34699999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|||++ .++|.+++.... .++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       133 ~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  208 (357)
T PHA03209        133 CMVLPHY-SSDLYTYLTKRS-RPLPIDQALIIEKQILEGLRYLHAQR--IIHRDVKTENIFINDVDQVCIGDLGAAQFPV  208 (357)
T ss_pred             EEEEEcc-CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEecCccccccc
Confidence            9999999 568888886543 36899999999999999999999866  9999999999999999999999999987532


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-------hhh----
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA-------RPK----  305 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-------~~~----  305 (431)
                      ...   ......||+.|+|||++.+..++.++|||||||++|||+++..++....+..........       ...    
T Consensus       209 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~  285 (357)
T PHA03209        209 VAP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH  285 (357)
T ss_pred             cCc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccC
Confidence            211   123456999999999999999999999999999999999965554332222111000000       000    


Q ss_pred             ---hh---ccchhhhhcCc--cccCc-------ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 ---LN---DKRKMLQIIDP--RLENQ-------YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ---~~---~~~~~~~~~~~--~~~~~-------~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         +.   .......+++.  .....       .....+.++.+||.+||+.||.+|||+.|++.|
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        286 PEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             hhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence               00   00000000000  00000       001224466779999999999999999999976

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=6.8e-42  Score=320.19  Aligned_cols=258  Identities=27%  Similarity=0.412  Sum_probs=198.4

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC----
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED----  153 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  153 (431)
                      |.+.+.||+|+||.||+|.+..+...    ..+|+|.++...  ......+.+|+.+++.++|+||+++++++...    
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~----~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   76 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSI----LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESE   76 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCe----eeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCccc
Confidence            35677899999999999998665321    248999886542  23456788999999999999999999987532    


Q ss_pred             --CeeEEEEEecCCCChHHhhhhC----CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 --DHRLLVYEFMFRGSLENHLFRK----ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 --~~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                        ...+++|||+.+++|.+++...    ....+++...+.++.|++.||.|||+.+  |+||||||+|||++.++.++|+
T Consensus        77 ~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~  154 (272)
T cd05075          77 GYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS--FIHRDLAARNCMLNENMNVCVA  154 (272)
T ss_pred             CCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhheEEcCCCCEEEC
Confidence              2468999999999999887432    2334789999999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++...............+++.|++||++.+..++.++|||||||++|||++ |+.||.......   ....    +
T Consensus       155 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~----~  227 (272)
T cd05075         155 DFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---IYDY----L  227 (272)
T ss_pred             CCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH----H
Confidence            9999987544332211222346778999999999999999999999999999999 888986533211   1110    0


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ....          ........+..+.+++.+||+.||++|||+.+|++.|+.+
T Consensus       228 ~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         228 RQGN----------RLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HcCC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0000          0011123446788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.9e-42  Score=318.19  Aligned_cols=254  Identities=28%  Similarity=0.443  Sum_probs=202.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+.++.       .+++|.+..... ....+.+|+.++++++|+||+++++++. ....
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-------~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~   75 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNT-------KVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPI   75 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCc-------eeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCc
Confidence            356889999999999999999876543       288998876433 3456889999999999999999999875 4568


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +++|||+.+++|.+++.......+++..++.++.+++.||.|||+.+  |+||||||+||+++.++.++|+|||++....
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~Nili~~~~~~~l~dfg~~~~~~  153 (260)
T cd05070          76 YIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN--YIHRDLRSANILVGDGLVCKIADFGLARLIE  153 (260)
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEEeCCceEEeCCceeeeecc
Confidence            99999999999999997755556899999999999999999999876  9999999999999999999999999997654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ...              .
T Consensus       154 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~--------------~  215 (260)
T cd05070         154 DNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLE--------------Q  215 (260)
T ss_pred             Ccccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHH--------------H
Confidence            32211 1112335668999999988899999999999999999999 889996543211   111              0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      +........+...+..+.+|+.+||..||.+|||+.++++.|++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            11111112223345678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-42  Score=319.40  Aligned_cols=255  Identities=28%  Similarity=0.457  Sum_probs=204.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..+.|++.++||+|+||.||+|...++.       .||+|.+..... ....+.+|+.++++++|+||+++++++. .+.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~-------~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   74 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHT-------KVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEP   74 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCc-------eEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCC
Confidence            3467899999999999999999876543       389998876543 3467889999999999999999999874 567


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .+++|||+.+++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~  152 (260)
T cd05067          75 IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN--YIHRDLRAANILVSETLCCKIADFGLARLI  152 (260)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHHhEEEcCCCCEEEccCcceeec
Confidence            899999999999999997766667899999999999999999999866  999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...... ......++..|+|||++.+..++.++||||||+++|||++ |+.||.........                 .
T Consensus       153 ~~~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~  214 (260)
T cd05067         153 EDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVI-----------------Q  214 (260)
T ss_pred             CCCCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHH-----------------H
Confidence            422211 1122346778999999998899999999999999999999 99999754321110                 0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      .+........+...+.++.+++.+||+.+|++||++.+++..|+.
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         215 NLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            011111111122334679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.9e-42  Score=331.34  Aligned_cols=243  Identities=27%  Similarity=0.405  Sum_probs=192.3

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||+|.+..++..      ||+|++++...   .....+..|..++..+ +||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv   74 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEY------FAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFV   74 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEE
Confidence            4699999999999998776543      99999876421   2334566788887754 899999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+.+++|.+++....  .+++.....++.|++.||+|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~E~~~~g~L~~~i~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          75 MEFLNGGDLMFHIQDKG--RFDLYRATFYAAEIVCGLQFLHSKG--IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             ECCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            99999999999986643  4788888899999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+              ....+ 
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~--------------~~~~~-  213 (316)
T cd05620         151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI--------------RVDTP-  213 (316)
T ss_pred             --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH--------------HhCCC-
Confidence              1233467999999999999999999999999999999999999999754321110000              00011 


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMS-DVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-eil~~  356 (431)
                         .++...+.++.+|+.+||+.||.+||++. ++++|
T Consensus       214 ---~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         214 ---HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             ---CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence               11122346788999999999999999985 66543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6e-42  Score=330.50  Aligned_cols=270  Identities=24%  Similarity=0.382  Sum_probs=209.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      ..+|++.+.||+|+||.||+|.+....+ ...+...||+|++.... .....++.+|+.+++++ +|+||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            3568999999999999999998654221 12233458999887543 23456788999999999 799999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +..+++|||+.+++|.+++....              ...+.+..++.++.|++.||.|||..+  |+||||||+|||++
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--ivH~dlkp~Nill~  168 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK--CIHRDLAARNVLVT  168 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEc
Confidence            99999999999999999987532              224778888999999999999999866  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.........  
T Consensus       169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~--  246 (334)
T cd05100         169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF--  246 (334)
T ss_pred             CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH--
Confidence            999999999999976543322211222334568999999999999999999999999999998 88888654321110  


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                                     ..+........+...+.++.+++.+||+.+|++||++.++++.|+.+.....
T Consensus       247 ---------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         247 ---------------KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             ---------------HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence                           0111111111222345688899999999999999999999999998875443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.2e-42  Score=331.74  Aligned_cols=238  Identities=29%  Similarity=0.390  Sum_probs=187.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHH-HHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVN-FLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++||+|+||.||+|.+..++..      ||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv   74 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSF------YAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFV   74 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEE
Confidence            3699999999999998776543      99999876432   22334555554 57889999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+.+....  .+.+.....++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          75 LDYVNGGELFFHLQRER--CFLEPRARFYAAEVASAIGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            99999999998886543  4778888889999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........   .             ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~-------------~~i~~~~  212 (321)
T cd05603         151 --ETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQM---Y-------------DNILHKP  212 (321)
T ss_pred             --CccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHH---H-------------HHHhcCC
Confidence              122346799999999999999999999999999999999999999976431110   0             0011111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMS  351 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~  351 (431)
                        ...+...+..+.+++.+||+.||.+||+..
T Consensus       213 --~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         213 --LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             --CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence              111223346788999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-42  Score=317.76  Aligned_cols=254  Identities=24%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ++|.+.+.||+|+||.||++.+..+..      +|++|.+.....     .....+.+|++++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   75 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGR------ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD   75 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCc------EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc
Confidence            468899999999999999998876544      489998765422     123467889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++|+||+++++|.+++....  .+++.....++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nilv~~~~~~~l~dfg~~  151 (263)
T cd06625          76 DETLSIFMEYMPGGSVKDQLKAYG--ALTETVTRKYTRQILEGVEYLHSNM--IVHRDIKGANILRDSAGNVKLGDFGAS  151 (263)
T ss_pred             CCeEEEEEEECCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccc
Confidence            999999999999999999987654  4788888999999999999999876  999999999999999999999999998


Q ss_pred             ccCCCCCCcce-eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          233 KAGPQGDETHV-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       233 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      +.......... .....|+..|+|||++.+..++.++||||||+++|||++|+.||........                
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~----------------  215 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA----------------  215 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH----------------
Confidence            76433221111 1234688899999999999999999999999999999999999965422111                


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .............+...+..+.+++.+||..+|.+|||+.+++.+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~  261 (263)
T cd06625         216 IFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHF  261 (263)
T ss_pred             HHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence            0011111111223334557888999999999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.7e-43  Score=320.79  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      .-.|...+++|.|+||.||+|...+...      .||||..-.+..    ---+|+.+|+.++|||||++..+|....  
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~------~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~   92 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEE------EVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTES   92 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCc------eeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCC
Confidence            3457778899999999999999987744      499997755422    1136999999999999999999887532  


Q ss_pred             ---eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEec
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSD  228 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~D  228 (431)
                         ...+||||| ..+|.+.++..  .+..++...+..+.+||++||.|||+.+  |+||||||.|+|+|.+ |.+||||
T Consensus        93 d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~--IcHRDIKPqNlLvD~~tg~LKicD  169 (364)
T KOG0658|consen   93 DEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG--ICHRDIKPQNLLVDPDTGVLKICD  169 (364)
T ss_pred             chhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC--cccCCCChheEEEcCCCCeEEecc
Confidence               345999999 67899888642  2345777778889999999999999977  9999999999999987 9999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PK  305 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~  305 (431)
                      ||.|+.+..+...   .....|..|+|||++.+ ..|+.+.||||.||++.||+-|++-|.+.........+....  |.
T Consensus       170 FGSAK~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt  246 (364)
T KOG0658|consen  170 FGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT  246 (364)
T ss_pred             CCcceeeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence            9999987655433   34568889999999886 579999999999999999999999998865544332221111  00


Q ss_pred             hhc------c---chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LND------K---RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~------~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..+      .   ....++....+..-+....+.++.+|+.++|..+|.+|.++.|++.+
T Consensus       247 ~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  247 REDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            000      0   00111111111111334456889999999999999999999999864

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-43  Score=334.17  Aligned_cols=259  Identities=24%  Similarity=0.405  Sum_probs=221.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ......++||.|.||.||.|+|+...-      .||||.++.+. ...++|+.|+.+|+.++|||+|+|+|+|..+-.+|
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkysl------TvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY  339 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY  339 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccce------eeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence            345567789999999999999986533      39999997765 45789999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ||.|||..|+|.++|.+.+..-++....+.++.||..||+||...+  +|||||..+|+|+.++..+||+|||+++++..
T Consensus       340 IiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn--FIHRDLAARNCLVgEnhiVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  340 IITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHIVKVADFGLSRLMTG  417 (1157)
T ss_pred             EEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh--hhhhhhhhhhccccccceEEeeccchhhhhcC
Confidence            9999999999999999887777888888999999999999999755  99999999999999999999999999998754


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ...+ .........-|.|||.+..+.++.|+|||+|||+|||+.| |-.||.+.+                 ...+..++
T Consensus       418 DTYT-AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid-----------------lSqVY~LL  479 (1157)
T KOG4278|consen  418 DTYT-AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID-----------------LSQVYGLL  479 (1157)
T ss_pred             Ccee-cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc-----------------HHHHHHHH
Confidence            4332 2233345667999999999999999999999999999999 888887643                 12233445


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ...++.+-+..|+..+++|++.||+++|.+||++.||-+.++.+...
T Consensus       480 EkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  480 EKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             hccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            55666667778899999999999999999999999999999876544

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-42  Score=329.92  Aligned_cols=242  Identities=27%  Similarity=0.427  Sum_probs=192.0

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhc-CCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQ-LRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+..+...      ||+|+++....   .....+..|..++.. ++||||+++++++.+.+.+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   74 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFV   74 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEE
Confidence            3699999999999998776543      99999876421   223456678888875 4899999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++|+|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~ey~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~LH~~~--ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          75 MEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKG--IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            99999999999986643  4788888899999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+              ....+.
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i--------------~~~~~~  214 (316)
T cd05619         151 A--KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI--------------RMDNPC  214 (316)
T ss_pred             C--ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHH--------------HhCCCC
Confidence            1  223457999999999999999999999999999999999999999764321110000              000111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMS-DVVE  355 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-eil~  355 (431)
                          ++...+.++.+++.+||+.||.+||++. +++.
T Consensus       215 ----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 ----YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             ----CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence                1122446788999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.5e-42  Score=320.64  Aligned_cols=263  Identities=24%  Similarity=0.379  Sum_probs=204.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||+||+|.+...+..  ....||+|++..... .....+.+|+.++..++|+||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~--~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGEN--VKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCc--cceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            5678889999999999999987654332  122489999875433 334678899999999999999999999875 457


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            89999999999999986643 35788999999999999999999866  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............+++.|+|||.+.+..++.++|||||||++|||++ |..||.........                 ..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~-----------------~~  223 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP-----------------DL  223 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH-----------------HH
Confidence            3322211222335678999999999999999999999999999998 89998654321110                 01


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +........+...+..+.+++.+||+.||++||++.++++.|..+...
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         224 LEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             HHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            101001111223456788999999999999999999999998877544

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.1e-42  Score=321.44  Aligned_cols=275  Identities=31%  Similarity=0.442  Sum_probs=204.8

Q ss_pred             cCC-CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           78 KSF-RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        78 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      ++| +..+.||+|+||+||++......  ...+..||+|+++.... .....+.+|+++|+.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~--~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPAN--DGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEcccc--CCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            344 88899999999999987653211  11223599999876532 2346688999999999999999999988653  


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ...++||||+.+++|.+++...   .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~  155 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK  155 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC--eeccccChheEEEcCCCcEEEeeccccc
Confidence            4578999999999999998653   4899999999999999999999866  9999999999999999999999999998


Q ss_pred             cCCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......... ......++..|+|||++.+..++.++||||||+++|||++|..||........ .......... ....+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~-~~~~~  233 (283)
T cd05080         156 AVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQM-TVVRL  233 (283)
T ss_pred             ccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhccccccc-chhhh
Confidence            654332211 11223456779999999988999999999999999999999999865432111 1111110000 00111


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      .+.++.......+...+..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            1112222211223344578999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.3e-42  Score=331.08  Aligned_cols=243  Identities=29%  Similarity=0.440  Sum_probs=195.0

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+..+..      .||+|++.+...   .....+..|..++..+ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv   74 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDE------LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFV   74 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCC------EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEE
Confidence            369999999999999876544      399999876432   2344567888998887 699999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++.+..  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  150 (318)
T cd05570          75 MEYVNGGDLMFHIQRSG--RFDEPRARFYAAEIVLGLQFLHERG--IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG  150 (318)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEccCCCHHHeEECCCCcEEecccCCCeecCcCC
Confidence            99999999999887654  5889999999999999999999866  9999999999999999999999999987532211


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||........   ..             .+....
T Consensus       151 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~---~~-------------~i~~~~  212 (318)
T cd05570         151 V--TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDEL---FQ-------------SILEDE  212 (318)
T ss_pred             C--cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHH---HH-------------HHHcCC
Confidence            1  12235699999999999999999999999999999999999999975432110   00             011000


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      .  .++...+..+.+|+.+||+.||.+||++     .+++.+
T Consensus       213 ~--~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         213 V--RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             C--CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            0  1122345678999999999999999999     777755

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-42  Score=336.51  Aligned_cols=268  Identities=21%  Similarity=0.219  Sum_probs=201.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+..+|.+.+.||+|+||.||++...+..    ....|++|.+....     ...+|+++|++++||||+++++++....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~----~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~  159 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDE----QRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKS  159 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCc----cceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence            34567999999999999999999765422    12348999876542     3457999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++|||++ +++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.++|+|||+++.
T Consensus       160 ~~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~g--ivHrDlkp~Nill~~~~~~~l~DfG~a~~  234 (392)
T PHA03207        160 TVCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRG--IIHRDVKTENIFLDEPENAVLGDFGAACK  234 (392)
T ss_pred             EEEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEccCccccc
Confidence            999999999 57888888433  45889999999999999999999866  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh-------
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN-------  307 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------  307 (431)
                      ..............||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+......+.       
T Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~  314 (392)
T PHA03207        235 LDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP  314 (392)
T ss_pred             cCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence            5443333223346799999999999999999999999999999999999999976544321111110000000       


Q ss_pred             c--cchhhh---hcCccccCcc-------cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 D--KRKMLQ---IIDPRLENQY-------SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~--~~~~~~---~~~~~~~~~~-------~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .  ...+..   .........+       ....+.++.++|.+||..||++||++.|++.+
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0  000000   0000000000       01224578899999999999999999999976

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-42  Score=325.35  Aligned_cols=269  Identities=25%  Similarity=0.427  Sum_probs=203.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCcee--------ccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeec
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRV--------GLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~--------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      ++|++.+.||+|+||.||++.+.+....        ......||+|.+..... .....+.+|++++++++|+||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5789999999999999999987543211        11223489999876532 23456889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCC----------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKA----------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL  218 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl  218 (431)
                      ++...+..++||||+.+++|.+++....          ...+++..++.++.|++.||.|||+.+  ++|+||||+|||+
T Consensus        85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~--i~H~dlkp~Nill  162 (295)
T cd05097          85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN--FVHRDLATRNCLV  162 (295)
T ss_pred             EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC--eeccccChhhEEE
Confidence            9999999999999999999999986432          123678888999999999999999866  9999999999999


Q ss_pred             CCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCcccc
Q 014079          219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT--GRKSVDKTRPSKEQ  296 (431)
Q Consensus       219 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~~  296 (431)
                      +.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  |..||........ 
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~-  241 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV-  241 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHH-
Confidence            9999999999999976543322222223456778999999999999999999999999999998  6677765432111 


Q ss_pred             hhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                        .....       ..............+...+..+.+|+.+||+.||++||++.+|++.|.
T Consensus       242 --~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         242 --IENTG-------EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             --HHHHH-------HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence              00000       000000000000111123468999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.1e-42  Score=344.79  Aligned_cols=264  Identities=22%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC---
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED---  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  153 (431)
                      ..+|++.++||+|+||.||+|.+..+..      .||+|.+....    ....+|+.+|+.++|||||++++++...   
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~------~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~  134 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSE------KVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFK  134 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCC------EEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccc
Confidence            4579999999999999999999876544      39999875542    2234799999999999999999887532   


Q ss_pred             -----CeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEE
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAK  225 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~k  225 (431)
                           ..+++||||++ ++|.+++..  .....+++..+..++.|++.||.|||+.+  |+||||||+||||+.++ .+|
T Consensus       135 ~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~--IiHrDLKp~NILl~~~~~~vk  211 (440)
T PTZ00036        135 KNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF--ICHRDLKPQNLLIDPNTHTLK  211 (440)
T ss_pred             cCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCcCHHHEEEcCCCCcee
Confidence                 24679999995 577776643  23446889999999999999999999866  99999999999998664 799


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--  302 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--  302 (431)
                      |+|||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.........+...  
T Consensus       212 L~DFGla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~  288 (440)
T PTZ00036        212 LCDFGSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG  288 (440)
T ss_pred             eeccccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999986543222   2235689999999988764 6999999999999999999999999765432221111000  


Q ss_pred             hhhhhccch----hh-----hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLNDKRK----ML-----QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~~~~~----~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+.......    ..     ......+...++...+.++.+||.+||+.||.+|||+.|++.+
T Consensus       289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            000000000    00     0000111111222345789999999999999999999999966

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.7e-43  Score=306.88  Aligned_cols=255  Identities=25%  Similarity=0.339  Sum_probs=207.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----h----hHHHHHHHHHHHhcCC-CCceee
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----Q----GHREWLTEVNFLGQLR-HPNLVK  145 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~----~~~~~~~E~~~l~~l~-h~niv~  145 (431)
                      .+-+.|...++||.|..++|-++..+.+...      +|+|++.....    +    -.+.-.+|+.||+++. ||+|++
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e------~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~   87 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKE------FAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIID   87 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccc------eeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEE
Confidence            3445677888999999999999988776553      88888764321    1    1234568999999995 999999


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      +.|+|+.+...++|+|.|+.|.|.|+|...-  .+++.....|+.|++.|+.|||..+  ||||||||+|||++++.++|
T Consensus        88 l~D~yes~sF~FlVFdl~prGELFDyLts~V--tlSEK~tR~iMrqlfegVeylHa~~--IVHRDLKpENILlddn~~i~  163 (411)
T KOG0599|consen   88 LQDVYESDAFVFLVFDLMPRGELFDYLTSKV--TLSEKETRRIMRQLFEGVEYLHARN--IVHRDLKPENILLDDNMNIK  163 (411)
T ss_pred             eeeeccCcchhhhhhhhcccchHHHHhhhhe--eecHHHHHHHHHHHHHHHHHHHHhh--hhhcccChhheeeccccceE
Confidence            9999999999999999999999999997654  5888899999999999999999866  99999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      |+|||++..+..+..   ....||||+|+|||.+..      ..|+..+|+|++|||||.|+.|.+||........    
T Consensus       164 isDFGFa~~l~~Gek---LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlM----  236 (411)
T KOG0599|consen  164 ISDFGFACQLEPGEK---LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLM----  236 (411)
T ss_pred             EeccceeeccCCchh---HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHH----
Confidence            999999998766543   346899999999998864      3578889999999999999999999964321111    


Q ss_pred             hhhhhhhhccchhhhhcCc--cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          300 DWARPKLNDKRKMLQIIDP--RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                  +.-++..  .+..+...+.+....+||.+||+.||.+|.|++|++.|--
T Consensus       237 ------------LR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpf  285 (411)
T KOG0599|consen  237 ------------LRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPF  285 (411)
T ss_pred             ------------HHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence                        1111221  2233445677889999999999999999999999998744

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=9.1e-42  Score=316.36  Aligned_cols=251  Identities=22%  Similarity=0.288  Sum_probs=203.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|++.+.||.|+||.||++.+..+..      .+++|.++... ....+.+.+|+.+++.++|+||+++++.+.+.+.++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQ------KYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLY   74 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCc------eEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEE
Confidence            47788999999999999999876544      38999886432 234566788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.......++....+.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  152 (255)
T cd08219          75 IVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR--VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS  152 (255)
T ss_pred             EEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence            9999999999999987655556889999999999999999999866  99999999999999999999999999876533


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...  ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.........                ..+..
T Consensus       153 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~----------------~~~~~  214 (255)
T cd08219         153 PGA--YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLI----------------LKVCQ  214 (255)
T ss_pred             ccc--ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHH----------------HHHhc
Confidence            221  223356899999999999889999999999999999999999999754321110                00000


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      . .....+...+..+.+|+.+||+.||++||++.+|+..
T Consensus       215 ~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 G-SYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             C-CCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            0 0111222345678899999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=8.3e-42  Score=318.84  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+..+...      |++|++..........+.+|+.++++++||||+++++++...+..+
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~------~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGEL------AAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeE------EEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            5689999999999999999998766543      9999987654444566788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++....  ++++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++.....
T Consensus        83 iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTG--PLSELQIAYVCRETLQGLAYLHSKG--KMHRDIKGANILLTDNGDVKLADFGVAAKITA  158 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCCEEECcCccceeecc
Confidence            9999999999999986543  5788899999999999999999866  99999999999999999999999999976532


Q ss_pred             CCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...  ......|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+.......       .. .   .
T Consensus       159 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-------~~-~---~  225 (267)
T cd06646         159 TIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-------SK-S---N  225 (267)
T ss_pred             ccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-------ec-C---C
Confidence            211  112346889999999874   445788999999999999999999998654322111000       00 0   0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...+.+.  .....+..+.+|+.+||+.||++||++.+|+++|
T Consensus       226 ~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         226 FQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000000  1122356888999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=346.79  Aligned_cols=263  Identities=25%  Similarity=0.468  Sum_probs=224.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ....+.++||.|.||.||+|+++...+   +.+.||||.++.... +...+|+.|+.||.+++||||++|.|+.......
T Consensus       629 s~i~Ie~VIGaGEFGEVc~GrLk~pgk---re~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~Pv  705 (996)
T KOG0196|consen  629 SCVKIEKVIGAGEFGEVCSGRLKLPGK---REITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPV  705 (996)
T ss_pred             hheEEEEEEecccccceecccccCCCC---cceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCcee
Confidence            345678899999999999999876543   345699999987643 4457899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      .||.|||++|+|+.+|..+.+. +.+.+..-++++|+.||.||.+.+  .|||||..+|||++.+...|++|||+++.+.
T Consensus       706 MIiTEyMENGsLDsFLR~~DGq-ftviQLVgMLrGIAsGMkYLsdm~--YVHRDLAARNILVNsnLvCKVsDFGLSRvle  782 (996)
T KOG0196|consen  706 MIITEYMENGSLDSFLRQNDGQ-FTVIQLVGMLRGIASGMKYLSDMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  782 (996)
T ss_pred             EEEhhhhhCCcHHHHHhhcCCc-eEeehHHHHHHHHHHHhHHHhhcC--chhhhhhhhheeeccceEEEeccccceeecc
Confidence            9999999999999999887754 899999999999999999999988  9999999999999999999999999999775


Q ss_pred             CCCCcceeecccC--CccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          237 QGDETHVSTRVMG--TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       237 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      +.... ..++.-|  ..+|.|||.+...+++.++||||||++|||.++ |..||.++..                 .++.
T Consensus       783 dd~~~-~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-----------------QdVI  844 (996)
T KOG0196|consen  783 DDPEA-AYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-----------------QDVI  844 (996)
T ss_pred             cCCCc-cccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-----------------HHHH
Confidence            54422 2222223  468999999999999999999999999999998 9999987643                 2333


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      +-++..++-..+.+++..+.+|+..||++|-.+||.+.+|+.+|+++....
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP  895 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNP  895 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCc
Confidence            444455555667789999999999999999999999999999999877553

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=7.6e-42  Score=330.89  Aligned_cols=267  Identities=27%  Similarity=0.397  Sum_probs=202.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC-C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED-D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  154 (431)
                      ++|++.+.||+|+||.||+|.+..... ...+..||||+++.... .....+.+|+.+|.++ +|+||+++++++... .
T Consensus         7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           7 DRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hHhcccccccCCccceEEEEeeccCCc-cccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            579999999999999999998643211 11233599999876432 2345688999999999 689999999988654 4


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC---------------------------------------------------------
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT---------------------------------------------------------  177 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  177 (431)
                      ..++||||+++|+|.+++.....                                                         
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            67899999999999999864321                                                         


Q ss_pred             --------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccC
Q 014079          178 --------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG  249 (431)
Q Consensus       178 --------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g  249 (431)
                              ..+++.....++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++................+
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  243 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL  243 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence                    23677788899999999999999866  99999999999999999999999999876433222111222345


Q ss_pred             CccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHH
Q 014079          250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRA  328 (431)
Q Consensus       250 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (431)
                      +..|+|||++.+..++.++||||||+++|+|++ |..||........  ..              ..+........+...
T Consensus       244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~--------------~~~~~~~~~~~~~~~  307 (343)
T cd05103         244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FC--------------RRLKEGTRMRAPDYT  307 (343)
T ss_pred             CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HH--------------HHHhccCCCCCCCCC
Confidence            678999999999999999999999999999997 9999865422110  00              000000001111123


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          329 AQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       329 ~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +.++.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            45788999999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.1e-41  Score=321.74  Aligned_cols=265  Identities=25%  Similarity=0.415  Sum_probs=204.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..++|++.+.||+|+||.||+|..++... ......||+|.+..... .....+.+|+.+++.++|+||+++++++.+.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCC-CCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35789999999999999999998653211 11233599998865532 33456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ..++||||+.+|+|.+++....        .....+..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dikp~nili~~~~~~~L  160 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK--FVHRDLAARNCMVAHDFTVKI  160 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCCChheEEEcCCCcEEE
Confidence            9999999999999999996532        123466778889999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......   ...     
T Consensus       161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~---~~~-----  232 (288)
T cd05061         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ---VLK-----  232 (288)
T ss_pred             CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-----
Confidence            99999986543322222222345778999999999999999999999999999998 788886543211   100     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                              .+.+... ...+...+..+.+++.+||+.||.+|||+.++++.|...
T Consensus       233 --------~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         233 --------FVMDGGY-LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             --------HHHcCCC-CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence                    0011100 011223346889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.3e-41  Score=325.32  Aligned_cols=267  Identities=24%  Similarity=0.394  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .+|.+.+.||+|+||.||++....... .......+|+|+++.... ....++.+|+.+++++ +||||+++++++.+.+
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~   91 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG   91 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence            568889999999999999998643211 111223489998875432 3345688999999999 5999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      ..++||||+.+++|.+++....              ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.
T Consensus        92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g--i~H~dlkp~Nill~~  169 (314)
T cd05099          92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR--CIHRDLAARNVLVTE  169 (314)
T ss_pred             ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeeccccceeEEEcC
Confidence            9999999999999999996532              134788889999999999999999866  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  299 (431)
                      ++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..........  
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~--  247 (314)
T cd05099         170 DNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK--  247 (314)
T ss_pred             CCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH--
Confidence            99999999999986543222111122234567999999999999999999999999999999 889986543211110  


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                     .+........+..++.++.+++.+||+.||++||++.++++.|..+...
T Consensus       248 ---------------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~  296 (314)
T cd05099         248 ---------------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAA  296 (314)
T ss_pred             ---------------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHH
Confidence                           0000111111223456788999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-41  Score=315.08  Aligned_cols=250  Identities=28%  Similarity=0.492  Sum_probs=205.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.+.||.|+||.||+|...+.        .|++|.+..... ...++.+|+.+++.++|+||+++++++.+.+..+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~--------~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQ--------KVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCc--------EEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            4688889999999999999987532        389999877643 4567899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||+++....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~  154 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN--FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccchhcccceEEEeCCCCEEEccccccccccc
Confidence            9999999999999997766556899999999999999999999866  99999999999999999999999999987532


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ...     ...++..|+|||++.++.++.++||||||+++|||++ |..||.......                 +...+
T Consensus       155 ~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-----------------~~~~~  212 (256)
T cd05039         155 GQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-----------------VVPHV  212 (256)
T ss_pred             ccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----------------HHHHH
Confidence            211     2335667999999998899999999999999999997 999986542111                 00111


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ........+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             hcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence            11111112223457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1.2e-41  Score=320.00  Aligned_cols=265  Identities=23%  Similarity=0.362  Sum_probs=207.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEe-CC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-DD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~  154 (431)
                      .++|++.++||+|+||.||+|.+.....  .....|++|++.... ......+.+|+.+++.++|+||+++++++.. ..
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~--~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKP--GKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCC--CceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4678899999999999999999876210  012248899886542 2345668899999999999999999998776 56


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ..++++||+.+++|.+++.....      ..+++..++.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG--VIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCHhhEEEcCCCcEEECC
Confidence            78999999999999999865422      45889999999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ||+++.+.............++..|+|||++.+..++.++|||||||++||+++ |+.||....+..   ...+      
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~------  231 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAY------  231 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHH------
Confidence            999986544332222223456778999999998899999999999999999999 999997643221   1110      


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                              +...........++..+.+++.+||..||++|||+.++++.|+.+..
T Consensus       232 --------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         232 --------LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             --------HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence                    00011111122345678999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-43  Score=331.15  Aligned_cols=252  Identities=23%  Similarity=0.356  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  154 (431)
                      ..|++++.||+||.+.||++...+...       ||+|.+...  .......+.+|+..|.+|+ |.+||+|+||-..++
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~~i-------yalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDKQI-------YALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCCcc-------hhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            468899999999999999998776544       555544332  2244567899999999996 999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+||||||= ..+|..+|.........| .+..+..|++.++.++|.++  |||.||||.|+|+- .|.+||+|||+|..
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~g--IVHSDLKPANFLlV-kG~LKLIDFGIA~a  508 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQHG--IVHSDLKPANFLLV-KGRLKLIDFGIANA  508 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHhc--eeecCCCcccEEEE-eeeEEeeeechhcc
Confidence            999999975 779999998877766556 77788999999999999988  99999999999985 56999999999998


Q ss_pred             CCCCCCcceeecccCCccccCccccccCC-----------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGH-----------LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      +......-.....+||+.||+||.+....           .+.++||||||||||+|+.|+.||....            
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~------------  576 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII------------  576 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH------------
Confidence            87766666666789999999999886432           5678999999999999999999997531            


Q ss_pred             hhhhccchhhhhcCccccCcccHHHH-HHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAA-QKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         +....+..+.++....+++.--. .++.++++.||.+||.+||+..|+|++
T Consensus       577 ---n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  577 ---NQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             ---HHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence               23345666777766555543222 349999999999999999999999976

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.2e-41  Score=320.78  Aligned_cols=277  Identities=26%  Similarity=0.353  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe--CCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--DDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~  155 (431)
                      +.|++.+.||+|+||.||++....-..  ..+..|++|.+..........+.+|++++++++||||+++++++..  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQD--NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcC--CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence            468888999999999999997532100  1123499999877655556778899999999999999999998754  346


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKR--YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            899999999999999996543 35789999999999999999999866  999999999999999999999999999876


Q ss_pred             CCCCCccee-ecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVS-TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......... ....++..|+|||++.+..++.++|||||||++|||++|..++......... ..............+.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  237 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMR-MMGNDKQGQMIVYHLIE  237 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhh-hcccccccccchHHHHH
Confidence            443322111 1123445699999999889999999999999999999988776432211000 00000000000001111


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      .+............+.++.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         238 LLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            1111111112233456899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1e-41  Score=323.45  Aligned_cols=261  Identities=23%  Similarity=0.389  Sum_probs=203.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.++||+|+||.||+|.+..+..    ...+++|.++.. .......+.+|+.++.++ +||||+++++++.+.+.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~   77 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGL----KMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGY   77 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCC----cceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCc
Confidence            468889999999999999998865432    112688877643 223446788999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nill~~~  155 (297)
T cd05089          78 LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ--FIHRDLAARNVLVGEN  155 (297)
T ss_pred             ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCcCCcceEEECCC
Confidence            999999999999999996532              124788899999999999999999866  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||++........   ......+..|+|||++.+..++.++|||||||++|||++ |..||........     
T Consensus       156 ~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~-----  227 (297)
T cd05089         156 LASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAEL-----  227 (297)
T ss_pred             CeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-----
Confidence            9999999999864221111   111223557999999998899999999999999999997 9999976432110     


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                  ...+........+..++..+.+|+.+||+.||.+||++.++++.|+.+....
T Consensus       228 ------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         228 ------------YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                        0001111111122234578899999999999999999999999998877554

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.5e-41  Score=319.47  Aligned_cols=253  Identities=26%  Similarity=0.364  Sum_probs=198.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|++.+.||+|+||.||+|.+..+..      .||+|++.... ......+.+|++++++++||||+++++++...+..+
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   75 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRR------ILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRIS   75 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCc------EEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEE
Confidence            57788899999999999999876554      39999886552 233456889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|..+.      .+++.....++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++.....
T Consensus        76 lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~  147 (279)
T cd06619          76 ICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLK--ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence            999999999997643      3677888899999999999999866  99999999999999999999999999876433


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ..    .....||..|+|||++.+..++.++|||||||++|+|++|+.||............         ......+.+
T Consensus       148 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~---------~~~~~~~~~  214 (279)
T cd06619         148 SI----AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMP---------LQLLQCIVD  214 (279)
T ss_pred             cc----ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccch---------HHHHHHHhc
Confidence            21    22357899999999999999999999999999999999999999754322111000         000000011


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...........+.++.+++.+||+.||++||++.+++++..
T Consensus       215 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~  255 (279)
T cd06619         215 EDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPF  255 (279)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcc
Confidence            10000011123467889999999999999999999997743

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.9e-42  Score=331.16  Aligned_cols=238  Identities=29%  Similarity=0.393  Sum_probs=188.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHH-HHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVN-FLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||+||+|.+..++..      ||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv   74 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKF------YAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFV   74 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEE
Confidence            3699999999999998766543      99999876432   22334555555 46789999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++.....++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~g--ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          75 LDYVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSLN--IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             EcCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            99999999999987644  5788888899999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~----------------~~i~~~~  212 (323)
T cd05575         151 --KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMY----------------DNILNKP  212 (323)
T ss_pred             --CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHH----------------HHHHcCC
Confidence              1223457999999999999999999999999999999999999999764321100                0011111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMS  351 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~  351 (431)
                      .  ......+..+.+++.+||+.||.+||++.
T Consensus       213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 L--RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             C--CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence            0  11122356788999999999999999885

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.8e-41  Score=323.51  Aligned_cols=267  Identities=24%  Similarity=0.317  Sum_probs=203.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||++.+..++..      +++|.+..... ....++.+|++++++++||||+++++++.+++.+
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   74 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLI------MARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEI   74 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeE------EEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEE
Confidence            3688999999999999999998776543      88898865422 2345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++||||+++++|.+++...  ..+++.....++.|++.||.|||+ .+  ++|+||||+|||++.++.++|+|||++...
T Consensus        75 ~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (308)
T cd06615          75 SICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL  150 (308)
T ss_pred             EEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCC--EEECCCChHHEEEecCCcEEEccCCCcccc
Confidence            9999999999999999765  357888899999999999999997 35  999999999999999999999999998754


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc------
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK------  309 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~------  309 (431)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||......................      
T Consensus       151 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (308)
T cd06615         151 IDSM----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPV  226 (308)
T ss_pred             cccc----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccc
Confidence            3221    233578999999999988889999999999999999999999996543221111111000000000      


Q ss_pred             ----------c---hhh-hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 ----------R---KML-QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ----------~---~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                .   .+. ...............+.++.+|+.+||..||++|||+.+|+.+..
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                      0   000 000000000001124567899999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=6.7e-42  Score=329.08  Aligned_cols=250  Identities=27%  Similarity=0.378  Sum_probs=195.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+..+...      ||+|++.+...   .....+.+|+.++.++ +||||+++++++.+.+.+|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   74 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQI------YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLV   74 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEE
Confidence            3699999999999998776554      99999986532   2334577899999888 599999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  150 (327)
T cd05617          75 IEYVNGGDLMFHMQRQR--KLPEEHARFYAAEICIALNFLHERG--IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG  150 (327)
T ss_pred             EeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEeCCCCEEEeccccceeccCCC
Confidence            99999999999886543  5889999999999999999999866  9999999999999999999999999987532211


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.............+...         .+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~---------~~~~~~  219 (327)
T cd05617         151 --DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQ---------VILEKP  219 (327)
T ss_pred             --CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHH---------HHHhCC
Confidence              122346799999999999999999999999999999999999999965432221111111000         001111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLM------SDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~eil~~  356 (431)
                        ...+...+..+.+++.+||+.||.+|+++      .+++.|
T Consensus       220 --~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         220 --IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             --CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence              11222344678899999999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=9.1e-42  Score=321.89  Aligned_cols=253  Identities=28%  Similarity=0.432  Sum_probs=202.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|+..+.||+|+||+||++.+..+.+.      ||+|.+......   ....+.+|+++|+.++|+||+.+++.+..++.
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~   74 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKM------YACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDA   74 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcE------EEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCE
Confidence            367788999999999999998766544      999988765332   23456789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+++|.+++......++++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--iiH~dikp~Nili~~~~~~kl~Dfg~~~~~  152 (285)
T cd05632          75 LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN--TVYRDLKPENILLDDYGHIRISDLGLAVKI  152 (285)
T ss_pred             EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEECCCCCEEEecCCcceec
Confidence            999999999999999887665557899999999999999999999866  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....   ......|+..|+|||++.+..++.++|||||||++|+|++|..||...........+..            ..
T Consensus       153 ~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~------------~~  217 (285)
T cd05632         153 PEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR------------RV  217 (285)
T ss_pred             CCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH------------hh
Confidence            3221   12235689999999999999999999999999999999999999976432111111000            00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      ...  ...+....+..+.+|+..||+.||++||+     +.+++.+
T Consensus       218 ~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         218 LET--EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             hcc--ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            000  01122234567889999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.6e-41  Score=316.89  Aligned_cols=260  Identities=23%  Similarity=0.343  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+|++.+.||.|+||.||++.+..++.      .+++|.+....   .....++.+|+.+++.++|+||+++++++.+.+
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   75 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGV------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN   75 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCc------eEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC
Confidence            357888899999999999999865544      38999776532   233457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..+++|||+++++|.+++...  ....+++...+.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++
T Consensus        76 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~dfg~~  153 (267)
T cd08229          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEECcchhh
Confidence            999999999999999988642  2345789999999999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........  ......|+..|+|||++.+..++.++||||||+++|+|++|..||........ ...          ..+
T Consensus       154 ~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~----------~~~  220 (267)
T cd08229         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLC----------KKI  220 (267)
T ss_pred             hccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHH-HHh----------hhh
Confidence            76533221  12235689999999999998999999999999999999999999965322100 000          000


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      .....+   .......+..+.+++.+||+.||.+|||+.+|++.+.++.
T Consensus       221 ~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 EQCDYP---PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             hcCCCC---CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            010001   1112235678999999999999999999999999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-41  Score=314.57  Aligned_cols=253  Identities=28%  Similarity=0.440  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+..+..       +++|.+.... .....+.+|+++++.++|+|++++++++. .+..+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~-------~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTK-------VAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCce-------EEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            568888999999999999998766532       8889876543 23456889999999999999999999875 46689


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++.....
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~  154 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN--YIHRDLRAANILVGDNLVCKIADFGLARLIED  154 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence            9999999999999997765556889999999999999999999866  99999999999999999999999999976533


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||........   ..+              +
T Consensus       155 ~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~~~--------------~  216 (260)
T cd05069         155 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREV---LEQ--------------V  216 (260)
T ss_pred             Cccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHH--------------H
Confidence            2211 1122346778999999988899999999999999999999 8999976432111   000              0


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      ........+...+..+.+++.+||++||.+||++.+|++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            0011111222345788999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.2e-41  Score=316.12  Aligned_cols=260  Identities=25%  Similarity=0.444  Sum_probs=204.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|...+.||+|+||.||+|.+.....   ....+++|.++... ......+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGR---KEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA   81 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence            467788899999999999999864322   11248999887653 23456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++.....++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          82 MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMN--YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999999986643 35788999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCccee-ecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDETHVS-TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||.......   ..              .
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~--------------~  221 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VM--------------K  221 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HH--------------H
Confidence            32221111 11223557999999998899999999999999999997 999996543211   00              0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      .+............+..+.+++.+||..+|.+||++.+|++.|+++
T Consensus       222 ~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         222 AINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0100111111223457789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=315.48  Aligned_cols=255  Identities=28%  Similarity=0.460  Sum_probs=205.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+.++.       .+++|.+..... ...++.+|+.++++++|+||+++++++......
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~-------~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   76 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTT-------KVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPI   76 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCc-------eEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCce
Confidence            467899999999999999999876542       389998876543 356788999999999999999999999998999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.......+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        77 ~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~  154 (261)
T cd05034          77 YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN--YIHRDLAARNILVGENLVCKIADFGLARLIE  154 (261)
T ss_pred             EEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcchheEEEcCCCCEEECccccceecc
Confidence            99999999999999997766556899999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......   ....              
T Consensus       155 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~--------------  216 (261)
T cd05034         155 DDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE---VLEQ--------------  216 (261)
T ss_pred             chhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHH--------------
Confidence            32111 1112235668999999998899999999999999999998 999996543211   1110              


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      +........+...+.++.+++.+||+.||.+||++.++++.|+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         217 VERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            00001111112235678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.8e-41  Score=314.60  Aligned_cols=249  Identities=27%  Similarity=0.433  Sum_probs=199.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEE-eCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC-EDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~  156 (431)
                      ++|.+.+.||+|+||.||++...+.        .+++|.+....  ....+.+|+.++++++|+|++++++++. +.+..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~--------~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYRGN--------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEcCC--------cEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            4688889999999999999976532        38999886543  3457889999999999999999999764 45678


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.......+++...+.++.|++.||+|||+.+  ++||||||+||+++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~  153 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  153 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeccccchheEEEcCCCcEEecCCccceecc
Confidence            99999999999999997766556889999999999999999999866  9999999999999999999999999987543


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ...     ....++..|+|||++.+..++.++|||||||++|||++ |+.||.......   ..              ..
T Consensus       154 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~--------------~~  211 (256)
T cd05082         154 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VV--------------PR  211 (256)
T ss_pred             ccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HH--------------HH
Confidence            221     12335668999999998899999999999999999997 999986532111   00              00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +............+..+.+++.+||+.||++|||+.++++.|+.+
T Consensus       212 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         212 VEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            101111112233457888999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-41  Score=337.95  Aligned_cols=264  Identities=22%  Similarity=0.268  Sum_probs=197.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ...|.+.+.||+|+||.||+|.+.....      .||+|....      ..+.+|+++|++++|+|||++++++...+..
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~------~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~  235 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQ------RVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLT  235 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCC------EEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEE
Confidence            3479999999999999999999877544      389985432      2356899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|||++ .++|.+++.... ..+++..++.++.|++.||.|||+.+  ||||||||+||||+.++.+||+|||+++...
T Consensus       236 ~lv~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDLKP~NILl~~~~~vkL~DFGla~~~~  311 (461)
T PHA03211        236 CLVLPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEG--IIHRDIKTENVLVNGPEDICLGDFGAACFAR  311 (461)
T ss_pred             EEEEEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEECcCCHHHEEECCCCCEEEcccCCceecc
Confidence            9999999 578888886543 36899999999999999999999866  9999999999999999999999999998654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc-----c---hhhhhhhhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE-----Q---SLVDWARPKLND  308 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-----~---~~~~~~~~~~~~  308 (431)
                      ............||+.|+|||++.+..++.++|||||||+||||++|..|+........     .   ..+.........
T Consensus       312 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~  391 (461)
T PHA03211        312 GSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDE  391 (461)
T ss_pred             cccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccccc
Confidence            33222223346799999999999999999999999999999999998876533221110     0   111111000000


Q ss_pred             cc-----hhh-hh-------cCccccCc-cc--HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KR-----KML-QI-------IDPRLENQ-YS--VRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~-----~~~-~~-------~~~~~~~~-~~--~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..     .+. ..       ..+..... +.  ......+.+||.+||+.||.+|||+.|++++
T Consensus       392 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        392 FPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            00     000 00       00000000 00  0223578899999999999999999999976

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.7e-41  Score=321.85  Aligned_cols=269  Identities=26%  Similarity=0.445  Sum_probs=203.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCcee----------ccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRV----------GLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----------~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      ++|++.+.||+|+||.||++.+.+....          ......+|+|++..... ....++.+|+.+|+.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            5689999999999999999875432110          11123489999876532 334678899999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCCC---------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEE
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKAT---------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL  217 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NIL  217 (431)
                      ++++...+..++||||+.+++|.+++.....         ..+++...+.++.|++.||+|||+.+  ++|+||||+|||
T Consensus        85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dlkp~Nil  162 (296)
T cd05095          85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN--FVHRDLATRNCL  162 (296)
T ss_pred             EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC--eecccCChheEE
Confidence            9999999999999999999999999866432         23667789999999999999999876  999999999999


Q ss_pred             ECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh--CCCCCCCCCCccc
Q 014079          218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT--GRKSVDKTRPSKE  295 (431)
Q Consensus       218 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~pf~~~~~~~~  295 (431)
                      ++.++.++|+|||+++...............++..|++||+..++.++.++|||||||++|||++  |..||........
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999986543322222223345678999999888899999999999999999998  7788865432211


Q ss_pred             chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .   .........       .........+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       243 ~---~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         243 I---ENTGEFFRD-------QGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             H---HHHHHHHhh-------ccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1   000000000       0000000111224478889999999999999999999999886

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=337.07  Aligned_cols=254  Identities=28%  Similarity=0.438  Sum_probs=215.1

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ++.++||+|.||.|++|.|..-   ..+.+.||||.++..... ...+|++|+.+|.+|+|+|+++|||+..+ ....||
T Consensus       113 ~l~e~LG~GsFgvV~rg~Wt~p---sgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV  188 (1039)
T KOG0199|consen  113 KLYELLGEGSFGVVKRGTWTQP---SGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV  188 (1039)
T ss_pred             HHHHHhcCcceeeEeeccccCC---CCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence            4556899999999999999752   234557999999887554 56789999999999999999999999987 678899


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||+++.|+|.+.|.+.....|.......++.||+.||.||.+.+  +|||||..+|+||.....+||+||||++.+...+
T Consensus       189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr--lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR--LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh--hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999998866667888999999999999999999866  9999999999999999999999999999876655


Q ss_pred             Ccceee-cccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          240 ETHVST-RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       240 ~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ....+. ...-...|+|||.+....|+-++|||+|||+||||++ |+.||.+...                 ..+.+.+|
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g-----------------~qIL~~iD  329 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG-----------------IQILKNID  329 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH-----------------HHHHHhcc
Confidence            443333 2334567999999999999999999999999999999 8899987543                 23445555


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+-+-.-+..++++++++++.||..+|.+|||+..|.+.+
T Consensus       330 ~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  330 AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            4444455677899999999999999999999999997443

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.2e-41  Score=331.72  Aligned_cols=267  Identities=24%  Similarity=0.294  Sum_probs=198.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||.||++.+...+.      .||+|++....  ......+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   91 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGI------NVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTP   91 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCc------eeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeecc
Confidence            456889999999999999999999876544      49999986542  2334567899999999999999999999865


Q ss_pred             CC------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          153 DD------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       153 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      .+      ..|+||||+. ++|.+.+..    .++...+..++.|++.||.|||+.+  |+||||||+|||++.++.+||
T Consensus        92 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~--ivHrDlkp~NIl~~~~~~~kl  164 (359)
T cd07876          92 QKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  164 (359)
T ss_pred             CCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEE
Confidence            43      4799999995 567666632    3678888899999999999999876  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RP  304 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~  304 (431)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............  .+
T Consensus       165 ~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  241 (359)
T cd07876         165 LDFGLARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTP  241 (359)
T ss_pred             ecCCCccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999997543221   223356899999999999999999999999999999999999999865422110000000  00


Q ss_pred             hhh---cc-chhhhhcC--ccc----------------cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 KLN---DK-RKMLQIID--PRL----------------ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~~~---~~-~~~~~~~~--~~~----------------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...   .. ........  +..                ........+..+.+|+.+||+.||++|||+.|++.+-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         242 SAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             cHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence            000   00 00000000  000                0001112346789999999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4e-41  Score=313.89  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=207.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .|++|.++...   ......+.+|++++++++|+||+++++++.+.+
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~   75 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGR------VVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENN   75 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCC------EEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCC
Confidence            578899999999999999999875443      38999876432   223457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..++||||+++++|.+++..  .....+++..++.++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        76 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~nil~~~~~~~~l~d~~~~  153 (267)
T cd08224          76 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR--IMHRDIKPANVFITATGVVKLGDLGLG  153 (267)
T ss_pred             eEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecCCcChhhEEECCCCcEEEecccee
Confidence            99999999999999998864  23345889999999999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||.......    ..           +
T Consensus       154 ~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~-----------~  216 (267)
T cd08224         154 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YS-----------L  216 (267)
T ss_pred             eeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccH----HH-----------H
Confidence            76433221  1223468899999999998899999999999999999999999996543110    00           0


Q ss_pred             hhhcCccccCccc-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          313 LQIIDPRLENQYS-VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       313 ~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      .+.+........+ ...+..+.+++.+||..+|.+|||+.+|++.|..+.
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         217 CKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            0000001111111 245568899999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.8e-42  Score=336.17  Aligned_cols=254  Identities=24%  Similarity=0.326  Sum_probs=198.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|++.+.||+|+||.||++.+..++..      ||+|++.....   .....+.+|+.++.+++|+||+++++.+.+.+
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   74 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHI------YAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKR   74 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            3688889999999999999998876554      99999875422   23456778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++|+|.+++.+..  .+++.....++.|++.||.|||+.+  |+||||||+||||+.++.++|+|||++..
T Consensus        75 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~~L~~lH~~g--ivHrDLkp~NIli~~~~~vkL~DfG~~~~  150 (360)
T cd05627          75 NLYLIMEFLPGGDMMTLLMKKD--TLSEEATQFYIAETVLAIDAIHQLG--FIHRDIKPDNLLLDAKGHVKLSDFGLCTG  150 (360)
T ss_pred             EEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEccCCCHHHEEECCCCCEEEeeccCCcc
Confidence            9999999999999999997644  4788889999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHH
Q 014079          235 GPQGDET---------------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL  281 (431)
Q Consensus       235 ~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  281 (431)
                      .......                                 ......+||+.|+|||++.+..++.++|||||||++|||+
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~  230 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML  230 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecc
Confidence            4221100                                 0011357999999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHH
Q 014079          282 TGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL---MSDVVET  356 (431)
Q Consensus       282 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt---~~eil~~  356 (431)
                      +|+.||....+......+             ... ...+........+.++.+||.+|+. ||.+|++   +.+++.|
T Consensus       231 tG~~Pf~~~~~~~~~~~i-------------~~~-~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         231 IGYPPFCSETPQETYRKV-------------MNW-KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSH  293 (360)
T ss_pred             cCCCCCCCCCHHHHHHHH-------------HcC-CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcC
Confidence            999999765432211100             000 0000000011234678889988774 9999985   6777765

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.1e-41  Score=324.12  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=202.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..+..    ...+++|.+.... ......+.+|+.++.++ +|+||+++++++.+.+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~----~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~   82 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGL----RMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   82 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCc----eeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence            467888999999999999999865432    1136777765432 23345688899999999 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      .|+||||+++++|.+++....              ...+++..++.++.|++.||+|||+.+  |+||||||+|||++.+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dlkp~Nili~~~  160 (303)
T cd05088          83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  160 (303)
T ss_pred             ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchheEEecCC
Confidence            999999999999999996542              235788899999999999999999866  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||++.......   ......++..|+|||++.+..++.++|||||||++|||++ |..||........   ..
T Consensus       161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~  234 (303)
T cd05088         161 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---YE  234 (303)
T ss_pred             CcEEeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH---HH
Confidence            999999999986421111   1111234667999999988889999999999999999998 9999965432110   00


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                    .+........+...+..+.+|+.+||+.+|++||++.+++..|+.+....
T Consensus       235 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         235 --------------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             --------------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                          00001111112223467889999999999999999999999998765543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2e-41  Score=316.68  Aligned_cols=260  Identities=24%  Similarity=0.433  Sum_probs=203.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..|++.+.||+|+||.||+|.+......   ...|++|++.... .....+|..|+.++++++||||+++++++.++...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~   80 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV   80 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCC---ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence            3478889999999999999998754321   2249999987652 23456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g--~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccChheEEEcCCCcEEECCCccccccc
Confidence            99999999999999987643 35788999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeec-cc--CCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          237 QGDETHVSTR-VM--GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       237 ~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .......... ..  .+..|+|||.+.+..++.++|||||||++|||++ |..||.......   ...+.          
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~~i----------  224 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VINAI----------  224 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHHHH----------
Confidence            3222111111 11  2457999999999999999999999999999886 999997643221   11110          


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                          ........+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       225 ----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 ----EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ----HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                00011111223456788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=313.43  Aligned_cols=253  Identities=32%  Similarity=0.502  Sum_probs=204.4

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-HHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +.||+|+||.||+|.+....   .....|++|++....... ...+.+|+++++.++|+||+++++++.+....++||||
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~---~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   77 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD---GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEY   77 (262)
T ss_pred             CccccCCceEEEEEEEecCC---CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEe
Confidence            36999999999999987541   112359999988764433 56788999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCC-------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          163 MFRGSLENHLFRKA-------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       163 ~~~gsL~~~l~~~~-------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++++|.+++....       ...+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||.+...
T Consensus        78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~--i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK--FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC--cccCccCcceEEECCCCcEEEccccccccc
Confidence            99999999997652       356899999999999999999999866  999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .............++..|+|||.+.+..++.++||||||+++|+|++ |..||........   .              +
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~---~--------------~  218 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV---L--------------E  218 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH---H--------------H
Confidence            54432222334567889999999988899999999999999999999 6999976532111   0              0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .+........+...+.++.+++.+||+.||.+||++.+++++|+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         219 YLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             HHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            01001111223334678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=9.2e-42  Score=319.31  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=200.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeC-
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED-  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  153 (431)
                      ....|++.+.||+|+||.||+|.+......      ||+|++.... .....+.+|+.+++++ +|+||+++++++... 
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~------~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQL------AAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   76 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcE------EEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecC
Confidence            456688888999999999999998766543      9999886553 3345678899999998 699999999998753 


Q ss_pred             -----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                           ..+|+||||+.+++|.+++.......+++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~--ivh~dl~~~nili~~~~~~~l~D  154 (272)
T cd06637          77 PPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLVD  154 (272)
T ss_pred             CCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHEEECCCCCEEEcc
Confidence                 46899999999999999998765567899999999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      ||++........  ......|++.|+|||++.     +..++.++|||||||++|||++|+.||....+.......    
T Consensus       155 fg~~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~----  228 (272)
T cd06637         155 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI----  228 (272)
T ss_pred             CCCceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH----
Confidence            999876432211  223456899999999886     346888999999999999999999999654321111000    


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                  .............+..+.+|+.+||..||.+|||+.+++++
T Consensus       229 ------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         229 ------------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             ------------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                        00000011112234678899999999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.2e-42  Score=330.31  Aligned_cols=241  Identities=29%  Similarity=0.392  Sum_probs=189.3

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHH-HHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVN-FLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||+||+|.+..+...      ||+|++.+...   .....+..|.. +++.++||||+++++++.+.+..|+|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv   74 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKF------YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV   74 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCE------EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEE
Confidence            3699999999999998776543      99999876432   12234444544 56788999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++....  .+.+.....++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~L~~lH~~g--iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~  150 (325)
T cd05602          75 LDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN  150 (325)
T ss_pred             EeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHeEECCCCCEEEccCCCCcccccCC
Confidence            99999999999997644  4677788889999999999999876  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........   ..             .+....
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---~~-------------~i~~~~  212 (325)
T cd05602         151 --GTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM---YD-------------NILNKP  212 (325)
T ss_pred             --CCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHH---HH-------------HHHhCC
Confidence              122346799999999999999999999999999999999999999975432111   00             011100


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV  354 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil  354 (431)
                      +  ......+..+.+++.+||+.||.+||++.+.+
T Consensus       213 ~--~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             c--CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence            0  11223456788999999999999999887443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.9e-42  Score=331.77  Aligned_cols=242  Identities=29%  Similarity=0.364  Sum_probs=192.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      +.||+|+||.||++.+..+..   .+..||+|++.+...  .....+.+|+++|++++||||+++++++.+.+..|+|||
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   78 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPD---AGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILD   78 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCC---CCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEc
Confidence            579999999999998642211   123599999876432  233456789999999999999999999999999999999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      |+++++|.+++.+..  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++......  
T Consensus        79 ~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--  152 (318)
T cd05582          79 FLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--  152 (318)
T ss_pred             CCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--
Confidence            999999999986543  5789999999999999999999876  9999999999999999999999999987643321  


Q ss_pred             ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                      .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..+....  
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~----------------~~i~~~~--  214 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETM----------------TMILKAK--  214 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHH----------------HHHHcCC--
Confidence            1223467999999999999889999999999999999999999999764321110                0011100  


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSD  352 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~e  352 (431)
                      ...+...+..+.+|+.+||+.||++||++.+
T Consensus       215 ~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            0122234567889999999999999999554

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.5e-41  Score=320.65  Aligned_cols=252  Identities=22%  Similarity=0.329  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..+|+..+.||+|+||.||+|.+..+..      .|++|.+..........+.+|+.+++.+.|+||+++++.+......
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~   92 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   92 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCc------EEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEE
Confidence            4678999999999999999999766544      3999988776555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~g--i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          93 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEeecccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999999998543   4788899999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....+....  ...             ..
T Consensus       168 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~-------------~~  230 (296)
T cd06654         168 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLI-------------AT  230 (296)
T ss_pred             cccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHH-------------hc
Confidence            3221  122346899999999999888999999999999999999999999764321110  000             00


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ........+......+.+++.+||..||++||++.+|+.+
T Consensus       231 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         231 NGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            0000011122345678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-42  Score=328.69  Aligned_cols=259  Identities=27%  Similarity=0.422  Sum_probs=217.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      ....++||.|.||.||+|.+.+-.  ..+.+.||||..+.+ ...+.+.|+.|..+|++++|||||+++|+|.+ ...||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~--kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPE--KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccc--cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            345678999999999999986542  224456999999885 34556779999999999999999999999975 57899


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      |||+++-|.|..+|..++. .++......+++||+.+|+|||+.+  +|||||..+|||+...-.+||+|||+++.+.+.
T Consensus       468 vmEL~~~GELr~yLq~nk~-sL~l~tL~ly~~Qi~talaYLeSkr--fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKD-SLPLRTLTLYCYQICTALAYLESKR--FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccc-cchHHHHHHHHHHHHHHHHHHHhhc--hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            9999999999999987654 5888999999999999999999966  999999999999999999999999999998776


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...... ...-..-|||||.+....++.++|||-|||++||++. |..||.+....+.                 ...+.
T Consensus       545 ~yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV-----------------I~~iE  606 (974)
T KOG4257|consen  545 AYYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV-----------------IGHIE  606 (974)
T ss_pred             chhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce-----------------EEEec
Confidence            655443 3345667999999999999999999999999999998 9999987543221                 11222


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .+-+...++.|+..++.|+.+||..+|.+||.+.+|...|..+..
T Consensus       607 nGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  607 NGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            233345567788999999999999999999999999999987665

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.4e-41  Score=320.86  Aligned_cols=266  Identities=25%  Similarity=0.329  Sum_probs=195.7

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcC---CCCceeeeecEEEe-
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQL---RHPNLVKLIGYCCE-  152 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-  152 (431)
                      +|++.+.||+|+||.||+|.+..++..      ||+|.++.....  ....+.+|+.+++.+   +||||+++++++.. 
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~   74 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHF------VALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATS   74 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcE------EEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccc
Confidence            488889999999999999998876554      999988653221  123455677766655   79999999998864 


Q ss_pred             ----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          153 ----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       153 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                          ....++||||+. ++|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        75 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dikp~Nili~~~~~~kl~d  151 (288)
T cd07863          75 RTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTSGGQVKLAD  151 (288)
T ss_pred             cCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECc
Confidence                345799999996 58998887665556899999999999999999999876  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-hhh-hhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DWA-RPKL  306 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~-~~~~  306 (431)
                      ||+++......   ......||..|+|||++.+..++.++|||||||++|+|++|+.||...........+ ... .+..
T Consensus       152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~  228 (288)
T cd07863         152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  228 (288)
T ss_pred             cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence            99998653322   122356899999999999999999999999999999999999999764332211110 000 0000


Q ss_pred             hccchhh----hhcCccc---cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKML----QIIDPRL---ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~----~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......    ....+..   ........+..+.+|+.+||+.||++|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000    0000000   001112345678899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.9e-42  Score=334.48  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=199.7

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      +|++.+.||+|+||.||++.+..++.      .||+|.+...  .....+.+.+|+.+|+.++|+||+++++++...+  
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~   74 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGK------RVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHID   74 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCC------EEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCcc
Confidence            47788999999999999999865544      3999988653  2234467889999999999999999999998876  


Q ss_pred             ---eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                         ..|+||||+. ++|.+.+....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivH~dlkp~Nili~~~~~~kL~Dfg~  149 (372)
T cd07853          75 PFEEIYVVTELMQ-SDLHKIIVSPQ--PLSSDHVKVFLYQILRGLKYLHSAG--ILHRDIKPGNLLVNSNCVLKICDFGL  149 (372)
T ss_pred             ccceEEEEeeccc-cCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChHHEEECCCCCEEeccccc
Confidence               7899999995 68888775543  5888999999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhc
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLND  308 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~  308 (431)
                      ++....... .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||....+......+...  .+....
T Consensus       150 a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  228 (372)
T cd07853         150 ARVEEPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA  228 (372)
T ss_pred             eeecccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            976433221 122334689999999998874 5899999999999999999999999876543221111100  000000


Q ss_pred             c----chhhhhc-Ccccc-------CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          309 K----RKMLQII-DPRLE-------NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       309 ~----~~~~~~~-~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .    ......+ .....       .......+.++.+|+.+||+.||++|||+.+++.+-
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  289 (372)
T cd07853         229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHP  289 (372)
T ss_pred             HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCH
Confidence            0    0000000 00000       011122356888999999999999999999999763

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=7.2e-42  Score=334.12  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=199.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ..++|++.+.||+|+||.||++.+..+...      ||+|++.+...   .....+.+|+.+++.++||||+++++++.+
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~------~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKV------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            347899999999999999999998876554      99999865322   223457789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++|+|.+++...   .++...+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--EEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            99999999999999999998653   3678888889999999999999866  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTG----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      +....... ......+||+.|+|||++.+.    .++.++|||||||++|||++|+.||........             
T Consensus       190 ~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~-------------  255 (371)
T cd05622         190 MKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT-------------  255 (371)
T ss_pred             eEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH-------------
Confidence            86543221 112346799999999998754    378999999999999999999999976432111             


Q ss_pred             cchhhhhcCc--cccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 014079          309 KRKMLQIIDP--RLENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETL  357 (431)
Q Consensus       309 ~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L  357 (431)
                         ...++..  .+........+..+.++|..||..++.+  |+++.+|+++.
T Consensus       256 ---~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         256 ---YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ---HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence               0111110  0111111234577889999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.8e-41  Score=316.87  Aligned_cols=255  Identities=30%  Similarity=0.491  Sum_probs=199.2

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||+|.+.+.......+..+++|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            68999999999998865331122233589998765432 34567889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhhCC-----CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-----cEEEecccCCc
Q 014079          164 FRGSLENHLFRKA-----TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-----TAKLSDFGLAK  233 (431)
Q Consensus       164 ~~gsL~~~l~~~~-----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-----~~kl~DFG~a~  233 (431)
                      ++++|.+++....     ...+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++     .++|+|||+++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH--FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC--cccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999996532     234788899999999999999999866  99999999999999877     89999999997


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ...............++..|+|||++.++.++.++|||||||++|||++ |+.||.......   ..             
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~-------------  223 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL-------------  223 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH-------------
Confidence            6543322222223346788999999999999999999999999999998 999996543211   00             


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                       ..+........+...+..+.+++.+||+.+|.+||++.+|++.|+
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         224 -QHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -HHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence             011111111122334578899999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=323.67  Aligned_cols=257  Identities=20%  Similarity=0.246  Sum_probs=196.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||++.+......      ||+|++.+...   .....+.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQV------YAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCC
Confidence            4688999999999999999998776543      99999875321   23345778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++++|.+++.+.. ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  151 (331)
T cd05597          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVLAIDSVHQLG--YVHRDIKPDNVLLDKNGHIRLADFGSCLR  151 (331)
T ss_pred             eEEEEEecCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEECCCCHHHEEECCCCCEEEEECCceee
Confidence            9999999999999999996532 35788889999999999999999866  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ....... ......||+.|+|||++..     ..++.++|||||||++|||++|+.||...........       +...
T Consensus       152 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-------i~~~  223 (331)
T cd05597         152 LLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-------IMNH  223 (331)
T ss_pred             cCCCCCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-------HHcC
Confidence            4332211 1122469999999999863     4578899999999999999999999975432111000       0000


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETL  357 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L  357 (431)
                      ....     .+. ......+..+.+++.+||..++++  |+++.+++++-
T Consensus       224 ~~~~-----~~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         224 KEHF-----QFP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             CCcc-----cCC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            0000     000 011124567889999988654443  78999999873

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-41  Score=312.36  Aligned_cols=252  Identities=30%  Similarity=0.467  Sum_probs=197.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ++||+|+||.||+|.+.....   ....+++|.+..... ...+++.+|+.+++.+.|+||+++++++. .+..++||||
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~---~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~   76 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSG---KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMEL   76 (257)
T ss_pred             CccCccCceeEEEeEeeccCC---CcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEe
Confidence            469999999999998754321   123599999886654 24467889999999999999999999875 5568999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +.+++|.+++....  .+++..++.++.|++.+|.|||..+  ++|+||||+|||++.++.+||+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lh~~~--i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          77 APLGPLLKYLKKRR--EIPVSDLKELAHQVAMGMAYLESKH--FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHhhcC--eeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            99999999997654  5789999999999999999999866  9999999999999999999999999998654332211


Q ss_pred             e-eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          243 V-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       243 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   ...+.              ....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~~~~~--------------~~~~  215 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---VIAML--------------ESGE  215 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHH--------------HcCC
Confidence            1 111224567999999998999999999999999999998 999997643211   11110              0000


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ....+...+..+.+++.+||..||.+||++.+|++.|+.+
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            1112223456888999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=3.1e-41  Score=313.10  Aligned_cols=253  Identities=30%  Similarity=0.424  Sum_probs=201.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +.||+|++|.||+|.+....   .+...||+|.+..... ...+.+.+|+.++++++|+||+++++++.. ...++||||
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~---~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~   76 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSG---GKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTEL   76 (257)
T ss_pred             CcCCccCcccEEeeeEecCC---CCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEe
Confidence            36899999999999986521   1223489999988766 556778999999999999999999999988 889999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++.......+++...+.++.|++.||+|||+.+  ++|+||||+||+++.++.+||+|||++..........
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR--FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC--ccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            99999999997754356899999999999999999999866  9999999999999999999999999998754432211


Q ss_pred             -eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          243 -VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       243 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                       ......++..|+|||++.+..++.++|||||||++|||++ |+.||............             ..   ...
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~-------------~~---~~~  218 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI-------------DK---EGE  218 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-------------Hh---cCC
Confidence             1122457788999999998999999999999999999998 99999654321110000             00   000


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            01112234568889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=5.1e-41  Score=311.94  Aligned_cols=251  Identities=27%  Similarity=0.410  Sum_probs=195.6

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||+|.+....    .+..||+|++..... ...+.+.+|+.++++++|+||+++++++. .+..++||||+
T Consensus         2 ~ig~G~~g~v~~~~~~~~~----~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~   76 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRK----KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMA   76 (257)
T ss_pred             ccCCCCcccEEEEEEecCC----CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeC
Confidence            3899999999999875221    112389999876533 23456889999999999999999999885 45789999999


Q ss_pred             CCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcce
Q 014079          164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV  243 (431)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~  243 (431)
                      ++++|.+++.... ..+++..++.++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||++...........
T Consensus        77 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  153 (257)
T cd05115          77 SGGPLNKFLSGKK-DEITVSNVVELMHQVSMGMKYLEGKN--FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK  153 (257)
T ss_pred             CCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhcC--eeecccchheEEEcCCCcEEeccCCccccccCCcccee
Confidence            9999999986533 35889999999999999999999866  99999999999999999999999999976443322111


Q ss_pred             -eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          244 -STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       244 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                       .....++..|+|||++.+..++.++|||||||++|||++ |..||.........                 ..+.....
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~~~~~~~  216 (257)
T cd05115         154 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVM-----------------SFIEQGKR  216 (257)
T ss_pred             ccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHH-----------------HHHHCCCC
Confidence             111234578999999988889999999999999999996 99999765322111                 11111111


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ...+..++.++.+++.+||..||++||++.+|.+.|+.+
T Consensus       217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            122234457888999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.8e-41  Score=323.62  Aligned_cols=268  Identities=23%  Similarity=0.333  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|.+.+.||+|+||.||+|.+..+..      .||+|.++..... ....+.+|+.++++++||||+++++++..++..
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   79 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTEN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSL   79 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCC------eEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeE
Confidence            468889999999999999999876544      3999988754322 234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  155 (309)
T cd07872          80 TLVFEYLD-KDLKQYMDDCG-NIMSMHNVKIFLYQILRGLAYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (309)
T ss_pred             EEEEeCCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECccccceecC
Confidence            99999996 58888876543 34788888899999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------hhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--------PKLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  307 (431)
                      ....  ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....        +.+.
T Consensus       156 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07872         156 VPTK--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS  233 (309)
T ss_pred             CCcc--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence            2221  1223467899999998865 468999999999999999999999997654432221111100        0000


Q ss_pred             ccchhhhhcCcccc----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLE----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ........-.+...    .......+.++.+|+.+||+.||.+|||+.|++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  287 (309)
T cd07872         234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA  287 (309)
T ss_pred             chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcCh
Confidence            00000000000000    001122456788999999999999999999999753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.2e-41  Score=331.31  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=198.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||.||++.+.....      .||+|.+....  ......+.+|+.+++.++||||+++++++..
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   87 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDR------NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTP   87 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCc------eEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeec
Confidence            356789999999999999999998876544      39999887542  2334567889999999999999999998865


Q ss_pred             C------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          153 D------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       153 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      .      ...++||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||
T Consensus        88 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDikp~Nill~~~~~~kl  160 (355)
T cd07874          88 QKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  160 (355)
T ss_pred             cccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEECCCCCEEE
Confidence            4      34699999995 567776643    3778888899999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--h-
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--R-  303 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~-  303 (431)
                      +|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.............  . 
T Consensus       161 ~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (355)
T cd07874         161 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP  237 (355)
T ss_pred             eeCcccccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            9999998643221   223357899999999999999999999999999999999999999765422111000000  0 


Q ss_pred             -hhh-hcc-chhhhhcC---------------cc-c--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 -PKL-NDK-RKMLQIID---------------PR-L--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 -~~~-~~~-~~~~~~~~---------------~~-~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       +.. ... ......++               .. .  ...........+.+||.+||+.||++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             CHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence             000 000 00000000               00 0  001112234678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.9e-41  Score=318.79  Aligned_cols=262  Identities=26%  Similarity=0.420  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..... ......|++|++..... ....++.+|+.++++++||||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCC-CCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            568889999999999999998753100 01123599999876533 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCC--------------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCE
Q 014079          157 LLVYEFMFRGSLENHLFRKA--------------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI  216 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~--------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NI  216 (431)
                      ++||||+.+++|.+++....                    ...+++..++.++.|++.||.|||+.+  ++||||||+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~--i~H~dl~p~ni  161 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK--FVHRDLATRNC  161 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--eecccccHhhe
Confidence            99999999999999996432                    124678888999999999999999866  99999999999


Q ss_pred             EECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCccc
Q 014079          217 LLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE  295 (431)
Q Consensus       217 Ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~  295 (431)
                      |++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||........
T Consensus       162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~  241 (288)
T cd05050         162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEV  241 (288)
T ss_pred             EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999876433322111222345677999999998999999999999999999998 8888865432110


Q ss_pred             chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                         ..             .+.+.... ..+...+.++.+|+.+||+.||.+|||+.|+++.|++
T Consensus       242 ---~~-------------~~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         242 ---IY-------------YVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH-------------HHhcCCCC-CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               00             00011110 1122345788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.1e-41  Score=314.28  Aligned_cols=260  Identities=25%  Similarity=0.440  Sum_probs=204.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|++.+.||+|+||.||+|.+..+..   ....+++|.++.... .....+.+|+.++++++||||+++++++.+++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~---~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   80 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGK---REIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV   80 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCC---CceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            468888999999999999998753321   122489998876432 2345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++...+.++.|++.||.|||+.+  ++||||||+|||++.++.++|+|||++....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~h~dlkp~nili~~~~~~~l~dfg~~~~~~  157 (267)
T cd05066          81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  157 (267)
T ss_pred             EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeehhhchhcEEECCCCeEEeCCCCcccccc
Confidence            99999999999999997654 35788999999999999999999866  9999999999999999999999999998754


Q ss_pred             CCCCcce-eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDETHV-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....... .....++..|+|||++.+..++.++|+||||+++||+++ |..||........   ....          .+
T Consensus       158 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~----------~~  224 (267)
T cd05066         158 DDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAI----------EE  224 (267)
T ss_pred             cccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHH----------hC
Confidence            3322111 112234568999999998899999999999999999887 9999976432211   1100          00


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                          ..........+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       225 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 ----GYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                001111223456788999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=4.3e-41  Score=312.34  Aligned_cols=250  Identities=28%  Similarity=0.412  Sum_probs=195.3

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      .||+|+||.||+|.+....    ....+|+|+++....  ...+++.+|+.+++.++|+||+++++++. .+..++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~   76 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKK----SEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMEL   76 (257)
T ss_pred             cCCCcCCcceEEeEEecCC----CceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEec
Confidence            5899999999999764221    112499999865432  23467889999999999999999999885 4567899999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||.|||++.++.++|+|||+++.........
T Consensus        77 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          77 AELGPLNKFLQKNK--HVTEKNITELVHQVSMGMKYLEETN--FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            99999999996543  5788999999999999999999866  9999999999999999999999999998654332211


Q ss_pred             -eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          243 -VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       243 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                       ......++..|+|||.+.+..++.++|||||||++|||++ |+.||........   .              +.+....
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~---~--------------~~i~~~~  215 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEV---T--------------QMIESGE  215 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---H--------------HHHHCCC
Confidence             1112334678999999988889999999999999999998 9999976432111   1              1111111


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ....+...+.++.++|.+||+.||++||++.+|.+.|++.
T Consensus       216 ~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            1112233457889999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-41  Score=315.71  Aligned_cols=252  Identities=32%  Similarity=0.534  Sum_probs=201.3

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHH--HHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR--EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      |++.+.||+|+||+||++.+..++..      ||+|++.........  ...+|+.++++++||||+++++++.+....+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~------~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQK------VAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLY   74 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEE------EEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeE------EEEEEeccccccccccchhhhhhhcccccccccccccccccccccccc
Confidence            67788999999999999999887664      999999887543332  3456999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.+++|.+++...  ..+++..++.++.|++.||.+||+.+  |+|+||||+|||++.++.++|+|||.+.... 
T Consensus        75 ~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~--i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-  149 (260)
T PF00069_consen   75 IVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKG--IVHRDIKPENILLDENGEVKLIDFGSSVKLS-  149 (260)
T ss_dssp             EEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTT--EEESSBSGGGEEESTTSEEEESSGTTTEEST-
T ss_pred             cccccccccccccccccc--cccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccc-
Confidence            999999999999999733  35799999999999999999999976  9999999999999999999999999987541 


Q ss_pred             CCCcceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                       ..........++..|+|||++. +..++.++||||||+++|+|++|..||.............             ...
T Consensus       150 -~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~-------------~~~  215 (260)
T PF00069_consen  150 -ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE-------------KIL  215 (260)
T ss_dssp             -STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH-------------HHH
T ss_pred             -ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh-------------hcc
Confidence             1122334467899999999998 8889999999999999999999999998652111111110             000


Q ss_pred             CccccCcc--cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQY--SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...+....  .......+.+++.+||+.||++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  216 KRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             cccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000000  00112788999999999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.6e-41  Score=315.42  Aligned_cols=262  Identities=24%  Similarity=0.389  Sum_probs=206.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|++.+.||+|+||.||+|.+...+..  ....+++|.+..... ....++.+|+.++++++|+||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~--~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEK--VKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCC--cceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4678889999999999999997654321  123589998876643 334678899999999999999999999987 788


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++..... .+++...+.++.|++.||+|||+.+  ++|+||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKD-NIGSQYLLNWCVQIAKGMSYLEEKR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHhCC--EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            999999999999999976543 4889999999999999999999866  9999999999999999999999999998755


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............++..|+|||.+....++.++||||||+++||+++ |+.||.........                 +.
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-----------------~~  223 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIP-----------------DL  223 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHH-----------------HH
Confidence            3332222222234678999999988899999999999999999998 99999765321111                 00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      +........+...+..+.+++.+||..||.+||++.++++.|..+..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         224 LEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            10000011112234578899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.4e-41  Score=326.36  Aligned_cols=242  Identities=26%  Similarity=0.379  Sum_probs=193.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  154 (431)
                      +|+..+.||+|+||.||+|.+..++..      ||+|++.+...   ...+.+..|..++..+. |++|+++++++.+.+
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   74 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDEL------YAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVD   74 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCC
Confidence            367788999999999999998776554      99999876422   23345778889988886 577888999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        75 ~~~lv~Ey~~~g~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivHrDikp~Nill~~~~~ikL~Dfg~~~~  150 (323)
T cd05615          75 RLYFVMEYVNGGDLMYHIQQVG--KFKEPQAVFYAAEISVGLFFLHRRG--IIYRDLKLDNVMLDSEGHIKIADFGMCKE  150 (323)
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEeccccccc
Confidence            9999999999999999986654  4788999999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  ......||+.|+|||++.+..++.++|||||||++|||++|+.||........   .             ..
T Consensus       151 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~---~-------------~~  212 (323)
T cd05615         151 HMVDGV--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL---F-------------QS  212 (323)
T ss_pred             cCCCCc--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHH---H-------------HH
Confidence            322211  12345699999999999999999999999999999999999999976432111   0             01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~  350 (431)
                      ++...  ..++...+.++.+++.+||+.||.+|++.
T Consensus       213 i~~~~--~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         213 IMEHN--VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             HHhCC--CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            11111  11222345678899999999999999975

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-41  Score=354.90  Aligned_cols=259  Identities=24%  Similarity=0.357  Sum_probs=201.5

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      ..+...++|.+.+.||+|+||+||+|.+......      ||+|++.....  .....+..|+.+|++|+|||||+++++
T Consensus         7 ~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~------vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~   80 (1021)
T PTZ00266          7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEF------FCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR   80 (1021)
T ss_pred             CCccccCCEEEEEEEecCCCeEEEEEEECCCCeE------EEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            3445567899999999999999999998876554      89998875432  234568899999999999999999998


Q ss_pred             EEeC--CeeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCC-----CCeeeccCCCCCEEECC
Q 014079          150 CCED--DHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAE-----RPVIYRDFKTSNILLDS  220 (431)
Q Consensus       150 ~~~~--~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~-----~~ivHrDlkp~NILl~~  220 (431)
                      |.+.  ..+||||||+.+++|.++|...  ....+++..++.|+.||+.||.|||+.+     ++||||||||+||||+.
T Consensus        81 f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s  160 (1021)
T PTZ00266         81 FLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLST  160 (1021)
T ss_pred             EEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeec
Confidence            8653  5689999999999999998653  2346899999999999999999999844     45999999999999964


Q ss_pred             -----------------CCcEEEecccCCccCCCCCCcceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHH
Q 014079          221 -----------------DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELL  281 (431)
Q Consensus       221 -----------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell  281 (431)
                                       .+.+||+|||++.......   ......||+.|+|||++.+  ..++.++||||||||||||+
T Consensus       161 ~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELL  237 (1021)
T PTZ00266        161 GIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELC  237 (1021)
T ss_pred             CccccccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHH
Confidence                             3458999999998653322   1234579999999999864  45889999999999999999


Q ss_pred             hCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          282 TGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       282 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +|+.||........  ++.    .+..        .+.+.   ....+.++.+||..||+.+|.+||++.+++.+
T Consensus       238 TGk~PF~~~~~~~q--li~----~lk~--------~p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        238 SGKTPFHKANNFSQ--LIS----ELKR--------GPDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HCCCCCCcCCcHHH--HHH----HHhc--------CCCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            99999975432110  000    0000        00010   01234678899999999999999999999954

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=4.4e-41  Score=323.96  Aligned_cols=253  Identities=21%  Similarity=0.257  Sum_probs=197.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||++.+..+.+.      ||+|++.+...   .....+.+|+.++..++|+||+++++++.+.+
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~   74 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERI------YAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDEN   74 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            4688999999999999999998766554      99999875321   22344778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||++||+|.+++.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~--iiHrDlkp~Nill~~~~~~kl~DfG~a~~  151 (331)
T cd05624          75 YLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLH--YVHRDIKPDNVLLDMNGHIRLADFGSCLK  151 (331)
T ss_pred             EEEEEEeCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCchHHEEEcCCCCEEEEeccceee
Confidence            9999999999999999997643 35788888899999999999999866  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ...... .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||.........             
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~-------------  217 (331)
T cd05624         152 MNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETY-------------  217 (331)
T ss_pred             ccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHH-------------
Confidence            543222 11223579999999998875     56889999999999999999999999754321110             


Q ss_pred             chhhhhcCcc--cc-CcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 014079          310 RKMLQIIDPR--LE-NQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~--~~-~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~  356 (431)
                         ..+....  +. .......+.++.+++.+||..++.+  |+++.+++++
T Consensus       218 ---~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         218 ---GKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ---HHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence               0111100  00 0011124578889999999876554  4688888876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-41  Score=330.79  Aligned_cols=265  Identities=23%  Similarity=0.293  Sum_probs=198.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||++.+......      ||+|++....  ......+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~   95 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQ   95 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcE------EEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccc
Confidence            467899999999999999999998765443      9999987542  23345678999999999999999999987643


Q ss_pred             ------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 ------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                            ...|+||||+. ++|.+.+..    .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        96 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~  168 (364)
T cd07875          96 KSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  168 (364)
T ss_pred             ccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEECCCCcEEEE
Confidence                  35799999995 577777743    3678888899999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh----h
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA----R  303 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~  303 (431)
                      |||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...    .
T Consensus       169 DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  245 (364)
T cd07875         169 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC  245 (364)
T ss_pred             eCCCccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998643221   223456899999999999999999999999999999999999999765432211110000    0


Q ss_pred             hh----h--------hccch-----hhhhcCc---cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 PK----L--------NDKRK-----MLQIIDP---RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 ~~----~--------~~~~~-----~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.    +        .....     .......   .............+.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            00    0        00000     0000000   00001111234578899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=321.94  Aligned_cols=258  Identities=28%  Similarity=0.421  Sum_probs=212.8

Q ss_pred             ccCHHHHHHHh-cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCc
Q 014079           67 AFSLFELETIT-KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPN  142 (431)
Q Consensus        67 ~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~n  142 (431)
                      .+.+.+...++ +.|+..++||+||||.||-++.+.+++.      ||+|.+.+..+.   .....++|-.||.+++.+.
T Consensus       173 QWK~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKM------YAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~F  246 (591)
T KOG0986|consen  173 QWKWLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKM------YACKKLDKKRIKKRKGETMALNEKQILEKVSSPF  246 (591)
T ss_pred             HHHHHHhhhccccceeeeEEEecccccceeEEEEecchhh------HHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCc
Confidence            34444444443 5688999999999999999998887765      888888765443   2344678999999999999


Q ss_pred             eeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       143 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      ||.+-..|++.+.+++||..|.||+|.-+|.+.+...+++...+.++.+|+.||++||...  ||+|||||+|||||+.|
T Consensus       247 iVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~--iVYRDLKPeNILLDd~G  324 (591)
T KOG0986|consen  247 IVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR--IVYRDLKPENILLDDHG  324 (591)
T ss_pred             EEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc--eeeccCChhheeeccCC
Confidence            9999999999999999999999999999999888778999999999999999999999755  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      +++|+|+|+|..+..+...   ...+||.+|||||++.++.|+...|+|||||+||||+.|+.||...........    
T Consensus       325 hvRISDLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE----  397 (591)
T KOG0986|consen  325 HVRISDLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE----  397 (591)
T ss_pred             CeEeeccceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH----
Confidence            9999999999887665432   334799999999999999999999999999999999999999976533221111    


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL  349 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt  349 (431)
                               +.+.+ .....+++...++++.++++..|++||.+|..
T Consensus       398 ---------vdrr~-~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG  434 (591)
T KOG0986|consen  398 ---------VDRRT-LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG  434 (591)
T ss_pred             ---------HHHHH-hcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence                     11111 01123556777899999999999999999953

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=5.8e-42  Score=329.33  Aligned_cols=239  Identities=29%  Similarity=0.374  Sum_probs=188.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHH-HHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVN-FLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+..++.      .||+|++.+...   .....+..|.. +++.++||||+++++++...+..|+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv   74 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGK------CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFV   74 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEE
Confidence            369999999999999876554      399999875422   22344555655 46779999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+.+++|.+++....  .+++..+..++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++......
T Consensus        75 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          75 LDFVNGGELFFHLQRER--SFPEPRARFYAAEIASALGYLHSIN--IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             EcCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            99999999998886543  5788899999999999999999866  9999999999999999999999999987532221


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                        .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..++...
T Consensus       151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~----------------~~~~~~~  212 (325)
T cd05604         151 --DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMY----------------DNILHKP  212 (325)
T ss_pred             --CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHH----------------HHHHcCC
Confidence              1223467999999999999999999999999999999999999999764321110                0011111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSD  352 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~e  352 (431)
                      +  ......+..+.+++.+||+.||.+||++.+
T Consensus       213 ~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~  243 (325)
T cd05604         213 L--VLRPGASLTAWSILEELLEKDRQRRLGAKE  243 (325)
T ss_pred             c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCC
Confidence            0  111123467889999999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=6e-41  Score=311.93  Aligned_cols=254  Identities=26%  Similarity=0.427  Sum_probs=203.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||++.+..+.       .+++|.+.... .....+.+|+.+++.++|+||+++++++.+ ...
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~-------~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   75 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHT-------KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPI   75 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCc-------cEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCe
Confidence            467899999999999999999866543       28889876543 234678899999999999999999999887 778


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +++|||+++++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        76 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  153 (260)
T cd05073          76 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVIE  153 (260)
T ss_pred             EEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCCcceeecc
Confidence            99999999999999997765566888899999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......++..|+|||++....++.++|||||||++|++++ |..||.........   .              .
T Consensus       154 ~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~--------------~  215 (260)
T cd05073         154 DNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---R--------------A  215 (260)
T ss_pred             CCCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---H--------------H
Confidence            32211 1122345677999999998899999999999999999999 89999754321110   0              0


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      +............+..+.+++.+||+.||++||++.+++..|+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         216 LERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            00011111122345678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=5.7e-41  Score=311.18  Aligned_cols=251  Identities=22%  Similarity=0.316  Sum_probs=202.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe-CCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE-DDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  155 (431)
                      +|++.+.||.|++|.||++.+..+..      .|++|.+.....  ...+.+.+|++++++++|+|++++++.+.. ...
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGK------QYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGL   74 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCc------EEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCE
Confidence            48889999999999999999876544      399998865432  334567889999999999999999998764 446


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++||||+++++|.+++.......+++..++.++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~--i~H~di~p~nil~~~~~~~~l~df~~~~~~  152 (257)
T cd08223          75 LYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH--ILHRDLKTQNVFLTRTNIIKVGDLGIARVL  152 (257)
T ss_pred             EEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCchhEEEecCCcEEEecccceEEe
Confidence            799999999999999997755556899999999999999999999866  999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||........   .             ..+
T Consensus       153 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~---~-------------~~~  214 (257)
T cd08223         153 ENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL---V-------------YRI  214 (257)
T ss_pred             cccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH---H-------------HHH
Confidence            3321  122345689999999999999999999999999999999999999975321110   0             000


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .... ....+...+..+.+++.+||+.||++||++.+++.+
T Consensus       215 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         215 IEGK-LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HhcC-CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000 111223455788999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=5e-41  Score=316.25  Aligned_cols=253  Identities=25%  Similarity=0.387  Sum_probs=201.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |++.+.||.|+||.||++.+..+...      +++|.+..........+.+|+++++.++|+||+++++++...+..++|
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~------~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v   80 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVL------AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWIL   80 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeE------EEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEE
Confidence            56777899999999999998776553      889988766555567788999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|..++.+.. .++++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~--i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  157 (282)
T cd06643          81 IEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYLHENK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI  157 (282)
T ss_pred             EEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEccCCCEEEccccccccccccc
Confidence            99999999998876533 36899999999999999999999866  9999999999999999999999999987643221


Q ss_pred             CcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          240 ETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                        .......++..|+|||++.     +..++.++|||||||++|||++|+.||.........  ..           ...
T Consensus       158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~-----------~~~  222 (282)
T cd06643         158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK-----------IAK  222 (282)
T ss_pred             --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH-----------Hhh
Confidence              1122356899999999874     456788999999999999999999999764321110  00           000


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...+.  ...+...+.++.+|+.+||+.||.+||++.+++++-.
T Consensus       223 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  264 (282)
T cd06643         223 SEPPT--LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF  264 (282)
T ss_pred             cCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence            00000  0112234568899999999999999999999987643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-41  Score=323.35  Aligned_cols=253  Identities=20%  Similarity=0.254  Sum_probs=197.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.++||+|+||.||++.+..+...      +|+|++.+...   .....+.+|+.++..++|+||+++++++.+.+
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKV------FAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDEN   74 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCE------EEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCC
Confidence            3688999999999999999998776543      99999865322   22334778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+++|+|.+++.+.. ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~--iiHrDlkp~Nili~~~~~~kL~DfG~a~~  151 (332)
T cd05623          75 NLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSCLK  151 (332)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCHHHEEECCCCCEEEeecchhee
Confidence            9999999999999999997643 25788888999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ...... ......+||+.|+|||++.     ...++.++|||||||++|||++|+.||..........            
T Consensus       152 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------------  218 (332)
T cd05623         152 LMEDGT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------------  218 (332)
T ss_pred             cccCCc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------------
Confidence            432221 1223357999999999886     3468899999999999999999999997643211110            


Q ss_pred             chhhhhcCcccc---CcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHH
Q 014079          310 RKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~  356 (431)
                          .+......   .......+.++.+|+.+||..++.+  |+++.+++++
T Consensus       219 ----~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         219 ----KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ----HHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                11110000   0011234578889999988665544  6899999877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=3.4e-41  Score=314.71  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|.+.+.||+|+||.||+|.+..+..      .|++|+++.........+.+|+.+++.++||||+++++++...+..+
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGE------LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLW   82 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCc------EEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEE
Confidence            467788899999999999999876554      39999987665445566788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++....  .+++...+.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++.....
T Consensus        83 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd06645          83 ICMEFCGGGSLQDIYHVTG--PLSESQIAYVSRETLQGLYYLHSKG--KMHRDIKGANILLTDNGHVKLADFGVSAQITA  158 (267)
T ss_pred             EEEeccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEECcceeeeEccC
Confidence            9999999999999986654  5788999999999999999999876  99999999999999999999999999875432


Q ss_pred             CCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ..  .......|+..|+|||++.   ...++.++|||||||++|+|++|+.||....+.........        .   .
T Consensus       159 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~--------~---~  225 (267)
T cd06645         159 TI--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTK--------S---N  225 (267)
T ss_pred             cc--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhc--------c---C
Confidence            21  1123356899999999874   45688999999999999999999999865432211100000        0   0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...+....  ....+..+.+++.+||+.||++||++.+|+++
T Consensus       226 ~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         226 FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            00000000  11234568899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.3e-41  Score=310.38  Aligned_cols=252  Identities=26%  Similarity=0.386  Sum_probs=205.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|+..+.||.|+||.||.+....++..      +++|.+....  .....++.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~------~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   74 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSL------VVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTL   74 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcE------EEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeE
Confidence            488899999999999999988765543      8999876543  23446688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +++|||+++++|.+++.+.....+++..+..++.|++.+|.|||+.+  ++|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~  152 (256)
T cd08221          75 LIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG--ILHRDIKTLNIFLTKAGLIKLGDFGISKILG  152 (256)
T ss_pred             EEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChHhEEEeCCCCEEECcCcceEEcc
Confidence            99999999999999998765556899999999999999999999876  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|++.|+|||++.+..++.++||||||+++|||++|..||.........                ..+.
T Consensus       153 ~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~----------------~~~~  214 (256)
T cd08221         153 SEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLV----------------VKIV  214 (256)
T ss_pred             cccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHH----------------HHHH
Confidence            3321  223456899999999998888999999999999999999999999654321110                0111


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...+. ......+.++.+++.+||+.+|.+||++.++++++
T Consensus       215 ~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         215 QGNYT-PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCCCC-CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            11111 11133457788999999999999999999999764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=8.7e-41  Score=316.27  Aligned_cols=253  Identities=25%  Similarity=0.391  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.+.||.|+||.||+|.+..+...      +++|++..........+.+|+.+++.++|+||+++++++..++..+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~------~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGAL------AAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW   85 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCce------EEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence            5688999999999999999998775543      9999987766556677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|..++.+.. ..+++..++.++.|++.+|.|||+.+  |+||||||+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          86 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMK--IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             EEEecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC--eeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            9999999999988876543 35889999999999999999999866  99999999999999999999999999865322


Q ss_pred             CCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ..  .......+++.|+|||++.     ...++.++|||||||++|||++|..||........  ...           +
T Consensus       163 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~~-----------~  227 (292)
T cd06644         163 TL--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLK-----------I  227 (292)
T ss_pred             cc--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HHH-----------H
Confidence            11  1122356889999999885     34578899999999999999999999965432111  000           0


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+.  ...+...+.++.+++.+||+.||++||++.+++++
T Consensus       228 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         228 AKSEPPT--LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             hcCCCcc--CCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0000000  01122345678899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.8e-41  Score=348.44  Aligned_cols=263  Identities=23%  Similarity=0.325  Sum_probs=203.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.++||+|+||.||+|.+..++.      .||+|++.....   ...+++.+|++++++++||||+++++++.+.+
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~------~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~   75 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSR------RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGD   75 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCc------EEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCC
Confidence            478999999999999999999876554      399999875422   23456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC---------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA---------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~---------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      ..++||||++|++|.+++....         ...+++...+.++.|++.||+|||+.+  |+||||||+|||++.++.++
T Consensus        76 ~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G--IIHRDLKPeNILLd~dg~vK  153 (932)
T PRK13184         76 PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG--VLHRDLKPDNILLGLFGEVV  153 (932)
T ss_pred             EEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchheEEEcCCCCEE
Confidence            9999999999999999886421         123456777889999999999999866  99999999999999999999


Q ss_pred             EecccCCccCCCCCC----------------cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          226 LSDFGLAKAGPQGDE----------------THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       226 l~DFG~a~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                      |+|||+++.......                ........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       154 LiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        154 ILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            999999976521100                0011235699999999999999999999999999999999999999976


Q ss_pred             CCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhhhc
Q 014079          290 TRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-LMSDVVETLEPLQCA  363 (431)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~  363 (431)
                      .........           .   ....+. ........+..+.+++.+||+.||++|| ++.++++.|+.....
T Consensus       234 ~~~~ki~~~-----------~---~i~~P~-~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        234 KKGRKISYR-----------D---VILSPI-EVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             cchhhhhhh-----------h---hccChh-hccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            332111000           0   000000 0000123446788999999999999996 667777888776543

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.6e-41  Score=308.68  Aligned_cols=248  Identities=29%  Similarity=0.453  Sum_probs=197.7

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ++||.|+||.||++.+.+ .+      .|++|.+...... ....+.+|++++++++|+||+++++++.+....++||||
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~------~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   73 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NT------EVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL   73 (251)
T ss_pred             CccccCCCceEEEEEEeC-CC------cEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEc
Confidence            369999999999999876 33      3899988765443 456788999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +.+++|.+++.... ..+++..++.++.+++.+|.|||+.+  ++||||||+|||++.++.++|+|||++..........
T Consensus        74 ~~~~~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~--i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~  150 (251)
T cd05041          74 VPGGSLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV  150 (251)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--EehhhcCcceEEEcCCCcEEEeeccccccccCCccee
Confidence            99999999986643 35788889999999999999999866  9999999999999999999999999987643222111


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                      ......++..|+|||.+.++.++.++|||||||++|||++ |..||...........                 +.....
T Consensus       151 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~-----------------~~~~~~  213 (251)
T cd05041         151 SDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER-----------------IESGYR  213 (251)
T ss_pred             ccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH-----------------HhcCCC
Confidence            1112234667999999998899999999999999999999 8888866532211111                 100111


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...+...+..+.+++.+||+.+|.+||++.||++.|+
T Consensus       214 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         214 MPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            1122234568899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-41  Score=314.49  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=203.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||.|+||.||+|.+..++.      .|++|++.... ......+.+|+.+++.++|+||+++++++.+....
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQ------VVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKL   74 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCe------EEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeE
Confidence            367888899999999999999876554      39999887653 33445688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+++++|.+++...   ++++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||+++...
T Consensus        75 ~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~  149 (274)
T cd06609          75 WIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEG--KIHRDIKAANILLSEEGDVKLADFGVSGQLT  149 (274)
T ss_pred             EEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEcccccceeec
Confidence            9999999999999998654   6889999999999999999999866  9999999999999999999999999997754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ...  .......+++.|+|||++.+..++.++||||||+++|+|++|+.||....+......             +..  
T Consensus       150 ~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-------------~~~--  212 (274)
T cd06609         150 STM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-------------IPK--  212 (274)
T ss_pred             ccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-------------hhh--
Confidence            332  112235688899999999988899999999999999999999999975432111000             000  


Q ss_pred             CccccCcccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVR-AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ......... .+..+.+++.+||..||++|||+++++.+
T Consensus       213 --~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         213 --NNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --cCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence              011111111 45678899999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-42  Score=309.10  Aligned_cols=248  Identities=28%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---HHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|..+++||+|.||.|.+++.+.+.+.      ||+|+++++-+-.   ...-+.|-++|+..+||.+..+-..|+..+
T Consensus       168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~------YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  168 EDFDFLKVLGKGTFGKVILCREKATGKL------YAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             chhhHHHHhcCCccceEEEEeecccCce------eehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            5677888999999999999999888776      9999999875433   334567999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||..||.|.-+|.+..  .+++.....+-..|+.||.|||+.+  ||+||||.+|+|+|.+|++||.|||+++.
T Consensus       242 rlCFVMeyanGGeLf~HLsrer--~FsE~RtRFYGaEIvsAL~YLHs~~--ivYRDlKLENLlLDkDGHIKitDFGLCKE  317 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRER--VFSEDRTRFYGAEIVSALGYLHSRN--IVYRDLKLENLLLDKDGHIKITDFGLCKE  317 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhh--cccchhhhhhhHHHHHHhhhhhhCC--eeeeechhhhheeccCCceEeeecccchh
Confidence            9999999999999999987754  4778888889999999999999866  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...  ......++||||.|+|||++..+.|..++|+|.+||++|||++|+.||......+                 +.+
T Consensus       318 ~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k-----------------LFe  378 (516)
T KOG0690|consen  318 EIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK-----------------LFE  378 (516)
T ss_pred             ccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH-----------------HHH
Confidence            322  2234557899999999999999999999999999999999999999997654322                 222


Q ss_pred             hc-CccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 II-DPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      .+ ...  -.++...++++..|+..+|.+||.+|.     ++.||.++
T Consensus       379 LIl~ed--~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  379 LILMED--LKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHHhhh--ccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            21 111  134556678899999999999999994     56777654

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-41  Score=321.08  Aligned_cols=255  Identities=26%  Similarity=0.336  Sum_probs=204.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|+..+.||+|+||.||+|.+...++      .|++|.+......   ....+.+|+++++.++|+||+++++.+.+..
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   74 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGK------LFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTET   74 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCc------EEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCC
Confidence            368888999999999999999877544      3999998765433   3456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+.+++|.+++.......+++.....++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~~l~dfg~~~~  152 (316)
T cd05574          75 YLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG--IVYRDLKPENILLHESGHIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChHHeEEcCCCCEEEeecchhhc
Confidence            9999999999999999997765567899999999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCc---------------------------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          235 GPQGDET---------------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       235 ~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      .......                           .......||..|+|||++.+..++.++||||||+++|+|++|+.||
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf  232 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPF  232 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCC
Confidence            4321110                           0111346899999999999989999999999999999999999999


Q ss_pred             CCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC----HHHHHHH
Q 014079          288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL----MSDVVET  356 (431)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt----~~eil~~  356 (431)
                      ........                +..+.............+..+.+++.+||+.||++||+    +.+++.+
T Consensus       233 ~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         233 KGSNRDET----------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             CCCchHHH----------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            75432111                11111111111111125678999999999999999999    7777654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.1e-41  Score=318.14  Aligned_cols=253  Identities=23%  Similarity=0.338  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||.||++.+...+.      .||+|.+........+.+.+|+.+++.++|+||+++++++...+.
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   90 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQ------EVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   90 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCC------EEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCE
Confidence            44789999999999999999999865544      399998876655555678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++...   .+++..+..++.|++.+|.|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        91 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~--i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~  165 (297)
T cd06656          91 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  165 (297)
T ss_pred             EEEeecccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEECcCccceEc
Confidence            99999999999999998543   4788899999999999999999876  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....  ......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+.......             .  
T Consensus       166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~-------------~--  228 (297)
T cd06656         166 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------A--  228 (297)
T ss_pred             cCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee-------------c--
Confidence            33221  122356889999999999999999999999999999999999999764332111000             0  


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .........+...+..+.+++.+||+.||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         229 TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000011122345678899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.4e-40  Score=311.09  Aligned_cols=255  Identities=27%  Similarity=0.385  Sum_probs=191.5

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||+|.+.++..    ...+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYT----PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFC   77 (269)
T ss_pred             cccccCCceEEEEEEcCCCC----ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence            58999999999998754321    22489998876532 33456888999999999999999999999999999999999


Q ss_pred             CCCChHHhhhhCC---CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          164 FRGSLENHLFRKA---TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       164 ~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ++++|.+++....   ....++..++.++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~  155 (269)
T cd05087          78 PLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN--FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY  155 (269)
T ss_pred             CCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--EeccccCcceEEEcCCCcEEECCccccccccCcce
Confidence            9999999996532   224567777889999999999999866  99999999999999999999999999875433222


Q ss_pred             cceeecccCCccccCccccccC-------CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          241 THVSTRVMGTYGYAAPEYVMTG-------HLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........++..|+|||++.+.       .++.++||||||+++|||++ |+.||............   .     ....
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~---~-----~~~~  227 (269)
T cd05087         156 YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT---V-----REQQ  227 (269)
T ss_pred             eecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---h-----hccc
Confidence            2222235678899999988642       35789999999999999996 99999754332111000   0     0000


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ....++.+    ....+..+.+++.+|| .+|++|||+.+|+..|+
T Consensus       228 ~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         228 LKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            11111111    1123456788999999 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=8.7e-41  Score=311.30  Aligned_cols=247  Identities=23%  Similarity=0.369  Sum_probs=191.5

Q ss_pred             ceecccCcEEEEEEEEcCCce------eccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           84 YILGEGGFGTVYKGYIDENVR------VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.||+|+||.||+|.......      ...+...+++|++..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            368999999999998643211      11234458999887665445567888999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc-------EEEeccc
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT-------AKLSDFG  230 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~-------~kl~DFG  230 (431)
                      +||||+++++|..++.... .++++..++.++.|++.||+|||+.+  |+||||||+|||++.++.       ++++|||
T Consensus        81 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRKS-DVLTTPWKFKVAKQLASALSYLEDKD--LVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             EEEecccCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHhhhCC--eECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            9999999999998886543 35888999999999999999999866  999999999999987654       8999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELL-TGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ++......      ....++..|+|||++. +..++.++|||||||++|||+ .|..||..........           
T Consensus       158 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~-----------  220 (262)
T cd05077         158 IPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-----------  220 (262)
T ss_pred             CCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHH-----------
Confidence            98654221      1245788999999886 567899999999999999998 4888876532211100           


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                            .......  .......++.+|+.+||+.||.+||++.+|++.|+
T Consensus       221 ------~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 ------FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ------HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                  0000000  01112357889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9e-41  Score=311.75  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=200.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---------hHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---------GHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      +|.+...||.|+||.||+|.+.....      .+++|.+......         ..+.+.+|+.++++++||||++++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   74 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGE------LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGS   74 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCc------EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            47788899999999999998865443      3899987654321         12457789999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                      +.+.+..++||||+++++|.+++....  .+++.....++.|++.||.|||+.+  ++||||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~~l~~~l~~lH~~~--ivH~di~p~nil~~~~~~~~l~df  150 (267)
T cd06628          75 SLDADHLNIFLEYVPGGSVAALLNNYG--AFEETLVRNFVRQILKGLNYLHNRG--IIHRDIKGANILVDNKGGIKISDF  150 (267)
T ss_pred             EEeCCccEEEEEecCCCCHHHHHHhcc--CccHHHHHHHHHHHHHHHHHHHhcC--cccccCCHHHEEEcCCCCEEeccc
Confidence            999999999999999999999997653  4788888899999999999999866  999999999999999999999999


Q ss_pred             cCCccCCCCCCc----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          230 GLAKAGPQGDET----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       230 G~a~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+++........    .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||........          
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------  220 (267)
T cd06628         151 GISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQA----------  220 (267)
T ss_pred             CCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHH----------
Confidence            998865422111    111234588999999999998999999999999999999999999975422110          


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            +..... ......+...+..+.+++.+||+.||.+||++.+|+++
T Consensus       221 ------~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         221 ------IFKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ------HHHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                  001000 11112223345788899999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=312.20  Aligned_cols=252  Identities=25%  Similarity=0.412  Sum_probs=196.0

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      ++||+|+||.||+|.+.++...    ..+++|.+.... ......+.+|+.++.++ +||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~----~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e   76 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIE   76 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCe----eEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEE
Confidence            3689999999999998764321    137888887543 23345788999999999 79999999999999999999999


Q ss_pred             ecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          162 FMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      |+++++|.+++....              ...+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nili~~~~~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGENYVAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccccceEEEcCCCeEEEC
Confidence            999999999986532              124788899999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||++.......   .......+..|+|||++.+..++.++|||||||++|||++ |..||........   .       
T Consensus       155 dfgl~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~-------  221 (270)
T cd05047         155 DFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL---Y-------  221 (270)
T ss_pred             CCCCccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHH---H-------
Confidence            999986422111   1111234567999999988899999999999999999997 9999965422110   0       


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                             ..+........+...+.++.+++.+||..||.+|||+.+++..|..+.
T Consensus       222 -------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         222 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -------HHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                   001111111112234467889999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-41  Score=315.67  Aligned_cols=247  Identities=24%  Similarity=0.377  Sum_probs=193.5

Q ss_pred             ceecccCcEEEEEEEEcCCcee-ccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRV-GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +.||+|+||.||+|.+...... .....++++|.+..........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            3699999999999988653322 233445888888766545556788999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--------EEEecccCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--------AKLSDFGLAKA  234 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--------~kl~DFG~a~~  234 (431)
                      +.+|+|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.        ++++|||++..
T Consensus        81 ~~~g~L~~~l~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~--iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          81 VKFGSLDTYLKKNKN-LINISWKLEVAKQLAWALHFLEDKG--LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             CCCCcHHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            999999999976543 5788999999999999999999866  999999999999987765        69999998865


Q ss_pred             CCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR-KSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ....      ....++..|+|||++.+ ..++.++|||||||++|||++|. .||...........              
T Consensus       158 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~--------------  217 (258)
T cd05078         158 VLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF--------------  217 (258)
T ss_pred             cCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH--------------
Confidence            4321      22457889999999886 45899999999999999999985 55544322111000              


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         ....  ...+.....++.+|+.+||+.||++|||+.+|++.|+
T Consensus       218 ---~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         218 ---YEDR--HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ---HHcc--ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence               0000  0111223357889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=8.7e-41  Score=321.47  Aligned_cols=267  Identities=21%  Similarity=0.245  Sum_probs=196.8

Q ss_pred             ccceeccc--CcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           82 SDYILGEG--GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        82 ~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.++||+|  +|++||++.+..++..      ||+|.++....  .....+.+|+.+++.++||||+++++++..++..+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~   75 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEY------VTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW   75 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcE------EEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEE
Confidence            45679999  7899999998877654      99999876532  22345678999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++++||+.......
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~  153 (327)
T cd08227          76 VVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSNLSMIN  153 (327)
T ss_pred             EEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCChhhEEEecCCcEEEcccchhhcccc
Confidence            9999999999999997654456889999999999999999999866  99999999999999999999999986543221


Q ss_pred             CCC-c----ceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhhhhhhcc
Q 014079          238 GDE-T----HVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL-VDWARPKLNDK  309 (431)
Q Consensus       238 ~~~-~----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~~~~~  309 (431)
                      ... .    .......++..|+|||++.+  ..++.++|||||||++|||++|+.||........... .....+...+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (327)
T cd08227         154 HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  233 (327)
T ss_pred             ccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccc
Confidence            111 0    01112356778999999876  4689999999999999999999999975432111000 00000000000


Q ss_pred             -----ch-------------hhh---------hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 -----RK-------------MLQ---------IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 -----~~-------------~~~---------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           ..             ...         ..............+..+.+|+.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         234 TTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             cchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                 00             000         000000011223446789999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.1e-40  Score=311.91  Aligned_cols=261  Identities=25%  Similarity=0.373  Sum_probs=204.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|.+.+.||+|+||.||+|.+.+..   .....|++|...... ....+.+.+|+.++++++||||+++++++.+ +..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~---~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE---NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC---CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            45788899999999999999876531   112348999887654 3445678899999999999999999999875 557


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.+++.||.|||+.+  ++|+||||+|||++.++.++|+|||+++...
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKR--FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccChheEEEecCCCeEEccCceeeecc
Confidence            89999999999999997643 35899999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |..||............       .        
T Consensus       159 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~-------~--------  222 (270)
T cd05056         159 DESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI-------E--------  222 (270)
T ss_pred             cccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------H--------
Confidence            33211 1122334568999999988899999999999999999996 99999765322111000       0        


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                       . ......+..++..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus       223 -~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         223 -N-GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             -c-CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             0 000011223456889999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=7.2e-41  Score=318.58  Aligned_cols=263  Identities=24%  Similarity=0.385  Sum_probs=203.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|+..+.||+|+||.||+|.+..++...  ...+|+|.+...... ...++.+|+.+++.++||||+++++++... ..
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~   83 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETV--KIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcc--eeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cc
Confidence            45778889999999999999986544321  224899988765332 234678999999999999999999998654 56


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++++||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||+++...
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERR--LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcC--eeccccccceeeecCCCceEEcccccccccc
Confidence            79999999999999987643 25788899999999999999999866  9999999999999999999999999998654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||.+..........                
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~----------------  224 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL----------------  224 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----------------
Confidence            3322212223446778999999999999999999999999999997 99999654321111100                


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                       ........+..++..+.+++..||..+|++||++.++++.|..+...
T Consensus       225 -~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         225 -EKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             -HCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence             00000011112345788999999999999999999999999877544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=8.7e-41  Score=313.38  Aligned_cols=246  Identities=24%  Similarity=0.380  Sum_probs=190.2

Q ss_pred             eecccCcEEEEEEEEcCCc------------------eeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeee
Q 014079           85 ILGEGGFGTVYKGYIDENV------------------RVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~------------------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      .||+|+||.||+|......                  ........|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            5999999999999853211                  0112334589999876654445678899999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----  222 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----  222 (431)
                      ++++.+....++||||+++++|..++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++..+    
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK-GRVPVAWKITVAQQLASALSYLEDKN--LVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHcCC--ccCCCCCcccEEEeccCcccC
Confidence            999999999999999999999999886533 35788889999999999999999865  99999999999997643    


Q ss_pred             ---cEEEecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHH-hCCCCCCCCCCcccch
Q 014079          223 ---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELL-TGRKSVDKTRPSKEQS  297 (431)
Q Consensus       223 ---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~pf~~~~~~~~~~  297 (431)
                         .++|+|||++......      ....++..|+|||++.+ ..++.++|||||||++|||+ +|+.||....+.....
T Consensus       159 ~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~  232 (274)
T cd05076         159 TSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER  232 (274)
T ss_pred             ccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence               4899999987643221      12347788999998875 56899999999999999995 6999997653321111


Q ss_pred             hhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...       .        ...+.    ......+.+++.+||+.+|++|||+.+|++.|.
T Consensus       233 ~~~-------~--------~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         233 FYE-------K--------KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH-------h--------ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            000       0        00011    112346889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=8.7e-41  Score=313.31  Aligned_cols=261  Identities=26%  Similarity=0.384  Sum_probs=204.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|+..+.||.|+||.||+|..+.... ......+++|.+...... ....+.+|++++++++|+||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEE-EGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCc-CCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            568888999999999999999865432 122335899988765433 346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCC-------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          157 LLVYEFMFRGSLENHLFRKAT-------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                      ++||||+++++|.+++.....       ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+||
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR--FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC--cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999999976541       25899999999999999999999876  999999999999999999999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      |++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||........   ..        
T Consensus       162 ~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~---~~--------  229 (275)
T cd05046         162 SLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEV---LN--------  229 (275)
T ss_pred             ccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHH---HH--------
Confidence            998754322111 1223456778999999988889999999999999999999 8889865332111   10        


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                           ......+........+..+.+++.+||+.||.+||++.+++..|.
T Consensus       230 -----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 -----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             -----HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                 000011111112234468889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9e-41  Score=314.87  Aligned_cols=276  Identities=26%  Similarity=0.376  Sum_probs=202.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeC--C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED--D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  154 (431)
                      +.|++.+.||+|+||.||++.+.....  ..+..|++|.++... ......+.+|+.++++++||||+++++++.+.  .
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGD--NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   81 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCC--CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence            457888999999999999998542111  112349999987553 23345788999999999999999999998875  5


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.+.. ..+++..++.++.|++.||+|||+.+  ++||||||+|||++.++.++|+|||+++.
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~g--i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccchheEEEcCCCCEEECCCccccc
Confidence            6899999999999999986543 35789999999999999999999866  99999999999999999999999999986


Q ss_pred             CCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ....... .......++..|+|||++.+..++.++|||||||++|||++++.|+......... ........... ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~~-~~~~  236 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMTV-TRLV  236 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccccccH-HHHH
Confidence            5433221 1122345777899999999889999999999999999999987765332110000 00000000000 0000


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ..+...........++..+.+|+.+||+.||.+||++.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            01111111111223457899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-41  Score=325.92  Aligned_cols=266  Identities=23%  Similarity=0.340  Sum_probs=197.6

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ..+.++|++.+.||.|+||.||+|.+..+..      .||+|.+.....  .....+.+|+.+|++++||||+++++++.
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (343)
T cd07878          11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQ------KVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFT   84 (343)
T ss_pred             hhhhhhhhhheecccCCCeEEEEEEECCCCC------EEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhc
Confidence            3466889999999999999999999876654      399999875422  23456778999999999999999999886


Q ss_pred             eC------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          152 ED------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       152 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      ..      ...|++++++ +++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+|
T Consensus        85 ~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrdikp~Nil~~~~~~~k  158 (343)
T cd07878          85 PATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAG--IIHRDLKPSNVAVNEDCELR  158 (343)
T ss_pred             ccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecccCChhhEEECCCCCEE
Confidence            43      3468999988 8899887743   34889999999999999999999876  99999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hh-
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-WA-  302 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~-  302 (431)
                      |+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||............. .. 
T Consensus       159 l~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  233 (343)
T cd07878         159 ILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVG  233 (343)
T ss_pred             EcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999864332     223568999999999876 578999999999999999999999997643221110000 00 


Q ss_pred             hh--hhh-c--cchhhhhcC--ccccC----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RP--KLN-D--KRKMLQIID--PRLEN----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~--~~~-~--~~~~~~~~~--~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+  ... .  .......+.  +....    .........+.+|+.+||+.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         234 TPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             CCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00  000 0  000000000  00000    0001123467899999999999999999999976

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=7.5e-41  Score=315.32  Aligned_cols=267  Identities=22%  Similarity=0.292  Sum_probs=198.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||+|+||.||+|.+..++.      .|++|.+.....  .....+.+|+.++++++||||+++++++.+++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   74 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQ------IVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRL   74 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCc------EEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeE
Confidence            47788899999999999999876544      399998865422  2235678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++||||+. ++|.+++.... ...+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++...
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  151 (285)
T cd07861          75 YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR--VLHRDLKPQNLLIDNKGVIKLADFGLARAF  151 (285)
T ss_pred             EEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCCHHHEEEcCCCcEEECcccceeec
Confidence            99999996 68888886533 256889999999999999999999866  999999999999999999999999998754


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-h-hhhh------hh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-D-WARP------KL  306 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~-~~~~------~~  306 (431)
                      ....  .......+++.|+|||++.+. .++.++|||||||++|+|++|+.||............ . +..+      ..
T Consensus       152 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (285)
T cd07861         152 GIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV  229 (285)
T ss_pred             CCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcc
Confidence            3221  112234578899999988654 5789999999999999999999999765332111000 0 0000      00


Q ss_pred             hccchhhhhcCc---cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQIIDP---RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ............   ..........+.++.+++.+||+.||.+|||+.+|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             hhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            000000000000   00001111245788899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.8e-40  Score=306.69  Aligned_cols=247  Identities=28%  Similarity=0.464  Sum_probs=195.6

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ++||+|+||.||+|...++.       .+|+|++...... ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~-------~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   73 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKT-------PVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL   73 (250)
T ss_pred             CccCCCCCceEEEEEecCCc-------EEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEEC
Confidence            36999999999999865433       3899988765432 234688999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++.... ..+.+..++.++.+++.+|.|||+.+  ++|+||||+||+++.++.++|+|||++......... 
T Consensus        74 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-  149 (250)
T cd05085          74 VPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKN--CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-  149 (250)
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccChheEEEcCCCeEEECCCccceeccccccc-
Confidence            99999999886543 35789999999999999999999866  999999999999999999999999998754322111 


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                      ......++..|+|||++.+..++.++||||||+++|+|++ |..||...........                 +.....
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-----------------~~~~~~  212 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-----------------VEKGYR  212 (250)
T ss_pred             cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-----------------HHcCCC
Confidence            1112234677999999998999999999999999999998 9999965432111000                 000111


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       213 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         213 MSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            1112234578899999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-40  Score=308.70  Aligned_cols=255  Identities=26%  Similarity=0.367  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||.|+||.||+|.+..+..      .+++|++..........+.+|+.++++++||||+++++++.+.+.++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~   76 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGE------LVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLW   76 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCC------EEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEE
Confidence            568889999999999999999876543      38999987665555677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ++|||+.+++|.+++.... .++++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++.....
T Consensus        77 l~~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~  153 (262)
T cd06613          77 IVMEYCGGGSLQDIYQVTR-GPLSELQIAYVCRETLKGLAYLHETG--KIHRDIKGANILLTEDGDVKLADFGVSAQLTA  153 (262)
T ss_pred             EEEeCCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ceecCCChhhEEECCCCCEEECccccchhhhh
Confidence            9999999999999886642 35888999999999999999999866  99999999999999999999999999876433


Q ss_pred             CCCcceeecccCCccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...  ......++..|+|||.+.+.   .++.++||||||+++|+|++|+.||....+........  .          .
T Consensus       154 ~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~--~----------~  219 (262)
T cd06613         154 TIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS--K----------S  219 (262)
T ss_pred             hhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--h----------c
Confidence            211  12335688999999998776   88999999999999999999999997644222111000  0          0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...+ .........+.++.+++.+||..||.+|||+.+|+.+
T Consensus       220 ~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         220 NFPP-PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             cCCC-ccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0000 0011223456788999999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-40  Score=318.39  Aligned_cols=200  Identities=25%  Similarity=0.385  Sum_probs=160.4

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe--CCeeEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--DDHRLLVY  160 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  160 (431)
                      .++||+|+||.||+|.+.++.    ....||+|.+.....  ...+.+|+.+|++++||||+++++++..  ....++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~----~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~   79 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGK----DDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF   79 (317)
T ss_pred             ccccccCCCeEEEEEEEccCC----CCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEE
Confidence            357999999999999876431    122499998876532  3456789999999999999999999864  45678999


Q ss_pred             EecCCCChHHhhhhC-------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE----CCCCcEEEecc
Q 014079          161 EFMFRGSLENHLFRK-------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSDF  229 (431)
Q Consensus       161 e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl----~~~~~~kl~DF  229 (431)
                      ||+ +++|.+++...       ....+++..+..++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+||
T Consensus        80 e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          80 DYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             ecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            998 56888877532       2235888899999999999999999866  9999999999999    45678999999


Q ss_pred             cCCccCCCCCCc-ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 014079          230 GLAKAGPQGDET-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTR  291 (431)
Q Consensus       230 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  291 (431)
                      |+++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            999865432211 12234678999999999877 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.7e-40  Score=307.63  Aligned_cols=251  Identities=26%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||.|+||.||+|.+..+..      .+++|.+.....  ..++.+|++++++++|+||+++++++.+....|
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~   74 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQ------VVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLW   74 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCc------EEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEE
Confidence            568888999999999999999876543      389998876532  567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +++||+.+++|.+++.... ..+++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 l~~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~  151 (256)
T cd06612          75 IVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSNK--KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence            9999999999999986543 46899999999999999999999876  99999999999999999999999999886543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...  ......|+..|+|||++.+..++.++||||||+++|+|++|+.||....+......             ......
T Consensus       152 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~  216 (256)
T cd06612         152 TMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM-------------IPNKPP  216 (256)
T ss_pred             Ccc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh-------------hccCCC
Confidence            321  12234588899999999999999999999999999999999999976432211100             000000


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +  ....+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       217 ~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         217 P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence            0  011123345688999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.4e-40  Score=315.60  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=204.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..+|+..+.||.|+||.||+|.+..++.      .|++|.+..........+.+|+.+++.++|+||+++++++...+..
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   91 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQ------EVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDEL   91 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCc------EEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence            3568899999999999999998866544      3999988766555567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+.+++|.+++...   .+++..+..++.+++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~--i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~  166 (296)
T cd06655          92 FVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQ--VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT  166 (296)
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccchhcc
Confidence            9999999999999988543   4789999999999999999999876  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+.......             ..  
T Consensus       167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~-------------~~--  229 (296)
T cd06655         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI-------------AT--  229 (296)
T ss_pred             cccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hh--
Confidence            3221  122346889999999999888999999999999999999999999765432111100             00  


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ........+...+..+.++|.+||..||.+||++.+|+.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         230 NGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            0000001122345678899999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.8e-40  Score=308.77  Aligned_cols=255  Identities=26%  Similarity=0.437  Sum_probs=193.0

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEE-eCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCC-EDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e  161 (431)
                      +.||+|+||.||+|.+.+...   ....+|+|.+... .......+.+|+.+++.++||||+++++++. .++..++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e   77 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDG---QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLP   77 (262)
T ss_pred             CcccccCCceEEEEEEecCCC---ceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEe
Confidence            368999999999998754321   1234999988543 2334567889999999999999999999775 4556899999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      |+.+++|.+++..... ...+...+.++.|++.||.|||+.+  ++||||||+|||++.++.+||+|||+++........
T Consensus        78 ~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          78 YMKHGDLRNFIRSETH-NPTVKDLIGFGLQVAKGMEYLASKK--FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             cCCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--ccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            9999999999976433 3567777889999999999999866  999999999999999999999999999764332111


Q ss_pred             c--eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          242 H--VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       242 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      .  ......++..|+|||.+.+..++.++|||||||++|||++| ..||.......   ....             ....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~-------------~~~~  218 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVY-------------LLQG  218 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHH-------------HhcC
Confidence            1  11223467789999999888999999999999999999995 55665432111   1100             0000


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                       .....+...+..+.+++.+||..+|++||++.+|++.|+.+.
T Consensus       219 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         219 -RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             -CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence             000111123467889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=327.52  Aligned_cols=242  Identities=27%  Similarity=0.363  Sum_probs=187.7

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcC---CCCceeeeecEEEeCCeeEEE
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQL---RHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ||+|+||+||+|.+..++..      ||+|++.+....   ....+..|..++..+   .||||+++++++.+.+..|+|
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv   74 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRI------YAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLV   74 (330)
T ss_pred             CCCCCceEEEEEEECCCCCE------EEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEE
Confidence            79999999999998766543      999998754322   223455677777665   699999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+.+++|.+++....  .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.++|+|||+++......
T Consensus        75 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~qil~al~~LH~~~--ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  150 (330)
T cd05586          75 TDYMSGGELFWHLQKEG--RFSEDRAKFYIAELVLALEHLHKYD--IVYRDLKPENILLDATGHIALCDFGLSKANLTDN  150 (330)
T ss_pred             EcCCCCChHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC
Confidence            99999999999887644  4788999999999999999999876  9999999999999999999999999987533222


Q ss_pred             CcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      .  .....+||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+       .       ....
T Consensus       151 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i-------~-------~~~~  214 (330)
T cd05586         151 K--TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI-------A-------FGKV  214 (330)
T ss_pred             C--CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH-------H-------cCCC
Confidence            1  22346799999999998764 4899999999999999999999999764321110000       0       0000


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCC----CHHHHHHH
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVET  356 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RP----t~~eil~~  356 (431)
                      .+.   ....+.++.+|+.+||+.||.+||    ++.+++++
T Consensus       215 ~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         215 RFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence            111   112346788999999999999998    56676654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.5e-40  Score=310.80  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=188.9

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||+|....+.    ....+++|.+..... .....+.+|+.+++.++|+||+++++++.+....++||||+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~----~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~   77 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGM----SKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFC   77 (269)
T ss_pred             cCCccCCceEEEEEEecCC----CCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeC
Confidence            5899999999999765432    223488888765432 23456789999999999999999999999999999999999


Q ss_pred             CCCChHHhhhhCCC---CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          164 FRGSLENHLFRKAT---VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       164 ~~gsL~~~l~~~~~---~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      ++|+|.+++.....   ....+...+.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++........
T Consensus        78 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  155 (269)
T cd05042          78 PLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD--FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY  155 (269)
T ss_pred             CCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC--EecccccHhheEecCCCcEEEeccccccccccchh
Confidence            99999999976432   22456777889999999999999866  99999999999999999999999999875432221


Q ss_pred             cceeecccCCccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          241 THVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........++..|+|||++..       ..++.++|||||||++|||++ |..||............      +.  ...
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~--~~~  227 (269)
T cd05042         156 YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV------VR--EQD  227 (269)
T ss_pred             eeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hh--ccC
Confidence            111122346778999998743       457889999999999999999 78888654321110000      00  000


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .....+    ......+..+.+++..|| .||++|||+.+|++.|
T Consensus       228 ~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         228 IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            001111    122234567778899998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-40  Score=313.46  Aligned_cols=276  Identities=27%  Similarity=0.391  Sum_probs=207.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEe--CC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCE--DD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  154 (431)
                      +.|++.+.||+|+||.||++.+.....  ..+..+|+|++...... ....+.+|+++++.++|+||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~--~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGD--NTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCC--CCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            356777899999999999998754311  12235999998866543 45678999999999999999999999887  56


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~l~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRD-QINLKRLLLFSSQICKGMDYLGSQR--YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCcc-ccCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            78999999999999999976542 5889999999999999999999866  99999999999999999999999999987


Q ss_pred             CCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ........ ......++..|++||.+.+..++.++||||||+++|||++|+.||......... ..... ........+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~-~~~~~-~~~~~~~~~~  236 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR-MIGIA-QGQMIVTRLL  236 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc-ccccc-cccccHHHHH
Confidence            65322211 111234566799999998889999999999999999999999998653221100 00000 0000011111


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ..+........+..++.++.+|+.+||+.+|.+|||+.+|++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            12211111122233457899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.2e-41  Score=314.38  Aligned_cols=258  Identities=27%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYC  150 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  150 (431)
                      ++......|++.+.||.|+||.||+|.+.....      .+++|++.... ....++..|+.+++++ +|+||+++++++
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636          10 ALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhcChhhhhhhheeeccCCCeEEEEEEEcCCCc------EEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            344455788999999999999999999876554      39999886543 2345678899999998 699999999998


Q ss_pred             Ee------CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          151 CE------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       151 ~~------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ..      .+..+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.+
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK--VIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCE
Confidence            53      467899999999999999997765566888888999999999999999866  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      +|+|||++........  ......|++.|+|||++.     +..++.++|||||||++|||++|..||....+...... 
T Consensus       161 ~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~-  237 (282)
T cd06636         161 KLVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL-  237 (282)
T ss_pred             EEeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh-
Confidence            9999999875432111  122356899999999876     34688899999999999999999999965432211110 


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                     ..............+..+.+|+.+||..||.+|||+.||+++
T Consensus       238 ---------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         238 ---------------IPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             ---------------HhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                           000000111112345688999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-40  Score=313.64  Aligned_cols=253  Identities=25%  Similarity=0.402  Sum_probs=202.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||.|+||.||++.+..+..      .+++|++..........+.+|++++++++|+||+++++++.++...+
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGL------FAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLW   78 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCc------EEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEE
Confidence            458888899999999999999876443      49999987665556677889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.... .++++..+..++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||++.....
T Consensus        79 lv~e~~~~~~L~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lh~~~--i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~  155 (280)
T cd06611          79 ILIEFCDGGALDSIMLELE-RGLTEPQIRYVCRQMLEALNFLHSHK--VIHRDLKAGNILLTLDGDVKLADFGVSAKNKS  155 (280)
T ss_pred             EEeeccCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEECCCCCEEEccCccchhhcc
Confidence            9999999999999886643 35889999999999999999999866  99999999999999999999999999876432


Q ss_pred             CCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ...  ......|++.|+|||++.     ...++.++||||||+++|+|++|+.||.........  ..           +
T Consensus       156 ~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~--~~-----------~  220 (280)
T cd06611         156 TLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL--LK-----------I  220 (280)
T ss_pred             ccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH--HH-----------H
Confidence            221  122356899999999875     345788999999999999999999999764322110  00           0


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+.+  ..+...+.++.+++.+||+.||.+||++.+++++
T Consensus       221 ~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         221 LKSEPPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             hcCCCCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            00000000  1122345678899999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.9e-40  Score=309.39  Aligned_cols=251  Identities=24%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..|+..+.||.|+||.||+|.+..+..      .||+|++..... .....+.+|+.+++++.|+||+++++++.+....
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQ------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKL   77 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCE------EEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEE
Confidence            356777889999999999999876544      399998875532 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++..   .++++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~--ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~  152 (277)
T cd06640          78 WIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEK--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCcCCChhhEEEcCCCCEEEcccccceecc
Confidence            999999999999998854   24788888899999999999999866  9999999999999999999999999997654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......++..|+|||++.+..++.++|+|||||++|||++|+.||....+.....                 .+
T Consensus       153 ~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~  213 (277)
T cd06640         153 DTQI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF-----------------LI  213 (277)
T ss_pred             CCcc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh-----------------hh
Confidence            3221  1223468889999999998899999999999999999999999997643221110                 01


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ............+..+.+++.+||+.+|.+||++.+++.+-.
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06640         214 PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF  255 (277)
T ss_pred             hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChH
Confidence            111112234456678899999999999999999999987743

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-40  Score=307.61  Aligned_cols=250  Identities=28%  Similarity=0.466  Sum_probs=198.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      .|++.+.||.|+||.||++.+..+.       .+++|.+..... ....+.+|++++++++||||+++++++......++
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~-------~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   76 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKR-------KVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICL   76 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCC-------eEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEE
Confidence            5777889999999999999876433       389998875432 34568899999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ||||+.+++|.+++.... .++++..++.++.+++.+|.|||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        77 v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~  153 (256)
T cd05112          77 VFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSN--VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDD  153 (256)
T ss_pred             EEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccccccccceEEEcCCCeEEECCCcceeecccC
Confidence            999999999999986543 35788899999999999999999866  999999999999999999999999998764332


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .. .......++..|+|||++.++.++.++||||||+++|||++ |..||........   ..              .+.
T Consensus       154 ~~-~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~---~~--------------~~~  215 (256)
T cd05112         154 QY-TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV---VE--------------TIN  215 (256)
T ss_pred             cc-cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH---HH--------------HHh
Confidence            11 11122335678999999998999999999999999999998 9999975432110   00              000


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .......+...+..+.+|+.+||+.+|++||++.++++.|
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         216 AGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            0000001112346789999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.2e-40  Score=308.10  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=196.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+|...+.||+|+||.||+|.+..+..      .|++|.+.....     .....+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   75 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGR------ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD   75 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCc------EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc
Confidence            468889999999999999999876544      389998764321     233567889999999999999999998875


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                        ....++++||+++++|.+++....  .+++...+.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~l~~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~LH~~~--i~H~~l~p~nil~~~~~~~~l~dfg  151 (266)
T cd06651          76 RAEKTLTIFMEYMPGGSVKDQLKAYG--ALTESVTRKYTRQILEGMSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (266)
T ss_pred             CCCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEccCC
Confidence              357789999999999999997644  4788888899999999999999866  9999999999999999999999999


Q ss_pred             CCccCCCCCC-cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          231 LAKAGPQGDE-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       231 ~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      +++....... ........++..|+|||++.+..++.++|||||||++|||++|+.||........              
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--------------  217 (266)
T cd06651         152 ASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--------------  217 (266)
T ss_pred             CccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--------------
Confidence            9876432211 1111234588999999999998999999999999999999999999975422111              


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        +............+......+.+++ +||..+|++||+++||+.+
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         218 --IFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             --HHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence              0111111111122333456677777 6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.4e-40  Score=308.31  Aligned_cols=246  Identities=29%  Similarity=0.472  Sum_probs=197.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||++...+.        .|++|.+....  ....+.+|+.++++++||||+++++++... ..+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~--------~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~   74 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEYTGQ--------KVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLY   74 (254)
T ss_pred             HHceeeeeeccCCCCceEecccCCC--------ceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcE
Confidence            4588899999999999999865322        38999886542  345788999999999999999999998654 579


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  ++||||||+|||++.++.++|+|||++.....
T Consensus        75 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~  152 (254)
T cd05083          75 IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK--LVHRDLAARNILVSEDGVAKVSDFGLARVGSM  152 (254)
T ss_pred             EEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccccCcceEEEcCCCcEEECCCccceeccc
Confidence            9999999999999997766556889999999999999999999866  99999999999999999999999999876432


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ..     .....+..|+|||.+.++.++.++|||||||++|||++ |+.||..........                 .+
T Consensus       153 ~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~-----------------~~  210 (254)
T cd05083         153 GV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKE-----------------CV  210 (254)
T ss_pred             cC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHH-----------------HH
Confidence            21     12234567999999998899999999999999999998 999997653221110                 00


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ............+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            111111112234577889999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2.8e-40  Score=308.78  Aligned_cols=253  Identities=23%  Similarity=0.356  Sum_probs=198.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.+.....||+|+||.||+|.+..+..      .|++|.+........+.+.+|+.+++.++|+||+++++++..++..+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   81 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQV------RIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK   81 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCc------EEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence            444455689999999999999876544      49999887766566678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCc--CHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCcc
Q 014079          158 LVYEFMFRGSLENHLFRKATVPL--SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKA  234 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~--~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~  234 (431)
                      +|+||+++++|.+++..... ++  ++..+..++.|++.||.|||+.+  |+||||||+||+++. ++.++|+|||++..
T Consensus        82 lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~--i~h~dl~p~nil~~~~~~~~~l~dfg~~~~  158 (268)
T cd06624          82 IFMEQVPGGSLSALLRSKWG-PLKDNEQTIIFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLVNTYSGVVKISDFGTSKR  158 (268)
T ss_pred             EEEecCCCCCHHHHHHHhcc-cCCCcHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCeEEEecchhhee
Confidence            99999999999999976422 34  77888889999999999999866  999999999999986 67999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......  ......|++.|+|||++.+..  ++.++||||||+++|+|++|+.||.........   .+.          
T Consensus       159 ~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~----------  223 (268)
T cd06624         159 LAGINP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK----------  223 (268)
T ss_pred             cccCCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh----------
Confidence            432221  122345889999999986643  788999999999999999999999653221110   000          


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ..........+.....++.+++.+||+.+|.+|||+.+++.+
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         224 --VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence              000001112233445778999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=293.31  Aligned_cols=246  Identities=27%  Similarity=0.412  Sum_probs=197.8

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEE
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  159 (431)
                      ....||.|+.|.||+++.+.++.+      .|||.+.+.. .+..++++..+.++.... +|+||+.+|+|..+...++.
T Consensus        96 ~l~dlGsGtcG~V~k~~~rs~~~i------iAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~Ic  169 (391)
T KOG0983|consen   96 NLGDLGSGTCGQVWKMRFRSTGHI------IAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFIC  169 (391)
T ss_pred             hHHhhcCCCccceEEEEEcccceE------EEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHH
Confidence            445699999999999999887765      9999887763 455677888888877665 89999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||.| ...++.++.+. ..++++...-.+...++.||.||-. +++|||||+||+|||+|+.|++||||||++..+.+..
T Consensus       170 MelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKe-KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  170 MELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHH-hcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9998 55666666554 3478988888999999999999986 3459999999999999999999999999997754432


Q ss_pred             CcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                         ..+...|-+.|||||.+.   ...|+.++||||||++++||.||+.||.+.....+               .+-.++
T Consensus       247 ---AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe---------------~ltkvl  308 (391)
T KOG0983|consen  247 ---AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE---------------VLTKVL  308 (391)
T ss_pred             ---ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH---------------HHHHHH
Confidence               234567999999999886   34689999999999999999999999987543221               111222


Q ss_pred             C---ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 D---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +   +.+...  ...+..+++|+..||++|+.+||...++++|
T Consensus       309 n~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  309 NEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             hcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            1   222222  2267899999999999999999999999976

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.9e-40  Score=307.64  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||+|+||.||++....+..      .|++|.+....  .....++.+|+.++++++|+||+++++++.+.+..
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGK------QYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNL   74 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCC------EEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeE
Confidence            47888999999999999999876544      39999886542  23345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+|||++.++.++|+|||++....
T Consensus        75 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~  152 (256)
T cd08218          75 YIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTIKLGDFGIARVLN  152 (256)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEEeeccceeecC
Confidence            99999999999999997765556889999999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|++.|+|||++.+..++.++|+|||||++|+|++|+.||.......   .             ...++
T Consensus       153 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~---~-------------~~~~~  214 (256)
T cd08218         153 STVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN---L-------------VLKII  214 (256)
T ss_pred             cchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH---H-------------HHHHh
Confidence            3221  1223458889999999998899999999999999999999999996532111   0             00111


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ... ....+...+.++.+++.+||+.+|.+||++.+|+++
T Consensus       215 ~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         215 RGS-YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cCC-CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            110 111223345788999999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.7e-40  Score=306.45  Aligned_cols=256  Identities=30%  Similarity=0.500  Sum_probs=202.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      +++.+.||.|+||.||++.+.....  .....||+|++...... ....+.+|+.+++.++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSG--EKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCC--CCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            3567789999999999999876431  12235999999766443 45678899999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      +|||+++++|.+++.......+++..+..++.|++.||+|||+.+  ++|+||||+||+++.++.++|+|||++......
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~--~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC--eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            999999999999997655433899999999999999999999866  999999999999999999999999999765443


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...... ...+++.|+|||.+.+..++.++||||||+++|+|++ |..||........   ..              .+.
T Consensus       157 ~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~---~~--------------~~~  218 (258)
T smart00219      157 DYYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEV---LE--------------YLK  218 (258)
T ss_pred             cccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HH--------------HHh
Confidence            222111 2337789999999988889999999999999999998 7888865321110   00              000


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...........+.++.+++.+||..||++|||+.++++.|
T Consensus       219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      219 KGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             cCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            0001111222457889999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.4e-40  Score=316.31  Aligned_cols=267  Identities=22%  Similarity=0.321  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||.|+||.||+|.+..+..      .||+|.+..... .....+.+|+.+++.++||||+++++++...+..
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~   79 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDN------LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   79 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCc------EEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeE
Confidence            468889999999999999999876544      499998865432 2234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~  155 (301)
T cd07873          80 TLVFEYLD-KDLKQYLDDCG-NSINMHNVKLFLFQLLRGLNYCHRRK--VLHRDLKPQNLLINERGELKLADFGLARAKS  155 (301)
T ss_pred             EEEEeccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence            99999995 68988886543 35788899999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------hhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--------PKLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  307 (431)
                      ....  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....        +.+.
T Consensus       156 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (301)
T cd07873         156 IPTK--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  233 (301)
T ss_pred             CCCC--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence            2221  1223457889999998865 457889999999999999999999997654322111110000        0000


Q ss_pred             ccchhhhhcCccccC----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLEN----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..........+....    ......+..+.+||.+||+.||.+|||+.|++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            000000000000000    0112345678899999999999999999999975

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.5e-40  Score=308.47  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=198.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc------hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL------QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +|+..+.||+|+||.||+|...++.       .+|+|.+.....      .....+.+|+.++++++|+||+++++++.+
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~-------~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   73 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQ-------LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD   73 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCC-------eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec
Confidence            4788899999999999999875433       388998764321      123457889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++++|.+++.+..  ++++..+..++.|++.||+|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        74 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~  149 (265)
T cd06631          74 DNTISIFMEFVPGGSISSILNRFG--PLPEPVFCKYTKQILDGVAYLHNNC--VVHRDIKGNNVMLMPNGIIKLIDFGCA  149 (265)
T ss_pred             CCeEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHhEEECCCCeEEeccchhh
Confidence            999999999999999999997654  4788888899999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCC----CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          233 KAGPQGD----ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       233 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      .......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||............       ..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~-------~~  222 (265)
T cd06631         150 RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYI-------GA  222 (265)
T ss_pred             HhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHh-------hh
Confidence            7542211    111222356899999999999989999999999999999999999999754321110000       00


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..        ......+...+.++.+++.+||+.+|.+||++.+++.+
T Consensus       223 ~~--------~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         223 HR--------GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             cc--------CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00        00111222345778999999999999999999999853

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.2e-40  Score=312.24  Aligned_cols=265  Identities=25%  Similarity=0.332  Sum_probs=205.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||+||++.+..++..      ||+|++..... ...+.+.+|+++++.++||||+++++++.....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTV------MAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI   78 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcE------EEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEE
Confidence            4577888999999999999998765543      88988765432 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++||||+++++|.+++....  ++++.....++.+++.+|.|||+ .+  ++|+||||+||+++.++.++|+|||++...
T Consensus        79 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~~--i~H~dl~p~nil~~~~~~~~l~d~gl~~~~  154 (284)
T cd06620          79 CMCMEFMDCGSLDRIYKKGG--PIPVEILGKIAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGEL  154 (284)
T ss_pred             EEEEecCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHhcC--eeccCCCHHHEEECCCCcEEEccCCcccch
Confidence            99999999999999886643  57889999999999999999996 35  999999999999999999999999998654


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....    .....|+..|+|||++.+..++.++|||||||++|+|++|+.||...............   +  ......+
T Consensus       155 ~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~---~--~~~~~~~  225 (284)
T cd06620         155 INSI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMG---I--LDLLQQI  225 (284)
T ss_pred             hhhc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhH---H--HHHHHHH
Confidence            2221    12356899999999998889999999999999999999999999865432111000000   0  0001111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      +............+.++.+|+.+||+.||.+|||+.|++++..-++
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         226 VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             hhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            1111111111224567899999999999999999999998754333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=3.7e-40  Score=307.30  Aligned_cols=258  Identities=28%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||.|+||+||+|....+..      .+++|++..... .....+.+|+.+++.++|+||+++++.+...+..
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNE------KVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL   74 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCc------EEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEE
Confidence            468899999999999999999766543      489999875432 3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCC-CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKAT-VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++|||++++++|.+++..... ..+++.....++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~--i~h~~l~p~ni~~~~~~~~~l~df~~~~~~  152 (267)
T cd06610          75 WLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG--QIHRDIKAGNILLGEDGSVKIADFGVSASL  152 (267)
T ss_pred             EEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHhEEEcCCCCEEEcccchHHHh
Confidence            999999999999999976433 46889999999999999999999866  999999999999999999999999998765


Q ss_pred             CCCCCcc--eeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDETH--VSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .......  ......|+..|+|||++... .++.++|+|||||++|+|++|+.||............  ..         
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~--~~---------  221 (267)
T cd06610         153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT--LQ---------  221 (267)
T ss_pred             ccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH--hc---------
Confidence            4433221  22335689999999998876 7899999999999999999999999765432211000  00         


Q ss_pred             hhhcCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ...+.+.... ....+..+.+++.+||+.||++||++.+|+.+
T Consensus       222 --~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         222 --NDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --CCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              0001111110 12345788999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.6e-40  Score=312.03  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=201.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +.|+..+.||+|+||.||+|.+..++.      .||+|.+..... .....+.+|+.++++++|+||+++++++...+..
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   77 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKE------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKL   77 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCe------EEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCce
Confidence            345666789999999999999876554      399998875532 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++..   ..+.+..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06642          78 WIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSER--KIHRDIKAANVLLSEQGDVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCC--eeccCCChheEEEeCCCCEEEcccccccccc
Confidence            999999999999998854   35788999999999999999999866  9999999999999999999999999987654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.....                 .+
T Consensus       153 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----------------~~  213 (277)
T cd06642         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----------------LI  213 (277)
T ss_pred             Ccch--hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----------------hh
Confidence            3221  1123468889999999999999999999999999999999999987543221100                 01


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ............+..+.+++.+||+.+|.+||++.+++.+-
T Consensus       214 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06642         214 PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHK  254 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhH
Confidence            11111112223456788999999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.3e-40  Score=306.36  Aligned_cols=245  Identities=26%  Similarity=0.426  Sum_probs=192.2

Q ss_pred             ceecccCcEEEEEEEEcCCcee----ccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRV----GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~----~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||+|+||.||+|.+.....+    ......+++|++...... ...+.+|+.++++++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            3699999999999998765421    122234788877655433 5778899999999999999999999988 778999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-------cEEEecccCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-------TAKLSDFGLA  232 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-------~~kl~DFG~a  232 (431)
                      |||+.+++|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++       .++|+|||++
T Consensus        79 ~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          79 EEYVKFGPLDVFLHREKN-NVSLHWKLDVAKQLASALHYLEDKK--LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEcCCCCcHHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhCC--eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            999999999999976543 5788899999999999999999866  99999999999999887       7999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccC--CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      .....      .....++..|+|||++.+.  .++.++|||||||++|||++ |..||.............         
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---------  220 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---------  220 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---------
Confidence            76433      1123467789999998876  78999999999999999999 577776543211110000         


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                            .....    +......+.+++.+||+.+|.+|||+.+|++.|+
T Consensus       221 ------~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ------DQHRL----PMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------cCCCC----CCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  00000    0011167889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.9e-40  Score=306.14  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=202.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|+..+.||+|+||.||++.+..+..      .+++|.+.....  .....+.+|+.++++++||||+++++.+...+..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQK------LVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKAL   74 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCc------EEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEE
Confidence            47888999999999999999876544      499998876532  3346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG~a~~~  235 (431)
                      ++||||+++++|.+++.......+++..+..++.+++.+|.|||+.+  ++|+||+|+||+++.+ +.++|+|||++...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          75 MIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL--ILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999999999999998765566899999999999999999999866  9999999999999865 46899999999865


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....   .....|+..|+|||.+.+..++.++||||||+++|+|++|+.||........   ..             .+
T Consensus       153 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~---~~-------------~~  213 (256)
T cd08220         153 SSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPAL---VL-------------KI  213 (256)
T ss_pred             CCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHH---HH-------------HH
Confidence            43221   1235688999999999988899999999999999999999999976432111   00             00


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ... .....+...+..+.+++.+||..||.+|||+.+++.+
T Consensus       214 ~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         214 MSG-TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             Hhc-CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            000 0011122345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.6e-40  Score=311.90  Aligned_cols=254  Identities=25%  Similarity=0.362  Sum_probs=200.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|++.+.||+|+||.||++.+...+.      .||+|.+.... ......+.+|+.++++++|+||+++++.+...+..+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~------~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGV------TMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVY   75 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCc------EEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEE
Confidence            57888899999999999999875544      38999886542 233467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          158 LVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +||||+++++|..++.... ...+++..+..++.|++.||.|||+. .+|+|+||||+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  154 (286)
T cd06622          76 MCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE-HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV  154 (286)
T ss_pred             EEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc-CCEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9999999999999886531 23589999999999999999999962 239999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTG------HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ...    .....+++.|+|||++.+.      .++.++|||||||++|+|++|+.||..........             
T Consensus       155 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-------------  217 (286)
T cd06622         155 ASL----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFA-------------  217 (286)
T ss_pred             CCc----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHH-------------
Confidence            221    2234688899999988554      35889999999999999999999996542211100             


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+..+.+. .....+...+.++.+++.+||+.+|.+||++.+++.+-
T Consensus       218 ~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         218 QLSAIVDG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             HHHHHhhc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            01111111 11123334667889999999999999999999999763

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6e-40  Score=306.00  Aligned_cols=252  Identities=23%  Similarity=0.314  Sum_probs=198.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-----chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-----LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+|++.+.||+|+||.||++.+.+++.      .|++|.+....     ......+.+|+.++++++||||+++++++.+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   75 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGR------ELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD   75 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCc------EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc
Confidence            468889999999999999999876554      39999875321     1234567889999999999999999999876


Q ss_pred             C--CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          153 D--DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       153 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                      .  ..+++||||+++++|.+++.+..  .+++...+.++.|++.+|.|||+.+  |+|+||||+|||++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~l~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~l~Dfg  151 (265)
T cd06652          76 PMERTLSIFMEHMPGGSIKDQLKSYG--ALTENVTRKYTRQILEGVSYLHSNM--IVHRDIKGANILRDSVGNVKLGDFG  151 (265)
T ss_pred             CCCceEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEecCCCCEEECcCc
Confidence            4  46789999999999999987653  4678888899999999999999866  9999999999999999999999999


Q ss_pred             CCccCCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          231 LAKAGPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       231 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ++......... .......|+..|+|||++.+..++.++|||||||++|||++|+.||........              
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--------------  217 (265)
T cd06652         152 ASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--------------  217 (265)
T ss_pred             cccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--------------
Confidence            98764322111 112235689999999999888899999999999999999999999965321111              


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ..+..........+......+.+++.+||. +|.+||++.+|+++
T Consensus       218 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         218 --IFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             --HHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence              111111111122344556788899999995 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=3.3e-40  Score=311.00  Aligned_cols=267  Identities=25%  Similarity=0.309  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|+..+.||+|+||.||+|.+..++.      .|++|++.....  ...+.+.+|+.++++++|+||+++++++.....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~   74 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQ------IVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRK   74 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCc------EEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCE
Confidence            468888999999999999999876544      389998765422  223457899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|..++....  .+++..++.++.|++.+|.|||+.+  ++|+||||+||+++.++.++|+|||++...
T Consensus        75 ~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~ql~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  150 (286)
T cd07847          75 LHLVFEYCDHTVLNELEKNPR--GVPEHLIKKIIWQTLQAVNFCHKHN--CIHRDVKPENILITKQGQIKLCDFGFARIL  150 (286)
T ss_pred             EEEEEeccCccHHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCChhhEEEcCCCcEEECccccceec
Confidence            999999999988888765433  4789999999999999999999866  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh-hhhhhhccchh-
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKM-  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~-~~~~~~~~~~~-  312 (431)
                      .....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||.+............ ........... 
T Consensus       151 ~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07847         151 TGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF  228 (286)
T ss_pred             CCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence            43321  1223457889999999876 5688999999999999999999999976543322111100 00000000000 


Q ss_pred             ------hhhcCccccC-----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 ------LQIIDPRLEN-----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ------~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            .....+....     ......+..+.+|+.+||+.||++||++.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence                  0000000000     0011235778899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.4e-40  Score=307.41  Aligned_cols=256  Identities=23%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----------hhHHHHHHHHHHHhcCCCCceeeeec
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----------QGHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      +|.+.+.||.|+||.||+|....++.      .+|+|.++....          ...+.+.+|+.+++.++|+||+++++
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~------~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   75 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGE------MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLG   75 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCc------eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEE
Confidence            47788899999999999998876544      389997753211          11245778999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ++...+..++||||+.+++|.+++....  .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|
T Consensus        76 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~~~nil~~~~~~~~l~d  151 (272)
T cd06629          76 FETTEEYLSIFLEYVPGGSIGSCLRTYG--RFEEQLVRFFTEQVLEGLAYLHSKG--ILHRDLKADNLLVDADGICKISD  151 (272)
T ss_pred             EeccCCceEEEEecCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHhhCC--eeecCCChhhEEEcCCCeEEEee
Confidence            9999999999999999999999997653  5788889999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      ||+++...............|+..|+|||++....  ++.++|+||||+++|+|++|..||.........  ..     .
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--~~-----~  224 (272)
T cd06629         152 FGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM--FK-----L  224 (272)
T ss_pred             ccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHH--HH-----h
Confidence            99987644322222223356889999999987654  889999999999999999999999643221100  00     0


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..     ......+........+..+.+++.+||+.+|.+||++.+|+.+
T Consensus       225 ~~-----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         225 GN-----KRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             hc-----cccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            00     0001111112222345788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.7e-40  Score=311.42  Aligned_cols=266  Identities=23%  Similarity=0.277  Sum_probs=196.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||+|+||.||+|.+...+.      .|++|.+.....  .....+.+|+.++++++|+||+++++++.+....
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~------~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHE------IVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKL   74 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCc------EEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCce
Confidence            47888999999999999999876554      389998865422  1234577899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||+++...
T Consensus        75 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  150 (284)
T cd07839          75 TLVFEYCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHN--VLHRDLKPQNLLINKNGELKLADFGLARAFG  150 (284)
T ss_pred             EEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence            99999995 68888776543 35899999999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-hhh-hhh-hhhhhccchh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-SLV-DWA-RPKLNDKRKM  312 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~-~~~-~~~~~~~~~~  312 (431)
                      ....  ......+++.|+|||++.+. .++.++|||||||++|+|++|+.||......... ..+ ... .+.......+
T Consensus       151 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (284)
T cd07839         151 IPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV  228 (284)
T ss_pred             CCCC--CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence            3221  12234578899999988764 4789999999999999999999986543321110 000 000 0000000000


Q ss_pred             hhhcCc----ccc-----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDP----RLE-----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~----~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+.    ...     .......+.++.+++.+||+.||.+|||+.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            000000    000     01112345788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=7.7e-40  Score=305.53  Aligned_cols=255  Identities=24%  Similarity=0.402  Sum_probs=201.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc------hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL------QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +|+..+.||+|+||.||++.+..+..      .|++|++.....      .....+.+|++++++++|+||+++++++.+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~------~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   74 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGT------LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE   74 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCc------EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc
Confidence            47788899999999999998866544      399998865321      124568899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL  231 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~  231 (431)
                      .+..++||||+++++|.+++.+..  ++++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~ql~~al~~LH~~~--i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          75 DSHFNLFVEWMAGGSVSHLLSKYG--AFKEAVIINYTEQLLRGLSYLHENQ--IIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEEccccc
Confidence            999999999999999999987643  5788899999999999999999866  99999999999998775 599999999


Q ss_pred             CccCCCCCC--cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          232 AKAGPQGDE--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       232 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      +........  ........|+..|+|||++.+..++.++||||||+++|+|++|..||...........           
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------  219 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL-----------  219 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHH-----------
Confidence            876543211  1112234688999999999888999999999999999999999999965432111110           


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .............+...+.++.+++.+||..||.+||++.+++.+
T Consensus       220 --~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         220 --IFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             --HHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence              001111111123344556788999999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=4.2e-40  Score=315.15  Aligned_cols=264  Identities=22%  Similarity=0.343  Sum_probs=187.5

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe--CCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--DDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e  161 (431)
                      .+||+|+||.||+|...++..    ...||+|.+.....  ...+.+|+.+|++++||||+++++++..  +...++|||
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~----~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKD----EKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCc----cceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            579999999999999765321    22499998876532  3457789999999999999999999854  567899999


Q ss_pred             ecCCCChHHhhhhC-------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE----CCCCcEEEeccc
Q 014079          162 FMFRGSLENHLFRK-------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSDFG  230 (431)
Q Consensus       162 ~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl----~~~~~~kl~DFG  230 (431)
                      |+. ++|.+++...       ....+++..+..++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+|||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG  157 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPERGRVKIADMG  157 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC--EEcCCCCHHHEEEccCCCCCCcEEEeecc
Confidence            985 5787776421       2235788889999999999999999866  9999999999999    566899999999


Q ss_pred             CCccCCCCCCc-ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-------hhh--
Q 014079          231 LAKAGPQGDET-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-------SLV--  299 (431)
Q Consensus       231 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-------~~~--  299 (431)
                      +++........ .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.........       ...  
T Consensus       158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~  237 (317)
T cd07867         158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI  237 (317)
T ss_pred             ceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHH
Confidence            99865433221 11233568999999999876 45899999999999999999999999754322110       000  


Q ss_pred             ----------hhhh-hhhhccchhhhhc-C-----ccc---cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          300 ----------DWAR-PKLNDKRKMLQII-D-----PRL---ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       300 ----------~~~~-~~~~~~~~~~~~~-~-----~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                .|.. ............. .     ..+   ...........+.+|+.+||+.||.+|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence                      0000 0000000000000 0     000   000011123568899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.3e-40  Score=310.22  Aligned_cols=267  Identities=25%  Similarity=0.319  Sum_probs=201.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||.|+||.||+|.+..++.      .|++|++.....  .....+.+|+.++++++||||+++++++......
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   74 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGE------TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGF   74 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCc------eEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCee
Confidence            47888999999999999999876544      389998876542  2345788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+ +++|.+++.... .++++..++.++.|++.+|.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~  150 (286)
T cd07832          75 VLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANG--IMHRDLKPANLLISADGVLKIADFGLARLFS  150 (286)
T ss_pred             EEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCHHHEEEcCCCcEEEeeeeeccccc
Confidence            9999999 999999986644 46899999999999999999999876  9999999999999999999999999988754


Q ss_pred             CCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--------hhhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--------ARPKLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--------~~~~~~  307 (431)
                      .... .......|+..|+|||++.+. .++.++||||||+++|||++|..+|..............        ..+...
T Consensus       151 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (286)
T cd07832         151 EEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT  229 (286)
T ss_pred             CCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence            4322 112235689999999988654 468999999999999999999888865433211100000        000000


Q ss_pred             ccchhhhhcCccc----cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRL----ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+..+..    ........+..+.+++.+||+.||++||++++++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000000000    001112335788999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.9e-40  Score=303.87  Aligned_cols=249  Identities=26%  Similarity=0.410  Sum_probs=199.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +|+..+.||+|+||.||+|....+..      .|++|.+.....     ...+.+.+|+.+++.++|+||+++++++.+.
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGD------FFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE   74 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCc------EEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC
Confidence            47778899999999999999875443      389998765431     2346788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..+++|+||+++++|.+++.+..  ++++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.+||+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~~~ni~~~~~~~~kl~d~~~~~  150 (258)
T cd06632          75 DNLYIFLELVPGGSLAKLLKKYG--SFPEPVIRLYTRQILLGLEYLHDRN--TVHRDIKGANILVDTNGVVKLADFGMAK  150 (258)
T ss_pred             CeEEEEEEecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEccCccce
Confidence            99999999999999999997653  4788889999999999999999876  9999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......   ......|+..|++||.+.... ++.++|+||||+++|+|++|+.||.........  .             
T Consensus       151 ~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~--~-------------  212 (258)
T cd06632         151 QVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV--F-------------  212 (258)
T ss_pred             eccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHH--H-------------
Confidence            643322   223456899999999987776 899999999999999999999999764321110  0             


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ...........+......+.+++.+||+.+|.+||++.+++.+
T Consensus       213 -~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         213 -KIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -HHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence             0000000011222345778899999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=310.40  Aligned_cols=268  Identities=25%  Similarity=0.328  Sum_probs=201.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+.++..      .|++|.++....  .....+.+|++++++++|+||+++++++...+.
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~------~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   74 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGE------IVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGR   74 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCc------EEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCE
Confidence            368889999999999999999877654      399998865422  234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.++.|..+....  ..+++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~  150 (288)
T cd07833          75 LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHN--IIHRDIKPENILVSESGVLKLCDFGFARAL  150 (288)
T ss_pred             EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEEEeeeccccc
Confidence            99999999887666655433  34788999999999999999999876  999999999999999999999999998875


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc------
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND------  308 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~------  308 (431)
                      ..... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||..................+..      
T Consensus       151 ~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (288)
T cd07833         151 RARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF  229 (288)
T ss_pred             CCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence            44332 122335688999999999888 8899999999999999999999999754322111100000000000      


Q ss_pred             --cc-----hhhhhcCc-cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 --KR-----KMLQIIDP-RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 --~~-----~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ..     ......+. .+...++...+.++.+|+++||..+|++||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence              00     00000000 00011122336789999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-40  Score=311.04  Aligned_cols=260  Identities=27%  Similarity=0.361  Sum_probs=200.4

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYC  150 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  150 (431)
                      .+....++|++.+.||+|+||.||++.+..+..      .+++|++.... .....+.+|+.+++.+ +|+||+++++++
T Consensus        12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~------~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   84 (286)
T cd06638          12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGS------KAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMY   84 (286)
T ss_pred             cCCCcccceeeeeeeccCCCcEEEEEEECCCCc------eeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeee
Confidence            345567889999999999999999999876544      38999876532 2235677899999999 699999999987


Q ss_pred             E-----eCCeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc
Q 014079          151 C-----EDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       151 ~-----~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~  223 (431)
                      .     .++..++||||+++++|.+++..  .....+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~nili~~~~~  162 (286)
T cd06638          85 YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK--TIHRDVKGNNILLTTEGG  162 (286)
T ss_pred             eecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC--ccccCCCHHhEEECCCCC
Confidence            4     34568999999999999998753  22345788889999999999999999866  999999999999999999


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      ++|+|||++........  ......|++.|+|||++..     ..++.++|||||||++|||++|+.||.......... 
T Consensus       163 ~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~-  239 (286)
T cd06638         163 VKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF-  239 (286)
T ss_pred             EEEccCCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh-
Confidence            99999999876533221  1223468999999998753     457889999999999999999999997643211110 


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       .           ......+.+  ..+...+..+.+|+.+||+.||++|||+.||++++
T Consensus       240 -~-----------~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         240 -K-----------IPRNPPPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -h-----------ccccCCCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence             0           000000000  01112345788999999999999999999999874

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1e-39  Score=305.04  Aligned_cols=254  Identities=25%  Similarity=0.374  Sum_probs=198.9

Q ss_pred             CCCccceecccCcEEEEEEEEcC-CceeccccceeEEEEccccC----------chhHHHHHHHHHHHhc-CCCCceeee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEG----------LQGHREWLTEVNFLGQ-LRHPNLVKL  146 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~vavK~~~~~~----------~~~~~~~~~E~~~l~~-l~h~niv~l  146 (431)
                      .|++.+.||+|+||.||++.+.. +..      .+++|.+....          .....++.+|+.++.+ ++|+||+++
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~------~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~   74 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQN------LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRY   74 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCc------eeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeE
Confidence            37788899999999999999876 332      48888775321          1233457788988865 799999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ++++.+.+..++||||+++++|.+++..  .....+++..++.++.|++.+|.|||+. ++++|+||+|+|||++.++.+
T Consensus        75 ~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~~i~H~dl~~~nil~~~~~~~  153 (269)
T cd08528          75 YKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE-KRIVHRDLTPNNIMLGEDDKV  153 (269)
T ss_pred             EeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC-CceeecCCCHHHEEECCCCcE
Confidence            9999999999999999999999998754  2344688899999999999999999952 349999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      +|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||.........        
T Consensus       154 ~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~--------  222 (269)
T cd08528         154 TITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA--------  222 (269)
T ss_pred             EEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH--------
Confidence            999999998654332   223456899999999999888999999999999999999999999653211100        


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                              ..+.+...........+..+.+++.+||+.||++||++.|+..+++
T Consensus       223 --------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         223 --------TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                    0011111110011123467889999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.6e-40  Score=311.02  Aligned_cols=246  Identities=27%  Similarity=0.393  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||++.+..+..      .+|+|++.....   .....+.+|++++++++||||+++++++.+.+
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   74 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGK------YYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDS   74 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCC------EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            368889999999999999999876544      399998865432   23456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .++...+..++.|++.||.|||+.+  |+|+||+|+|||++.++.+||+|||++..
T Consensus        75 ~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~qil~~l~~lH~~~--i~H~dl~p~nili~~~~~~kl~dfg~~~~  150 (290)
T cd05580          75 NLYLVMEYVPGGELFSHLRKSG--RFPEPVARFYAAQVVLALEYLHSLD--IVYRDLKPENLLLDSDGYIKITDFGFAKR  150 (290)
T ss_pred             eEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999997653  5788899999999999999999866  99999999999999999999999999887


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||.........                ..
T Consensus       151 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~----------------~~  209 (290)
T cd05580         151 VKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIY----------------EK  209 (290)
T ss_pred             cCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence            5433     22356899999999998888999999999999999999999999764311100                00


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +....  ...+...+..+.+++.+||+.||.+|+     ++++++.+
T Consensus       210 ~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         210 ILEGK--VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HhcCC--ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence            01100  011223357888999999999999999     77777754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3e-40  Score=312.64  Aligned_cols=249  Identities=24%  Similarity=0.360  Sum_probs=198.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |.....||+|+||.||++.+..+..      .|++|.+........+.+.+|+.+++.++|+||+++++.+...+..++|
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv   97 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGK------QVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVV   97 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCC------EEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEE
Confidence            3334569999999999998866544      3999988765545566788999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++...   .+++..++.++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++.......
T Consensus        98 ~e~~~~~~L~~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658          98 MEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQG--VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             EeCCCCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            9999999999988442   4788899999999999999999876  9999999999999999999999999987543222


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  ......|+..|+|||++.+..++.++||||||+++|||++|+.||..........             .+...+.+.
T Consensus       173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~-------------~~~~~~~~~  237 (292)
T cd06658         173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR-------------RIRDNLPPR  237 (292)
T ss_pred             c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH-------------HHHhcCCCc
Confidence            1  1223568999999999988899999999999999999999999997543221110             011111111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..  ....+..+.+++.+||..||.+|||+.+++++
T Consensus       238 ~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         238 VKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111  11234678899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.8e-39  Score=303.49  Aligned_cols=255  Identities=24%  Similarity=0.365  Sum_probs=188.8

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||++....+..    ...+++|.+.... ....+.+.+|+.+++.++||||+++++.+.+....++||||+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~----~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~   77 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTG----VARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYC   77 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCC----cceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecC
Confidence            59999999999997654322    1236677665543 234567899999999999999999999999999999999999


Q ss_pred             CCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          164 FRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       164 ~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      ++++|.+++....  ....+....+.++.|++.||.|||+.+  ++||||||+|||++.++.++|+|||++.........
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~--i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~  155 (268)
T cd05086          78 ELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN--FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYI  155 (268)
T ss_pred             CCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC--eeccCCccceEEEcCCccEEecccccccccCcchhh
Confidence            9999999997642  234566777889999999999999866  999999999999999999999999998643222211


Q ss_pred             ceeecccCCccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          242 HVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......++..|+|||++..       ..++.++|||||||++|||++ |..||............      +.  ....
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~------~~--~~~~  227 (268)
T cd05086         156 ETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHV------IK--DQQV  227 (268)
T ss_pred             hcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------Hh--hccc
Confidence            12234568899999998753       245789999999999999997 56787654321111000      00  0011


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...++.+..    .....+.+++..|| .+|++||++.+|++.|.
T Consensus       228 ~~~~~~~~~----~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         228 KLFKPQLEL----PYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ccCCCccCC----CCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            112222221    23467788999999 67999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-41  Score=325.81  Aligned_cols=247  Identities=24%  Similarity=0.387  Sum_probs=193.3

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEE---EEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe-
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV---KVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH-  155 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vav---K~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  155 (431)
                      +...+||+|+|-+||+|.+...+.      .||-   |+-+.. ......+|..|+.+|+.|+|||||++|+++.+... 
T Consensus        43 k~~evLGrGafKtVYka~De~~gi------EVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~  116 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGI------EVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNK  116 (632)
T ss_pred             ehhhhcccccceeeeeccccccch------hhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCc
Confidence            445679999999999999966542      2332   222111 12345789999999999999999999999998766 


Q ss_pred             -eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEecccCCc
Q 014079          156 -RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAK  233 (431)
Q Consensus       156 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG~a~  233 (431)
                       +.+|+|++..|+|..|+.+...  +....+..|++||++||.|||++..+|||||||-+||+|+.+ |.+||+|+|||.
T Consensus       117 ~in~iTEL~TSGtLr~Y~kk~~~--vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAt  194 (632)
T KOG0584|consen  117 TINFITELFTSGTLREYRKKHRR--VNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLAT  194 (632)
T ss_pred             eeeeeeecccCCcHHHHHHHhcc--CCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHH
Confidence             7899999999999999988765  677789999999999999999999999999999999999865 899999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .+....    ...++|||.|||||+.. ..|+..+||||||++|+||+|+.+||.........  ..             
T Consensus       195 l~r~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI--YK-------------  254 (632)
T KOG0584|consen  195 LLRKSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI--YK-------------  254 (632)
T ss_pred             Hhhccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH--HH-------------
Confidence            754332    22378999999999776 88999999999999999999999999765432111  00             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +++....+..+..-...++++||.+||.. ..+|||+.|+|.+
T Consensus       255 KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  255 KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            00011111111111135788999999999 9999999999964

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-40  Score=306.41  Aligned_cols=254  Identities=28%  Similarity=0.374  Sum_probs=200.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .+++|++.+.||.|+||.||+|.+..+..      .+++|++..... ....+.+|+.+++++ .|+||+++++++.+..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~   76 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQ------LVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKN   76 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCc------EEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecC
Confidence            35789999999999999999999876543      389998876543 345688999999999 6999999999997654


Q ss_pred             ------eeEEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 ------HRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 ------~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                            .+++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|
T Consensus        77 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~--i~H~~l~p~ni~~~~~~~~~l  154 (275)
T cd06608          77 PPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK--VIHRDIKGQNILLTKNAEVKL  154 (275)
T ss_pred             CCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEEccCCeEEE
Confidence                  4899999999999999986533  456889999999999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      +|||++.......  .......|+..|+|||++..     ..++.++|||||||++|+|++|+.||.........     
T Consensus       155 ~d~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-----  227 (275)
T cd06608         155 VDFGVSAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRAL-----  227 (275)
T ss_pred             CCCccceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHH-----
Confidence            9999987643221  11223568999999998753     34778999999999999999999999653221110     


Q ss_pred             hhhhhhccchhhhhcCccc-cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          302 ARPKLNDKRKMLQIIDPRL-ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                 .++..... ....+...+.++.+|+.+||..||++|||+.+++++
T Consensus       228 -----------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         228 -----------FKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             -----------HHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                       01110000 011122356788999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=4.2e-40  Score=306.82  Aligned_cols=253  Identities=26%  Similarity=0.371  Sum_probs=202.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|+..+.||.|+||.||++.+......      +++|.+..... ....++.+|++++++++||||+++++++...+.++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   75 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKI------MAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDIS   75 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcE------EEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEE
Confidence            577788999999999999998765443      89998876543 34467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +++||+.+++|.+++.... .+++......++.|++.+|.|||+ .+  ++|+||||+||+++.++.++|+|||.+....
T Consensus        76 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~--i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~  152 (265)
T cd06605          76 ICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV  152 (265)
T ss_pred             EEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCC--eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence            9999999999999997653 468888999999999999999998 66  9999999999999999999999999987543


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++|+.||......... ...          .+..+.
T Consensus       153 ~~~~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~-~~~----------~~~~~~  217 (265)
T cd06605         153 NSLA----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG-IFE----------LLQYIV  217 (265)
T ss_pred             HHHh----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc-HHH----------HHHHHh
Confidence            2211    1156889999999999999999999999999999999999999754321111 000          001111


Q ss_pred             CccccCcccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVR-AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .... ...+.. .+.++.++|.+||..||++|||+.+++.+
T Consensus       218 ~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         218 NEPP-PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             cCCC-CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence            1110 111112 56788999999999999999999999865

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9e-40  Score=306.01  Aligned_cols=259  Identities=27%  Similarity=0.426  Sum_probs=197.7

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC---
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD---  154 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  154 (431)
                      |.+.+.||+|+||.||+|.+.....   .+..||+|++..+.  ....+++.+|+++++.++||||+++++++....   
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDG---SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKG   77 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCC---CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCC
Confidence            5677899999999999998754311   12359999887643  234566889999999999999999999886542   


Q ss_pred             ---eeEEEEEecCCCChHHhhhhC----CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRK----ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~----~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                         ..++++||+.+++|.+++...    ....+++...+.++.|++.||+|||+.+  |+||||||+|||++.++.+||+
T Consensus        78 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~nili~~~~~~kl~  155 (273)
T cd05074          78 RLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN--FIHRDLAARNCMLNENMTVCVA  155 (273)
T ss_pred             cccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--EeecccchhhEEEcCCCCEEEC
Confidence               247889999999999887532    2234788889999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++...............+++.|++||.+.+..++.++|||||||++|+|++ |+.||.......   ...+.    
T Consensus       156 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~---~~~~~----  228 (273)
T cd05074         156 DFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE---IYNYL----  228 (273)
T ss_pred             cccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH---HHHHH----
Confidence            9999986543322212223345678999999998999999999999999999999 888886543211   11100    


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ....        .+  ......+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       229 ~~~~--------~~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         229 IKGN--------RL--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HcCC--------cC--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0000        00  11122346889999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-39  Score=303.13  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=201.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe--CC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE--DD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  154 (431)
                      +|++.+.||.|+||.||++.+..++.      .+++|++.....  .....+.+|+.+++.++|+||+++++++..  ..
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGK------ILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQ   74 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCC------EEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCC
Confidence            47788899999999999998876544      389998865432  334568889999999999999999998764  45


Q ss_pred             eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhH-----hCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          155 HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLH-----NAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH-----~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      ..+++|||+++++|.+++...  ...++++...+.++.|++.||.|||     +.+  ++|+||||+||+++.++.+||+
T Consensus        75 ~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~--i~h~dl~p~nili~~~~~~kl~  152 (265)
T cd08217          75 TLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT--VLHRDLKPANIFLDANNNVKLG  152 (265)
T ss_pred             EEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc--ceecCCCHHHEEEecCCCEEEe
Confidence            679999999999999998653  2456889999999999999999999     645  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||++........  ......|++.|+|||++.+..++.++|+||||+++|+|++|+.||......   ...        
T Consensus       153 d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~---~~~--------  219 (265)
T cd08217         153 DFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL---QLA--------  219 (265)
T ss_pred             cccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH---HHH--------
Confidence            9999987543321  122356899999999999888999999999999999999999999764311   111        


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            +.+........+...+..+.+++.+||+.+|.+||++.+|+++
T Consensus       220 ------~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         220 ------SKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ------HHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                  1111111112333455788999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.2e-39  Score=308.78  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|.+.+.||+|+||.||++.+..+..      .|++|.+..........+.+|+.+++.++||||+++++++...+..
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~   91 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQ------EVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL   91 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCC------EEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence            3678899999999999999998765443      3899988765445556788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      |+|+||+++++|.+++.+.   .+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~g--i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~  166 (293)
T cd06647          92 WVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  166 (293)
T ss_pred             EEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--EeeccCCHHHEEEcCCCCEEEccCcceeccc
Confidence            9999999999999998653   3678888999999999999999866  9999999999999999999999999887544


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......|++.|+|||.+.++.++.++||||||+++|+|++|+.||.............               .
T Consensus       167 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~---------------~  229 (293)
T cd06647         167 PEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---------------T  229 (293)
T ss_pred             cccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh---------------c
Confidence            3222  1223468899999999988889999999999999999999999997643321110000               0


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ............+..+.+++.+||..+|.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         230 NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000011122345678899999999999999999999977

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.9e-40  Score=310.63  Aligned_cols=267  Identities=25%  Similarity=0.331  Sum_probs=199.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+.++++      .||+|++......  ..+.+.+|+++++.++||||+++++++...+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQ------IVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKR   74 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCC------EEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCe
Confidence            368888999999999999999876544      3999987654322  24567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.++.....  .+++..++.++.|++.||.|||+.+  ++|+||+|+||++++++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~LH~~~--i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~  150 (286)
T cd07846          75 LYLVFEFVDHTVLDDLEKYPN--GLDESRVRKYLFQILRGIEFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL  150 (286)
T ss_pred             EEEEEecCCccHHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEECCCCcEEEEeeeeeeec
Confidence            999999999999988765433  4789999999999999999999866  999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh-hcc----
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL-NDK----  309 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~~----  309 (431)
                      ....  .......++..|+|||++.+ ..++.++||||||+++|||++|+.||...........+......+ ...    
T Consensus       151 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (286)
T cd07846         151 AAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF  228 (286)
T ss_pred             cCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence            3322  12233568899999998875 457889999999999999999999997543221110000000000 000    


Q ss_pred             ---chhhhhcCccccC-----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 ---RKMLQIIDPRLEN-----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ---~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         ........+....     ......+..+.+|+.+||+.||++||++.+++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence               0000000000000     0112345789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.8e-39  Score=302.06  Aligned_cols=252  Identities=26%  Similarity=0.374  Sum_probs=205.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|++.+.||.|++|.||+|.+...+.      .|++|++..... .....+.+|+.++.+++|+||+++++++...+..+
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~------~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGK------IYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS   75 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCc------EEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEE
Confidence            57888999999999999999887544      389998877644 34567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +||||+++++|.+++...  .+++....+.++.|++.+|.|||+ .+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~--~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~  151 (264)
T cd06623          76 IVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEVKIADFGISKVLE  151 (264)
T ss_pred             EEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCC--CccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            999999999999999765  458899999999999999999998 77  9999999999999999999999999988654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .....  .....++..|+|||.+.+..++.++||||||+++|+|++|+.||.............             .+.
T Consensus       152 ~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~-------------~~~  216 (264)
T cd06623         152 NTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQ-------------AIC  216 (264)
T ss_pred             cCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHH-------------HHh
Confidence            33221  123458889999999999999999999999999999999999997654311111110             111


Q ss_pred             CccccCcccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVR-AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      . ......+.. .+..+.+++.+||..+|++||++.+++++
T Consensus       217 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         217 D-GPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             c-CCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            1 111112222 55788999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-40  Score=292.86  Aligned_cols=259  Identities=22%  Similarity=0.258  Sum_probs=206.7

Q ss_pred             HHhcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           75 TITKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      .++++|++. ++||-|-.|.|..+..+.+++.      +|+|++...     ....+|+++.-.. .|||||.++|+|..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ek------fALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeN  126 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEK------FALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYEN  126 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhh------hHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence            355666654 5799999999999998877654      999988654     3345788775554 59999999999864


Q ss_pred             ----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEE
Q 014079          153 ----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAK  225 (431)
Q Consensus       153 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~k  225 (431)
                          ...+.+|||+|+||.|...+..++...+++.....|..||..|+.|||+.+  |.||||||+|+|...   |..+|
T Consensus       127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n--IAHRDlKpENLLyt~t~~na~lK  204 (400)
T KOG0604|consen  127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN--IAHRDLKPENLLYTTTSPNAPLK  204 (400)
T ss_pred             hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc--hhhccCChhheeeecCCCCcceE
Confidence                356789999999999999999999999999999999999999999999988  999999999999964   56799


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||+|+....   .....+.+.||+|.|||++....|+...|+||+||++|-|++|.+||.........       |.
T Consensus       205 LtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-------pg  274 (400)
T KOG0604|consen  205 LTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-------PG  274 (400)
T ss_pred             ecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-------hh
Confidence            999999987432   23445678999999999999999999999999999999999999999765432111       00


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      +.   .-...-.-.+..+.....++...++|+.+|..+|.+|.|+.+++++-+-
T Consensus       275 Mk---~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi  325 (400)
T KOG0604|consen  275 MK---RRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWI  325 (400)
T ss_pred             HH---hHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchh
Confidence            00   0000111123344456788999999999999999999999999987543

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.6e-40  Score=308.37  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|+..+.||.|+||.||+|.+..++.      .|++|.+.....  .....+.+|++++++++||||+++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   74 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGE------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKL   74 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCC------EEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcE
Confidence            47888999999999999999876544      389998865432  2235688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~--i~H~~l~p~nill~~~~~~~l~dfg~~~~~~  151 (284)
T cd07860          75 YLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFG  151 (284)
T ss_pred             EEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence            99999995 68999887765667899999999999999999999866  9999999999999999999999999987643


Q ss_pred             CCCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch-hhhhhhh-------hhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS-LVDWARP-------KLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~~~~-------~~~  307 (431)
                      ....  ......+++.|+|||++.+.. ++.++|||||||++|+|++|+.||.......... .......       ...
T Consensus       152 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07860         152 VPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT  229 (284)
T ss_pred             cCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence            3221  122345788999999887654 6889999999999999999999997643221110 0000000       000


Q ss_pred             ccc----hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKR----KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...    .........+ .......+.++.++|.+||+.||.+|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         230 SLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            000    0000000000 00111234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.1e-39  Score=306.94  Aligned_cols=253  Identities=24%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHH-HhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNF-LGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||++.+..++..      ||+|.++.... ....++..|+.+ ++.++||||+++++++...+.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~   74 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTI------MAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGD   74 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcE------EEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCc
Confidence            3688889999999999999998866543      99998876532 233456666665 666789999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      .|+||||++ ++|.+++...  ....+++..++.++.|++.||.|||+. .+++||||||+|||++.++.+||+|||++.
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~~i~h~dlkp~nil~~~~~~~kl~dfg~~~  152 (283)
T cd06617          75 VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK-LSVIHRDVKPSNVLINRNGQVKLCDFGISG  152 (283)
T ss_pred             EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc-CCeecCCCCHHHEEECCCCCEEEeeccccc
Confidence            999999995 7888877542  234689999999999999999999974 139999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ......   ......|+..|+|||++.+    ..++.++|+|||||++|+|++|+.||........              
T Consensus       153 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~--------------  215 (283)
T cd06617         153 YLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ--------------  215 (283)
T ss_pred             cccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHH--------------
Confidence            643221   1223468889999998865    4578899999999999999999999965321110              


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+...+............+.++.+++.+||..+|.+||++.+++++
T Consensus       216 -~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         216 -QLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -HHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0011111000000111245788999999999999999999999975

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-39  Score=307.85  Aligned_cols=267  Identities=24%  Similarity=0.343  Sum_probs=196.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .|++|.+...... ....+.+|+.++++++|+||+++++++.+.+..
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQ------LVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTL   78 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCc------EEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeE
Confidence            568889999999999999999876544      3999988654321 224567899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++..... .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+++...
T Consensus        79 ~lv~e~~~-~~L~~~~~~~~~-~~~~~~~~~~~~ql~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  154 (291)
T cd07844          79 TLVFEYLD-TDLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQRR--VLHRDLKPQNLLISERGELKLADFGLARAKS  154 (291)
T ss_pred             EEEEecCC-CCHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhCC--eecccCCHHHEEEcCCCCEEECccccccccC
Confidence            99999996 599998876543 6788999999999999999999866  9999999999999999999999999987532


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhhh--------hhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-SLVDWA--------RPKL  306 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~--------~~~~  306 (431)
                      ....  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... ......        .+..
T Consensus       155 ~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (291)
T cd07844         155 VPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV  232 (291)
T ss_pred             CCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence            2111  1122357889999998875 45889999999999999999999999755421111 000000        0000


Q ss_pred             hccchhhh----hc-CccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQ----II-DPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~----~~-~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ........    .. ...+.... ......++.+++.+||+.||++||++.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            00000000    00 00000000 00112677899999999999999999999864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.9e-39  Score=309.10  Aligned_cols=256  Identities=25%  Similarity=0.314  Sum_probs=198.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||++.+.....      .|++|.+.....   .....+.+|+++++.++||||+++++.+..++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~   74 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQ------RFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKR   74 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCc------EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCC
Confidence            368888999999999999999876644      399998876532   23456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||++|++|.+++....  .+++.....++.|++.||.|||+.+  ++||||||+|||++.++.++|+|||+++.
T Consensus        75 ~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~NIll~~~~~~~l~dfg~~~~  150 (305)
T cd05609          75 HLCMVMEYVEGGDCATLLKNIG--ALPVDMARMYFAETVLALEYLHNYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKI  150 (305)
T ss_pred             EEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence            9999999999999999996653  5788888899999999999999866  99999999999999999999999999864


Q ss_pred             CCCCCC-------------cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          235 GPQGDE-------------THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       235 ~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      ......             ........|+..|+|||.+.+..++.++|||||||++|||++|..||.+........... 
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~-  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI-  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-
Confidence            211100             001112457889999999988899999999999999999999999997543211000000 


Q ss_pred             hhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                           .     .....+.    .....+.++.+++.+||+.||++||++.++.+.|+
T Consensus       230 -----~-----~~~~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         230 -----S-----DDIEWPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             -----h-----cccCCCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence                 0     0000000    01134567889999999999999999665555554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.5e-39  Score=308.70  Aligned_cols=266  Identities=27%  Similarity=0.348  Sum_probs=199.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-----hHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-----GHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +|.+.+.||.|+||.||+|.+..++.      .|++|.+......     ....+..|+.++++++|+||+++++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~   74 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGR------IVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK   74 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCc------EEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC
Confidence            47788899999999999999876544      4999998765432     234567899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nill~~~~~~~l~dfg~~~  150 (298)
T cd07841          75 SNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNW--ILHRDLKPNNLLIASDGVLKLADFGLAR  150 (298)
T ss_pred             CEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecCCChhhEEEcCCCCEEEccceeee
Confidence            9999999999 999999997654 36899999999999999999999876  9999999999999999999999999997


Q ss_pred             cCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhc--
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLND--  308 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~--  308 (431)
                      .......  ......+++.|+|||.+.+ ..++.++|||||||++|||++|..+|...............  .+....  
T Consensus       151 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (298)
T cd07841         151 SFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP  228 (298)
T ss_pred             eccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence            6543321  1223456888999998865 46789999999999999999998888654432211110000  000000  


Q ss_pred             -cchhhhhcCccc-----cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 -KRKMLQIIDPRL-----ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 -~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ............     ........+..+.+++.+||++||.+|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence             000000000000     001112345788999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-39  Score=329.72  Aligned_cols=279  Identities=18%  Similarity=0.237  Sum_probs=191.5

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceec--cc-----------cceeEEEEccccCchhHHHHHHHHHHHhcCC
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVG--LK-----------SLPVAVKVLNKEGLQGHREWLTEVNFLGQLR  139 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~--~~-----------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  139 (431)
                      ...+.++|++.+.||+|+||+||++..+......  .+           ...++.|.+.. .......+.+|+.+|++++
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~-~~~~~~~~~~Ei~il~~l~  221 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKA-GSRAAIQLENEILALGRLN  221 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhc-chHHHHHHHHHHHHHHhCC
Confidence            3456789999999999999999998765322110  00           00011121111 1123456789999999999


Q ss_pred             CCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCC---CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCE
Q 014079          140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA---TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI  216 (431)
Q Consensus       140 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NI  216 (431)
                      |||||++++++.+.+..|+|++++ +++|.+++....   ...........++.|++.||.|||+.+  ||||||||+||
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g--IiHrDLKP~NI  298 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK--LIHRDIKLENI  298 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHE
Confidence            999999999999999999999998 567777765422   112234566789999999999999866  99999999999


Q ss_pred             EECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC-CCCCCCccc
Q 014079          217 LLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS-VDKTRPSKE  295 (431)
Q Consensus       217 Ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-f~~~~~~~~  295 (431)
                      ||+.++.+||+|||+++........ ......||..|+|||++.+..++.++|||||||++|||++|..+ |........
T Consensus       299 Ll~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~  377 (501)
T PHA03210        299 FLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPG  377 (501)
T ss_pred             EECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHH
Confidence            9999999999999999865433221 22335799999999999999999999999999999999998754 433222111


Q ss_pred             chhhhhhh------hhhh-ccchhhhhcCcc-c---cCcc-----cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          296 QSLVDWAR------PKLN-DKRKMLQIIDPR-L---ENQY-----SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       296 ~~~~~~~~------~~~~-~~~~~~~~~~~~-~---~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..+.....      ..+. ....+...++.. +   ....     .......+.+++.+||+.||.+|||+.|++.+
T Consensus       378 ~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        378 KQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            11111000      0000 000111111100 0   0000     00123467788999999999999999999976

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.5e-39  Score=307.61  Aligned_cols=260  Identities=29%  Similarity=0.366  Sum_probs=200.9

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecE
Q 014079           71 FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGY  149 (431)
Q Consensus        71 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~  149 (431)
                      .++....++|.+.+.||+|+||.||++....+..      .+++|++.... .....+.+|+.+++++ +||||++++++
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~------~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~   87 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGS------LAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGM   87 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCC------EEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEE
Confidence            3445567889999999999999999999876554      38999886543 2245677899999999 79999999999


Q ss_pred             EEeC-----CeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          150 CCED-----DHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       150 ~~~~-----~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      +...     +..++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++
T Consensus        88 ~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--ivH~dlkp~nili~~~~  165 (291)
T cd06639          88 FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR--IIHRDVKGNNILLTTEG  165 (291)
T ss_pred             EEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCC
Confidence            8754     358999999999999998864  23346889999999999999999999866  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS  297 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  297 (431)
                      .++|+|||++........  ......|+..|+|||++...     .++.++|||||||++|||++|+.||....+.... 
T Consensus       166 ~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~-  242 (291)
T cd06639         166 GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL-  242 (291)
T ss_pred             CEEEeecccchhcccccc--cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH-
Confidence            999999999876433221  11234688999999987643     3688999999999999999999999764322111 


Q ss_pred             hhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ....           ....+.+  ..+......+.+|+.+||+.||++||++.+++++
T Consensus       243 -~~~~-----------~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         243 -FKIP-----------RNPPPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -HHHh-----------cCCCCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence             0000           0000000  1112334578899999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.2e-39  Score=304.01  Aligned_cols=260  Identities=25%  Similarity=0.303  Sum_probs=201.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  154 (431)
                      ++|+..+.||.|++|.||++.+..+..      .+++|.+..... .....+.+|++++++++||||++++++|.+.  +
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   74 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGM------IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSS   74 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCe------EEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCC
Confidence            357788899999999999999876544      399998875432 3456788999999999999999999998654  4


Q ss_pred             eeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+++||||+++++|.+++..  .....++......++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++
T Consensus        75 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~--i~H~dl~~~nil~~~~~~~~l~dfg~~  152 (287)
T cd06621          75 SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK--IIHRDIKPSNILLTRKGQVKLCDFGVS  152 (287)
T ss_pred             eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecCCeEEEeecccc
Confidence            68999999999999988754  23445788899999999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc--ccchhhhhhhhhhhccc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS--KEQSLVDWARPKLNDKR  310 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~~~~~~~~  310 (431)
                      ........    ....++..|+|||.+.+..++.++|||||||++|+|++|+.||......  .......+...    . 
T Consensus       153 ~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~-  223 (287)
T cd06621         153 GELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN----M-  223 (287)
T ss_pred             cccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhc----C-
Confidence            75432221    2345788999999999999999999999999999999999999765321  11111111100    0 


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .... +....  ......+..+.+++.+||..||.+|||+.|++++-
T Consensus       224 ~~~~-~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         224 PNPE-LKDEP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             Cchh-hccCC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence            0000 00000  00112456789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=9e-40  Score=310.10  Aligned_cols=251  Identities=22%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |.....||+|+||.||++.+.....      .|++|.+..........+.+|+.+++.++||||+++++++..++..++|
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCC------EEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            3334479999999999998865443      3999998765445556788999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+++++|.+++..   ..+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++.......
T Consensus        97 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~  171 (297)
T cd06659          97 MEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQG--VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV  171 (297)
T ss_pred             EecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHeEEccCCcEEEeechhHhhccccc
Confidence            999999999997744   24788999999999999999999876  9999999999999999999999999987543322


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      .  ......|+..|+|||++.+..++.++|||||||++|||++|+.||....+........             ......
T Consensus       172 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-------------~~~~~~  236 (297)
T cd06659         172 P--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-------------DSPPPK  236 (297)
T ss_pred             c--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-------------ccCCCC
Confidence            1  1223568999999999998899999999999999999999999997543221110000             000000


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .  ......+..+.+++.+||+.+|.+||++.+++++-.
T Consensus       237 ~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~  273 (297)
T cd06659         237 L--KNAHKISPVLRDFLERMLTREPQERATAQELLDHPF  273 (297)
T ss_pred             c--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChh
Confidence            0  011123467889999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=6.1e-40  Score=304.65  Aligned_cols=249  Identities=26%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +|++.+.||.|+||.||+|.+..+..      .|++|++.+...   ...+.+.+|++++++++||||+++++.+.+...
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   74 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKK------MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEEN   74 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCc------EEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCe
Confidence            47888999999999999999876544      399999876532   235678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++|+||+.+++|.+++...  .++++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~--i~h~dl~~~nil~~~~~~~~l~d~~~~~~~  150 (258)
T cd05578          75 MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKG--IIHRDIKPDNILLDEQGHVHITDFNIATKV  150 (258)
T ss_pred             EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEEcCCCCEEEeeccccccc
Confidence            99999999999999999765  46888999999999999999999876  999999999999999999999999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....   ......|+..|+|||++.+..++.++|+||||+++|+|++|..||............              +.
T Consensus       151 ~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~--------------~~  213 (258)
T cd05578         151 TPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR--------------AK  213 (258)
T ss_pred             CCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH--------------HH
Confidence            4332   123356888999999999888999999999999999999999999765432111110              01


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH--HHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM--SDVVE  355 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~--~eil~  355 (431)
                      ... .....+...+..+.+++.+||+.||.+||++  .|++.
T Consensus       214 ~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         214 QET-ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             hcc-ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence            100 1112233345788999999999999999999  66653

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.2e-39  Score=302.28  Aligned_cols=251  Identities=24%  Similarity=0.385  Sum_probs=202.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|.+.+.||.|+||.||++.+..+...      +++|.+.....  .....+.+|+.+++.++|+||+++++.+.+.+..
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~   74 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEH------CVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRL   74 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCce------EEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeE
Confidence            478889999999999999998776543      89998865422  2345678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~~~  235 (431)
                      ++|+||+.+++|.+++.+.....+++..+..++.|++.||.|||+.+  ++|+||||+||++++++ .++|+|||.+...
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          75 FIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK--ILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999999999999998766556899999999999999999999866  99999999999998885 4699999998765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....  ......|++.|+|||++.+..++.++|+||||+++|||++|+.||........                ....
T Consensus       153 ~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----------------~~~~  214 (257)
T cd08225         153 NDSME--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL----------------VLKI  214 (257)
T ss_pred             cCCcc--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------------HHHH
Confidence            43221  12234689999999999888899999999999999999999999965422110                0011


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..... .......+..+.+++.+||..+|++|||+.+++.+
T Consensus       215 ~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         215 CQGYF-APISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             hcccC-CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            11111 11112334678899999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=304.22  Aligned_cols=249  Identities=26%  Similarity=0.420  Sum_probs=198.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC---CCceeeeecEEEeCC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR---HPNLVKLIGYCCEDD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~  154 (431)
                      .|+..+.||.|+||.||+|.+..++.      .|++|.+..... ....++.+|+.++++++   |||++++++++....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~   75 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGR------VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGP   75 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCc------EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCC
Confidence            46777899999999999999876544      399998875432 34456788999999986   999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++...   .+++...+.++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++..
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  150 (277)
T cd06917          76 RLWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVG--VIHRDIKAANILVTNTGNVKLCDFGVAAL  150 (277)
T ss_pred             EEEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCcCHHHEEEcCCCCEEEccCCceee
Confidence            999999999999999988543   5889999999999999999999866  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ......|+..|+|||.+.++ .++.++|||||||++|+|++|..||............             .
T Consensus       151 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~-------------~  215 (277)
T cd06917         151 LNQNSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLI-------------P  215 (277)
T ss_pred             cCCCcc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhcc-------------c
Confidence            544331  12234689999999988754 5789999999999999999999999764322111000             0


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+.+..   ...+.++.+++.+||+.||.+||++.+++.+
T Consensus       216 ~~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         216 KSKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cCCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence            000011111   1144678899999999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-39  Score=305.27  Aligned_cols=250  Identities=24%  Similarity=0.357  Sum_probs=199.6

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      .|...+.||+|++|.||++.+..+..      .+++|.+........+.+.+|+.+++.++|+||+++++++...+..++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~   93 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGR------QVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWV   93 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCC------EEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEE
Confidence            34556789999999999998865543      389998865544455668899999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      |+||+.+++|.+++..   ..+++..+..++.|++.||+|||+.+  |+||||+|+||+++.++.++|+|||++......
T Consensus        94 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~  168 (285)
T cd06648          94 VMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQG--VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE  168 (285)
T ss_pred             EEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChhhEEEcCCCcEEEcccccchhhccC
Confidence            9999999999999866   34788899999999999999999876  999999999999999999999999988754322


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      ..  ......|++.|+|||++.+..++.++|||||||++|+|++|+.||....+......             +.....+
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~-------------~~~~~~~  233 (285)
T cd06648         169 VP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR-------------IRDNLPP  233 (285)
T ss_pred             Cc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH-------------HHhcCCC
Confidence            11  12235689999999999888899999999999999999999999975432111100             0000000


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+.  .....+..+.+++.+||+.+|++||++.+++++
T Consensus       234 ~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         234 KLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             CCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence            110  111244678999999999999999999999964

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.1e-39  Score=315.21  Aligned_cols=266  Identities=23%  Similarity=0.320  Sum_probs=199.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|+..+.||+|+||.||+|.+..++.      .||+|.+.+..  ......+.+|+.+++.++|+||++++++|..
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   86 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQ------NVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTP   86 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCC------EEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeecc
Confidence            356889999999999999999999876554      39999986532  2334567789999999999999999998864


Q ss_pred             C------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          153 D------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       153 ~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      .      ...|+||||+ .++|.+.+...    ++......++.|++.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nil~~~~~~~kL  159 (353)
T cd07850          87 QKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI  159 (353)
T ss_pred             CCCccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEE
Confidence            4      3569999999 56888877542    788888899999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-hh-hhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DW-ARP  304 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~-~~~  304 (431)
                      +|||+++......   ......++..|+|||++.+..++.++|||||||++|+|++|+.||...........+ .. ..+
T Consensus       160 ~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  236 (353)
T cd07850         160 LDFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP  236 (353)
T ss_pred             ccCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999998653322   122346889999999999999999999999999999999999999765321110000 00 000


Q ss_pred             --------------hhhc-----cchhhhhcCccc----cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 --------------KLND-----KRKMLQIIDPRL----ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 --------------~~~~-----~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                    ....     ...+.+......    ........+..+.+++.+||+.||.+|||+.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             CHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                          0000     000000000000    000012345678899999999999999999999976

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.4e-39  Score=302.23  Aligned_cols=249  Identities=26%  Similarity=0.385  Sum_probs=200.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +-|+..+.||.|+||.||+|.+..+..      .||+|++..... .....+.+|+.++++++||||+++++++..++..
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   77 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL   77 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCc------EEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeE
Confidence            346778899999999999998866544      399998765432 3345688899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++..   ..+++.....++.+++.++.|||+.+  ++|+||+|+||+++.++.++|+|||++....
T Consensus        78 ~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~--i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~  152 (277)
T cd06641          78 WIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQLT  152 (277)
T ss_pred             EEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCC--eecCCCCHHhEEECCCCCEEEeecccceecc
Confidence            999999999999998854   25789999999999999999999866  9999999999999999999999999987653


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ....  ......++..|+|||.+.+..++.++|+|||||++|+|++|..||...........                 +
T Consensus       153 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-----------------~  213 (277)
T cd06641         153 DTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-----------------I  213 (277)
T ss_pred             cchh--hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-----------------H
Confidence            3221  12234688899999999888899999999999999999999999965432111000                 0


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ............+.++.+++.+||..+|.+||++.+++.+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         214 PKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             hcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            0000111222345678899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.6e-39  Score=300.22  Aligned_cols=254  Identities=27%  Similarity=0.400  Sum_probs=201.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|.+.+.||+|+||.||+|.+..+..      .|++|.+......  ....+.+|+.+++.++|+||+++++++...+..
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~   74 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGE------LMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKV   74 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCc------EEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEE
Confidence            57888999999999999998876544      3999998766443  567788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+++++|.+++....  .+++..+..++.+++.||.|||+.+  |+|+||+|+||+++.++.+||+|||++....
T Consensus        75 ~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~  150 (264)
T cd06626          75 YIFMEYCSGGTLEELLEHGR--ILDEHVIRVYTLQLLEGLAYLHSHG--IVHRDIKPANIFLDHNGVIKLGDFGCAVKLK  150 (264)
T ss_pred             EEEEecCCCCcHHHHHhhcC--CCChHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEcccccccccC
Confidence            99999999999999987643  4678888899999999999999866  9999999999999999999999999987754


Q ss_pred             CCCCcce--eecccCCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          237 QGDETHV--STRVMGTYGYAAPEYVMTGH---LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       237 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      .......  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||.........   .+.         
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~---~~~---------  218 (264)
T cd06626         151 NNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQI---MFH---------  218 (264)
T ss_pred             CCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHH---HHH---------
Confidence            3322111  11356788999999988766   889999999999999999999999754311110   000         


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.....+.+.  .....+..+.+++.+||+.+|.+||++.+++.+
T Consensus       219 ~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         219 VGAGHKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HhcCCCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000111  111235677899999999999999999998753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-39  Score=306.10  Aligned_cols=251  Identities=29%  Similarity=0.406  Sum_probs=198.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ..+.|...+.||+|+||.||+|.+..++.      .|++|.+.....   ....++.+|+.+++.++||||+++++++.+
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~   86 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR   86 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCc------EEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence            34568888999999999999999876544      399998864422   233568899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+. |+|.+++.... .++++..+..++.|++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~--i~H~dl~p~nIl~~~~~~~kL~dfg~~  162 (307)
T cd06607          87 EHTAWLVMEYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHE--RIHRDIKAGNILLTEPGTVKLADFGSA  162 (307)
T ss_pred             CCeEEEEHHhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEECCCCCEEEeecCcc
Confidence            999999999995 67777775433 35889999999999999999999866  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ......      ....++..|+|||++.   ...++.++||||||+++|||++|+.||...........           
T Consensus       163 ~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~-----------  225 (307)
T cd06607         163 SLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH-----------  225 (307)
T ss_pred             eecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH-----------
Confidence            764322      2346888999999874   45688999999999999999999999965432111000           


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                           +.............+..+.+++.+||..||.+||++.+|+.+..
T Consensus       226 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  269 (307)
T cd06607         226 -----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRF  269 (307)
T ss_pred             -----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChh
Confidence                 00000001112234568899999999999999999999997643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=349.29  Aligned_cols=255  Identities=27%  Similarity=0.358  Sum_probs=203.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      ++-++.....||.|.||.||.|...+++..      .|+|-++-..  ......+.+|+.++..++|||+|++||+-.+.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGel------lAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR 1306 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGEL------LAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR 1306 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccch------hhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH
Confidence            455777788999999999999999888775      7888665432  23345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..+|.||||++|+|.+++....  -+++.....+..|++.|+.|||.++  ||||||||+||||+.+|.+|++|||.|.
T Consensus      1307 ekv~IFMEyC~~GsLa~ll~~gr--i~dE~vt~vyt~qll~gla~LH~~g--IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1307 EKVYIFMEYCEGGSLASLLEHGR--IEDEMVTRVYTKQLLEGLAYLHEHG--IVHRDIKPANILLDFNGLIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHHHhccCcHHHHHHhcc--hhhhhHHHHHHHHHHHHHHHHHhcC--ceecCCCccceeeecCCcEEeeccccee
Confidence            99999999999999999996543  2566666667889999999999977  9999999999999999999999999998


Q ss_pred             cCCCCCCc--ceeecccCCccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          234 AGPQGDET--HVSTRVMGTYGYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       234 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      .......+  .......||+.|||||++.+.   ....++||||||||+.||+||+.||...+..-..            
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aI------------ 1450 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAI------------ 1450 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHH------------
Confidence            75443211  112346899999999999764   4567899999999999999999999765422110            


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                          .--+-..-....+...+.+-.+||.+||+.||++|.++.||+++
T Consensus      1451 ----My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1451 ----MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             ----HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                00011112223455577889999999999999999999988876

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.7e-39  Score=303.66  Aligned_cols=246  Identities=27%  Similarity=0.395  Sum_probs=195.3

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||+|+||+||++.+..+++.      |++|.+.....   .....+.+|+++|++++||||+++++++...+..|+||||
T Consensus         1 lg~g~~g~vy~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   74 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKM------YACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTL   74 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcE------EEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEec
Confidence            69999999999988765543      99998865432   2234567899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---  149 (277)
T cd05577          75 MNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR--IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---  149 (277)
T ss_pred             CCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEECCCCCEEEccCcchhhhccCC---
Confidence            99999999998766557899999999999999999999866  9999999999999999999999999987643311   


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ......++..|+|||++.++.++.++|||||||++|+|++|+.||.............             .... ....
T Consensus       150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~-~~~~  215 (277)
T cd05577         150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK-------------RRTL-EMAV  215 (277)
T ss_pred             ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH-------------hccc-cccc
Confidence            1223457889999999988889999999999999999999999997654321111100             0000 0011


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      ..+...+..+.+++.+||+.||.+||     ++.+++.+
T Consensus       216 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         216 EYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             cCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence            12223457889999999999999999     66667654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-40  Score=316.49  Aligned_cols=251  Identities=23%  Similarity=0.321  Sum_probs=207.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      -...|.+.+.||+|.|+.|.+|++..+..      .||||++++....  ....+.+|+++|+.|+|||||+++.+...+
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~------~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~  127 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGT------EVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE  127 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCc------eEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec
Confidence            34578899999999999999999876543      4999999987543  335588999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..+|+||||+.+|.+++++.+.+..  .+.....++.|++.+++|||+.+  |||||||.+||||+.+.++||+|||++.
T Consensus       128 ~~lylV~eya~~ge~~~yl~~~gr~--~e~~ar~~F~q~vsaveYcH~k~--ivHrdLk~eNilL~~~mnikIaDfgfS~  203 (596)
T KOG0586|consen  128 ATLYLVMEYASGGELFDYLVKHGRM--KEKEARAKFRQIVSAVEYCHSKN--IVHRDLKAENILLDENMNIKIADFGFST  203 (596)
T ss_pred             ceeEEEEEeccCchhHHHHHhcccc--hhhhhhhhhHHHHHHHHHHhhcc--eeccccchhhcccccccceeeeccccce
Confidence            9999999999999999999887764  34667778899999999999866  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .+...   ....+.+|++.|.|||++.+..|+ +.+|+||+|+++|.|+.|..||++..-......              
T Consensus       204 ~~~~~---~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r--------------  266 (596)
T KOG0586|consen  204 FFDYG---LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR--------------  266 (596)
T ss_pred             eeccc---ccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch--------------
Confidence            86533   345568999999999999988774 689999999999999999999987543221110              


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                        .+-..+  ..+...+.++.++|+++|..+|.+|+++.++..+-
T Consensus       267 --vl~gk~--rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  267 --VLRGKY--RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             --heeeee--cccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence              000011  11223346778999999999999999999998653

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.3e-39  Score=306.62  Aligned_cols=267  Identities=23%  Similarity=0.318  Sum_probs=199.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      ++|++.+.||.|+||.||+|.+..+..      .+++|.++.....  ....+.+|+.++++++||||+++++++...  
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   78 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGE------IVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNL   78 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCc------EEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCC
Confidence            468888899999999999999876544      3899988654322  223567899999999999999999999877  


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..|+||||+. ++|.+++..... .+++...+.++.|++.||.|||+.+  ++|+||||+|||++.++.++|+|||++.
T Consensus        79 ~~~~lv~e~~~-~~L~~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~~~~~l~d~g~~~  154 (293)
T cd07843          79 DKIYMVMEYVE-HDLKSLMETMKQ-PFLQSEVKCLMLQLLSGVAHLHDNW--ILHRDLKTSNLLLNNRGILKICDFGLAR  154 (293)
T ss_pred             CcEEEEehhcC-cCHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCcEEEeecCcee
Confidence            88999999996 599998866443 5899999999999999999999876  9999999999999999999999999988


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hh------
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RP------  304 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~------  304 (431)
                      .......  ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...........+...  .+      
T Consensus       155 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  232 (293)
T cd07843         155 EYGSPLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP  232 (293)
T ss_pred             eccCCcc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence            6544321  12234578899999988754 4688999999999999999999999765432221111000  00      


Q ss_pred             hhhcc-----chhhhhcCccccCcccHH-HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDK-----RKMLQIIDPRLENQYSVR-AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....     ..........+...++.. .+..+.+++.+||+.||++|||+.|++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00000     000000000111112211 35778899999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.9e-39  Score=304.72  Aligned_cols=268  Identities=26%  Similarity=0.358  Sum_probs=196.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-HHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++.|++.+.||+|+||.||+|.+...+.      .|++|++....... ...+.+|+.+++.++|+||+++++++.+.+.
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   77 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQ------LVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKET   77 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCc------EEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCe
Confidence            3678999999999999999999876544      39999986543222 2356789999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+. ++|.+++.... ..+.+..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||+++..
T Consensus        78 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  153 (291)
T cd07870          78 LTFVFEYMH-TDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQH--ILHRDLKPQNLLISYLGELKLADFGLARAK  153 (291)
T ss_pred             EEEEEeccc-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChHHEEEcCCCcEEEecccccccc
Confidence            999999994 77777765433 34677888889999999999999866  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc-----
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK-----  309 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----  309 (431)
                      ......  .....+++.|+|||++.+. .++.++|||||||++|+|++|+.||.........-...+........     
T Consensus       154 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (291)
T cd07870         154 SIPSQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG  231 (291)
T ss_pred             CCCCCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhh
Confidence            322211  1234578999999988754 58889999999999999999999997654321110000000000000     


Q ss_pred             -chhh----hhcCccccCcc-----cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 -RKML----QIIDPRLENQY-----SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 -~~~~----~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ..+.    ...........     .......+.+++.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         232 VSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             hhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             0000    00000000000     00124578899999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=308.76  Aligned_cols=269  Identities=21%  Similarity=0.276  Sum_probs=197.3

Q ss_pred             CCCccceecccCcEEEEEEEEcC--CceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDE--NVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +|++.+.||+|+||.||+|.+..  .+.      .||+|.+....   ......+.+|+.++++++||||+++++++.+.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~------~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGK------EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH   74 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCC------eEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC
Confidence            47888899999999999999876  333      49999987732   23345678899999999999999999999988


Q ss_pred             --CeeEEEEEecCCCChHHhhhhC---CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC----CCcE
Q 014079          154 --DHRLLVYEFMFRGSLENHLFRK---ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----DYTA  224 (431)
Q Consensus       154 --~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~----~~~~  224 (431)
                        ...++||||++ ++|.+++...   ....++...++.++.|++.||.|||+.+  |+||||||+|||++.    ++.+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~h~dlkp~Nil~~~~~~~~~~~  151 (316)
T cd07842          75 ADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW--VLHRDLKPANILVMGEGPERGVV  151 (316)
T ss_pred             CCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC--EeeCCCCHHHEEEcCCCCccceE
Confidence              88999999995 5777766432   2236888999999999999999999866  999999999999999    8999


Q ss_pred             EEecccCCccCCCCCC-cceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch-----
Q 014079          225 KLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS-----  297 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-----  297 (431)
                      ||+|||++........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||..........     
T Consensus       152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~  231 (316)
T cd07842         152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR  231 (316)
T ss_pred             EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence            9999999986543322 1122235688999999988764 58899999999999999999999997654432000     


Q ss_pred             -hhhhhhhhh-----------hccchhhh---hc-C-----ccccCcccH--HHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 014079          298 -LVDWARPKL-----------NDKRKMLQ---II-D-----PRLENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV  354 (431)
Q Consensus       298 -~~~~~~~~~-----------~~~~~~~~---~~-~-----~~~~~~~~~--~~~~~~~~li~~cl~~dP~~RPt~~eil  354 (431)
                       ........+           ........   .. .     ..+......  ..+.++.+++.+||+.||++|||+.|++
T Consensus       232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil  311 (316)
T cd07842         232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL  311 (316)
T ss_pred             HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence             000000000           00000000   00 0     000000011  3346789999999999999999999998


Q ss_pred             HH
Q 014079          355 ET  356 (431)
Q Consensus       355 ~~  356 (431)
                      .+
T Consensus       312 ~~  313 (316)
T cd07842         312 EH  313 (316)
T ss_pred             cC
Confidence            64

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=7.3e-39  Score=296.55  Aligned_cols=253  Identities=26%  Similarity=0.392  Sum_probs=205.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--C
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--D  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  154 (431)
                      +|+..+.||+|++|.||+|.+..+..      .|++|++.....  .....+.+|+.++++++|+||+++++.+.+.  .
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGE------LMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKN   74 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCc------EEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCC
Confidence            47778899999999999999886544      399998876543  3456788999999999999999999999988  8


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++|+||+.+++|.+++....  .+++..++.++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||.+..
T Consensus        75 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~--~~h~dl~p~ni~i~~~~~~~l~d~~~~~~  150 (260)
T cd06606          75 TLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNG--IVHRDIKGANILVDSDGVVKLADFGCAKR  150 (260)
T ss_pred             eEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEcCCCCEEEcccccEEe
Confidence            9999999999999999997654  6899999999999999999999866  99999999999999999999999999887


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ..............++..|++||.+.+..++.++||||||+++|+|++|..||........               ....
T Consensus       151 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~---------------~~~~  215 (260)
T cd06606         151 LGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA---------------ALYK  215 (260)
T ss_pred             cccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH---------------HHHh
Confidence            5544321112345688999999999888899999999999999999999999976541100               0111


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..........+...+..+.+++.+||+.||.+||++.+++.+
T Consensus       216 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             ccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence            111111122333446789999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.8e-39  Score=302.81  Aligned_cols=255  Identities=24%  Similarity=0.371  Sum_probs=205.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ...+.|+..+.||+|+||.||++.+.....      .+++|++..... ....+.+|+++++.++|+||+++++++...+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   88 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGK------EVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGD   88 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCc------EEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECC
Confidence            455678888899999999999999875433      489999876543 4567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++|+||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~g--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~  165 (286)
T cd06614          89 ELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQN--VIHRDIKSDNILLSKDGSVKLADFGFAAQ  165 (286)
T ss_pred             EEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCChhhEEEcCCCCEEECccchhhh
Confidence            9999999999999999997754 36899999999999999999999866  99999999999999999999999998865


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  ......++..|++||++.+..++.++||||||+++|+|++|+.||....+.....                .
T Consensus       166 ~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~----------------~  227 (286)
T cd06614         166 LTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF----------------L  227 (286)
T ss_pred             hccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------H
Confidence            433211  1223458889999999988889999999999999999999999997543221110                0


Q ss_pred             hcCcccc-CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      +...... .......+..+.+++.+||+.+|.+||++.+++.+.
T Consensus       228 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         228 ITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             HHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            0000000 011122456788999999999999999999998754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1e-38  Score=305.68  Aligned_cols=253  Identities=28%  Similarity=0.422  Sum_probs=199.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|...+.||+|+||.||++.+..++.      .+++|.+.....   .....+.+|++++++++|+|++++++++.+++
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   98 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNE------VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREH   98 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCc------EEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCC
Confidence            346777889999999999999876544      399998865422   23356889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+. |+|.+++... ..++++..+..++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||++..
T Consensus        99 ~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~--i~H~dL~p~Nil~~~~~~~kl~dfg~~~~  174 (317)
T cd06635          99 TAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASI  174 (317)
T ss_pred             eEEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcccEEECCCCCEEEecCCCccc
Confidence            9999999996 5787777543 345899999999999999999999866  99999999999999999999999999875


Q ss_pred             CCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ....      ....|++.|+|||++.   .+.++.++|||||||++|||++|+.||.........               
T Consensus       175 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~---------------  233 (317)
T cd06635         175 ASPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL---------------  233 (317)
T ss_pred             cCCc------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---------------
Confidence            4321      2346889999999874   457899999999999999999999998654211110               


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                       ..+.............+..+.+++.+||+.+|.+||++.++++++..+..
T Consensus       234 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         234 -YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             -HHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence             01111111111122345678899999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=304.03  Aligned_cols=266  Identities=22%  Similarity=0.287  Sum_probs=198.3

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      |++.+.||.|++|.||+|.+..++.      .|++|++.....  .....+.+|+.+++.++|+||+++++++.+.+..+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~   74 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGE------IVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLY   74 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCC------EEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEE
Confidence            5677899999999999999876544      389998865432  22356788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ++|||+ +++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~--~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~  151 (283)
T cd07835          75 LVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR--VLHRDLKPQNLLIDREGALKLADFGLARAFGV  151 (283)
T ss_pred             EEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCcEEEeecccccccCC
Confidence            999999 579999987765456899999999999999999999866  99999999999999999999999999876432


Q ss_pred             CCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhhhhh-------hhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL-VDWARPK-------LND  308 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~~~~-------~~~  308 (431)
                      ...  ......++..|+|||++.+. .++.++||||||+++|+|++|+.||........... .......       ...
T Consensus       152 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (283)
T cd07835         152 PVR--TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS  229 (283)
T ss_pred             Ccc--ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence            211  11223568899999988664 578999999999999999999999976543221100 0000000       000


Q ss_pred             cchhhhhcC---ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .........   ...........+..+.+++.+||+.||.+|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            000000000   000001112234678899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.1e-39  Score=297.57  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|.+.+.||.|+||.||++.+..+..      .+++|++.....  .....+.+|+++++.++|+|++++++.+...+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~   74 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGK------LYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKL   74 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCc------EEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEE
Confidence            47888899999999999999876443      499999876543  4456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ++|+||+++++|.+++....  ...+++..+..++.+++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++..
T Consensus        75 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~--~~H~dl~~~nil~~~~~~~~l~d~~~~~~  152 (258)
T cd08215          75 CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK--ILHRDIKPQNIFLTSNGLVKLGDFGISKV  152 (258)
T ss_pred             EEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHHeEEcCCCcEEECCccceee
Confidence            99999999999999997643  356899999999999999999999876  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....  .......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||........   ..             .
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~---~~-------------~  214 (258)
T cd08215         153 LSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL---AL-------------K  214 (258)
T ss_pred             cccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHH---HH-------------H
Confidence            54332  122335689999999999888899999999999999999999999965432110   00             0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ... ......+...+..+.+++.+||..+|.+|||+.+++++
T Consensus       215 ~~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         215 ILK-GQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             Hhc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000 00111222345788899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=9.3e-39  Score=294.62  Aligned_cols=251  Identities=29%  Similarity=0.444  Sum_probs=203.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      .|...+.||+|++|.||++.+..+..      .+++|++..........+.+|+.++++++|+||+++++++......++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   74 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGK------EVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWI   74 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCc------EEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            36778899999999999999876544      399999877654456788999999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ++||+++++|.+++.... ..+++..+..++.|++.+|.|||..+  ++|+||+|+||+++.++.++|+|||.+......
T Consensus        75 ~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~--i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  151 (253)
T cd05122          75 VMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNG--IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT  151 (253)
T ss_pred             EEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCC--EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence            999999999999987653 46899999999999999999999866  999999999999999999999999998775443


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      ..   .....++..|++||.+.+..++.++||||||+++|+|++|+.||............             ....-+
T Consensus       152 ~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~~  215 (253)
T cd05122         152 KA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKI-------------ATNGPP  215 (253)
T ss_pred             cc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHH-------------HhcCCC
Confidence            21   23356889999999998888999999999999999999999999764321111000             000000


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+  ......+..+.+++.+||+.||.+|||+.+++++
T Consensus       216 ~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00  0111125678999999999999999999999865

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.7e-39  Score=306.67  Aligned_cols=255  Identities=26%  Similarity=0.333  Sum_probs=194.4

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  156 (431)
                      +|...+.||+|+||.||++.+..++.      .+|+|.+..... .....+.+|+.++.++. |+||+++++++..++..
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~   78 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGT------IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDC   78 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCC------EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcE
Confidence            34556689999999999999876654      399998875432 34456889999999996 99999999999999999


Q ss_pred             EEEEEecCCCChHHhh---hhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          157 LLVYEFMFRGSLENHL---FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l---~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +++|||+. ++|.++.   .......+++.....++.+++.||+|||+. .+|+||||||+|||++.++.++|+|||+++
T Consensus        79 ~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~-~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  156 (288)
T cd06616          79 WICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE-LKIIHRDVKPSNILLDRNGNIKLCDFGISG  156 (288)
T ss_pred             EEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc-CCeeccCCCHHHEEEccCCcEEEeecchhH
Confidence            99999984 5655543   333345689999999999999999999963 239999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      .......   .....|+..|+|||++.+.   .++.++|||||||++|+|++|+.||......     ...       ..
T Consensus       157 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-----~~~-------~~  221 (288)
T cd06616         157 QLVDSIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV-----FDQ-------LT  221 (288)
T ss_pred             HhccCCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH-----HHH-------Hh
Confidence            5432211   1234588999999998766   6899999999999999999999999754310     000       00


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+.+........+.++.+|+.+||+.||.+|||+.+|+.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             hhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000001111112223356788999999999999999999999976

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.3e-39  Score=308.66  Aligned_cols=265  Identities=23%  Similarity=0.287  Sum_probs=195.2

Q ss_pred             ceeccc--CcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEG--GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ..||.|  +||+||++.+...+..      ||+|++.....  ...+.+.+|+.+++.++||||++++++|..++..++|
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v   77 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTL------VTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI   77 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcE------EEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEE
Confidence            356666  9999999998765543      99999875432  2345678899999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      |||+.+++|.+++.+.....+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.++++||+.+.......
T Consensus        78 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~  155 (328)
T cd08226          78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG--YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNG  155 (328)
T ss_pred             EecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEeCCCcEEEechHHHhhhhccC
Confidence            99999999999998765556888999999999999999999866  9999999999999999999999998654322111


Q ss_pred             Cc-ce----eecccCCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh--h-----
Q 014079          240 ET-HV----STRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP--K-----  305 (431)
Q Consensus       240 ~~-~~----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--~-----  305 (431)
                      .. ..    .....++..|+|||++.+.  .++.++|||||||++|||++|+.||.........  ......  .     
T Consensus       156 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~  233 (328)
T cd08226         156 QKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDI  233 (328)
T ss_pred             ccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccc
Confidence            10 00    0112356679999998764  4789999999999999999999999765321110  000000  0     


Q ss_pred             --hhccc-----------------h-----hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          306 --LNDKR-----------------K-----MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       306 --~~~~~-----------------~-----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                        .....                 .     ........+.......++..+.+|+++||+.||++|||+.+++++-.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~  310 (328)
T cd08226         234 TTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF  310 (328)
T ss_pred             cccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence              00000                 0     00001111222223456788999999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=6.7e-39  Score=298.36  Aligned_cols=244  Identities=28%  Similarity=0.387  Sum_probs=196.7

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||.|+||.||++.+..+..      .+++|++.+...   ...+.+.+|+.+++.++||||+++++++.++...++||||
T Consensus         1 lg~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   74 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNR------TFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEY   74 (262)
T ss_pred             CCCCCceEEEEEEECCCCc------EEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEec
Confidence            6999999999999876443      499999876432   2345688999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++.+..  .++...+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~~i~~~l~~lH~~~--~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---  147 (262)
T cd05572          75 CLGGELWTILRDRG--LFDEYTARFYIACVVLAFEYLHNRG--IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---  147 (262)
T ss_pred             CCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---
Confidence            99999999997653  4788899999999999999999866  9999999999999999999999999998754432   


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ......|++.|++||.+.+..++.++|+||||+++|+|++|..||........              .....+.......
T Consensus       148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~~~~~~  213 (262)
T cd05572         148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPM--------------EIYNDILKGNGKL  213 (262)
T ss_pred             ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHH--------------HHHHHHhccCCCC
Confidence            12234688999999999888899999999999999999999999976542110              0011111111111


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      .++...+..+.+++.+||+.||.+||+     ++|++++
T Consensus       214 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         214 EFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence            223333678999999999999999999     7888764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=7.1e-39  Score=301.21  Aligned_cols=244  Identities=26%  Similarity=0.364  Sum_probs=188.2

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHH---HhcCCCCceeeeecEEEeCCeeEE
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNF---LGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~---l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      +||+|+||.||++.+..++.      .+|+|.+.+....   ....+.+|..+   +....||||+.+++++...+..++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~l   74 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCF   74 (279)
T ss_pred             CcccCCCeEEEEEEECCCCc------EEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEE
Confidence            48999999999999876544      3999988654321   12223444433   334479999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ||||+.+++|.+++....  .+++.....++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~i~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~  150 (279)
T cd05633          75 ILDLMNGGDLHYHLSQHG--VFSEKEMRFYATEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (279)
T ss_pred             EEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCCCCCCHHHEEECCCCCEEEccCCcceecccc
Confidence            999999999999886554  4899999999999999999999876  999999999999999999999999998754322


Q ss_pred             CCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .    .....||..|+|||.+.+ ..++.++|||||||++|+|++|..||............              .. .
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~--------------~~-~  211 (279)
T cd05633         151 K----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID--------------RM-T  211 (279)
T ss_pred             C----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHH--------------HH-h
Confidence            1    123468999999998864 56899999999999999999999999764322111000              00 0


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L  357 (431)
                      .......+...+.++.+++.+||+.||.+||     ++.+++++.
T Consensus       212 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         212 LTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             hcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            0111122334567889999999999999999     599998764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=297.00  Aligned_cols=252  Identities=23%  Similarity=0.308  Sum_probs=199.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-----CchhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-----GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+|++.+.||+|+||.||+|.+..++.      .|++|.+...     .......+.+|+.++++++|+||+++++++.+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   75 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGR------ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD   75 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCC------EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc
Confidence            468899999999999999999876544      3899986432     12234568889999999999999999999876


Q ss_pred             C--CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          153 D--DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       153 ~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                      .  ..+++|+||+++++|.+++....  .+++.....++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||
T Consensus        76 ~~~~~~~~v~e~~~~~~L~~~~~~~~--~l~~~~~~~~~~~i~~al~~LH~~~--i~H~dl~p~ni~i~~~~~~~l~dfg  151 (264)
T cd06653          76 PEEKKLSIFVEYMPGGSIKDQLKAYG--ALTENVTRRYTRQILQGVSYLHSNM--IVHRDIKGANILRDSAGNVKLGDFG  151 (264)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECccc
Confidence            4  46889999999999999987644  4778888899999999999999866  9999999999999999999999999


Q ss_pred             CCccCCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          231 LAKAGPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       231 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      +++........ .......|+..|+|||++.+..++.++|||||||++|+|++|+.||.......               
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------  216 (264)
T cd06653         152 ASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------  216 (264)
T ss_pred             cccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------
Confidence            99764321111 11123568999999999998889999999999999999999999997542111               


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+.+..........+...++.+.+++.+||. +|.+||+..+++.|
T Consensus       217 -~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         217 -AIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             -HHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence             1111111112223344566789999999999 57999999998865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-38  Score=301.19  Aligned_cols=264  Identities=16%  Similarity=0.170  Sum_probs=187.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-----------HHHHHHHHHHHhcCCCCcee
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-----------HREWLTEVNFLGQLRHPNLV  144 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv  144 (431)
                      ..++|++.++||+|+||.||+|.+.++...   ...+++|+........           ......++..+..+.|+||+
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~---~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~   86 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCI---NNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP   86 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCccc---ccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence            346899999999999999999998765211   1126666543322111           01123445556778899999


Q ss_pred             eeecEEEeCC----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          145 KLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       145 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      ++++++....    ..++++|++ ..++.+.+....  ..++..+..++.|++.||.|||+.+  |+||||||+|||++.
T Consensus        87 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--iiHrDiKp~Nill~~  161 (294)
T PHA02882         87 KYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIK--CKNKKLIKNIMKDMLTTLEYIHEHG--ISHGDIKPENIMVDG  161 (294)
T ss_pred             cEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhc--cCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcC
Confidence            9998766543    346788877 456766665432  3567778899999999999999866  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc
Q 014079          221 DYTAKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE  295 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  295 (431)
                      ++.++|+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            999999999999765322111     111234699999999999999999999999999999999999999986532211


Q ss_pred             chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .  .....     ...+..+....+.   ....+..+.+++..||..+|++||++.+|++.|
T Consensus       242 ~--~~~~~-----~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 L--IHAAK-----CDFIKRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             H--HHHhH-----HHHHHHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            1  10000     0000111111110   112357889999999999999999999999876

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.4e-39  Score=303.75  Aligned_cols=268  Identities=22%  Similarity=0.298  Sum_probs=197.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||.|++|.||+|.+..++.      .|++|.+.....  .....+.+|++++++++|+||+++++++.+...
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   75 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNE------TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKR   75 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCc------EEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCe
Confidence            468889999999999999999876544      399998865432  223567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~  234 (431)
                      .++||||+. ++|.+++.......+++.....++.|++.||+|||+.+  ++|+||+|+||+++. ++.+||+|||++..
T Consensus        76 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dl~p~nill~~~~~~~kl~dfg~~~~  152 (294)
T PLN00009         76 LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR--VLHRDLKPQNLLIDRRTNALKLADFGLARA  152 (294)
T ss_pred             EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCcceEEEECCCCEEEEcccccccc
Confidence            999999994 68888886655555688888899999999999999866  999999999999985 56799999999976


Q ss_pred             CCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh--hhhhhh---c
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--ARPKLN---D  308 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~--~~~~~~---~  308 (431)
                      .....  .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||..............  ..+...   .
T Consensus       153 ~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (294)
T PLN00009        153 FGIPV--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG  230 (294)
T ss_pred             cCCCc--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            43221  11223457889999998876 4578999999999999999999999976533211110000  000000   0


Q ss_pred             cchhhhhc--Ccccc----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQII--DPRLE----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~--~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...+....  -+...    .......+.++.+++.+||+.||++||++.+++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000000  00000    00112345678899999999999999999999864

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.2e-39  Score=311.78  Aligned_cols=268  Identities=23%  Similarity=0.312  Sum_probs=197.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|.+.... ......+.+|+.++++++|+||+++++++....
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~   76 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGV------KVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPS   76 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCC------eEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeeccc
Confidence            35789999999999999999999876544      49999886432 233456788999999999999999999876543


Q ss_pred             -----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          155 -----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       155 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                           ..++|+||+. ++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|+||
T Consensus        77 ~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~--ivH~dlkp~Nill~~~~~~kl~df  150 (336)
T cd07849          77 FESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTNCDLKICDF  150 (336)
T ss_pred             ccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEECCCCCEEECcc
Confidence                 5799999995 588877743   35888999999999999999999876  999999999999999999999999


Q ss_pred             cCCccCCCCCCc-ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          230 GLAKAGPQGDET-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       230 G~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |++......... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.................. .
T Consensus       151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~-~  229 (336)
T cd07849         151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT-P  229 (336)
T ss_pred             cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC-C
Confidence            998764332211 11223568999999998754 56899999999999999999999999754321110000000000 0


Q ss_pred             ccchhhhhcCc-----------cccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDP-----------RLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~-----------~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+.+.           .....   .....+.++.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         230 SQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             CHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            00000000000           00000   011235678999999999999999999999987

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=4.7e-39  Score=310.76  Aligned_cols=270  Identities=28%  Similarity=0.369  Sum_probs=199.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcC-CCCceeeeecEEE
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQL-RHPNLVKLIGYCC  151 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  151 (431)
                      .+.++|.+.+.||+|+||.||+|.+..++.      .+++|.+...  .......+.+|+.+++++ +|+||+++++++.
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~   77 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKE------VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIK   77 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCe------EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeec
Confidence            456788999999999999999999876544      3899977543  223345677899999999 9999999999986


Q ss_pred             eC--CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          152 ED--DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       152 ~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                      ..  ...++||||+. ++|.+++...   .+.+..+..++.|++.||.|||+.+  |+|+||||+|||++.++.+||+||
T Consensus        78 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--i~H~dl~p~nill~~~~~~kl~d~  151 (337)
T cd07852          78 AENDKDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGN--VIHRDLKPSNILLNSDCRVKLADF  151 (337)
T ss_pred             cCCCceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEEeec
Confidence            54  36899999996 6999888654   5788888899999999999999866  999999999999999999999999


Q ss_pred             cCCccCCCCCCc---ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          230 GLAKAGPQGDET---HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       230 G~a~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |++.........   .......||..|+|||++.+ ..++.++||||||+++|+|++|+.||..................
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~  231 (337)
T cd07852         152 GLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP  231 (337)
T ss_pred             cchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            999865433221   12234568999999998765 56788999999999999999999999765432211111000000


Q ss_pred             hh----------ccchhhhhcCc-c--ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LN----------DKRKMLQIIDP-R--LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~----------~~~~~~~~~~~-~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..          ....+...+.. .  .........+.++.+++.+||+.||.+|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             CCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            00          00000000000 0  0001111245788999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=9.8e-39  Score=295.78  Aligned_cols=249  Identities=22%  Similarity=0.313  Sum_probs=203.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||.|+||.||++.+..++.      .+++|.+.....  ....++.+|++++++++|+||+++++++.+....
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQ------FYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKL   74 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCC------EEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEE
Confidence            47888999999999999998876543      389998876432  3345678899999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ++||||+++++|.+++.+.  ....+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.+||+|||++..
T Consensus        75 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~--i~h~~l~~~ni~~~~~~~~kl~d~g~~~~  152 (256)
T cd08530          75 CIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK--ILHRDLKSANILLVANDLVKIGDLGISKV  152 (256)
T ss_pred             EEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCcceEEEecCCcEEEeeccchhh
Confidence            9999999999999998662  2345788999999999999999999866  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....    ......+++.|++||.+.+..++.++|+||||+++|+|++|+.||........                 ..
T Consensus       153 ~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~-----------------~~  211 (256)
T cd08530         153 LKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDL-----------------RY  211 (256)
T ss_pred             hccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-----------------HH
Confidence            5443    12234588899999999999999999999999999999999999976432110                 00


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+........+...+.++.+++.+||+.+|++||++.+++++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         212 KVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            011111112233556789999999999999999999999865

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.5e-38  Score=345.77  Aligned_cols=269  Identities=32%  Similarity=0.503  Sum_probs=208.9

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ..+.+...|...++||+|+||.||+|.+..++.      .||+|.+......    ...|++++++++|||||+++++|.
T Consensus       684 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~  753 (968)
T PLN00113        684 TINDILSSLKEENVISRGKKGASYKGKSIKNGM------QFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR  753 (968)
T ss_pred             hHHHHHhhCCcccEEccCCCeeEEEEEECCCCc------EEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence            344555678888999999999999999865544      3999988654321    134688999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                      +.+..++||||+++|+|.+++..     ++|..+..++.|++.||+|||.. .++|+||||||+||+++.++..++. ||
T Consensus       754 ~~~~~~lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~  827 (968)
T PLN00113        754 SEKGAYLIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LS  827 (968)
T ss_pred             cCCCCEEEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ec
Confidence            99999999999999999999942     78999999999999999999954 3459999999999999999888875 66


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ........      ....||+.|+|||++.+..++.++|||||||++|||++|+.||+..... ......|....... .
T Consensus       828 ~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~-~  899 (968)
T PLN00113        828 LPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGV-HGSIVEWARYCYSD-C  899 (968)
T ss_pred             cccccccC------CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCC-CCcHHHHHHHhcCc-c
Confidence            65432111      1235889999999999999999999999999999999999999543222 22334443322211 2


Q ss_pred             hhhhhcCccccC--cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          311 KMLQIIDPRLEN--QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       311 ~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      ....++++.+..  ........++.+++.+||+.||++|||+.|+++.|+.+....
T Consensus       900 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        900 HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             chhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            233344554432  234456678899999999999999999999999999776543

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.8e-38  Score=299.02  Aligned_cols=267  Identities=25%  Similarity=0.355  Sum_probs=199.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +|+..+.||.|++|.||+|.+..++..      |++|.++..... ....+.+|+.++++++|+||+++++++.+.+..+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~------~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   74 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEI------VALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLM   74 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeE------EEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEE
Confidence            478889999999999999998766543      999988765322 3456778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          158 LVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +||||+. ++|.+++.... ...+++..+..++.|++.||.|||+.+  ++|+||||+||+++.++.++|+|||++....
T Consensus        75 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~  151 (284)
T cd07836          75 LVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR--VLHRDLKPQNLLINKRGELKLADFGLARAFG  151 (284)
T ss_pred             EEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence            9999996 58888876543 345899999999999999999999876  9999999999999999999999999987543


Q ss_pred             CCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-hh-hhhhhhccchhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DW-ARPKLNDKRKML  313 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~-~~~~~~~~~~~~  313 (431)
                      ....  ......++..|++||++.+. .++.++|||||||++|+|++|+.||...........+ .. ..+.......+.
T Consensus       152 ~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (284)
T cd07836         152 IPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS  229 (284)
T ss_pred             CCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh
Confidence            2211  11234578899999988654 5788999999999999999999999765432211100 00 000000000000


Q ss_pred             --hhcCccc-------cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 --QIIDPRL-------ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 --~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .......       ........+..+.+++.+||+.||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence              0000000       001112345788899999999999999999999854

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=335.41  Aligned_cols=254  Identities=22%  Similarity=0.251  Sum_probs=208.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      -.++|.+.++||+|+||.|.+++.+.+.++      ||+|++++...   .+..-|..|-.+|..-+.+.|+.++..|.+
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~V------YAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKV------YAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccc------hhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            346899999999999999999999988877      99999988432   233457789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..++|||||||+||+|..++.+..  ++++....+++..|+.||.-||+.|  +|||||||+|||||..|++||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mg--yVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMG--YVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhcc--ceeccCCcceeEecccCcEeeccchhH
Confidence            999999999999999999997766  5888888899999999999999988  999999999999999999999999988


Q ss_pred             ccCCCCCCcceeecccCCccccCccccc----c-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVM----T-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      -.+..... -.....+|||.|.+||++.    + +.|+..+|+||+||++|||+.|..||....-..             
T Consensus       223 lkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve-------------  288 (1317)
T KOG0612|consen  223 LKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE-------------  288 (1317)
T ss_pred             HhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH-------------
Confidence            76654332 3344578999999999986    2 579999999999999999999999996542111             


Q ss_pred             ccchhhhhcCccccCccc--HHHHHHHHHHHHHhhhcCCCCCCC---HHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYS--VRAAQKACSLAYYCLSQNPKARPL---MSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~dP~~RPt---~~eil~~L  357 (431)
                         ....|++-.-.-.+|  ..++.++.+||++.+. +|+.|-.   +.++..|.
T Consensus       289 ---TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  289 ---TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             ---HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence               111222221111122  3467899999999887 6888887   88888763

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.2e-38  Score=304.01  Aligned_cols=269  Identities=26%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCED-  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  153 (431)
                      .++|++.+.||.|+||.||+|.+..++.      .||+|.+......  ....+.+|+.++++++|+||+++++++... 
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGE------IVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKH   79 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCc------EEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCC
Confidence            3568899999999999999999876544      3999988654321  123456899999999999999999998765 


Q ss_pred             -CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          154 -DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       154 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                       +..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+  ++||||||+||+++.++.+||+|||++
T Consensus        80 ~~~~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~kL~dfg~~  155 (309)
T cd07845          80 LDSIFLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENF--IIHRDLKVSNLLLTDKGCLKIADFGLA  155 (309)
T ss_pred             CCeEEEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEECcccee
Confidence             56899999995 58888886543 46899999999999999999999876  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--------  303 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------  303 (431)
                      ........  ......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....        
T Consensus       156 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~  233 (309)
T cd07845         156 RTYGLPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIW  233 (309)
T ss_pred             eecCCccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            86543221  1122346788999998865 568899999999999999999999997654332211111000        


Q ss_pred             hhhhccchhhhh-cCccccCcc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          304 PKLNDKRKMLQI-IDPRLENQY---SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      +........... +........   ....+..+.++|.+||+.||++|||+.+++.+-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         234 PGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             hhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            000000000000 000000000   011356788999999999999999999999764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-39  Score=315.49  Aligned_cols=270  Identities=29%  Similarity=0.377  Sum_probs=204.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC----
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD----  154 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  154 (431)
                      +...+.||+|+||.||+++++.+++.      ||||.+++.. ....+.+.+|+++|++|+|+|||+++++-.+..    
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~------vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~   88 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRL------VAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLV   88 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccc------hhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcc
Confidence            34456799999999999998887664      9999998754 345677889999999999999999999865443    


Q ss_pred             --eeEEEEEecCCCChHHhhhhC-CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC--CCC--cEEEe
Q 014079          155 --HRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDY--TAKLS  227 (431)
Q Consensus       155 --~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~--~~~--~~kl~  227 (431)
                        ...+|||||.||+|...+.+- +...+++...+.++.+++.||.|||.++  |+||||||.||++-  ++|  ..||+
T Consensus        89 ~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~--IvHRDlKP~NIvl~~Gedgq~IyKLt  166 (732)
T KOG4250|consen   89 TRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG--IVHRDLKPGNIVLQIGEDGQSIYKLT  166 (732)
T ss_pred             cccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC--ceeccCCCCcEEEeecCCCceEEeee
Confidence              458999999999999999763 4456999999999999999999999866  99999999999983  333  57999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||.|+.+.++.   ....+.||+.|++||++. .+.|+..+|.|||||++|+++||..||......+....+.|..-.-
T Consensus       167 DfG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk  243 (732)
T KOG4250|consen  167 DFGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK  243 (732)
T ss_pred             cccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc
Confidence            999999876654   456688999999999998 4889999999999999999999999997765554322222221110


Q ss_pred             hccchh---hhhcCcc--------ccCcccHHHHHHHHHHHHHhhhcCCCCCC--CHHHHHHHHhhh
Q 014079          307 NDKRKM---LQIIDPR--------LENQYSVRAAQKACSLAYYCLSQNPKARP--LMSDVVETLEPL  360 (431)
Q Consensus       307 ~~~~~~---~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dP~~RP--t~~eil~~L~~l  360 (431)
                      +.....   .+-.+..        ............+-.++..+|+.+|++|-  .+.+....+..+
T Consensus       244 kp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI  310 (732)
T KOG4250|consen  244 KPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI  310 (732)
T ss_pred             CCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence            100000   0000000        11223344556677888999999999998  655555555544

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=292.29  Aligned_cols=249  Identities=28%  Similarity=0.466  Sum_probs=203.2

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      +|++.+.||+|++|.||++.+.....      .|++|.+.....  .....+.+|++++++++|+|++++++++.+.+..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGD------FVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSL   74 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCc------EEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEE
Confidence            47788899999999999998876544      399999877654  3456788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++...  ..+++..+..++.|++.+|.|||+.+  |+|+||+|+||+++.++.++|+|||++....
T Consensus        75 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  150 (254)
T cd06627          75 YIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQG--VIHRDIKAANILTTKDGVVKLADFGVATKLN  150 (254)
T ss_pred             EEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCC--cccCCCCHHHEEECCCCCEEEeccccceecC
Confidence            9999999999999998765  35899999999999999999999866  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .....  .....++..|+|||.+.+..++.++|||+||+++|+|++|+.||.........    +.         ...  
T Consensus       151 ~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~----~~---------~~~--  213 (254)
T cd06627         151 DVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL----FR---------IVQ--  213 (254)
T ss_pred             CCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHH----HH---------Hhc--
Confidence            43321  23356889999999998888899999999999999999999999754321100    00         000  


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ......+...+..+.+++.+||..+|++||++.+++.+
T Consensus       214 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         214 --DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence              00111222345788899999999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.3e-38  Score=297.75  Aligned_cols=263  Identities=22%  Similarity=0.284  Sum_probs=193.6

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeC--Ce
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCED--DH  155 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~  155 (431)
                      |++.+.||+|+||.||+|.+..+...      ||+|.++.... .......+|+.++.++. |+||+++++++.+.  +.
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~------~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~   74 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKY------YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGR   74 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcE------EEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCc
Confidence            56778999999999999998765443      89998876422 22234567999999885 99999999999988  88


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.+  ++||||||+||+++. +.+||+|||+++..
T Consensus        75 ~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~  149 (282)
T cd07831          75 LALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNG--IFHRDIKPENILIKD-DILKLADFGSCRGI  149 (282)
T ss_pred             EEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEcC-CCeEEEeccccccc
Confidence            999999995 58888776543 35899999999999999999999866  999999999999999 99999999999765


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh----hhhhccc
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR----PKLNDKR  310 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~  310 (431)
                      .....   .....++..|+|||++.. +.++.++|||||||++|||++|..||................    ..+....
T Consensus       150 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (282)
T cd07831         150 YSKPP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF  226 (282)
T ss_pred             ccCCC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence            33221   123458899999997654 567889999999999999999999997654322111000000    0000000


Q ss_pred             hhhhhcCcccc-------CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLE-------NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ......+....       .......+..+.+++.+||+.||++||++.+++.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            00000000000       00112346889999999999999999999999865

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.9e-38  Score=294.25  Aligned_cols=250  Identities=22%  Similarity=0.261  Sum_probs=193.1

Q ss_pred             HHHHHhcCCCcccee--cccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeec
Q 014079           72 ELETITKSFRSDYIL--GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIG  148 (431)
Q Consensus        72 ~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~  148 (431)
                      +.....+.|.+.+.+  |.|+||.||++....++..      +++|.+........     |+.+...+ +|+||+++++
T Consensus         8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~------~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~   76 (267)
T PHA03390          8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKL------FVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYY   76 (267)
T ss_pred             HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcE------EEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEE
Confidence            344455677777666  9999999999998766543      89998876532221     22222222 6999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEe
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLS  227 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~  227 (431)
                      ++...+..++||||+++++|.+++....  ++++..++.++.|++.||.|||+.+  ++||||||+||+++.++ .++|+
T Consensus        77 ~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~nil~~~~~~~~~l~  152 (267)
T PHA03390         77 SVTTLKGHVLIMDYIKDGDLFDLLKKEG--KLSEAEVKKIIRQLVEALNDLHKHN--IIHNDIKLENVLYDRAKDRIYLC  152 (267)
T ss_pred             EEecCCeeEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEeCCCCeEEEe
Confidence            9999999999999999999999997654  6899999999999999999999876  99999999999999998 99999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||++......      ....|+..|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.     
T Consensus       153 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~-----  220 (267)
T PHA03390        153 DYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL-----  220 (267)
T ss_pred             cCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH-----
Confidence            99998764322      12458899999999999999999999999999999999999997443211 1111110     


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-MSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~eil~~  356 (431)
                            ......  .......+..+.++|.+||+.||.+||+ +++++++
T Consensus       221 ------~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        221 ------KRQQKK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             ------Hhhccc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence                  000000  0112245678899999999999999995 6998854

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.1e-39  Score=309.09  Aligned_cols=272  Identities=20%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe-
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  152 (431)
                      +..+|++.+.||.|+||.||+|.+..++.      .|++|++....  ......+.+|+.+|++++||||+++++++.. 
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   76 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGK------KVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPP   76 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCC------EEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhcccc
Confidence            34789999999999999999999876654      39999887642  2334567789999999999999999998763 


Q ss_pred             ---CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          153 ---DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       153 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                         ....++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~-~~~l~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~df  151 (334)
T cd07855          77 GADFKDVYVVMDLM-ESDLHHIIHSDQ--PLTEEHIRYFLYQLLRGLKYIHSAN--VIHRDLKPSNLLVNEDCELRIGDF  151 (334)
T ss_pred             CCCCceEEEEEehh-hhhHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCcEEeccc
Confidence               35689999999 568999886543  4889999999999999999999866  999999999999999999999999


Q ss_pred             cCCccCCCCCCc--ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h
Q 014079          230 GLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P  304 (431)
Q Consensus       230 G~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~  304 (431)
                      |++.........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+....  +
T Consensus       152 g~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~  231 (334)
T cd07855         152 GMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSP  231 (334)
T ss_pred             ccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCC
Confidence            998764332211  11234578999999998865 468899999999999999999999997654322111100000  0


Q ss_pred             h--hh---ccchhhhh---cCcccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          305 K--LN---DKRKMLQI---IDPRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       305 ~--~~---~~~~~~~~---~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .  +.   ....+...   ......   .......+.++.+++.+||+.||.+||++.+++.+-.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  296 (334)
T cd07855         232 SEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPF  296 (334)
T ss_pred             hhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChh
Confidence            0  00   00000000   000000   0111234678999999999999999999999998643

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.5e-38  Score=301.31  Aligned_cols=268  Identities=22%  Similarity=0.265  Sum_probs=195.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|.+.....  .....+.+|+.+++.+. |+||+++++++...+
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~------~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~   74 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEE   74 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCc------EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecC
Confidence            368889999999999999999876654      399998765432  22356788999999995 699999999998766


Q ss_pred             e-----eEEEEEecCCCChHHhhhhCC---CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEE
Q 014079          155 H-----RLLVYEFMFRGSLENHLFRKA---TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAK  225 (431)
Q Consensus       155 ~-----~~lv~e~~~~gsL~~~l~~~~---~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~k  225 (431)
                      .     .|+||||+++ +|.+++....   ...+++..++.++.|++.||.|||+.+  |+||||||+||+++. ++.++
T Consensus        75 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~--i~H~dl~~~nil~~~~~~~~k  151 (295)
T cd07837          75 KNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG--VMHRDLKPQNLLVDKQKGLLK  151 (295)
T ss_pred             CCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEecCCCeEE
Confidence            6     8999999975 8888876532   346899999999999999999999866  999999999999998 89999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-hhh-
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DWA-  302 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~-  302 (431)
                      |+|||++........  ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||...........+ ... 
T Consensus       152 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  229 (295)
T cd07837         152 IADLGLGRAFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLG  229 (295)
T ss_pred             EeecccceecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999875432211  1122357889999998865 45789999999999999999999999765432211000 000 


Q ss_pred             hhhhh---ccchhhhhc-----CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLN---DKRKMLQII-----DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~---~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+...   ....+....     .+..........+.++.++|.+||..||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            00000   000000000     0000001112345778999999999999999999999864

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.8e-38  Score=302.69  Aligned_cols=271  Identities=23%  Similarity=0.301  Sum_probs=196.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .-++|++.+.||+|+||.||+|.+..+..      .||+|.+.....  .....+.+|++++++++||||+++++++...
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   83 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQ------IVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTK   83 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCc------EEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecc
Confidence            34579999999999999999999876554      399998764322  2233456899999999999999999998765


Q ss_pred             C--------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          154 D--------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       154 ~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      .        ..++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.+  ++|+||||+|||++.++.+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~k  159 (310)
T cd07865          84 ATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN-VKFTLSEIKKVMKMLLNGLYYIHRNK--ILHRDMKAANILITKDGILK  159 (310)
T ss_pred             cccccCCCceEEEEEcCCC-cCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEECCCCcEE
Confidence            4        4599999994 58888775543 35889999999999999999999876  99999999999999999999


Q ss_pred             EecccCCccCCCCCCc--ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          226 LSDFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      |+|||++.........  .......++..|+|||++.+. .++.++||||||+++|||++|+.||...........+...
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~  239 (310)
T cd07865         160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL  239 (310)
T ss_pred             ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999765432211  112234578899999988664 4788999999999999999999999765433222111111


Q ss_pred             hhhhh-----ccch--hhhhc--CccccCcc-----cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLN-----DKRK--MLQII--DPRLENQY-----SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~-----~~~~--~~~~~--~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....     ....  ....+  ........     .......+.+||.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            00000     0000  00000  00000000     00123567899999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1e-38  Score=308.30  Aligned_cols=267  Identities=23%  Similarity=0.328  Sum_probs=199.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|.+.+.||+|+||+||+|.+..++.      .|++|.+....  ......+.+|+.+++.++|+||+++++++...
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~   76 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNE------KVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPP   76 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCC------eEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecc
Confidence            45679999999999999999999876544      49999886532  22345677899999999999999999988654


Q ss_pred             -----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                           ...++|+||+ +++|.+++....  .+++.....++.|++.||.|||+.+  ++||||||+|||++.++.+||+|
T Consensus        77 ~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--i~H~dlkp~Nil~~~~~~~kL~D  151 (337)
T cd07858          77 HREAFNDVYIVYELM-DTDLHQIIRSSQ--TLSDDHCQYFLYQLLRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICD  151 (337)
T ss_pred             cccccCcEEEEEeCC-CCCHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCCCCEEECc
Confidence                 3479999999 578988886543  5889999999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-hhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA-RPKL  306 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~  306 (431)
                      ||++.......  .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||............... ....
T Consensus       152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  229 (337)
T cd07858         152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS  229 (337)
T ss_pred             CccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99998654322  12233568889999998865 46899999999999999999999999764321111000000 0000


Q ss_pred             hc------cchhh---hhc----CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 ND------KRKML---QII----DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~------~~~~~---~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..      .....   ..+    ...+ .......+.++.+|+.+||+.||++|||+.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         230 EEDLGFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hHHhhhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            00      00000   000    0000 01112356788999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.5e-38  Score=295.82  Aligned_cols=246  Identities=27%  Similarity=0.385  Sum_probs=194.7

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||.|+||.||++.+..++.      .+++|++.....   .....+.+|++++++++|+||+++++.+...+..|+||||
T Consensus         1 lg~g~~~~vy~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   74 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGD------IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEY   74 (265)
T ss_pred             CCCCCceEEEEEEECCCCC------EEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEec
Confidence            6899999999999876544      399999876543   3445688899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC--
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--  240 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~--  240 (431)
                      +.+++|.+++.+..  .+++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++........  
T Consensus        75 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  150 (265)
T cd05579          75 LPGGDLASLLENVG--SLDEDVARIYIAEIVLALEYLHSNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQIN  150 (265)
T ss_pred             CCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHcC--eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccc
Confidence            99999999997654  5889999999999999999999866  99999999999999999999999999876433211  


Q ss_pred             ----cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          241 ----THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       241 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                          ........++..|++||.+.+..++.++||||||+++|+|++|..||..........                .+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----------------~~~  214 (265)
T cd05579         151 LNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQ----------------NIL  214 (265)
T ss_pred             cccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH----------------HHh
Confidence                112233568889999999988889999999999999999999999997543211100                000


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ............+..+.+++.+||+.+|.+|||+.++.+.|
T Consensus       215 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         215 NGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             cCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            00000000111257889999999999999999995554444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-38  Score=298.80  Aligned_cols=266  Identities=25%  Similarity=0.331  Sum_probs=199.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC--Ce
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED--DH  155 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  155 (431)
                      |++.+.||.|+||.||+|.+..++..      +++|.+....  ......+.+|+.++++++|+|++++++++.+.  +.
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~------~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGEL------VALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGS   74 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeE------EEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCc
Confidence            56778999999999999998875543      8999987653  23345678999999999999999999999988  88


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+. ++|.+++.... ..+++..++.++.|++.||+|||+.+  ++|+||+|+|||+++++.++|+|||++...
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~--~~h~dl~p~nil~~~~~~~~l~d~g~~~~~  150 (287)
T cd07840          75 IYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNG--ILHRDIKGSNILINNDGVLKLADFGLARPY  150 (287)
T ss_pred             EEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEEcCCCCEEEccccceeec
Confidence            999999996 58988886543 36889999999999999999999866  999999999999999999999999999865


Q ss_pred             CCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hhhhccchh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~  312 (431)
                      ..... .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+....  +........
T Consensus       151 ~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (287)
T cd07840         151 TKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV  229 (287)
T ss_pred             cCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence            44321 11223457889999998765 468899999999999999999999997655322211111000  000000000


Q ss_pred             hh-----hc------CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQ-----II------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~-----~~------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..     ..      ...+...+...++..+.+++.+||..||.+||++.+++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            00     00      0000000111126788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-38  Score=298.76  Aligned_cols=245  Identities=23%  Similarity=0.353  Sum_probs=195.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      ..||+|+||.||++....++.      .|++|.+..........+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGK------LVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCe------EEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            569999999999998876554      39999886554445567889999999999999999999999999999999999


Q ss_pred             CCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcce
Q 014079          164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV  243 (431)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~  243 (431)
                      ++++|.+++...   .+++.....++.|++.+|+|||+.+  ++|+||+|+||+++.++.++|+|||++........  .
T Consensus       100 ~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~g--ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~  172 (292)
T cd06657         100 EGGALTDIVTHT---RMNEEQIAAVCLAVLKALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--R  172 (292)
T ss_pred             CCCcHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEECCCCCEEEcccccceecccccc--c
Confidence            999999987432   4788889999999999999999876  99999999999999999999999999875433221  1


Q ss_pred             eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCc
Q 014079          244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ  323 (431)
Q Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (431)
                      .....|++.|+|||.+.+..++.++|+||||+++|+|++|..||............             .......+.  
T Consensus       173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~-------------~~~~~~~~~--  237 (292)
T cd06657         173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI-------------RDNLPPKLK--  237 (292)
T ss_pred             ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhhCCcccC--
Confidence            22356899999999998888999999999999999999999999754322111100             000111110  


Q ss_pred             ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       324 ~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+..+.+++.+||+.||.+||++.+++.+
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence            011234577899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=297.87  Aligned_cols=265  Identities=24%  Similarity=0.293  Sum_probs=200.7

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      |...+.||.|++|.||++.+..++.      .+++|.+......  ....+.+|+.++++++|+||+++++++.+++..+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   74 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGE------IVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLY   74 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCc------EEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEE
Confidence            5667889999999999999876554      3899988765332  3456788999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +|+||++ ++|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+||+++.++.++|+|||.+.....
T Consensus        75 ~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~dl~p~nili~~~~~~~l~df~~~~~~~~  150 (283)
T cd05118          75 LVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHG--ILHRDLKPENLLINTEGVLKLADFGLARSFGS  150 (283)
T ss_pred             EEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCC--eeecCcCHHHEEECCCCcEEEeeeeeeEecCC
Confidence            9999996 58888886643 46899999999999999999999876  99999999999999999999999999876544


Q ss_pred             CCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhccchhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDKRKMLQ  314 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~  314 (431)
                      ..  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||...............  .+.......+.+
T Consensus       151 ~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd05118         151 PV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS  228 (283)
T ss_pred             Cc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence            32  112234588899999998876 7899999999999999999999999765432211111000  000000000000


Q ss_pred             --------hcCc--cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 --------IIDP--RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 --------~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              ....  ..........+.++.++|.+||+.||.+||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    0000  00011223456889999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.6e-38  Score=295.58  Aligned_cols=243  Identities=28%  Similarity=0.384  Sum_probs=187.8

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHH---HHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEV---NFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      +||+|+||.||++.+..+++      .||+|.+.+....   ....+..|.   .+++...||||+.+++++.+.+..++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGK------MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   74 (278)
T ss_pred             CcccCCCeEEEEEEEecCCC------EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEE
Confidence            48999999999998876544      3999988764322   112233343   34555679999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ||||+.|++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++......
T Consensus        75 v~e~~~g~~L~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~  150 (278)
T cd05606          75 ILDLMNGGDLHYHLSQHG--VFSEAEMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  150 (278)
T ss_pred             EEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEcCCCCHHHEEECCCCCEEEccCcCccccCcc
Confidence            999999999999886543  5899999999999999999999866  999999999999999999999999998754322


Q ss_pred             CCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .    .....|+..|+|||++.++ .++.++|||||||++|||++|+.||............           .......
T Consensus       151 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~-----------~~~~~~~  215 (278)
T cd05606         151 K----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RMTLTMA  215 (278)
T ss_pred             C----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHH-----------HHhhccC
Confidence            1    1234689999999998754 6899999999999999999999999765322111100           0000001


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                          ...+...+..+.+++.+||..||.+||     ++.+++++
T Consensus       216 ----~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         216 ----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             ----CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                112223457889999999999999999     99999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.7e-38  Score=299.60  Aligned_cols=261  Identities=21%  Similarity=0.253  Sum_probs=190.7

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      .+|.|++  ||.+....++.      .||+|++...  .......+.+|+.+++.++|+||+++++++.+.+..+++|||
T Consensus         9 ~~~~~~~--v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   80 (314)
T cd08216           9 CFEDLMI--VHLAKHKPTNT------LVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPL   80 (314)
T ss_pred             hhcCCce--EEEEEecCCCC------EEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEec
Confidence            3444444  45544444333      4999998765  234456788999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC--
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--  240 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~--  240 (431)
                      +++++|.+++.......+++.....++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||.+........  
T Consensus        81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~--ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~  158 (314)
T cd08216          81 MAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG--FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQ  158 (314)
T ss_pred             cCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCcceEEEecCCceEEecCccceeeccccccc
Confidence            99999999998765556888999999999999999999876  99999999999999999999999998865432211  


Q ss_pred             ---cceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh---h------
Q 014079          241 ---THVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK---L------  306 (431)
Q Consensus       241 ---~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~---~------  306 (431)
                         ........++..|+|||++.+  ..++.++|||||||++|||++|+.||.........  .......   .      
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         159 RVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQML--LEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             cccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHhccCccccccCch
Confidence               111123457788999999876  35889999999999999999999999764322110  0000000   0      


Q ss_pred             h-ccchhhh----hcC----ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          307 N-DKRKMLQ----IID----PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       307 ~-~~~~~~~----~~~----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      . ....+..    ..+    ...........+.++.+|+.+||+.||++|||+.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            0 0000000    000    0011122334567899999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.6e-38  Score=298.43  Aligned_cols=246  Identities=29%  Similarity=0.453  Sum_probs=194.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .|...+.||+|+||.||+|.+..++..      |++|.+.....   .....+.+|+.+++.++|||++++++++.+.+.
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~------v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   95 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEV------VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHT   95 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcE------EEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCE
Confidence            366777899999999999998765543      89998865432   233567889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .|+||||+. ++|.+++.... .++++..++.++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||++...
T Consensus        96 ~~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~al~~LH~~g--i~H~dl~p~nili~~~~~~kL~dfg~~~~~  171 (313)
T cd06633          96 AWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHN--MIHRDIKAGNILLTEPGQVKLADFGSASKS  171 (313)
T ss_pred             EEEEEecCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence            999999994 67877775543 36889999999999999999999866  999999999999999999999999998643


Q ss_pred             CCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ..      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||............             
T Consensus       172 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~-------------  232 (313)
T cd06633         172 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-------------  232 (313)
T ss_pred             CC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH-------------
Confidence            21      12356889999999874   466889999999999999999999999765322111100             


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         .............+..+.+|+.+||+.+|.+||++.+++.+
T Consensus       233 ---~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         233 ---AQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---HhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               00000011112234568899999999999999999999965

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=6.4e-39  Score=328.35  Aligned_cols=255  Identities=26%  Similarity=0.389  Sum_probs=192.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ......|+.+++||+||||.||+++.+-++.      .||||.|.... ......+.+|+..|.+|+|||||+++..+.+
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr------~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVE  548 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGR------EYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVE  548 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccch------hhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhc
Confidence            4456778888999999999999998765544      39999987663 2334668899999999999999999865400


Q ss_pred             --------------------------------------------------------------------------------
Q 014079          153 --------------------------------------------------------------------------------  152 (431)
Q Consensus       153 --------------------------------------------------------------------------------  152 (431)
                                                                                                      
T Consensus       549 s~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~  628 (1351)
T KOG1035|consen  549 STAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGR  628 (1351)
T ss_pred             cCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccc
Confidence                                                                                            


Q ss_pred             -------------------------------C--------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHH
Q 014079          153 -------------------------------D--------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA  193 (431)
Q Consensus       153 -------------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~  193 (431)
                                                     +        ..+||-||||+..+|.+++.++.... .....+.++.+|+
T Consensus       629 ~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrLFreIl  707 (1351)
T KOG1035|consen  629 NLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRLFREIL  707 (1351)
T ss_pred             ccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHHHHHHH
Confidence                                           0        13589999999988888887754321 4667788999999


Q ss_pred             HHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC----------------CCCCcceeecccCCccccCcc
Q 014079          194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP----------------QGDETHVSTRVMGTYGYAAPE  257 (431)
Q Consensus       194 ~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE  257 (431)
                      +||.|+|+.+  ||||||||.||+|++++.+||+|||+|....                .+......+..+||.-|+|||
T Consensus       708 EGLaYIH~~g--iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPE  785 (1351)
T KOG1035|consen  708 EGLAYIHDQG--IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPE  785 (1351)
T ss_pred             HHHHHHHhCc--eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHH
Confidence            9999999877  9999999999999999999999999997611                011111344578999999999


Q ss_pred             ccccC---CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCc--ccHHHHHHH
Q 014079          258 YVMTG---HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ--YSVRAAQKA  332 (431)
Q Consensus       258 ~~~~~---~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  332 (431)
                      ++.+.   .|+.|+|||||||||+||+.   ||...-               .....+..+.+..++..  +.......-
T Consensus       786 ll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsM---------------ERa~iL~~LR~g~iP~~~~f~~~~~~~e  847 (1351)
T KOG1035|consen  786 LLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSM---------------ERASILTNLRKGSIPEPADFFDPEHPEE  847 (1351)
T ss_pred             HhcccccccccchhhhHHHHHHHHHHhc---cCCchH---------------HHHHHHHhcccCCCCCCcccccccchHH
Confidence            98764   59999999999999999985   565421               11111222222222222  222333455


Q ss_pred             HHHHHHhhhcCCCCCCCHHHHHH
Q 014079          333 CSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       333 ~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      ..+|++||+.||.+|||+.|+|.
T Consensus       848 ~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  848 ASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HHHHHHHhcCCCccCCCHHHHhh
Confidence            67999999999999999999984

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2e-39  Score=288.31  Aligned_cols=278  Identities=22%  Similarity=0.265  Sum_probs=202.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe-
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE-  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  152 (431)
                      ....|+....||+|+||.||+|...++....  ...+|+|.++.+..  .-.....+|+.+++.++||||+.+..+|.. 
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr--~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKR--TKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCccc--chhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            3456888899999999999999766554321  23589999876522  122456789999999999999999999987 


Q ss_pred             CCeeEEEEEecCCCChHHhhhhC---CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC----CcEE
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRK---ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD----YTAK  225 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~----~~~k  225 (431)
                      +...+|++||. .-+|...|+-.   ....++...+..|+.||+.|+.|||++-  |+||||||.||||..+    |.+|
T Consensus       100 d~~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW--vlHRDLKPaNIlvmgdgperG~VK  176 (438)
T KOG0666|consen  100 DKKVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW--VLHRDLKPANILVMGDGPERGRVK  176 (438)
T ss_pred             CceEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh--eeeccCCcceEEEeccCCccCeeE
Confidence            78889999999 55888877532   2245888899999999999999999977  9999999999999776    9999


Q ss_pred             EecccCCccCCCCCCcc-eeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch------
Q 014079          226 LSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS------  297 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~------  297 (431)
                      |+|||+++.+...-... ....++-|.+|+|||++.+. .|+.+.|||++|||+.||++-++-|.+........      
T Consensus       177 IaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~d  256 (438)
T KOG0666|consen  177 IADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHD  256 (438)
T ss_pred             eecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHH
Confidence            99999999876554333 23346789999999999875 69999999999999999999998887653321110      


Q ss_pred             hhhh-----hhhhhhccchhhhhcCc---------cccCc--cc------HHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          298 LVDW-----ARPKLNDKRKMLQIIDP---------RLENQ--YS------VRAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       298 ~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~--~~------~~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      .++.     ..|...+...+...-+-         .....  +.      ..-++..++|+.++|+.||.+|.|+++.++
T Consensus       257 Ql~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAle  336 (438)
T KOG0666|consen  257 QLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALE  336 (438)
T ss_pred             HHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhc
Confidence            0000     00111111111100000         00000  00      001234789999999999999999999998


Q ss_pred             HHh
Q 014079          356 TLE  358 (431)
Q Consensus       356 ~L~  358 (431)
                      +.-
T Consensus       337 h~y  339 (438)
T KOG0666|consen  337 HPY  339 (438)
T ss_pred             ccc
Confidence            753

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-38  Score=306.06  Aligned_cols=267  Identities=25%  Similarity=0.351  Sum_probs=201.8

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      +|++.+.||.|+||.||+|.+...+.      .|++|.+....  ....+.+.+|+.+++.++|+||+++++++...+  
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   74 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGR------KVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPE   74 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCc------EEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcc
Confidence            57888999999999999999876544      39999887643  234467889999999999999999999998775  


Q ss_pred             ---eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          155 ---HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       155 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                         ..|+||||+. ++|.+++.+..  ++++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.++|+|||+
T Consensus        75 ~~~~~~lv~e~~~-~~l~~~l~~~~--~l~~~~~~~i~~~l~~~l~~LH~~g--i~H~dlkp~nili~~~~~~~L~dfg~  149 (330)
T cd07834          75 DFNDVYIVTELME-TDLHKVIKSPQ--PLTDDHIQYFLYQILRGLKYLHSAN--VIHRDLKPSNILVNSNCDLKICDFGL  149 (330)
T ss_pred             cccceEEEecchh-hhHHHHHhCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccCc
Confidence               7899999996 58988886544  6899999999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCc-ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hhhh
Q 014079          232 AKAGPQGDET-HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PKLN  307 (431)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~  307 (431)
                      +......... .......++..|+|||++.+. .++.++||||||+++|+|++|+.||...........+....  +...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  229 (330)
T cd07834         150 ARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE  229 (330)
T ss_pred             eEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChh
Confidence            9875443210 112335688999999999887 89999999999999999999999997664322111100000  0000


Q ss_pred             -----ccchhhhhcC---cccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 -----DKRKMLQIID---PRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 -----~~~~~~~~~~---~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           ........+.   ....   .......+..+.+++.+||++||.+||++.+++.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             HhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                 0000000000   0000   00112245788999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-38  Score=291.69  Aligned_cols=242  Identities=24%  Similarity=0.275  Sum_probs=186.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHH-HhcCCCCceeeeecEEEeCCeeEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNF-LGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      +.||.|+||.||+|.+.....      .||+|++.+....   ....+..|..+ ...++|+||+++++++...+..|+|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv   75 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGD------YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLV   75 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCC------eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEE
Confidence            469999999999999876544      3999998765322   22334455444 4455899999999999999999999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      +||+++++|.+++....  ++++..+..++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.....  
T Consensus        76 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--  149 (260)
T cd05611          76 MEYLNGGDCASLIKTLG--GLPEDWAKQYIAEVVLGVEDLHQRG--IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--  149 (260)
T ss_pred             EeccCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCcEEEeecccceeccc--
Confidence            99999999999996644  4788888899999999999999876  99999999999999999999999999875432  


Q ss_pred             CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                          .....|+..|+|||.+.+..++.++||||||+++|+|++|..||............       .      . ....
T Consensus       150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-------~------~-~~~~  211 (260)
T cd05611         150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI-------L------S-RRIN  211 (260)
T ss_pred             ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-------H------h-cccC
Confidence                12346888999999998888999999999999999999999999754321110000       0      0 0000


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      ........++..+.+++.+||+.||++||++.++.+
T Consensus       212 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~  247 (260)
T cd05611         212 WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQE  247 (260)
T ss_pred             CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence            111112234578899999999999999997654443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2.2e-38  Score=297.33  Aligned_cols=251  Identities=26%  Similarity=0.381  Sum_probs=202.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCC-CCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLR-HPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  153 (431)
                      ++|.+.+.||+|+||.||++.+..+..      .|++|++.+...   .....+.+|+.++++++ |+||+++++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~   74 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNK------EYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE   74 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCC------EEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC
Confidence            368889999999999999999876544      499999876422   23456788999999998 99999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~i~~ql~~~l~~Lh~~~--~~H~dl~~~ni~i~~~~~~~l~df~~~~  150 (280)
T cd05581          75 ENLYFVLEYAPNGELLQYIRKYG--SLDEKCTRFYAAEILLALEYLHSKG--IIHRDLKPENILLDKDMHIKITDFGTAK  150 (280)
T ss_pred             ceEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHeEECCCCCEEecCCcccc
Confidence            99999999999999999997654  5899999999999999999999876  9999999999999999999999999987


Q ss_pred             cCCCCCCc------------------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc
Q 014079          234 AGPQGDET------------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE  295 (431)
Q Consensus       234 ~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  295 (431)
                      ........                  .......++..|+|||++.+..++.++||||||+++|++++|+.||........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLT  230 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHH
Confidence            64432211                  112235678999999999888899999999999999999999999976542110


Q ss_pred             chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH----HHHHHH
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM----SDVVET  356 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~----~eil~~  356 (431)
                                      ...+..  ....++...+..+.+++.+||+.||.+||++    .+++.+
T Consensus       231 ----------------~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         231 ----------------FQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             ----------------HHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence                            000100  1112223335778899999999999999999    887754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2e-39  Score=305.78  Aligned_cols=247  Identities=25%  Similarity=0.346  Sum_probs=203.8

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  160 (431)
                      .++||+|.||+||-|.++.+++.      ||||+|++...  .....+.+|+.||+++.||.||.+...|+..+..++||
T Consensus       569 devLGSGQFG~VYgg~hRktGrd------VAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVM  642 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRD------VAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVM  642 (888)
T ss_pred             HhhccCCcceeeecceecccCce------eeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEe
Confidence            46899999999999999887664      99999988644  33466889999999999999999999999999999999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---CcEEEecccCCccCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~~kl~DFG~a~~~~~  237 (431)
                      |.+ +|+..+.|.......+++..-..++.||+.||.|||..+  |+|+||||+|||+...   ..+||||||+|+....
T Consensus       643 EKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn--IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgE  719 (888)
T KOG4236|consen  643 EKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN--IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGE  719 (888)
T ss_pred             hhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc--eeeccCCchheeeccCCCCCceeeccccceeecch
Confidence            999 566666665655667999999999999999999999866  9999999999999653   5799999999998755


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ..   ....++|||.|+|||+++++.|+..-|+||.|||+|--++|..||....+..++         ++    -..++ 
T Consensus       720 ks---FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQ---------IQ----NAaFM-  782 (888)
T KOG4236|consen  720 KS---FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQ---------IQ----NAAFM-  782 (888)
T ss_pred             hh---hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHH---------hh----ccccc-
Confidence            43   344588999999999999999999999999999999999999999865432211         11    01111 


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                        .......+.+.++++||..+|+..-.+|-+....+.+.
T Consensus       783 --yPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  783 --YPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             --cCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccch
Confidence              12233456778999999999999999999998887653

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.4e-38  Score=299.04  Aligned_cols=271  Identities=25%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      +...++|++.+.||+|+||.||+|.+..++.      .|++|+++....  .....+.+|+.+++.++||||+++++++.
T Consensus         3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~   76 (302)
T cd07864           3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGE------LVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVT   76 (302)
T ss_pred             hhhhhhhheeeeecccCCEEEEEEEECCCCc------EEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheec
Confidence            3456789999999999999999999976544      389998865432  22345678999999999999999999987


Q ss_pred             eCC----------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          152 EDD----------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       152 ~~~----------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      +..          .+++|+||+.+ +|.+.+... ...+++..+..++.|++.||+|||+.+  |+|+||||+||+++.+
T Consensus        77 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~--i~H~dl~p~nili~~~  152 (302)
T cd07864          77 DKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKN--FLHRDIKCSNILLNNK  152 (302)
T ss_pred             CcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence            655          78999999965 777777554 336899999999999999999999876  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||++........ .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+.
T Consensus       153 ~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~  231 (302)
T cd07864         153 GQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS  231 (302)
T ss_pred             CcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            9999999999986543322 11122346788999998865 457889999999999999999999997543322111111


Q ss_pred             hhh--hhhhccchhhhh-----cC------ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 WAR--PKLNDKRKMLQI-----ID------PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 ~~~--~~~~~~~~~~~~-----~~------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...  +.......+.+.     .+      ..... .....+..+.+++.+||+.||.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         232 RLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             HHhCCCChhhcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            000  000000000000     00      00000 011235678999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=296.88  Aligned_cols=270  Identities=21%  Similarity=0.315  Sum_probs=210.0

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-C-C----ceee
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-H-P----NLVK  145 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~  145 (431)
                      ..+.++++|.+...+|+|.||.|-.+.+.....      .||+|+++.-. ...+...-|+++|.++. + |    -+|.
T Consensus        83 ~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~------~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~  155 (415)
T KOG0671|consen   83 VGDILTNRYEIVDLLGEGTFGKVVECWDRETKE------HVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQ  155 (415)
T ss_pred             eccccccceehhhhhcCCcccceEEEeecCCCc------eehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence            345568999999999999999999999987644      49999987643 33445567999999994 2 3    3788


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-----
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-----  220 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-----  220 (431)
                      +.++|...++.|||+|.+ |-++.+++..++-.+++...+..++.|++.+++|||+.+  ++|.||||+|||+-.     
T Consensus       156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k--l~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK--LTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             eehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc--eeecCCChheEEEeccceEE
Confidence            899999999999999998 889999999999999999999999999999999999977  999999999999831     


Q ss_pred             ---------------CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 014079          221 ---------------DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK  285 (431)
Q Consensus       221 ---------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  285 (431)
                                     +..++|+|||.|.......     ..++.|..|+|||++.+-.|+..+||||+||||+|+.+|..
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~  307 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGET  307 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccce
Confidence                           3458999999998743322     44678999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccchhhhhhhhhhhcc------------------------chhhhhcCcccc----CcccHHHHHHHHHHHH
Q 014079          286 SVDKTRPSKEQSLVDWARPKLNDK------------------------RKMLQIIDPRLE----NQYSVRAAQKACSLAY  337 (431)
Q Consensus       286 pf~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~----~~~~~~~~~~~~~li~  337 (431)
                      .|......+...++......++..                        ++.....++...    .........++.+|++
T Consensus       308 LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~  387 (415)
T KOG0671|consen  308 LFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLR  387 (415)
T ss_pred             ecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHH
Confidence            998776444322222221111100                        000000110000    0112345678999999


Q ss_pred             HhhhcCCCCCCCHHHHHHH
Q 014079          338 YCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       338 ~cl~~dP~~RPt~~eil~~  356 (431)
                      +||..||.+|+|+.|++.|
T Consensus       388 ~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  388 RMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHccCccccccHHHHhcC
Confidence            9999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=5.1e-38  Score=297.93  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=194.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~  155 (431)
                      ++|.+.+.||+|+||.||+|.+..++.      .||+|.++.... .....+..|+.++.++. |+||+++++++.+...
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   88 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGH------VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD   88 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCe------EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence            457888999999999999999876544      399999876432 23455677887776665 9999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .|+||||+ +++|.+++.... .++++..+..++.|++.||.|||+. .+|+||||+|+||+++.++.++|+|||++...
T Consensus        89 ~~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~-~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          89 VFICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEK-HGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             EEEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhh-CCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999998 557777765533 3688999999999999999999973 23999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      .....   .....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||........  ..            
T Consensus       166 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~------------  228 (296)
T cd06618         166 VDSKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE--VL------------  228 (296)
T ss_pred             cCCCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH--HH------------
Confidence            33221   12235788999999987553    88899999999999999999999965321100  00            


Q ss_pred             hhhhcCccc-cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          312 MLQIIDPRL-ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       312 ~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                       ...+.... ........+.++.+|+.+||+.||.+||++.+++.+..
T Consensus       229 -~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  275 (296)
T cd06618         229 -TKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPF  275 (296)
T ss_pred             -HHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChh
Confidence             00111000 00011123467899999999999999999999997743

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=7.2e-38  Score=298.62  Aligned_cols=252  Identities=29%  Similarity=0.409  Sum_probs=196.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|...+.||+|+||.||+|.+..+..      .+++|.+....   .....++.+|+++++.++|+|++++++++....
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   88 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSE------VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCc------EEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCC
Confidence            346667789999999999999876544      38899876432   123456788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+. ++|.+++.... .++++..+..++.|++.||.|||+.+  ++||||+|+|||++.++.++|+|||++..
T Consensus        89 ~~~lv~e~~~-~~l~~~~~~~~-~~l~~~~~~~~~~~l~~~l~~LH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~~  164 (308)
T cd06634          89 TAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (308)
T ss_pred             eeEEEEEccC-CCHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHhEEECCCCcEEECCccccee
Confidence            9999999995 68887775443 35788999999999999999999866  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ....      ....|++.|+|||++.   ...++.++|||||||++|+|++|..||..........              
T Consensus       165 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~--------------  224 (308)
T cd06634         165 MAPA------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--------------  224 (308)
T ss_pred             ecCc------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH--------------
Confidence            4321      2346888999999875   3568889999999999999999999986542211100              


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                        ...............+..+.+||.+||+.+|.+||++.+++.+.....
T Consensus       225 --~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         225 --HIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             --HHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence              000000011112234567889999999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=293.09  Aligned_cols=265  Identities=26%  Similarity=0.306  Sum_probs=196.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcC---CCCceeeeecEEEeCC
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQL---RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~  154 (431)
                      |++.+.||+|+||.||+|.+..+..      .||+|++......  ....+.+|+.+++++   +|+||+++++++...+
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   74 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGR------FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPR   74 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCC------EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeecc
Confidence            5677899999999999999876433      4999998744221  224466787777665   5999999999999887


Q ss_pred             e-----eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          155 H-----RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       155 ~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                      .     .+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+||
T Consensus        75 ~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~--i~h~~l~~~nili~~~~~~~l~df  151 (287)
T cd07838          75 TDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR--IVHRDLKPQNILVTSDGQVKIADF  151 (287)
T ss_pred             CCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhEEEccCCCEEEecc
Confidence            7     899999995 58999887655456899999999999999999999876  999999999999999999999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh-hhhhh----
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DWARP----  304 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-~~~~~----  304 (431)
                      |++........   .....++..|+|||++.+..++.++|||||||++|||++|+.||...........+ .....    
T Consensus       152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (287)
T cd07838         152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE  228 (287)
T ss_pred             CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence            99876533221   12345788999999999999999999999999999999999999764432211100 00000    


Q ss_pred             hhhccc-hhhhhcCccc---cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKR-KMLQIIDPRL---ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~-~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...... ..........   ........+..+.+++.+||+.||.+||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence            000000 0000000000   011123446788899999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9.2e-38  Score=293.97  Aligned_cols=265  Identities=27%  Similarity=0.367  Sum_probs=198.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  157 (431)
                      |++.+.||.|+||+||+|...++...      |++|.+..... .......+|+..+++++ |+||+++++++.+++..+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~------~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   74 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGEL------VAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELY   74 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcE------EEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEE
Confidence            56778999999999999998765443      89998865432 22234567999999999 999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+ +++|.+++.......+++..++.++.|++.+|.|||+.+  ++|+||+|+||+++.++.++|+|||++.....
T Consensus        75 lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~--i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~  151 (283)
T cd07830          75 FVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG--FFHRDLKPENLLVSGPEVVKIADFGLAREIRS  151 (283)
T ss_pred             EEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence            999999 889999887765556899999999999999999999876  99999999999999999999999999876533


Q ss_pred             CCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hhhhh----hhccch
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-WARPK----LNDKRK  311 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~~----~~~~~~  311 (431)
                      ...   .....++..|+|||++.+ ..++.++|+||||+++|||++|+.||............. ...+.    ......
T Consensus       152 ~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (283)
T cd07830         152 RPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK  228 (283)
T ss_pred             CCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence            221   123468889999998754 457899999999999999999999997654322111000 00000    000000


Q ss_pred             hhhhcCcccc-------CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLE-------NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +...++..+.       .......+.++.+++.+||+.||++|||+.|++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            0000000000       00111124678999999999999999999999864

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.3e-38  Score=303.77  Aligned_cols=271  Identities=25%  Similarity=0.324  Sum_probs=197.0

Q ss_pred             HhcCCC-ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh--------------HHHHHHHHHHHhcCCC
Q 014079           76 ITKSFR-SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--------------HREWLTEVNFLGQLRH  140 (431)
Q Consensus        76 ~~~~y~-~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h  140 (431)
                      +.++|. +.+.||.|+||+||+|.+...+.      .||+|.+.......              ...+.+|++++++++|
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   79 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGK------IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKH   79 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCC------eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCC
Confidence            345565 45779999999999999876543      38999876543221              1246789999999999


Q ss_pred             CceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       141 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      +||+++++++...+..++||||+. ++|.+++....  .+++.....++.|++.||.|||+.+  |+|+||+|+|||++.
T Consensus        80 ~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~~~~ql~~aL~~LH~~~--i~H~dl~~~nill~~  154 (335)
T PTZ00024         80 ENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKI--RLTESQVKCILLQILNGLNVLHKWY--FMHRDLSPANIFINS  154 (335)
T ss_pred             cceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHeEECC
Confidence            999999999999999999999995 68999886543  4788899999999999999999866  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCC------------CcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          221 DYTAKLSDFGLAKAGPQGD------------ETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      ++.++|+|||++.......            .........+++.|+|||++.+. .++.++|||||||++|+|++|+.||
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~  234 (335)
T PTZ00024        155 KGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF  234 (335)
T ss_pred             CCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence            9999999999987644111            01111223578899999988764 4789999999999999999999999


Q ss_pred             CCCCCcccchhh-hhh-hhh---hhccchhh------hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          288 DKTRPSKEQSLV-DWA-RPK---LNDKRKML------QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       288 ~~~~~~~~~~~~-~~~-~~~---~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...........+ ... .+.   ......+.      ......+ .......+.++.+++.+||+.+|++||++.+++.+
T Consensus       235 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        235 PGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDL-KTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccH-HHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            765432211100 000 000   00000000      0000000 00111235678899999999999999999999976


Q ss_pred             Hh
Q 014079          357 LE  358 (431)
Q Consensus       357 L~  358 (431)
                      -.
T Consensus       314 ~~  315 (335)
T PTZ00024        314 EY  315 (335)
T ss_pred             cc
Confidence            43

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.5e-38  Score=290.96  Aligned_cols=250  Identities=23%  Similarity=0.321  Sum_probs=194.7

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc---C--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---G--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +|.+.+.||+|+||.||++.+......      +++|+++..   .  ......+..|+.+++.++||||+++++++.+.
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAE------ERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER   74 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCc------ceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC
Confidence            578889999999999999988654321      444444321   1  12334566799999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          154 DHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      ...++||||+++++|.+++..  .....+++...+.++.|++.||.|||+.+  ++|+||+|+||+++. +.++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~--i~h~~l~~~nili~~-~~~~l~d~g~  151 (260)
T cd08222          75 DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR--ILHRDLKAKNIFLKN-NLLKIGDFGV  151 (260)
T ss_pred             CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC--ccccCCChhheEeec-CCEeecccCc
Confidence            999999999999999998864  23346899999999999999999999866  999999999999975 5799999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      +........  ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||........                
T Consensus       152 ~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~----------------  213 (260)
T cd08222         152 SRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV----------------  213 (260)
T ss_pred             eeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH----------------
Confidence            876533221  22235688899999999888899999999999999999999999964321110                


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...... ......+...+.++.+++.+||+.||++||++.+++++
T Consensus       214 ~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         214 VLRIVE-GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHHc-CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence            001111 11112234556788999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.3e-38  Score=305.39  Aligned_cols=268  Identities=22%  Similarity=0.320  Sum_probs=196.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC---
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED---  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---  153 (431)
                      ..+|.+.+.||.|+||.||+|.+..++..      |++|.+........+.+.+|++++++++||||+++++++...   
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~------v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~   77 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKR------VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSD   77 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcE------EEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccc
Confidence            46899999999999999999998776543      999988766555567788999999999999999999876654   


Q ss_pred             -----------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-C
Q 014079          154 -----------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-D  221 (431)
Q Consensus       154 -----------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~  221 (431)
                                 ...++||||+. ++|.+++..   ..+++.....++.|++.||.|||+.+  |+||||||+|||++. +
T Consensus        78 ~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g--ivH~dikp~Nili~~~~  151 (342)
T cd07854          78 LTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANVFINTED  151 (342)
T ss_pred             cccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCC
Confidence                       35789999995 689888753   24788999999999999999999866  999999999999974 5


Q ss_pred             CcEEEecccCCccCCCCCCc-ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          222 YTAKLSDFGLAKAGPQGDET-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      +.++|+|||++......... .......++..|+|||++.+ ..++.++|||||||++|+|++|+.||....+.......
T Consensus       152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~  231 (342)
T cd07854         152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI  231 (342)
T ss_pred             ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            67899999998764322111 11122457889999998754 56888999999999999999999999765432221111


Q ss_pred             hhhhhhhh--ccchh----hhhcC---cccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          300 DWARPKLN--DKRKM----LQIID---PRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       300 ~~~~~~~~--~~~~~----~~~~~---~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+...  .....    ...+.   ....   .......+.++.+|+.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         232 LESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             HHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            11000000  00000    00000   0000   00111245678899999999999999999999965

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.2e-38  Score=299.61  Aligned_cols=270  Identities=26%  Similarity=0.312  Sum_probs=195.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||.|+||.||+|.+..+..      .+++|.+......  ....+.+|+++++.++|+||+++++++.+..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~------~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGR------VVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERP   80 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCc------EEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccc
Confidence            4789999999999999999999876544      3899987654322  2245678999999999999999999875443


Q ss_pred             --------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 --------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 --------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                              .+++||||+. ++|...+... ...+++..+..++.|++.||.|||+.+  |+|+||||+|||++.++.++|
T Consensus        81 ~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~--i~H~dl~p~nil~~~~~~~~l  156 (311)
T cd07866          81 DKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENH--ILHRDIKAANILIDNQGILKI  156 (311)
T ss_pred             ccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCCCCEEE
Confidence                    4699999995 5777766543 235899999999999999999999876  999999999999999999999


Q ss_pred             ecccCCccCCCCCCc---------ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 014079          227 SDFGLAKAGPQGDET---------HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ  296 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  296 (431)
                      +|||+++........         ...+...+++.|+|||++.+. .++.++|||||||++|||++|+.||.+.......
T Consensus       157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~  236 (311)
T cd07866         157 ADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQL  236 (311)
T ss_pred             CcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999754332211         111234678899999987654 5889999999999999999999999765443221


Q ss_pred             hhhhhhh--hh---hhccchhhhhc----CccccCcc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          297 SLVDWAR--PK---LNDKRKMLQII----DPRLENQY---SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       297 ~~~~~~~--~~---~~~~~~~~~~~----~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..+....  +.   ......+....    ........   .......+.+++.+||+.||.+|||+.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         237 HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            1111000  00   00000000000    00000000   01223678899999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=288.67  Aligned_cols=286  Identities=28%  Similarity=0.420  Sum_probs=217.9

Q ss_pred             hhcccccccccccccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHH
Q 014079           54 DSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN  133 (431)
Q Consensus        54 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~  133 (431)
                      +..........+...++.-..++.++..+.+.||+|.||.||+|.|++..        ||||++...   +...|.+|.+
T Consensus       187 Dll~~~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~wrGe~--------VAVKiF~sr---dE~SWfrEtE  255 (513)
T KOG2052|consen  187 DLLDDLETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRWRGED--------VAVKIFSSR---DERSWFRETE  255 (513)
T ss_pred             HHHHhhccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccccCCc--------eEEEEeccc---chhhhhhHHH
Confidence            33333334455566777888889999999999999999999999998753        999998764   4456788888


Q ss_pred             HHhc--CCCCceeeeecEEEeC----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-----C
Q 014079          134 FLGQ--LRHPNLVKLIGYCCED----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-----A  202 (431)
Q Consensus       134 ~l~~--l~h~niv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-----~  202 (431)
                      |.+.  |+|+||+.+++.-..+    ..+|||.+|.+.|+|.|+|.+.   .++....+++++.++.||++||.     .
T Consensus       256 IYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTq  332 (513)
T KOG2052|consen  256 IYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQ  332 (513)
T ss_pred             HHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCC
Confidence            8775  4899999999875433    2579999999999999999773   58999999999999999999995     2


Q ss_pred             C-CCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC--cceeecccCCccccCccccccC----CC-Cc-chhhHHH
Q 014079          203 E-RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYVMTG----HL-TA-RSDVYSF  273 (431)
Q Consensus       203 ~-~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~----~~-~~-~~Diwsl  273 (431)
                      + ..|.|||||..|||+..++...|+|||||........  ....+..+||.+|||||++...    .+ ++ .+|||||
T Consensus       333 gKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYaf  412 (513)
T KOG2052|consen  333 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAF  412 (513)
T ss_pred             CCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHH
Confidence            3 4499999999999999999999999999976544321  1123346899999999998643    22 22 4899999


Q ss_pred             HHHHHHHHhC----------CCCCCCCCCcccchhhhhhhhhhhccchhhhh-----cCccccCcc-cHHHHHHHHHHHH
Q 014079          274 GVVLLELLTG----------RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI-----IDPRLENQY-SVRAAQKACSLAY  337 (431)
Q Consensus       274 G~il~ell~g----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~li~  337 (431)
                      |+++||+...          +.||.+..+....            ..++.+.     +.|.+...+ ..++...+.++++
T Consensus       413 gLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs------------~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMk  480 (513)
T KOG2052|consen  413 GLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS------------FEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMK  480 (513)
T ss_pred             HHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC------------HHHHhcceeecccCCCCCcccccCHHHHHHHHHHH
Confidence            9999999874          3566554332211            1122221     223333333 4567788999999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          338 YCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       338 ~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      .||..||..|-|+-.|.+.|.++....+
T Consensus       481 eCW~~Np~aRltALriKKtl~~l~~~~e  508 (513)
T KOG2052|consen  481 ECWYANPAARLTALRIKKTLAKLSNSDE  508 (513)
T ss_pred             HhhcCCchhhhHHHHHHHHHHHHhcChh
Confidence            9999999999999999999988875433

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-37  Score=301.60  Aligned_cols=267  Identities=23%  Similarity=0.301  Sum_probs=198.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEE
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYC  150 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~  150 (431)
                      +..+.++|++.+.||+|+||.||++.+...+.      .||+|.+.....  .....+.+|+.+|++++||||+++++++
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   83 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGA------KVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVF   83 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCc------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeee
Confidence            44567889999999999999999999876544      399998865322  2235678999999999999999999998


Q ss_pred             EeCC------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          151 CEDD------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       151 ~~~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ....      .+++||||+ +++|.+++..   ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~g--i~H~dlkp~Nill~~~~~~  157 (343)
T cd07880          84 TPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAG--IIHRDLKPGNLAVNEDCEL  157 (343)
T ss_pred             cCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCE
Confidence            7654      358999999 8899888754   35789999999999999999999866  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh-hhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL-VDWA  302 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~-~~~~  302 (431)
                      +|+|||++.......     ....+++.|+|||++.+ ..++.++|+||||+++|+|++|+.||........... ....
T Consensus       158 kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~  232 (343)
T cd07880         158 KILDFGLARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVT  232 (343)
T ss_pred             EEeecccccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999997643221     23457889999998876 4588999999999999999999999976432111000 0000


Q ss_pred             h-------hhhhc--cchhhhhcCcc---ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 R-------PKLND--KRKMLQIIDPR---LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~-------~~~~~--~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .       ..+..  .......+...   .........+..+.+++.+||+.||.+|||+.+++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            0       00000  00000000000   0001112345678899999999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=261.14  Aligned_cols=265  Identities=24%  Similarity=0.301  Sum_probs=199.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      |.-.++||+|.||+||+|+..++.++      ||+|..+.+..  .-....++|+.+|+.++|.|||+++++...+..+-
T Consensus         4 ydkmekigegtygtvfkarn~~t~ei------valkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkklt   77 (292)
T KOG0662|consen    4 YDKMEKIGEGTYGTVFKARNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLT   77 (292)
T ss_pred             hHHHHhhcCCcceeeEecccCCccce------EEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeE
Confidence            44556799999999999999888776      99998765432  12356789999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +|+||| ..+|..+...-++ .++......++.|+++||.|+|+++  ++||||||.|.||+.+|.+||+|||+++.+.-
T Consensus        78 lvfe~c-dqdlkkyfdslng-~~d~~~~rsfmlqllrgl~fchshn--vlhrdlkpqnllin~ngelkladfglarafgi  153 (292)
T KOG0662|consen   78 LVFEFC-DQDLKKYFDSLNG-DLDPEIVRSFMLQLLRGLGFCHSHN--VLHRDLKPQNLLINRNGELKLADFGLARAFGI  153 (292)
T ss_pred             EeHHHh-hHHHHHHHHhcCC-cCCHHHHHHHHHHHHhhhhhhhhhh--hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence            999999 7788888765443 5788889999999999999999977  99999999999999999999999999997543


Q ss_pred             CCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh--hhhhhccchhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWA--RPKLNDKRKML  313 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~  313 (431)
                      ..  ......+-|.+|.+|.++.+. -|+...|+||.||++.|+.. |++-|.+.+-......+-|.  .+.......+.
T Consensus       154 pv--rcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t  231 (292)
T KOG0662|consen  154 PV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMT  231 (292)
T ss_pred             ce--EeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccc
Confidence            32  233345679999999999875 58999999999999999998 66666654332222111111  11111112222


Q ss_pred             hhcCccccCcc---------cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQY---------SVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~---------~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..|-..-.-+         -+.....-++|+...|..+|.+|.++++.+++
T Consensus       232 ~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  232 KLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22221111111         12233455789999999999999999988865

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.6e-37  Score=299.45  Aligned_cols=269  Identities=23%  Similarity=0.280  Sum_probs=192.3

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcC-CCCceeeeecEEEeC--
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED--  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--  153 (431)
                      +|++.+.||+|+||.||++.+....    .+..||+|.+....  ......+.+|+.+++++ +||||+++++.+...  
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~----~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~   76 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETS----EEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPG   76 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCC----cCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccc
Confidence            4778889999999999999987541    01249999876532  12345678899999999 599999999875432  


Q ss_pred             --CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          154 --DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       154 --~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                        ...++++||+ +++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||+
T Consensus        77 ~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~g--ivH~dlkp~Nili~~~~~~kl~Dfg~  151 (332)
T cd07857          77 NFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSAN--VLHRDLKPGNLLVNADCELKICDFGL  151 (332)
T ss_pred             cCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHeEEcCCCCEEeCcCCC
Confidence              4578899988 57899888653  35788999999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCc--ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh----
Q 014079          232 AKAGPQGDET--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP----  304 (431)
Q Consensus       232 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~----  304 (431)
                      ++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....    
T Consensus       152 a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  231 (332)
T cd07857         152 ARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE  231 (332)
T ss_pred             ceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence            9765432211  11223568999999998765 4689999999999999999999999976542211100000000    


Q ss_pred             ----hhhcc--chhhhhcCcccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 ----KLNDK--RKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ----~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                          .+...  ............   .......+..+.+|+.+||+.||.+|||+.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                00000  000000000000   00011124678899999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-37  Score=301.62  Aligned_cols=270  Identities=22%  Similarity=0.345  Sum_probs=196.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|.+.+.||+|+||.||+|.+..++.      .||+|++.+...  .....+.+|+.+++.++|+||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~   85 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGE------KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTS   85 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCc------EEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecc
Confidence            345789999999999999999999865544      399998865422  223457899999999999999999999875


Q ss_pred             CC------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          153 DD------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       153 ~~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ..      .+++|+||+. .+|..++    ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~--i~H~dlkp~NIll~~~~~~kL  158 (342)
T cd07879          86 AVSGDEFQDFYLVMPYMQ-TDLQKIM----GHPLSEDKVQYLVYQMLCGLKYIHSAG--IIHRDLKPGNLAVNEDCELKI  158 (342)
T ss_pred             cccCCCCceEEEEecccc-cCHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEE
Confidence            43      4689999994 5777655    224788889999999999999999876  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--  303 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--  303 (431)
                      +|||+++......     ....++..|+|||++.+ ..++.++|||||||++|||++|+.||...........+....  
T Consensus       159 ~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  233 (342)
T cd07879         159 LDFGLARHADAEM-----TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV  233 (342)
T ss_pred             eeCCCCcCCCCCC-----CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999987643221     23457889999998876 468899999999999999999999997654222111100000  


Q ss_pred             --hhhhc---cchhhhhcC--cc-ccCcc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--Hhhhhh
Q 014079          304 --PKLND---KRKMLQIID--PR-LENQY---SVRAAQKACSLAYYCLSQNPKARPLMSDVVET--LEPLQC  362 (431)
Q Consensus       304 --~~~~~---~~~~~~~~~--~~-~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~--L~~l~~  362 (431)
                        +.+..   .........  +. .....   ....+..+.+|+.+||+.||.+||++.+++.+  ++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         234 PGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             CCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence              00000   000000000  00 00000   01234678899999999999999999999966  655543

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=304.18  Aligned_cols=250  Identities=26%  Similarity=0.367  Sum_probs=210.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++....||-|+||.|-++..+....      .+|+|++++..+.   ..+.+..|-+||..++.|.||++|..|.++...
T Consensus       422 l~~iaTLGvGgFGRVELV~~~~~~~------~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv  495 (732)
T KOG0614|consen  422 LKRIATLGVGGFGRVELVKVNSQKA------TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV  495 (732)
T ss_pred             hhhhhhcccCccceEEEEEecccch------HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence            4455569999999999988766433      2888988887653   345578999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ||+||-|-||.|+..+..++  .++......++..+++|++|||+.+  ||+|||||+|.|++.+|.+||.|||+|+...
T Consensus       496 YmLmEaClGGElWTiLrdRg--~Fdd~tarF~~acv~EAfeYLH~k~--iIYRDLKPENllLd~~Gy~KLVDFGFAKki~  571 (732)
T KOG0614|consen  496 YMLMEACLGGELWTILRDRG--SFDDYTARFYVACVLEAFEYLHRKG--IIYRDLKPENLLLDNRGYLKLVDFGFAKKIG  571 (732)
T ss_pred             hhhHHhhcCchhhhhhhhcC--CcccchhhhhHHHHHHHHHHHHhcC--ceeccCChhheeeccCCceEEeehhhHHHhc
Confidence            99999999999999997765  4777888889999999999999876  9999999999999999999999999999887


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .+..+.   ++||||.|.|||++.+...+.++|.||||+++|||++|.+||.+.++.+...++-..             +
T Consensus       572 ~g~KTw---TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-------------i  635 (732)
T KOG0614|consen  572 SGRKTW---TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-------------I  635 (732)
T ss_pred             cCCcee---eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-------------h
Confidence            766544   588999999999999999999999999999999999999999998776654443211             1


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHHh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVETLE  358 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~L~  358 (431)
                      |   ...++......+.+|+++++..+|.+|..     +.+|.+|.+
T Consensus       636 d---~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~W  679 (732)
T KOG0614|consen  636 D---KIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRW  679 (732)
T ss_pred             h---hhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhh
Confidence            1   12344556678889999999999999975     677777654

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.7e-37  Score=300.72  Aligned_cols=271  Identities=23%  Similarity=0.346  Sum_probs=200.2

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeee
Q 014079           70 LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLI  147 (431)
Q Consensus        70 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~  147 (431)
                      ..++..+.++|.+.+.||+|+||.||++.+..++.      .||+|++....  ....+.+.+|+.++++++|+||++++
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~   82 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGL------RVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL   82 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCe------EEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCccccee
Confidence            34566778999999999999999999998876544      39999887542  22345678899999999999999999


Q ss_pred             cEEEeC------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          148 GYCCED------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       148 ~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      +++...      ...+++++++ +++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+||+++.+
T Consensus        83 ~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIll~~~  156 (345)
T cd07877          83 DVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNED  156 (345)
T ss_pred             eeeeecccccccccEEEEehhc-ccCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChHHEEEcCC
Confidence            988643      3467888887 88998887543   4788999999999999999999866  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      +.++|+|||++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus       157 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~  231 (345)
T cd07877         157 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL  231 (345)
T ss_pred             CCEEEeccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998764321     123468899999998866 568899999999999999999999996543322111100


Q ss_pred             h-h-------hhhhhcc--chhhhhcCccccCcc---cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          301 W-A-------RPKLNDK--RKMLQIIDPRLENQY---SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       301 ~-~-------~~~~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      . .       ...+...  ......+.......+   ....+.++.+|+.+||+.||.+||++.+++.+-
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~  301 (345)
T cd07877         232 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  301 (345)
T ss_pred             HHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcCh
Confidence            0 0       0000000  000000000000000   011346788999999999999999999999774

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=310.37  Aligned_cols=253  Identities=26%  Similarity=0.389  Sum_probs=209.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEe---
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCE---  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~---  152 (431)
                      ++.|++.+.||.|.+|.||++....+...      .|+|+..... ...+++..|.+||+.+ .|||++.++++|..   
T Consensus        18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~------aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQL------AAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCccEEEEEEeeccceeEEEEeeeecCce------eeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            45688999999999999999998776554      7888876553 3345677889999888 59999999999864   


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                        ++.+|||||||.|||..|+++...+..+.|..+..|++.++.||.+||...  ++|||||-.|||++.++.+||+|||
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk--viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK--VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc--eeeecccCceEEEeccCcEEEeeee
Confidence              578999999999999999998877888999999999999999999999866  9999999999999999999999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      ++..+.....  ...+.+|||.|||||++...     .|+..+|+||||++..||.-|.+|+-+..+..           
T Consensus       169 vSaQldsT~g--rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-----------  235 (953)
T KOG0587|consen  169 VSAQLDSTVG--RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-----------  235 (953)
T ss_pred             eeeeeecccc--cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-----------
Confidence            9987543322  23457899999999999643     47788999999999999999999997765432           


Q ss_pred             hhccchhhhhc-CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQII-DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           .+..+. +|.....-+...++++.++|..||.+|-++||++.++++|
T Consensus       236 -----aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 -----ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             -----hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence                 233332 3333333466778999999999999999999999999865

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-38  Score=279.95  Aligned_cols=270  Identities=24%  Similarity=0.346  Sum_probs=207.1

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeee
Q 014079           69 SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLI  147 (431)
Q Consensus        69 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~  147 (431)
                      .++++..++.     ++||+|+|+.|--+....+..      .||||++.+..--...+..+|++++.+.+ |+||+.++
T Consensus        74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~------EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLi  142 (463)
T KOG0607|consen   74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGK------EYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLI  142 (463)
T ss_pred             hHHHHHHhHH-----HHhcCccceeeeeeeeeccch------hhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHH
Confidence            3556666654     479999999998887655443      49999999886556778999999999997 99999999


Q ss_pred             cEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC---cE
Q 014079          148 GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TA  224 (431)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~---~~  224 (431)
                      ++|+++...|||||-|.||+|..+|..+..  +.+.....+..+|+.||.|||..+  |.||||||+|||.....   -+
T Consensus       143 efFEdd~~FYLVfEKm~GGplLshI~~~~~--F~E~EAs~vvkdia~aLdFlH~kg--IAHRDlKPENiLC~~pn~vsPv  218 (463)
T KOG0607|consen  143 EFFEDDTRFYLVFEKMRGGPLLSHIQKRKH--FNEREASRVVKDIASALDFLHTKG--IAHRDLKPENILCESPNKVSPV  218 (463)
T ss_pred             HHhcccceEEEEEecccCchHHHHHHHhhh--ccHHHHHHHHHHHHHHHHHHhhcC--cccccCCccceeecCCCCcCce
Confidence            999999999999999999999999987654  788888889999999999999855  99999999999996543   58


Q ss_pred             EEecccCCccCCCC-----CCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 014079          225 KLSDFGLAKAGPQG-----DETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK  294 (431)
Q Consensus       225 kl~DFG~a~~~~~~-----~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  294 (431)
                      |||||.+..-....     ..+....+.+|+..|||||+..     ...|+.+.|.||||||||-||+|.+||.+.-...
T Consensus       219 KiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d  298 (463)
T KOG0607|consen  219 KICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD  298 (463)
T ss_pred             eeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc
Confidence            99999887532111     1122233568999999999864     3468899999999999999999999998765432


Q ss_pred             cchhhhhhhhhhhc--cchhhhhc-Ccc--ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          295 EQSLVDWARPKLND--KRKMLQII-DPR--LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       295 ~~~~~~~~~~~~~~--~~~~~~~~-~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      -.    |.+...-.  ...+.+-+ +..  ++..-....+.+..+|+..+|..|+.+|-++.+++.+-
T Consensus       299 CG----WdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhP  362 (463)
T KOG0607|consen  299 CG----WDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHP  362 (463)
T ss_pred             CC----ccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCc
Confidence            11    21111100  01122222 221  22333456788999999999999999999999998753

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-38  Score=291.62  Aligned_cols=241  Identities=27%  Similarity=0.400  Sum_probs=197.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---HHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .+|....+||+|+||.|.+|..+.+.+.      ||||+++++-+-.   .+--..|-++|... +-|.+++++..|+.-
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdEL------yAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTm  422 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDEL------YAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTM  422 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchh------hhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhh
Confidence            3577888999999999999988776654      9999998874322   22234577777665 478999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||+.||+|--.++..+.  +.+.....++..|+-||-+||+.+  ||+||||.+|||||.+|++||+|||+++
T Consensus       423 DRLyFVMEyvnGGDLMyhiQQ~Gk--FKEp~AvFYAaEiaigLFFLh~kg--IiYRDLKLDNvmLd~eGHiKi~DFGmcK  498 (683)
T KOG0696|consen  423 DRLYFVMEYVNGGDLMYHIQQVGK--FKEPVAVFYAAEIAIGLFFLHSKG--IIYRDLKLDNVMLDSEGHIKIADFGMCK  498 (683)
T ss_pred             hheeeEEEEecCchhhhHHHHhcc--cCCchhhhhhHHHHHHhhhhhcCC--eeeeeccccceEeccCCceEeeeccccc
Confidence            999999999999999999987665  566677789999999999999866  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......  ...+.+|||.|+|||++..++|+.++|+||+||+||||+.|+.||++.+...                ...
T Consensus       499 Eni~~~~--TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e----------------lF~  560 (683)
T KOG0696|consen  499 ENIFDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE----------------LFQ  560 (683)
T ss_pred             ccccCCc--ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHH
Confidence            6433332  3456899999999999999999999999999999999999999998864321                122


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP  348 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  348 (431)
                      .+++..  -.++...+.++.++++..|.++|.+|.
T Consensus       561 aI~ehn--vsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  561 AIMEHN--VSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             HHHHcc--CcCcccccHHHHHHHHHHhhcCCcccc
Confidence            222222  235667788999999999999999994

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.4e-37  Score=296.51  Aligned_cols=265  Identities=24%  Similarity=0.308  Sum_probs=197.5

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ..++++|++.+.||.|+||.||++.+..++..      |++|.+.+...  ...+.+.+|+.+++.++||||++++++|.
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   79 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQN------VAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFI   79 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCE------EEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEe
Confidence            34678999999999999999999998765543      89998765322  23456788999999999999999999987


Q ss_pred             e-CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          152 E-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       152 ~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                      . ....++|+||+ +++|.+++..   .+++......++.|++.||.|||+.+  |+||||+|+|||++.++.++|+|||
T Consensus        80 ~~~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~--iiH~dl~p~Nili~~~~~~~l~dfg  153 (328)
T cd07856          80 SPLEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAG--VVHRDLKPSNILINENCDLKICDFG  153 (328)
T ss_pred             cCCCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEeECCCCCEEeCccc
Confidence            6 56789999998 6789888753   24677888889999999999999876  9999999999999999999999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-----
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP-----  304 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-----  304 (431)
                      ++......     .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||.................     
T Consensus       154 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~  228 (328)
T cd07856         154 LARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDD  228 (328)
T ss_pred             cccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            98754321     123457889999998766 5789999999999999999999999976543111100000000     


Q ss_pred             ---hhhccchhhhhcC-ccccCccc-----HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 ---KLNDKRKMLQIID-PRLENQYS-----VRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ---~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         ..... ...+.+. -......+     ...+..+.+++.+||+.+|++||++.+++.+
T Consensus       229 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         229 VINTICSE-NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             HHHhccch-hhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               00000 0000000 00000011     1235788999999999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=291.26  Aligned_cols=265  Identities=26%  Similarity=0.359  Sum_probs=198.9

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      |+..+.||+|+||.||+|....+..      .|++|++....  ......+..|+.+++.++|+||+++++++.+.+..+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~   74 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGE------IVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY   74 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCc------EEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceE
Confidence            5667789999999999999876544      49999987653  223456778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+. ++|.+++.+.. ..+++..++.++.+++.||.|||+.+  |+|+||+|+||+++.++.++|+|||+++....
T Consensus        75 ~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~--i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~  150 (282)
T cd07829          75 LVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHR--ILHRDLKPQNILINRDGVLKLADFGLARAFGI  150 (282)
T ss_pred             EEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence            9999996 69999997653 35889999999999999999999876  99999999999999999999999999876543


Q ss_pred             CCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hh-------hhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-WA-------RPKLND  308 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~-------~~~~~~  308 (431)
                      ...  ......++..|+|||.+.+. .++.++|||||||++|||++|+.||...........+. ..       .+.+..
T Consensus       151 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (282)
T cd07829         151 PLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK  228 (282)
T ss_pred             Ccc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence            221  12234567889999998776 88999999999999999999999997654321110000 00       000000


Q ss_pred             c---chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 K---RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .   ...................+..+.+++.+||+.||++||++.+++.+
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence            0   00000000000001111235689999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=3.8e-37  Score=291.02  Aligned_cols=256  Identities=27%  Similarity=0.336  Sum_probs=195.3

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      +|++.+.||.|+||.||++.+..+..   .+..||+|++.....    ...+.+.+|+.+++++ +|+||+++++++..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~---~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHD---SGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD   77 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCC---CCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC
Confidence            47788899999999999998753211   123599999875422    2335678899999999 599999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ...++||||+++++|.+++....  ++++.....++.|++.||.|||+.+  ++||||+|+|||++.++.++|+|||++.
T Consensus        78 ~~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          78 TKLHLILDYINGGELFTHLSQRE--RFKEQEVQIYSGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             CeEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeEECCCCCEEEeeCccce
Confidence            99999999999999999997653  4788888889999999999999866  9999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ........ ......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||...........             
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~-------------  219 (290)
T cd05613         154 EFHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE-------------  219 (290)
T ss_pred             eccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH-------------
Confidence            65332211 12235689999999988753  477899999999999999999999964322111100             


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +...+... ...++...+..+.+++.+||+.||.+||     ++.+++.+
T Consensus       220 ~~~~~~~~-~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         220 ISRRILKS-EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             HHHHhhcc-CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            00000000 0112223456788999999999999997     66777654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.1e-37  Score=291.31  Aligned_cols=259  Identities=28%  Similarity=0.358  Sum_probs=198.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      +|++.+.||+|+||.||++.+.....   .+..||+|++++...    .....+.+|+.++.++ +||||+++++.+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~   77 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHD---AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD   77 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecccc---CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC
Confidence            37788899999999999998653221   123599998875422    2235578899999999 599999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ...++||||+.+++|.+++....  .+++.....++.|++.+|.|||+.+  ++|+||||+||+++.++.++|+|||+++
T Consensus        78 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~~--~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          78 TKLHLILDYVNGGELFTHLYQRE--HFTESEVRVYIAEIVLALDHLHQLG--IIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             CEEEEEEecCCCCcHHHHHhhcC--CcCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHeEECCCCCEEEEECcccc
Confidence            99999999999999999986543  5788888899999999999999866  9999999999999999999999999987


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ........ ......|+..|+|||.+.+..  ++.++||||||+++|||++|..||............  ..        
T Consensus       154 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~--~~--------  222 (288)
T cd05583         154 EFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI--SR--------  222 (288)
T ss_pred             cccccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHH--HH--------
Confidence            64433211 122346899999999987655  788999999999999999999999643221110000  00        


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                        .+...  ....+...+..+.+++.+||+.||++|||+.++.+.|+.
T Consensus       223 --~~~~~--~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 --RILKS--KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --HHHcc--CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence              00000  011222344678899999999999999998888776653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=290.96  Aligned_cols=272  Identities=28%  Similarity=0.437  Sum_probs=201.8

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhc--CCCCceeeeecEEEeCC---
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ--LRHPNLVKLIGYCCEDD---  154 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  154 (431)
                      ....++||+|.||.||+|...+.        .||||++...   ....|.+|-+|...  ++|+||++++++-....   
T Consensus       212 l~l~eli~~Grfg~V~KaqL~~~--------~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~  280 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLDNR--------LVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR  280 (534)
T ss_pred             hhhHHHhhcCccceeehhhccCc--------eeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence            34556899999999999998763        4999998764   45567788887665  47999999998866554   


Q ss_pred             -eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-------CCCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 -HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-------AERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                       .++||++|.+.|+|.++|..+.   ++|.....++..+++||+|||.       ++.+|+|||||..||||..|++..|
T Consensus       281 ~eywLVt~fh~kGsL~dyL~~nt---isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  281 MEYWLVTEFHPKGSLCDYLKANT---ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cceeEEeeeccCCcHHHHHHhcc---ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence             7899999999999999997654   7999999999999999999996       3456999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccC-CCC-----cchhhHHHHHHHHHHHhCCCCCCC-CCCcccchhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLT-----ARSDVYSFGVVLLELLTGRKSVDK-TRPSKEQSLV  299 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~-----~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~~  299 (431)
                      +|||+|..+..+.........+||.+|||||++.+. .+.     .+.||||+|.+||||++...-+.. ..+.....+.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999887665554444557899999999999764 222     258999999999999998765532 1111111000


Q ss_pred             --hhhhhhhhccc--hhhhhcCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          300 --DWARPKLNDKR--KMLQIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       300 --~~~~~~~~~~~--~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                        .-..|.+.+..  .+.+...|.++..+ .-....-+++.+..||..|++.|.|+.=+.+++..+.....
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence              00111111111  11111222222222 11345678899999999999999999999988887765543

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.9e-38  Score=302.86  Aligned_cols=265  Identities=24%  Similarity=0.337  Sum_probs=198.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|.+.+.||+|+||.||+|.+..+..      .|++|++....  ......+.+|+.++++++|+||+++++++..
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   85 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGR------KVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTP   85 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCc------EEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhc
Confidence            456789999999999999999999877554      39999886532  2234567789999999999999999998876


Q ss_pred             CCe------eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          153 DDH------RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       153 ~~~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      .+.      .++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+||+++.++.++|
T Consensus        86 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~g--i~H~dlkp~Nill~~~~~~kL  159 (343)
T cd07851          86 ASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAG--IIHRDLKPSNIAVNEDCELKI  159 (343)
T ss_pred             cccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEECCCCCEEE
Confidence            654      89999998 7899998864   35889999999999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh-
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP-  304 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-  304 (431)
                      +|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...........+..... 
T Consensus       160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~  234 (343)
T cd07851         160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT  234 (343)
T ss_pred             cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence            999999764332     223467889999998865 3678999999999999999999999976543211110000000 


Q ss_pred             ---hh----hc--cchhhhhcCccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 ---KL----ND--KRKMLQIIDPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ---~~----~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         .+    ..  .......+.......   .....+..+.+++.+||+.||.+|||+.+|+.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               00    00  000000000000000   011235789999999999999999999999875

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=310.83  Aligned_cols=257  Identities=27%  Similarity=0.413  Sum_probs=212.5

Q ss_pred             CccceecccCcEEEEEEEEcCC-ceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           81 RSDYILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      +..++||+|+||+||+|.+--. ..+   +++||+|++.... .+...+++.|+-+|.+++|||+++|++++.... +.|
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~v---KipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql  774 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENV---KIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL  774 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCcee---cceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence            4457899999999999998543 333   4679999987654 345678999999999999999999999998765 889


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      |++|+++|+|.|+++.+. .++.....+.|..||++||.|||.++  +|||||-.+|||+.+-..+||.|||+++.....
T Consensus       775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qr--lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d  851 (1177)
T KOG1025|consen  775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQR--LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD  851 (1177)
T ss_pred             HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcc--hhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence            999999999999997754 46888899999999999999999755  999999999999999999999999999987665


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ..........-.+.|||-|.+....|+.++|||||||++||++| |..|+++....                 ++.+.+.
T Consensus       852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----------------eI~dlle  914 (1177)
T KOG1025|consen  852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----------------EIPDLLE  914 (1177)
T ss_pred             cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----------------HhhHHHh
Confidence            54433333344667999999999999999999999999999999 99999876422                 2233333


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      ...+-..++.++.+++.++.+||-.|+..||+++++...+....
T Consensus       915 ~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  915 KGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             ccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            33333456677889999999999999999999999998876544

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.4e-37  Score=321.26  Aligned_cols=146  Identities=27%  Similarity=0.378  Sum_probs=129.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||+|.+.....      .||+|+++....   .....+..|+.++..++|+||+++++++...+
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~------~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   77 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSK------LYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSAN   77 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCc------EEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECC
Confidence            578899999999999999999876544      399999876432   22356788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..||||||+.+++|.+++....  .+++...+.++.||+.||.|||..+  ||||||||+||||+.++.+||+|||+++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~~~--~l~~~~~~~i~~qil~aL~yLH~~g--IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHIYG--YFDEEMAVKYISEVALALDYLHRHG--IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999999997644  4778888999999999999999866  9999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=306.42  Aligned_cols=245  Identities=25%  Similarity=0.263  Sum_probs=198.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .+..|.....+|.|+|+.|-.+.+..+..      ..++|++.+...    +..+|+.++... +||||+++.+.+.+..
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~------~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~  389 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQ------EPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGK  389 (612)
T ss_pred             cchhhccccccCCCCccceeeeecccccc------chhheecccccc----ccccccchhhhhcCCCcceeecceecCCc
Confidence            35678888889999999999988876554      389999987621    223566565555 6999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE-CCCCcEEEecccCCc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL-DSDYTAKLSDFGLAK  233 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl-~~~~~~kl~DFG~a~  233 (431)
                      +.|+|||++.|+-|.+.+.....   ....+..|+.+|+.++.|||.++  ||||||||+|||+ +..++++|+|||.++
T Consensus       390 ~~~~v~e~l~g~ell~ri~~~~~---~~~e~~~w~~~lv~Av~~LH~~g--vvhRDLkp~NIL~~~~~g~lrltyFG~a~  464 (612)
T KOG0603|consen  390 EIYLVMELLDGGELLRRIRSKPE---FCSEASQWAAELVSAVDYLHEQG--VVHRDLKPGNILLDGSAGHLRLTYFGFWS  464 (612)
T ss_pred             eeeeeehhccccHHHHHHHhcch---hHHHHHHHHHHHHHHHHHHHhcC--eeecCCChhheeecCCCCcEEEEEechhh
Confidence            99999999999999888866543   23566679999999999999866  9999999999999 688999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....     ..+.+-|..|.|||++....|++++||||||++||+||+|+.||......                ..+.
T Consensus       465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~----------------~ei~  523 (612)
T KOG0603|consen  465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG----------------IEIH  523 (612)
T ss_pred             hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch----------------HHHH
Confidence            75443     23356788999999999999999999999999999999999999765332                0111


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                      ..   -....+....+..+++|+.+||+.||.+||++.++..+=..
T Consensus       524 ~~---i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  524 TR---IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             Hh---hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            11   11223345678899999999999999999999999987544

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=317.40  Aligned_cols=264  Identities=27%  Similarity=0.476  Sum_probs=213.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCcee-ccccceeEEEEccccCc-hhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRV-GLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  154 (431)
                      ++..+.+.||+|.||.|++|....-... ......||||.++.... ...+.+..|+++|+.+. |+||+.++++|...+
T Consensus       296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~  375 (609)
T KOG0200|consen  296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDG  375 (609)
T ss_pred             hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCC
Confidence            3445566899999999999986542221 11245699999886643 45577899999999994 999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC-------C-------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA-------T-------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~-------~-------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      ..++|+||+..|+|.+++....       .       ..+.....+.++.||+.|++||++..  +|||||-.+|||+..
T Consensus       376 ~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~--~vHRDLAaRNVLi~~  453 (609)
T KOG0200|consen  376 PLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP--CVHRDLAARNVLITK  453 (609)
T ss_pred             ceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC--ccchhhhhhhEEecC
Confidence            9999999999999999997654       0       13788899999999999999999855  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccC--CccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMG--TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQS  297 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  297 (431)
                      +..+||+|||+++............ -.|  ...|||||.+....|+.++|||||||+||||++ |..||.+...     
T Consensus       454 ~~~~kIaDFGlar~~~~~~~y~~~~-~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-----  527 (609)
T KOG0200|consen  454 NKVIKIADFGLARDHYNKDYYRTKS-SAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-----  527 (609)
T ss_pred             CCEEEEccccceeccCCCCceEecC-CCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-----
Confidence            9999999999999755444332211 122  345999999999999999999999999999999 8899966221     


Q ss_pred             hhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                                 ...+.+.+....+.+.+..+..+++++++.||+.+|++||++.++.+.++..
T Consensus       528 -----------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  528 -----------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             -----------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence                       1122334444555566677789999999999999999999999999999874

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-38  Score=293.38  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=203.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-ch------hHHHHHHHHHHHhcCCCCceeeee
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQ------GHREWLTEVNFLGQLRHPNLVKLI  147 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~------~~~~~~~E~~~l~~l~h~niv~l~  147 (431)
                      ++.++|-++.+||+|||+.||+|++....++      ||+|+-..+. +.      ..+...+|.+|.+.|+||.||++|
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRY------vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlY  533 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRY------VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLY  533 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhhe------eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeee
Confidence            4556788899999999999999999877776      9999864331 21      234467899999999999999999


Q ss_pred             cEEE-eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCc
Q 014079          148 GYCC-EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYT  223 (431)
Q Consensus       148 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~  223 (431)
                      |+|. +.+.+|-|+|||+|.+|.-+|..+.  .+++.....|+.||+.||.||.....+|||-||||.||||-.   -|.
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhk--lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGe  611 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHK--LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGE  611 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhh--hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccce
Confidence            9987 4567899999999999999997765  368888889999999999999998899999999999999954   378


Q ss_pred             EEEecccCCccCCCCCCc-----ceeecccCCccccCccccccC----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 014079          224 AKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTG----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSK  294 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  294 (431)
                      +||.|||+++.+......     .......||.+|++||.+.-+    ..+.|+||||+|||+|..+.|+.||.......
T Consensus       612 IKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ  691 (775)
T KOG1151|consen  612 IKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ  691 (775)
T ss_pred             eEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH
Confidence            999999999987654433     233456899999999988633    47889999999999999999999997653221


Q ss_pred             cchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                        +++..        ..+....  .......+.++.++.+||++||+..-++|.+..++..
T Consensus       692 --dILqe--------NTIlkAt--EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~  740 (775)
T KOG1151|consen  692 --DILQE--------NTILKAT--EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLAC  740 (775)
T ss_pred             --HHHhh--------hchhcce--eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHcc
Confidence              11110        0010000  1111122345678899999999999999998877754

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-38  Score=300.02  Aligned_cols=243  Identities=26%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      |..++.||-|+||.|.++...++...      ||+|.+++...-   .......|-.||..-+.+.||+||..|.+.+.+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~l------YAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL  704 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRAL------YAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL  704 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhH------HHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence            55567799999999999998887654      999998876542   233456799999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      |+||+|++||++-.+|.+.+-  +++.....++.++.+|+++.|..|  +|||||||+|||||.+|++||.||||+.-+.
T Consensus       705 YFVMdYIPGGDmMSLLIrmgI--FeE~LARFYIAEltcAiesVHkmG--FIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  705 YFVMDYIPGGDMMSLLIRMGI--FEEDLARFYIAELTCAIESVHKMG--FIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EEEEeccCCccHHHHHHHhcc--CHHHHHHHHHHHHHHHHHHHHhcc--ceecccCccceEEccCCceeeeeccccccce
Confidence            999999999999999988764  677888888899999999999877  9999999999999999999999999984211


Q ss_pred             ---------CCCCcc-------------------------------eeecccCCccccCccccccCCCCcchhhHHHHHH
Q 014079          237 ---------QGDETH-------------------------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVV  276 (431)
Q Consensus       237 ---------~~~~~~-------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  276 (431)
                               .++...                               ....++||+.|+|||++....|+..+|+||.|||
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                     000000                               0113579999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcccchhh-hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC
Q 014079          277 LLELLTGRKSVDKTRPSKEQSLV-DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP  348 (431)
Q Consensus       277 l~ell~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  348 (431)
                      ||||+.|+.||....+...+..+ .|        ..       .+...+....+.++.++|.+++. +++.|.
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~nw--------~~-------~l~~~~~~~ls~e~~~li~kLc~-sad~RL  917 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVINW--------RN-------FLHIPYQGNLSKEALDLIQKLCC-SADSRL  917 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeeeeh--------hh-------ccccccccccCHHHHHHHHHHhc-Chhhhh
Confidence            99999999999988776654322 12        11       11122334455677777776443 466664

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-37  Score=282.15  Aligned_cols=240  Identities=30%  Similarity=0.410  Sum_probs=193.1

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      ||.|+||.||++.+.....      .+++|++.+....   ....+..|+.++++++|+||+++++.+..++..++||||
T Consensus         1 lg~G~~~~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   74 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGK------LYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEY   74 (250)
T ss_pred             CCCCCceEEEEEEECCCCc------EEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEec
Confidence            6999999999999876443      4999988765432   345678899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      +++++|.+++....  .+++.....++.|++.||.|||+.+  ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        75 ~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~~l~~lh~~~--~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~  148 (250)
T cd05123          75 APGGELFSHLSKEG--RFSEERARFYAAEIVLALEYLHSLG--IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--S  148 (250)
T ss_pred             CCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcceEEEcCCCcEEEeecCcceecccCC--C
Confidence            99999999997654  4788999999999999999999866  9999999999999999999999999987653321  1


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      ......++..|++||.+.+..++.++|+||||+++|+|++|+.||.......   ...             .+...  ..
T Consensus       149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~-------------~~~~~--~~  210 (250)
T cd05123         149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKE---IYE-------------KILKD--PL  210 (250)
T ss_pred             cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH---HHH-------------HHhcC--CC
Confidence            2233568889999999988889999999999999999999999996543211   000             00000  01


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCCH---HHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPLM---SDVVE  355 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt~---~eil~  355 (431)
                      .++...+..+.+++.+||..||++||++   .+++.
T Consensus       211 ~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         211 RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence            1222235788899999999999999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-39  Score=278.54  Aligned_cols=247  Identities=27%  Similarity=0.349  Sum_probs=192.2

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      ..||.|+||+|++-.++..++.      .|||.++.... ...++++.|.+...+- +.||||++||.+..++..||.||
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~------mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKL------MAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcE------EEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            4599999999999888877665      99999988765 4567788888875554 69999999999999999999999


Q ss_pred             ecCCCChHHhhh---hCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          162 FMFRGSLENHLF---RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       162 ~~~~gsL~~~l~---~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      +| ..+|..+..   ......+++...-.|....+.||.||-.. ..|||||+||+||||+..|.+||||||++..+...
T Consensus       144 LM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~-lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  144 LM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE-LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             HH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH-hhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            99 677765543   23344578888888888889999999752 33999999999999999999999999998654322


Q ss_pred             CCcceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                         ...+...|-..|||||.+..  ..|+.++||||||++|||+.||+.|+..+....+               .+.+++
T Consensus       222 ---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfe---------------ql~~Vv  283 (361)
T KOG1006|consen  222 ---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFE---------------QLCQVV  283 (361)
T ss_pred             ---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHH---------------HHHHHH
Confidence               12233568889999998863  4599999999999999999999999987643111               111221


Q ss_pred             --Cc-cccC-cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 --DP-RLEN-QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 --~~-~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ++ .+.. ....+.+..+..+|..||.+|-..||.+.+++++
T Consensus       284 ~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  284 IGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence              11 1111 1123467789999999999999999999999864

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.8e-36  Score=276.72  Aligned_cols=220  Identities=25%  Similarity=0.218  Sum_probs=176.4

Q ss_pred             cCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecCCCCh
Q 014079           89 GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL  168 (431)
Q Consensus        89 G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  168 (431)
                      |.||.||++.+..++..      ||+|.+....     .+.+|...+....||||+++++++.+.+..++||||+++++|
T Consensus         4 g~~~~v~~~~~~~~~~~------~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   72 (237)
T cd05576           4 GVIDKVLLVMDTRTQQT------FILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKL   72 (237)
T ss_pred             cccceEEEEEEccCCcE------EEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCH
Confidence            89999999999877654      9999987653     223455555666799999999999999999999999999999


Q ss_pred             HHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeeccc
Q 014079          169 ENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM  248 (431)
Q Consensus       169 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~  248 (431)
                      .+++....  .+++.....++.|++.||.|||+.+  |+||||||+||+++.++.++|+|||++......     .....
T Consensus        73 ~~~l~~~~--~l~~~~~~~~~~ql~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-----~~~~~  143 (237)
T cd05576          73 WSHISKFL--NIPEECVKRWAAEMVVALDALHREG--IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-----CDGEA  143 (237)
T ss_pred             HHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHEEEcCCCCEEEecccchhccccc-----cccCC
Confidence            99987654  4788999999999999999999866  999999999999999999999999987654322     12234


Q ss_pred             CCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHH
Q 014079          249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRA  328 (431)
Q Consensus       249 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  328 (431)
                      ++..|+|||.+.+..++.++||||||+++|||++|..||.......            .      ..    .....+...
T Consensus       144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~------------~------~~----~~~~~~~~~  201 (237)
T cd05576         144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI------------N------TH----TTLNIPEWV  201 (237)
T ss_pred             cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc------------c------cc----cccCCcccC
Confidence            6778999999988889999999999999999999998875321100            0      00    000112224


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCH
Q 014079          329 AQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       329 ~~~~~~li~~cl~~dP~~RPt~  350 (431)
                      +..+.+++.+||+.||.+||++
T Consensus       202 ~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         202 SEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CHHHHHHHHHHccCCHHHhcCC
Confidence            4678899999999999999996

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-35  Score=278.88  Aligned_cols=286  Identities=23%  Similarity=0.283  Sum_probs=215.1

Q ss_pred             cccccccccccCHHHHHHHh-cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHh
Q 014079           58 NAVLYTHVIAFSLFELETIT-KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG  136 (431)
Q Consensus        58 ~~~~~~~~~~~~~~~~~~~~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~  136 (431)
                      ....|...-..+....+.+. .+|.+.++||.|.|++||+|.+..+.++      ||+|+.+... ...+..+.||++|+
T Consensus        57 ~~~dY~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~------VAlKVvKSAq-hYtEaAlDEIklL~  129 (590)
T KOG1290|consen   57 DPEDYRKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRY------VALKVVKSAQ-HYTEAALDEIKLLQ  129 (590)
T ss_pred             ChhhhhcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeE------EEEEEEehhh-HHHHHHHHHHHHHH
Confidence            33345555555666677777 8999999999999999999999988776      9999987653 23455678999999


Q ss_pred             cCC-----C---CceeeeecEEEe----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCC
Q 014079          137 QLR-----H---PNLVKLIGYCCE----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER  204 (431)
Q Consensus       137 ~l~-----h---~niv~l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~  204 (431)
                      +++     |   .+||+|+|+|..    +.++|||+|++ |.+|..+|.......++...+..|++|++.||.|||. ..
T Consensus       130 ~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~-ec  207 (590)
T KOG1290|consen  130 QVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR-EC  207 (590)
T ss_pred             HHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH-hc
Confidence            983     3   369999999975    56899999999 9999999998888889999999999999999999997 45


Q ss_pred             CeeeccCCCCCEEECCC---------------------------------------------------------------
Q 014079          205 PVIYRDFKTSNILLDSD---------------------------------------------------------------  221 (431)
Q Consensus       205 ~ivHrDlkp~NILl~~~---------------------------------------------------------------  221 (431)
                      +|||-||||+|||+..+                                                               
T Consensus       208 gIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~  287 (590)
T KOG1290|consen  208 GIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEAS  287 (590)
T ss_pred             CccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhh
Confidence            69999999999998200                                                               


Q ss_pred             --------------------------------------------------------------------------------
Q 014079          222 --------------------------------------------------------------------------------  221 (431)
Q Consensus       222 --------------------------------------------------------------------------------  221 (431)
                                                                                                      
T Consensus       288 l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s  367 (590)
T KOG1290|consen  288 LAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSS  367 (590)
T ss_pred             hcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccC
Confidence                                                                                            


Q ss_pred             -----------------------CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHH
Q 014079          222 -----------------------YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL  278 (431)
Q Consensus       222 -----------------------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  278 (431)
                                             ..+||+|||-|.....     ..+.-+.|..|+|||++.+..|++.+||||++|+++
T Consensus       368 ~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~k-----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~F  442 (590)
T KOG1290|consen  368 PSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHK-----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAF  442 (590)
T ss_pred             cCCccccccccccCCCCCCCccceeEEEeeccchhhhhh-----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHH
Confidence                                   0144555555443211     122345677899999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcc----cchhhh-----------------hhhhhhhccchhhhhcCccc---------cCcccHHH
Q 014079          279 ELLTGRKSVDKTRPSK----EQSLVD-----------------WARPKLNDKRKMLQIIDPRL---------ENQYSVRA  328 (431)
Q Consensus       279 ell~g~~pf~~~~~~~----~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~  328 (431)
                      ||+||...|+......    +.++..                 +.+..++....+..|-.-+.         ...++.+.
T Consensus       443 ELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~  522 (590)
T KOG1290|consen  443 ELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEED  522 (590)
T ss_pred             HhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHH
Confidence            9999999997644322    111111                 11222232333332221111         12356788


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          329 AQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       329 ~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      +.++.+|+.-||+.+|++|||+.+.+++-
T Consensus       523 A~~fsdFL~PmLef~PeKR~tA~~cl~hP  551 (590)
T KOG1290|consen  523 AQQFSDFLSPMLEFDPEKRPTAAQCLKHP  551 (590)
T ss_pred             HHHHHHHHHHHHhcCccccccHHHHhcCc
Confidence            89999999999999999999999999764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-38  Score=270.12  Aligned_cols=271  Identities=23%  Similarity=0.309  Sum_probs=199.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccc--cCchhHHHHHHHHHHHhcCCCCceeeeecEEEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  152 (431)
                      ..|.-..+||+|.||.||+|+..++++.      ||+|.+--  +....-...++|+++|..|+|+|++.++..|..   
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kk------valkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~T   90 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKK------VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAT   90 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccch------hHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence            3455566899999999999998877653      67765422  222233556899999999999999999988753   


Q ss_pred             -----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 -----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           ...+|+||.+| ..+|.-++... ...++...+..++.++..||.|+|...  |+|||+|++|+||+.+|.+||+
T Consensus        91 p~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~k--ilHRDmKaaNvLIt~dgilklA  166 (376)
T KOG0669|consen   91 PTNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNK--ILHRDMKAANVLITKDGILKLA  166 (376)
T ss_pred             CcccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhh--HHhhcccHhhEEEcCCceEEee
Confidence                 34579999999 55788877543 245888899999999999999999877  9999999999999999999999


Q ss_pred             cccCCccCCCCCCc--ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--
Q 014079          228 DFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--  302 (431)
Q Consensus       228 DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--  302 (431)
                      |||+++.+......  ...+..+-|.+|++||.+.+. .|+.+.|||+.|||+.||+++.+-+.+........++...  
T Consensus       167 DFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcG  246 (376)
T KOG0669|consen  167 DFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCG  246 (376)
T ss_pred             ccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhc
Confidence            99999865433221  123345579999999998874 6999999999999999999999988877665544333221  


Q ss_pred             ------hhhhhccchhhhhcCccccCc-c--------cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          303 ------RPKLNDKRKMLQIIDPRLENQ-Y--------SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       303 ------~~~~~~~~~~~~~~~~~~~~~-~--------~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                            +|.+....-...+--+.+... +        +..-.++..+|+..+|..||.+|+++.+++.+.-
T Consensus       247 s~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~  317 (376)
T KOG0669|consen  247 SITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDF  317 (376)
T ss_pred             cCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhh
Confidence                  222222111111111111110 0        0011347889999999999999999999998754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-36  Score=270.88  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=197.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---HHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      .+.|.++++||+|+|..|.++.++.+.++      ||+|+++++-..+   ..-...|-.+..+- +||.+|-++.+|..
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qi------yamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt  322 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT  322 (593)
T ss_pred             cccceeeeeecCcchhhhhheehccccee------eehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence            36789999999999999999999888776      9999998764332   22344566666665 69999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      +..+++|.||++||+|--++.++.  .+++.....+...|..||.|||+.+  ||+||||.+|||||..|++||.|+|+.
T Consensus       323 esrlffvieyv~ggdlmfhmqrqr--klpeeharfys~ei~lal~flh~rg--iiyrdlkldnvlldaeghikltdygmc  398 (593)
T KOG0695|consen  323 ESRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEICLALNFLHERG--IIYRDLKLDNVLLDAEGHIKLTDYGMC  398 (593)
T ss_pred             cceEEEEEEEecCcceeeehhhhh--cCcHHHhhhhhHHHHHHHHHHhhcC--eeeeeccccceEEccCCceeecccchh
Confidence            999999999999999988886654  4888899999999999999999855  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +.....  .....++||||.|.|||++.+..|...+|+|+|||+++||+.|+.||+......         +..+...-+
T Consensus       399 ke~l~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n---------~d~ntedyl  467 (593)
T KOG0695|consen  399 KEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDN---------PDMNTEDYL  467 (593)
T ss_pred             hcCCCC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCC---------cccchhHHH
Confidence            863322  223456899999999999999999999999999999999999999997643221         111112222


Q ss_pred             hhhc-CccccCcccHHHHHHHHHHHHHhhhcCCCCCC
Q 014079          313 LQII-DPRLENQYSVRAAQKACSLAYYCLSQNPKARP  348 (431)
Q Consensus       313 ~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  348 (431)
                      .+++ ...+  ..+...+-.+..+++.-|++||.+|.
T Consensus       468 fqvilekqi--riprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  468 FQVILEKQI--RIPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHhhhcc--cccceeehhhHHHHHHhhcCCcHHhc
Confidence            2222 2211  12334445667899999999999984

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=4.7e-35  Score=298.22  Aligned_cols=267  Identities=19%  Similarity=0.212  Sum_probs=170.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecE------E
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGY------C  150 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~  150 (431)
                      .++|.+.+.||+|+||.||+|.+..+..  ..+..||+|.+.....  .+.+..|  .++...+.+++.++..      .
T Consensus       131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~--~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~  204 (566)
T PLN03225        131 KDDFVLGKKLGEGAFGVVYKASLVNKQS--KKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSS  204 (566)
T ss_pred             cCCeEEeEEEeeCCCeEEEEEEEcCCcc--ccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence            4679999999999999999999876521  1233599998765421  1111111  1222223333332222      2


Q ss_pred             EeCCeeEEEEEecCCCChHHhhhhCCCC------------------CcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCC
Q 014079          151 CEDDHRLLVYEFMFRGSLENHLFRKATV------------------PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFK  212 (431)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlk  212 (431)
                      ......++||||+.+++|.+++......                  ......+..++.|++.||.|||+.+  |+|||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g--IiHRDLK  282 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG--IVHRDVK  282 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC--EEeCcCC
Confidence            4566789999999999999988654210                  0112345578999999999999866  9999999


Q ss_pred             CCCEEECC-CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccC----------------------CCCcchh
Q 014079          213 TSNILLDS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG----------------------HLTARSD  269 (431)
Q Consensus       213 p~NILl~~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D  269 (431)
                      |+|||++. ++.+||+|||+++....... .......+|+.|+|||++...                      .++.++|
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D  361 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGIN-YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD  361 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccc-cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence            99999986 58999999999986543222 223346789999999976422                      2445679


Q ss_pred             hHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCc------ccHHHHHHHHHHHHHhhhcC
Q 014079          270 VYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ------YSVRAAQKACSLAYYCLSQN  343 (431)
Q Consensus       270 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~d  343 (431)
                      ||||||+||||+++..+++.....    +.......-.+.......+.+.....      ..........+|+.+||+.|
T Consensus       362 VwSlGviL~el~~~~~~~~~~~~~----~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        362 IYSAGLIFLQMAFPNLRSDSNLIQ----FNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             cHHHHHHHHHHHhCcCCCchHHHH----HHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999999999977665432100    00000000000000001111110000      00011234568999999999


Q ss_pred             CCCCCCHHHHHHH
Q 014079          344 PKARPLMSDVVET  356 (431)
Q Consensus       344 P~~RPt~~eil~~  356 (431)
                      |++|||+.++++|
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1.9e-34  Score=264.00  Aligned_cols=237  Identities=32%  Similarity=0.461  Sum_probs=191.6

Q ss_pred             CcEEEEEEEEcCCceeccccceeEEEEccccCchh-HHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecCCCCh
Q 014079           90 GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL  168 (431)
Q Consensus        90 ~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  168 (431)
                      +||.||+|.+.+++.      .+++|++....... ...+.+|++.+++++|+||+++++++......++++||+.+++|
T Consensus         1 ~~g~v~~~~~~~~~~------~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   74 (244)
T smart00220        1 SFGKVYLARDKKTGK------LVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDL   74 (244)
T ss_pred             CceEEEEEEECCCCc------EEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCH
Confidence            589999999876443      49999987765444 67888999999999999999999999999999999999999999


Q ss_pred             HHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeeccc
Q 014079          169 ENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM  248 (431)
Q Consensus       169 ~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~  248 (431)
                      .+++.....  +++...+.++.+++.++.|||..+  ++|+||+|+||+++.++.++|+|||.+.......   ......
T Consensus        75 ~~~~~~~~~--~~~~~~~~~~~~l~~~l~~lh~~~--i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~  147 (244)
T smart00220       75 FDLLKKRGR--LSEDEARFYARQILSALEYLHSNG--IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFV  147 (244)
T ss_pred             HHHHHhccC--CCHHHHHHHHHHHHHHHHHHHHcC--eecCCcCHHHeEECCCCcEEEccccceeeecccc---cccccc
Confidence            999876543  788899999999999999999876  9999999999999999999999999998754432   223456


Q ss_pred             CCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC-ccccCccc-H
Q 014079          249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID-PRLENQYS-V  326 (431)
Q Consensus       249 gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~  326 (431)
                      ++..|++||.+.+..++.++|||+||+++|+|++|..||.......  .              +.+.+. ........ .
T Consensus       148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~--~--------------~~~~~~~~~~~~~~~~~  211 (244)
T smart00220      148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL--E--------------LFKKIGKPKPPFPPPEW  211 (244)
T ss_pred             CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH--H--------------HHHHHhccCCCCccccc
Confidence            8889999999988889999999999999999999999996631110  0              011110 00000000 0


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          327 RAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       327 ~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      ..+.++.+++.+||..+|++||++.++++
T Consensus       212 ~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      212 KISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             cCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence            04568889999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.2e-34  Score=286.48  Aligned_cols=273  Identities=20%  Similarity=0.254  Sum_probs=183.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCcee----------ccccceeEEEEccccCchhHHH--------------HHHHH
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRV----------GLKSLPVAVKVLNKEGLQGHRE--------------WLTEV  132 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----------~~~~~~vavK~~~~~~~~~~~~--------------~~~E~  132 (431)
                      .++|.+.++||+|+||+||+|.+......          ..++..||||.+........++              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            46899999999999999999976432211          1233469999986543222222              33466


Q ss_pred             HHHhcCCCCce-----eeeecEEEe--------CCeeEEEEEecCCCChHHhhhhCCC----------------------
Q 014079          133 NFLGQLRHPNL-----VKLIGYCCE--------DDHRLLVYEFMFRGSLENHLFRKAT----------------------  177 (431)
Q Consensus       133 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~----------------------  177 (431)
                      .++.+++|.++     ++++++|..        .+..+|||||+++++|.+++.....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766544     667777653        3568999999999999998864211                      


Q ss_pred             CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcc
Q 014079          178 VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE  257 (431)
Q Consensus       178 ~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE  257 (431)
                      ..+++..+..++.|++.+|.|||+.+  |+||||||+|||++.++.+||+|||++.......... .....+|+.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~--ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG--IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChh
Confidence            12456778889999999999999866  9999999999999999999999999997643322111 11234588999999


Q ss_pred             ccccCC--------------------C--CcchhhHHHHHHHHHHHhCCC-CCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          258 YVMTGH--------------------L--TARSDVYSFGVVLLELLTGRK-SVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       258 ~~~~~~--------------------~--~~~~DiwslG~il~ell~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ++....                    |  ..+.||||+||++|+|++|.. ||......... ...+ ...+.   ....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~-~~~~-~~~~~---~~r~  455 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTE-LRQY-DNDLN---RWRM  455 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhH-Hhhc-cchHH---HHHh
Confidence            875432                    1  124799999999999999875 66543211110 0000 00000   0000


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCC---CCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNP---KARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPt~~eil~~L  357 (431)
                      ..............+....+|+.+||..+|   .+|+|+.|++.|-
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp  501 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHR  501 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCC
Confidence            011111111223446788999999999876   6899999999873

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=263.43  Aligned_cols=273  Identities=25%  Similarity=0.345  Sum_probs=221.2

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeec
Q 014079           70 LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        70 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      ..++.....+++...++-+|.||.||.|.|.+...+ -+...|.+|.++.... -....++.|.-.+..+.|||+..+.+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~-n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~  354 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY-NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG  354 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCc-chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence            334555567788888999999999999988764332 2333467776655432 23456888999999999999999999


Q ss_pred             EEEeC-CeeEEEEEecCCCChHHhhhh------CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          149 YCCED-DHRLLVYEFMFRGSLENHLFR------KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       149 ~~~~~-~~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      ++.+. ...+.++.++.-|+|..++..      +..+.+...+...++.|++.|++|||.++  |||.||..+|++||+.
T Consensus       355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~--ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG--VIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC--cccchhhhhcceehhh
Confidence            87654 567889999999999999972      33445677788889999999999999877  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  300 (431)
                      ..+||+|=.+++.+-..+.............||+||.+.+..|+.++|||||||+||||+| |+.|+...++.+      
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE------  506 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE------  506 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH------
Confidence            9999999999998777777666665666778999999999999999999999999999999 999998765543      


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                                 +...+..+.+-..+..++++++.++..||..+|++||++++++.-|.++..
T Consensus       507 -----------m~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  507 -----------MEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             -----------HHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                       333333344444566788999999999999999999999999998876654

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=264.85  Aligned_cols=267  Identities=23%  Similarity=0.352  Sum_probs=201.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC---
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD---  154 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  154 (431)
                      .+-.+-||.|+||.||.+.+...++.      |+.|.+..-  +....+.+.+|+++|.-++|.|++..+|+..-..   
T Consensus        55 i~PDRPIGYGAFGVVWsVTDPRdgrr------valkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~df  128 (449)
T KOG0664|consen   55 IQPDRPIGYGAFGVVWSVTDPRSGKR------VALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSF  128 (449)
T ss_pred             CCCCCcccccceeEEEeccCCCCccc------hhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchH
Confidence            45567899999999999998765543      777766542  3445678999999999999999999998875442   


Q ss_pred             --eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 --HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                        .+|++.|+| ..+|...|..  ..+++...+..+++||++||.|||+.+  |+||||||.|+|++.+..+||||||++
T Consensus       129 FqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~--ILHRDIKPGNLLVNSNCvLKICDFGLA  203 (449)
T KOG0664|consen  129 FQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTAN--ILHRDIKPGNLLVNSNCILKICDFGLA  203 (449)
T ss_pred             HHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcc--hhhccCCCccEEeccCceEEecccccc
Confidence              457888888 6788887754  456888899999999999999999988  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhcc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDK  309 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~  309 (431)
                      +.-...+. ..++..+-|.+|+|||++.+. .|+.+.||||.|||+.|++..+.-|....+....+++...  .|.+...
T Consensus       204 Rvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM  282 (449)
T KOG0664|consen  204 RTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM  282 (449)
T ss_pred             cccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence            87544333 334445678999999999875 6999999999999999999999999887776554443221  1111111


Q ss_pred             c-----hhhhhcCcccc-----Cc--c--cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 R-----KMLQIIDPRLE-----NQ--Y--SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~-----~~~~~~~~~~~-----~~--~--~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      +     .-..++.....     .-  .  +.....+..+++..+|..||++|.+..+.+.++.
T Consensus       283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccc
Confidence            0     00111111111     00  1  1233457778999999999999999999988764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-35  Score=292.90  Aligned_cols=247  Identities=28%  Similarity=0.386  Sum_probs=187.3

Q ss_pred             CCCccceecccCcEE-EEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCee
Q 014079           79 SFRSDYILGEGGFGT-VYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~-V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  156 (431)
                      .|...+++|.|+.|+ ||+|...+.        .||||.+-.+.   ..-..+|+..|+.-+ |||||++|+.-.+++..
T Consensus       510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R--------~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~  578 (903)
T KOG1027|consen  510 FFSPKEILGYGSNGTVVFRGVYEGR--------EVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFL  578 (903)
T ss_pred             eeccHHHcccCCCCcEEEEEeeCCc--------eehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceE
Confidence            355567899999885 599987643        49999775542   234568999999885 99999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---C--CcEEEecc
Q 014079          157 LLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---D--YTAKLSDF  229 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~--~~~kl~DF  229 (431)
                      ||..|.| ..+|.+++...  ..........+.++.|++.||++||+.+  ||||||||.||||+.   +  ..++|+||
T Consensus       579 YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~--iVHRDLkPQNILI~~~~~~~~~ra~iSDf  655 (903)
T KOG1027|consen  579 YIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK--IVHRDLKPQNILISVPSADGTLRAKISDF  655 (903)
T ss_pred             EEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc--cccccCCCceEEEEccCCCcceeEEeccc
Confidence            9999999 88999999763  1111111344677889999999999977  999999999999976   3  57899999


Q ss_pred             cCCccCCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhh
Q 014079          230 GLAKAGPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       230 G~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |+++.+..+.... ...+..||.+|+|||++....-+.++|||||||++|+.++ |.+||......+..        .+.
T Consensus       656 glsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~N--------Il~  727 (903)
T KOG1027|consen  656 GLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQAN--------ILT  727 (903)
T ss_pred             ccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhh--------hhc
Confidence            9999876554322 2345789999999999999888889999999999999999 59999765321111        011


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+..+     .    .....++.+||.+|++++|..||++.+|+.|
T Consensus       728 ~~~~L~~L-----~----~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  728 GNYTLVHL-----E----PLPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             Cccceeee-----c----cCchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            11111111     0    0111178899999999999999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-34  Score=240.22  Aligned_cols=201  Identities=26%  Similarity=0.324  Sum_probs=163.9

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCeeEE
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  158 (431)
                      .-...||+|++|.|-+-++..++.+      .|+|.+... +.+..++.++|+.+..+. .+|.+|.+||........|+
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~i------mAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTI------MAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeE------EEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            3445699999999988877766655      899988754 334556788899886555 69999999999999999999


Q ss_pred             EEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          159 VYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      .||.| ..+|..+-..  ..+..+++...-+|+..++.||.|||+. -.|||||+||+||||+.+|.+|+||||++-.+.
T Consensus       123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k-L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~  200 (282)
T KOG0984|consen  123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK-LSVIHRDVKPSNILINYDGQVKICDFGISGYLV  200 (282)
T ss_pred             eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH-hhhhhccCCcceEEEccCCcEEEcccccceeeh
Confidence            99999 7788766543  3445688888999999999999999984 349999999999999999999999999997654


Q ss_pred             CCCCcceeecccCCccccCcccccc----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT----GHLTARSDVYSFGVVLLELLTGRKSVDKTRP  292 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~pf~~~~~  292 (431)
                      +.-.   .+...|...|||||.+..    ..|+.++||||||+++.||.+++.||+.+..
T Consensus       201 dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  201 DSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             hhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            3321   122457788999998753    4799999999999999999999999987654

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2.1e-34  Score=271.72  Aligned_cols=275  Identities=21%  Similarity=0.243  Sum_probs=209.2

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC------C
Q 014079           67 AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR------H  140 (431)
Q Consensus        67 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h  140 (431)
                      .|.....+.+..+|.+....|+|-|++|..|.+...+.      .||||+|..+... .+.=+.|++||++|+      -
T Consensus       421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~------~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk  493 (752)
T KOG0670|consen  421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQ------EVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDK  493 (752)
T ss_pred             eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCC------eeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhh
Confidence            34555677888999999999999999999998866443      4999999887543 244568999999995      3


Q ss_pred             CceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       141 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      -++++|+-.|...+++|||+|-+ ..+|.++|...+ ...|....+..++.|+..||..|-.++  |+|.||||+|||++
T Consensus       494 ~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~--vlHaDIKPDNiLVN  570 (752)
T KOG0670|consen  494 FHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG--VLHADIKPDNILVN  570 (752)
T ss_pred             hHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC--eeecccCccceEec
Confidence            47999999999999999999988 889999997743 345778888999999999999999877  99999999999999


Q ss_pred             CC-CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          220 SD-YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~-~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      +. ..+||||||.|........+.    ..-+..|.|||++.|-.|+...|+||+||+||||.||+..|.+........+
T Consensus       571 E~k~iLKLCDfGSA~~~~eneitP----YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl  646 (752)
T KOG0670|consen  571 ESKNILKLCDFGSASFASENEITP----YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRL  646 (752)
T ss_pred             cCcceeeeccCccccccccccccH----HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHH
Confidence            86 578999999998754433221    2334569999999999999999999999999999999999987654332211


Q ss_pred             hhhh-----------------------------------------hhhhhccchhhhhcC--ccccCcccHHHHHHHHHH
Q 014079          299 VDWA-----------------------------------------RPKLNDKRKMLQIID--PRLENQYSVRAAQKACSL  335 (431)
Q Consensus       299 ~~~~-----------------------------------------~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l  335 (431)
                      .-..                                         ...+....++...+.  +.+.. -.......|.+|
T Consensus       647 ~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~d-eq~~~~~~~rdL  725 (752)
T KOG0670|consen  647 FMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPD-EQPKIVQQLRDL  725 (752)
T ss_pred             HHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCc-hhHHHHHHHHHH
Confidence            1000                                         000000011111111  01111 123456789999


Q ss_pred             HHHhhhcCCCCCCCHHHHHHH
Q 014079          336 AYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       336 i~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..||..||++|.|..+.|.|
T Consensus       726 Ldkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  726 LDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             HHHHhccChhhcCCHHHHhcC
Confidence            999999999999999999876

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-34  Score=270.47  Aligned_cols=196  Identities=27%  Similarity=0.363  Sum_probs=168.5

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hH-----HHHHHHHHHHhcCC---CCceeeee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GH-----REWLTEVNFLGQLR---HPNLVKLI  147 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~-----~~~~~E~~~l~~l~---h~niv~l~  147 (431)
                      .|...+.+|.|+||.|++|.++.+...      |++|+|.++..-   +.     -..-.|+.||..|+   |+||++++
T Consensus       562 ~yttlq~lG~GAyGkV~lai~K~n~~e------VViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  562 DYTTLQPLGEGAYGKVNLAIHKENNYE------VVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             cceeeeeccccccceEEEeeecccceE------EEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            488899999999999999999987553      999999886431   11     12457999999997   99999999


Q ss_pred             cEEEeCCeeEEEEEec-CCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          148 GYCCEDDHRLLVYEFM-FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       148 ~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ++|++++++||+||.- +|-+|.++|..+..  +.+.....|++|++.|+++||+.+  |||||||-+||.++.+|.+||
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~--m~E~eAk~IFkQV~agi~hlh~~~--ivhrdikdenvivd~~g~~kl  711 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPR--MDEPEAKLIFKQVVAGIKHLHDQG--IVHRDIKDENVIVDSNGFVKL  711 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCc--cchHHHHHHHHHHHhccccccccC--ceecccccccEEEecCCeEEE
Confidence            9999999999999986 56699999987765  677788889999999999999977  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCc-chhhHHHHHHHHHHHhCCCCCC
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTA-RSDVYSFGVVLLELLTGRKSVD  288 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~pf~  288 (431)
                      +|||.+.....+-    ...+.||..|.|||++.+..|-- .-|||+||++||.++....||.
T Consensus       712 idfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  712 IDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             eeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999987654332    33477999999999999988855 4899999999999999888874

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=253.24  Aligned_cols=263  Identities=24%  Similarity=0.327  Sum_probs=196.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      ...+|.-.+.+|.|.- .|..+.+.-.      ..+|++|.....  +....++..+|+.++..+.|+||++++.+|.-.
T Consensus        15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~------~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~   87 (369)
T KOG0665|consen   15 VPKRYVNLKPIGSGAQ-IVVAAFDQVL------GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQ   87 (369)
T ss_pred             eeeeeeeecccCCCCc-eEEecchhhc------cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCcc
Confidence            4567788888999998 6777766433      335888876544  223456678999999999999999999998754


Q ss_pred             C------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 D------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      .      ..|+|||+| ..+|...+.    ..++-.....+++|+++|+.|||+.+  |+||||||+||+++.++.+||.
T Consensus        88 ~~l~~~~e~y~v~e~m-~~nl~~vi~----~elDH~tis~i~yq~~~~ik~lhs~~--IihRdLkPsnivv~~~~~lKi~  160 (369)
T KOG0665|consen   88 KTLEEFQEVYLVMELM-DANLCQVIL----MELDHETISYILYQMLCGIKHLHSAG--IIHRDLKPSNIVVNSDCTLKIL  160 (369)
T ss_pred             ccHHHHHhHHHHHHhh-hhHHHHHHH----HhcchHHHHHHHHHHHHHHHHHHhcc--eeecccCcccceecchhheeec
Confidence            3      469999999 789999886    34677888999999999999999987  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-------
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-------  300 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-------  300 (431)
                      |||+|+.-..   ....+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+......-..+.       
T Consensus       161 dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd  237 (369)
T KOG0665|consen  161 DFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD  237 (369)
T ss_pred             cchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence            9999986322   234566788999999999999999999999999999999999999887543221110000       


Q ss_pred             -----h----h------hhhhhccchhhhhc-CccccC--cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 -----W----A------RPKLNDKRKMLQII-DPRLEN--QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 -----~----~------~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           .    +      .++... ....+.+ |..+..  +.+......+.+++.+||..||++|.++.++|.|
T Consensus       238 ~~F~~qL~~~~r~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  238 PSFMKQLQPTVRNYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhHHHHHHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                 0    0      000000 0011111 111111  1112234577899999999999999999999987

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-34  Score=276.70  Aligned_cols=254  Identities=25%  Similarity=0.350  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|.+..++|.|+||.||+++++...+.      .|+|+++-....+..-+..|+-+++..+|||||.+++.+...+.+|
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~el------aavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGEL------AAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCch------hhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            5688888999999999999999876554      8899988776666667778999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +.||||.||+|.+..+-  ..++++.++..+++..++||+|||+.+  =+|||||-.|||+++.|.+|+.|||.+..+..
T Consensus        89 icMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~g--k~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQG--KIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCC--cccccccccceeecccCceeecccCchhhhhh
Confidence            99999999999997744  557999999999999999999999877  79999999999999999999999999865432


Q ss_pred             CCCcceeecccCCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .  ......++||++|||||+.   ..+.|...+|||++|++..|+-.-+.|-....+.....+.....           
T Consensus       165 t--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~-----------  231 (829)
T KOG0576|consen  165 T--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSG-----------  231 (829)
T ss_pred             h--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccC-----------
Confidence            1  1122347899999999976   36789999999999999999988887765544332222211100           


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .++. ..+-.....+.|-+|++.||.++|++||+++.++.|
T Consensus       232 -~qpp-~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  232 -FQPP-TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             -CCCC-cccCCccchHHHHHHHHHHhcCCCccCCChhhheec
Confidence             0110 001122345678899999999999999999887753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=4.2e-33  Score=238.23  Aligned_cols=261  Identities=18%  Similarity=0.309  Sum_probs=194.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDD-  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~-  154 (431)
                      .++|++.+++|+|.++.||.|....+..      .++||+++.-   ..+.+.+|++||+.|. ||||++++++..+.. 
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e------K~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S  107 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNE------KCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPES  107 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCc------eEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccc
Confidence            3578889999999999999998765544      3889988754   3456779999999998 999999999998754 


Q ss_pred             -eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEecccCC
Q 014079          155 -HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLA  232 (431)
Q Consensus       155 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG~a  232 (431)
                       ...||+||+.+.+...+..     .++...+..++.+++.||.|+|+.|  |+|||+||.|++||.. -.++|+|+|+|
T Consensus       108 ktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~G--ImHRDVKPhNvmIdh~~rkLrlIDWGLA  180 (338)
T KOG0668|consen  108 KTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMG--IMHRDVKPHNVMIDHELRKLRLIDWGLA  180 (338)
T ss_pred             cCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcC--cccccCCcceeeechhhceeeeeecchH
Confidence             4579999998887776552     3666677889999999999999977  9999999999999875 57999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-----------hhhh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-----------SLVD  300 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-----------~~~~  300 (431)
                      .+...+.....   .+.+..|--||++.. ..|+..-|+|||||+|..|+..+.||-.......+           .+..
T Consensus       181 EFYHp~~eYnV---RVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~  257 (338)
T KOG0668|consen  181 EFYHPGKEYNV---RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA  257 (338)
T ss_pred             hhcCCCceeee---eeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence            98766554432   346778999998864 56899999999999999999999998665443322           0111


Q ss_pred             hhh-hhhhccchhhhhcCccccCcc-------c-HHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 WAR-PKLNDKRKMLQIIDPRLENQY-------S-VRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 ~~~-~~~~~~~~~~~~~~~~~~~~~-------~-~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.. -.+........++....+..+       . .-.++++.+|+...|..|-.+|+|+.|.+.|
T Consensus       258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            100 001111111122211111111       1 1124789999999999999999999999876

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=1e-30  Score=233.51  Aligned_cols=212  Identities=38%  Similarity=0.583  Sum_probs=181.2

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecC
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMF  164 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  164 (431)
                      ||+|++|.||++...+++.      .+++|++...... ....+.+|++.++.++|++|+++++++......++++|++.
T Consensus         1 l~~g~~~~v~~~~~~~~~~------~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~   74 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGK------KVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCE   74 (215)
T ss_pred             CCcCCceEEEEEEecCCCc------EEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCC
Confidence            6899999999999876433      3899998876432 34678899999999999999999999999999999999999


Q ss_pred             CCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCccCCCCCCcce
Q 014079          165 RGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQGDETHV  243 (431)
Q Consensus       165 ~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~~~~~~~~~~  243 (431)
                      +++|.+++.... ..+++..+..++.+++.++.+||+.+  ++|+||+|.||+++. ++.++|+|||.+........  .
T Consensus        75 ~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~--~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~  149 (215)
T cd00180          75 GGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNG--IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--L  149 (215)
T ss_pred             CCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--h
Confidence            999999987643 35788999999999999999999876  999999999999999 89999999999876543321  1


Q ss_pred             eecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccC
Q 014079          244 STRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN  322 (431)
Q Consensus       244 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (431)
                      .....+...|++||.+... .++.+.|+|+||+++++|                                          
T Consensus       150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------  187 (215)
T cd00180         150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------  187 (215)
T ss_pred             hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------
Confidence            2234578889999998877 888999999999999998                                          


Q ss_pred             cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       323 ~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                             ..+.+++..||+.||.+||++.++++++
T Consensus       188 -------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                   3456899999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=6.3e-31  Score=243.67  Aligned_cols=272  Identities=26%  Similarity=0.366  Sum_probs=198.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEE
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCC  151 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  151 (431)
                      +..+.+.|...++||+|.|++||++.+...   ..+...||+|.+.....  ...+.+|+++|..+. +.||+++.+++.
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~---~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~r  105 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ---DTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFR  105 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh---ccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhc
Confidence            445667899999999999999999988662   12334599998877643  356789999999996 899999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEeccc
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFG  230 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG  230 (431)
                      .++...+|+||++.....++...     ++...+..+++.++.||.++|..|  ||||||||.|+|.+.. +.-.|+|||
T Consensus       106 nnd~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~G--IvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  106 NNDQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNG--IVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             cCCeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccC--ccccCCCccccccccccCCceEEech
Confidence            99999999999999999888843     567788889999999999999876  9999999999999864 678999999


Q ss_pred             CCccCC-----------------C--C---------------C--------CcceeecccCCccccCcccccc-CCCCcc
Q 014079          231 LAKAGP-----------------Q--G---------------D--------ETHVSTRVMGTYGYAAPEYVMT-GHLTAR  267 (431)
Q Consensus       231 ~a~~~~-----------------~--~---------------~--------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~  267 (431)
                      +|....                 .  +               .        .........||++|.|||++.. ...+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            986100                 0  0               0        0000112569999999999875 567889


Q ss_pred             hhhHHHHHHHHHHHhCCCCCCCCCCcccc--hhh-------------------hhhhhh---hhcc----chh-hhhcCc
Q 014079          268 SDVYSFGVVLLELLTGRKSVDKTRPSKEQ--SLV-------------------DWARPK---LNDK----RKM-LQIIDP  318 (431)
Q Consensus       268 ~DiwslG~il~ell~g~~pf~~~~~~~~~--~~~-------------------~~~~~~---~~~~----~~~-~~~~~~  318 (431)
                      +||||.|||+..++++++||-........  .++                   .|....   +...    ..+ .+.+.+
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999999654433211  000                   000000   0000    000 000000


Q ss_pred             --c--cc-CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          319 --R--LE-NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       319 --~--~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .  .. .......+..+++|+.+||+.||.+|.|+++.|+|
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence              0  11 11122234588999999999999999999999976

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.1e-29  Score=229.98  Aligned_cols=200  Identities=36%  Similarity=0.465  Sum_probs=171.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL  158 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  158 (431)
                      |.+.+.||.|++|.||++...++..      .+++|.+...... ....+.+|++.++.++|+|++++++++......++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~------~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~   74 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGE------LVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYL   74 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCc------EEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEE
Confidence            5667889999999999999876433      3999999876544 56778899999999999999999999999999999


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCC
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG  238 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~  238 (431)
                      ++|++.+++|.+++...... +++.....++.+++.++.+||..+  ++|+||+|.||+++.++.++|+|||++......
T Consensus        75 v~e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~l~~~l~~lh~~~--i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~  151 (225)
T smart00221       75 VMEYCEGGDLFDYLRKKGGK-LSEEEARFYLRQILEALEYLHSLG--IVHRDLKPENILLGMDGLVKLADFGLARFIHRD  151 (225)
T ss_pred             EEeccCCCCHHHHHHhcccC-CCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence            99999999999999765431 788889999999999999999876  999999999999999999999999998875443


Q ss_pred             CCcceeecccCCccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          239 DETHVSTRVMGTYGYAAPEYV-MTGHLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                      ... ......++..|++||.+ ....++.++|||+||+++|+|++|+.||..
T Consensus       152 ~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      152 LAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            211 12235678899999988 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.7e-31  Score=229.01  Aligned_cols=251  Identities=22%  Similarity=0.317  Sum_probs=186.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecE-EEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGY-CCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~  152 (431)
                      ++.+.|.+.+.||+|-||.+-++.++....      .+++|.+.+.. ...++|.+|...--.|. |.||+.-|++ |+.
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t------~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt   93 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKT------RIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQT   93 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCce------EEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhc
Confidence            456789999999999999999999887654      38999887653 45688999998766664 8999988875 667


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC--CCcEEEeccc
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFG  230 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG  230 (431)
                      .+.+++++||++-|+|...+...   .+.+.....++.|++.|+.|+|+.+  +||||||.+||||-.  .-.+||||||
T Consensus        94 ~d~YvF~qE~aP~gdL~snv~~~---GigE~~~K~v~~ql~SAi~fMHskn--lVHRdlK~eNiLif~~df~rvKlcDFG  168 (378)
T KOG1345|consen   94 SDAYVFVQEFAPRGDLRSNVEAA---GIGEANTKKVFAQLLSAIEFMHSKN--LVHRDLKAENILIFDADFYRVKLCDFG  168 (378)
T ss_pred             CceEEEeeccCccchhhhhcCcc---cccHHHHHHHHHHHHHHHHHhhccc--hhhcccccceEEEecCCccEEEeeecc
Confidence            78888999999999999988553   4778888899999999999999976  999999999999933  3489999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccC-----CCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc--chhhhhhh
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE--QSLVDWAR  303 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~  303 (431)
                      +++.....     ....--+..|.+||+....     ...+.+|||.||+++|.+++|+.||........  -....|..
T Consensus       169 ~t~k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~  243 (378)
T KOG1345|consen  169 LTRKVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK  243 (378)
T ss_pred             cccccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc
Confidence            98764321     1123356679999976532     346779999999999999999999984322111  12222222


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV  354 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil  354 (431)
                      ....           .++..+ ...++.+..+.++-|..++++|--..++.
T Consensus       244 rk~~-----------~~P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~k  282 (378)
T KOG1345|consen  244 RKNP-----------ALPKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAK  282 (378)
T ss_pred             ccCc-----------cCchhh-cccCHHHHHHHHHhcCCcccccchhHHHH
Confidence            2111           111111 12346777899999999999994444443

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=4.5e-30  Score=274.01  Aligned_cols=198  Identities=21%  Similarity=0.286  Sum_probs=140.7

Q ss_pred             hcCCC-CceeeeecEE-------EeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCee
Q 014079          136 GQLRH-PNLVKLIGYC-------CEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVI  207 (431)
Q Consensus       136 ~~l~h-~niv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~iv  207 (431)
                      +.++| .||++++|+|       .+.+.+++++||+ +++|.++|... ..++++..++.++.||+.||.|||+.+  ||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~g--Iv  102 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQG--IV  102 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCC--ee
Confidence            34455 6888888887       3334677889987 77999999653 345899999999999999999999866  99


Q ss_pred             eccCCCCCEEECC-------------------CCcEEEecccCCccCCCCCC--------------cceeecccCCcccc
Q 014079          208 YRDFKTSNILLDS-------------------DYTAKLSDFGLAKAGPQGDE--------------THVSTRVMGTYGYA  254 (431)
Q Consensus       208 HrDlkp~NILl~~-------------------~~~~kl~DFG~a~~~~~~~~--------------~~~~~~~~gt~~y~  254 (431)
                      ||||||+||||+.                   ++.+||+|||+++.......              ........||++||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            9999999999964                   34566666666653211000              00011246899999


Q ss_pred             CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHH
Q 014079          255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACS  334 (431)
Q Consensus       255 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (431)
                      |||++.+..|+.++|||||||+||||++|..|+......    ...     +.     ...+.+..     ........+
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~-----~~-----~~~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSS-----LR-----HRVLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHH-----HH-----HhhcChhh-----hhcCHHHHH
Confidence            999999999999999999999999999988876432100    000     00     00011100     011234568


Q ss_pred             HHHHhhhcCCCCCCCHHHHHHH
Q 014079          335 LAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       335 li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ++.+||++||.+||++.|++++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhhc
Confidence            8999999999999999999865

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=4.9e-28  Score=211.43  Aligned_cols=169  Identities=24%  Similarity=0.246  Sum_probs=126.8

Q ss_pred             CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceee
Q 014079          166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST  245 (431)
Q Consensus       166 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~  245 (431)
                      |+|.+++...+ .++++..++.++.|++.||.|||+.+        ||+|||++.++.+++  ||+++......      
T Consensus         1 GsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~lH~~~--------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVRG-RPLNEEEIWAVCLQCLRALRELHRQA--------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhcC--------CcccEeEcCccceee--ccceEeecccc------
Confidence            68999997643 36899999999999999999999744        999999999999999  99987643321      


Q ss_pred             cccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCccc
Q 014079          246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS  325 (431)
Q Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  325 (431)
                       ..||+.|+|||++.+..++.++|||||||++|||++|+.||......... .....    .   ..... .+. .....
T Consensus        64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~-~~~~~----~---~~~~~-~~~-~~~~~  132 (176)
T smart00750       64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAI-LEILL----N---GMPAD-DPR-DRSNL  132 (176)
T ss_pred             -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHH-HHHHH----H---HhccC-Ccc-ccccH
Confidence             25899999999999999999999999999999999999999654321110 00000    0   00000 000 00111


Q ss_pred             HHHHH--HHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          326 VRAAQ--KACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       326 ~~~~~--~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .....  .+.+++.+||+.||.+||++.++++++..+..
T Consensus       133 ~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      133 ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            22333  68999999999999999999999999876543

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-26  Score=222.39  Aligned_cols=265  Identities=23%  Similarity=0.247  Sum_probs=199.1

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC----CceeeeecEE-EeC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH----PNLVKLIGYC-CED  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~  153 (431)
                      +|.+.+.||+|+||.||++.+....     ...+|+|+...........+..|+.++..+..    .++..+++.+ ...
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~-----~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~   93 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEK-----NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE   93 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCC-----CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCC
Confidence            7999999999999999999987654     12388888766532222256678888888863    6899999998 577


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-----CcEEEec
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-----YTAKLSD  228 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-----~~~kl~D  228 (431)
                      ...++||+.+ |.+|.++........++..+.+.++.|++.+|++||+.+  ++||||||+|+++...     ..+.|.|
T Consensus        94 ~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G--~iHRDiKp~N~~~g~~~~~~~~~~~llD  170 (322)
T KOG1164|consen   94 DFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG--FIHRDIKPENFVVGQSSRSEVRTLYLLD  170 (322)
T ss_pred             ceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC--cccCCcCHHHeeecCCCCcccceEEEEe
Confidence            8889999988 999999887666667999999999999999999999877  9999999999999765     4699999


Q ss_pred             ccCCc--cCCCCCCc----c-e-eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          229 FGLAK--AGPQGDET----H-V-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       229 FG~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      ||+++  ........    . . .....||..|+++.+..+...+.+.|+||++.++.|++.|..||.............
T Consensus       171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            99998  32211111    0 1 123559999999999999999999999999999999999999996654322111110


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                   +..............+..+.++...+-..+...+|....+...|.......
T Consensus       251 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  251 -------------KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             -------------HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence                         000000000011123356667777777789999999999999987665543

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-26  Score=206.86  Aligned_cols=259  Identities=20%  Similarity=0.257  Sum_probs=201.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  156 (431)
                      -.|++.++||+|+||..+.|..--++.      +||||.-....  ...++..|.+..+.|. .++|...|.+..++-+-
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne------~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNE------PVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             ccceeccccccCcceeeecccccccCc------eEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            458999999999999999997654433      59999865542  3345667888888775 68999999888888888


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-----CcEEEecccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-----YTAKLSDFGL  231 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-----~~~kl~DFG~  231 (431)
                      .||+|++ |.+|+|++.- .+..++..+++.++.|++.-++|+|++.  +|.|||||+|+||...     ..+.|+|||+
T Consensus       100 iLVidLL-GPSLEDLFD~-CgR~FSvKTV~miA~Qmi~rie~vH~k~--LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDL-CGRRFSVKTVAMIAKQMITRIEYVHEKD--LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhh-CcCHHHHHHH-hcCcccHHhHHHHHHHHHHHHHHHHhcc--eeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999998 9999998754 4457999999999999999999999877  9999999999999653     4689999999


Q ss_pred             CccCCCCCCcc-----eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          232 AKAGPQGDETH-----VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       232 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |+...+.....     ....+.||.+||+--...+...+.+.|+-|||-++++.|.|..||.+........         
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~---------  246 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKE---------  246 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHH---------
Confidence            99765543321     1234679999999999999999999999999999999999999998864332211         


Q ss_pred             hccchhhhhcCc---cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          307 NDKRKMLQIIDP---RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       307 ~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                          ...+|-+.   .-...+....+.++...++..-..+-.+-|+..-+...+..+.
T Consensus       247 ----kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvl  300 (449)
T KOG1165|consen  247 ----KYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVL  300 (449)
T ss_pred             ----HHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                11111111   1112234456678888888888899999999988877766554

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.3e-27  Score=202.42  Aligned_cols=265  Identities=20%  Similarity=0.237  Sum_probs=204.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC-CceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH-PNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~  154 (431)
                      ....|++.+.||+|+||.+|.|.....+.      .||||+-....  ...++.-|.++.+.|++ ..|..+..++.+..
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge------~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~   84 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGE------EVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKD   84 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCc------eEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccc
Confidence            34679999999999999999998876554      49999876542  33467789999999975 78888899999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---CcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~~kl~DFG~  231 (431)
                      .-.|||+++ |.+|++++.-.. ..++..+++.++-|++.-++|+|..+  +|||||||+|+|+.-+   ..+.|+|||+
T Consensus        85 ynvlVMdLL-GPsLEdLfnfC~-R~ftmkTvLMLaDQml~RiEyvH~r~--fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   85 YNVLVMDLL-GPSLEDLFNFCS-RRFTMKTVLMLADQMLSRIEYVHLRN--FIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             cceeeeecc-CccHHHHHHHHh-hhhhHHhHHHHHHHHHHHHHHHHhhc--cccccCCccceeeccccccceEEEEeccc
Confidence            999999998 999999886533 35889999999999999999999866  9999999999999644   5699999999


Q ss_pred             CccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          232 AKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       232 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |+...+....     .......||..|.+-....+...+...|+-|+|.+|.++..|..||.+...........      
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyE------  234 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYE------  234 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHH------
Confidence            9876543321     12234679999999888888888999999999999999999999998865433221111      


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                          .+.+.-.......+....+.++.-.+..|-..--++-|+..-+.+...-+..
T Consensus       235 ----kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr  286 (341)
T KOG1163|consen  235 ----KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFR  286 (341)
T ss_pred             ----HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHh
Confidence                1111111111122334456788889999999999999999888777665443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=1.6e-26  Score=221.11  Aligned_cols=168  Identities=21%  Similarity=0.160  Sum_probs=128.3

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcC-CceeccccceeEEEEccccC-----chhHHHHHHHHHHHhcCCCCceee-
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEG-----LQGHREWLTEVNFLGQLRHPNLVK-  145 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~-  145 (431)
                      ...+..+|.+.+.||+|+||+||+|++.. ++..      +|||++....     ......+.+|+++|++++|+|++. 
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~------vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~   86 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTA------RAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQ   86 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeE------EEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcE
Confidence            34566789999999999999999998765 3333      7998865331     123456889999999999999985 


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccC-CCCCEEECCCCcE
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDF-KTSNILLDSDYTA  224 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDl-kp~NILl~~~~~~  224 (431)
                      ++++    +..|+||||++|++|.... .     ..   ...++.+++.+|.|||+.+  |+|||| ||+|||++.++.+
T Consensus        87 l~~~----~~~~LVmE~~~G~~L~~~~-~-----~~---~~~~~~~i~~aL~~lH~~g--IiHrDL~KP~NILv~~~~~i  151 (365)
T PRK09188         87 LLAT----GKDGLVRGWTEGVPLHLAR-P-----HG---DPAWFRSAHRALRDLHRAG--ITHNDLAKPQNWLMGPDGEA  151 (365)
T ss_pred             EEEc----CCcEEEEEccCCCCHHHhC-c-----cc---hHHHHHHHHHHHHHHHHCC--CeeCCCCCcceEEEcCCCCE
Confidence            4432    4679999999999997321 1     11   1356789999999999866  999999 9999999999999


Q ss_pred             EEecccCCccCCCCCCcce------eecccCCccccCcccccc
Q 014079          225 KLSDFGLAKAGPQGDETHV------STRVMGTYGYAAPEYVMT  261 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  261 (431)
                      ||+|||+++..........      .+...+++.|+|||.+..
T Consensus       152 kLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        152 AVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             EEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999987544321111      134678999999998864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-26  Score=201.63  Aligned_cols=246  Identities=23%  Similarity=0.350  Sum_probs=195.7

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +|.+.-.|..|+|++.++.        +++|+++.....  ..++|..|.-.|+-+.||||+.+++.|....++.++..|
T Consensus       197 kl~e~hsgelwrgrwqgnd--------ivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~  268 (448)
T KOG0195|consen  197 KLAESHSGELWRGRWQGND--------IVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY  268 (448)
T ss_pred             hhccCCCcccccccccCcc--------hhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence            5888889999999998763        566776654332  235688899999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH  242 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~  242 (431)
                      |+-|+|...++.....-.+..+...++.++++|++|||+..+-|.---|....++||++.+.+|.= +-+++      ..
T Consensus       269 mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kf------sf  341 (448)
T KOG0195|consen  269 MPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKF------SF  341 (448)
T ss_pred             ccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-cccee------ee
Confidence            999999999998877778888899999999999999999876555667899999999998877641 11111      11


Q ss_pred             eeecccCCccccCccccccCCCC---cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLT---ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      ........|.||+||.+...+-+   .++|+|||++++|||.|...||....+.+....+                --..
T Consensus       342 qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki----------------aleg  405 (448)
T KOG0195|consen  342 QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI----------------ALEG  405 (448)
T ss_pred             eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh----------------hhcc
Confidence            11223467889999999876543   4699999999999999999999887665433222                2234


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      ++...++..+..+.+|+.-|++.||.+||.+..|+-.|++..
T Consensus       406 lrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  406 LRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            444556667788999999999999999999999999888653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=8.9e-27  Score=236.97  Aligned_cols=261  Identities=21%  Similarity=0.256  Sum_probs=191.1

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      ....++|.|++|.|+.............. .+.+|........ ....+..|+.+-..+.|+|++..+..+.+....+-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~-~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEK-EFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhh-hhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhh
Confidence            45668999999988777654433321111 1222200111111 112266788888899999999988888877777777


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCC
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD  239 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~  239 (431)
                      ||||++ +|..++.+..  .+....+..++.|++.|+.|+|+.+  |.|||||++|+++..+|.+||+|||.+.......
T Consensus       400 mE~~~~-Dlf~~~~~~~--~~~~~e~~c~fKqL~~Gv~y~h~~G--iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSNG--KLTPLEADCFFKQLLRGVKYLHSMG--LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhcccH-HHHHHHhccc--ccchhhhhHHHHHHHHHHHHHHhcC--ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999999 9999997653  4677778889999999999999987  9999999999999999999999999997655444


Q ss_pred             Cc--ceeecccCCccccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          240 ET--HVSTRVMGTYGYAAPEYVMTGHLTAR-SDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       240 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ..  ......+|+..|+|||++.+..|++. .||||.|++++.|++|+.||......+......      .   ...+.-
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~------~---~~~~~~  545 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN------N---YSDQRN  545 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh------c---cccccc
Confidence            43  55667899999999999999999875 899999999999999999997655443321000      0   000000


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...-........+.+.+.+|.+||+.||.+|.|+.+|++.
T Consensus       546 ~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 IFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             cccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            0011112234556788899999999999999999999853

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.2e-24  Score=205.71  Aligned_cols=260  Identities=33%  Similarity=0.450  Sum_probs=196.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCC-ceeeeecEEEeCCe
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHP-NLVKLIGYCCEDDH  155 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~  155 (431)
                      |.+.+.||.|+||.||++.+.         ..+++|.+......   ....+.+|+.++..+.|+ +|+++++++.....
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~   72 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGS   72 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCE
Confidence            667788999999999999887         23888988765433   356788999999999988 79999999987777


Q ss_pred             eEEEEEecCCCChHHhhhhCCC-CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT-VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~  233 (431)
                      .+++++++.+++|.+++..... ..+.......+..|++.++.|+|..+  ++|||+||+||+++..+ .++++|||+++
T Consensus        73 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~--~~hrd~kp~nil~~~~~~~~~l~dfg~~~  150 (384)
T COG0515          73 LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG--IIHRDIKPENILLDRDGRVVKLIDFGLAK  150 (384)
T ss_pred             EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeecCCCCeEEEeccCcce
Confidence            8999999999999976654432 25788889999999999999999877  99999999999999988 79999999998


Q ss_pred             cCCCCCCcc----eeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc-cchhhhhhhhh
Q 014079          234 AGPQGDETH----VSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK-EQSLVDWARPK  305 (431)
Q Consensus       234 ~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~  305 (431)
                      .........    ......||..|++||.+.+   ..++...|+|++|++++++++|..||....... ...........
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  230 (384)
T COG0515         151 LLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILEL  230 (384)
T ss_pred             ecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhc
Confidence            544433221    2355789999999999987   578889999999999999999999976654310 00000000000


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         ...   .................+.+++..|+..+|..|.+..+....
T Consensus       231 ---~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         231 ---PTP---SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             ---CCc---ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence               000   000000000002223577899999999999999999887765

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2.9e-24  Score=191.46  Aligned_cols=174  Identities=11%  Similarity=0.115  Sum_probs=133.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHH---H------HHHHHHHHhcCCCCcee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---E------WLTEVNFLGQLRHPNLV  144 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv  144 (431)
                      +-+.++|+..++||.|+||.||++.. ++.       .+++|++.........   .      +.+|++.+.++.|++|.
T Consensus        27 ~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~-------~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~   98 (232)
T PRK10359         27 DFLSYNIKTIKVFRNIDDTKVSLIDT-DYG-------KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLA   98 (232)
T ss_pred             HHhhCceEEEEEecCCCceEEEEEec-CCC-------cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCC
Confidence            44678999999999999999999655 322       3999999754332222   2      57899999999999999


Q ss_pred             eeecEEEeC--------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCE
Q 014079          145 KLIGYCCED--------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI  216 (431)
Q Consensus       145 ~l~~~~~~~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NI  216 (431)
                      .+.+++...        ...+|||||++|.+|.++..      ++.    ....+++.+|..+|..+  ++|||+||.||
T Consensus        99 ~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~g--i~H~Dikp~Ni  166 (232)
T PRK10359         99 SLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQHG--MVSGDPHKGNF  166 (232)
T ss_pred             cceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHcC--CccCCCChHHE
Confidence            999986643        35789999999999988741      222    23558899999999877  99999999999


Q ss_pred             EECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh
Q 014079          217 LLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT  282 (431)
Q Consensus       217 Ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  282 (431)
                      +++.+| ++|+|||...........              ..++....|..++|+|+||+++..+..
T Consensus       167 li~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        167 IVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             EEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999988 999999988654221111              113455667789999999998876543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.2e-24  Score=208.88  Aligned_cols=229  Identities=30%  Similarity=0.376  Sum_probs=180.5

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh--HHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEE
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      .+|+|.||.|+++....+...   +.-+++|+.++.....  ......|..++..++ ||.+|++...++.+...+++++
T Consensus         1 vlg~g~~gkvfLvrk~~g~da---~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld   77 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADA---GHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILD   77 (612)
T ss_pred             CCCcCCCcchHHHHHhccccc---cchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhh
Confidence            379999999998865443322   2348888887654321  113445778888887 9999999999999999999999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      |..||.|...+....  .+.+.....+...++.+++++|..+  |+|||+|++||+++.+|++++.|||+++....... 
T Consensus        78 ~~rgg~lft~l~~~~--~f~~~~~~~~~aelaLald~lh~l~--iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   78 FLRGGDLFTRLSKEV--MFDELDVAFYLAELALALDHLHKLG--IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             hcccchhhhccccCC--chHHHHHHHHHHHHHHHHhhcchhH--HHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            999999998886544  3566667777888999999999877  99999999999999999999999999987443322 


Q ss_pred             ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                           .|||..|||||++.  ....++|+||||++++||++|..||...                    .+..++  ...
T Consensus       153 -----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~--------------------~~~~Il--~~~  203 (612)
T KOG0603|consen  153 -----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD--------------------TMKRIL--KAE  203 (612)
T ss_pred             -----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH--------------------HHHHHh--hhc
Confidence                 28999999999887  5677899999999999999999999651                    011111  112


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~  350 (431)
                      ...+......+.+++.+++..+|..|--.
T Consensus       204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  204 LEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence            23466777888999999999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.88  E-value=1.9e-22  Score=185.11  Aligned_cols=233  Identities=21%  Similarity=0.271  Sum_probs=148.2

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCC----------Cceee
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRH----------PNLVK  145 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~  145 (431)
                      .+.....||.|+|+.||.+.+.++++.      +|+|++....   ....+++.+|.-....+.+          -.++.
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~------~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~   86 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEE------FAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV   86 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred             EEEEccccccCCceEEEEEEEccCCce------EEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence            345567899999999999999887664      9999865432   2334556666544444322          12222


Q ss_pred             eecEEE---------eCC--------eeEEEEEecCCCChHHhhhh---CC--CCCcCHHHHHHHHHHHHHHHHHhHhCC
Q 014079          146 LIGYCC---------EDD--------HRLLVYEFMFRGSLENHLFR---KA--TVPLSWATRMMIAFGAAKGLAFLHNAE  203 (431)
Q Consensus       146 l~~~~~---------~~~--------~~~lv~e~~~~gsL~~~l~~---~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~  203 (431)
                      .++...         ...        +.+++|+-+ .++|.+++..   ..  ...+....++.+..|+++.+++||..+
T Consensus        87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G  165 (288)
T PF14531_consen   87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG  165 (288)
T ss_dssp             -SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             eeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence            223221         111        236778877 7788887542   22  224556677778899999999999977


Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcccccc--------CCCCcchhhHHHHH
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT--------GHLTARSDVYSFGV  275 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~  275 (431)
                        |||+||+|+|+|++.+|.++|+||+.......    . ......+..|.+||....        -.++.+.|.|+||+
T Consensus       166 --lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~----~-~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~  238 (288)
T PF14531_consen  166 --LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT----R-YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGI  238 (288)
T ss_dssp             --EEEST-SGGGEEE-TTS-EEE--GGGEEETTE----E-EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHH
T ss_pred             --eEecccceeeEEEcCCCCEEEcChHHHeecCc----e-eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHH
Confidence              99999999999999999999999987765321    1 111345678999997643        25788999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCC
Q 014079          276 VLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR  347 (431)
Q Consensus       276 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R  347 (431)
                      ++|.|++|..||+...+......                    .+ .... +.++.+..||..+|+.||++|
T Consensus       239 ~ly~lWC~~lPf~~~~~~~~~~~--------------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  239 TLYSLWCGRLPFGLSSPEADPEW--------------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHSS-STCCCGGGSTSGG--------------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHHHccCCCCCCCccccccc--------------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999999999986533221110                    01 1112 566888999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=3e-22  Score=176.37  Aligned_cols=139  Identities=16%  Similarity=0.151  Sum_probs=104.5

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--h------------------------HHHHHHHHHHHh
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--G------------------------HREWLTEVNFLG  136 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~  136 (431)
                      ...||+|+||.||+|.+.++ +      .||+|+++.....  .                        ......|+++|.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g-~------~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05147           2 NGCISTGKEANVYHATTANG-E------ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLK   74 (190)
T ss_pred             CCccccccceEEEEEECCCC-C------EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            45799999999999988633 2      4999998654211  0                        011235999999


Q ss_pred             cCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHh-HhCCCCeeeccCCCCC
Q 014079          137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL-HNAERPVIYRDFKTSN  215 (431)
Q Consensus       137 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivHrDlkp~N  215 (431)
                      ++.++++.....+..  ...+|||||++|++|...+...  .+++......++.|++.+|.|+ |+.+  |+||||||+|
T Consensus        75 ~l~~~~v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~g--iiHrDlkP~N  148 (190)
T cd05147          75 RLVTAGIPCPEPILL--KSHVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCR--LVHADLSEYN  148 (190)
T ss_pred             HHHHCCCCCCcEEEe--cCCEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHH
Confidence            998877644333222  2338999999888776554332  3578888999999999999999 6766  9999999999


Q ss_pred             EEECCCCcEEEecccCCccC
Q 014079          216 ILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~~~  235 (431)
                      ||++ ++.++|+|||+|...
T Consensus       149 Ili~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         149 LLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EEEE-CCcEEEEEccccccC
Confidence            9998 478999999998753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.9e-21  Score=169.81  Aligned_cols=187  Identities=19%  Similarity=0.128  Sum_probs=135.5

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch----hHHHHHHHHHHHhcCC-CCceeeeecEEEeCCee
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ----GHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  156 (431)
                      ....|++|+||+||.+...+ .       +++.+.+......    ....+.+|+++|++|. |++|++++++    +..
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~-~-------k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~   73 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGE-R-------KFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGR   73 (218)
T ss_pred             cceeecCCCcceEEEeecCC-c-------eeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCE
Confidence            45679999999999765522 2       2565555444321    1124678999999996 5889999886    346


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccC-CCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDF-KTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDl-kp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++|||+.|.+|.+.+..      .   ...++.|++.+|.++|..+  |+|||| ||+|||++.++.++|+|||++...
T Consensus        74 ~lvmeyI~G~~L~~~~~~------~---~~~~~~qi~~~L~~lH~~G--IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         74 HLDRSYLAGAAMYQRPPR------G---DLAYFRAARRLLQQLHRCG--VAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             EEEEeeecCccHHhhhhh------h---hHHHHHHHHHHHHHHHHCc--CccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence            999999999999764421      1   1346778999999999877  999999 799999999999999999999864


Q ss_pred             CCCCCc----c---e----eecccCCccccCccccccC-CCC-cchhhHHHHHHHHHHHhCCCCCCCCC
Q 014079          236 PQGDET----H---V----STRVMGTYGYAAPEYVMTG-HLT-ARSDVYSFGVVLLELLTGRKSVDKTR  291 (431)
Q Consensus       236 ~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~ell~g~~pf~~~~  291 (431)
                      ......    .   .    ......++.|+.|+...-- ..+ ...++++.|.-+|.++|++.++....
T Consensus       143 ~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        143 NPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             CCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            432210    0   0    0112367888888754322 233 56799999999999999998875543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-22  Score=207.47  Aligned_cols=246  Identities=25%  Similarity=0.315  Sum_probs=178.3

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC----chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG----LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .|...+.||.+.|=+|.+|++++|.        |+||++-+..    .....+.+.|++ ....+|||++.+..+-....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~--------vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~k   94 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL--------VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDK   94 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce--------EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhH
Confidence            5667778999999999999998874        7778765543    233344455665 55668999999998888888


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|||-+|. .-+|.|.|..+.  -+.......|+.|++.||..+|..+  |+|+|||.+||||+.=..+.|+||...+.
T Consensus        95 AAylvRqyv-khnLyDRlSTRP--FL~~iEKkWiaFQLL~al~qcH~~g--VcHGDIKsENILiTSWNW~~LtDFAsFKP  169 (1431)
T KOG1240|consen   95 AAYLVRQYV-KHNLYDRLSTRP--FLVLIEKKWIAFQLLKALSQCHKLG--VCHGDIKSENILITSWNWLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHH-hhhhhhhhccch--HHHHHHHHHHHHHHHHHHHHHHHcC--ccccccccceEEEeeechhhhhcccccCC
Confidence            889999998 668999885433  3566677788999999999999877  99999999999999988999999987654


Q ss_pred             C--CCCC---CcceeecccCCccccCccccccC----------C-CCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 014079          235 G--PQGD---ETHVSTRVMGTYGYAAPEYVMTG----------H-LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQS  297 (431)
Q Consensus       235 ~--~~~~---~~~~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  297 (431)
                      .  +...   ......+...-.+|.|||.+...          . .+++-||||+||++.||++ |+++|.-.      .
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS------Q  243 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS------Q  243 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH------H
Confidence            2  2111   11112222233469999987531          1 5778999999999999999 78888532      1


Q ss_pred             hhhhhhhhhhccc-hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          298 LVDWARPKLNDKR-KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       298 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..|....-.+.. .+.++-|            ..+++++..|++.||.+|.++++.|+.
T Consensus       244 L~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  244 LLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            2222211111111 1222222            356789999999999999999999976

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=1.6e-21  Score=202.62  Aligned_cols=249  Identities=17%  Similarity=0.167  Sum_probs=178.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC---CCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---HPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  152 (431)
                      -...|.+.+.||+|+||.||+|...++ +      .||+|+-+.......   .-=.+++.+|+   -+.|..+...+.-
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~-~------~~alK~e~P~~~WEf---YI~~q~~~RLk~~~~~~~~~~~~a~~~  765 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHSNG-K------LVALKVEKPPNPWEF---YICLQVMERLKPQMLPSIMHISSAHVF  765 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecCCC-c------EEEEEeecCCCceee---eehHHHHHhhchhhhcchHHHHHHHcc
Confidence            345688899999999999999998773 3      399999776643311   11112233333   3556666676777


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-------CCcEE
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-------DYTAK  225 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-------~~~~k  225 (431)
                      .+..+||+||.+-|||.++++..  ..+++..+..+..|++..++.||.++  |||+||||+|+||..       ...++
T Consensus       766 ~~~S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~~--IIHgDiKPDNfll~~~~~~~~~~~~l~  841 (974)
T KOG1166|consen  766 QNASVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAMG--IIHGDIKPDNFLLRREICADSDSKGLY  841 (974)
T ss_pred             CCcceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhcc--eecccCCcceeEeecccCCCCcccceE
Confidence            78889999999999999999743  35788899999999999999999988  999999999999932       35699


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||.+..+..-.........++|-.+-++|+..|..|++.+|.|.|+.+++.||.|++-=                 .
T Consensus       842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------------~  904 (974)
T KOG1166|consen  842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------------V  904 (974)
T ss_pred             EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------------h
Confidence            99999986543322233455678999999999999999999999999999999999997421                 0


Q ss_pred             hhccchhhhhcCccccCcccHHHH-HHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAA-QKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .+..   ...++..    ++.... +-..+++..+|+.|=..=|...+|...|+....
T Consensus       905 ~~g~---~~~~~~~----~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~  955 (974)
T KOG1166|consen  905 KNGS---SWMVKTN----FPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLA  955 (974)
T ss_pred             cCCc---ceecccc----chhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHH
Confidence            0000   0001111    111111 223467778888555555777788777775543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=3.5e-21  Score=170.10  Aligned_cols=140  Identities=19%  Similarity=0.142  Sum_probs=106.8

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---------------------h-----HHHHHHHHHHHh
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---------------------G-----HREWLTEVNFLG  136 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~  136 (431)
                      ...||+|+||.||+|.+.++.       .||||+++.....                     .     ...+..|.+.+.
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~-------~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   74 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGE-------ELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK   74 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCC-------EEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH
Confidence            467999999999999876332       4999998754210                     0     112357899999


Q ss_pred             cCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCC
Q 014079          137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSN  215 (431)
Q Consensus       137 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~N  215 (431)
                      ++.|++|.....+...  ..+|||||++|+++.......  ..++......++.|++.++.++|+ .+  |+||||||+|
T Consensus        75 ~l~~~~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~g--ivHrDlkP~N  148 (190)
T cd05145          75 RLYEAGVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEAG--LVHGDLSEYN  148 (190)
T ss_pred             HHHhCCCCCceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCChhh
Confidence            9999987554444333  248999999888654432222  346777888999999999999998 77  9999999999


Q ss_pred             EEECCCCcEEEecccCCccCC
Q 014079          216 ILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ||++ ++.++|+|||++....
T Consensus       149 Ill~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         149 ILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EEEE-CCCEEEEEcccceecC
Confidence            9999 7899999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.86  E-value=1.3e-21  Score=190.61  Aligned_cols=220  Identities=26%  Similarity=0.394  Sum_probs=163.4

Q ss_pred             HhcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCC
Q 014079          135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTS  214 (431)
Q Consensus       135 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~  214 (431)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ....+++.....+.++++.||.|||...- ..|+.|++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i-~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPI-GYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcc-eeeeeeccc
Confidence            4678999999999999999999999999999999999976 34568999999999999999999997552 299999999


Q ss_pred             CEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccC-------CCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          215 NILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-------HLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       215 NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      |+++|....+||.|||+.................-..-|.|||.+.+.       ..+.+.||||||++++|+++.+.||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998775431111111112234469999988763       1466799999999999999999999


Q ss_pred             CCCCCccc-chhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          288 DKTRPSKE-QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       288 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      ........ ..++.+...      .-...+.|.+...  .+..+++..++.+||..+|.+||++.+|...++.+....
T Consensus       159 ~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~~  228 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK------GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKGG  228 (484)
T ss_pred             ccccccCChHHHHHHHHh------cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcccc
Confidence            87433222 112221110      0001111111111  134457889999999999999999999998887665543

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.9e-21  Score=169.29  Aligned_cols=135  Identities=17%  Similarity=0.193  Sum_probs=104.0

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-----CCCceeeeecEEEeCC--
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-----RHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~--  154 (431)
                      ..+.||+|+||.||.  +.....       .+||++........+.+.+|+.+++.+     .||||+++++++.++.  
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~-------k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~   76 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQ-------RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGT   76 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcC-------eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCC
Confidence            456899999999995  433221       468887765444567789999999999     5799999999998874  


Q ss_pred             -e-eEEEEEe--cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHH-HHhHhCCCCeeeccCCCCCEEECC----CCcEE
Q 014079          155 -H-RLLVYEF--MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL-AFLHNAERPVIYRDFKTSNILLDS----DYTAK  225 (431)
Q Consensus       155 -~-~~lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l-~~LH~~~~~ivHrDlkp~NILl~~----~~~~k  225 (431)
                       . +.+|+||  +.+++|.+++.+.   .+++.  ..++.+++.++ +|||+++  ||||||||+|||++.    ++.++
T Consensus        77 g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~--IvhrDlKp~NILl~~~~~~~~~~~  149 (210)
T PRK10345         77 GYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNR--IVTMELKPQNILCQRISESEVIPV  149 (210)
T ss_pred             eEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCC--EeecCCCHHHEEEeccCCCCCcEE
Confidence             3 3378999  5579999999653   24444  34567778777 9999877  999999999999974    34799


Q ss_pred             EecccCC
Q 014079          226 LSDFGLA  232 (431)
Q Consensus       226 l~DFG~a  232 (431)
                      |+||+.+
T Consensus       150 LiDg~G~  156 (210)
T PRK10345        150 VCDNIGE  156 (210)
T ss_pred             EEECCCC
Confidence            9995544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.9e-21  Score=178.04  Aligned_cols=198  Identities=22%  Similarity=0.297  Sum_probs=138.9

Q ss_pred             CCCceeeeecEEEe---------------------------CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHH
Q 014079          139 RHPNLVKLIGYCCE---------------------------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG  191 (431)
Q Consensus       139 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~  191 (431)
                      +|||||++..+|.+                           ...+|+||.-+ ..+|.+++-.+.   .+......++.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~---~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH---RSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC---CchHHHHHHHHH
Confidence            59999999988743                           23568999887 679999985543   456667778889


Q ss_pred             HHHHHHHhHhCCCCeeeccCCCCCEEE--CCC--CcEEEecccCCccCCCCC----CcceeecccCCccccCccccccCC
Q 014079          192 AAKGLAFLHNAERPVIYRDFKTSNILL--DSD--YTAKLSDFGLAKAGPQGD----ETHVSTRVMGTYGYAAPEYVMTGH  263 (431)
Q Consensus       192 i~~~l~~LH~~~~~ivHrDlkp~NILl--~~~--~~~kl~DFG~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~  263 (431)
                      +++|+.|||.++  |.|||||.+||||  |++  ..+.|+|||++-.-....    .........|...-||||+....+
T Consensus       350 lLEav~hL~~hg--vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  350 LLEAVTHLHKHG--VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHcc--chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999877  9999999999999  333  357899999874321110    111112345788899999875421


Q ss_pred             -----CC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHH
Q 014079          264 -----LT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAY  337 (431)
Q Consensus       264 -----~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  337 (431)
                           .+ .|+|.|+.|.+.||++....||....... .+...+...++               ...+..++..+.+|+.
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~-L~~r~Yqe~qL---------------Palp~~vpp~~rqlV~  491 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEML-LDTRTYQESQL---------------PALPSRVPPVARQLVF  491 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhe-echhhhhhhhC---------------CCCcccCChHHHHHHH
Confidence                 12 37999999999999999999997632211 11111111111               1233455678889999


Q ss_pred             HhhhcCCCCCCCHHHHHHHHh
Q 014079          338 YCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       338 ~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ..|+.||.+|++..-....|.
T Consensus       492 ~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  492 DLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHhcCCccccCCccHHHhHHH
Confidence            999999999998765554443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.85  E-value=1.7e-21  Score=199.00  Aligned_cols=211  Identities=27%  Similarity=0.387  Sum_probs=146.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ...+|...+.|..|+||.||.++++.+..      ++|+|+ ++.+..     ++-  |+.....|.+|           
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trq------rfa~ki-Nkq~li-----lRn--ilt~a~npfvv-----------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQ------RFAMKI-NKQNLI-----LRN--ILTFAGNPFVV-----------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeecccccc------chhhcc-cccchh-----hhc--cccccCCccee-----------
Confidence            34678889999999999999998876644      488844 333211     110  33333444444           


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                                |+-..++...+..+.  .        ++.+++|||+.+  |+|||+||+|.||..-|++|+.|||+++..
T Consensus       136 ----------gDc~tllk~~g~lPv--d--------mvla~Eylh~yg--ivhrdlkpdnllIT~mGhiKlTDfgLsk~G  193 (1205)
T KOG0606|consen  136 ----------GDCATLLKNIGPLPV--D--------MVLAVEYLHSYG--IVHRDLKPDNLLITSMGHIKLTDFGLSKKG  193 (1205)
T ss_pred             ----------chhhhhcccCCCCcc--h--------hhHHhHhhccCC--eecCCCCCCcceeeecccccccchhhhhhh
Confidence                      333444433333332  2        267899999866  999999999999999999999999998753


Q ss_pred             CCCCCc-------------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          236 PQGDET-------------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       236 ~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      .....+             .....++|||.|.|||++..+.|...+|+|++|+|+||.+-|+.||.+..+......+.  
T Consensus       194 Lms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--  271 (1205)
T KOG0606|consen  194 LMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--  271 (1205)
T ss_pred             hhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--
Confidence            211111             11224699999999999999999999999999999999999999999876543221110  


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP  348 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP  348 (431)
                          .+.   .     .+. +-......++.++|.++|+.+|..|-
T Consensus       272 ----sd~---i-----~wp-E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  272 ----SDD---I-----EWP-EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             ----hhh---c-----ccc-ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence                000   0     001 11223446888999999999999995

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.84  E-value=7.4e-22  Score=188.96  Aligned_cols=175  Identities=24%  Similarity=0.358  Sum_probs=129.9

Q ss_pred             CeeEEEEEecCCCChHHhhhhC-CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..+||.|++|...+|.++|.+. .....++...+.++.|++.+++|     ++.+|+|+||.||+...+..+||.|||+.
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y-----k~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY-----KGLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh-----ccchhhhccccccccccchhhhhhhhhhe
Confidence            3578999999999999999743 33346778888999999999999     34999999999999999999999999998


Q ss_pred             ccCCCCC----CcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhh
Q 014079          233 KAGPQGD----ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       233 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      .......    .....+...||..||+||++.+..|+.++||||||++|+|++. -...|+.                  
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er------------------  465 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER------------------  465 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH------------------
Confidence            7654443    1223345679999999999999999999999999999999998 2222221                  


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV  353 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~ei  353 (431)
                       ...+..+-+..+...+..+. ++-+.|+.++|.+.|.+||++.+.
T Consensus       466 -~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  466 -IATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             -HHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHH
Confidence             11111222222221111111 234579999999999999955443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=6.1e-19  Score=158.61  Aligned_cols=134  Identities=19%  Similarity=0.252  Sum_probs=110.1

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--------hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--------GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +.||+|++|.||+|.+.+.        .+++|+.......        ....+.+|+.++..+.|++|.....++.+.+.
T Consensus         2 ~~l~~G~~~~vy~~~~~~~--------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~   73 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGI--------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPEN   73 (211)
T ss_pred             cccccCceEEEEEEeeCCC--------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCC
Confidence            4799999999999987432        3788875533211        12357789999999999998887777777888


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .++||||++|++|.+++....     . ....++.+++.+|.++|+.+  ++|+|++|.|||++ ++.++|+|||++..
T Consensus        74 ~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~--i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         74 FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAG--IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCC--cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999999885432     1 67788999999999999876  99999999999999 78999999998865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=7.7e-19  Score=156.47  Aligned_cols=130  Identities=21%  Similarity=0.281  Sum_probs=103.7

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .||+|+||.||+|.+.+.        .+++|+......        ....++.+|++++..+.|+++....-++...+..
T Consensus         1 ~ig~G~~~~vy~~~~~~~--------~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~   72 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFLGL--------KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNK   72 (199)
T ss_pred             CCCCCceEEEEEeecCCc--------cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCC
Confidence            489999999999985432        388887543221        1124567899999999988766555556667778


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ++||||++|++|.+++.....         .++.+++.+|.+||+.+  ++|+|++|.||+++ ++.++++|||++..
T Consensus        73 ~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~g--i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        73 TIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKAG--IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHCC--eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999999999998744221         67889999999999876  99999999999999 88999999999876

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=4.3e-19  Score=181.27  Aligned_cols=140  Identities=23%  Similarity=0.278  Sum_probs=111.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEc-cc----cCc---hhHHHHHHHHHHHhcCCCCceee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NK----EGL---QGHREWLTEVNFLGQLRHPNLVK  145 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~-~~----~~~---~~~~~~~~E~~~l~~l~h~niv~  145 (431)
                      ......|...+.||+|+||.||++.+....        +++|+. .+    ...   .....+.+|+++++.++|++++.
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~--------~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~  400 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGRD--------AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPT  400 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCcc--------ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCe
Confidence            334455677889999999999999876543        222221 11    111   12345789999999999999998


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      .+.++.+....++||||++|++|.+++.          ....++.+++.+|.|||+.+  |+||||||+|||+ .++.++
T Consensus       401 p~~~~~~~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~g--iiHrDlkp~NILl-~~~~~~  467 (535)
T PRK09605        401 PVIYDVDPEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAG--IVHGDLTTSNFIV-RDDRLY  467 (535)
T ss_pred             eEEEEEeCCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCC--CccCCCChHHEEE-ECCcEE
Confidence            8888777778899999999999999884          34568889999999999876  9999999999999 577999


Q ss_pred             EecccCCcc
Q 014079          226 LSDFGLAKA  234 (431)
Q Consensus       226 l~DFG~a~~  234 (431)
                      |+|||+++.
T Consensus       468 liDFGla~~  476 (535)
T PRK09605        468 LIDFGLGKY  476 (535)
T ss_pred             EEeCccccc
Confidence            999999876

>smart00090 RIO RIO-like kinase

Probab=99.79  E-value=9.2e-19  Score=159.45  Aligned_cols=142  Identities=18%  Similarity=0.143  Sum_probs=105.9

Q ss_pred             CCCccceecccCcEEEEEEE-EcCCceeccccceeEEEEccccCch------------------------hHHHHHHHHH
Q 014079           79 SFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQ------------------------GHREWLTEVN  133 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~  133 (431)
                      -|.+.+.||+|+||.||+|. +..++.      .||+|+++.....                        ....+..|+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~------~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~  102 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGK------ERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR  102 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCc------EEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence            37888999999999999998 333322      4999988653210                        0123567999


Q ss_pred             HHhcCCCCc--eeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCC-eeecc
Q 014079          134 FLGQLRHPN--LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP-VIYRD  210 (431)
Q Consensus       134 ~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~-ivHrD  210 (431)
                      ++.++.+.+  +.+++++    ...++||||+.|.+|.......  ..+.......++.|++.+|.+||+  .+ |+|||
T Consensus       103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~g~iiH~D  174 (237)
T smart00090      103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYK--EGELVHGD  174 (237)
T ss_pred             HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHh--cCCEEeCC
Confidence            999997532  3344432    2358999999998887655332  235555667889999999999997  55 99999


Q ss_pred             CCCCCEEECCCCcEEEecccCCccC
Q 014079          211 FKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       211 lkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      |||+||+++ ++.++|+|||.+...
T Consensus       175 ikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      175 LSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CChhhEEEE-CCCEEEEEChhhhcc
Confidence            999999999 889999999998753

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.76  E-value=6e-18  Score=150.60  Aligned_cols=138  Identities=17%  Similarity=0.093  Sum_probs=105.0

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch----------------------hHHHHHHHHHHHh
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ----------------------GHREWLTEVNFLG  136 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~  136 (431)
                      .|.+.+.||+|+||.||++...++.       .||||++......                      ....+..|+.++.
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~-------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   88 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGN-------PVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK   88 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCC-------EEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence            4788899999999999999875433       3899986543200                      0112567888999


Q ss_pred             cCCCCc--eeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCC
Q 014079          137 QLRHPN--LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTS  214 (431)
Q Consensus       137 ~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~  214 (431)
                      .+.|++  ++..++    ....++||||++|++|.++...        .....++.+++.++.++|..+  |+|+||||+
T Consensus        89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~g--i~H~Dl~p~  154 (198)
T cd05144          89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHG--IIHGDLSEF  154 (198)
T ss_pred             HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCC--CCcCCCCcc
Confidence            888774  444443    2456899999999999875421        233467789999999999866  999999999


Q ss_pred             CEEECCCCcEEEecccCCccCCC
Q 014079          215 NILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       215 NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ||++++++.++|+|||++.....
T Consensus       155 Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         155 NILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEcCCCcEEEEECCccccCCC
Confidence            99999999999999999966443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.73  E-value=2.9e-19  Score=182.17  Aligned_cols=256  Identities=24%  Similarity=0.286  Sum_probs=187.9

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCee
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  156 (431)
                      |.+.+-||+|+|+.|-..........     .+++|.+....  .........|..+-..+. |.|++.+++...+.+..
T Consensus        22 ~~~~~~ig~gs~~~~~~~~~~~~~~~-----~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~   96 (601)
T KOG0590|consen   22 YKLSRSIGKGSFSSSALASNSRDPES-----SSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSY   96 (601)
T ss_pred             ccccccccccccchhhhhhhcCCCcc-----eeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccc
Confidence            45556699999999988776443322     36666665443  122334445777777777 99999999999999999


Q ss_pred             EEEEEecCCCChHHhh-hhCCCCCcCHHHHHHHHHHHHHHHHHhH-hCCCCeeeccCCCCCEEECCCC-cEEEecccCCc
Q 014079          157 LLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAK  233 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l-~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~  233 (431)
                      +++++|..|+++.+.+ .... ...+....-.++.|+..++.|+| ..+  +.|+||||+|.+++..+ .+++.|||+|.
T Consensus        97 ~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~~--~~h~~ikP~n~~l~~s~~~l~~~df~~At  173 (601)
T KOG0590|consen   97 LLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPENG--VTHRDIKPSNSLLDESGSALKIADFGLAT  173 (601)
T ss_pred             ccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCcccc--cccCCCCCccchhccCCCcccCCCchhhc
Confidence            9999999999999988 3332 12344455568889999999999 655  99999999999999999 99999999998


Q ss_pred             cCCC-CCCcceeecccC-CccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          234 AGPQ-GDETHVSTRVMG-TYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       234 ~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      .... ..........+| ++.|+|||...+. ......|+||.|+++..+++|..||......... ...|....     
T Consensus       174 ~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~-----  247 (601)
T KOG0590|consen  174 AYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK-----  247 (601)
T ss_pred             cccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc-----
Confidence            8766 444444555778 9999999998884 4566799999999999999999999765443321 11111000     


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                             ................+++.+++..+|..|.+.+++...
T Consensus       248 -------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  248 -------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -------cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                   000011122334566788999999999999999888643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.70  E-value=1.5e-16  Score=134.56  Aligned_cols=134  Identities=22%  Similarity=0.160  Sum_probs=111.1

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC--CceeeeecEEEeCCeeEEE
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH--PNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  159 (431)
                      +.+.||.|.++.||++...+.        .+++|.......  ...+.+|+.+++.++|  .+++++++++...+..+++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~--------~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v   71 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDE--------DYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLL   71 (155)
T ss_pred             cceecccccccceEEEEecCC--------eEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEE
Confidence            346799999999999987552        389998866543  4567889999999976  5899999988888889999


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC-CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE-RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      |||+.++.+..+         +......++.+++.+|.+||... .+++|+||+|+|||++..+.++++|||.+..
T Consensus        72 ~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          72 MEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            999988877654         44556677889999999999743 3599999999999999989999999998865

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.9e-16  Score=144.57  Aligned_cols=135  Identities=24%  Similarity=0.210  Sum_probs=101.3

Q ss_pred             cceec-ccCcEEEEEEEEcCCceeccccceeEEEEccccCc-------------hhHHHHHHHHHHHhcCCCCce--eee
Q 014079           83 DYILG-EGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-------------QGHREWLTEVNFLGQLRHPNL--VKL  146 (431)
Q Consensus        83 ~~~lg-~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~ni--v~l  146 (431)
                      ..+|| .||.|+||.+...+.        .+++|.+...+.             .....+.+|+.++.+|.|++|  +..
T Consensus        36 ~~~lg~~~g~gtv~~v~~~~~--------~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~p  107 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTPGV--------NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRP  107 (239)
T ss_pred             CceeecCCCCccEEEEEeCCc--------eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCcee
Confidence            35687 899999999877532        277776643221             123457889999999998774  667


Q ss_pred             ecEEEeCCe----eEEEEEecCC-CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          147 IGYCCEDDH----RLLVYEFMFR-GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       147 ~~~~~~~~~----~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      +++......    .++|||+++| .+|.+++...   +++..    .+.+++.+|.+||+.+  |+||||||+|||++.+
T Consensus       108 l~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~G--I~HrDlkp~NILv~~~  178 (239)
T PRK01723        108 IAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDAG--VYHADLNAHNILLDPD  178 (239)
T ss_pred             EeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHCC--CCCCCCCchhEEEcCC
Confidence            766443322    2599999987 6899887542   34433    3568899999999877  9999999999999999


Q ss_pred             CcEEEecccCCcc
Q 014079          222 YTAKLSDFGLAKA  234 (431)
Q Consensus       222 ~~~kl~DFG~a~~  234 (431)
                      +.++|+|||.+..
T Consensus       179 ~~v~LIDfg~~~~  191 (239)
T PRK01723        179 GKFWLIDFDRGEL  191 (239)
T ss_pred             CCEEEEECCCccc
Confidence            9999999998875

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.8e-16  Score=139.77  Aligned_cols=136  Identities=21%  Similarity=0.193  Sum_probs=93.1

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHH----------------------HHHHHHHHhcC
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHRE----------------------WLTEVNFLGQL  138 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~----------------------~~~E~~~l~~l  138 (431)
                      .+.||+|+||.||+|.+.++.       .||||++......  ....                      ...|...+..+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~-------~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l   74 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGE-------PVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRL   74 (187)
T ss_pred             CcccccccceeEEEEECCCCC-------EEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHH
Confidence            457999999999999876332       4999987654211  1111                      12455566665


Q ss_pred             CCCc--eeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCC
Q 014079          139 RHPN--LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSN  215 (431)
Q Consensus       139 ~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~N  215 (431)
                      .+.+  +.+.++.    ...++||||++++++.........  .. .....++.+++.++.++|. .+  |+|+||||+|
T Consensus        75 ~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~~-~~~~~~~~~~~~~l~~lh~~~~--ivH~Dl~p~N  145 (187)
T cd05119          75 YEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--LL-EDPEELYDQILELMRKLYREAG--LVHGDLSEYN  145 (187)
T ss_pred             HHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhh--hc-ccHHHHHHHHHHHHHHHhhccC--cCcCCCChhh
Confidence            4332  3344432    246899999988544321111110  11 4566788999999999998 66  9999999999


Q ss_pred             EEECCCCcEEEecccCCccC
Q 014079          216 ILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~~~  235 (431)
                      |+++ ++.++|+|||.+...
T Consensus       146 ili~-~~~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DGKVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CCcEEEEECcccccc
Confidence            9999 899999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.62  E-value=1.1e-15  Score=149.43  Aligned_cols=251  Identities=24%  Similarity=0.262  Sum_probs=181.7

Q ss_pred             hcCCCccceecc--cCcEEEEEEEE--cCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCC-CCceeeeecE
Q 014079           77 TKSFRSDYILGE--GGFGTVYKGYI--DENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLR-HPNLVKLIGY  149 (431)
Q Consensus        77 ~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~l~~~  149 (431)
                      ...|.+.+.+|.  |.+|.||.+..  ....      ..+|+|.-+....  .....-.+|+...+.++ |+|.++.+..
T Consensus       113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~------~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~  186 (524)
T KOG0601|consen  113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESP------HKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPA  186 (524)
T ss_pred             hhhcccccccccCCCCCceeecccCCcccCC------cccccccccCCCCCccccccccchhhcccccCccccccccCcc
Confidence            356778888999  99999999877  3332      2478776433221  22233356777777775 9999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHH----HHHHhHhCCCCeeeccCCCCCEEECCC-CcE
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK----GLAFLHNAERPVIYRDFKTSNILLDSD-YTA  224 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~----~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~  224 (431)
                      +...+..++-+|++ +.+|..+...... .++....+....+...    ||.++|+..  ++|-|+||+||++..+ ...
T Consensus       187 ~e~~~~lfiqtE~~-~~sl~~~~~~~~~-~~p~~~l~~~~~~~~~~~~~al~~~hs~~--~~~~~~kp~~i~~~~~~~s~  262 (524)
T KOG0601|consen  187 WEGSGILFIQTELC-GESLQSYCHTPCN-FLPDNLLWNSLRDWLSRDVTALSHLHSNN--IVHDDLKPANIFTTSDWTSC  262 (524)
T ss_pred             cccCCcceeeeccc-cchhHHhhhcccc-cCCchhhhhHHhhhhhcccccccccCCCc--ccccccchhheeccccccee
Confidence            99999999999999 6888888866543 2566677777778888    999999866  9999999999999999 889


Q ss_pred             EEecccCCccCCCCCCcce---eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHV---STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      +++|||+...+........   .....|...|++|| +.++.++.++|||+||.++.+..++...+......      .|
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke-~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W  335 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKE-LLNGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SW  335 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecCCCCceEeChh-hhccccchHhhhcchhhhhHhhHhhcccccCCCCC------Cc
Confidence            9999999987665542221   22335777899999 55677899999999999999999987665433110      01


Q ss_pred             hhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH
Q 014079          302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE  355 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~  355 (431)
                      .        .+.+.   .+..++....+.++..++.+|++.+|..|++...+..
T Consensus       336 ~--------~~r~~---~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  336 S--------QLRQG---YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             c--------ccccc---cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0        00010   1122232233445556899999999999999887764

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=9.8e-15  Score=132.30  Aligned_cols=205  Identities=22%  Similarity=0.290  Sum_probs=141.3

Q ss_pred             HHHhcCCCCceeeeecEEEeCC-----eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCC
Q 014079          133 NFLGQLRHPNLVKLIGYCCEDD-----HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERP  205 (431)
Q Consensus       133 ~~l~~l~h~niv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~  205 (431)
                      .-|-++.|.|||+++.|+.+..     ...++.|||..|+|..+|++.  ....+......+|+.||+.||.|||+...+
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            3455667999999999987543     468999999999999999763  334567777788999999999999999999


Q ss_pred             eeeccCCCCCEEECCCCcEEEecccCCccCCCCCC--cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhC
Q 014079          206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG  283 (431)
Q Consensus       206 ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  283 (431)
                      |+|+++..+.|++..+|-+|+.----.........  ........+-++|.+||.=...+.+.++|||+||....||..+
T Consensus       199 iihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemail  278 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAIL  278 (458)
T ss_pred             cccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHh
Confidence            99999999999999998888753211111000000  0111123477899999977666778899999999999999987


Q ss_pred             CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          284 RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       284 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ..--.........        +.+-...+. .+...           .-++++..||+..|..||++.+++-|.
T Consensus       279 Eiq~tnseS~~~~--------ee~ia~~i~-~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHp  332 (458)
T KOG1266|consen  279 EIQSTNSESKVEV--------EENIANVII-GLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHP  332 (458)
T ss_pred             eeccCCCcceeeh--------hhhhhhhee-eccCc-----------cccCcCcccccCCCCCCcchhhhhcCc
Confidence            6542221111100        000000000 01111           113578899999999999999998653

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.52  E-value=7.2e-14  Score=138.45  Aligned_cols=140  Identities=19%  Similarity=0.131  Sum_probs=94.1

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH--------------------------------------
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--------------------------------------  125 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------  125 (431)
                      +.||.|++|.||+|+.+++.       .||||+.+..-....                                      
T Consensus       123 ~plasaSigQVh~A~l~~G~-------~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~  195 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGK-------EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLR  195 (437)
T ss_pred             cceeeeehhheEEEEecCCC-------EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHH
Confidence            57999999999999987664       389998754311100                                      


Q ss_pred             --HHHHHHHHHHhcC----CCCceeeeecEEE-eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHH-HHH
Q 014079          126 --REWLTEVNFLGQL----RHPNLVKLIGYCC-EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK-GLA  197 (431)
Q Consensus       126 --~~~~~E~~~l~~l----~h~niv~l~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~-~l~  197 (431)
                        -++.+|++.+.++    +|.+-+.+-.++. .....+|||||++|++|.++...... ...   ...++..++. .+.
T Consensus       196 ~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~  271 (437)
T TIGR01982       196 RELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLN  271 (437)
T ss_pred             HHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHH
Confidence              0244555555554    2322233322222 23456899999999999887643211 122   2334455554 467


Q ss_pred             HhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       198 ~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      .+|..+  ++|+|+||.||+++.++.++|+|||++....
T Consensus       272 ql~~~g--~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       272 QVLRDG--FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHhCC--ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            888766  9999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.45  E-value=1.8e-12  Score=128.34  Aligned_cols=161  Identities=20%  Similarity=0.248  Sum_probs=119.8

Q ss_pred             eeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHH
Q 014079          111 PVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF  190 (431)
Q Consensus       111 ~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~  190 (431)
                      +|.|..++...........+-++.|+.++||||+++++.++.++..|||+|-+  ..|..++.+.+     ...+..-+.
T Consensus        39 ~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~-----~~~v~~Gl~  111 (690)
T KOG1243|consen   39 PVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG-----KEEVCLGLF  111 (690)
T ss_pred             ceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH-----HHHHHHHHH
Confidence            47777776654433445667888999999999999999999999999999987  45666665433     445556788


Q ss_pred             HHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhh
Q 014079          191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDV  270 (431)
Q Consensus       191 ~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  270 (431)
                      ||+.||.|||+ ..+++|++|.-+.|+|++.|..||++|.++........  ......--..|..|+.+....  -..|.
T Consensus       112 qIl~AL~FL~~-d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~  186 (690)
T KOG1243|consen  112 QILAALSFLND-DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDS  186 (690)
T ss_pred             HHHHHHHHHhc-cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhh
Confidence            99999999985 23499999999999999999999999998765332221  011111222366666543332  34799


Q ss_pred             HHHHHHHHHHHhC
Q 014079          271 YSFGVVLLELLTG  283 (431)
Q Consensus       271 wslG~il~ell~g  283 (431)
                      |.|||++||++.|
T Consensus       187 ~~Lg~li~el~ng  199 (690)
T KOG1243|consen  187 WGLGCLIEELFNG  199 (690)
T ss_pred             hhHHHHHHHHhCc
Confidence            9999999999999

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.44  E-value=1.9e-13  Score=137.15  Aligned_cols=144  Identities=19%  Similarity=0.170  Sum_probs=89.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch----------------------------------
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ----------------------------------  123 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----------------------------------  123 (431)
                      ..|.. +.||+|++|.||+|+.+++++      .||||+.+..-..                                  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~~~G~------~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e  192 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLKDNGR------EVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAE  192 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEECCCCC------EEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHH
Confidence            34665 689999999999999987333      3999998754110                                  


Q ss_pred             hHHH------HHHHHHHHhcCC----CCceeeeecEEEe-CCeeEEEEEecCCCChHHhh--hhCCCC--CcCHHHHHHH
Q 014079          124 GHRE------WLTEVNFLGQLR----HPNLVKLIGYCCE-DDHRLLVYEFMFRGSLENHL--FRKATV--PLSWATRMMI  188 (431)
Q Consensus       124 ~~~~------~~~E~~~l~~l~----h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l--~~~~~~--~~~~~~~~~i  188 (431)
                      ..+.      +.+|+..+.++.    +.+.+.+-.++.+ ....+|||||+.|+.|.++.  ...+..  .+.......+
T Consensus       193 ~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~  272 (537)
T PRK04750        193 FEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF  272 (537)
T ss_pred             HHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH
Confidence            0111      233443333332    3333333233322 34567999999999998743  222110  1222223333


Q ss_pred             HHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cEEEecccCCccCCC
Q 014079          189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAKLSDFGLAKAGPQ  237 (431)
Q Consensus       189 ~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~kl~DFG~a~~~~~  237 (431)
                      +.|+       +..+  ++|+|+||.||+++.++    .++++|||++..+..
T Consensus       273 ~~Qi-------f~~G--ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        273 FTQV-------FRDG--FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHH-------HhCC--eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            3333       3345  99999999999999888    999999999876543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.43  E-value=5e-13  Score=115.66  Aligned_cols=129  Identities=20%  Similarity=0.091  Sum_probs=93.2

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  162 (431)
                      +.|+.|.++.||++...+.        .|++|+...... ....+..|+.+++.+.+.++ .+++.+.  ....++||||
T Consensus         4 ~~l~~G~~~~vy~~~~~~~--------~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~   72 (170)
T cd05151           4 SPLKGGMTNKNYRVEVANK--------KYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEF   72 (170)
T ss_pred             eecCCcccCceEEEEECCe--------EEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEe
Confidence            4689999999999886522        389998765431 12345679999998865554 3455443  3345899999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC---CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE---RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ++|.++.+..       ..   ...++.+++.+|+.||..+   ..++|+|++|.||+++ ++.++++|||.+..
T Consensus        73 i~G~~l~~~~-------~~---~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          73 IEGSELLTED-------FS---DPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cCCCcccccc-------cc---CHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            9998876530       11   1234568899999999865   1259999999999999 67899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=2e-13  Score=133.71  Aligned_cols=248  Identities=19%  Similarity=0.129  Sum_probs=172.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEc-CCceeccccceeEEEEccccCchhHHH--HHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGHRE--WLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~~~~~~vavK~~~~~~~~~~~~--~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      ..+|.....||.|.|+.|+....+ .+..      .|++|...+.-.....+  -+.|+-+...+ .|.+++.++..+..
T Consensus       264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~------~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~  337 (524)
T KOG0601|consen  264 LTDFGLVSKISDGNFSSVFKVSKRPEGDC------IYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ  337 (524)
T ss_pred             cCCcceeEEccCCccccceeeeecCCCCc------eEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence            346777888999999999998755 2322      37888766553332222  24566665555 48999999988888


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEecccC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGL  231 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG~  231 (431)
                      -+..|+-.|||+++++...+.-  ...+....++.+..|++.++.++|+..  ++|+|+||+||++..+ +..++.|||+
T Consensus       338 ~r~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~--~~~~d~~psni~i~~~~~~~~~~~~~~  413 (524)
T KOG0601|consen  338 LRQGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKL--FVHLDVKPSNILISNDGFFSKLGDFGC  413 (524)
T ss_pred             cccccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchh--hhcccccccceeeccchhhhhcccccc
Confidence            8888999999999998876622  234677788889999999999999876  9999999999999886 7889999998


Q ss_pred             CccCCCCCCcceeecccCCcccc--CccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYA--APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ...+....     ......-+++  +++......+..+.|+++||..+.|.+++..--.....        |.       
T Consensus       414 ~t~~~~~~-----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~-------  473 (524)
T KOG0601|consen  414 WTRLAFSS-----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SL-------  473 (524)
T ss_pred             ccccceec-----ccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ce-------
Confidence            76421111     1122333444  55555667888999999999999999998643222110        00       


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                          .+.. ......+ .....+..+.+.++..++..||.+.++..+.+..
T Consensus       474 ----~i~~-~~~p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  474 ----TIRS-GDTPNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             ----eeec-ccccCCC-chHHhhhhhhhhhcCCccccchhhhhhcccchhh
Confidence                0000 0000111 1225667788899999999999999887765543

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.38  E-value=5.5e-12  Score=110.32  Aligned_cols=142  Identities=13%  Similarity=0.086  Sum_probs=95.1

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----------------------hhHHHH----HHHHHHHhc
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----------------------QGHREW----LTEVNFLGQ  137 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----------------------~~~~~~----~~E~~~l~~  137 (431)
                      ..||.|.-+.||.|...++..-......+|+|+.+-...                      .....+    .+|++.|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            469999999999998653210001223488998642110                      001122    379999999


Q ss_pred             CC--CCceeeeecEEEeCCeeEEEEEecCCCChHH-hhhhCCCCCcCHHHHHHHHHHHHHHHHHh-HhCCCCeeeccCCC
Q 014079          138 LR--HPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN-HLFRKATVPLSWATRMMIAFGAAKGLAFL-HNAERPVIYRDFKT  213 (431)
Q Consensus       138 l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~i~~~i~~~l~~L-H~~~~~ivHrDlkp  213 (431)
                      +.  .-++...+++    ...+|||||+.+..+.. .+..   ..++......+..+++.+|..| |..+  |||+||++
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g--lVHGDLs~  153 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN--LVHADLSE  153 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC--eecCCCCH
Confidence            85  3456666654    45689999996643322 1211   1234445556778999999998 8766  99999999


Q ss_pred             CCEEECCCCcEEEecccCCccC
Q 014079          214 SNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       214 ~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .|||++ ++.+.|+|||.+...
T Consensus       154 ~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         154 YNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             HHEEEE-CCcEEEEECCCceeC
Confidence            999997 468999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.35  E-value=1e-11  Score=105.07  Aligned_cols=130  Identities=24%  Similarity=0.290  Sum_probs=96.7

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEcccc-----Cch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-----GLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-----~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .|++|+-+.+|.+.+.+.        ++++|.--..     ...   ...+..+|++++.++.--.|..-+=+..+.+..
T Consensus         3 ~i~~GAEa~i~~~~~~g~--------~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~   74 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGL--------PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNG   74 (204)
T ss_pred             hhhCCcceeEEeeeccCc--------ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            588999999999866432        2555543222     111   123467899999998755554444455677788


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .|+|||++|..|.+.+...         ...++..+-.-+.-||.++  |||+||.++||++..++ +.++|||++..
T Consensus        75 ~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~g--ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          75 LIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAG--IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcC--eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            8999999999999988654         2446667777788999877  99999999999998764 99999999875

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.35  E-value=2.3e-13  Score=140.09  Aligned_cols=248  Identities=21%  Similarity=0.210  Sum_probs=169.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.+.+.+-+-+|.|+.++.+.-......      .+.|+.....   ..+.+....+-.++-...+|.++....-+....
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~------~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rs  877 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHT------RPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRS  877 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccc------cchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCC
Confidence            3455556788899999988766554422      3333322211   111222333333444445677877776666778


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..+|+++|+.+++|...++...  +............+...++|||+..  ++|+|++|.|+|+..++..++.|||....
T Consensus       878 P~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~--r~h~~~~p~~~l~~~~gh~~l~~~~t~~~  953 (1205)
T KOG0606|consen  878 PLPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSL--RKHRDLKPDSLLIAYDGHRPLTDFGTLSK  953 (1205)
T ss_pred             CcchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccch--hhcccccccchhhcccCCcccCccccccc
Confidence            8999999999999999987655  3344444445566788999999755  89999999999999999999999984321


Q ss_pred             CCCC-----------------------------CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 014079          235 GPQG-----------------------------DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK  285 (431)
Q Consensus       235 ~~~~-----------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  285 (431)
                      ....                             +.........||+.|.+||.+.+......+|+|++|++++|.++|..
T Consensus       954 vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  954 VGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             cccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCC
Confidence            1000                             00011223579999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc-CcccHHHHHHHHHHHHHhhhcCCCCCCCHH
Q 014079          286 SVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKARPLMS  351 (431)
Q Consensus       286 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~  351 (431)
                      ||....+...-                ..++..... ...+...+.++.+++...|..+|.+|-.+.
T Consensus      1034 p~na~tpq~~f----------------~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIF----------------ENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhh----------------hccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            99876554321                111111111 122344557788899999999999998766

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5.7e-11  Score=100.04  Aligned_cols=143  Identities=21%  Similarity=0.222  Sum_probs=102.9

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEE-----ccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV-----LNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~-----~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      ...+|-+|+-+.|+++.+....        +.||-     .+.....   ...+..+|+++|.++.--.|.--.=+|.+.
T Consensus        11 ~l~likQGAEArv~~~~~~Ge~--------~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~   82 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFSGEA--------AIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDT   82 (229)
T ss_pred             cceeeeccceeeEeeeccCCce--------eEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEec
Confidence            5668999999999999887542        34443     2222221   235577899999988644444444445566


Q ss_pred             CeeEEEEEecCC-CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC---cEEEecc
Q 014079          154 DHRLLVYEFMFR-GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLSDF  229 (431)
Q Consensus       154 ~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~---~~kl~DF  229 (431)
                      ..-.|+|||++| .++.+++...............++..+-..+.-||..+  |||+||..+||+|..++   .+.|+||
T Consensus        83 ~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~nd--iiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   83 YGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDND--IIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             CCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCC--eecccccccceEEecCCCcCceEEEee
Confidence            667899999966 37888887654433344444677888889999999877  99999999999997654   4689999


Q ss_pred             cCCcc
Q 014079          230 GLAKA  234 (431)
Q Consensus       230 G~a~~  234 (431)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.26  E-value=6.4e-11  Score=107.03  Aligned_cols=141  Identities=21%  Similarity=0.224  Sum_probs=103.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCC--CceeeeecEEEeC---CeeE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRH--PNLVKLIGYCCED---DHRL  157 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~---~~~~  157 (431)
                      +.|+.|.++.||++...++       ..+++|+...... .....+..|+++++.+.+  .++.+++.+....   +..+
T Consensus         4 ~~l~~G~~n~~~~v~~~~g-------~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~   76 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGG-------RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPF   76 (223)
T ss_pred             eecCCCccceEEEEEecCC-------cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCce
Confidence            4689999999999987542       2389998765432 134567889999999975  3456677766553   2568


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-----------------------------------
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-----------------------------------  202 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-----------------------------------  202 (431)
                      +||||++|.+|.+.+..   ..++......++.+++..|.+||+.                                   
T Consensus        77 ~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  153 (223)
T cd05154          77 YVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE  153 (223)
T ss_pred             EEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence            99999999988876532   2355666666777777777777742                                   


Q ss_pred             -------------------CCCeeeccCCCCCEEECC--CCcEEEecccCCcc
Q 014079          203 -------------------ERPVIYRDFKTSNILLDS--DYTAKLSDFGLAKA  234 (431)
Q Consensus       203 -------------------~~~ivHrDlkp~NILl~~--~~~~kl~DFG~a~~  234 (431)
                                         ...++|+|+++.|||++.  ++.+.|+||+.+..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                               134799999999999998  66789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.18  E-value=8.2e-10  Score=106.58  Aligned_cols=215  Identities=17%  Similarity=0.200  Sum_probs=148.0

Q ss_pred             cEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEE----eCCeeEEEEEecCC-
Q 014079           91 FGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC----EDDHRLLVYEFMFR-  165 (431)
Q Consensus        91 ~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-  165 (431)
                      -.+.|++...-++..      |++|++..+..........-+++++++.|.|||++.++|.    .+..+++|++|+++ 
T Consensus       289 ~~Ttyk~~s~~DG~~------YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s  362 (655)
T KOG3741|consen  289 SITTYKATSNVDGNA------YVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSS  362 (655)
T ss_pred             cceeEeeeeccCCce------eeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCC
Confidence            357789887655544      8899885443333223345677899999999999999886    34567999999865 


Q ss_pred             CChHHhhhhC-------------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          166 GSLENHLFRK-------------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       166 gsL~~~l~~~-------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ++|.++-...             .+...++...|.++.|+..||.++|+.|  +.-+-|.|.+||++.+.+++|...|+.
T Consensus       363 ~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG--LAck~L~~~kIlv~G~~RIriS~C~i~  440 (655)
T KOG3741|consen  363 PTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG--LACKTLDLKKILVTGKMRIRISGCGIM  440 (655)
T ss_pred             chHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC--ceeecccHhHeEeeCcceEEEecccce
Confidence            4777765432             1234678899999999999999999987  888999999999999989999988877


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........                |-+.+.   .+-|.=.||.++..|.+|..--........              .. 
T Consensus       441 Dvl~~d~~----------------~~le~~---Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~--------------s~-  486 (655)
T KOG3741|consen  441 DVLQEDPT----------------EPLESQ---QQNDLRDLGLLLLALATGTENSNRTDSTQS--------------SH-  486 (655)
T ss_pred             eeecCCCC----------------cchhHH---hhhhHHHHHHHHHHHhhcccccccccchHH--------------HH-
Confidence            65433220                112221   256899999999999998643211110000              00 


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              ........+.++++++......++++ -++.+++.+
T Consensus       487 --------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  487 --------LTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             --------HHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                    01122345677888888888888886 466666544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.14  E-value=4.1e-09  Score=99.46  Aligned_cols=268  Identities=16%  Similarity=0.175  Sum_probs=162.3

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecE------EEeCC
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGY------CCEDD  154 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~  154 (431)
                      ..+.||+|+-+.+|-.-...+         .+.|++.........+...|   |... .||-+-.-+.+      ..+.+
T Consensus        15 ~gr~LgqGgea~ly~l~e~~d---------~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~   82 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVRD---------QVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRG   82 (637)
T ss_pred             CCccccCCccceeeecchhhc---------hhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCcc
Confidence            345699999999997543322         34577766544333332222   2222 45543321111      11222


Q ss_pred             e-eEEEEEecCCC-ChHHhhh----hCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          155 H-RLLVYEFMFRG-SLENHLF----RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       155 ~-~~lv~e~~~~g-sL~~~l~----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      . .-++|..+.|. .+.+++.    ++......|...++.+..++.+.+.||.++  -+-+|+.++|+|+++++.+.|+|
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G--h~vGDVn~~~~lVsd~~~V~LVd  160 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG--HVVGDVNQNSFLVSDDSKVVLVD  160 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC--CcccccCccceeeecCceEEEEc
Confidence            2 56888887665 2333332    122233679999999999999999999877  88899999999999999999998


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccc--hhh-
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQ--SLV-  299 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~--~~~-  299 (431)
                      =......   .........+|.+.|.+||.-.     +..-+...|.|.||+++++++.| ++||.+.......  ... 
T Consensus       161 sDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~  237 (637)
T COG4248         161 SDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLET  237 (637)
T ss_pred             ccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchh
Confidence            5543332   1222333457899999999643     33456789999999999999996 9999764321110  000 


Q ss_pred             hhhhhhhhccchhhhhcCccccCccc-HHHHHHHHHHHHHhhhcC--CCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYS-VRAAQKACSLAYYCLSQN--PKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~d--P~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                      +..........+...-..+. ....+ .-.+..+..|..+|+...  +.-|||++.++..|..+......+
T Consensus       238 ~Ia~g~f~ya~~~~~g~~p~-P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~~C  307 (637)
T COG4248         238 DIAHGRFAYASDQRRGLKPP-PRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLKKC  307 (637)
T ss_pred             hhhcceeeechhccCCCCCC-CCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhhhh
Confidence            00000000000000000000 11111 223456777888998753  458999999999998877665544

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.06  E-value=2.8e-09  Score=98.54  Aligned_cols=106  Identities=19%  Similarity=0.112  Sum_probs=79.8

Q ss_pred             HHHHHHHHHhcCCCCc--eeeeecEEEe-----CCeeEEEEEecCCC-ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHH
Q 014079          127 EWLTEVNFLGQLRHPN--LVKLIGYCCE-----DDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKGLAF  198 (431)
Q Consensus       127 ~~~~E~~~l~~l~h~n--iv~l~~~~~~-----~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  198 (431)
                      .+.+|...+.+|..-+  ++.+++++..     ....+||+|++++. +|.+++......+........++.+++..+.-
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~  153 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD  153 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            3678888888874332  3344455543     23468999999876 89998854323345566777889999999999


Q ss_pred             hHhCCCCeeeccCCCCCEEECC-------CCcEEEecccCCcc
Q 014079          199 LHNAERPVIYRDFKTSNILLDS-------DYTAKLSDFGLAKA  234 (431)
Q Consensus       199 LH~~~~~ivHrDlkp~NILl~~-------~~~~kl~DFG~a~~  234 (431)
                      ||..+  |+|+||++.|||++.       ++.+.|+||+.+..
T Consensus       154 LH~~G--i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        154 MHAAG--INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHCc--CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            99977  999999999999975       46899999998754

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.01  E-value=2.3e-09  Score=93.45  Aligned_cols=98  Identities=22%  Similarity=0.188  Sum_probs=62.3

Q ss_pred             HHHHHHHHHhcCCCC--ceeeeecEEEeCCeeEEEEEecC--CCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHH-hHh
Q 014079          127 EWLTEVNFLGQLRHP--NLVKLIGYCCEDDHRLLVYEFMF--RGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF-LHN  201 (431)
Q Consensus       127 ~~~~E~~~l~~l~h~--niv~l~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~-LH~  201 (431)
                      ...+|.+.|.++..-  ++.+++++.    ..+|||||++  |..+..+....    +.......++.+++..+.. +|.
T Consensus        54 ~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~  125 (188)
T PF01163_consen   54 WAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHK  125 (188)
T ss_dssp             HHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHh
Confidence            356899999999755  566666543    3479999997  55555433221    1122234455666664544 577


Q ss_pred             CCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       202 ~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .+  |||+||.+.|||++++ .+.|+|||.+...
T Consensus       126 ~g--ivHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  126 AG--IVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TT--EEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             cC--ceecCCChhhEEeecc-eEEEEecCcceec
Confidence            66  9999999999999987 9999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.89  E-value=1e-08  Score=92.19  Aligned_cols=134  Identities=18%  Similarity=0.085  Sum_probs=91.4

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC------------------ch----hHHHHHHHHHHHhc
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG------------------LQ----GHREWLTEVNFLGQ  137 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~------------------~~----~~~~~~~E~~~l~~  137 (431)
                      +.+...||-|.-+.||.|.+.++..       +++|.-+...                  ..    ......+|.++|.+
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~-------~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~  165 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRK-------VAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQR  165 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCE-------EEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHH
Confidence            4566789999999999999886654       7888643210                  00    12335789999999


Q ss_pred             CCCC--ceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCC
Q 014079          138 LRHP--NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSN  215 (431)
Q Consensus       138 l~h~--niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~N  215 (431)
                      |...  .|.+.+++    +...+||||++|-.|...-..    ......   ++..|++-+..+-..+  |||+|+.+-|
T Consensus       166 L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~r~~----~en~~~---il~~il~~~~~~~~~G--iVHGDlSefN  232 (304)
T COG0478         166 LYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLD----VENPDE---ILDKILEEVRKAYRRG--IVHGDLSEFN  232 (304)
T ss_pred             hhhcCCCCCCcccc----ccceeeeehcccceeecccCc----ccCHHH---HHHHHHHHHHHHHHcC--ccccCCchhe
Confidence            9754  67777765    455899999988777654321    122223   2333333333333334  9999999999


Q ss_pred             EEECCCCcEEEecccCCc
Q 014079          216 ILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~  233 (431)
                      ||++++|.+.++||--+.
T Consensus       233 IlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         233 ILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             EEEecCCCEEEEeCcccc
Confidence            999999999999996543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=4.9e-08  Score=87.22  Aligned_cols=105  Identities=24%  Similarity=0.190  Sum_probs=80.7

Q ss_pred             HHHHHHHHHHhcCCC--CceeeeecEEEeC----CeeEEEEEecCCC-ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHH
Q 014079          126 REWLTEVNFLGQLRH--PNLVKLIGYCCED----DHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKGLAF  198 (431)
Q Consensus       126 ~~~~~E~~~l~~l~h--~niv~l~~~~~~~----~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  198 (431)
                      ....+|...+..|..  =.+...+++....    ...++|+|++++. +|.+++.....  .+......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            456778888777743  2344555555543    2358999999875 89998866333  4555667788999999999


Q ss_pred             hHhCCCCeeeccCCCCCEEECCCC---cEEEecccCCcc
Q 014079          199 LHNAERPVIYRDFKTSNILLDSDY---TAKLSDFGLAKA  234 (431)
Q Consensus       199 LH~~~~~ivHrDlkp~NILl~~~~---~~kl~DFG~a~~  234 (431)
                      ||..+  |+|+|+++.|||++.++   .+.|+||+-++.
T Consensus       134 lH~~g--i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAG--IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCc--CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99977  99999999999999887   899999997765

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.82  E-value=1.6e-09  Score=108.16  Aligned_cols=149  Identities=21%  Similarity=0.295  Sum_probs=101.7

Q ss_pred             HHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCccee-------ecccCCccccCccccccCC
Q 014079          191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS-------TRVMGTYGYAAPEYVMTGH  263 (431)
Q Consensus       191 ~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~~  263 (431)
                      +++.||.|+|.. .++||++|.|++|.++.++..||+.|+.+............       .-..-...|.|||++.+..
T Consensus       107 ~v~dgl~flh~s-Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  107 NVADGLAFLHRS-AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             cccchhhhhccC-cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            445999999974 34999999999999999999999999987653331111100       0112345799999999988


Q ss_pred             CCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhc
Q 014079          264 LTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQ  342 (431)
Q Consensus       264 ~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  342 (431)
                      .+.++|+|||||++|.+..| +.-+...........              ....+.--...+....+.++++-+.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHHhcC
Confidence            89999999999999999954 444433221111110              001111111122345668889999999999


Q ss_pred             CCCCCCCHHHHH
Q 014079          343 NPKARPLMSDVV  354 (431)
Q Consensus       343 dP~~RPt~~eil  354 (431)
                      ++..||++.++.
T Consensus       252 ~~~~rp~~~~l~  263 (700)
T KOG2137|consen  252 DSAVRPTLDLLL  263 (700)
T ss_pred             CcccCcchhhhh
Confidence            999999777765

>PRK09902 hypothetical protein; Provisional

Probab=98.81  E-value=5.9e-08  Score=85.26  Aligned_cols=138  Identities=17%  Similarity=0.134  Sum_probs=98.9

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccC------chhHHHHHHHHHHHhcCCC--CceeeeecEEE-e----
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG------LQGHREWLTEVNFLGQLRH--PNLVKLIGYCC-E----  152 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~-~----  152 (431)
                      -|.||.+.|+.....+. .       +-+|.-...-      .-....|.+|+..|.+|..  -.+.+.+ ++. .    
T Consensus        26 ~~rgG~SgV~r~~~~g~-~-------~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~   96 (216)
T PRK09902         26 YRRNGMSGVQCVERNGK-K-------LYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEG   96 (216)
T ss_pred             cCCCCcceEEEEEeCCc-E-------EEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCC
Confidence            46789999998765443 2       5555543110      1245678899999998853  2244444 332 1    


Q ss_pred             CCeeEEEEEecCC-CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--EEEecc
Q 014079          153 DDHRLLVYEFMFR-GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--AKLSDF  229 (431)
Q Consensus       153 ~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--~kl~DF  229 (431)
                      .-..+||+|-+.| .+|.+++....-.+.+...+..++.+++..+.-||+.+  +.|+|+.+.|||++.++.  ++++||
T Consensus        97 ~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~G--v~Hgdly~khIll~~~g~~~v~lIDl  174 (216)
T PRK09902         97 EWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVN--RQHGCCYVRHIYVKTEGKAEAGFLDL  174 (216)
T ss_pred             ceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHhheeecCCCCeeEEEEEh
Confidence            1235799997743 48888886654445677778889999999999999977  999999999999987677  999999


Q ss_pred             cCCcc
Q 014079          230 GLAKA  234 (431)
Q Consensus       230 G~a~~  234 (431)
                      .-++.
T Consensus       175 Ek~r~  179 (216)
T PRK09902        175 EKSRR  179 (216)
T ss_pred             hccch
Confidence            87654

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.67  E-value=4e-07  Score=82.43  Aligned_cols=137  Identities=15%  Similarity=0.130  Sum_probs=83.6

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc--eeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN--LVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e  161 (431)
                      ..||+|..+.||+..   +.       .+++|+.....  ......+|.++++.+..-+  +.+.+++....+...+|||
T Consensus         7 ~~i~~G~t~~~y~~~---~~-------~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e   74 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---TG-------KWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYE   74 (226)
T ss_pred             eeecCCCCcceeEec---CC-------CEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeee
Confidence            358999999999832   11       27788876532  3345678999998886433  4677788777788889999


Q ss_pred             ecCCCC-hHHhh---------------------hhC--CCCCcCHHHHHHHHH----------HHHH-HHHHhH--hCCC
Q 014079          162 FMFRGS-LENHL---------------------FRK--ATVPLSWATRMMIAF----------GAAK-GLAFLH--NAER  204 (431)
Q Consensus       162 ~~~~gs-L~~~l---------------------~~~--~~~~~~~~~~~~i~~----------~i~~-~l~~LH--~~~~  204 (431)
                      +++|.+ +...+                     +.-  ....+.... ..+..          .+.. ...+|.  ....
T Consensus        75 ~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~-~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~  153 (226)
T TIGR02172        75 LIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYK-EKIRKFIEEKDFVPKDYKEKARAFIKEVPDTS  153 (226)
T ss_pred             ecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHH-HHHHHHHHhccCCCHHHHHHHHHHHHhCCCCC
Confidence            998863 21111                     110  011111000 00000          0001 122222  2233


Q ss_pred             CeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       205 ~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .++|+|+.|.||++++++ +.|+||+.+..
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            478999999999999888 99999997754

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.63  E-value=1.7e-07  Score=93.89  Aligned_cols=141  Identities=18%  Similarity=0.151  Sum_probs=88.3

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh---------------------------------------
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---------------------------------------  124 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~---------------------------------------  124 (431)
                      +-|+.++-|.||+|+.+++..       ||||+.+..-...                                       
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~-------VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~  203 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEE-------VAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLR  203 (517)
T ss_pred             CchhhhhHhhheeEEecCCCE-------EEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHH
Confidence            469999999999999988543       8999875421100                                       


Q ss_pred             -HHHHHHHHHHHhcCC-----CCceeeeecEE-EeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHH
Q 014079          125 -HREWLTEVNFLGQLR-----HPNLVKLIGYC-CEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA  197 (431)
Q Consensus       125 -~~~~~~E~~~l~~l~-----h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~  197 (431)
                       .-++.+|..-+.++.     .++| .+=.+| .-.....|+|||++|-.+.+...... ...+.........++.  +.
T Consensus       204 ~ElDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~  279 (517)
T COG0661         204 EELDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LR  279 (517)
T ss_pred             HHhCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HH
Confidence             011344555555442     2332 121222 22456689999999999988753322 2244333222222222  22


Q ss_pred             HhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       198 ~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      .+-..+  ++|.|..|.||+++.+|.+.+.|||+......
T Consensus       280 q~~~dg--ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         280 QLLRDG--FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHHhcC--ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            222235  99999999999999999999999999876544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.54  E-value=5.4e-09  Score=103.40  Aligned_cols=187  Identities=18%  Similarity=0.133  Sum_probs=131.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~  156 (431)
                      +.|...+-+++|+++.++|.+......       ...+++...     ....-++++|.+++||| .+..++-+..++..
T Consensus       242 kws~~fh~fvK~altknpKkRptaekl-------L~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~  309 (829)
T KOG0576|consen  242 KWSEFFHNFVKGALTKNPKKRPTAEKL-------LQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYL  309 (829)
T ss_pred             cchHHHHHHHHHHhcCCCccCCChhhh-------eeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccccc
Confidence            344455568999999999976544322       223443322     33445888999999999 78888888888889


Q ss_pred             EEEEEecCCC-ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          157 LLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       157 ~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++++++.++ +-...... ....+.......+...-.+++++||+..  =+|+|    |||..+ +..+..||+....+
T Consensus       310 ~i~~~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~--~~~~d----~~l~s~-~~~~~~~~~v~~~L  381 (829)
T KOG0576|consen  310 WIPMRICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSY--KVHRD----NILGSE-EEVKLLDFAVPPQL  381 (829)
T ss_pred             chhhhhhcCCccccccCCh-hhHhhhhhhhhhhhhhhccccccccccc--ccCcc----cccccc-cccccccccCCccc
Confidence            9999999776 22221111 1112333344445556678899999743  48998    887765 68899999988766


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      ....   ..+...+|+.|+|||+...+.+..+.|+|++|+-..+|--|-+|-
T Consensus       382 ~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  382 TRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             Cccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            5443   234577999999999999999999999999998777777776664

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.50  E-value=1.5e-06  Score=79.86  Aligned_cols=138  Identities=20%  Similarity=0.136  Sum_probs=82.4

Q ss_pred             ecccCc-EEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEEec
Q 014079           86 LGEGGF-GTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        86 lg~G~~-g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      |-.|.. ..||+....+ .       .+.+|+.....   ...+.+|+++++.+. +--+.+++++....+..++|||++
T Consensus         6 ~~~g~~~~~v~~~~~~~-~-------~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   74 (244)
T cd05150           6 VTEGQSGATVYRLDGKN-P-------GLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAV   74 (244)
T ss_pred             cCCCCCcCeEEEEcCCC-C-------cEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEee
Confidence            444544 7889986543 2       37888876543   234567888888874 344667777777666789999999


Q ss_pred             CCCChHHhh-------------------hhCC--CCCcCHH--HHHHHHH--------------------HHHHHHHHhH
Q 014079          164 FRGSLENHL-------------------FRKA--TVPLSWA--TRMMIAF--------------------GAAKGLAFLH  200 (431)
Q Consensus       164 ~~gsL~~~l-------------------~~~~--~~~~~~~--~~~~i~~--------------------~i~~~l~~LH  200 (431)
                      +|.+|....                   +...  ..++...  ..+....                    .+...+..|-
T Consensus        75 ~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  154 (244)
T cd05150          75 PGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELE  154 (244)
T ss_pred             CCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHH
Confidence            998876432                   1110  1111100  0000000                    0111122221


Q ss_pred             h-----CCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          201 N-----AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       201 ~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .     ....++|+|+.|.|||+++++.+.|+||+.+..
T Consensus       155 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         155 ATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             hhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            1     123489999999999999987788999987653

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.48  E-value=1.9e-06  Score=76.08  Aligned_cols=138  Identities=13%  Similarity=0.080  Sum_probs=87.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHH---------HHHHHHHHhcCCC---Cce
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---------WLTEVNFLGQLRH---PNL  143 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~~l~~l~h---~ni  143 (431)
                      +.++|...+++-......|.+-....+        .+++|..+.......+.         ..+++..+..+..   -.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~~~--------kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~  100 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEIDGK--------KYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEP  100 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEECCc--------EEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccc
Confidence            456788888888877777776544432        38889876654322222         2234444444432   222


Q ss_pred             eeeecEEE-----eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE
Q 014079          144 VKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL  218 (431)
Q Consensus       144 v~l~~~~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl  218 (431)
                      ..++-+..     -....+|+|||++|..|.++..      ++.    .+...+...+.-||..|  ++|+|..|.|+++
T Consensus       101 ~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G--~~HGD~hpgNFlv  168 (229)
T PF06176_consen  101 ADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHG--FYHGDPHPGNFLV  168 (229)
T ss_pred             ccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcC--CccCCCCcCcEEE
Confidence            22222221     2234579999999998877542      222    23345677899999987  9999999999999


Q ss_pred             CCCCcEEEecccCCcc
Q 014079          219 DSDYTAKLSDFGLAKA  234 (431)
Q Consensus       219 ~~~~~~kl~DFG~a~~  234 (431)
                      +.+ .++++||+..+.
T Consensus       169 ~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  169 SNN-GIRIIDTQGKRM  183 (229)
T ss_pred             ECC-cEEEEECccccc
Confidence            865 599999987653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.46  E-value=2e-06  Score=76.79  Aligned_cols=150  Identities=21%  Similarity=0.166  Sum_probs=93.1

Q ss_pred             CHHHHHHHhcCCCccce---ecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-------------------HH
Q 014079           69 SLFELETITKSFRSDYI---LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-------------------HR  126 (431)
Q Consensus        69 ~~~~~~~~~~~y~~~~~---lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------------------~~  126 (431)
                      +...+..+..+..+...   |..|.-+.||+|...++.       .+|+|+++......                   .+
T Consensus        36 t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~-------~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          36 TLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGR-------YVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             HHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCc-------eEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            34445555666666554   556777889998764433       38999876432211                   11


Q ss_pred             H-----HHHHHHHHhcCC--CCceeeeecEEEeCCeeEEEEEecCCCCh-HHhhhhCCCCCcCHHHHHHHHHHHHHHHHH
Q 014079          127 E-----WLTEVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKATVPLSWATRMMIAFGAAKGLAF  198 (431)
Q Consensus       127 ~-----~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~  198 (431)
                      +     ..+|..-|+++.  +-.+.+-+++.    .-.|||||+....+ .=.|.   ..++.......+..++++.+.-
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~  181 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRR  181 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHH
Confidence            1     245777777774  33444445443    34799999843311 11111   1122222444566677777777


Q ss_pred             hHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          199 LHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       199 LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      |-. .+  +||+||..-|||+. ++.+.|+|||-|...
T Consensus       182 l~~~a~--LVHgDLSEyNiL~~-~~~p~iID~~QaV~~  216 (268)
T COG1718         182 LYKEAG--LVHGDLSEYNILVH-DGEPYIIDVSQAVTI  216 (268)
T ss_pred             HHHhcC--cccccchhhheEEE-CCeEEEEECcccccc
Confidence            765 55  99999999999999 889999999987653

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.44  E-value=1.3e-06  Score=79.42  Aligned_cols=140  Identities=20%  Similarity=0.187  Sum_probs=81.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC--ceeeeecEEE---eCCeeEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--NLVKLIGYCC---EDDHRLL  158 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~---~~~~~~l  158 (431)
                      +.|+.|..+.||+....++        .+++|+....  .....+.+|..+++.+...  .+.+++.+..   .....++
T Consensus         3 ~~l~~G~~n~~~~v~~~~~--------~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~   72 (239)
T PF01636_consen    3 RPLSGGFSNRVYRVTTDDG--------RYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYL   72 (239)
T ss_dssp             EEEEESSSSEEEEEEETTS--------EEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEE
T ss_pred             ccCCCCCeeeEEEEEECCc--------EEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceE
Confidence            4689999999999988763        2899987655  3455677888888888533  3556665432   2345689


Q ss_pred             EEEecCCCChHH----------------hh---hhC--CCCCcCHHHH---------HHH------------HHHHHH-H
Q 014079          159 VYEFMFRGSLEN----------------HL---FRK--ATVPLSWATR---------MMI------------AFGAAK-G  195 (431)
Q Consensus       159 v~e~~~~gsL~~----------------~l---~~~--~~~~~~~~~~---------~~i------------~~~i~~-~  195 (431)
                      +|++++|..+..                .+   +..  ...+......         ...            ...+.. .
T Consensus        73 ~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (239)
T PF01636_consen   73 LMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERL  152 (239)
T ss_dssp             EEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHH
T ss_pred             EEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHH
Confidence            999999988877                11   111  1111111100         000            011122 2


Q ss_pred             HHHhHh-----CCCCeeeccCCCCCEEEC-CCCcEEEecccCCc
Q 014079          196 LAFLHN-----AERPVIYRDFKTSNILLD-SDYTAKLSDFGLAK  233 (431)
Q Consensus       196 l~~LH~-----~~~~ivHrDlkp~NILl~-~~~~~kl~DFG~a~  233 (431)
                      +..++.     ....++|+|+.|.|||++ +++.+.|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  153 LQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            333332     234499999999999999 66667899998764

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.32  E-value=9.4e-06  Score=71.46  Aligned_cols=128  Identities=20%  Similarity=0.253  Sum_probs=88.6

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccC----------------chhHHHHHHHHHHHhcCC------C
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG----------------LQGHREWLTEVNFLGQLR------H  140 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h  140 (431)
                      ...||+|+.-.||.--+..+         ..||+.....                ....++..+|+.....+.      +
T Consensus         6 ~~~i~~G~~R~cy~HP~dp~---------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~   76 (199)
T PF10707_consen    6 SDLIAQGGERDCYQHPDDPN---------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDW   76 (199)
T ss_pred             CcccccCCCceEEECCCCCC---------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcc
Confidence            34799999999997333222         6788877665                122455666776666665      7


Q ss_pred             CceeeeecEEEeCCeeEEEEEecCC------CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCC
Q 014079          141 PNLVKLIGYCCEDDHRLLVYEFMFR------GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTS  214 (431)
Q Consensus       141 ~niv~l~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~  214 (431)
                      .+|.+++|+.+++.-.-+|+|.+.+      .||.+++....   ++. .....+.   +-..||-.+.  |+.+||+|.
T Consensus        77 ~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~---~~~-~~~~~L~---~f~~~l~~~~--Iv~~dl~~~  147 (199)
T PF10707_consen   77 SHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG---LTE-ELRQALD---EFKRYLLDHH--IVIRDLNPH  147 (199)
T ss_pred             cccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC---ccH-HHHHHHH---HHHHHHHHcC--CeecCCCcc
Confidence            8999999999999999999998732      27888884432   444 3333333   3355666555  999999999


Q ss_pred             CEEECCC---C-cEEEec
Q 014079          215 NILLDSD---Y-TAKLSD  228 (431)
Q Consensus       215 NILl~~~---~-~~kl~D  228 (431)
                      ||++..+   . .+.|+|
T Consensus       148 NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  148 NIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             cEEEEecCCCceEEEEEe
Confidence            9999543   2 578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.26  E-value=7.1e-06  Score=69.42  Aligned_cols=128  Identities=18%  Similarity=0.194  Sum_probs=87.8

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCcee-eeecEEEeCCeeEEE
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV-KLIGYCCEDDHRLLV  159 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv  159 (431)
                      +..+.|++|++|.||++.+...        .+|+|+-+.+.  ....+..|+++|..+...++- ++|.|..    -++.
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~~~--------~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~   90 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWRGG--------EVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIR   90 (201)
T ss_pred             hhhhhhhcccccEEEEeeccCc--------eEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEech----hhhh
Confidence            3456799999999999998765        38999877663  456788999999999866553 3444432    2455


Q ss_pred             EEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCC--CCEEECCCCcEEEecccCCcc
Q 014079          160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT--SNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp--~NILl~~~~~~kl~DFG~a~~  234 (431)
                      |||+.|-.|.+.....     +-.+    ...+++.-.-|-..+  |-|..|.-  .||+++. +.+.|+||.-|+.
T Consensus        91 me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~G--I~H~El~~~~k~vlv~~-~~~~iIDFd~At~  155 (201)
T COG2112          91 MEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRLG--IEHGELSRPWKNVLVND-RDVYIIDFDSATF  155 (201)
T ss_pred             hhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHhc--cchhhhcCCceeEEecC-CcEEEEEccchhh
Confidence            9999888888765321     1222    223444444444445  88998864  4566654 4999999998874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.22  E-value=3.5e-05  Score=67.48  Aligned_cols=101  Identities=24%  Similarity=0.236  Sum_probs=78.2

Q ss_pred             HHHHHHhcCCC-CceeeeecEEEeCCeeEEEEEecCCCChHHhhhh-CCCCCcCHHHHHHHHHHHHHHHHHhHhCCC-Ce
Q 014079          130 TEVNFLGQLRH-PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAER-PV  206 (431)
Q Consensus       130 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~i  206 (431)
                      .|.-+|+.+++ +++++++|+|..    ++|.||...+++...... ..-...+|..+..++.++++.+.+|+..-. .+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            57888888876 699999999943    679999977766432100 011235899999999999999999986321 27


Q ss_pred             eeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          207 IYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       207 vHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .-.|++++|+-+++++++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            7799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PLN02876 acyl-CoA dehydrogenase

Probab=98.21  E-value=1.9e-05  Score=85.12  Aligned_cols=82  Identities=13%  Similarity=0.161  Sum_probs=56.7

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCC-CCce--eeeecEEEeC---Ce
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLR-HPNL--VKLIGYCCED---DH  155 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~  155 (431)
                      .+.|+.|.+..+|+.....+..    ...+++|+..... ......+.+|+++|+.+. |.+|  .+++.++.+.   +.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~----~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~  118 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGS----VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGT  118 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCc----ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCC
Confidence            4568999999999987654321    0136777654432 223456789999999995 6664  7778877664   46


Q ss_pred             eEEEEEecCCCCh
Q 014079          156 RLLVYEFMFRGSL  168 (431)
Q Consensus       156 ~~lv~e~~~~gsL  168 (431)
                      .|+||||++|..+
T Consensus       119 ~flVME~v~G~~~  131 (822)
T PLN02876        119 AFYIMEYLEGRIF  131 (822)
T ss_pred             ceEEEEecCCccc
Confidence            7899999987653

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.15  E-value=1.5e-05  Score=72.68  Aligned_cols=73  Identities=14%  Similarity=0.161  Sum_probs=44.7

Q ss_pred             ceecccCcE-EEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC---ceeeeecEEEeC---Cee
Q 014079           84 YILGEGGFG-TVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP---NLVKLIGYCCED---DHR  156 (431)
Q Consensus        84 ~~lg~G~~g-~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~  156 (431)
                      +.|+.|+.. .||+..  +         .+++|+.....  ....+.+|.++|..+...   -+.++++.....   ...
T Consensus         3 ~~~~~gG~~n~vy~~~--~---------~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~   69 (235)
T cd05155           3 EPVDSGGTDNATFRLG--D---------DMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWP   69 (235)
T ss_pred             eeccCCCcccceEEcC--C---------ceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcc
Confidence            357777766 588752  1         27778765432  234677899998877531   234444433322   235


Q ss_pred             EEEEEecCCCChH
Q 014079          157 LLVYEFMFRGSLE  169 (431)
Q Consensus       157 ~lv~e~~~~gsL~  169 (431)
                      +++|++++|.++.
T Consensus        70 ~~l~~~i~G~~l~   82 (235)
T cd05155          70 WSVYRWLEGETAT   82 (235)
T ss_pred             eEEEEeecCCCCC
Confidence            8899999987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=2.4e-05  Score=78.38  Aligned_cols=138  Identities=17%  Similarity=0.126  Sum_probs=84.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch----h---------------------------------HH
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ----G---------------------------------HR  126 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~----~---------------------------------~~  126 (431)
                      +.||.-+.|.||+|+.+++..       ||||+-+..-..    +                                 .-
T Consensus       167 ~piaaASlaQVhrA~L~~G~~-------VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~EL  239 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKNGED-------VAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQEL  239 (538)
T ss_pred             chhhhcchhheEEEEecCCCE-------EEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhc
Confidence            469999999999999998654       888886432100    0                                 01


Q ss_pred             HHHHHHHHHhcC----CCCc------eeeeecEEEeCCeeEEEEEecCCCChHHhh--hhCCCCCcCHHHHHHHHHHHHH
Q 014079          127 EWLTEVNFLGQL----RHPN------LVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAK  194 (431)
Q Consensus       127 ~~~~E~~~l~~l----~h~n------iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l--~~~~~~~~~~~~~~~i~~~i~~  194 (431)
                      +|.+|++-..++    .|-+      |.++|-.+  .....|+||||+|..+.|.-  .+.+   ++...+...+.++..
T Consensus       240 DF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~g---i~~~~i~~~l~~~~~  314 (538)
T KOG1235|consen  240 DFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRG---ISPHDILNKLVEAYL  314 (538)
T ss_pred             chHHHHHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcC---CCHHHHHHHHHHHHH
Confidence            134444443333    3444      33443332  34568999999999776653  3333   333333333222221


Q ss_pred             HHHHhHhCCCCeeeccCCCCCEEECC----CCcEEEecccCCccCCC
Q 014079          195 GLAFLHNAERPVIYRDFKTSNILLDS----DYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       195 ~l~~LH~~~~~ivHrDlkp~NILl~~----~~~~kl~DFG~a~~~~~  237 (431)
                      -+-+ + .|  ++|+|=.|.||++..    ++.+.+.|||+......
T Consensus       315 ~qIf-~-~G--ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  315 EQIF-K-TG--FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             HHHH-h-cC--CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            1112 2 25  999999999999984    67899999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.00  E-value=2.3e-05  Score=83.33  Aligned_cols=196  Identities=19%  Similarity=0.231  Sum_probs=136.0

Q ss_pred             HHHHHHHHhcCCCCceeeeecEEEeCCee----EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC
Q 014079          128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE  203 (431)
Q Consensus       128 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~----~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~  203 (431)
                      ..-|+..+.++.|+|++.++.|..+....    .+..+++..-++...+....  ..+....+.+..++.+||.|+|++.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~--~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVG--SIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhcc--ccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            34577778888999999999987655332    24456777888888776554  4677777788889999999999875


Q ss_pred             CCeeeccCCCC---CEEECCCCcEEEe--cccCCccCCCCCCcceeecccCCccccCccccccCCCCcc--hhhHHHHHH
Q 014079          204 RPVIYRDFKTS---NILLDSDYTAKLS--DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTAR--SDVYSFGVV  276 (431)
Q Consensus       204 ~~ivHrDlkp~---NILl~~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~i  276 (431)
                        +.|.-|...   +..++..+...+.  ||+.++.+.......   ...-+..|.++|......+..+  .|+|.+|..
T Consensus       307 --l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  307 --LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             --cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHHHH
Confidence              566555544   4445566777777  999887765543322   1234556888887776666554  799999999


Q ss_pred             HHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          277 LLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       277 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..+..|..+-....                   ....+++.        .......+...+|+..++++|+++.+++.+
T Consensus       382 ~~~~~~~~~i~~~~~-------------------~~~~~l~~--------~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSA-------------------VPVSLLDV--------LSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCccccccc-------------------chhhhhcc--------ccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            999999865432210                   01111111        011145678889999999999999999976


Q ss_pred             H
Q 014079          357 L  357 (431)
Q Consensus       357 L  357 (431)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            5

>PRK10593 hypothetical protein; Provisional

Probab=98.00  E-value=0.00012  Score=69.23  Aligned_cols=77  Identities=12%  Similarity=0.020  Sum_probs=54.7

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC---CceeeeecEEEe---CCe
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH---PNLVKLIGYCCE---DDH  155 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~  155 (431)
                      ..+.||.|..+.||.....++.        +.+|+.+..  .....+..|...|+.|.-   -.+.++++++..   .+.
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~~~--------~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQGN--------PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             eeeecCCccceeEEEEEcCCCC--------EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            3456999999999998655442        667774331  123467789999988853   357788877654   366


Q ss_pred             eEEEEEecCCCCh
Q 014079          156 RLLVYEFMFRGSL  168 (431)
Q Consensus       156 ~~lv~e~~~~gsL  168 (431)
                      .+||||+++|.++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998765

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.99  E-value=6.3e-05  Score=65.77  Aligned_cols=125  Identities=27%  Similarity=0.335  Sum_probs=86.8

Q ss_pred             cCCCccceecccCc-EEEEEEEEcCCceeccccceeEEEEccc---cCc------------------hhHHHHHHHHHHH
Q 014079           78 KSFRSDYILGEGGF-GTVYKGYIDENVRVGLKSLPVAVKVLNK---EGL------------------QGHREWLTEVNFL  135 (431)
Q Consensus        78 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l  135 (431)
                      ..++..+.||.|.- |.||++...+.        .||+|++..   ...                  .....|..|.+..
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~g~--------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAf  108 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEIDGR--------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAF  108 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEECCe--------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhh
Confidence            67788899999999 99999987654        399999321   100                  0112477888887


Q ss_pred             hcCC---CCce--eeeecEEEeC------------------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHH
Q 014079          136 GQLR---HPNL--VKLIGYCCED------------------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA  192 (431)
Q Consensus       136 ~~l~---h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i  192 (431)
                      .+|+   +.++  |+++||..-.                  ....||.||++...           .+.    ..-+.++
T Consensus       109 gRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~----~~~~~~~  173 (207)
T PF13095_consen  109 GRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQ----IRDIPQM  173 (207)
T ss_pred             HHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccc----hhHHHHH
Confidence            7775   4456  9999987432                  11257778764432           112    2234567


Q ss_pred             HHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       193 ~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+-|..+|..+  |+-+|+++.|..     .-+|+|||.+
T Consensus       174 ~~dl~~~~k~g--I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  174 LRDLKILHKLG--IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHHHHHHCC--eeeccCcccccc-----CCEEEecccC
Confidence            77888999877  999999999986     4589999864

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.97  E-value=4.6e-05  Score=72.10  Aligned_cols=141  Identities=21%  Similarity=0.155  Sum_probs=81.4

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC--ceeeeec------EEEeCC
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--NLVKLIG------YCCEDD  154 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~------~~~~~~  154 (431)
                      .+.|..|....+|+....++        .+++|+....   ....+..|+.++..+.+.  .+.+++.      +....+
T Consensus        19 i~~i~~G~~n~~y~v~~~~~--------~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~   87 (296)
T cd05153          19 FEGISAGIENTNYFVTTDSG--------RYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAG   87 (296)
T ss_pred             eecccCccccceEEEEeCCC--------cEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCC
Confidence            34577787789998765433        2888887642   234556677777777432  2444433      123345


Q ss_pred             eeEEEEEecCCCChHH----hh----------hhC--C-C------CCcCHHHHH----------HHHHHHHHHHHHhHh
Q 014079          155 HRLLVYEFMFRGSLEN----HL----------FRK--A-T------VPLSWATRM----------MIAFGAAKGLAFLHN  201 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~----~l----------~~~--~-~------~~~~~~~~~----------~i~~~i~~~l~~LH~  201 (431)
                      ..++|++|++|..+..    ..          +..  . .      ....|....          .....+...+.++..
T Consensus        88 ~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  167 (296)
T cd05153          88 KPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDA  167 (296)
T ss_pred             ceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHh
Confidence            6789999998876532    00          100  0 0      001111110          001112233444432


Q ss_pred             -----CCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          202 -----AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       202 -----~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                           ....++|+|+.|.|||++.++.+.|+||+.+..
T Consensus       168 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         168 FDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             hhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence                 224599999999999999887778999987654

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.91  E-value=0.00011  Score=66.97  Aligned_cols=74  Identities=22%  Similarity=0.129  Sum_probs=45.6

Q ss_pred             ceecccCcEEEEEEEEcC--CceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDE--NVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~--~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  160 (431)
                      +.|..|-...+|+....+  ..       .|++|+....... ..+..+|+.+++.+...+ .+++++.+.    -.+||
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~-------~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~   71 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQD-------AVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIY   71 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCC-------eEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEE
Confidence            457788888999987553  22       3788876543211 122346888888885333 344444332    24899


Q ss_pred             EecCCCChH
Q 014079          161 EFMFRGSLE  169 (431)
Q Consensus       161 e~~~~gsL~  169 (431)
                      ||++|.++.
T Consensus        72 e~i~G~~l~   80 (235)
T cd05157          72 EFIPGRTLE   80 (235)
T ss_pred             EeeCCCcCC
Confidence            999987763

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.91  E-value=7e-05  Score=69.29  Aligned_cols=136  Identities=16%  Similarity=0.097  Sum_probs=74.5

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEEecC
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYEFMF  164 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~  164 (431)
                      +..|-.+.+|+....+ .       .+++|+.........-+..+|..+++.+...++ .+++...  .  -++||||++
T Consensus         4 ~~~G~tn~~y~~~~~~-~-------~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~   71 (256)
T TIGR02721         4 LSGGLTNRSWRIEHPG-I-------SFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLE   71 (256)
T ss_pred             CCCcCcCCeEEEEeCC-c-------cEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEecc
Confidence            5567778899876322 1       378887654322111134578888888864333 3344332  2  368999998


Q ss_pred             CCChHHh-----------------hhhCC--CCCcCHHHH-HHHHHHH---------HHHHHHhHhC------CCCeeec
Q 014079          165 RGSLENH-----------------LFRKA--TVPLSWATR-MMIAFGA---------AKGLAFLHNA------ERPVIYR  209 (431)
Q Consensus       165 ~gsL~~~-----------------l~~~~--~~~~~~~~~-~~i~~~i---------~~~l~~LH~~------~~~ivHr  209 (431)
                      |.++...                 ++...  ..++..... ..+..++         ...+..+-..      ...++|+
T Consensus        72 G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~  151 (256)
T TIGR02721        72 GEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHM  151 (256)
T ss_pred             CcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecC
Confidence            8765421                 11111  111221111 1111111         1112222111      1248999


Q ss_pred             cCCCCCEEECCCCcEEEecccCCcc
Q 014079          210 DFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       210 Dlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      |+.|.||++++++ +.|+||..+..
T Consensus       152 Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       152 DVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCcCcEEEeCCC-CEEEeccccCc
Confidence            9999999999876 78999998764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.81  E-value=0.00028  Score=67.14  Aligned_cols=154  Identities=18%  Similarity=0.147  Sum_probs=84.4

Q ss_pred             HHHHHHhcCCCc-----cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC--ce
Q 014079           71 FELETITKSFRS-----DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--NL  143 (431)
Q Consensus        71 ~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--ni  143 (431)
                      ..+..+-..|.+     .+.++.|....+|+....++        .+++|+.....  ....+..|++++..|...  .+
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~--------~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pv   79 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG--------RYILTLYEKRV--KAEELPFFLALTTHLAARGLPV   79 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC--------cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCC
Confidence            344444445544     34567777788998765433        27788765431  123445667777666422  23


Q ss_pred             eeeecE------EEeCCeeEEEEEecCCCChHH-----------h---hhhC-CCC--C-------cCHHHHHH------
Q 014079          144 VKLIGY------CCEDDHRLLVYEFMFRGSLEN-----------H---LFRK-ATV--P-------LSWATRMM------  187 (431)
Q Consensus       144 v~l~~~------~~~~~~~~lv~e~~~~gsL~~-----------~---l~~~-~~~--~-------~~~~~~~~------  187 (431)
                      .+++..      ....+..+++++|++|..+..           .   ++.. ...  +       ..|.....      
T Consensus        80 p~~i~t~~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~  159 (307)
T TIGR00938        80 PKPVKSRDGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAA  159 (307)
T ss_pred             CccccCCCCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcc
Confidence            344331      122456789999998865421           0   1110 000  0       01111000      


Q ss_pred             ------HHHHHHHHHHHhHh-----CCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          188 ------IAFGAAKGLAFLHN-----AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       188 ------i~~~i~~~l~~LH~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                            ....+...++++..     ...+++|+|+.+.||+++.++...|+||+.+..
T Consensus       160 ~~l~~~~~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       160 PQLEAHMGAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cccCHHHHHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence                  01112334555532     235699999999999999887778999997653

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.79  E-value=0.00037  Score=68.11  Aligned_cols=76  Identities=18%  Similarity=0.130  Sum_probs=51.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccc------cC-chhHHHHHHHHHHHhcCC---CCceeeeecEEEeC
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK------EG-LQGHREWLTEVNFLGQLR---HPNLVKLIGYCCED  153 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  153 (431)
                      +.||.|.+..||++...++.+      .++||....      .. .....++..|.+.|+.+.   ..++++++.+  +.
T Consensus        32 ~elggGn~N~VyrV~~~~g~~------svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~  103 (401)
T PRK09550         32 REIGDGNLNLVFRVSDTEGGK------SVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DE  103 (401)
T ss_pred             eEcCCCceEEEEEEEeCCCCe------EEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CC
Confidence            468999999999999876532      277886431      11 123455667888888763   3457777766  44


Q ss_pred             CeeEEEEEecCCCC
Q 014079          154 DHRLLVYEFMFRGS  167 (431)
Q Consensus       154 ~~~~lv~e~~~~gs  167 (431)
                      +..++||||+++..
T Consensus       104 ~~~~lVME~L~~~~  117 (401)
T PRK09550        104 ELAVTVMEDLSDHK  117 (401)
T ss_pred             CCCEEEEecCCCcc
Confidence            66789999997654

>PRK05231 homoserine kinase; Provisional

Probab=97.74  E-value=0.0009  Score=64.03  Aligned_cols=31  Identities=32%  Similarity=0.412  Sum_probs=26.3

Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .++||+|+.|.|||++.+...-|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            4699999999999999765568999998754

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.61  E-value=0.00041  Score=65.84  Aligned_cols=80  Identities=19%  Similarity=0.152  Sum_probs=46.2

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .|..|-...||+....++......+..+++|+..... ....+..+|.+++..+...+ ..++++++. +   .+|+||+
T Consensus         5 ~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i   79 (302)
T cd05156           5 KISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFI   79 (302)
T ss_pred             EecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cchhhee
Confidence            4566666789988754321000111248888876542 22234567888888875332 334555443 2   3689999


Q ss_pred             CCCChH
Q 014079          164 FRGSLE  169 (431)
Q Consensus       164 ~~gsL~  169 (431)
                      +|.++.
T Consensus        80 ~G~~l~   85 (302)
T cd05156          80 PSRTLT   85 (302)
T ss_pred             CCCcCC
Confidence            888764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.50  E-value=2.3e-05  Score=85.22  Aligned_cols=174  Identities=13%  Similarity=0.036  Sum_probs=119.6

Q ss_pred             eEEEEccccCchhHHH-----HHHHHHHHhcCCCCceeeeecEEEe--CCeeEEEEEecCCCChHHhhhhCC--CCCcCH
Q 014079          112 VAVKVLNKEGLQGHRE-----WLTEVNFLGQLRHPNLVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFRKA--TVPLSW  182 (431)
Q Consensus       112 vavK~~~~~~~~~~~~-----~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~  182 (431)
                      +.+|+.+.-..+...+     .+.|...++...|+++...+.-...  ....|.+++|+.+|.+.+.|.+..  ..++..
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence            4566655443333222     3445555666789998877655443  345589999999999999986632  223333


Q ss_pred             HHHHHHHHHHHHHHHHhHh---CCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcccc
Q 014079          183 ATRMMIAFGAAKGLAFLHN---AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV  259 (431)
Q Consensus       183 ~~~~~i~~~i~~~l~~LH~---~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~  259 (431)
                      .-+.....+.+....-+|+   .+...+|++||+-|.+|..+..++++++|+.+.....  ........+++.|+.+++.
T Consensus      1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~qli~ 1412 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQLIK 1412 (2724)
T ss_pred             chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHHHH
Confidence            3333333333555555554   2344799999999999999999999999999832211  1122335688899999988


Q ss_pred             ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          260 MTGHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       260 ~~~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      ..-.++.++|+|..|+.+|+..-|..+|
T Consensus      1413 N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1413 NEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            8888998999999999999998887766

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.48  E-value=9e-05  Score=68.74  Aligned_cols=144  Identities=18%  Similarity=0.129  Sum_probs=93.7

Q ss_pred             cCHHHHHHHhcC---CCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--------------------Cchh
Q 014079           68 FSLFELETITKS---FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--------------------GLQG  124 (431)
Q Consensus        68 ~~~~~~~~~~~~---y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--------------------~~~~  124 (431)
                      +.+.-+.++.++   +.+.+.||-|.-+-||.+.+.++..       .++|+-+..                    .+..
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~-------~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWly  151 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNP-------LILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLY  151 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCc-------hhHHHHhhhhhhHHHhhhhhhhHhcCCccchhh
Confidence            344445555543   5677889999999999999887654       555542210                    0111


Q ss_pred             H--HHHHHHHHHHhcCC-C-CceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhH
Q 014079          125 H--REWLTEVNFLGQLR-H-PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH  200 (431)
Q Consensus       125 ~--~~~~~E~~~l~~l~-h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH  200 (431)
                      .  -...+|...|+.|. | --|.+.+++    +..++|||++.|..|...-+-.     ....+..   .+..-+--|-
T Consensus       152 LSRlaa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d~~~ly~---~lm~~Iv~la  219 (465)
T KOG2268|consen  152 LSRLAATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----DPPTLYD---DLMGLIVRLA  219 (465)
T ss_pred             hHHHHHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeeecC-----ChHHHHH---HHHHHHHHHH
Confidence            1  22457888888885 2 234555554    3568999999998887654222     2222222   2333344555


Q ss_pred             hCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       201 ~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+|  +||+|..--||+|++++.++++||--.
T Consensus       220 ~~G--lIHgDFNEFNimv~dd~~i~vIDFPQm  249 (465)
T KOG2268|consen  220 NHG--LIHGDFNEFNIMVKDDDKIVVIDFPQM  249 (465)
T ss_pred             HcC--ceecccchheeEEecCCCEEEeechHh
Confidence            445  999999999999999999999999644

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.38  E-value=0.0025  Score=59.50  Aligned_cols=30  Identities=30%  Similarity=0.431  Sum_probs=25.3

Q ss_pred             CeeeccCCCCCEEECCCCc-EEEecccCCcc
Q 014079          205 PVIYRDFKTSNILLDSDYT-AKLSDFGLAKA  234 (431)
Q Consensus       205 ~ivHrDlkp~NILl~~~~~-~kl~DFG~a~~  234 (431)
                      .++|+|++|.|||++.++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            3899999999999997555 46999998765

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.08  E-value=0.0073  Score=57.09  Aligned_cols=31  Identities=23%  Similarity=0.508  Sum_probs=28.2

Q ss_pred             CeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       205 ~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++|+|+.+.||+|+.++-+=|+||+++...
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            4899999999999999888999999998764

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.01  E-value=0.005  Score=59.06  Aligned_cols=80  Identities=19%  Similarity=0.179  Sum_probs=48.0

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccc------cC-chhHHHHHHHHHHHhcCC--CC-ceeeeecEEEeCC
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK------EG-LQGHREWLTEVNFLGQLR--HP-NLVKLIGYCCEDD  154 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~------~~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~  154 (431)
                      .||.|....||++...++.+      .++||.-..      .. .-...+..-|...|+...  .| .+.++|.+  +..
T Consensus         2 EigdGnlN~VfrV~~~~g~~------svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e   73 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDR------AAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTE   73 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCe------eEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccc
Confidence            48999999999998754322      277775321      11 122344456777776653  34 45555543  566


Q ss_pred             eeEEEEEecCCC-ChHHhh
Q 014079          155 HRLLVYEFMFRG-SLENHL  172 (431)
Q Consensus       155 ~~~lv~e~~~~g-sL~~~l  172 (431)
                      ...+|||+++.. .|.+.|
T Consensus        74 ~~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        74 MAVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             cceehHhhCccchHHHHHH
Confidence            678999998543 343433

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.00  E-value=0.004  Score=54.94  Aligned_cols=102  Identities=14%  Similarity=0.126  Sum_probs=67.0

Q ss_pred             eEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHH
Q 014079          112 VAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF  190 (431)
Q Consensus       112 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~  190 (431)
                      ..+|.+..-... ...-+.++.+++.++  -.|+++..-  ....+-++.|+|-..              .....-.+. 
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Arm--hGilrL~ND--n~~~yGvIlE~Cy~~--------------~i~~~N~i~-  148 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARM--HGILRLKND--NNYKYGVILERCYKI--------------KINFSNFIT-  148 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHh--hheeEeecC--CCceeEEEEeeccCc--------------ccchhHHHH-
Confidence            455555444333 344567788888876  357777632  334456899988211              111111122 


Q ss_pred             HHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       191 ~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .-+..|.-.|+...+.+|+|..|+||+-|..|.+||.|-+..
T Consensus       149 agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  149 AGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence            124678888977777999999999999999999999997753

The function of this family is unknown.

>PLN02236 choline kinase

Probab=96.98  E-value=0.0062  Score=58.89  Aligned_cols=144  Identities=15%  Similarity=0.106  Sum_probs=78.3

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  162 (431)
                      ..|-.|-.-.+|++...++...  ....|++|+...... ..-+..+|..+++.+..-++ .++++.+.. +   .|.+|
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~--~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ef  114 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGN--LGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEEF  114 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCC--CCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECC-c---eEEEe
Confidence            3455677788999865432110  112488888765432 11123568888888854333 345555532 2   58999


Q ss_pred             cCCCChHHh-----------------hhhCC----CCCcCHHHHHHHHHH-----------------HHHHHHHh----H
Q 014079          163 MFRGSLENH-----------------LFRKA----TVPLSWATRMMIAFG-----------------AAKGLAFL----H  200 (431)
Q Consensus       163 ~~~gsL~~~-----------------l~~~~----~~~~~~~~~~~i~~~-----------------i~~~l~~L----H  200 (431)
                      +++.+|...                 ++...    ..+..+.....+..+                 +...+..|    .
T Consensus       115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~  194 (344)
T PLN02236        115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS  194 (344)
T ss_pred             eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence            987776421                 11111    001112222222211                 11111122    1


Q ss_pred             h--CCCCeeeccCCCCCEEECC-CCcEEEecccCCcc
Q 014079          201 N--AERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKA  234 (431)
Q Consensus       201 ~--~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~  234 (431)
                      .  ....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            1  1234899999999999986 46899999987754

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.95  E-value=0.013  Score=55.79  Aligned_cols=31  Identities=16%  Similarity=0.179  Sum_probs=27.7

Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+++|+|+.+.|||++.++.+.|+||..+..
T Consensus       196 ~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       196 TVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            4599999999999999999999999987754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.81  E-value=0.008  Score=56.33  Aligned_cols=73  Identities=23%  Similarity=0.245  Sum_probs=44.2

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC---CCceeeeecEEEeCCeeEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---HPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  159 (431)
                      .+.|+.|....+|+... ++.       .+.+|+-...   ....|..|..-|+.|.   .-.+.+.+++....+..+||
T Consensus        22 ~~~v~GG~i~~a~~~~~-~~~-------~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLDT-DGG-------SYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             EEEE--SSSSEEEEEET-TS--------EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eEecCCCChhheEEEEC-CCc-------cEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            34688899999998763 222       3888887632   2235667777777773   45678888888877888999


Q ss_pred             EEecCCC
Q 014079          160 YEFMFRG  166 (431)
Q Consensus       160 ~e~~~~g  166 (431)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.78  E-value=0.0029  Score=62.44  Aligned_cols=51  Identities=24%  Similarity=0.347  Sum_probs=40.1

Q ss_pred             HHHHHHHHHHHhcCCCCceeeeecEEEeC-CeeEEEEEecCCCChHHhhhhCC
Q 014079          125 HREWLTEVNFLGQLRHPNLVKLIGYCCED-DHRLLVYEFMFRGSLENHLFRKA  176 (431)
Q Consensus       125 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~  176 (431)
                      ..+++.-..+++.+.|+|+..++++.... ....+|||++ +.+|++.+....
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~   77 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN   77 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc
Confidence            34566778889999999999999987643 3467999998 889999886543

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.69  E-value=0.019  Score=54.57  Aligned_cols=30  Identities=27%  Similarity=0.375  Sum_probs=25.7

Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            45999999999999987 6789999986643

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.68  E-value=0.017  Score=54.91  Aligned_cols=140  Identities=15%  Similarity=0.064  Sum_probs=84.5

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-------------------------hHH-HHHHHHHHH
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-------------------------GHR-EWLTEVNFL  135 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-------------------------~~~-~~~~E~~~l  135 (431)
                      +..+|..|.-+.||.|...++..       +|||+++-.-+.                         -.+ -...|++-|
T Consensus       148 inGCiSTGKEANVYHat~~dG~~-------~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNL  220 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSE-------FAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNL  220 (520)
T ss_pred             cccccccCccceeEeeecCCCce-------EEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHH
Confidence            44568889999999998887754       778876421100                         011 134688888


Q ss_pred             hcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCC
Q 014079          136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSN  215 (431)
Q Consensus       136 ~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~N  215 (431)
                      .++....|.----+..  ....|||+|+. .+=+-.-. -....++......+-.+++.-|.-|.+. .++||.||.--|
T Consensus       221 kRl~~aGIP~PePIlL--k~hVLVM~FlG-rdgw~aPk-LKd~~ls~~ka~~~Y~~~v~~MR~lY~~-c~LVHADLSEfN  295 (520)
T KOG2270|consen  221 KRLNNAGIPCPEPILL--KNHVLVMEFLG-RDGWAAPK-LKDASLSTSKARELYQQCVRIMRRLYQK-CRLVHADLSEFN  295 (520)
T ss_pred             HHHHhcCCCCCCceee--ecceEeeeecc-CCCCcCcc-cccccCChHHHHHHHHHHHHHHHHHHHH-hceeccchhhhh
Confidence            8876544322111111  13369999993 32111100 0112344444445555666666666542 349999999999


Q ss_pred             EEECCCCcEEEecccCCcc
Q 014079          216 ILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       216 ILl~~~~~~kl~DFG~a~~  234 (431)
                      +|+. +|.+.|+|-+-+..
T Consensus       296 ~Lyh-dG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  296 LLYH-DGKLYIIDVSQSVE  313 (520)
T ss_pred             heEE-CCEEEEEEcccccc
Confidence            9985 56899999876654

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.68  E-value=0.02  Score=55.99  Aligned_cols=79  Identities=11%  Similarity=0.033  Sum_probs=48.8

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccc-----cC-c-hhHHHHHHHHHHHhcCC---CCceeeeecEEEe
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-----EG-L-QGHREWLTEVNFLGQLR---HPNLVKLIGYCCE  152 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~-----~~-~-~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~  152 (431)
                      .+.||.|....||+....+ ..       ++||.-..     .. + -...+...|...|+.+.   ..++.+++.++. 
T Consensus        37 ~~eiggGn~N~VyrV~~~~-~s-------vVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-  107 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSSS-GS-------FVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-  107 (418)
T ss_pred             EEEcCCCceeeEEEEEcCC-cc-------EEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC-
Confidence            4568999999999987643 22       67776441     10 0 12223334566666553   347888888776 


Q ss_pred             CCeeEEEEEecCC--CChHHh
Q 014079          153 DDHRLLVYEFMFR--GSLENH  171 (431)
Q Consensus       153 ~~~~~lv~e~~~~--gsL~~~  171 (431)
                       +..+++||++++  ..+.+.
T Consensus       108 -d~~vlvME~L~~~~~ilr~~  127 (418)
T PLN02756        108 -TMALIGMRYLEPPHIILRKG  127 (418)
T ss_pred             -CCCEEEEeecCCcceehhhh
Confidence             456889999976  344443

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.58  E-value=0.0092  Score=56.62  Aligned_cols=72  Identities=18%  Similarity=0.177  Sum_probs=53.3

Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ...|++|++- |++|.-.-      .-.+.+.+.++.+.+..++-+.. +.+.-|||+.-.||||+ +|++.|+||-+++
T Consensus       299 ~y~yl~~kdh-gt~is~ik------~~~~~e~lsff~s~~sil~~lek-kf~fehrnlt~~niLId-~GnvtLIDfklsR  369 (488)
T COG5072         299 LYLYLHFKDH-GTPISIIK------ADRSEEELSFFWSCISILDILEK-KFPFEHRNLTLDNILID-EGNVTLIDFKLSR  369 (488)
T ss_pred             eEEEEEEecC-Cceeeeee------cccHHHHHHHHHHHHHHHhhhhh-cCCcccccccccceeee-cCceEEEEeeeee
Confidence            4457777764 55554321      13567777888877766665553 45689999999999999 8999999999998


Q ss_pred             c
Q 014079          234 A  234 (431)
Q Consensus       234 ~  234 (431)
                      .
T Consensus       370 l  370 (488)
T COG5072         370 L  370 (488)
T ss_pred             c
Confidence            5

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.32  E-value=0.024  Score=54.47  Aligned_cols=76  Identities=16%  Similarity=0.201  Sum_probs=43.8

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~  163 (431)
                      .|..|=-..+|+....+...   ....|++|+...... ..-+-.+|..+++.+..-++ .++++++. .+   +|.+|+
T Consensus        21 ~l~gGlTN~~~~v~~~~~~~---~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi   92 (330)
T PLN02421         21 RISGGITNLLLKVSVKEENG---NEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFI   92 (330)
T ss_pred             EeCCcccceEEEEEecCCCC---CCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhh
Confidence            45556667788876543210   112488888765422 11223468888888864444 35555552 22   589999


Q ss_pred             CCCCh
Q 014079          164 FRGSL  168 (431)
Q Consensus       164 ~~gsL  168 (431)
                      +|.+|
T Consensus        93 ~g~~l   97 (330)
T PLN02421         93 NARTL   97 (330)
T ss_pred             cCCCC
Confidence            77765

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.25  E-value=0.0055  Score=54.80  Aligned_cols=30  Identities=33%  Similarity=0.404  Sum_probs=20.9

Q ss_pred             CeeeccCCCCCEEE-CCCCcEEEecccCCcc
Q 014079          205 PVIYRDFKTSNILL-DSDYTAKLSDFGLAKA  234 (431)
Q Consensus       205 ~ivHrDlkp~NILl-~~~~~~kl~DFG~a~~  234 (431)
                      .+.|.||.+.|||+ +.++.++|+||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            37899999999999 8889999999987653

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=96.24  E-value=0.027  Score=53.07  Aligned_cols=77  Identities=16%  Similarity=0.105  Sum_probs=46.2

Q ss_pred             cccCcEEEEEEEEcC--CceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcCC-------------CCceeee
Q 014079           87 GEGGFGTVYKGYIDE--NVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQLR-------------HPNLVKL  146 (431)
Q Consensus        87 g~G~~g~V~~~~~~~--~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~-------------h~niv~l  146 (431)
                      |.|-.|.+|++....  ...-......++||.......     .....|.+|+.+.+.+-             ...+.++
T Consensus         2 Gd~y~s~~~rv~v~~~~~~~~~~~~~s~ivK~~p~~~~~~~~~~~~~~f~~E~~fY~~~~p~l~~~~~~~~~~~~~~P~~   81 (294)
T PF02958_consen    2 GDNYLSDMYRVTVTYELKGDGKNEPLSLIVKSPPTNPSRREFLREMGSFRREIFFYRELLPELEELQKEAGDPFKFFPKC   81 (294)
T ss_pred             CCcceeEEEEEEEEEEEccCCCceEEEEEEEeCCCchhhhhhhhhhhHHHHHHHHHHHHHHHHHHHHHhccccceeeceE
Confidence            778889999987643  111223345689998763211     12234667777766551             1234566


Q ss_pred             ecEEEeCCeeEEEEEec
Q 014079          147 IGYCCEDDHRLLVYEFM  163 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~  163 (431)
                      +....+....+||||-+
T Consensus        82 ~~~~~~~~~~~lvlEDL   98 (294)
T PF02958_consen   82 YYADEDPGDEVLVLEDL   98 (294)
T ss_pred             EEeccCCCceeeehhhh
Confidence            66655555678999876

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK06148 hypothetical protein; Provisional

Probab=96.18  E-value=0.076  Score=58.77  Aligned_cols=33  Identities=39%  Similarity=0.416  Sum_probs=27.0

Q ss_pred             CCCCeeeccCCCCCEEECCCC--cEE-EecccCCcc
Q 014079          202 AERPVIYRDFKTSNILLDSDY--TAK-LSDFGLAKA  234 (431)
Q Consensus       202 ~~~~ivHrDlkp~NILl~~~~--~~k-l~DFG~a~~  234 (431)
                      ....+||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       201 Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        201 LPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            345599999999999999875  565 999998754

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.07  E-value=0.023  Score=55.33  Aligned_cols=76  Identities=16%  Similarity=0.143  Sum_probs=47.1

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccc-----cC-chhHHHHHHHHHHHhcCC--CC-ceeeeecEEEeC
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-----EG-LQGHREWLTEVNFLGQLR--HP-NLVKLIGYCCED  153 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~-----~~-~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~  153 (431)
                      .+.||.|....||++.+..+..      .|+||.-..     .. .-..++..-|.++|+.+.  .| .+.++|.+  +.
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~------svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~  105 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNI------SVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DS  105 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCc------eEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--Cc
Confidence            3468999999999998743221      267765321     11 123455566777777663  34 45555543  56


Q ss_pred             CeeEEEEEecCCC
Q 014079          154 DHRLLVYEFMFRG  166 (431)
Q Consensus       154 ~~~~lv~e~~~~g  166 (431)
                      ....+|||+++..
T Consensus       106 e~~~~vMEdL~~~  118 (409)
T PRK12396        106 VMNCCVMEDLSDH  118 (409)
T ss_pred             HHhhHHHHhCccc
Confidence            6678999998543

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.73  E-value=0.32  Score=46.59  Aligned_cols=72  Identities=17%  Similarity=0.093  Sum_probs=41.7

Q ss_pred             cCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC--ceee---eec--EEEeCCeeEEEEE
Q 014079           89 GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--NLVK---LIG--YCCEDDHRLLVYE  161 (431)
Q Consensus        89 G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~---l~~--~~~~~~~~~lv~e  161 (431)
                      +.-..||+....++.       .+++|+.+... ....++..|++.+..|...  .++.   .-|  +...++..+.+++
T Consensus        36 s~eN~vy~v~~~~~~-------~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~  107 (325)
T PRK11768         36 SYENRVYQFGDEDGR-------RVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFP  107 (325)
T ss_pred             cccceEEEEecCCCC-------EEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEe
Confidence            344678888765443       38889875432 2345566677777666321  1222   112  2233567789999


Q ss_pred             ecCCCCh
Q 014079          162 FMFRGSL  168 (431)
Q Consensus       162 ~~~~gsL  168 (431)
                      +++|...
T Consensus       108 ~~~G~~~  114 (325)
T PRK11768        108 RRGGRAP  114 (325)
T ss_pred             eeCCCCC
Confidence            9987643

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.72  E-value=0.12  Score=49.42  Aligned_cols=138  Identities=19%  Similarity=0.210  Sum_probs=79.4

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC---Cc---eeeeecE--EEeCC--e
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH---PN---LVKLIGY--CCEDD--H  155 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~l~~~--~~~~~--~  155 (431)
                      |.+ .-..||+....++.        +++|+.+..  ....++..|+..|..|.-   +-   |..+-|-  ..-..  .
T Consensus        34 l~s-~eN~~f~~~~~~g~--------~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r  102 (331)
T COG2334          34 LNS-EENSNFRVQTEDGR--------YILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPR  102 (331)
T ss_pred             ccc-ccCceEEEEecCCC--------eEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCce
Confidence            444 55678888776653        788988776  344556677777777731   11   1222111  11123  7


Q ss_pred             eEEEEEecCCCChHH-hh--------------hh--CC--------CCCcCHHH-------------HHHHHHHHHHHHH
Q 014079          156 RLLVYEFMFRGSLEN-HL--------------FR--KA--------TVPLSWAT-------------RMMIAFGAAKGLA  197 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~-~l--------------~~--~~--------~~~~~~~~-------------~~~i~~~i~~~l~  197 (431)
                      .+-+++|++|..+.. ..              +.  .+        .....|..             ......++...+.
T Consensus       103 ~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~  182 (331)
T COG2334         103 PAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALD  182 (331)
T ss_pred             eEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHH
Confidence            788999999988872 11              10  00        00122220             0011223333444


Q ss_pred             HhHhC------CCC--eeeccCCCCCEEECCCCc-EEEecccCCcc
Q 014079          198 FLHNA------ERP--VIYRDFKTSNILLDSDYT-AKLSDFGLAKA  234 (431)
Q Consensus       198 ~LH~~------~~~--ivHrDlkp~NILl~~~~~-~kl~DFG~a~~  234 (431)
                      .+...      ..+  +||+|+.|.|||++.+.. .-++|||-+..
T Consensus       183 ~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         183 RLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             HHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            44431      122  899999999999998874 89999997754

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.16  E-value=0.084  Score=51.11  Aligned_cols=60  Identities=17%  Similarity=0.066  Sum_probs=39.3

Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      ..|+-+|..|-++..++...+.   ++..+..++.-.+.++.-+--. .+++|.|+.|.||++-
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~~---pe~l~kkva~lg~~AllkMl~v-DNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKSQ---PEALVKKVAKLGVNALLKMLIV-DNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhhcccC---hHHHHHHHHHHHHHHHHHHHHh-hcceecccCCCcEEEE
Confidence            3577778888899888865442   4444555555445554333221 2299999999999994

>PTZ00384 choline kinase; Provisional

Probab=95.06  E-value=0.18  Score=49.46  Aligned_cols=81  Identities=15%  Similarity=0.084  Sum_probs=44.6

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~e~  162 (431)
                      +.|..|-...+|++...++.........|.+++..... ...-+-.+|+++++.+...+ -.++++.+.    -++|.||
T Consensus        56 ~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~-~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~ef  130 (383)
T PTZ00384         56 KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYN-SLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQEW  130 (383)
T ss_pred             EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCC-ceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEEEE
Confidence            35656777899998754432100000114444432211 11112246888999886544 445566553    2699999


Q ss_pred             cCCCChH
Q 014079          163 MFRGSLE  169 (431)
Q Consensus       163 ~~~gsL~  169 (431)
                      ++|.+|.
T Consensus       131 IeGr~l~  137 (383)
T PTZ00384        131 VEGNTMG  137 (383)
T ss_pred             eccccCC
Confidence            9988764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	431
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-54
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-53
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-51
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-50
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-48
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-47
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		9e-47
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		7e-45
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-28
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-24
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-23
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-23
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		9e-22
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-21
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-21
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-21
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-21
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-21
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-21
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-21
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-21
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-21
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-21
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-21
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-21
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-21
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-21
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-21
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-21
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-21
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-21
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-21
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-21
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-21
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-21
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-21
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-21
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-21
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		8e-21
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		8e-21
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-20
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-20
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		6e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		9e-20
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		9e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		9e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		9e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		9e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		9e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-19
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-19
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-19
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-19
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-19
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-19
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-19
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-19
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-19
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-19
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-19
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		4e-19
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-19
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-19
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-19
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		7e-19
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-19
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		8e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-19
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		9e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		9e-19
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-18
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-18
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-18
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-18
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-18
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-18
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-18
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-18
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-18
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-18
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-18
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-18
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-18
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-18
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-18
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-18
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-18
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-18
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		2e-18
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-18
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-18
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-18
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		3e-18
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-18
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		3e-18
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-18
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-18
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-18
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		4e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-18
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-18
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		4e-18
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-18
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		4e-18
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-18
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-18
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-18
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		6e-18
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		6e-18
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-18
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		7e-18
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		7e-18
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		7e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-18
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-18
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		8e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		8e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		8e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		8e-18
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-18
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		8e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		9e-18
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-17
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-17
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-17
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-17
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		4e-17
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-17
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-17
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-17
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-17
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-17
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		5e-17
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		6e-17
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		6e-17
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-17
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		6e-17
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		6e-17
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-17
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-17
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-17
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-17
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-17
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		8e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		8e-17
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-17
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		9e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-17
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		1e-16
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-16
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-16
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-16
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-16
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-16
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		1e-16
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		1e-16
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-16
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-16
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-16
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-16
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-16
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-16
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-16
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-16
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-16
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-16
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-16
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-16
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-16
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-16
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-16
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-16
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		3e-16
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		3e-16
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-16
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-16
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-16
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-16
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-16
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-16
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-16
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		4e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-16
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-16
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-16
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-16
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-16
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-16
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		7e-16
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		7e-16
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-16
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-16
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		8e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-15
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-15
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-15
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		2e-15
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-15
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-15
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-15
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-15
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-15
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-15
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-15
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-15
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-15
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-15
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-15
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-15
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-15
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-15
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-15
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-15
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		3e-15
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-15
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		4e-15
3g51_A	325	Structural Diversity Of The Active Conformation Of		5e-15
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-15
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-15
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-15
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-15
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		6e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		6e-15
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-15
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		6e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		6e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		6e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		6e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		6e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		7e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		7e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		7e-15
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		7e-15
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-15
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		7e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		8e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		8e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		8e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		8e-15
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		9e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-14
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-14
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-14
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-14
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-14
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		1e-14
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-14
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-14
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-14
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-14
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-14
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-14
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		3e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-14
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		3e-14
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-14
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		4e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		5e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-14
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		5e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		5e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-14
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		5e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		6e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		6e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		6e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		6e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		6e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		6e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		6e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		6e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		7e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		7e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		7e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		8e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		8e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		8e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		9e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		9e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		9e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-14
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		9e-14
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-13
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-13
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-13
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		1e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		1e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-13
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-13
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		1e-13
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-13
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-13
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-13
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-13
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		2e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-13
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-13
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-13
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		3e-13
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		3e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-13
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-13
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-13
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-13
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-13
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-13
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		4e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-13
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-13
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-13
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-13
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-13
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		5e-13
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		5e-13
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		5e-13
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		5e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		5e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-13
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-13
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-13
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-13
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		6e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-13
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		7e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		7e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-12
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-12
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-12
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-12
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-12
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-12
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-12
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-12
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-12
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-12
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-12
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-12
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-12
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-12
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-12
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		5e-12
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-12
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-12
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-12
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		6e-12
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-12
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-12
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		7e-12
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-12
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		8e-12
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-12
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-12
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-12
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		8e-12
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		8e-12
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		8e-12
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-12
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-12
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-12
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		9e-12
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		1e-11
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-11
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-11
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-11
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		2e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-11
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		2e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		2e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-11
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-11
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-11
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-11
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		3e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-11
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-11
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-11
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-11
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		3e-11
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-11
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		3e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-11
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-11
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-11
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-11
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-11
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-11
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-11
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-11
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		5e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-11
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-11
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		5e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-11
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		6e-11
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-11
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		6e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		7e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		7e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		8e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-11
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		8e-11
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		8e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-11
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-11
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-10
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-10
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-10
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-10
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-10
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		3e-10
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		3e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-10
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-10
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		5e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-10
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-10
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-10
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		5e-10
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		5e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		6e-10
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		6e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-10
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-10
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		7e-10
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		7e-10
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		7e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		7e-10
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		7e-10
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-10
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		8e-10
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		8e-10
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		9e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		9e-10
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		9e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-09
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-09
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-09
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-09
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		1e-09
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-09
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-09
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-09
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-09
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		4e-09
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-09
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-09
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-09
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-09
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		5e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-09
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		5e-09
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		7e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-09
3soa_A	444	Full-Length Human Camkii Length = 444		8e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		8e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-08
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-08
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-08
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		1e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-08
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-08
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-08
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-08
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-08
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-08
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-08
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		3e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		3e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		3e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		4e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		4e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		4e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		5e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-08
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		5e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		5e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		5e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		5e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		6e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		6e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		6e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		6e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		6e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		6e-08
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		6e-08
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		6e-08
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-08
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		6e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-08
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-08
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		7e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		8e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		9e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		9e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		9e-08
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		9e-08
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-08
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		9e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-08
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		9e-08
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-07
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-07
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-07
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-07
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-07
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-07
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-07
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-07
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		3e-07
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		3e-07
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		5e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		7e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		8e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-06
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		2e-06
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		2e-06
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-06
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-06
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-06
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		4e-06
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		4e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		4e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-06
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		6e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		6e-06
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		8e-06
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		1e-05
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-05
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  209 bits (532), Expect = 2e-54,   Method: Compositional matrix adjust.
 Identities = 116/291 (39%), Positives = 175/291 (60%), Gaps = 12/291 (4%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
           L +LE  T +F   +++G G FG VYKG + +  +V LK           E  QG  E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR-------TPESSQGIEEFE 83
Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMM 187
           TE+  L   RHP+LV LIG+C E +  +L+Y++M  G+L+ HL+     T+ +SW  R+ 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           I  GAA+GL +LH   R +I+RD K+ NILLD ++  K++DFG++K G + D+TH+   V
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVV 201
Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
            GT GY  PEY + G LT +SDVYSFGVVL E+L  R ++ ++ P +  +L +WA    N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           +  ++ QI+DP L ++    + +K    A  CL+ + + RP M DV+  LE
Sbjct: 262 NG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  206 bits (524), Expect = 2e-53,   Method: Compositional matrix adjust.
 Identities = 115/291 (39%), Positives = 174/291 (59%), Gaps = 12/291 (4%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
           L +LE  T +F   +++G G FG VYKG + +  +V LK           E  QG  E+ 
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRR-------TPESSQGIEEFE 83
Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMM 187
           TE+  L   RHP+LV LIG+C E +  +L+Y++M  G+L+ HL+     T+ +SW  R+ 
Sbjct: 84  TEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE 143
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           I  GAA+GL +LH   R +I+RD K+ NILLD ++  K++DFG++K G +  +TH+   V
Sbjct: 144 ICIGAARGLHYLHT--RAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVV 201
Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
            GT GY  PEY + G LT +SDVYSFGVVL E+L  R ++ ++ P +  +L +WA    N
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           +  ++ QI+DP L ++    + +K    A  CL+ + + RP M DV+  LE
Sbjct: 262 NG-QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  198 bits (504), Expect = 4e-51,   Method: Compositional matrix adjust.
 Identities = 118/297 (39%), Positives = 172/297 (57%), Gaps = 15/297 (5%)
Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HR 126
           FSL EL+  + +F +  ILG GGFG VYKG + +   V       AVK L +E  QG   
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV-------AVKRLKEERXQGGEL 80
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--ATVPLSWAT 184
           ++ TEV  +    H NL++L G+C     RLLVY +M  GS+ + L  +  +  PL W  
Sbjct: 81  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 140
Query: 185 RMMIAFGAAKGLAFLHNAERP-VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
           R  IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D  HV
Sbjct: 141 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHV 199
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS--LVDW 301
              V GT G+ APEY+ TG  + ++DV+ +GV+LLEL+TG+++ D  R + +    L+DW
Sbjct: 200 XXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 259
Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
            +  L +K K+  ++D  L+  Y     ++   +A  C   +P  RP MS+VV  LE
Sbjct: 260 VKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  196 bits (499), Expect = 2e-50,   Method: Compositional matrix adjust.
 Identities = 117/297 (39%), Positives = 171/297 (57%), Gaps = 15/297 (5%)
Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HR 126
           FSL EL+  + +F +  ILG GGFG VYKG + +   V       AVK L +E  QG   
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLV-------AVKRLKEERTQGGEL 72
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--ATVPLSWAT 184
           ++ TEV  +    H NL++L G+C     RLLVY +M  GS+ + L  +  +  PL W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132
Query: 185 RMMIAFGAAKGLAFLHNAERP-VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
           R  IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D  HV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-XHV 191
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS--LVDW 301
              V G  G+ APEY+ TG  + ++DV+ +GV+LLEL+TG+++ D  R + +    L+DW
Sbjct: 192 XXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251
Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
            +  L +K K+  ++D  L+  Y     ++   +A  C   +P  RP MS+VV  LE
Sbjct: 252 VKGLLKEK-KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  187 bits (476), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 116/301 (38%), Positives = 177/301 (58%), Gaps = 17/301 (5%)
Query: 67  AFSLFELETITKSFRSDYI------LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +FS +EL+ +T +F    I      +GEGGFG VYKGY++ N  V +K L   V +  +E
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVP 179
             Q   ++  E+  + + +H NLV+L+G+  + D   LVY +M  GSL + L     T P
Sbjct: 73  LKQ---QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSW  R  IA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SDFGLA+A  +  
Sbjct: 130 LSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           +T + +R++GT  Y APE  + G +T +SD+YSFGVVLLE++TG  +VD+ R  + Q L+
Sbjct: 188 QTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLL 244
Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           D      ++++ +   ID ++ N     + +   S+A  CL +    RP +  V + L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 360 L 360
           +
Sbjct: 304 M 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  186 bits (473), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 116/301 (38%), Positives = 176/301 (58%), Gaps = 17/301 (5%)
Query: 67  AFSLFELETITKSFRSDYI------LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +FS +EL+ +T +F    I      +GEGGFG VYKGY++ N  V +K L   V +  +E
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 72
Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVP 179
             Q   ++  E+  + + +H NLV+L+G+  + D   LVY +M  GSL + L     T P
Sbjct: 73  LKQ---QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSW  R  IA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SDFGLA+A  +  
Sbjct: 130 LSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           +T +  R++GT  Y APE  + G +T +SD+YSFGVVLLE++TG  +VD+ R  + Q L+
Sbjct: 188 QTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLL 244
Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           D      ++++ +   ID ++ N     + +   S+A  CL +    RP +  V + L+ 
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303
Query: 360 L 360
           +
Sbjct: 304 M 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  184 bits (467), Expect = 9e-47,   Method: Compositional matrix adjust.
 Identities = 115/301 (38%), Positives = 175/301 (58%), Gaps = 17/301 (5%)
Query: 67  AFSLFELETITKSFRSDYI------LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +FS +EL+ +T +F    I      +GEGGFG VYKGY++ N  V +K L   V +  +E
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 66
Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVP 179
             Q   ++  E+  + + +H NLV+L+G+  + D   LVY +M  GSL + L     T P
Sbjct: 67  LKQ---QFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 123
Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSW  R  IA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SDFGLA+A  +  
Sbjct: 124 LSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 181
Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           +  +  R++GT  Y APE  + G +T +SD+YSFGVVLLE++TG  +VD+ R  + Q L+
Sbjct: 182 QXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLL 238
Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           D      ++++ +   ID ++ N     + +   S+A  CL +    RP +  V + L+ 
Sbjct: 239 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 297
Query: 360 L 360
           +
Sbjct: 298 M 298

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  177 bits (450), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 114/299 (38%), Positives = 170/299 (56%), Gaps = 17/299 (5%)
Query: 67  AFSLFELETITKSFRSDYI------LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +FS +EL+ +T +F    I       GEGGFG VYKGY++ N  V +K L   V +  +E
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEE 63
Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVP 179
             Q   ++  E+    + +H NLV+L+G+  + D   LVY +   GSL + L     T P
Sbjct: 64  LKQ---QFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPP 120
Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LSW  R  IA GAA G+ FLH  E   I+RD K++NILLD  +TAK+SDFGLA+A  +  
Sbjct: 121 LSWHXRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 178
Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           +    +R++GT  Y APE  + G +T +SD+YSFGVVLLE++TG  +VD+ R  + Q L+
Sbjct: 179 QXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITGLPAVDEHR--EPQLLL 235
Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D      ++++ +   ID +  N     + +   S+A  CL +    RP +  V + L+
Sbjct: 236 DIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQ 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/278 (32%), Positives = 139/278 (50%), Gaps = 29/278 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR--EWLTEVNFLGQLRHPNL 143
           +G G FGTV+        R       VAVK+L ++     R  E+L EV  + +LRHPN+
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNA 202
           V  +G   +  +  +V E++ RGSL   L +  A   L    R+ +A+  AKG+ +LHN 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             P+++RD K+ N+L+D  YT K+ DFGL++   +      S    GT  + APE +   
Sbjct: 157 NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDE 214
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               +SDVYSFGV+L EL T ++      P++  + V +       K K L+I  PR  N
Sbjct: 215 PSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-------KCKRLEI--PRNLN 265
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                   +  ++   C +  P  RP  + +++ L PL
Sbjct: 266 -------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 142/279 (50%), Gaps = 31/279 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR--EWLTEVNFLGQLRHPNL 143
           +G G FGTV+        R       VAVK+L ++     R  E+L EV  + +LRHPN+
Sbjct: 45  IGAGSFGTVH--------RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNI 96
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNA 202
           V  +G   +  +  +V E++ RGSL   L +  A   L    R+ +A+  AKG+ +LHN 
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYGYAAPEYVMT 261
             P+++R+ K+ N+L+D  YT K+ DFGL++       T +S++   GT  + APE +  
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS---TFLSSKSAAGTPEWMAPEVLRD 213
Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE 321
                +SDVYSFGV+L EL T ++      P++  + V +       K K L+I  PR  
Sbjct: 214 EPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF-------KCKRLEI--PRNL 264
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           N        +  ++   C +  P  RP  + +++ L PL
Sbjct: 265 N-------PQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 139/288 (48%), Gaps = 40/288 (13%)
Query: 86  LGEGGFGTVYKGYI--DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +G+GGFG V+KG +  D++V V +KSL +       E ++  +E+  EV  +  L HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV-VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL G         +V EF+  G L + L  KA  P+ W+ ++ +    A G+ ++ N  
Sbjct: 86  VKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 204 RPVIYRDFKTSNILLDS-----DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            P+++RD ++ NI L S        AK++DFGL++        H  + ++G + + APE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWMAPET 197
Query: 259 VMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL----VDWARPKLNDKRKM 312
           +       T ++D YSF ++L  +LTG    D+    K + +     +  RP + +    
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED--- 254
Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                PRL N   +            C S +PK RP  S +V+ L  L
Sbjct: 255 ---CPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 139/288 (48%), Gaps = 40/288 (13%)
Query: 86  LGEGGFGTVYKGYI--DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +G+GGFG V+KG +  D++V V +KSL +       E ++  +E+  EV  +  L HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV-VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL G     +   +V EF+  G L + L  KA  P+ W+ ++ +    A G+ ++ N  
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 204 RPVIYRDFKTSNILLDS-----DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            P+++RD ++ NI L S        AK++DFG ++        H  + ++G + + APE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHSVSGLLGNFQWMAPET 197
Query: 259 VMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL----VDWARPKLNDKRKM 312
           +       T ++D YSF ++L  +LTG    D+    K + +     +  RP + +    
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED--- 254
Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                PRL N   +            C S +PK RP  S +V+ L  L
Sbjct: 255 ---CPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 139/288 (48%), Gaps = 40/288 (13%)
Query: 86  LGEGGFGTVYKGYI--DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +G+GGFG V+KG +  D++V V +KSL +       E ++  +E+  EV  +  L HPN+
Sbjct: 27  IGKGGFGLVHKGRLVKDKSV-VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL G     +   +V EF+  G L + L  KA  P+ W+ ++ +    A G+ ++ N  
Sbjct: 86  VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAH-PIKWSVKLRLMLDIALGIEYMQNQN 142
Query: 204 RPVIYRDFKTSNILLDS-----DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            P+++RD ++ NI L S        AK++DF L++        H  + ++G + + APE 
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHSVSGLLGNFQWMAPET 197
Query: 259 VMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL----VDWARPKLNDKRKM 312
           +       T ++D YSF ++L  +LTG    D+    K + +     +  RP + +    
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED--- 254
Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                PRL N   +            C S +PK RP  S +V+ L  L
Sbjct: 255 ---CPPRLRNVIEL------------CWSGDPKKRPHFSYIVKELSEL 287

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 133/283 (46%), Gaps = 23/283 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           ++G G FG VYKG +  +   G K +PVA+K L     +  R ++L E   +GQ  H N+
Sbjct: 51  VIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           ++L G   +    +++ E+M  G+L+  L R+     S    + +  G A G+ +L N  
Sbjct: 109 IRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEYVMTG 262
              ++RD    NIL++S+   K+SDFGL++      E T+ ++       + APE +   
Sbjct: 168 --YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
             T+ SDV+SFG+V+ E++T  +     RP  E S             ++++ I+     
Sbjct: 226 KFTSASDVWSFGIVMWEVMTYGE-----RPYWELS-----------NHEVMKAINDGFRL 269
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
              +        L   C  Q    RP  +D+V  L+ L  A D
Sbjct: 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 312

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--S 123
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 228
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 229 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 77/232 (33%), Positives = 115/232 (49%), Gaps = 42/232 (18%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYI--DENVRVGLKSLPVAVKVL----NKEGLQGHR 126
           LE        + I+G GGFG VY+ +   DE          VAVK      +++  Q   
Sbjct: 2   LEIDFAELTLEEIIGIGGFGKVYRAFWIGDE----------VAVKAARHDPDEDISQTIE 51
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP---LSWA 183
               E      L+HPN++ L G C ++ +  LV EF   G L   L  K   P   ++WA
Sbjct: 52  NVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWA 111
Query: 184 TRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLD--------SDYTAKLSDFGLAKA 234
            ++      A+G+ +LH+ A  P+I+RD K+SNIL+         S+   K++DFGLA+ 
Sbjct: 112 VQI------ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR- 164
Query: 235 GPQGDETHVSTRV--MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
                E H +T++   G Y + APE +     +  SDV+S+GV+L ELLTG 
Sbjct: 165 -----EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEEAEVMMKLSHPKLVQ 66
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 67  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 123
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 228
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 229 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 258

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEEAEVMMKLSHPKLVQ 64
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 65  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 121
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 226
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 227 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 256

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 79  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFT 194
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 195 IKSDVWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 80
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 81  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 137
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFT 196
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 197 IKSDVWSFGILLTEIVT 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 32/283 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 81
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 82  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 138
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLI-EDNEXTAREGAKFPIKWTAPEAINYGTFT 197
Query: 266 ARSDVYSFGVVLLELLT-GRKSVD-KTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            +SDV+SFG++L E++T GR      T P   Q+L            +  +++ P     
Sbjct: 198 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD---- 242
Query: 324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG 366
                 ++   L   C  + P+ RP    +   LE    A +G
Sbjct: 243 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 282

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        KEG     +++ E   + +L HP LV+
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTI--------KEGSMSEDDFIEEAEVMMKLSHPKLVQ 86
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 87  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 143
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 248
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 249 --ASTHVYQIMNHCWKERPEDRPAFSRLLRQL 278

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 125/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEEAEVMMKLSHPKLVQ 69
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV+EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 70  LYGVCLEQAPICLVFEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 126
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 231
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 232 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQL 261

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 32/283 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 266 ARSDVYSFGVVLLELLT-GRKSVD-KTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            +SDV+SFG++L E++T GR      T P   Q+L            +  +++ P     
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD---- 233
Query: 324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG 366
                 ++   L   C  + P+ RP    +   LE    A +G
Sbjct: 234 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 273

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 81/227 (35%), Positives = 116/227 (51%), Gaps = 14/227 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y  +    G   + VAVK L  +    HR  W  E++ L  L H +++
Sbjct: 39  LGEGHFGKV-SLYCYDPTNDGTGEM-VAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96
Query: 145 KLIGYCCEDDHRL---LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           K  G CCED       LV E++  GSL ++L R +   +  A  ++ A    +G+A+LH 
Sbjct: 97  KYKG-CCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA 152
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVM 260
                I+RD    N+LLD+D   K+ DFGLAKA P+G E + V         + APE + 
Sbjct: 153 QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
                  SDV+SFGV L ELLT   S  ++ P+K   L+  A+ ++ 
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMT 256

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 74
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 75  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFT 190
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 191 IKSDVWSFGILLTEIVT 207

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 74  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 130
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFT 189
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 190 IKSDVWSFGILLTEIVT 206

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 38  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 150
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALES 209
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 96  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 208
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 209 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 35  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 147
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 206
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTAPEAINYGTFT 188
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 79  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 135
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 194
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 195 IKSDVWSFGILLTEIVT 211

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 133/283 (46%), Gaps = 32/283 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 82
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 83  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 139
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 198
Query: 266 ARSDVYSFGVVLLELLT-GRKSVD-KTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            +SDV+SFG++L E++T GR      T P   Q+L            +  +++ P     
Sbjct: 199 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-----------ERGYRMVRPD---- 243
Query: 324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG 366
                 ++   L   C  + P+ RP    +   LE    A +G
Sbjct: 244 ---NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG 283

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 77
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 78  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 134
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 193
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 194 IKSDVWSFGILLTEIVT 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 38  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 94
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 95  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 150
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 151 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 209
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 210 LQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 67
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 68  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 124
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 183
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 184 IKSDVWSFGILLTEIVT 200

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 208
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/204 (34%), Positives = 105/204 (51%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 42  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 98
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ FL 
Sbjct: 99  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFL- 154
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E 
Sbjct: 155 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 213
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 214 LQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 117/227 (51%), Gaps = 14/227 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y  +    G   + VAVK L  +    HR  W  E++ L  L H +++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEM-VAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 145 KLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           K  G CCED       LV E++  GSL ++L R +   +  A  ++ A    +G+A+LH+
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHS 135
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVM 260
                I+R+    N+LLD+D   K+ DFGLAKA P+G E + V         + APE + 
Sbjct: 136 QH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
                  SDV+SFGV L ELLT   S  ++ P+K   L+  A+ ++ 
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMT 239

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 188
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 80/227 (35%), Positives = 116/227 (51%), Gaps = 14/227 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y  +    G   + VAVK L  +    HR  W  E++ L  L H +++
Sbjct: 22  LGEGHFGKV-SLYCYDPTNDGTGEM-VAVKALKADCGPQHRSGWKQEIDILRTLYHEHII 79
Query: 145 KLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           K  G CCED       LV E++  GSL ++L R +   +  A  ++ A    +G+A+LH 
Sbjct: 80  KYKG-CCEDQGEKSLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHA 135
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYVM 260
                I+R+    N+LLD+D   K+ DFGLAKA P+G E + V         + APE + 
Sbjct: 136 QH--YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
                  SDV+SFGV L ELLT   S  ++ P+K   L+  A+ ++ 
Sbjct: 194 EYKFYYASDVWSFGVTLYELLTHCDS-SQSPPTKFLELIGIAQGQMT 239

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 74/272 (27%), Positives = 124/272 (45%), Gaps = 28/272 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V+ GY     +V +K++        +EG     +++ E   + +L HP LV+
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTI--------REGAMSEEDFIEEAEVMMKLSHPKLVQ 67
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L G C E     LV EFM  G L ++L R      +  T + +     +G+A+L  A   
Sbjct: 68  LYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYLEEA--C 124
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       +
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
           ++SDV+SFGV++ E+ +  K   + R + E          + D     ++  PRL     
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRLYKPRL----- 229
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             A+     +  +C  + P+ RP  S ++  L
Sbjct: 230 --ASTHVYQIMNHCWRERPEDRPAFSRLLRQL 259

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 106/197 (53%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 68
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 69  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 125
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+R+ + +NIL+    + K++DFGLA+   + +E            + APE +  G  T
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAINYGTFT 184
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 185 IKSDVWSFGILLTEIVT 201

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 104/197 (52%), Gaps = 12/197 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G  G V+ GY + + +V +KSL        K+G      +L E N + QL+H  LV+
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSL--------KQGSMSPDAFLAEANLMKQLQHQRLVR 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     ++   ++  E+M  GSL + L   + + L+    + +A   A+G+AF+   ER 
Sbjct: 73  LYAVVTQEPIYIIT-EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE--ERN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD + +NIL+    + K++DFGLA+     + T           + APE +  G  T
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXT-AREGAKFPIKWTAPEAINYGTFT 188
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV+SFG++L E++T
Sbjct: 189 IKSDVWSFGILLTEIVT 205

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 36  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 148
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALES 207
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/290 (26%), Positives = 131/290 (45%), Gaps = 28/290 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 19  LGGGQFGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L    + 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 ARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +SDV++FGV+L E+ T G        PS+   L++                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMERPE 233
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
                +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 234 G--CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 281

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 20  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 67
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 68  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH 125
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 126 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 261 ---TGHLTARSDVYSFGVVLLELLTGR 284
              +   + +SDVY+FG+VL EL+TG+
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 107/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 32  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 79
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 80  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH 137
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 261 ---TGHLTARSDVYSFGVVLLELLTGR 284
              +   + +SDVY+FG+VL EL+TG+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 56  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 112
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 113 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 168
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 169 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 227
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 228 LQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 117/219 (53%), Gaps = 21/219 (9%)
Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPN 142
           +LG G FGTVYKG ++ E   V    +PVA+K+LN+  G + + E++ E   +  + HP+
Sbjct: 45  VLGSGAFGTVYKGIWVPEGETV---KIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 101
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGAAKGLA 197
           LV+L+G C     +L V + M  G L  ++        + + L+W  ++      AKG+ 
Sbjct: 102 LVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 154
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +L   ER +++RD    N+L+ S    K++DFGLA+     ++ + +        + A E
Sbjct: 155 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE 295
            +     T +SDV+S+GV + EL+T G K  D   P++E
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTRE 250

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 55  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 111
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 112 LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 167
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 168 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 226
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 227 LQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 37  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 93
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 94  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 150 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 208
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 209 LQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 32  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 79
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY        +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 80  VNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASET-KFEMKKLIDIARQTARGMDYLH 137
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 138 --AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 261 ---TGHLTARSDVYSFGVVLLELLTGR 284
              +   + +SDVY+FG+VL EL+TG+
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 35  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 91
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 92  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 147
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 148 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 206
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 207 LQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 36  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 92
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 93  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 148
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 149 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 207
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 208 LQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 29  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 85
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 86  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 141
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 142 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 200
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 201 LQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 32  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 144
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 145 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 104/204 (50%), Gaps = 14/204 (6%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 34  VIGRGHFGCVYHGTLLDN---DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90
Query: 144 VKLIGYCCEDDHR-LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--AAKGLAFLH 200
           + L+G C   +   L+V  +M  G L N +  +   P     + +I FG   AKG+ +L 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKYL- 146
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD--ETHVSTRVMGTYGYAAPEY 258
            A +  ++RD    N +LD  +T K++DFGLA+     +    H  T       + A E 
Sbjct: 147 -ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 205
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           + T   T +SDV+SFGV+L EL+T
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/219 (31%), Positives = 117/219 (53%), Gaps = 21/219 (9%)
Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPN 142
           +LG G FGTVYKG ++ E   V    +PVA+K+LN+  G + + E++ E   +  + HP+
Sbjct: 22  VLGSGAFGTVYKGIWVPEGETV---KIPVAIKILNETTGPKANVEFMDEALIMASMDHPH 78
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGAAKGLA 197
           LV+L+G C     +L V + M  G L  ++        + + L+W  ++      AKG+ 
Sbjct: 79  LVRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQI------AKGMM 131
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +L   ER +++RD    N+L+ S    K++DFGLA+     ++ + +        + A E
Sbjct: 132 YLE--ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE 295
            +     T +SDV+S+GV + EL+T G K  D   P++E
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI-PTRE 227

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L    L   +++  E   L  L+H ++VK
Sbjct: 23  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLF--------------RKATVPLSWATRMMIAFG 191
             G C + D  ++V+E+M  G L   L               R+A   L  +  + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A G+ +L  A +  ++RD  T N L+ ++   K+ DFG+++     D   V    M   
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE +M    T  SDV+SFGV+L E+ T
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGLA+      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 131/290 (45%), Gaps = 28/290 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 19  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L    + 
Sbjct: 72  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK--KN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 ARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +SDV++FGV+L E+ T G        PS+   L++                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMERPE 233
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
                +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 234 G--CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 281

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 43  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 90
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 91  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 148
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 149 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQ 233

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 21  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 68
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 69  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 126
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 44  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 91
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 18  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 65
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 66  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 123
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 124 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQ 208

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 21  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 68
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 69  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 126
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 127 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQ 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 63
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 121
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 36  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 83
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 84  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 141
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 142 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQ 226

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 44  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 91
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 92  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 149
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 150 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQ 234

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 64
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 123
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 124 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 106/207 (51%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 63
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY  +     +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTKP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 121
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           LGEG FG V   Y  +    G   + VAVK L KEG   Q    W  E+  L  L H ++
Sbjct: 16  LGEGHFGKV-SLYCYDPTNDGTGEM-VAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 144 VKLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           VK  G CCED       LV E++  GSL ++L R     +  A  ++ A    +G+A+LH
Sbjct: 73  VKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 128
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYV 259
                 I+R     N+LLD+D   K+ DFGLAKA P+G E + V         + APE +
Sbjct: 129 AQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 186
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
                   SDV+SFGV L ELLT
Sbjct: 187 KECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/203 (38%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           LGEG FG V   Y  +    G   + VAVK L KEG   Q    W  E+  L  L H ++
Sbjct: 17  LGEGHFGKV-SLYCYDPTNDGTGEM-VAVKAL-KEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 144 VKLIGYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           VK  G CCED       LV E++  GSL ++L R     +  A  ++ A    +G+A+LH
Sbjct: 74  VKYKG-CCEDQGEKSVQLVMEYVPLGSLRDYLPRHC---VGLAQLLLFAQQICEGMAYLH 129
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEYV 259
                 I+R     N+LLD+D   K+ DFGLAKA P+G E + V         + APE +
Sbjct: 130 AQH--YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 187
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
                   SDV+SFGV L ELLT
Sbjct: 188 KECKFYYASDVWSFGVTLYELLT 210

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 26  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 81
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 82  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 140
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 141 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 198
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 199 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 233

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/276 (26%), Positives = 127/276 (46%), Gaps = 28/276 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 19  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 71
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 72  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 129
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 266 ARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +SDV++FGV+L E+ T G        PS+   L++                D R+E   
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLE---------------KDYRMERPE 233
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                +K   L   C   NP  RP  +++ +  E +
Sbjct: 234 G--CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 112/215 (52%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 36  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 91
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 92  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 150
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 151 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 208
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 209 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 243

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 69/207 (33%), Positives = 105/207 (50%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-----KEGLQGHREWLTEVNFLGQLRH 140
           +G G FGTVYKG    +V         AVK+LN      + LQ  +    EV  L + RH
Sbjct: 16  IGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFK---NEVGVLRKTRH 63
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N++  +GY        +V ++    SL +HL    T        + IA   A+G+ +LH
Sbjct: 64  VNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQGMDYLH 121
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE + 
Sbjct: 122 --AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 261 TGH---LTARSDVYSFGVVLLELLTGR 284
                  + +SDVY+FG+VL EL+TG+
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQ 206

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 139/295 (47%), Gaps = 35/295 (11%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           K    + ++G G FG V K           ++  VA+K +  E  +  + ++ E+  L +
Sbjct: 9   KEIEVEEVVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSR 58
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM-IAFGAAKGL 196
           + HPN+VKL G C   +   LV E+   GSL N L     +P   A   M      ++G+
Sbjct: 59  VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 116
Query: 197 AFLHNAE-RPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           A+LH+ + + +I+RD K  N+LL +  T  K+ DFG A       +TH+ T   G+  + 
Sbjct: 117 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWM 171
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE     + + + DV+S+G++L E++T RK  D+         + WA    N  R    
Sbjct: 172 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA--VHNGTRP--- 224
Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNE 369
              P ++N       +   SL   C S++P  RP M ++V+ +  L     G +E
Sbjct: 225 ---PLIKN-----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 271

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E+M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL +      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 139/295 (47%), Gaps = 35/295 (11%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           K    + ++G G FG V K           ++  VA+K +  E  +  + ++ E+  L +
Sbjct: 8   KEIEVEEVVGRGAFGVVCKA--------KWRAKDVAIKQIESESER--KAFIVELRQLSR 57
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM-IAFGAAKGL 196
           + HPN+VKL G C   +   LV E+   GSL N L     +P   A   M      ++G+
Sbjct: 58  VNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 197 AFLHNAE-RPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           A+LH+ + + +I+RD K  N+LL +  T  K+ DFG A       +TH+ T   G+  + 
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA----CDIQTHM-TNNKGSAAWM 170
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE     + + + DV+S+G++L E++T RK  D+         + WA    N  R    
Sbjct: 171 APEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI--GGPAFRIMWA--VHNGTRP--- 223
Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNE 369
              P ++N       +   SL   C S++P  RP M ++V+ +  L     G +E
Sbjct: 224 ---PLIKN-----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADE 270

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 12/217 (5%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V  G++      G + + VA+K L K G   +  R++
Sbjct: 26  FAKEIDISCVKIEQVIGAGEFGEVCSGHLK---LPGKREIFVAIKTL-KSGYTEKQRRDF 81
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN++ L G   +    +++ EFM  GSL++ L R+     +    + +
Sbjct: 82  LSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGM 140
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  A+   ++RD    NIL++S+   K+SDFGL++           T  +
Sbjct: 141 LRGIAAGMKYL--ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 198
Query: 249 G---TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           G      + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 199 GGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 102/199 (51%), Gaps = 8/199 (4%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG GG  TVY   + E+  + +K    A+ +  +E  +  + +  EV+   QL H N+V 
Sbjct: 19  LGGGGMSTVY---LAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           +I    EDD   LV E++   +L  ++  ++  PLS  T +        G+   H+    
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI--ESHGPLSVDTAINFTNQILDGIKHAHDMR-- 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           +++RD K  NIL+DS+ T K+ DFG+AKA  +   T  +  V+GT  Y +PE        
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGTVQYFSPEQAKGEATD 190
Query: 266 ARSDVYSFGVVLLELLTGR 284
             +D+YS G+VL E+L G 
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLR 139
           +D  LG G FG+V +G      R+  K + VA+KVL K+G +     E + E   + QL 
Sbjct: 14  ADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 68
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAF 198
           +P +V+LIG  C+ +  +LV E    G L   L  ++  +P+S    ++     + G+ +
Sbjct: 69  NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL--HQVSMGMKY 125
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAP 256
           L   E+  ++RD    N+LL + + AK+SDFGL+KA    D+++ + R  G +   + AP
Sbjct: 126 LE--EKNFVHRDLAARNVLLVNRHYAKISDFGLSKA-LGADDSYYTARSAGKWPLKWYAP 182
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
           E +     ++RSDV+S+GV + E L+ G+K   K +  +  + ++
Sbjct: 183 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 9   FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 64
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E M  GSL++ L RK     +    + +
Sbjct: 65  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGM 123
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 124 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 181
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 216

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 288

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 125/278 (44%), Gaps = 38/278 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ G  + N +V +K+L        K G      +L E   + +L+H  LV+
Sbjct: 17  LGNGQFGEVWMGTWNGNTKVAIKTL--------KPGTMSPESFLEEAQIMKKLKHDKLVQ 68
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     E+    +V E+M +GSL + L       L     + +A   A G+A++      
Sbjct: 69  LYAVVSEEPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN-- 125
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD +++NIL+ +    K++DFGLA+   + +E            + APE  + G  T
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTAPEAALYGRFT 184
Query: 266 ARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +SDV+SFG++L EL+T GR                   P +N++  + Q+     E  Y
Sbjct: 185 IKSDVWSFGILLTELVTKGRVPY----------------PGMNNREVLEQV-----ERGY 223
Query: 325 SVRAAQKAC----SLAYYCLSQNPKARPLMSDVVETLE 358
            +   Q        L  +C  ++P+ RP    +   LE
Sbjct: 224 RMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLE 261

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 42/283 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    +KG  D           VAVK++ KEG     E+  E   + +L HP
Sbjct: 16  LGSGQFGVVKLGKWKGQYD-----------VAVKMI-KEGSMSEDEFFQEAQTMMKLSHP 63
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LVK  G C ++    +V E++  G L N+L R     L  +  + + +   +G+AFL +
Sbjct: 64  KLVKFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFLES 122
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPEY 258
            +   I+RD    N L+D D   K+SDFG+ +     D+ +VS+  +GT     ++APE 
Sbjct: 123 HQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSS--VGTKFPVKWSAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
                 +++SDV++FG+++ E+ +  K       + E  L      K++   ++ +   P
Sbjct: 177 FHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL------KVSQGHRLYR---P 227
Query: 319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
            L       A+     + Y C  + P+ RP    ++ ++EPL+
Sbjct: 228 HL-------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 133/286 (46%), Gaps = 40/286 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G FGTVYKG    +V V +      +KV++   E  Q  R    EV  L + RH N+
Sbjct: 44  IGSGSFGTVYKGKWHGDVAVKI------LKVVDPTPEQFQAFR---NEVAVLRKTRHVNI 94
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           +  +GY  +D+   +V ++    SL  HL  + T        + IA   A+G+ +LH   
Sbjct: 95  LLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQET-KFQMFQLIDIARQTAQGMDYLH--A 150
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM--- 260
           + +I+RD K++NI L    T K+ DFGLA    +   +    +  G+  + APE +    
Sbjct: 151 KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQD 210
Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII---- 316
               + +SDVYS+G+VL EL+TG                +     +N++ +++ ++    
Sbjct: 211 NNPFSFQSDVYSYGIVLYELMTG----------------ELPYSHINNRDQIIFMVGRGY 254
Query: 317 -DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
             P L   Y     +    L   C+ +  + RPL   ++ ++E LQ
Sbjct: 255 ASPDLSKLYK-NCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQ 299

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 283

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E    +   D ++G G FG V  G +    +   K + VA+K L K G   +  R++
Sbjct: 38  FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTL-KVGYTEKQRRDF 93
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E + +GQ  HPN+++L G   +    ++V E M  GSL++ L RK     +    + +
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFL-RKHDAQFTVIQLVGM 152
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  ++   ++RD    NIL++S+   K+SDFGL++      E   +TR  
Sbjct: 153 LRGIASGMKYL--SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGG 210
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + +PE +     T+ SDV+S+G+VL E+++
Sbjct: 211 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMS 245

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+   + V E+M +GSL + L  +    L     + +A   A
Sbjct: 56  VMKKLRHEKLVQLYAVVSEEPIXI-VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 114
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 115 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKW 171
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 172 TAPEAALYGRFTIKSDVWSFGILLTELTT 200

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 104/203 (51%), Gaps = 23/203 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +K+L        K G    + +L E N +  L+H  LV+
Sbjct: 21  LGAGQFGEVWMGYYNNSTKVAVKTL--------KPGTMSVQAFLEEANLMKTLQHDKLVR 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFR----KATVPLSWATRMMIAFGA--AKGLAFL 199
           L      ++   ++ E+M +GSL + L      K  +P       +I F A  A+G+A++
Sbjct: 73  LYAVVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLP------KLIDFSAQIAEGMAYI 126
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
               +  I+RD + +N+L+      K++DFGLA+   + +E            + APE +
Sbjct: 127 ER--KNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI 183
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
             G  T +SDV+SFG++L E++T
Sbjct: 184 NFGCFTIKSDVWSFGILLYEIVT 206

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+   +++ E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 12/217 (5%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V +G +      G K   VA+K L K G   +  RE+
Sbjct: 9   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAP---GKKESCVAIKTL-KGGYTERQRREF 64
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN+++L G        +++ EFM  G+L++ L R      +    + +
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGM 123
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  AE   ++RD    NIL++S+   K+SDFGL++   +       T  +
Sbjct: 124 LRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSL 181
Query: 249 G---TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           G      + APE +     T+ SD +S+G+V+ E+++
Sbjct: 182 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 22  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 74
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 75  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 235
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 284

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/335 (23%), Positives = 149/335 (44%), Gaps = 34/335 (10%)
Query: 40  ISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYI 99
           I+ L  P+  RN         +Y     +  +E+E    + +  + LG G +G VY+G  
Sbjct: 190 ITTLHYPAPKRN------KPTIYGVSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVW 241
Query: 100 DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 159
            +       SL VAVK L ++ ++   E+L E   + +++HPNLV+L+G C  +    ++
Sbjct: 242 KK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 294
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
            EFM  G+L ++L       +S    + +A   +  + +L   ++  I+R+    N L+ 
Sbjct: 295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVG 352
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 279
            ++  K++DFGL++    GD             + APE +     + +SDV++FGV+L E
Sbjct: 353 ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 411
Query: 280 LLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYC 339
           + T   S                 P + D  ++ ++++     +      +K   L   C
Sbjct: 412 IATYGMS---------------PYPGI-DLSQVYELLEKDYRMERPEGCPEKVYELMRAC 455
Query: 340 LSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
              NP  RP  +++ +  E +   +   +E+   L
Sbjct: 456 WQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 490

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 105/203 (51%), Gaps = 23/203 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V+ GY + + +V +K+L        K G    + +L E N +  L+H  LV+
Sbjct: 20  LGAGQFGEVWMGYYNNSTKVAVKTL--------KPGTMSVQAFLEEANLMKTLQHDKLVR 71
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFR----KATVPLSWATRMMIAFGA--AKGLAFL 199
           L     +++   ++ EFM +GSL + L      K  +P       +I F A  A+G+A++
Sbjct: 72  LYAVVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLP------KLIDFSAQIAEGMAYI 125
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
               +  I+RD + +N+L+      K++DFGLA+   + +E            + APE +
Sbjct: 126 ER--KNYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAI 182
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
             G  T +S+V+SFG++L E++T
Sbjct: 183 NFGCFTIKSNVWSFGILLYEIVT 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 314
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 315 VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 374 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 430
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTT 459

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 18  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 76
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 77  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 136
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 137 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 194
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 195 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 239
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 240 EGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 285

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 58
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 59  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 117
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 118 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 174
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 175 TAPEAALYGRFTIKSDVWSFGILLTELTT 203

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+   +++ E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPIYIVI-EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 107/201 (53%), Gaps = 10/201 (4%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           ++G G FG V  G +      G + LPVA+K L K G   +  R++L E + +GQ  HPN
Sbjct: 29  VIGAGEFGEVCSGRLK---LPGKRELPVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPN 84
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++ L G   +    ++V E+M  GSL+  L +K     +    + +  G + G+ +L  +
Sbjct: 85  IIHLEGVVTKSKPVMIVTEYMENGSLDTFL-KKNDGQFTVIQLVGMLRGISAGMKYL--S 141
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGYAAPEYVMT 261
           +   ++RD    NIL++S+   K+SDFGL++      E   +TR       + APE +  
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 262 GHLTARSDVYSFGVVLLELLT 282
              T+ SDV+S+G+V+ E+++
Sbjct: 202 RKFTSASDVWSYGIVMWEVVS 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 146 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMSP 203
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 248
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 249 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S + +  LG G FG V+    +++ +V +K++        K G      +L E N
Sbjct: 11  EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--------KPGSMSVEAFLAEAN 62
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA- 192
            +  L+H  LVKL     ++   ++  EFM +GSL +  F K+          +I F A 
Sbjct: 63  VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQ 119
Query: 193 -AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A+G+AF+   +R  I+RD + +NIL+ +    K++DFGLA+   + +E           
Sbjct: 120 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPI 176
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            + APE +  G  T +SDV+SFG++L+E++T
Sbjct: 177 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 207

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 288

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 108/211 (51%), Gaps = 26/211 (12%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S + +  LG G FG V+    +++ +V +K++        K G      +L E N
Sbjct: 178 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--------KPGSMSVEAFLAEAN 229
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA- 192
            +  L+H  LVKL     ++   ++  EFM +GSL +  F K+          +I F A 
Sbjct: 230 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQ 286
Query: 193 -AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A+G+AF+   +R  I+RD + +NIL+ +    K++DFGLA+ G +              
Sbjct: 287 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARVGAK-----------FPI 333
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            + APE +  G  T +SDV+SFG++L+E++T
Sbjct: 334 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 364

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 144 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NPK RP   ++V  L+
Sbjct: 247 DGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 84  YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           + LGEG FG V+      N+      + VAVK L +      +++  E   L  L+H ++
Sbjct: 24  WELGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 82
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--------------ATVPLSWATRMMIA 189
           V+  G C E    L+V+E+M  G L N   R               A  PL     + +A
Sbjct: 83  VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 141
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A G+ +L  A    ++RD  T N L+      K+ DFG+++     D   V  R M 
Sbjct: 142 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              +  PE ++    T  SDV+SFGVVL E+ T
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 22  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 141 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 198
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 199 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 243
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NPK RP   ++V  L+
Sbjct: 244 DGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 284

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 55  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 114 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 170
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 171 TAPEAALYGRFTIKSDVWSFGILLTELTT 199

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 84  YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           + LGEG FG V+      N+      + VAVK L +      +++  E   L  L+H ++
Sbjct: 18  WELGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 76
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--------------ATVPLSWATRMMIA 189
           V+  G C E    L+V+E+M  G L N   R               A  PL     + +A
Sbjct: 77  VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 135
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A G+ +L  A    ++RD  T N L+      K+ DFG+++     D   V  R M 
Sbjct: 136 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              +  PE ++    T  SDV+SFGVVL E+ T
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 22  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQ 74
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 75  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 132
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 235
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 284

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 12/217 (5%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V +G +      G K   VA+K L K G   +  RE+
Sbjct: 7   FAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAP---GKKESCVAIKTL-KGGYTERQRREF 62
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN+++L G        +++ EFM  G+L++ L R      +    + +
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFL-RLNDGQFTVIQLVGM 121
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G A G+ +L  AE   ++RD    NIL++S+   K+SDFGL++   +       T  +
Sbjct: 122 LRGIASGMRYL--AEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSL 179
Query: 249 G---TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           G      + APE +     T+ SD +S+G+V+ E+++
Sbjct: 180 GGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 23  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 75
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 76  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 133
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 236
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 285

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 96/210 (45%), Gaps = 18/210 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L        +++  E   L  L+H ++VK
Sbjct: 21  LGEGAFGKVFLAEC-YNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 79
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-------------LSWATRMMIAFGA 192
             G C E D  ++V+E+M  G L    F +A  P             L+ +  + IA   
Sbjct: 80  FYGVCVEGDPLIMVFEYMKHGDLNK--FLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           A G+ +L  A +  ++RD  T N L+  +   K+ DFG+++     D   V    M    
Sbjct: 138 AAGMVYL--ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 195
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +  PE +M    T  SDV+S GVVL E+ T
Sbjct: 196 WMPPESIMYRKFTTESDVWSLGVVLWEIFT 225

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 95/213 (44%), Gaps = 18/213 (8%)
Query: 84  YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           + LGEG FG V+      N+      + VAVK L +      +++  E   L  L+H ++
Sbjct: 47  WELGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--------------ATVPLSWATRMMIA 189
           V+  G C E    L+V+E+M  G L N   R               A  PL     + +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A G+ +L  A    ++RD  T N L+      K+ DFG+++     D   V  R M 
Sbjct: 165 SQVAAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              +  PE ++    T  SDV+SFGVVL E+ T
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 56
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 57  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 115
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 116 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 172
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 173 TAPEAALYGRFTIKSDVWSFGILLTELTT 201

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E   + +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQVMKK 235
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A
Sbjct: 236 LRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++       ++RD + +NIL+  +   K++DFGLA+   + +E            + APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
             + G  T +SDV+SFG++L EL T
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/289 (24%), Positives = 132/289 (45%), Gaps = 26/289 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 34  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 86
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 87  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 144
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 204 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 247
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
               +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 248 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 296

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 135/287 (47%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 23  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 81
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATV------PLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L   R A        P S +  + +A   A G+
Sbjct: 82  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 141
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 142 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 199
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 200 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 244
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 245 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 135/287 (47%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATV------PLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L   R A        P S +  + +A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 152 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 254
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 255 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E   + +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQVMKK 235
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A
Sbjct: 236 LRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++       ++RD + +NIL+  +   K++DFGLA+   + +E            + APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
             + G  T +SDV+SFG++L EL T
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTT 376

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 19/211 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLG 136
             R   +LG G FGTV+KG +I E   +    +PV +KV+ +K G Q  +     +  +G
Sbjct: 32  ELRKLKVLGSGVFGTVHKGVWIPEGESI---KIPVCIKVIEDKSGRQSFQAVTDHMLAIG 88
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVP---LSWATRMMIAFG 191
            L H ++V+L+G C     +L V +++  GSL +H+   R A  P   L+W  ++     
Sbjct: 89  SLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----- 142
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            AKG+ +L   E  +++R+    N+LL S    +++DFG+A   P  D+  + +      
Sbjct: 143 -AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 199
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            + A E +  G  T +SDV+S+GV + EL+T
Sbjct: 200 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/225 (30%), Positives = 122/225 (54%), Gaps = 17/225 (7%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLR 139
           +D  LG G FG+V +G      R+  K + VA+KVL K+G +     E + E   + QL 
Sbjct: 340 ADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLD 394
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAF 198
           +P +V+LIG  C+ +  +LV E    G L   L  ++  +P+S    ++     + G+ +
Sbjct: 395 NPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELL--HQVSMGMKY 451
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAP 256
           L   E+  ++R+    N+LL + + AK+SDFGL+KA    D+++ + R  G +   + AP
Sbjct: 452 LE--EKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAP 508
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
           E +     ++RSDV+S+GV + E L+ G+K   K +  +  + ++
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 553

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 62
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + ++   A
Sbjct: 63  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIA 121
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 122 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEWTARQGAKFPIKW 178
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 109/211 (51%), Gaps = 16/211 (7%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S + +  LG G FG V+    +++ +V +K++        K G      +L E N
Sbjct: 184 EIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM--------KPGSMSVEAFLAEAN 235
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA- 192
            +  L+H  LVKL     ++   ++  EFM +GSL +  F K+          +I F A 
Sbjct: 236 VMKTLQHDKLVKLHAVVTKEPIYIIT-EFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQ 292
Query: 193 -AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            A+G+AF+   +R  I+RD + +NIL+ +    K++DFGLA+   + +E           
Sbjct: 293 IAEGMAFIE--QRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPI 349
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            + APE +  G  T +SDV+SFG++L+E++T
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 111/211 (52%), Gaps = 19/211 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLG 136
             R   +LG G FGTV+KG +I E   +    +PV +KV+ +K G Q  +     +  +G
Sbjct: 14  ELRKLKVLGSGVFGTVHKGVWIPEGESI---KIPVCIKVIEDKSGRQSFQAVTDHMLAIG 70
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVP---LSWATRMMIAFG 191
            L H ++V+L+G C     +L V +++  GSL +H+   R A  P   L+W  ++     
Sbjct: 71  SLDHAHIVRLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQI----- 124
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            AKG+ +L   E  +++R+    N+LL S    +++DFG+A   P  D+  + +      
Sbjct: 125 -AKGMYYLE--EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPI 181
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            + A E +  G  T +SDV+S+GV + EL+T
Sbjct: 182 KWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 77/335 (22%), Positives = 149/335 (44%), Gaps = 34/335 (10%)
Query: 40  ISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYI 99
           I+ L  P+  RN         +Y     +  +E+E    + +  + LG G +G VY+G  
Sbjct: 229 ITTLHYPAPKRN------KPTVYGVSPNYDKWEMERTDITMK--HKLGGGQYGEVYEGVW 280
Query: 100 DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV 159
            +       SL VAVK L ++ ++   E+L E   + +++HPNLV+L+G C  +    ++
Sbjct: 281 KK------YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 333
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
            EFM  G+L ++L       ++    + +A   +  + +L   ++  I+R+    N L+ 
Sbjct: 334 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKNFIHRNLAARNCLVG 391
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 279
            ++  K++DFGL++    GD             + APE +     + +SDV++FGV+L E
Sbjct: 392 ENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWE 450
Query: 280 LLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYC 339
           + T   S                 P + D  ++ ++++     +      +K   L   C
Sbjct: 451 IATYGMS---------------PYPGI-DLSQVYELLEKDYRMERPEGCPEKVYELMRAC 494
Query: 340 LSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
              NP  RP  +++ +  E +   +   +E+   L
Sbjct: 495 WQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 529

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E   + +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQVMKK 235
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A
Sbjct: 236 LRHEKLVQLYAVVSEEPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 294
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++       ++RD + +NIL+  +   K++DFGLA+   + +E            + APE
Sbjct: 295 YVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
             + G  T +SDV+SFG++L EL T
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTT 376

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 62
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + ++   A
Sbjct: 63  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIA 121
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 122 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 178
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 179 TAPEAALYGRFTIKSDVWSFGILLTELTT 207

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 111/220 (50%), Gaps = 12/220 (5%)
Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QG 124
           A   F  E      + + ++G G FG V  G +      G + + VA+K L K G   + 
Sbjct: 32  AVHQFAKELDASCIKIERVIGAGEFGEVCSGRLK---LPGKRDVAVAIKTL-KVGYTEKQ 87
Query: 125 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWAT 184
            R++L E + +GQ  HPN+V L G        ++V EFM  G+L+  L RK     +   
Sbjct: 88  RRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFL-RKHDGQFTVIQ 146
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            + +  G A G+ +L  A+   ++RD    NIL++S+   K+SDFGL++   + D   V 
Sbjct: 147 LVGMLRGIAAGMRYL--ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-IEDDPEAVY 203
Query: 245 TRVMGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           T   G     + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 243

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + ++RH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKIRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +G L + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/209 (30%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD   +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 25  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 77
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 135
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 238
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 26  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 78
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 79  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 239
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V  G +      G + + VA+K L K G   +  R++
Sbjct: 22  FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVP---GKREICVAIKTL-KAGYTDKQRRDF 77
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN++ L G   +    +++ E+M  GSL+  L RK     +    + +
Sbjct: 78  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGM 136
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G   G+ +L  ++   ++RD    NIL++S+   K+SDFG+++      E   +TR  
Sbjct: 137 LRGIGSGMKYL--SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGG 194
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 195 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 139 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 241
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 242 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGTMSPEAFLQEAQ 65
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +G L + L  +    L     + +A   A
Sbjct: 66  VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIA 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGLA+   + +E            +
Sbjct: 125 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKW 181
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 182 TAPEAALYGRFTIKSDVWSFGILLTELTT 210

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 109/215 (50%), Gaps = 12/215 (5%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRV-GLKSLPVAVKVLNKEGL--QGHRE 127
           F  E        + I+G G  G V  G     +RV G + +PVA+K L K G   +  R+
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYG----RLRVPGQRDVPVAIKAL-KAGYTERQRRD 96
Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           +L+E + +GQ  HPN+++L G        ++V E+M  GSL+  L R      +    + 
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVG 155
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +  G   G+ +L  ++   ++RD    N+L+DS+   K+SDFGL++      D  + +T 
Sbjct: 156 MLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTG 213
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
                 + APE +     ++ SDV+SFGVV+ E+L
Sbjct: 214 GKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 145 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 247
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 248 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 127/275 (46%), Gaps = 26/275 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 21  LGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 73
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    ++ EFM  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 74  LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLE--KKN 131
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 266 ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYS 325
            +SDV++FGV+L E+ T   S                 P + D  ++ ++++     +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMS---------------PYPGI-DLSQVYELLEKDYRMERP 234
Query: 326 VRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +K   L   C   NP  RP  +++ +  E +
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 107/203 (52%), Gaps = 12/203 (5%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           ++G G FG V  G++      G + + VA+K L K G   +  R++L+E + +GQ  HPN
Sbjct: 14  VIGAGEFGEVCSGHLK---LPGKREIFVAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++ L G   +    +++ EFM  GSL++ L R+     +    + +  G A G+ +L  A
Sbjct: 70  VIHLEGVVTKSTPVMIITEFMENGSLDSFL-RQNDGQFTVIQLVGMLRGIAAGMKYL--A 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG---TYGYAAPEYV 259
           +   ++R     NIL++S+   K+SDFGL++           T  +G      + APE +
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
                T+ SDV+S+G+V+ E+++
Sbjct: 187 QYRKFTSASDVWSYGIVMWEVMS 209

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 33  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 92  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 151
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 152 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 210 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 254
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 255 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 300

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 27  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 85
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 86  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 145
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 146 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 203
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 204 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 248
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 249 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 294

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 24  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 82
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 83  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 142
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 143 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 200
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 201 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 245
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 246 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 291

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 24  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 143 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 200
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 201 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 245
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NPK RP   ++V  L+
Sbjct: 246 DGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 26  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 85  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 144
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 145 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 202
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 203 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 247
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 248 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 293

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 109/217 (50%), Gaps = 16/217 (7%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRV-GLKSLPVAVKVLNKEGL--QGHRE 127
           F  E        + I+G G  G V  G     +RV G + +PVA+K L K G   +  R+
Sbjct: 42  FTREIEASRIHIEKIIGSGDSGEVCYG----RLRVPGQRDVPVAIKAL-KAGYTERQRRD 96
Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           +L+E + +GQ  HPN+++L G        ++V E+M  GSL+  L R      +    + 
Sbjct: 97  FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVG 155
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVS 244
           +  G   G+ +L  ++   ++RD    N+L+DS+   K+SDFGL++     P    T   
Sbjct: 156 MLRGVGAGMRYL--SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTG 213
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
            ++     + APE +     ++ SDV+SFGVV+ E+L
Sbjct: 214 GKI--PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V  G +      G + + VA+K L K G   +  R++
Sbjct: 7   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVP---GKREICVAIKTL-KAGYTDKQRRDF 62
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN++ L G   +    +++ E+M  GSL+  L RK     +    + +
Sbjct: 63  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGM 121
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G   G+ +L  ++   ++RD    NIL++S+   K+SDFG+++      E   +TR  
Sbjct: 122 LRGIGSGMKYL--SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGG 179
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 180 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 144 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAP 201
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NP  RP   ++V  L+
Sbjct: 247 DGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 133/287 (46%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 55  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 113
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 114 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 173
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 174 AYL-NANK-FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 231
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 232 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 276
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 277 EGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 322

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 110/215 (51%), Gaps = 10/215 (4%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREW 128
           F  E      + + ++G G FG V  G +      G + + VA+K L K G   +  R++
Sbjct: 1   FAKEIDASCIKIEKVIGVGEFGEVCSGRLKVP---GKREICVAIKTL-KAGYTDKQRRDF 56
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L+E + +GQ  HPN++ L G   +    +++ E+M  GSL+  L RK     +    + +
Sbjct: 57  LSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDAFL-RKNDGRFTVIQLVGM 115
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
             G   G+ +L  ++   ++RD    NIL++S+   K+SDFG+++      E   +TR  
Sbjct: 116 LRGIGSGMKYL--SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGG 173
Query: 249 GT-YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                + APE +     T+ SDV+S+G+V+ E+++
Sbjct: 174 KIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 131/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 144 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NPK RP   ++V  L+
Sbjct: 247 DGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 132/287 (45%), Gaps = 32/287 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G + + V        VA+K +N+      R E+L E + + +    ++V
Sbjct: 20  LGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 78
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L++ E M RG L+++L              P S +  + +A   A G+
Sbjct: 79  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGM 138
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA +  ++RD    N  +  D+T K+ DFG+ +   + D      + +    + +P
Sbjct: 139 AYL-NANK-FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 196
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SDV+SFGVVL E+ T               L +     L++++ +  ++
Sbjct: 197 ESLKDGVFTTYSDVWSFGVVLWEIAT---------------LAEQPYQGLSNEQVLRFVM 241
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLEP 359
           +  L ++           L   C   NPK RP    ++S + E +EP
Sbjct: 242 EGGLLDKPD-NCPDMLLELMRMCWQYNPKMRPSFLEIISSIKEEMEP 287

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           E   +S R +  LG+G FG V+ G  +   RV +K+L        K G      +L E  
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL--------KPGNMSPEAFLQEAQ 232
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            + +LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A
Sbjct: 233 VMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIA 291
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+A++       ++RD + +NIL+  +   K++DFGL +   + +E            +
Sbjct: 292 SGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLGRL-IEDNEYTARQGAKFPIKW 348
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE  + G  T +SDV+SFG++L EL T
Sbjct: 349 TAPEAALYGRFTIKSDVWSFGILLTELTT 377

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 28/214 (13%)
Query: 82  SDYILGEGGFGTVYKG-YIDE---NVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           SD ++G+G FG VY G YID+    ++  +KSL    ++   E       +L E   +  
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA------FLREGLLMRG 78
Query: 138 LRHPNLVKLIGYCCEDD---HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG--A 192
           L HPN++ LIG     +   H LL Y  M  G L   +      P     + +I+FG   
Sbjct: 79  LNHPNVLALIGIMLPPEGLPHVLLPY--MCHGDLLQFIRSPQRNP---TVKDLISFGLQV 133
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD----ETHVSTRVM 248
           A+G+ +L  AE+  ++RD    N +LD  +T K++DFGLA+     +    + H   R+ 
Sbjct: 134 ARGMEYL--AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL- 190
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
               + A E + T   T +SDV+SFGV+L ELLT
Sbjct: 191 -PVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 11/221 (4%)
Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P 
Sbjct: 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 431
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L   
Sbjct: 432 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE-- 486
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYVM 260
           E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE + 
Sbjct: 487 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECIN 545
Query: 261 TGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
               +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 546 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 586

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 112/221 (50%), Gaps = 11/221 (4%)
Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P 
Sbjct: 375 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNPY 432
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L   
Sbjct: 433 IVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE-- 487
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYVM 260
           E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE + 
Sbjct: 488 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECIN 546
Query: 261 TGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
               +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 547 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 587

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 88
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 89  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 144
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 145 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 202
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 88
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 89  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 144
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 145 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 202
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 244

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 86
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 87  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 142
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 143 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 200
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 242

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 68
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 69  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 124
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 125 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 182
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 78
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 79  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 134
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 135 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 192
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 72
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 73  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 128
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 129 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 186
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 66
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 67  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 122
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE +   +  G +   + APE +
Sbjct: 123 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENYYKAQTHGKWPVKWYAPECI 180
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 222

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 86  LGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           LGEG FG V     D E    G +   VAVK L  E    H  +   E+  L  L H N+
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85
Query: 144 VKLIGYCCED--DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           VK  G C ED  +   L+ EF+  GSL+ +L +     ++   ++  A    KG+ +L  
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL-- 142
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYV 259
             R  ++RD    N+L++S++  K+ DFGL KA     E  T    R    + Y APE +
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 201
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
           M       SDV+SFGV L ELLT
Sbjct: 202 MQSKFYIASDVWSFGVTLHELLT 224

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/324 (27%), Positives = 139/324 (42%), Gaps = 49/324 (15%)
Query: 65  VIAFSLFE---LETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKE 120
           V AF + E    E   K+      LGEG FG V K        R G  +  VAVK+L + 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKEN 64
Query: 121 GLQGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV- 178
                 R+ L+E N L Q+ HP+++KL G C +D   LL+ E+   GSL   L     V 
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 179 ---------------------PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
                                 L+    +  A+  ++G+ +L  AE  +++RD    NIL
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNIL 182
Query: 218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVL 277
           +      K+SDFGL++   + D     ++      + A E +     T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 278 LELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLA 336
            E++T G        P +  +L       L    +M      R +N      +++   L 
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNL-------LKTGHRM-----ERPDN-----CSEEMYRLM 285
Query: 337 YYCLSQNPKARPLMSDVVETLEPL 360
             C  Q P  RP+ +D+ + LE +
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 89/324 (27%), Positives = 139/324 (42%), Gaps = 49/324 (15%)
Query: 65  VIAFSLFE---LETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKE 120
           V AF + E    E   K+      LGEG FG V K        R G  +  VAVK+L + 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKEN 64
Query: 121 GLQGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV- 178
                 R+ L+E N L Q+ HP+++KL G C +D   LL+ E+   GSL   L     V 
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 179 ---------------------PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
                                 L+    +  A+  ++G+ +L  AE  +++RD    NIL
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMSLVHRDLAARNIL 182
Query: 218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVL 277
           +      K+SDFGL++   + D     ++      + A E +     T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 278 LELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLA 336
            E++T G        P +  +L       L    +M      R +N      +++   L 
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNL-------LKTGHRM-----ERPDN-----CSEEMYRLM 285
Query: 337 YYCLSQNPKARPLMSDVVETLEPL 360
             C  Q P  RP+ +D+ + LE +
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 99/203 (48%), Gaps = 13/203 (6%)
Query: 86  LGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           LGEG FG V     D E    G +   VAVK L  E    H  +   E+  L  L H N+
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQ---VAVKSLKPESGGNHIADLKKEIEILRNLYHENI 73
Query: 144 VKLIGYCCED--DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           VK  G C ED  +   L+ EF+  GSL+ +L +     ++   ++  A    KG+ +L  
Sbjct: 74  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN-KINLKQQLKYAVQICKGMDYL-- 130
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYV 259
             R  ++RD    N+L++S++  K+ DFGL KA     E  T    R    + Y APE +
Sbjct: 131 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWY-APECL 189
Query: 260 MTGHLTARSDVYSFGVVLLELLT 282
           M       SDV+SFGV L ELLT
Sbjct: 190 MQSKFYIASDVWSFGVTLHELLT 212

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 130
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 131 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 187
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 188 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 237

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 130 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 187 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 126/281 (44%), Gaps = 32/281 (11%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNF 134
           + F+   +LG+G F  VY+    E++  GL+   VA+K+++K+ +      +    EV  
Sbjct: 11  EDFKVGNLLGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKI 64
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
             QL+HP++++L  Y  + ++  LV E    G +  +L +    P S             
Sbjct: 65  HCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL-KNRVKPFSENEARHFMHQIIT 123
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+ +LH+    +++RD   SN+LL  +   K++DFGLA       E H +  + GT  Y 
Sbjct: 124 GMLYLHS--HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYI 179
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           +PE          SDV+S G +   LL GR   D           D  +  LN     + 
Sbjct: 180 SPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFD----------TDTVKNTLNK----VV 225
Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           + D  + +  S+ A      L +  L +NP  R  +S V++
Sbjct: 226 LADYEMPSFLSIEAKD----LIHQLLRRNPADRLSLSSVLD 262

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 127
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 128 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 185 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 234

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 89/324 (27%), Positives = 139/324 (42%), Gaps = 49/324 (15%)
Query: 65  VIAFSLFE---LETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKE 120
           V AF + E    E   K+      LGEG FG V K        R G  +  VAVK+L + 
Sbjct: 7   VDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTT--VAVKMLKEN 64
Query: 121 GLQGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV- 178
                 R+ L+E N L Q+ HP+++KL G C +D   LL+ E+   GSL   L     V 
Sbjct: 65  ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVG 124
Query: 179 ---------------------PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
                                 L+    +  A+  ++G+ +L  AE  +++RD    NIL
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNIL 182
Query: 218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVL 277
           +      K+SDFGL++   + D     ++      + A E +     T +SDV+SFGV+L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 278 LELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLA 336
            E++T G        P +  +L       L    +M      R +N      +++   L 
Sbjct: 243 WEIVTLGGNPYPGIPPERLFNL-------LKTGHRM-----ERPDN-----CSEEMYRLM 285
Query: 337 YYCLSQNPKARPLMSDVVETLEPL 360
             C  Q P  RP+ +D+ + LE +
Sbjct: 286 LQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 184 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 17  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 73
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 74  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI----- 127
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 128 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 184
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 185 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 121/231 (52%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 129 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 186 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 111/222 (50%), Gaps = 11/222 (4%)
Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
            D  LG G FGTV KGY      V   ++ +     N   L+   E L E N + QL +P
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD--ELLAEANVMQQLDNP 72
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       + +    + G+ +L  
Sbjct: 73  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDK--NIIELVHQVSMGMKYLE- 128
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY--GYAAPEYV 259
            E   ++RD    N+LL + + AK+SDFGL+KA  + DE     +  G +   + APE +
Sbjct: 129 -ESNFVHRDLAARNVLLVTQHYAKISDFGLSKA-LRADENXYKAQTHGKWPVKWYAPECI 186
Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
                +++SDV+SFGV++ E  + G+K     + S+  ++++
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 228

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 68/230 (29%), Positives = 120/230 (52%), Gaps = 22/230 (9%)
Query: 80  FRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQ 137
           F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   +  
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMAS 79
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFGA 192
           + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++      
Sbjct: 80  VDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------ 132
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTY 251
           AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +   
Sbjct: 133 AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI- 189
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
            + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 190 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 239

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 134 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-P 189
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 240

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 130 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 187 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 184 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 130 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 187 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV-P 182
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 26  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 82
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 83  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 136
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 137 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 193
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 194 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 243

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 129 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 185
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 186 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 19  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 75
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 76  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 129
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 130 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 186
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 187 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 236

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG V  G    N         VAVK +  +     + +L E + + QLRH NLV+
Sbjct: 201 IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 250
Query: 146 LIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L     
Sbjct: 251 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 309
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             ++RD    N+L+  D  AK+SDFGL K A    D   +  +      + APE +    
Sbjct: 310 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 362
Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            + +SDV+SFG++L E+ + GR              V + R  L D       + PR+E 
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPRVEK 401
Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
            Y + A    C  A Y     C   +   RP    + E LE ++
Sbjct: 402 GYKMDAPD-GCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIR 444

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 184 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG V  G    N         VAVK +  +     + +L E + + QLRH NLV+
Sbjct: 20  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 69
Query: 146 LIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L     
Sbjct: 70  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 128
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             ++RD    N+L+  D  AK+SDFGL K A    D   +  +      + APE +    
Sbjct: 129 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREAA 181
Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            + +SDV+SFG++L E+ + GR              V + R  L D       + PR+E 
Sbjct: 182 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPRVEK 220
Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
            Y + A    C  A Y     C   +   RP    + E LE ++
Sbjct: 221 GYKMDAPD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 263

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 98/217 (45%), Gaps = 22/217 (10%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW- 128
           LF  +   K F     +G G FG VY      N  V      VA+K ++  G Q + +W 
Sbjct: 46  LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQ 99
Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             + EV FL +LRHPN ++  G    +    LV E+   GS  + L      PL      
Sbjct: 100 DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIA 157
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            +  GA +GLA+LH+    +I+RD K  NILL      KL DFG A           +  
Sbjct: 158 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI------MAPANX 209
Query: 247 VMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLEL 280
            +GT  + APE ++    G    + DV+S G+  +EL
Sbjct: 210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 66
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 67  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 120
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 121 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 178 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 41  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 97
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 98  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 151
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 152 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 208
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 209 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 258

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++RD    N ++  D+T K+ DFG+ +   +        + +    + AP
Sbjct: 144 AYL-NAKK-FVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAP 201
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NPK RP   ++V  L+
Sbjct: 247 DGGYLDQPD-NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLK 287

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ EF+  GSL  +L +K    +     +       KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL-QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 107
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--------PLSWATRMMIAF 190
           +H N+V L+G C      L++ E+   G L N L RKA          PL     +  + 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 167
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V       
Sbjct: 168 QVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 225
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             + APE +     T +SDV+S+G++L E+ +
Sbjct: 226 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQL-RH 140
           ++G G +  V    + +  R+       A+KV+ KE +    +  W+ TE +   Q   H
Sbjct: 27  VIGRGSYAKVLLVRLKKTDRI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 141 PNLVKLIGYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      + A   LA  
Sbjct: 81  PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLALN 135
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T  ++   GT  Y APE +
Sbjct: 136 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 193
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D ++ GV++ E++ GR   D    S          P  N +  + Q+I   
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD--------NPDQNTEDYLFQVI--- 242
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKAR 347
           LE Q  +    + KA S+    L+++PK R
Sbjct: 243 LEKQIRIPRSMSVKAASVLKSFLNKDPKER 272

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 23/212 (10%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 99
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--------PLSWATRMMIAF 190
           +H N+V L+G C      L++ E+   G L N L RKA          PL     +  + 
Sbjct: 100 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSS 159
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V       
Sbjct: 160 QVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLP 217
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             + APE +     T +SDV+S+G++L E+ +
Sbjct: 218 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 24/218 (11%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW- 128
           LF  +   K F     +G G FG VY      N  V      VA+K ++  G Q + +W 
Sbjct: 7   LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQ 60
Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             + EV FL +LRHPN ++  G    +    LV E+   GS  + L      PL      
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASD-LLEVHKKPLQEVEIA 118
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVST 245
            +  GA +GLA+LH+    +I+RD K  NILL      KL DFG A    P       + 
Sbjct: 119 AVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-------AN 169
Query: 246 RVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLEL 280
             +GT  + APE ++    G    + DV+S G+  +EL
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG V  G    N         VAVK +  +     + +L E + + QLRH NLV+
Sbjct: 14  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 63
Query: 146 LIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L     
Sbjct: 64  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 122
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             ++RD    N+L+  D  AK+SDFGL K A    D   +  +      + APE +    
Sbjct: 123 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 175
Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            + +SDV+SFG++L E+ + GR              V + R  L D       + PR+E 
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPRVEK 214
Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
            Y + A    C  A Y     C   +   RP    + E LE ++
Sbjct: 215 GYKMDAPD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 257

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 125/284 (44%), Gaps = 48/284 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G FG V  G    N         VAVK +  +     + +L E + + QLRH NLV+
Sbjct: 29  IGKGEFGDVMLGDYRGN--------KVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQ 78
Query: 146 LIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L     
Sbjct: 79  LLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN- 137
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             ++RD    N+L+  D  AK+SDFGL K A    D   +  +      + APE +    
Sbjct: 138 -FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK------WTAPEALREKK 190
Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            + +SDV+SFG++L E+ + GR              V + R  L D       + PR+E 
Sbjct: 191 FSTKSDVWSFGILLWEIYSFGR--------------VPYPRIPLKD-------VVPRVEK 229
Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
            Y + A    C  A Y     C   +   RP    + E LE ++
Sbjct: 230 GYKMDAPD-GCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 272

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 101/210 (48%), Gaps = 15/210 (7%)
Query: 86  LGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G+VYK    E  + V +K +PV   +         +E + E++ + Q   P++V
Sbjct: 37  LGEGSYGSVYKAIHKETGQIVAIKQVPVESDL---------QEIIKEISIMQQCDSPHVV 87
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   ++    +V E+   GS+ + + R     L+      I     KGL +LH   +
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K  NILL+++  AKL+DFG+  AG   D       V+GT  + APE +     
Sbjct: 147 --IHRDIKAGNILLNTEGHAKLADFGV--AGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY 202
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
              +D++S G+  +E+  G+       P +
Sbjct: 203 NCVADIWSLGITAIEMAEGKPPYADIHPMR 232

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 26  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++R+    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 145 AYL-NAKK-FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 202
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 203 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 247
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NP  RP   ++V  L+
Sbjct: 248 DGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 288

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 130/282 (46%), Gaps = 28/282 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG+G FG VY+G   + ++ G     VAVK +N+   L+   E+L E + +      ++V
Sbjct: 25  LGQGSFGMVYEGNARDIIK-GEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMMIAFGAAKGL 196
           +L+G   +    L+V E M  G L+++L              P +    + +A   A G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L NA++  ++R+    N ++  D+T K+ DFG+ +   + D      + +    + AP
Sbjct: 144 AYL-NAKK-FVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 201
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T  SD++SFGVVL E+                SL +     L++++ +  ++
Sbjct: 202 ESLKDGVFTTSSDMWSFGVVLWEI---------------TSLAEQPYQGLSNEQVLKFVM 246
Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           D    +Q      ++   L   C   NP  RP   ++V  L+
Sbjct: 247 DGGYLDQPD-NCPERVTDLMRMCWQFNPNMRPTFLEIVNLLK 287

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQL-RH 140
           ++G G +  V    + +  R+       A+KV+ KE +    +  W+ TE +   Q   H
Sbjct: 12  VIGRGSYAKVLLVRLKKTDRI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 141 PNLVKLIGYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      + A   LA  
Sbjct: 66  PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLALN 120
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T  ++   GT  Y APE +
Sbjct: 121 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 178
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D ++ GV++ E++ GR   D    S          P  N +  + Q+I   
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD--------NPDQNTEDYLFQVI--- 227
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKAR 347
           LE Q  +    + KA S+    L+++PK R
Sbjct: 228 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 257

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/270 (29%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQL-RH 140
           ++G G +  V    + +  R+       A+KV+ KE +    +  W+ TE +   Q   H
Sbjct: 16  VIGRGSYAKVLLVRLKKTDRI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 141 PNLVKLIGYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      + A   LA  
Sbjct: 70  PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLALN 124
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T  ++   GT  Y APE +
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSXFCGTPNYIAPEIL 182
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D ++ GV++ E++ GR   D    S          P  N +  + Q+I   
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD--------NPDQNTEDYLFQVI--- 231
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKAR 347
           LE Q  +    + KA S+    L+++PK R
Sbjct: 232 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 70
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 129
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 130 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFT 211

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 75
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 134
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 135 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFT 216

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 78
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 137
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 138 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFT 219

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 69
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 128
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 129 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 76
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 135
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 136 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFT 217

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 102
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 162 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFT 243

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 28/221 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           +GEG FG V++      +     ++ VAVK+L +E     + ++  E   + +  +PN+V
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTM-VAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFR-----------------KATV------PLS 181
           KL+G C       L++E+M  G L N   R                 +A V      PLS
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDL-NEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
            A ++ IA   A G+A+L  +ER  ++RD  T N L+  +   K++DFGL++     D  
Sbjct: 173 CAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                      +  PE +     T  SDV+++GVVL E+ +
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 77
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 136
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 137 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFT 218

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 12/207 (5%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV--LNKEGLQGHREWLTEVNFLGQLRHPN 142
           ILGEG FG+V +G + +     LK   VAVK   L+    +   E+L+E   +    HPN
Sbjct: 41  ILGEGEFGSVMEGNLKQEDGTSLK---VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97
Query: 143 LVKLIGYCCEDDHR-----LLVYEFMFRGSLENHLF--RKATVPLSWATRMMIAFGAAKG 195
           +++L+G C E   +     +++  FM  G L  +L   R  T P     + ++ F     
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L   + + R  ++RD    N +L  D T  ++DFGL+K    GD             + A
Sbjct: 158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 217
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT 282
            E +     T++SDV++FGV + E+ T
Sbjct: 218 IESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 13  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 69
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 70  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 123
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            A+G+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 124 -AEGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 180
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 181 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 230

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 89
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 148
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 149 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFT 230

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/270 (28%), Positives = 126/270 (46%), Gaps = 31/270 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WL-TEVNFLGQL-RH 140
           ++G G +  V    + +  R+       A++V+ KE +    +  W+ TE +   Q   H
Sbjct: 59  VIGRGSYAKVLLVRLKKTDRI------YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 141 PNLVKLIGYCCEDDHRLL-VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      + A   LA  
Sbjct: 113 PFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR----FYSAEISLALN 167
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T  ++   GT  Y APE +
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--TSTFCGTPNYIAPEIL 225
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D ++ GV++ E++ GR   D    S          P  N +  + Q+I   
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD--------NPDQNTEDYLFQVI--- 274
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKAR 347
           LE Q  +    + KA S+    L+++PK R
Sbjct: 275 LEKQIRIPRSLSVKAASVLKSFLNKDPKER 304

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +L  G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 134 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 191 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 240

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 107
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV----PL------SWATRMMI 188
           +H N+V L+G C      L++ E+   G L N L RK+ V    P       + +TR ++
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLL 167
Query: 189 AFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            F +  A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V   
Sbjct: 168 HFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+S+G++L E+ +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 96/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 71
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 131 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFT 212

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 20  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 76
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 77  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 130
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 131 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 187
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 188 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 237

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 129 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 185
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 186 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +L  G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 134 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 190
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 191 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 240

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +L  G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLSSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 184 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+  L +    + ++E L E   + 
Sbjct: 50  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIMELREATSPKANKEILDEAYVMA 106
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 107 SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 160
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFGLAK  G +  E H     +  
Sbjct: 161 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 217
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 218 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 267

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 120/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L++ + M  G L +++        +   L+W  ++     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 129 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-P 184
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 27/216 (12%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 107
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV----PL------SWATRMMI 188
           +H N+V L+G C      L++ E+   G L N L RK+ V    P       + +TR ++
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 189 AFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            F +  A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V   
Sbjct: 168 HFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGN 225
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+S+G++L E+ +
Sbjct: 226 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 23  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 79
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 80  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 133
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 134 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-P 189
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 190 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 240

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 18  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 74
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 75  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 128
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 129 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKV-P 184
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 185 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 235

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 119/231 (51%), Gaps = 22/231 (9%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLG 136
            F+   +LG G FGTVYKG +I E  +V    +PVA+K L +    + ++E L E   + 
Sbjct: 16  EFKKIKVLGSGAFGTVYKGLWIPEGEKV---KIPVAIKELREATSPKANKEILDEAYVMA 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-----ATVPLSWATRMMIAFG 191
            + +P++ +L+G C     +L+  + M  G L +++        +   L+W  ++     
Sbjct: 73  SVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNWCVQI----- 126
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGT 250
            AKG+ +L +  R +++RD    N+L+ +    K++DFG AK  G +  E H     +  
Sbjct: 127 -AKGMNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPI 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
             + A E ++    T +SDV+S+GV + EL+T G K  D    S+  S+++
Sbjct: 184 -KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 23/291 (7%)
Query: 58  NAVLYTHVIAFSLFELETITK-SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           +++ +   + +   E + +TK +FR   +LG+GGFG V    +      G       ++ 
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRA---TGKMYACKKLEK 219
Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA 176
              +  +G    L E   L ++    +V L       D   LV   M  G L+ H++   
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
                 A  +  A     GL  LH  ER ++YRD K  NILLD     ++SD GLA   P
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHR-ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
           +G    +  RV GT GY APE V     T   D ++ G +L E++ G+    +       
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR------ 388
Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
                   K   KR+ ++ +   +  +YS R + +A SL    L ++P  R
Sbjct: 389 --------KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 78/291 (26%), Positives = 124/291 (42%), Gaps = 23/291 (7%)
Query: 58  NAVLYTHVIAFSLFELETITK-SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           +++ +   + +   E + +TK +FR   +LG+GGFG V    +      G       ++ 
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEK 219
Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA 176
              +  +G    L E   L ++    +V L       D   LV   M  G L+ H++   
Sbjct: 220 KRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279
Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
                 A  +  A     GL  LH  ER ++YRD K  NILLD     ++SD GLA   P
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHR-ER-IVYRDLKPENILLDDHGHIRISDLGLAVHVP 337
Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
           +G    +  RV GT GY APE V     T   D ++ G +L E++ G+    +       
Sbjct: 338 EGQT--IKGRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR------ 388
Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
                   K   KR+ ++ +   +  +YS R + +A SL    L ++P  R
Sbjct: 389 --------KKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAER 431

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 67/221 (30%), Positives = 111/221 (50%), Gaps = 15/221 (6%)
Query: 80  FRSDYILGEGGFGTVYKGYI---DENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFL 135
            R   +LG G FGTVYKG      ENV++     PVA+KVL +    + ++E L E   +
Sbjct: 19  LRKVKVLGSGAFGTVYKGIWIPDGENVKI-----PVAIKVLRENTSPKANKEILDEAYVM 73
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
             +  P + +L+G C     +L V + M  G L +H+ R+    L     +      AKG
Sbjct: 74  AGVGSPYVSRLLGICLTSTVQL-VTQLMPYGCLLDHV-RENRGRLGSQDLLNWCMQIAKG 131
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           +++L +    +++RD    N+L+ S    K++DFGLA+     +  + +        + A
Sbjct: 132 MSYLEDVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMA 189
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKE 295
            E ++    T +SDV+S+GV + EL+T G K  D   P++E
Sbjct: 190 LESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGI-PARE 229

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 126
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/204 (32%), Positives = 97/204 (47%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 72
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL 131
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH-VSTRVMGTYGYAAPEY 258
               +  I+R+  T NIL++++   K+ DFGL K  PQ  E + V         + APE 
Sbjct: 132 --GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFT 213

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 16/204 (7%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG+G FG+V    Y    D    V      VAVK L     +  R++  E+  L  L+H 
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEV------VAVKKLQHSTEEHLRDFEREIEILKSLQHD 74
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+VK  G C     R   L+ E++  GSL ++L   A   +     +       KG+ +L
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAE-RIDHIKLLQYTSQICKGMEYL 133
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEY 258
               +  I+RD  T NIL++++   K+ DFGL K  PQ  E   V         + APE 
Sbjct: 134 --GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 259 VMTGHLTARSDVYSFGVVLLELLT 282
           +     +  SDV+SFGVVL EL T
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFT 215

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    E       S+  A KV++ +  +   +++ E++ L    HPN+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+     +++  ++ EF   G+++  +  +   PL+ +   ++       L +LH+    
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NK 155
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           +I+RD K  NIL   D   KL+DFG++    +  +   S   +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSK 213
Query: 266 AR-----SDVYSFGVVLLEL 280
            R     +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G +G VY G   +       SL VAVK L ++ ++   E+L E   + +++HPNLV+
Sbjct: 40  LGGGQYGEVYVGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQ 92
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+G C  +    +V E+M  G+L ++L       ++    + +A   +  + +L   ++ 
Sbjct: 93  LLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE--KKN 150
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
            I+RD    N L+  ++  K++DFGL++    GD             + APE +     +
Sbjct: 151 FIHRDLAARNCLVGENHVVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 266 ARSDVYSFGVVLLELLT 282
            +SDV++FGV+L E+ T
Sbjct: 210 IKSDVWAFGVLLWEIAT 226

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 100/200 (50%), Gaps = 16/200 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    E       S+  A KV++ +  +   +++ E++ L    HPN+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+     +++  ++ EF   G+++  +  +   PL+ +   ++       L +LH+    
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NK 155
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           +I+RD K  NIL   D   KL+DFG++    +  +   S   +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDS--FIGTPYWMAPEVVMCETSK 213
Query: 266 AR-----SDVYSFGVVLLEL 280
            R     +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 103/217 (47%), Gaps = 24/217 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +LG+G FG   K    E   V      + +K L +   +  R +L EV  +  L HPN++
Sbjct: 17  VLGKGCFGQAIKVTHRETGEV------MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K IG   +D     + E++  G+L   + +       W+ R+  A   A G+A+LH+   
Sbjct: 71  KFIGVLYKDKRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN- 128
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLA------KAGPQG-------DETHVSTRVMGTY 251
            +I+RD  + N L+  +    ++DFGLA      K  P+G       D     T V+G  
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYT-VVGNP 186
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVD 288
            + APE +       + DV+SFG+VL E++ GR + D
Sbjct: 187 YWMAPEMINGRSYDEKVDVFSFGIVLCEII-GRVNAD 222

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 122
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 132
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 122
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 100/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 12  KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 68
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 69  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 126
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 127 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 184
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 185 CAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    E       S+  A KV++ +  +   +++ E++ L    HPN+VK
Sbjct: 45  LGDGAFGKVYKAQNKET------SVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 98
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+     +++  ++ EF   G+++  +  +   PL+ +   ++       L +LH+    
Sbjct: 99  LLDAFYYENNLWILIEFCAGGAVDAVML-ELERPLTESQIQVVCKQTLDALNYLHD--NK 155
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT 265
           +I+RD K  NIL   D   KL+DFG++    +          +GT  + APE VM     
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRX--IQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 266 AR-----SDVYSFGVVLLEL 280
            R     +DV+S G+ L+E+
Sbjct: 214 DRPYDYKADVWSLGITLIEM 233

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 107
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA------------TRM 186
           +H N+V L+G C      L++ E+   G L N L RK    L ++            +R 
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRD 167
Query: 187 MIAFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
           ++ F +  A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V 
Sbjct: 168 LLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK 225
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                   + APE +     T +SDV+S+G++L E+ +
Sbjct: 226 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ +E      +   E+  L Q   P + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +D    ++ E++  GS  + L      PL       I     KGL +LH+ ++
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 140
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE +     
Sbjct: 141 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 196
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G     +  P K   L+    PK N          P LE  Y
Sbjct: 197 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNN---------PPTLEGNY 243
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL++ P  RP   ++++
Sbjct: 244 S----KPLKEFVEACLNKEPSFRPTAKELLK 270

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 18  KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNA 74
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 75  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 132
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+  V        + +
Sbjct: 133 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 190
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 191 CAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 99/209 (47%), Gaps = 11/209 (5%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAP---SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G       ++ V E    GSL + L RK        T    A   A+
Sbjct: 65  MHSLDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAE 122
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT-YGY 253
           G+ +L +  +  I+RD    N+LL +    K+ DFGL +A PQ D+  V        + +
Sbjct: 123 GMGYLES--KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAW 180
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE + T   +  SD + FGV L E+ T
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ +E      +   E+  L Q   P + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +D    ++ E++  GS  + L      PL       I     KGL +LH+ ++
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE +     
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 181
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G     +  P K   L+    PK N          P LE  Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNN---------PPTLEGNY 228
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL++ P  RP   ++++
Sbjct: 229 S----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ +E      +   E+  L Q   P + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +D    ++ E++  GS  + L      PL       I     KGL +LH+ ++
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE +     
Sbjct: 126 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 181
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G     +  P K   L+    PK N          P LE  Y
Sbjct: 182 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNN---------PPTLEGNY 228
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL++ P  RP   ++++
Sbjct: 229 S----KPLKEFVEACLNKEPSFRPTAKELLK 255

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 53
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 168
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 53
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 168
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 120/271 (44%), Gaps = 31/271 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ +E      +   E+  L Q   P + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +D    ++ E++  GS  + L      PL       I     KGL +LH+ ++
Sbjct: 89  KYYGSYLKDTKLWIIMEYLGGGSALDLL---EPGPLDETQIATILREILKGLDYLHSEKK 145
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+A  G   D        +GT  + APE +     
Sbjct: 146 --IHRDIKAANVLLSEHGEVKLADFGVA--GQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 201
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
            +++D++S G+  +EL  G     +  P K   L+    PK N          P LE  Y
Sbjct: 202 DSKADIWSLGITAIELARGEPPHSELHPMKVLFLI----PKNN---------PPTLEGNY 248
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL++ P  RP   ++++
Sbjct: 249 S----KPLKEFVEACLNKEPSFRPTAKELLK 275

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 58
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 118 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 173
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 36  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           F  +  P   LS  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSK 150
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 151 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKK 208
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 61
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 176
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 177 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 170
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y      +V LK   +  KVL K  +QG  E   E+++L  LRHP+++
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKI--INKKVLAKSDMQGRIE--REISYLRLLRHPHII 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL       D  ++V E+     L +++ ++  +    A R      +A      H    
Sbjct: 68  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--- 123
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K  N+LLD     K++DFGL+     G+    S    G+  YAAPE V++G L
Sbjct: 124 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 178
Query: 265 TA--RSDVYSFGVVLLELLTGRKSVD 288
            A    DV+S GV+L  +L  R   D
Sbjct: 179 YAGPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 10  ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 61
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 62  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 121 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 176
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 177 RAPEILLGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y      +V LK   +  KVL K  +QG  E   E+++L  LRHP+++
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKI--INKKVLAKSDMQGRIE--REISYLRLLRHPHII 76
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL       D  ++V E+     L +++ ++  +    A R      +A      H    
Sbjct: 77  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--- 132
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K  N+LLD     K++DFGL+     G+    S    G+  YAAPE V++G L
Sbjct: 133 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 187
Query: 265 TA--RSDVYSFGVVLLELLTGRKSVD 288
            A    DV+S GV+L  +L  R   D
Sbjct: 188 YAGPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y      +V LK   +  KVL K  +QG  E   E+++L  LRHP+++
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKI--INKKVLAKSDMQGRIE--REISYLRLLRHPHII 77
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL       D  ++V E+     L +++ ++  +    A R      +A      H    
Sbjct: 78  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--- 133
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K  N+LLD     K++DFGL+     G+    S    G+  YAAPE V++G L
Sbjct: 134 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 188
Query: 265 TA--RSDVYSFGVVLLELLTGRKSVD 288
            A    DV+S GV+L  +L  R   D
Sbjct: 189 YAGPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT----VPLSWATRMMIA 189
            L +L HPN+VKL+     ++   LV+EF+   S++   F  A+    +PL      +  
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYL-- 112
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           F   +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  
Sbjct: 113 FQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 250 TYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT----VPLSWATRMMIA 189
            L +L HPN+VKL+     ++   LV+EF+   S++   F  A+    +PL      +  
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKKFMDASALTGIPLPLIKSYL-- 110
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           F   +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  
Sbjct: 111 FQLLQGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 166
Query: 250 TYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG V   Y      +V LK   +  KVL K  +QG  E   E+++L  LRHP+++
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKI--INKKVLAKSDMQGRIE--REISYLRLLRHPHII 71
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL       D  ++V E+     L +++ ++  +    A R      +A      H    
Sbjct: 72  KLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK--- 127
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K  N+LLD     K++DFGL+     G+    S    G+  YAAPE V++G L
Sbjct: 128 -IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VISGKL 182
Query: 265 TA--RSDVYSFGVVLLELLTGRKSVD 288
            A    DV+S GV+L  +L  R   D
Sbjct: 183 YAGPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 83  DYILGE----GGFGTVYKGYID-ENVRVGLKS----LPVAVKVLNKEGLQGHREWLTEVN 133
           D +LGE    G FG V+ G +  +N  V +KS    LP  +K           ++L E  
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----------KFLQEAR 164
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L Q  HPN+V+LIG C +     +V E +  G     L R     L   T + +   AA
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAA 223
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+ +L +  +  I+RD    N L+      K+SDFG+++    G              +
Sbjct: 224 AGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKW 281
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE +  G  ++ SDV+SFG++L E  +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 110/221 (49%), Gaps = 37/221 (16%)
Query: 89  GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIG 148
           G FG V+K  +  N  V +K  P+     +K+  Q       EV  L  ++H N+++ IG
Sbjct: 35  GRFGCVWKAQL-LNEYVAVKIFPIQ----DKQSWQNE----YEVYSLPGMKHENILQFIG 85
Query: 149 Y----CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH---- 200
                   D    L+  F  +GSL +  F KA V +SW     IA   A+GLA+LH    
Sbjct: 86  AEKRGTSVDVDLWLITAFHEKGSLSD--FLKANV-VSWNELCHIAETMARGLAYLHEDIP 142
Query: 201 ---NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLA---KAGPQGDETHVSTRVMGTYGY 253
              +  +P I +RD K+ N+LL ++ TA ++DFGLA   +AG    +TH     +GT  Y
Sbjct: 143 GLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQ---VGTRRY 199
Query: 254 AAPEYVMTGHLT------ARSDVYSFGVVLLELLTGRKSVD 288
            APE V+ G +        R D+Y+ G+VL EL +   + D
Sbjct: 200 MAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+  RG +   L + +          +     A  L++ H+ 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--ANALSYCHS- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 186
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 228
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 277

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 31/217 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V K  I ++   GL+ +  A+K + +   +  HR++  E+  L +L  HPN
Sbjct: 22  VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 77
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV---------------PLSWATRMM 187
           ++ L+G C    +  L  E+   G+L + L RK+ V                LS    + 
Sbjct: 78  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 136
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            A   A+G+ +L  +++  I+RD    NIL+  +Y AK++DFGL++    G E +V  + 
Sbjct: 137 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 189
Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T  SDV+S+GV+L E+++
Sbjct: 190 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 112/217 (51%), Gaps = 31/217 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V K  I ++   GL+ +  A+K + +   +  HR++  E+  L +L  HPN
Sbjct: 32  VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV---------------PLSWATRMM 187
           ++ L+G C    +  L  E+   G+L + L RK+ V                LS    + 
Sbjct: 88  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 146
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            A   A+G+ +L  +++  I+RD    NIL+  +Y AK++DFGL++    G E +V  + 
Sbjct: 147 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 199
Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T  SDV+S+GV+L E+++
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT----VPLSWATRMMIA 189
            L +L HPN+VKL+     ++   LV+EF+   S++   F  A+    +PL      +  
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYL-- 112
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           F   +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  
Sbjct: 113 FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 168
Query: 250 TYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG +G VYK    +   V LK + +  +    EG+      + E++ L +L HPN+V 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTA--IREISLLKELHHPNIVS 83
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           LI     +    LV+EFM +  L+  L    T  L  +   +  +   +G+A  H  +  
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCH--QHR 139
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHL 264
           +++RD K  N+L++SD   KL+DFGLA+A   G      T  + T  Y AP+ +M +   
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 265 TARSDVYSFGVVLLELLTGR 284
           +   D++S G +  E++TG+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 26/216 (12%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 56
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT----VPLSWATRMMIA 189
            L +L HPN+VKL+     ++   LV+EF+   S++   F  A+    +PL      +  
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYL-- 111
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
           F   +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  
Sbjct: 112 FQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-- 167
Query: 250 TYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE ++   + +   D++S G +  E++T R
Sbjct: 168 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 84  YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLR 139
           Y+LG+  G GT  K  I E+   G K   VAVK+LN++ ++      +   E+  L   R
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HP+++KL           +V E++  G L +++ +   V    A R+     +A      
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     V++RD K  N+LLD+   AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-V 181
Query: 260 MTGHLTA--RSDVYSFGVVLLELLTGRKSVD 288
           ++G L A    D++S GV+L  LL G    D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 102/200 (51%), Gaps = 12/200 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG +G VYK    +   V LK + +  +    EG+      + E++ L +L HPN+V 
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRIRLDAE---DEGIPSTA--IREISLLKELHHPNIVS 83
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           LI     +    LV+EFM +  L+  L    T  L  +   +  +   +G+A  H  +  
Sbjct: 84  LIDVIHSERCLTLVFEFMEK-DLKKVLDENKT-GLQDSQIKIYLYQLLRGVAHCH--QHR 139
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHL 264
           +++RD K  N+L++SD   KL+DFGLA+A   G      T  + T  Y AP+ +M +   
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSKKY 197
Query: 265 TARSDVYSFGVVLLELLTGR 284
           +   D++S G +  E++TG+
Sbjct: 198 STSVDIWSIGCIFAEMITGK 217

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 98/225 (43%), Gaps = 36/225 (16%)
Query: 86  LGEGGFGTVYK------GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL- 138
           LG G FG V +      G  D  ++V +K L        KE L      ++E+  +  L 
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEAL------MSELKIMSHLG 92
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV-------------------- 178
           +H N+V L+G C      L++ E+   G L N L RKA                      
Sbjct: 93  QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDG 152
Query: 179 -PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 237
            PL     +  +   A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+    
Sbjct: 153 RPLELRDLLHFSSQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 210
Query: 238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                V         + APE +     T +SDV+S+G++L E+ +
Sbjct: 211 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GL+F H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 114 QGLSFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 95/209 (45%), Gaps = 22/209 (10%)
Query: 83  DYILGE----GGFGTVYKGYID-ENVRVGLKS----LPVAVKVLNKEGLQGHREWLTEVN 133
           D +LGE    G FG V+ G +  +N  V +KS    LP  +K           ++L E  
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----------KFLQEAR 164
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L Q  HPN+V+LIG C +     +V E +  G     L R     L   T + +   AA
Sbjct: 165 ILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAA 223
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            G+ +L +  +  I+RD    N L+      K+SDFG+++    G              +
Sbjct: 224 AGMEYLES--KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW 281
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            APE +  G  ++ SDV+SFG++L E  +
Sbjct: 282 TAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 107/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L++ +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 85  ILGEGGFGTVY--KGYIDENVR--VGLKSLPVA-VKVLNKEGLQGHREWLTEVNFLGQLR 139
           +LG+G FG V+  K     + R    +K L  A +KV ++   +  R+ L EVN      
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 84
Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           HP +VKL  Y  + + +L L+ +F+  G L    F + +  + +    +  + A   LA 
Sbjct: 85  HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H     +IYRD K  NILLD +   KL+DFGL+K     ++   S    GT  Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPEV 197
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           V     T  +D +SFGV++ E+LTG
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           +LG+G FG V K       +  +     AVKV+NK   +       L EV  L +L HPN
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++KL     +     +V E    G L + + ++       A R++    +  G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMH-- 138
Query: 203 ERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  +++RD K  NILL+S   D   K+ DFGL+    Q   T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-V 194
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
           + G    + DV+S GV+L  LL+G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 85  ILGEGGFGTVY--KGYIDENVR--VGLKSLPVA-VKVLNKEGLQGHREWLTEVNFLGQLR 139
           +LG+G FG V+  K     + R    +K L  A +KV ++   +  R+ L EVN      
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 85
Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           HP +VKL  Y  + + +L L+ +F+  G L    F + +  + +    +  + A   LA 
Sbjct: 86  HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H     +IYRD K  NILLD +   KL+DFGL+K     D    +    GT  Y APE 
Sbjct: 141 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEV 198
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           V     T  +D +SFGV++ E+LTG
Sbjct: 199 VNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 85  ILGEGGFGTVY--KGYIDENVR--VGLKSLPVA-VKVLNKEGLQGHREWLTEVNFLGQLR 139
           +LG+G FG V+  K     + R    +K L  A +KV ++   +  R+ L EVN      
Sbjct: 31  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 84
Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           HP +VKL  Y  + + +L L+ +F+  G L    F + +  + +    +  + A   LA 
Sbjct: 85  HPFIVKL-HYAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H     +IYRD K  NILLD +   KL+DFGL+K     D    +    GT  Y APE 
Sbjct: 140 DHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESI--DHEKKAYSFCGTVEYMAPEV 197
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           V     T  +D +SFGV++ E+LTG
Sbjct: 198 VNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ILGEG FG VY+G    +     + + VAVK   K+  L    ++++E   +  L HP++
Sbjct: 31  ILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 87
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKLIG   E++   ++ E    G L ++L R     L   T ++ +    K +A+L +  
Sbjct: 88  VKLIGII-EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESIN 145
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
              ++RD    NIL+ S    KL DFGL++     D    S   +    + +PE +    
Sbjct: 146 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFRR 202
Query: 264 LTARSDVYSFGVVLLELLT 282
            T  SDV+ F V + E+L+
Sbjct: 203 FTTASDVWMFAVCMWEILS 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ILGEG FG VY+G    +     + + VAVK   K+  L    ++++E   +  L HP++
Sbjct: 15  ILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 71
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKLIG   E++   ++ E    G L ++L R     L   T ++ +    K +A+L +  
Sbjct: 72  VKLIGII-EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESIN 129
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
              ++RD    NIL+ S    KL DFGL++     D    S   +    + +PE +    
Sbjct: 130 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFRR 186
Query: 264 LTARSDVYSFGVVLLELLT 282
            T  SDV+ F V + E+L+
Sbjct: 187 FTTASDVWMFAVCMWEILS 205

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 56
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 56
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 101/221 (45%), Gaps = 26/221 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-RHPN 142
           +LG G FG V         + G+ S+ VAVK+L ++     RE L +E+  + QL  H N
Sbjct: 52  VLGSGAFGKVMNATAYGISKTGV-SIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL------FRKATVP---------------LS 181
           +V L+G C       L++E+   G L N+L      F +  +                L+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
           +   +  A+  AKG+ FL    +  ++RD    N+L+      K+ DFGLA+        
Sbjct: 171 FEDLLCFAYQVAKGMEFLEF--KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            V         + APE +  G  T +SDV+S+G++L E+ +
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 97/199 (48%), Gaps = 9/199 (4%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ILGEG FG VY+G    +     + + VAVK   K+  L    ++++E   +  L HP++
Sbjct: 19  ILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKLIG   E++   ++ E    G L ++L R     L   T ++ +    K +A+L +  
Sbjct: 76  VKLIGII-EEEPTWIIMELYPYGELGHYLERNKN-SLKVLTLVLYSLQICKAMAYLESIN 133
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
              ++RD    NIL+ S    KL DFGL++     D    S   +    + +PE +    
Sbjct: 134 --CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI-KWMSPESINFRR 190
Query: 264 LTARSDVYSFGVVLLELLT 282
            T  SDV+ F V + E+L+
Sbjct: 191 FTTASDVWMFAVCMWEILS 209

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 53
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 5   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 56
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 57  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 116 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 171
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 172 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 54
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 55  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 114 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 169
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 170 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 53
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 168
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 127
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +S    GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLS----GTLDYLPPEMIEGR 182
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 224
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 264

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 108/214 (50%), Gaps = 12/214 (5%)
Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVR--VGLKSLPVAVKVLNKEGLQGHREW 128
            ++++  K +     LGEG F TVYK   D+N    V +K + +  +   K+G+  +R  
Sbjct: 3   LDVKSRAKRYEKLDFLGEGQFATVYKAR-DKNTNQIVAIKKIKLGHRSEAKDGI--NRTA 59
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L E+  L +L HPN++ L+       +  LV++FM    LE  + +  ++ L+ +     
Sbjct: 60  LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEV-IIKDNSLVLTPSHIKAY 117
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
                +GL +LH  +  +++RD K +N+LLD +   KL+DFGLAK+   G         +
Sbjct: 118 MLMTLQGLEYLH--QHWILHRDLKPNNLLLDENGVLKLADFGLAKSF--GSPNRAYXHQV 173
Query: 249 GTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELL 281
            T  Y APE +    +     D+++ G +L ELL
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 17/211 (8%)
Query: 84  YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLR 139
           Y+LG+  G GT  K  I E+   G K   VAVK+LN++ ++      +   E+  L   R
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HP+++KL           +V E++  G L +++ +   V    A R+     +A      
Sbjct: 70  HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHR 129
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     V++RD K  N+LLD+   AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 130 HM----VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSC---GSPNYAAPE-V 181
Query: 260 MTGHLTA--RSDVYSFGVVLLELLTGRKSVD 288
           ++G L A    D++S GV+L  LL G    D
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 4   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 55
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 56  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 115 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 170
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 171 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 106/212 (50%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 7   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 58
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F   
Sbjct: 59  LLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 118 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 173
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 174 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-----WLTEV 132
           ++F+    +GEG +G VYK     N   G       V  L K  L    E      + E+
Sbjct: 3   ENFQKVEKIGEGTYGVVYKA---RNKLTG------EVVALXKIRLDTETEGVPSTAIREI 53
Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
           + L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F  
Sbjct: 54  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL 112
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
            +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  
Sbjct: 113 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 168
Query: 253 YAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           Y APE ++   + +   D++S G +  E++T R
Sbjct: 169 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 103/213 (48%), Gaps = 20/213 (9%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-----WLTEV 132
           ++F+    +GEG +G VYK     N   G       V  L K  L    E      + E+
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA---RNKLTG------EVVALXKIRLDTETEGVPSTAIREI 52
Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
           + L +L HPN+VKL+     ++   LV+EF+ +  L+  +   A   +         F  
Sbjct: 53  SLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQL 111
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
            +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  
Sbjct: 112 LQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLW 167
Query: 253 YAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           Y APE ++   + +   D++S G +  E++T R
Sbjct: 168 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+  RG +   L + +          +     A  L++ H+ 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--ANALSYCHS- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----XXLXGTLDYLPPEMIEGR 186
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 228
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 277

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 112/217 (51%), Gaps = 31/217 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQL-RHPN 142
           ++GEG FG V K  I ++   GL+ +  A+K + +   +  HR++  E+  L +L  HPN
Sbjct: 29  VIGEGNFGQVLKARIKKD---GLR-MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 84
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV---------------PLSWATRMM 187
           ++ L+G C    +  L  E+   G+L + L RK+ V                LS    + 
Sbjct: 85  IINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLH 143
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            A   A+G+ +L  +++  I+R+    NIL+  +Y AK++DFGL++    G E +V  + 
Sbjct: 144 FAADVARGMDYL--SQKQFIHRNLAARNILVGENYVAKIADFGLSR----GQEVYVK-KT 196
Query: 248 MGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           MG     + A E +     T  SDV+S+GV+L E+++
Sbjct: 197 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 21  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 75
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 76  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 135
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 136 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 193
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 194 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 25  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 79
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 80  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 139
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 140 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 197
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 198 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 42  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 152
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 153 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 207
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 249
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 298

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 17/211 (8%)
Query: 84  YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLR 139
           YILG+  G GT  K  + ++   G K   VAVK+LN++ ++      +   E+  L   R
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HP+++KL           +V E++  G L +++ +   +    + R+     +  G+ + 
Sbjct: 75  HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS--GVDYC 132
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     V++RD K  N+LLD+   AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 133 HR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSC---GSPNYAAPE-V 186
Query: 260 MTGHLTA--RSDVYSFGVVLLELLTGRKSVD 288
           ++G L A    D++S GV+L  LL G    D
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 28  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 82
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 83  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 142
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 143 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 200
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 201 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 272

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 29  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 83
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 84  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 143
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 144 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 201
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 202 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 36  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSK 150
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 151 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 118/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R   +   +A+KVL K  L+      +   EV     LRHPN
Sbjct: 13  LGKGKFGNVYLA------REKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 123
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 124 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 178
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 220
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 221 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 260

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/227 (27%), Positives = 108/227 (47%), Gaps = 13/227 (5%)
Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +  F+    LG G + TVYKG    N   G+      VK+ ++EG       + E++ + 
Sbjct: 4   SSQFKQLEKLGNGTYATVYKGL---NKTTGVYVALKEVKLDSEEGTPSTA--IREISLMK 58
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           +L+H N+V+L      ++   LV+EFM    +  +++         L         +   
Sbjct: 59  ELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H  E  +++RD K  N+L++     KL DFGLA+A   G   +  +  + T  Y
Sbjct: 119 QGLAFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAF--GIPVNTFSSEVVTLWY 174
Query: 254 AAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
            AP+ +M     + S D++S G +L E++TG+     T   ++  L+
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLI 221

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 36  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 150
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 151 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           +LG+G FG V K       +  +     AVKV+NK   +       L EV  L +L HPN
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++KL     +     +V E    G L + + ++       A R++    +  G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMH-- 138
Query: 203 ERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  +++RD K  NILL+S   D   K+ DFGL+    Q   T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-V 194
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
           + G    + DV+S GV+L  LL+G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 112/230 (48%), Gaps = 46/230 (20%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ--LRHPN 142
           I   G FG V+K  +  +         VAVK+     LQ  + W +E        ++H N
Sbjct: 22  IKARGRFGCVWKAQLMNDF--------VAVKIFP---LQDKQSWQSEREIFSTPGMKHEN 70
Query: 143 LVKLI-----GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           L++ I     G   E +   L+  F  +GSL ++L  K  + ++W     +A   ++GL+
Sbjct: 71  LLQFIAAEKRGSNLEVE-LWLITAFHDKGSLTDYL--KGNI-ITWNELCHVAETMSRGLS 126
Query: 198 FLHN--------AERPVI-YRDFKTSNILLDSDYTAKLSDFGLA----KAGPQGDETHVS 244
           +LH           +P I +RDFK+ N+LL SD TA L+DFGLA       P GD TH  
Sbjct: 127 YLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGD-THGQ 185
Query: 245 TRVMGTYGYAAPEYVMTGHLT------ARSDVYSFGVVLLELLTGRKSVD 288
              +GT  Y APE V+ G +        R D+Y+ G+VL EL++  K+ D
Sbjct: 186 ---VGTRRYMAPE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 36  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 90
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 91  GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSK 150
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 151 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 208
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 209 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 19/204 (9%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           +LG+G FG V K       +  +     AVKV+NK   +       L EV  L +L HPN
Sbjct: 29  MLGKGSFGEVLK------CKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPN 82
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++KL     +     +V E    G L + + ++       A R++    +  G+ ++H  
Sbjct: 83  IMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS--GITYMH-- 138
Query: 203 ERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  +++RD K  NILL+S   D   K+ DFGL+    Q   T +  R+ GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRI-GTAYYIAPE-V 194
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
           + G    + DV+S GV+L  LL+G
Sbjct: 195 LRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 102/218 (46%), Gaps = 18/218 (8%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT 130
           +++   + F    +LG+G FG V+   +   N    +K+L   V VL  + ++     + 
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECT---MV 67
Query: 131 EVNFLG-QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           E   L     HP L  +       ++   V E++  G L  H+       LS AT     
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT----- 122
Query: 190 FGAAK---GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
           F AA+   GL FLH+  + ++YRD K  NILLD D   K++DFG+ K    GD    +  
Sbjct: 123 FYAAEIILGLQFLHS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNE 178
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
             GT  Y APE ++        D +SFGV+L E+L G+
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 33  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 87  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 143
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 144 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGR 198
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 240
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 241 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 289

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 127
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 182
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 224
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 272

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 186
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 228
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 277

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 79/281 (28%), Positives = 137/281 (48%), Gaps = 43/281 (15%)
Query: 25  SSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFS--------LFELETI 76
           + S  ++P+++  R++     PS P+ L ++ K  V  +H ++ S        + E +T 
Sbjct: 325 TQSFIIRPQKEGERAL-----PSIPK-LANNEKQGV-RSHTVSVSETDDYAEIIDEEDTY 377
Query: 77  TKSFRSDY-----------ILGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQ 123
           T     DY            +GEG FG V++G Y+  EN      ++ VA+K        
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-----PAMAVAIKTCKNCTSD 432
Query: 124 GHRE-WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLS 181
             RE +L E   + Q  HP++VKLIG   E+    ++ E    G L + L  RK ++ L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL- 490
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
            A+ ++ A+  +  LA+L +  +  ++RD    N+L+ S+   KL DFGL++     D T
Sbjct: 491 -ASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDST 545
Query: 242 HV-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
           +  +++      + APE +     T+ SDV+ FGV + E+L
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 272

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 272

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 275

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL----KSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-R 139
           LG G FG V      E    GL     ++ VAVK+L        RE L +E+  L  L  
Sbjct: 31  LGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----------- 188
           H N+V L+G C      L++ E+   G L N L RK    +   T   I           
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145
Query: 189 -----AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
                ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V
Sbjct: 146 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
                    + APE +     T  SDV+S+G+ L EL                SL     
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPY 248
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P +    K  ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 186
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 228
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 277

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P    T +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 15  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 125
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 126 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 180
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 222
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 223 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 262

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 2   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 53
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+E + +  L+  +   A   +         F   
Sbjct: 54  LLKELNHPNIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A   G      T  + T  Y
Sbjct: 113 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWY 168
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 80/295 (27%), Positives = 114/295 (38%), Gaps = 44/295 (14%)
Query: 86  LGEGGFGTVYK----GYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-R 139
           LG G FG V +    G I  +      ++ VAVK+L        RE L +E+  L  L  
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDA-----AMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 101
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----------- 188
           H N+V L+G C      L++ E+   G L N L RK    +   T   I           
Sbjct: 102 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 161
Query: 189 -----AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
                ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V
Sbjct: 162 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
                    + APE +     T  SDV+S+G+ L EL                SL     
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPY 264
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P +    K  ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 265 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 319

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL-KSLP-----VAVKVLNKEGLQGH-REWLTEVNFLGQL 138
           LGEG FG V          +GL K  P     VAVK+L  +  +    + ++E+  +  +
Sbjct: 77  LGEGAFGQVVLAEA-----IGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMI 131
Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWA 183
            +H N++ L+G C +D    ++ E+  +G+L  +L           +  +  P   LS  
Sbjct: 132 GKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSK 191
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    
Sbjct: 192 DLVSCAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKK 249
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +T       + APE +     T +SDV+SFGV+L E+ T
Sbjct: 250 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 20  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 130
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 185
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 227
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 228 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 267

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 37/292 (12%)
Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFL 135
           R DY    ++G G    V   Y         K   VA+K +N E  Q    E L E+  +
Sbjct: 9   RDDYELQEVIGSGATAVVQAAY------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 62
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN---HLFRKA---TVPLSWATRMMIA 189
            Q  HPN+V         D   LV + +  GS+ +   H+  K    +  L  +T   I 
Sbjct: 63  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 122
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTR-- 246
               +GL +LH   +  I+RD K  NILL  D + +++DFG+ A     GD T    R  
Sbjct: 123 REVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 180
Query: 247 VMGTYGYAAPEYV--MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
            +GT  + APE +  + G+   ++D++SFG+  +EL TG     K  P K   L      
Sbjct: 181 FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----- 234
Query: 305 KLNDKRKMLQ--IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
            L +    L+  + D  +  +Y  ++ +K  SL   CL ++P+ RP  ++++
Sbjct: 235 -LQNDPPSLETGVQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELL 281

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 97/205 (47%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG-QLRHPN 142
           +LG+G FG V+   +   N    +K+L   V VL  + ++     + E   L     HP 
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDV-VLMDDDVECT---MVEKRVLSLAWEHPF 79
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAFL 199
           L  +       ++   V E++  G L  H+       LS AT     F AA+   GL FL
Sbjct: 80  LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-----FYAAEIILGLQFL 134
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H+  + ++YRD K  NILLD D   K++DFG+ K    GD    +    GT  Y APE +
Sbjct: 135 HS--KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK--TNXFCGTPDYIAPEIL 190
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
           +        D +SFGV+L E+L G+
Sbjct: 191 LGQKYNHSVDWWSFGVLLYEMLIGQ 215

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 266

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/292 (28%), Positives = 132/292 (45%), Gaps = 37/292 (12%)
Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFL 135
           R DY    ++G G    V   Y         K   VA+K +N E  Q    E L E+  +
Sbjct: 14  RDDYELQEVIGSGATAVVQAAY------CAPKKEKVAIKRINLEKCQTSMDELLKEIQAM 67
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN---HLFRKA---TVPLSWATRMMIA 189
            Q  HPN+V         D   LV + +  GS+ +   H+  K    +  L  +T   I 
Sbjct: 68  SQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATIL 127
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTR-- 246
               +GL +LH   +  I+RD K  NILL  D + +++DFG+ A     GD T    R  
Sbjct: 128 REVLEGLEYLHKNGQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185
Query: 247 VMGTYGYAAPEYV--MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
            +GT  + APE +  + G+   ++D++SFG+  +EL TG     K  P K   L      
Sbjct: 186 FVGTPCWMAPEVMEQVRGY-DFKADIWSFGITAIELATGAAPYHKYPPMKVLMLT----- 239
Query: 305 KLNDKRKMLQ--IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
            L +    L+  + D  +  +Y  ++ +K  SL   CL ++P+ RP  ++++
Sbjct: 240 -LQNDPPSLETGVQDKEMLKKYG-KSFRKMISL---CLQKDPEKRPTAAELL 286

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL----KSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-R 139
           LG G FG V      E    GL     ++ VAVK+L        RE L +E+  L  L  
Sbjct: 54  LGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----------- 188
           H N+V L+G C      L++ E+   G L N L RK    +   T   I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 189 -----AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
                ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V
Sbjct: 169 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
                    + APE +     T  SDV+S+G+ L EL                SL     
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPY 271
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P +    K  ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 272 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 21  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y  PE +   
Sbjct: 132 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEXIEGR 186
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 228
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP + +V+E       + +P  C N
Sbjct: 229 TFPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQN 277

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL----KSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-R 139
           LG G FG V      E    GL     ++ VAVK+L        RE L +E+  L  L  
Sbjct: 49  LGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 103
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----------- 188
           H N+V L+G C      L++ E+   G L N L RK    +   T   I           
Sbjct: 104 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 163
Query: 189 -----AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
                ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V
Sbjct: 164 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
                    + APE +     T  SDV+S+G+ L EL                SL     
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPY 266
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P +    K  ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 267 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 113/295 (38%), Gaps = 44/295 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGL----KSLPVAVKVLNKEGLQGHREWL-TEVNFLGQL-R 139
           LG G FG V      E    GL     ++ VAVK+L        RE L +E+  L  L  
Sbjct: 54  LGAGAFGKVV-----EATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 108
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI----------- 188
           H N+V L+G C      L++ E+   G L N L RK    +   T   I           
Sbjct: 109 HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 168
Query: 189 -----AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
                ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V
Sbjct: 169 DLLSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
                    + APE +     T  SDV+S+G+ L EL                SL     
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF---------------SLGSSPY 271
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           P +    K  ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 272 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 326

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 116/271 (42%), Gaps = 31/271 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG VYKG  +    V      VA+K+++ +E      +   E+  L Q   P + 
Sbjct: 27  IGKGSFGEVYKGIDNHTKEV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +  G   +     ++ E++  GS  + L      PL       I     KGL +LH+  +
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATILREILKGLDYLHSERK 137
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+  AG   D        +GT  + APE +     
Sbjct: 138 --IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNXFVGTPFWMAPEVIKQSAY 193
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
             ++D++S G+  +EL  G        P +   L+    P             P LE Q+
Sbjct: 194 DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-------------PTLEGQH 240
Query: 325 SVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           S    +        CL+++P+ RP   ++++
Sbjct: 241 S----KPFKEFVEACLNKDPRFRPTAKELLK 267

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSX-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 145 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 42  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 96  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 152
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 153 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 207
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 249
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 250 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 298

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 147 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 129/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     +ET  S        ++ PE +M 
Sbjct: 139 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETS-SVGSKFPVRWSPPEVLMY 195
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 245
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEIXINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG FG V    +     +V LK   ++ ++L K  +  H     E+++L  LRHP+++
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKF--ISRQLLKKSDM--HMRVEREISYLKLLRHPHII 72
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL          ++V E+   G L +++  K  +      R       A  + + H  + 
Sbjct: 73  KLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA--IEYCHRHK- 128
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K  N+LLD +   K++DFGL+     G+    S    G+  YAAPE V+ G L
Sbjct: 129 -IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-VINGKL 183
Query: 265 TA--RSDVYSFGVVLLELLTGRKSVD 288
            A    DV+S G+VL  +L GR   D
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFD 209

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 105 GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 164
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 165 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 222
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 93  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 152
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 153 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 210
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 211 KGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 145 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 85  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 144
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 145 --VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 202
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 203 KGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +L H N+V
Sbjct: 39  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIV 97
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 158 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINAMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 114/282 (40%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 127 -KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                   D  K +     R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEAN--------------TYQDTYKRIS----RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 263

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 23  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 77
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 78  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 134
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 135 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 190
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 191 FRRFTSASDVWMFGVCMWEIL 211

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 15  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 70  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 126
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 182
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 183 FRRFTSASDVWMFGVCMWEIL 203

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 207
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 91  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 150
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 151 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 208
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 209 KGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 82  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 141
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 142 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 199
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 200 KGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 83  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 142
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 143 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 200
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 201 KGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 21  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 75
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 76  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 132
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 133 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 188
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 189 FRRFTSASDVWMFGVCMWEIL 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 18  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 73  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 129
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 185
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 20  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 74
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 75  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 131
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 132 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 187
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 188 FRRFTSASDVWMFGVCMWEIL 208

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 18  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 128
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 129 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 183
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 225
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 274

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 97/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +L 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKLN 106
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 167 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 224
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 225 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 90/302 (29%), Positives = 125/302 (41%), Gaps = 49/302 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKML-KEGATHSEHRALMSELKILIHIGH 91
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP----------LSWATRM 186
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP          L+    +
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLI 151
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
             +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +      
Sbjct: 152 XYSFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
                 + APE +     T +SDV+SFGV+L E+                SL     P +
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV 254
Query: 307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQC 362
               +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  
Sbjct: 255 KIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 310
Query: 363 AN 364
           AN
Sbjct: 311 AN 312

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      +L VA+K          RE +L E   + Q  HP+
Sbjct: 46  IGEGQFGDVHQGIYMSPEN-----PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 100
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 101 IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 157
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 158 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 213
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 214 FRRFTSASDVWMFGVCMWEIL 234

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 18  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 128
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE +   
Sbjct: 129 -KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 183
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 225
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 226 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 274

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 90/303 (29%), Positives = 125/303 (41%), Gaps = 50/303 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRT----VAVKML-KEGATHSEHRALMSELKILIHIGH 90
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP-----------LSWATR 185
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP           L+    
Sbjct: 91  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHL 150
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
           +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +     
Sbjct: 151 ICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK 305
                  + APE +     T +SDV+SFGV+L E+                SL     P 
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPG 253
Query: 306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQ 361
           +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L 
Sbjct: 254 VKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL 309
Query: 362 CAN 364
            AN
Sbjct: 310 QAN 312

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 136/281 (48%), Gaps = 43/281 (15%)
Query: 25  SSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFS--------LFELETI 76
           + S  ++P+++  R++     PS P+ L ++ K  V  +H ++ S        + E +T 
Sbjct: 325 TQSFIIRPQKEGERAL-----PSIPK-LANNEKQGV-RSHTVSVSETDDYAEIIDEEDTY 377
Query: 77  TKSFRSDY-----------ILGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQ 123
           T     DY            +GEG FG V++G Y+  EN      ++ VA+K        
Sbjct: 378 TMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPEN-----PAMAVAIKTCKNCTSD 432
Query: 124 GHRE-WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLS 181
             RE +L E   + Q  HP++VKLIG   E+    ++ E    G L + L  RK ++ L 
Sbjct: 433 SVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL- 490
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
            A+ ++ A+  +  LA+L +  +  ++RD    N+L+ +    KL DFGL++     D T
Sbjct: 491 -ASLILYAYQLSTALAYLES--KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDST 545
Query: 242 HV-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
           +  +++      + APE +     T+ SDV+ FGV + E+L
Sbjct: 546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 13  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 123
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 232
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 233 -------DSAPLALLHKILVENPSARITIPDI 257

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 101/200 (50%), Gaps = 15/200 (7%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      ++ VA+K          RE +L E   + Q  HP+
Sbjct: 18  IGEGQFGDVHQGIYMSPEN-----PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 73  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES 129
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N+L+ S+   KL DFGL++          S   +    + APE +  
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPI-KWMAPESINF 186
Query: 262 GHLTARSDVYSFGVVLLELL 281
              T+ SDV+ FGV + E+L
Sbjct: 187 RRFTSASDVWMFGVCMWEIL 206

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 275

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 15  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 125
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 126 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 234
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 235 -------DSAPLALLHKILVENPSARITIPDI 259

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 117/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K+++FG +   P        T + GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 266

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 263

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L   RH N++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 147 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/289 (25%), Positives = 118/289 (40%), Gaps = 42/289 (14%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 17  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 127
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P          + GT  Y  PE +   
Sbjct: 128 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGR 182
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 224
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-------TLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E       + +P  C N
Sbjct: 225 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQN 273

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 126/300 (42%), Gaps = 47/300 (15%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP--------LSWATRMMI 188
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP        L+    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXY 149
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 150 SFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDAR 207
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGV-- 250
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             K+ +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 251 --KIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 115/272 (42%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG +G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAYGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC----GTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 266

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 80
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 243
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 244 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299
Query: 361 QCAN 364
             AN
Sbjct: 300 LQAN 303

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 19  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 129
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 130 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC----GTLDYLPPEMIEGR 184
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 226
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 227 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 266

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/282 (25%), Positives = 116/282 (41%), Gaps = 37/282 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 16  LGKGKFGNVYLA------REKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--ANALSYCHS- 126
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S    K++DFG +   P      +     GT  Y  PE +   
Sbjct: 127 -KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALC----GTLDYLPPEMIEGR 181
Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               + D++S GV+  E L G+   +                  N  ++  + I  R+E 
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFEA-----------------NTYQETYKRIS-RVEF 223
Query: 323 QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
            +     + A  L    L  NP  RP++ +V+E   P   AN
Sbjct: 224 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE--HPWITAN 263

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 80
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 198
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 243
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 244 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299
Query: 361 QCAN 364
             AN
Sbjct: 300 LQAN 303

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    +N   G  +   A KV+  +  +   +++ E+  L    HP +VK
Sbjct: 27  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLEN---HLFRKATVP-LSWATRMMIAFGAAKGLAFLHN 201
           L+G    D    ++ EF   G+++     L R  T P +    R M+     + L FLH+
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHS 135
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             + +I+RD K  N+L+  +   +L+DFG++    +  +   S   +GT  + APE VM 
Sbjct: 136 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMC 191
Query: 262 GHLTA-----RSDVYSFGVVLLEL 280
             +       ++D++S G+ L+E+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           +LG G F  V    + E+ R       VA+K + KE L+G    +  E+  L +++HPN+
Sbjct: 25  VLGTGAFSEVI---LAEDKRT---QKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V L        H  L+ + +  G L + +  K       A+R++  F     + +LH+  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI--FQVLDAVKYLHDL- 135
Query: 204 RPVIYRDFKTSNIL---LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY APE + 
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L   RH N++
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 87  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 146
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 147 --VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 204
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 205 KGYTKSIDIWSVGCILAEMLSNR 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/204 (28%), Positives = 101/204 (49%), Gaps = 24/204 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    +N   G  +   A KV+  +  +   +++ E+  L    HP +VK
Sbjct: 19  LGDGAFGKVYKA---KNKETGALA---AAKVIETKSEEELEDYIVEIEILATCDHPYIVK 72
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLEN---HLFRKATVP-LSWATRMMIAFGAAKGLAFLHN 201
           L+G    D    ++ EF   G+++     L R  T P +    R M+     + L FLH+
Sbjct: 73  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-----EALNFLHS 127
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             + +I+RD K  N+L+  +   +L+DFG++    +  +   S   +GT  + APE VM 
Sbjct: 128 --KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVMC 183
Query: 262 GHLTA-----RSDVYSFGVVLLEL 280
             +       ++D++S G+ L+E+
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/205 (33%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--EVNFLGQLRHPN 142
           +LG+G FG V+   + +  R     L  A+KVL K  L+      T  E + L  + HP 
Sbjct: 35  VLGQGSFGKVF--LVRKVTRPDSGHL-YAMKVLKKATLKVRDRVRTKMERDILADVNHPF 91
Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           +VKL  Y  + + +L L+ +F+  G L   L ++        T   + F  A+   GL  
Sbjct: 92  VVKL-HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMF-----TEEDVKFYLAELALGLDH 145
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+    +IYRD K  NILLD +   KL+DFGL+K     D    +    GT  Y APE 
Sbjct: 146 LHSL--GIIYRDLKPENILLDEEGHIKLTDFGLSKEAI--DHEKKAYSFCGTVEYMAPEV 201
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           V     +  +D +S+GV++ E+LTG
Sbjct: 202 VNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/201 (31%), Positives = 105/201 (52%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      ++ VA+K          RE +L E   + Q  HP+
Sbjct: 18  IGEGQFGDVHQGIYMSPEN-----PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 73  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDL--ASLILYAYQLSTALAYLES 129
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ S+   KL DFGL++     D T+  +++      + APE + 
Sbjct: 130 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 185
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           +LG G F  V    + E+ R       VA+K + KE L+G    +  E+  L +++HPN+
Sbjct: 25  VLGTGAFSEVI---LAEDKRT---QKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V L        H  L+ + +  G L + +  K       A+R++  F     + +LH+  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI--FQVLDAVKYLHDL- 135
Query: 204 RPVIYRDFKTSNIL---LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY APE + 
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLA 191
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT----VAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRK 207
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 252
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 253 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
Query: 361 QCAN 364
             AN
Sbjct: 309 LQAN 312

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 90/300 (30%), Positives = 125/300 (41%), Gaps = 47/300 (15%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTA----TXRTVAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP--------LSWATRMMI 188
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP        L+    +  
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICY 149
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 150 SFQVAKGMEFL--ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 207
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 208 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 252
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 253 DEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 308

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           +LG G F  V    + E+ R       VA+K + KE L+G    +  E+  L +++HPN+
Sbjct: 25  VLGTGAFSEVI---LAEDKRT---QKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNI 78
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V L        H  L+ + +  G L + +  K       A+R++  F     + +LH+  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI--FQVLDAVKYLHDL- 135
Query: 204 RPVIYRDFKTSNIL---LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY APE + 
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 32  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 79
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 138
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M 
Sbjct: 139 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 195
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 196 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 245
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 246 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 280

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 91
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 152 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV ++      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIR------KISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 65  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 123
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 124 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 183
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 184 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-LSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++      LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 91
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 152 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 210 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 12  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 59
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 60  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 118
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M 
Sbjct: 119 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 175
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 176 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 225
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 226 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 260

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 94/216 (43%), Gaps = 32/216 (14%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
            + D  +G G F TVYKG +D    V +    +  + L K   Q  +E   E   L  L+
Sbjct: 28  LKFDIEIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKE---EAEXLKGLQ 83
Query: 140 HPNLVKLI--------GYCCEDDHRLLVYEFMFRGSLENHLFR----KATVPLSWATRMM 187
           HPN+V+          G  C     +LV E    G+L+ +L R    K  V  SW  +++
Sbjct: 84  HPNIVRFYDSWESTVKGKKC----IVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQIL 139
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVSTR 246
                 KGL FLH    P+I+RD K  NI +     + K+ D GLA           +  
Sbjct: 140 ------KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKA 189
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           V+GT  + APE     +     DVY+FG   LE  T
Sbjct: 190 VIGTPEFXAPEXYEEKY-DESVDVYAFGXCXLEXAT 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 16  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 63
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 64  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 122
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M 
Sbjct: 123 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 179
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 180 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 229
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 230 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 264

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/285 (23%), Positives = 133/285 (46%), Gaps = 48/285 (16%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 64
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPEY 258
             +  ++RD    N L++     K+SDFGL++     D+ + S+R  G+     ++ PE 
Sbjct: 124 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL--DDEYTSSR--GSKFPVRWSPPEV 177
Query: 259 VMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
           +M    +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  
Sbjct: 178 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYR 227
Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
           P L       A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 228 PHL-------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LGE  FG VYKG++      G ++  VA+K L K+  +G    E+  E     +L+HPN+
Sbjct: 34  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLF--------------RKATVPLSWATRMMIA 189
           V L+G   +D    +++ +   G L   L               R     L     + + 
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A G+ +L  +   V+++D  T N+L+      K+SD GL +     D   +    + 
Sbjct: 152 AQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 209
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 210 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDK--PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 265 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 97/208 (46%), Gaps = 22/208 (10%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK------ATVPLSWATRMMIAFGAAKGLAF 198
            +      D  R    E M    L  HL          T  LS        +   +GL +
Sbjct: 105 GI-----NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPE 257
           +H+A   V++RD K SN+LL++    K+ DFGLA+ A P  D T   T  + T  Y APE
Sbjct: 160 IHSAN--VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 258 YVMTGHLTARS-DVYSFGVVLLELLTGR 284
            ++      +S D++S G +L E+L+ R
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 108
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 109 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 169 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 226
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 227 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 105/212 (49%), Gaps = 18/212 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVN 133
           ++F+    +GEG +G VYK       R  L    VA+K +      EG+      + E++
Sbjct: 6   ENFQKVEKIGEGTYGVVYKA------RNKLTGEVVALKKIRLDTETEGVPSTA--IREIS 57
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN+VKL+     ++   LV+E + +  L+  +   A   +         F   
Sbjct: 58  LLKELNHPNIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           +GLAF H+    V++RD K  N+L++++   KL+DFGLA+A      T+    V  T  Y
Sbjct: 117 QGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV--TLWY 172
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE ++   + +   D++S G +  E++T R
Sbjct: 173 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 105/225 (46%), Gaps = 43/225 (19%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF--LGQLRHPN 142
           ++G G +G VYKG +DE         PVAVKV +       + ++ E N   +  + H N
Sbjct: 20  LIGRGRYGAVYKGSLDER--------PVAVKVFS---FANRQNFINEKNIYRVPLMEHDN 68
Query: 143 LVKLI--GYCCEDDHR---LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + + I        D R   LLV E+   GSL  +L    +    W +   +A    +GLA
Sbjct: 69  IARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS---DWVSSCRLAHSVTRGLA 125
Query: 198 FLH------NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLA------KAGPQGDETHVS 244
           +LH      +  +P I +RD  + N+L+ +D T  +SDFGL+      +    G+E + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 245 TRVMGTYGYAAPEYVMTGHLTARS--------DVYSFGVVLLELL 281
              +GT  Y APE V+ G +  R         D+Y+ G++  E+ 
Sbjct: 186 ISEVGTIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 23  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 70
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 71  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 129
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M 
Sbjct: 130 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 186
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 187 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 236
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 237 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 271

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 53  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 111
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 112 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 172 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 39  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 158 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 98
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 99  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 159 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 216
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 217 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/282 (23%), Positives = 128/282 (45%), Gaps = 42/282 (14%)
Query: 86  LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
           LG G FG V    ++G  D           VA+K++ KEG     E++ E   +  L H 
Sbjct: 17  LGTGQFGVVKYGKWRGQYD-----------VAIKMI-KEGSMSEDEFIEEAKVMMNLSHE 64
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LV+L G C +     ++ E+M  G L N+L R+          + +     + + +L +
Sbjct: 65  KLVQLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYLES 123
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +  ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M 
Sbjct: 124 --KQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMY 180
Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SD+++FGV++ E+ + G+   ++   S+    +           + L++  P L
Sbjct: 181 SKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI----------AQGLRLYRPHL 230
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP----LMSDVVETLE 358
                  A++K  ++ Y C  +    RP    L+S++++ ++
Sbjct: 231 -------ASEKVYTIMYSCWHEKADERPTFKILLSNILDVMD 265

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 83
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 84  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 144 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 201
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 202 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/226 (30%), Positives = 106/226 (46%), Gaps = 28/226 (12%)
Query: 85  ILGEGGFGTVYKGYIDENVRVG----LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           +LG+GG+G V++         G    +K L  A+ V N +     +    E N L +++H
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK---AERNILEEVKH 80
Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P +V LI Y  +   +L L+ E++  G L   L R+       A   +     A G    
Sbjct: 81  PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG---- 135
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ-GDETHVSTRVMGTYGYAAPEY 258
           H  ++ +IYRD K  NI+L+     KL+DFGL K     G  TH      GT  Y APE 
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT---FCGTIEYMAPEI 192
Query: 259 VM-TGHLTARSDVYSFGVVLLELLTG---------RKSVDKTRPSK 294
           +M +GH  A  D +S G ++ ++LTG         +K++DK    K
Sbjct: 193 LMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 39  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 97
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 98  RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 157
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 158 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 15/207 (7%)
Query: 79  SFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +FR +  +G G F  VY+   + + V V LK     V++ +    +   + + E++ L Q
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKK----VQIFDLMDAKARADCIKEIDLLKQ 88
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKAT--VPLSWATRMMIAFGAA 193
           L HPN++K      ED+   +V E    G L   +  F+K    +P     +  +   +A
Sbjct: 89  LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L  +H+  R V++RD K +N+ + +    KL D GL +      +T  +  ++GT  Y
Sbjct: 149 --LEHMHS--RRVMHRDIKPANVFITATGVVKLGDLGLGRFF--SSKTTAAHSLVGTPYY 202
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLEL 280
            +PE +       +SD++S G +L E+
Sbjct: 203 MSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-EGLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 53  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIV 111
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 171
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 172 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 98/200 (49%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V+K      V      L +A K+++ E     R + + E+  L +   P +V
Sbjct: 17  LGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 70
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     ++ IA    KGL +L    +
Sbjct: 71  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 128
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   DE  ++   +GT  Y +PE +   H 
Sbjct: 129 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDE--MANEFVGTRSYMSPERLQGTHY 183
Query: 265 TARSDVYSFGVVLLELLTGR 284
           + +SD++S G+ L+E+  GR
Sbjct: 184 SVQSDIWSMGLSLVEMAVGR 203

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 20/213 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LGE  FG VYKG++      G ++  VA+K L K+  +G    E+  E     +L+HPN+
Sbjct: 17  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLF--------------RKATVPLSWATRMMIA 189
           V L+G   +D    +++ +   G L   L               R     L     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              A G+ +L  +   V+++D  T N+L+      K+SD GL +     D   +    + 
Sbjct: 135 AQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
              + APE +M G  +  SD++S+GVVL E+ +
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT----VAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRK 207
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 252
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 253 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
Query: 361 QCAN 364
             AN
Sbjct: 309 LQAN 312

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 106/225 (47%), Gaps = 26/225 (11%)
Query: 85  ILGEGGFGTVYKGYIDENVRVG----LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH 140
           +LG+GG+G V++         G    +K L  A+ V N +     +    E N L +++H
Sbjct: 24  VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTK---AERNILEEVKH 80
Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           P +V LI Y  +   +L L+ E++  G L   L R+       A   +     A G    
Sbjct: 81  PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG---- 135
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  ++ +IYRD K  NI+L+     KL+DFGL K      +  V+    GT  Y APE +
Sbjct: 136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCGTIEYMAPEIL 193
Query: 260 M-TGHLTARSDVYSFGVVLLELLTG---------RKSVDKTRPSK 294
           M +GH  A  D +S G ++ ++LTG         +K++DK    K
Sbjct: 194 MRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCK 237

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 155 LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 208
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFL 199
            L  L       D    V E+   G L  HL R+       A      +GA     L +L
Sbjct: 209 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDYL 264
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H +E+ V+YRD K  N++LD D   K++DFGL K G +   T  +    GT  Y APE +
Sbjct: 265 H-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVL 321
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D +  GVV+ E++ GR
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 91/205 (44%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 158 LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 211
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFL 199
            L  L       D    V E+   G L  HL R+       A      +GA     L +L
Sbjct: 212 FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDYL 267
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H +E+ V+YRD K  N++LD D   K++DFGL K G +   T  +    GT  Y APE +
Sbjct: 268 H-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVL 324
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D +  GVV+ E++ GR
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID------ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           LG G FG VY+G +         ++V +K+LP   +V ++   Q   ++L E   + +  
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLP---EVCSE---QDELDFLMEALIISKFN 109
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAK 194
           H N+V+ IG   +   R ++ E M  G L++ L      P     L+    + +A   A 
Sbjct: 110 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           G  +L   E   I+RD    N LL        AK+ DFG+A+   +          M   
Sbjct: 170 GCQYLE--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPV 227
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
            +  PE  M G  T+++D +SFGV+L E+ +
Sbjct: 228 KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLR-H 140
           +LG+G FG V    + E   +       AVKVL K+ +    +    +TE   L   R H
Sbjct: 30  VLGKGSFGKVMLARVKETGDL------YAVKVLKKDVILQDDDVECTMTEKRILSLARNH 83
Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           P L +L  +CC    D    V EF+  G L  H+  + +     A     A      L F
Sbjct: 84  PFLTQL--FCCFQTPDRLFFVMEFVNGGDLMFHI--QKSRRFDEARARFYAAEIISALMF 139
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  + +IYRD K  N+LLD +   KL+DFG+ K G     T  +    GT  Y APE 
Sbjct: 140 LHD--KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT--TATFCGTPDYIAPEI 195
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           +         D ++ GV+L E+L G
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 12/206 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLV 144
           LG G FG VY+G +   +      L VAVK L +    Q   ++L E   + +  H N+V
Sbjct: 79  LGHGAFGEVYEGQVS-GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-----LSWATRMMIAFGAAKGLAFL 199
           + IG   +   R ++ E M  G L++ L      P     L+    + +A   A G  +L
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 197
Query: 200 HNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              E   I+RD    N LL        AK+ DFG+A+   +          M    +  P
Sbjct: 198 E--ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT 282
           E  M G  T+++D +SFGV+L E+ +
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 148
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T      + T  Y APE ++  
Sbjct: 149 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 206
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 207 KGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y + N VRV +K      K+   E     +  L E+  L + RH N++
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIK------KISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   T  LS        +   +GL ++H+A 
Sbjct: 90  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN 149
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+LL++    K+ DFGLA+ A P  D T      + T  Y APE ++  
Sbjct: 150 --VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNS 207
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 208 KGYTKSIDIWSVGCILAEMLSNR 230

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 80
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 243
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 244 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299
Query: 361 QCAN 364
             AN
Sbjct: 300 LQAN 303

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDK--PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 88  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 148 SCTYQLARGMEYL--ASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 205
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 206 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 26  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 80
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 81  HLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 140
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 141 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 198
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 199 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 243
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 244 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 299
Query: 361 QCAN 364
             AN
Sbjct: 300 LQAN 303

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRT----VAVKML-KEGATHSEHRALMSELKILIHIGH 89
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 90  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 149
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 150 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 207
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 252
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 253 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 308
Query: 361 QCAN 364
             AN
Sbjct: 309 LQAN 312

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 90  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 150 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 207
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 208 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 93  KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 153 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 210
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 211 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 72  LGRGAFGQVIEADAFGIDKTA----TCRTVAVKML-KEGATHSEHRALMSELKILIHIGH 126
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 127 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEH 186
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 187 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 244
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 245 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 289
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 290 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 345
Query: 361 QCAN 364
             AN
Sbjct: 346 LQAN 349

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLRHPN 142
           LG+G FG VY     +N  +      +A+KVL K  L+      +   E+     LRHPN
Sbjct: 22  LGKGKFGNVYLAREKQNKFI------MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++++  Y  +     L+ EF  RG L   L +        +   M     A  L + H  
Sbjct: 76  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCH-- 131
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVMT 261
           ER VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE +  
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEG 186
Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVD 288
                + D++  GV+  E L G    D
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 90/304 (29%), Positives = 125/304 (41%), Gaps = 51/304 (16%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-R 139
           LG G FG V +     ID+          VAVK+L KEG     HR  ++E+  L  +  
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRT----VAVKML-KEGATHSEHRALMSELKILIHIGH 91
Query: 140 HPNLVKLIGYCCEDDHRLLVY-EFMFRGSLENHLF--RKATVP------------LSWAT 184
           H N+V L+G C +    L+V  EF   G+L  +L   R   VP            L+   
Sbjct: 92  HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEH 151
Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS 244
            +  +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +    
Sbjct: 152 LICYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 209
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP 304
                   + APE +     T +SDV+SFGV+L E+                SL     P
Sbjct: 210 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYP 254
Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPL 360
            +    +  +    RL+    +RA        Y     C    P  RP  S++VE L  L
Sbjct: 255 GVKIDEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 310
Query: 361 QCAN 364
             AN
Sbjct: 311 LQAN 314

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 17  LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 70
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFL 199
            L  L       D    V E+   G L  HL R+       A      +GA     L +L
Sbjct: 71  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDYL 126
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H +E+ V+YRD K  N++LD D   K++DFGL K G +   T       GT  Y APE +
Sbjct: 127 H-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVL 183
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D +  GVV+ E++ GR
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGR 208

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 19/207 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLRHPN 142
           LG+G FG VY     +N  +      +A+KVL K  L+      +   E+     LRHPN
Sbjct: 23  LGKGKFGNVYLAREKQNKFI------MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++++  Y  +     L+ EF  RG L   L +        +   M     A  L + H  
Sbjct: 77  ILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEEL--ADALHYCH-- 132
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVMT 261
           ER VI+RD K  N+L+      K++DFG +   P      +  R M GT  Y  PE +  
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-----LRRRXMCGTLDYLPPEMIEG 187
Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVD 288
                + D++  GV+  E L G    D
Sbjct: 188 KTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 114/272 (41%), Gaps = 31/272 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG  G V         RV  ++  VAVK+++ K  +        E+     L H N+V
Sbjct: 14  LGEGAAGEVQLAV----NRVTEEA--VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 67
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G+  E + + L  E+   G L + +     +P   A R      A  G+ +LH    
Sbjct: 68  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA--GVVYLHGIG- 124
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE +     
Sbjct: 125 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 183
Query: 265 TARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRKMLQIIDPRLE 321
            A   DV+S G+VL  +L G    D+   S  Q   DW   K  LN  +K+         
Sbjct: 184 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSC-QEYSDWKEKKTYLNPWKKI--------- 233
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                       +L +  L +NP AR  + D+
Sbjct: 234 -------DSAPLALLHKILVENPSARITIPDI 258

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 15  LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 68
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFL 199
            L  L       D    V E+   G L  HL R+       A      +GA     L +L
Sbjct: 69  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDYL 124
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H +E+ V+YRD K  N++LD D   K++DFGL K G +   T       GT  Y APE +
Sbjct: 125 H-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVL 181
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D +  GVV+ E++ GR
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGR 206

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 95/203 (46%), Gaps = 17/203 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNL 143
           +LG G F  V    + E+ R       VA+K + K+ L+G    +  E+  L +++HPN+
Sbjct: 25  VLGTGAFSEVI---LAEDKRT---QKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNI 78
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V L        H  L+ + +  G L + +  K       A+R++  F     + +LH+  
Sbjct: 79  VALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLI--FQVLDAVKYLHDL- 135
Query: 204 RPVIYRDFKTSNIL---LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+L   LD D    +SDFGL+K    G    V +   GT GY APE + 
Sbjct: 136 -GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLA 191
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D +S GV+   LL G
Sbjct: 192 QKPYSKAVDCWSIGVIAYILLCG 214

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 107/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDK--PKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   +++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 90/205 (43%), Gaps = 18/205 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP
Sbjct: 16  LLGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHP 69
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAFL 199
            L  L       D    V E+   G L  HL R+       A      +GA     L +L
Sbjct: 70  FLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRAR----FYGAEIVSALDYL 125
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H +E+ V+YRD K  N++LD D   K++DFGL K G +   T       GT  Y APE +
Sbjct: 126 H-SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT--MKXFCGTPEYLAPEVL 182
Query: 260 MTGHLTARSDVYSFGVVLLELLTGR 284
                    D +  GVV+ E++ GR
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 24/204 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---GLQGHREWLTEVNFLGQLRHPN 142
           LG G FG V+      N R        A+KVL KE    L+       E   L  + HP 
Sbjct: 14  LGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAFL 199
           ++++ G   +     ++ +++  G L + L +    P   A      F AA+    L +L
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KFYAAEVCLALEYL 122
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H+ +  +IYRD K  NILLD +   K++DFG AK  P      V+  + GT  Y APE V
Sbjct: 123 HSKD--IIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYXLCGTPDYIAPEVV 175
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
            T       D +SFG+++ E+L G
Sbjct: 176 STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 30/281 (10%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTE 131
           +E     F     LG G  G V+K      V      L +A K+++ E     R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +   +P     ++ IA  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 112
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK 311
            Y +PE +   H + +SD++S G+ L+E+  GR  +     +KE S     RP +     
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPD-AKEDS-----RPPM----A 217
Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKAR 347
           + +++D  + N+   +      SL +      CL +NP  R
Sbjct: 218 IFELLD-YIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 257

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 15  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 69  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 123
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T  +    GT  Y APE 
Sbjct: 124 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 179
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 180 LEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LG GGFG V + +I ++         VA+K   +E    +RE W  E+  + +L HPN+V
Sbjct: 23  LGTGGFGYVLR-WIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 145 KL------IGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGL 196
                   +     +D  LL  E+   G L  +L  F           R +++   +  L
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 197 AFLHNAERPVIYRDFKTSNILLD---SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            +LH  E  +I+RD K  NI+L         K+ D G AK   QG+   + T  +GT  Y
Sbjct: 136 RYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 190
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE +     T   D +SFG +  E +TG
Sbjct: 191 LAPELLEQKKYTVTVDYWSFGTLAFECITG 220

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 75  TITKSFRSDYI--LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           TI +     YI  LG+G FG+V    Y    D    +      VAVK L   G    R++
Sbjct: 5   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGAL------VAVKQLQHSGPDQQRDF 58
Query: 129 LTEVNFLGQLRHPNLVKLIG--YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             E+  L  L    +VK  G  Y        LV E++  G L + L R     L  +  +
Sbjct: 59  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLL 117
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
           + +    KG+ +L    R  ++RD    NIL++S+   K++DFGLAK  P  D+ +   R
Sbjct: 118 LYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVR 174
Query: 247 VMGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             G     + APE +     + +SDV+SFGVVL EL T
Sbjct: 175 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V+K      V      L +A K+++ E     R + + E+  L +   P +V
Sbjct: 76  LGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 129
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     ++ IA    KGL +L    +
Sbjct: 130 GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 187
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   D   ++   +GT  Y +PE +   H 
Sbjct: 188 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 242
Query: 265 TARSDVYSFGVVLLELLTGR 284
           + +SD++S G+ L+E+  GR
Sbjct: 243 SVQSDIWSMGLSLVEMAVGR 262

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 37  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 90
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +C +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 91  MSRLDHPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 147
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 148 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 206 VSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 94/210 (44%), Gaps = 24/210 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           LG GGFG V + +I ++         VA+K   +E    +RE W  E+  + +L HPN+V
Sbjct: 22  LGTGGFGYVLR-WIHQDT-----GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 145 KL------IGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGL 196
                   +     +D  LL  E+   G L  +L  F           R +++   +  L
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 197 AFLHNAERPVIYRDFKTSNILLD---SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            +LH  E  +I+RD K  NI+L         K+ D G AK   QG+   + T  +GT  Y
Sbjct: 135 RYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQY 189
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE +     T   D +SFG +  E +TG
Sbjct: 190 LAPELLEQKKYTVTVDYWSFGTLAFECITG 219

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 107/219 (48%), Gaps = 21/219 (9%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R+      VAVKVL  +  +    +L    E
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRRE 62
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHR------LLVYEFMFRGSLENHLFRKATVPLSWATR 185
                 L HP +V +  Y   +          +V E++   +L + +  +   P++    
Sbjct: 63  AQNAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRA 118
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVS 244
           + +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+A    G+    +
Sbjct: 119 IEVIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
             V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKG-YID-ENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPN 142
           +GEG FG V++G Y+  EN      ++ VA+K          RE +L E   + Q  HP+
Sbjct: 18  IGEGQFGDVHQGIYMSPEN-----PAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPH 72
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +VKLIG   E+    ++ E    G L + L  RK ++ L  A+ ++ A+  +  LA+L +
Sbjct: 73  IVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDL--ASLILYAYQLSTALAYLES 129
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGYAAPEYVM 260
             +  ++RD    N+L+ +    KL DFGL++     D T+  +++      + APE + 
Sbjct: 130 --KRFVHRDIAARNVLVSATDCVKLGDFGLSRY--MEDSTYYKASKGKLPIKWMAPESIN 185
Query: 261 TGHLTARSDVYSFGVVLLELL 281
               T+ SDV+ FGV + E+L
Sbjct: 186 FRRFTSASDVWMFGVCMWEIL 206

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 98/217 (45%), Gaps = 18/217 (8%)
Query: 75  TITKSFRSDYI--LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           TI +     YI  LG+G FG+V    Y    D    +      VAVK L   G    R++
Sbjct: 2   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGAL------VAVKQLQHSGPDQQRDF 55
Query: 129 LTEVNFLGQLRHPNLVKLIG--YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             E+  L  L    +VK  G  Y        LV E++  G L + L R     L  +  +
Sbjct: 56  QREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRAR-LDASRLL 114
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP-QGDETHVST 245
           + +    KG+ +L    R  ++RD    NIL++S+   K++DFGLAK  P   D   V  
Sbjct: 115 LYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVRE 172
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                  + APE +     + +SDV+SFGVVL EL T
Sbjct: 173 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P   E    + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSEMVGTPYWMAPEVVTRKAY 193
Query: 265 TARSDVYSFGVVLLELLTGR 284
             + D++S G++ +E++ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 120
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T  +    GT  Y APE 
Sbjct: 121 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 75  TITKSFRSDYI--LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           TI +     YI  LG+G FG+V    Y    D    +      VAVK L   G    R++
Sbjct: 18  TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGAL------VAVKQLQHSGPDQQRDF 71
Query: 129 LTEVNFLGQLRHPNLVKLIG--YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             E+  L  L    +VK  G  Y        LV E++  G L + L R     L  +  +
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLL 130
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
           + +    KG+ +L    R  ++RD    NIL++S+   K++DFGLAK  P  D+ +   R
Sbjct: 131 LYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVR 187
Query: 247 VMGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             G     + APE +     + +SDV+SFGVVL EL T
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 101/218 (46%), Gaps = 20/218 (9%)
Query: 75  TITKSFRSDYI--LGEGGFGTV----YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           TI +     YI  LG+G FG+V    Y    D    +      VAVK L   G    R++
Sbjct: 6   TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGAL------VAVKQLQHSGPDQQRDF 59
Query: 129 LTEVNFLGQLRHPNLVKLIG--YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             E+  L  L    +VK  G  Y        LV E++  G L + L R     L  +  +
Sbjct: 60  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR-LDASRLL 118
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
           + +    KG+ +L    R  ++RD    NIL++S+   K++DFGLAK  P  D+ +   R
Sbjct: 119 LYSSQICKGMEYL--GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL-DKDYYVVR 175
Query: 247 VMGTYG--YAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             G     + APE +     + +SDV+SFGVVL EL T
Sbjct: 176 EPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 92/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 120
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T  +    GT  Y APE 
Sbjct: 121 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 102/203 (50%), Gaps = 12/203 (5%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNLV 144
           +GEG +G V   Y  ++VR       VA+K ++    Q + +  L E+  L + RH N++
Sbjct: 51  IGEGAYGMVSSAY--DHVR----KTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAE 203
            +           +   ++ +  +E  L++   +  LS        +   +GL ++H+A 
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILRGLKYIHSAN 164
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
             V++RD K SN+L+++    K+ DFGLA+ A P+ D T   T  + T  Y APE ++  
Sbjct: 165 --VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNS 222
Query: 263 HLTARS-DVYSFGVVLLELLTGR 284
               +S D++S G +L E+L+ R
Sbjct: 223 KGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P+  ++  ST V GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 193
Query: 265 TARSDVYSFGVVLLELLTGR 284
             + D++S G++ +E++ G 
Sbjct: 194 GPKVDIWSLGIMAIEMIEGE 213

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 120
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE 
Sbjct: 121 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 17  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 71  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 125
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE 
Sbjct: 126 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 181
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 120
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE 
Sbjct: 121 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R       VAVKVL  +  +    +L    E
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 132 VNFLGQLRHPNLVKL--IGYCCEDDHRL--LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +   G        L  +V E++   +L + +  +   P++    + 
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NIL+ +    K+ DFG+A+A    G+    +  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAA 178
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 108/232 (46%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 28  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 136
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P   E    + ++GT  + APE V     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSXMVGTPYWMAPEVVTRKAY 193
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKMLQI 315
             + D++S G++ +E++ G        P +   L+     P+L +  K+  I
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 245

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 29  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+RD K+ NILL  D + KL+DFG  A+  P   E    + ++GT  + APE V     
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP---EQSKRSXMVGTPYWMAPEVVTRKAY 194
Query: 265 TARSDVYSFGVVLLELLTGR 284
             + D++S G++ +E++ G 
Sbjct: 195 GPKVDIWSLGIMAIEMIEGE 214

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 91/206 (44%), Gaps = 21/206 (10%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA--AKGLAF 198
            L  L  Y  +   RL  V E+   G L  HL R+       A      +GA     L +
Sbjct: 66  FLTAL-KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR----FYGAEIVSALEY 120
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+  R V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE 
Sbjct: 121 LHS--RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT--MKXFCGTPEYLAPEV 176
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGR 284
           +         D +  GVV+ E++ GR
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTE 131
           +E     F     LG G  G V+K      V      L +A K+++ E     R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +   +P     ++ IA  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 112
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV 287
            Y +PE +   H + +SD++S G+ L+E+  GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V+K      V      L +A K+++ E     R + + E+  L +   P +V
Sbjct: 41  LGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     ++ IA    KGL +L    +
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 152
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   D   ++   +GT  Y +PE +   H 
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 207
Query: 265 TARSDVYSFGVVLLELLTGR 284
           + +SD++S G+ L+E+  GR
Sbjct: 208 SVQSDIWSMGLSLVEMAVGR 227

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 107/217 (49%), Gaps = 17/217 (7%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R+      VAVKVL  +  +    +L    E
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRRE 62
Query: 132 VNFLGQLRHPNLVKL--IGYCCEDDHRL--LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +   G        L  +V E++   +L + +  +   P++    + 
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+A    G+    +  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTE 131
           +E     F     LG G  G V+K      V      L +A K+++ E     R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +   +P     ++ IA  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 112
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV 287
            Y +PE +   H + +SD++S G+ L+E+  GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++  +  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS- 130
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S+   K++DFG +   P        T + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----TTLCGTLDYLPPEMIEGR 185
Query: 263 HLTARSDVYSFGVVLLELLTG 283
               + D++S GV+  E L G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTE 131
           +E     F     LG G  G V+K      V      L +A K+++ E     R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +   +P     ++ IA  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 112
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV 287
            Y +PE +   H + +SD++S G+ L+E+  GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 14/216 (6%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTE 131
           +E     F     LG G  G V+K      V      L +A K+++ E     R + + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRE 54
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +   +P     ++ IA  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA-- 112
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L    + +++RD K SNIL++S    KL DFG++  G   D   ++   +GT 
Sbjct: 113 VIKGLTYLREKHK-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTR 167
Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV 287
            Y +PE +   H + +SD++S G+ L+E+  GR  +
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYK-GYIDENVRVGLKSLP--VAVKVLNKEGLQGHR 126
           L +  T+ +  R  + LG+GGF   Y+   +D       K +P  + +K   KE +    
Sbjct: 35  LVDPRTMKRYMRGRF-LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--- 90
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLS-WA 183
              TE+     L +P++V   G+  +DD   +V E   R SL E H  RKA T P + + 
Sbjct: 91  ---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETH 242
            R  I     +G+ +LHN    VI+RD K  N+ L+ D   K+ DFGLA K    G+   
Sbjct: 148 MRQTI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKK 200
Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
               + GT  Y APE +     +   D++S G +L  LL G+
Sbjct: 201 T---LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYK-GYIDENVRVGLKSLP--VAVKVLNKEGLQGHR 126
           L +  T+ +  R  + LG+GGF   Y+   +D       K +P  + +K   KE +    
Sbjct: 35  LVDPRTMKRYMRGRF-LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--- 90
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLS-WA 183
              TE+     L +P++V   G+  +DD   +V E   R SL E H  RKA T P + + 
Sbjct: 91  ---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETH 242
            R  I     +G+ +LHN    VI+RD K  N+ L+ D   K+ DFGLA K    G+   
Sbjct: 148 MRQTI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 198
Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
               + GT  Y APE +     +   D++S G +L  LL G+
Sbjct: 199 -KKXLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG 136
           ++   +LG+G FG V         +  +     AVKV++K  ++   +    L EV  L 
Sbjct: 51  YKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 104
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL HPN++KL  +  +  +  LV E    G L + +  +       A R++       G+
Sbjct: 105 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--VLSGI 162
Query: 197 AFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            ++H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y
Sbjct: 163 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYY 217
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE V+ G    + DV+S GV+L  LL+G
Sbjct: 218 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 246

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/161 (31%), Positives = 81/161 (50%), Gaps = 7/161 (4%)
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
           + + E+  L +   P +V   G    D    +  E M  GSL+  L     +P     ++
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKV 119
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            IA    +GLA+L    + +++RD K SNIL++S    KL DFG++  G   D   ++  
Sbjct: 120 SIA--VLRGLAYLREKHQ-IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANS 172
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSV 287
            +GT  Y APE +   H + +SD++S G+ L+EL  GR  +
Sbjct: 173 FVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG 136
           ++   +LG+G FG V         +  +     AVKV++K  ++   +    L EV  L 
Sbjct: 52  YKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 105
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL HPN++KL  +  +  +  LV E    G L + +  +       A R++       G+
Sbjct: 106 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--VLSGI 163
Query: 197 AFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            ++H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y
Sbjct: 164 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYY 218
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE V+ G    + DV+S GV+L  LL+G
Sbjct: 219 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 247

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R       VAVKVL  +  +    +L    E
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 132 VNFLGQLRHPNLVKL--IGYCCEDDHRL--LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +   G        L  +V E++   +L + +  +   P++    + 
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+A    G+    +  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYK-GYIDENVRVGLKSLP--VAVKVLNKEGLQGHR 126
           L +  T+ +  R  + LG+GGF   Y+   +D       K +P  + +K   KE +    
Sbjct: 35  LVDPRTMKRYMRGRF-LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--- 90
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLS-WA 183
              TE+     L +P++V   G+  +DD   +V E   R SL E H  RKA T P + + 
Sbjct: 91  ---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 147
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETH 242
            R  I     +G+ +LHN    VI+RD K  N+ L+ D   K+ DFGLA K    G+   
Sbjct: 148 MRQTI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 198
Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
               + GT  Y APE +     +   D++S G +L  LL G+
Sbjct: 199 -KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 239

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 106/216 (49%), Gaps = 23/216 (10%)
Query: 86  LGEGGFGTVYKGY---IDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQL-RH 140
           LGEG FG V       ID++     +++ VAVK+L  +  +    + ++E+  +  + +H
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPK--EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----------FRKATVP---LSWATRM 186
            N++ L+G C +D    ++  +  +G+L  +L           +    VP   +++   +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 161 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 218
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                 + APE +     T +SDV+SFGV++ E+ T
Sbjct: 219 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG 136
           ++   +LG+G FG V         +  +     AVKV++K  ++   +    L EV  L 
Sbjct: 28  YKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL HPN++KL  +  +  +  LV E    G L + +  +       A R  I      G+
Sbjct: 82  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGI 139
Query: 197 AFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            ++H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y
Sbjct: 140 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYY 194
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE V+ G    + DV+S GV+L  LL+G
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R       VAVKVL  +  +    +L    E
Sbjct: 6   TPSHLSDRYELGEILGFGGMSEVHLARDLR---DHRDVAVKVLRADLARDPSFYLRFRRE 62
Query: 132 VNFLGQLRHPNLVKL--IGYCCEDDHRL--LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +   G        L  +V E++   +L + +  +   P++    + 
Sbjct: 63  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 120
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+A    G+    +  
Sbjct: 121 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 178
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 179 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LG G  G V+K      V      L +A K+++ E     R + + E+  L +   P +V
Sbjct: 33  LGAGNGGVVFK------VSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     ++ IA    KGL +L    +
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIA--VIKGLTYLREKHK 144
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++  G   D   ++   +GT  Y +PE +   H 
Sbjct: 145 -IMHRDVKPSNILVNSRGEIKLCDFGVS--GQLIDS--MANSFVGTRSYMSPERLQGTHY 199
Query: 265 TARSDVYSFGVVLLELLTGR 284
           + +SD++S G+ L+E+  GR
Sbjct: 200 SVQSDIWSMGLSLVEMAVGR 219

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG 136
           ++   +LG+G FG V         +  +     AVKV++K  ++   +    L EV  L 
Sbjct: 34  YKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 87
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL HPN++KL  +  +  +  LV E    G L + +  +       A R++       G+
Sbjct: 88  QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--VLSGI 145
Query: 197 AFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            ++H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y
Sbjct: 146 TYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE V+ G    + DV+S GV+L  LL+G
Sbjct: 201 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 93/203 (45%), Gaps = 16/203 (7%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVN-FLGQLRH 140
           ++G+G FG V         R   + +  AVKVL K+ +   +E    ++E N  L  ++H
Sbjct: 45  VIGKGSFGKVLLA------RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P LV L       D    V +++  G L  HL R+    L    R   A   A  L +LH
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCF-LEPRARFYAA-EIASALGYLH 156
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +    ++YRD K  NILLDS     L+DFGL K   + + T  ++   GT  Y APE + 
Sbjct: 157 SLN--IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST--TSTFCGTPEYLAPEVLH 212
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D +  G VL E+L G
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 77  TKSFRSD-YILGEG-GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---E 131
           T S  SD Y LGE  GFG + + ++  ++R+      VAVKVL  +  +    +L    E
Sbjct: 23  TPSHLSDRYELGEILGFGGMSEVHLARDLRLHRD---VAVKVLRADLARDPSFYLRFRRE 79
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +      +        +V E++   +L + +  +   P++    + 
Sbjct: 80  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 137
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+A    G+    +  
Sbjct: 138 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 195
Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           V+GT  Y +PE      + ARSDVYS G VL E+LTG
Sbjct: 196 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 105/222 (47%), Gaps = 24/222 (10%)
Query: 70  LFELETITKSFRSDYILGEGGFGTVYK-GYIDENVRVGLKSLP--VAVKVLNKEGLQGHR 126
           L +  T+ +  R  + LG+GGF   Y+   +D       K +P  + +K   KE +    
Sbjct: 19  LVDPRTMKRYMRGRF-LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMS--- 74
Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLS-WA 183
              TE+     L +P++V   G+  +DD   +V E   R SL E H  RKA T P + + 
Sbjct: 75  ---TEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYF 131
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETH 242
            R  I     +G+ +LHN    VI+RD K  N+ L+ D   K+ DFGLA K    G+   
Sbjct: 132 MRQTI-----QGVQYLHNNR--VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGER-- 182
Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
               + GT  Y APE +     +   D++S G +L  LL G+
Sbjct: 183 -KKDLCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGK 223

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 27/241 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           LE S   A  Y   +  +++E+    +  R    +G G +G+V   Y   + R+  K   
Sbjct: 5   LEMSGPRAGFYRQELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAY---DARLRQK--- 55
Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRLLVYEFMF 164
           VAVK L++  + L   R    E+  L  L+H N++ L+         ED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 165 RGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA 224
              L N +  +A   LS      + +   +GL ++H+A   +I+RD K SN+ ++ D   
Sbjct: 116 GADLNNIVKSQA---LSDEHVQFLVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSEL 170
Query: 225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           ++ DFGLA+   +    +V+TR      Y APE ++   H     D++S G ++ ELL G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 284 R 284
           +
Sbjct: 226 K 226

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V         R G + L  A+K+L K+ +    +    + E   L  L  P
Sbjct: 26  VLGKGSFGKVMLA-----DRKGTEEL-YAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
             +  +  C +   RL  V E++  G L  H+  +          +  A   + GL FLH
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFKEPQAVFYAAEISIGLFFLH 137
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR-VMGTYGYAAPEYV 259
             +R +IYRD K  N++LDS+   K++DFG+ K         V+TR   GT  Y APE +
Sbjct: 138 --KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMM---DGVTTREFCGTPDYIAPEII 192
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVD 288
                    D +++GV+L E+L G+   D
Sbjct: 193 AYQPYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 104/208 (50%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   Y   +V+ GLK   +AVK L++  + +   +    E+  L  ++H N+
Sbjct: 59  VGSGAYGSVCSSY---DVKSGLK---IAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 112
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 113 IGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 168
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 169 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 221
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 110/232 (47%), Gaps = 16/232 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G+G  GTVY      +V  G +   VA++ +N +        + E+  + + ++PN+V 
Sbjct: 29  IGQGASGTVYTAM---DVATGQE---VAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 82
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            +      D   +V E++  GSL + +       +       +     + L FLH+ +  
Sbjct: 83  YLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSNQ-- 137
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
           VI+R+ K+ NILL  D + KL+DFG  A+  P+  ++  ST V GT  + APE V     
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMV-GTPYWMAPEVVTRKAY 194
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW-ARPKLNDKRKMLQI 315
             + D++S G++ +E++ G        P +   L+     P+L +  K+  I
Sbjct: 195 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAI 246

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 20/210 (9%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLG 136
           ++   +LG+G FG V         +  +     AVKV++K  ++   +    L EV  L 
Sbjct: 28  YKGQRVLGKGSFGEVIL------CKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL HPN+ KL  +  +  +  LV E    G L + +  +       A R++       G+
Sbjct: 82  QLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQ--VLSGI 139
Query: 197 AFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            + H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +      +GT  Y
Sbjct: 140 TYXH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKXKDKIGTAYY 194
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE V+ G    + DV+S GV+L  LL+G
Sbjct: 195 IAPE-VLHGTYDEKCDVWSTGVILYILLSG 223

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 101/211 (47%), Gaps = 17/211 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGCLLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYG 252
             L +LH   + +I+RD K  NILL+ D   +++DFG AK   P+  +   ++ V GT  
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQ 199
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +PE +     +  SD+++ G ++ +L+ G
Sbjct: 200 YVSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 113/241 (46%), Gaps = 27/241 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           LE S   A  Y   +  +++E+    +  R    +G G +G+V   Y   + R+  K   
Sbjct: 5   LEMSGPRAGFYRQELNKTVWEVPQRLQGLRP---VGSGAYGSVCSAY---DARLRQK--- 55
Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRLLVYEFMF 164
           VAVK L++  + L   R    E+  L  L+H N++ L+         ED   + +   + 
Sbjct: 56  VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLM 115
Query: 165 RGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA 224
              L N +  +A   LS      + +   +GL ++H+A   +I+RD K SN+ ++ D   
Sbjct: 116 GADLNNIVKCQA---LSDEHVQFLVYQLLRGLKYIHSA--GIIHRDLKPSNVAVNEDSEL 170
Query: 225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           ++ DFGLA+   +    +V+TR      Y APE ++   H     D++S G ++ ELL G
Sbjct: 171 RILDFGLARQADEEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 284 R 284
           +
Sbjct: 226 K 226

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 89/201 (44%), Gaps = 17/201 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 20  LGKGKFGNVYLA------RERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L GY  +     L+ E+   G++   L + +          +     A  L++ H+ 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--ANALSYCHS- 130
Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            + VI+RD K  N+LL S+   K++DFG +   P          + GT  Y  PE +   
Sbjct: 131 -KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRR----DTLCGTLDYLPPEMIEGR 185
Query: 263 HLTARSDVYSFGVVLLELLTG 283
               + D++S GV+  E L G
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVG 206

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 143
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYG 252
             L +LH   + +I+RD K  NILL+ D   +++DFG AK   P+  +   ++ V GT  
Sbjct: 144 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQ 200
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +PE +        SD+++ G ++ +L+ G
Sbjct: 201 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   Y   + R+  K   VAVK L++  + L   R    E+  L  L+H N+
Sbjct: 28  VGSGAYGSVCSAY---DARLRQK---VAVKKLSRPFQSLIHARRTYRELRLLKHLKHENV 81
Query: 144 VKLI-----GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           + L+         ED   + +   +    L N +  +A   LS      + +   +GL +
Sbjct: 82  IGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQA---LSDEHVQFLVYQLLRGLKY 138
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           +H+A   +I+RD K SN+ ++ D   ++ DFGLA+   +    +V+TR      Y APE 
Sbjct: 139 IHSA--GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVATR-----WYRAPEI 191
Query: 259 VMTG-HLTARSDVYSFGVVLLELLTGR 284
           ++   H     D++S G ++ ELL G+
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 10  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 63
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 64  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 120
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 121 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 178
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 179 VSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 9   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 62
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 63  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 119
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 120 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 177
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 178 VSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 17/211 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 139
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYG 252
             L +LH   + +I+RD K  NILL+ D   +++DFG AK   P+  +   ++ V GT  
Sbjct: 140 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV-GTAQ 196
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +PE +        SD+++ G ++ +L+ G
Sbjct: 197 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 7   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 60
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 61  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 117
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 118 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 175
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 176 VSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 8   EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 61
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 62  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 118
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 119 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 176
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 17/211 (8%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 140
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYG 252
             L +LH   + +I+RD K  NILL+ D   +++DFG AK   P+  +   +  V GT  
Sbjct: 141 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV-GTAQ 197
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +PE +        SD+++ G ++ +L+ G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 33  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 86
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 87  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 143
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 144 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 140
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 141 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 14  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 67
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 68  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 124
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 125 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 30  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 140
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 141 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 120/248 (48%), Gaps = 29/248 (11%)
Query: 46  PSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRV 105
           P     LE S++    Y   +  +++E   + + +++   +G G +G+V   +   + + 
Sbjct: 16  PRGSHMLEMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKT 69
Query: 106 GLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRL 157
           GL+   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   
Sbjct: 70  GLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 126
Query: 158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
           LV   M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ 
Sbjct: 127 LVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLA 180
Query: 218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVV 276
           ++ D   K+ DFGLA+        +V+TR      Y APE ++   H     D++S G +
Sbjct: 181 VNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCI 235
Query: 277 LLELLTGR 284
           + ELLTGR
Sbjct: 236 MAELLTGR 243

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 25/221 (11%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFL 135
           + F    +LG+G FG+V +  + +     +K   VAVK+L  + +      E+L E   +
Sbjct: 23  QQFTLGRMLGKGEFGSVREAQLKQEDGSFVK---VAVKMLKADIIASSDIEEFLREAACM 79
Query: 136 GQLRHPNLVKLIGYCCEDDHR------LLVYEFMFRGSLENHLFRKAT--------VPLS 181
            +  HP++ KL+G       +      +++  FM  G L  H F  A+        +PL 
Sbjct: 80  KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL--HAFLLASRIGENPFNLPLQ 137
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
              R M+    A G+ +L  + R  I+RD    N +L  D T  ++DFGL++    GD  
Sbjct: 138 TLVRFMVDI--ACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY 193
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                      + A E +     T  SDV++FGV + E++T
Sbjct: 194 RQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 35  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 88
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 89  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 145
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 146 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK--LTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 29  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 82
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 83  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 139
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 140 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F TV         R    S   A+K+L K  +  +    ++T E + 
Sbjct: 32  EDFKFGKILGEGSFSTVVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 85
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 86  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 142
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 143 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           LE S++    Y   +  +++E   + + +++   +G G +G+V   +   + + GL+   
Sbjct: 5   LEMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGLR--- 55
Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFM 163
           VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV   M
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 115
Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
             G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++ D  
Sbjct: 116 --GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDSE 169
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
            K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ ELLT
Sbjct: 170 LKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 283 GR 284
           GR
Sbjct: 225 GR 226

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L+K  + +   +    E+  L  ++H N+
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 151
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 152 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 204
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 18/234 (7%)
Query: 58  NAVLYTHVIAFSLFELETITKSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           +++ +   + +   E + + + +  D+ +LG GGFG V+   +    ++         ++
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRK 175
             ++G QG    + E   L ++ H   +  + Y  E    L LV   M  G +  H++  
Sbjct: 224 KKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 176 ATVPLSWATRMMIAFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA- 232
                 +     I + A    GL  LH  +R +IYRD K  N+LLD D   ++SD GLA 
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 233 --KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
             KAG    + +      GT G+ APE ++        D ++ GV L E++  R
Sbjct: 338 ELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 18/234 (7%)
Query: 58  NAVLYTHVIAFSLFELETITKSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           +++ +   + +   E + + + +  D+ +LG GGFG V+   +    ++         ++
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRK 175
             ++G QG    + E   L ++ H   +  + Y  E    L LV   M  G +  H++  
Sbjct: 224 KKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 176 ATVPLSWATRMMIAFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA- 232
                 +     I + A    GL  LH  +R +IYRD K  N+LLD D   ++SD GLA 
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 233 --KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
             KAG    + +      GT G+ APE ++        D ++ GV L E++  R
Sbjct: 338 ELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 101/201 (50%), Gaps = 14/201 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNLV 144
           LGEG + TVYKG      +  L    VA+K +  E  +G     + EV+ L  L+H N+V
Sbjct: 10  LGEGTYATVYKG------KSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV 63
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L      +    LV+E++ +  L+ +L     + ++     +  F   +GLA+ H   +
Sbjct: 64  TLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNI-INMHNVKLFLFQLLRGLAYCHR--Q 119
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGH 263
            V++RD K  N+L++     KL+DFGLA+A     +T+ +  V  T  Y  P+ ++ +  
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV--TLWYRPPDILLGSTD 177
Query: 264 LTARSDVYSFGVVLLELLTGR 284
            + + D++  G +  E+ TGR
Sbjct: 178 YSTQIDMWGVGCIFYEMATGR 198

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 104/234 (44%), Gaps = 18/234 (7%)
Query: 58  NAVLYTHVIAFSLFELETITKSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV 116
           +++ +   + +   E + + + +  D+ +LG GGFG V+   +    ++         ++
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 117 LNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRK 175
             ++G QG    + E   L ++ H   +  + Y  E    L LV   M  G +  H++  
Sbjct: 224 KKRKGYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNV 279
Query: 176 ATVPLSWATRMMIAFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA- 232
                 +     I + A    GL  LH  +R +IYRD K  N+LLD D   ++SD GLA 
Sbjct: 280 DEDNPGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 233 --KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
             KAG    + +      GT G+ APE ++        D ++ GV L E++  R
Sbjct: 338 ELKAGQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           LE S++    Y   +  +++E   + + +++   +G G +G+V   +   + + GL+   
Sbjct: 5   LEMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGLR--- 55
Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFM 163
           VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV   M
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 115
Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
             G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++ D  
Sbjct: 116 --GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 169
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
            K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ ELLT
Sbjct: 170 LKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224
Query: 283 GR 284
           GR
Sbjct: 225 GR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 119/246 (48%), Gaps = 29/246 (11%)
Query: 48  TPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGL 107
            PR    S++    Y   +  +++E   + + +++   +G G +G+V   +   + + GL
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGL 68
Query: 108 KSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLV 159
           +   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV
Sbjct: 69  R---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
              M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++
Sbjct: 126 THLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 179
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLL 278
            D   K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ 
Sbjct: 180 EDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 279 ELLTGR 284
           ELLTGR
Sbjct: 235 ELLTGR 240

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/246 (25%), Positives = 119/246 (48%), Gaps = 29/246 (11%)
Query: 48  TPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGL 107
            PR    S++    Y   +  +++E   + + +++   +G G +G+V   +   + + GL
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGL 67
Query: 108 KSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLV 159
           +   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV
Sbjct: 68  R---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
              M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++
Sbjct: 125 THLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 178
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLL 278
            D   K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ 
Sbjct: 179 EDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 279 ELLTGR 284
           ELLTGR
Sbjct: 234 ELLTGR 239

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 119/242 (49%), Gaps = 29/242 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           LE S++    Y   +  +++E   + + +++   +G G +G+V   +   + + GL+   
Sbjct: 4   LEMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGLR--- 54
Query: 112 VAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFM 163
           VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV   M
Sbjct: 55  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM 114
Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
             G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++ D  
Sbjct: 115 --GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCE 168
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLT 282
            K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ ELLT
Sbjct: 169 LKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223
Query: 283 GR 284
           GR
Sbjct: 224 GR 225

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 86  LGEGGFG-TVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +GEG FG  +     ++  +  +K + ++ ++ +KE  +  RE    V  L  ++HPN+V
Sbjct: 32  IGEGSFGKAILVKSTEDGRQYVIKEINIS-RMSSKEREESRRE----VAVLANMKHPNIV 86
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSL-------ENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           +      E+    +V ++   G L       +  LF++  + L W  ++         LA
Sbjct: 87  QYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-LDWFVQIC--------LA 137
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
             H  +R +++RD K+ NI L  D T +L DFG+A+         ++   +GT  Y +PE
Sbjct: 138 LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVELARACIGTPYYLSPE 195
Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
                    +SD+++ G VL EL T
Sbjct: 196 ICENKPYNNKSDIWALGCVLYELCT 220

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 35  IGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 144
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 145 YIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPE 197
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQK--LTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 48  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 102 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 157
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETHVSTRVMGTYGYAAPEY 258
           H     VI+RD K  N+ L+ D   K+ DFGLA K    G+   V   + GT  Y APE 
Sbjct: 158 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEV 212
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
           +     +   DV+S G ++  LL G       +P  E S +         K   L+I   
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI--- 253
Query: 319 RLENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
             +N+YS+       A SL    L  +P ARP +++++
Sbjct: 254 -KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 46  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 99
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 100 HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 155
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETHVSTRVMGTYGYAAPEY 258
           H     VI+RD K  N+ L+ D   K+ DFGLA K    G+   V   + GT  Y APE 
Sbjct: 156 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEV 210
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
           +     +   DV+S G ++  LL G       +P  E S +         K   L+I   
Sbjct: 211 LSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI--- 251
Query: 319 RLENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
             +N+YS+       A SL    L  +P ARP +++++
Sbjct: 252 -KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 288

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 95/211 (45%), Gaps = 29/211 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLRHPN 142
           +G+G FG V     ++  ++       A+K +NK+        R    E+  +  L HP 
Sbjct: 23  IGKGSFGKVCIVQKNDTKKM------YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----FRKATVPLSWATRMMIAFGAAKGLA 197
           LV L     +++   +V + +  G L  HL     F++ TV L     +M        L 
Sbjct: 77  LVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM-------ALD 129
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +L N    +I+RD K  NILLD      ++DF +A   P+  ET ++T + GT  Y APE
Sbjct: 130 YLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ETQITT-MAGTKPYMAPE 184
Query: 258 YVMTGHLTARS---DVYSFGVVLLELLTGRK 285
              +      S   D +S GV   ELL GR+
Sbjct: 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/274 (24%), Positives = 119/274 (43%), Gaps = 18/274 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G+G FG V+KG  +   +V      VA+K+++ +E      +   E+  L Q     + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQV------VAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G   +     ++ E++  GS  + L          AT +       KGL +LH+ ++
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL---KGLDYLHSEKK 141
Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD K +N+LL      KL+DFG+  AG   D        +GT  + APE +     
Sbjct: 142 --IHRDIKAANVLLSEQGDVKLADFGV--AGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY 197
Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL---NDKRKMLQIIDPRLE 321
            +++D++S G+  +EL  G        P +   L+    P     +  +   + ID  L 
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLN 257
Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
              S R   K   L +  + +N K    ++++++
Sbjct: 258 KDPSFRPTAKEL-LKHKFIVKNSKKTSYLTELID 290

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 40/311 (12%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           TI ++      +G+G FG V++G          +   VAVK+ +    +  R W  E   
Sbjct: 3   TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEI 51
Query: 135 LG--QLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                LRH N++  I    +D+       LV ++   GSL ++L R  TV +     + +
Sbjct: 52  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVE--GMIKL 108
Query: 189 AFGAAKGLAFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET- 241
           A   A GLA LH        +P I +RD K+ NIL+  + T  ++D GLA       +T 
Sbjct: 109 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 168
Query: 242 -HVSTRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSK 294
                  +GT  Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       
Sbjct: 169 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 227
Query: 295 EQSLVDW--ARPKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPL 349
           +    D   + P + + RK++  Q + P + N++ S  A +    +   C   N  AR  
Sbjct: 228 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 287
Query: 350 MSDVVETLEPL 360
              + +TL  L
Sbjct: 288 ALRIKKTLSQL 298

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 40/311 (12%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           TI ++      +G+G FG V++G          +   VAVK+ +    +  R W  E   
Sbjct: 1   TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEI 49
Query: 135 LG--QLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                LRH N++  I    +D+       LV ++   GSL ++L R  TV +     + +
Sbjct: 50  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVE--GMIKL 106
Query: 189 AFGAAKGLAFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET- 241
           A   A GLA LH        +P I +RD K+ NIL+  + T  ++D GLA       +T 
Sbjct: 107 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 166
Query: 242 -HVSTRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSK 294
                  +GT  Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       
Sbjct: 167 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 225
Query: 295 EQSLVDW--ARPKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPL 349
           +    D   + P + + RK++  Q + P + N++ S  A +    +   C   N  AR  
Sbjct: 226 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 285
Query: 350 MSDVVETLEPL 360
              + +TL  L
Sbjct: 286 ALRIKKTLSQL 296

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/288 (24%), Positives = 118/288 (40%), Gaps = 39/288 (13%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEV 132
           E     +R   +LG+GGFGTV+ G+ + + ++V +K +P   +VL    L        EV
Sbjct: 27  EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRN-RVLGWSPLSDSVTCPLEV 85
Query: 133 NFLGQL----RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
             L ++     HP +++L+ +    +  +LV E   R      LF   T           
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLE---RPLPAQDLFDYITEKGPLGEGPSR 142
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSDFGLAKAGPQGDETHVSTRV 247
            F      A  H   R V++RD K  NIL+D     AKL DFG        DE +  T  
Sbjct: 143 CFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG--SGALLHDEPY--TDF 198
Query: 248 MGTYGYAAPEYVMTGHLTA-RSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
            GT  Y+ PE++      A  + V+S G++L +++ G    ++ +   E  L        
Sbjct: 199 DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQEILEAEL-------- 250
Query: 307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
                            +    +   C+L   CL+  P +RP + +++
Sbjct: 251 ----------------HFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL--NKEGLQGHREWLTEVNFLGQLRHPN 142
           ++GEG +G V K    +  R+      VA+K    + +     +  + E+  L QLRH N
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRI------VAIKKFLESDDDKMVKKIAMREIKLLKQLRHEN 85
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLEN-HLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           LV L+  C +     LV+EF+    L++  LF      L +       F    G+ F H+
Sbjct: 86  LVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQVVQKYLFQIINGIGFCHS 142
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               +I+RD K  NIL+      KL DFG A+      E +     + T  Y APE ++ 
Sbjct: 143 HN--IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDE--VATRWYRAPELLVG 198
Query: 262 GHLTARS-DVYSFGVVLLELLTG 283
                ++ DV++ G ++ E+  G
Sbjct: 199 DVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 40/311 (12%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           TI ++      +G+G FG V++G          +   VAVK+ +    +  R W  E   
Sbjct: 6   TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEI 54
Query: 135 LG--QLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                LRH N++  I    +D+       LV ++   GSL ++L R  TV +     + +
Sbjct: 55  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVE--GMIKL 111
Query: 189 AFGAAKGLAFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET- 241
           A   A GLA LH        +P I +RD K+ NIL+  + T  ++D GLA       +T 
Sbjct: 112 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 171
Query: 242 -HVSTRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSK 294
                  +GT  Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       
Sbjct: 172 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 230
Query: 295 EQSLVDW--ARPKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPL 349
           +    D   + P + + RK++  Q + P + N++ S  A +    +   C   N  AR  
Sbjct: 231 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 290
Query: 350 MSDVVETLEPL 360
              + +TL  L
Sbjct: 291 ALRIKKTLSQL 301

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 146
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPE 199
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 144
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 145 YIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPE 197
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 40/311 (12%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           TI ++      +G+G FG V++G          +   VAVK+ +    +  R W  E   
Sbjct: 26  TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEI 74
Query: 135 LG--QLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                LRH N++  I    +D+       LV ++   GSL ++L R  TV +    ++  
Sbjct: 75  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKL-- 131
Query: 189 AFGAAKGLAFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET- 241
           A   A GLA LH        +P I +RD K+ NIL+  + T  ++D GLA       +T 
Sbjct: 132 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 191
Query: 242 -HVSTRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSK 294
                  +GT  Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       
Sbjct: 192 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 250
Query: 295 EQSLVDW--ARPKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPL 349
           +    D   + P + + RK++  Q + P + N++ S  A +    +   C   N  AR  
Sbjct: 251 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 310
Query: 350 MSDVVETLEPL 360
              + +TL  L
Sbjct: 311 ALRIKKTLSQL 321

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/262 (27%), Positives = 125/262 (47%), Gaps = 27/262 (10%)
Query: 24  LSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSD 83
           L+  +PVK +R    ++ D+  P  P    D R        V +F      T++K+    
Sbjct: 48  LTERMPVKSKRTSALAV-DIPAPPAPF---DHRIVTAKQGAVNSFY-----TVSKT---- 94
Query: 84  YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
            ILG G FG V+K    E    GLK   +A K++   G++   E   E++ + QL H NL
Sbjct: 95  EILGGGRFGQVHKC---EETATGLK---LAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           ++L       +  +LV E++  G L + +  + +  L+    ++      +G+  +H  +
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMH--Q 205
Query: 204 RPVIYRDFKTSNIL-LDSDYTA-KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             +++ D K  NIL ++ D    K+ DFGLA+     ++  V+    GT  + APE V  
Sbjct: 206 MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEFLAPEVVNY 262
Query: 262 GHLTARSDVYSFGVVLLELLTG 283
             ++  +D++S GV+   LL+G
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSG 284

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 82/311 (26%), Positives = 134/311 (43%), Gaps = 40/311 (12%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           TI ++      +G+G FG V++G          +   VAVK+ +    +  R W  E   
Sbjct: 39  TIARTIVLQESIGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEI 87
Query: 135 LG--QLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                LRH N++  I    +D+       LV ++   GSL ++L R  TV +    ++  
Sbjct: 88  YQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKL-- 144
Query: 189 AFGAAKGLAFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET- 241
           A   A GLA LH        +P I +RD K+ NIL+  + T  ++D GLA       +T 
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTI 204
Query: 242 -HVSTRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSK 294
                  +GT  Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       
Sbjct: 205 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDY 263
Query: 295 EQSLVDW--ARPKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPL 349
           +    D   + P + + RK++  Q + P + N++ S  A +    +   C   N  AR  
Sbjct: 264 QLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT 323
Query: 350 MSDVVETLEPL 360
              + +TL  L
Sbjct: 324 ALRIKKTLSQL 334

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/186 (30%), Positives = 88/186 (47%), Gaps = 15/186 (8%)
Query: 106 GLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFM 163
            +K + V  + L+ E L+  RE    E + L Q+  HP+++ LI          LV++ M
Sbjct: 123 AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLM 182
Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
            +G L ++L  K  V LS      I     + ++FLH     +++RD K  NILLD +  
Sbjct: 183 RKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDNMQ 238
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS------DVYSFGVVL 277
            +LSDFG +     G++      + GT GY APE +               D+++ GV+L
Sbjct: 239 IRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVIL 295
Query: 278 LELLTG 283
             LL G
Sbjct: 296 FTLLAG 301

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 146
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPE 199
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 146
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATR-----WYRAPE 199
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 41  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 150
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 151 YIHSAD--IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR-----WYRAPE 203
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 53  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 106
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 107 IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 162
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 163 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATR-----WYRAPE 215
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 151
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 152 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 204
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 42  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 95
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 96  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 151
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 152 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 204
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 37  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 90
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 91  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 146
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 147 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 199
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 141
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 142 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 194
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 35  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 88
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 89  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 144
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 145 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 197
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 29  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 82
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 83  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 138
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 139 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 191
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 141
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 142 YIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR-----WYRAPE 194
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG +GTV+K    E   +      VA+K +    + EG+      L E+  L +L+H 
Sbjct: 10  IGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           N+V+L      D    LV+EF  +  L+ + F      L         F   KGL F H+
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             R V++RD K  N+L++ +   KL+DFGLA+A   G      +  + T  Y  P+ +  
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 262 GHLTARS-DVYSFGVVLLEL 280
             L + S D++S G +  EL
Sbjct: 176 AKLYSTSIDMWSAGCIFAEL 195

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 96/210 (45%), Gaps = 15/210 (7%)
Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNF 134
           + F+   ILGEG F T          R    S   A+K+L K  +  +    ++T E + 
Sbjct: 30  EDFKFGKILGEGSFSTTVLA------RELATSREYAIKILEKRHIIKENKVPYVTRERDV 83
Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLV-YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           + +L HP  VKL  +  +DD +L     +   G L  ++ RK        TR   A    
Sbjct: 84  MSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDETCTRFYTA-EIV 140
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y
Sbjct: 141 SALEYLHG--KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +PE +        SD+++ G ++ +L+ G
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 141
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 142 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 194
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 136
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 137 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 189
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/230 (26%), Positives = 101/230 (43%), Gaps = 18/230 (7%)
Query: 62  YTHVIAFSLFELETITKSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +   + +   E + + + +  D+ +LG GGFG V+   +    ++         ++  ++
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRK 227
Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVP 179
           G QG    + E   L ++ H   +  + Y  E    L LV   M  G +  H++      
Sbjct: 228 GYQGA---MVEKKILAKV-HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 180 LSWATRMMIAFGA--AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA---KA 234
             +     I + A    GL  LH  +R +IYRD K  N+LLD D   ++SD GLA   KA
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341
Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           G    + +      GT G+ APE ++        D ++ GV L E++  R
Sbjct: 342 GQTKTKGYA-----GTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 41  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 94
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 95  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 150
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 151 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 203
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 32  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 85
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 86  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 141
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 142 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 194
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 81/278 (29%), Positives = 122/278 (43%), Gaps = 43/278 (15%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 22  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 76  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 131
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGDETHVSTRVMGTYGYAAPEY 258
           H     VI+RD K  N+ L+ D   K+ DFGLA K    G+   V   + GT  Y APE 
Sbjct: 132 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV---LCGTPNYIAPEV 186
Query: 259 VMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
           +     +   DV+S G ++  LL G       +P  E S +         K   L+I   
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI--- 227
Query: 319 RLENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
             +N+YS+       A SL    L  +P ARP +++++
Sbjct: 228 -KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 264

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 203
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 204 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 254
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 255 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGT 310
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 311 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 367
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 368 KNLHKVSPSLK 378

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFL 135
            F    I+G GGFG VY        R        A+K L+K+ +   QG    L E   L
Sbjct: 189 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 136 GQLRHPN--LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
             +   +   +  + Y      +L  + + M  G L  HL +      S A     A   
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEI 300
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             GL  +HN  R V+YRD K +NILLD     ++SD GLA       + H S   +GT+G
Sbjct: 301 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 354
Query: 253 YAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           Y APE +  G    + +D +S G +L +LL G
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 386

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 26  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 135
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 188
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFL 135
            F    I+G GGFG VY        R        A+K L+K+ +   QG    L E   L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 136 GQLRHPN--LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
             +   +   +  + Y      +L  + + M  G L  HL +      S A     A   
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEI 301
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             GL  +HN  R V+YRD K +NILLD     ++SD GLA       + H S   +GT+G
Sbjct: 302 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 253 YAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           Y APE +  G    + +D +S G +L +LL G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 15/259 (5%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           + + +++I +GEG  G V    I      G +   VAVK ++    Q       EV  + 
Sbjct: 44  REYLANFIKIGEGSTGIVC---IATEKHTGKQ---VAVKKMDLRKQQRRELLFNEVVIMR 97
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
              H N+V +       D   +V EF+  G+L + +          AT   +     + L
Sbjct: 98  DYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRAL 154
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           ++LHN  + VI+RD K+ +ILL SD   KLSDFG         E      ++GT  + AP
Sbjct: 155 SYLHN--QGVIHRDIKSDSILLTSDGRIKLSDFGF--CAQVSKEVPKRKXLVGTPYWMAP 210
Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV-DWARPKLNDKRKMLQI 315
           E +         D++S G++++E++ G        P +    + D   P++ D  K+  +
Sbjct: 211 EVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHKVSSV 270
Query: 316 IDPRLENQYSVRAAQKACS 334
           +   L+       +Q+A +
Sbjct: 271 LRGFLDLMLVREPSQRATA 289

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 27  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 80
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 81  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 136
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 137 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 189
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 28  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 81
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 82  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLK 137
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 138 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 190
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 95/213 (44%), Gaps = 16/213 (7%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLG 136
           ++R    +G+G F  V      +  R  L    VAVK+++K  L     ++   EV  + 
Sbjct: 16  NYRLQKTIGKGNFAKV------KLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMK 69
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            L HPN+VKL      +    LV E+   G + ++L     +    A        +A  +
Sbjct: 70  ILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--V 127
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            + H  ++ +++RD K  N+LLD D   K++DFG +     G++        G+  YAAP
Sbjct: 128 QYCH--QKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDT---FCGSPPYAAP 182
Query: 257 EYVMTGHLTA-RSDVYSFGVVLLELLTGRKSVD 288
           E            DV+S GV+L  L++G    D
Sbjct: 183 ELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 36  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 145
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 146 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 198
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFL 135
            F    I+G GGFG VY        R        A+K L+K+ +   QG    L E   L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 136 GQLRHPN--LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
             +   +   +  + Y      +L  + + M  G L  HL +      S A     A   
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEI 301
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             GL  +HN  R V+YRD K +NILLD     ++SD GLA       + H S   +GT+G
Sbjct: 302 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 253 YAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           Y APE +  G    + +D +S G +L +LL G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 21/212 (9%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFL 135
            F    I+G GGFG VY        R        A+K L+K+ +   QG    L E   L
Sbjct: 190 DFSVHRIIGRGGFGEVY------GCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 136 GQLRHPN--LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
             +   +   +  + Y      +L  + + M  G L  HL +      S A     A   
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEI 301
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
             GL  +HN  R V+YRD K +NILLD     ++SD GLA       + H S   +GT+G
Sbjct: 302 ILGLEHMHN--RFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHAS---VGTHG 355
Query: 253 YAAPEYVMTG-HLTARSDVYSFGVVLLELLTG 283
           Y APE +  G    + +D +S G +L +LL G
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 387

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 130/300 (43%), Gaps = 40/300 (13%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG--QLRHPNL 143
           +G+G FG V++G          +   VAVK+ +    +  R W  E        LRH N+
Sbjct: 11  IGKGRFGEVWRG--------KWRGEEVAVKIFSS---REERSWFREAEIYQTVMLRHENI 59
Query: 144 VKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           +  I    +D+       LV ++   GSL ++L R  TV +     + +A   A GLA L
Sbjct: 60  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVE--GMIKLALSTASGLAHL 116
Query: 200 H-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET--HVSTRVMGTY 251
           H        +P I +RD K+ NIL+  + T  ++D GLA       +T        +GT 
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 252 GYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW--AR 303
            Y APE     +   H  +  R+D+Y+ G+V  E +  R S+       +    D   + 
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE-IARRCSIGGIHEDYQLPYYDLVPSD 235
Query: 304 PKLNDKRKML--QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           P + + RK++  Q + P + N++ S  A +    +   C   N  AR     + +TL  L
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 73  RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 126
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 127 DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 177
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 178 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGT 233
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 234 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 290
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 291 KNLHKVSPSLK 301

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 28  RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 81
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 82  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 132
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 133 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGT 188
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 189 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 245
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 246 KNLHKVSPSLK 256

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 28  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 81
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 82  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 137
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     VI+RD K  N+ L+ D   K+ DFGLA       E   +  + GT  Y APE +
Sbjct: 138 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVL 193
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                +   DV+S G ++  LL G       +P  E S +         K   L+I    
Sbjct: 194 SKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI---- 233
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
            +N+YS+       A SL    L  +P ARP +++++
Sbjct: 234 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 270

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 30  RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 83
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 84  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 134
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 135 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGT 190
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 191 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 247
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 248 KNLHKVSPSLK 258

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQK--LTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGL +        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+K+++K    +   RE    
Sbjct: 5   KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPA 58
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 59  LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 117
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 118 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 165
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 166 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 214
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 215 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 265

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+K+++K    +   RE    
Sbjct: 12  KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPA 65
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 66  LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 124
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 125 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 172
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 173 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 221
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 222 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 272

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 19/208 (9%)
Query: 85  ILGEGGFGTVY-----KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           +LG G +G V+      G+ D      +K L  A  V   +  +  R   TE   L  +R
Sbjct: 61  VLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTR---TERQVLEHIR 116
Query: 140 HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
               +  + Y  + + +L L+ +++  G L  HL ++      +    +  +     LA 
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYVGEIVLAL 172
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            H  +  +IYRD K  NILLDS+    L+DFGL+K     DET  +    GT  Y AP+ 
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV-ADETERAYDFCGTIEYMAPDI 231
Query: 259 VM---TGHLTARSDVYSFGVVLLELLTG 283
           V    +GH  A  D +S GV++ ELLTG
Sbjct: 232 VRGGDSGHDKA-VDWWSLGVLMYELLTG 258

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 23  RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 76
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 77  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 127
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 128 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKXLVGT 183
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 184 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 240
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 241 KNLHKVSPSLK 251

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+K+++K    +   RE    
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPA 59
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 119 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 166
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 215
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 216 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+K+++K    +   RE    
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPA 59
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 119 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 166
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 215
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 216 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/251 (25%), Positives = 108/251 (43%), Gaps = 29/251 (11%)
Query: 78  KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           +S+  ++I +GEG  G V    +  + ++      VAVK ++    Q       EV  + 
Sbjct: 19  RSYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMR 72
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM------MIAF 190
             +H N+V++       D   +V EF+  G+L +         +   TRM       +  
Sbjct: 73  DYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD---------IVTHTRMNEEQIAAVCL 123
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              + L+ LH   + VI+RD K+ +ILL  D   KLSDFG         E      ++GT
Sbjct: 124 AVLQALSVLH--AQGVIHRDIKSDSILLTHDGRVKLSDFGF--CAQVSKEVPRRKXLVGT 179
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             + APE +         D++S G++++E++ G        P K   ++   R  L  + 
Sbjct: 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---RDNLPPRL 236
Query: 311 KMLQIIDPRLE 321
           K L  + P L+
Sbjct: 237 KNLHKVSPSLK 247

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 88/204 (43%), Gaps = 23/204 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-----NKEGLQGHREWLTEVNFLGQLRH 140
           LG+G FG VY        R       VA+KVL      KEG++   +   E+     L H
Sbjct: 31  LGKGKFGNVYLA------REKKSHFIVALKVLFKSQIEKEGVE--HQLRREIEIQAHLHH 82
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           PN+++L  Y  +     L+ E+  RG L   L +  T        +M     A  L + H
Sbjct: 83  PNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEEL--ADALMYCH 140
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYV 259
              + VI+RD K  N+LL      K++DFG +   P      +  + M GT  Y  PE +
Sbjct: 141 G--KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPS-----LRRKTMCGTLDYLPPEMI 193
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
                  + D++  GV+  ELL G
Sbjct: 194 EGRMHNEKVDLWCIGVLCYELLVG 217

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+K+++K    +   RE    
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIKIISKRKFAIGSAREADPA 59
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 60  LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 119 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 166
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 215
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 216 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 24  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 77
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 133
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     VI+RD K  N+ L+ D   K+ DFGLA       E   +  + GT  Y APE +
Sbjct: 134 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVL 189
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                +   DV+S G ++  LL G       +P  E S +         K   L+I    
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI---- 229
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
            +N+YS+       A SL    L  +P ARP +++++
Sbjct: 230 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 120/277 (43%), Gaps = 41/277 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLT-EVNFLGQLRHP 141
            LG+GGF   ++    +   V       A K++ K  L     RE ++ E++    L H 
Sbjct: 24  FLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 77
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSL-ENHLFRKA-TVPLSWATRMMIAFGAAKGLAFL 199
           ++V   G+  ++D   +V E   R SL E H  RKA T P +      I  G      +L
Sbjct: 78  HVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQ----YL 133
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     VI+RD K  N+ L+ D   K+ DFGLA       E   +  + GT  Y APE +
Sbjct: 134 HRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKT--LCGTPNYIAPEVL 189
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                +   DV+S G ++  LL G       +P  E S +         K   L+I    
Sbjct: 190 SKKGHSFEVDVWSIGCIMYTLLVG-------KPPFETSCL---------KETYLRI---- 229
Query: 320 LENQYSV--RAAQKACSLAYYCLSQNPKARPLMSDVV 354
            +N+YS+       A SL    L  +P ARP +++++
Sbjct: 230 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELL 266

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 86  LGEGGFGTVYKGYIDEN--VRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHP 141
           +GEG +G V+K    +N    V LK + V      +EG  L   RE +  +  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIRE-VAVLRHLETFEHP 74
Query: 142 NLVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAK 194
           N+V+L   C       +    LV+E + +  L  +L +  +  VP      MM  F   +
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM--FQLLR 131
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL FLH+    V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 255 APEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKT--------RPSKEQSLVD 300
           APE ++        D++S G +  E      L  G   VD+          P +E    D
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
            A P+     K  Q I+     ++     +    L   CL+ NP  R
Sbjct: 247 VALPRQAFHSKSAQPIE-----KFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+     DE    T  + T  Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARH--TDDEM---TGXVATRWYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/228 (24%), Positives = 100/228 (43%), Gaps = 34/228 (14%)
Query: 79  SFRSDYILGEGGFGTVY--KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
            F     LG GGFG V+  K  +D +    +K + +  + L +E +      + EV  L 
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVD-DCNYAIKRIRLPNRELAREKV------MREVKALA 58
Query: 137 QLRHPNLVKLIGYCCEDD------------HRLLVYEFMFRGSLENHLFRKATVP-LSWA 183
           +L HP +V+      E +            +  +  +   + +L++ +  + T+     +
Sbjct: 59  KLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERS 118
Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             + I    A+ + FLH+  + +++RD K SNI    D   K+ DFGL  A  Q +E   
Sbjct: 119 VCLHIFLQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 176
Query: 244 ----------STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELL 281
                      T  +GT  Y +PE +     + + D++S G++L ELL
Sbjct: 177 VLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ + A   L+      + +   +GL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAK--LTDDHVQFLIYQILRGLK 135
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 188
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAVK+++K  L     ++   EV  +  L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G+  YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG +G VYK   +      LK +      L KE        + E++ L +L+H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L          +LV+E + +      L       L   T          G+A+ H+  R 
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RR 120
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHL 264
           V++RD K  N+L++ +   K++DFGLA+A   G      T  + T  Y AP+ +M +   
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 265 TARSDVYSFGVVLLELLTG 283
           +   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 103/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ D+GLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAVK+++K  L     ++   EV  +  L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G+  YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 17/216 (7%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-T 130
           + E I K F     LG G F  V     +E     L     AVK + K+ L+G    +  
Sbjct: 16  QAEDIKKIFEFKETLGTGAFSEVVLA--EEKATGKL----FAVKCIPKKALKGKESSIEN 69
Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E+  L +++H N+V L       +H  LV + +  G L + +  K       A+ ++   
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQV 129
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
             A  + +LH     +++RD K  N+L    D +    +SDFGL+K   +GD   V +  
Sbjct: 130 LDA--VYYLHRM--GIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGD---VMSTA 182
Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            GT GY APE +     +   D +S GV+   LL G
Sbjct: 183 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCG 218

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 118/246 (47%), Gaps = 29/246 (11%)
Query: 48  TPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGL 107
            PR    S++    Y   +  +++E   + + +++   +G G +G+V   +   + + G 
Sbjct: 14  VPRGSHMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGH 67
Query: 108 KSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLV 159
           +   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV
Sbjct: 68  R---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
              M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++
Sbjct: 125 THLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 178
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLL 278
            D   K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ 
Sbjct: 179 EDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 233
Query: 279 ELLTGR 284
           ELLTGR
Sbjct: 234 ELLTGR 239

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG +G VYK   +      LK +      L KE        + E++ L +L+H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L          +LV+E + +      L       L   T          G+A+ H+  R 
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RR 120
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHL 264
           V++RD K  N+L++ +   K++DFGLA+A   G      T  + T  Y AP+ +M +   
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 265 TARSDVYSFGVVLLELLTG 283
           +   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG +G VYK   +      LK +      L KE        + E++ L +L+H N+VK
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L          +LV+E + +      L       L   T          G+A+ H+  R 
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQDL--KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD--RR 120
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-TGHL 264
           V++RD K  N+L++ +   K++DFGLA+A   G      T  + T  Y AP+ +M +   
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSKKY 178
Query: 265 TARSDVYSFGVVLLELLTG 283
           +   D++S G +  E++ G
Sbjct: 179 STTIDIWSVGCIFAEMVNG 197

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 86  LGEGGFGTVYKGYIDEN--VRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHP 141
           +GEG +G V+K    +N    V LK + V      +EG  L   RE +  +  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIRE-VAVLRHLETFEHP 74
Query: 142 NLVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAK 194
           N+V+L   C       +    LV+E + +  L  +L +  +  VP      MM  F   +
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM--FQLLR 131
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL FLH+    V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 255 APEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKT--------RPSKEQSLVD 300
           APE ++        D++S G +  E      L  G   VD+          P +E    D
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
            A P+     K  Q I+     ++     +    L   CL+ NP  R
Sbjct: 247 VALPRQAFHSKSAQPIE-----KFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 118/246 (47%), Gaps = 29/246 (11%)
Query: 48  TPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGL 107
            PR    S++    Y   +  +++E   + + +++   +G G +G+V   +   + + G 
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGH 68
Query: 108 KSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLV 159
           +   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV
Sbjct: 69  R---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
              M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++
Sbjct: 126 THLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 179
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLL 278
            D   K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ 
Sbjct: 180 EDCELKILDFGLARHTDDEMTGYVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 279 ELLTGR 284
           ELLTGR
Sbjct: 235 ELLTGR 240

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 82/287 (28%), Positives = 120/287 (41%), Gaps = 42/287 (14%)
Query: 86  LGEGGFGTVYKGYIDEN--VRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHP 141
           +GEG +G V+K    +N    V LK + V      +EG  L   RE +  +  L    HP
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQT---GEEGMPLSTIRE-VAVLRHLETFEHP 74
Query: 142 NLVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAK 194
           N+V+L   C       +    LV+E + +  L  +L +  +  VP      MM  F   +
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM--FQLLR 131
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL FLH+    V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y 
Sbjct: 132 GLDFLHSHR--VVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYR 186
Query: 255 APEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKT--------RPSKEQSLVD 300
           APE ++        D++S G +  E      L  G   VD+          P +E    D
Sbjct: 187 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 246
Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
            A P+     K  Q I+     ++     +    L   CL+ NP  R
Sbjct: 247 VALPRQAFHSKSAQPIE-----KFVTDIDELGKDLLLKCLTFNPAKR 288

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 15/175 (8%)
Query: 117 LNKEGLQGHRE-WLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
            + E +Q  RE  L EV+ L ++  HPN+++L      +    LV++ M +G L ++L  
Sbjct: 45  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 104
Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           K T+      ++M A    + +  LH     +++RD K  NILLD D   KL+DFG +  
Sbjct: 105 KVTLSEKETRKIMRAL--LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 160
Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGH------LTARSDVYSFGVVLLELLTG 283
              G++      V GT  Y APE +               D++S GV++  LL G
Sbjct: 161 LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 102/218 (46%), Gaps = 24/218 (11%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVN 133
           TI   F     LG G FG V+   + E    GL+ +   +K +NK+  Q   E +  E+ 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVH---LVEERSSGLERV---IKTINKDRSQVPMEQIEAEIE 72
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLF----RKATVPLSWATRMMI 188
            L  L HPN++K+     ED H + +V E    G L   +     R   +   +   +M 
Sbjct: 73  VLKSLDHPNIIKIFE-VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVST 245
               A  LA+ H+  + V+++D K  NIL          K+ DFGLA+   + DE   ST
Sbjct: 132 QMMNA--LAYFHS--QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELF-KSDEH--ST 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
              GT  Y APE V    +T + D++S GVV+  LLTG
Sbjct: 185 NAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 19/203 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNL 143
           LG G +G V         R  +  +  A+K++ K  +    + + L EV  L  L HPN+
Sbjct: 45  LGSGAYGEVLL------CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           +KL  +  +  +  LV E    G L + +  +  +  +     +I      G+ +LH  +
Sbjct: 99  MKLYDFFEDKRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLH--K 154
Query: 204 RPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+LL+S   D   K+ DFGL+      ++  +  R +GT  Y APE V+
Sbjct: 155 HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKER-LGTAYYIAPE-VL 210
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                 + DV+S GV+L  LL G
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAG 233

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +LG+G +G VY G  +   VR+ +K +P       +   +  +    E+     L+H N+
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-------ERDSRYSQPLHEEIALHKHLKHKNI 81
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAFLH 200
           V+ +G   E+    +  E +  GSL + L R    PL       I F   +   GL +LH
Sbjct: 82  VQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLH 139
Query: 201 NAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAP 256
           + +  +++RD K  N+L+++ Y+   K+SDFG +K  AG        +    GT  Y AP
Sbjct: 140 DNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGI----NPCTETFTGTLQYMAP 192
Query: 257 EYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           E +  G       +D++S G  ++E+ TG+
Sbjct: 193 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 11/169 (6%)
Query: 118 NKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT 177
           NK   + H E   E++ L  L HPN++KL     +  +  LV EF   G L   +  +  
Sbjct: 83  NKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHK 142
Query: 178 VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AKLSDFGLAKA 234
                A  +M    +  G+ +LH  +  +++RD K  NILL++  +    K+ DFGL+  
Sbjct: 143 FDECDAANIMKQILS--GICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
             +  +  +  R +GT  Y APE V+      + DV+S GV++  LL G
Sbjct: 199 FSK--DYKLRDR-LGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCG 243

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAVK+++K  L     ++   EV  +  L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G   YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 15/175 (8%)
Query: 117 LNKEGLQGHRE-WLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
            + E +Q  RE  L EV+ L ++  HPN+++L      +    LV++ M +G L ++L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           K T+      ++M A    + +  LH     +++RD K  NILLD D   KL+DFG +  
Sbjct: 118 KVTLSEKETRKIMRAL--LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGH------LTARSDVYSFGVVLLELLTG 283
              G++      V GT  Y APE +               D++S GV++  LL G
Sbjct: 174 LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG +GTV+K    E   +      VA+K +    + EG+      L E+  L +L+H 
Sbjct: 10  IGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSA--LREICLLKELKHK 61
Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           N+V+L      D    LV+EF  +  L+ + F      L         F   KGL F H+
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQ-DLKKY-FDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119
Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             R V++RD K  N+L++ +   KL++FGLA+A   G      +  + T  Y  P+ +  
Sbjct: 120 --RNVLHRDLKPQNLLINRNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFG 175
Query: 262 GHLTARS-DVYSFGVVLLEL 280
             L + S D++S G +  EL
Sbjct: 176 AKLYSTSIDMWSAGCIFAEL 195

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 77/305 (25%), Positives = 123/305 (40%), Gaps = 61/305 (20%)
Query: 75  TITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT 130
           T+ K F  D+    ++G GGFG V+K       R+  K+  +     N E  +       
Sbjct: 4   TVDKRFGMDFKEIELIGSGGFGQVFKA----KHRIDGKTYVIKRVKYNNEKAE------R 53
Query: 131 EVNFLGQLRHPNLVKLIGYCCED--DHR----------------LLVYEFMFRGSLENHL 172
           EV  L +L H N+V   G  C D  D+                  +  EF  +G+LE  +
Sbjct: 54  EVKALAKLDHVNIVHYNG--CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
            ++    L     + +     KG+ ++H+  + +I RD K SNI L      K+ DFGL 
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIHS--KKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
Query: 233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP 292
            +     +     R  GT  Y +PE + +       D+Y+ G++L ELL     V  T  
Sbjct: 170 TSLKNDGK---RXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----HVCDTAF 222
Query: 293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSD 352
              +   D     ++D      I D            +K  +L    LS+ P+ RP  S+
Sbjct: 223 ETSKFFTDLRDGIISD------IFD------------KKEKTLLQKLLSKKPEDRPNTSE 264
Query: 353 VVETL 357
           ++ TL
Sbjct: 265 ILRTL 269

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAV++++K  L     ++   EV  +  L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G+  YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAV++++K  L     ++   EV  +  L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G+  YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKL---DEFCGSPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 15/175 (8%)
Query: 117 LNKEGLQGHRE-WLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
            + E +Q  RE  L EV+ L ++  HPN+++L      +    LV++ M +G L ++L  
Sbjct: 58  FSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE 117
Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           K T+      ++M A    + +  LH     +++RD K  NILLD D   KL+DFG +  
Sbjct: 118 KVTLSEKETRKIMRAL--LEVICALHKLN--IVHRDLKPENILLDDDMNIKLTDFGFSCQ 173
Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGH------LTARSDVYSFGVVLLELLTG 283
              G++      V GT  Y APE +               D++S GV++  LL G
Sbjct: 174 LDPGEKLR---SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/246 (24%), Positives = 117/246 (47%), Gaps = 29/246 (11%)
Query: 48  TPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGL 107
            PR    S++    Y   +  +++E   + + +++   +G G +G+V   +   + + G 
Sbjct: 15  VPRGSHMSQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAF---DTKTGH 68
Query: 108 KSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLV 159
           +   VAVK L++  + +   +    E+  L  ++H N++ L+          E +   LV
Sbjct: 69  R---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
              M  G+  N++ +     L+      + +   +GL ++H+A+  +I+RD K SN+ ++
Sbjct: 126 THLM--GADLNNIVKCQK--LTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVN 179
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLL 278
            D   K+ DFGLA+         V+TR      Y APE ++   H     D++S G ++ 
Sbjct: 180 EDCELKILDFGLARHTDDEMXGXVATR-----WYRAPEIMLNWMHYNQTVDIWSVGCIMA 234
Query: 279 ELLTGR 284
           ELLTGR
Sbjct: 235 ELLTGR 240

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAVK+++K  L     ++   EV  +  L HPN+
Sbjct: 15  IGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNI 68
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L     +    A        +A  + + H  +
Sbjct: 69  VKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSA--VQYCH--Q 124
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G+  YAAPE      
Sbjct: 125 KFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT---FCGSPPYAAPELFQGKK 181
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYID----ENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           + K++ S   +G G +G+V    ID    E V +   S P   ++  K   + +RE L  
Sbjct: 40  LPKTYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELL-- 93
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF-MFRGSLENHLFRKATVPLSWATRMMIAF 190
              L  ++H N++ L+            Y+F +    ++  L +   +  S      + +
Sbjct: 94  --LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVY 151
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              KGL ++H+A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR    
Sbjct: 152 QMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 205
Query: 251 YGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
             Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 206 -WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 110/273 (40%), Gaps = 48/273 (17%)
Query: 43  LSDPSTPRNLE---DSRKNAVLYTHVIAFS--------LFELETITKSFR------SDY- 84
           + DP +P N+E   D   + VL     A          L   E I K  R       DY 
Sbjct: 19  IRDPRSPINVESLLDGLNSLVLDLDFPALRKNKNIDNFLNRYEKIVKKIRGLQMKAEDYD 78
Query: 85  ---ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQL 138
              ++G G FG V      + VR        A+K+L+K  +    +   +  E + +   
Sbjct: 79  VVKVIGRGAFGEV------QLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA 132
Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAK 194
             P +V+L     +D +  +V E+M  G L N L     VP  WA      +++A  A  
Sbjct: 133 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAIH 191
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
            +  +H        RD K  N+LLD     KL+DFG      +    H  T V GT  Y 
Sbjct: 192 SMGLIH--------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYI 242
Query: 255 APEYVMT----GHLTARSDVYSFGVVLLELLTG 283
           +PE + +    G+     D +S GV L E+L G
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 21/215 (9%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYID----ENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           + K++ S   +G G +G+V    ID    E V +   S P   ++  K   + +RE L  
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSA-IDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELL-- 75
Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF-MFRGSLENHLFRKATVPLSWATRMMIAF 190
              L  ++H N++ L+            Y+F +    ++  L +   +  S      + +
Sbjct: 76  --LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVY 133
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              KGL ++H+A   V++RD K  N+ ++ D   K+ DFGLA+        +V TR    
Sbjct: 134 QMLKGLKYIHSA--GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTR---- 187
Query: 251 YGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
             Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 188 -WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEFK---NIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V       + R G   L  AVK+L K+ +    +    + E   L     P
Sbjct: 348 VLGKGSFGKVML-----SERKGTDEL-YAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
             +  +  C +   RL  V E++  G L  H+ +        A  +  A   A GL FL 
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQ 459
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +  + +IYRD K  N++LDS+   K++DFG+ K       T  +    GT  Y APE + 
Sbjct: 460 S--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIA 515
Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
                   D ++FGV+L E+L G+
Sbjct: 516 YQPYGKSVDWWAFGVLLYEMLAGQ 539

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 40  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 93
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 94  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 149
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 150 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 202
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 122/280 (43%), Gaps = 47/280 (16%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNL 143
           ++G G +G VYKG    +V+ G  +   A+KV++  G +   E   E+N L +   H N+
Sbjct: 31  LVGNGTYGQVYKG---RHVKTGQLA---AIKVMDVTGDE-EEEIKQEINMLKKYSHHRNI 83
Query: 144 VKLIGYCCE------DDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKG 195
               G   +      DD   LV EF   GS+ + +   +  T+   W     I     +G
Sbjct: 84  ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRG 141
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGY 253
           L+ LH  +  VI+RD K  N+LL  +   KL DFG++    Q D T V  R   +GT  +
Sbjct: 142 LSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDRT-VGRRNTFIGTPYW 195
Query: 254 AAPEYVMTGH-----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
            APE +            +SD++S G+  +E+  G   +    P +   L+    P    
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP-RNPA--- 251
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                    PRL+   S + ++K  S    CL +N   RP
Sbjct: 252 ---------PRLK---SKKWSKKFQSFIESCLVKNHSQRP 279

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 188
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 26/210 (12%)
Query: 85  ILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           +LG+G +G VY G  +   VR+ +K +P       +   +  +    E+     L+H N+
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIP-------ERDSRYSQPLHEEIALHKHLKHKNI 67
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAFLH 200
           V+ +G   E+    +  E +  GSL + L R    PL       I F   +   GL +LH
Sbjct: 68  VQYLGSFSENGFIKIFMEQVPGGSL-SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLH 125
Query: 201 NAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAP 256
           + +  +++RD K  N+L+++ Y+   K+SDFG +K  AG        +    GT  Y AP
Sbjct: 126 DNQ--IVHRDIKGDNVLINT-YSGVLKISDFGTSKRLAGI----NPCTETFTGTLQYMAP 178
Query: 257 EYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           E +  G       +D++S G  ++E+ TG+
Sbjct: 179 EIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 36  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 89
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 90  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 145
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+        +V+TR      Y APE
Sbjct: 146 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR-----WYRAPE 198
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 92/206 (44%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VA+K+++K  L     ++   EV  +  L HPN+
Sbjct: 20  IGKGNFAKV------KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 73
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    L+ E+   G + ++L     +    A        +A  + + H  +
Sbjct: 74  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCH--Q 129
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G +        G+  YAAPE      
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT---FCGSPPYAAPELFQGKK 186
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 97/225 (43%), Gaps = 23/225 (10%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           S F  E +   +     LG G F  V K       R        A K + K  L   R  
Sbjct: 3   STFRQEDVEDHYEMGEELGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLSSSRRG 56
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EVN L ++RHPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 57  VSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDE 116
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDY---TAKLSDFGLAKAGPQG 238
           AT+ +       G+ +LH+  + + + D K  NI LLD +      KL DFG+A     G
Sbjct: 117 ATQFLKQI--LDGVHYLHS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG 172
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           +E      + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 173 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 103/236 (43%), Gaps = 49/236 (20%)
Query: 84  YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHP 141
           +++G G +G VY  Y D+N         VA+K +N+  E L   +  L E+  L +L+  
Sbjct: 32  HLIGRGSYGYVYLAY-DKNTEKN-----VAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 142 NLVKLIGYCCEDDHRLLVYEFMF-----RGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            +++L      DD  LL ++ ++       S    LF K  + L+      I +    G 
Sbjct: 86  YIIRLYDLIIPDD--LLKFDELYIVLEIADSDLKKLF-KTPIFLTEEHIKTILYNLLLGE 142
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-------------------GPQ 237
            F+H  E  +I+RD K +N LL+ D + K+ DFGLA+                    GP 
Sbjct: 143 NFIH--ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 238 GDE------THVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKS 286
                    +HV TR      Y APE ++      +S D++S G +  ELL   +S
Sbjct: 201 NKNLKKQLTSHVVTR-----WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQS 251

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+  FGLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VA+K+++K  L     ++   EV  +  L HPN+
Sbjct: 23  IGKGNFAKV------KLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    L+ E+   G + ++L     +    A        +A  + + H  +
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSA--VQYCH--Q 132
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G +        G   YAAPE      
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA---FCGAPPYAAPELFQGKK 189
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 190 YDGPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + + +VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-- 182
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ D GLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/241 (25%), Positives = 109/241 (45%), Gaps = 22/241 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG  G V       + R       VAVK+++    Q       EV  +   +H N+V+
Sbjct: 53  IGEGSTGIVCLAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           +       +   ++ EF+  G+L + +   + V L+      +     + LA+LH   + 
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQALAYLHA--QG 161
Query: 206 VIYRDFKTSNILLDSDYTAKLSDFG----LAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
           VI+RD K+ +ILL  D   KLSDFG    ++K  P+         ++GT  + APE +  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK------RKXLVGTPYWMAPEVISR 215
Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE-QSLVDWARPKLNDKRKMLQIIDPRL 320
                  D++S G++++E++ G        P +  + L D   PKL +  K+  ++   L
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFL 275
Query: 321 E 321
           E
Sbjct: 276 E 276

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/341 (23%), Positives = 143/341 (41%), Gaps = 56/341 (16%)
Query: 39  SISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGY 98
           ++S LS  S PR  + S+ +  L    I F   E+  +         +G+G FG VY G 
Sbjct: 5   NLSLLSARSFPR--KASQTSIFLQEWDIPFEQLEIGEL---------IGKGRFGQVYHGR 53
Query: 99  IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLL 158
               V + L    + ++  N++ L+  +    EV    Q RH N+V  +G C    H L 
Sbjct: 54  WHGEVAIRL----IDIERDNEDQLKAFKR---EVMAYRQTRHENVVLFMGACMSPPH-LA 105
Query: 159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL 218
           +   + +G     + R A + L       IA    KG+ +LH   + ++++D K+ N+  
Sbjct: 106 IITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH--AKGILHKDLKSKNVFY 163
Query: 219 DSDYTAKLSDFGL------AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH--------- 263
           D+     ++DFGL       +AG + D+  +     G   + APE +             
Sbjct: 164 DNGKVV-ITDFGLFSISGVLQAGRREDKLRIQN---GWLCHLAPEIIRQLSPDTEEDKLP 219
Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
            +  SDV++ G +  E L  R+   KT+P++    + W         +M   + P L   
Sbjct: 220 FSKHSDVFALGTIWYE-LHAREWPFKTQPAEA---IIW---------QMGTGMKPNLSQ- 265
Query: 324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN 364
             +   ++   +  +C +   + RP  + +++ LE L   N
Sbjct: 266 --IGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN 304

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 79/318 (24%), Positives = 125/318 (39%), Gaps = 74/318 (23%)
Query: 75  TITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT 130
           T+ K F  D+    ++G GGFG V+K       R+  K+  +     N E  +       
Sbjct: 5   TVDKRFGMDFKEIELIGSGGFGQVFKA----KHRIDGKTYVIRRVKYNNEKAE------R 54
Query: 131 EVNFLGQLRHPNLVKLIGYCCED---------DHRL----------------------LV 159
           EV  L +L H N+V   G  C D         D  L                      + 
Sbjct: 55  EVKALAKLDHVNIVHYNG--CWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQ 112
Query: 160 YEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD 219
            EF  +G+LE  + ++    L     + +     KG+ ++H+  + +I+RD K SNI L 
Sbjct: 113 MEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS--KKLIHRDLKPSNIFLV 170
Query: 220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE 279
                K+ DFGL  +     +    TR  GT  Y +PE + +       D+Y+ G++L E
Sbjct: 171 DTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
Query: 280 LLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYC 339
           LL     V  T     +   D     ++D      I D            +K  +L    
Sbjct: 228 LL----HVCDTAFETSKFFTDLRDGIISD------IFD------------KKEKTLLQKL 265
Query: 340 LSQNPKARPLMSDVVETL 357
           LS+ P+ RP  S+++ TL
Sbjct: 266 LSKKPEDRPNTSEILRTL 283

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ D GLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           +LG+G FG V       + R G   L  AVK+L K+ +    +    + E   L     P
Sbjct: 27  VLGKGSFGKVML-----SERKGTDEL-YAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
             +  +  C +   RL  V E++  G L  H+ +        A  +  A   A GL FL 
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA--VFYAAEIAIGLFFLQ 138
Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +  + +IYRD K  N++LDS+   K++DFG+ K       T  +    GT  Y APE + 
Sbjct: 139 S--KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIA 194
Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
                   D ++FGV+L E+L G+
Sbjct: 195 YQPYGKSVDWWAFGVLLYEMLAGQ 218

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+++++K    +   RE    
Sbjct: 145 KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIRIISKRKFAIGSAREADPA 198
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 199 LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 257
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 258 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 305
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 306 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 354
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 355 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 405

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 54
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 114
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 115 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 171 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 212
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 213 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 270 Q--HPWIKPKDTQQALSSAWS 288

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 54
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 114
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 115 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 171 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 212
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 213 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 270 Q--HPWIKPKDTQQALSSAWS 288

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGKFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 271 Q--HPWIKPKDTQQALSSAWS 289

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G+G F  V      +  R  L    VAVK+++K  L     ++   EV     L HPN+
Sbjct: 22  IGKGNFAKV------KLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNI 75
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL      +    LV E+   G + ++L          A        +A  + + H  +
Sbjct: 76  VKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSA--VQYCH--Q 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           + +++RD K  N+LLD+D   K++DFG +     G++        G   YAAPE      
Sbjct: 132 KFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDA---FCGAPPYAAPELFQGKK 188
Query: 264 LTA-RSDVYSFGVVLLELLTGRKSVD 288
                 DV+S GV+L  L++G    D
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 128/299 (42%), Gaps = 67/299 (22%)
Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREW--- 128
           K+ R +YI    LG G  G V   +  +  +       VA+++++K    +   RE    
Sbjct: 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCK------KVAIRIISKRKFAIGSAREADPA 184
Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPL 180
               TE+  L +L HP ++K+  +   +D+  +V E M  G L      N   ++AT  L
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKL 243
Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQ 237
            +  +M++A      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    
Sbjct: 244 -YFYQMLLA------VQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--- 291
Query: 238 GDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK 294
             ET +   + GT  Y APE ++   T       D +S GV+L   L+G           
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG----------- 340
Query: 295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYS------VRAAQKACSLAYYCLSQNPKAR 347
                    P  ++ R  + + D     +Y+         ++KA  L    L  +PKAR
Sbjct: 341 --------YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKAR 391

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 17/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LG+G F  V +      V+V L     A K++N + L    H++   E      L+HPN+
Sbjct: 30  LGKGAFSVVRRC-----VKV-LAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNI 83
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+ H  L+++ +  G L   +  +     + A+  +         A LH  +
Sbjct: 84  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----AVLHCHQ 139
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             V++RD K  N+LL S       KL+DFGLA    +G E        GT GY +PE + 
Sbjct: 140 MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEG-EQQAWFGFAGTPGYLSPEVLR 197
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D+++ GV+L  LL G
Sbjct: 198 KDPYGKPVDLWACGVILYILLVG 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 271 Q--HPWIKPKDTQQALSSAWS 289

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+         V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/242 (25%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVN 133
           +  ++   +++G G +G VY  Y D+N         VA+K +N+  E L   +  L E+ 
Sbjct: 26  VPDNYEIKHLIGRGSYGYVYLAY-DKNANKN-----VAIKKVNRMFEDLIDCKRILREIT 79
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMF-----RGSLENHLFRKATVPLSWATRMMI 188
            L +L+   +++L      +D  LL ++ ++       S    LF K  + L+      I
Sbjct: 80  ILNRLKSDYIIRLHDLIIPED--LLKFDELYIVLEIADSDLKKLF-KTPIFLTEQHVKTI 136
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS---- 244
            +    G  F+H  E  +I+RD K +N LL+ D + K+ DFGLA+      + H+     
Sbjct: 137 LYNLLLGEKFIH--ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLE 194
Query: 245 -------------------TRVMGTYGYAAPEYV-MTGHLTARSDVYSFGVVLLELLTGR 284
                              T  + T  Y APE + +  + T   D++S G +  ELL   
Sbjct: 195 EKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMM 254
Query: 285 KS 286
           KS
Sbjct: 255 KS 256

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+         V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 26  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 135
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DFGLA+         V+TR      Y APE
Sbjct: 136 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATR-----WYRAPE 188
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R        A K + K  L   R  ++      EVN L ++R
Sbjct: 13  LGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HPN++ L          +L+ E +  G L + L  K ++    AT+ +       G+ +L
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYL 124
Query: 200 HNAERPVIYRDFKTSNI-LLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H+  + + + D K  NI LLD +      KL DFG+A     G+E      + GT  + A
Sbjct: 125 HS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 179
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 180 PEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + GL+   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGLR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ D GLA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 73/301 (24%), Positives = 124/301 (41%), Gaps = 45/301 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 E 355
           +
Sbjct: 271 Q 271

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 104
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 162
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  + 
Sbjct: 163 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-IC 218
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
             Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 219 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVN 133
           I+  F+   +LGEG +G V          +      VA+K +    + L   R  L E+ 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEI------VAIKKIEPFDKPLFALRT-LREIK 61
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGA 192
            L   +H N++ +      D        ++ +  ++  L R  +T  LS        +  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---------AGPQGDETHV 243
            + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+         + P G ++ +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 244 STRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
            T  + T  Y APE ++T    +R+ DV+S G +L EL   R
Sbjct: 180 -TEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGVFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 271 Q--HPWIKPKDTQQALSSAWS 289

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 88
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 147
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  +
Sbjct: 148 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-I 202
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
              Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 203 CSRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 78
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 79  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 136
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  + 
Sbjct: 137 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-IC 192
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
             Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 193 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 104
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 162
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 163 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 217
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 218 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 77/321 (23%), Positives = 131/321 (40%), Gaps = 47/321 (14%)
Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K       R     L  A K + K   +  R  
Sbjct: 2   TVFRQENVDDYYDTGEELGSGQFAVVKK------CREKSTGLQYAAKFIKKRRTKSSRRG 55
Query: 129 LT------EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
           ++      EV+ L +++HPN++ L          +L+ E +  G L + L  K ++    
Sbjct: 56  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEE 115
Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQG 238
           AT  +       G+ +LH+ +  + + D K  NI LLD +      K+ DFGLA     G
Sbjct: 116 ATEFLKQI--LNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 172 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG--------------- 213
Query: 299 VDWARPKLNDKRKM----LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
              A P L D ++     +  ++   E++Y    +  A       L ++PK R  + D +
Sbjct: 214 ---ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 270
Query: 355 ETLEPLQCANDGGNEISSSLT 375
           +   P     D    +SS+ +
Sbjct: 271 Q--HPWIKPKDTQQALSSAWS 289

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 106
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 107 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 164
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 165 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 219
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 220 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 82
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 140
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  + 
Sbjct: 141 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-IC 196
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
             Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 197 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 100/222 (45%), Gaps = 23/222 (10%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVN 133
           I+  F+   +LGEG +G V          +      VA+K +    + L   R  L E+ 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEI------VAIKKIEPFDKPLFALRT-LREIK 61
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGA 192
            L   +H N++ +      D        ++ +  ++  L R  +T  LS        +  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---------AGPQGDETHV 243
            + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+         + P G ++ +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 244 STRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
            T  + T  Y APE ++T    +R+ DV+S G +L EL   R
Sbjct: 180 -TEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 90/204 (44%), Gaps = 20/204 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPN 142
           LG G +G V         +  L     A+K++ K  +         L EV  L QL HPN
Sbjct: 29  LGSGAYGEVLL------CKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 82
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++KL  +  +  +  LV E    G L + +  +     S     +I      G  +LH  
Sbjct: 83  IMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQK--FSEVDAAVIMKQVLSGTTYLH-- 138
Query: 203 ERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           +  +++RD K  N+LL+S   D   K+ DFGL+     G +       +GT  Y APE V
Sbjct: 139 KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---KERLGTAYYIAPE-V 194
Query: 260 MTGHLTARSDVYSFGVVLLELLTG 283
           +      + DV+S GV+L  LL G
Sbjct: 195 LRKKYDEKCDVWSCGVILYILLCG 218

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R        A K + K  L   R  ++      EVN L ++R
Sbjct: 34  LGSGQFAIVRK------CRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HPN++ L          +L+ E +  G L + L  K ++    AT+ +       G+ +L
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI--LDGVHYL 145
Query: 200 HNAERPVIYRDFKTSNI-LLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H+  + + + D K  NI LLD +      KL DFG+A     G+E      + GT  + A
Sbjct: 146 HS--KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF---KNIFGTPEFVA 200
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 201 PEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 108
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 109 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 166
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 167 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 221
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 222 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 82
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 83  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 140
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  + 
Sbjct: 141 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-IC 196
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
             Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 197 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-- 182
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 98
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 99  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 156
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 157 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 211
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 212 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 88/321 (27%), Positives = 143/321 (44%), Gaps = 50/321 (15%)
Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVN 133
           TI K  +    +G+G +G V+ G          +   VAVKV    E     RE  TE+ 
Sbjct: 34  TIAKQIQMVKQIGKGRYGEVWMG--------KWRGEKVAVKVFFTTEEASWFRE--TEIY 83
Query: 134 FLGQLRHPNLVKLIGYCCED-------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
               +RH N+   +G+   D           L+ ++   GSL ++L  K+T  L   + +
Sbjct: 84  QTVLMRHENI---LGFIAADIKGTGSWTQLYLITDYHENGSLYDYL--KSTT-LDAKSML 137
Query: 187 MIAFGAAKGLAFLHN-----AERPVI-YRDFKTSNILLDSDYTAKLSDFGLA-KAGPQGD 239
            +A+ +  GL  LH        +P I +RD K+ NIL+  + T  ++D GLA K     +
Sbjct: 138 KLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTN 197
Query: 240 ETHV--STRVMGTYGYAAPEY----VMTGHLTA--RSDVYSFGVVLLELLTGRKSVDKTR 291
           E  +  +TRV GT  Y  PE     +   H  +   +D+YSFG++L E+   R+ V    
Sbjct: 198 EVDIPPNTRV-GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV--ARRCVSGGI 254
Query: 292 PSKEQ----SLVDWARPKLNDKRKMLQI--IDPRLENQYSV-RAAQKACSLAYYCLSQNP 344
             + Q     LV  + P   D R+++ I  + P   N++S     ++   L   C + NP
Sbjct: 255 VEEYQLPYHDLVP-SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNP 313
Query: 345 KARPLMSDVVETLEPLQCAND 365
            +R     V +TL  +  + D
Sbjct: 314 ASRLTALRVKKTLAKMSESQD 334

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 83
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 84  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 141
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 142 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 196
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 197 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 32/219 (14%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 149
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 150 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 207
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDE--THVSTR 246
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G+   +++ +R
Sbjct: 208 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR 265
Query: 247 VMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
                 Y APE +      T+  DV+S G VL ELL G+
Sbjct: 266 Y-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 35/270 (12%)
Query: 42  DLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGY 98
           D+S  +   N+  S+ +   Y+  +  S F   T+ K +++   +G G  G V   Y   
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 99  IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------E 152
           +D NV +   S P   +   K   +       E+  +  + H N++ L+          E
Sbjct: 86  LDRNVAIKKLSRPFQNQTHAKRAYR-------ELVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFK 212
                LV E M     + +L +   + L       + +    G+  LH+A   +I+RD K
Sbjct: 139 FQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 213 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYS 272
            SNI++ SD T K+ DFGLA+    G    ++  V+  Y Y APE ++        D++S
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWS 248
Query: 273 FGVVLLE------LLTGRKSVDKTRPSKEQ 296
            G ++ E      L  GR  +D+     EQ
Sbjct: 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-- 182
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 75
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 76  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 133
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   +
Sbjct: 134 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--YI 188
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 54/307 (17%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ--LRHPNL 143
           +G+G +G V++G              VAVK+ +    Q    W  E        LRH N+
Sbjct: 16  VGKGRYGEVWRGL--------WHGESVAVKIFSSRDEQS---WFRETEIYNTVLLRHDNI 64
Query: 144 VKLIGYCCED-------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
              +G+   D           L+  +   GSL + L R+   P      + +A  AA GL
Sbjct: 65  ---LGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEP---HLALRLAVSAACGL 118
Query: 197 AFLH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD---ETHVSTRV 247
           A LH        +P I +RDFK+ N+L+ S+    ++D GLA    QG    +   + RV
Sbjct: 119 AHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV 178
Query: 248 MGTYGYAAPEYVMTGHLT------ARSDVYSFGVVLLELLTGRKS-----VDKTRPSKEQ 296
            GT  Y APE +     T        +D+++FG+VL E+   R++     V+  RP    
Sbjct: 179 -GTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRTIVNGIVEDYRPPFYD 235
Query: 297 SLVDWARPKLNDKRKMLQIID--PRLENQYSVRAAQKACS-LAYYCLSQNPKARPLMSDV 353
            + +   P   D +K++ +    P + N+ +        + +   C   NP AR     +
Sbjct: 236 VVPN--DPSFEDMKKVVCVDQQTPTIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRI 293
Query: 354 VETLEPL 360
            +TL+ +
Sbjct: 294 KKTLQKI 300

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 80/325 (24%), Positives = 143/325 (44%), Gaps = 31/325 (9%)
Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN 142
           D  LGEG F    K    ++ +        AVK+++K      ++ +T +       HPN
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQA------FAVKIISKRMEANTQKEITALKLCEG--HPN 67
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +VKL     +  H  LV E +  G L   + +K     + A+ +M    +A  ++ +H+ 
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSA--VSHMHDV 125
Query: 203 ERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
              V++RD K  N+L    + +   K+ DFG A+  P  D   + T    T  YAAPE +
Sbjct: 126 --GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP-DNQPLKTPCF-TLHYAAPELL 181
Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                    D++S GV+L  +L+G+        S ++SL   +  ++    K ++  D  
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQ----SHDRSLTCTSAVEI---MKKIKKGDFS 234
Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSS--LTAN 377
            E +     +Q+A  L    L+ +P  R  MS +    E LQ     G+++SS+  +T +
Sbjct: 235 FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN-EWLQ----DGSQLSSNPLMTPD 289
Query: 378 LVVAAGGATNAFAMGGIPGYRTRPR 402
           ++ ++G A +         +    R
Sbjct: 290 ILGSSGAAVHTCVKATFHAFNKYKR 314

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 86  LGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLR---H 140
           +G G +GTVYK     +   V LKS    V+V N +EGL      + EV  L +L    H
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKS----VRVPNGEEGLPIST--VREVALLRRLEAFEH 65
Query: 141 PNLVKLIGYCCED--DHRL---LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V+L+  C     D  +   LV+E + +  L  +L +     L   T   +     +G
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH     +++RD K  NIL+ S  T KL+DFGLA+             V+ T  Y A
Sbjct: 125 LDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVTLWYRA 179
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELL 281
           PE ++        D++S G +  E+ 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 27/280 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVG-LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG+G F  ++KG   E    G L    V +KVL+K        +    + + +L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAE 203
              G C   D  +LV EF+  GSL+ +L + K  + + W  ++ +A   A  + FL   E
Sbjct: 76  LNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAAAMHFLE--E 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYAAPEYVMT 261
             +I+ +    NILL  +   K  +    K    G    V  +  +     +  PE +  
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 262 -GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
             +L   +D +SFG  L E+ +G                D     L+ +RK LQ  + R 
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSGG---------------DKPLSALDSQRK-LQFYEDR- 234
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
            +Q     A +  +L   C+   P  RP    ++  L  L
Sbjct: 235 -HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 75/158 (47%), Gaps = 11/158 (6%)
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           L EV  L QL HPN++KL  +  +  +  LV E    G L + +  +     S     +I
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQ--KFSEVDAAVI 109
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVST 245
                 G  +LH  +  +++RD K  N+LL+S   D   K+ DFGL+     G +     
Sbjct: 110 MKQVLSGTTYLH--KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM---K 164
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
             +GT  Y APE V+      + DV+S GV+L  LL G
Sbjct: 165 ERLGTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCG 201

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 70
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 129
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 130 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-- 183
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 184 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKL 74
Query: 139 RHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMIA 189
            H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M  
Sbjct: 75  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM-- 132
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRVM 248
           +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS  + 
Sbjct: 133 YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-IC 188
Query: 249 GTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
             Y Y APE +      T+  DV+S G VL ELL G+
Sbjct: 189 SRY-YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 35/270 (12%)
Query: 42  DLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGY 98
           D+S  +   N+  S+ +   Y+  +  S F   T+ K +++   +G G  G V   Y   
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAV 85
Query: 99  IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------E 152
           +D NV +   S P   +   K   +       E+  +  + H N++ L+          E
Sbjct: 86  LDRNVAIKKLSRPFQNQTHAKRAYR-------ELVLMKCVNHKNIISLLNVFTPQKTLEE 138
Query: 153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFK 212
                LV E M     + +L +   + L       + +    G+  LH+A   +I+RD K
Sbjct: 139 FQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLK 191
Query: 213 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYS 272
            SNI++ SD T K+ DFGLA+    G    ++  V+  Y Y APE ++        D++S
Sbjct: 192 PSNIVVKSDCTLKILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWS 248
Query: 273 FGVVLLE------LLTGRKSVDKTRPSKEQ 296
            G ++ E      L  GR  +D+     EQ
Sbjct: 249 VGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 278

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K +           LQ  R    E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-----------LQDKRFKNRELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVS--Y 182
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 121/286 (42%), Gaps = 44/286 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVNFLGQLRHPNL 143
           L E   G ++KG    N         + VKVL       +  R++  E   L    HPN+
Sbjct: 18  LNENHSGELWKGRWQGN--------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 144 VKLIGYCCEDD--HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           + ++G C      H  L+  +M  GSL N L       +  +  +  A   A+G+AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT 129
Query: 202 AERPVIYRD-FKTSNILLDSDYTAKLS--DFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
            E P+I R    + ++++D D TA++S  D   +   P           M    + APE 
Sbjct: 130 LE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGR---------MYAPAWVAPEA 179
Query: 259 VMTG-HLTAR--SDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           +      T R  +D++SF V+L EL+T           +E    D +  ++  K   L+ 
Sbjct: 180 LQKKPEDTNRRSADMWSFAVLLWELVT-----------REVPFADLSNMEIGMKVA-LEG 227
Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
           + P +    S   ++    L   C++++P  RP    +V  LE +Q
Sbjct: 228 LRPTIPPGISPHVSK----LMKICMNEDPAKRPKFDMIVPILEKMQ 269

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K      KVL  +  +       E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNR-----ELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDE--THVST 245
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G+   +++ +
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 246 RVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           R      Y APE +      T+  DV+S G VL ELL G+
Sbjct: 186 RY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 86  LGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLR---H 140
           +G G +GTVYK     +   V LKS    V+V N +EGL      + EV  L +L    H
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKS----VRVPNGEEGLPIST--VREVALLRRLEAFEH 65
Query: 141 PNLVKLIGYCC--EDDHRL---LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V+L+  C     D  +   LV+E + +  L  +L +     L   T   +     +G
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH     +++RD K  NIL+ S  T KL+DFGLA+             V+ T  Y A
Sbjct: 125 LDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVTLWYRA 179
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELL 281
           PE ++        D++S G +  E+ 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 34/220 (15%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K      KVL  +  +       E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNR-----ELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDE--THVST 245
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G+   +++ +
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS 185
Query: 246 RVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           R      Y APE +      T+  DV+S G VL ELL G+
Sbjct: 186 RY-----YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 120/289 (41%), Gaps = 44/289 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG--QLRHPN 142
           +G+G +G V++G +  ENV         AVK+ +    +  + W  E        LRH N
Sbjct: 45  VGKGRYGEVWRGSWQGENV---------AVKIFSS---RDEKSWFRETELYNTVMLRHEN 92
Query: 143 LVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           ++  I       H      L+  +   GSL ++L       L   + + I    A GLA 
Sbjct: 93  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 149
Query: 199 LH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQG-DETHVSTRV-MGT 250
           LH        +P I +RD K+ NIL+  +    ++D GLA    Q  ++  V     +GT
Sbjct: 150 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGT 209
Query: 251 YGYAAPEY------VMTGHLTARSDVYSFGVVLLEL---LTGRKSVDKTRPSKEQSLVDW 301
             Y APE       V       R D+++FG+VL E+   +     V+  +P     + + 
Sbjct: 210 KRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN- 268
Query: 302 ARPKLNDKRKMLQIID--PRLENQY-SVRAAQKACSLAYYCLSQNPKAR 347
             P   D RK++ +    P + N++ S         L   C  QNP AR
Sbjct: 269 -DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 316

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNL 143
           +G G +G+V   +   + + G +   VAVK L++  + +   +    E+  L  ++H N+
Sbjct: 30  VGSGAYGSVCAAF---DTKTGHR---VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 83
Query: 144 VKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           + L+          E +   LV   M  G+  N++ +     L+      + +   +GL 
Sbjct: 84  IGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVK--CQKLTDDHVQFLIYQILRGLK 139
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++H+A+  +I+RD K SN+ ++ D   K+ DF LA+        +V+TR      Y APE
Sbjct: 140 YIHSAD--IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVATR-----WYRAPE 192
Query: 258 YVMTG-HLTARSDVYSFGVVLLELLTGR 284
            ++   H     D++S G ++ ELLTGR
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 99/222 (44%), Gaps = 23/222 (10%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVN 133
           I+  F+   +LGEG +G V          +      VA+K +    + L   R  L E+ 
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEI------VAIKKIEPFDKPLFALRT-LREIK 61
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGA 192
            L   +H N++ +      D        ++ +  ++  L R  +T  LS        +  
Sbjct: 62  ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK---------AGPQGDETHV 243
            + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+         + P G ++ +
Sbjct: 122 LRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 244 STRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
               + T  Y APE ++T    +R+ DV+S G +L EL   R
Sbjct: 180 -VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 79  SFRSDYILGEGGFGTVYKGYI-DENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           S+    ++G G FG VY+  + D    V +K      KVL  +  +       E+  + +
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK------KVLQGKAFKNR-----ELQIMRK 69
Query: 138 LRHPNLVKL-IGYCCEDDHRLLVYEFMFRGSLENHLFR--------KATVPLSWATRMMI 188
           L H N+V+L   +    + +  VY  +    +   ++R        K T+P+ +    M 
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM- 128
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDETHVSTRV 247
            +   + LA++H+    + +RD K  N+LLD D    KL DFG AK   +G E +VS   
Sbjct: 129 -YQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-EPNVSX-- 182
Query: 248 MGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           + +  Y APE +      T+  DV+S G VL ELL G+
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G G +G V          +V +K +P A  V+        +  L E+  L   +H N++
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA-----KRTLRELKILKHFKHDNII 117
Query: 145 KL-------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
            +       + Y  E     +V + M     + H    ++ PL+        +   +GL 
Sbjct: 118 AIKDILRPTVPYG-EFKSVYVVLDLM---ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 173
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAA 255
           ++H+A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T  Y A
Sbjct: 174 YMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 256 PEYVMTGH-LTARSDVYSFGVVLLELLTGRK 285
           PE +++ H  T   D++S G +  E+L  R+
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG--QLRHPN 142
           +G+G +G V++G +  ENV         AVK+ +    +  + W  E        LRH N
Sbjct: 16  VGKGRYGEVWRGSWQGENV---------AVKIFSS---RDEKSWFRETELYNTVMLRHEN 63
Query: 143 LVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           ++  I       H      L+  +   GSL ++L       L   + + I    A GLA 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 120
Query: 199 LH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD---ETHVSTRVMG 249
           LH        +P I +RD K+ NIL+  +    ++D GLA    Q     +   + RV G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-G 179
Query: 250 TYGYAAPEY------VMTGHLTARSDVYSFGVVLLEL---LTGRKSVDKTRPSKEQSLVD 300
           T  Y APE       V       R D+++FG+VL E+   +     V+  +P     + +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 301 WARPKLNDKRKMLQIID--PRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
              P   D RK++ +    P + N++ S         L   C  QNP AR     + +TL
Sbjct: 240 --DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 358 EPL 360
             +
Sbjct: 298 TKI 300

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 125/303 (41%), Gaps = 46/303 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG--QLRHPN 142
           +G+G +G V++G +  ENV         AVK+ +    +  + W  E        LRH N
Sbjct: 16  VGKGRYGEVWRGSWQGENV---------AVKIFSS---RDEKSWFRETELYNTVMLRHEN 63
Query: 143 LVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           ++  I       H      L+  +   GSL ++L       L   + + I    A GLA 
Sbjct: 64  ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL---QLTTLDTVSCLRIVLSIASGLAH 120
Query: 199 LH-----NAERPVI-YRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD---ETHVSTRVMG 249
           LH        +P I +RD K+ NIL+  +    ++D GLA    Q     +   + RV G
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-G 179
Query: 250 TYGYAAPEY------VMTGHLTARSDVYSFGVVLLEL---LTGRKSVDKTRPSKEQSLVD 300
           T  Y APE       V       R D+++FG+VL E+   +     V+  +P     + +
Sbjct: 180 TKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPN 239
Query: 301 WARPKLNDKRKMLQIID--PRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
              P   D RK++ +    P + N++ S         L   C  QNP AR     + +TL
Sbjct: 240 --DPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
Query: 358 EPL 360
             +
Sbjct: 298 TKI 300

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 86  LGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLN-KEGLQGHREWLTEVNFLGQLR---H 140
           +G G +GTVYK     +   V LKS    V+V N +EGL      + EV  L +L    H
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKS----VRVPNGEEGLPIST--VREVALLRRLEAFEH 65
Query: 141 PNLVKLIGYCCED--DHRL---LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V+L+  C     D  +   LV+E + +  L  +L +     L   T   +     +G
Sbjct: 66  PNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRG 124
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH     +++RD K  NIL+ S  T KL+DFGLA+             V+ T  Y A
Sbjct: 125 LDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVTLWYRA 179
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELL 281
           PE ++        D++S G +  E+ 
Sbjct: 180 PEVLLQSTYATPVDMWSVGCIFAEMF 205

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 130/308 (42%), Gaps = 48/308 (15%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
            R   +L EGGF  VY+    ++V  G +    A+K L     + +R  + EV F+ +L 
Sbjct: 30  LRVRRVLAEGGFAFVYEA---QDVGSGRE---YALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 140 -HPNLVKL-----IGYCCED--DHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAF 190
            HPN+V+      IG    D      L+   + +G L   L + ++  PLS  T + I +
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG- 249
              + +  +H  + P+I+RD K  N+LL +  T KL DFG A       +   S +    
Sbjct: 144 QTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRAL 203
Query: 250 ---------TYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS 297
                    T  Y  PE +       +  + D+++ G +L  L             ++  
Sbjct: 204 VEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF-----------RQHP 252
Query: 298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
             D A+ ++ + +  +    P  + QY+V       SL    L  NP+ R  +++VV  L
Sbjct: 253 FEDGAKLRIVNGKYSI----PPHDTQYTVFH-----SLIRAMLQVNPEERLSIAEVVHQL 303
Query: 358 EPLQCAND 365
           + +  A +
Sbjct: 304 QEIAAARN 311

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           ++G G FG V++  + E+  V +K +           LQ  R    E+  +  ++HPN+V
Sbjct: 47  VIGNGSFGVVFQAKLVESDEVAIKKV-----------LQDKRFKNRELQIMRIVKHPNVV 95
Query: 145 KLIGYCCED----DHRLL------VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
            L  +   +    D   L      V E ++R S  ++   K T+P+      M  +   +
Sbjct: 96  DLKAFFYSNGDKKDEVFLNLVLEYVPETVYRAS-RHYAKLKQTMPMLLIKLYM--YQLLR 152
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            LA++H+    + +RD K  N+LLD      KL DFG AK    G E +VS  +   Y Y
Sbjct: 153 SLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-EPNVSX-ICSRY-Y 207
Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE +    + T   D++S G V+ EL+ G+
Sbjct: 208 RAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 86  LGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGLQGHREWLT--EVNFLGQLR--- 139
           +G G +GTVYK     +   V LKS    V+V N  G  G     T  EV  L +L    
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKS----VRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 140 HPNLVKLIGYCCED--DHRL---LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           HPN+V+L+  C     D  +   LV+E + +  L  +L +     L   T   +     +
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL FLH     +++RD K  NIL+ S  T KL+DFGLA+           T V+ T  Y 
Sbjct: 132 GLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVVVTLWYR 186
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELL 281
           APE ++        D++S G +  E+ 
Sbjct: 187 APEVLLQSTYATPVDMWSVGCIFAEMF 213

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 66
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERM 121
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 122 SYLLYQMLXGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTP 177
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 178 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 96/211 (45%), Gaps = 22/211 (10%)
Query: 86  LGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +G G +G V          +V +K +P A  V+        +  L E+  L   +H N++
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNA-----KRTLRELKILKHFKHDNII 116
Query: 145 KL-------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
            +       + Y  E     +V + M     + H    ++ PL+        +   +GL 
Sbjct: 117 AIKDILRPTVPYG-EFKSVYVVLDLM---ESDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAA 255
           ++H+A+  VI+RD K SN+L++ +   K+ DFG+A+       +  +  T  + T  Y A
Sbjct: 173 YMHSAQ--VIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 256 PEYVMTGH-LTARSDVYSFGVVLLELLTGRK 285
           PE +++ H  T   D++S G +  E+L  R+
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V      + VR        A+K+L+K  +    +   +  E + +     P
Sbjct: 76  VIGRGAFGEV------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGL 196
            +V+L  Y  +DD  L +V E+M  G L N L     VP  WA      +++A  A   +
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 187
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            F+H        RD K  N+LLD     KL+DFG      +       T V GT  Y +P
Sbjct: 188 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 238
Query: 257 EYVMT----GHLTARSDVYSFGVVLLELLTG 283
           E + +    G+     D +S GV L E+L G
Sbjct: 239 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 71/280 (25%), Positives = 115/280 (41%), Gaps = 27/280 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVG-LKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG+G F  ++KG   E    G L    V +KVL+K        +    + + +L H +LV
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLV 75
Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAE 203
              G C   D  +LV EF+  GSL+ +L + K  + + W  ++ +A   A  + FL   E
Sbjct: 76  LNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILW--KLEVAKQLAWAMHFLE--E 131
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYAAPEYVMT 261
             +I+ +    NILL  +   K  +    K    G    V  +  +     +  PE +  
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWVPPECIEN 191
Query: 262 -GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
             +L   +D +SFG  L E+ +G                D     L+ +RK LQ  + R 
Sbjct: 192 PKNLNLATDKWSFGTTLWEICSGG---------------DKPLSALDSQRK-LQFYEDR- 234
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
            +Q     A +  +L   C+   P  RP    ++  L  L
Sbjct: 235 -HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V      + VR        A+K+L+K  +    +   +  E + +     P
Sbjct: 81  VIGRGAFGEV------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGL 196
            +V+L  Y  +DD  L +V E+M  G L N L     VP  WA      +++A  A   +
Sbjct: 135 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            F+H        RD K  N+LLD     KL+DFG      +       T V GT  Y +P
Sbjct: 193 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243
Query: 257 EYVMT----GHLTARSDVYSFGVVLLELLTG 283
           E + +    G+     D +S GV L E+L G
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           F+ + + G+G FGTV  G      +     + VA+K + ++    +RE L  +  L  L 
Sbjct: 25  FQVERMAGQGTFGTVQLG------KEKSTGMSVAIKKVIQDPRFRNRE-LQIMQDLAVLH 77
Query: 140 HPNLVKLIGY---CCEDDHRLL----VYEFM---FRGSLENHLFRKATVPLSWATRMMIA 189
           HPN+V+L  Y     E D R +    V E++         N+ +R+   P     ++ + 
Sbjct: 78  HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNY-YRRQVAPPPILIKVFL- 135
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILL-DSDYTAKLSDFGLAK--AGPQGDETHVSTR 246
           F   + +  LH     V +RD K  N+L+ ++D T KL DFG AK  +  + +  ++ +R
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195
Query: 247 VMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTG 283
                 Y APE +    H T   D++S G +  E++ G
Sbjct: 196 Y-----YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 29/211 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V      + VR        A+K+L+K  +    +   +  E + +     P
Sbjct: 81  VIGRGAFGEV------QLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWA----TRMMIAFGAAKGL 196
            +V+L  Y  +DD  L +V E+M  G L N L     VP  WA      +++A  A   +
Sbjct: 135 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAIHSM 192
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            F+H        RD K  N+LLD     KL+DFG      +       T V GT  Y +P
Sbjct: 193 GFIH--------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISP 243
Query: 257 EYVMT----GHLTARSDVYSFGVVLLELLTG 283
           E + +    G+     D +S GV L E+L G
Sbjct: 244 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDXTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 94/225 (41%), Gaps = 27/225 (12%)
Query: 71  FELETITKSFRSDYIL----GEGGFGTVYKGYIDENVRVGLKSLPV---AVKVLNKEGLQ 123
           F+       F  DY L    G+G F  V         R  +K  P    A K++N + L 
Sbjct: 20  FQXMATCTRFTDDYQLFEELGKGAFSVV---------RRCVKKTPTQEYAAKIINTKKLS 70
Query: 124 G--HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLS 181
              H++   E      L+HPN+V+L     E+    LV++ +  G L   +  +     +
Sbjct: 71  ARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEA 130
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQG 238
            A+  +     +      H  +  +++RD K  N+LL S       KL+DFGLA    QG
Sbjct: 131 DASHCIHQILESVN----HIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQG 185
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            E        GT GY +PE +         D+++ GV+L  LL G
Sbjct: 186 -EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 86  LGEGGFGTVYKGYIDE--NVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           LGEG +G VYK  ID   N  V +K + +  +   +EG+ G    + EV+ L +L+H N+
Sbjct: 42  LGEGTYGEVYKA-IDTVTNETVAIKRIRLEHE---EEGVPGTA--IREVSLLKELQHRNI 95
Query: 144 VKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++L       +HRL L++E+     L+ ++ +   V +      +  +    G+ F H+ 
Sbjct: 96  IELKS-VIHHNHRLHLIFEYA-ENDLKKYMDKNPDVSMRVIKSFL--YQLINGVNFCHS- 150
Query: 203 ERPVIYRDFKTSNILL---DSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
            R  ++RD K  N+LL   D+  T   K+ DFGLA+A   G      T  + T  Y  PE
Sbjct: 151 -RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPE 207
Query: 258 YVM-TGHLTARSDVYSFGVVLLELL 281
            ++ + H +   D++S   +  E+L
Sbjct: 208 ILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFR----KATVPLSW 182
           ++EVN L +L+HPN+V+      +  +  L  V E+   G L + + +    +  +   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 183 ATRMMIAFGAA-KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
             R+M     A K      +    V++RD K +N+ LD     KL DFGLA+      +T
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDT 170
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEL 280
             +   +GT  Y +PE +       +SD++S G +L EL
Sbjct: 171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 74
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 129
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 130 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFR----KATVPLSW 182
           ++EVN L +L+HPN+V+      +  +  L  V E+   G L + + +    +  +   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 183 ATRMMIAFGAA-KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
             R+M     A K      +    V++RD K +N+ LD     KL DFGLA+      +T
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDT 170
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEL 280
             +   +GT  Y +PE +       +SD++S G +L EL
Sbjct: 171 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 22  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 74
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 75  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 129
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 130 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 185
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 186 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 241

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 90/222 (40%), Gaps = 57/222 (25%)
Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSL------PVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           +GEG +G V+K    D    V +K        PV  K+            L E+  L QL
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIA-----------LREIRMLKQL 59
Query: 139 RHPNLVKLIG-------------YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +HPNLV L+              YC   DH +L     ++  +  HL +  T    W T 
Sbjct: 60  KHPNLVNLLEVFRRKRRLHLVFEYC---DHTVLHELDRYQRGVPEHLVKSIT----WQTL 112
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQG-DETH 242
             + F         HN     I+RD K  NIL+      KL DFG A+   GP    +  
Sbjct: 113 QAVNFCHK------HNC----IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE 162
Query: 243 VSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTG 283
           V+TR      Y +PE ++         DV++ G V  ELL+G
Sbjct: 163 VATR-----WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 20  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 72
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 73  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 127
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 128 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 183
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 184 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 67
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 122
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 123 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 178
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 179 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 21  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 73
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 74  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 128
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 129 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 184
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 185 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 240

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 66
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 67  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 121
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 122 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 177
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 178 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 233

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   +D NV +   S P   +   K   +       E
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-------E 67
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     LV E M     + +L +   + L     
Sbjct: 68  LVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERM 122
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 123 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 178
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 179 YVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ 234

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E+M  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     K
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIK 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VADFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S GV++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 82/159 (51%), Gaps = 12/159 (7%)
Query: 131 EVNFLGQLRHPNLVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           E+  L +L HPN+VKL+    +  +DH  +V+E + +G +   +      PLS       
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV---MEVPTLKPLSEDQARFY 142
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
                KG+ +LH  +  +I+RD K SN+L+  D   K++DFG++    +G +  +S  V 
Sbjct: 143 FQDLIKGIEYLHYQK--IIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTV- 198
Query: 249 GTYGYAAPEYVMTGH--LTARS-DVYSFGVVLLELLTGR 284
           GT  + APE +       + ++ DV++ GV L   + G+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/214 (30%), Positives = 101/214 (47%), Gaps = 26/214 (12%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNL 143
           +LGEG +  V      +N +        AVK++ K+          EV  L Q + + N+
Sbjct: 20  LLGEGAYAKVQGAVSLQNGK------EYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNI 73
Query: 144 VKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++LI +  EDD R  LV+E +  GS+  H+ ++       A+R++    AA  L FLH  
Sbjct: 74  LELIEFF-EDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAA--LDFLHT- 129
Query: 203 ERPVIYRDFKTSNILLDSDYT---AKLSDFGLAKAGPQGDE-THVSTRVM----GTYGYA 254
            + + +RD K  NIL +S       K+ DF L       +  T ++T  +    G+  Y 
Sbjct: 130 -KGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYM 188
Query: 255 APEY--VMTGHLT---ARSDVYSFGVVLLELLTG 283
           APE   V T   T    R D++S GVVL  +L+G
Sbjct: 189 APEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/181 (28%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E+M  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     K
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIK 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VADFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S GV++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 80/183 (43%), Gaps = 25/183 (13%)
Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
           P++    +  +F  A+G+ FL  + R  I+RD    NILL  +   K+ DFGLA+   + 
Sbjct: 195 PITMEDLISYSFQVARGMEFL--SSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
            +            + APE +     + +SDV+S+GV+L E+                SL
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIF---------------SL 297
Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVV 354
                P +    +M +    RL     +RA + +    Y     C  ++PK RP  +++V
Sbjct: 298 GGSPYPGV----QMDEDFCSRLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELV 353
Query: 355 ETL 357
           E L
Sbjct: 354 EKL 356

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 62/208 (29%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR------EWLTEVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R      E   EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HPN++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 76/159 (47%), Gaps = 9/159 (5%)
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLL--VYEFMFRGSLENHLFR----KATVPLSW 182
           ++EVN L +L+HPN+V+      +  +  L  V E+   G L + + +    +  +   +
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEF 112
Query: 183 ATRMMIAFGAA-KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
             R+M     A K      +    V++RD K +N+ LD     KL DFGLA+     ++ 
Sbjct: 113 VLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDED- 171
Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEL 280
             +   +GT  Y +PE +       +SD++S G +L EL
Sbjct: 172 -FAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/225 (27%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH---REWLTEVNFLGQLR-HP 141
           LG+G +G V+K  ID   R G     VAVK +  +  Q     +    E+  L +L  H 
Sbjct: 17  LGKGAYGIVWKS-IDR--RTGE---VVAVKKI-FDAFQNSTDAQRTFREIMILTELSGHE 69
Query: 142 NLVKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           N+V L+     D+ R   LV+++M     + H   +A + L    +  + +   K + +L
Sbjct: 70  NIVNLLNVLRADNDRDVYLVFDYM---ETDLHAVIRANI-LEPVHKQYVVYQLIKVIKYL 125
Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ-------------------GDE 240
           H+    +++RD K SNILL+++   K++DFGL+++                       D+
Sbjct: 126 HSG--GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 241 THVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
             + T  + T  Y APE ++ +   T   D++S G +L E+L G+
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 17/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LG+G F  V +      V+V L     A  ++N + L    H++   E      L+HPN+
Sbjct: 19  LGKGAFSVVRRC-----VKV-LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+ H  L+++ +  G L   +  +     + A+  +         A LH  +
Sbjct: 73  VRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE----AVLHCHQ 128
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             V++R+ K  N+LL S       KL+DFGLA    +G E        GT GY +PE + 
Sbjct: 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEG-EQQAWFGFAGTPGYLSPEVLR 186
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D+++ GV+L  LL G
Sbjct: 187 KDPYGKPVDLWACGVILYILLVG 209

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 92/203 (45%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++    E+ + G +    AVK +  E  +       E+     L  P +V 
Sbjct: 82  LGRGSFGEVHR---MEDKQTGFQ---CAVKKVRLEVFRAE-----ELMACAGLTSPRIVP 130
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA-KGLAFLHNAER 204
           L G   E     +  E +  GSL   +  +  +P     R +   G A +GL +LH+  R
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYLGQALEGLEYLHS--R 185
Query: 205 PVIYRDFKTSNILLDSDYT-AKLSDFGLA---KAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +++ D K  N+LL SD + A L DFG A   +    G +      + GT  + APE V+
Sbjct: 186 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVL 245
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                A+ DV+S   ++L +L G
Sbjct: 246 GRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 89/211 (42%), Gaps = 17/211 (8%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
           I K+F    +LG G F  V+       V+  L     A+K + K           E+  L
Sbjct: 7   IRKTFIFMEVLGSGAFSEVFL------VKQRLTGKLFALKCIKKSPAFRDSSLENEIAVL 60
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            +++H N+V L        H  LV + +  G L + +  +       A+  ++       
Sbjct: 61  KKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS--LVIQQVLSA 118
Query: 196 LAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           + +LH  E  +++RD K  N+L    + +    ++DFGL+K    G    + +   GT G
Sbjct: 119 VKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG----IMSTACGTPG 172
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y APE +     +   D +S GV+   LL G
Sbjct: 173 YVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+ +   +E    L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFGLAK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGLAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++    E+ + G +    AVK +  E  +       E+     L  P +V 
Sbjct: 101 LGRGSFGEVHR---MEDKQTGFQ---CAVKKVRLEVFRAE-----ELMACAGLTSPRIVP 149
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA-KGLAFLHNAER 204
           L G   E     +  E +  GSL   +  +  +P     R +   G A +GL +LH+  R
Sbjct: 150 LYGAVREGPWVNIFMELLEGGSLGQLVKEQGCLP---EDRALYYLGQALEGLEYLHS--R 204
Query: 205 PVIYRDFKTSNILLDSDYT-AKLSDFGLA---KAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +++ D K  N+LL SD + A L DFG A   +    G        + GT  + APE V+
Sbjct: 205 RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVL 264
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                A+ DV+S   ++L +L G
Sbjct: 265 GRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 35/257 (13%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------ 279
           + DFGLA+    G    +   V+  Y Y APE ++        D++S G ++ E      
Sbjct: 167 ILDFGLARTA--GTSFMMEPEVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVCHKI 223
Query: 280 LLTGRKSVDKTRPSKEQ 296
           L  GR  +D+     EQ
Sbjct: 224 LFPGRDYIDQWNKVIEQ 240

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           LG+G F  V +     +   GL+    A K++N + L     ++   E     +L+HPN+
Sbjct: 37  LGKGAFSVVRRCV---HKTTGLE---FAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +      + +A+ H+  
Sbjct: 91  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCHS-- 146
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++R+ K  N+LL S       KL+DFGLA      +  H      GT GY +PE + 
Sbjct: 147 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLK 203
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D+++ GV+L  LL G
Sbjct: 204 KDPYSKPVDIWACGVILYILLVG 226

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 5   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 61
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 62  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 112
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 113 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 167
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 168 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 73/180 (40%), Gaps = 25/180 (13%)
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 197 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 299
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 300 DEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 355

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 20/178 (11%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 150
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 151 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 202
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           ++DFG AK       T     + GT  Y APE +++       D ++ GV++ E+  G
Sbjct: 203 VTDFGFAKRVKGATWT-----LCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 73/180 (40%), Gaps = 25/180 (13%)
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 199 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 301
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 302 DEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 357

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 7/186 (3%)
Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIA 189
           E    G+L+ P++V +  +  E D +L V   +  G  L   L R+  +    A  ++  
Sbjct: 84  EARTAGRLQEPHVVPIHDFG-EIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQ 142
Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
            G+A   A    A     +RD K  NIL+ +D  A L DFG+A A      T +   V G
Sbjct: 143 IGSALDAAHAAGA----THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-G 197
Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK 309
           T  Y APE     H T R+D+Y+   VL E LTG       + S   + ++ A P+ +  
Sbjct: 198 TLYYXAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAIPRPSTV 257
Query: 310 RKMLQI 315
           R  + +
Sbjct: 258 RPGIPV 263

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 73/180 (40%), Gaps = 25/180 (13%)
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 204 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 306
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 307 DEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 362

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 93/203 (45%), Gaps = 8/203 (3%)
Query: 85  ILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           ++G+G F  V +    E   +  +K + VA K  +  GL    +   E +    L+HP++
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVA-KFTSSPGLST-EDLKREASICHMLKHPHI 88
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L+     D    +V+EFM    L   + ++A     ++  +   +      A  +  +
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 204 RPVIYRDFKTSNILLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +I+RD K  N+LL S   +   KL DFG+A     G+   V+   +GT  + APE V 
Sbjct: 149 NNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVK 206
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   DV+  GV+L  LL+G
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 73/180 (40%), Gaps = 25/180 (13%)
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
           +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +        
Sbjct: 206 SFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
               + APE +     T +SDV+SFGV+L E+                SL     P +  
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF---------------SLGASPYPGVKI 308
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYY----CLSQNPKARPLMSDVVETLEPLQCAN 364
             +  +    RL+    +RA        Y     C    P  RP  S++VE L  L  AN
Sbjct: 309 DEEFCR----RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 364

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/169 (29%), Positives = 71/169 (42%), Gaps = 28/169 (16%)
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           I     K L  L    + +I+RD K SNILLD     KL DFG++    Q  ++   TR 
Sbjct: 130 ITLATVKALNHLKENLK-IIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRD 185
Query: 248 MGTYGYAAPEYVMTGH----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
            G   Y APE +           RSDV+S G+ L EL TGR                +  
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR----------------FPY 229
Query: 304 PKLNDK-RKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
           PK N    ++ Q++    P+L N      +    +    CL+++   RP
Sbjct: 230 PKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           LG+G F  V +     +   GL+    A K++N + L     ++   E     +L+HPN+
Sbjct: 13  LGKGAFSVVRRCV---HKTTGLE---FAAKIINTKKLSARDFQKLEREARICRKLQHPNI 66
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +      + +A+ H+  
Sbjct: 67  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCHS-- 122
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++R+ K  N+LL S       KL+DFGLA      +  H      GT GY +PE + 
Sbjct: 123 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLK 179
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D+++ GV+L  LL G
Sbjct: 180 KDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           LG+G F  V +     +   GL+    A K++N + L     ++   E     +L+HPN+
Sbjct: 14  LGKGAFSVVRRCV---HKTTGLE---FAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +      + +A+ H+  
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCHS-- 123
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++R+ K  N+LL S       KL+DFGLA      +  H      GT GY +PE + 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLK 180
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D+++ GV+L  LL G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 80/176 (45%), Gaps = 11/176 (6%)
Query: 113 AVKVLNKEGLQG--HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN 170
           A K++N + L    H++   E      L+H N+V+L     E+    LV++ +  G L  
Sbjct: 33  AAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFE 92
Query: 171 HLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLS 227
            +  +     + A+  +     A     LH  +  V++RD K  N+LL S       KL+
Sbjct: 93  DIVAREYYSEADASHCIQQILEA----VLHCHQMGVVHRDLKPENLLLASKCKGAAVKLA 148
Query: 228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           DFGLA    QGD+        GT GY +PE +         D+++ GV+L  LL G
Sbjct: 149 DFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 12/104 (11%)
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           I    A+ + FLH+  + +++RD K SNI    D   K+ DFGL  A  Q +E       
Sbjct: 169 IFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 248 MGTYG----------YAAPEYVMTGHLTARSDVYSFGVVLLELL 281
           M  Y           Y +PE +   + + + D++S G++L ELL
Sbjct: 227 MPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 19/224 (8%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           ++ +  F   Y L E   G      +   + + + S   AVK++ K+          EV 
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVE 62
Query: 134 FLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
            L Q + H N+++LI +  E+D   LV+E M  GS+ +H+ ++       A+  ++    
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--VVVQDV 120
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AKLSDFGLAKA-GPQGDETHVSTRVM 248
           A  L FLHN  + + +RD K  NIL +        K+ DFGL       GD + +ST  +
Sbjct: 121 ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPEL 178
Query: 249 ----GTYGYAAPEYVMTGHLTA-----RSDVYSFGVVLLELLTG 283
               G+  Y APE V      A     R D++S GV+L  LL+G
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     K
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIK 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VADFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLVGIKHLHSAG--IIHRDLKPSNIVVKSDATLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V        V+        A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLA 197
           LVKL  Y  +D+  L +V E++  G + +HL R  + + P +  +A ++++ F       
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------E 155
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYA 254
           +LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y 
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYL 205
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE +++       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDATLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDATLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V        V+        A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLA 197
           LVKL  Y  +D+  L +V E++  G + +HL R  + + P +  +A ++++ F       
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------E 155
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYA 254
           +LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y 
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYL 205
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE +++       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 99/209 (47%), Gaps = 34/209 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V        V+        A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLA 197
           LVKL  Y  +D+  L +V E++  G + +HL R  + + P +  +A ++++ F       
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------E 155
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYA 254
           +LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y 
Sbjct: 156 YLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYL 205
Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE +++       D ++ GV++ E+  G
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 105/238 (44%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLSQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 167 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 91/200 (45%), Gaps = 14/200 (7%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++       RV +         L+K  ++       E++ + QL HP L+ 
Sbjct: 59  LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK------NEISIMNQLHHPKLIN 112
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     +    +L+ EF+  G L + +       +S A  +     A +GL  +H  E  
Sbjct: 113 LHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEVINYMRQACEGLKHMH--EHS 169
Query: 206 VIYRDFKTSNILLDSDY--TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +++ D K  NI+ ++    + K+ DFGLA      +   V+T    T  +AAPE V    
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---ATAEFAAPEIVDREP 226
Query: 264 LTARSDVYSFGVVLLELLTG 283
           +   +D+++ GV+   LL+G
Sbjct: 227 VGFYTDMWAIGVLGYVLLSG 246

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 93/203 (45%), Gaps = 18/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           LG+G F  V +     +   GL+    A K++N + L     ++   E     +L+HPN+
Sbjct: 14  LGKGAFSVVRRCV---HKTTGLE---FAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +      + +A+ H+  
Sbjct: 68  VRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI--LESIAYCHS-- 123
Query: 204 RPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++R+ K  N+LL S       KL+DFGLA      +  H      GT GY +PE + 
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH---GFAGTPGYLSPEVLK 180
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
               +   D+++ GV+L  LL G
Sbjct: 181 KDPYSKPVDIWACGVILYILLVG 203

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 109/257 (42%), Gaps = 35/257 (13%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 4   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 60
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 61  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 111
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 112 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 166
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------ 279
           + DFGLA+    G    +   V+  Y Y APE ++        D++S G ++ E      
Sbjct: 167 ILDFGLARTA--GTSFMMEPEVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 223
Query: 280 LLTGRKSVDKTRPSKEQ 296
           L  GR  +D+     EQ
Sbjct: 224 LFPGRDYIDQWNKVIEQ 240

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTR---VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R   + GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 27/240 (11%)
Query: 52  LEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLP 111
           +  S+ +   Y+  +A S F   T+ K ++    +G G  G V   +   +  +G+    
Sbjct: 1   MSKSKVDNQFYSVEVADSTF---TVLKRYQQLKPIGSGAQGIVCAAF---DTVLGIN--- 51
Query: 112 VAVKVLNKEGL-QGH-REWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFM 163
           VAVK L++    Q H +    E+  L  + H N++ L+          E     LV E M
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
                + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T
Sbjct: 112 -----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA--GIIHRDLKPSNIVVKSDCT 164
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            K+ DFGLA+         + T  + T  Y APE ++     A  D++S G ++ EL+ G
Sbjct: 165 LKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNF-LGQLRHPNL 143
           +G G  G V+K    +   V      +AVK + + G  + ++  L +++  L     P +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHV------IAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYI 86
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+  G    +    +  E M  G+    L ++   P+       +     K L +L   +
Sbjct: 87  VQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE-K 143
Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             VI+RD K SNILLD     KL DFG+  +G   D+     R  G   Y APE +    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGI--SGRLVDD-KAKDRSAGCAAYMAPERIDPPD 200
Query: 264 LTA-----RSDVYSFGVVLLELLTGR 284
            T      R+DV+S G+ L+EL TG+
Sbjct: 201 PTKPDYDIRADVWSLGISLVELATGQ 226

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           + ++  F  +  LG G    VY+       +      P A+KVL K      +   TE+ 
Sbjct: 49  DALSDFFEVESELGRGATSIVYR------CKQKGTQKPYALKVLKKT--VDKKIVRTEIG 100
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L +L HPN++KL           LV E +  G L + +  K       A   +     A
Sbjct: 101 VLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEA 160
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             +A+LH  E  +++RD K  N+L  +   D   K++DFGL+K     +   +   V GT
Sbjct: 161 --VAYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV---EHQVLMKTVCGT 213
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            GY APE +         D++S G++   LL G
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/257 (24%), Positives = 110/257 (42%), Gaps = 35/257 (13%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 9   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 65
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 66  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 116
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 117 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 171
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------ 279
           + DFGLA+    G    ++  V+  Y Y APE ++        D++S G ++ E      
Sbjct: 172 ILDFGLARTA--GTSFMMTPYVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKI 228
Query: 280 LLTGRKSVDKTRPSKEQ 296
           L  GR  +D+     EQ
Sbjct: 229 LFPGRDYIDQWNKVIEQ 245

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTR---VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R   + GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/238 (24%), Positives = 104/238 (43%), Gaps = 29/238 (12%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLP 111
           S+++   Y+  I  S F   T+ K +++   +G G  G V   Y   ++ NV +   S P
Sbjct: 6   SKRDNNFYSVEIGDSTF---TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP 62
Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFR 165
              +   K   +       E+  +  + H N++ L+          E     +V E M  
Sbjct: 63  FQNQTHAKRAYR-------ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-- 113
Query: 166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
              + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K
Sbjct: 114 ---DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLK 168
Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + DFGLA+    G    +   V+  Y Y APE ++        D++S G ++ E++ G
Sbjct: 169 ILDFGLARTA--GTSFMMVPFVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 101/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+ +   +E    L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     +++DFGLAK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLMIDQQGYIQVTDFGLAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LG+G F  V +      +  G +    A K++N + L    H++   E      L+HPN+
Sbjct: 12  LGKGAFSVVRRCM---KIPTGQE---YAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +     +     L+   
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 204 RPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+LL S       KL+DFGLA    QGD+        GT GY +PE + 
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEVLR 179
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D+++ GV+L  LL G
Sbjct: 180 KDPYGKPVDMWACGVILYILLVG 202

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+ +  +IYRD K  N+L+D     +++DFG AK       T     + GT  Y APE 
Sbjct: 158 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEI 210
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           +++       D ++ GV++ E+  G
Sbjct: 211 ILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 101/234 (43%), Gaps = 31/234 (13%)
Query: 61  LYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK- 119
            Y   +  + +E+  + +  +    +G G +G V       + R G K   VA+K L + 
Sbjct: 11  FYRQEVTKTAWEVRAVYRDLQP---VGSGAYGAVCSAV---DGRTGAK---VAIKKLYRP 61
Query: 120 --EGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD------HRLLVYEFMFRGSLENH 171
               L   R +  E+  L  +RH N++ L+     D+         LV  FM  G+    
Sbjct: 62  FQSELFAKRAY-RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGK 118
Query: 172 LFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 231
           L +     L       + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGL
Sbjct: 119 LMKHEK--LGEDRIQFLVYQMLKGLRYIHAA--GIIHRDLKPGNLAVNEDCELKILDFGL 174
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGR 284
           A+         V TR      Y APE ++     T   D++S G ++ E++TG+
Sbjct: 175 ARQADSEMXGXVVTR-----WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/261 (24%), Positives = 124/261 (47%), Gaps = 35/261 (13%)
Query: 86  LGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LG GG G V+    ++ + RV +K +     VL     Q  +  L E+  + +L H N+V
Sbjct: 19  LGCGGNGLVFSAVDNDCDKRVAIKKI-----VLTDP--QSVKHALREIKIIRRLDHDNIV 71
Query: 145 KL--------------IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           K+              +G   E +   +V E+M    L N L +    PL      +  +
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQG---PLLEEHARLFMY 127
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAK-AGPQ-GDETHVSTRV 247
              +GL ++H+A   V++RD K +N+ +++ D   K+ DFGLA+   P    + H+S  +
Sbjct: 128 QLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL 185
Query: 248 MGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
           + T  Y +P  +++  + T   D+++ G +  E+LTG+         ++  L+  + P +
Sbjct: 186 V-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV 244
Query: 307 N--DKRKMLQIIDPRLENQYS 325
           +  D++++L +I   + N  +
Sbjct: 245 HEEDRQELLSVIPVYIRNDMT 265

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 158 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           +G+G FG V+K  +     +V LK      KVL +   +G     L E+  L  L+H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 144 VKLIGYC---------CEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFG 191
           V LI  C         C+     LV++F      G L N L +     +    +M++   
Sbjct: 80  VNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL--- 135
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVM 248
              GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+A              RV+
Sbjct: 136 --NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT 282
            T  Y  PE ++         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 100/208 (48%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 100/205 (48%), Gaps = 26/205 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 35  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  + + P +  +A ++++ F       +
Sbjct: 89  LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 142
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH+ +  +IYRD K  N+L+D     +++DFG AK       T     + GT  Y APE 
Sbjct: 143 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEYLAPEI 195
Query: 259 VMTGHLTARSDVYSFGVVLLELLTG 283
           +++       D ++ GV++ E+  G
Sbjct: 196 ILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFAEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 57  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 116
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 117 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDEQGYIQ 168
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 169 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 220
Query: 283 G 283
           G
Sbjct: 221 G 221

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++    ++ + G +    AVK +  E  +     + E+     L  P +V 
Sbjct: 80  LGRGSFGEVHR---MKDKQTGFQ---CAVKKVRLEVFR-----VEELVACAGLSSPRIVP 128
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA-KGLAFLHNAER 204
           L G   E     +  E +  GSL   + +   +P     R +   G A +GL +LH   R
Sbjct: 129 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT--R 183
Query: 205 PVIYRDFKTSNILLDSDYT-AKLSDFGLA---KAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +++ D K  N+LL SD + A L DFG A   +    G        + GT  + APE VM
Sbjct: 184 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 243
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                A+ D++S   ++L +L G
Sbjct: 244 GKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 17/203 (8%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           LG+G F  V +      +  G +    A K++N + L    H++   E      L+HPN+
Sbjct: 12  LGKGAFSVVRRCM---KIPTGQE---YAAKIINTKKLSARDHQKLEREARICRLLKHPNI 65
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L     E+    LV++ +  G L   +  +     + A+  +     +     L+   
Sbjct: 66  VRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG-- 123
Query: 204 RPVIYRDFKTSNILLDSD---YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +++RD K  N+LL S       KL+DFGLA    QGD+        GT GY +PE + 
Sbjct: 124 --IVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQ-QAWFGFAGTPGYLSPEVLR 179
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   D+++ GV+L  LL G
Sbjct: 180 KDPYGKPVDMWACGVILYILLVG 202

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 150
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 151 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 202
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 203 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
Query: 283 G 283
           G
Sbjct: 255 G 255

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 91  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 150
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 151 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 202
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 203 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254
Query: 283 G 283
           G
Sbjct: 255 G 255

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E+   G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+++D     K
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLMIDQQGYIK 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 40/238 (16%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVN 133
           I   +   +++G G +G V + Y     RV      VA+K + +  E L   +  L E+ 
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRV------VAIKKILRVFEDLIDCKRILREIA 104
Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA---F 190
            L +L H ++VK++      D      E      + +  F+K      + T + I    +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFD-ELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY 163
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-------------GPQ 237
               G+ ++H+A   +++RD K +N L++ D + K+ DFGLA+               P+
Sbjct: 164 NLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221
Query: 238 GDETHVST---------RVMG---TYGYAAPEYV-MTGHLTARSDVYSFGVVLLELLT 282
            D+ ++ T         ++ G   T  Y APE + +  + T   DV+S G +  ELL 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 83
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 144 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 188
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 189 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 245
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 246 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 281
Query: 351 SDV 353
            ++
Sbjct: 282 EEI 284

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 63  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 122
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 123 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 174
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 175 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226
Query: 283 G 283
           G
Sbjct: 227 G 227

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           +G+G FG V+K  +     +V LK      KVL +   +G     L E+  L  L+H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 144 VKLIGYC---------CEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFG 191
           V LI  C         C+     LV++F      G L N L +     +    +M++   
Sbjct: 80  VNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL--- 135
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVM 248
              GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+A              RV+
Sbjct: 136 --NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT 282
            T  Y  PE ++         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           +G+G FG V+K  +     +V LK      KVL +   +G     L E+  L  L+H N+
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 144 VKLIGYC---------CEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFG 191
           V LI  C         C+     LV++F      G L N L +     +    +M++   
Sbjct: 80  VNLIEICRTKASPYNRCKASI-YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL--- 135
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVM 248
              GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+A              RV+
Sbjct: 136 --NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT 282
            T  Y  PE ++         D++  G ++ E+ T
Sbjct: 192 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 65  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 124
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 125 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 176
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 177 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 228
Query: 283 G 283
           G
Sbjct: 229 G 229

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 33/215 (15%)
Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           +G+G FG V+K  +     +V LK      KVL +   +G     L E+  L  L+H N+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 144 VKLIGYC---------CEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFG 191
           V LI  C         C+     LV++F      G L N L +     +    +M++   
Sbjct: 79  VNLIEICRTKASPYNRCKGSI-YLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL--- 134
Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVM 248
              GL ++H  +  +++RD K +N+L+  D   KL+DFGLA+A              RV+
Sbjct: 135 --NGLYYIHRNK--ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 249 GTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLT 282
            T  Y  PE ++         D++  G ++ E+ T
Sbjct: 191 -TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E+   G + +HL R  +   P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+++D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLIIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 70
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 131 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 175
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 176 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 233 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 268
Query: 351 SDV 353
            ++
Sbjct: 269 EEI 271

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E+  +  LRHP LV L     +D+  +++YEFM  G L   +  +    +S    +    
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMR 262
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVM 248
              KGL  +H  E   ++ D K  NI+  +  +   KL DFGL           V+T   
Sbjct: 263 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 317
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           GT  +AAPE      +   +D++S GV+   LL+G
Sbjct: 318 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  +   P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/237 (26%), Positives = 106/237 (44%), Gaps = 27/237 (11%)
Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV 114
           S  ++  Y+  +A S F   T+ K ++    +G G  G V   +   +  +G+    VAV
Sbjct: 2   SHMDSQFYSVQVADSTF---TVLKRYQQLKPIGSGAQGIVCAAF---DTVLGIN---VAV 52
Query: 115 KVLNKEGL-QGH-REWLTEVNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRG 166
           K L++    Q H +    E+  L  + H N++ L+          E     LV E M   
Sbjct: 53  KKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM--- 109
Query: 167 SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL 226
             + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T K+
Sbjct: 110 --DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKI 165
Query: 227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            DFGLA+         + T  + T  Y APE ++        D++S G ++ EL+ G
Sbjct: 166 LDFGLART---ASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  +   P +  +A ++++ F       +
Sbjct: 104 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 158 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 89/181 (49%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ ++  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E++  G + +HL R  +   P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+L+D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 50  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 103
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 104 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 163
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 164 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 208
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 209 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 265
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 266 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTF 301
Query: 351 SDV 353
            ++
Sbjct: 302 EEI 304

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 71
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 132 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 176
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 177 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 234 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 269
Query: 351 SDV 353
            ++
Sbjct: 270 EEI 272

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 71
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 132 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 176
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 177 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 234 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTF 269
Query: 351 SDV 353
            ++
Sbjct: 270 EEI 272

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 98
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 159 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 203
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 204 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 261 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTF 296
Query: 351 SDV 353
            ++
Sbjct: 297 EEI 299

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 17  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 70
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 71  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 130
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 131 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 175
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 176 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 232
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 233 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTF 268
Query: 351 SDV 353
            ++
Sbjct: 269 EEI 271

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 56
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 57  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 117 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 161
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 162 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 219 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 254
Query: 351 SDV 353
            ++
Sbjct: 255 EEI 257

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 18  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 71
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 72  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 131
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 132 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 176
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 177 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 233
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 234 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPXDRPTF 269
Query: 351 SDV 353
            ++
Sbjct: 270 EEI 272

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 90
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 91  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 151 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 195
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 196 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 253 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 288
Query: 351 SDV 353
            ++
Sbjct: 289 EEI 291

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 56
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 57  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 117 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 161
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 162 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 219 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 254
Query: 351 SDV 353
            ++
Sbjct: 255 EEI 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 45  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 98
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 99  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 158
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 159 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 203
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 204 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 260
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 261 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 296
Query: 351 SDV 353
            ++
Sbjct: 297 EEI 299

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 55
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 56  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 115
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 116 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 160
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 161 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 218 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 253
Query: 351 SDV 353
            ++
Sbjct: 254 EEI 256

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 8/155 (5%)
Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E+  +  LRHP LV L     +D+  +++YEFM  G L   +  +    +S    +    
Sbjct: 98  EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMR 156
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVM 248
              KGL  +H  E   ++ D K  NI+  +  +   KL DFGL           V+T   
Sbjct: 157 QVCKGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--- 211
Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           GT  +AAPE      +   +D++S GV+   LL+G
Sbjct: 212 GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 3   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 56
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 57  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 116
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 117 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 161
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 162 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 218
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 219 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 254
Query: 351 SDV 353
            ++
Sbjct: 255 EEI 257

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 2   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 55
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 56  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEEL 115
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 116 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 160
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 161 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 217
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 218 E----------------------EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 253
Query: 351 SDV 353
            ++
Sbjct: 254 EEI 256

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 49  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           LVKL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 156
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     +++DFG AK         V  R     GT  Y A
Sbjct: 157 LHSLD--LIYRDLKPENLMIDQQGYIQVTDFGFAK--------RVKGRTWXLCGTPEYLA 206
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 63  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMF 122
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  +   P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 123 SHLRRIGRFXEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 174
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 175 VTDFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226
Query: 283 G 283
           G
Sbjct: 227 G 227

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V++    ++ + G +    AVK +  E  +     + E+     L  P +V 
Sbjct: 66  VGRGSFGEVHR---MKDKQTGFQ---CAVKKVRLEVFR-----VEELVACAGLSSPRIVP 114
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA-KGLAFLHNAER 204
           L G   E     +  E +  GSL   + +   +P     R +   G A +GL +LH   R
Sbjct: 115 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT--R 169
Query: 205 PVIYRDFKTSNILLDSDYT-AKLSDFGLA---KAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +++ D K  N+LL SD + A L DFG A   +    G        + GT  + APE VM
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                A+ D++S   ++L +L G
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 77/303 (25%), Positives = 128/303 (42%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 1   EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 54
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 55  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 114
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 115 ARS------------FFWQVLEAVRHCHNC--GVLHRDIKDENILIDLNRGELKLIDFG- 159
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G       
Sbjct: 160 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI----- 211
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                        P  +D+    +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 212 -------------PFEHDE----EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTF 252
Query: 351 SDV 353
            ++
Sbjct: 253 EEI 255

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 84
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 145 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 189
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 190 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 83
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 144 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 188
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 189 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 75/303 (24%), Positives = 125/303 (41%), Gaps = 69/303 (22%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 25  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 78
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 79  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 138
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 139 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 183
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKT 290
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G    +  
Sbjct: 184 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 240
Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM 350
                                  +II  R +  +  R + +   L  +CL+  P  RP  
Sbjct: 241 E----------------------EII--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTF 276
Query: 351 SDV 353
            ++
Sbjct: 277 EEI 279

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 84
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 145 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 189
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 190 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 83
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 144 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 188
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 189 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 101/237 (42%), Gaps = 32/237 (13%)
Query: 75  TITKSFRSDYILGEGGFGTV---YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           T+ K +++   +G G  G V   Y   ++ NV +   S P   +   K   +       E
Sbjct: 15  TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-------E 67
Query: 132 VNFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
           +  +  + H N++ L+          E     +V E M     + +L +   + L     
Sbjct: 68  LVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERM 122
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             + +    G+  LH+A   +I+RD K SNI++ SD T K+ DFGLA+    G    ++ 
Sbjct: 123 SYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILDFGLARTA--GTSFMMTP 178
Query: 246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLE------LLTGRKSVDKTRPSKEQ 296
            V+  Y Y APE ++        D++S G ++ E      L  GR  +D+     EQ
Sbjct: 179 YVVTRY-YRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQ 234

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 84
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 145 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 189
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 190 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 31  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 84
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 85  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 144
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 145 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 189
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 190 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 105/233 (45%), Gaps = 45/233 (19%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT- 130
           E E +   ++   +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E    
Sbjct: 30  EKEPLESQYQVGPLLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNG 83
Query: 131 -----EVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHL 172
                EV  L ++      +++L+ +    D  +L+ E        F F   RG+L+  L
Sbjct: 84  TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 143
Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGL 231
            R               +   + +   HN    V++RD K  NIL+D +    KL DFG 
Sbjct: 144 ARS------------FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG- 188
Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
             +G    +T V T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 189 --SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 21/203 (10%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG V++    ++ + G +    AVK +  E  +     + E+     L  P +V 
Sbjct: 82  VGRGSFGEVHR---MKDKQTGFQ---CAVKKVRLEVFR-----VEELVACAGLSSPRIVP 130
Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA-KGLAFLHNAER 204
           L G   E     +  E +  GSL   + +   +P     R +   G A +GL +LH   R
Sbjct: 131 LYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLP---EDRALYYLGQALEGLEYLHT--R 185
Query: 205 PVIYRDFKTSNILLDSDYT-AKLSDFGLA---KAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +++ D K  N+LL SD + A L DFG A   +    G        + GT  + APE VM
Sbjct: 186 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 245
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                A+ D++S   ++L +L G
Sbjct: 246 GKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           L KL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFG AK         V  R     GT  Y A
Sbjct: 158 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 19/224 (8%)
Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           ++ +  F   Y L E   G      +   + + + S   AVK++ K+          EV 
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTCINL-ITSQEYAVKIIEKQPGHIRSRVFREVE 62
Query: 134 FLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGA 192
            L Q + H N+++LI +  E+D   LV+E M  GS+ +H+ ++       A+  ++    
Sbjct: 63  MLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS--VVVQDV 120
Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AKLSDFGLAKA-GPQGDETHVSTRVM 248
           A  L FLHN  + + +RD K  NIL +        K+ DF L       GD + +ST  +
Sbjct: 121 ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 249 ----GTYGYAAPEYVMTGHLTA-----RSDVYSFGVVLLELLTG 283
               G+  Y APE V      A     R D++S GV+L  LL+G
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           L KL     ++ +  +V E+   G + +HL R  + + P +  +A ++++ F       +
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFG AK         V  R     GT  Y A
Sbjct: 158 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y AP  +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R  ++      EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           H N++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 112/281 (39%), Gaps = 34/281 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEVNFLGQLRHPNL 143
           L E   G ++KG    N         + VKVL       +  R++  E   L    HPN+
Sbjct: 18  LNENHSGELWKGRWQGND--------IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNV 69
Query: 144 VKLIGYCCEDD--HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           + ++G C      H  L+  +   GSL N L       +  +  +  A   A+G AFLH 
Sbjct: 70  LPVLGACQSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT 129
Query: 202 AERPVIYRD-FKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
            E P+I R    + ++ +D D TA++S   +  +       +    V        PE   
Sbjct: 130 LE-PLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPE--D 186
Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
           T   +A  D +SF V+L EL+T           +E    D +  ++  K   L+ + P +
Sbjct: 187 TNRRSA--DXWSFAVLLWELVT-----------REVPFADLSNXEIGXK-VALEGLRPTI 232
Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
               S   ++    L   C +++P  RP    +V  LE  Q
Sbjct: 233 PPGISPHVSK----LXKICXNEDPAKRPKFDXIVPILEKXQ 269

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 85/180 (47%), Gaps = 15/180 (8%)
Query: 109 SLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGS 167
           ++  AVK+++K      R+   E+  L +  +HPN++ L     +  +  +V E M  G 
Sbjct: 47  NMEFAVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102
Query: 168 LENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----T 223
           L + + R+       A+ ++  F   K + +LH   + V++RD K SNIL   +     +
Sbjct: 103 LLDKILRQKFFSEREASAVL--FTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPES 158
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            ++ DFG AK      E  +      T  + APE +      A  D++S GV+L  +LTG
Sbjct: 159 IRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 87/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E      +  P LVKL     ++ +  +V E+   G + 
Sbjct: 71  AMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMF 130
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     K
Sbjct: 131 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIK 182
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT  Y APE +++       D ++ GV++ E+  
Sbjct: 183 VADFGFAK--------RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234
Query: 283 G 283
           G
Sbjct: 235 G 235

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 97/208 (46%), Gaps = 32/208 (15%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPN 142
           LG G FG V    + +++  G      A+K+L+K+    L+     L E   L  +  P 
Sbjct: 50  LGTGSFGRVM---LVKHMETGNH---YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR--KATVPLS--WATRMMIAFGAAKGLAF 198
           L KL     ++ +  +V E+   G + +HL R  +   P +  +A ++++ F       +
Sbjct: 104 LTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF------EY 157
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM---GTYGYAA 255
           LH+ +  +IYRD K  N+++D     K++DFG AK         V  R     GT  Y A
Sbjct: 158 LHSLD--LIYRDLKPENLMIDQQGYIKVTDFGFAK--------RVKGRTWXLCGTPEYLA 207
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE +++       D ++ GV++ E+  G
Sbjct: 208 PEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 116/275 (42%), Gaps = 46/275 (16%)
Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR 139
           F    +LG+G FG V K       R  L S   A+K + +   +     L+EV  L  L 
Sbjct: 8   FEEIAVLGQGAFGQVVKA------RNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLN 60
Query: 140 HP-------------NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
           H              N VK +    +     +  E+   G+L + L     +        
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYW 119
Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG------DE 240
            +     + L+++H+  + +I+RD K  NI +D     K+ DFGLAK   +       D 
Sbjct: 120 RLFRQILEALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177
Query: 241 THVS------TRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELL----TGRKSVDK 289
            ++       T  +GT  Y A E +  TGH   + D+YS G++  E++    TG + V+ 
Sbjct: 178 QNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNI 237
Query: 290 TRPSKEQSLV---DWARPKLNDKRKMLQII---DP 318
            +  +  S+    D+   K+  ++K+++++   DP
Sbjct: 238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R  ++      EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           H N++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/208 (29%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR------EWLTEVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R      E   EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           H N++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R  ++      EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           H N++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 113/286 (39%), Gaps = 39/286 (13%)
Query: 71  FELETITKSFRSDYI--LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
            ++  +  S R D++  +G G FG      +   +R  L    VAVK + + G       
Sbjct: 11  LDMPIMHDSDRYDFVKDIGSGNFG------VARLMRDKLTKELVAVKYIER-GAAIDENV 63
Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
             E+     LRHPN+V+         H  ++ E+   G L   +          A     
Sbjct: 64  QREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQ 123
Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTR 246
                 G+++ H+ +  + +RD K  N LLD       K+ DFG +K+     +   +  
Sbjct: 124 QL--LSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 177
Query: 247 VMGTYGYAAPEYVMTGHLTAR-SDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK 305
            +GT  Y APE ++      + +DV+S GV L  +L G    +           D   P+
Sbjct: 178 -VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE-----------DPEEPR 225
Query: 306 LNDKRKMLQIIDPRLENQYS----VRAAQKACSLAYYCLSQNPKAR 347
             D RK +Q I   L  +YS    +R + + C L       +P  R
Sbjct: 226 --DYRKTIQRI---LSVKYSIPDDIRISPECCHLISRIFVADPATR 266

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 89/208 (42%), Gaps = 23/208 (11%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG G F  V K       R     L  A K + K   +  R  ++      EV+ L Q+ 
Sbjct: 20  LGSGQFAIVKK------CREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           H N++ L          +L+ E +  G L + L +K ++    AT  +       G+ +L
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI--LDGVNYL 131
Query: 200 HNAERPVIYRDFKTSNI-LLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           H   + + + D K  NI LLD +      KL DFGLA     G E      + GT  + A
Sbjct: 132 HT--KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF---KNIFGTPEFVA 186
Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTG 283
           PE V    L   +D++S GV+   LL+G
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 26/181 (14%)
Query: 113 AVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE 169
           A+K+L+K+    L+     L E   L  +  P LVKL     ++ +  +V E++  G + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 170 NHLFR--KATVPLS--WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
           +HL R  + + P +  +A ++++ F       +LH+ +  +IYRD K  N+L+D     +
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTF------EYLHSLD--LIYRDLKPENLLIDQQGYIQ 181
Query: 226 LSDFGLAKAGPQGDETHVSTRVM---GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           ++DFG AK         V  R     GT    APE +++       D ++ GV++ E+  
Sbjct: 182 VTDFGFAK--------RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233
Query: 283 G 283
           G
Sbjct: 234 G 234

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 116/279 (41%), Gaps = 47/279 (16%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQL 138
           +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E         EV  L ++
Sbjct: 11  LLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 139 R--HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
                 +++L+ +    D  +L+ E   R      LF   T   +    +  +F      
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILE---RPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 197 AFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           A  H     V++RD K  NIL+D +    KL DFG   +G    +T V T   GT  Y+ 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VYTDFDGTRVYSP 177
Query: 256 PEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           PE++       RS  V+S G++L +++ G    +                         +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------------E 215
Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
           II  R +  +  R + +   L  +CL+  P  RP   ++
Sbjct: 216 II--RGQVFFRQRVSXECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 75/290 (25%), Positives = 123/290 (42%), Gaps = 69/290 (23%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQL 138
           +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E         EV  L ++
Sbjct: 11  LLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 139 R--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHLFRKATVPLSWATR 185
                 +++L+ +    D  +L+ E        F F   RG+L+  L R           
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS---------- 114
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVS 244
               +   + +   HN    V++RD K  NIL+D +    KL DFG   +G    +T V 
Sbjct: 115 --FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VY 166
Query: 245 TRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
           T   GT  Y+ PE++       RS  V+S G++L +++ G                    
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI------------------ 208
Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
           P  +D+    +II  R +  +  R + +   L  +CL+  P  RP   ++
Sbjct: 209 PFEHDE----EII--RGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
           I + +  +  +G G +G V K  + +  R+       A K + K  ++    +  E+  +
Sbjct: 7   INQYYTLENTIGRGSWGEV-KIAVQKGTRIRR-----AAKKIPKYFVEDVDRFKQEIEIM 60
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
             L HPN+++L     ++    LV E    G L   +  K     S A R+M    +A  
Sbjct: 61  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA-- 118
Query: 196 LAFLHNAERPVIYRDFKTSNILL--DS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           +A+ H     V +RD K  N L   DS D   KL DFGLA     G    + T+V GT  
Sbjct: 119 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV-GTPY 173
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +P+ V+ G      D +S GV++  LL G
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 64/287 (22%), Positives = 122/287 (42%), Gaps = 70/287 (24%)
Query: 80  FRSDYILGEGGFGTVYKG---------------YIDENVRVGLKSLPVAVKVLNKEGLQG 124
           F    +LG+G FG V K                + +E +   L  + +   + ++  ++ 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67
Query: 125 HREWLTEVNFLGQL----RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH------LFR 174
           +  WL   NF+  +    +   L   + YC   ++R L Y+ +   +L         LFR
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYC---ENRTL-YDLIHSENLNQQRDEYWRLFR 123
Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           +                  + L+++H+  + +I+RD K  NI +D     K+ DFGLAK 
Sbjct: 124 QIL----------------EALSYIHS--QGIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 235 GPQG------DETHVS------TRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELL 281
             +       D  ++       T  +GT  Y A E +  TGH   + D+YS G++  E++
Sbjct: 166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225
Query: 282 ----TGRKSVDKTRPSKEQSLV---DWARPKLNDKRKMLQII---DP 318
               TG + V+  +  +  S+    D+   K+  ++K+++++   DP
Sbjct: 226 YPFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDP 272

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 94/211 (44%), Gaps = 17/211 (8%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
           I + +  +  +G G +G V K  + +  R+       A K + K  ++    +  E+  +
Sbjct: 24  INQYYTLENTIGRGSWGEV-KIAVQKGTRIRR-----AAKKIPKYFVEDVDRFKQEIEIM 77
Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
             L HPN+++L     ++    LV E    G L   +  K     S A R+M    +A  
Sbjct: 78  KSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSA-- 135
Query: 196 LAFLHNAERPVIYRDFKTSNILL--DS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           +A+ H     V +RD K  N L   DS D   KL DFGLA     G    + T+V GT  
Sbjct: 136 VAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKV-GTPY 190
Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           Y +P+ V+ G      D +S GV++  LL G
Sbjct: 191 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 220

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 71/297 (23%), Positives = 117/297 (39%), Gaps = 49/297 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEGGF      Y+D    +         ++L  E  Q   E   E +      HPN+++
Sbjct: 37  LGEGGFS-----YVDLVEGLHDGHFYALKRILCHEQ-QDREEAQREADMHRLFNHPNILR 90
Query: 146 LIGYCCED----DHRLLVYEFMFRGSLENHLFR---KATVPLSWATRMMIAFGAAKGLAF 198
           L+ YC  +        L+  F  RG+L N + R   K    L+    + +  G  +GL  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEA 149
Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFG---LAKAGPQGDETHVSTRVMG----TY 251
           +H   +   +RD K +NILL  +    L D G    A    +G    ++ +       T 
Sbjct: 150 IH--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 252 GYAAPE-YVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
            Y APE + +  H  +  R+DV+S G VL  ++ G    D      +             
Sbjct: 208 SYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------------ 255
Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQ----NPKARPLMSDVVETLEPLQ 361
                  +   ++NQ S+  + +  S  +  L+     +P  RP +  ++  LE LQ
Sbjct: 256 -------VALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 81/176 (46%), Gaps = 15/176 (8%)
Query: 113 AVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH 171
           AVKV++K      R+   E+  L +  +HPN++ L     +  H  LV E M  G L + 
Sbjct: 56  AVKVIDK----SKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDK 111
Query: 172 LFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAKLS 227
           + R+       A+ ++   G  K + +LH+  + V++RD K SNIL   +       ++ 
Sbjct: 112 ILRQKFFSEREASFVLHTIG--KTVEYLHS--QGVVHRDLKPSNILYVDESGNPECLRIC 167
Query: 228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           DFG AK      E  +      T  + APE +         D++S G++L  +L G
Sbjct: 168 DFGFAKQ--LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 100/220 (45%), Gaps = 45/220 (20%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQL 138
           +LG GGFG+VY G     +RV   +LPVA+K + K+ +    E         EV  L ++
Sbjct: 11  LLGSGGFGSVYSG-----IRVS-DNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 139 R--HPNLVKLIGYCCEDDHRLLVYE--------FMF---RGSLENHLFRKATVPLSWATR 185
                 +++L+ +    D  +L+ E        F F   RG+L+  L R           
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS---------- 114
Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVS 244
               +   + +   HN    V++RD K  NIL+D +    KL DFG   +G    +T V 
Sbjct: 115 --FFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKLIDFG---SGALLKDT-VY 166
Query: 245 TRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTG 283
           T   GT  Y+ PE++       RS  V+S G++L +++ G
Sbjct: 167 TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 206

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 15/180 (8%)
Query: 109 SLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGS 167
           ++  AVKV++K      R+   E+  L +  +HPN++ L     +  H  LV E M  G 
Sbjct: 52  NMEYAVKVIDK----SKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGE 107
Query: 168 LENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----T 223
           L + + R+       A+ ++   G  K + +LH+  + V++RD K SNIL   +      
Sbjct: 108 LLDKILRQKFFSEREASFVLHTIG--KTVEYLHS--QGVVHRDLKPSNILYVDESGNPEC 163
Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            ++ DFG AK      E  +      T  + APE +         D++S G++L  +L G
Sbjct: 164 LRICDFGFAKQ--LRAENGLLMTPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--- 141
           ++G+G FG V K Y D  V        VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGSFGQVVKAY-DHKVHQH-----VALKMVRNEK-RFHRQAAEEIRILEHLRKQDKD 156
Query: 142 ---NLVKLIGYCCEDDHRLLVYEFMFRGSLE---NHLFRKATVPLSWATRMMIAFGAAKG 195
              N++ ++      +H  + +E +     E    + F+  ++PL        A    + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK----FAHSILQC 212
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           L  LH     +I+ D K  NILL     +  K+ DFG +    Q   T + +R      Y
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----Y 265
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE ++        D++S G +L ELLTG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--- 141
           ++G+G FG V K Y D  V        VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGSFGQVVKAY-DHKVHQH-----VALKMVRNEK-RFHRQAAEEIRILEHLRKQDKD 156
Query: 142 ---NLVKLIGYCCEDDHRLLVYEFMFRGSLE---NHLFRKATVPLSWATRMMIAFGAAKG 195
              N++ ++      +H  + +E +     E    + F+  ++PL        A    + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK----FAHSILQC 212
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           L  LH     +I+ D K  NILL     +  K+ DFG +    Q   T + +R      Y
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTXIQSRF-----Y 265
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE ++        D++S G +L ELLTG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 125 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL---ENHLF---RKATV 178
           + ++  E+  +  +++   +   G     D   ++YE+M   S+   + + F   +  T 
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTC 146
Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
            +       I        +++HN E+ + +RD K SNIL+D +   KLSDFG +      
Sbjct: 147 FIPIQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGES------ 199
Query: 239 DETHVSTRVM---GTYGYAAPEYVM--TGHLTARSDVYSFGVVL 277
            E  V  ++    GTY +  PE+    + +  A+ D++S G+ L
Sbjct: 200 -EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 22/228 (9%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK------SLPVAVKVLNKEGLQGH 125
           EL  +   +     +  G +G V  G   E + V +K      S    V +L+   L   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-- 73
Query: 126 REWLTEVNFLGQLRHPNLVKL----IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLS 181
           +  L E+  L    HPN++ L    + +     H+L +   + R  L   +     + +S
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-VIHDQRIVIS 132
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG-PQGDE 240
                   +    GL  LH A   V++RD    NILL  +    + DF LA+      ++
Sbjct: 133 PQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 241 THVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSV 287
           TH  T       Y APE VM     T   D++S G V+ E+   RK++
Sbjct: 191 THYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 92/228 (40%), Gaps = 22/228 (9%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLK------SLPVAVKVLNKEGLQGH 125
           EL  +   +     +  G +G V  G   E + V +K      S    V +L+   L   
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC-- 73
Query: 126 REWLTEVNFLGQLRHPNLVKL----IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLS 181
           +  L E+  L    HPN++ L    + +     H+L +   + R  L   +     + +S
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ-VIHDQRIVIS 132
Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG-PQGDE 240
                   +    GL  LH A   V++RD    NILL  +    + DF LA+      ++
Sbjct: 133 PQHIQYFMYHILLGLHVLHEA--GVVHRDLHPGNILLADNNDITICDFNLAREDTADANK 190
Query: 241 THVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSV 287
           TH  T       Y APE VM     T   D++S G V+ E+   RK++
Sbjct: 191 THYVTH----RWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 85  ILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           ++G+G F  V +    E   +  +K + VA K  +  GL    +   E +    L+HP++
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVA-KFTSSPGLST-EDLKREASICHMLKHPHI 90
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L+     D    +V+EFM    L   + ++A     ++  +   +      A  +  +
Sbjct: 91  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 150
Query: 204 RPVIYRDFKTSNILLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +I+RD K   +LL S   +   KL  FG+A     G+   V+   +GT  + APE V 
Sbjct: 151 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVK 208
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   DV+  GV+L  LL+G
Sbjct: 209 REPYGKPVDVWGCGVILFILLSG 231

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 91/203 (44%), Gaps = 8/203 (3%)
Query: 85  ILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
           ++G+G F  V +    E   +  +K + VA K  +  GL    +   E +    L+HP++
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVA-KFTSSPGLST-EDLKREASICHMLKHPHI 88
Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L+     D    +V+EFM    L   + ++A     ++  +   +      A  +  +
Sbjct: 89  VELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148
Query: 204 RPVIYRDFKTSNILLDSDYTA---KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             +I+RD K   +LL S   +   KL  FG+A     G+   V+   +GT  + APE V 
Sbjct: 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ--LGESGLVAGGRVGTPHFMAPEVVK 206
Query: 261 TGHLTARSDVYSFGVVLLELLTG 283
                   DV+  GV+L  LL+G
Sbjct: 207 REPYGKPVDVWGCGVILFILLSG 229

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 81/176 (46%), Gaps = 15/176 (8%)
Query: 113 AVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH 171
           AVK+++K      R+   E+  L +  +HPN++ L     +  +  +V E    G L + 
Sbjct: 51  AVKIIDK----SKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDK 106
Query: 172 LFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAKLS 227
           + R+       A+ ++  F   K + +LH   + V++RD K SNIL   +     + ++ 
Sbjct: 107 ILRQKFFSEREASAVL--FTITKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRIC 162
Query: 228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           DFG AK      E  +      T  + APE +      A  D++S GV+L   LTG
Sbjct: 163 DFGFAKQ--LRAENGLLXTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           IA    K L  LH ++  VI+RD K SN+L+++    K+ DFG+  +G   D     T  
Sbjct: 158 IAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDSV-AKTID 213
Query: 248 MGTYGYAAPEYV-----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
            G   Y APE +       G+ + +SD++S G+ ++EL   R   D            W 
Sbjct: 214 AGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDS-----------WG 261
Query: 303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
            P     +++++   P+L      + + +       CL +N K RP   ++++
Sbjct: 262 TP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 310

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 106/254 (41%), Gaps = 57/254 (22%)
Query: 82  SDYILGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR- 139
           S+ ILG G  GTV ++G          +  PVAVK +  +        L E+  L +   
Sbjct: 19  SEKILGYGSSGTVVFQG--------SFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 67
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMF------------RGSLENHLFRKATVPLSWATRMM 187
           HPN+++   YC E   R L                    S EN   +K   P+S   ++ 
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 124
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYTAK-----------LSDFGLAKA 234
                A G+A LH+ +  +I+RD K  NIL+   S +TA            +SDFGL K 
Sbjct: 125 -----ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 235 GPQGDETHVST--RVMGTYGYAAPEYVMTGH-------LTARSDVYSFGVVLLELLTGRK 285
              G  +  +      GT G+ APE +   +       LT   D++S G V   +L+  K
Sbjct: 178 LDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 286 SVDKTRPSKEQSLV 299
                + S+E +++
Sbjct: 238 HPFGDKYSRESNII 251

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 103/250 (41%), Gaps = 53/250 (21%)
Query: 82  SDYILGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR- 139
           S+ ILG G  GTV ++G          +  PVAVK +  +        L E+  L +   
Sbjct: 37  SEKILGYGSSGTVVFQG--------SFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 85
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMF------------RGSLENHLFRKATVPLSWATRMM 187
           HPN+++   YC E   R L                    S EN   +K   P+S   ++ 
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 142
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYTAK-----------LSDFGLAKA 234
                A G+A LH+ +  +I+RD K  NIL+   S +TA            +SDFGL K 
Sbjct: 143 -----ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 235 GPQGDETHVST--RVMGTYGYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDK 289
              G            GT G+ APE +       LT   D++S G V   +L+  K    
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 290 TRPSKEQSLV 299
            + S+E +++
Sbjct: 256 DKYSRESNII 265

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 103/250 (41%), Gaps = 53/250 (21%)
Query: 82  SDYILGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR- 139
           S+ ILG G  GTV ++G          +  PVAVK +  +        L E+  L +   
Sbjct: 37  SEKILGYGSSGTVVFQG--------SFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 85
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMF------------RGSLENHLFRKATVPLSWATRMM 187
           HPN+++   YC E   R L                    S EN   +K   P+S   ++ 
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 142
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYTAK-----------LSDFGLAKA 234
                A G+A LH+ +  +I+RD K  NIL+   S +TA            +SDFGL K 
Sbjct: 143 -----ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 195
Query: 235 GPQGDETHVST--RVMGTYGYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDK 289
              G            GT G+ APE +       LT   D++S G V   +L+  K    
Sbjct: 196 LDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 255
Query: 290 TRPSKEQSLV 299
            + S+E +++
Sbjct: 256 DKYSRESNII 265

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 25/173 (14%)
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           IA    K L  LH ++  VI+RD K SN+L+++    K+ DFG+  +G   D+       
Sbjct: 114 IAVSIVKALEHLH-SKLSVIHRDVKPSNVLINALGQVKMCDFGI--SGYLVDDVAKDIDA 170
Query: 248 MGTYGYAAPEYV-----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
            G   Y APE +       G+ + +SD++S G+ ++EL   R   D            W 
Sbjct: 171 -GCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDS-----------WG 217
Query: 303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
            P     +++++   P+L      + + +       CL +N K RP   ++++
Sbjct: 218 TP-FQQLKQVVEEPSPQLPAD---KFSAEFVDFTSQCLKKNSKERPTYPELMQ 266

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 62/250 (24%), Positives = 100/250 (40%), Gaps = 52/250 (20%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----------------QGHRE 127
           ++G G FG V        V++       A+K+LNK  +                  G  +
Sbjct: 81  VIGRGAFGEV------AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134
Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           W+T +++  Q  + NL  ++ Y    D   L+ +F  R   E   F        +   M+
Sbjct: 135 WITTLHYAFQDDN-NLYLVMDYYVGGDLLTLLSKFEDRLPEEMARF--------YLAEMV 185
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           IA  +   L ++H        RD K  NIL+D +   +L+DFG +      D T  S+  
Sbjct: 186 IAIDSVHQLHYVH--------RDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVA 236
Query: 248 MGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
           +GT  Y +PE +       G      D +S GV + E+L G        P   +SLV+  
Sbjct: 237 VGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET------PFYAESLVETY 290
Query: 303 RPKLNDKRKM 312
              +N K + 
Sbjct: 291 GKIMNHKERF 300

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 29/210 (13%)
Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--- 141
           ++G+G FG V K Y D  V        VA+K++  E  + HR+   E+  L  LR     
Sbjct: 104 VIGKGXFGQVVKAY-DHKVHQH-----VALKMVRNEK-RFHRQAAEEIRILEHLRKQDKD 156
Query: 142 ---NLVKLIGYCCEDDHRLLVYEFMFRGSLE---NHLFRKATVPLSWATRMMIAFGAAKG 195
              N++ ++      +H  + +E +     E    + F+  ++PL        A    + 
Sbjct: 157 NTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRK----FAHSILQC 212
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           L  LH     +I+ D K  NILL     +  K+ DFG +    Q     + +R      Y
Sbjct: 213 LDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQSRF-----Y 265
Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE ++        D++S G +L ELLTG
Sbjct: 266 RAPEVILGARYGMPIDMWSLGCILAELLTG 295

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/149 (28%), Positives = 63/149 (42%), Gaps = 10/149 (6%)
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRHPN+V+         H  +V E+   G L   +          A           G++
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS 129
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           + H  +  V +RD K  N LLD       K++DFG +KA     +       +GT  Y A
Sbjct: 130 YAHAMQ--VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQ---PKSAVGTPAYIA 184
Query: 256 PEYVMTGHLTAR-SDVYSFGVVLLELLTG 283
           PE ++      + +DV+S GV L  +L G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 123/307 (40%), Gaps = 84/307 (27%)
Query: 73  LETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           LET +K +     LG G FG V + + I+   R  LK +           LQ  R    E
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKV-----------LQDPRYKNRE 50
Query: 132 VNFLGQLRHPNLVKLIGYCC------------EDDHRLL--------------------- 158
           ++ +  L H N++KL+ Y               DDH  L                     
Sbjct: 51  LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110
Query: 159 -----VYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRD 210
                + E++       L++ +    ++P++  +  +  +   + + F+H+    + +RD
Sbjct: 111 KYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLIS--IYIYQLFRAVGFIHSLG--ICHRD 166
Query: 211 FKTSNILLDS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARS 268
            K  N+L++S D T KL DFG AK   +   +  S   + +  Y APE ++     T   
Sbjct: 167 IKPQNLLVNSKDNTLKLCDFGSAK---KLIPSEPSVAXICSRFYRAPELMLGATEYTPSI 223
Query: 269 DVYSFGVVLLELLTGRK------SVDKT--------RPSKEQSL--------VDWARPKL 306
           D++S G V  EL+ G+       S+D+          P+KEQ +        V +   K 
Sbjct: 224 DLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKA 283
Query: 307 NDKRKML 313
            D RK+L
Sbjct: 284 KDWRKIL 290

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 56/207 (27%), Positives = 87/207 (42%), Gaps = 25/207 (12%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---------EVNFLG 136
           LG G FG V+     E      K+  V VK + KE +     W+          E+  L 
Sbjct: 32  LGSGAFGFVWTAVDKE------KNKEVVVKFIKKEKVL-EDCWIEDPKLGKVTLEIAILS 84
Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKG 195
           ++ H N++K++          LV E    G  L   + R   +    A+ +     +A G
Sbjct: 85  RVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
              L +    +I+RD K  NI++  D+T KL DFG A    +G    +     GT  Y A
Sbjct: 145 YLRLKD----IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG---KLFYTFCGTIEYCA 197
Query: 256 PEYVMTG-HLTARSDVYSFGVVLLELL 281
           PE +M   +     +++S GV L  L+
Sbjct: 198 PEVLMGNPYRGPELEMWSLGVTLYTLV 224

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 81/309 (26%), Positives = 125/309 (40%), Gaps = 52/309 (16%)
Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-----EGLQGHREWLTEVNFLGQLRH 140
           LGEG FG V +  ID   + G +   VAVK++       E  +   + L  +N       
Sbjct: 22  LGEGAFGKVVEC-IDH--KAGGRH--VAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNST 76
Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKAT--VPLSWATRMMIAFGAAKGLAF 198
              V+++ +     H  +V+E +    L  + F K    +P        +A+   K + F
Sbjct: 77  FRCVQMLEWFEHHGHICIVFELL---GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNF 133
Query: 199 LHNAERPVIYRDFKTSNIL-LDSDYTA------------------KLSDFGLAKAGPQGD 239
           LH+ +  + + D K  NIL + SDYT                   K+ DFG A    +  
Sbjct: 134 LHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH 191
Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ--- 296
            T VSTR      Y APE ++    +   DV+S G +L+E   G  +V  T  SKE    
Sbjct: 192 STLVSTR-----HYRAPEVILALGWSQPCDVWSIGCILIEYYLGF-TVFPTHDSKEHLAM 245
Query: 297 ---SLVDWARPKLNDKRKMLQIIDPRL---ENQYSVRAAQKACS-LAYYCLSQNPKARPL 349
               L    +  +   RK       RL   E+  + R   +AC  L  + LSQ+ +   L
Sbjct: 246 MERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERL 305
Query: 350 MSDVVETLE 358
              + + LE
Sbjct: 306 FDLIQKMLE 314

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/254 (27%), Positives = 104/254 (40%), Gaps = 57/254 (22%)
Query: 82  SDYILGEGGFGTV-YKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR- 139
           S+ ILG G  GTV ++G          +  PVAVK +  +        L E+  L +   
Sbjct: 19  SEKILGYGSSGTVVFQG--------SFQGRPVAVKRMLIDFCDIA---LMEIKLLTESDD 67
Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMF------------RGSLENHLFRKATVPLSWATRMM 187
           HPN+++   YC E   R L                    S EN   +K   P+S   ++ 
Sbjct: 68  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 124
Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYTAK-----------LSDFGLAKA 234
                A G+A LH+ +  +I+RD K  NIL+   S +TA            +SDFGL K 
Sbjct: 125 -----ASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177
Query: 235 GPQGDETHVST--RVMGTYGYAAPEYVMTGH-------LTARSDVYSFGVVLLELLTGRK 285
              G            GT G+ APE +   +       LT   D++S G V   +L+  K
Sbjct: 178 LDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGK 237
Query: 286 SVDKTRPSKEQSLV 299
                + S+E +++
Sbjct: 238 HPFGDKYSRESNII 251

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 76  ITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           +   FR    +G G FG +Y G  I  N  V +K   V  K         H + L E   
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK---------HPQLLYESKI 55
Query: 135 LGQLRH----PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
              L+     PN V+  G   E D+ +LV + +   SLE+ LF   +  LS  T +M+A 
Sbjct: 56  YRILQGGTGIPN-VRWFG--VEGDYNVLVMD-LLGPSLED-LFNFCSRKLSLKTVLMLAD 110
Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK---LSDFGLAKA-GPQGDETHVSTR 246
                + F+H+  +  ++RD K  N L+     A    + DFGLAK         H+  R
Sbjct: 111 QMINRVEFVHS--KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYR 168
Query: 247 ----VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
               + GT  YA+    +    + R D+ S G VL+  L G
Sbjct: 169 ENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRG 209

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 10/149 (6%)
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRHPN+V+         H  +V E+   G L   +          A           G++
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS 129
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           + H  +  V +RD K  N LLD       K+ DFG +K+     +       +GT  Y A
Sbjct: 130 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIA 184
Query: 256 PEYVMTGHLTAR-SDVYSFGVVLLELLTG 283
           PE ++      + +DV+S GV L  +L G
Sbjct: 185 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 213

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/149 (27%), Positives = 62/149 (41%), Gaps = 10/149 (6%)
Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRHPN+V+         H  +V E+   G L   +          A           G++
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL--ISGVS 128
Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           + H  +  V +RD K  N LLD       K+ DFG +K+     +       +GT  Y A
Sbjct: 129 YCHAMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIA 183
Query: 256 PEYVMTGHLTAR-SDVYSFGVVLLELLTG 283
           PE ++      + +DV+S GV L  +L G
Sbjct: 184 PEVLLKKEYDGKVADVWSCGVTLYVMLVG 212

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 29/92 (31%), Positives = 49/92 (53%), Gaps = 8/92 (8%)
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQGDETHVSTRVMGT 250
           +G+ +LH  +  +++ D K  NILL S Y     K+ DFG+++      E      +MGT
Sbjct: 142 EGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR---EIMGT 196
Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
             Y APE +    +T  +D+++ G++   LLT
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 50/101 (49%), Gaps = 15/101 (14%)
Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG------DETHVS--- 244
           + L+++H+  + +I+R+ K  NI +D     K+ DFGLAK   +       D  ++    
Sbjct: 127 EALSYIHS--QGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 245 ---TRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELL 281
              T  +GT  Y A E +  TGH   + D YS G++  E +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/256 (23%), Positives = 102/256 (39%), Gaps = 62/256 (24%)
Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------- 122
           E++   + F    ++G G FG V    +    R+       A+K+LNK  +         
Sbjct: 68  EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERI------YAMKILNKWEMLKRAETACF 121
Query: 123 --------QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFR 174
                    G  +W+T +++  Q              +++H  LV ++   G L   L +
Sbjct: 122 REERDVLVNGDCQWITALHYAFQ--------------DENHLYLVMDYYVGGDLLTLLSK 167
Query: 175 -KATVPLSWAT----RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF 229
            +  +P   A      M++A  +   L ++H        RD K  N+LLD +   +L+DF
Sbjct: 168 FEDKLPEDMARFYIGEMVLAIDSIHQLHYVH--------RDIKPDNVLLDVNGHIRLADF 219
Query: 230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGR 284
           G +      D T  S+  +GT  Y +PE +       G      D +S GV + E+L G 
Sbjct: 220 G-SCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278
Query: 285 KSVDKTRPSKEQSLVD 300
                  P   +SLV+
Sbjct: 279 T------PFYAESLVE 288
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	431
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	0.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-179
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-149
3soc_A	322	Activin receptor type-2A; structural genomics cons	9e-90
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-69
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	9e-69
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	2e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-64
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-63
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-61
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	2e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-60
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-60
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	9e-60
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-59
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-58
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-57
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-45
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-45
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-45
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-44
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-44
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-44
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-43
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-41
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-41
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-40
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-40
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-40
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-40
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-40
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-40
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	9e-40
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-39
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-39
2a19_B	284	Interferon-induced, double-stranded RNA-activated	3e-39
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-39
4aoj_A	329	High affinity nerve growth factor receptor; transf	5e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-39
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-39
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	8e-39
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-38
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-38
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-38
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	8e-38
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-37
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-37
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-37
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-37
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-36
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-36
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-36
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	8e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-35
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-35
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-35
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-35
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-35
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	9e-35
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-34
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-34
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-34
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-34
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-34
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-33
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-33
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-33
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-33
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-33
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	8e-33
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-32
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-32
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	8e-32
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-31
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-31
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-31
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-30
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	9e-30
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	5e-29
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	6e-29
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-28
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-28
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-28
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-28
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	9e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-27
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	9e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	9e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-26
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-26
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-26
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	5e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	6e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-26
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	8e-26
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-25
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-25
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-25
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-25
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-25
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	6e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-24
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-24
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-24
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-24
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-24
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-24
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-24
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-24
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-24
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-24
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-24
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-24
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	6e-24
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	9e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-23
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-23
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-23
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	7e-23
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	8e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-22
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-06
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-22
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-22
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	3e-22
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-22
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-22
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	7e-22
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-22
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-21
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-21
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-21
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-21
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-21
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-20
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-20
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	7e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-19
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-18
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-17
3uqc_A	286	Probable conserved transmembrane protein; structur	2e-17
3rp9_A	458	Mitogen-activated protein kinase; structural genom	5e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-17
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	9e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-16
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-16
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	9e-16
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-15
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-15
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-15
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	3e-14
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	3e-13
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	5e-13
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	5e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	9e-11
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-09
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-09
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-05

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  517 bits (1335), Expect = 0.0
 Identities = 114/321 (35%), Positives = 180/321 (56%), Gaps = 25/321 (7%)

Query: 54  DSRKNAVLYTHVIAFSLFELETITKSFRSDY------ILGEGGFGTVYKGYIDENVRVGL 107
           +++   V  T   +FS +EL+ +T +F           +GEGGFG VYKGY++       
Sbjct: 1   ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT----- 55

Query: 108 KSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM 163
               VAVK L    +    +  +++  E+  + + +H NLV+L+G+  + D   LVY +M
Sbjct: 56  ---TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112

Query: 164 FRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY 222
             GSL + L     T PLSW  R  IA GAA G+ FLH  E   I+RD K++NILLD  +
Sbjct: 113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH--ENHHIHRDIKSANILLDEAF 170

Query: 223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           TAK+SDFGLA+A  +  +T +++R++GT  Y APE  + G +T +SD+YSFGVVLLE++T
Sbjct: 171 TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIIT 229

Query: 283 GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQ 342
           G  +VD+ R    Q L+D      ++++ +   ID ++ +     + +   S+A  CL +
Sbjct: 230 GLPAVDEHRE--PQLLLDIKEEIEDEEKTIEDYIDKKMND-ADSTSVEAMYSVASQCLHE 286

Query: 343 NPKARPLMSDVVETLEPLQCA 363
               RP +  V + L+ +  +
Sbjct: 287 KKNKRPDIKKVQQLLQEMTAS 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  502 bits (1295), Expect = e-179
 Identities = 120/320 (37%), Positives = 184/320 (57%), Gaps = 13/320 (4%)

Query: 41  SDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYID 100
           S  S  +   N +    + ++        L +LE  T +F   +++G G FG VYKG + 
Sbjct: 3   SKYSKATNSIN-DALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR 61

Query: 101 ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVY 160
           +          VA+K    E  QG  E+ TE+  L   RHP+LV LIG+C E +  +L+Y
Sbjct: 62  DGA-------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIY 114

Query: 161 EFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL 218
           ++M  G+L+ HL+     T+ +SW  R+ I  GAA+GL +LH   R +I+RD K+ NILL
Sbjct: 115 KYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH--TRAIIHRDVKSINILL 172

Query: 219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 278
           D ++  K++DFG++K G + D+TH+ST V GT GY  PEY + G LT +SDVYSFGVVL 
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 279 ELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY 338
           E+L  R ++ ++ P +  +L +WA     +  ++ QI+DP L ++    + +K    A  
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESLRKFGDTAVK 291

Query: 339 CLSQNPKARPLMSDVVETLE 358
           CL+ + + RP M DV+  LE
Sbjct: 292 CLALSSEDRPSMGDVLWKLE 311

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  425 bits (1094), Expect = e-149
 Identities = 119/297 (40%), Positives = 175/297 (58%), Gaps = 15/297 (5%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-R 126
           FSL EL+  + +F +  ILG GGFG VYKG + +   V       AVK L +E  QG   
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLV-------AVKRLKEERTQGGEL 72

Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF--RKATVPLSWAT 184
           ++ TEV  +    H NL++L G+C     RLLVY +M  GS+ + L    ++  PL W  
Sbjct: 73  QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPK 132

Query: 185 RMMIAFGAAKGLAFLHNAERP-VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
           R  IA G+A+GLA+LH+   P +I+RD K +NILLD ++ A + DFGLAK     D THV
Sbjct: 133 RQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD-THV 191

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS--LVDW 301
           +T V GT G+ APEY+ TG  + ++DV+ +GV+LLEL+TG+++ D  R + +    L+DW
Sbjct: 192 TTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDW 251

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
            +  L +K+ +  ++D  L+  Y     ++   +A  C   +P  RP MS+VV  LE
Sbjct: 252 VKGLLKEKK-LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  274 bits (702), Expect = 9e-90
 Identities = 77/318 (24%), Positives = 122/318 (38%), Gaps = 38/318 (11%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE 127
                L   +   +   +   G FG V+K  +            VAVK+      Q  + 
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE--------YVAVKIFPI---QDKQS 62

Query: 128 WL--TEVNFLGQLRHPNLVKLIGYCCEDDH----RLLVYEFMFRGSLENHLFRKATVPLS 181
           W    EV  L  ++H N+++ IG             L+  F  +GSL + L       +S
Sbjct: 63  WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN---VVS 119

Query: 182 WATRMMIAFGAAKGLAFLHNAER--------PVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
           W     IA   A+GLA+LH             + +RD K+ N+LL ++ TA ++DFGLA 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-----TARSDVYSFGVVLLELLTGRKSVD 288
               G     +   +GT  Y APE +            R D+Y+ G+VL EL +   + D
Sbjct: 180 KFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

Query: 289 KTRPSKEQSLVD--WARPKLNDKRKM--LQIIDPRLENQYSVRAAQKA-CSLAYYCLSQN 343
                      +     P L D +++   +   P L + +   A     C     C   +
Sbjct: 240 GPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHD 299

Query: 344 PKARPLMSDVVETLEPLQ 361
            +AR     V E +  +Q
Sbjct: 300 AEARLSAGCVGERITQMQ 317

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  221 bits (564), Expect = 3e-69
 Identities = 87/334 (26%), Positives = 148/334 (44%), Gaps = 45/334 (13%)

Query: 35  KHNRSISDLSDPSTPRNLEDSRKNAVLYTHV-IAFSLFELETITKSFRSDYILGEGGFGT 93
           KH+     +SD   P       + A+    + I +    ++           +G G FGT
Sbjct: 2   KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEK---------IGAGSFGT 52

Query: 94  VYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNLVKLIGYCC 151
           V++               VAVK+L ++        E+L EV  + +LRHPN+V  +G   
Sbjct: 53  VHRAE--------WHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT 104

Query: 152 EDDHRLLVYEFMFRGSLENHLFRKAT-VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRD 210
           +  +  +V E++ RGSL   L +      L    R+ +A+  AKG+ +LHN   P+++R+
Sbjct: 105 QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRN 164

Query: 211 FKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDV 270
            K+ N+L+D  YT K+ DFGL++       +  S    GT  + APE +       +SDV
Sbjct: 165 LKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPEWMAPEVLRDEPSNEKSDV 222

Query: 271 YSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI---IDPRLENQYSVR 327
           YSFGV+L EL T ++      P    +            ++ L+I   ++P++       
Sbjct: 223 YSFGVILWELATLQQ------PWGNLNPAQVVAAVGFKCKR-LEIPRNLNPQVAA----- 270

Query: 328 AAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
                  +   C +  P  RP  + +++ L PL 
Sbjct: 271 -------IIEGCWTNEPWKRPSFATIMDLLRPLI 297

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  220 bits (562), Expect = 9e-69
 Identities = 70/343 (20%), Positives = 125/343 (36%), Gaps = 49/343 (14%)

Query: 66  IAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH 125
           +  +  E      + +   ++G G +G VYKG         L   PVAVKV +       
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGS--------LDERPVAVKVFSF---ANR 49

Query: 126 REWLTEVN--FLGQLRHPNLVKLIGYCCEDD-----HRLLVYEFMFRGSLENHLFRKATV 178
           + ++ E N   +  + H N+ + I              LLV E+   GSL  +L      
Sbjct: 50  QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH--- 106

Query: 179 PLSWATRMMIAFGAAKGLAFLHN-------AERPVIYRDFKTSNILLDSDYTAKLSDFGL 231
              W +   +A    +GLA+LH         +  + +RD  + N+L+ +D T  +SDFGL
Sbjct: 107 TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL 166

Query: 232 AK------AGPQGDETHVSTRVMGTYGYAAPEYVM-------TGHLTARSDVYSFGVVLL 278
           +           G+E + +   +GT  Y APE +              + D+Y+ G++  
Sbjct: 167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYW 226

Query: 279 ELLTGRKSVDKTRPSKEQSL----VDWARPKLNDKRKM--LQIIDPRLENQYSV--RAAQ 330
           E+      +       E  +         P   D + +   +   P+    +     A +
Sbjct: 227 EIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVR 286

Query: 331 KACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSS 373
                   C  Q+ +AR       E +  L    +    +S +
Sbjct: 287 SLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  209 bits (534), Expect = 2e-65
 Identities = 65/288 (22%), Positives = 111/288 (38%), Gaps = 46/288 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
            L E   G ++KG          +   + VKVL          R++  E   L    HPN
Sbjct: 17  KLNENHSGELWKGR--------WQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68

Query: 143 LVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           ++ ++G C      H  L+  +M  GSL N L       +  +  +  A   A+G+AFLH
Sbjct: 69  VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH 128

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
             E  +      + ++++D D TA++S   +         +  S   M    + APE  +
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKF-------SFQSPGRMYAPAWVAPE-AL 180

Query: 261 TG----HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI- 315
                      +D++SF V+L EL+T         P  + S ++       +  +   I 
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREV------PFADLSNMEIGMKVALEGLR-PTIP 233

Query: 316 --IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
             I P +              L   C++++P  RP    +V  LE +Q
Sbjct: 234 PGISPHV------------SKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  208 bits (532), Expect = 2e-64
 Identities = 82/312 (26%), Positives = 137/312 (43%), Gaps = 50/312 (16%)

Query: 64  HVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ 123
           H+I +   E+E +         +G G FG V K           ++  VA+K +  E  +
Sbjct: 3   HMIDYKEIEVEEV---------VGRGAFGVVCKAK--------WRAKDVAIKQIESESER 45

Query: 124 GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP-LSW 182
             + ++ E+  L ++ HPN+VKL G C   +   LV E+   GSL N L     +P  + 
Sbjct: 46  --KAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTA 101

Query: 183 ATRMMIAFGAAKGLAFLHNAE-RPVIYRDFKTSNILLDSDYT-AKLSDFGLAKAGPQGDE 240
           A  M      ++G+A+LH+ + + +I+RD K  N+LL +  T  K+ DFG A      D 
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DI 156

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD 300
               T   G+  + APE     + + + DV+S+G++L E++T RK      P  E     
Sbjct: 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK------PFDEIGGPA 210

Query: 301 WARPKLNDKRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 357
           +             +I      +E+            L   C S++P  RP M ++V+ +
Sbjct: 211 FRIMWAVHNGTRPPLIKNLPKPIES------------LMTRCWSKDPSQRPSMEEIVKIM 258

Query: 358 EPLQCANDGGNE 369
             L     G +E
Sbjct: 259 THLMRYFPGADE 270

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  204 bits (522), Expect = 2e-63
 Identities = 80/296 (27%), Positives = 131/296 (44%), Gaps = 54/296 (18%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGH-------REWLTEVNFLG 136
            +G+GGFG V+KG  + +          VA+K L     +G        +E+  EV  + 
Sbjct: 26  QIGKGGFGLVHKGRLVKDKS-------VVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            L HPN+VKL G         +V EF+  G L + L      P+ W+ ++ +    A G+
Sbjct: 79  NLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRL-LDKAHPIKWSVKLRLMLDIALGI 135

Query: 197 AFLHNAERPVIYRDFKTSNILLDS-----DYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
            ++ N   P+++RD ++ NI L S        AK++DFGL++        H  + ++G +
Sbjct: 136 EYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-----QSVHSVSGLLGNF 190

Query: 252 GYAAPEYVMTG---HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA----RP 304
            + APE  +       T ++D YSF ++L  +LTG    D+    K + +        RP
Sbjct: 191 QWMAPE-TIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP 249

Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
            + +         PRL N            +   C S +PK RP  S +V+ L  L
Sbjct: 250 TIPED------CPPRLRN------------VIELCWSGDPKKRPHFSYIVKELSEL 287

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  201 bits (513), Expect = 1e-61
 Identities = 67/304 (22%), Positives = 114/304 (37%), Gaps = 42/304 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG   K    E   V      + +K L +   +  R +L EV  +  L HPN++K
Sbjct: 18  LGKGCFGQAIKVTHRETGEV------MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            IG   +D     + E++  G+L   + +       W+ R+  A   A G+A+LH     
Sbjct: 72  FIGVLYKDKRLNFITEYIKGGTLRGII-KSMDSQYPWSQRVSFAKDIASGMAYLH--SMN 128

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAK------------AGPQGDETHVSTRVMGTYGY 253
           +I+RD  + N L+  +    ++DFGLA+               +  +      V+G   +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW---ARPKLNDKR 310
            APE +       + DV+SFG+VL E++    +     P      ++             
Sbjct: 189 MAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN- 247

Query: 311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEI 370
                  P                +   C   +P+ RP    +   LE L+    G   +
Sbjct: 248 -----CPPSFFP------------ITVRCCDLDPEKRPSFVKLEHWLETLRMHLAGHLPL 290

Query: 371 SSSL 374
              L
Sbjct: 291 GPQL 294

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (504), Expect = 1e-60
 Identities = 75/282 (26%), Positives = 122/282 (43%), Gaps = 32/282 (11%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
           +G G FGTVYKG +  +          VAVK+LN         + +  EV  L + RH N
Sbjct: 32  IGSGSFGTVYKGKWHGD----------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           ++  +G         +V ++    SL +HL   +         + IA   A+G+ +LH  
Sbjct: 82  ILLFMG-YSTAPQLAIVTQWCEGSSLYHHL-HASETKFEMKKLIDIARQTARGMDYLHA- 138

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE---YV 259
            + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + APE     
Sbjct: 139 -KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
            +   + +SDVY+FG+VL EL+TG+       P    +  D     +        +   R
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMVGRGSLSPDLSKVR 251

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
                 ++       L   CL +    RP    ++  +E L 
Sbjct: 252 SNCPKRMK------RLMAECLKKKRDERPSFPRILAEIEELA 287

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  197 bits (503), Expect = 6e-60
 Identities = 73/322 (22%), Positives = 125/322 (38%), Gaps = 40/322 (12%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
            L    TI K  +    +G+G +G V+ G          +   VAVKV           W
Sbjct: 28  PLLVQRTIAKQIQMVKQIGKGRYGEVWMGK--------WRGEKVAVKVFFT---TEEASW 76

Query: 129 L--TEVNFLGQLRHPNLVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSW 182
              TE+     +RH N++  I    +         L+ ++   GSL ++L       L  
Sbjct: 77  FRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDA 133

Query: 183 ATRMMIAFGAAKGLAFLH------NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
            + + +A+ +  GL  LH        +  + +RD K+ NIL+  + T  ++D GLA    
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

Query: 237 QGDETH--VSTRVMGTYGYAAPEYVMTGHLTA-------RSDVYSFGVVLLELLTGRKSV 287
                        +GT  Y  PE V+   L          +D+YSFG++L E+     S 
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSG 252

Query: 288 DKTRPSKE-QSLVDWARPKLNDKRKM--LQIIDPRLENQYSVRAAQKA-CSLAYYCLSQN 343
                 +     +  + P   D R++  ++ + P   N++S     +    L   C + N
Sbjct: 253 GIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHN 312

Query: 344 PKARPLMSDVVETLEPLQCAND 365
           P +R     V +TL  +  + D
Sbjct: 313 PASRLTALRVKKTLAKMSESQD 334

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  195 bits (497), Expect = 9e-60
 Identities = 78/292 (26%), Positives = 124/292 (42%), Gaps = 50/292 (17%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH----REWLTEVNFLGQLRH 140
           I+G GGFG VY+ +             VAVK    +  +           E      L+H
Sbjct: 14  IIGIGGFGKVYRAF--------WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           PN++ L G C ++ +  LV EF   G L   L  K    +     +  A   A+G+ +LH
Sbjct: 66  PNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQIARGMNYLH 122

Query: 201 N-AERPVIYRDFKTSNILLD--------SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           + A  P+I+RD K+SNIL+         S+   K++DFGLA+   +   T   +   G Y
Sbjct: 123 DEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAA-GAY 178

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK 311
            + APE +     +  SDV+S+GV+L ELLTG        P +    +  A     +K  
Sbjct: 179 AWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEV------PFRGIDGLAVAYGVAMNKLA 232

Query: 312 MLQI---IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           +  I                      L   C + +P +RP  +++++ L  +
Sbjct: 233 L-PIPSTCPEPFAK------------LMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  195 bits (497), Expect = 3e-59
 Identities = 71/347 (20%), Positives = 127/347 (36%), Gaps = 70/347 (20%)

Query: 37  NRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYK 96
             ++S LS  S PR    +      +   I F   E+  +         +G+G FG VY 
Sbjct: 3   EMNLSLLSARSFPRKASQTSIFLQEWD--IPFEQLEIGEL---------IGKGRFGQVYH 51

Query: 97  G-YIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNLVKLIGYCCED 153
           G +  E          VA+++++ E       + +  EV    Q RH N+V  +G C   
Sbjct: 52  GRWHGE----------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP 101

Query: 154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT 213
            H  ++       +L + + R A + L       IA    KG+ +LH   + ++++D K+
Sbjct: 102 PHLAIITSLCKGRTLYSVV-RDAKIVLDVNKTRQIAQEIVKGMGYLHA--KGILHKDLKS 158

Query: 214 SNILLDSDYTAKLSDFGLAK---AGPQGDETHVSTRVMGTYGYAAPEYVMTG-------- 262
            N+  D +    ++DFGL         G          G   + APE +           
Sbjct: 159 KNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDK 217

Query: 263 -HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL--VDWA-----RPKLNDKRKMLQ 314
              +  SDV++ G +  EL           P K Q    + W      +P L+       
Sbjct: 218 LPFSKHSDVFALGTIWYELHAREW------PFKTQPAEAIIWQMGTGMKPNLSQIG---- 267

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
            +   + +            +  +C +   + RP  + +++ LE L 
Sbjct: 268 -MGKEISD------------ILLFCWAFEQEERPTFTKLMDMLEKLP 301

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  192 bits (491), Expect = 1e-58
 Identities = 75/313 (23%), Positives = 121/313 (38%), Gaps = 42/313 (13%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL--TE 131
            T+ +       +G+G +G V++G          +   VAVK+ +    +  + W   TE
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGS--------WQGENVAVKIFSS---RDEKSWFRETE 52

Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHR----LLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
           +     LRH N++  I       H      L+  +   GSL ++L       L   + + 
Sbjct: 53  LYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLR 109

Query: 188 IAFGAAKGLAFLH------NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
           I    A GLA LH        +  + +RD K+ NIL+  +    ++D GLA    Q    
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQ 169

Query: 242 HV--STRVMGTYGYAAPEYVMTGHL-------TARSDVYSFGVVLLELLTGRKSVDKTRP 292
               +   +GT  Y APE V+   +         R D+++FG+VL E+     S      
Sbjct: 170 LDVGNNPRVGTKRYMAPE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228

Query: 293 SKE--QSLVDWARPKLNDKRKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQNPKAR 347
            K     +V    P   D RK++ +   R       +S         L   C  QNP AR
Sbjct: 229 YKPPFYDVVP-NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSAR 287

Query: 348 PLMSDVVETLEPL 360
                + +TL  +
Sbjct: 288 LTALRIKKTLTKI 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  191 bits (488), Expect = 1e-57
 Identities = 76/318 (23%), Positives = 128/318 (40%), Gaps = 42/318 (13%)

Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
           L    TI ++      +G+G FG V++G          +   VAVK+ +    +  R W 
Sbjct: 34  LLVQRTIARTIVLQESIGKGRFGEVWRGK--------WRGEEVAVKIFSS---REERSWF 82

Query: 130 TE--VNFLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWA 183
            E  +     LRH N++  I    +D+       LV ++   GSL ++L R     ++  
Sbjct: 83  REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVE 139

Query: 184 TRMMIAFGAAKGLAFLH------NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 237
             + +A   A GLA LH        +  + +RD K+ NIL+  + T  ++D GLA     
Sbjct: 140 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS 199

Query: 238 GDETH--VSTRVMGTYGYAAPEYVMTGHL-------TARSDVYSFGVVLLELLTGRKSVD 288
             +T        +GT  Y APE V+   +         R+D+Y+ G+V  E+   R S+ 
Sbjct: 200 ATDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIAR-RCSIG 257

Query: 289 KTRPSKEQ--SLVDWARPKLNDKRKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQN 343
                 +     +  + P + + RK++     R        S  A +    +   C   N
Sbjct: 258 GIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYAN 317

Query: 344 PKARPLMSDVVETLEPLQ 361
             AR     + +TL  L 
Sbjct: 318 GAARLTALRIKKTLSQLS 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  160 bits (407), Expect = 2e-45
 Identities = 72/284 (25%), Positives = 114/284 (40%), Gaps = 40/284 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           +G G FG V+ G +  +      +  VAVK   +E L      ++L E   L Q  HPN+
Sbjct: 122 IGRGNFGEVFSGRLRAD------NTLVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNI 174

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+LIG C +     +V E +  G     L R     L   T + +   AA G+ +L    
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFL-RTEGARLRVKTLLQMVGDAAAGMEYLE--S 231

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +  I+RD    N L+      K+SDFG+++    G              + APE +  G 
Sbjct: 232 KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR 291

Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            ++ SDV+SFG++L E  + G        P    S     R  +    ++     P  E 
Sbjct: 292 YSSESDVWSFGILLWETFSLGA------SPYPNLSNQQ-TREFVEKGGRL-----PCPEL 339

Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
                     C  A +     C +  P  RP  S + + L+ ++
Sbjct: 340 ----------CPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR 373

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  159 bits (403), Expect = 2e-45
 Identities = 78/291 (26%), Positives = 121/291 (41%), Gaps = 34/291 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG+G FG+V     D           VAVK L   G    R++  E+  L  L    +V
Sbjct: 30  QLGKGNFGSVELCRYD--PLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIV 87

Query: 145 KLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           K  G       +   LV E++  G L + L ++    L  +  ++ +    KG+ +L   
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFL-QRHRARLDASRLLLYSSQICKGMEYLG-- 144

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-------RVMGTYGYAA 255
            R  ++RD    NIL++S+   K++DFGLAK  P   + +V                  A
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY------A 198

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           PE +     + +SDV+SFGVVL EL T   KS   +         +   P L+   ++L+
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLE 258

Query: 315 IIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
               RL        A  AC    +     C + +P+ RP  S +   L+ L
Sbjct: 259 -EGQRLP-------APPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  157 bits (398), Expect = 5e-45
 Identities = 75/292 (25%), Positives = 120/292 (41%), Gaps = 33/292 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG+G FG+V     D           VAVK L     +  R++  E+  L  L+H N+V
Sbjct: 17  QLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74

Query: 145 KLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           K  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L   
Sbjct: 75  KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYLG-- 131

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-------RVMGTYGYAA 255
            +  I+RD  T NIL++++   K+ DFGL K  PQ  E                     A
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWY------A 185

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE +     +  SDV+SFGVVL EL T  +          + + +  + ++        +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF----HL 241

Query: 316 IDPRLENQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETLEPLQ 361
           I+  L+N    R  +   C    Y     C + N   RP   D+   ++ ++
Sbjct: 242 IE-LLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR 290

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  157 bits (398), Expect = 1e-44
 Identities = 76/297 (25%), Positives = 122/297 (41%), Gaps = 33/297 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG+G FG+V     D           VAVK L     +  R++  E+  L  L+H N+V
Sbjct: 48  QLGKGNFGSVEMCRYDP--LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 145 KLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           K  G C     R   L+ E++  GSL ++L +K    +     +       KG+ +L   
Sbjct: 106 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-QKHKERIDHIKLLQYTSQICKGMEYL--G 162

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-------RVMGTYGYAA 255
            +  I+RD  T NIL++++   K+ DFGL K  PQ  E +                   A
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWY------A 216

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE +     +  SDV+SFGVVL EL T  +          + + +  + ++        +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVF----HL 272

Query: 316 IDPRLENQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETLEPLQCANDG 366
           I+  L+N    R  +   C    Y     C + N   RP   D+   ++ ++    G
Sbjct: 273 IE-LLKNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMAG 326

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  155 bits (393), Expect = 4e-44
 Identities = 79/292 (27%), Positives = 110/292 (37%), Gaps = 35/292 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
            LGEG FG V     D           VAVK L  E G     +   E+  L  L H N+
Sbjct: 28  DLGEGHFGKVELCRYD--PEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 144 VKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           VK  G C ED      L+ EF+  GSL+ +L  K    ++   ++  A    KG+ +L  
Sbjct: 86  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL-PKNKNKINLKQQLKYAVQICKGMDYL-- 142

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-------RVMGTYGYA 254
             R  ++RD    N+L++S++  K+ DFGL KA     E +                   
Sbjct: 143 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWY------ 196

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
           APE +M       SDV+SFGV L ELLT             +       +  +      L
Sbjct: 197 APECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTL 256

Query: 314 QIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
           +    RL            C    Y     C    P  R    +++E  E L
Sbjct: 257 K-EGKRLP-------CPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL 300

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  155 bits (393), Expect = 6e-44
 Identities = 83/298 (27%), Positives = 121/298 (40%), Gaps = 37/298 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
            LGEG FG V     D           VAVK L  + G Q    W  E++ L  L H ++
Sbjct: 38  DLGEGHFGKVSLYCYDPTNDG--TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 144 VKLIGYCCEDDHR--LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +K  G C +       LV E++  GSL ++L R +   +  A  ++ A    +G+A+LH 
Sbjct: 96  IKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLH- 151

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-------RVMGTYGYA 254
             +  I+RD    N+LLD+D   K+ DFGLAKA P+G E +                   
Sbjct: 152 -AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY------ 204

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
           APE +        SDV+SFGV L ELLT    S        E   +   +  +    ++L
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL 264

Query: 314 QIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQCANDG 366
           +    RL            C    Y     C       RP   +++  L+ +     G
Sbjct: 265 E-RGERLP-------RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  154 bits (391), Expect = 2e-43
 Identities = 71/284 (25%), Positives = 125/284 (44%), Gaps = 41/284 (14%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHP 141
           +LG G FGTVYKG +I E  +V    +PVA+K L +E       +E L E   +  + +P
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV---KIPVAIKEL-REATSPKANKEILDEAYVMASVDNP 77

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           ++ +L+G  C      L+ + M  G L +++ R+    +     +      AKG+ +L  
Sbjct: 78  HVCRLLG-ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL-- 133

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            +R +++RD    N+L+ +    K++DFGLAK     ++ + +        + A E ++ 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              T +SDV+S+GV + EL+T G       +P       +              I    L
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGS------KPYDGIPASE--------------ISS-IL 232

Query: 321 ENQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETLE 358
           E     R  Q   C++  Y     C   +  +RP   +++    
Sbjct: 233 EKGE--RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFS 274

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  155 bits (394), Expect = 1e-42
 Identities = 76/297 (25%), Positives = 126/297 (42%), Gaps = 38/297 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G +G VY+G   +       SL VAVK L KE      E+L E   + +++HPNLV
Sbjct: 227 KLGGGQYGEVYEGVWKK------YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 279

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK 337

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+R+    N L+  ++  K++DFGL++    GD             + APE +     
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 396

Query: 265 TARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
           + +SDV++FGV+L E+ T G        P     L       L    +M      R E  
Sbjct: 397 SIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQ-VYELLEKDYRM-----ERPEG- 443

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLT 375
                    C    Y     C   NP  RP  +++ +  E +   +   +E+   L 
Sbjct: 444 ---------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  151 bits (383), Expect = 3e-41
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG+G FG V+ G  +           VA+K L K G      +L E   + +LRH  LV
Sbjct: 191 KLGQGCFGEVWMGTWNGTT-------RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L      ++   +V E+M +GSL + L  +    L     + +A   A G+A++     
Sbjct: 243 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM 299

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             ++RD + +NIL+  +   K++DFGLA+   + +E            + APE  + G  
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRF 358

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
           T +SDV+SFG++L EL T  +      P       +    ++    +M     P      
Sbjct: 359 TIKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRM-----PCPPE-- 405

Query: 325 SVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                   C  + +     C  + P+ RP    +   LE  
Sbjct: 406 --------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 438

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  147 bits (372), Expect = 7e-41
 Identities = 75/285 (26%), Positives = 127/285 (44%), Gaps = 39/285 (13%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPN 142
           +LG G FGTV+KG +I E   +    +PV +KV+  + G Q  +     +  +G L H +
Sbjct: 20  VLGSGVFGTVHKGVWIPEGESI---KIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAH 76

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +V+L+G  C      LV +++  GSL +H+ R+    L     +      AKG+ +L   
Sbjct: 77  IVRLLG-LCPGSSLQLVTQYLPLGSLLDHV-RQHRGALGPQLLLNWGVQIAKGMYYL--E 132

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
           E  +++R+    N+LL S    +++DFG+A   P  D+  + +       + A E +  G
Sbjct: 133 EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 263 HLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE 321
             T +SDV+S+GV + EL+T G        P     L +              + D  LE
Sbjct: 193 KYTHQSDVWSYGVTVWELMTFGA------EPYAGLRLAE--------------VPD-LLE 231

Query: 322 NQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                R AQ + C++  Y     C   +   RP   ++      +
Sbjct: 232 KGE--RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM 274

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  146 bits (370), Expect = 1e-40
 Identities = 71/286 (24%), Positives = 128/286 (44%), Gaps = 41/286 (14%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHP 141
           +LG G FGTVYKG +I E  +V    +PVA+K L +E    + ++E L E   +  + +P
Sbjct: 22  VLGSGAFGTVYKGLWIPEGEKV---KIPVAIKEL-REATSPKANKEILDEAYVMASVDNP 77

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           ++ +L+G  C      L+ + M  G L +++ R+    +     +      AKG+ +L  
Sbjct: 78  HVCRLLG-ICLTSTVQLITQLMPFGCLLDYV-REHKDNIGSQYLLNWCVQIAKGMNYL-- 133

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
            +R +++RD    N+L+ +    K++DFGLAK     ++ + +        + A E ++ 
Sbjct: 134 EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILH 193

Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              T +SDV+S+GV + EL+T G       +P       +              I    L
Sbjct: 194 RIYTHQSDVWSYGVTVWELMTFGS------KPYDGIPASE--------------ISS-IL 232

Query: 321 ENQYSVRAAQ-KACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
           E     R  Q   C++  Y     C   +  +RP   +++     +
Sbjct: 233 EKGE--RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 276

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  144 bits (366), Expect = 2e-40
 Identities = 55/212 (25%), Positives = 90/212 (42%), Gaps = 20/212 (9%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL 143
            LG+G F  ++KG   +      L    V +KVL+K        +    + + +L H +L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V   G C   D  +LV EF+  GSL+ +L +K    ++   ++ +A   A  + FL   E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYL-KKNKNCINILWKLEVAKQLAAAMHFL--EE 131

Query: 204 RPVIYRDFKTSNILLDSDYT--------AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
             +I+ +    NILL  +           KLSD G++      D        +       
Sbjct: 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIPWV------P 185

Query: 256 PEYVMTG-HLTARSDVYSFGVVLLELLT-GRK 285
           PE +    +L   +D +SFG  L E+ + G K
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDK 217

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  143 bits (364), Expect = 3e-40
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 46/285 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G FG V  G              VAVK++ KEG     E+  E   + +L HP LV
Sbjct: 15  ELGSGQFGVVKLGKWKGQY-------DVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           K  G C ++    +V E++  G L N+L R     L  +  + + +   +G+AFL     
Sbjct: 67  KFYGVCSKEYPIYIVTEYISNGCLLNYL-RSHGKGLEPSQLLEMCYDVCEGMAFL--ESH 123

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPEYVMT 261
             I+RD    N L+D D   K+SDFG+ +              +GT     ++APE    
Sbjct: 124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY----VSSVGTKFPVKWSAPEVFHY 179

Query: 262 GHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
              +++SDV++FG+++ E+ + G+       P    +  +    K++   ++      R 
Sbjct: 180 FKYSSKSDVWAFGILMWEVFSLGK------MPYDLYTNSE-VVLKVSQGHRL-----YRP 227

Query: 321 ENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                        S   Y     C  + P+ RP    ++ ++EPL
Sbjct: 228 HL----------ASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPL 262

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  148 bits (376), Expect = 6e-40
 Identities = 70/281 (24%), Positives = 117/281 (41%), Gaps = 38/281 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG+G FG V+ G  +           VA+K L K G      +L E   + +LRH  LV
Sbjct: 274 KLGQGCFGEVWMGTWNGTT-------RVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L      ++   +V E+M +GSL + L  +    L     + +A   A G+A++     
Sbjct: 326 QLYA-VVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM 382

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             ++RD + +NIL+  +   K++DFGLA+   + +E            + APE  + G  
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAALYGRF 441

Query: 265 TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY 324
           T +SDV+SFG++L EL T  +      P       +    ++    +M     P      
Sbjct: 442 TIKSDVWSFGILLTELTTKGR-----VPYPGMVNRE-VLDQVERGYRM-----PCPPE-- 488

Query: 325 SVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                   C  + +     C  + P+ RP    +   LE  
Sbjct: 489 --------CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 521

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  144 bits (366), Expect = 7e-40
 Identities = 66/210 (31%), Positives = 108/210 (51%), Gaps = 20/210 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           ++G G FG VYKG +      G K +PVA+K L K G   +   ++L E   +GQ  H N
Sbjct: 51  VIGAGEFGEVYKGML--KTSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQFSHHN 107

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L G   +    +++ E+M  G+L+  L R+     S    + +  G A G+ +L  A
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFL-REKDGEFSVLQLVGMLRGIAAGMKYL--A 164

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG------YAAP 256
               ++RD    NIL++S+   K+SDFGL++      E   +T      G      + AP
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS-----GGKIPIRWTAP 219

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRK 285
           E +     T+ SDV+SFG+V+ E++T G +
Sbjct: 220 EAISYRKFTSASDVWSFGIVMWEVMTYGER 249

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  142 bits (361), Expect = 7e-40
 Identities = 63/202 (31%), Positives = 100/202 (49%), Gaps = 13/202 (6%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            +G G FG V+ GY        L    VA+K + +EG     +++ E   + +L HP LV
Sbjct: 15  EIGSGQFGLVHLGYW-------LNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L G C E     LV EFM  G L ++L R      +  T + +     +G+A+L   E 
Sbjct: 67  QLYGVCLEQAPICLVTEFMEHGCLSDYL-RTQRGLFAAETLLGMCLDVCEGMAYL--EEA 123

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+PE       
Sbjct: 124 CVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFSFSRY 182

Query: 265 TARSDVYSFGVVLLELLT-GRK 285
           +++SDV+SFGV++ E+ + G+ 
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKI 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  143 bits (362), Expect = 8e-40
 Identities = 65/212 (30%), Positives = 104/212 (49%), Gaps = 23/212 (10%)

Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRH 140
           D  LG G FG+V +G      R+  K + VA+KVL K+G +     E + E   + QL +
Sbjct: 15  DIELGCGNFGSVRQGV----YRMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDN 69

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P +V+LIG C  +   +LV E    G L   L       +  +    +    + G+ +L 
Sbjct: 70  PYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL- 126

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG------YA 254
             E+  ++RD    N+LL + + AK+SDFGL+KA    D  + +              + 
Sbjct: 127 -EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS-----AGKWPLKWY 180

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT-GRK 285
           APE +     ++RSDV+S+GV + E L+ G+K
Sbjct: 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQK 212

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  147 bits (372), Expect = 9e-40
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 18/199 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            +G+G FG V  G          +   VAVK + K      + +L E + + QLRH NLV
Sbjct: 200 TIGKGEFGDVMLGD--------YRGNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLV 249

Query: 145 KLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           +L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L    
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 307

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
              ++RD    N+L+  D  AK+SDFGL K   +   T  + ++     + APE +    
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKL--PVKWTAPEALREKK 362

Query: 264 LTARSDVYSFGVVLLELLT 282
            + +SDV+SFG++L E+ +
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  142 bits (360), Expect = 1e-39
 Identities = 60/282 (21%), Positives = 111/282 (39%), Gaps = 40/282 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G FG V  G              VA+K++ KEG     E++ E   +  L H  LV
Sbjct: 31  ELGTGQFGVVKYGKWRGQY-------DVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L G C +     ++ E+M  G L N+L R+          + +     + + +L    +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEAMEYL--ESK 139

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             ++RD    N L++     K+SDFGL++     DE   S        ++ PE +M    
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSSVGSKFPVRWSPPEVLMYSKF 198

Query: 265 TARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
           +++SD+++FGV++ E+ + G+       P +  +  +     +    ++      R    
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGK------MPYERFTNSE-TAEHIAQGLRL-----YRPHL- 245

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                     S   Y     C  +    RP    ++  +  +
Sbjct: 246 ---------ASEKVYTIMYSCWHEKADERPTFKILLSNILDV 278

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  143 bits (363), Expect = 2e-39
 Identities = 63/205 (30%), Positives = 106/205 (51%), Gaps = 11/205 (5%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
           I+G G  G V  G +      G + +PVA+K L K G   +  R++L+E + +GQ  HPN
Sbjct: 56  IIGSGDSGEVCYGRLRVP---GQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPN 111

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L G        ++V E+M  GSL+  L R      +    + +  G   G+ +L  +
Sbjct: 112 IIRLEGVVTRGRLAMIVTEYMENGSLDTFL-RTHDGQFTIMQLVGMLRGVGAGMRYL--S 168

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYGYAAPEYVMT 261
           +   ++RD    N+L+DS+   K+SDFGL++      D  + +T       + APE +  
Sbjct: 169 DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 262 GHLTARSDVYSFGVVLLELLT-GRK 285
              ++ SDV+SFGVV+ E+L  G +
Sbjct: 229 RTFSSASDVWSFGVVMWEVLAYGER 253

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  141 bits (359), Expect = 2e-39
 Identities = 79/283 (27%), Positives = 125/283 (44%), Gaps = 42/283 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G FG V+ GY + +         VAVK L K+G      +L E N + QL+H  LV
Sbjct: 20  RLGAGQFGEVWMGYYNGHT-------KVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L       +   ++ E+M  GSL + L   + + L+    + +A   A+G+AF+   ER
Sbjct: 72  RLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER 128

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD-ETHVSTRVMGTYGYAAPEYVMTGH 263
             I+RD + +NIL+    + K++DFGLA+     +       +      + APE +  G 
Sbjct: 129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFP--IKWTAPEAINYGT 186

Query: 264 LTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
            T +SDV+SFG++L E++T GR       P    +  +     L    +M      R +N
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGR------IPYPGMTNPE-VIQNLERGYRM-----VRPDN 234

Query: 323 QYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                     C    Y     C  + P+ RP    +   LE  
Sbjct: 235 ----------CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  141 bits (358), Expect = 3e-39
 Identities = 69/304 (22%), Positives = 115/304 (37%), Gaps = 57/304 (18%)

Query: 74  ETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
            T+ K F  D+    ++G GGFG V+K       +  +      +K +     +  RE  
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFK------AKHRIDGKTYVIKRVKYNNEKAERE-- 54

Query: 130 TEVNFLGQLRHPNLVKLIGYCCEDDHRL----------------LVYEFMFRGSLENHLF 173
             V  L +L H N+V   G     D+                  +  EF  +G+LE  + 
Sbjct: 55  --VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE 112

Query: 174 RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
           ++    L     + +     KG+ ++H   + +I RD K SNI L      K+ DFGL  
Sbjct: 113 KRRGEKLDKVLALELFEQITKGVDYIH--SKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS 293
                      TR  GT  Y +PE + +       D+Y+ G++L ELL            
Sbjct: 171 ---SLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHV---------- 217

Query: 294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                           +    + D  + + +     +K  +L    LS+ P+ RP  S++
Sbjct: 218 --------CDTAFETSKFFTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265

Query: 354 VETL 357
           + TL
Sbjct: 266 LRTL 269

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  141 bits (357), Expect = 5e-39
 Identities = 75/282 (26%), Positives = 121/282 (42%), Gaps = 38/282 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G +G VY+G   +       SL VAVK L KE      E+L E   + +++HPNLV
Sbjct: 20  KLGGGQYGEVYEGVWKK------YSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLV 72

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           +L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  + +L   ++
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL--EKK 130

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD    N L+  ++  K++DFGL++    GD             + APE +     
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 265 TARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
           + +SDV++FGV+L E+ T G        P     L       L    +M      R E  
Sbjct: 190 SIKSDVWAFGVLLWEIATYGM------SPYPGIDLSQ-VYELLEKDYRM-----ERPEG- 236

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                    C    Y     C   NP  RP  +++ +  E +
Sbjct: 237 ---------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 269

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  142 bits (359), Expect = 5e-39
 Identities = 78/309 (25%), Positives = 118/309 (38%), Gaps = 64/309 (20%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L +      +++  E   L  L+H ++V+
Sbjct: 49  LGEGAFGKVFLAEC-HNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHL-------------FRKATVPLSWATRMMIAFGA 192
             G C E    L+V+E+M  G L   L                A  PL     + +A   
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV----- 247
           A G+ +L  A    ++RD  T N L+      K+ DFG+++     D   V  R      
Sbjct: 168 AAGMVYL--AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 248 -MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKEQSLVDW 301
            M       PE ++    T  SDV+SFGVVL E+ T G+      +P    S  +++   
Sbjct: 226 WM------PPESILYRKFTTESDVWSFGVVLWEIFTYGK------QPWYQLSNTEAI--- 270

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVET 356
                  + + L     R             C    Y     C  + P+ R  + DV   
Sbjct: 271 ---DCITQGREL----ERPRA----------CPPEVYAIMRGCWQREPQQRHSIKDVHAR 313

Query: 357 LEPLQCAND 365
           L+ L  A  
Sbjct: 314 LQALAQAPP 322

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  142 bits (361), Expect = 6e-39
 Identities = 64/207 (30%), Positives = 109/207 (52%), Gaps = 15/207 (7%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPN 142
           ++G G FG V  G +        K + VA+K L K G   +  R++L E + +GQ  HPN
Sbjct: 52  VVGAGEFGEVCSGRLKLP---SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPN 107

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +++L G   +    ++V E+M  GSL++ L RK     +    + +  G A G+ +L  +
Sbjct: 108 IIRLEGVVTKSKPVMIVTEYMENGSLDSFL-RKHDAQFTVIQLVGMLRGIASGMKYL--S 164

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPEYV 259
           +   ++RD    NIL++S+   K+SDFGL +      E   +TR  G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIPIRWTSPEAI 222

Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRK 285
                T+ SDV+S+G+VL E+++ G +
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGER 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  140 bits (356), Expect = 7e-39
 Identities = 77/287 (26%), Positives = 117/287 (40%), Gaps = 44/287 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRH 140
            LG+G FG V +G  D       K++ VAVK L K  +    +   +++ EVN +  L H
Sbjct: 25  KLGDGSFGVVRRGEWD---APSGKTVSVAVKCL-KPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            NL++L G         +V E    GSL + L RK        T    A   A+G+ +L 
Sbjct: 81  RNLIRLYG-VVLTPPMKMVTELAPLGSLLDRL-RKHQGHFLLGTLSRYAVQVAEGMGYL- 137

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPE 257
              +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V          + + APE
Sbjct: 138 -ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKVPFAWCAPE 194

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
            + T   +  SD + FGV L E+ T G++      P        W     +     +   
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQE------P--------WIGLNGSQILHKIDKE 240

Query: 317 DPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLE 358
             RL          + C    Y     C +  P+ RP    + + L 
Sbjct: 241 GERLP-------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 280

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  141 bits (357), Expect = 8e-39
 Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 60/302 (19%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
            LG+G FG VY+G   + V        VA+K +N+   ++   E+L E + + +    ++
Sbjct: 32  ELGQGSFGMVYEGVA-KGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL--------FRKATVPLSWATRMMIAFGAAKG 195
           V+L+G   +    L++ E M RG L+++L              P S +  + +A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV------MG 249
           +A+L       ++RD    N ++  D+T K+ DFG+ +   + D      +       M 
Sbjct: 151 MAYL--NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM- 207

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKEQSLVDWARP 304
                +PE +  G  T  SDV+SFGVVL E+ T   +      P    S EQ L      
Sbjct: 208 -----SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ------PYQGLSNEQVLR----- 251

Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEP 359
            + +   +      + +N          C    +     C   NPK RP   +++ +++ 
Sbjct: 252 FVMEGGLL-----DKPDN----------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 296

Query: 360 LQ 361
             
Sbjct: 297 EM 298

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  144 bits (364), Expect = 1e-38
 Identities = 77/282 (27%), Positives = 120/282 (42%), Gaps = 40/282 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            LG G FG V+    +++         VAVK + K G      +L E N +  L+H  LV
Sbjct: 195 KLGAGQFGEVWMATYNKHT-------KVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
           KL       +   ++ EFM +GSL + L             +  +   A+G+AF+   +R
Sbjct: 247 KLHA-VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFI--EQR 303

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
             I+RD + +NIL+ +    K++DFGLA+   + +E            + APE +  G  
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 265 TARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
           T +SDV+SFG++L+E++T GR       P    S  +     L    +M     PR EN 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGR------IPYPGMSNPE-VIRALERGYRM-----PRPEN- 409

Query: 324 YSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
                    C    Y     C    P+ RP    +   L+  
Sbjct: 410 ---------CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  140 bits (354), Expect = 1e-38
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 27/207 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
            +G+G FG V  G          +   VAVK + K      + +L E + + QLRH NLV
Sbjct: 28  TIGKGEFGDVMLGD--------YRGNKVAVKCI-KNDAT-AQAFLAEASVMTQLRHSNLV 77

Query: 145 KLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           +L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + + +L    
Sbjct: 78  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EG 135

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV----MGTYGYAAPEYV 259
              ++RD    N+L+  D  AK+SDFGL K   +   T  + ++           APE +
Sbjct: 136 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTGKLPVKWT------APEAL 186

Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRK 285
                + +SDV+SFG++L E+ + GR 
Sbjct: 187 REKKFSTKSDVWSFGILLWEIYSFGRV 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  140 bits (354), Expect = 1e-38
 Identities = 76/290 (26%), Positives = 122/290 (42%), Gaps = 46/290 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ++G G FG VY G +   +    K +  AVK LN+   +    ++LTE   +    HPN+
Sbjct: 32  VIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 88

Query: 144 VKLIGYCCEDDH-RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           + L+G C   +   L+V  +M  G L N + R  T   +    +      AKG+ +L  A
Sbjct: 89  LSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYL--A 145

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG------TYGYAAP 256
            +  ++RD    N +LD  +T K++DFGLA+     +   V  +              A 
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWM----AL 201

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           E + T   T +SDV+SFGV+L EL+T G        P  + +  D     L   R++   
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFD-ITVYLLQGRRL--- 251

Query: 316 IDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
              + E           C    Y     C     + RP  S++V  +  +
Sbjct: 252 --LQPEY----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (352), Expect = 3e-38
 Identities = 76/305 (24%), Positives = 121/305 (39%), Gaps = 65/305 (21%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEG FG V+      N+      + VAVK L    L   +++  E   L  L+H ++VK
Sbjct: 23  LGEGAFGKVFLAEC-YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMMIAFG 191
             G C + D  ++V+E+M  G L   L               R+A   L  +  + IA  
Sbjct: 82  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV---- 247
            A G+ +L  A +  ++RD  T N L+ ++   K+ DFG+++     D   V        
Sbjct: 142 IASGMVYL--ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 248 --MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKEQSLVD 300
             M       PE +M    T  SDV+SFGV+L E+ T G+      +P    S  + +  
Sbjct: 200 RWM------PPESIMYRKFTTESDVWSFGVILWEIFTYGK------QPWFQLSNTEVIE- 246

Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVE 355
                +   R +      R             C    Y     C  + P+ R  + ++ +
Sbjct: 247 ----CITQGRVL-----ERPRV----------CPKEVYDVMLGCWQREPQQRLNIKEIYK 287

Query: 356 TLEPL 360
            L  L
Sbjct: 288 ILHAL 292

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  138 bits (350), Expect = 3e-38
 Identities = 57/204 (27%), Positives = 99/204 (48%), Gaps = 12/204 (5%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
            +GEG FG V++G     +     +L VA+K   K         ++L E   + Q  HP+
Sbjct: 22  CIGEGQFGDVHQGIY---MSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 77

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +VKLIG    ++   ++ E    G L + L +     L  A+ ++ A+  +  LA+L   
Sbjct: 78  IVKLIG-VITENPVWIIMELCTLGELRSFL-QVRKYSLDLASLILYAYQLSTALAYL--E 133

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
            +  ++RD    N+L+ S+   KL DFGL++   +    + +++      + APE +   
Sbjct: 134 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 263 HLTARSDVYSFGVVLLELLT-GRK 285
             T+ SDV+ FGV + E+L  G K
Sbjct: 193 RFTSASDVWMFGVCMWEILMHGVK 216

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  138 bits (350), Expect = 4e-38
 Identities = 72/288 (25%), Positives = 122/288 (42%), Gaps = 47/288 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQLRHPNL 143
           ILGEG FG VY+G    +     + + VAVK   K+    ++ ++++E   +  L HP++
Sbjct: 19  ILGEGFFGEVYEGVYTNH---KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHI 75

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKLIG   E++   ++ E    G L ++L  +    L   T ++ +    K +A+L    
Sbjct: 76  VKLIG-IIEEEPTWIIMELYPYGELGHYL-ERNKNSLKVLTLVLYSLQICKAMAYL--ES 131

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-----RVMGTYGYAAPEY 258
              ++RD    NIL+ S    KL DFGL++     D    S      + M      +PE 
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM------SPES 185

Query: 259 VMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
           +     T  SDV+ F V + E+L+ G+      +P       D     L    ++     
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGK------QPFFWLENKD-VIGVLEKGDRL----- 233

Query: 318 PRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
           P+ +           C    Y     C   +P  RP  +++V +L  +
Sbjct: 234 PKPDL----------CPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV 271

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  138 bits (349), Expect = 8e-38
 Identities = 65/211 (30%), Positives = 101/211 (47%), Gaps = 25/211 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHP 141
            LG G FGTV KGY     ++      VAVK+L K          E L E N + QL +P
Sbjct: 24  ELGSGNFGTVKKGY----YQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNP 78

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V++IG  CE +  +LV E    G L  +L +   V       +      + G+ +L  
Sbjct: 79  YIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIEL--VHQVSMGMKYL-- 133

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG------YAA 255
            E   ++RD    N+LL + + AK+SDFGL+KA    +  + +              + A
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT-----HGKWPVKWYA 188

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLT-GRK 285
           PE +     +++SDV+SFGV++ E  + G+K
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  139 bits (353), Expect = 1e-37
 Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 46/290 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ++G G FG VY G +   +    K +  AVK LN+   +    ++LTE   +    HPN+
Sbjct: 96  VIGRGHFGCVYHGTL---LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 152

Query: 144 VKLIGYCCEDDH-RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           + L+G C   +   L+V  +M  G L N + R  T   +    +      AKG+ FL  A
Sbjct: 153 LSLLGICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFL--A 209

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG------TYGYAAP 256
            +  ++RD    N +LD  +T K++DFGLA+     +   V  +              A 
Sbjct: 210 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM----AL 265

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           E + T   T +SDV+SFGV+L EL+T G        P  + +  D     L   R++   
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGA------PPYPDVNTFD-ITVYLLQGRRL--- 315

Query: 316 IDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
              + E           C    Y     C     + RP  S++V  +  +
Sbjct: 316 --LQPEY----------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  144 bits (364), Expect = 1e-37
 Identities = 67/287 (23%), Positives = 118/287 (41%), Gaps = 45/287 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
            +GEG FG V++G     +     ++ VA+K   K         ++L E   + Q  HP+
Sbjct: 397 CIGEGQFGDVHQGIY---MSPENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPH 452

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +VKLIG    ++   ++ E    G L + L +     L  A+ ++ A+  +  LA+L   
Sbjct: 453 IVKLIG-VITENPVWIIMELCTLGELRSFL-QVRKFSLDLASLILYAYQLSTALAYL--E 508

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR---VMGTYGYAAPEYV 259
            +  ++RD    N+L+ S+   KL DFGL++          S     +       APE +
Sbjct: 509 SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM----APESI 564

Query: 260 MTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP 318
                T+ SDV+ FGV + E+L  G       +P +     D    ++ +  ++     P
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGV------KPFQGVKNND-VIGRIENGERL-----P 612

Query: 319 RLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
              N          C    Y     C + +P  RP  +++   L  +
Sbjct: 613 MPPN----------CPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 649

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  138 bits (349), Expect = 1e-37
 Identities = 64/297 (21%), Positives = 103/297 (34%), Gaps = 45/297 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LGEGGF  V        V         A+K +     Q   E   E +      HPN+++
Sbjct: 37  LGEGGFSYVDL------VEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90

Query: 146 LIGYCCEDDHR----LLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAFL 199
           L+ YC  +        L+  F  RG+L N +   +     L+    + +  G  +GL  +
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-------GTYG 252
           H   +   +RD K +NILL  +    L D G         E       +        T  
Sbjct: 151 H--AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS 208

Query: 253 YAAPE------YVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
           Y APE      + +      R+DV+S G VL  ++ G    D      +           
Sbjct: 209 YRAPELFSVQSHCVIDE---RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV--------- 256

Query: 307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA 363
                +   +      ++S         L    ++ +P  RP +  ++  LE LQ  
Sbjct: 257 --ALAVQNQLSIPQSPRHS----SALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP 307

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  137 bits (348), Expect = 2e-37
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 28/215 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPN 142
           ILGEG FG+V +G + +       SL VAVK +  +    +   E+L+E   +    HPN
Sbjct: 41  ILGEGEFGSVMEGNLKQE---DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPN 97

Query: 143 LVKLIGYCCEDD-----HRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGA--A 193
           +++L+G C E         +++  FM  G L  +L   R  T P     + ++ F    A
Sbjct: 98  VIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA 157

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV------ 247
            G+ +L  + R  ++RD    N +L  D T  ++DFGL+K    GD              
Sbjct: 158 LGMEYL--SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 215

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           +      A E +     T++SDV++FGV + E+ T
Sbjct: 216 I------AIESLADRVYTSKSDVWAFGVTMWEIAT 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  137 bits (346), Expect = 2e-37
 Identities = 74/290 (25%), Positives = 119/290 (41%), Gaps = 46/290 (15%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNL 143
           ++G+G FG VY G   +        +  A+K L++   +Q    +L E   +  L HPN+
Sbjct: 28  VIGKGHFGVVYHGEYIDQ---AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84

Query: 144 VKLIGYCCEDD-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           + LIG     +    ++  +M  G L   + R      +    +      A+G+ +L  A
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARGMEYL--A 141

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG------TYGYAAP 256
           E+  ++RD    N +LD  +T K++DFGLA+     +   V            T    A 
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT----AL 197

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           E + T   T +SDV+SFGV+L ELLT G        P +     D     L   R++   
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGA------PPYRHIDPFD-LTHFLAQGRRL--- 247

Query: 316 IDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
             P+ E           C  + Y     C   +P  RP    +V  +E +
Sbjct: 248 --PQPEY----------CPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  136 bits (345), Expect = 2e-37
 Identities = 71/308 (23%), Positives = 120/308 (38%), Gaps = 68/308 (22%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNL 143
           LGE  FG VYKG++      G ++  VA+K L K+        E+  E     +L+HPN+
Sbjct: 17  LGEDRFGKVYKGHL-FGPAPGEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMMIA 189
           V L+G   +D    +++ +   G L   L               R     L     + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST---- 245
              A G+ +L  +   V+++D  T N+L+      K+SD GL +     D   +      
Sbjct: 135 AQIAAGMEYL--SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192

Query: 246 --RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKEQSL 298
             R M      APE +M G  +  SD++S+GVVL E+ + G       +P    S +  +
Sbjct: 193 PIRWM------APEAIMYGKFSIDSDIWSYGVVLWEVFSYGL------QPYCGYSNQDVV 240

Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDV 353
                  + +++ +     P  ++          C    Y     C ++ P  RP   D+
Sbjct: 241 -----EMIRNRQVL-----PCPDD----------CPAWVYALMIECWNEFPSRRPRFKDI 280

Query: 354 VETLEPLQ 361
              L    
Sbjct: 281 HSRLRAWG 288

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  136 bits (344), Expect = 3e-37
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 20/212 (9%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWL-TEVNFLGQ 137
            + D  +G G F TVYKG    +    ++   VA   L    L +  R+    E   L  
Sbjct: 28  LKFDIEIGRGSFKTVYKGL---DTETTVE---VAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 138 LRHPNLVKLIGYC---CEDDHRLLVY-EFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           L+HPN+V+         +    +++  E M  G+L+   + K    +             
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKT--YLKRFKVMKIKVLRSWCRQIL 139

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           KGL FLH    P+I+RD K  NI +     + K+ D GLA        +     V+GT  
Sbjct: 140 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT---LKRASFAKA-VIGTPE 195

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           + APE     +     DVY+FG+ +LE+ T  
Sbjct: 196 FMAPEMYEEKY-DESVDVYAFGMCMLEMATSE 226

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  140 bits (355), Expect = 1e-36
 Identities = 64/209 (30%), Positives = 104/209 (49%), Gaps = 17/209 (8%)

Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRH 140
           D  LG G FG+V +G      R+  K + VA+KVL K+G       E + E   + QL +
Sbjct: 341 DIELGCGNFGSVRQGVY----RMRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDN 395

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P +V+LIG  C+ +  +LV E    G L   L       +  +    +    + G+ +L 
Sbjct: 396 PYIVRLIG-VCQAEALMLVMEMAGGGPLHKFL-VGKREEIPVSNVAELLHQVSMGMKYL- 452

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT---YGYAAPE 257
             E+  ++R+    N+LL + + AK+SDFGL+KA    D  + +           + APE
Sbjct: 453 -EEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWPLKWYAPE 509

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT-GRK 285
            +     ++RSDV+S+GV + E L+ G+K
Sbjct: 510 CINFRKFSSRSDVWSYGVTMWEALSYGQK 538

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  135 bits (341), Expect = 2e-36
 Identities = 69/319 (21%), Positives = 117/319 (36%), Gaps = 59/319 (18%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHP 141
           +LG+G FG+V +  + +        + VAVK+L K  +    +    L E   + +  HP
Sbjct: 30  MLGKGEFGSVREAQLKQE---DGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHP 85

Query: 142 NLVKLIGYCCEDDHR------LLVYEFMFRGSLENHL----FRKATVPLSWATRMMIAFG 191
           ++ KL+G       +      +++  FM  G L   L      +    L   T +     
Sbjct: 86  HVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVD 145

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV---- 247
            A G+ +L  + R  I+RD    N +L  D T  ++DFGL++    GD            
Sbjct: 146 IACGMEYL--SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPV 203

Query: 248 --MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARP 304
             +      A E +     T  SDV++FGV + E++T G+       P       +    
Sbjct: 204 KWL------ALESLADNLYTVHSDVWAFGVTMWEIMTRGQT------PYAGIENAE-IYN 250

Query: 305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEP 359
            L    ++      +             C    Y     C S +PK RP  + +   LE 
Sbjct: 251 YLIGGNRL-----KQPPE----------CMEEVYDLMYQCWSADPKQRPSFTCLRMELEN 295

Query: 360 LQCANDGGNEISSSLTANL 378
           +       +     L  N+
Sbjct: 296 ILGHLSVLSTSQDPLYINI 314

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  134 bits (340), Expect = 2e-36
 Identities = 66/278 (23%), Positives = 97/278 (34%), Gaps = 40/278 (14%)

Query: 78  KSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTE 131
             F+  +     LG G +G V+K    E+ R+       AVK       G +     L E
Sbjct: 53  SFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRL------YAVKRSMSPFRGPKDRARKLAE 106

Query: 132 VNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           V    ++ +HP  V+L     E     L  E     SL+ H        L  A       
Sbjct: 107 VGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC-EAWGASLPEAQVWGYLR 164

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
                LA LH   + +++ D K +NI L      KL DFGL           V     G 
Sbjct: 165 DTLLALAHLH--SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV---QEGD 219

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             Y APE +   + TA +DV+S G+ +LE+    +      P   +        +L    
Sbjct: 220 PRYMAPELLQGSYGTA-ADVFSLGLTILEVACNME-----LPHGGEGW-----QQLRQG- 267

Query: 311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                + P      S     +  S+    L  +PK R 
Sbjct: 268 ----YLPPEFTAGLS----SELRSVLVMMLEPDPKLRA 297

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  133 bits (337), Expect = 8e-36
 Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 50/296 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPN 142
            LG G FG VY+G +   +      L VAVK L  E    Q   ++L E   + +  H N
Sbjct: 37  GLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 94

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----FRKATVPLSWATRMMIAFGAAKGLA 197
           +V+ IG   +   R ++ E M  G L++ L            L+    + +A   A G  
Sbjct: 95  IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 198 FLHNAERPVIYRDFKTSNILLD---SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           +L   E   I+RD    N LL        AK+ DFG+A+   +          M    + 
Sbjct: 155 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
            PE  M G  T+++D +SFGV+L E+ + G        P           P  +++  + 
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPY----------PSKSNQEVLE 256

Query: 314 QIID----PRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
            +         +N          C    Y     C    P+ RP  + ++E +E  
Sbjct: 257 FVTSGGRMDPPKN----------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 302

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  133 bits (336), Expect = 8e-36
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 16/203 (7%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT----EVNFLGQLRHP 141
           +G GG G VY+   D      ++   VA+K++++  L     + T    E    G+L+ P
Sbjct: 42  VGRGGMGDVYEAE-DT-----VRERIVALKLMSET-LSSDPVFRTRMQREARTAGRLQEP 94

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           ++V +  +   D    +    +    L   L R+  +    A  ++        L   H 
Sbjct: 95  HVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVR--QIGSALDAAH- 151

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
                 +RD K  NIL+ +D  A L DFG+A A      T +    +GT  Y APE    
Sbjct: 152 -AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN-TVGTLYYMAPERFSE 209

Query: 262 GHLTARSDVYSFGVVLLELLTGR 284
            H T R+D+Y+   VL E LTG 
Sbjct: 210 SHATYRADIYALTCVLYECLTGS 232

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  131 bits (333), Expect = 1e-35
 Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGTVYKGYIDENV-RVGLKSLPVAVKVLNKEGLQGHREWLT----EVNFLGQLRH 140
           LG GG  TVY    D  +         VA+K +     +   E L     EV+   QL H
Sbjct: 19  LGGGGMSTVYLAE-DTILNI------KVAIKAI-FIPPREKEETLKRFEREVHNSSQLSH 70

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            N+V +I    EDD   LV E++   +L  ++      PLS  T +        G+   H
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAH 128

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
           +    +++RD K  NIL+DS+ T K+ DFG+AKA  +   T  +  V+GT  Y +PE   
Sbjct: 129 DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH-VLGTVQYFSPEQAK 185

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
                  +D+YS G+VL E+L G 
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGE 209

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  132 bits (335), Expect = 2e-35
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 67/305 (21%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
           ++GEG FG V K  I ++       +  A+K + KE      HR++  E+  L +L  HP
Sbjct: 32  VIGEGNFGQVLKARIKKDG----LRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHP 86

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMM 187
           N++ L+G C    +  L  E+   G+L + L                     LS    + 
Sbjct: 87  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 146

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-- 245
            A   A+G+ +L  +++  I+RD    NIL+  +Y AK++DFGL++     +     T  
Sbjct: 147 FAADVARGMDYL--SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMG 201

Query: 246 ----RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD 300
               R M      A E +     T  SDV+S+GV+L E+++ G        P    +  +
Sbjct: 202 RLPVRWM------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------TPYCGMTCAE 249

Query: 301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVE 355
               KL    ++      +  N          C    Y     C  + P  RP  + ++ 
Sbjct: 250 -LYEKLPQGYRL-----EKPLN----------CDDEVYDLMRQCWREKPYERPSFAQILV 293

Query: 356 TLEPL 360
           +L  +
Sbjct: 294 SLNRM 298

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  132 bits (333), Expect = 2e-35
 Identities = 61/301 (20%), Positives = 110/301 (36%), Gaps = 60/301 (19%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL 135
           + SD+    +LG+G FG V K     N          A+K +     +     L+EV  L
Sbjct: 4   YASDFEEIAVLGQGAFGQVVKA---RNALDSRY---YAIKKIRHTEEK-LSTILSEVMLL 56

Query: 136 GQLRHPNLVKLIGYCCEDDHRL-------------LVYEFMFRGSLENHLFRKATVPLSW 182
             L H  +V+      E  + +             +  E+   G+L + +     +    
Sbjct: 57  ASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI-HSENLNQQR 115

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--------- 233
                +     + L+++H   + +I+RD K  NI +D     K+ DFGLAK         
Sbjct: 116 DEYWRLFRQILEALSYIH--SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 234 ----AGPQGDETHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYSFGVVLLELLTGRKSV 287
                   G   ++++ + GT  Y A E V+  TGH   + D+YS G++  E++      
Sbjct: 174 KLDSQNLPGSSDNLTSAI-GTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFS-- 229

Query: 288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
                  E+  +      L   R +     P  ++       +    +    +  +P  R
Sbjct: 230 ----TGMERVNI------LKKLRSVSIEFPPDFDDNKM----KVEKKIIRLLIDHDPNKR 275

Query: 348 P 348
           P
Sbjct: 276 P 276

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  132 bits (335), Expect = 2e-35
 Identities = 71/302 (23%), Positives = 113/302 (37%), Gaps = 56/302 (18%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
            LG G FG V +      +      L VAVK+L K           ++E+  +  L +H 
Sbjct: 53  TLGAGAFGKVVEATA-FGLGKEDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHE 110

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV------------PLSWATRMMIA 189
           N+V L+G C      L++ E+   G L N L RK+ V              S    +  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST---- 245
              A+G+AFL  A +  I+RD    N+LL + + AK+ DFGLA+         V      
Sbjct: 171 SQVAQGMAFL--ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL 228

Query: 246 --RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
             + M      APE +     T +SDV+S+G++L E+ +   +         +       
Sbjct: 229 PVKWM------APESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY----- 277

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLE 358
             + D  +M      +                  Y     C +  P  RP    +   L+
Sbjct: 278 KLVKDGYQM-----AQPAF----------APKNIYSIMQACWALEPTHRPTFQQICSFLQ 322

Query: 359 PL 360
             
Sbjct: 323 EQ 324

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  131 bits (332), Expect = 3e-35
 Identities = 74/306 (24%), Positives = 111/306 (36%), Gaps = 60/306 (19%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
            LG G FG V +      +     ++ VAVK+L K    L      ++E+  L  L  H 
Sbjct: 30  TLGAGAFGKVVEATA-YGLIKSDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHM 87

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL----------------FRKATVPLSWATR 185
           N+V L+G C      L++ E+   G L N L                     + L     
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
           +  ++  AKG+AFL  A +  I+RD    NILL      K+ DFGLA+         V  
Sbjct: 148 LSFSYQVAKGMAFL--ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 246 ------RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
                 + M      APE +     T  SDV+S+G+ L EL +   S     P   +   
Sbjct: 206 NARLPVKWM------APESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY- 258

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVV 354
                 + +  +M        E+               Y     C   +P  RP    +V
Sbjct: 259 ----KMIKEGFRM-----LSPEH----------APAEMYDIMKTCWDADPLKRPTFKQIV 299

Query: 355 ETLEPL 360
           + +E  
Sbjct: 300 QLIEKQ 305

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  132 bits (335), Expect = 3e-35
 Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 50/296 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPN 142
            LG G FG VY+G +   +      L VAVK L  E    Q   ++L E   + +  H N
Sbjct: 78  GLGHGAFGEVYEGQV-SGMPNDPSPLQVAVKTL-PEVCSEQDELDFLMEALIISKFNHQN 135

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL-----FRKATVPLSWATRMMIAFGAAKGLA 197
           +V+ IG   +   R ++ E M  G L++ L            L+    + +A   A G  
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195

Query: 198 FLHNAERPVIYRDFKTSNILLD---SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           +L   E   I+RD    N LL        AK+ DFG+A+   +          M    + 
Sbjct: 196 YL--EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
            PE  M G  T+++D +SFGV+L E+ + G        P           P  +++  + 
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY------MPY----------PSKSNQEVLE 297

Query: 314 QIID----PRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMSDVVETLEPL 360
            +         +N          C    Y     C    P+ RP  + ++E +E  
Sbjct: 298 FVTSGGRMDPPKN----------CPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  130 bits (328), Expect = 9e-35
 Identities = 58/286 (20%), Positives = 115/286 (40%), Gaps = 49/286 (17%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G GG   V++  ++E  ++       A+K +N E         +  E+ +L +L+  + 
Sbjct: 36  IGSGGSSKVFQV-LNEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 144 --VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA---TRMMIAFGAAKGLAF 198
             ++L  Y   D +  +V E      L + L +K ++         + M+     + +  
Sbjct: 89  KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML-----EAVHT 142

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           +H  +  +++ D K +N L+      KL DFG+A        + V    +GT  Y  PE 
Sbjct: 143 IH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEA 199

Query: 259 VM-----------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
           +               ++ +SDV+S G +L  +  G+       P        + +   N
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP--------FQQII-N 244

Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
              K+  IIDP  E ++     +    +   CL ++PK R  + ++
Sbjct: 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  130 bits (328), Expect = 1e-34
 Identities = 67/228 (29%), Positives = 103/228 (45%), Gaps = 40/228 (17%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPN 142
            LGEG FG V K     +++       VAVK+L KE       R+ L+E N L Q+ HP+
Sbjct: 30  TLGEGEFGKVVKATA-FHLKGRAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPH 87

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL----------------------FRKATVPL 180
           ++KL G C +D   LL+ E+   GSL   L                             L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE 240
           +    +  A+  ++G+ +L  AE  +++RD    NIL+      K+SDFGL++   + D 
Sbjct: 148 TMGDLISFAWQISQGMQYL--AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS 205

Query: 241 THVST------RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
               +      + M      A E +     T +SDV+SFGV+L E++T
Sbjct: 206 YVKRSQGRIPVKWM------AIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  130 bits (330), Expect = 1e-34
 Identities = 62/266 (23%), Positives = 101/266 (37%), Gaps = 29/266 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPN 142
            +GEG FG          V+         +K +N   +      E   EV  L  ++HPN
Sbjct: 31  KIGEGSFGKAIL------VKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPN 84

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           +V+      E+    +V ++   G L   +  +  V       +         L  +H  
Sbjct: 85  IVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH-- 142

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG 262
           +R +++RD K+ NI L  D T +L DFG+A+             + GT  Y +PE     
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACI-GTPYYLSPEICENK 200

Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLEN 322
               +SD+++ G VL EL T +         +  S+       L    K++    P +  
Sbjct: 201 PYNNKSDIWALGCVLYELCTLK------HAFEAGSM-----KNL--VLKIISGSFPPVSL 247

Query: 323 QYSVRAAQKACSLAYYCLSQNPKARP 348
            YS        SL      +NP+ RP
Sbjct: 248 HYS----YDLRSLVSQLFKRNPRDRP 269

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  130 bits (328), Expect = 1e-34
 Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 48/286 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHPN 142
           +G G F  VY+      +  G+    VA+K +    L   +     + E++ L QL HPN
Sbjct: 40  IGRGQFSEVYRA---ACLLDGVP---VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAFLH 200
           ++K      ED+   +V E    G L   +  F+K    +   T           L  +H
Sbjct: 94  VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              R V++RD K +N+ + +    KL D GL +       T   + V GT  Y +PE + 
Sbjct: 154 --SRRVMHRDIKPANVFITATGVVKLGDLGLGRF-FSSKTTAAHSLV-GTPYYMSPERIH 209

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII---- 316
                 +SD++S G +L E+   +                   P   DK  +  +     
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQ------------------SPFYGDKMNLYSLCKKIE 251

Query: 317 ----DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
                P   + YS    ++   L   C++ +P+ RP   DV    +
Sbjct: 252 QCDYPPLPSDHYS----EELRQLVNMCINPDPEKRP---DVTYVYD 290

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  130 bits (330), Expect = 1e-34
 Identities = 71/310 (22%), Positives = 128/310 (41%), Gaps = 69/310 (22%)

Query: 85  ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RH 140
            LGEG FG V     +  +     +++ VAVK+L K+    +   + ++E+  +  + +H
Sbjct: 88  PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRM 186
            N++ L+G C +D    ++ E+  +G+L  +L               R     +++   +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST- 245
              +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T 
Sbjct: 207 SCTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTN 264

Query: 246 -----RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKE 295
                + M      APE +     T +SDV+SFGV++ E+ T G        P      E
Sbjct: 265 GRLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFTLGGS------PYPGIPVE 312

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLM 350
           +         L +  +M      +  N          C+   Y     C    P  RP  
Sbjct: 313 ELF-----KLLKEGHRM-----DKPAN----------CTNELYMMMRDCWHAVPSQRPTF 352

Query: 351 SDVVETLEPL 360
             +VE L+ +
Sbjct: 353 KQLVEDLDRI 362

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  129 bits (326), Expect = 2e-34
 Identities = 64/308 (20%), Positives = 116/308 (37%), Gaps = 63/308 (20%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNF 134
           + +D+     LG GGFG V++       +  +     A+K +     +  RE  + EV  
Sbjct: 3   YLTDFEPIQCLGRGGFGVVFE------AKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 56

Query: 135 LGQLRHPNLVKLIGYCCEDD---------HRLLVY---EFMFRGSLENHL-FRKATVPLS 181
           L +L HP +V+      E +          ++ +Y   +   + +L++ +  R       
Sbjct: 57  LAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERE 116

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA------- 234
            +  + I    A+ + FLH   + +++RD K SNI    D   K+ DFGL  A       
Sbjct: 117 RSVCLHIFLQIAEAVEFLH--SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 174

Query: 235 ---GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR 291
                        T  +GT  Y +PE +     + + D++S G++L ELL          
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL---------- 224

Query: 292 PSKEQSLVDWARPKLNDKRKMLQIID----PRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
                    +      ++ + L  +     P L  Q           +    LS +P  R
Sbjct: 225 ---------YPFSTQMERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSPMER 271

Query: 348 PLMSDVVE 355
           P   +++E
Sbjct: 272 PEAINIIE 279

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  130 bits (328), Expect = 2e-34
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 33/221 (14%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
           LGEG FG V     +  +     +++ VAVK+L K+    +   + ++E+  +  + +H 
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHK 101

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMM 187
           N++ L+G C +D    ++ E+  +G+L  +L               R     +++   + 
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-- 245
             +  A+G+ +L  A +  I+RD    N+L+  +   K++DFGLA+     D    +T  
Sbjct: 162 CTYQLARGMEYL--ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNG 219

Query: 246 ----RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
               + M      APE +     T +SDV+SFGV++ E+ T
Sbjct: 220 RLPVKWM------APEALFDRVYTHQSDVWSFGVLMWEIFT 254

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  130 bits (328), Expect = 2e-34
 Identities = 57/280 (20%), Positives = 110/280 (39%), Gaps = 47/280 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH--REWLTEVNFLGQLRHPNL 143
           +G GG   V++  ++E  ++       A+K +N E         +  E+ +L +L+  + 
Sbjct: 17  IGSGGSSKVFQV-LNEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 144 --VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM--IAFGAAKGLAFL 199
             ++L  Y   D +  +V E      L + L +K ++           +     + +  +
Sbjct: 70  KIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML----EAVHTI 124

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +  +++ D K +N L+      KL DFG+A        + V    +GT  Y  PE +
Sbjct: 125 H--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 260 M-----------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
                          ++ +SDV+S G +L  +  G+       P        + +   N 
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TP--------FQQII-NQ 226

Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
             K+  IIDP  E ++     +    +   CL ++PK R 
Sbjct: 227 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 266

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  130 bits (328), Expect = 4e-34
 Identities = 64/347 (18%), Positives = 128/347 (36%), Gaps = 64/347 (18%)

Query: 23  MLSSSLPVKPERKHNRSISDLSDPSTPRNLED---SRKNAVLYTHVIAFSLFELETITKS 79
           ++     +K           +  P    + +D   S  N  +      +S+ +       
Sbjct: 10  LVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQ------ 63

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQ 137
                 +G GG   V++  ++E  ++       A+K +N E    Q    +  E+ +L +
Sbjct: 64  ------IGSGGSSKVFQV-LNEKKQI------YAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 138 LRHPNL--VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA---TRMMIAFGA 192
           L+  +   ++L  Y   D +  +V E      L + L +K ++         + M+    
Sbjct: 111 LQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNML---- 165

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
            + +  +H  +  +++ D K +N L+      KL DFG+A        + V    +G   
Sbjct: 166 -EAVHTIH--QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVN 221

Query: 253 YAAPEYVM-----------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW 301
           Y  PE +               ++ +SDV+S G +L  +  G+       P        +
Sbjct: 222 YMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------P--------F 267

Query: 302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
            +   N   K+  IIDP  E ++     +    +   CL ++PK R 
Sbjct: 268 QQII-NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI 313

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  128 bits (324), Expect = 7e-34
 Identities = 62/227 (27%), Positives = 96/227 (42%), Gaps = 40/227 (17%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNL 143
           +GEG FG V++      +        VAVK+L KE        ++  E   + +  +PN+
Sbjct: 55  IGEGAFGRVFQARA-PGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNI 112

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHL----------------------FRKATVPLS 181
           VKL+G C       L++E+M  G L   L                            PLS
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
            A ++ IA   A G+A+L  +ER  ++RD  T N L+  +   K++DFGL++     D  
Sbjct: 173 CAEQLCIARQVAAGMAYL--SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 242 HVSTRV------MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
                       M       PE +     T  SDV+++GVVL E+ +
Sbjct: 231 KADGNDAIPIRWM------PPESIFYNRYTTESDVWAYGVVLWEIFS 271

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (321), Expect = 1e-33
 Identities = 79/310 (25%), Positives = 118/310 (38%), Gaps = 69/310 (22%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
            LG G FG V +      +        VAVK+L KEG     HR  ++E+  L  +  H 
Sbjct: 34  PLGRGAFGQVIEADA-FGIDKTATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHL 91

Query: 142 NLVKLIGYCC-EDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRM 186
           N+V L+G C       +++ EF   G+L  +L                     L+    +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST- 245
             +F  AKG+ FL  A R  I+RD    NILL      K+ DFGLA+   +  +      
Sbjct: 152 CYSFQVAKGMEFL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209

Query: 246 -----RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKE 295
                + M      APE +     T +SDV+SFGV+L E+ + G        P      +
Sbjct: 210 ARLPLKWM------APETIFDRVYTIQSDVWSFGVLLWEIFSLGAS------PYPGVKID 257

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLM 350
           +        +L +  +M        +            +   Y     C    P  RP  
Sbjct: 258 EEFCR----RLKEGTRM-----RAPDY----------TTPEMYQTMLDCWHGEPSQRPTF 298

Query: 351 SDVVETLEPL 360
           S++VE L  L
Sbjct: 299 SELVEHLGNL 308

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  127 bits (321), Expect = 2e-33
 Identities = 69/317 (21%), Positives = 115/317 (36%), Gaps = 77/317 (24%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
           +LG G FG V        +     S+ VAVK+L KE          ++E+  + QL  H 
Sbjct: 52  VLGSGAFGKVMNATA-YGISKTGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHE 109

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL---------------------FRKATVPL 180
           N+V L+G C       L++E+   G L N+L                       +    L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE 240
           ++   +  A+  AKG+ FL    +  ++RD    N+L+      K+ DFGLA+       
Sbjct: 170 TFEDLLCFAYQVAKGMEFL--EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 227

Query: 241 THVST------RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPS 293
             V        + M      APE +  G  T +SDV+S+G++L E+ + G        P 
Sbjct: 228 YVVRGNARLPVKWM------APESLFEGIYTIKSDVWSYGILLWEIFSLGV------NPY 275

Query: 294 KEQSLVDWARPKLNDKRKMLQIID-----PRLENQYSVRAAQKACSLAYY-----CLSQN 343
                     P +       ++I       +              +   Y     C + +
Sbjct: 276 ----------PGIPVDANFYKLIQNGFKMDQPFY----------ATEEIYIIMQSCWAFD 315

Query: 344 PKARPLMSDVVETLEPL 360
            + RP   ++   L   
Sbjct: 316 SRKRPSFPNLTSFLGCQ 332

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  125 bits (316), Expect = 2e-33
 Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 34/280 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPN 142
            +G G +G   K      +R       +  K L+   +     +  ++EVN L +L+HPN
Sbjct: 13  TIGTGSYGRCQK------IRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 66

Query: 143 LVKLIG-YCCEDDHRL-LVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAF 198
           +V+         +  L +V E+   G L + +    K    L     + +       L  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126

Query: 199 LH---NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
            H   +    V++RD K +N+ LD     KL DFGLA+     D +   T V GT  Y +
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFV-GTPYYMS 184

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE +       +SD++S G +L EL           P    S  + A        K+ + 
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA-------GKIREG 231

Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
              R+  +YS     +   +    L+     RP + +++E
Sbjct: 232 KFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 267

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (322), Expect = 2e-33
 Identities = 76/309 (24%), Positives = 124/309 (40%), Gaps = 69/309 (22%)

Query: 86  LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHP 141
           LGEG FG V     I  +     +   VAVK+L K     +   + ++E+  +  + +H 
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHK 135

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--------------FRKATVPLSWATRMM 187
           N++ L+G C +D    ++ E+  +G+L  +L                     LS    + 
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-- 245
            A+  A+G+ +L  A +  I+RD    N+L+  D   K++DFGLA+     D    +T  
Sbjct: 196 CAYQVARGMEYL--ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253

Query: 246 ----RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP----SKEQ 296
               + M      APE +     T +SDV+SFGV+L E+ T G        P      E+
Sbjct: 254 RLPVKWM------APEALFDRIYTHQSDVWSFGVLLWEIFTLGG------SPYPGVPVEE 301

Query: 297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYY-----CLSQNPKARPLMS 351
                    L +  +M      +  N          C+   Y     C    P  RP   
Sbjct: 302 LF-----KLLKEGHRM-----DKPSN----------CTNELYMMMRDCWHAVPSQRPTFK 341

Query: 352 DVVETLEPL 360
            +VE L+ +
Sbjct: 342 QLVEDLDRI 350

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  131 bits (330), Expect = 3e-33
 Identities = 66/352 (18%), Positives = 109/352 (30%), Gaps = 53/352 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNLV 144
           +  GG G +Y    D N    +   PV +K L   G    +   + E  FL ++ HP++V
Sbjct: 88  IAHGGLGWIYLAL-DRN----VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIV 142

Query: 145 KLIGYCCEDDHRL-----LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           ++  +    D        +V E++   SL+    +     L  A  +         L++L
Sbjct: 143 QIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYL 198

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     ++Y D K  NI+L  +   KL D G                + GT G+ APE +
Sbjct: 199 H--SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS------FGYLYGTPGFQAPE-I 248

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
           +    T  +D+Y+ G  L  L               + +                  DP 
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDL------PTRNGRYVDGLPED------------DPV 290

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPL----MSDVVETLEPLQCANDGGNEISSSLT 375
           L+   S         L    +  +P+ R      MS  +  +     A D G       T
Sbjct: 291 LKTYDSYGR------LLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQDTGVPRPGLST 344

Query: 376 ANLVVAAGGATNAFAMGGIPGYRTRPRFSNNVGPGSSCRSPNPNCSPGGPAA 427
                 +    +            +                 P   P   AA
Sbjct: 345 IFSPSRSTFGVDLLVAHTDVYLDGQVHAEKLTANEIVTALSVPLVDPTDVAA 396

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  125 bits (317), Expect = 8e-33
 Identities = 43/226 (19%), Positives = 84/226 (37%), Gaps = 42/226 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--------------- 130
           L +G F  +     D            A+K   K  L+  R++                 
Sbjct: 39  LNQGKFNKIILCEKDNKF--------YALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90

Query: 131 --EVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
             E+  +  +++   +   G    +   + ++YE+M   S+         +  ++   + 
Sbjct: 91  KNELQIITDIKNEYCLTCEGII-TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 188 IAFGA------AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
           I              +++HN E+ + +RD K SNIL+D +   KLSDFG ++        
Sbjct: 150 IQVIKCIIKSVLNSFSYIHN-EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK--- 205

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLT---ARSDVYSFGVVLLELLTGR 284
            +     GTY +  PE   +   +   A+ D++S G+ L  +    
Sbjct: 206 KIKG-SRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNV 249

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  125 bits (315), Expect = 8e-33
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 31/228 (13%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVN 133
           T    +    ILG+G    V++G    + + G      A+KV N        +  + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRGR---HKKTGDL---FAIKVFNNISFLRPVDVQMREFE 59

Query: 134 FLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATV-PLSWATRMMI 188
            L +L H N+VKL  +  E++    H++L+ EF   GSL   L   +    L  +  +++
Sbjct: 60  VLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSDFGLAKAGPQGDETHVS 244
                 G+  L   E  +++R+ K  NI+     D     KL+DFG A+     D+    
Sbjct: 118 LRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173

Query: 245 TRVMGTYGYAAPEYVMTGHL--------TARSDVYSFGVVLLELLTGR 284
           +   GT  Y  P+      L         A  D++S GV      TG 
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  129 bits (325), Expect = 1e-32
 Identities = 62/215 (28%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRHPNL 143
            LG GGFG V +     +   G +   VA+K   +E    +RE W  E+  + +L HPN+
Sbjct: 21  RLGTGGFGYVLRWI---HQDTGEQ---VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74

Query: 144 VKLI------GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPL---SWATRMM--IAFGA 192
           V              +D  LL  E+   G L  +L +              ++  I+   
Sbjct: 75  VSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS--- 131

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVMG 249
              L +LH  E  +I+RD K  NI+L         K+ D G AK   QG+       V G
Sbjct: 132 -SALRYLH--ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCT--EFV-G 185

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE +     T   D +SFG +  E +TG 
Sbjct: 186 TLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  123 bits (310), Expect = 3e-32
 Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 24/210 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSL--PVAVKVLNKEGLQGHREWLT----EVNFLGQLR 139
           LG GG   V+    D             VAVKVL +  L     +      E      L 
Sbjct: 20  LGFGGMSEVHLAR-DL-------RDHRDVAVKVL-RADLARDPSFYLRFRREAQNAAALN 70

Query: 140 HPNLVKLIGYCCEDDHRL----LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           HP +V +      +        +V E++   +L + +  +  +    A  ++    A + 
Sbjct: 71  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA--DACQA 128

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST-RVMGTYGYA 254
           L F H     +I+RD K +NI++ +    K+ DFG+A+A      +   T  V+GT  Y 
Sbjct: 129 LNFSHQNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 186

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           +PE      + ARSDVYS G VL E+LTG 
Sbjct: 187 SPEQARGDSVDARSDVYSLGCVLYEVLTGE 216

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  121 bits (307), Expect = 5e-32
 Identities = 58/204 (28%), Positives = 89/204 (43%), Gaps = 21/204 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPN 142
           LG+G FG VY        +       +A+KVL K  L+      +   EV     LRHPN
Sbjct: 17  LGKGKFGNVYLA---REKQSKFI---LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +++L GY   D  R+ L+ E+   G++   L + +                A  L++ H 
Sbjct: 71  ILRLYGYF-HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT--YITELANALSYCH- 126

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVM 260
             + VI+RD K  N+LL S    K++DFG +   P           + GT  Y  PE + 
Sbjct: 127 -SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-----RRTDLCGTLDYLPPEMIE 180

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
                 + D++S GV+  E L G+
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  124 bits (312), Expect = 8e-32
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 31/228 (13%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVN 133
           T    +    ILG+G    V++G    + + G      A+KV N        +  + E  
Sbjct: 6   TSNHLWLLSDILGQGATANVFRG---RHKKTGDL---FAIKVFNNISFLRPVDVQMREFE 59

Query: 134 FLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATV-PLSWATRMMI 188
            L +L H N+VKL  +  E++    H++L+ EF   GSL   L   +    L  +  +++
Sbjct: 60  VLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIV 117

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSDFGLAKAGPQGDETHVS 244
                 G+  L   E  +++R+ K  NI+     D     KL+DFG A+     D+    
Sbjct: 118 LRDVVGGMNHLR--ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE--LEDDEQFV 173

Query: 245 TRVMGTYGYAAPEYVMTGHL--------TARSDVYSFGVVLLELLTGR 284
           +   GT  Y  P+      L         A  D++S GV      TG 
Sbjct: 174 SLY-GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  122 bits (308), Expect = 2e-31
 Identities = 38/228 (16%), Positives = 70/228 (30%), Gaps = 17/228 (7%)

Query: 71  FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT 130
            E +  +K     ++LGEG F  VY+    +      K     +KV              
Sbjct: 58  TEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQK-FVLKVQKPANPWEFYIGTQ 116

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV---PLSWATRMM 187
            +  L        +K        +  +LV E    G+L N +          +     + 
Sbjct: 117 LMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVIS 176

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA-----------KLSDFGLAKAGP 236
            A      +  +H+ E  +I+ D K  N +L + +              L D G +    
Sbjct: 177 FAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMK 234

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
              +  + T    T G+   E +       + D +     +  +L G 
Sbjct: 235 LFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  121 bits (306), Expect = 2e-31
 Identities = 73/337 (21%), Positives = 115/337 (34%), Gaps = 49/337 (14%)

Query: 25  SSSLPVKPERKH---NRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFR 81
           S S+            ++ S  S        E      VL T  +    +E         
Sbjct: 2   SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMT 61

Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP 141
               +G G FG V++     + + G +    AVK +  E  +       E+     L  P
Sbjct: 62  HQPRVGRGSFGEVHRMK---DKQTGFQ---CAVKKVRLEVFRVE-----ELVACAGLSSP 110

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            +V L G   E     +  E +  GSL   +  K    L     +     A +GL +LH 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLI--KQMGCLPEDRALYYLGQALEGLEYLH- 167

Query: 202 AERPVIYRDFKTSNILLDSD-YTAKLSDFGLAK--AGPQGDETHVSTRVM-GTYGYAAPE 257
             R +++ D K  N+LL SD   A L DFG A         ++ ++   + GT  + APE
Sbjct: 168 -TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 258 YVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI- 315
            VM      A+ D++S   ++L +L G        P        W   +       L+I 
Sbjct: 227 VVMGKPC-DAKVDIWSSCCMMLHMLNGC------HP--------WT--QYFRGPLCLKIA 269

Query: 316 ----IDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                   +    +   AQ         L + P  R 
Sbjct: 270 SEPPPIREIPPSCAPLTAQ----AIQEGLRKEPVHRA 302

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  120 bits (302), Expect = 3e-31
 Identities = 60/204 (29%), Positives = 86/204 (42%), Gaps = 21/204 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPN 142
           LG+G FG VY        R       +A+KVL K  L+      +   E+     LRHPN
Sbjct: 22  LGKGKFGNVYL------AREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           ++++  Y   D  R+ L+ EF  RG L   L +        +         A  L + H 
Sbjct: 76  ILRMYNYF-HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT--FMEELADALHYCH- 131

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVM 260
            ER VI+RD K  N+L+      K++DFG +   P         R M GT  Y  PE + 
Sbjct: 132 -ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-----RRRTMCGTLDYLPPEMIE 185

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
                 + D++  GV+  E L G 
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGM 209

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  119 bits (300), Expect = 7e-31
 Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 19/204 (9%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPN 142
           LG+GGF   ++     +          A K++ K  L       +   E++    L H +
Sbjct: 23  LGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 76

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +V   G+  ED+  + +V E   R SL     R+  +    A   +       G  +LH 
Sbjct: 77  VVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR--QIVLGCQYLHR 133

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM- 260
               VI+RD K  N+ L+ D   K+ DFGLA    + D       + GT  Y APE +  
Sbjct: 134 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLA-TKVEYDGERKKV-LCGTPNYIAPEVLSK 189

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
            GH +   DV+S G ++  LL G+
Sbjct: 190 KGH-SFEVDVWSIGCIMYTLLVGK 212

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  118 bits (299), Expect = 8e-31
 Identities = 62/204 (30%), Positives = 98/204 (48%), Gaps = 18/204 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPN 142
           LG+G F  VY+    E++  GL+   VA+K+++K+ +           EV    QL+HP+
Sbjct: 19  LGKGSFAGVYRA---ESIHTGLE---VAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +++L  Y  ED + + LV E    G +  +L  +         R  +      G+ +LH 
Sbjct: 73  ILELYNYF-EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH-QIITGMLYLH- 129

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM- 260
               +++RD   SN+LL  +   K++DFGLA       E H  T + GT  Y +PE    
Sbjct: 130 -SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-YT-LCGTPNYISPEIATR 186

Query: 261 TGHLTARSDVYSFGVVLLELLTGR 284
           + H    SDV+S G +   LL GR
Sbjct: 187 SAH-GLESDVWSLGCMFYTLLIGR 209

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  119 bits (301), Expect = 1e-30
 Identities = 65/298 (21%), Positives = 114/298 (38%), Gaps = 48/298 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLV 144
           L EGGF  VY+       +        A+K L     + +R  + EV F+ +L  HPN+V
Sbjct: 36  LAEGGFAFVYE------AQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 145 KLIGYCCEDDHR-------LLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGL 196
           +                   L+   + +G L   L   ++  PLS  T + I +   + +
Sbjct: 90  QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA---GPQGDETHVSTRVM----- 248
             +H  + P+I+RD K  N+LL +  T KL DFG A      P    +     ++     
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 249 --GTYGYAAPEYV-MTGHL--TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
              T  Y  PE + +  +     + D+++ G +L  L           P ++ +      
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR------QHPFEDGA------ 257

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
                    L+I++ +              SL    L  NP+ R  +++VV  L+ + 
Sbjct: 258 --------KLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA 307

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (297), Expect = 4e-30
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 21/205 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR---EWLTEVNFLGQLRHPN 142
           LG+GGF   ++     +          A K++ K  L       +   E++    L H +
Sbjct: 49  LGKGGFAKCFEI---SDADTKEV---FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQH 102

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
           +V   G+  ED+  + +V E   R SL     R+  +    A   +       G  +LH 
Sbjct: 103 VVGFHGFF-EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLR--QIVLGCQYLHR 159

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVM 260
               VI+RD K  N+ L+ D   K+ DFGLA       E     +V+ GT  Y APE + 
Sbjct: 160 --NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK---KVLCGTPNYIAPEVLS 214

Query: 261 -TGHLTARSDVYSFGVVLLELLTGR 284
             GH +   DV+S G ++  LL G+
Sbjct: 215 KKGH-SFEVDVWSIGCIMYTLLVGK 238

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  118 bits (296), Expect = 6e-30
 Identities = 68/294 (23%), Positives = 118/294 (40%), Gaps = 48/294 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLV 144
           LG G  G V+K     +  V      +A K+++ E       + + E+  L +   P +V
Sbjct: 41  LGAGNGGVVFKVSHKPSGLV------MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
              G    D    +  E M  GSL+  L +   +P     +  ++    KGL +L   + 
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK--VSIAVIKGLTYLRE-KH 151

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL 264
            +++RD K SNIL++S    KL DFG++    Q  ++  ++ V GT  Y +PE +   H 
Sbjct: 152 KIMHRDVKPSNILVNSRGEIKLCDFGVSG---QLIDSMANSFV-GTRSYMSPERLQGTHY 207

Query: 265 TARSDVYSFGVVLLELLTGR-------------------KSVDKTRPSKEQSLVDWARPK 305
           + +SD++S G+ L+E+  GR                   +      P + ++        
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267

Query: 306 LNDKRKMLQIID----------PRL-ENQYSVRAAQKACSLAYYCLSQNPKARP 348
             D R  + I +          P+L    +S     +       CL +NP  R 
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGVFS----LEFQDFVNKCLIKNPAERA 317

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  119 bits (299), Expect = 9e-30
 Identities = 71/335 (21%), Positives = 122/335 (36%), Gaps = 53/335 (15%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           SF    +LG G  GT+         R    +  VAVK +  E          EV  L + 
Sbjct: 25  SFCPKDVLGHGAEGTIVY-------RGMFDNRDVAVKRILPECFSFADR---EVQLLRES 74

Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
             HPN+++      +   + +  E     +L+ ++ +K    L      ++      GLA
Sbjct: 75  DEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLL-QQTTSGLA 132

Query: 198 FLHNAERPVIYRDFKTSNILL-----DSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGT 250
            LH     +++RD K  NIL+          A +SDFGL K  A  +   +  S    GT
Sbjct: 133 HLH--SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVP-GT 189

Query: 251 YGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTG----------RKSVDKTRPSKEQS 297
            G+ APE +      + T   D++S G V   +++           R++           
Sbjct: 190 EGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDC 249

Query: 298 LVDWARPKLNDK---RKMLQIIDPRLENQYSVRAA-------QKACSLAYYC-LSQNPKA 346
           L       +  +    KM+  +DP  + + S +              L ++  +S   + 
Sbjct: 250 LHPEKHEDVIARELIEKMIA-MDP--QKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEK 306

Query: 347 RPLMSDVVETLEPLQCANDGGNE---ISSSLTANL 378
             L   +V+ LE    A    +    I+  L  +L
Sbjct: 307 ESLDGPIVKQLERGGRAVVKMDWRENITVPLQTDL 341

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  118 bits (297), Expect = 2e-29
 Identities = 61/309 (19%), Positives = 103/309 (33%), Gaps = 55/309 (17%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           +++     S+ ILG G  GTV      +         PVAVK +  +          E+ 
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGR-------PVAVKRMLIDFCDIALM---EIK 60

Query: 134 FLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSL-----ENHLFRKATVPLSWATRMM 187
            L +   HPN+++       D    +  E     +L       ++  +          + 
Sbjct: 61  LLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPIS 119

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-------------DYTAKLSDFGLAK- 233
           +    A G+A LH     +I+RD K  NIL+ +             +    +SDFGL K 
Sbjct: 120 LLRQIASGVAHLH--SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKK 177

Query: 234 --AGPQGDETHVSTRVMGTYGYAAPE-------YVMTGHLTARSDVYSFGVVLLELLTGR 284
             +G     T+++    GT G+ APE             LT   D++S G V   +L+  
Sbjct: 178 LDSGQSSFRTNLNNPS-GTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK- 235

Query: 285 KSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNP 344
                  P          +                ++  +      +A  L    +  +P
Sbjct: 236 ----GKHPF-------GDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284

Query: 345 KARPLMSDV 353
             RP    V
Sbjct: 285 LKRPTAMKV 293

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  113 bits (286), Expect = 5e-29
 Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 28/211 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           +LG+G +G VY G    ++   ++   +A+K + +   +  +    E+     L+H N+V
Sbjct: 29  VLGKGTYGIVYAGR---DLSNQVR---IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIV 82

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWA-------TRMMIAFGAAKGLA 197
           + +G   E+    +  E +  GSL   L R    PL          T+ ++     +GL 
Sbjct: 83  QYLGSFSENGFIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQIL-----EGLK 136

Query: 198 FLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           +LH  +  +++RD K  N+L+++     K+SDFG +K     +    +    GT  Y AP
Sbjct: 137 YLH--DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGTLQYMAP 192

Query: 257 EYV---MTGHLTARSDVYSFGVVLLELLTGR 284
           E +     G+    +D++S G  ++E+ TG+
Sbjct: 193 EIIDKGPRGY-GKAADIWSLGCTIIEMATGK 222

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  113 bits (286), Expect = 6e-29
 Identities = 54/303 (17%), Positives = 101/303 (33%), Gaps = 71/303 (23%)

Query: 79  SFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEV 132
            + +++     +G G FG+V+K     +  +       A+K   K   G    +  L EV
Sbjct: 8   RYTTEFHELEKIGSGEFGSVFKCVKRLDGCI------YAIKRSKKPLAGSVDEQNALREV 61

Query: 133 NFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL--FRKATVPLSWATRMMIA 189
                L +H ++V+      EDDH L+  E+   GSL + +    +       A    + 
Sbjct: 62  YAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-------------------YTAKLSDFG 230
               +GL ++H     +++ D K SNI +                         K+ D G
Sbjct: 122 LQVGRGLRYIH--SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179

Query: 231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYSFGVVLLELLTGRKSVD 288
                 +     V     G   + A E +     HL   +D+++  + ++          
Sbjct: 180 HVT---RISSPQVEE---GDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGA----- 227

Query: 289 KTRPSKEQSLVDWARPKLNDKRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPK 345
                          P   +  +  +I     PR+    S    Q+   L    +  +P+
Sbjct: 228 --------------EPLPRNGDQWHEIRQGRLPRIPQVLS----QEFTELLKVMIHPDPE 269

Query: 346 ARP 348
            RP
Sbjct: 270 RRP 272

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (287), Expect = 1e-28
 Identities = 40/381 (10%), Positives = 87/381 (22%), Gaps = 72/381 (18%)

Query: 12  VVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLF 71
                 +++   L      +  ++    +  ++    P+N E +  +             
Sbjct: 9   SFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDS------------- 55

Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW--- 128
            L    +  +    L  G    V+      +V         A+KV          E    
Sbjct: 56  LLSQGERKLKLVEPLRVGDRSVVFLV---RDVERLE---DFALKVFTMGAENSRSELERL 109

Query: 129 LTEVNFLGQLRHPNLVKLIGYC--------------------------CEDDHRLLVYEF 162
                   +L   +  +                                   + LL+   
Sbjct: 110 HEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPA 169

Query: 163 MFRGSLEN--HLFRKATV---PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL 217
                LE          V           ++     +  A L    + +++  F   N+ 
Sbjct: 170 A-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ--SKGLVHGHFTPDNLF 226

Query: 218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL--TARSDVYSFGV 275
           +  D    L D                        YA  E++       T   + +  G+
Sbjct: 227 IMPDGRLMLGDVSALWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 276 VLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSL 335
            +  +           P  + S           +  +       L             +L
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSW---------KRPSLRVPGTDSLAFGSCTPLPDFVKTL 332

Query: 336 AYYCLSQNPKARPLMSDVVET 356
               L+ + + R L  + +ET
Sbjct: 333 IGRFLNFDRRRRLLPLEAMET 353

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  113 bits (284), Expect = 1e-28
 Identities = 74/281 (26%), Positives = 117/281 (41%), Gaps = 47/281 (16%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFL 135
            + F     +G+G FG V+KG  +   +V      VA+K+++ E  +   E +  E+  L
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKV------VAIKIIDLEEAEDEIEDIQQEITVL 74

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            Q   P + K  G   +D    ++ E++  GS    L      PL       I     KG
Sbjct: 75  SQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSA-LDLLEPG--PLDETQIATILREILKG 131

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGY 253
           L +LH+     I+RD K +N+LL      KL+DFG+A    Q  +T    R   +GT  +
Sbjct: 132 LDYLHS--EKKIHRDIKAANVLLSEHGEVKLADFGVAG---QLTDT-QIKRNTFVGTPFW 185

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM- 312
            APE +      +++D++S G+  +EL  G                    P  ++   M 
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARG-------------------EPPHSELHPMK 226

Query: 313 -LQIID----PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
            L +I     P LE  YS    +        CL++ P  RP
Sbjct: 227 VLFLIPKNNPPTLEGNYS----KPLKEFVEACLNKEPSFRP 263

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  116 bits (293), Expect = 2e-28
 Identities = 77/290 (26%), Positives = 121/290 (41%), Gaps = 23/290 (7%)

Query: 3   NCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLY 62
           N  +     ++  V  Q +   +  L   P +   + ++ L+             +++ +
Sbjct: 108 NFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFADYLDSIYF 167

Query: 63  THVIAFSLFELETITKS-FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG 121
              + +   E + +TK+ FR   +LG+GGFG V         +V       A K L K+ 
Sbjct: 168 NRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCA------CQVRATGKMYACKKLEKKR 221

Query: 122 LQGHREW---LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKAT 177
           ++  +     L E   L ++    +V L  Y  E    L LV   M  G L+ H++    
Sbjct: 222 IKKRKGEAMALNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLMNGGDLKFHIYHMGQ 280

Query: 178 VPLSWATRMMIAFGAAK---GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
                A      F AA+   GL  LH     ++YRD K  NILLD     ++SD GLA  
Sbjct: 281 AGFPEAR---AVFYAAEICCGLEDLH--RERIVYRDLKPENILLDDHGHIRISDLGLAVH 335

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
            P+G       RV GT GY APE V     T   D ++ G +L E++ G+
Sbjct: 336 VPEGQTIK--GRV-GTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  116 bits (291), Expect = 2e-28
 Identities = 65/232 (28%), Positives = 100/232 (43%), Gaps = 22/232 (9%)

Query: 62  YTHVIAFSLFELETITKS-FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE 120
           +   + +   E + + +  F    +LG GGFG V+        ++       A K LNK+
Sbjct: 168 FLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFA------CQMKATGKLYACKKLNKK 221

Query: 121 GLQGHREW---LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKA 176
            L+  + +   + E   L ++    +V L  Y  E    L LV   M  G +  H++   
Sbjct: 222 RLKKRKGYQGAMVEKKILAKVHSRFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVD 280

Query: 177 TVPLSWATRMMIAFGAAK---GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
                +     I F  A+   GL  LH  +R +IYRD K  N+LLD D   ++SD GLA 
Sbjct: 281 EDNPGFQEPRAI-FYTAQIVSGLEHLH--QRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
               G          GT G+ APE ++ G     S D ++ GV L E++  R
Sbjct: 338 ELKAGQTK-TKGYA-GTPGFMAPE-LLLGEEYDFSVDYFALGVTLYEMIAAR 386

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  111 bits (280), Expect = 4e-28
 Identities = 73/280 (26%), Positives = 112/280 (40%), Gaps = 39/280 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TEVNFLGQLRHPNLV 144
           +G G    V   Y             VA+K +N E  Q   + L  E+  + Q  HPN+V
Sbjct: 23  IGSGATAVVQAAYCAPKKEK------VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM----IAF---GAAKGLA 197
                    D   LV + +  GS+   + +         + ++    IA       +GL 
Sbjct: 77  SYYTSFVVKDELWLVMKLLSGGSV-LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL-AKAGPQGDETHVSTR--VMGTYGYA 254
           +LH      I+RD K  NILL  D + +++DFG+ A     GD T    R   +GT  + 
Sbjct: 136 YLHK--NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWM 193

Query: 255 APEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
           APE +        ++D++SFG+  +EL TG     K  P K    V     + ND     
Sbjct: 194 APEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMK----VLMLTLQ-NDP---- 244

Query: 314 QIIDPRLENQYSVRAAQKACSLAY-----YCLSQNPKARP 348
               P LE     +   K    ++      CL ++P+ RP
Sbjct: 245 ----PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  111 bits (279), Expect = 9e-28
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 23/208 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHP 141
           ILGEG F TV         R        A+K+L K  +    +      E + + +L HP
Sbjct: 37  ILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 90

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLA 197
             VKL  +  +DD +L     +   G L  ++ +  +   +        F  A+    L 
Sbjct: 91  FFVKLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT-----RFYTAEIVSALE 144

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           +LH   + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y +PE
Sbjct: 145 YLH--GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 258 YVMT-GHLTARSDVYSFGVVLLELLTGR 284
            +       + SD+++ G ++ +L+ G 
Sbjct: 203 LLTEKSACKS-SDLWALGCIIYQLVAGL 229

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  112 bits (280), Expect = 1e-27
 Identities = 42/369 (11%), Positives = 96/369 (26%), Gaps = 91/369 (24%)

Query: 43  LSDPSTPRNLEDSRKNAVLYTHVIAFSLF----------ELETITKSFRSDYILGEGGFG 92
            +          S         +++ SL+          EL    ++     +LG+    
Sbjct: 28  FNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPY 87

Query: 93  TVYKGYIDENVRVGLKSLPVAVKVLNKEGL----------------------------QG 124
              +     +   G       V V                                  + 
Sbjct: 88  AYLEA---TDQETGE---SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141

Query: 125 HREWLTEVNFLGQLRHPNLVKLIGYCCEDD--HRLLVYEFMF--RGSLENHLFRKATV-- 178
           H  ++   + +   +   ++++     +     R  +Y  M     +    L   ++   
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
            L    R+ +     + LA LH+    +++   +  +I+LD      L+ F         
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH--YGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----- 254

Query: 239 DETHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYSFGVVLLELLTGRKSV 287
                      + G+  PE                 +T   D ++ G+V+  +       
Sbjct: 255 -RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD--- 310

Query: 288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
               P  + + +  +       + +     P           Q   +L    L    + R
Sbjct: 311 ---LPITKDAALGGSEWIFRSCKNI-----P-----------QPVRALLEGFLRYPKEDR 351

Query: 348 PLMSDVVET 356
            L    +ET
Sbjct: 352 LLPLQAMET 360

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  113 bits (284), Expect = 2e-27
 Identities = 64/270 (23%), Positives = 107/270 (39%), Gaps = 39/270 (14%)

Query: 73  LETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HR 126
           + +        Y     LG G +G V       +    ++    A+K++ K  +    + 
Sbjct: 28  ITSKKGHLSEMYQRVKKLGSGAYGEVLLC---RDKVTHVE---RAIKIIRKTSVSTSSNS 81

Query: 127 EWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATR 185
           + L EV  L  L HPN++KL  +  ED     LV E    G L + +  +       A  
Sbjct: 82  KLLEEVAVLKLLDHPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAV 140

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETH 242
           ++       G+ +LH  +  +++RD K  N+LL+S   D   K+ DFGL+      +   
Sbjct: 141 IIKQV--LSGVTYLH--KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSA---VFENQK 193

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA 302
                +GT  Y APE V+      + DV+S GV+L  LL G          +    V+  
Sbjct: 194 KMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG 252

Query: 303 RPKLNDK-------------RKMLQIIDPR 319
           +   +               ++MLQ  D +
Sbjct: 253 KYTFDSPEWKNVSEGAKDLIKQMLQ-FDSQ 281

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (283), Expect = 2e-27
 Identities = 66/223 (29%), Positives = 106/223 (47%), Gaps = 26/223 (11%)

Query: 73  LETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++  T  F   Y    +LG+G FG V      ++   G +    AVKV++K  ++   + 
Sbjct: 17  VQHSTAIFSDRYKGQRVLGKGSFGEVILC---KDKITGQE---CAVKVISKRQVKQKTDK 70

Query: 129 ---LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWAT 184
              L EV  L QL HPN++KL  +  ED     LV E    G L + +  +       A 
Sbjct: 71  ESLLREVQLLKQLDHPNIMKLYEF-FEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA 129

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDET 241
           R++       G+ ++H  +  +++RD K  N+LL+S   D   ++ DFGL+      + +
Sbjct: 130 RIIRQV--LSGITYMH--KNKIVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEAS 182

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
                 +GT  Y APE V+ G    + DV+S GV+L  LL+G 
Sbjct: 183 KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGC 224

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (275), Expect = 3e-27
 Identities = 63/293 (21%), Positives = 113/293 (38%), Gaps = 50/293 (17%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHR 126
             + +LE + +       +G G  G V+K    +   V      +AVK + + G  + ++
Sbjct: 22  AEINDLENLGE-------MGSGTCGQVWKMRFRKTGHV------IAVKQMRRSGNKEENK 68

Query: 127 EWLTEVNFL-GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
             L +++ +      P +V+  G    +    +  E M   + +     +  +P     +
Sbjct: 69  RILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK 128

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             +     K L +L   +  VI+RD K SNILLD     KL DFG++    +  +     
Sbjct: 129 --MTVAIVKALYYLKE-KHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKD 182

Query: 246 RVMGTYGYAAPEYVMTGHL-----TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD 300
           R  G   Y APE +            R+DV+S G+ L+EL TG+      +   E     
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV---- 238

Query: 301 WARPKLNDKRKMLQIID---PRLEN--QYSVRAAQKACSLAYYCLSQNPKARP 348
                      + +++    P L     +S        S    CL+++ + RP
Sbjct: 239 -----------LTKVLQEEPPLLPGHMGFS----GDFQSFVKDCLTKDHRKRP 276

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  113 bits (284), Expect = 3e-27
 Identities = 67/211 (31%), Positives = 92/211 (43%), Gaps = 29/211 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL--- 138
           I+G GGFG VY        R        A+K L+K+ +   QG    L E   L  +   
Sbjct: 196 IIGRGGFGEVYG------CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 249

Query: 139 RHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK--- 194
             P +V +  Y      +L  + + M  G L  HL +      +        F AA+   
Sbjct: 250 DCPFIVCMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADM-----RFYAAEIIL 303

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           GL  +H   R V+YRD K +NILLD     ++SD GLA       + H    V GT+GY 
Sbjct: 304 GLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS-KKKPH--ASV-GTHGYM 357

Query: 255 APEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           APE +  G     S D +S G +L +LL G 
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (274), Expect = 5e-27
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 49/295 (16%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHR 126
           F+  +L+ + +       +G G +G+V K     +   G     +AVK +      +  +
Sbjct: 19  FTAEDLKDLGE-------IGRGAYGSVNKMV---HKPSGQ---IMAVKRIRSTVDEKEQK 65

Query: 127 EWLTEVNF-LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLEN-----HLFRKATVPL 180
           + L +++  +     P +V+  G    +    +  E M   S +      +      +P 
Sbjct: 66  QLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPE 124

Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE 240
               +  I     K L  L      +I+RD K SNILLD     KL DFG++    Q  +
Sbjct: 125 EILGK--ITLATVKALNHLKE-NLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVD 178

Query: 241 THVSTRVMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ 296
           +   TR  G   Y APE +           RSDV+S G+ L EL TGR    K     +Q
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238

Query: 297 SLVDWARPKLNDKRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
                          + Q++    P+L N      +    +    CL+++   RP
Sbjct: 239 ---------------LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP 278

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  109 bits (274), Expect = 6e-27
 Identities = 68/210 (32%), Positives = 99/210 (47%), Gaps = 29/210 (13%)

Query: 86  LGEGGFGTVY---KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW--LTEVNFLGQLRH 140
           LG+G FG V+   K    +  ++       A+KVL K  L+         E + L ++ H
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQL------YAMKVLKKATLKVRDRVRTKMERDILVEVNH 85

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GL 196
           P +VKL  Y  + + +L L+ +F+  G L   L ++              F  A+    L
Sbjct: 86  PFIVKLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV-----KFYLAELALAL 139

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAA 255
             LH     +IYRD K  NILLD +   KL+DFGL+K     ++         GT  Y A
Sbjct: 140 DHLH--SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK---AYSFCGTVEYMA 194

Query: 256 PEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
           PE V   GH T  +D +SFGV++ E+LTG 
Sbjct: 195 PEVVNRRGH-TQSADWWSFGVLMFEMLTGT 223

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (276), Expect = 7e-27
 Identities = 41/324 (12%), Positives = 93/324 (28%), Gaps = 80/324 (24%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---------------- 120
            ++     +LG+       +     +   G       V V                    
Sbjct: 77  PRTLVRGTVLGQEDPYAYLEA---TDQETGE---SFEVHVPYFTERPPSNAIKQMKEEVL 130

Query: 121 ------GLQGHREWLTEVNFLGQ---LRHPNLVKLIGYCCEDDHRLLVYEFM----FRGS 167
                 G++  ++    + F+     ++ P   K+I    ++    ++  F      + +
Sbjct: 131 RLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSN 190

Query: 168 LEN---HLFRKATV--PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY 222
           L+     L   ++    L    R+ +     + LA LH     +++   +  +I+LD   
Sbjct: 191 LQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH--HYGLVHTYLRPVDIVLDQRG 248

Query: 223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM----------TGHLTARSDVYS 272
              L+ F        G     S       G+A PE                +T   D ++
Sbjct: 249 GVFLTGFEHLV--RDGA----SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWT 302

Query: 273 FGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKA 332
            G+ +  +           P+ + + +  +       + +     P+             
Sbjct: 303 LGLAIYWIWCAD------LPNTDDAALGGSEWIFRSCKNI-----PQP-----------V 340

Query: 333 CSLAYYCLSQNPKARPLMSDVVET 356
            +L    L    + R L    +ET
Sbjct: 341 RALLEGFLRYPKEDRLLPLQAMET 364

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 9e-27
 Identities = 53/209 (25%), Positives = 93/209 (44%), Gaps = 17/209 (8%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
            K +     +G+G  GTVY        +       VA++ +N +        + E+  + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQE------VAIRQMNLQQQPKKELIINEILVMR 72

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           + ++PN+V  +      D   +V E++  GSL + +       +       +     + L
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQAL 129

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYA 254
            FLH+    VI+RD K+ NILL  D + KL+DFG      Q      S R  ++GT  + 
Sbjct: 130 EFLHS--NQVIHRDIKSDNILLGMDGSVKLTDFGFCA---QITPE-QSKRSTMVGTPYWM 183

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE V       + D++S G++ +E++ G
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  107 bits (270), Expect = 9e-27
 Identities = 67/295 (22%), Positives = 117/295 (39%), Gaps = 53/295 (17%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHR 126
               +LE I +       LG G +G V K     +V  G     +AVK +      Q  +
Sbjct: 4   VKADDLEPIME-------LGRGAYGVVEKMR---HVPSGQ---IMAVKRIRATVNSQEQK 50

Query: 127 EWLTEVNF-LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLE----NHLFRKATVPLS 181
             L +++  +  +  P  V   G    +    +  E M   SL+      + +  T+P  
Sbjct: 51  RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPED 109

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET 241
              +  IA    K L  LH+ +  VI+RD K SN+L+++    K+ DFG++       + 
Sbjct: 110 ILGK--IAVSIVKALEHLHS-KLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDD 163

Query: 242 HVSTRVMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS 297
                  G   Y APE +         + +SD++S G+ ++EL   R       P     
Sbjct: 164 VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRF------P----- 212

Query: 298 LVDWARPKLNDKRKMLQIID---PRL-ENQYSVRAAQKACSLAYYCLSQNPKARP 348
              W        +++ Q+++   P+L  +++S     +       CL +N K RP
Sbjct: 213 YDSWG----TPFQQLKQVVEEPSPQLPADKFS----AEFVDFTSQCLKKNSKERP 259

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  107 bits (269), Expect = 1e-26
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           LGEG +G V       N         VAVK+++ +      E +  E+     L H N+V
Sbjct: 15  LGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFLHN 201
           K  G+  E + + L  E+   G L + +     +P   A R    ++A     G+ +LH 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG 123

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE ++ 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLK 180

Query: 262 GHL--TARSDVYSFGVVLLELLTGR 284
                    DV+S G+VL  +L G 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  107 bits (270), Expect = 1e-26
 Identities = 54/214 (25%), Positives = 101/214 (47%), Gaps = 20/214 (9%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
            + +     LG+G FG VYK     N   G      A KV+  +  +   +++ E+  L 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAK---NKETGAL---AAAKVIETKSEEELEDYIVEIEILA 71

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
              HP +VKL+G    D    ++ EF   G+++  +  +    L+     ++     + L
Sbjct: 72  TCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDA-IMLELDRGLTEPQIQVVCRQMLEAL 130

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYA 254
            FLH+  + +I+RD K  N+L+  +   +L+DFG++    +  +T +  R   +GT  + 
Sbjct: 131 NFLHS--KRIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKT-LQKRDSFIGTPYWM 184

Query: 255 APEYVMTGHLT-----ARSDVYSFGVVLLELLTG 283
           APE VM   +       ++D++S G+ L+E+   
Sbjct: 185 APEVVMCETMKDTPYDYKADIWSLGITLIEMAQI 218

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  107 bits (269), Expect = 2e-26
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 31/214 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT----EVNFLGQLRHP 141
           LGEG +G V +     +     +    AVK+L K+ L+           E+  L +LRH 
Sbjct: 13  LGEGSYGKVKEV---LDSETLCR---RAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 142 NLVKL--IGYCCEDDHRLLVYEFMFRGSLENHLFRKAT---VPLSWATRM---MIAFGAA 193
           N+++L  + Y  E     +V E+   G  E  +         P+  A      +I     
Sbjct: 67  NVIQLVDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLID---- 120

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            GL +LH+  + ++++D K  N+LL +  T K+S  G+A+A              G+  +
Sbjct: 121 -GLEYLHS--QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAF 177

Query: 254 AAPEYVMTGHLT---ARSDVYSFGVVLLELLTGR 284
             PE +  G  T    + D++S GV L  + TG 
Sbjct: 178 QPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGL 210

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  107 bits (269), Expect = 2e-26
 Identities = 65/212 (30%), Positives = 96/212 (45%), Gaps = 31/212 (14%)

Query: 86  LGEGGFGTVY---KGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREW-LTEVNFLGQL 138
           LG+GG+G V+   K       ++       A+KVL K  +            E N L ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKI------FAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 139 RHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK--- 194
           +HP +V LI Y  +   +L L+ E++  G L   L R+       A      F  A+   
Sbjct: 79  KHPFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTA-----CFYLAEISM 132

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGY 253
            L  LH  ++ +IYRD K  NI+L+     KL+DFGL K           T    GT  Y
Sbjct: 133 ALGHLH--QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTV---THTFCGTIEY 187

Query: 254 AAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
            APE +M +GH     D +S G ++ ++LTG 
Sbjct: 188 MAPEILMRSGH-NRAVDWWSLGALMYDMLTGA 218

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (275), Expect = 3e-26
 Identities = 57/228 (25%), Positives = 91/228 (39%), Gaps = 34/228 (14%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---------- 122
                  Y     LG G +G V      +      +    A+KV+ K             
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLC---KEKNGHSE---KAIKVIKKSQFDKGRYSDDNK 84

Query: 123 --QGHREWL-TEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 179
             +   E +  E++ L  L HPN++KL     +  +  LV EF   G L   +  +    
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGP 236
              A  +M       G+ +LH  +  +++RD K  NILL++       K+ DFGL+    
Sbjct: 145 ECDAANIMKQI--LSGICYLH--KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSS--- 197

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
              + +     +GT  Y APE V+      + DV+S GV++  LL G 
Sbjct: 198 FFSKDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGY 244

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  109 bits (274), Expect = 3e-26
 Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 43/289 (14%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLT 130
             +F   Y    +LG+G FG V K    ++     +    AVKV+NK   +       L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILR 70

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           EV  L +L HPN++KL     ED     +V E    G L + + ++       A R++  
Sbjct: 71  EVELLKKLDHPNIMKLFEI-LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTR 246
                G+ ++H  +  +++RD K  NILL+S   D   K+ DFGL+       +      
Sbjct: 130 V--FSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKD 182

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
            +GT  Y APE V+ G    + DV+S GV+L  LL+G        P        + +   
Sbjct: 183 RIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGT------PPF-------YGK--- 225

Query: 307 NDKRKMLQII--DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
           N+   + ++       +       +  A  L    L+ +P  R   +  
Sbjct: 226 NEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (269), Expect = 5e-26
 Identities = 71/305 (23%), Positives = 122/305 (40%), Gaps = 43/305 (14%)

Query: 1   MGNCGTREESAVVSTVQVQQLHMLSSSLPVKPERKHNR-----SISDLSDPSTPRNLEDS 55
           MG+      S V    +      + +S        HN      S +DL++    ++   S
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTS 60

Query: 56  RKNAVLYTHVIAFSLFELETITKSFRSDY------ILGEGGFGTVYKGYIDENVRVGLKS 109
                +      F    +     +  S Y      ILG G FG V+K    E    GLK 
Sbjct: 61  ALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKC---EETATGLK- 116

Query: 110 LPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSL 168
             +A K++   G++   E   E++ + QL H NL++L     E  + + LV E++  G L
Sbjct: 117 --LAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGEL 173

Query: 169 ------ENHLF--RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS 220
                 E++               + +      +G+  +H  +  +++ D K  NIL  +
Sbjct: 174 FDRIIDESYNLTELDT----ILFMKQIC-----EGIRHMH--QMYILHLDLKPENILCVN 222

Query: 221 DYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLL 278
                 K+ DFGLA+     ++  V     GT  + APE V    ++  +D++S GV+  
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKV---NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAY 279

Query: 279 ELLTG 283
            LL+G
Sbjct: 280 MLLSG 284

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  106 bits (266), Expect = 6e-26
 Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT-EVNFLGQLRHPNLV 144
           LGEG +G V       N         VAVK+++ +      E +  E+     L H N+V
Sbjct: 15  LGEGAYGEVQLA---VNRVTEEA---VAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFLHN 201
           K  G+  E + + L  E+   G L + +     +P   A R    ++A     G+ +LH 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA-----GVVYLHG 123

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y APE ++ 
Sbjct: 124 --IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLK 180

Query: 262 GHL--TARSDVYSFGVVLLELLTGR 284
                    DV+S G+VL  +L G 
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE 205

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (270), Expect = 7e-26
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 34/226 (15%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---- 128
            K+ R +YI    LG G  G V         +   K   VA+++++K             
Sbjct: 130 PKALRDEYIMSKTLGSGACGEVKLA---FERKTCKK---VAIRIISKRKFAIGSAREADP 183

Query: 129 ----LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWAT 184
                TE+  L +L HP ++K+  +  + +   +V E M  G L + +     +  +   
Sbjct: 184 ALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK 242

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDET 241
                      + +LH  E  +I+RD K  N+LL S   D   K++DFG +K    G+ +
Sbjct: 243 LYFYQM--LLAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI--LGETS 296

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTAR----SDVYSFGVVLLELLTG 283
            + T   GT  Y APE V+    TA      D +S GV+L   L+G
Sbjct: 297 LMRTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  105 bits (265), Expect = 8e-26
 Identities = 65/231 (28%), Positives = 103/231 (44%), Gaps = 33/231 (14%)

Query: 74  ETITKSFRSDY-----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++ +  F   Y     +LGEG    V       N+    +    AVK++ K+        
Sbjct: 4   DSFSGRFEDVYQLQEDVLGEGAHARVQTC---INLITSQE---YAVKIIEKQPGHIRSRV 57

Query: 129 LTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
             EV  L Q + H N+++LI +  E+D   LV+E M  GS+ +H+ ++       A+ ++
Sbjct: 58  FREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV 117

Query: 188 --IAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKA-GPQGDET 241
             +    A  L FLHN  + + +RD K  NIL    +     K+ DF L       GD +
Sbjct: 118 QDV----ASALDFLHN--KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCS 171

Query: 242 HVSTRVM----GTYGYAAPEYVMTGHLTARS-----DVYSFGVVLLELLTG 283
            +ST  +    G+  Y APE V      A       D++S GV+L  LL+G
Sbjct: 172 PISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  105 bits (264), Expect = 9e-26
 Identities = 55/209 (26%), Positives = 94/209 (44%), Gaps = 17/209 (8%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
                S   +GEG  G V       + R       VAVK+++    Q       EV  + 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQ------VAVKMMDLRKQQRRELLFNEVVIMR 97

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
             +H N+V++       +   ++ EF+  G+L + +   + V L+      +     + L
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIV---SQVRLNEEQIATVCEAVLQAL 154

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYA 254
           A+LH   + VI+RD K+ +ILL  D   KLSDFG      Q  +  V  R  ++GT  + 
Sbjct: 155 AYLHA--QGVIHRDIKSDSILLTLDGRVKLSDFGFCA---QISKD-VPKRKSLVGTPYWM 208

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE +         D++S G++++E++ G
Sbjct: 209 APEVISRSLYATEVDIWSLGIMVIEMVDG 237

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  106 bits (267), Expect = 1e-25
 Identities = 58/210 (27%), Positives = 86/210 (40%), Gaps = 29/210 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           +G+G FG V        V+        A+K +NK+      E      E+  +  L HP 
Sbjct: 23  IGKGSFGKVCI------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           LV L  Y  +D+  + +V + +  G L  HL +                   +    L +
Sbjct: 77  LVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV-----KLFICELVMALDY 130

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           L    + +I+RD K  NILLD      ++DF +A   P+  +    T + GT  Y APE 
Sbjct: 131 LQ--NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI---TTMAGTKPYMAPEM 185

Query: 259 VM----TGHLTARSDVYSFGVVLLELLTGR 284
                  G+  A  D +S GV   ELL GR
Sbjct: 186 FSSRKGAGYSFA-VDWWSLGVTAYELLRGR 214

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 2e-25
 Identities = 46/211 (21%), Positives = 72/211 (34%), Gaps = 25/211 (11%)

Query: 87  GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLV 144
           G     TV                 V V+ +N E            E++      HPN+V
Sbjct: 36  GFEDLMTVNLARYKPTGEY------VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIV 89

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
                   D+   +V  FM  GS ++ +       ++      I  G  K L ++H    
Sbjct: 90  PYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH--HM 147

Query: 205 PVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA--------AP 256
             ++R  K S+IL+  D    LS                  RV+  +           +P
Sbjct: 148 GYVHRSVKASHILISVDGKVYLSGLRSNL---SMISHGQRQRVVHDFPKYSVKVLPWLSP 204

Query: 257 EYVMTGHL---TARSDVYSFGVVLLELLTGR 284
           E V+  +L    A+SD+YS G+   EL  G 
Sbjct: 205 E-VLQQNLQGYDAKSDIYSVGITACELANGH 234

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 2e-25
 Identities = 62/209 (29%), Positives = 103/209 (49%), Gaps = 17/209 (8%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
            + F     LGEG +G+VYK    E  ++      VA+K +  E     +E + E++ + 
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQI------VAIKQVPVE--SDLQEIIKEISIMQ 79

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           Q   P++VK  G   ++    +V E+   GS+ + + R     L+      I     KGL
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD-IIRLRNKTLTEDEIATILQSTLKGL 138

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTYGYA 254
            +LH      I+RD K  NILL+++  AKL+DFG+A    Q  +T ++ R  V+GT  + 
Sbjct: 139 EYLHF--MRKIHRDIKAGNILLNTEGHAKLADFGVAG---QLTDT-MAKRNTVIGTPFWM 192

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTG 283
           APE +        +D++S G+  +E+  G
Sbjct: 193 APEVIQEIGYNCVADIWSLGITAIEMAEG 221

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  106 bits (266), Expect = 3e-25
 Identities = 71/208 (34%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG+G FG V        V+        A+K+L KE +    E    LTE   L   RHP 
Sbjct: 156 LGKGTFGKVIL------VKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           L  L  Y  +   RL  V E+   G L  HL R+       A      F  A+    L +
Sbjct: 210 LTALK-YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA-----RFYGAEIVSALDY 263

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPE 257
           LH+ E+ V+YRD K  N++LD D   K++DFGL K G +   T    +   GT  Y APE
Sbjct: 264 LHS-EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGAT---MKTFCGTPEYLAPE 319

Query: 258 YVMTGHLTARS-DVYSFGVVLLELLTGR 284
            V+  +   R+ D +  GVV+ E++ GR
Sbjct: 320 -VLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  104 bits (261), Expect = 4e-25
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 31/214 (14%)

Query: 86  LGEGGFGTVY---KGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW----LTEVNFLGQL 138
           LG G +G V+   K    +  ++       A+KVL K  +    +      TE   L  +
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKL------YAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 139 RH-PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK-- 194
           R  P LV L  Y  + + +L L+ +++  G L  HL ++                  +  
Sbjct: 116 RQSPFLVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEV-----QIYVGEIV 169

Query: 195 -GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             L  LH  +  +IYRD K  NILLDS+    L+DFGL+K     +         GT  Y
Sbjct: 170 LALEHLH--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEY 226

Query: 254 AAPEYVM---TGHLTARSDVYSFGVVLLELLTGR 284
            AP+ V    +GH  A  D +S GV++ ELLTG 
Sbjct: 227 MAPDIVRGGDSGHDKA-VDWWSLGVLMYELLTGA 259

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  103 bits (260), Expect = 5e-25
 Identities = 71/208 (34%), Positives = 94/208 (45%), Gaps = 27/208 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG+G FG V        VR        A+K+L KE +    E    +TE   L   RHP 
Sbjct: 13  LGKGTFGKVIL------VREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           L  L  Y  +   RL  V E+   G L  HL R+       A      F  A+    L +
Sbjct: 67  LTALK-YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERAR-----FYGAEIVSALEY 120

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPE 257
           LH   R V+YRD K  N++LD D   K++DFGL K G     T    +   GT  Y APE
Sbjct: 121 LH--SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT---MKTFCGTPEYLAPE 175

Query: 258 YVMTGHLTARS-DVYSFGVVLLELLTGR 284
            V+  +   R+ D +  GVV+ E++ GR
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  102 bits (257), Expect = 6e-25
 Identities = 64/220 (29%), Positives = 93/220 (42%), Gaps = 28/220 (12%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL-TE 131
             +    +I    LG G FG V+     E    GL+     +K +NK+  Q   E +  E
Sbjct: 17  QGTIDDLFIFKRKLGSGAFGDVHLV---EERSSGLE---RVIKTINKDRSQVPMEQIEAE 70

Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSW----ATRM 186
           +  L  L HPN++K+     ED H + +V E    G L   +        +        +
Sbjct: 71  IEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHV 243
           M        LA+ H   + V+++D K  NIL          K+ DFGLA+          
Sbjct: 130 MKQ--MMNALAYFH--SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEH 182

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           ST   GT  Y APE V    +T + D++S GVV+  LLTG
Sbjct: 183 STNAAGTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  101 bits (255), Expect = 1e-24
 Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 35/228 (15%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK--------EGLQG 124
           T  F  +Y    ILG G    V +     +     +    AVK+++         E +Q 
Sbjct: 12  THGFYENYEPKEILGRGVSSVVRRC---IHKPTCKE---YAVKIIDVTGGGSFSAEEVQE 65

Query: 125 HREWL-TEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
            RE    EV+ L ++  HPN+++L      +    LV++ M +G L ++L  K T+    
Sbjct: 66  LREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE 125

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH 242
             ++M A    + +  LH  +  +++RD K  NILLD D   KL+DFG +    Q D   
Sbjct: 126 TRKIMRAL--LEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGE 178

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARS-------DVYSFGVVLLELLTG 283
               V GT  Y APE ++   +           D++S GV++  LL G
Sbjct: 179 KLREVCGTPSYLAPE-IIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  101 bits (254), Expect = 1e-24
 Identities = 64/216 (29%), Positives = 100/216 (46%), Gaps = 23/216 (10%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WLT 130
             +F   Y    +LG+G FG V K    ++     +    AVKV+NK   +       L 
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKC---KDRITQQE---YAVKVINKASAKNKDTSTILR 70

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           EV  L +L HPN++KL     +     +V E    G L + + ++       A R++   
Sbjct: 71  EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ- 129

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRV 247
               G+ ++H  +  +++RD K  NILL+S   D   K+ DFGL+       +       
Sbjct: 130 -VFSGITYMH--KHNIVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDR 183

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           +GT  Y APE V+ G    + DV+S GV+L  LL+G
Sbjct: 184 IGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  101 bits (254), Expect = 1e-24
 Identities = 55/215 (25%), Positives = 86/215 (40%), Gaps = 23/215 (10%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEV 132
                  Y     +G G +G V            ++    A K + K  ++    +  E+
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIA---VQKGTRIR---RAAKKIPKYFVEDVDRFKQEI 57

Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
             +  L HPN+++L     ED+  + LV E    G L   +  K     S A R+M    
Sbjct: 58  EIMKSLDHPNIIRLYET-FEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD-- 114

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRVM 248
               +A+ H  +  V +RD K  N L  +   D   KL DFGLA    +     +    +
Sbjct: 115 VLSAVAYCH--KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKV 169

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           GT  Y +P+ V+ G      D +S GV++  LL G
Sbjct: 170 GTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  101 bits (255), Expect = 2e-24
 Identities = 63/236 (26%), Positives = 96/236 (40%), Gaps = 46/236 (19%)

Query: 73  LETITKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           +    K+ R +YI    LG G  G V         +   K   VA+K+++K         
Sbjct: 1   MSVYPKALRDEYIMSKTLGSGACGEVKLA---FERKTCKK---VAIKIISKRKFAIGSAR 54

Query: 129 --------LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSL------ENHLFR 174
                    TE+  L +L HP ++K+  +  + +   +V E M  G L         L  
Sbjct: 55  EADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKE 113

Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGL 231
                       M+       + +LH  E  +I+RD K  N+LL S   D   K++DFG 
Sbjct: 114 ATCKLY---FYQML-----LAVQYLH--ENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163

Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTAR----SDVYSFGVVLLELLTG 283
           +K    G+ + + T   GT  Y APE V+    TA      D +S GV+L   L+G
Sbjct: 164 SKI--LGETSLMRTLC-GTPTYLAPE-VLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  101 bits (254), Expect = 2e-24
 Identities = 58/212 (27%), Positives = 89/212 (41%), Gaps = 35/212 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-----LTEVNFLGQLRH 140
           +GEG +G V+K    +  ++      VA+K   K              L E+  L QL+H
Sbjct: 11  IGEGSYGVVFKCRNRDTGQI------VAIK---KFLESEDDPVIKKIALREIRMLKQLKH 61

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           PNLV L+          LV+E+    ++ + L  +    +       I +   + + F H
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL-DRYQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETH-VSTRVMGTYGYAAPE 257
             +   I+RD K  NIL+      KL DFG A+   GP       V+TR      Y +PE
Sbjct: 120 --KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR-----WYRSPE 172

Query: 258 YVMTGHLTARS-----DVYSFGVVLLELLTGR 284
            ++ G           DV++ G V  ELL+G 
Sbjct: 173 -LLVG---DTQYGPPVDVWAIGCVFAELLSGV 200

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  101 bits (253), Expect = 3e-24
 Identities = 53/225 (23%), Positives = 89/225 (39%), Gaps = 43/225 (19%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEV 132
           T + R  +    +LG G F  V+     +    G      A+K + K           E+
Sbjct: 4   TTNIRKTFIFMEVLGSGAFSEVFLV---KQRLTGKL---FALKCIKKSPAFRDSSLENEI 57

Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF-----------RKATVPLS 181
             L +++H N+V L        H  LV + +  G  E  LF           + A    S
Sbjct: 58  AVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGG--E--LFDRILERGVYTEKDA----S 109

Query: 182 WATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQG 238
              + +        + +LH  E  +++RD K  N+L  +   +    ++DFGL+K     
Sbjct: 110 LVIQQV-----LSAVKYLH--ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---- 158

Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           ++  + +   GT GY APE +     +   D +S GV+   LL G
Sbjct: 159 EQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG 203

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  101 bits (255), Expect = 3e-24
 Identities = 82/275 (29%), Positives = 127/275 (46%), Gaps = 41/275 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRH 140
           ++G G +  V        VR+       A+KV+ KE +    +     TE +   Q   H
Sbjct: 16  VIGRGSYAKVLL------VRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GL 196
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      F +A+    L
Sbjct: 70  PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYSAEISLAL 123

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAA 255
            +LH  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T   T    GT  Y A
Sbjct: 124 NYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIA 178

Query: 256 PEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           PE ++ G     S D ++ GV++ E++ GR        S    +     P  N +  + Q
Sbjct: 179 PE-ILRGEDYGFSVDWWALGVLMFEMMAGR--------SPFDIVGSSDNPDQNTEDYLFQ 229

Query: 315 IIDPRLEN--QYSVRAAQKACSLAYYCLSQNPKAR 347
           +I   LE   +     + KA S+    L+++PK R
Sbjct: 230 VI---LEKQIRIPRSLSVKAASVLKSFLNKDPKER 261

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  101 bits (253), Expect = 3e-24
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 31/212 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL---NKEGLQGHREWLT---EVNFLGQLR 139
           LG G + TVYKG              VA+K +   ++EG        T   E++ + +L+
Sbjct: 13  LGNGTYATVYKGLNKTTGVY------VALKEVKLDSEEGTP-----STAIREISLMKELK 61

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           H N+V+L      ++   LV+EFM    +  +++         L         +   +GL
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYA 254
           AF H  E  +++RD K  N+L++     KL DFGLA+A   P    +     V+ T  Y 
Sbjct: 122 AFCH--ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS---EVV-TLWYR 175

Query: 255 APEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           AP+ V+ G    +   D++S G +L E++TG+
Sbjct: 176 APD-VLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  101 bits (254), Expect = 3e-24
 Identities = 55/271 (20%), Positives = 95/271 (35%), Gaps = 65/271 (23%)

Query: 69  SLFELETITKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG 124
           +L+         +  Y     +G+G +G V         +        A+K++NK  ++ 
Sbjct: 13  NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVA---IENQTRAI---RAIKIMNKNKIRQ 66

Query: 125 HREW-----LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVP 179
                     TEV  + +L HPN+ +L     ++ +  LV E    G L + L       
Sbjct: 67  INPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDS 126

Query: 180 LSWATRMMIAFG-------------------------------AAK-------GLAFLHN 201
                  ++                                   +         L +LH 
Sbjct: 127 TGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH- 185

Query: 202 AERPVIYRDFKTSNILLDSDYTA--KLSDFGLAK---AGPQGDETHVSTRVMGTYGYAAP 256
             + + +RD K  N L  ++ +   KL DFGL+K       G+   ++T+  GT  + AP
Sbjct: 186 -NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAP 243

Query: 257 EYVMTGHL---TARSDVYSFGVVLLELLTGR 284
           E V+         + D +S GV+L  LL G 
Sbjct: 244 E-VLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  101 bits (253), Expect = 4e-24
 Identities = 82/296 (27%), Positives = 121/296 (40%), Gaps = 63/296 (21%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
              F    ++G G +G VYKG    +V+ G      A+KV++  G     E   E+N L 
Sbjct: 23  AGIFELVELVGNGTYGQVYKGR---HVKTGQL---AAIKVMDVTG-DEEEEIKQEINMLK 75

Query: 137 QL-RHPNLVKLIG-----YCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIA 189
           +   H N+    G          D +L LV EF   GS+ + +       L       IA
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTL---KEEWIA 132

Query: 190 F---GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
           +      +GL+ LH  +  VI+RD K  N+LL  +   KL DFG++    Q D T V  R
Sbjct: 133 YICREILRGLSHLH--QHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRT-VGRR 186

Query: 247 --VMGTYGYAAPEYVMTGHLT-----ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
              +GT  + APE +            +SD++S G+  +E+  G                
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEG---------------- 230

Query: 300 DWARPKLNDKRKM--LQIID----PRLE-NQYSVRAAQKACSLAYYCLSQNPKARP 348
               P L D   M  L +I     PRL+  ++S    +K  S    CL +N   RP
Sbjct: 231 ---APPLCDMHPMRALFLIPRNPAPRLKSKKWS----KKFQSFIESCLVKNHSQRP 279

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  101 bits (254), Expect = 4e-24
 Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 28/207 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG G FG V        V+        A+K+L+K+ +   ++    L E   L  +  P 
Sbjct: 49  LGTGSFGRVML------VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           LVKL  +  +D+  L +V E++  G + +HL R        A      F AA+      +
Sbjct: 103 LVKLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR-----FYAAQIVLTFEY 156

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH     +IYRD K  N+L+D     +++DFG AK       T     + GT    APE 
Sbjct: 157 LH--SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEI 209

Query: 259 VMT-GHLTARSDVYSFGVVLLELLTGR 284
           +++ G+  A  D ++ GV++ E+  G 
Sbjct: 210 ILSKGYNKA-VDWWALGVLIYEMAAGY 235

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  101 bits (255), Expect = 4e-24
 Identities = 72/253 (28%), Positives = 107/253 (42%), Gaps = 29/253 (11%)

Query: 43  LSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKS-FRSDYILGEGGFGTVYKGYIDE 101
           +S P  P  +  +       +  I            S F    ++G+G FG V       
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLL----- 56

Query: 102 NVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRHPNLVKLIGYCCEDDHRL 157
             R   + +  AVKVL K+ +   +E    ++E N L + ++HP LV L  +  +   +L
Sbjct: 57  -ARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH-FSFQTADKL 114

Query: 158 -LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAFLHNAERPVIYRDFKT 213
             V +++  G L  HL R+       A      F AA+    L +LH     ++YRD K 
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPRAR-----FYAAEIASALGYLH--SLNIVYRDLKP 167

Query: 214 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAPEYVM-TGHLTARSDVY 271
            NILLDS     L+DFGL K   + + T   T    GT  Y APE +    +     D +
Sbjct: 168 ENILLDSQGHIVLTDFGLCKENIEHNST---TSTFCGTPEYLAPEVLHKQPY-DRTVDWW 223

Query: 272 SFGVVLLELLTGR 284
             G VL E+L G 
Sbjct: 224 CLGAVLYEMLYGL 236

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  101 bits (253), Expect = 5e-24
 Identities = 67/215 (31%), Positives = 97/215 (45%), Gaps = 26/215 (12%)

Query: 77  TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVN 133
            K F     +G G FG VY      N  V      VA+K ++  G Q + +W   + EV 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVR 106

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           FL +LRHPN ++  G    +    LV E+   GS  + L      PL       +  GA 
Sbjct: 107 FLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSASD-LLEVHKKPLQEVEIAAVTHGAL 164

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR--VMGTY 251
           +GLA+LH+    +I+RD K  NILL      KL DFG A        + ++     +GT 
Sbjct: 165 QGLAYLHS--HNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAPANSFVGTP 214

Query: 252 GYAAPEYVMT---GHLTARSDVYSFGVVLLELLTG 283
            + APE ++    G    + DV+S G+  +EL   
Sbjct: 215 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAER 249

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =   99 bits (250), Expect = 5e-24
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 25/207 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL---TEVNFLGQLRHPN 142
           LG G FG V  G   E+   G K   VAVK+LN++ ++          E+  L   RHP+
Sbjct: 19  LGVGTFGKVKIG---EHQLTGHK---VAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPH 72

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFL 199
           ++KL           +V E++  G L +++ +   V    A R+   +++      + + 
Sbjct: 73  IIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AVDYC 127

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     V++RD K  N+LLD+   AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 128 HR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-V 181

Query: 260 MTGHL--TARSDVYSFGVVLLELLTGR 284
           ++G L      D++S GV+L  LL G 
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYALLCGT 208

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  100 bits (250), Expect = 6e-24
 Identities = 60/236 (25%), Positives = 100/236 (42%), Gaps = 56/236 (23%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--------------- 130
           +G+G +G V   Y   N          A+KVL+K+ L     +                 
Sbjct: 21  IGKGSYGVVKLAY---NENDNTY---YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 131 -----------EVNFLGQLRHPNLVKL--IGYCCEDDHRLLVYEFMFRGSLENHLFRKAT 177
                      E+  L +L HPN+VKL  +     +DH  +V+E + +G +        T
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV----MEVPT 130

Query: 178 V-PLSWAT-----RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL 231
           + PLS        + +I      G+ +LH   + +I+RD K SN+L+  D   K++DFG+
Sbjct: 131 LKPLSEDQARFYFQDLIK-----GIEYLHY--QKIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT---ARSDVYSFGVVLLELLTGR 284
           +    +G +  +S  V GT  + APE +            DV++ GV L   + G+
Sbjct: 184 S-NEFKGSDALLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  100 bits (252), Expect = 9e-24
 Identities = 62/294 (21%), Positives = 112/294 (38%), Gaps = 32/294 (10%)

Query: 7   REESAVVSTVQVQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVI 66
           R E   +  +  +Q      SL   P +  N                ++     +     
Sbjct: 23  RREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDE 82

Query: 67  AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR 126
                  +   + +    ++G G    V +     +   G +    AVK++     +   
Sbjct: 83  LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRC---VHRATGHE---FAVKIMEVTAERLSP 136

Query: 127 EWL--------TEVNFLGQLR-HPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKA 176
           E L         E + L Q+  HP+++ LI    E    + LV++ M +G L ++L  K 
Sbjct: 137 EQLEEVREATRRETHILRQVAGHPHIITLIDSY-ESSSFMFLVFDLMRKGELFDYLTEKV 195

Query: 177 TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP 236
            +       +M +    + ++FLH     +++RD K  NILLD +   +LSDFG +    
Sbjct: 196 ALSEKETRSIMRSL--LEAVSFLH--ANNIVHRDLKPENILLDDNMQIRLSDFGFSC--- 248

Query: 237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARS-------DVYSFGVVLLELLTG 283
             +       + GT GY APE ++   +           D+++ GV+L  LL G
Sbjct: 249 HLEPGEKLRELCGTPGYLAPE-ILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 56/219 (25%), Positives = 100/219 (45%), Gaps = 28/219 (12%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLT 130
           +  F  +Y     LG+G F  V +     +   GL+    A K++N + L     ++   
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLER 54

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM--I 188
           E     +L+HPN+V+L     E+    LV++ +  G L   +  +     + A+  +  I
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 114

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVST 245
                + +A+ H     +++R+ K  N+LL S       KL+DFGLA    + +++    
Sbjct: 115 ----LESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWH 165

Query: 246 RVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTG 283
              GT GY +PE V+     +   D+++ GV+L  LL G
Sbjct: 166 GFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVG 203

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (252), Expect = 1e-23
 Identities = 53/222 (23%), Positives = 88/222 (39%), Gaps = 36/222 (16%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEV 132
             S    Y     LG G FG V++         G        K +N            E+
Sbjct: 46  QGSVYDYYDILEELGSGAFGVVHRC---VEKATGRV---FVAKFINTPYPLDKYTVKNEI 99

Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSL------ENHLF--RKATVPLSWA 183
           + + QL HP L+ L     ED + + L+ EF+  G L      E++     +        
Sbjct: 100 SIMNQLHHPKLINLHDA-FEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN----Y 154

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFGLAKAGPQGDET 241
            R        +GL  +H  E  +++ D K  NI+ ++    + K+ DFGLA    + +  
Sbjct: 155 MRQAC-----EGLKHMH--EHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPD 204

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            +      T  +AAPE V    +   +D+++ GV+   LL+G
Sbjct: 205 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  100 bits (252), Expect = 1e-23
 Identities = 73/315 (23%), Positives = 121/315 (38%), Gaps = 52/315 (16%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG 121
              V+A      E    ++ +  ++G G FG V++  + E+  V +K      KV     
Sbjct: 24  VIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK------KV----- 72

Query: 122 LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL------LVYEFMFRGSLENHL--F 173
           LQ  R    E+  +  ++HPN+V L  +   +  +       LV E++   ++      +
Sbjct: 73  LQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHY 131

Query: 174 RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLA 232
            K    +      +  +   + LA++H+    + +RD K  N+LLD      KL DFG A
Sbjct: 132 AKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSA 189

Query: 233 KA-GPQGDETH-VSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGR---- 284
           K           + +R    Y Y APE ++ G  + T   D++S G V+ EL+ G+    
Sbjct: 190 KILIAGEPNVSYICSR----Y-YRAPE-LIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 285 --KSVDKTR--------PSKEQSLVDWARPKLNDKRKMLQIIDPR-LENQYSVRAAQKAC 333
               +D+          PS+EQ          N        I P      +  R    A 
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQ----IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAI 299

Query: 334 SLAYYCLSQNPKARP 348
            L    L   P AR 
Sbjct: 300 DLISRLLEYTPSARL 314

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  100 bits (252), Expect = 1e-23
 Identities = 49/215 (22%), Positives = 80/215 (37%), Gaps = 30/215 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G F  V        V++       A+K++NK  +    E   +  E + L      
Sbjct: 68  VIGRGAFSEVAV------VKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRR 121

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATV-PLSWATRMMIAFGAAK---GL 196
            + +L  +  +D++ L LV E+   G L   L +     P   A      F  A+    +
Sbjct: 122 WITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMAR-----FYLAEIVMAI 175

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
             +H      ++RD K  NILLD     +L+DFG                V GT  Y +P
Sbjct: 176 DSVH--RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSP 232

Query: 257 EYVMTGHLTARSDVY-------SFGVVLLELLTGR 284
           E +        +  Y       + GV   E+  G+
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  100 bits (251), Expect = 2e-23
 Identities = 79/273 (28%), Positives = 127/273 (46%), Gaps = 37/273 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRH 140
           ++G G +  V        VR+       A++V+ KE +    +     TE +   Q   H
Sbjct: 59  VIGRGSYAKVLL------VRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112

Query: 141 PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GL 196
           P LV L   C + + RL  V E++  G L  H+ R+  +P   A      F +A+    L
Sbjct: 113 PFLVGLH-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHAR-----FYSAEISLAL 166

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAA 255
            +LH  ER +IYRD K  N+LLDS+   KL+D+G+ K G +  +T   T    GT  Y A
Sbjct: 167 NYLH--ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT---TSTFCGTPNYIA 221

Query: 256 PEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           PE ++ G     S D ++ GV++ E++ GR        S    +     P  N +  + Q
Sbjct: 222 PE-ILRGEDYGFSVDWWALGVLMFEMMAGR--------SPFDIVGSSDNPDQNTEDYLFQ 272

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR 347
           +I  + + +     + KA S+    L+++PK R
Sbjct: 273 VILEK-QIRIPRSLSVKAASVLKSFLNKDPKER 304

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  100 bits (251), Expect = 2e-23
 Identities = 54/213 (25%), Positives = 86/213 (40%), Gaps = 28/213 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V        V++       A+K+LNK  +    E   +  E + L      
Sbjct: 81  VIGRGAFGEVAV------VKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSK 134

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAK---GL 196
            +  L  Y  +DD+ L LV ++   G L   L + +  +P   A      F  A+    +
Sbjct: 135 WITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMAR-----FYLAEMVIAI 188

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
             +H      ++RD K  NIL+D +   +L+DFG      +      S  V GT  Y +P
Sbjct: 189 DSVHQ--LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISP 245

Query: 257 EYVMTGHLTARS-----DVYSFGVVLLELLTGR 284
           E +              D +S GV + E+L G 
Sbjct: 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 98.8 bits (247), Expect = 3e-23
 Identities = 58/208 (27%), Positives = 87/208 (41%), Gaps = 27/208 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-----LTEVNFLGQLRH 140
           +GEG +G V K    +  R+      VA+K   K       +      + E+  L QLRH
Sbjct: 33  VGEGSYGMVMKCRNKDTGRI------VAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
            NLV L+  C +     LV+EF+   ++ + L       L +       F    G+ F H
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDL-ELFPNGLDYQVVQKYLFQIINGIGFCH 141

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETH-VSTRVMGTYGYAAPE 257
                +I+RD K  NIL+      KL DFG A+    P       V+TR      Y APE
Sbjct: 142 --SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR-----WYRAPE 194

Query: 258 YVM-TGHLTARSDVYSFGVVLLELLTGR 284
            ++         DV++ G ++ E+  G 
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.5 bits (246), Expect = 4e-23
 Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 30/220 (13%)

Query: 77  TKSFRSDY-------ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL 129
              F   Y        LGEG F    K     + +        AVK+++K      ++  
Sbjct: 3   DSPFYQHYDLDLKDKPLGEGSFSICRKC---VHKKSNQA---FAVKIISKRMEANTQK-- 54

Query: 130 TEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM- 187
            E+  L     HPN+VKL     +  H  LV E +  G L   + +K     + A+ +M 
Sbjct: 55  -EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMR 113

Query: 188 -IAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHV 243
            +       ++ +H  +  V++RD K  N+L    + +   K+ DFG A+  P  ++  +
Sbjct: 114 KL----VSAVSHMH--DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP-L 166

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            T    T  YAAPE +         D++S GV+L  +L+G
Sbjct: 167 KTPC-FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSG 205

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 53/206 (25%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE--WLTEVNFLGQLRHPNL 143
           +G+G F  V       ++  G +   VA+K+++K  L          EV  +  L HPN+
Sbjct: 23  IGKGNFAKVKLA---RHILTGRE---VAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNI 76

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFLH 200
           VKL      +    L+ E+   G + ++L     +    A      +++      + + H
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCH 131

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + +++RD K  N+LLD+D   K++DFG +     G +        G   YAAPE + 
Sbjct: 132 Q--KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPE-LF 185

Query: 261 TGHL--TARSDVYSFGVVLLELLTGR 284
            G        DV+S GV+L  L++G 
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGS 211

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 98.4 bits (246), Expect = 5e-23
 Identities = 66/208 (31%), Positives = 93/208 (44%), Gaps = 26/208 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRHP 141
           LG+G FG V+     +  +        A+K L K+ +    +    + E   L     HP
Sbjct: 25  LGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLA 197
            L  +     +    L  V E++  G L  H+       LS AT     F AA+   GL 
Sbjct: 79  FLTHMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRAT-----FYAAEIILGLQ 132

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAP 256
           FLH   + ++YRD K  NILLD D   K++DFG+ K    GD     T    GT  Y AP
Sbjct: 133 FLH--SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK---TNTFCGTPDYIAP 187

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGR 284
           E ++        D +SFGV+L E+L G+
Sbjct: 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 99.5 bits (248), Expect = 7e-23
 Identities = 62/207 (29%), Positives = 102/207 (49%), Gaps = 25/207 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT---EVNFLGQLRHPN 142
           LG G FG V  G   ++   G K   VAVK+LN++ ++          E+  L   RHP+
Sbjct: 24  LGVGTFGKVKVG---KHELTGHK---VAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFL 199
           ++KL           +V E++  G L +++ +   +    + R+   +++     G+ + 
Sbjct: 78  IIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GVDYC 132

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     V++RD K  N+LLD+   AK++DFGL+     G+    S    G+  YAAPE V
Sbjct: 133 HR--HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPE-V 186

Query: 260 MTGHL--TARSDVYSFGVVLLELLTGR 284
           ++G L      D++S GV+L  LL G 
Sbjct: 187 ISGRLYAGPEVDIWSSGVILYALLCGT 213

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 97.7 bits (244), Expect = 8e-23
 Identities = 60/207 (28%), Positives = 99/207 (47%), Gaps = 26/207 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL---TEVNFLGQLRHPN 142
           LGEG FG V       + +   K   VA+K ++++ L+     +    E+++L  LRHP+
Sbjct: 17  LGEGSFGKVKLA---THYKTQQK---VALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFL 199
           ++KL          ++V E+   G L +++  K  +      R    +I       + + 
Sbjct: 71  IIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYC 124

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H     +++RD K  N+LLD +   K++DFGL+     G+    S    G+  YAAPE V
Sbjct: 125 HR--HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPE-V 178

Query: 260 MTGHL--TARSDVYSFGVVLLELLTGR 284
           + G L      DV+S G+VL  +L GR
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGR 205

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 97.5 bits (243), Expect = 8e-23
 Identities = 52/213 (24%), Positives = 87/213 (40%), Gaps = 31/213 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--------EVNFLGQ 137
           LG G FG V+      +     +   V VK + KE +                E+  L +
Sbjct: 32  LGSGAFGFVWTA---VDKEKNKE---VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGS-LENHLFRKATVPLSWATRM---MIAFGAA 193
           + H N++K++          LV E    G  L   + R   +    A+ +   +++    
Sbjct: 86  VEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS---- 141

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
             + +L    + +I+RD K  NI++  D+T KL DFG A    +G   +      GT  Y
Sbjct: 142 -AVGYLRL--KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFC---GTIEY 195

Query: 254 AAPEYVMTGHL--TARSDVYSFGVVLLELLTGR 284
            APE V+ G+       +++S GV L  L+   
Sbjct: 196 CAPE-VLMGNPYRGPELEMWSLGVTLYTLVFEE 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 26/215 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G +G VYK    ++ +        A+K +   G+        E+  L +L+HPN++ 
Sbjct: 29  VGRGTYGHVYKA-KRKDGKDDKD---YALKQIEGTGI--SMSACREIALLRELKHPNVIS 82

Query: 146 LIGYCCED-DHRL-LVYEFM---FRGSLENHLFRKA---TVPLSWATRMMIAFGAAKGLA 197
           L        D ++ L++++        ++ H   KA    V L       + +    G+ 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTA----KLSDFGLAKA--GPQGDETHVSTRVMGTY 251
           +LH     V++RD K +NIL+  +       K++D G A+    P      +   V+ T+
Sbjct: 143 YLH--ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TF 199

Query: 252 GYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
            Y APE ++ G  H T   D+++ G +  ELLT  
Sbjct: 200 WYRAPE-LLLGARHYTKAIDIWAIGCIFAELLTSE 233

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 34/211 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL---NKEGL--QGHREWLTEVNFLGQLRH 140
           LGEG + TVYKG       +      VA+K +   ++EG      RE    V+ L  L+H
Sbjct: 10  LGEGTYATVYKGKSKLTDNL------VALKEIRLEHEEGAPCTAIRE----VSLLKDLKH 59

Query: 141 PNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
            N+V L      +    LV+E++    +  L++         ++     +  F   +GLA
Sbjct: 60  ANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDC-----GNIINMHNVKLFLFQLLRGLA 114

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAA 255
           + H   + V++RD K  N+L++     KL+DFGLA+A   P     +    V+ T  Y  
Sbjct: 115 YCH--RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN---EVV-TLWYRP 168

Query: 256 PEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           P+ ++ G    + + D++  G +  E+ TGR
Sbjct: 169 PD-ILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 96.4 bits (241), Expect = 1e-22
 Identities = 63/207 (30%), Positives = 100/207 (48%), Gaps = 28/207 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHPN 142
           LG G FG V+       +R        A+KVL KE +   ++      E   L  + HP 
Sbjct: 14  LGTGSFGRVHL------IRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 143 LVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLAF 198
           ++++     +D  ++ ++ +++  G L + L +    P   A      F AA+    L +
Sbjct: 68  IIRMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA-----KFYAAEVCLALEY 121

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEY 258
           LH   + +IYRD K  NILLD +   K++DFG AK     D T+  T + GT  Y APE 
Sbjct: 122 LH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV--PDVTY--T-LCGTPDYIAPEV 174

Query: 259 VMT-GHLTARSDVYSFGVVLLELLTGR 284
           V T  +  +  D +SFG+++ E+L G 
Sbjct: 175 VSTKPYNKS-IDWWSFGILIYEMLAGY 200

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 96.9 bits (241), Expect = 2e-22
 Identities = 50/242 (20%), Positives = 93/242 (38%), Gaps = 32/242 (13%)

Query: 125 HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-FRKATVPLSWA 183
                 ++  +      N V  +       +  +  +   + +L++ +  R +       
Sbjct: 105 MDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETH- 242
             + I    A+ + FLH+  + +++RD K SNI    D   K+ DFGL  A  Q +E   
Sbjct: 165 VCLHIFIQIAEAVEFLHS--KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 243 ---------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS 293
                      T  +GT  Y +PE +   + + + D++S G++L ELL            
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFS------TQ 276

Query: 294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
            E+  +      + D R    +  P L  Q       +   +    LS +P  RP  +D+
Sbjct: 277 MERVRI------ITDVRN---LKFPLLFTQKY----PQEHMMVQDMLSPSPTERPEATDI 323

Query: 354 VE 355
           +E
Sbjct: 324 IE 325

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 19/81 (23%), Positives = 34/81 (41%), Gaps = 11/81 (13%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNF 134
           + +D+     +G GGFG V++       +  +     A+K +     +  RE  + EV  
Sbjct: 4   YLTDFEPIQCMGRGGFGVVFE------AKNKVDDCNYAIKRIRLPNRELAREKVMREVKA 57

Query: 135 LGQLRHPNLVKLIGYCCEDDH 155
           L +L HP +V+      E   
Sbjct: 58  LAKLEHPGIVRYFNAWLETPP 78

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 63/210 (30%), Positives = 102/210 (48%), Gaps = 32/210 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGL--QGHREWLTEVNFLGQLR 139
           +GEG +G VYK   D   R+      VA+K +      EG+     RE    ++ L +L 
Sbjct: 29  VGEGTYGVVYKA-KDSQGRI------VALKRIRLDAEDEGIPSTAIRE----ISLLKELH 77

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           HPN+V LI     +    LV+EFM    +  L+ +        L  +   +  +   +G+
Sbjct: 78  HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-----KTGLQDSQIKIYLYQLLRGV 132

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A  H  +  +++RD K  N+L++SD   KL+DFGLA+A   G      T  + T  Y AP
Sbjct: 133 AHCH--QHRILHRDLKPQNLLINSDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAP 188

Query: 257 EYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           + V+ G    +   D++S G +  E++TG+
Sbjct: 189 D-VLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 99.1 bits (247), Expect = 2e-22
 Identities = 61/276 (22%), Positives = 99/276 (35%), Gaps = 37/276 (13%)

Query: 25  SSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETI---TKSFR 81
           ++ + +  + +  R   D+ +       + +  +         +  +  + +        
Sbjct: 97  TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156

Query: 82  SDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
             Y     LG G FG V++         G      A K +             E+  +  
Sbjct: 157 DHYDIHEELGTGAFGVVHRV---TERATGNN---FAAKFVMTPHESDKETVRKEIQTMSV 210

Query: 138 LRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSL-------ENHLFRKATVPLSWATRMMIA 189
           LRHP LV L     EDD+ + ++YEFM  G L        N +     V      R +  
Sbjct: 211 LRHPTLVNLHDA-FEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEY---MRQVC- 265

Query: 190 FGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFGLAKAGPQGDETHVSTRV 247
               KGL  +H  E   ++ D K  NI+  +      KL DFGL           V    
Sbjct: 266 ----KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---T 316

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            GT  +AAPE      +   +D++S GV+   LL+G
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 63/209 (30%), Positives = 94/209 (44%), Gaps = 28/209 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRHP 141
           LG+G FG V                  AVK+L K+ +    +    + E   L    + P
Sbjct: 28  LGKGSFGKVML------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLA 197
            L +L   C +   RL  V E++  G L  H+ +        A      F AA+   GL 
Sbjct: 82  FLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIGLF 135

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAP 256
           FL    + +IYRD K  N++LDS+   K++DFG+ K       T   T+   GT  Y AP
Sbjct: 136 FLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYIAP 190

Query: 257 EYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           E ++      +S D ++FGV+L E+L G+
Sbjct: 191 E-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 59/211 (27%), Positives = 94/211 (44%), Gaps = 31/211 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLTEVNFLGQLRHP 141
           +GEG +GTV+K    E   +      VA+K +    + EG+      L E+  L +L+H 
Sbjct: 10  IGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGV--PSSALREICLLKELKHK 61

Query: 142 NLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
           N+V+L      D    LV+EF     +   ++         L         F   KGL F
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC-----NGDLDPEIVKSFLFQLLKGLGF 116

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYAAP 256
            H   R V++RD K  N+L++ +   KL++FGLA+A   P    +     V+ T  Y  P
Sbjct: 117 CH--SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA---EVV-TLWYRPP 170

Query: 257 EYVMTG--HLTARSDVYSFGVVLLELLTGRK 285
           + V+ G    +   D++S G +  EL    +
Sbjct: 171 D-VLFGAKLYSTSIDMWSAGCIFAELANAGR 200

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 54/216 (25%), Positives = 98/216 (45%), Gaps = 22/216 (10%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLT 130
           +  F  +Y     LG+G F  V +     +   GL+    A K++N + L     ++   
Sbjct: 24  STKFSDNYDVKEELGKGAFSVVRRC---VHKTTGLE---FAAKIINTKKLSARDFQKLER 77

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E     +L+HPN+V+L     E+    LV++ +  G L   +  +     + A+  +   
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI 137

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRV 247
              + +A+ H     +++R+ K  N+LL S       KL+DFGLA    + +++      
Sbjct: 138 --LESIAYCH--SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGF 190

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            GT GY +PE +     +   D+++ GV+L  LL G
Sbjct: 191 AGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 96.3 bits (240), Expect = 3e-22
 Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 40/229 (17%)

Query: 73  LETITKSFRSDY-----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE 127
            E    +   DY     +LG G  G V +     + R G K    A+K+L          
Sbjct: 19  PEPKKYAVTDDYQLSKQVLGLGVNGKVLEC---FHRRTGQK---CALKLLYDSPKAR--- 69

Query: 128 WLTEVNFLGQL-RHPNLVKLIGYCCEDDHR-----LLVYEFMFRGSLENHLFRKATVPLS 181
              EV+   Q    P++V ++    E+ H      L++ E M  G L + +  +     +
Sbjct: 70  --QEVDHHWQASGGPHIVCILDVY-ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFT 126

Query: 182 --WATRMM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKA 234
              A  +M  I       + FLH     + +RD K  N+L    + D   KL+DFG AK 
Sbjct: 127 EREAAEIMRDIG----TAIQFLH--SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
             Q     + T    T  Y APE +         D++S GV++  LL G
Sbjct: 181 TTQNA---LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 96.7 bits (241), Expect = 3e-22
 Identities = 58/230 (25%), Positives = 88/230 (38%), Gaps = 45/230 (19%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKS--LPVAVKVLNKEGLQGHREW-- 128
            +     Y     LG G F  V         +   KS  L  A K + K   +  R    
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVK--------KCREKSTGLEYAAKFIKKRQSRASRRGVC 58

Query: 129 ----LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSL------ENHLFRKAT 177
                 EV+ L Q+ HPN++ L     E+   + L+ E +  G L      +  L  +  
Sbjct: 59  REEIEREVSILRQVLHPNIITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEA 117

Query: 178 VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----DYTAKLSDFGLAK 233
                  + ++      G+ +LH   + + + D K  NI+L          KL DFGLA 
Sbjct: 118 TSF---IKQIL-----DGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
               G E      + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 168 EIEDGVEFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 96.1 bits (240), Expect = 3e-22
 Identities = 70/209 (33%), Positives = 96/209 (45%), Gaps = 28/209 (13%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRHP 141
           LG+G FG V         RV       AVKVL K+ +    +    +TE   L     HP
Sbjct: 31  LGKGSFGKVML------ARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLA 197
            L +L   C +   RL  V EF+  G L  H+ +      + A      F AA+    L 
Sbjct: 85  FLTQLF-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARAR-----FYAAEIISALM 138

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYAAP 256
           FLH  ++ +IYRD K  N+LLD +   KL+DFG+ K G     T   T    GT  Y AP
Sbjct: 139 FLH--DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT---TATFCGTPDYIAP 193

Query: 257 EYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           E ++   L   + D ++ GV+L E+L G 
Sbjct: 194 E-ILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 96.2 bits (240), Expect = 4e-22
 Identities = 58/234 (24%), Positives = 94/234 (40%), Gaps = 34/234 (14%)

Query: 69  SLFELETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG 124
            + ++      F   Y    ++G+G F  V +     N   G +    AVK+++      
Sbjct: 11  GILDMADDDVLFEDVYELCEVIGKGPFSVVRRC---INRETGQQ---FAVKIVDVAKFTS 64

Query: 125 HREW-----LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATV 178
                      E +    L+HP++V+L+      D  L +V+EFM    L   + ++A  
Sbjct: 65  SPGLSTEDLKREASICHMLKHPHIVELLET-YSSDGMLYMVFEFMDGADLCFEIVKRADA 123

Query: 179 PLSW----ATRMM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDF 229
              +    A+  M  I     + L + H  +  +I+RD K   +LL S       KL  F
Sbjct: 124 GFVYSEAVASHYMRQI----LEALRYCH--DNNIIHRDVKPHCVLLASKENSAPVKLGGF 177

Query: 230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           G+A    +        RV GT  + APE V         DV+  GV+L  LL+G
Sbjct: 178 GVAIQLGESGLV-AGGRV-GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 95.4 bits (238), Expect = 4e-22
 Identities = 61/224 (27%), Positives = 91/224 (40%), Gaps = 33/224 (14%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---- 128
            +     Y     LG G F  V K         GL+    A K + K   +  R      
Sbjct: 7   QQKVEDFYDIGEELGSGQFAIVKKC---REKSTGLE---YAAKFIKKRQSRASRRGVSRE 60

Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATR 185
               EV+ L Q+ H N++ L     E+   + L+ E +  G L + L +K ++    AT 
Sbjct: 61  EIEREVSILRQVLHHNVITLHDV-YENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119

Query: 186 MM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----DYTAKLSDFGLAKAGPQGD 239
            +  I      G+ +LH   + + + D K  NI+L          KL DFGLA     G 
Sbjct: 120 FIKQI----LDGVNYLH--TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           E      + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 174 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 52/221 (23%), Positives = 94/221 (42%), Gaps = 25/221 (11%)

Query: 72  ELETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE 127
           +L   +  F   Y     +G G +    +     +    ++    AVK+++K       E
Sbjct: 12  QLHRNSIQFTDGYEVKEDIGVGSYSVCKRC---IHKATNME---FAVKIIDKSKRDPTEE 65

Query: 128 WLTEVNFLGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
               +  L +  +HPN++ L     +  +  +V E M  G L + + R+       A+ +
Sbjct: 66  ----IEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV 121

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD----YTAKLSDFGLAKAGPQGDETH 242
           +      K + +LH   + V++RD K SNIL   +     + ++ DFG AK     +   
Sbjct: 122 LFTI--TKTVEYLH--AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL- 176

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           + T    T  + APE +      A  D++S GV+L  +LTG
Sbjct: 177 LMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 96.3 bits (240), Expect = 6e-22
 Identities = 64/272 (23%), Positives = 111/272 (40%), Gaps = 32/272 (11%)

Query: 26  SSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYI 85
           S  P       +              +   +  + + T V             S+    +
Sbjct: 2   SGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKV 61

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG VY+  + ++  +      VA+K +    LQ  R    E+  + +L H N+V+
Sbjct: 62  IGNGSFGVVYQAKLCDSGEL------VAIKKV----LQDKRFKNRELQIMRKLDHCNIVR 111

Query: 146 LIGYCCEDDHRL------LVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLA 197
           L  +      +       LV +++   ++      + +A   L      +  +   + LA
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170

Query: 198 FLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDE-TH-VSTRVMGTYGYA 254
           ++H+    + +RD K  N+LLD D    KL DFG AK   +G+     + +R    Y Y 
Sbjct: 171 YIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSR----Y-YR 223

Query: 255 APEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           APE ++ G    T+  DV+S G VL ELL G+
Sbjct: 224 APE-LIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.1 bits (235), Expect = 6e-22
 Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 36/212 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGL--QGHREWLTEVNFLGQLR 139
           +GEG +G VYK   +            A+K +      EG+     RE    ++ L +L+
Sbjct: 10  IGEGTYGVVYKA-QNNYGET------FALKKIRLEKEDEGIPSTTIRE----ISILKELK 58

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           H N+VKL          +LV+E +    +  L+          L   T          G+
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGI 113

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETHVSTRVMGTYGYA 254
           A+ H  +R V++RD K  N+L++ +   K++DFGLA+A   P    TH    ++ T  Y 
Sbjct: 114 AYCH--DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH---EIV-TLWYR 167

Query: 255 APEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           AP+ V+ G    +   D++S G +  E++ G 
Sbjct: 168 APD-VLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 94.7 bits (236), Expect = 7e-22
 Identities = 55/225 (24%), Positives = 90/225 (40%), Gaps = 35/225 (15%)

Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT--- 130
           +   S Y     LG GGFG+VY G     V   L    VA+K + K+ +    E      
Sbjct: 39  EPLESQYQVGPLLGSGGFGSVYSGI---RVSDNLP---VAIKHVEKDRISDWGELPNGTR 92

Query: 131 ---EVNFLGQLRH--PNLVKLIGYCCEDDHRLLVYEFMF-RGSLENHLFRKATVPLSWAT 184
              EV  L ++      +++L+ +    D  +L+ E       L + +  +  +    A 
Sbjct: 93  VPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELAR 152

Query: 185 RMM---IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDE 240
                 +       +   HN    V++RD K  NIL+D +    KL DFG   A  +   
Sbjct: 153 SFFWQVLE-----AVRHCHN--CGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTV 204

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
                   GT  Y+ PE++       RS  V+S G++L +++ G 
Sbjct: 205 YTDFD---GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 95.9 bits (239), Expect = 7e-22
 Identities = 61/211 (28%), Positives = 89/211 (42%), Gaps = 27/211 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNFLGQLRHP 141
           ++G G FG V        VR        A+K+L+K  +    +   +  E + +     P
Sbjct: 76  VIGRGAFGEVQL------VRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129

Query: 142 NLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---GLA 197
            +V+L  Y  +DD  L +V E+M  G L N +     VP  WA      F  A+    L 
Sbjct: 130 WVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM-SNYDVPEKWA-----RFYTAEVVLALD 182

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
            +H+     I+RD K  N+LLD     KL+DFG      +       T V GT  Y +PE
Sbjct: 183 AIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPE 239

Query: 258 YVMTGHLTAR----SDVYSFGVVLLELLTGR 284
            + +           D +S GV L E+L G 
Sbjct: 240 VLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 94.3 bits (235), Expect = 7e-22
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 33/215 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLT------EVNFLGQLR 139
           LG+GGFGTV+ G     +   L+   VA+KV+ +  + G            EV  L ++ 
Sbjct: 39  LGKGGFGTVFAG---HRLTDRLQ---VAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 140 ----HPNLVKLIGYCCEDDHRLLVYEFMFRGS-LENHLFRKATVPLSWATRMM---IAFG 191
               HP +++L+ +    +  +LV E       L +++  K  +    +       +A  
Sbjct: 93  AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA-- 150

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGPQGDETHVSTRVMGT 250
               +   H+  R V++RD K  NIL+D     AKL DFG   A    +         GT
Sbjct: 151 ---AIQHCHS--RGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYTDFD---GT 201

Query: 251 YGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
             Y+ PE++      A    V+S G++L +++ G 
Sbjct: 202 RVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD 236

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 62/222 (27%), Positives = 93/222 (41%), Gaps = 33/222 (14%)

Query: 79  SFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW------ 128
                Y     LG G F  V K         G +    A K + K  L   R        
Sbjct: 2   MVEDHYEMGEELGSGQFAIVRKC---RQKGTGKE---YAAKFIKKRRLSSSRRGVSREEI 55

Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
             EVN L ++RHPN++ L     E+   + L+ E +  G L + L  K ++    AT+ +
Sbjct: 56  EREVNILREIRHPNIITLHDI-FENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFL 114

Query: 188 --IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----DYTAKLSDFGLAKAGPQGDET 241
             I      G+ +LH   + + + D K  NI+L      +   KL DFG+A     G+E 
Sbjct: 115 KQI----LDGVHYLH--SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
                + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 169 KN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 95.1 bits (237), Expect = 9e-22
 Identities = 51/209 (24%), Positives = 80/209 (38%), Gaps = 31/209 (14%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPN 142
           +G G FG         +         VAVK + +         RE    +     LRHPN
Sbjct: 28  IGSGNFGVARLM---RDKLTKEL---VAVKYIERGAAIDENVQRE----IINHRSLRHPN 77

Query: 143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM---MIAFGAAKGLAFL 199
           +V+         H  ++ E+   G L   +          A      +++     G+++ 
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS-----GVSYC 132

Query: 200 HNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           H+    + +RD K  N LLD       K+ DFG +K+     +    + V GT  Y APE
Sbjct: 133 HS--MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV-GTPAYIAPE 187

Query: 258 YVMTGHL--TARSDVYSFGVVLLELLTGR 284
            V+         +DV+S GV L  +L G 
Sbjct: 188 -VLLRQEYDGKIADVWSCGVTLYVMLVGA 215

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 94.7 bits (236), Expect = 1e-21
 Identities = 64/238 (26%), Positives = 101/238 (42%), Gaps = 31/238 (13%)

Query: 63  THVIAFSLFELET-ITKSFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKE 120
           +   A +  E        F+ + + G+G FGTV  G      + V +K      KV+   
Sbjct: 7   SLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIK------KVIQDP 60

Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLI------GYCCEDDHRL-LVYEFMFRGSLENHL- 172
             + +RE L  +  L  L HPN+V+L       G     D  L +V E++   +L     
Sbjct: 61  RFR-NRE-LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCR 117

Query: 173 -FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSDFG 230
            + +  V        +  F   + +  LH     V +RD K  N+L++ +D T KL DFG
Sbjct: 118 NYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG 177

Query: 231 LAKA-GPQGDETH-VSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
            AK   P       + +R    Y Y APE ++ G  H T   D++S G +  E++ G 
Sbjct: 178 SAKKLSPSEPNVAYICSR----Y-YRAPE-LIFGNQHYTTAVDIWSVGCIFAEMMLGE 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 93.9 bits (234), Expect = 1e-21
 Identities = 60/224 (26%), Positives = 93/224 (41%), Gaps = 33/224 (14%)

Query: 77  TKSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---- 128
            ++    Y     LG G F  V K         GL+    A K + K   +  R      
Sbjct: 6   QENVDDYYDTGEELGSGQFAVVKKC---REKSTGLQ---YAAKFIKKRRTKSSRRGVSRE 59

Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATR 185
               EV+ L +++HPN++ L     E+   + L+ E +  G L + L  K ++    AT 
Sbjct: 60  DIEREVSILKEIQHPNVITLHEV-YENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118

Query: 186 MM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----DYTAKLSDFGLAKAGPQGD 239
            +  I      G+ +LH     + + D K  NI+L          K+ DFGLA     G+
Sbjct: 119 FLKQI----LNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           E      + GT  + APE V    L   +D++S GV+   LL+G
Sbjct: 173 EFKN---IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 96.6 bits (240), Expect = 1e-21
 Identities = 62/211 (29%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQ-LRH 140
           +LG+G FG V                  AVK+L K+ +    +    + E   L    + 
Sbjct: 348 VLGKGSFGKVML------SERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401

Query: 141 PNLVKLIGYCC--EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK---G 195
           P L +L  + C    D    V E++  G L  H+ +        A      F AA+   G
Sbjct: 402 PFLTQL--HSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV-----FYAAEIAIG 454

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM-GTYGYA 254
           L FL    + +IYRD K  N++LDS+   K++DFG+ K       T   T+   GT  Y 
Sbjct: 455 LFFLQ--SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT---TKTFCGTPDYI 509

Query: 255 APEYVMTGHLTARS-DVYSFGVVLLELLTGR 284
           APE ++      +S D ++FGV+L E+L G+
Sbjct: 510 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.8 bits (234), Expect = 1e-21
 Identities = 44/220 (20%), Positives = 82/220 (37%), Gaps = 35/220 (15%)

Query: 78  KSFRSDYILGE----GGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           K     Y++ E    G FG V++                  K +  +G         E++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRC---VETSSKKT---YMAKFVKVKGTD-QVLVKKEIS 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSL-------ENHLFRKATVPLSWATR 185
            L   RH N++ L     E    L +++EF+    +          L  +  V       
Sbjct: 54  ILNIARHRNILHLHESF-ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSY---VH 109

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDETHV 243
            +      + L FLH     + + D +  NI+  +  ++  K+ +FG A+    GD   +
Sbjct: 110 QVC-----EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL 162

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
              +     Y APE      ++  +D++S G ++  LL+G
Sbjct: 163 ---LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG 199

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 66/211 (31%), Positives = 107/211 (50%), Gaps = 30/211 (14%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV 144
           LGEG F TVYK    + N  V +K + +  +   K+G+  +R  L E+  L +L HPN++
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGI--NRTALREIKLLQELSHPNII 75

Query: 145 KLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            L+       +  LV++FM       ++++     ++ L+ +          +GL +LH 
Sbjct: 76  GLLDAFGHKSNISLVFDFMETDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLH- 129

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA--GPQGDETH-VSTRVMGTYGYAAPEY 258
            +  +++RD K +N+LLD +   KL+DFGLAK+   P    TH V TR      Y APE 
Sbjct: 130 -QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTR-----WYRAPE- 182

Query: 259 VMTGHLTARS-----DVYSFGVVLLELLTGR 284
           ++ G   AR      D+++ G +L ELL   
Sbjct: 183 LLFG---ARMYGVGVDMWAVGCILAELLLRV 210

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 53/235 (22%), Positives = 85/235 (36%), Gaps = 24/235 (10%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG 121
               +   L     +   +     +  G +G V  G   E + V +K +   V       
Sbjct: 9   AMRDLIAELHA---MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVN 65

Query: 122 LQGHREW----LTEVNFLGQLRHPNLVKL----IGYCCEDDHRL-LVYEFMFRGSLENHL 172
           +          L E+  L    HPN++ L    + +     H+L LV E M   +    +
Sbjct: 66  ILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM--RTDLAQV 123

Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
                + +S        +    GL  LH A   V++RD    NILL  +    + DF LA
Sbjct: 124 IHDQRIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLHPGNILLADNNDITICDFNLA 181

Query: 233 KAGPQGDET--HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
           +          +V+ R      Y APE VM     T   D++S G V+ E+   +
Sbjct: 182 REDTADANKTHYVTHRW-----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 93.9 bits (234), Expect = 5e-21
 Identities = 56/217 (25%), Positives = 94/217 (43%), Gaps = 23/217 (10%)

Query: 77  TKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWL-T 130
              F  +Y     LG+G F  V +      V  G +    A  ++N + L     + L  
Sbjct: 6   CTRFTEEYQLFEELGKGAFSVVRRC---VKVLAGQE---YAAMIINTKKLSARDHQKLER 59

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E      L+HPN+V+L     E+ H  L+++ +  G L   +  +     + A+  +   
Sbjct: 60  EARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQ- 118

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVSTRV 247
              + +   H  +  V++R+ K  N+LL S       KL+DFGLA    +G++       
Sbjct: 119 -ILEAVLHCH--QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE-VEGEQQAWFGFA 174

Query: 248 MGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTG 283
            GT GY +PE V+         D+++ GV+L  LL G
Sbjct: 175 -GTPGYLSPE-VLRKDPYGKPVDLWACGVILYILLVG 209

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 41/217 (18%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGL--QGHREWLTEVNFLGQLR 139
           LGEG +G VYK               VA+K +     +EG+     RE    V+ L +L+
Sbjct: 42  LGEGTYGEVYKAIDTVTNET------VAIKRIRLEHEEEGVPGTAIRE----VSLLKELQ 91

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFM---FRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           H N+++L      +    L++E+     +  ++ +        +S        +    G+
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLINGV 145

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTA-----KLSDFGLAKA--GPQGDETHVSTRVMG 249
            F H   R  ++RD K  N+LL     +     K+ DFGLA+A   P    TH    ++ 
Sbjct: 146 NFCH--SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH---EII- 199

Query: 250 TYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGR 284
           T  Y  PE ++ G  H +   D++S   +  E+L   
Sbjct: 200 TLWYRPPE-ILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.8 bits (233), Expect = 6e-21
 Identities = 59/253 (23%), Positives = 110/253 (43%), Gaps = 31/253 (12%)

Query: 42  DLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDE 101
           D+S  +   N+  S+ +   Y+  +  S F    + K +++   +G G  G V   Y   
Sbjct: 29  DVSYIAKHYNMSKSKVDNQFYSVEVGDSTFT---VLKRYQNLKPIGSGAQGIVCAAY--- 82

Query: 102 NVRVGLKSLPVAVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDD 154
           +  +      VA+K L++  +     +    E+  +  + H N++ L+         E+ 
Sbjct: 83  DAVLDRN---VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139

Query: 155 HRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT 213
             + LV E M     + +L +   + L       + +    G+  LH+A   +I+RD K 
Sbjct: 140 QDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKP 192

Query: 214 SNILLDSDYTAKLSDFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTGHLTARSDVY 271
           SNI++ SD T K+ DFGLA+          +V TR      Y APE ++        D++
Sbjct: 193 SNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIW 247

Query: 272 SFGVVLLELLTGR 284
           S G ++ E++  +
Sbjct: 248 SVGCIMGEMVRHK 260

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 46/270 (17%)

Query: 33  ERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDY----ILGE 88
              H+  +   ++    +++     +A   T  +    +   +   +    +     LG 
Sbjct: 4   HHHHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGR 63

Query: 89  GGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLI 147
           G    VY+           LK L    K ++K+ ++      TE+  L +L HPN++KL 
Sbjct: 64  GATSIVYRCKQKGTQKPYALKVLK---KTVDKKIVR------TEIGVLLRLSHPNIIKLK 114

Query: 148 GYCCEDDHRLLVYEFMFRGSLENHLF-----------RKATVPLSWATRMMIAFGAAKGL 196
                     LV E +  G L    F           R A    + A + +      + +
Sbjct: 115 EIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDA----ADAVKQI-----LEAV 161

Query: 197 AFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
           A+LH  E  +++RD K  N+L      D   K++DFGL+K     +   +   V GT GY
Sbjct: 162 AYLH--ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGY 216

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
            APE +         D++S G++   LL G
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 53/223 (23%), Positives = 93/223 (41%), Gaps = 32/223 (14%)

Query: 77  TKSFRSDYI-----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWL 129
            ++F + YI     LG G F  V +     +   G +    A K L K         E L
Sbjct: 23  MENFNNFYILTSKELGRGKFAVVRQC---ISKSTGQE---YAAKFLKKRRRGQDCRAEIL 76

Query: 130 TEVNFLGQLRH-PNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLS--WATR 185
            E+  L   +  P ++ L     E+   + L+ E+   G + +    +    +S     R
Sbjct: 77  HEIAVLELAKSCPRVINLHEVY-ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIR 135

Query: 186 MM--IAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDE 240
           ++  I     +G+ +LH  +  +++ D K  NILL         K+ DFG+++      E
Sbjct: 136 LIKQIL----EGVYYLH--QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE 189

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
                 +MGT  Y APE +    +T  +D+++ G++   LLT 
Sbjct: 190 LRE---IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 89.7 bits (223), Expect = 7e-20
 Identities = 57/242 (23%), Positives = 105/242 (43%), Gaps = 31/242 (12%)

Query: 53  EDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 112
             S+++   Y+  I  S F    + K +++   +G G  G V   Y   +  +      V
Sbjct: 3   SRSKRDNNFYSVEIGDSTFT---VLKRYQNLKPIGSGAQGIVCAAY---DAILERN---V 53

Query: 113 AVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRL-LVYEFMF 164
           A+K L++  +     +    E+  +  + H N++ L+         E+   + +V E M 
Sbjct: 54  AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM- 112

Query: 165 RGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA 224
               + +L +   + L       + +    G+  LH+A   +I+RD K SNI++ SD T 
Sbjct: 113 ----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTL 166

Query: 225 KLSDFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT 282
           K+ DFGLA+          +V TR      Y APE ++        D++S G ++ E++ 
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRY-----YRAPEVILGMGYKENVDIWSVGCIMGEMIK 221

Query: 283 GR 284
           G 
Sbjct: 222 GG 223

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 88.4 bits (220), Expect = 9e-20
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 35/217 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGH-----REWLTEVNFLG 136
           +G G +GTVYK     +         VA+K +       G  G      RE    V  L 
Sbjct: 17  IGVGAYGTVYKARDPHSGHF------VALKSVRVPNGGGGGGGLPISTVRE----VALLR 66

Query: 137 QLR---HPNLVKLI----GYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           +L    HPN+V+L+        + + ++ LV+E + +  L  +L +     L   T   +
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRV 247
                +GL FLH     +++RD K  NIL+ S  T KL+DFGLA+    Q   T     V
Sbjct: 126 MRQFLRGLDFLH--ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP---VV 180

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           + T  Y APE ++        D++S G +  E+   +
Sbjct: 181 V-TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.1 bits (219), Expect = 2e-19
 Identities = 60/223 (26%), Positives = 91/223 (40%), Gaps = 45/223 (20%)

Query: 86  LGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVL---NKEGL--QGHREWLTEVNFLGQLR 139
           +G+G FG V+K        +V LK      KVL    KEG      RE    +  L  L+
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALK------KVLMENEKEGFPITALRE----IKILQLLK 74

Query: 140 HPNLVKLIGYCCEDDHRL--------LVYEFM---FRGSLENHLFRKATVPLSWATRMMI 188
           H N+V LI  C               LV++F      G L N       V  + +    +
Sbjct: 75  HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV-----LVKFTLSEIKRV 129

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA------GPQGDETH 242
                 GL ++H     +++RD K +N+L+  D   KL+DFGLA+A            T+
Sbjct: 130 MQMLLNGLYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187

Query: 243 VSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGR 284
              RV+ T  Y  PE ++         D++  G ++ E+ T  
Sbjct: 188 ---RVV-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 87.3 bits (217), Expect = 3e-19
 Identities = 62/215 (28%), Positives = 100/215 (46%), Gaps = 33/215 (15%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL----NKEGLQGHREWLT---EVNFLGQL 138
           +GEG +G V+K     +++ G +   VA+K +     +EG+      L+   EV  L  L
Sbjct: 19  IGEGAYGKVFKA---RDLKNGGRF--VALKRVRVQTGEEGMP-----LSTIREVAVLRHL 68

Query: 139 R---HPNLVKLI----GYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
               HPN+V+L         + + +L LV+E + +  L  +L +     +   T   + F
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMF 127

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMG 249
              +GL FLH     V++RD K  NIL+ S    KL+DFGLA+    Q   T     V+ 
Sbjct: 128 QLLRGLDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS---VVV- 181

Query: 250 TYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           T  Y APE ++        D++S G +  E+   +
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 61/279 (21%), Positives = 103/279 (36%), Gaps = 38/279 (13%)

Query: 23  MLSSSLPVKPER-----KHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETIT 77
           MLS+S    P                + P  P              HV +    +   I 
Sbjct: 1   MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII 60

Query: 78  KSFR-SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
             ++ +  +LG G  G V +     N R   K    A+K+L             EV    
Sbjct: 61  DDYKVTSQVLGLGINGKVLQI---FNKRTQEK---FALKMLQDCPKAR-----REVELHW 109

Query: 137 QL-RHPNLVKLIGYC----CEDDHRLLVYEFMFRGSLENHLFRKATVPLS--WATRMM-- 187
           +  + P++V+++             L+V E +  G L + +  +     +   A+ +M  
Sbjct: 110 RASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKS 169

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDETHVS 244
           I     + + +LH     + +RD K  N+L  S   +   KL+DFG AK     +   ++
Sbjct: 170 IG----EAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS--LT 221

Query: 245 TRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
           T    T  Y APE +         D++S GV++  LL G
Sbjct: 222 TPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 58/232 (25%), Positives = 107/232 (46%), Gaps = 30/232 (12%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-- 119
           Y   +  + +E   + K++ S   +G G +G+V       + R G K   VA+K L++  
Sbjct: 11  YKQDVNKTAWE---LPKTYVSPTHVGSGAYGSVCSAI---DKRSGEK---VAIKKLSRPF 61

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRL-LVYEFMFRGSLENHLF 173
           +     +    E+  L  ++H N++ L+          + +   LV  FM     +  L 
Sbjct: 62  QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQ 116

Query: 174 RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
           +   +  S      + +   KGL ++H+A   V++RD K  N+ ++ D   K+ DFGLA+
Sbjct: 117 KIMGLKFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILDFGLAR 174

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
                   +V TR    + Y APE +++  H     D++S G ++ E+LTG+
Sbjct: 175 HADAEMTGYVVTR----W-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 45/206 (21%), Positives = 86/206 (41%), Gaps = 26/206 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLV 144
           LG G +  V++     N+    K   V VK+L        ++   E+  L  LR  PN++
Sbjct: 44  LGRGKYSEVFEAI---NITNNEK---VVVKILKPVK---KKKIKREIKILENLRGGPNII 94

Query: 145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            L     +   R     F     + N  F++    L+        +   K L + H+   
Sbjct: 95  TLADIVKDPVSRTPALVFEH---VNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMG- 150

Query: 205 PVIYRDFKTSNILLDSDYTA-KLSDFGLAKAGPQGDE-TH-VSTRVMGTYGYAAPEYVMT 261
            +++RD K  N+++D ++   +L D+GLA+    G E    V++R      +  PE ++ 
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY-----FKGPE-LLV 203

Query: 262 G--HLTARSDVYSFGVVLLELLTGRK 285
                    D++S G +L  ++  ++
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKE 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 83.2 bits (206), Expect = 1e-17
 Identities = 62/258 (24%), Positives = 100/258 (38%), Gaps = 66/258 (25%)

Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
           LET +K +     LG G FG V + +  E   R  LK      KVL        R    E
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALK------KVLQDP-----RYKNRE 50

Query: 132 VNFLGQLRHPNLVKL--IGYCCEDDHRL-------------------------------- 157
           ++ +  L H N++KL    Y   D+                                   
Sbjct: 51  LDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQN 110

Query: 158 ----LVYEFMFRGSLENHL--FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDF 211
               ++ E++   +L   L  F ++   +      +  +   + + F+H+    + +RD 
Sbjct: 111 KYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG--ICHRDI 167

Query: 212 KTSNILLDS-DYTAKLSDFGLAKAGPQGDE-TH-VSTRVMGTYGYAAPEYVMTG--HLTA 266
           K  N+L++S D T KL DFG AK     +     + +R    + Y APE +M G    T 
Sbjct: 168 KPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSR----F-YRAPE-LMLGATEYTP 221

Query: 267 RSDVYSFGVVLLELLTGR 284
             D++S G V  EL+ G+
Sbjct: 222 SIDLWSIGCVFGELILGK 239

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 81.3 bits (201), Expect = 2e-17
 Identities = 29/208 (13%), Positives = 56/208 (26%), Gaps = 44/208 (21%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLG 136
           +R     G       ++   D  +        VA+  ++ +G+      +E L+    L 
Sbjct: 33  YRLLIFHGGVPPLQFWQAL-DTALDR-----QVALTFVDPQGVLPDDVLQETLSRTLRLS 86

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           ++  P + +++         L+V E++  GSL+           S    +      A   
Sbjct: 87  RIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAA 142

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
              H     V       S + +  D    L+                             
Sbjct: 143 DAAH--RAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPD 178

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGR 284
                     + D+   G  L  LL  R
Sbjct: 179 A-------NPQDDIRGIGASLYALLVNR 199

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 81.8 bits (202), Expect = 5e-17
 Identities = 56/306 (18%), Positives = 107/306 (34%), Gaps = 57/306 (18%)

Query: 26  SSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYI 85
           ++   +       ++S        R    S K     +     S ++   I   +   ++
Sbjct: 6   AAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPT--ASMPRPHSDWQ---IPDRYEIRHL 60

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVK----VLNKEGLQGHREWLTEVNFLGQLRHP 141
           +G G +G V + Y   +         VA+K    V         R  L E+  L +L H 
Sbjct: 61  IGTGSYGHVCEAY---DKLEKRV---VAIKKILRVFEDLID-CKRI-LREIAILNRLNHD 112

Query: 142 NLVKL----IGYCCEDDHRL-LVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAK 194
           ++VK+    I    E    L +V E       ++   +  +  V L+      + +    
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIA-----DSDFKKLFRTPVYLTELHIKTLLYNLLV 167

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+ ++H+A   +++RD K +N L++ D + K+ DFGLA+     +  +    +       
Sbjct: 168 GVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225

Query: 255 AP--------------EYVMT------------GHLTARSDVYSFGVVLLELLTGRKSVD 288
                            +V+T             + T   DV+S G +  ELL   K   
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285

Query: 289 KTRPSK 294
                +
Sbjct: 286 AYHADR 291

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 59/241 (24%), Positives = 110/241 (45%), Gaps = 33/241 (13%)

Query: 55  SRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDE-NVRVGLK--SLP 111
           S++    Y   +  +++E   + + +++   +G G +G+V   +  +  +RV +K  S P
Sbjct: 9   SQERPTFYRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 65

Query: 112 VAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRL-LVYEFMFR 165
               +  K      RE    +  L  ++H N++ L+         E+ + + LV   M  
Sbjct: 66  FQSIIHAKRTY---RE----LRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-- 116

Query: 166 GSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA 224
                 L        L+      + +   +GL ++H+A+  +I+RD K SN+ ++ D   
Sbjct: 117 ---GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCEL 171

Query: 225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTG 283
           K+ DFGLA+        +V+TR      Y APE ++   H     D++S G ++ ELLTG
Sbjct: 172 KILDFGLARHTADEMTGYVATRW-----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226

Query: 284 R 284
           R
Sbjct: 227 R 227

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 62/231 (26%), Positives = 104/231 (45%), Gaps = 23/231 (9%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKE 120
              ++   +F+   +   + +   +GEG +G V   Y     VRV +K      K+   E
Sbjct: 14  GPEMVRGQVFD---VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK------KISPFE 64

Query: 121 GLQGHREWLTEVNFLGQLRHPNLVKLIG----YCCEDDHRL-LVYEFMFRGSLENHLFRK 175
                +  L E+  L + RH N++ +         E    + +V + M   +    L + 
Sbjct: 65  HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM--ETDLYKLLK- 121

Query: 176 ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-A 234
            T  LS        +   +GL ++H+A   V++RD K SN+LL++    K+ DFGLA+ A
Sbjct: 122 -TQHLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFGLARVA 178

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
            P  D T   T  + T  Y APE ++     T   D++S G +L E+L+ R
Sbjct: 179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 9e-17
 Identities = 61/265 (23%), Positives = 86/265 (32%), Gaps = 70/265 (26%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTE------------ 131
            LG G FG V +      +        VAVK+L +      HR  ++E            
Sbjct: 29  PLGRGAFGQVIEADA-FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 132 -VNFLGQ--------------LRHPNLVK------------------------LIGYCCE 152
            VN LG                +  NL                           +G    
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPV 147

Query: 153 DDHRLLVYEFMFRGSL---------------ENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           D  R L      + S                E          L+    +  +F  AKG+ 
Sbjct: 148 DLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGME 207

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           FL  A R  I+RD    NILL      K+ DFGLA+   +  +            + APE
Sbjct: 208 FL--ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 265

Query: 258 YVMTGHLTARSDVYSFGVVLLELLT 282
            +     T +SDV+SFGV+L E+ +
Sbjct: 266 TIFDRVYTIQSDVWSFGVLLWEIFS 290

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 58/233 (24%), Positives = 98/233 (42%), Gaps = 31/233 (13%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK-- 119
           Y   +  + +E   +   +R    +G G +G V       + R G K   VA+K L +  
Sbjct: 12  YRQEVTKTAWE---VRAVYRDLQPVGSGAYGAVCSAV---DGRTGAK---VAIKKLYRPF 62

Query: 120 EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRL-LVYEFMFRGSLENHLF 173
           +     +    E+  L  +RH N++ L+         +D     LV  FM        L 
Sbjct: 63  QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLG 117

Query: 174 R-KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
           +      L       + +   KGL ++H A   +I+RD K  N+ ++ D   K+ DFGLA
Sbjct: 118 KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKILDFGLA 175

Query: 233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
           +        +V TR      Y APE ++     T   D++S G ++ E++TG+
Sbjct: 176 RQADSEMTGYVVTRW-----YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 55/224 (24%), Positives = 88/224 (39%), Gaps = 33/224 (14%)

Query: 76  ITKSFRSDYILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           +   +R    +G G FG +Y G  I     V +K   V       +  Q H E       
Sbjct: 7   VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECV-----KTKHPQLHIES----KI 57

Query: 135 LGQLRH-PNLVKLIGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGA 192
              ++    +  +     E D+ ++V E +  G SLE  LF   +   S  T +++A   
Sbjct: 58  YKMMQGGVGIPTIRWCGAEGDYNVMVMELL--GPSLE-DLFNFCSRKFSLKTVLLLADQM 114

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK---LSDFGLAKA-GPQGDETHVSTR-- 246
              + ++H+  +  I+RD K  N L+          + DFGLAK         H+  R  
Sbjct: 115 ISRIEYIHS--KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 172

Query: 247 --VMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
             + GT  YA+    +  HL    + R D+ S G VL+    G 
Sbjct: 173 KNLTGTARYAS----INTHLGIEQSRRDDLESLGYVLMYFNLGS 212

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.9 bits (190), Expect = 9e-16
 Identities = 51/228 (22%), Positives = 100/228 (43%), Gaps = 31/228 (13%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
            +   +     LG GG G V+     D + RV +K + +      K  L   RE    + 
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL---RE----IK 60

Query: 134 FLGQLRHPNLVKLI-------------GYCCEDDHRL-LVYEFMFRGSLENHLFRKATVP 179
            + +L H N+VK+                   + + + +V E+M   +   ++  +   P
Sbjct: 61  IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM--ETDLANVLEQG--P 116

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAK-AGPQ 237
           L      +  +   +GL ++H+A   V++RD K +N+ +++ D   K+ DFGLA+   P 
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPH 174

Query: 238 GDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGR 284
                  +  + T  Y +P  +++  + T   D+++ G +  E+LTG+
Sbjct: 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 48/240 (20%), Positives = 90/240 (37%), Gaps = 43/240 (17%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
               +++    +G+GGFG +Y   ++ +  VG    P  VKV   +    +    TE+ F
Sbjct: 32  MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSD-APCVVKVEPSD----NGPLFTELKF 86

Query: 135 LGQLRHPNLV---------------KLIGY----CCEDDHRLLVYEFMFRGSLENHLFRK 175
             +   P  +               K  G          +R ++ +  F   L+  ++  
Sbjct: 87  YQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMD-RFGSDLQ-KIYEA 144

Query: 176 ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK--LSDFGLAK 233
                S  T + ++      L ++H  E   ++ D K SN+LL+     +  L D+GLA 
Sbjct: 145 NAKRFSRKTVLQLSLRILDILEYIH--EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

Query: 234 A-GPQGDETHVSTR----VMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
              P+G     +        GT  + +    +  H     + R D+   G  +++ LTG 
Sbjct: 203 RYCPEGVHKAYAADPKRCHDGTIEFTS----IDAHNGVAPSRRGDLEILGYCMIQWLTGH 258

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 77.4 bits (190), Expect = 2e-15
 Identities = 60/223 (26%), Positives = 90/223 (40%), Gaps = 31/223 (13%)

Query: 76  ITKSFRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF 134
           +   FR    +G G FG +Y G  I  N  V +K   V       +  Q   E       
Sbjct: 5   VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENV-----KTKHPQLLYES----KI 55

Query: 135 LGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
              L+    +  +  +  E D+ +LV + +   SLE  LF   +  LS  T +M+A    
Sbjct: 56  YRILQGGTGIPNVRWFGVEGDYNVLVMD-LLGPSLE-DLFNFCSRKLSLKTVLMLADQMI 113

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAK---LSDFGLAKA-GPQGDETHVSTR--- 246
             + F+H   +  ++RD K  N L+     A    + DFGLAK         H+  R   
Sbjct: 114 NRVEFVH--SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENK 171

Query: 247 -VMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
            + GT  YA+    +  HL    + R D+ S G VL+  L G 
Sbjct: 172 NLTGTARYAS----VNTHLGIEQSRRDDLESLGYVLMYFLRGS 210

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.7 bits (184), Expect = 3e-15
 Identities = 51/220 (23%), Positives = 86/220 (39%), Gaps = 31/220 (14%)

Query: 80  FRSDYILGEGGFGTVYKGY-IDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           ++    +GEG FG +++G  +  N +V +K  P        +  Q   E+ T     G  
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-----RSDAPQLRDEYRTYKLLAGC- 65

Query: 139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAF 198
               +  +  +  E  H +LV + +   SLE  L        S  T  M A      +  
Sbjct: 66  --TGIPNVYYFGQEGLHNVLVID-LLGPSLE-DLLDLCGRKFSVKTVAMAAKQMLARVQS 121

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAK-----LSDFGLAKA-GPQGDETHVSTR----VM 248
           +H  E+ ++YRD K  N L+    +       + DFG+ K       + H+  R    + 
Sbjct: 122 IH--EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179

Query: 249 GTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
           GT  Y +    +  HL    + R D+ + G V +  L G 
Sbjct: 180 GTARYMS----INTHLGREQSRRDDLEALGHVFMYFLRGS 215

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 39/231 (16%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEGLQGHREWLTEV 132
            I+  F+   +LGEG +G V       +   G     VA+K +    + L   R  L E+
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSAT---HKPTGEI---VAIKKIEPFDKPLFALRT-LREI 60

Query: 133 NFLGQLRHPNLVKLI----GYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
             L   +H N++ +         E+ + + ++ E M   +  + +    T  LS      
Sbjct: 61  KILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM--QTDLHRVIS--TQMLSDDHIQY 116

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET------ 241
             +   + +  LH +   VI+RD K SN+L++S+   K+ DFGLA+   +          
Sbjct: 117 FIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTG 174

Query: 242 -------HVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGR 284
                   V+TR      Y APE ++T    +   DV+S G +L EL   R
Sbjct: 175 QQSGMVEFVATR-----WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 74.8 bits (184), Expect = 9e-15
 Identities = 52/273 (19%), Positives = 102/273 (37%), Gaps = 46/273 (16%)

Query: 53  EDSRKNAVLYTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 112
                +     +           +  ++   +++G G +G VY  Y   +         V
Sbjct: 4   HHHHSSGRENLYFQGIKNVH---VPDNYIIKHLIGRGSYGYVYLAY---DKNTEKN---V 54

Query: 113 AVKVLNK--EGLQGHREWLTEVNFLGQLRHPNLVKLI-----GYCCEDDHRLLVYEFMFR 165
           A+K +N+  E L   +  L E+  L +L+   +++L          + D   +V E    
Sbjct: 55  AIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-- 112

Query: 166 GSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT 223
              ++ L +  K  + L+      I +    G  F+H +   +I+RD K +N LL+ D +
Sbjct: 113 ---DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCS 167

Query: 224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP---------EYVMT------------G 262
            K+ DFGLA+      +T++   +                   +V+T             
Sbjct: 168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQE 227

Query: 263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE 295
           + T   D++S G +  ELL   +S      ++ 
Sbjct: 228 NYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 72.0 bits (177), Expect = 3e-14
 Identities = 52/226 (23%), Positives = 88/226 (38%), Gaps = 35/226 (15%)

Query: 76  ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKV--LNKEGLQGHREWLTEVN 133
           +  +FR    +G G FG +  G   +N+        VA+K+  +     Q H E+     
Sbjct: 7   VGPNFRVGKKIGCGNFGELRLG---KNLYTNEY---VAIKLEPMKSRAPQLHLEYRFYKQ 60

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGA 192
                    + ++  +     +  +V E +  G SLE  LF       S  T +MIA   
Sbjct: 61  LGSG---DGIPQVYYFGPCGKYNAMVLELL--GPSLE-DLFDLCDRTFSLKTVLMIAIQL 114

Query: 193 AKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK-----LSDFGLAKA-GPQGDETHVSTR 246
              + ++H+  + +IYRD K  N L+            + DF LAK       + H+  R
Sbjct: 115 ISRMEYVHS--KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172

Query: 247 ----VMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
               + GT  Y +    +  HL    + R D+ + G + +  L G 
Sbjct: 173 EHKSLTGTARYMS----INTHLGKEQSRRDDLEALGHMFMYFLRGS 214

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 57/232 (24%), Positives = 90/232 (38%), Gaps = 47/232 (20%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEV 132
           E     +  D ++G+G FG V K Y             VA+K++ NK+      +   EV
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEW------VAIKIIKNKKAF--LNQAQIEV 101

Query: 133 NFLGQLRHPNLVKLIGYCCEDDHRLLVYE--FMFRGSLENHL-------------FRKAT 177
             L  +          +  E  + ++  +  FMFR    NHL               + T
Sbjct: 102 RLLELMNK--------HDTEMKYYIVHLKRHFMFR----NHLCLVFEMLSYNLYDLLRNT 149

Query: 178 --VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAK 233
               +S       A      L FL   E  +I+ D K  NILL +   +  K+ DFG + 
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSC 209

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGR 284
              Q    ++ +R      Y +PE V+ G       D++S G +L+E+ TG 
Sbjct: 210 QLGQRIYQYIQSRF-----YRSPE-VLLGMPYDLAIDMWSLGCILVEMHTGE 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 42/222 (18%), Positives = 85/222 (38%), Gaps = 37/222 (16%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLGQLR---- 139
            LG G F TV+      N         VA+K++   +          E+  L ++     
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTH------VAMKIVRGDK--VYTEAAEDEIKLLQRVNDADN 77

Query: 140 -------HPNLVKLIGY----CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
                    +++KL+ +         H ++V+E +   +L   + +     +       I
Sbjct: 78  TKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQI 136

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLD------SDYTAKLSDFGLAKAGPQGDETH 242
           +     GL ++H     +I+ D K  N+L++      +    K++D G A    +     
Sbjct: 137 SKQLLLGLDYMHRRCG-IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           + TR      Y +PE ++       +D++S   ++ EL+TG 
Sbjct: 196 IQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 45/226 (19%), Positives = 80/226 (35%), Gaps = 37/226 (16%)

Query: 86  LGEGGFGTVYKGY--IDENVRVGLKSLPVAVKVLNKEG-----------LQGHREWLTEV 132
                 G +Y+           G +    ++K+  K+G                +     
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 133 NFLGQLRHPNLVKLIGY-CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
             L       +   +G+   +D +R LV   + R SL++ L       LS  + + +A  
Sbjct: 110 K-LYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSALDVSPKHVLSERSVLQVACR 167

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK--LSDFGLAKA-GPQGDETHVSTR-- 246
               L FLH  E   ++ +    NI +D +  ++  L+ +G A    P G   HV+    
Sbjct: 168 LLDALEFLH--ENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG--KHVAYVEG 223

Query: 247 ----VMGTYGYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
                 G   + +    M  H     + RSD+ S G  +L+ L G 
Sbjct: 224 SRSPHEGDLEFIS----MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 68.1 bits (167), Expect = 5e-13
 Identities = 49/222 (22%), Positives = 83/222 (37%), Gaps = 54/222 (24%)

Query: 77  TKSFRSDY-----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTE 131
             +   DY     +LG G  G V +     N R   K    A+K+L             E
Sbjct: 12  KNAIIDDYKVTSQVLGLGINGKVLQI---FNKRTQEK---FALKMLQDCPKAR-----RE 60

Query: 132 VNFLGQL-RHPNLVKLIGYC----CEDDHRLLVYEFMFRGSLENHLFRKATVPLS--WAT 184
           V    +  + P++V+++             L+V E +  G L + +  +     +   A+
Sbjct: 61  VELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS 120

Query: 185 RMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGDET 241
            +M + G A  + +LH     + +RD K  N+L  S   +   KL+DFG AK        
Sbjct: 121 EIMKSIGEA--IQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK-------- 168

Query: 242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG 283
             +      Y  +              D++S GV++  LL G
Sbjct: 169 ETTGE---KYDKSC-------------DMWSLGVIMYILLCG 194

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 53/236 (22%), Positives = 99/236 (41%), Gaps = 39/236 (16%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK---EGLQGHREWLTE 131
            + + +     LG+G +G V+K     + R G     VAVK +           R    E
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSI---DRRTGEV---VAVKKIFDAFQNSTDAQRT-FRE 58

Query: 132 VNFLGQLR-HPNLVKLIG-YCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           +  L +L  H N+V L+     ++D  + LV+++M   +  + + R     L    +  +
Sbjct: 59  IMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM--ETDLHAVIR--ANILEPVHKQYV 114

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
            +   K + +LH+    +++RD K SNILL+++   K++DFGL+++         +  + 
Sbjct: 115 VYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 249 GTYGYAAP--------EYVMT------------GHLTARSDVYSFGVVLLELLTGR 284
                           +YV T               T   D++S G +L E+L G+
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 68.2 bits (167), Expect = 1e-12
 Identities = 56/224 (25%), Positives = 87/224 (38%), Gaps = 55/224 (24%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLGQLRH--- 140
           ++G+G FG V K Y  +  +       VA+K++ N++    HR+   E+  L  LR    
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQH------VALKMVRNEKRF--HRQAAEEIRILEHLRKQDK 155

Query: 141 ---PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-------------FRKAT--VPLSW 182
               N++ ++              F FR    NH+               K       S 
Sbjct: 156 DNTMNVIHMLEN------------FTFR----NHICMTFELLSMNLYELIKKNKFQGFSL 199

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA--KLSDFGLAKAGPQGDE 240
                 A    + L  LH     +I+ D K  NILL     +  K+ DFG +    Q   
Sbjct: 200 PLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY 257

Query: 241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
           T++ +R      Y APE ++        D++S G +L ELLTG 
Sbjct: 258 TYIQSRF-----YRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.7 bits (159), Expect = 5e-12
 Identities = 42/207 (20%), Positives = 65/207 (31%), Gaps = 52/207 (25%)

Query: 68  FSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV-AVKVLNKEGLQGHR 126
               +L+   K       +GEG FG V++  I ++  V +K + +    ++N    +   
Sbjct: 17  LPTEKLQRCEK-------IGEGVFGEVFQT-IADHTPVAIKIIAIEGPDLVNGSHQKTFE 68

Query: 127 EWLTEVNFLGQL---------RHPNLVKLIGYCC-------------------------- 151
           E L E+    +L         R    + L    C                          
Sbjct: 69  EILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDR 128

Query: 152 ----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVI 207
               +DD   +V EF F G     +  K     S AT   I       LA    + R   
Sbjct: 129 PDFFKDDQLFIVLEFEFGGIDLEQMRTK---LSSLATAKSILHQLTASLAVAEASLR-FE 184

Query: 208 YRDFKTSNILLDSDYTAKLSDFGLAKA 234
           +RD    N+LL      KL      K+
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKS 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 48/277 (17%), Positives = 91/277 (32%), Gaps = 62/277 (22%)

Query: 45  DPSTPRNLEDSRKNAVLYTHVIAFSLFELETITKSFRSDYIL----GEGGFGTVYKGYID 100
             S+  +L           +  +    E + +     + ++L    G GGFG +Y     
Sbjct: 6   HHSSGVDLGTENL------YFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLA--- 56

Query: 101 ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLV---------------K 145
                  K     VKV  +E    +    +E+ F  ++   + +                
Sbjct: 57  FPTNKPEKDARHVVKVEYQE----NGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL 112

Query: 146 LIGY----CCEDDHRLLVYEFMFRGSLENHLF---RKATVPLSWATRMMIAFGAAKGLAF 198
             G          +R +V E +    L+  +             +T + +       L +
Sbjct: 113 FYGSGLTEFKGRSYRFMVMERLGI-DLQ-KISGQNGT----FKKSTVLQLGIRMLDVLEY 166

Query: 199 LHNAERPVIYRDFKTSNILLDSDYTAK--LSDFGLAKA-GPQGDETHVSTRV----MGTY 251
           +H  E   ++ D K +N+LL      +  L+D+GL+    P G+             GT 
Sbjct: 167 IH--ENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTI 224

Query: 252 GYAAPEYVMTGHL----TARSDVYSFGVVLLELLTGR 284
            + +    +  H     + RSDV   G  +L  L G+
Sbjct: 225 EFTS----LDAHKGVALSRRSDVEILGYCMLRWLCGK 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 62.2 bits (151), Expect = 9e-11
 Identities = 50/273 (18%), Positives = 86/273 (31%), Gaps = 77/273 (28%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW-LTEV 132
           +     +     LG G F TV+  +  +  +       VA+KV+     + + E  L E+
Sbjct: 33  DLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKF------VAMKVVKSA--EHYTETALDEI 84

Query: 133 NFLGQLR-----HPN---LVKLIGY----CCEDDHRLLVYEFMFRGSLENHLFRKATVPL 180
             L  +R      PN   +V+L+           H  +V+E +    L   + +     L
Sbjct: 85  RLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGL 143

Query: 181 SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---------------------- 218
                  I     +GL +LH  +  +I+ D K  NILL                      
Sbjct: 144 PLPCVKKIIQQVLQGLDYLH-TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202

Query: 219 ---------------------------DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
                                            K++D G A    +     + TR     
Sbjct: 203 PPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ---- 258

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR 284
            Y + E ++       +D++S   +  EL TG 
Sbjct: 259 -YRSLEVLIGSGYNTPADIWSTACMAFELATGD 290

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 52/255 (20%), Positives = 83/255 (32%), Gaps = 79/255 (30%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEV 132
           + + + +     LGEG FG V +       +       VA+K++ N            E+
Sbjct: 15  DWLQERYEIVGNLGEGTFGKVVECLDHARGKS-----QVALKIIRNVGKY--REAARLEI 67

Query: 133 NFLGQLRHP------NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-------------F 173
           N L +++          V +  +            F F      H+             F
Sbjct: 68  NVLKKIKEKDKENKFLCVLMSDW------------FNFH----GHMCIAFELLGKNTFEF 111

Query: 174 RKAT--VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL-DSDYTA------ 224
            K     P        +A+     L FLH  +  + + D K  NIL  +S++        
Sbjct: 112 LKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNEHK 169

Query: 225 ------------KLSDFGLAKAGPQGDETH---VSTRVMGTYGYAAPEYVMTGHL-TARS 268
                       +++DFG A       E H   V+TR      Y  PE V+         
Sbjct: 170 SCEEKSVKNTSIRVADFGSAT---FDHEHHTTIVATRH-----YRPPE-VILELGWAQPC 220

Query: 269 DVYSFGVVLLELLTG 283
           DV+S G +L E   G
Sbjct: 221 DVWSIGCILFEYYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 60/244 (24%), Positives = 85/244 (34%), Gaps = 79/244 (32%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLGQLRHP-- 141
            LGEG FG V +   D           VAVK++ N +         +E+  L  L     
Sbjct: 21  TLGEGAFGKVVECI-DHKA----GGRHVAVKIVKNVDRY--CEAARSEIQVLEHLNTTDP 73

Query: 142 ----NLVKLIGYCCEDDHRLLVYEFMFRGSLENHL-------------FRKAT--VPLSW 182
                 V+++ +            F        H+             F K    +P   
Sbjct: 74  NSTFRCVQMLEW------------FEHH----GHICIVFELLGLSTYDFIKENGFLPFRL 117

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL-DSDYTA----------------- 224
                +A+   K + FLH+ +  + + D K  NIL   SDYT                  
Sbjct: 118 DHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPD 175

Query: 225 -KLSDFGLAKAGPQGDETH---VSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLE 279
            K+ DFG A      DE H   VSTR      Y APE ++  G      DV+S G +L+E
Sbjct: 176 IKVVDFGSAT---YDDEHHSTLVSTRH-----YRAPEVILALGWSQP-CDVWSIGCILIE 226

Query: 280 LLTG 283
              G
Sbjct: 227 YYLG 230

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 56/245 (22%), Positives = 84/245 (34%), Gaps = 77/245 (31%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVL-NKEGLQGHREWLTEVNFLGQLRH--- 140
            +G+G FG V      +N +        AVKV+ N +     R    E + L ++++   
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKY------YAVKVVRNIKKY--TRSAKIEADILKKIQNDDI 93

Query: 141 --PNLVKLIGYCCEDDHR--------LL---VYEFMFRGSLENHLFRKATVPLSWATRMM 187
              N+VK  G      +          L   +YE      +  + +             +
Sbjct: 94  NNNNIVKYHGKF---MYYDHMCLIFEPLGPSLYEI-----ITRNNYN----GFHIEDIKL 141

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILL-DSDYTA---------------------- 224
                 K L +L      + + D K  NILL D  +                        
Sbjct: 142 YCIEILKALNYLRKMS--LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199

Query: 225 --KLSDFGLAKAGPQGDETH---VSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLL 278
             KL DFG A       + H   ++TR      Y APE V+        SD++SFG VL 
Sbjct: 200 GIKLIDFGCAT---FKSDYHGSIINTRQ-----YRAPE-VILNLGWDVSSDMWSFGCVLA 250

Query: 279 ELLTG 283
           EL TG
Sbjct: 251 ELYTG 255

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 1e-06
 Identities = 42/273 (15%), Positives = 87/273 (31%), Gaps = 54/273 (19%)

Query: 6   TREESAVVSTVQVQQLHMLSSSLPVKPERKHNRSIS----DLSD-PSTPRNLEDSRKNAV 60
           T +E     ++ ++ L      LP +    + R +S     + D  +T  N +    + +
Sbjct: 299 TPDEVK---SLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKL 355

Query: 61  LYTHVIAFSLFELE-TITKS-------FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPV 112
             T +I  SL  LE    +        F     +       ++   I  +V V +  L  
Sbjct: 356 --TTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKL-H 412

Query: 113 AVKVLNKEGLQG-------HREWLTEVNFLGQLRHPNLV----KLIGYCCEDDHRLLV-- 159
              ++ K+  +        + E   ++     L H ++V        +  +D     +  
Sbjct: 413 KYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLDQ 471

Query: 160 YEFMFRG----SLENH----LFRKATVPLSWATRMMIAFGAAKG-----LAFLHNAERPV 206
           Y +   G    ++E+     LFR   +   +  + +     A       L  L   +   
Sbjct: 472 YFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLK--- 528

Query: 207 IYRDFKTSNILLDSDYTAKLSDFG--LAKAGPQ 237
            Y+ +   N   D  Y   ++     L K    
Sbjct: 529 FYKPYICDN---DPKYERLVNAILDFLPKIEEN 558

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 5e-05
 Identities = 32/202 (15%), Positives = 62/202 (30%), Gaps = 43/202 (21%)

Query: 18  VQQLHMLSSSLPVKPERKHNRSISDLSDPSTPRNLEDSRKNAVLYTHVIAFSLFELETIT 77
           V +LH    SL  K  ++   SI  +      +   +   +  +  H      F+ + + 
Sbjct: 408 VNKLH--KYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLI 465

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
             +   Y          + G+        LK       + + E +   R    +  FL Q
Sbjct: 466 PPYLDQYFYS-------HIGH-------HLK------NIEHPERMTLFRMVFLDFRFLEQ 505

Query: 138 -LRHPNL-VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            +RH +      G       +L  Y        + ++            R++ A      
Sbjct: 506 KIRHDSTAWNASGSILNTLQQLKFY--------KPYICDNDPKY----ERLVNAI----- 548

Query: 196 LAFLHNAERPVIYRDFKTSNIL 217
           L FL   E   +    K +++L
Sbjct: 549 LDFLPKIE-ENLICS-KYTDLL 568

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	431
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.74
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.47
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.25
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.2
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.78
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.69
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.6
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.6
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.41
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.28
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.25
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.97
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.76
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.56
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.54
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.38
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.36
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.26
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.08
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.93
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.86
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.61
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.6
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	91.77
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.66
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.57
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	84.09
1cja_A	342	Protein (actin-fragmin kinase); transferase; HET:	80.61

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.1e-61  Score=463.21  Aligned_cols=252  Identities=24%  Similarity=0.355  Sum_probs=206.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||||++++...  ...+.+.+|+++|++|+|||||+++++|.+++.
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~   97 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQ------YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGS   97 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCE------EEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCE------EEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCE
Confidence            5799999999999999999999876554      99999976543  345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|||||||+||+|.++|.......+++..++.++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+..
T Consensus        98 ~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  175 (350)
T 4b9d_A           98 LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK--ILHRDIKSQNIFLTKDGTVQLGDFGIARVL  175 (350)
T ss_dssp             EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CEETTCCGGGEEECTTCCEEECSTTEESCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHHHEEECCCCCEEEcccccceee
Confidence            999999999999999998777777899999999999999999999976  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ...  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+......                +..+
T Consensus       176 ~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~----------------~~~i  237 (350)
T 4b9d_A          176 NST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL----------------VLKI  237 (350)
T ss_dssp             CHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----------------HHHH
T ss_pred             cCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH----------------HHHH
Confidence            322  1223456899999999999999999999999999999999999999976532111                1111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.... ...+...+.++.+||.+||++||++|||+.|++++
T Consensus       238 ~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          238 ISGSF-PPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HcCCC-CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11111 11223345788999999999999999999999975

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.8e-60  Score=452.94  Aligned_cols=266  Identities=27%  Similarity=0.452  Sum_probs=210.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|.+.+.||+|+||+||+|.+..... ...+..||||+++.......++|.+|+++|++++|||||+++++|.+.+.+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLP-EQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC----CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCccc-CCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            456778899999999999999764211 1123359999998776666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC-------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          158 LVYEFMFRGSLENHLFRKA-------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~-------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ||||||++|+|.+++....             ..++++..++.++.|++.||+|||+.+  ||||||||+||||+.++.+
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH--FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecccccHhhEEECCCCcE
Confidence            9999999999999997642             246899999999999999999999866  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      ||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||........   ..   
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~---  271 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA---ID---  271 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHH---HH---
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHH---HH---
Confidence            9999999987655444444456789999999999999999999999999999999999 8999976532211   11   


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                 .+........+..+++++.+|+.+||+.||++|||+.||+++|+.+...
T Consensus       272 -----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          272 -----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             -----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             -----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                       0101111123334567899999999999999999999999999988754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.6e-61  Score=452.30  Aligned_cols=267  Identities=27%  Similarity=0.413  Sum_probs=216.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|.+.+.||+|+||+||+|.+..... ...+..||||+++.......++|.+|+++|++++|||||+++++|.+++.+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCP-EQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC-----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCccc-CCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEE
Confidence            467888999999999999998764211 1123459999998776666788999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC-----------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          158 LVYEFMFRGSLENHLFRKA-----------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~-----------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ||||||++|+|.++|....           ...+++..++.++.|++.||.|||+.+  ||||||||+||||+.++.+||
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH--FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccCHhhEEECCCCcEEE
Confidence            9999999999999997632           346899999999999999999999866  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |+.||.+......   ..     
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~---~~-----  241 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEV---IE-----  241 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HH-----
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH---HH-----
Confidence            99999986544333333334579999999999999999999999999999999999 8999976532211   11     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                               .+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       242 ---------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~~  291 (299)
T 4asz_A          242 ---------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKAS  291 (299)
T ss_dssp             ---------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHS
T ss_pred             ---------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                     11011111223445678999999999999999999999999999877543

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-59  Score=443.13  Aligned_cols=262  Identities=28%  Similarity=0.449  Sum_probs=205.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +++++.+.||+|+||+||+|.+.++         ||||+++...  ....+.|.+|+.+|++++|||||++++++.+ +.
T Consensus        36 ~~l~l~~~iG~G~fG~Vy~~~~~~~---------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~  105 (307)
T 3omv_A           36 SEVMLSTRIGSGSFGTVYKGKWHGD---------VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DN  105 (307)
T ss_dssp             TSCCEEEECCCCSSSEEEEEESSSE---------EEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCc---------EEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-Ce
Confidence            5678889999999999999987542         8999987543  2345679999999999999999999998854 67


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      ++||||||+||+|.++|.... .++++..++.++.|++.||+|||+.+  ||||||||+||||++++.+||+|||+|+..
T Consensus       106 ~~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~--IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKN--IIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            899999999999999997654 36899999999999999999999866  999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ............+||+.|||||++.+   +.|+.++|||||||+||||+||+.||.+...........      ..    
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~------~~----  252 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV------GR----  252 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH------HT----
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH------hc----
Confidence            54443444456789999999999864   469999999999999999999999997654322111000      00    


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                       ....+.+ ...+..++.++.+|+.+||+.||++|||+.||+++|+.++...
T Consensus       253 -~~~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          253 -GYASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             -TCCCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             -CCCCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence             0011111 1223345678999999999999999999999999999887543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.1e-59  Score=444.72  Aligned_cols=262  Identities=26%  Similarity=0.395  Sum_probs=211.2

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .+++.+.||+|+||+||+|.+..... ...+..||||+++.... ...++|.+|+.+|++++|||||+++|+|.+++.++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~-~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAP-GEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC--------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCcc-CCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            45677889999999999998753211 11233599999976532 34578999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc
Q 014079          158 LVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~  223 (431)
                      ||||||++|+|.++|....              ...+++..++.++.||+.||+|||+.+  ||||||||+||||++++.
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~--iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH--VVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGC
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCccccceEECCCCC
Confidence            9999999999999996532              235899999999999999999999976  999999999999999999


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhh
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~  302 (431)
                      +||+|||+|+.....+........+||+.|||||++.++.|+.++|||||||+||||+| |+.||.+.....   +.   
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~---~~---  257 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD---VV---  257 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH---HH---
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH---HH---
Confidence            99999999987544433334455789999999999999999999999999999999998 899997654211   11   


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                                 ..+........+..++.++.+|+.+||+.||++|||+.||+++|+.+
T Consensus       258 -----------~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 -----------EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             -----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             -----------HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                       11111111223445667899999999999999999999999999854

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-59  Score=441.96  Aligned_cols=251  Identities=23%  Similarity=0.313  Sum_probs=211.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||+|++.+...   ...+.+.+|+++|++++|||||+++++|.+++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~------~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~  105 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE  105 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCE------EEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            4699999999999999999999877654      99999976532   33567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|||||||+||+|.+++.+.+  .+++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+.
T Consensus       106 ~~yivmEy~~gG~L~~~i~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDlKPeNILl~~~g~vKl~DFGla~~  181 (311)
T 4aw0_A          106 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  181 (311)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEEcCCCCEEEEEcCCcee
Confidence            9999999999999999997754  5889999999999999999999977  99999999999999999999999999997


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      +............+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.......                ..
T Consensus       182 ~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~----------------~~  245 (311)
T 4aw0_A          182 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIF----------------AK  245 (311)
T ss_dssp             CCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred             cCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------HH
Confidence            65544444455689999999999999999999999999999999999999999764321110                11


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +....+  .++...+.++.+||.+||++||++|||+.|++.+
T Consensus       246 i~~~~~--~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          246 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HHHTCC--CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCH
T ss_pred             HHcCCC--CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCC
Confidence            111111  1223345788999999999999999999987543

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.6e-59  Score=446.08  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=211.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ..|++.+.||+|+||+||+|.+..+++.      ||||+++.......+.+.+|+.+|++++|||||+++++|.+++.+|
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~------vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  147 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  147 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCE------EEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            5699999999999999999999877654      9999997765555567889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ||||||+||+|.+++...   .+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+....
T Consensus       148 ivmEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  222 (346)
T 4fih_A          148 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  222 (346)
T ss_dssp             EEECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEECCCCCEEEecCcCceecCC
Confidence            999999999999999653   4899999999999999999999977  99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ..  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........             +.....
T Consensus       223 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-------------i~~~~~  287 (346)
T 4fih_A          223 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLP  287 (346)
T ss_dssp             SS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHSSC
T ss_pred             CC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------------HHcCCC
Confidence            32  223457899999999999999999999999999999999999999976532211111             111111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.+  ......+.++.+||.+||++||++|||+.|+++|
T Consensus       288 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          288 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             CCC--SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  1223456788999999999999999999999976

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-58  Score=440.57  Aligned_cols=256  Identities=22%  Similarity=0.220  Sum_probs=209.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.++||+|+||.||+|.+..++..      ||||+++.....     .+|+.+|++++|||||+++++|.+++.+|
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~------vAiK~i~~~~~~-----~~E~~il~~l~HpnIV~l~~~~~~~~~~~  126 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQ------CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVN  126 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEETTTCC-----THHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCE------EEEEEECHHHhH-----HHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            4578888999999999999999876554      999999765432     46999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCccCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAKAGP  236 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~~~~  236 (431)
                      ||||||+||+|.++|.+.+  ++++..+..++.||+.||+|||+.+  ||||||||+||||+.+| .+||+|||+|+...
T Consensus       127 ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~  202 (336)
T 4g3f_A          127 IFMELLEGGSLGQLIKQMG--CLPEDRALYYLGQALEGLEYLHTRR--ILHGDVKADNVLLSSDGSRAALCDFGHALCLQ  202 (336)
T ss_dssp             EEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCCGGGEEECTTSCCEEECCCTTCEEC-
T ss_pred             EEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecccCHHHEEEeCCCCEEEEeeCCCCeEcc
Confidence            9999999999999997754  5899999999999999999999866  99999999999999987 69999999998764


Q ss_pred             CCCCcc---eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          237 QGDETH---VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       237 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+..      .     
T Consensus       203 ~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~------~-----  271 (336)
T 4g3f_A          203 PDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS------E-----  271 (336)
T ss_dssp             -----------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH------S-----
T ss_pred             CCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc------C-----
Confidence            432211   22346899999999999999999999999999999999999999987544332211110      0     


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                          +......+..++.++.+||.+||++||.+|||+.||+++|......
T Consensus       272 ----~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          272 ----PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             ----CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhh
Confidence                0001122334567889999999999999999999999999876544

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.1e-58  Score=431.38  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=200.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe----C
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE----D  153 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  153 (431)
                      |++.+.||+|+||+||+|.+..++..      ||+|++.....  ...+.|.+|+++|++|+|||||+++++|.+    +
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~  101 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK  101 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeE------EEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCC
Confidence            36677899999999999999876553      99999875432  344678999999999999999999999875    3


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a  232 (431)
                      +.+|||||||+||+|.+++.+..  ++++..+..++.||+.||+|||+++.+||||||||+||||+. ++.+||+|||+|
T Consensus       102 ~~~~lvmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla  179 (290)
T 3fpq_A          102 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  179 (290)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             cEEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCC
Confidence            56899999999999999997754  588999999999999999999986666999999999999974 799999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +.....    .....+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.......  ..            
T Consensus       180 ~~~~~~----~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~--~~------------  240 (290)
T 3fpq_A          180 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR------------  240 (290)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH------------
T ss_pred             EeCCCC----ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHH--HH------------
Confidence            864322    2345789999999998864 6999999999999999999999999754321110  00            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+........++...++++.+||.+||++||++|||+.|+++|
T Consensus       241 -~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          241 -RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             -HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             0011111111222234678899999999999999999999976

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.1e-58  Score=443.58  Aligned_cols=269  Identities=27%  Similarity=0.386  Sum_probs=218.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCC-CceeeeecEEEeC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRH-PNLVKLIGYCCED-  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~-  153 (431)
                      .++|++.+.||+|+||+||+|.+....+. .....||||++..... ...+.|.+|+++|.++.| ||||+++++|.+. 
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~-~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSST-TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcc-cCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            47899999999999999999998764321 1223599999976543 345679999999999975 8999999999764 


Q ss_pred             CeeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +.++||||||++|+|.++|....              ...+++..++.++.||+.||+|||+.+  ||||||||+||||+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~--iiHRDLK~~NILl~  219 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLS  219 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEC
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC--eecCccCccceeeC
Confidence            56899999999999999997532              235899999999999999999999976  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      +++.+||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+......   
T Consensus       220 ~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~---  296 (353)
T 4ase_A          220 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE---  296 (353)
T ss_dssp             GGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH---
T ss_pred             CCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999997655444444455789999999999999999999999999999999998 9999976543211   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                   +...+........+..++.++.+|+.+||+.||++|||+.||+++|+.+.+..
T Consensus       297 -------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          297 -------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             -------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                         11111111122233345678999999999999999999999999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.8e-58  Score=448.64  Aligned_cols=251  Identities=23%  Similarity=0.343  Sum_probs=211.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.+.||+|+||.||+|.+..+++.      ||||++........+.+.+|+.+|++++|||||+++++|.+.+.+|
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~------vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~  224 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKL------VAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELW  224 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCE------EEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEE
Confidence            5699999999999999999999877654      9999998765555667889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ||||||+||+|.+++...   .+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+....
T Consensus       225 iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~--IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~  299 (423)
T 4fie_A          225 VVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQG--VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK  299 (423)
T ss_dssp             EEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSTTTEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEecCccceECCC
Confidence            999999999999999653   4899999999999999999999977  99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ..  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........             +.....
T Consensus       300 ~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~-------------i~~~~~  364 (423)
T 4fie_A          300 EV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-------------IRDNLP  364 (423)
T ss_dssp             SC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHSCC
T ss_pred             CC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH-------------HHcCCC
Confidence            32  223457899999999999999999999999999999999999999976532221111             111111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.+  ......+.++.+||.+||++||++|||+.|+++|
T Consensus       365 ~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          365 PRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             CCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             CCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            111  1122345788999999999999999999999986

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2.1e-57  Score=420.97  Aligned_cols=247  Identities=26%  Similarity=0.385  Sum_probs=192.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||+|++++...   .....+.+|+++|++++|||||++++++.+++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQK------VALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCE------EEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCE------EEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            5799999999999999999998776554      99999976533   23456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||+ +|+|.+++.+.+  ++++..+..++.||+.||+|||+++  |+||||||+||||+.++.+||+|||+|+.
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  161 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRD--KMSEQEARRFFQQIISAVEYCHRHK--IVHRDLKPENLLLDEHLNVKIADFGLSNI  161 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTCCEEECCSSCC--
T ss_pred             EEEEEEeCC-CCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCChHHeEECCCCCEEEeecCCCee
Confidence            999999999 789999997754  5899999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....   .....+||+.|||||++.+..| +.++|||||||++|||++|+.||.+.....   +..             
T Consensus       162 ~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~---~~~-------------  222 (275)
T 3hyh_A          162 MTDGN---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV---LFK-------------  222 (275)
T ss_dssp             ----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH-------------
T ss_pred             cCCCC---ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHH-------------
Confidence            54322   2345789999999999998876 579999999999999999999997643211   100             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+....  ..++...+.++.+|+.+||+.||++|||+.|+++|
T Consensus       223 ~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          223 NISNGV--YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHHTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHcCC--CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            011000  01222345788999999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1.5e-57  Score=427.57  Aligned_cols=252  Identities=28%  Similarity=0.365  Sum_probs=198.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|++..+..   .+..||+|++++...  .....+.+|+++|++++|||||+++++|.+++.
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~  100 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSD---ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGK  100 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTT---TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCC---CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence            569999999999999999998743211   123499999876532  223467889999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|||||||+||+|.+++.+..  .+++..+..++.|++.||+|||+.+  ||||||||+|||++.+|.+||+|||+|+..
T Consensus       101 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~ylH~~~--IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          101 LYLILDFLRGGDLFTRLSKEV--MFTEEDVKFYLAELALALDHLHSLG--IIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EEEEECCCTTCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEEEEcCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            999999999999999997754  5899999999999999999999977  999999999999999999999999999864


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ....  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.......                ..+
T Consensus       177 ~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~----------------~~i  238 (304)
T 3ubd_A          177 IDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETM----------------TMI  238 (304)
T ss_dssp             ------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHH
T ss_pred             cCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHH----------------HHH
Confidence            3322  2234578999999999999999999999999999999999999999765322111                111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      ....+  .++...+.++.+||.+||++||++|||+     +|+++|
T Consensus       239 ~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          239 LKAKL--GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HcCCC--CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            11111  1223345788999999999999999984     677764

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.1e-56  Score=420.92  Aligned_cols=273  Identities=26%  Similarity=0.341  Sum_probs=202.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      .++|.+.+.||+|+||+||+|.+.+  .      .||||+++..... ...+..|+..+.+++|||||++++++.+++  
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~~g--~------~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~   72 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKWRG--E------EVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGT   72 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETT--E------EEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECC--E------EEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCC
Confidence            3568888999999999999998753  2      4999999765321 122345666677899999999999998764  


Q ss_pred             --eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC------CCCeeeccCCCCCEEECCCCcEEE
Q 014079          155 --HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA------ERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       155 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                        .+|||||||++|+|.+++...   ++++..++.++.|++.||+|||+.      ..+||||||||+||||+.++++||
T Consensus        73 ~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki  149 (303)
T 3hmm_A           73 WTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  149 (303)
T ss_dssp             SEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred             ceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEE
Confidence              579999999999999999764   489999999999999999999975      235999999999999999999999


Q ss_pred             ecccCCccCCCCCCc--ceeecccCCccccCccccccC------CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          227 SDFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTG------HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      +|||+|+........  ......+||+.|||||++.+.      .|+.++|||||||+||||+||..||........- .
T Consensus       150 ~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p-~  228 (303)
T 3hmm_A          150 ADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP-Y  228 (303)
T ss_dssp             CCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT-T
T ss_pred             EeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc-c
Confidence            999999865433221  122346799999999998764      4678999999999999999998887544322110 0


Q ss_pred             hhhhhhhhhccchhh-----hhcCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          299 VDWARPKLNDKRKML-----QIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .... +.......+.     ..+++.+.... ..++...+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       229 ~~~~-~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          229 YDLV-PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTS-CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hhcc-cccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            0000 0000000111     11222222222 335677899999999999999999999999999988754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-55  Score=413.54  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=190.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      ++|++.+.||+|+||+||+|.++.++..      ||||+++..... ..+.+.+|+++|++|+|||||+++++|.+.+  
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~   78 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCN------YAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT   78 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCE------EEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCE------EEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcc
Confidence            4589999999999999999998876554      999998765433 3467889999999999999999999997654  


Q ss_pred             ----------eeEEEEEecCCCChHHhhhhCCCC-CcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc
Q 014079          155 ----------HRLLVYEFMFRGSLENHLFRKATV-PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       155 ----------~~~lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~  223 (431)
                                .+|||||||++|+|.+++...... ..++..++.++.||+.||+|||+.+  ||||||||+||||+.++.
T Consensus        79 ~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~--IiHRDlKp~NILl~~~~~  156 (299)
T 4g31_A           79 EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDV  156 (299)
T ss_dssp             --------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCC
T ss_pred             ccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc--CccccCcHHHeEECCCCc
Confidence                      369999999999999999765432 2456678889999999999999976  999999999999999999


Q ss_pred             EEEecccCCccCCCCCCc----------ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 014079          224 AKLSDFGLAKAGPQGDET----------HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS  293 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  293 (431)
                      +||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||....  
T Consensus       157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--  231 (299)
T 4g31_A          157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--  231 (299)
T ss_dssp             EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred             EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence            999999999876443221          11234679999999999999999999999999999999996   774311  


Q ss_pred             ccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        . .          ...+..+.+.... .......+.+.+||.+||++||.+|||+.|++++
T Consensus       232 --~-~----------~~~~~~~~~~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          232 --E-R----------VRTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             --H-H----------HHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --H-H----------HHHHHHHhcCCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence              0 0          0011111111111 1223344567889999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=422.27  Aligned_cols=269  Identities=23%  Similarity=0.307  Sum_probs=204.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      .++|++.+.||+|+||+||+|.+..+++.      ||||++++...  ...+.+.+|+++|+.|+|||||++++++..  
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~------vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~  126 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQ------VAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTV  126 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSS
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCE------EEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeeccc
Confidence            46799999999999999999999876654      99999976532  344678899999999999999999998764  


Q ss_pred             ----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          153 ----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       153 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                          .+.+|||||||+ |+|.+++....  ++++..+..++.||+.||.|||+++  ||||||||+|||++.++.+||+|
T Consensus       127 ~~~~~~~~~ivmE~~~-g~L~~~i~~~~--~l~~~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NIl~~~~~~~Ki~D  201 (398)
T 4b99_A          127 PYGEFKSVYVVLDLME-SDLHQIIHSSQ--PLTLEHVRYFLYQLLRGLKYMHSAQ--VIHRDLKPSNLLVNENCELKIGD  201 (398)
T ss_dssp             CTTTCCCEEEEEECCS-EEHHHHHTSSS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             ccccCCEEEEEEeCCC-CCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CcCCCcCccccccCCCCCEEEee
Confidence                367899999994 78999996644  6899999999999999999999977  99999999999999999999999


Q ss_pred             ccCCccCCCCC--CcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--
Q 014079          229 FGLAKAGPQGD--ETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--  303 (431)
Q Consensus       229 FG~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--  303 (431)
                      ||+|+.+....  ........+||+.|||||++.+. .|+.++|||||||++|||++|+.||.+.........+....  
T Consensus       202 FGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~  281 (398)
T 4b99_A          202 FGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGT  281 (398)
T ss_dssp             CTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             cceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCC
Confidence            99998754322  12233457899999999998875 56999999999999999999999998754332221111000  


Q ss_pred             hhhhcc--------chhhhhcCccccC---cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 PKLNDK--------RKMLQIIDPRLEN---QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 ~~~~~~--------~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.....        ......+.+....   ......+.++.+||.+||+.||.+|||+.|+++|
T Consensus       282 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          282 PSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             CCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             CChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            000000        0000000000000   0111235788999999999999999999999986

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.2e-52  Score=406.00  Aligned_cols=270  Identities=24%  Similarity=0.302  Sum_probs=200.3

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .+.++|++.+.||+|+||+||+|.++....   .+..||+|.+.+..  ...++.+|+++|+.+ +|||||+++++|.+.
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~---~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVG---PEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTS---CEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCC---CCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            456889999999999999999998752110   12249999887653  345678999999998 699999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~DFG~a  232 (431)
                      +.+||||||++||+|.+++.     .+++..+..++.|++.||+|||+.+  ||||||||+||||+.+ +.+||+|||+|
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~g--IiHRDiKPeNiLl~~~~~~~kl~DFGla  165 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFG--IVHRDVKPSNFLYNRRLKKYALVDFGLA  165 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             CEEEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCcCCHHHeEEeCCCCeEEECcCCCC
Confidence            99999999999999999983     3788999999999999999999977  9999999999999877 89999999999


Q ss_pred             ccCCCCCC--------------------------cceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCC
Q 014079          233 KAGPQGDE--------------------------THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRK  285 (431)
Q Consensus       233 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~  285 (431)
                      +.......                          .......+||+.|+|||++.+. .|+.++||||+||++|||++|+.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~  245 (361)
T 4f9c_A          166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY  245 (361)
T ss_dssp             EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence            75433211                          0112345799999999999875 58999999999999999999999


Q ss_pred             CCCCCCCcccc-hhhhhhh--hhh-----------------h--ccchhhhhc---C---ccc---------cCcccHHH
Q 014079          286 SVDKTRPSKEQ-SLVDWAR--PKL-----------------N--DKRKMLQII---D---PRL---------ENQYSVRA  328 (431)
Q Consensus       286 pf~~~~~~~~~-~~~~~~~--~~~-----------------~--~~~~~~~~~---~---~~~---------~~~~~~~~  328 (431)
                      ||......... ..+....  +..                 .  ......+.+   +   +.+         ........
T Consensus       246 Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~i  325 (361)
T 4f9c_A          246 PFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEV  325 (361)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTC
T ss_pred             CCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccC
Confidence            99665432211 0000000  000                 0  000000000   0   000         00111234


Q ss_pred             HHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          329 AQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       329 ~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ++++.+||.+||+.||++|||+.|+++|
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            5688999999999999999999999976

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4e-52  Score=425.58  Aligned_cols=255  Identities=22%  Similarity=0.290  Sum_probs=213.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +.++|++.+.||+|+||+||+|.++.+++.      ||+|++........+.+.+|+.+|+.|+|||||+++++|.+.+.
T Consensus       155 il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~------~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~  228 (573)
T 3uto_A          155 VLDHYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNE  228 (573)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSE
T ss_pred             CccccEEEEEEeeccCeEEEEEEECCCCCE------EEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            346899999999999999999999877654      99999987766666778999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC--CcEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD--YTAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~--~~~kl~DFG~a~  233 (431)
                      +|||||||+||+|.++|.... ..+++..+..++.||+.||.|||+.+  |+||||||+|||++.+  +.+||+|||+|+
T Consensus       229 ~~iv~E~~~gg~L~~~i~~~~-~~l~e~~~~~~~~qi~~al~ylH~~~--iiHRDlKp~Nill~~~~~~~vKl~DFG~a~  305 (573)
T 3uto_A          229 MVMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTA  305 (573)
T ss_dssp             EEEEEECCCCCBHHHHHTCTT-SCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCSSCE
T ss_pred             EEEEEeecCCCcHHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeccCChhhccccCCCCCCEEEeecccee
Confidence            999999999999999986543 35899999999999999999999977  9999999999999854  899999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .+....   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.             
T Consensus       306 ~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~-------------  369 (573)
T 3uto_A          306 HLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-------------  369 (573)
T ss_dssp             ECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-------------
T ss_pred             EccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-------------
Confidence            865432   2345689999999999999999999999999999999999999997654221111100             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      . .+..+........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       370 ~-~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          370 S-CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             T-TCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h-CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0 01111222223456788999999999999999999999986

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.1e-51  Score=420.70  Aligned_cols=250  Identities=26%  Similarity=0.353  Sum_probs=202.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHH---HHHHHHHhcCCCCceeeeecEEE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREW---LTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ++|++.++||+|+||.||+|.+..+++.      ||||++++....   ....+   ..++.+++.++|||||+++++|.
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~------~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCE------EEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            5799999999999999999999887665      999999764321   12222   34567788889999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      +.+.+|||||||+||+|.++|.+.+  .+++..+..++.||+.||+|||+.+  ||||||||+||||+.+|++||+|||+
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~--~l~E~~a~~y~~qIl~aL~yLH~~g--IiHRDLKPeNILld~~G~vKL~DFGl  338 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  338 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCchHHeEEeCCCCEEecccce
Confidence            9999999999999999999998754  4889999999999999999999866  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      |+......    ..+.+||+.|||||++.+ ..|+.++|||||||+||||++|+.||.+........+..          
T Consensus       339 A~~~~~~~----~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~----------  404 (689)
T 3v5w_A          339 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----------  404 (689)
T ss_dssp             CEECSSCC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH----------
T ss_pred             eeecCCCC----CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH----------
Confidence            98754332    234689999999999975 579999999999999999999999997543221111110          


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                         .+...  ...++...+.++.+||.+||++||.+|++     +.||++|
T Consensus       405 ---~i~~~--~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          405 ---MTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ---HHHHC--CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ---hhcCC--CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence               01111  11223345678899999999999999998     6888876

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-50  Score=386.97  Aligned_cols=285  Identities=41%  Similarity=0.724  Sum_probs=237.7

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           70 LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        70 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      ..++...+++|++.+.||+|+||.||+|.+.++.       .||+|++........+.+.+|+.+++.++||||++++++
T Consensus        31 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           31 LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGA-------KVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             CSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCC-------EEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             HHHHHHHHhccCccceeecCCCeeEEEEEECCCC-------EEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3344556789999999999999999999975432       499999887665667789999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      +.+.+..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~  181 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA--IIHRDVKSINILLDENFVPKIT  181 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCSTTEEECTTCCEEEC
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC--eecCCCCHHHEEECCCCCEEEe
Confidence            999999999999999999999996643  235899999999999999999999866  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+........|.... .
T Consensus       182 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-~  260 (321)
T 2qkw_B          182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVES-H  260 (321)
T ss_dssp             CCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHH-H
T ss_pred             ecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhc-c
Confidence            999998654333333334456899999999999999999999999999999999999999877665555444443322 1


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      ....+...+++.+........+..+.+++.+||+.||++|||+.+++++|+.+....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            223344555666666677888999999999999999999999999999999876543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4e-49  Score=377.70  Aligned_cols=289  Identities=40%  Similarity=0.695  Sum_probs=232.6

Q ss_pred             ccccccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCC
Q 014079           63 THVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHP  141 (431)
Q Consensus        63 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~  141 (431)
                      .....++..++....++|++.+.||+|+||.||+|.+.++.       .||+|++...... ....+.+|+.+++.++||
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~   87 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGT-------LVAVKRLKEERTQGGELQFQTEVEMISMAVHR   87 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSC-------CEEEEECCC-----CCCHHHHHHHGGGTCCCT
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCC-------EEEEEEeccccCchHHHHHHHHHHHHHhccCC
Confidence            44566888899999999999999999999999999765432       4999998765322 223688999999999999


Q ss_pred             ceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEE
Q 014079          142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILL  218 (431)
Q Consensus       142 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl  218 (431)
                      ||+++++++.+.+..++||||+.+++|.+++....  ..++++..++.++.|++.||.|||+. ..+|+||||||+|||+
T Consensus        88 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             TBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             CccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            99999999999999999999999999999997643  33589999999999999999999986 1139999999999999


Q ss_pred             CCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC--cccc
Q 014079          219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP--SKEQ  296 (431)
Q Consensus       219 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~  296 (431)
                      +.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.....  ....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  246 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDV  246 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCS
T ss_pred             CCCCCEEeccCccccccCcccc-cccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccch
Confidence            9999999999999987543332 233446699999999999999999999999999999999999999963211  1111


Q ss_pred             hhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ....|.... .....+....+..+........+..+.+++.+||+.||.+|||+.+|+++|+..
T Consensus       247 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          247 MLLDWVKGL-LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             BHHHHHTTT-TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             hHHHHHHHH-hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            222222221 122334455566666677788899999999999999999999999999999853

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=7e-49  Score=382.60  Aligned_cols=269  Identities=22%  Similarity=0.377  Sum_probs=216.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..... ....+..||+|+++.... .....+.+|+.+|+.+ +||||+++++++.+.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            3678999999999999999998753211 112234599999976533 3456789999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +.+|+||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+.+  |+||||||+||||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~  237 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT  237 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEC
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeccccchhhEEEC
Confidence            999999999999999999976532              34788999999999999999999876  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........  
T Consensus       238 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~--  315 (370)
T 2psq_A          238 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF--  315 (370)
T ss_dssp             TTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH--
T ss_pred             CCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH--
Confidence            999999999999986544333222334567899999999999999999999999999999999 99999764321111  


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                     ..+........+..++.++.+|+.+||+.||.+|||+.|+++.|+.+....
T Consensus       316 ---------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          316 ---------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             ---------------HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---------------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence                           111111111223345578899999999999999999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.5e-49  Score=372.80  Aligned_cols=265  Identities=25%  Similarity=0.393  Sum_probs=215.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++........+.+.+|++++++++||||+++++++.+.+..+
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~------va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   83 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEV------MVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLN   83 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCE------EEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEE
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcE------EEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeE
Confidence            5788999999999999999999876554      9999887766666778999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus        84 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  160 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSMD-SQYPWSQRVSFAKDIASGMAYLHSMN--IIHRDLNSHNCLVRENKNVVVADFGLARLMVD  160 (310)
T ss_dssp             EEEECCTTCBHHHHHHHCC-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEECTTSCEEECCCTTCEECC-
T ss_pred             EEEEecCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCcCeEEECCCCCEEEeecccceeccc
Confidence            9999999999999997743 35899999999999999999999977  99999999999999999999999999986543


Q ss_pred             CCCcc------------eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          238 GDETH------------VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       238 ~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      .....            ......||+.|+|||++.+..++.++||||||+++|||++|..||............      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~------  234 (310)
T 3s95_A          161 EKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGL------  234 (310)
T ss_dssp             -------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSB------
T ss_pred             ccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhh------
Confidence            32211            111457999999999999999999999999999999999999998765433221100      


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                           ......+..    .+..++..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus       235 -----~~~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          235 -----NVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             -----CHHHHHHHT----CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             -----hhhcccccc----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence                 000111111    1122345788999999999999999999999999988765443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.5e-48  Score=369.01  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=210.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||+||+|.+..++.      .||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCC------EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCc------EEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            34689999999999999999999876554      399999876655566778999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        92 ~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEECCCCCEEEeeCCCceec
Confidence            99999999999999999764   4788999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....  ......||+.|+|||++.+..++.++|||||||++|||++|+.||............             ...
T Consensus       167 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~-------------~~~  231 (297)
T 3fxz_A          167 TPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------ATN  231 (297)
T ss_dssp             CSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHH
T ss_pred             CCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------HhC
Confidence            43322  233467999999999999999999999999999999999999999764322111100             000


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ..+  ....+...+..+.+|+.+||+.||++|||+.|++++-
T Consensus       232 ~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~  271 (297)
T 3fxz_A          232 GTP--ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ  271 (297)
T ss_dssp             CSC--CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCG
T ss_pred             CCC--CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence            000  1111233457788999999999999999999999763

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.8e-48  Score=372.70  Aligned_cols=273  Identities=26%  Similarity=0.342  Sum_probs=209.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD---  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---  154 (431)
                      ++|++.++||+|+||.||+|.+.+  .      .||+|++.... .....+..|+.+|++++||||+++++++.+..   
T Consensus        24 ~~y~~~~~lg~G~~g~Vy~~~~~~--~------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           24 MPLQLLEVKARGRFGCVWKAQLLN--E------YVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             EEEEEEEEEECSTTCEEEEEEETT--E------EEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             hhchhhheecccCceEEEEEEECC--C------EEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            678999999999999999998763  2      49999987653 23345567999999999999999999998754   


Q ss_pred             -eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC--------CCCeeeccCCCCCEEECCCCcEE
Q 014079          155 -HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA--------ERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       155 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~--------~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                       .+++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.        ..+|+||||||+|||++.++.+|
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~k  171 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC  171 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEE
T ss_pred             ceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEE
Confidence             369999999999999999764   389999999999999999999986        11499999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      |+|||+++...............||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............
T Consensus       172 L~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~  251 (322)
T 3soc_A          172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEE  251 (322)
T ss_dssp             ECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHH
T ss_pred             EccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhh
Confidence            999999976544333333334679999999999886     356678999999999999999999998754433222111


Q ss_pred             hhhhhhhccchhhhh-----cCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          301 WARPKLNDKRKMLQI-----IDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~-----~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .... ......+...     ..+.+...+ ....+.++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       252 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          252 EIGQ-HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             HHCS-SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhcc-CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1000 0000111111     111111111 234567799999999999999999999999999988754

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.7e-48  Score=371.93  Aligned_cols=267  Identities=25%  Similarity=0.418  Sum_probs=213.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..++.   ....||+|+++.... ...+.+.+|+.+|++++||||+++++++.+.+.
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQ---RDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTS---CCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCC---CCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            3678999999999999999999865432   123499999976532 345678999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHD-GQFTIMQLVGMLRGVGAGMRYLSDLG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            999999999999999996543 35899999999999999999999876  999999999999999999999999999875


Q ss_pred             CCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          236 PQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       236 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ...... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.........                 
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----------------  264 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI-----------------  264 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHH-----------------
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHH-----------------
Confidence            443222 12223457889999999999999999999999999999999 99999764321111                 


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      ..+........+..++..+.+|+.+||+.||.+|||+.+|++.|+.+......
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~~  317 (325)
T 3kul_A          265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPES  317 (325)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC-
T ss_pred             HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCccc
Confidence            11111111122334457889999999999999999999999999988765443

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.6e-48  Score=370.88  Aligned_cols=263  Identities=30%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..+|++.+.||+|+||+||+|.+.+.        .||+|++.....  .....+.+|+++|++++||||+++++++.+.+
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~~~--------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  107 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWHGS--------DVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPP  107 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTE--------EEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             hhHceeeeEeecCCCeEEEEEEECCC--------cEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            46789999999999999999987432        399999876543  33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC-CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT-VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~-~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..++||||+++++|.+++..... ..+++..++.++.|++.||+|||+.+.+|+||||||+|||++.++.+||+|||+++
T Consensus       108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~  187 (309)
T 3p86_A          108 NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR  187 (309)
T ss_dssp             CCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---
T ss_pred             ceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCc
Confidence            99999999999999999976432 23889999999999999999999855559999999999999999999999999997


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.............             
T Consensus       188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~-------------  252 (309)
T 3p86_A          188 LKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG-------------  252 (309)
T ss_dssp             ----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH-------------
T ss_pred             cccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence            643321  12234679999999999999999999999999999999999999997653221111000             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                         ........+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       253 ---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          253 ---FKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             ---HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             ---hcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence               0011112223345778999999999999999999999999998876543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.4e-48  Score=370.67  Aligned_cols=250  Identities=23%  Similarity=0.354  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||+|++.+...  .....+.+|+++|+.++||||+++++++.+.+
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   87 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGR------EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK   87 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCC------EEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECC
Confidence            3579999999999999999999876554      399999876532  34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~l~~~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           88 TLYLIMEYASGGEVFDYLVAHG--RMKEKEARSKFRQIVSAVQYCHQKR--IVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEEEEECCCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEEEEECCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            9999999999999999997754  4788999999999999999999977  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....   .....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+........                
T Consensus       164 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~----------------  224 (328)
T 3fe3_A          164 FTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRE----------------  224 (328)
T ss_dssp             GSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------
T ss_pred             cCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHH----------------
Confidence            54332   23446799999999999988875 79999999999999999999997653211110                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+.....  ..+...+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       225 ~i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~  266 (328)
T 3fe3_A          225 RVLRGKY--RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDR  266 (328)
T ss_dssp             HHHHCCC--CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCT
T ss_pred             HHHhCCC--CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCH
Confidence            0010100  11223456788999999999999999999999763

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.7e-48  Score=370.63  Aligned_cols=257  Identities=25%  Similarity=0.338  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..+++.      ||+|++...... ..+.+.+|+.+++.++||||+++++++.+.+.
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   79 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   79 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcE------EEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCe
Confidence            46899999999999999999998866553      999998654332 23567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .|+||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  155 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  155 (323)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccccchHHEEEeCCCCEEEEEeecccee
Confidence            999999999999999996543  5889999999999999999999876  999999999999999999999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......... ...+.            
T Consensus       156 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~~~------------  222 (323)
T 3tki_A          156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWK------------  222 (323)
T ss_dssp             EETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHHHH------------
T ss_pred             ccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHHh------------
Confidence            43333333345689999999999988775 77999999999999999999999765432111 11110            


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                        ............+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       223 --~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~  264 (323)
T 3tki_A          223 --EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRW  264 (323)
T ss_dssp             --TTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred             --cccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence              000000111233467889999999999999999999997643

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-47  Score=372.21  Aligned_cols=253  Identities=24%  Similarity=0.304  Sum_probs=208.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCCCCceeeeec
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      .+.++|++.+.||+|+||.||+|.+..++..      ||+|++.+....      ..+.+.+|+.+|++++||||+++++
T Consensus         9 ~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~------~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~   82 (361)
T 2yab_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGLE------YAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD   82 (361)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ChhhceEEeeEEeeCcCEEEEEEEECCCCCE------EEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEE
Confidence            3567899999999999999999998876543      999998765432      3467889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cE
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TA  224 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~  224 (431)
                      ++.+.+.+++||||++|++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++    .+
T Consensus        83 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~~~v  158 (361)
T 2yab_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHI  158 (361)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHHTTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEEeCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEeCCCCCccCE
Confidence            9999999999999999999999996543  5899999999999999999999976  99999999999998877    79


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      ||+|||++.......   .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.......        
T Consensus       159 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~--------  227 (361)
T 2yab_A          159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL--------  227 (361)
T ss_dssp             EECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH--------
T ss_pred             EEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence            999999998754432   223467999999999999999999999999999999999999999764321111        


Q ss_pred             hhhccchhhhhcCc--cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKRKMLQIIDP--RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              ..+...  .+........+..+.+||.+||..||.+|||+.|+++|
T Consensus       228 --------~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          228 --------ANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             --------HHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             --------HHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    011110  11111122345788999999999999999999999975

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=376.06  Aligned_cols=272  Identities=24%  Similarity=0.375  Sum_probs=219.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .++|.+.+.||+|+||.||+|.+....+ .......||+|++..... .....+.+|+++++++ +||||+++++++.+.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  147 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD  147 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence            4678999999999999999999754221 112234599999876533 3446788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.+  |+||||||+||||+
T Consensus       148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVT  225 (382)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEC
T ss_pred             CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCcceEEEc
Confidence            999999999999999999976542              35899999999999999999999976  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||........   
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~---  302 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL---  302 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            999999999999987654433333344568899999999999999999999999999999999 9999976432111   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                                    ...+........+..++.++.+|+.+||+.||++|||+.+|+++|+.+.......
T Consensus       303 --------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          303 --------------FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             --------------HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             --------------HHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence                          1111111111122334578899999999999999999999999999987665443

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.1e-46  Score=357.47  Aligned_cols=284  Identities=38%  Similarity=0.632  Sum_probs=226.8

Q ss_pred             ccccCHHHHHHHhcCCCcc------ceecccCcEEEEEEEEcCCceeccccceeEEEEccccC----chhHHHHHHHHHH
Q 014079           65 VIAFSLFELETITKSFRSD------YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG----LQGHREWLTEVNF  134 (431)
Q Consensus        65 ~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~E~~~  134 (431)
                      ...|++.++..++++|...      +.||+|+||.||+|.+.+.        .||+|++....    ......+.+|+.+
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~--------~vavK~~~~~~~~~~~~~~~~~~~E~~~   83 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNT--------TVAVKKLAAMVDITTEELKQQFDQEIKV   83 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSC--------EEEEEEECCCTTSCTTTHHHHHHHHHHH
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCc--------eEEEEEEecccCcchHHHHHHHHHHHHH
Confidence            4567889999999988877      8999999999999986422        48999886532    2335678899999


Q ss_pred             HhcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhC-CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCC
Q 014079          135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT  213 (431)
Q Consensus       135 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp  213 (431)
                      +++++||||+++++++.+.+..++||||+++++|.+++... ...++++..++.++.|++.||.|||+.+  |+||||||
T Consensus        84 l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp  161 (307)
T 2nru_A           84 MAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH--HIHRDIKS  161 (307)
T ss_dssp             HHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCG
T ss_pred             HHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC--eecCCCCH
Confidence            99999999999999999999999999999999999998643 2346899999999999999999999876  99999999


Q ss_pred             CCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 014079          214 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS  293 (431)
Q Consensus       214 ~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  293 (431)
                      +|||++.++.+||+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||......
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  240 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREP  240 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcch
Confidence            999999999999999999987554333333344679999999998765 5889999999999999999999999875433


Q ss_pred             ccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ......  ..........+...++..+ .......+..+.+++.+||+.||.+|||+.+|+++|+.+..
T Consensus       241 ~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          241 QLLLDI--KEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             SBTTHH--HHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHH--HHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            221111  1111111222333344333 23456778899999999999999999999999999998753

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-48  Score=377.07  Aligned_cols=276  Identities=26%  Similarity=0.363  Sum_probs=217.2

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeee
Q 014079           69 SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKL  146 (431)
Q Consensus        69 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l  146 (431)
                      ....++...++|++.+.||+|+||.||+|.+..... ...+..||+|+++.... ...+.+.+|++++.++ +||||+++
T Consensus        13 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           13 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CcccccccccceeeceeecCCCCceEEEEEeccccc-cccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            334444456889999999999999999998654211 12233599999976533 3446789999999999 78999999


Q ss_pred             ecEEEeCCe-eEEEEEecCCCChHHhhhhCCC------------------------------------------------
Q 014079          147 IGYCCEDDH-RLLVYEFMFRGSLENHLFRKAT------------------------------------------------  177 (431)
Q Consensus       147 ~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------  177 (431)
                      ++++.+.+. .++||||+++|+|.+++.....                                                
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            999987654 8999999999999999976432                                                


Q ss_pred             ----------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          178 ----------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       178 ----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                                      ..+++..++.++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++........
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  249 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY  249 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTC
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChhhEEEcCCCcEEEEeccceeeecccccc
Confidence                            12889999999999999999999976  999999999999999999999999999876444433


Q ss_pred             ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          242 HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       242 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                      .......||+.|+|||++.+..++.++|||||||++|||++ |..||.........                ...+....
T Consensus       250 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----------------~~~~~~~~  313 (359)
T 3vhe_A          250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----------------CRRLKEGT  313 (359)
T ss_dssp             EEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----------------HHHHHHTC
T ss_pred             hhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----------------HHHHHcCC
Confidence            34445678999999999999999999999999999999998 99999765432211                00111111


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ....+...+.++.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       314 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          314 RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            1112223446789999999999999999999999999987654

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.3e-48  Score=380.01  Aligned_cols=261  Identities=24%  Similarity=0.386  Sum_probs=210.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|.+.+.||+|+||.||+|.+..++.      .||+|+++.... .....+.+|+++|++++||||+++++++.+.+.
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  186 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLRADNT------LVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP  186 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCC------EEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEecCCe------EEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCC
Confidence            3578889999999999999999976544      499999876532 233468899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       187 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~  263 (377)
T 3cbl_A          187 IYIVMELVQGGDFLTFLRTEG-ARLRVKTLLQMVGDAAAGMEYLESKC--CIHRDLAARNCLVTEKNVLKISDFGMSREE  263 (377)
T ss_dssp             CEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cCCcccCHHHEEEcCCCcEEECcCCCceec
Confidence            999999999999999997643 35889999999999999999999977  999999999999999999999999999864


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .............+++.|+|||++.++.++.++|||||||++|||++ |..||.........                 .
T Consensus       264 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~-----------------~  326 (377)
T 3cbl_A          264 ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR-----------------E  326 (377)
T ss_dssp             TTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-----------------H
T ss_pred             CCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------H
Confidence            33221111112235778999999999999999999999999999998 99999765321111                 1


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+..++..+.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       327 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          327 FVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            1111111122233457889999999999999999999999999988653

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.4e-47  Score=368.23  Aligned_cols=250  Identities=28%  Similarity=0.365  Sum_probs=206.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+++.      ||+|++++..   ......+.+|+.+|+.++||||+++++++.+.+
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~   78 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCE------EEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCC
Confidence            5789999999999999999998876554      9999997642   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++||+|.+++....  .+++..+..++.||+.||.|||+.+  |+||||||+|||++.+|.+||+|||+++.
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  154 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCCHHHEEECCCCCEEEeeccchhh
Confidence            9999999999999999997654  4788999999999999999999876  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..........                .
T Consensus       155 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~----------------~  216 (337)
T 1o6l_A          155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------L  216 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cccCCC--cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH----------------H
Confidence            432221  2334679999999999999999999999999999999999999997643211100                0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L  357 (431)
                      +....+  .++...+.++.+||.+||+.||.+||     ++.+|++|-
T Consensus       217 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~  262 (337)
T 1o6l_A          217 ILMEEI--RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR  262 (337)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCC
Confidence            110000  12223457889999999999999999     899998763

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.1e-47  Score=363.53  Aligned_cols=267  Identities=28%  Similarity=0.421  Sum_probs=215.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|.+.+.||+|+||.||+|.+..... ...+..||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHLKG-RAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETGGG-CSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             hhheeeeeeecccCCeeEEEEEEeccCc-ccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            4678999999999999999998743211 01123599999976532 345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC----------------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT----------------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT  213 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~----------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp  213 (431)
                      .++||||+++++|.+++.....                      ..+++..++.++.|++.||.|||+.+  |+||||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dikp  178 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--LVHRDLAA  178 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT--EECCCCSG
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC--Ccccccch
Confidence            9999999999999999976532                      34889999999999999999999976  99999999


Q ss_pred             CCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 014079          214 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP  292 (431)
Q Consensus       214 ~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  292 (431)
                      +|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  258 (314)
T 2ivs_A          179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP  258 (314)
T ss_dssp             GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred             heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999987644433322334567889999999999999999999999999999999 9999976543


Q ss_pred             cccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .....                 .+........+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       259 ~~~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          259 ERLFN-----------------LLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             GGHHH-----------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHH-----------------HhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            22111                 1111111122233457889999999999999999999999999987653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.2e-47  Score=367.85  Aligned_cols=263  Identities=24%  Similarity=0.370  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..++..  -..+||+|.+.... ....+.+.+|+.++++++||||+++++++.+.. .
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~   91 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V   91 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-E
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCce--EEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-e
Confidence            5688999999999999999998654432  12237888886543 234567899999999999999999999998754 7


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|+||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        92 ~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~  168 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred             EEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence            89999999999999997754 35899999999999999999999976  9999999999999999999999999998654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............||+.|+|||++.+..++.++|||||||++|||++ |+.||.........                 ..
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-----------------~~  231 (327)
T 3poz_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------SI  231 (327)
T ss_dssp             TTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------HH
T ss_pred             CCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHH-----------------HH
Confidence            4433333344567889999999999999999999999999999999 99999765432211                 11


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +........+..++..+.+++.+||+.||.+||++.+++++|+.+...
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          232 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            111111112233456788999999999999999999999999887643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.6e-47  Score=359.96  Aligned_cols=266  Identities=26%  Similarity=0.360  Sum_probs=208.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++.....   ...+.+.+|+.++++++||||+++++++.+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~   82 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNI------KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE   82 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCS------EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCC------eEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence            45789999999999999999999876544      399998854322   334678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++++|.+++....  ++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        83 ~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~  158 (294)
T 4eqm_A           83 DDCYYLVMEYIEGPTLSEYIESHG--PLSVDTAINFTNQILDGIKHAHDMR--IVHRDIKPQNILIDSNKTLKIFDFGIA  158 (294)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCSSS
T ss_pred             CCeEEEEEeCCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCCEEEEeCCCc
Confidence            999999999999999999997654  5889999999999999999999877  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +........ ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........  ..    .+..    
T Consensus       159 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~~----~~~~----  227 (294)
T 4eqm_A          159 KALSETSLT-QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--IK----HIQD----  227 (294)
T ss_dssp             TTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--HH----HHSS----
T ss_pred             ccccccccc-ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--HH----Hhhc----
Confidence            875433221 223457999999999999999999999999999999999999999765321110  00    0000    


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhhhcCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-LMSDVVETLEPLQCAND  365 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~~~  365 (431)
                         ..+..........+..+.+++.+||+.||.+|| ++.++.+.|+.+.....
T Consensus       228 ---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~  278 (294)
T 4eqm_A          228 ---SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENR  278 (294)
T ss_dssp             ---CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSS
T ss_pred             ---cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhcc
Confidence               000111112223457888999999999999999 89999999987665443

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.9e-48  Score=363.87  Aligned_cols=282  Identities=24%  Similarity=0.330  Sum_probs=210.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC--C
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED--D  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  154 (431)
                      .++|++.+.||+|+||.||+|.+.....  ..+..||+|++........+.+.+|+.+|++++||||+++++++...  .
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQD--NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCS--SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHT
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccC--CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence            4679999999999999999998532110  11234999999877666667899999999999999999999998653  5


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             ceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            6899999999999999997653 35889999999999999999999876  99999999999999999999999999987


Q ss_pred             CCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ....... .......+|..|+|||++.+..++.++||||||+++|||++|..||................... ....+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  242 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM-IVFHLI  242 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH-HHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch-hHHHHH
Confidence            5433221 22233457888999999999999999999999999999999999986431110000000000000 000111


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      ..+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       243 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          243 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            111112222233455678999999999999999999999999999887653

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-47  Score=369.19  Aligned_cols=270  Identities=25%  Similarity=0.374  Sum_probs=213.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..++|++.+.||+|+||.||+|.+..... ...+..||+|+++.... .....+.+|+.++++++||||+++++++.+.+
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  123 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGK  123 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCC-CCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCC
Confidence            35789999999999999999999874210 01123599999986543 33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC----------------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA----------------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFK  212 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlk  212 (431)
                      ..++||||+++++|.+++....                      ...+++..++.++.|++.||.|||+.+  |+|||||
T Consensus       124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlk  201 (343)
T 1luf_A          124 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLA  201 (343)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCS
T ss_pred             ceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCC
Confidence            9999999999999999997642                      146899999999999999999999976  9999999


Q ss_pred             CCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCC
Q 014079          213 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTR  291 (431)
Q Consensus       213 p~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~  291 (431)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  281 (343)
T 1luf_A          202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  281 (343)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCC
Confidence            9999999999999999999976433222222334568999999999999999999999999999999999 999997643


Q ss_pred             CcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          292 PSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      .....   .             .+.+.. ....+..++..+.+|+.+||+.||.+|||+.+|+++|+.+.....
T Consensus       282 ~~~~~---~-------------~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~~  338 (343)
T 1luf_A          282 HEEVI---Y-------------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE  338 (343)
T ss_dssp             HHHHH---H-------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC---
T ss_pred             hHHHH---H-------------HHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhhh
Confidence            21110   0             000100 011222345688999999999999999999999999998876543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.9e-47  Score=365.58  Aligned_cols=267  Identities=25%  Similarity=0.386  Sum_probs=196.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..+...   ...||+|++....  ....+.+.+|+.++++++||||+++++++....
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGS---FVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC----------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCc---ceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            46799999999999999999987665421   1249999987652  244577899999999999999999999998876


Q ss_pred             ee------EEEEEecCCCChHHhhhhCC----CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          155 HR------LLVYEFMFRGSLENHLFRKA----TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       155 ~~------~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ..      ++||||+.+++|.+++....    ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--ivH~Dikp~NIli~~~~~~  176 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN--FIHRDLAARNCMLAEDMTV  176 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCE
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC--cccCCCCcceEEEcCCCCE
Confidence            65      99999999999999986532    225899999999999999999999976  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      ||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||............    
T Consensus       177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~----  252 (323)
T 3qup_A          177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYL----  252 (323)
T ss_dssp             EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----
T ss_pred             EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHH----
Confidence            9999999987554433333334567889999999999999999999999999999999 99999765432211110    


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                                  .. ......+...+.++.+|+.+||+.||.+|||+.++++.|+++.....
T Consensus       253 ------------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          253 ------------IG-GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             ------------HT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             ------------hc-CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence                        00 00111222345788999999999999999999999999998876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-47  Score=356.42  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=210.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+.++.       .||+|++..... ..+++.+|+.++++++||||+++++++.+.+..+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   81 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKD-------KVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   81 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCC-------eEEEEEeccccc-CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence            57889999999999999999987543       389999876543 3467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus        82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  158 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  158 (269)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCC--eecCCcchheEEEcCCCCEEeccccccccccc
Confidence            9999999999999996643 35899999999999999999999877  99999999999999999999999999986433


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      ... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||..........                 .+
T Consensus       159 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~-----------------~~  220 (269)
T 4hcu_A          159 DQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-----------------DI  220 (269)
T ss_dssp             HHH-HSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH-----------------HH
T ss_pred             ccc-ccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH-----------------HH
Confidence            211 11223457888999999999999999999999999999999 999997643211110                 00


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ........+...+..+.+++.+||+.||++|||+.+++++|+.+...
T Consensus       221 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          221 STGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             hcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence            00111111222356788999999999999999999999999988754

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4e-48  Score=376.95  Aligned_cols=267  Identities=25%  Similarity=0.356  Sum_probs=209.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..... ...+..||+|++.... ......+.+|+.++++++||||+++++++.+...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCC-CCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            3678999999999999999999654211 1123359999987543 2344578899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC-----CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC---cEEEe
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT-----VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLS  227 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~---~~kl~  227 (431)
                      .++||||+++|+|.+++.....     ..+++..++.++.|++.||.|||+.+  |+||||||+||||+.++   .+||+
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEEecCCCCceEEEC
Confidence            9999999999999999976432     35889999999999999999999976  99999999999999554   59999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........          
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~----------  296 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL----------  296 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH----------
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----------
Confidence            9999974322222222234568999999999999999999999999999999998 99999765321111          


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                             ..+........+..++..+.+|+.+||+.||.+|||+.+|+++|+.+...
T Consensus       297 -------~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          297 -------EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             -------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -------HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence                   11111111112233456788999999999999999999999999987654

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-47  Score=364.68  Aligned_cols=254  Identities=19%  Similarity=0.255  Sum_probs=208.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~------~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   75 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcE------EEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCE
Confidence            357899999999999999999999876654      9999987553 344568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC--CCcEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG~a~  233 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.  ++.+||+|||+++
T Consensus        76 ~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~g--ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~  152 (321)
T 1tki_A           76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEEeCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEccCCCCCEEEEECCCCe
Confidence            999999999999999996543 35899999999999999999999976  999999999999987  7899999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||..........                
T Consensus       153 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~----------------  213 (321)
T 1tki_A          153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE----------------  213 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------
T ss_pred             ECCCCC---ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHH----------------
Confidence            764432   2334679999999999998889999999999999999999999997643211110                


Q ss_pred             hhcCccc--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          314 QIIDPRL--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       314 ~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .+.....  ........+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus       214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~  260 (321)
T 1tki_A          214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW  260 (321)
T ss_dssp             HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             HHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChh
Confidence            1111000  11111234578899999999999999999999998654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=363.67  Aligned_cols=255  Identities=24%  Similarity=0.333  Sum_probs=208.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      +.++|.+.+.||+|+||.||+|.+..++..      ||+|++......      ....+.+|+.+|++++||||++++++
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   82 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQ------YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   82 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCE------EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcE------EEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            557799999999999999999998876543      999998764322      35678899999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cEE
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAK  225 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~k  225 (431)
                      +.+.+..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++    .+|
T Consensus        83 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           83 YENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSSSCCEE
T ss_pred             EEeCCEEEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCC--eEcCCCCHHHEEEecCCCCCCCEE
Confidence            99999999999999999999999654  35899999999999999999999877  99999999999999887    899


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........+.     
T Consensus       159 l~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~-----  230 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-----  230 (326)
T ss_dssp             ECCCTTCEECCTTSC---CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH-----
T ss_pred             EEECCCCeECCCCCc---cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH-----
Confidence            999999987543321   234579999999999999999999999999999999999999997643211110000     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                               .....+........+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       231 ---------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  273 (326)
T 2y0a_A          231 ---------AVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHP  273 (326)
T ss_dssp             ---------HTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHST
T ss_pred             ---------hcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCC
Confidence                     0001111111123356788999999999999999999999863

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.7e-47  Score=371.72  Aligned_cols=263  Identities=25%  Similarity=0.443  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|.+.+.||+|+||.||+|.+.....   .+..||+|+++.... ...+.+.+|+.+|++++||||+++++++.+.+..
T Consensus        45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           45 TNISIDKVVGAGEFGEVCSGRLKLPSK---KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             GGCCCCEEEEECSSSEEEEC-CBCTTS---CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhceeeeEEeeCCCeEEEEEEEecCCC---CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCce
Confidence            579999999999999999998763211   223599999876532 3456789999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHD-AQFTVIQLVGMLRGIASGMKYLSDMG--YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999997643 35899999999999999999999876  9999999999999999999999999998754


Q ss_pred             CCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........                 ..
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~-----------------~~  261 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDV-----------------IK  261 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHH-----------------HH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HH
Confidence            332211 1122346788999999999999999999999999999998 9999976432111                 11


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+..++..+.+|+.+||+.||.+||++.+|++.|+.+...
T Consensus       262 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          262 AVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            1111111112223457889999999999999999999999999988654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.3e-47  Score=354.04  Aligned_cols=259  Identities=26%  Similarity=0.411  Sum_probs=210.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+.++.       .||+|++..... ...++.+|+.++++++||||+++++++.+.+..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQY-------DVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             hhheeeeeeeccCCCceEEEEEecCce-------eEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            467899999999999999999887543       389999876543 346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++....
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  155 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHG-KGLEPSQLLEMCYDVCEGMAFLESHQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVL  155 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCSGGGEEECTTCCEEECCTTCEEECC
T ss_pred             EEEEEccCCCcHHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCcCcceEEECCCCCEEEccCccceecc
Confidence            99999999999999997643 35899999999999999999999876  9999999999999999999999999998654


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||............                
T Consensus       156 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~----------------  218 (268)
T 3sxs_A          156 DDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV----------------  218 (268)
T ss_dssp             TTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH----------------
T ss_pred             hhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH----------------
Confidence            43221 2233457788999999999999999999999999999999 99999764322111000                


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      . .......+...+..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus       219 ~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          219 S-QGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             H-TTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             H-cCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            0 00001111223467889999999999999999999999999887553

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=375.41  Aligned_cols=258  Identities=22%  Similarity=0.281  Sum_probs=208.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ..+.++|++.+.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.+|+.++||||+++++++.
T Consensus         7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~------~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~   80 (444)
T 3soa_A            7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQE------YAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS   80 (444)
T ss_dssp             CHHHHHEEEEEEEEEC--CEEEEEEETTTTEE------EEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             ccccCCeEEEEEeccCCCeEEEEEEECCCCcE------EEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            34678899999999999999999998776654      99999876543  23456889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC---CCCcEEEec
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD---SDYTAKLSD  228 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~---~~~~~kl~D  228 (431)
                      +.+..|+||||+.||+|.+.+....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++   .++.+||+|
T Consensus        81 ~~~~~~lv~E~~~gg~L~~~i~~~~--~~~e~~~~~i~~qil~aL~~lH~~g--ivHrDlKp~NIll~~~~~~~~vkL~D  156 (444)
T 3soa_A           81 EEGHHYLIFDLVTGGELFEDIVARE--YYSEADASHCIQQILEAVLHCHQMG--VVHRNLKPENLLLASKLKGAAVKLAD  156 (444)
T ss_dssp             CSSEEEEEECCCBCCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSSTTEEESBSSTTCCEEECC
T ss_pred             ECCEEEEEEEeCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEeccCCCCcEEEcc
Confidence            9999999999999999999997754  4889999999999999999999976  99999999999998   468899999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ||++........  ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+.        
T Consensus       157 FG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~--------  226 (444)
T 3soa_A          157 FGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK--------  226 (444)
T ss_dssp             CSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH--------
T ss_pred             CceeEEecCCCc--eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH--------
Confidence            999987544322  2234679999999999999999999999999999999999999997643211110000        


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                           .. ...+........+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       227 -----~~-~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp  269 (444)
T 3soa_A          227 -----AG-AYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHP  269 (444)
T ss_dssp             -----HT-CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSC
T ss_pred             -----hC-CCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCc
Confidence                 00 00111111123457889999999999999999999999863

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.7e-46  Score=358.82  Aligned_cols=264  Identities=22%  Similarity=0.319  Sum_probs=213.4

Q ss_pred             ccCHHHHHHHhcC----------CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHh
Q 014079           67 AFSLFELETITKS----------FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG  136 (431)
Q Consensus        67 ~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~  136 (431)
                      .++..++...++.          |...+.||+|+||.||+|.+..++.      .||||++........+.+.+|+.+++
T Consensus        24 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~------~vavK~~~~~~~~~~~~~~~E~~~l~   97 (321)
T 2c30_A           24 VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGR------QVAVKMMDLRKQQRRELLFNEVVIMR   97 (321)
T ss_dssp             -CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCSHHHHHHHHHHHT
T ss_pred             cCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCc------EEEEEEEeccchhHHHHHHHHHHHHH
Confidence            4566666665543          6777899999999999999876544      39999997766566678899999999


Q ss_pred             cCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCE
Q 014079          137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNI  216 (431)
Q Consensus       137 ~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NI  216 (431)
                      +++||||+++++++...+..++||||+++++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+||
T Consensus        98 ~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NI  172 (321)
T 2c30_A           98 DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV---RLNEEQIATVCEAVLQALAYLHAQG--VIHRDIKSDSI  172 (321)
T ss_dssp             TCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGE
T ss_pred             hCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHE
Confidence            999999999999999999999999999999999998543   5899999999999999999999976  99999999999


Q ss_pred             EECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 014079          217 LLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ  296 (431)
Q Consensus       217 Ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  296 (431)
                      |++.++.+||+|||++........  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~  250 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM  250 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999986543221  223467999999999999999999999999999999999999999764321110


Q ss_pred             hhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          297 SLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         .          .+.....+.+.  .....+..+.+|+.+||+.||++|||+.+++++-.
T Consensus       251 ---~----------~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~  297 (321)
T 2c30_A          251 ---K----------RLRDSPPPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF  297 (321)
T ss_dssp             ---H----------HHHHSSCCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             ---H----------HHhcCCCCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence               0          01111111111  11233467889999999999999999999998744

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=367.87  Aligned_cols=270  Identities=24%  Similarity=0.390  Sum_probs=211.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+...... ..+..||+|++..... .....+.+|+.+|+++ +||||+++++++.+.+
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGISKT-GVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSS-SCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccccC-CcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            46799999999999999999997432110 1223599999875432 2346788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC---------------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT---------------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT  213 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp  213 (431)
                      ..++||||+++|+|.+++.....                     ..+++..++.++.|++.||.|||+.+  |+||||||
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp  200 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAA  200 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCh
Confidence            99999999999999999976532                     23788999999999999999999976  99999999


Q ss_pred             CCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCC
Q 014079          214 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRP  292 (431)
Q Consensus       214 ~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~  292 (431)
                      +||||+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999986544433333344568899999999999999999999999999999998 9999976543


Q ss_pred             cccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      ....                ...+........+...+.++.+|+.+||+.||.+|||+.+|+++|+.+.....
T Consensus       281 ~~~~----------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  337 (344)
T 1rjb_A          281 DANF----------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADAE  337 (344)
T ss_dssp             SHHH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC----
T ss_pred             HHHH----------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHHH
Confidence            2111                11111111112222345788999999999999999999999999998765543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-47  Score=367.45  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcCCCCceeeeecEE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQLRHPNLVKLIGYC  150 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~  150 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++.....     ...+.+.+|+.+++.++||||+++++++
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   95 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQ------FAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETY   95 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCE------EEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            456899999999999999999998776543      99999864321     2356788999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc---EE
Q 014079          151 CEDDHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AK  225 (431)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~---~k  225 (431)
                      .+.+..|+||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.   +|
T Consensus        96 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivHrDlkp~NIl~~~~~~~~~vk  173 (351)
T 3c0i_A           96 SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN--IIHRDVKPHCVLLASKENSAPVK  173 (351)
T ss_dssp             EETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECSSSTTCCEE
T ss_pred             EeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChHHeEEecCCCCCcEE
Confidence            9999999999999999999888653  3345889999999999999999999976  999999999999987654   99


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||+++......  ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.....    ....     
T Consensus       174 l~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----~~~~-----  242 (351)
T 3c0i_A          174 LGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE----RLFE-----  242 (351)
T ss_dssp             ECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH----HHHH-----
T ss_pred             EecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH----HHHH-----
Confidence            99999998754432  123346799999999999999999999999999999999999999976321    0000     


Q ss_pred             hhccchhhhhcCccc--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRL--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              .+.....  ........+.++.+||.+||+.||++|||+.+++++
T Consensus       243 --------~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          243 --------GIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             --------HHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                    0000000  000111235788999999999999999999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-47  Score=370.98  Aligned_cols=250  Identities=28%  Similarity=0.401  Sum_probs=201.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      .++|++.++||+|+||.||+|.+..++..      ||+|++++...   .....+.+|..+|+.+ +||||+++++++.+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~   95 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDL------YAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT   95 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCE------EEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe
Confidence            36799999999999999999999876554      99999976522   2345678899999988 69999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+.+|+||||++||+|.+++....  .+++..+..++.||+.||+|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NILl~~~g~ikL~DFG~a  171 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQKSR--RFDEARARFYAAEIISALMFLHDKG--IIYRDLKLDNVLLDHEGHCKLADFGMC  171 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCCHHHEEECCCCCEEEccccce
Confidence            999999999999999999997754  4889999999999999999999976  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........                
T Consensus       172 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~----------------  233 (353)
T 3txo_A          172 KEGICNG--VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLF----------------  233 (353)
T ss_dssp             BCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------
T ss_pred             eecccCC--ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHH----------------
Confidence            8633222  2234568999999999999999999999999999999999999999765321111                


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM------SDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~eil~~  356 (431)
                      ..+....+  .++...+..+.+||.+||++||.+||++      .+|++|
T Consensus       234 ~~i~~~~~--~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          234 EAILNDEV--VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHHCCC--CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHHHcCCC--CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            11111111  1122345678899999999999999998      778765

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-46  Score=357.57  Aligned_cols=274  Identities=20%  Similarity=0.239  Sum_probs=213.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD-  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  154 (431)
                      .++|++.++||+|+||.||+|.+..++.      .||+|++..... .....+.+|+++|++++||||+++++++.... 
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence            4679999999999999999999987554      399999876432 34567789999999999999999999998765 


Q ss_pred             -eeEEEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE----CCCCcEEEec
Q 014079          155 -HRLLVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSD  228 (431)
Q Consensus       155 -~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl----~~~~~~kl~D  228 (431)
                       ..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (319)
T 4euu_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (319)
T ss_dssp             CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEECTTSCEEEEECC
T ss_pred             ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEEeccCCCCceEEEcc
Confidence             7799999999999999997643 234899999999999999999999976  9999999999999    7888899999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccc--------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM--------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      ||+++.......   .....||+.|+|||++.        +..++.++|||||||++|||++|+.||.............
T Consensus       160 fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  236 (319)
T 4euu_A          160 FGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (319)
T ss_dssp             CTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHH
T ss_pred             CCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHH
Confidence            999987544332   23457999999999886        5788999999999999999999999997654332211111


Q ss_pred             -hhhhhhhc--cchhhhhc--------CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          301 -WARPKLND--KRKMLQII--------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       301 -~~~~~~~~--~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                       ........  ...+....        .-.....+....+..+.+|+.+||+.||++|||+.|++++..+-.
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             HHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence             00000000  00000000        001122445778889999999999999999999999999987544

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.7e-47  Score=372.23  Aligned_cols=257  Identities=26%  Similarity=0.395  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      ++|++.++||+|+||.||+|.+..++..      ||+|++++....   ....+.+|..+|.++ +||||++++++|.+.
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~------~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRI------YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE  125 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence            5789999999999999999999877664      999999865332   223477899999887 899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||++||+|.+++.+..  .+++..+..++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||+++
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFGla~  201 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK  201 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEECCCCCEEEeecceee
Confidence            99999999999999999997754  4889999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........        .....+.
T Consensus       202 ~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~--------~~~~~~~  271 (396)
T 4dc2_A          202 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLF  271 (396)
T ss_dssp             CCCCTT--CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC--------------CCHHHHH
T ss_pred             ecccCC--CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccch--------hhHHHHH
Confidence            633222  223457899999999999999999999999999999999999999975432211000        0000000


Q ss_pred             -hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 014079          314 -QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM------SDVVET  356 (431)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~eil~~  356 (431)
                       .+....  ..++...+.++.+||.+||+.||.+||++      .||++|
T Consensus       272 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          272 QVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             HHHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence             111111  11233345788999999999999999985      677765

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.1e-47  Score=360.62  Aligned_cols=268  Identities=26%  Similarity=0.405  Sum_probs=215.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..... ...+..||+|++..... ...+.+.+|+.+++++ +||||+++++++.+.+
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIK-SDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccc-cchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            3678999999999999999998643110 11223599999976543 3456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCC----------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE
Q 014079          155 HRLLVYEFMFRGSLENHLFRKAT----------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL  218 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~----------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl  218 (431)
                      ..++||||+++++|.+++.....                .++++..++.++.|++.||.|||+.+  |+||||||+|||+
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~  178 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILL  178 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEE
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCccceEEE
Confidence            99999999999999999976542                24899999999999999999999976  9999999999999


Q ss_pred             CCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccch
Q 014079          219 DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQS  297 (431)
Q Consensus       219 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~  297 (431)
                      +.++.+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |+.||......... 
T Consensus       179 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~-  257 (313)
T 1t46_A          179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF-  257 (313)
T ss_dssp             ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH-
T ss_pred             cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH-
Confidence            9999999999999987655443333344567889999999999999999999999999999999 99999765432111 


Q ss_pred             hhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                     ...+........+...+..+.+++.+||+.||.+|||+.+++++|+++...
T Consensus       258 ---------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          258 ---------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             ---------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHH
Confidence                           011111111111223457889999999999999999999999999987654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.6e-47  Score=385.25  Aligned_cols=259  Identities=24%  Similarity=0.406  Sum_probs=215.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..+|++.+.||+|+||.||+|.+.....      .||||+++... ...++|.+|+.+|++++||||+++++++.+.+.+
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~  291 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSL------TVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF  291 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTE------EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCe------EEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence            3568889999999999999999876444      49999997654 3467899999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus       292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCChhhEEECCCCcEEEeecccceecc
Confidence            99999999999999998766667899999999999999999999976  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .... .......+++.|+|||++.+..++.++|||||||++|||++ |..||........                 .+.
T Consensus       370 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~-----------------~~~  431 (495)
T 1opk_A          370 GDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-----------------YEL  431 (495)
T ss_dssp             TCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH-----------------HHH
T ss_pred             CCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHH
Confidence            3221 12223456789999999999999999999999999999999 9999976532211                 111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      +........+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       432 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          432 LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            11122222333456788999999999999999999999999987753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.6e-47  Score=367.08  Aligned_cols=257  Identities=23%  Similarity=0.312  Sum_probs=208.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ..+.++|++.+.||+|+||.||+|.+..++.      .||+|++.....  .....+.+|+.++++++||||+++++++.
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~   98 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGL------EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ   98 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCC------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            3456789999999999999999999876654      399999876533  34467889999999999999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---CcEEEec
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSD  228 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~~kl~D  228 (431)
                      +.+..|+||||+.+++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.+   +.+||+|
T Consensus        99 ~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~D  174 (362)
T 2bdw_A           99 EESFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLAD  174 (362)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHTTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEESCSSTTCCEEECC
T ss_pred             eCCEEEEEEecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEee
Confidence            9999999999999999999986643  5889999999999999999999976  9999999999999865   4599999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ||++.......   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||...........+.        
T Consensus       175 fG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~--------  243 (362)
T 2bdw_A          175 FGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK--------  243 (362)
T ss_dssp             CTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH--------
T ss_pred             cCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH--------
Confidence            99998754332   2234679999999999999999999999999999999999999997643211100000        


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                           .. ............+.++.+||.+||+.||++|||+.+++++-
T Consensus       244 -----~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  286 (362)
T 2bdw_A          244 -----AG-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  286 (362)
T ss_dssp             -----HT-CCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSH
T ss_pred             -----hC-CCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCc
Confidence                 00 00011111123457889999999999999999999999763

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=369.30  Aligned_cols=256  Identities=23%  Similarity=0.296  Sum_probs=209.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++..........+.+|+.+|++++||||+++++++.+.+.
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~------~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRV------FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCE------EEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            456899999999999999999999876554      99999987655556678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC--CCcEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG~a~  233 (431)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.  ++.+||+|||+++
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeecccchHHeEEecCCCCceEEEecccce
Confidence            999999999999999996543 35899999999999999999999876  999999999999974  4789999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......   ......||+.|+|||++.+..++.++|||||||++|||++|..||...........+             .
T Consensus       200 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i-------------~  263 (387)
T 1kob_A          200 KLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV-------------K  263 (387)
T ss_dssp             ECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-------------H
T ss_pred             ecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHH-------------H
Confidence            754432   223357999999999999999999999999999999999999999764321111000             0


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      . ....+........+.++.+||.+||+.||.+|||+.+++++-
T Consensus       264 ~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp  306 (387)
T 1kob_A          264 R-CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP  306 (387)
T ss_dssp             H-CCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTST
T ss_pred             h-CCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCc
Confidence            0 000111111223457889999999999999999999999863

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.3e-47  Score=377.02  Aligned_cols=252  Identities=26%  Similarity=0.425  Sum_probs=208.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC-ee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD-HR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~  156 (431)
                      ++|++.+.||+|+||.||+|.+.+.        .||||+++...  ..+.+.+|+.+|++++||||+++++++.+.+ ..
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~~~--------~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYRGN--------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTE--------EEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             HHeEEEeeecCcCCeeEEEEEecCC--------eEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            5688899999999999999987532        49999998764  4567899999999999999999999987765 78


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  340 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  340 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence            99999999999999998776656789999999999999999999976  9999999999999999999999999998643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ...     ....+++.|+|||++.+..++.++|||||||++|||++ |+.||..........                 .
T Consensus       341 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~-----------------~  398 (450)
T 1k9a_A          341 STQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP-----------------R  398 (450)
T ss_dssp             -----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHH-----------------H
T ss_pred             ccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH-----------------H
Confidence            221     12357889999999999999999999999999999998 999997654322111                 1


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +........+..++..+.+||.+||+.||.+|||+.+|++.|+.+...
T Consensus       399 i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          399 VEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            111111222334567899999999999999999999999999988754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.7e-47  Score=381.42  Aligned_cols=261  Identities=25%  Similarity=0.417  Sum_probs=211.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||.||+|.+..+.       .||||+++... ...+.+.+|+.+|++++||||+++++++. .+.
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~  256 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYNKHT-------KVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEP  256 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEETTTE-------EEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             chHHeEEEEEcccCCceEEEEEEECCcc-------EEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCc
Confidence            3467889999999999999999986543       39999997654 34678999999999999999999999986 667


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++..
T Consensus       257 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  334 (454)
T 1qcf_A          257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN--YIHRDLRAANILVSASLVCKIADFGLARVI  334 (454)
T ss_dssp             CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTCCEEECSTTGGGGB
T ss_pred             cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEECCCCcEEEeeCCCceEc
Confidence            899999999999999997654445788899999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ..... .......+|+.|+|||++..+.++.++|||||||++|||++ |+.||.+.......                 .
T Consensus       335 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~  396 (454)
T 1qcf_A          335 EDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI-----------------R  396 (454)
T ss_dssp             CCHHH-HTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-----------------H
T ss_pred             CCCce-eccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------------H
Confidence            33211 11223456789999999999999999999999999999999 99999764321111                 0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      .+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus       397 ~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          397 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             HHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            011111112223455788999999999999999999999999998876543

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2e-47  Score=365.90  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..++..  -...|++|.+.... ......+.+|+.++++++||||+++++++. .+..
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   89 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGES--IKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSL   89 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCS--CCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCce--EEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcc
Confidence            5688999999999999999998765432  12238888875442 222345678999999999999999999986 5678


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        90 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           90 QLVTQYLPLGSLLDHVRQHR-GALGPQLLLNWGVQIAKGMYYLEEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEEEECCTTCBSHHHHHSSG-GGSCTTHHHHHHHHHHHHHHHHHHTT--CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEEEeCCCCCHHHHHHHcc-ccCCHHHHHHHHHHHHHHHHHHHhCC--CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999999997642 35788899999999999999999977  9999999999999999999999999998765


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............||+.|+|||++.+..++.++|||||||++|+|++ |+.||...........+..              
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~--------------  232 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK--------------  232 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHT--------------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHc--------------
Confidence            5544444455678889999999999999999999999999999999 9999987543322111110              


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                         ......+..++.++.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       233 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~  276 (325)
T 3kex_A          233 ---GERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMAR  276 (325)
T ss_dssp             ---TCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTT
T ss_pred             ---CCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence               00111111233467789999999999999999999999988754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.7e-47  Score=355.32  Aligned_cols=258  Identities=22%  Similarity=0.378  Sum_probs=207.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||++.+.++.       .||+|++..... ...++.+|++++++++||||+++++++.+.+..
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   94 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWRGQY-------DVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI   94 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEETTTE-------EEEEEEECTTSB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEcCCC-------eEEEEEecCCCC-CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence            467889999999999999999887543       389999976543 346788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  171 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVL  171 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCSGGGEEECTTSCEEECSTTGGGGBC
T ss_pred             EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCccceEEEcCCCCEEEcccccccccc
Confidence            99999999999999996632 35899999999999999999999876  9999999999999999999999999998643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .... .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........             +.. 
T Consensus       172 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~-------------~~~-  236 (283)
T 3gen_A          172 DDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-------------IAQ-  236 (283)
T ss_dssp             CHHH-HSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-------------HHT-
T ss_pred             cccc-ccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH-------------Hhc-
Confidence            3211 11223457888999999999999999999999999999998 9999976532211110             001 


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                         ......+...+..+.+++.+||+.||.+|||+.+++++|..+...
T Consensus       237 ---~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          237 ---GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             ---TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence               111111222346788999999999999999999999999987654

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=9.6e-47  Score=351.01  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      ++|++.+.||+|+||.||+|.+.+.        .||+|++.....  ...+.+.+|+.++++++||||+++++++.+.  
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~--------~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   81 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGN--------DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPA   81 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTE--------EEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTS
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCe--------eEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCC
Confidence            5788999999999999999998532        399999876532  3446789999999999999999999999887  


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+.+|+||||||+|||++.++.++|+|||++.
T Consensus        82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           82 PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEecccee
Confidence            78899999999999999998876667899999999999999999999866569999999999999999999999998875


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCc---chhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTA---RSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ....       ....||+.|+|||++.+..++.   ++|||||||++|||++|+.||........               
T Consensus       162 ~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------  219 (271)
T 3kmu_A          162 SFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------  219 (271)
T ss_dssp             TTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------------
T ss_pred             eecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------------
Confidence            4222       1246899999999998765544   89999999999999999999976432111               


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                       .............+...+..+.+++.+||+.||++|||+.++++.|+.+..
T Consensus       220 -~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          220 -GMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             -HHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             -HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence             011111111122233445788999999999999999999999999998753

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1e-46  Score=359.62  Aligned_cols=246  Identities=27%  Similarity=0.383  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+++.      ||+|++++...   ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~   79 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   79 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCC
Confidence            5689999999999999999998776554      99999876432   34566788999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++||+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.+|.+||+|||+++.
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~Dfg~a~~  155 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY  155 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChheEEEcCCCCEEEeecCccee
Confidence            9999999999999999997654  4788899999999999999999866  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||........                ...
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----------------~~~  214 (318)
T 1fot_A          156 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKT----------------YEK  214 (318)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HHH
T ss_pred             cCCc-----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHH----------------HHH
Confidence            5332     2346799999999999999999999999999999999999999976432111                011


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      ++...+  .++...+.++.+|+.+||+.||.+||     ++.+|++|
T Consensus       215 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          215 ILNAEL--RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHCCC--CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHhCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            111111  12223457888999999999999999     88999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=360.38  Aligned_cols=264  Identities=23%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..+....  ..+|++|.+... .......+.+|+.++++++||||+++++++.+.. 
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~--~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKV--KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-   90 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSC--CEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceE--EEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-
Confidence            367899999999999999999986654321  123788877544 2345677899999999999999999999998754 


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++|+||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCC--CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            789999999999999997654 35889999999999999999999976  999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .............+|+.|+|||++.+..++.++|||||||++|||++ |..||.........                 .
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~-----------------~  230 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------S  230 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-----------------H
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------H
Confidence            44433333334567889999999999999999999999999999999 99999765432211                 1


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+...+.++.+|+.+||+.||.+||++.|+++.|+.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          231 ILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            1111111112223456788999999999999999999999999987643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-46  Score=358.58  Aligned_cols=269  Identities=24%  Similarity=0.323  Sum_probs=203.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||+||+|.+.++.       .||+|++.....  .....+.+|++++++++||||+++++++.+
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   90 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGR-------IVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS   90 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSC-------EEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCC-------EEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc
Confidence            35578999999999999999999986533       399999875432  234668899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||++ ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a  166 (311)
T 3niz_A           91 ERCLTLVFEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHR--ILHRDLKPQNLLINSDGALKLADFGLA  166 (311)
T ss_dssp             SSCEEEEEECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             CCEEEEEEcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCchHhEEECCCCCEEEccCcCc
Confidence            999999999996 58888876543 35899999999999999999999876  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hh---h
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PK---L  306 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~---~  306 (431)
                      +.......  ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....  +.   .
T Consensus       167 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  244 (311)
T 3niz_A          167 RAFGIPVR--SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW  244 (311)
T ss_dssp             EETTSCCC-----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred             eecCCCcc--cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence            87543221  2234578999999999876 568999999999999999999999998765443221111000  00   0


Q ss_pred             hccchhhhh-------cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQI-------IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+...       .............+.++.+||.+||+.||.+|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            000000000       00000011112234688999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.5e-47  Score=355.72  Aligned_cols=261  Identities=25%  Similarity=0.400  Sum_probs=217.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||.||+|.+..+...      ||+|++.... ...+.+.+|+.++++++||||+++++++.+.+.
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   83 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPP   83 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEE------EEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEE------EEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            356789999999999999999999875543      9999987653 345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++...
T Consensus        84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT--CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC--ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999999998877777999999999999999999999877  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ..... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........                 .
T Consensus       162 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~-----------------~  223 (288)
T 3kfa_A          162 TGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY-----------------E  223 (288)
T ss_dssp             CSSSS-EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH-----------------H
T ss_pred             cCCcc-ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------H
Confidence            43322 22333557889999999999999999999999999999999 99999765322111                 1


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       224 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          224 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111122233457889999999999999999999999999877654

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.5e-46  Score=353.16  Aligned_cols=255  Identities=31%  Similarity=0.536  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-------HHHHHHHHHHHhcCCCCceeeeecEE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-------HREWLTEVNFLGQLRHPNLVKLIGYC  150 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~l~~~~  150 (431)
                      ++|++.+.||+|+||.||+|.+..+...      ||+|++.......       .+.+.+|+.++++++||||+++++++
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSV------VAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM   92 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCE------EEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccceehhccccCCceeEEEEEEcCCceE------EEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee
Confidence            6788999999999999999999766543      9999986543221       15788999999999999999999998


Q ss_pred             EeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc-----EE
Q 014079          151 CEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT-----AK  225 (431)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~-----~k  225 (431)
                      .+..  ++||||+++++|.+++.... .++++..++.++.|++.||.|||+.+.+|+||||||+|||++.++.     +|
T Consensus        93 ~~~~--~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           93 HNPP--RMVMEFVPCGDLYHRLLDKA-HPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             TTTT--EEEEECCTTCBHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             cCCC--eEEEEecCCCCHHHHHhccc-CCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            6654  79999999999999886643 3689999999999999999999986555999999999999988776     99


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccc--cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM--TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      |+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|||++|+.||............    
T Consensus       170 l~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----  240 (287)
T 4f0f_A          170 VADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----  240 (287)
T ss_dssp             ECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----
T ss_pred             eCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----
Confidence            999999975332     234467999999999984  456789999999999999999999999765432211000    


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                                ...........+..++..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       241 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          241 ----------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                      01111112222334457889999999999999999999999999764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-46  Score=353.10  Aligned_cols=262  Identities=24%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..+..   ....||+|++..... ...+.+.+|+.++++++||||+++++++. .+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPEN---PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC-----CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCC---CceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            4679999999999999999999865432   122499999876432 34467889999999999999999999984 567


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecccccHHHEEECCCCCEEECcccccccc
Confidence            899999999999999997653 35899999999999999999999876  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|||++ |..||...........+               
T Consensus       167 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i---------------  230 (281)
T 1mp8_A          167 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---------------  230 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH---------------
T ss_pred             Cccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH---------------
Confidence            433221 1223457889999999999999999999999999999997 99999765322111100               


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                       .. ......+..++..+.+++.+||+.||++|||+.++++.|+.+...
T Consensus       231 -~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          231 -EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             -HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -Hc-CCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence             00 001112233457888999999999999999999999999987643

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-46  Score=356.10  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=196.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--------------------------hHHHHHHH
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--------------------------GHREWLTE  131 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------------------------~~~~~~~E  131 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++......                          ..+.+.+|
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTY------YAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEE------EEEEEEECC-------------------------------CHHHHH
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcE------EEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            5799999999999999999998776554      999998764321                          12457899


Q ss_pred             HHHHhcCCCCceeeeecEEEe--CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeec
Q 014079          132 VNFLGQLRHPNLVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYR  209 (431)
Q Consensus       132 ~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHr  209 (431)
                      +++|++++||||+++++++.+  .+..++||||+++++|.+++..   .++++..++.++.|++.||.|||+.+  |+||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~  161 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQK--IIHR  161 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECC
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eecc
Confidence            999999999999999999987  5688999999999999987633   35899999999999999999999976  9999


Q ss_pred             cCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCC
Q 014079          210 DFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH---LTARSDVYSFGVVLLELLTGRKS  286 (431)
Q Consensus       210 Dlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p  286 (431)
                      ||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++|+|++|+.|
T Consensus       162 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p  239 (298)
T 2zv2_A          162 DIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP  239 (298)
T ss_dssp             CCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            999999999999999999999998754332  1233467999999999988765   37789999999999999999999


Q ss_pred             CCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          287 VDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       287 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      |........   ..             .+....+........+.++.+|+.+||+.||++|||+.|++++
T Consensus       240 f~~~~~~~~---~~-------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          240 FMDERIMCL---HS-------------KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             SCCSSHHHH---HH-------------HHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             CCCccHHHH---HH-------------HHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            975421110   00             0000000001111234678899999999999999999999865

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=8.8e-47  Score=362.20  Aligned_cols=265  Identities=18%  Similarity=0.192  Sum_probs=210.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++.....  ...+.+|+.+++++ +||||+++++++.+.+.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   79 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEY------VAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY   79 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEE------EEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcE------EEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence            46799999999999999999998766553      99999875532  23577899999999 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc-----EEEeccc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT-----AKLSDFG  230 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~-----~kl~DFG  230 (431)
                      .++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.     +||+|||
T Consensus        80 ~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~Nill~~~~~~~~~~~kl~DFg  155 (330)
T 2izr_A           80 NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKN--LIYRDVKPENFLIGRPGNKTQQVIHIIDFA  155 (330)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTCTTSEEECCCT
T ss_pred             cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCCHHHeeeccCCCCCCceEEEEEcc
Confidence            99999999 99999999765 346899999999999999999999976  999999999999999887     9999999


Q ss_pred             CCccCCCCCCcc-----eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          231 LAKAGPQGDETH-----VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       231 ~a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||..................
T Consensus       156 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~  235 (330)
T 2izr_A          156 LAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDT  235 (330)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHH
T ss_pred             cceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhh
Confidence            998654332211     123467999999999999999999999999999999999999999876433222111110000


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                             ....   .........+ ++.+++.+||+.||.+||++.+|++.|+.+....
T Consensus       236 -------~~~~---~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~  283 (330)
T 2izr_A          236 -------KRAT---PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRK  283 (330)
T ss_dssp             -------HHHS---CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             -------hccC---CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHc
Confidence                   0000   0000011123 8899999999999999999999999999876654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.3e-46  Score=367.21  Aligned_cols=251  Identities=27%  Similarity=0.381  Sum_probs=205.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++.+...   .....+.+|+.+|+.++|||||+++++|.+.+
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~------~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKM------YAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            5789999999999999999999876654      99999876432   33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+.||+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a~~  164 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNV--HFKEETVKLFICELVMALDYLQNQR--IIHRDMKPDNILLDEHGHVHITDFNIAAM  164 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCcHHHeEECCCCCEEEeccceeee
Confidence            9999999999999999997643  5889999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      .....   .....+||+.|+|||++.+   ..|+.++|||||||++|||++|+.||................        
T Consensus       165 ~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~--------  233 (384)
T 4fr4_A          165 LPRET---QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE--------  233 (384)
T ss_dssp             CCTTC---CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHH--------
T ss_pred             ccCCC---ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHh--------
Confidence            54332   2345689999999999864   458999999999999999999999997654332221111100        


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-MSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~eil~~  356 (431)
                           .  ....++...+..+.+||.+||+.||.+||+ +.+|+.+
T Consensus       234 -----~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          234 -----T--TVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -----H--CCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -----h--cccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                 0  001122334578899999999999999998 7777653

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=7e-47  Score=372.11  Aligned_cols=256  Identities=20%  Similarity=0.244  Sum_probs=194.7

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHh-cCCCCceeeeecEEEe--
Q 014079           77 TKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG-QLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~--  152 (431)
                      .++|.+. ++||+|+||+||+|.+..++..      ||+|++...     ..+.+|+.++. ..+||||++++++|..  
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~------vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~  128 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY  128 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCE------EEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence            3456665 6899999999999998876554      999998643     34567888874 4589999999999876  


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEe
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLS  227 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~  227 (431)
                        ...+||||||++||+|.+++.......+++..+..++.|++.||.|||+.+  |+||||||+|||++.   ++.+||+
T Consensus       129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~~~kl~  206 (400)
T 1nxk_A          129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  206 (400)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSTTCCEEEC
T ss_pred             cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCcceEEEecCCCCccEEEE
Confidence              567899999999999999998766667999999999999999999999976  999999999999987   7899999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||..............      
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~------  277 (400)
T 1nxk_A          207 DFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT------  277 (400)
T ss_dssp             CCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH------
T ss_pred             ecccccccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH------
Confidence            999998654322   23356799999999999999999999999999999999999999976543221100000      


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         .+. .....+........+.++.+||.+||+.||++|||+.+++++-.
T Consensus       278 ---~i~-~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          278 ---RIR-MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             ---HHH-HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             ---HHH-cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence               000 00000111111234578899999999999999999999998754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.2e-46  Score=367.67  Aligned_cols=272  Identities=20%  Similarity=0.236  Sum_probs=206.6

Q ss_pred             hcCCCccceeccc--CcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEG--GFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .++|++.+.||+|  +||.||+|.+..++..      ||+|++.....  .....+.+|+.+|+.++|||||++++++.+
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~   97 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEY------VTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA   97 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCE------EEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCE------EEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence            3679999999999  9999999999876543      99999876532  334567889999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++++|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~kl~dfg~~  175 (389)
T 3gni_B           98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG--YVHRSVKASHILISVDGKVYLSGLRSN  175 (389)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCGGGC
T ss_pred             CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEcccccc
Confidence            999999999999999999998875567899999999999999999999977  999999999999999999999999988


Q ss_pred             ccCCCCCC-----cceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-hhhh
Q 014079          233 KAGPQGDE-----THVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-WARP  304 (431)
Q Consensus       233 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-~~~~  304 (431)
                      ........     ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||.+........... ...+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  255 (389)
T 3gni_B          176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVP  255 (389)
T ss_dssp             EECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC------
T ss_pred             eeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC
Confidence            64322111     111123478999999999987  679999999999999999999999997654332211000 0000


Q ss_pred             hhhccc------------------hhhhhc---------CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKR------------------KMLQII---------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~------------------~~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+....                  .+...+         ............+..+.+||.+||+.||.+|||+.|++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence            000000                  000000         0000011233446789999999999999999999999976

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=3e-46  Score=358.02  Aligned_cols=254  Identities=24%  Similarity=0.358  Sum_probs=198.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++..... ...+.+.+|+++|++++||||++++++|.+..
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   77 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDC------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETP   77 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCC------EEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECC
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCc------EEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEec
Confidence            45679999999999999999999876544      399999875433 34567899999999999999999999986654


Q ss_pred             ---------------------------------------------------------eeEEEEEecCCCChHHhhhhCCC
Q 014079          155 ---------------------------------------------------------HRLLVYEFMFRGSLENHLFRKAT  177 (431)
Q Consensus       155 ---------------------------------------------------------~~~lv~e~~~~gsL~~~l~~~~~  177 (431)
                                                                               ..++||||+++++|.+++.....
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  157 (332)
T 3qd2_B           78 PEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS  157 (332)
T ss_dssp             SCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCS
T ss_pred             cchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccC
Confidence                                                                     37999999999999999977543


Q ss_pred             -CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc----------ceeec
Q 014079          178 -VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET----------HVSTR  246 (431)
Q Consensus       178 -~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~----------~~~~~  246 (431)
                       ....+..++.++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++........          .....
T Consensus       158 ~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T 3qd2_B          158 LEDREHGVCLHIFIQIAEAVEFLHSKG--LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTG  235 (332)
T ss_dssp             GGGSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCS
T ss_pred             ccchhhHHHHHHHHHHHHHHHHHHhCC--eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccc
Confidence             23456678899999999999999876  999999999999999999999999999875543211          12234


Q ss_pred             ccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccH
Q 014079          247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSV  326 (431)
Q Consensus       247 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (431)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..|+...                  .......... .......
T Consensus       236 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~------------------~~~~~~~~~~-~~~~~~~  296 (332)
T 3qd2_B          236 QVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMER------------------VRIITDVRNL-KFPLLFT  296 (332)
T ss_dssp             CC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHH------------------HHHHHHHHTT-CCCHHHH
T ss_pred             cCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHH------------------HHHHHHhhcc-CCCcccc
Confidence            57999999999999999999999999999999999987654210                  0000011111 1111223


Q ss_pred             HHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          327 RAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       327 ~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+.+|+.+||+.||.+|||+.|++++
T Consensus       297 ~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          297 QKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             cCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence            445677899999999999999999999975

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.5e-47  Score=366.97  Aligned_cols=276  Identities=24%  Similarity=0.317  Sum_probs=213.0

Q ss_pred             cccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-----C
Q 014079           66 IAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-----H  140 (431)
Q Consensus        66 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h  140 (431)
                      ..+++.+...+.++|++.+.||+|+||.||+|.+..++.      .||+|++.... .....+..|+.+++.++     |
T Consensus        23 ~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h   95 (360)
T 3llt_A           23 VHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKK------YYAVKVVRNIK-KYTRSAKIEADILKKIQNDDINN   95 (360)
T ss_dssp             GSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTG
T ss_pred             eeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCe------EEEEEEeccch-hhhhhhHHHHHHHHHhcccCCCC
Confidence            345666666778999999999999999999999876654      39999987532 33456778999999986     9


Q ss_pred             CceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       141 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      |||+++++++...+..++||||+ +++|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+||||+.
T Consensus        96 ~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~  172 (360)
T 3llt_A           96 NNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS--LTHTDLKPENILLDD  172 (360)
T ss_dssp             GGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESC
T ss_pred             CCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCcccEEEcc
Confidence            99999999999999999999999 999999998877667899999999999999999999876  999999999999975


Q ss_pred             -------------------------CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHH
Q 014079          221 -------------------------DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGV  275 (431)
Q Consensus       221 -------------------------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  275 (431)
                                               ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  247 (360)
T 3llt_A          173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGC  247 (360)
T ss_dssp             TTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHH
T ss_pred             ccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHH
Confidence                                     789999999999864332     23457999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc-------hhhhhcC-ccc--------------------cCcccHH
Q 014079          276 VLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR-------KMLQIID-PRL--------------------ENQYSVR  327 (431)
Q Consensus       276 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~~--------------------~~~~~~~  327 (431)
                      ++|+|++|+.||...........+...........       .....++ ..+                    .......
T Consensus       248 il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~  327 (360)
T 3llt_A          248 VLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKII  327 (360)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHC
T ss_pred             HHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccc
Confidence            99999999999976543222111111000000000       0000000 000                    0000111


Q ss_pred             HHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          328 AAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       328 ~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....+.+|+.+||+.||.+|||+.|++++
T Consensus       328 ~~~~l~~li~~~L~~dP~~Rpta~elL~h  356 (360)
T 3llt_A          328 KHELFCDFLYSILQIDPTLRPSPAELLKH  356 (360)
T ss_dssp             CCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             hHHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            12678899999999999999999999865

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.2e-47  Score=377.23  Aligned_cols=261  Identities=26%  Similarity=0.410  Sum_probs=207.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+..+.       .||||+++... ...+.+.+|+.+|++++||||+++++++.+ +..
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~  253 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  253 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCc-------eEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-Cce
Confidence            456888999999999999999987643       39999998654 345678999999999999999999999876 678


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       254 ~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          254 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            99999999999999997644445889999999999999999999976  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .... .......+|..|+|||++.++.++.++|||||||++|||++ |+.||.+.......                 ..
T Consensus       332 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~-----------------~~  393 (452)
T 1fmk_A          332 DNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----------------DQ  393 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH-----------------HH
T ss_pred             CCce-ecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HH
Confidence            3221 12223457889999999999999999999999999999999 99999764321111                 11


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      +........+..++..+.+|+.+||+.||++|||+.+|++.|+.+......
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~~  444 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  444 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccCCc
Confidence            111111122334567889999999999999999999999999988765443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.2e-46  Score=361.31  Aligned_cols=257  Identities=26%  Similarity=0.397  Sum_probs=204.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      ++|++.+.||+|+||.||+|.+..+++.      ||+|++.+...   .....+.+|+.+++++ +||||+++++++.+.
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   82 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRI------YAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE   82 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCE------EEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC
Confidence            5688999999999999999999876654      99999976532   2345678899999988 899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||+++|+|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        83 ~~~~lv~e~~~gg~L~~~l~~~~--~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFG~a~  158 (345)
T 3a8x_A           83 SRLFFVIEYVNGGDLMFHMQRQR--KLPEEHARFYSAEISLALNYLHERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCK  158 (345)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCGGGCB
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEEeccccc
Confidence            99999999999999999997654  4889999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||...........        .....+.
T Consensus       159 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~--------~~~~~~~  228 (345)
T 3a8x_A          159 EGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ--------NTEDYLF  228 (345)
T ss_dssp             CSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC---------------CHHHHH
T ss_pred             cccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc--------ccHHHHH
Confidence            633222  123456899999999999999999999999999999999999999975322111000        0000000


Q ss_pred             -hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH------HHHHHH
Q 014079          314 -QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM------SDVVET  356 (431)
Q Consensus       314 -~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~------~eil~~  356 (431)
                       .+....  ..++...+.++.+||.+||+.||.+||++      .+++.|
T Consensus       229 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          229 QVILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             HHHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence             111111  11223345788999999999999999995      677655

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.2e-46  Score=351.79  Aligned_cols=268  Identities=18%  Similarity=0.207  Sum_probs=213.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++....  ....+.+|+.+++.+ +|+|++++++++.+..
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ------QVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTE------EEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCc------EEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            34679999999999999999999876655      39999886543  224577899999999 7999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc-----EEEecc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT-----AKLSDF  229 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~-----~kl~DF  229 (431)
                      ..++||||+ +++|.+++.... .++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.     +||+||
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~~~~~~~~kl~Df  155 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDF  155 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCC
T ss_pred             eeEEEEEec-CCCHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEeccCCCCCCCeEEEEEC
Confidence            999999999 999999997653 35899999999999999999999866  999999999999987776     999999


Q ss_pred             cCCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          230 GLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       230 G~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      |+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.................
T Consensus       156 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  235 (298)
T 1csn_A          156 GMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE  235 (298)
T ss_dssp             TTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH
T ss_pred             ccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHh
Confidence            999865443221     122346799999999999999999999999999999999999999987543322211111000


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      ..          ............+.++.+++.+||+.||.+||++.+|++.|+++.....
T Consensus       236 ~~----------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          236 KK----------QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             HH----------HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             hc----------cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence            00          0000001111335788999999999999999999999999998876543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-46  Score=362.67  Aligned_cols=250  Identities=26%  Similarity=0.380  Sum_probs=205.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      .++|++.+.||+|+||.||+|.+..+++.      ||+|++++...   .....+..|..+|..+ +||||+++++++.+
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~   92 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDEL------YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT   92 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc
Confidence            46799999999999999999999876554      99999876532   3346678899999988 79999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+.+|+||||++||+|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+||||+.+|.+||+|||++
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~vkL~DFG~a  168 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC  168 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--EEeccCCHHHEEEcCCCcEEEEeCCcc
Confidence            999999999999999999997654  4889999999999999999999976  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||........                .
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----------------~  230 (353)
T 2i0e_A          169 KENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------F  230 (353)
T ss_dssp             BCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------H
T ss_pred             cccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHH----------------H
Confidence            8643222  123356899999999999999999999999999999999999999976432111                0


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      ..++...+  .++...+.++.+||.+||+.||.+||+     +.+|++|
T Consensus       231 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          231 QSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHHCCC--CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHhCCC--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            11111111  122334578899999999999999995     5788765

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5e-47  Score=365.46  Aligned_cols=251  Identities=26%  Similarity=0.395  Sum_probs=205.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCC  151 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  151 (431)
                      ..++|++.+.||+|+||.||+|.++.+++.      ||+|++++...   .....+..|..++..+ +||||+++++++.
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~   88 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQ   88 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEE
Confidence            357899999999999999999999876654      99999976432   2345677899999877 8999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      +.+.+|+||||++||+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+|.+||+|||+
T Consensus        89 ~~~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~vkL~DFG~  164 (345)
T 1xjd_A           89 TKENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGM  164 (345)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTT
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCChhhEEECCCCCEEEeEChh
Confidence            9999999999999999999997654  4788999999999999999999976  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ++.......  .....+||+.|+|||++.+..++.++|||||||++|||++|+.||...........             
T Consensus       165 a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~-------------  229 (345)
T 1xjd_A          165 CKENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS-------------  229 (345)
T ss_dssp             CBCCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-------------
T ss_pred             hhhcccCCC--cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHH-------------
Confidence            986432221  23456899999999999999999999999999999999999999976432111100             


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS-DVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-eil~~  356 (431)
                         +....  ..++...+.++.+||.+||+.||.+||++. +|++|
T Consensus       230 ---i~~~~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          230 ---IRMDN--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ---HHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---HHhCC--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence               00000  011223457888999999999999999997 77654

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-46  Score=360.67  Aligned_cols=271  Identities=22%  Similarity=0.381  Sum_probs=214.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..... ....+..||+|++..... .....+.+|+.+++++ +||||+++++++.+.
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  113 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  113 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence            4678999999999999999999853211 112334599999976533 3456788999999999 899999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      +..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.+  |+||||||+|||++
T Consensus       114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~  191 (334)
T 2pvf_A          114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK--CIHRDLAARNVLVT  191 (334)
T ss_dssp             SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC
T ss_pred             CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCccceEEEc
Confidence            999999999999999999976432              24789999999999999999999976  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||........   
T Consensus       192 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---  268 (334)
T 2pvf_A          192 ENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL---  268 (334)
T ss_dssp             TTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH---
T ss_pred             CCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH---
Confidence            999999999999987654433222334567889999999999999999999999999999999 9999976432111   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      .              ..+........+..++..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus       269 ~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          269 F--------------KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             H--------------HHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            0              00000111112223457889999999999999999999999999988765443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.1e-46  Score=356.60  Aligned_cols=248  Identities=25%  Similarity=0.260  Sum_probs=196.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      +.++|++.++||+|+||+||+|.+..++..      ||||++.....  .....+..|+..+.++ +||||+++++++.+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~  128 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRL------YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE  128 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCE------EEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeE------EEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe
Confidence            457899999999999999999999865543      99998765432  2334455666666555 89999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+ +++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kl~DFG~a  204 (311)
T 3p1a_A          129 GGILYLQTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQG--LVHLDVKPANIFLGPRGRCKLGDFGLL  204 (311)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECGGGCEEECCCTTC
T ss_pred             CCEEEEEEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EecCCCCHHHEEECCCCCEEEccceee
Confidence            99999999999 789999887654 36899999999999999999999976  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .......   ......||+.|+|||++.+ .++.++|||||||++|||++|..||.....                   .
T Consensus       205 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~-------------------~  261 (311)
T 3p1a_A          205 VELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG-------------------W  261 (311)
T ss_dssp             EECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH-------------------H
T ss_pred             eecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH-------------------H
Confidence            7654322   2234569999999998875 799999999999999999999776643210                   0


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..+........+....+.++.+|+.+||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          262 QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhC
Confidence            01111111112223345788999999999999999999999975

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-47  Score=358.10  Aligned_cols=260  Identities=24%  Similarity=0.356  Sum_probs=207.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..+.. ...+...||+|++........+.+.+|+.++++++||||+++++++.+.+.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3578999999999999999999875432 233445699999987766667889999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--------EEEe
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--------AKLS  227 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--------~kl~  227 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.        +||+
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~  163 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENT--LIHGNVCAKNILLIREEDRKTGNPPFIKLS  163 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEEECCBGGGTBCCEEEEC
T ss_pred             CEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCC--eECCCcCcceEEEecCCcccccccceeeec
Confidence            999999999999999997653 34889999999999999999999977  999999999999998877        9999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||++......      ....||+.|+|||++.+ ..++.++|||||||++|||++|..|+.........  ...    .
T Consensus       164 Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~--~~~----~  231 (289)
T 4fvq_A          164 DPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK--LQF----Y  231 (289)
T ss_dssp             CCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--HHH----H
T ss_pred             cCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH--HHH----h
Confidence            99998754221      22458899999999987 77999999999999999999965554332211110  000    0


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ..        ...+    +...+.++.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus       232 ~~--------~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          232 ED--------RHQL----PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             HT--------TCCC----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             hc--------cCCC----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            00        0001    111235678999999999999999999999999987754

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-46  Score=352.92  Aligned_cols=262  Identities=29%  Similarity=0.465  Sum_probs=196.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      ..++|++.+.||+|+||.||+|.+...         ||+|+++....  ...+.+.+|+.+|++++||||+++++++ ..
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWHGD---------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESSSE---------EEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CccceeeeeEecCCCCeEEEEEEEcCc---------eEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            346799999999999999999986542         89998875532  3446788999999999999999999965 56


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ...++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~--i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASE-TKFEMKKLIDIARQTARGMDYLHAKS--IIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             CccEEEEEecCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--cccccCccceEEECCCCCEEEccceecc
Confidence            67899999999999999996543 45899999999999999999999976  9999999999999999999999999997


Q ss_pred             cCCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ...............||+.|+|||++.   +..++.++||||||+++|+|++|+.||.........  ....    ..  
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~----~~--  240 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IEMV----GR--  240 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH--HHHH----HH--
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH--HHHh----cc--
Confidence            654333333334467999999999986   667899999999999999999999999765432111  0000    00  


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                         ....+. .......++..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       241 ---~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 ---GSLSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             ---TSCCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             ---cccCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence               000010 111222345788999999999999999999999999998753

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.6e-46  Score=362.93  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=205.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++.+...   .....+.+|+.+|+.++||||+++++++.+.+
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCE------EEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            5789999999999999999998866543      99999876432   34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++|++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~g~~kL~DFg~a~~  190 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEcCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccccCccceEEECCCCCEEEccccccee
Confidence            9999999999999999997754  4889999999999999999999877  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||.........                ..
T Consensus       191 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~----------------~~  249 (350)
T 1rdq_E          191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----------------EK  249 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred             ccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHH----------------HH
Confidence            5332     22457999999999999999999999999999999999999999764321110                01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~L  357 (431)
                      +....+  .++...+.++.+||.+||+.||.+||+     +.+|++|-
T Consensus       250 i~~~~~--~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~  295 (350)
T 1rdq_E          250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHK  295 (350)
T ss_dssp             HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSG
T ss_pred             HHcCCC--CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCc
Confidence            111111  122234578899999999999999998     88888763

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-46  Score=362.60  Aligned_cols=254  Identities=22%  Similarity=0.342  Sum_probs=198.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCC--CceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRH--PNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~  152 (431)
                      .++|++.+.||+|+||.||++.+.++.       .||+|++.....  .....+.+|+.+|++++|  +||+++++++.+
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~   80 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQ-------IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT   80 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSC-------EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCC-------EEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee
Confidence            467999999999999999999875532       399998875432  334678899999999986  999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++|||+ .+++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++ ++.+||+|||++
T Consensus        81 ~~~~~lv~e~-~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--iiHrDikp~NIll~-~~~~kl~DFG~a  154 (343)
T 3dbq_A           81 DQYIYMVMEC-GNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIA  154 (343)
T ss_dssp             SSEEEEEECC-CSEEHHHHHHHSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEE-TTEEEECCCSSS
T ss_pred             CCEEEEEEeC-CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCcceEEEE-CCcEEEeecccc
Confidence            9999999995 5899999998754  5788899999999999999999976  99999999999997 678999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      +...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||......        
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--------  226 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ--------  226 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH--------
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH--------
Confidence            87654433333445679999999999865           67899999999999999999999999754221        


Q ss_pred             hhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                             ...+..++++.....++...+..+.+|+.+||+.||.+|||+.+++++..
T Consensus       227 -------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          227 -------ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             -------HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             -------HHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence                   11122222222222333333467889999999999999999999998754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.3e-46  Score=365.49  Aligned_cols=256  Identities=21%  Similarity=0.325  Sum_probs=195.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||+||++.+..++..      ||+|++..... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   91 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKEL------VAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHL   91 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCE------EEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcE------EEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence            35799999999999999999999866553      99999876532 235678999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--EEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--AKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--~kl~DFG~a~~  234 (431)
                      ++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.  +||+|||+++.
T Consensus        92 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~--ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           92 AIIMEYASGGELYERICNAG--RFSEDEARFFFQQLLSGVSYCHSMQ--ICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            99999999999999997654  4889999999999999999999877  999999999999987765  99999999975


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTAR-SDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....   ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||............            +.
T Consensus       168 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~------------~~  232 (361)
T 3uc3_A          168 SVLHS---QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT------------IQ  232 (361)
T ss_dssp             ----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH------------HH
T ss_pred             ccccC---CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH------------HH
Confidence            32221   2234579999999999988888765 89999999999999999999765432221110            01


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .+.............+..+.+||.+||+.||.+|||+.|+++|-.
T Consensus       233 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~  277 (361)
T 3uc3_A          233 RILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSW  277 (361)
T ss_dssp             HHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHH
T ss_pred             HHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcc
Confidence            111111111111123467889999999999999999999998743

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.3e-47  Score=363.48  Aligned_cols=268  Identities=25%  Similarity=0.374  Sum_probs=213.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+...... .....||+|++..... .....+.+|+.+|+++ +||||+++++++.+.+
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLGKE-DAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCSSS-CCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCCcc-cchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            46789999999999999999998654321 1223599999876543 3456788999999999 8999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      ..++||||+++|+|.+++....            ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN--CIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGCEEEGGG
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC--cccCCcccceEEECCCC
Confidence            9999999999999999997532            335789999999999999999999876  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~  301 (431)
                      .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||.........     
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~-----  276 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF-----  276 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH-----
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH-----
Confidence            999999999986544333333334567889999999999999999999999999999998 99999765322111     


Q ss_pred             hhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          302 ARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                 ...+........+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       277 -----------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          277 -----------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -----------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHh
Confidence                       011111111111222346788999999999999999999999999876543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1e-46  Score=361.26  Aligned_cols=281  Identities=25%  Similarity=0.344  Sum_probs=213.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEE--eCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC--EDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+.....  ..+..||+|++........+.+.+|++++++++||||+++++++.  +...
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGD--NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSS--SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCC--CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            578999999999999999998532111  112349999998876666677999999999999999999999987  4567


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  177 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRA-RLDASRLLLYSSQICKGMEYLGSRR--CVHRDLAARNILVESEAHVKIADFGLAKLL  177 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGG-GCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred             EEEEEeecCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChhhEEECCCCCEEEcccccceec
Confidence            8999999999999999976432 5899999999999999999999876  999999999999999999999999999876


Q ss_pred             CCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........... . ..........+..
T Consensus       178 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~-~~~~~~~~~~~~~  255 (327)
T 3lxl_A          178 PLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-G-CERDVPALSRLLE  255 (327)
T ss_dssp             CTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C-----CCHHHHHHH
T ss_pred             ccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-c-cccccccHHHHHH
Confidence            4433221 22235688899999999999999999999999999999999999864321100000 0 0000011112222


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      .+........+..++..+.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus       256 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~  306 (327)
T 3lxl_A          256 LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSR  306 (327)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-----
T ss_pred             HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence            222222333344556789999999999999999999999999998765443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=6e-47  Score=375.43  Aligned_cols=259  Identities=21%  Similarity=0.238  Sum_probs=206.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ..++|++.++||+|+||+||+|.+..+++.      ||+|++.+....   ....+.+|+.++..++||||++++++|.+
T Consensus        72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~------vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           72 HREDFEILKVIGRGAFGEVAVVKLKNADKV------FAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             ChhheEEEEEEEeCCCEEEEEEEEcCCCcE------EEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            457899999999999999999999877654      999998764221   12237789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+.+|+||||++||+|.+++.... ..+++..+..++.|++.||.|||+.+  ||||||||+||||+.++.+||+|||++
T Consensus       146 ~~~~~lV~Ey~~gg~L~~~l~~~~-~~l~e~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILl~~~g~vkL~DFGla  222 (437)
T 4aw2_A          146 DNNLYLVMDYYVGGDLLTLLSKFE-DRLPEEMARFYLAEMVIAIDSVHQLH--YVHRDIKPDNILMDMNGHIRLADFGSC  222 (437)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eEecccCHHHeeEcCCCCEEEcchhhh
Confidence            999999999999999999997642 35899999999999999999999877  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      +....... ......+||+.|+|||++.     ...|+.++|||||||++|||++|+.||...........+.      .
T Consensus       223 ~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~------~  295 (437)
T 4aw2_A          223 LKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------N  295 (437)
T ss_dssp             EECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------T
T ss_pred             hhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh------h
Confidence            76543322 2233468999999999987     4678999999999999999999999997653221111100      0


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L  357 (431)
                      ..   ....-+.    .....+.++.+||.+||..+|++  ||++.|+++|-
T Consensus       296 ~~---~~~~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          296 HK---ERFQFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HH---HHCCCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             cc---ccccCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            00   0000000    01124578889999999988888  99999999863

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=7.4e-47  Score=362.97  Aligned_cols=249  Identities=24%  Similarity=0.336  Sum_probs=204.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++.+...   .....+.+|+.+|+.++||||+++++++.+.+
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~   82 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQ------KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPT   82 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCC
Confidence            579999999999999999999876654      399999875422   12356889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+ +|+|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        83 ~~~lv~E~~-~g~l~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kl~DFG~s~~  157 (336)
T 3h4j_B           83 DIVMVIEYA-GGELFDYIVEKK--RMTEDEGRRFFQQIICAIEYCHRHK--IVHRDLKPENLLLDDNLNVKIADFGLSNI  157 (336)
T ss_dssp             EEEEEECCC-CEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--CCCCCCSTTTEEECTTCCEEECCSSCTBT
T ss_pred             EEEEEEECC-CCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCchhhEEEcCCCCEEEEEecccee
Confidence            999999999 889999887654  4889999999999999999999877  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........               
T Consensus       158 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------  219 (336)
T 3h4j_B          158 MTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------  219 (336)
T ss_dssp             TTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------
T ss_pred             ccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------
Confidence            54332   2234679999999999988776 6899999999999999999999976432211100               


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                        +... ....+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       220 --i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  261 (336)
T 3h4j_B          220 --VNSC-VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPW  261 (336)
T ss_dssp             --CCSS-CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHH
T ss_pred             --HHcC-CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChh
Confidence              0000 01112234567889999999999999999999998643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.3e-46  Score=351.90  Aligned_cols=267  Identities=23%  Similarity=0.290  Sum_probs=201.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|.+..++..      ||+|++.....  .....+.+|+.++++++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   75 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCce------EEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCE
Confidence            4789999999999999999999876553      99999875432  234678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+ +|.+.+.... ..+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        76 ~~lv~e~~~~-~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~--ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           76 LTLVFEFCDQ-DLKKYFDSCN-GDLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSE-EHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            9999999965 6666665433 35899999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc-hhhhh--hhhhhhccch
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-SLVDW--ARPKLNDKRK  311 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~--~~~~~~~~~~  311 (431)
                      ....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ..+..  ..+.......
T Consensus       152 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~  229 (292)
T 3o0g_A          152 GIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             CCcc--ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhh
Confidence            4322  1223457899999999988765 899999999999999999988886443322111 00000  0000000000


Q ss_pred             hhhhcC---------ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIID---------PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~---------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....+         ...........+..+.+|+.+||+.||++|||+.|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            000000         000011122345788899999999999999999999975

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-46  Score=357.63  Aligned_cols=264  Identities=27%  Similarity=0.449  Sum_probs=204.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|.+.+.||+|+||.||+|.+.....  .....||+|++..... .....+.+|+.++++++||||+++++++.+.+..
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCC--CccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            567788999999999999998865422  1233599999876532 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus       122 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEeCCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999999997643 35899999999999999999999976  9999999999999999999999999998754


Q ss_pred             CCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||........   .              .
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~---~--------------~  261 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---M--------------K  261 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---H--------------H
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHH---H--------------H
Confidence            332211 1222456889999999999999999999999999999999 9999965432111   0              0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+..++..+.+++.+||+.||.+||++.+|++.|+.+...
T Consensus       262 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          262 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            0100111111223457889999999999999999999999999987654

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.9e-46  Score=348.12  Aligned_cols=252  Identities=29%  Similarity=0.474  Sum_probs=194.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      ++|++.+.||+|+||.||+|.+.+.        .||+|++.....    ...+.+.+|+++++.++||||+++++++.+.
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~~~--------~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   78 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWIGD--------EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE   78 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEETTE--------EEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC
T ss_pred             hheeeeeeeccCCCeEEEEEEEcCC--------eEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            5788999999999999999987532        399999876432    2246788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCC-CeeeccCCCCCEEECC--------CCcE
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER-PVIYRDFKTSNILLDS--------DYTA  224 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~-~ivHrDlkp~NILl~~--------~~~~  224 (431)
                      +..++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.+. +|+||||||+|||++.        ++.+
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             CceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcce
Confidence            999999999999999999853   358899999999999999999998652 2889999999999986        6789


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      ||+|||++.......    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........        
T Consensus       156 kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~--------  223 (271)
T 3dtc_A          156 KITDFGLAREWHRTT----KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA--------  223 (271)
T ss_dssp             EECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHH--------
T ss_pred             EEccCCccccccccc----ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--------
Confidence            999999997643322    12356999999999999999999999999999999999999999764321110        


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                              ............+..++..+.+++.+||+.||.+|||+.|++++|+.+
T Consensus       224 --------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          224 --------YGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             --------HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             --------HhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                    111111111222334457889999999999999999999999999754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-46  Score=360.59  Aligned_cols=261  Identities=25%  Similarity=0.282  Sum_probs=204.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-----chhHHHHHHHHHHHhcCCCCceeee
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-----LQGHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      .+..+.++|++.+.||+|+||.||+|.+..++..      ||+|++....     ......+.+|++++++++||||+++
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~   93 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAI------RAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARL   93 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCce------EEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCccee
Confidence            3567889999999999999999999998776553      9999986542     2345678899999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhC--------------------------------------CCCCcCHHHHHHH
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRK--------------------------------------ATVPLSWATRMMI  188 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------------------------------~~~~~~~~~~~~i  188 (431)
                      ++++.+.+..++||||+++++|.+++...                                      ....+++..++.+
T Consensus        94 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  173 (345)
T 3hko_A           94 YEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI  173 (345)
T ss_dssp             EEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHH
T ss_pred             ehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHH
Confidence            99999999999999999999999998521                                      0122467778889


Q ss_pred             HHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC--cEEEecccCCccCCCCCC--cceeecccCCccccCcccccc--C
Q 014079          189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY--TAKLSDFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYVMT--G  262 (431)
Q Consensus       189 ~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~--~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~--~  262 (431)
                      +.|++.||.|||+.+  |+||||||+|||++.++  .+||+|||+++.......  ........||+.|+|||++.+  .
T Consensus       174 ~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  251 (345)
T 3hko_A          174 MRQIFSALHYLHNQG--ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE  251 (345)
T ss_dssp             HHHHHHHHHHHHHTT--EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSS
T ss_pred             HHHHHHHHHHHHHCC--ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCC
Confidence            999999999999976  99999999999998776  899999999975432211  112334679999999999875  6


Q ss_pred             CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc--ccCcccHHHHHHHHHHHHHhh
Q 014079          263 HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR--LENQYSVRAAQKACSLAYYCL  340 (431)
Q Consensus       263 ~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl  340 (431)
                      .++.++|||||||++|||++|+.||.........                ..++...  +........+..+.+||.+||
T Consensus       252 ~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  315 (345)
T 3hko_A          252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTI----------------SQVLNKKLCFENPNYNVLSPLARDLLSNLL  315 (345)
T ss_dssp             CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HHHHHCCCCTTSGGGGGSCHHHHHHHHHHS
T ss_pred             CCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHH----------------HHHHhcccccCCcccccCCHHHHHHHHHHc
Confidence            7899999999999999999999999765322111                1111111  111111224578899999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 014079          341 SQNPKARPLMSDVVET  356 (431)
Q Consensus       341 ~~dP~~RPt~~eil~~  356 (431)
                      +.||.+|||+.+++++
T Consensus       316 ~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          316 NRNVDERFDAMRALQH  331 (345)
T ss_dssp             CSCTTTSCCHHHHHHS
T ss_pred             CCChhHCCCHHHHhcC
Confidence            9999999999999986

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=5.6e-47  Score=372.84  Aligned_cols=254  Identities=22%  Similarity=0.265  Sum_probs=205.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.++||+|+||.||+|.+..++..      ||+|++.+...   .....+.+|+.+++.++|||||+++++|.+.
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~------~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKV------YAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcE------EEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            46899999999999999999999876554      99999876322   1223477899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||++||+|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~g--ivHrDLKp~NILl~~~g~ikL~DFG~a~  216 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMG--FIHRDVKPDNMLLDKSGHLKLADFGTCM  216 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCCHHHeeECCCCCEEEeccceeE
Confidence            9999999999999999998653   4788999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCC----CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGH----LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      ....... ......+||+.|+|||++.+..    |+.++|||||||++|||++|+.||..........            
T Consensus       217 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~------------  283 (410)
T 3v8s_A          217 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYS------------  283 (410)
T ss_dssp             ECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------------
T ss_pred             eeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHH------------
Confidence            7543321 1233578999999999998765    8899999999999999999999997643221111            


Q ss_pred             chhhhhcCcc--ccCcccHHHHHHHHHHHHHhhhcCCCC--CCCHHHHHHHHh
Q 014079          310 RKMLQIIDPR--LENQYSVRAAQKACSLAYYCLSQNPKA--RPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~--RPt~~eil~~L~  358 (431)
                          .++...  +........+.++.+||.+||+.+|.+  ||++.||++|-.
T Consensus       284 ----~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~  332 (410)
T 3v8s_A          284 ----KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF  332 (410)
T ss_dssp             ----HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGG
T ss_pred             ----HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcc
Confidence                111100  000011123578899999999999998  999999998743

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-46  Score=358.01  Aligned_cols=273  Identities=27%  Similarity=0.373  Sum_probs=214.6

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGY  149 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~  149 (431)
                      .++...++|++.+.||+|+||.||+|.+..... ...+..||+|++..... .....+.+|+.++.++ +||||++++++
T Consensus        21 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~   99 (316)
T 2xir_A           21 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDK-TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   99 (316)
T ss_dssp             HHBCCGGGEEEEEEEEECSSEEEEEEEEESSSS-TTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ceecchhheeeeeEEcCCCceeEEEEEEecCCc-cccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEE
Confidence            333446789999999999999999998643111 11223599999976543 3346788999999999 69999999999


Q ss_pred             EEeCC-eeEEEEEecCCCChHHhhhhCCC--------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCC
Q 014079          150 CCEDD-HRLLVYEFMFRGSLENHLFRKAT--------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTS  214 (431)
Q Consensus       150 ~~~~~-~~~lv~e~~~~gsL~~~l~~~~~--------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~  214 (431)
                      +...+ ..++||||+++++|.+++.....              ..+++..++.++.|++.||.|||+.+  |+||||||+
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~--i~H~dikp~  177 (316)
T 2xir_A          100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAAR  177 (316)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGG
T ss_pred             EecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC--cccccCccc
Confidence            88755 48999999999999999976542              12789999999999999999999976  999999999


Q ss_pred             CEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCc
Q 014079          215 NILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPS  293 (431)
Q Consensus       215 NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  293 (431)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999987654433333344568999999999999999999999999999999998 99999765422


Q ss_pred             ccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ...  .              ..+........+...+..+.+++.+||+.||.+|||+.+|+++|+.+...
T Consensus       258 ~~~--~--------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          258 EEF--C--------------RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HHH--H--------------HHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHH--H--------------HHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111  0              00000001111222346788999999999999999999999999987654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.8e-46  Score=360.09  Aligned_cols=277  Identities=18%  Similarity=0.221  Sum_probs=209.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH-----------HHHHHHHHHHhcCCCCceee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-----------REWLTEVNFLGQLRHPNLVK  145 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  145 (431)
                      .++|++.+.||+|+||.||+|.+..+.... .+..||+|++........           ..+..|+..+..++||||++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~-~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSESVG-SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSSCCC-TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCccccc-cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            458999999999999999999987754332 233599999876542111           22456777788889999999


Q ss_pred             eecEEEeC----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC--
Q 014079          146 LIGYCCED----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--  219 (431)
Q Consensus       146 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~--  219 (431)
                      +++++...    ...+|||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+||||+  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~-~~l~~~~~~~i~~qi~~~l~~lH~~~--iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANA-KRFSRKTVLQLSLRILDILEYIHEHE--YVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eEEecCCHHHEEEecC
Confidence            99998875    4589999999 999999997643 46899999999999999999999976  99999999999998  


Q ss_pred             CCCcEEEecccCCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 014079          220 SDYTAKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK  294 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  294 (431)
                      .++.+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999765332111     11123569999999999999999999999999999999999999997533221


Q ss_pred             cchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      ..  ......  .....+..++++.+..   ...+.++.+++..||..||.+||++.+|++.|+.+.....
T Consensus       269 ~~--~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~  332 (364)
T 3op5_A          269 KY--VRDSKI--RYRENIASLMDKCFPA---ANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIG  332 (364)
T ss_dssp             HH--HHHHHH--HHHHCHHHHHHHHSCT---TCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HH--HHHHHH--HhhhhHHHHHHHhccc---ccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcC
Confidence            11  111000  0011122222222210   1234688999999999999999999999999998776544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=2.9e-46  Score=366.57  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=198.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCC--CCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLR--HPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~  153 (431)
                      +.|++.+.||+|+||.||+|.+..+ .      .||||++.....  .....+.+|+.+|++++  ||||+++++++...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~-~------~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~  128 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKK-Q------IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  128 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTC-C------EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCC-C------EEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC
Confidence            4699999999999999999987653 2      399999865432  34567889999999997  59999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||| +.+++|.+++....  .+++..++.++.||+.||.|||+.+  |+||||||+||||+ ++.+||+|||+++
T Consensus       129 ~~~~lv~E-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivHrDlkp~NIll~-~~~~kl~DFG~a~  202 (390)
T 2zmd_A          129 QYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIV-DGMLKLIDFGIAN  202 (390)
T ss_dssp             SEEEEEEE-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCCGGGEEES-SSCEEECCCSSSC
T ss_pred             CEEEEEEe-cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCHHHEEEE-CCeEEEEecCccc
Confidence            99999999 56899999997754  5788889999999999999999866  99999999999996 5799999999998


Q ss_pred             cCCCCCCcceeecccCCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      ..............+||+.|+|||++.+           ..++.++|||||||++|||++|+.||.......        
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------  274 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------  274 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------
Confidence            7654433333345679999999999865           468999999999999999999999997543210        


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                             ..+..++++.....++...+.++.+||.+||+.||.+|||+.|++++-.
T Consensus       275 -------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~  323 (390)
T 2zmd_A          275 -------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  323 (390)
T ss_dssp             -------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             -------HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcC
Confidence                   1112222222222222223467889999999999999999999998754

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.7e-46  Score=350.95  Aligned_cols=262  Identities=25%  Similarity=0.372  Sum_probs=199.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhc--CCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ--LRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||+|.+.+  .      .||+|++...   ....+..|.+++..  ++||||+++++++.+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~--~------~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~   74 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSWQG--E------NVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTS   74 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEETT--E------EEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEECC--E------EEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence            45789999999999999999998742  2      4999998764   33455566666665  7999999999987653


Q ss_pred             ----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhH--------hCCCCeeeccCCCCCEEECCC
Q 014079          154 ----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH--------NAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       154 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivHrDlkp~NILl~~~  221 (431)
                          ...++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.+  |+||||||+|||++.+
T Consensus        75 ~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlkp~Nill~~~  149 (301)
T 3q4u_A           75 RHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA--IAHRDLKSKNILVKKN  149 (301)
T ss_dssp             ETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE--EECSCCCGGGEEECTT
T ss_pred             cCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC--eecCCCChHhEEEcCC
Confidence                457999999999999999954   35899999999999999999999        655  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcc--eeecccCCccccCccccccC------CCCcchhhHHHHHHHHHHHhC----------
Q 014079          222 YTAKLSDFGLAKAGPQGDETH--VSTRVMGTYGYAAPEYVMTG------HLTARSDVYSFGVVLLELLTG----------  283 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------  283 (431)
                      +.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|          
T Consensus       150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~  229 (301)
T 3q4u_A          150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY  229 (301)
T ss_dssp             SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence            999999999997543322211  12234799999999999876      455799999999999999999          


Q ss_pred             CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc-CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          284 RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE-NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       284 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      +.||................  .     ......+.+. .......+..+.+|+.+||+.||.+|||+.+|++.|+++
T Consensus       230 ~~pf~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          230 KPPFYDVVPNDPSFEDMRKV--V-----CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCTTTTTSCSSCCHHHHHHH--H-----TTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccccCCCCcchhhhhHH--H-----hccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            77876543322211000000  0     0000111111 112345778999999999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-45  Score=352.53  Aligned_cols=280  Identities=24%  Similarity=0.352  Sum_probs=210.0

Q ss_pred             cccccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC--CCC
Q 014079           64 HVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL--RHP  141 (431)
Q Consensus        64 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~  141 (431)
                      .....+......+.++|++.+.||+|+||.||+|.+.+        ..||+|++....   ...+..|.+++..+  +||
T Consensus        23 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~   91 (337)
T 3mdy_A           23 SGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRG--------EKVAVKVFFTTE---EASWFRETEIYQTVLMRHE   91 (337)
T ss_dssp             SCSSSCHHHHTTHHHHCEEEEEEEEETTEEEEEEEETT--------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCT
T ss_pred             CCCCCCcccccccccceEEEeEeecCCCeEEEEEEECC--------ceEEEEEEeccc---cchhhhHHHHHHHHhhcCC
Confidence            33445566667788999999999999999999998752        249999986542   33445566666554  899


Q ss_pred             ceeeeecEEEeC----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC------CCCeeeccC
Q 014079          142 NLVKLIGYCCED----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA------ERPVIYRDF  211 (431)
Q Consensus       142 niv~l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDl  211 (431)
                      ||+++++++.+.    ...++||||+++++|.+++...   .+++..++.++.|++.||.|||+.      ..+|+||||
T Consensus        92 ~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Di  168 (337)
T 3mdy_A           92 NILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDL  168 (337)
T ss_dssp             TBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCC
T ss_pred             CeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEeccc
Confidence            999999999887    7899999999999999999654   489999999999999999999986      124999999


Q ss_pred             CCCCEEECCCCcEEEecccCCccCCCCCCcc--eeecccCCccccCccccccCCCCcc------hhhHHHHHHHHHHHhC
Q 014079          212 KTSNILLDSDYTAKLSDFGLAKAGPQGDETH--VSTRVMGTYGYAAPEYVMTGHLTAR------SDVYSFGVVLLELLTG  283 (431)
Q Consensus       212 kp~NILl~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g  283 (431)
                      ||+|||++.++.+||+|||+++.........  ......||+.|+|||++.+..++..      +|||||||++|||++|
T Consensus       169 kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg  248 (337)
T 3mdy_A          169 KSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR  248 (337)
T ss_dssp             CGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred             chHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence            9999999999999999999997654332211  1124579999999999988776665      9999999999999999


Q ss_pred             ----------CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 014079          284 ----------RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSD  352 (431)
Q Consensus       284 ----------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~e  352 (431)
                                +.||.............      .. ........+.+...+ ...++.++.+|+.+||+.||.+|||+.+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          249 CVSGGIVEEYQLPYHDLVPSDPSYEDM------RE-IVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             BCBTTBCCCCCCTTTTTSCSSCCHHHH------HH-HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             cCcccccccccccHhhhcCCCCchhhh------HH-HHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence                      55554432221110000      00 000011111111111 2367889999999999999999999999


Q ss_pred             HHHHHhhhhhcC
Q 014079          353 VVETLEPLQCAN  364 (431)
Q Consensus       353 il~~L~~l~~~~  364 (431)
                      |+++|+.+....
T Consensus       322 ll~~L~~l~~~~  333 (337)
T 3mdy_A          322 VKKTLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHhhc
Confidence            999999887654

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.4e-46  Score=352.00  Aligned_cols=262  Identities=27%  Similarity=0.448  Sum_probs=210.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||.||+|.+.++.       .||+|++.... ...+.+.+|++++++++||||+++++++. .+.
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHT-------KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCc-------EEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            3467899999999999999999976543       38999987654 34567889999999999999999999986 456


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLI  159 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHhhEEEcCCCCEEECCCcccccc
Confidence            899999999999999997644345889999999999999999999877  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ..... .......+++.|+|||++.+..++.++||||||+++|||++ |+.||........   .              .
T Consensus       160 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~---~--------------~  221 (279)
T 1qpc_A          160 EDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---I--------------Q  221 (279)
T ss_dssp             SSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---H--------------H
T ss_pred             cCccc-ccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHH---H--------------H
Confidence            43321 11223457889999999998999999999999999999999 9999976432111   0              0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      .+........+...+..+.+++.+||+.||++|||+.++++.|+.+......
T Consensus       222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            0000111112223457889999999999999999999999999988765443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1e-46  Score=360.24  Aligned_cols=268  Identities=25%  Similarity=0.399  Sum_probs=211.3

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +...++|++.+.||+|+||.||+|.+..... ...+..||+|++..... .....+.+|+.++++++||||+++++++.+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           21 EVAREKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             cchhhheeeeeEeccCCceEEEeeeecCccC-CCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            3456789999999999999999998763100 01223599999876533 344568899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCC--------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKA--------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      .+..++||||+++++|.+++....        ..++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dikp~NIli~~~~~~  177 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTV  177 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC--CccCCCccceEEEcCCCeE
Confidence            999999999999999999986532        235688999999999999999999976  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWAR  303 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~  303 (431)
                      ||+|||+++...............||+.|+|||++.+..++.++||||||+++|+|++ |..||..........      
T Consensus       178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~------  251 (322)
T 1p4o_A          178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR------  251 (322)
T ss_dssp             EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH------
T ss_pred             EECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHH------
Confidence            9999999976433222222223457899999999999999999999999999999999 899997643211100      


Q ss_pred             hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                                .+.... ....+..++..+.+|+.+||+.||.+|||+.+++++|+.+.
T Consensus       252 ----------~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~  298 (322)
T 1p4o_A          252 ----------FVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  298 (322)
T ss_dssp             ----------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             ----------HHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhh
Confidence                      000000 01112234577889999999999999999999999998654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.8e-46  Score=361.45  Aligned_cols=253  Identities=25%  Similarity=0.330  Sum_probs=192.4

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+.++|++.+.||+|+||.||+|.+..++.      .||+|++....  ..+.+.+|+.+|++++||||+++++++.+.+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~------~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  121 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQK------PYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPT  121 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSS
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCc------EEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCC
Confidence            356789999999999999999999987654      39999987653  3456778999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG~  231 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.   ++.+||+|||+
T Consensus       122 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIll~~~~~~~~~kl~Dfg~  197 (349)
T 2w4o_A          122 EISLVLELVTGGELFDRIVEKG--YYSERDAADAVKQILEAVAYLHENG--IVHRDLKPENLLYATPAPDAPLKIADFGL  197 (349)
T ss_dssp             EEEEEECCCCSCBHHHHHTTCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESSSSTTCCEEECCCC-
T ss_pred             eEEEEEEeCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEecCCCcccEEEecCCCCCCEEEccCcc
Confidence            9999999999999999996643  4889999999999999999999876  999999999999975   88999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.........  .            
T Consensus       198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~------------  260 (349)
T 2w4o_A          198 SKIVEHQV---LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM--F------------  260 (349)
T ss_dssp             ------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH--H------------
T ss_pred             ccccCccc---ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH--H------------
Confidence            98653321   223467999999999999999999999999999999999999999764322110  0            


Q ss_pred             hhhhcCc--cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          312 MLQIIDP--RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       312 ~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       ..+...  ..........+.++.+||.+||+.||++|||+.+++++-
T Consensus       261 -~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  307 (349)
T 2w4o_A          261 -RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHP  307 (349)
T ss_dssp             -HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHST
T ss_pred             -HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence             001110  011111223457888999999999999999999999863

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-46  Score=345.90  Aligned_cols=254  Identities=23%  Similarity=0.288  Sum_probs=207.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+.++|++.+.||+|+||.||+|.+..+...      ||+|++........+.+.+|++++++++||||+++++++.+.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   79 (277)
T 3f3z_A            6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIR------RAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNT   79 (277)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhhhEEeeeEEeecCCEEEEEEEeCCCCcE------EEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            4667899999999999999999998876543      8999988765566778999999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DFG~  231 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.++|+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~  155 (277)
T 3f3z_A           80 DIYLVMELCTGGELFERVVHKR--VFRESDAARIMKDVLSAVAYCHKLN--VAHRDLKPENFLFLTDSPDSPLKLIDFGL  155 (277)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             eEEEEEeccCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEecCCCCCcEEEEeccc
Confidence            9999999999999999987654  4789999999999999999999876  9999999999999   7889999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      +.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+.           
T Consensus       156 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-----------  220 (277)
T 3f3z_A          156 AARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR-----------  220 (277)
T ss_dssp             CEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----------
T ss_pred             ceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH-----------
Confidence            98654332   2234579999999998765 48999999999999999999999997643211110000           


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        .. ............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       221 --~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          221 --EG-TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             --HC-CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             --hC-CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              00 0000000011235788999999999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=8.8e-46  Score=352.41  Aligned_cols=266  Identities=26%  Similarity=0.399  Sum_probs=200.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|.+.+.||+|+||.||+|.+.....   .+..||+|++.....  .....+.+|+.++++++||||+++++++.+.+
T Consensus        33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           33 RNLLILGKILGEGEFGSVMEGNLKQEDG---TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             GGGEEEEEEEEC-CCCCEEEEEEECTTS---CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             HHHeeeccceeecCCeEEEEEEEeccCC---ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            4678999999999999999998765321   123499999876532  34467889999999999999999999998765


Q ss_pred             -----eeEEEEEecCCCChHHhhhh----CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          155 -----HRLLVYEFMFRGSLENHLFR----KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       155 -----~~~lv~e~~~~gsL~~~l~~----~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                           ..++||||+++++|.+++..    .....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+|
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~k  187 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN--FLHRDLAARNCMLRDDMTVC  187 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT--CCCCCCSGGGEEECTTSCEE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEE
Confidence                 34999999999999999853    23356899999999999999999999866  99999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      |+|||+++...............+++.|+|||++.+..++.++||||||+++|+|++ |..||............     
T Consensus       188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-----  262 (313)
T 3brb_A          188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL-----  262 (313)
T ss_dssp             ECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-----
T ss_pred             EeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHH-----
Confidence            999999987544333233334567889999999999999999999999999999999 88999765322111100     


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                                 .. ......+..++..+.+++.+||+.||.+|||+.+++++|+.+....
T Consensus       263 -----------~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          263 -----------LH-GHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             -----------HT-TCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -----------Hc-CCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence                       00 0111122334578899999999999999999999999999887654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=354.71  Aligned_cols=271  Identities=24%  Similarity=0.284  Sum_probs=201.7

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----hhHHHHHHHHHHHhcC---CCCceee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----QGHREWLTEVNFLGQL---RHPNLVK  145 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l---~h~niv~  145 (431)
                      ..+.++|++.+.||+|+||+||+|.+..+++.      ||+|++.....     .....+.+|+.+++.+   +||||++
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~   78 (308)
T 3g33_A            5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHF------VALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVR   78 (308)
T ss_dssp             -----CCEEEEEECCSSSCCEEEEECTTTCCE------EEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCC
T ss_pred             cccccceEEEEEEecCCCeEEEEEEECCCCcE------EEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEE
Confidence            34568999999999999999999998766543      99999864321     1123556777777666   4999999


Q ss_pred             eecEEEeCC-----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          146 LIGYCCEDD-----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       146 l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      +++++....     ..++||||+. ++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.
T Consensus        79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~  155 (308)
T 3g33_A           79 LMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC--IVHRDLKPENILVTS  155 (308)
T ss_dssp             EEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCTTTEEECT
T ss_pred             eeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEcC
Confidence            999998765     5799999995 69999998876666999999999999999999999977  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.
T Consensus       156 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~  232 (308)
T 3g33_A          156 GGTVKLADFGLARIYSYQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF  232 (308)
T ss_dssp             TSCEEECSCSCTTTSTTCC---CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHH
T ss_pred             CCCEEEeeCccccccCCCc---ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            9999999999998654322   2234679999999999999999999999999999999999999997654322111110


Q ss_pred             hhhhhhh-----ccchhh-hhcC---ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 WARPKLN-----DKRKML-QIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 ~~~~~~~-----~~~~~~-~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......     ....+. ....   +..........+..+.+||.+||+.||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             HHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0000000     000000 0000   000001112345788999999999999999999999976

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=2.6e-46  Score=355.90  Aligned_cols=261  Identities=25%  Similarity=0.350  Sum_probs=197.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++.....   .....+.+|+.++++++||||+++++++..
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   83 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRD------VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   83 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCce------EEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence            357899999999999999999998776554      99999976533   234568899999999999999999999886


Q ss_pred             CCe----eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          153 DDH----RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       153 ~~~----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ...    .|+||||+++++|.+++....  ++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~D  159 (311)
T 3ork_A           84 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  159 (311)
T ss_dssp             EETTEEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEETTSCEEECC
T ss_pred             cCCCCcccEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcCCCCHHHEEEcCCCCEEEee
Confidence            654    399999999999999997654  5889999999999999999999876  99999999999999999999999


Q ss_pred             ccCCccCCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          229 FGLAKAGPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       229 FG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||............      ..
T Consensus       160 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~------~~  233 (311)
T 3ork_A          160 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VR  233 (311)
T ss_dssp             CSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH
T ss_pred             ccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH------hc
Confidence            9999865433221 1223457999999999999999999999999999999999999999765321110000      00


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHH-HHhhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE-TLEPL  360 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~-~L~~l  360 (431)
                      .        ............+.++.+|+.+||+.||.+||+..+++. .|..+
T Consensus       234 ~--------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          234 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             C--------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             C--------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            0        000000111224567889999999999999997776664 44433

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=362.95  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=198.3

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEe
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      .+.||+|+||.||+|.+..++.      .||+|+++.......+.+.+|+.+|++++||||+++++++.+.+..++||||
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~------~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~  167 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGL------KLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEY  167 (373)
T ss_dssp             EEECC-----CEEEEEETTTCC------EEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEecCcCEEEEEEEEcCCCc------EEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeC
Confidence            5679999999999999876554      3999999887666677899999999999999999999999999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE--CCCCcEEEecccCCccCCCCCC
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL--DSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl--~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      +++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||+  +.++.+||+|||+++.......
T Consensus       168 ~~~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          168 VDGGELFDRIIDES-YNLTELDTILFMKQICEGIRHMHQMY--ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             CTTCEEHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             CCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            99999999886543 35889999999999999999999977  9999999999999  6678999999999987544322


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL  320 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (431)
                         .....||+.|+|||++.+..++.++|||||||++|||++|+.||...........+             ... ...+
T Consensus       245 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i-------------~~~-~~~~  307 (373)
T 2x4f_A          245 ---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI-------------LAC-RWDL  307 (373)
T ss_dssp             ---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------HHT-CCCS
T ss_pred             ---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------Hhc-cCCC
Confidence               22356999999999999999999999999999999999999999765322111000             000 0001


Q ss_pred             cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       321 ~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ........+.++.+||.+||+.||.+|||+.|++++
T Consensus       308 ~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          308 EDEEFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111112345788999999999999999999999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=3.6e-46  Score=373.92  Aligned_cols=271  Identities=23%  Similarity=0.342  Sum_probs=188.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||+||+|.+..++..      ||||++.+.  .....+.+.+|+.+|+.++|||||++++++...
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  124 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRV------VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPK  124 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CE------EEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcE------EEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecC
Confidence            347899999999999999999998776553      999998654  233456788999999999999999999998543


Q ss_pred             -----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                           ..+|+||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.+  ||||||||+||||+.++.+||+|
T Consensus       125 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~--iiHrDlKp~NILl~~~~~~kl~D  199 (458)
T 3rp9_A          125 DVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAG--ILHRDLKPANCLVNQDCSVKVCD  199 (458)
T ss_dssp             CTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTCCEEECC
T ss_pred             CcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cCCCCCChhhEEECCCCCEeecc
Confidence                 5689999998 68999998654  35899999999999999999999977  99999999999999999999999


Q ss_pred             ccCCccCCCCCCc-------------------------ceeecccCCccccCcccc-ccCCCCcchhhHHHHHHHHHHHh
Q 014079          229 FGLAKAGPQGDET-------------------------HVSTRVMGTYGYAAPEYV-MTGHLTARSDVYSFGVVLLELLT  282 (431)
Q Consensus       229 FG~a~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~  282 (431)
                      ||+++........                         ...+..+||++|+|||++ .+..|+.++|||||||++|||++
T Consensus       200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            9999875432211                         123446789999999986 46679999999999999999999


Q ss_pred             -----------CCCCCCCCCCcccc-----------------hhhhhhh-----hhhh--------ccchhhhhcCccc-
Q 014079          283 -----------GRKSVDKTRPSKEQ-----------------SLVDWAR-----PKLN--------DKRKMLQIIDPRL-  320 (431)
Q Consensus       283 -----------g~~pf~~~~~~~~~-----------------~~~~~~~-----~~~~--------~~~~~~~~~~~~~-  320 (431)
                                 |+.+|.+.......                 .......     +...        ........+.... 
T Consensus       280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~  359 (458)
T 3rp9_A          280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG  359 (458)
T ss_dssp             TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred             hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence                       56666543311000                 0000000     0000        0000000000000 


Q ss_pred             --cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          321 --ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       321 --~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                        ........+.++.+||.+||+.||++|||+.|+++|-
T Consensus       360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp  398 (458)
T 3rp9_A          360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHP  398 (458)
T ss_dssp             CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCH
Confidence              0011123357889999999999999999999999873

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.2e-46  Score=374.11  Aligned_cols=251  Identities=29%  Similarity=0.361  Sum_probs=197.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++....   ......+.+|+.+|+.++||||+++++++.+.
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~  220 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRY------YAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH  220 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCE------EEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC
Confidence            36799999999999999999998776554      9999987642   22345678899999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      +.+++||||+++++|.+++....  .+++..+..++.|++.||+|||+ .+  |+||||||+||||+.++.+||+|||++
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~g--iiHrDlkp~NIll~~~~~~kl~DFG~a  296 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSRER--VFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLC  296 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHHTC--CCCCCCCGGGEEECSSSCEEECCCCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHhhcCC--EEECCCCHHHEEECCCCCEEEccCCCc
Confidence            99999999999999999997654  58899999999999999999997 66  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........              
T Consensus       297 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~--------------  360 (446)
T 4ejn_A          297 KEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL--------------  360 (446)
T ss_dssp             CTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--------------
T ss_pred             eeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH--------------
Confidence            8643222  223457899999999999999999999999999999999999999976432111110              


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETL  357 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L  357 (431)
                        +....  ..++...+.++.+||.+||+.||.+||     ++.|+++|-
T Consensus       361 --i~~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp  406 (446)
T 4ejn_A          361 --ILMEE--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHR  406 (446)
T ss_dssp             --HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSG
T ss_pred             --HHhCC--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCc
Confidence              00000  012223457889999999999999999     999999763

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=347.63  Aligned_cols=267  Identities=24%  Similarity=0.364  Sum_probs=208.9

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee-
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR-  156 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-  156 (431)
                      .|...++||+|+||.||+|.+.++..   ....||+|++..... ...+.+.+|+.++++++||||+++++++.+.+.. 
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQ---NRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSS---CEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             EEccCceeccCCCceEEEEEEecCCC---ceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            45667899999999999999765432   123499999876433 3456788999999999999999999999876665 


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQ-RNPTVKDLISFGLQVARGMEYLAEQK--FVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EEEEecccCCCHHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            99999999999999996643 45789999999999999999999976  9999999999999999999999999998654


Q ss_pred             CCCC--cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          237 QGDE--THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       237 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....  ........+|+.|+|||++.+..++.++||||||+++|+|++|..||........                +..
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~  239 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTH  239 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHH
Confidence            3221  1122335688999999999999999999999999999999996665543222111                001


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                      .+........+...+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus       240 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          240 FLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             HhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            11111111112234467899999999999999999999999999988766544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.4e-46  Score=378.33  Aligned_cols=255  Identities=29%  Similarity=0.448  Sum_probs=210.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.++||+|+||.||+|.+..++..      ||+|++.+...   .....+.+|+.+|+.++||||+++++++.+.
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~------vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~  256 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKM------YACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK  256 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC
Confidence            35699999999999999999999776553      99999876432   2345678999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||++||+|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+||||+.+|.+||+|||+++
T Consensus       257 ~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g--IvHrDLKPeNILld~~g~vKL~DFGla~  334 (576)
T 2acx_A          257 DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER--IVYRDLKPENILLDDHGHIRISDLGLAV  334 (576)
T ss_dssp             SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC--EeccCCchheEEEeCCCCeEEEecccce
Confidence            99999999999999999998766666899999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.             
T Consensus       335 ~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~-------------  398 (576)
T 2acx_A          335 HVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE-------------  398 (576)
T ss_dssp             ECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHH-------------
T ss_pred             ecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHH-------------
Confidence            764432   2234689999999999999999999999999999999999999997654322111110             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      ..+. .....++...+.++.+||.+||+.||.+||     ++.||++|
T Consensus       399 ~~i~-~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          399 RLVK-EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHH-HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHhh-cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            0000 001112233457889999999999999999     78999876

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.5e-46  Score=355.27  Aligned_cols=265  Identities=25%  Similarity=0.354  Sum_probs=190.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||+|+++.... .....+.+|+.+|++++||||+++++++.+.+.
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   77 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGV------YVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENK   77 (317)
T ss_dssp             ---------------CEEEEEECSSSCC------EEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCc------EEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCe
Confidence            3578999999999999999999876554      399999875532 233668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC----CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA----TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~----~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      .++||||++ ++|.+++....    ...+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+
T Consensus        78 ~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~Dfg~  154 (317)
T 2pmi_A           78 LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK--ILHRDLKPQNLLINKRGQLKLGDFGL  154 (317)
T ss_dssp             EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCSS
T ss_pred             EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCChHHeEEcCCCCEEECcCcc
Confidence            999999996 69999886532    235889999999999999999999876  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh-------
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR-------  303 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-------  303 (431)
                      ++.......  ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+....       
T Consensus       155 ~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  232 (317)
T 2pmi_A          155 ARAFGIPVN--TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESL  232 (317)
T ss_dssp             CEETTSCCC--CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTT
T ss_pred             ceecCCCcc--cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhH
Confidence            986543221  2234578999999999876 468999999999999999999999997654322111110000       


Q ss_pred             -hhhhcc------------chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 -PKLNDK------------RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 -~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       +.....            ..+.+.+.+.    .....+.++.+|+.+||+.||++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          233 WPSVTKLPKYNPNIQQRPPRDLRQVLQPH----TKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CGGGGGCTTCCTTCCCCCCCCSHHHHGGG----CSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhhhhhhcccccccccchhHHHhhccc----ccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence             000000            0000001111    111234688999999999999999999999976

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-46  Score=345.42  Aligned_cols=257  Identities=26%  Similarity=0.401  Sum_probs=209.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+.++.       .||+|++..... ..+.+.+|+.++++++||||+++++++.+.+..+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKD-------KVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             hheeeeeEecCCCceeEEEEEecCCC-------eEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            57889999999999999999987543       399999987543 3467889999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.....
T Consensus        80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  156 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  156 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred             EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEECCCCCEEEccccccccccc
Confidence            9999999999999997653 35889999999999999999999876  99999999999999999999999999976432


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .. ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........             +..  
T Consensus       157 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-------------i~~--  220 (267)
T 3t9t_A          157 DQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-------------IST--  220 (267)
T ss_dssp             HH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-------------HHT--
T ss_pred             cc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH-------------Hhc--
Confidence            21 111223457889999999999999999999999999999999 8999976432111000             000  


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                        ......+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       221 --~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          221 --GFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             --TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --CCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence              011111222346788999999999999999999999999988653

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.8e-46  Score=382.44  Aligned_cols=261  Identities=26%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .++|++.+.||+|+||.||+|.+..+.       .||||+++... ...+.|.+|+++|++++||||+++++++.+ +..
T Consensus       266 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~-------~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~  336 (535)
T 2h8h_A          266 RESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI  336 (535)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTE-------EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCc-------eEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence            456888899999999999999987643       39999997654 345678999999999999999999999876 678


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      +|||||+.+|+|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus       337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  414 (535)
T 2h8h_A          337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIE  414 (535)
T ss_dssp             EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred             eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence            99999999999999997644445889999999999999999999876  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ... ........++..|+|||++.+..++.++|||||||+||||++ |+.||.........                 ..
T Consensus       415 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~-----------------~~  476 (535)
T 2h8h_A          415 DNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-----------------DQ  476 (535)
T ss_dssp             CHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH-----------------HH
T ss_pred             CCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------HH
Confidence            321 111223457889999999999999999999999999999999 99999764321110                 11


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      +........+..++..+.+||.+||+.||++|||+.+|++.|+.+......
T Consensus       477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~~  527 (535)
T 2h8h_A          477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP  527 (535)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCSC
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccCc
Confidence            111111122334557889999999999999999999999999987765443

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.2e-46  Score=352.63  Aligned_cols=275  Identities=27%  Similarity=0.368  Sum_probs=208.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeC--C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED--D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~  154 (431)
                      ++|++.+.||+|+||.||+|.+.....  ..+..||+|++.... ......+.+|+.+++.++||||+++++++.+.  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGD--NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSS--SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccC--ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            458889999999999999998532111  123359999987543 23456788999999999999999999999876  6


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQ--YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCC--cccCCCchheEEEcCCCCEEECccccccc
Confidence            6899999999999999996543 35899999999999999999999876  99999999999999999999999999987


Q ss_pred             CCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh--hhccch
Q 014079          235 GPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--LNDKRK  311 (431)
Q Consensus       235 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~  311 (431)
                      ....... .......||..|+|||++.+..++.++||||||+++|+|++|..|+......    ......+.  ......
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~  251 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMAL----FLKMIGPTHGQMTVTR  251 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH----HHHHHCSCCGGGHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhH----HhhccCCcccccCHHH
Confidence            6543322 2233456889999999999999999999999999999999999886432100    00000000  000111


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      +...+........+...+..+.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          252 LVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            11112122222233445678999999999999999999999999998764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.6e-46  Score=358.24  Aligned_cols=263  Identities=25%  Similarity=0.349  Sum_probs=192.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEE----
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCC----  151 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----  151 (431)
                      ..+|++.+.||+|+||.||+|.+..++.      .||+|++..........+.+|+.+++++. ||||+++++++.    
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~  100 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGR------EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE  100 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCC------EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCc------EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence            3578999999999999999999876554      39999987766566677899999999996 999999999984    


Q ss_pred             ----eCCeeEEEEEecCCCChHHhhhh-CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          152 ----EDDHRLLVYEFMFRGSLENHLFR-KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       152 ----~~~~~~lv~e~~~~gsL~~~l~~-~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                          ....+++||||+ +|+|.+++.. ....++++..++.++.|++.||.|||+.+.+|+||||||+||||+.++.+||
T Consensus       101 ~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl  179 (337)
T 3ll6_A          101 ESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKL  179 (337)
T ss_dssp             TSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEB
T ss_pred             ccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEE
Confidence                344579999999 5799998865 2334689999999999999999999986555999999999999999999999


Q ss_pred             ecccCCccCCCCCCcc----------eeecccCCccccCcccc---ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCc
Q 014079          227 SDFGLAKAGPQGDETH----------VSTRVMGTYGYAAPEYV---MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS  293 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  293 (431)
                      +|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.||......
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~  259 (337)
T 3ll6_A          180 CDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL  259 (337)
T ss_dssp             CCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             ecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH
Confidence            9999998754322111          11135699999999998   5677899999999999999999999999754321


Q ss_pred             ccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      ..                    +............+..+.+|+.+||+.||.+|||+.|++++|+.+......
T Consensus       260 ~~--------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~  312 (337)
T 3ll6_A          260 RI--------------------VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNV  312 (337)
T ss_dssp             --------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTTC
T ss_pred             Hh--------------------hcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccCC
Confidence            10                    000000001111224577899999999999999999999999988766443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.2e-45  Score=352.92  Aligned_cols=255  Identities=23%  Similarity=0.299  Sum_probs=207.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCCCCceeeeec
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLRHPNLVKLIG  148 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~  148 (431)
                      .+.++|++.+.||+|+||.||+|.+..++.      .||+|++......      ....+.+|+.++++++||||+++++
T Consensus         9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (321)
T 2a2a_A            9 KVEDFYDIGEELGSGQFAIVKKCREKSTGL------EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD   82 (321)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhhccEEEeeEeeecCCEEEEEEEECCCCe------EEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEE
Confidence            356789999999999999999999876554      3999998764322      3567889999999999999999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cE
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TA  224 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~  224 (431)
                      ++.+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++    .+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~lH~~~--ivH~dikp~NIl~~~~~~~~~~~  158 (321)
T 2a2a_A           83 VYENRTDVVLILELVSGGELFDFLAQKE--SLSEEEATSFIKQILDGVNYLHTKK--IAHFDLKPENIMLLDKNIPIPHI  158 (321)
T ss_dssp             EEECSSEEEEEECCCCSCBHHHHHHTCS--CEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCTTSSSCCE
T ss_pred             EEecCCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCChHHEEEecCCCCcCCE
Confidence            9999999999999999999999997643  5889999999999999999999976  99999999999999887    79


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+     
T Consensus       159 kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i-----  230 (321)
T 2a2a_A          159 KLIDFGLAHEIEDGVE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI-----  230 (321)
T ss_dssp             EECCCTTCEECCTTCC---CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH-----
T ss_pred             EEccCccceecCcccc---ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH-----
Confidence            9999999987544321   23456999999999999999999999999999999999999999764321110000     


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              .. ....+........+..+.+|+.+||+.||++|||+.+++++
T Consensus       231 --------~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          231 --------TS-VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             --------HT-TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             --------Hh-cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                    00 00001111112234678899999999999999999999976

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=351.72  Aligned_cols=258  Identities=29%  Similarity=0.468  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.+.+.        .||+|++...  ...+.+.+|+++|++++||||+++++++.  +..+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~--------~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~   75 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAK--------DVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVC   75 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTE--------EEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTE
T ss_pred             hHeeeeeEeecCCCceEEEEEECCe--------eEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcE
Confidence            5688899999999999999987532        3999998754  34567899999999999999999999886  4589


Q ss_pred             EEEEecCCCChHHhhhhCCCC-CcCHHHHHHHHHHHHHHHHHhHhCC-CCeeeccCCCCCEEECCCCc-EEEecccCCcc
Q 014079          158 LVYEFMFRGSLENHLFRKATV-PLSWATRMMIAFGAAKGLAFLHNAE-RPVIYRDFKTSNILLDSDYT-AKLSDFGLAKA  234 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~-~~~~~~~~~i~~~i~~~l~~LH~~~-~~ivHrDlkp~NILl~~~~~-~kl~DFG~a~~  234 (431)
                      +||||+++++|.+++...... .+++..++.++.|++.||.|||+.+ ++|+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999999999999999765432 3678889999999999999999833 45999999999999998886 79999999975


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     .....||+.|+|||++.+..++.++||||||+++|||++|+.||.........  ..+.         ...
T Consensus       156 ~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~~~~---------~~~  219 (307)
T 2eva_A          156 IQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR--IMWA---------VHN  219 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH--HHHH---------HHT
T ss_pred             cccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH--HHHH---------Hhc
Confidence            4322     12346999999999999999999999999999999999999999754322111  0000         000


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                          ..........+..+.+++.+||+.||.+|||+.++++.|+.+.......
T Consensus       220 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~  268 (307)
T 2eva_A          220 ----GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGA  268 (307)
T ss_dssp             ----TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCT
T ss_pred             ----CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCC
Confidence                0011112234467889999999999999999999999999887665443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5e-46  Score=355.09  Aligned_cols=279  Identities=29%  Similarity=0.399  Sum_probs=212.9

Q ss_pred             cCC-CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           78 KSF-RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        78 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      ++| ++.+.||+|+||.||++.+.....  ..+..||+|++..... .....+.+|+++|++++||||+++++++.+.  
T Consensus        30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           30 KRYLKKIRDLGEGHFGKVSLYCYDPTND--GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECSCC----CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             HHHHhhhheecCCCCeEEEEEEEccCCC--CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            344 889999999999999987643211  1234599999987543 3456788999999999999999999999884  


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      ..+++||||+++++|.+++....   +++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~i~~~l~~~l~~LH~~~--ivH~Dikp~Nil~~~~~~~kl~Dfg~a~  182 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRHS---IGLAQLLLFAQQICEGMAYLHAQH--YIHRDLAARNVLLDNDRLVKIGDFGLAK  182 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGSC---CCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             ceEEEEEecccCCcHHHHHhhCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEEcCCCCEEECCccccc
Confidence            67899999999999999996643   889999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||....... .....+.... .....+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~-~~~~~~  260 (318)
T 3lxp_A          183 AVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQ-MTVLRL  260 (318)
T ss_dssp             ECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHH-HHHHHH
T ss_pred             cccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccc-hhHHHH
Confidence            76543322 12234568889999999999999999999999999999999999986431110 0000000000 001112


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      ...+........+..++.++.+|+.+||+.||.+|||+.++++.|+.+.....
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~  313 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQ  313 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhc
Confidence            22222222233344556789999999999999999999999999998876543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.6e-46  Score=355.67  Aligned_cols=254  Identities=27%  Similarity=0.358  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .++|++.+.||+|+||.||++.+..+..   .+..||+|++++...    .....+.+|+.+|++++||||+++++++.+
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~---~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   92 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGAN---TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTT---TTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCC---CCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc
Confidence            3678999999999999999998752110   122499999976532    233457789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..|+||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--ivH~Dlkp~Nill~~~~~~kl~Dfg~~  168 (327)
T 3a62_A           93 GGKLYLILEYLSGGELFMQLEREG--IFMEDTACFYLAEISMALGHLHQKG--IIYRDLKPENIMLNHQGHVKLTDFGLC  168 (327)
T ss_dssp             SSCEEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCTTTEEECTTSCEEECCCSCC
T ss_pred             CCEEEEEEeCCCCCcHHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EEcccCCHHHeEECCCCcEEEEeCCcc
Confidence            999999999999999999997654  4788899999999999999999876  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +......  ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.........                
T Consensus       169 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~----------------  230 (327)
T 3a62_A          169 KESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI----------------  230 (327)
T ss_dssp             ------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH----------------
T ss_pred             cccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH----------------
Confidence            7543221  1233467999999999999999999999999999999999999999764321110                


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETL  357 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L  357 (431)
                      ..+....  ..++...+.++.+|+.+||+.||.+||     ++.++++|-
T Consensus       231 ~~i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp  278 (327)
T 3a62_A          231 DKILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHP  278 (327)
T ss_dssp             HHHHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSG
T ss_pred             HHHHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCC
Confidence            0111100  011223457889999999999999999     788888763

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=5.7e-46  Score=349.61  Aligned_cols=266  Identities=23%  Similarity=0.307  Sum_probs=197.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..+.       .||+|++.....  .....+.+|+.++++++||||+++++++.+.+.
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   74 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGE-------TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSC-------EEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCC-------EEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCe
Confidence            46889999999999999999885433       389998865432  223668899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        75 ~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           75 LVLVFEHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (288)
T ss_dssp             EEEEEECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             EEEEEEecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEeECcccccc
Confidence            999999996 49999886543 35889999999999999999999876  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhccchh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~  312 (431)
                      ....  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...  .+........
T Consensus       151 ~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (288)
T 1ob3_A          151 GIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (288)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             Cccc--cccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhh
Confidence            3221  112335689999999998764 5899999999999999999999999765322111110000  0000000000


Q ss_pred             h--hhcCccc-------cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 L--QIIDPRL-------ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~--~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .  ...++.+       ........+.++.+|+.+||+.||++|||+.|++++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0  0000000       011112345788899999999999999999999875

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=9.7e-46  Score=354.17  Aligned_cols=252  Identities=26%  Similarity=0.330  Sum_probs=182.4

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      .+.||+|+||.||+|.+..++..      ||+|++.+.   ....+.+|+.+++.+. ||||+++++++.+....|+|||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e   86 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQA------FAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVME   86 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCE------EEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCccccCCCeEEEEEEECCCCCE------EEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEE
Confidence            37899999999999999876543      999998754   3456778999999997 9999999999999999999999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC---cEEEecccCCccCCCC
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY---TAKLSDFGLAKAGPQG  238 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~---~~kl~DFG~a~~~~~~  238 (431)
                      |+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++   .+||+|||+++.....
T Consensus        87 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~  162 (325)
T 3kn6_A           87 LLNGGELFERIKKKK--HFSETEASYIMRKLVSAVSHMHDVG--VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD  162 (325)
T ss_dssp             CCCSCBHHHHHHHCS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred             ccCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence            999999999997754  5899999999999999999999876  99999999999997765   8999999999865432


Q ss_pred             CCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      ..  .....+||+.|+|||++.+..++.++|||||||++|+|++|+.||.............         ..+..+...
T Consensus       163 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~---------~~~~~i~~~  231 (325)
T 3kn6_A          163 NQ--PLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAV---------EIMKKIKKG  231 (325)
T ss_dssp             -----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHH---------HHHHHHTTT
T ss_pred             CC--cccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHH---------HHHHHHHcC
Confidence            22  2234578999999999999999999999999999999999999997654321110000         001111111


Q ss_pred             --cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          319 --RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       319 --~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                        .+........+.++.+|+.+||+.||.+|||+.+++++-.
T Consensus       232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w  273 (325)
T 3kn6_A          232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEW  273 (325)
T ss_dssp             CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGG
T ss_pred             CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChh
Confidence              1111222345678999999999999999999999987643

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-46  Score=366.14  Aligned_cols=270  Identities=23%  Similarity=0.344  Sum_probs=195.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCC-CCceeeeecEE
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLR-HPNLVKLIGYC  150 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  150 (431)
                      ..+.++|++.+.||+|+||.||+|.+..++..      ||+|++.+.  .......+.+|+.+|+.+. ||||+++++++
T Consensus         5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~   78 (388)
T 3oz6_A            5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEV------VAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVL   78 (388)
T ss_dssp             HHHHTTEEEEEC-------CEEEEEETTTCCE------EEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE
T ss_pred             CcccCceEEEEEeeeCCCeEEEEEEECCCCCE------EEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEE
Confidence            35678899999999999999999998876554      999988654  2344567889999999997 99999999999


Q ss_pred             EeCC--eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          151 CEDD--HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       151 ~~~~--~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ...+  .+|+||||++ ++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        79 ~~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~--ivHrDlkp~NIll~~~~~~kl~D  152 (388)
T 3oz6_A           79 RADNDRDVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGG--LLHRDMKPSNILLNAECHVKVAD  152 (388)
T ss_dssp             ECTTSSCEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             ecCCCCEEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC--EEeCCCCHHHeEEcCCCCEEecC
Confidence            7654  6899999996 6899988663   5788999999999999999999977  99999999999999999999999


Q ss_pred             ccCCccCCCCC-------------------CcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCC
Q 014079          229 FGLAKAGPQGD-------------------ETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVD  288 (431)
Q Consensus       229 FG~a~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~  288 (431)
                      ||+++......                   ........+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.
T Consensus       153 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~  232 (388)
T 3oz6_A          153 FGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFP  232 (388)
T ss_dssp             CTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             CcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCC
Confidence            99997643211                   1112334689999999999886 679999999999999999999999998


Q ss_pred             CCCCcccchhhhhhhhhhhccchhhhhc------------------CccccCcc------------cHHHHHHHHHHHHH
Q 014079          289 KTRPSKEQSLVDWARPKLNDKRKMLQII------------------DPRLENQY------------SVRAAQKACSLAYY  338 (431)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~~~~li~~  338 (431)
                      +.........+..... ......+..+.                  .......+            ....+.++.+|+.+
T Consensus       233 ~~~~~~~~~~i~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  311 (388)
T 3oz6_A          233 GSSTMNQLERIIGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDK  311 (388)
T ss_dssp             CSSHHHHHHHHHHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHH
T ss_pred             CCCHHHHHHHHHHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHH
Confidence            7543222111100000 00000000000                  00000000            00234678999999


Q ss_pred             hhhcCCCCCCCHHHHHHH
Q 014079          339 CLSQNPKARPLMSDVVET  356 (431)
Q Consensus       339 cl~~dP~~RPt~~eil~~  356 (431)
                      ||+.||++|||+.|+++|
T Consensus       312 ~L~~dP~~R~t~~e~l~H  329 (388)
T 3oz6_A          312 LLQFNPNKRISANDALKH  329 (388)
T ss_dssp             HCCSSGGGSCCHHHHTTS
T ss_pred             hhccCcccCCCHHHHhCC
Confidence            999999999999999987

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=8.3e-46  Score=352.98  Aligned_cols=271  Identities=25%  Similarity=0.289  Sum_probs=201.1

Q ss_pred             HhcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           76 ITKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      +.+.|++. ++||+|+||.||+|.+..++.      .||+|++..........+.+|+.+|.++ +||||+++++++.+.
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQ------EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCC------EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCc------EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            34678874 789999999999999876544      4999999776555567889999999985 799999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc---EEEeccc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AKLSDFG  230 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~---~kl~DFG  230 (431)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.   +||+|||
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRR--HFNELEASVVVQDVASALDFLHNKG--IAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             CEEEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            99999999999999999997754  5788999999999999999999976  999999999999988766   9999999


Q ss_pred             CCccCCCCCC-----cceeecccCCccccCcccccc-----CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          231 LAKAGPQGDE-----THVSTRVMGTYGYAAPEYVMT-----GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       231 ~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      ++........     .......+||+.|+|||++.+     ..++.++|||||||++|||++|+.||.............
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            9876432211     111223569999999999875     568899999999999999999999998754332110000


Q ss_pred             hhhhhhhccchhhhhcCccc--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          301 WARPKLNDKRKMLQIIDPRL--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...+.. .......+.....  ........+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       240 ~~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  297 (316)
T 2ac3_A          240 EACPAC-QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHP  297 (316)
T ss_dssp             -CCHHH-HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHST
T ss_pred             ccchhH-HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcCh
Confidence            000000 0000001111111  0000112456889999999999999999999999863

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.6e-45  Score=347.98  Aligned_cols=266  Identities=26%  Similarity=0.393  Sum_probs=205.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEE-eCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCC-EDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~  155 (431)
                      .+|++.+.||+|+||.||+|.+..+..   +...+|+|.+..... .....+.+|+.++++++||||+++++++. .++.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  101 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC--------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSC
T ss_pred             eehhhcceeeecCCceEEEEEEecCCC---ceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCc
Confidence            568889999999999999998754332   223489998876432 34567889999999999999999999864 4567


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       102 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~ql~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A          102 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKYLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             eEEEEeCCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCchheEEECCCCCEEECcccccccc
Confidence            899999999999999996543 45789999999999999999999876  999999999999999999999999999865


Q ss_pred             CCCCCc--ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDET--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......  .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.............            
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------------  246 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------  246 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------------
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------------
Confidence            433211  12234568889999999999999999999999999999999 555665443222111100            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                       .    ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.....+
T Consensus       247 -~----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          247 -Q----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             -c----CCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence             0    000111122346788999999999999999999999999988765443

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-45  Score=370.17  Aligned_cols=266  Identities=23%  Similarity=0.289  Sum_probs=198.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||+||+|.+..++..      ||+|++.+.  .....+.+.+|+.+|+.++||||+++++++...
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~  133 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQ  133 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEE------EEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCE------EEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccC
Confidence            357899999999999999999998876554      999998764  223456788999999999999999999999755


Q ss_pred             ------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 ------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                            ...|+||||+.+ +|.+.+..    .+++..+..++.|++.||+|||+.+  |+||||||+||||+.++.+||+
T Consensus       134 ~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDlkp~NIll~~~~~~kl~  206 (464)
T 3ttj_A          134 KTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKIL  206 (464)
T ss_dssp             CSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEEC
T ss_pred             CccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCChHhEEEeCCCCEEEE
Confidence                  356999999965 57666633    3788999999999999999999977  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h-
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P-  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~-  304 (431)
                      |||+++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+....  + 
T Consensus       207 DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~  283 (464)
T 3ttj_A          207 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC  283 (464)
T ss_dssp             CCCCC-----CC---CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             EEEeeeecCCCc---ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999998754322   2344679999999999999999999999999999999999999997754322111110000  0 


Q ss_pred             -h-hhc----------------cchhhhhcCccc---cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 -K-LND----------------KRKMLQIIDPRL---ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 -~-~~~----------------~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       . +..                ...+.......+   ........+.++.+||.+||+.||++|||+.|+++|-
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp  357 (464)
T 3ttj_A          284 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP  357 (464)
T ss_dssp             HHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTST
T ss_pred             HHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcCh
Confidence             0 000                000000000000   0111223367899999999999999999999999873

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=9.9e-46  Score=346.59  Aligned_cols=262  Identities=26%  Similarity=0.378  Sum_probs=206.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+.....   .+..||+|++.... ....+.+.+|+.++++++||||+++++++.+ +.
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~   86 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKG---EKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EP   86 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTC---CEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SS
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCC---CcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CC
Confidence            4678999999999999999998765322   12349999987753 3345678899999999999999999999865 46


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           87 TWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESIN--CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             CEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             CEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            789999999999999997643 35889999999999999999999877  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.............             .
T Consensus       164 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~-------------~  229 (281)
T 3cc6_A          164 EDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE-------------K  229 (281)
T ss_dssp             ----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH-------------H
T ss_pred             cccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh-------------c
Confidence            433221 1233457889999999999999999999999999999998 999997543222111100             0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                          ......+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       230 ----~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          230 ----GDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                000111222346788999999999999999999999999987643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-45  Score=344.57  Aligned_cols=256  Identities=25%  Similarity=0.354  Sum_probs=206.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEE------AVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN   78 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCc------EEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCC
Confidence            45679999999999999999999876544      399999865432 34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++..
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  154 (276)
T 2yex_A           79 IQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATV  154 (276)
T ss_dssp             EEEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC--eeccCCChHHEEEccCCCEEEeeCCCccc
Confidence            999999999999999998654  35889999999999999999999876  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ..............||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......... ...+..          
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~----------  223 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE----------  223 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH-HHHHHT----------
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH-HHHhhh----------
Confidence            543322223344679999999999987765 77999999999999999999999765432111 111100          


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                          ...........+..+.+|+.+||+.||.+|||+.+++++
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          224 ----KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ----TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                000000112234678899999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.9e-45  Score=349.65  Aligned_cols=266  Identities=23%  Similarity=0.335  Sum_probs=200.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++....   ......+.+|+.++++++||||+++++++.+.+
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~  105 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGV------PVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN  105 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCC------EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCc------eEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            568999999999999999999876544      49999987532   234567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ..++||||+.+++|.+++..  .....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIl~~~~~~~kl~Dfg~~  183 (310)
T 2wqm_A          106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR--VMHRDIKPANVFITATGVVKLGDLGLG  183 (310)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCC---
T ss_pred             cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eeCCCCcHHHEEEcCCCCEEEEeccce
Confidence            99999999999999999864  23446889999999999999999999976  999999999999999999999999998


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ ....            
T Consensus       184 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~-~~~~------------  248 (310)
T 2wqm_A          184 RFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLY-SLCK------------  248 (310)
T ss_dssp             -----------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHH-HHHH------------
T ss_pred             eeecCCCc--cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHH-HHHH------------
Confidence            76543221  22335689999999999999999999999999999999999999975432111 0000            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                       .+.............+.++.+|+.+||+.||.+|||+.+|++.|+++.......
T Consensus       249 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~~~  302 (310)
T 2wqm_A          249 -KIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASS  302 (310)
T ss_dssp             -HHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC--
T ss_pred             -HhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhhhh
Confidence             000000111111234467889999999999999999999999999988765543

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.1e-45  Score=353.92  Aligned_cols=262  Identities=24%  Similarity=0.399  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..++..    ..+++|.+.... ......+.+|+.+++++ +||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  100 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY  100 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEE----EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcc----cceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCc
Confidence            5789999999999999999998765432    135888886532 23345688999999999 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      .++||||+++++|.+++....              ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~  178 (327)
T 1fvr_A          101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  178 (327)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred             eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCccceEEEcCC
Confidence            999999999999999997643              246899999999999999999999876  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||+++......   ......+++.|+|||++.+..++.++|||||||++|||++ |+.||........     
T Consensus       179 ~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~-----  250 (327)
T 1fvr_A          179 YVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL-----  250 (327)
T ss_dssp             GCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----
T ss_pred             CeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHH-----
Confidence            999999999987432211   1223457889999999999899999999999999999998 9999976532111     


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                                  ...+........+...+..+.+|+.+||+.||.+|||+.+++++|+.+.....
T Consensus       251 ------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          251 ------------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ------------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ------------HHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                        00111111111222345788999999999999999999999999998876543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-46  Score=361.46  Aligned_cols=267  Identities=27%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEe-CCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-DDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~  155 (431)
                      ..|.+.+.||+|+||.||+|.+.....   +...||+|.++... ....+.+.+|+.++++++||||+++++++.+ .+.
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTT---EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCC---cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            346778899999999999998753321   12348999987543 2445778999999999999999999998754 567


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kL~DFG~a~~~  242 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDM  242 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEECCCCCCHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC--EecCccchheEEECCCCCEEEeeccccccc
Confidence            899999999999999996543 35788999999999999999999976  999999999999999999999999999865


Q ss_pred             CCCCCc--ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDET--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......  .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.............            
T Consensus       243 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------------  310 (373)
T 3c1x_A          243 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------------  310 (373)
T ss_dssp             ---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------------
T ss_pred             cccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------------
Confidence            433211  11233567889999999999999999999999999999999 677776544322111110            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                       .    ......+..++..+.+++.+||+.||++|||+.++++.|+.+.......
T Consensus       311 -~----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          311 -Q----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             -T----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             -c----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence             0    0000112234467899999999999999999999999999988765544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.7e-46  Score=357.52  Aligned_cols=257  Identities=23%  Similarity=0.297  Sum_probs=204.5

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCED  153 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  153 (431)
                      .+.++|++.+.||+|+||.||+|.+..++..      ||+|++.+....    ..+|+++|.++ +||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~   88 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNME------FAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDG   88 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECS
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCE------EEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcC
Confidence            3567899999999999999999999876554      999999765432    34688888887 799999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC----CcEEEecc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD----YTAKLSDF  229 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~----~~~kl~DF  229 (431)
                      +..|+||||++||+|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||+..+    +.+||+||
T Consensus        89 ~~~~lv~E~~~gg~L~~~i~~~~--~~~~~~~~~~~~qi~~al~~lH~~g--ivHrDlkp~NIl~~~~~~~~~~~kl~Df  164 (342)
T 2qr7_A           89 KYVYVVTELMKGGELLDKILRQK--FFSEREASAVLFTITKTVEYLHAQG--VVHRDLKPSNILYVDESGNPESIRICDF  164 (342)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSCSGGGEEECCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeccCCHHHEEEecCCCCcCeEEEEEC
Confidence            99999999999999999997654  5889999999999999999999976  9999999999998443    35999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |+++.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||..........+.....    . 
T Consensus       165 g~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~----~-  237 (342)
T 2qr7_A          165 GFAKQLRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIG----S-  237 (342)
T ss_dssp             TTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHH----H-
T ss_pred             CCcccCcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHc----c-
Confidence            99986543322  2234679999999999998889999999999999999999999997643222111111100    0 


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                            -...+........+.++.+|+.+||+.||++|||+.+++++-.
T Consensus       238 ------~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          238 ------GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             ------CCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             ------CCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence                  0001111222344578899999999999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=4.2e-46  Score=362.67  Aligned_cols=245  Identities=28%  Similarity=0.369  Sum_probs=192.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHH-HhcCCCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNF-LGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~  153 (431)
                      ++|++.+.||+|+||.||+|.++.++..      ||+|++.+....   ....+.+|..+ ++.++||||+++++++.+.
T Consensus        38 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~------~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           38 SDFHFLKVIGKGSFGKVLLARHKAEEVF------YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             GGEEEEEEEECCTTCEEEEEEETTTCCE------EEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             hheEEEEEEeeCCCeEEEEEEEcCCCCE------EEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            5689999999999999999999876554      999999776432   23456677776 5778999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+|+||||++||+|.+++.+..  .+++..+..++.||+.||+|||+.+  |+||||||+||||+.+|.+||+|||+++
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~g~ikL~DFG~a~  187 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRER--CFLEPRARFYAAEIASALGYLHSLN--IVYRDLKPENILLDSQGHIVLTDFGLCK  187 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCBCG
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEECCCCCEEEeeCcccc
Confidence            99999999999999999997654  4788889999999999999999877  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......  ......+||+.|+|||++.+..|+.++|||||||++|||++|..||........                ..
T Consensus       188 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~----------------~~  249 (373)
T 2r5t_A          188 ENIEHN--STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM----------------YD  249 (373)
T ss_dssp             GGBCCC--CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHH----------------HH
T ss_pred             ccccCC--CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH----------------HH
Confidence            532221  123456899999999999999999999999999999999999999976432111                01


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSD  352 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~e  352 (431)
                      .++...+  .++...+..+.+||.+||+.||.+||++.+
T Consensus       250 ~i~~~~~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          250 NILNKPL--QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHSCC--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             HHHhccc--CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence            1111111  112234567889999999999999999753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-45  Score=345.86  Aligned_cols=265  Identities=26%  Similarity=0.372  Sum_probs=209.6

Q ss_pred             cCCCccc-eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|.+.+ .||+|+||.||+|.+....    .+..||+|+++.... ...+.+.+|+.++++++||||+++++++ ..+.
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~   83 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEA   83 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSS
T ss_pred             HHhhhhhccccccCceeEEEeEeccCC----CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCC
Confidence            4555655 8999999999999864321    123499999987532 3456788999999999999999999999 5667


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  160 (287)
T 1u59_A           84 LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL  160 (287)
T ss_dssp             EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCC--EeeCCCchheEEEcCCCCEEECcccceeee
Confidence            89999999999999999654 345899999999999999999999976  999999999999999999999999999875


Q ss_pred             CCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          236 PQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       236 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ...... .......||+.|+|||++.+..++.++||||||+++|||++ |+.||...........               
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---------------  225 (287)
T 1u59_A          161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---------------  225 (287)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH---------------
T ss_pred             ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH---------------
Confidence            433221 11223457899999999998899999999999999999998 9999976543211111               


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                        +........+..++..+.+++.+||+.||.+||++.+++++|+.+.......
T Consensus       226 --i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          226 --IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             --HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             --HhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence              0001111222344578899999999999999999999999999887665443

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.7e-46  Score=367.21  Aligned_cols=258  Identities=20%  Similarity=0.213  Sum_probs=204.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ..++|++.+.||+|+||.||+|.++.+++.      ||+|++++....   ....+.+|..++..++||||++++++|.+
T Consensus        59 ~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~------vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           59 QRDDFEILKVIGRGAFSEVAVVKMKQTGQV------YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             ChhhEEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            357899999999999999999999766554      999999764321   22347789999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+.+|+||||++||+|.+++.+.. ..+++..+..++.|++.||+|||+.+  |+||||||+||||+.++++||+|||++
T Consensus       133 ~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g--iiHrDLKp~NILld~~g~vkL~DFGla  209 (412)
T 2vd5_A          133 ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLG--YVHRDIKPDNILLDRCGHIRLADFGSC  209 (412)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccCHHHeeecCCCCEEEeechhh
Confidence            999999999999999999997643 25889999999999999999999876  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccc-------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVM-------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +....... ......+||+.|+|||++.       +..|+.++|||||||++|||++|+.||...........+.     
T Consensus       210 ~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~-----  283 (412)
T 2vd5_A          210 LKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV-----  283 (412)
T ss_dssp             EECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----
T ss_pred             eeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH-----
Confidence            87543322 1223468999999999987       3578999999999999999999999997643221111000     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCC---CCHHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR---PLMSDVVETL  357 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Pt~~eil~~L  357 (431)
                       . ..  ....-+    ......+.++.+||.+||. +|.+|   |++.||++|-
T Consensus       284 -~-~~--~~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hp  329 (412)
T 2vd5_A          284 -H-YK--EHLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHP  329 (412)
T ss_dssp             -T-HH--HHCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSG
T ss_pred             -h-cc--cCcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCC
Confidence             0 00  000000    1112345788999999999 99998   5899998763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.3e-46  Score=354.47  Aligned_cols=267  Identities=25%  Similarity=0.320  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe----
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE----  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----  152 (431)
                      .++|++.+.||+|+||.||++.+..++.      .||+|++..........+.+|+.+++.++||||+++++++..    
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  101 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGH------FYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGA  101 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCC------EEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETT
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCc------EEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCC
Confidence            3679999999999999999999866544      499999877665666788999999999999999999999873    


Q ss_pred             CCeeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                      ....++||||+.+++|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~dfg  179 (317)
T 2buj_A          102 KHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG--YAHRDLKPTNILLGDEGQPVLMDLG  179 (317)
T ss_dssp             EEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCS
T ss_pred             CceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEcCCCCEEEEecC
Confidence            34789999999999999998752  3456899999999999999999999976  9999999999999999999999999


Q ss_pred             CCccCCCCCCcc-------eeecccCCccccCccccccCC---CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          231 LAKAGPQGDETH-------VSTRVMGTYGYAAPEYVMTGH---LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       231 ~a~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      ++..........       ......||+.|+|||++.+..   ++.++|||||||++|+|++|+.||........     
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-----  254 (317)
T 2buj_A          180 SMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGD-----  254 (317)
T ss_dssp             SCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTS-----
T ss_pred             cchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccc-----
Confidence            987543211100       011245799999999987554   78899999999999999999999953110000     


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                                .+...+............+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus       255 ----------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  310 (317)
T 2buj_A          255 ----------SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPG  310 (317)
T ss_dssp             ----------CHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCCC
T ss_pred             ----------hhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCCC
Confidence                      00000000111111223456889999999999999999999999999987654433

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-45  Score=353.95  Aligned_cols=263  Identities=21%  Similarity=0.275  Sum_probs=210.0

Q ss_pred             HHHHHHHhcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCC-CCceee
Q 014079           70 LFELETITKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLR-HPNLVK  145 (431)
Q Consensus        70 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~  145 (431)
                      +...+.+.++|.+. +.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.+++.+. ||||++
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQE------YAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCE------EEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            34567788889988 8999999999999998876543      99999876432  33567889999999995 699999


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CC
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DY  222 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~  222 (431)
                      +++++.+.+..++||||+.+++|.+++.......+++..++.++.|++.||+|||+.+  |+||||||+|||++.   ++
T Consensus        94 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g--ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           94 LHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN--IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESCBTTBC
T ss_pred             EEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC--eecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999999997765667899999999999999999999876  999999999999988   78


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      .+||+|||+++.......   .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+   
T Consensus       172 ~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i---  245 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNI---  245 (327)
T ss_dssp             CEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH---
T ss_pred             cEEEeeCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHH---
Confidence            999999999987543221   23457999999999999999999999999999999999999999764321111000   


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                                .. .............+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       246 ----------~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          246 ----------SQ-VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             ----------HH-TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             ----------Hh-cccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence                      00 011111112223457788999999999999999999999763

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.9e-45  Score=343.75  Aligned_cols=255  Identities=23%  Similarity=0.308  Sum_probs=206.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.++++++||||+++++++.+.
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   77 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLE------FAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE   77 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCce------EEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC
Confidence            457899999999999999999998776543      99999876532  3446688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc---EEEeccc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT---AKLSDFG  230 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~---~kl~DFG  230 (431)
                      +..++||||+.+++|.+.+....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.   +||+|||
T Consensus        78 ~~~~~v~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           78 SFHYLVFDLVTGGELFEDIVARE--FYSEADASHCIQQILESIAYCHSNG--IVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             SEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            99999999999999999887654  4889999999999999999999976  999999999999976655   9999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||..............         
T Consensus       154 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~---------  221 (284)
T 3kk8_A          154 LAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA---------  221 (284)
T ss_dssp             TCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH---------
T ss_pred             eeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh---------
Confidence            9976543322   2346799999999999999999999999999999999999999976432111110000         


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                          . ............+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       222 ----~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (284)
T 3kk8_A          222 ----G-AYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP  263 (284)
T ss_dssp             ----T-CCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSH
T ss_pred             ----c-cccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCc
Confidence                0 00001111123346788999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=2.3e-45  Score=354.54  Aligned_cols=271  Identities=18%  Similarity=0.194  Sum_probs=200.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-----------hHHHHHHHHHHHhcCCCCceee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-----------GHREWLTEVNFLGQLRHPNLVK  145 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~  145 (431)
                      .++|++.+.||+|+||.||+|.+..+..   ....+|+|++......           ....+.+|+.+++.++||||++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~  112 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPE---KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPL  112 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCG---GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCC---ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcce
Confidence            3679999999999999999999876211   1234999988765321           1123678899999999999999


Q ss_pred             eecEEEe----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          146 LIGYCCE----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       146 l~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      +++++.+    ....|+||||+ +++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~  187 (345)
T 2v62_A          113 FYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENE--YVHGDIKAANLLLGYK  187 (345)
T ss_dssp             EEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEESS
T ss_pred             eecccccccCCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeCCCcCHHHEEEccC
Confidence            9999988    77899999999 999999997654  6899999999999999999999976  9999999999999888


Q ss_pred             C--cEEEecccCCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 014079          222 Y--TAKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK  294 (431)
Q Consensus       222 ~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  294 (431)
                      +  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  267 (345)
T 2v62_A          188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDP  267 (345)
T ss_dssp             STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCH
T ss_pred             CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccccccc
Confidence            7  9999999999765322111     11134579999999999999999999999999999999999999996432211


Q ss_pred             cchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          295 EQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .... .......   ..+...+.....   ....+.++.+++.+||+.||++|||+.+|++.|+.+..
T Consensus       268 ~~~~-~~~~~~~---~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          268 VAVQ-TAKTNLL---DELPQSVLKWAP---SGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHH-HHHHHHH---HTTTHHHHHHSC---TTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHH-HHHHhhc---ccccHHHHhhcc---ccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            1100 0000000   000000000000   00234688999999999999999999999999987654

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.2e-45  Score=345.72  Aligned_cols=249  Identities=27%  Similarity=0.422  Sum_probs=202.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+...      ||+|++.....   .....+.+|+.++++++||||+++++++.+.+
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   82 (279)
T 3fdn_A            9 EDFEIGRPLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   82 (279)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccEEEeeEEecCCCeEEEEEEEccCCcE------EEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCC
Confidence            5789999999999999999998876543      99999865432   22456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--i~H~dlkp~Nili~~~~~~~l~Dfg~~~~  158 (279)
T 3fdn_A           83 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  158 (279)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--CEECCCCGGGEEECTTSCEEECSCCEESC
T ss_pred             EEEEEEecCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecccCChHhEEEcCCCCEEEEecccccc
Confidence            9999999999999999997654  4788999999999999999999866  99999999999999999999999999865


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+             . 
T Consensus       159 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-------------~-  220 (279)
T 3fdn_A          159 APSSR----RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI-------------S-  220 (279)
T ss_dssp             C------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH-------------H-
T ss_pred             CCccc----ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHH-------------H-
Confidence            43322    23357999999999999999999999999999999999999999754321111000             0 


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ...    ...+...+..+.+|+.+||+.||.+|||+.|++++-.
T Consensus       221 ~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~  260 (279)
T 3fdn_A          221 RVE----FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  260 (279)
T ss_dssp             HTC----CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHH
T ss_pred             hCC----CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCcc
Confidence            001    1112224467889999999999999999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=361.60  Aligned_cols=276  Identities=20%  Similarity=0.234  Sum_probs=213.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD-  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-  154 (431)
                      .++|++.++||+|+||.||+|.+..++.      .||+|++..... .....+.+|+++|++++||||+++++++.+.+ 
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~   81 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGD------LFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT   81 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCc------EEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence            4679999999999999999999987554      399999876532 34567789999999999999999999998765 


Q ss_pred             -eeEEEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE----CCCCcEEEec
Q 014079          155 -HRLLVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSDYTAKLSD  228 (431)
Q Consensus       155 -~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl----~~~~~~kl~D  228 (431)
                       ..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+  |+||||||+|||+    +.++.+||+|
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~kL~D  159 (396)
T 4eut_A           82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG--IVHRNIKPGNIMRVIGEDGQSVYKLTD  159 (396)
T ss_dssp             CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEEEECTTSCEEEEECC
T ss_pred             CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC--EEECCcCHHHEEEeecCCCceeEEEec
Confidence             7799999999999999997643 233899999999999999999999976  9999999999999    7788899999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCcccccc--------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch-hh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT--------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS-LV  299 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~  299 (431)
                      ||+++......   ......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.......... ..
T Consensus       160 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~  236 (396)
T 4eut_A          160 FGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM  236 (396)
T ss_dssp             GGGCEECCCGG---GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHH
T ss_pred             CCCceEccCCC---ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHH
Confidence            99998754322   2234679999999999875        567889999999999999999999997543322111 11


Q ss_pred             hhhhhhhh--ccchhhhhc--------CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          300 DWARPKLN--DKRKMLQII--------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       300 ~~~~~~~~--~~~~~~~~~--------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ........  .........        +......+.......+.+++.+||+.||++||++.++++.++.+...
T Consensus       237 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             HHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            10000000  000000000        00112234577888999999999999999999999999999887653

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=348.96  Aligned_cols=268  Identities=24%  Similarity=0.300  Sum_probs=200.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++......  ..+.+.+|+.++++++||||+++++++.+.+
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   75 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQI------VAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKR   75 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcE------EEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCC
Confidence            36799999999999999999999776543      999988655332  2456789999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~i~~~l~~~l~~lH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~  151 (311)
T 4agu_A           76 RLHLVFEYCDHTVLHELDRYQR--GVPEHLVKSITWQTLQAVNFCHKHN--CIHRDVKPENILITKHSVIKLCDFGFARL  151 (311)
T ss_dssp             EEEEEEECCSEEHHHHHHHTSS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eEEEEEEeCCCchHHHHHhhhc--CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCChhhEEEcCCCCEEEeeCCCchh
Confidence            9999999999999999886543  4889999999999999999999876  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh-------
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL-------  306 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~-------  306 (431)
                      ......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+.......       
T Consensus       152 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (311)
T 4agu_A          152 LTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQV  229 (311)
T ss_dssp             CC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHH
T ss_pred             ccCccc--ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccc
Confidence            543221  2234579999999999876 678999999999999999999999997754332221111100000       


Q ss_pred             -hccchhhh--hcCccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 -NDKRKMLQ--IIDPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 -~~~~~~~~--~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ........  +.++.....   .....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          230 FSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             HHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             00000000  000000000   012345678999999999999999999999976

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2e-45  Score=344.60  Aligned_cols=256  Identities=25%  Similarity=0.381  Sum_probs=207.0

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe-
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-  152 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  152 (431)
                      ..+..+|++.+.||+|+||.||+|.+..++.      .||+|++....    ..+.+|++++++++||||+++++++.. 
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~   76 (284)
T 2a19_B            7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGK------TYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGF   76 (284)
T ss_dssp             HHHHHHEEEEEEEECSSSCCEEEEEETTTCC------EEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEE
T ss_pred             chhccccceeeeeccCCceEEEEEEEcCCCe------EEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEecc
Confidence            3466789999999999999999999875544      39999987653    245689999999999999999998864 


Q ss_pred             ---------------CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEE
Q 014079          153 ---------------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL  217 (431)
Q Consensus       153 ---------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NIL  217 (431)
                                     ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||
T Consensus        77 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil  154 (284)
T 2a19_B           77 DYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK--LINRDLKPSNIF  154 (284)
T ss_dssp             EEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEE
T ss_pred             ccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCCHHHEE
Confidence                           455799999999999999998765557899999999999999999999876  999999999999


Q ss_pred             ECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch
Q 014079          218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS  297 (431)
Q Consensus       218 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  297 (431)
                      ++.++.+||+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|..||....     .
T Consensus       155 ~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----~  226 (284)
T 2a19_B          155 LVDTKQVKIGDFGLVTSLKNDGK---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS-----K  226 (284)
T ss_dssp             EEETTEEEECCCTTCEESSCCSC---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH-----H
T ss_pred             EcCCCCEEECcchhheecccccc---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH-----H
Confidence            99999999999999987544321   223569999999999999999999999999999999999988863210     0


Q ss_pred             hhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          298 LVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      .             ...+....+.    ...+..+.+++.+||+.||.+|||+.+++++|+.+......
T Consensus       227 ~-------------~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~~  278 (284)
T 2a19_B          227 F-------------FTDLRDGIIS----DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK  278 (284)
T ss_dssp             H-------------HHHHHTTCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC----
T ss_pred             H-------------HHHhhccccc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCCc
Confidence            0             0011111111    12335688999999999999999999999999988765443

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.5e-46  Score=355.63  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=204.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..... ...+..||+|++.... .....++.+|+.++++++||||+++++++.+.+.
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPN-DPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC---------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCC-CCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            4679999999999999999998543211 1123359999987543 2345678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC-----CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEe
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT-----VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLS  227 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~  227 (431)
                      .++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.   +..+||+
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~--i~H~dlkp~NIli~~~~~~~~~kl~  185 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH--FIHRDIAARNCLLTCPGPGRVAKIG  185 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC--eecCcCCHhHEEEecCCCcceEEEC
Confidence            9999999999999999976532     34889999999999999999999876  999999999999984   4569999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||.........   .      
T Consensus       186 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~---~------  256 (327)
T 2yfx_A          186 DFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL---E------  256 (327)
T ss_dssp             CCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---H------
T ss_pred             ccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHH---H------
Confidence            9999875433222222334568999999999999999999999999999999998 99999764321111   0      


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                              .+........+..++..+.+++.+||+.||.+||++.+|+++|+.+...
T Consensus       257 --------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          257 --------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             --------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence                    0000001111223456788999999999999999999999999977653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.2e-45  Score=356.79  Aligned_cols=250  Identities=30%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .+.|+..+.||+|+||.||+|.+..++..      ||+|++.....   .....+.+|+++|++++||||+++++++.+.
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~  126 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE  126 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeE------EEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            45689999999999999999998766554      99999875432   2345688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+. |+|.+++.... .++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus       127 ~~~~lv~e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kL~DfG~a~  202 (348)
T 1u5q_A          127 HTAWLVMEYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSAS  202 (348)
T ss_dssp             TEEEEEEECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCB
T ss_pred             CeEEEEEecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEECCCCCEEEeeccCce
Confidence            99999999996 68888876433 36899999999999999999999976  9999999999999999999999999997


Q ss_pred             cCCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      .....      ....||+.|+|||++.   ++.++.++|||||||++|||++|+.||..........             
T Consensus       203 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-------------  263 (348)
T 1u5q_A          203 IMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY-------------  263 (348)
T ss_dssp             SSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH-------------
T ss_pred             ecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-------------
Confidence            65322      2357999999999985   5678999999999999999999999997643211100             


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      .+.....+.+   .....+..+.+|+.+||+.||++|||+.+++++..
T Consensus       264 ~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          264 HIAQNESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             HHHHSCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             HHHhcCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChh
Confidence            0000001111   11223467889999999999999999999998754

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.8e-45  Score=345.38  Aligned_cols=260  Identities=28%  Similarity=0.406  Sum_probs=204.7

Q ss_pred             cCCCccc-eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDY-ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~-~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+ .||+|+||.||+|.+....    .+..||+|++.....  ...+.+.+|+.+++.++||||+++++++ ..+
T Consensus        16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           16 KLLTLEDKELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             GGEEEEEEEEEECSSEEEEEEEEECSS----SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             hhhhhccCccccccCeeeEeeeecCCC----ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            5677777 9999999999999764321    122499999876532  2356788999999999999999999999 667


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  166 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKA  166 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             CcEEEEEeCCCCCHHHHHHhCc--CCCHHHHHHHHHHHHHHHHHHHhCC--eEcCCCCcceEEEeCCCcEEEccCCccee
Confidence            8899999999999999997754  4889999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ........ ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........                
T Consensus       167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~----------------  230 (291)
T 1xbb_A          167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT----------------  230 (291)
T ss_dssp             CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----------------
T ss_pred             eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHH----------------
Confidence            54433221 1222457789999999999899999999999999999999 99999765321111                


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                       ..+........+..++..+.+++.+||+.||.+||++.++++.|+.+...
T Consensus       231 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          231 -AMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             -HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence             11111111122234457889999999999999999999999999987654

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.6e-45  Score=368.89  Aligned_cols=248  Identities=27%  Similarity=0.368  Sum_probs=204.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|.+.+.||+|+||.||+|.+..++.      .||+|++.....   .....+.+|+.+|+.++||||+++++++.+.+
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~------~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGH------KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCC------EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCC------EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            578999999999999999999876544      399999876432   23457889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDLkp~NIll~~~~~vkL~DFG~a~~  165 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNG--RLDEKESRRLFQQILSGVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSNM  165 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--CCcccccHHHEEEecCCCeEEEeccchhh
Confidence            9999999999999999997543  5899999999999999999999866  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .....   .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........                .
T Consensus       166 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~----------------~  226 (476)
T 2y94_A          166 MSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLF----------------K  226 (476)
T ss_dssp             CCTTC---CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHH----------------H
T ss_pred             ccccc---cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHH----------------H
Confidence            54432   2334679999999999988766 68999999999999999999999764321111                0


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+.+...  ..+...+.++.+||.+||+.||.+|||+.+|+++
T Consensus       227 ~i~~~~~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          227 KICDGIF--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHTTCC--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHhcCCc--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence            1111111  1112234678899999999999999999999975

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.4e-46  Score=346.53  Aligned_cols=253  Identities=25%  Similarity=0.409  Sum_probs=200.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC-Ce
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED-DH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~  155 (431)
                      .++|++.+.||+|+||.||++.+.+        ..||+|+++...  ..+.+.+|+.++++++||||+++++++.+. +.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRG--------NKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETT--------EEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             hhhceEEeEEecCCCceEEEEEEcC--------CEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            3678999999999999999998752        249999997653  456788999999999999999999997654 47


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~  167 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEA  167 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCcceEEEeCCCcEEEeeccccccc
Confidence            899999999999999997654444788899999999999999999876  999999999999999999999999998764


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.........                 .
T Consensus       168 ~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~-----------------~  225 (278)
T 1byg_A          168 SSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV-----------------P  225 (278)
T ss_dssp             -------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH-----------------H
T ss_pred             cccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH-----------------H
Confidence            3221     22357889999999999999999999999999999998 99999764321110                 1


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .+........+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       226 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          226 RVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            1111111122233457889999999999999999999999999988754

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2.8e-45  Score=344.40  Aligned_cols=254  Identities=26%  Similarity=0.334  Sum_probs=199.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .+|+|++..... ...+.+.+|+++|++++||||+++++++.+.+
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   93 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGL------ERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYH   93 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCC------EEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCc------eEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCC
Confidence            55789999999999999999999876554      389998876532 34577889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecc
Q 014079          155 HRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDF  229 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DF  229 (431)
                      ..++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+||
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~--ivH~dikp~NIl~~~~~~~~~~kl~Df  171 (285)
T 3is5_A           94 NMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH--VVHKDLKPENILFQDTSPHSPIKIIDF  171 (285)
T ss_dssp             EEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             eEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC--EEECCCCHHHEEEecCCCCCCEEEEee
Confidence            999999999999999988643  2346899999999999999999999876  9999999999999   45688999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |++.......   ......||+.|+|||++. +.++.++||||||+++|||++|+.||..............        
T Consensus       172 g~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~--------  239 (285)
T 3is5_A          172 GLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY--------  239 (285)
T ss_dssp             CCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--------
T ss_pred             ecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc--------
Confidence            9997654322   223467999999999875 5789999999999999999999999976432211111100        


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            ........ ....+..+.+|+.+||+.||.+|||+.|++++
T Consensus       240 ------~~~~~~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          240 ------KEPNYAVE-CRPLTPQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             ------CCCCCCC---CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             ------CCcccccc-cCcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  00000000 01134678899999999999999999999865

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.7e-45  Score=365.99  Aligned_cols=202  Identities=27%  Similarity=0.425  Sum_probs=168.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc--CchhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE--GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||||++...  .....+.+.+|+.+|++++||||+++++++...
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~   97 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKN------VAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPD   97 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCS
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcE------EEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecC
Confidence            457899999999999999999999877654      999998764  233456789999999999999999999999876


Q ss_pred             -----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                           ...|+||||+ +++|.+++...  ..+++..++.++.||+.||.|||+.+  |+||||||+||||+.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~g--ivHrDlkp~NILl~~~~~~kL~D  172 (432)
T 3n9x_A           98 DLLKFDELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESG--IIHRDLKPANCLLNQDCSVKVCD  172 (432)
T ss_dssp             CTTTCCCEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcCCeEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCHHHeEECCCCCEEEcc
Confidence                 5789999998 46999999654  35899999999999999999999977  99999999999999999999999


Q ss_pred             ccCCccCCCCCCc--------------------ceeecccCCccccCcccc-ccCCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          229 FGLAKAGPQGDET--------------------HVSTRVMGTYGYAAPEYV-MTGHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       229 FG~a~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      ||+++........                    ......+||++|+|||++ .+..|+.++|||||||++|||++|..||
T Consensus       173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            9999875433211                    123457899999999986 5667999999999999999999865555


Q ss_pred             C
Q 014079          288 D  288 (431)
Q Consensus       288 ~  288 (431)
                      .
T Consensus       253 ~  253 (432)
T 3n9x_A          253 I  253 (432)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-45  Score=378.16  Aligned_cols=258  Identities=26%  Similarity=0.376  Sum_probs=203.8

Q ss_pred             eecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEec
Q 014079           85 ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM  163 (431)
Q Consensus        85 ~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  163 (431)
                      .||+|+||.||+|.+....    .+..||||+++.... ...+++.+|+++|++++|||||++++++.. +.+++||||+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~  417 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMA  417 (613)
T ss_dssp             EEEECSSSEEEEEEEECSS----CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECC
T ss_pred             EEecCCCcEEEEEEEecCC----CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeC
Confidence            7999999999999876422    123499999986532 356789999999999999999999999976 5689999999


Q ss_pred             CCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc-c
Q 014079          164 FRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET-H  242 (431)
Q Consensus       164 ~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~-~  242 (431)
                      .+|+|.+++... ...+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++........ .
T Consensus       418 ~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~--iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          418 GGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             TTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             CCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC--EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            999999999654 346899999999999999999999876  999999999999999999999999999875433221 1


Q ss_pred             eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcccc
Q 014079          243 VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE  321 (431)
Q Consensus       243 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (431)
                      ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.........                 ..+.....
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~-----------------~~i~~~~~  557 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------AFIEQGKR  557 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHH-----------------HHHHTTCC
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HHHHcCCC
Confidence            1122346789999999999999999999999999999998 99999875432211                 11111111


Q ss_pred             CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCCC
Q 014079          322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGG  367 (431)
Q Consensus       322 ~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~~  367 (431)
                      ...+..++.++.+||.+||+.||++||++.+|++.|+.+.......
T Consensus       558 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~~  603 (613)
T 2ozo_A          558 MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  603 (613)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhccc
Confidence            2233345678999999999999999999999999999876554443

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.8e-45  Score=342.98  Aligned_cols=251  Identities=27%  Similarity=0.388  Sum_probs=199.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  152 (431)
                      +.|++.+.||+|+||.||+|.+..+...      ||+|++.....  .....+.+|+.++++++||||+++++++..   
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~------va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   99 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK   99 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceE------EEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccC
Confidence            4578888999999999999998776543      99998875432  345678899999999999999999999875   


Q ss_pred             -CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-CCCcEEEeccc
Q 014079          153 -DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSDFG  230 (431)
Q Consensus       153 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-~~~~~kl~DFG  230 (431)
                       ...+++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+.+|+||||||+|||++ .++.+||+|||
T Consensus       100 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg  177 (290)
T 1t4h_A          100 GKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLG  177 (290)
T ss_dssp             SCEEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTT
T ss_pred             CCceEEEEEEecCCCCHHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCC
Confidence             356899999999999999997653  47889999999999999999998655599999999999997 78999999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.........  ..          
T Consensus       178 ~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~----------  240 (290)
T 1t4h_A          178 LATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR----------  240 (290)
T ss_dssp             GGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH----------
T ss_pred             Cccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH--HH----------
Confidence            99764332    223457999999999776 56999999999999999999999999764322111  00          


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         .+.........+...+.++.+|+.+||+.||.+|||+.+++++
T Consensus       241 ---~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          241 ---RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             ---HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ---HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence               0000001111122233678899999999999999999999975

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.5e-45  Score=345.07  Aligned_cols=269  Identities=20%  Similarity=0.257  Sum_probs=205.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEE-EeC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYC-CED  153 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~  153 (431)
                      .+.++|++.+.||+|+||.||+|.+..++..      ||+|++.....  ...+.+|+.+++.++|++++..+.++ .+.
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~   77 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEE------VAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEG   77 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEET
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCce------EEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCC
Confidence            4568899999999999999999998766553      99998655432  23477899999999988776666655 667


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEeccc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFG  230 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DFG  230 (431)
                      +..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+|||
T Consensus        78 ~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg  153 (296)
T 4hgt_A           78 DYNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFG  153 (296)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECCGGGTTCEEECCCT
T ss_pred             CceEEEEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeeeeccCCCCeEEEecCc
Confidence            7889999999 999999997543 35899999999999999999999977  9999999999999   788999999999


Q ss_pred             CCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          231 LAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       231 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus       154 ~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  233 (296)
T 4hgt_A          154 LAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK  233 (296)
T ss_dssp             TCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH
T ss_pred             cceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcc
Confidence            99865443221     1223467999999999999999999999999999999999999999875543322221110000


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      .         .. ..........+..+.+|+.+||+.||++|||+.+|++.|+.+.....
T Consensus       234 ~---------~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          234 K---------MS-TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             H---------HH-SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             c---------cc-chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence            0         00 00000111234688999999999999999999999999998876543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2.5e-45  Score=371.73  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=207.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.++||+|+||.||+|.+..+++.      ||+|++.+...   .....+.+|+.+|++++||||+++++++.+.+
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~------vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~  258 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKL------YACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKT  258 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcE------EEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCC
Confidence            5788999999999999999999776554      99999876532   23456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+|+||||++||+|.+++....  ...+++..++.++.||+.||.|||+.+  |+||||||+||||+.+|.+||+|||++
T Consensus       259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g--IvHrDLKP~NILl~~~g~vkL~DFGla  336 (543)
T 3c4z_A          259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN--IIYRDLKPENVLLDDDGNVRISDLGLA  336 (543)
T ss_dssp             EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC--CcccCCChHHEEEeCCCCEEEeeccee
Confidence            9999999999999999987643  446899999999999999999999977  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||...........+.            
T Consensus       337 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~------------  402 (543)
T 3c4z_A          337 VELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK------------  402 (543)
T ss_dssp             EECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHH------------
T ss_pred             eeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHH------------
Confidence            87544322  1234589999999999999999999999999999999999999997654321111100            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      ..+....  ..++...+..+.+||.+||+.||.+||++     .+|+.|
T Consensus       403 ~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          403 QRVLEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             HHHHHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             HHHhhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            0011110  11223345788999999999999999975     667654

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.8e-45  Score=346.67  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=204.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .+.++|.+.+.||+|+||.||+|.+..+++      .||+|++..........+.+|+.++++++||||+++++++.+.+
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   79 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGK------LFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTT   79 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCC------EEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCC
Confidence            456789999999999999999999876544      39999998765444567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DFG~  231 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+|||+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dikp~NIl~~~~~~~~~~kl~Dfg~  155 (304)
T 2jam_A           80 HYYLVMQLVSGGELFDRILERG--VYTEKDASLVIQQVLSAVKYLHENG--IVHRDLKPENLLYLTPEENSKIMITDFGL  155 (304)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCSCCGGGCEESSSSTTCCEEBCSCST
T ss_pred             EEEEEEEcCCCccHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCCHHHEEEecCCCCCCEEEccCCc
Confidence            9999999999999999987654  4788999999999999999999876  9999999999999   7789999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      +.......    .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+            
T Consensus       156 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------------  219 (304)
T 2jam_A          156 SKMEQNGI----MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI------------  219 (304)
T ss_dssp             TCCCCCBT----THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------------
T ss_pred             ceecCCCc----cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------------
Confidence            87643221    22356999999999999999999999999999999999999999764321110000            


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                       ... ...+........+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       220 -~~~-~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          220 -KEG-YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             -HHC-CCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             -HcC-CCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCc
Confidence             000 00011112223457889999999999999999999999764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.6e-45  Score=363.24  Aligned_cols=257  Identities=24%  Similarity=0.355  Sum_probs=195.9

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------hhHHHHHHHHHHHhcCCCCceee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------QGHREWLTEVNFLGQLRHPNLVK  145 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~  145 (431)
                      ..+.++|.+.+.||+|+||.||+|.+..++..      ||+|++.+...        .....+.+|+.+|++++||||++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  204 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKK------VAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK  204 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcE------EEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEee
Confidence            56788999999999999999999999876554      99999876422        11224789999999999999999


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---C
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---Y  222 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~  222 (431)
                      +++++. .+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.+   +
T Consensus       205 l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--ivHrDlkp~NIll~~~~~~~  279 (419)
T 3i6u_A          205 IKNFFD-AEDYYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDC  279 (419)
T ss_dssp             CCEEEE-SSEEEEEEECCTTCBGGGGTSSSC--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSSSC
T ss_pred             EEEEEe-cCceEEEEEcCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCCCcc
Confidence            999975 556899999999999999986544  5899999999999999999999876  9999999999999754   4


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                      .+||+|||+++......   .....+||+.|+|||++.+   ..|+.++|||||||++|+|++|+.||..........  
T Consensus       280 ~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--  354 (419)
T 3i6u_A          280 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLK--  354 (419)
T ss_dssp             CEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHH--
T ss_pred             eEEEeecccceecCCCc---cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHH--
Confidence            59999999998754322   2334679999999999863   678899999999999999999999997643322110  


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...    .      .. ............+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       355 ~~i----~------~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp  401 (419)
T 3i6u_A          355 DQI----T------SG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHP  401 (419)
T ss_dssp             HHH----H------TT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             HHH----h------cC-CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCc
Confidence            000    0      00 00000011122357889999999999999999999999863

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-45  Score=358.49  Aligned_cols=268  Identities=24%  Similarity=0.317  Sum_probs=205.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++..... .....+.+|+.++++++||||+++++++.+.+.
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLV------MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcE------EEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            46799999999999999999999866543      99999876532 334678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .++||||+++++|.+++....  .+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~~i~~~l~~lh~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  181 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEECCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence            999999999999999997654  478899999999999999999984 6  99999999999999999999999999864


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh------------
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA------------  302 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~------------  302 (431)
                      ...    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...............            
T Consensus       182 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (360)
T 3eqc_A          182 LID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  257 (360)
T ss_dssp             HHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------
T ss_pred             ccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCc
Confidence            321    1123357999999999999999999999999999999999999999764322111000000            


Q ss_pred             --------------hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          303 --------------RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       303 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                    .+.......+..+.............+.++.+|+.+||+.||++|||+.++++|-.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  327 (360)
T 3eqc_A          258 RTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  327 (360)
T ss_dssp             ----------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHH
T ss_pred             ccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChH
Confidence                          00000000000011111111111224568899999999999999999999998644

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.2e-45  Score=346.13  Aligned_cols=263  Identities=25%  Similarity=0.296  Sum_probs=200.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ..++|++.+.||+|+||.||+|.+..++..      ||+|++......   ....+.+|+.++++++||||+++++++.+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERI------VALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI  105 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEE------EEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeE------EEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence            347899999999999999999998766553      999998765332   24678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++++|.+++....  ++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~NIl~~~~~~~kl~Dfg~~  181 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQG--PLAPPRAVAIVRQIGSALDAAHAAG--ATHRDVKPENILVSADDFAYLVDFGIA  181 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSCCC-
T ss_pred             CCeEEEEEEecCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCc--CCcCCCChHHEEEcCCCCEEEecCccC
Confidence            999999999999999999997654  5889999999999999999999976  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ..    .+...   
T Consensus       182 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~----~~~~~---  250 (309)
T 2h34_A          182 SATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM---GA----HINQA---  250 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH---HH----HHHSC---
T ss_pred             ccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH---HH----HhccC---
Confidence            765433211 22345699999999999999999999999999999999999999976421100   00    00000   


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhhhcC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-LMSDVVETLEPLQCAN  364 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~eil~~L~~l~~~~  364 (431)
                         .  ..........+.++.+++.+||+.||++|| ++.++++.|+.+....
T Consensus       251 ---~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          251 ---I--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             ---C--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             ---C--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence               0  000112223446788999999999999999 9999999998765543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=352.90  Aligned_cols=246  Identities=24%  Similarity=0.316  Sum_probs=203.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--------hHHHHHHHHHHHhcCCCCceeee
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--------GHREWLTEVNFLGQLRHPNLVKL  146 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l  146 (431)
                      .+.++|++.+.||+|+||.||+|.+..++..      ||+|++......        ....+.+|+.+|++++||||+++
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~   94 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKE------VVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKV   94 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEE------EEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCE
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcE------EEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeE
Confidence            4678899999999999999999998776654      999998765321        22346789999999999999999


Q ss_pred             ecEEEeCCeeEEEEEecCCC-ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          147 IGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      ++++.+.+..++||||+.+| +|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+|
T Consensus        95 ~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~k  170 (335)
T 3dls_A           95 LDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLVSAVGYLRLKD--IIHRDIKDENIVIAEDFTIK  170 (335)
T ss_dssp             EEEEECSSEEEEEEECCTTSCBHHHHHHTCC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEE
T ss_pred             EEEEeeCCEEEEEEEeCCCCccHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEEeccCHHHEEEcCCCcEE
Confidence            99999999999999998666 9999997654  4889999999999999999999976  99999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      |+|||+++.......   .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......           
T Consensus       171 L~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-----------  236 (335)
T 3dls_A          171 LIDFGSAAYLERGKL---FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-----------  236 (335)
T ss_dssp             ECCCTTCEECCTTCC---BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG-----------
T ss_pred             EeecccceECCCCCc---eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH-----------
Confidence            999999987544332   233579999999999988876 78999999999999999999999642110           


Q ss_pred             hhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 KLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                             ......      .+...+.++.+|+.+||+.||++|||+.+++++-
T Consensus       237 -------~~~~~~------~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp  276 (335)
T 3dls_A          237 -------VEAAIH------PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDP  276 (335)
T ss_dssp             -------TTTCCC------CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCT
T ss_pred             -------HhhccC------CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence                   000000      0111346788999999999999999999999874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.7e-45  Score=342.18  Aligned_cols=261  Identities=25%  Similarity=0.362  Sum_probs=206.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++......      ..+.+.+|+.++++++||||++++++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   76 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGK------EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDI   76 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCC------eeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhhe
Confidence            45679999999999999999999886544      3999988764321      35678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cEE
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAK  225 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~k  225 (431)
                      +.+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++    .+|
T Consensus        77 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~~~~k  152 (283)
T 3bhy_A           77 FENKTDVVLILELVSGGELFDFLAEKE--SLTEDEATQFLKQILDGVHYLHSKR--IAHFDLKPENIMLLDKNVPNPRIK  152 (283)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSSSSCCEE
T ss_pred             ecCCCeEEEEEeecCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCChHHEEEecCCCCCCceE
Confidence            999999999999999999999997643  5889999999999999999999876  99999999999998877    899


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||++........   .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.     
T Consensus       153 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-----  224 (283)
T 3bhy_A          153 LIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS-----  224 (283)
T ss_dssp             ECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH-----
T ss_pred             EEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhH-----
Confidence            999999986543221   233569999999999999999999999999999999999999997643211100000     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--Hhhhhhc
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET--LEPLQCA  363 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~--L~~l~~~  363 (431)
                               ..............+..+.+|+.+||+.||.+|||+.+++++  +..+...
T Consensus       225 ---------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~  275 (283)
T 3bhy_A          225 ---------AVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR  275 (283)
T ss_dssp             ---------TTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred             ---------hcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence                     000011111112234678899999999999999999999985  4444433

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=3.7e-45  Score=366.84  Aligned_cols=265  Identities=23%  Similarity=0.283  Sum_probs=208.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC-CceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH-PNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  155 (431)
                      .++|++.++||+|+||.||+|.+..++.      .||||++.....  ..++.+|+++++.++| ++|..+..++.+.+.
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~------~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~   77 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNE------EVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY   77 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCC------EEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCc------EEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence            4689999999999999999999876554      399998765532  2357789999999986 566666777778889


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecccCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLA  232 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DFG~a  232 (431)
                      .+|||||+ +++|.+++.... ..+++..++.++.||+.||.|||+.+  ||||||||+||||   +.++.+||+|||++
T Consensus        78 ~~lvme~~-g~sL~~ll~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~g--IvHrDIKP~NILl~~~~~~~~vkL~DFGla  153 (483)
T 3sv0_A           78 NVLVMDLL-GPSLEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS--FLHRDIKPDNFLMGLGRRANQVYIIDFGLA  153 (483)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECCGGGTTCEEECCCTTC
T ss_pred             EEEEEECC-CCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--EeecccCcceEEEecCCCCCeEEEEeCCcc
Confidence            99999999 999999997543 35899999999999999999999976  9999999999999   58899999999999


Q ss_pred             ccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          233 KAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       233 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      +........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||..................  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~--  231 (483)
T 3sv0_A          154 KKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK--  231 (483)
T ss_dssp             EECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH--
T ss_pred             eeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc--
Confidence            875443221     1122467999999999999999999999999999999999999999876543322221111000  


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                         .+..     ........++.++.+|+.+||+.||++||++.+|++.|+.+...
T Consensus       232 ---~~~~-----~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          232 ---KVAT-----SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             ---HHHS-----CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---cccc-----cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence               0000     00011122347889999999999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-45  Score=354.62  Aligned_cols=269  Identities=22%  Similarity=0.274  Sum_probs=195.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ...++|++.+.||+|+||.||+|.+..++..      ||+|++......  ....+.+|+.+|++++||||+++++++.+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  104 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNET------VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH  104 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEE------EEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCce------EEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec
Confidence            3456899999999999999999998876654      999999765432  23457799999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE-----CCCCcEEEe
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL-----DSDYTAKLS  227 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl-----~~~~~~kl~  227 (431)
                      .+..++||||+. ++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||+     +.++.+||+
T Consensus       105 ~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~i~~ql~~~l~~LH~~~--ivH~Dlkp~NIll~~~~~~~~~~~kl~  179 (329)
T 3gbz_A          105 NHRLHLIFEYAE-NDLKKYMDKNP--DVSMRVIKSFLYQLINGVNFCHSRR--CLHRDLKPQNLLLSVSDASETPVLKIG  179 (329)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEC-----CCEEEEC
T ss_pred             CCEEEEEEecCC-CCHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EECCCCCHHHEEEecCCCCccceEEEC
Confidence            999999999996 59999997754  4889999999999999999999976  9999999999999     455669999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RP  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~  304 (431)
                      |||+++......  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...........+...  .+
T Consensus       180 Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  257 (329)
T 3gbz_A          180 DFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP  257 (329)
T ss_dssp             CTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCC
Confidence            999997643221  122345689999999999874 5899999999999999999999999765432211111000  00


Q ss_pred             hhhc---cch-------hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLND---KRK-------MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~---~~~-------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....   ...       ........+........+.++.+||.+||+.||.+|||+.|++++
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          258 DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            0000   000       000000001111112245788999999999999999999999975

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=9.3e-45  Score=343.88  Aligned_cols=255  Identities=22%  Similarity=0.284  Sum_probs=202.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCCCCceeeeecEEE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++.....    .....+.+|+.++++++||||+++++++.
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLC------RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLY   76 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCC------EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCc------EEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence            45789999999999999999999876554      399999876432    33567889999999999999999999984


Q ss_pred             --eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          152 --EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       152 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                        +....++||||+.++ |.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+||
T Consensus        77 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~--i~H~dlkp~NIl~~~~~~~kl~df  153 (305)
T 2wtk_C           77 NEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG--IVHKDIKPGNLLLTTGGTLKISAL  153 (305)
T ss_dssp             CC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC--eeecCCCcccEEEcCCCcEEeecc
Confidence              456789999999766 888887766667899999999999999999999976  999999999999999999999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |++................||+.|+|||++.+..  ++.++||||||+++|+|++|+.||...........         
T Consensus       154 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---------  224 (305)
T 2wtk_C          154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN---------  224 (305)
T ss_dssp             TTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH---------
T ss_pred             ccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH---------
Confidence            9998765433333344567999999999987644  37799999999999999999999976431111000         


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                             +....  ...+..++..+.+|+.+||+.||.+|||+.+++++-
T Consensus       225 -------i~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  265 (305)
T 2wtk_C          225 -------IGKGS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHS  265 (305)
T ss_dssp             -------HHHCC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSH
T ss_pred             -------HhcCC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCc
Confidence                   00000  011123346788999999999999999999999864

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=1.4e-44  Score=341.06  Aligned_cols=269  Identities=20%  Similarity=0.252  Sum_probs=208.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEE-EeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYC-CEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~  154 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++.....  ...+.+|+.+++.++|++++..+.++ .+.+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~   78 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEE------VAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD   78 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcE------EEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence            357899999999999999999998766553      99999866532  24578999999999988766666554 5677


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DFG~  231 (431)
                      ..++||||+ +++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+|||+
T Consensus        79 ~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~  154 (296)
T 3uzp_A           79 YNVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGL  154 (296)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCTT
T ss_pred             ceEEEEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHeEEecCCCCCeEEEeeCCC
Confidence            889999999 999999997543 35899999999999999999999876  9999999999999   4788999999999


Q ss_pred             CccCCCCCCcc-----eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          232 AKAGPQGDETH-----VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       232 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      +..........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.................. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  233 (296)
T 3uzp_A          155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK-  233 (296)
T ss_dssp             CEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHH-
T ss_pred             cccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccc-
Confidence            98654432211     123467999999999999999999999999999999999999999875433222111110000 


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                              .... .........+.++.+++.+||+.||.+|||+.+|++.|+.+......
T Consensus       234 --------~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          234 --------KMST-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             --------HHHS-CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             --------ccCC-chHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence                    0000 00001122346789999999999999999999999999988766443

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=352.05  Aligned_cols=259  Identities=16%  Similarity=0.148  Sum_probs=203.9

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC---CCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---HPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..... ...+..||+|++....   ..++..|+++++.++   |+||+++++++...
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLND-AKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC--------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcc-cccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence            4679999999999999999996433211 1223359999997653   345667777777776   99999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhC---CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC----------
Q 014079          154 DHRLLVYEFMFRGSLENHLFRK---ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS----------  220 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~---~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~----------  220 (431)
                      +..|+||||+++|+|.+++...   ....+++..++.++.|++.||+|||+.+  ||||||||+||||+.          
T Consensus       140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~--ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE--IIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECGGGTCC-----
T ss_pred             CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC--eecCCCCHHHEEecccccCcccccc
Confidence            9999999999999999999752   3446899999999999999999999866  999999999999998          


Q ss_pred             -CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          221 -DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                       ++.+||+|||+++..............+||+.|+|||++.+..|+.++|||||||++|||++|+.||........    
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~----  293 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGEC----  293 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEE----
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCce----
Confidence             899999999999754333333344567899999999999999999999999999999999999999954321100    


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCC-CCHHHHHHHHhhhhhc
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKAR-PLMSDVVETLEPLQCA  363 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R-Pt~~eil~~L~~l~~~  363 (431)
                                 .+    ...+...   ...+.+.+++..||+.+|.+| |++.++.+.|+.+...
T Consensus       294 -----------~~----~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          294 -----------KP----EGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             -----------EE----CSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----------ee----chhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence                       00    0001000   124567789999999999999 5788888888876654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2e-45  Score=361.22  Aligned_cols=267  Identities=21%  Similarity=0.252  Sum_probs=207.0

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC--------CCceeee
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR--------HPNLVKL  146 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l  146 (431)
                      .+.++|++.+.||+|+||+||+|.+..++..      ||+|++.... .....+.+|+.+|+.++        |+||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~  106 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKF------VAMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQL  106 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeE------EEEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeee
Confidence            3457899999999999999999998776554      9999997542 34567889999999985        7889999


Q ss_pred             ecEEE----eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCC
Q 014079          147 IGYCC----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       147 ~~~~~----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~  221 (431)
                      ++++.    +....++||||+ +++|.+.+.......+++..++.++.||+.||.|||+. +  |+||||||+||||+.+
T Consensus       107 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g--ivHrDikp~NIll~~~  183 (397)
T 1wak_A          107 LDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVN  183 (397)
T ss_dssp             EEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECCCCSGGGEEECCC
T ss_pred             ecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHeeEecc
Confidence            99988    556889999999 77887777766556789999999999999999999986 6  9999999999999977


Q ss_pred             C-------------------------------------------------cEEEecccCCccCCCCCCcceeecccCCcc
Q 014079          222 Y-------------------------------------------------TAKLSDFGLAKAGPQGDETHVSTRVMGTYG  252 (431)
Q Consensus       222 ~-------------------------------------------------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~  252 (431)
                      +                                                 .+||+|||+++.....     .....||+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~  258 (397)
T 1wak_A          184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQ  258 (397)
T ss_dssp             HHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGG
T ss_pred             chhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCc
Confidence            5                                                 7999999999865332     233579999


Q ss_pred             ccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh---hhhhhh------------------ccch
Q 014079          253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW---ARPKLN------------------DKRK  311 (431)
Q Consensus       253 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~------------------~~~~  311 (431)
                      |+|||++.+..++.++|||||||++|||++|+.||..............   ......                  ....
T Consensus       259 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~  338 (397)
T 1wak_A          259 YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD  338 (397)
T ss_dssp             GCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred             ccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence            9999999999999999999999999999999999987554322110000   000000                  0000


Q ss_pred             hhhhcCcc---------ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPR---------LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~---------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...+.+..         -....+...+..+.+||.+||+.||++|||+.|+++|
T Consensus       339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00000000         0012356778899999999999999999999999975

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=8.6e-45  Score=366.50  Aligned_cols=256  Identities=27%  Similarity=0.343  Sum_probs=205.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||+||+|.+..++.      .||+|++.+..  ......+.+|+.+|++++||||+++++++.+
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   92 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED   92 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCC------EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCC------EEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc
Confidence            466789999999999999999999876554      39999986532  2345678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC---CCCcEEEecc
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD---SDYTAKLSDF  229 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~---~~~~~kl~DF  229 (431)
                      .+..|+||||+.+++|.+.+....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++   .++.+||+||
T Consensus        93 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           93 SSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeccCchHHEEEecCCCCCCEEEEEC
Confidence            999999999999999999887654  4889999999999999999999977  99999999999995   4567999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |+++......   .....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.........+.         
T Consensus       169 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---------  235 (486)
T 3mwu_A          169 GLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE---------  235 (486)
T ss_dssp             SCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred             CcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---------
Confidence            9998654322   2234679999999998875 59999999999999999999999997653211111000         


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                          . .............+.++.+||.+||+.||.+|||+.+++++-.
T Consensus       236 ----~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~  279 (486)
T 3mwu_A          236 ----T-GKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (486)
T ss_dssp             ----H-TCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHH
T ss_pred             ----h-CCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHh
Confidence                0 0000111112234578899999999999999999999998743

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=341.77  Aligned_cols=251  Identities=26%  Similarity=0.401  Sum_probs=184.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||+|++.....   .....+.+|+.++++++||||+++++++.+.
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGL------EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS   83 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCc------eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC
Confidence            3579999999999999999999866544      399999865432   2246788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+++++|.+++.... .++++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nili~~~~~~kl~dfg~~~  160 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKNRV-KPFSENEARHFMHQIITGMLYLHSHG--ILHRDLTLSNLLLTRNMNIKIADFGLAT  160 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHTCS-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECSSCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCcHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHEEEcCCCCEEEEeeccee
Confidence            99999999999999999997643 46899999999999999999999876  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........                
T Consensus       161 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~----------------  222 (278)
T 3cok_A          161 QLKMPHE--KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----------------  222 (278)
T ss_dssp             ECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------
T ss_pred             eccCCCC--cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHH----------------
Confidence            6543221  1223568999999999999999999999999999999999999997653221110                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+.....  ..+...+.++.+|+.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          223 KVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             -CCSSCC--CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHhhccc--CCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence            0000000  1122234678899999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2e-44  Score=347.13  Aligned_cols=274  Identities=27%  Similarity=0.400  Sum_probs=212.7

Q ss_pred             ccCHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhc--CCCCcee
Q 014079           67 AFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ--LRHPNLV  144 (431)
Q Consensus        67 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv  144 (431)
                      ..+......+.++|++.+.||+|+||.||+|.+.+  .      .||+|++...   ....+.+|++++..  ++||||+
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~--~------~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~   99 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWRG--E------EVAVKIFSSR---EERSWFREAEIYQTVMLRHENIL   99 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEETT--E------EEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBC
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEcC--c------cEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEE
Confidence            44566677888999999999999999999998742  2      4999998654   34567788888877  7899999


Q ss_pred             eeecEEEeCC----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhH--------hCCCCeeeccCC
Q 014079          145 KLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH--------NAERPVIYRDFK  212 (431)
Q Consensus       145 ~l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH--------~~~~~ivHrDlk  212 (431)
                      ++++++....    ..++||||+++++|.+++...   .+++..++.++.|++.||.|||        +.+  |+|||||
T Consensus       100 ~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~--ivH~Dlk  174 (342)
T 1b6c_B          100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA--IAHRDLK  174 (342)
T ss_dssp             CEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE--EECSCCS
T ss_pred             EEEeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC--eeeCCCC
Confidence            9999998876    789999999999999999764   4899999999999999999999        655  9999999


Q ss_pred             CCCEEECCCCcEEEecccCCccCCCCCCcc--eeecccCCccccCccccccC------CCCcchhhHHHHHHHHHHHhC-
Q 014079          213 TSNILLDSDYTAKLSDFGLAKAGPQGDETH--VSTRVMGTYGYAAPEYVMTG------HLTARSDVYSFGVVLLELLTG-  283 (431)
Q Consensus       213 p~NILl~~~~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g-  283 (431)
                      |+||||+.++.+||+|||++..........  ......||+.|+|||++.+.      .++.++|||||||++|||++| 
T Consensus       175 p~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~  254 (342)
T 1b6c_B          175 SKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRC  254 (342)
T ss_dssp             GGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             HHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhcc
Confidence            999999999999999999997644332211  12345799999999998765      234689999999999999999 


Q ss_pred             ---------CCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCc-ccHHHHHHHHHHHHHhhhcCCCCCCCHHHH
Q 014079          284 ---------RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ-YSVRAAQKACSLAYYCLSQNPKARPLMSDV  353 (431)
Q Consensus       284 ---------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~dP~~RPt~~ei  353 (431)
                               ..||........... .+..      ........+.+... ....+...+.+|+.+||+.||++|||+.+|
T Consensus       255 ~~~~~~~~~~~p~~~~~~~~~~~~-~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          255 SIGGIHEDYQLPYYDLVPSDPSVE-EMRK------VVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             CBTTBCCCCCCTTTTTSCSSCCHH-HHHH------HHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             CcCCcccccccCccccCcCcccHH-HHHH------HHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence                     677765433221100 0000      00001111222211 134667889999999999999999999999


Q ss_pred             HHHHhhhhhc
Q 014079          354 VETLEPLQCA  363 (431)
Q Consensus       354 l~~L~~l~~~  363 (431)
                      +++|+.+...
T Consensus       328 ~~~L~~i~~~  337 (342)
T 1b6c_B          328 KKTLSQLSQQ  337 (342)
T ss_dssp             HHHHHHHHHT
T ss_pred             HHHHHHHHHH
Confidence            9999988765

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=8.9e-45  Score=367.05  Aligned_cols=254  Identities=24%  Similarity=0.340  Sum_probs=200.7

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||+||+|.+..+...      ||+|++.+...  .....+.+|+.+|+.++||||+++++++.+
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~  107 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE------RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED  107 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCE------EEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcE------EEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe
Confidence            4567899999999999999999998766543      99999876532  234678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---CcEEEecc
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLSDF  229 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~~kl~DF  229 (431)
                      .+..|+||||+.+|+|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++..   +.+||+||
T Consensus       108 ~~~~~lv~e~~~~g~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  183 (494)
T 3lij_A          108 KRNYYLVMECYKGGELFDEIIHRM--KFNEVDAAVIIKQVLSGVTYLHKHN--IVHRDLKPENLLLESKEKDALIKIVDF  183 (494)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEECCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCChhhEEEeCCCCCCcEEEEEC
Confidence            999999999999999999887654  4788999999999999999999876  9999999999999764   55999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |+++......   .....+||+.|+|||++. +.|+.++|||||||++|+|++|..||...........+...       
T Consensus       184 G~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~-------  252 (494)
T 3lij_A          184 GLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKG-------  252 (494)
T ss_dssp             TTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-------
T ss_pred             CCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-------
Confidence            9998754322   223467999999999876 57999999999999999999999999765322111110000       


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                             ...+........+..+.+||.+||+.||.+|||+.+++++
T Consensus       253 -------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          253 -------KYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -------CCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -------CCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                   0001111112345788899999999999999999999976

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.3e-45  Score=362.64  Aligned_cols=202  Identities=25%  Similarity=0.342  Sum_probs=175.8

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC------CCCceeeeec
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL------RHPNLVKLIG  148 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~  148 (431)
                      .+..+|++.+.||+|+||.||+|.+..++..      ||||++.... .....+.+|+++++.+      .|+||+++++
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~------vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~  166 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQH------VALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLE  166 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEE------EEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcE------EEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEe
Confidence            3557899999999999999999998876554      9999997643 3345677788888776      5779999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--EEE
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--AKL  226 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--~kl  226 (431)
                      ++...+..++||||+ +++|.+++.......+++..++.++.||+.||+|||+.+  |+||||||+||||+.++.  +||
T Consensus       167 ~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NILl~~~~~~~vkL  243 (429)
T 3kvw_A          167 NFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR--IIHCDLKPENILLKQQGRSGIKV  243 (429)
T ss_dssp             EEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT--EECSCCSGGGEEESSTTSCCEEE
T ss_pred             ecccCCeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEccCCCcceEE
Confidence            999999999999999 579999998877667999999999999999999999876  999999999999999887  999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR  291 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  291 (431)
                      +|||++......     ....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       244 ~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          244 IDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999764322     223579999999999999999999999999999999999999997754

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.3e-45  Score=342.11  Aligned_cols=248  Identities=20%  Similarity=0.245  Sum_probs=199.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++....  ......+.+|+.++..+ +||||+++++++.+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~   82 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGC------IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE   82 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCc------eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence            56789999999999999999999876544      39999987642  23456788999999999 89999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCC--CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---------
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKA--TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---------  221 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~--~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---------  221 (431)
                      .+..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.+         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dikp~NIl~~~~~~~~~~~~~  160 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS--LVHMDIKPSNIFISRTSIPNAASEE  160 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEC-----------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeecCCCHHHEEEcCCCCCcccccc
Confidence            999999999999999999997642  245899999999999999999999976  9999999999999844         


Q ss_pred             ----------CcEEEecccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 014079          222 ----------YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKT  290 (431)
Q Consensus       222 ----------~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~  290 (431)
                                ..+||+|||++.......      ...||+.|+|||++.+. .++.++|||||||++|+|++|..++...
T Consensus       161 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~  234 (289)
T 1x8b_A          161 GDEDDWASNKVMFKIGDLGHVTRISSPQ------VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG  234 (289)
T ss_dssp             ---------CCCEEECCCTTCEETTCSC------CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred             cccccccCCceEEEEcccccccccCCcc------ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence                      479999999998754322      23599999999998866 6678999999999999999998776432


Q ss_pred             CCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ..     ..           .+.....+    ..+...+..+.+|+.+||+.||++|||+.+++++-
T Consensus       235 ~~-----~~-----------~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  281 (289)
T 1x8b_A          235 DQ-----WH-----------EIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHS  281 (289)
T ss_dssp             HH-----HH-----------HHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCT
T ss_pred             hH-----HH-----------HHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhCh
Confidence            10     00           00000111    11223346888999999999999999999999763

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=5.4e-45  Score=350.51  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=206.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|.+.+.||+|+||.||++.+..++..      ||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  113 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN  113 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            46789999999999999999999876554      99999876532   3456688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~Dfg~~~  189 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  189 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CeEEEEEecCCCCCHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CEecCCCchhEEEcCCCCEEEeeccCce
Confidence            99999999999999999987654  5889999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........                
T Consensus       190 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----------------  251 (335)
T 2owb_A          190 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL----------------  251 (335)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------
T ss_pred             ecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH----------------
Confidence            6543222  2234579999999999999999999999999999999999999997643211100                


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+....  ...+...+..+.+|+.+||+.||++|||+.+++++-
T Consensus       252 ~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~  293 (335)
T 2owb_A          252 RIKKNE--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  293 (335)
T ss_dssp             HHHHTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHhcCC--CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCc
Confidence            000000  011122346788999999999999999999999753

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=350.76  Aligned_cols=281  Identities=24%  Similarity=0.331  Sum_probs=211.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD--  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  154 (431)
                      .++|++.+.||+|+||.||+|.+....  ...+..||+|++........+.+.+|+.++++++||||+++++++...+  
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQ--DNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTS--SSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             HHHceeeeeeccCCCeEEEEEEecccc--CCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCC
Confidence            356889999999999999999853210  0112349999998766566678999999999999999999999987654  


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKR--YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             ceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            7899999999999999997653 35899999999999999999999876  99999999999999999999999999987


Q ss_pred             CCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ........ ......++..|+|||++.+..++.++||||||+++|||++|..||........ ...............+.
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  273 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM-RMIGNDKQGQMIVFHLI  273 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHH-HHHCTTCCTHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHH-HhhccccchhhhHHHHH
Confidence            65433221 12234578889999999999999999999999999999999998854210000 00000000000000111


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +.+........+..++.++.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       274 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          274 ELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            11111111122334567899999999999999999999999999988654

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.4e-45  Score=342.06  Aligned_cols=252  Identities=23%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  159 (431)
                      |....+||+|+||.||+|.+..++.      .||+|.+..........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   97 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQV------RIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIF   97 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCC------EEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCe------EEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEE
Confidence            4445589999999999999876654      3999998776555567789999999999999999999999999999999


Q ss_pred             EEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CCcEEEecccCCccCCC
Q 014079          160 YEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       160 ~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~~~kl~DFG~a~~~~~  237 (431)
                      |||+++++|.+++.... ...+++..+..++.|++.||.|||+.+  |+|+||||+|||++. ++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           98 MEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC--EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            99999999999997653 345678889999999999999999876  999999999999987 89999999999986543


Q ss_pred             CCCcceeecccCCccccCccccccCC--CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ...  ......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||.......... ..          .....
T Consensus       176 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~-~~----------~~~~~  242 (295)
T 2clq_A          176 INP--CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM-FK----------VGMFK  242 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH-HH----------HHHHC
T ss_pred             CCC--cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH-Hh----------hcccc
Confidence            221  223457999999999987654  8899999999999999999999996432211100 00          00000


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..    ...+...+.++.+|+.+||+.||++||++.+++++
T Consensus       243 ~~----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 VH----PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             CC----CCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             cc----ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11    12223345788899999999999999999999865

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=355.04  Aligned_cols=264  Identities=22%  Similarity=0.328  Sum_probs=197.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++....  ....+.+.+|+++|+.++||||+++++++...
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   96 (367)
T 1cm8_A           23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGA------KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   96 (367)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCC------EEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             ecceEEEeEEeeecCCeEEEEEEECCCCC------EEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecC
Confidence            35689999999999999999999876654      39999986542  23346788999999999999999999999876


Q ss_pred             C------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 D------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      .      .+|+||||+ +++|.+++...   .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~  170 (367)
T 1cm8_A           97 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  170 (367)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCcCHHHEEEcCCCCEEEE
Confidence            3      459999999 89999998763   4889999999999999999999977  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~  304 (431)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....  +
T Consensus       171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~  245 (367)
T 1cm8_A          171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  245 (367)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99999875332     234578999999999887 689999999999999999999999998654322111110000  0


Q ss_pred             ------hhhc--cchhhhhcC---ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 ------KLND--KRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ------~~~~--~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            .+..  .......+.   ...........+..+.+|+.+||+.||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                  0000  000000000   000011122345788999999999999999999999986

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=7.9e-45  Score=341.00  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=204.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+...      ||+|++.....   .....+.+|+.+++.++||||+++++++.+.+
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   87 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFI------MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRK   87 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcE------EEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCC
Confidence            5789999999999999999998776553      99999865422   22456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           88 RIYLMLEFAPRGELYKELQKHG--RFDEQRSATFMEELADALHYCHERK--VIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            9999999999999999997654  4789999999999999999999866  99999999999999999999999999876


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.........                ..
T Consensus       164 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~----------------~~  223 (284)
T 2vgo_A          164 APSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETH----------------RR  223 (284)
T ss_dssp             CSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             Ccccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHH----------------HH
Confidence            43321    23457999999999999999999999999999999999999999764321110                00


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      +....  ..++...+..+.++|.+||+.||.+||++.+++++-
T Consensus       224 ~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~  264 (284)
T 2vgo_A          224 IVNVD--LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP  264 (284)
T ss_dssp             HHTTC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCH
T ss_pred             Hhccc--cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCH
Confidence            11100  012223456788999999999999999999999763

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=350.45  Aligned_cols=278  Identities=24%  Similarity=0.355  Sum_probs=198.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHH--HhcCCCCceeeeecEEEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNF--LGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~~~---  152 (431)
                      ++|++.+.||+|+||.||+|.+.+        ..||+|++....   ...+..|.++  +..++||||+++++++..   
T Consensus        13 ~~y~~~~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~   81 (336)
T 3g2f_A           13 DNLKLLELIGRGRYGAVYKGSLDE--------RPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTA   81 (336)
T ss_dssp             TSEEEEEEEEECSSEEEEEEEETT--------EEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT
T ss_pred             HHhheeeecccCCCeEEEEEEECC--------eEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheeccccccc
Confidence            578999999999999999997642        249999987543   2334444444  556899999999986542   


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-------CCCeeeccCCCCCEEECCCCc
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-------ERPVIYRDFKTSNILLDSDYT  223 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------~~~ivHrDlkp~NILl~~~~~  223 (431)
                        ...+++||||+++|+|.+++....   .++..++.++.|++.||.|||+.       ..+|+||||||+||||+.++.
T Consensus        82 ~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~  158 (336)
T 3g2f_A           82 DGRMEYLLVMEYYPNGSLXKYLSLHT---SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT  158 (336)
T ss_dssp             TSCEEEEEEECCCTTCBHHHHHHHCC---BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC
T ss_pred             CCCceEEEEEecCCCCcHHHHHhhcc---cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc
Confidence              235789999999999999996643   48888899999999999999986       114999999999999999999


Q ss_pred             EEEecccCCccCCCCCC------cceeecccCCccccCcccccc-------CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 014079          224 AKLSDFGLAKAGPQGDE------THVSTRVMGTYGYAAPEYVMT-------GHLTARSDVYSFGVVLLELLTGRKSVDKT  290 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~pf~~~  290 (431)
                      +||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|..||...
T Consensus       159 ~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  238 (336)
T 3g2f_A          159 CVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPG  238 (336)
T ss_dssp             EEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred             EEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCc
Confidence            99999999986543211      112234579999999999876       45677899999999999999998776543


Q ss_pred             CCcccch-hhhhhhhhhhccchhhhh-----cCccccCc--ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          291 RPSKEQS-LVDWARPKLNDKRKMLQI-----IDPRLENQ--YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       291 ~~~~~~~-~~~~~~~~~~~~~~~~~~-----~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ....... ..............+...     ..+.+...  .....+..+.+||.+||+.||++|||+.|+++.|+.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~  318 (336)
T 3g2f_A          239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM  318 (336)
T ss_dssp             SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence            3322111 000000000000000000     01111111  123467789999999999999999999999999999886


Q ss_pred             cCCCCCC
Q 014079          363 ANDGGNE  369 (431)
Q Consensus       363 ~~~~~~~  369 (431)
                      .-...+.
T Consensus       319 ~~~~~~~  325 (336)
T 3g2f_A          319 IWERNKS  325 (336)
T ss_dssp             CCCC---
T ss_pred             HHHhccc
Confidence            6555433

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=352.77  Aligned_cols=268  Identities=23%  Similarity=0.330  Sum_probs=196.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhH-HHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++........ ..+.+|+.+|++++||||+++++++.+.+..
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   75 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNL------VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSL   75 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcE------EEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEE
Confidence            4789999999999999999998766543      99999875432211 2345799999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+. ++|.+++.... ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        76 ~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           76 TLVFEYLD-KDLKQYLDDCG-NIINMHNVKLFLFQLLRGLAYCHRQK--VLHRDLKPQNLLINERGELKLADFGLARAKS  151 (324)
T ss_dssp             EEEEECCS-EEHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred             EEEecccc-cCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence            99999996 69999887654 35889999999999999999999877  9999999999999999999999999997643


Q ss_pred             CCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--------hhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--------PKLN  307 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--------~~~~  307 (431)
                      ...  .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....        +...
T Consensus       152 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  229 (324)
T 3mtl_A          152 IPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL  229 (324)
T ss_dssp             -------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred             CCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhh
Confidence            322  12234578999999999876 578999999999999999999999998754322211111000        0000


Q ss_pred             ccchhhhhcCcccc----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLE----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ..........+...    .......+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  283 (324)
T 3mtl_A          230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP  283 (324)
T ss_dssp             GCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSG
T ss_pred             cchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcCh
Confidence            00000000000000    001123356788999999999999999999999863

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=352.82  Aligned_cols=274  Identities=18%  Similarity=0.236  Sum_probs=207.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCcee--ccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceee---------
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRV--GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK---------  145 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  145 (431)
                      .++|++.+.||+|+||.||+|.+..+...  ...+..||+|++...     ..+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            36899999999999999999998763110  012335999998765     35778999999999999988         


Q ss_pred             ------eecEEEe-CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE
Q 014079          146 ------LIGYCCE-DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL  218 (431)
Q Consensus       146 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl  218 (431)
                            +++++.. .+..++||||+ +++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE--YVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC--ccCCCCCHHHEEE
Confidence                  5667766 67889999999 999999998764456899999999999999999999976  9999999999999


Q ss_pred             CCCC--cEEEecccCCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 014079          219 DSDY--TAKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTR  291 (431)
Q Consensus       219 ~~~~--~~kl~DFG~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  291 (431)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  9999999999765432211     11233579999999999999999999999999999999999999997654


Q ss_pred             CcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          292 PSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                      ..... ..........   ....+.....   .....+.++.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       273 ~~~~~-~~~~~~~~~~---~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          273 PNTED-IMKQKQKFVD---KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TCHHH-HHHHHHHHHH---SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCHHH-HHHHHHhccC---Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            22111 1110000000   0000000000   001234788999999999999999999999999998876543

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.4e-44  Score=366.63  Aligned_cols=254  Identities=24%  Similarity=0.320  Sum_probs=203.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-------------hhHHHHHHHHHHHhcCCCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-------------QGHREWLTEVNFLGQLRHP  141 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~  141 (431)
                      .+.++|++.+.||+|+||+||+|.+..++..      ||+|++.+...             ...+.+.+|+.+|++++||
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~------~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  106 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSE------KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP  106 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCE------EEEEEEEC----------------CTHHHHHHHHHHHHTCCCT
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcE------EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCC
Confidence            4568899999999999999999998876543      99999876432             2346788999999999999


Q ss_pred             ceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       142 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      ||+++++++.+....|+||||+++|+|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       107 niv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~  182 (504)
T 3q5i_A          107 NIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH--KFDECDAANIMKQILSGICYLHKHN--IVHRDIKPENILLENK  182 (504)
T ss_dssp             TBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESST
T ss_pred             CCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eEeCCCcHHHEEEecC
Confidence            99999999999999999999999999999997654  4899999999999999999999976  9999999999999877


Q ss_pred             C---cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          222 Y---TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       222 ~---~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      +   .+||+|||++.......   ......||+.|+|||++. +.|+.++|||||||++|+|++|..||...........
T Consensus       183 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  258 (504)
T 3q5i_A          183 NSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKK  258 (504)
T ss_dssp             TCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            6   69999999998754332   223467999999999876 5699999999999999999999999976532211110


Q ss_pred             hhhhhhhhhccchhhhhcCccc--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          299 VDWARPKLNDKRKMLQIIDPRL--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                                      +.....  ........+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus       259 ----------------i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~  304 (504)
T 3q5i_A          259 ----------------VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRW  304 (504)
T ss_dssp             ----------------HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ----------------HHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHh
Confidence                            000000  00111224578899999999999999999999997643

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=6e-45  Score=367.57  Aligned_cols=255  Identities=25%  Similarity=0.349  Sum_probs=207.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++.+..   ......+.+|+.+|++++||||+++++++.+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   97 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQ------ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED   97 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCC------EEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence            56789999999999999999999876654      39999986543   2346778999999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE---CCCCcEEEecc
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDF  229 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl---~~~~~~kl~DF  229 (431)
                      .+..++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||+   +.++.+||+||
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~kl~Df  173 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIISRK--RFSEVDAARIIRQVLSGITYMHKNK--IVHRDLKPENLLLESKSKDANIRIIDF  173 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCS--CCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHHHEEEecCCCCCcEEEEee
Confidence            999999999999999999997654  5889999999999999999999976  9999999999999   56789999999


Q ss_pred             cCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          230 GLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       230 G~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      |+++.......   ....+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||...........+.         
T Consensus       174 g~a~~~~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---------  240 (484)
T 3nyv_A          174 GLSTHFEASKK---MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE---------  240 (484)
T ss_dssp             THHHHBCCCCS---HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---------
T ss_pred             eeeEEcccccc---cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH---------
Confidence            99976543322   234579999999998865 69999999999999999999999997653221111100         


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                          . .............+..+.+||.+||+.||.+|||+.++++|-.
T Consensus       241 ----~-~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~  284 (484)
T 3nyv_A          241 ----K-GKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEW  284 (484)
T ss_dssp             ----H-CCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHH
T ss_pred             ----c-CCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChh
Confidence                0 0000111112234578899999999999999999999998643

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.8e-45  Score=351.86  Aligned_cols=267  Identities=24%  Similarity=0.386  Sum_probs=200.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++......  ..+.+.+|+.++++++||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   98 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRI------VAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR   98 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCE------EEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCce------EEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence            5789999999999999999999876543      999988654322  24557899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+.+++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++..
T Consensus        99 ~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~qi~~~l~~LH~~~--ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~  174 (331)
T 4aaa_A           99 WYLVFEFVDHTILDDLELFPN--GLDYQVVQKYLFQIINGIGFCHSHN--IIHRDIKPENILVSQSGVVKLCDFGFARTL  174 (331)
T ss_dssp             EEEEEECCSEEHHHHHHHSTT--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCTTC---
T ss_pred             EEEEEecCCcchHHHHHhhcc--CCCHHHHHHHHHHHHHHHHHHHHCC--EEccCcChheEEEcCCCcEEEEeCCCceee
Confidence            999999999999988775443  4889999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh--------hh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP--------KL  306 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~--------~~  306 (431)
                      .....  ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.................        ..
T Consensus       175 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          175 AAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             -----------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHH
T ss_pred             cCCcc--ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHh
Confidence            43221  22345799999999998875 789999999999999999999999977543221111100000        00


Q ss_pred             hccchhhhhcCccccC-----cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQIIDPRLEN-----QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...........+.+..     ......+..+.+|+.+||+.||.+|||+.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0000000000111110     1112346789999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.7e-45  Score=344.17  Aligned_cols=264  Identities=28%  Similarity=0.378  Sum_probs=199.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+.....   +...||+|+++...   ....+.+.+|++++++++||||+++++++.+.
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCC---ceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3578999999999999999998653221   12248999987642   23456788999999999999999999999876


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      . .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++.
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dikp~Nili~~~~~~kl~Dfg~~~  169 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMR  169 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCC--cccCCCchheEEEcCCCCEEEccccccc
Confidence            5 899999999999999997643 35889999999999999999999976  9999999999999999999999999998


Q ss_pred             cCCCCCCcc-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          234 AGPQGDETH-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       234 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.........               
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~---------------  234 (291)
T 1u46_A          170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL---------------  234 (291)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---------------
T ss_pred             cccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHH---------------
Confidence            764433221 2223567889999999999899999999999999999999 99999765321111               


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                       ..+.........+...+..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       235 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          235 -HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             -HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             -HHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence             011111111112223457889999999999999999999999999877643

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.1e-44  Score=341.61  Aligned_cols=251  Identities=25%  Similarity=0.374  Sum_probs=206.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|.+.+.||+|+||.||+|.+..++..      ||+|++.....   ...+.+.+|+.+++.++||||+++++++.+.
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   87 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEV------FAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN   87 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCce------EEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC
Confidence            46789999999999999999999876554      99999866432   3446688999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~  163 (294)
T 2rku_A           88 DFVFVVLELCRRRSLLELHKRRK--ALTEPEARYYLRQIVLGCQYLHRNR--VIHRDLKLGNLFLNEDLEVKIGDFGLAT  163 (294)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             CEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEcCCCCEEEEeccCce
Confidence            99999999999999999887654  5889999999999999999999876  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........                .
T Consensus       164 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----------------~  225 (294)
T 2rku_A          164 KVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETY----------------L  225 (294)
T ss_dssp             ECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------H
T ss_pred             ecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH----------------H
Confidence            6543222  123457999999999999999999999999999999999999999764321110                0


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .+.....  ..+...+..+.+++.+||+.||++|||+.+++++-
T Consensus       226 ~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          226 RIKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             HHHTTCC--CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             HHhhccC--CCccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            0000000  11223346788999999999999999999999764

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=7.8e-45  Score=376.74  Aligned_cols=253  Identities=28%  Similarity=0.407  Sum_probs=199.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      +.||+|+||.||+|.+....    .+..||||+++....  ...+++.+|+++|++++|||||++++++. .+..++|||
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~----~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E  449 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKK----VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVME  449 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSS----CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEE
T ss_pred             CEeccCCCEEEEEEEEcCCC----cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEE
Confidence            47999999999999765321    112499999976532  33578999999999999999999999996 456899999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC-
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE-  240 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~-  240 (431)
                      |+++|+|.+++....  .+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++....... 
T Consensus       450 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~yLH~~~--iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          450 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             ccCCCCHHHHHhhCC--CCCHHHHHHHHHHHHHHHHHHHHCC--EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            999999999997654  5889999999999999999999976  99999999999999999999999999987544322 


Q ss_pred             cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          241 THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       241 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+......                 ...+...
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~-----------------~~~i~~~  588 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG  588 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence            122233457889999999999999999999999999999998 9999976532211                 1111111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .....+..++.++.+||.+||+.||++||++.+|++.|+.+..
T Consensus       589 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          589 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            1222333456789999999999999999999999999987653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.2e-44  Score=350.31  Aligned_cols=257  Identities=24%  Similarity=0.344  Sum_probs=206.0

Q ss_pred             HHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------hhHHHHHHHHHHHhcC-CCC
Q 014079           71 FELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------QGHREWLTEVNFLGQL-RHP  141 (431)
Q Consensus        71 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~  141 (431)
                      .....+.++|++.+.||+|+||.||+|.+..++.      .||||++.....        ...+.+.+|+.+++++ +||
T Consensus        87 ~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~------~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp  160 (365)
T 2y7j_A           87 AAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGH------EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP  160 (365)
T ss_dssp             HHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCT
T ss_pred             hhhhhhhhhcccceEEecCCCEEEEEEEECCCCc------EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            3456677889999999999999999999876544      399999865431        1134578899999999 799


Q ss_pred             ceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       142 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      ||+++++++...+..++||||+++++|.+++....  .+++..+..++.|++.||.|||+.+  |+||||||+|||++.+
T Consensus       161 ~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~g--i~H~Dlkp~NIl~~~~  236 (365)
T 2y7j_A          161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV--ALSEKETRSIMRSLLEAVSFLHANN--IVHRDLKPENILLDDN  236 (365)
T ss_dssp             TBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTT
T ss_pred             CEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEECCC
Confidence            99999999999999999999999999999997643  5889999999999999999999976  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCccc
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKE  295 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  295 (431)
                      +.+||+|||++........   .....||+.|+|||++.+      ..++.++|||||||++|+|++|+.||........
T Consensus       237 ~~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  313 (365)
T 2y7j_A          237 MQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILM  313 (365)
T ss_dssp             CCEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             CCEEEEecCcccccCCCcc---cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999987544322   234679999999998864      3588899999999999999999999976432111


Q ss_pred             chhhhhhhhhhhccchhhhhcCcccc--CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          296 QSLVDWARPKLNDKRKMLQIIDPRLE--NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...                +......  .......+..+.+|+.+||+.||++|||+.+++++
T Consensus       314 ~~~----------------i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          314 LRM----------------IMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             HHH----------------HHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHH----------------HHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000                0000000  00001234678899999999999999999999975

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.3e-44  Score=345.09  Aligned_cols=259  Identities=20%  Similarity=0.297  Sum_probs=200.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEe--CC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCE--DD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++...   ..+.+.+|+.+|++++ ||||+++++++.+  ..
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEK------VVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcE------EEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            6799999999999999999998766543      999998754   3467889999999997 9999999999988  67


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAK  233 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~  233 (431)
                      ..++||||+.+++|.+++..     +++..+..++.|++.||.|||+.+  |+||||||+|||++.++ .+||+|||+++
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~  179 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  179 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCC--eeeCCCCHHHEEEcCCCCEEEEEeCCCce
Confidence            78999999999999998843     788889999999999999999877  99999999999999776 89999999998


Q ss_pred             cCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh----hhh--
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR----PKL--  306 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~----~~~--  306 (431)
                      .......   .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +.....    +..  
T Consensus       180 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~  255 (330)
T 3nsz_A          180 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYD  255 (330)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHH
T ss_pred             EcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhh
Confidence            6543322   233579999999999887 67999999999999999999999999654332111 000000    000  


Q ss_pred             -------hccchhhhhcC--------ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 -------NDKRKMLQIID--------PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 -------~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                             ...........        ...........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          256 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                   00000000000        001111122246789999999999999999999999976

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2e-45  Score=359.33  Aligned_cols=243  Identities=16%  Similarity=0.173  Sum_probs=189.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEcccc---CchhHHHHHHHH---HHHhcCCCCceeeee---
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE---GLQGHREWLTEV---NFLGQLRHPNLVKLI---  147 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~---  147 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||||++...   .....+.+.+|+   ++|++++|||||+++   
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~  145 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRF  145 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCC------EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCB
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCc------EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhh
Confidence            4678899999999999999999866544      4999998743   223456788999   555566899999998   


Q ss_pred             ----cEEEeCC-----------------eeEEEEEecCCCChHHhhhhCCC-----CCcCHHHHHHHHHHHHHHHHHhHh
Q 014079          148 ----GYCCEDD-----------------HRLLVYEFMFRGSLENHLFRKAT-----VPLSWATRMMIAFGAAKGLAFLHN  201 (431)
Q Consensus       148 ----~~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~-----~~~~~~~~~~i~~~i~~~l~~LH~  201 (431)
                          +++.+.+                 ..|+||||+ +|+|.+++.....     ..+++..++.++.|++.||+|||+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~  224 (377)
T 3byv_A          146 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH  224 (377)
T ss_dssp             CCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence                6665553                 278999999 7899999976422     224467888899999999999999


Q ss_pred             CCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccC-----------CCCcchhh
Q 014079          202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-----------HLTARSDV  270 (431)
Q Consensus       202 ~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di  270 (431)
                      .+  |+||||||+||||+.++.+||+|||+++....     ......| +.|+|||++.+.           .++.++||
T Consensus       225 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          225 YG--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             TT--EECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             CC--eecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            77  99999999999999999999999999986322     2344678 999999999887           89999999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 014079          271 YSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       271 wslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~  350 (431)
                      |||||++|||++|+.||..........                .+...      ....+.++.+|+.+||+.||++|||+
T Consensus       297 wSlG~il~elltg~~Pf~~~~~~~~~~----------------~~~~~------~~~~~~~~~~li~~~L~~dp~~Rpt~  354 (377)
T 3byv_A          297 WALGLVIYWIWCADLPITKDAALGGSE----------------WIFRS------CKNIPQPVRALLEGFLRYPKEDRLLP  354 (377)
T ss_dssp             HHHHHHHHHHHHSSCCC------CCSG----------------GGGSS------CCCCCHHHHHHHHHHTCSSGGGCCCH
T ss_pred             HHHHHHHHHHHHCCCCCcccccccchh----------------hhhhh------ccCCCHHHHHHHHHHcCCCchhCCCH
Confidence            999999999999999997643222111                00000      01224678899999999999999999


Q ss_pred             HHHHHH
Q 014079          351 SDVVET  356 (431)
Q Consensus       351 ~eil~~  356 (431)
                      .+++++
T Consensus       355 ~e~l~h  360 (377)
T 3byv_A          355 LQAMET  360 (377)
T ss_dssp             HHHHTS
T ss_pred             HHHhhC
Confidence            999974

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=7.3e-45  Score=379.43  Aligned_cols=250  Identities=26%  Similarity=0.381  Sum_probs=206.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      .++|++.++||+|+||.||+|.+..+++.      ||||++++...   .....+..|..+|..+ +||||+++++++.+
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~------vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~  413 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDEL------YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT  413 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCE------EEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcE------EEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe
Confidence            35799999999999999999999876554      99999876422   2345678899999988 69999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+.+||||||++||+|.+++....  .+++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||++
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~g--IiHrDLKp~NILl~~~g~ikL~DFGla  489 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQVG--RFKEPHAVFYAAEIAIGLFFLQSKG--IIYRDLKLDNVMLDSEGHIKIADFGMC  489 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTS--EECCCCCSTTEEECSSSCEEECCCTTC
T ss_pred             CCEEEEEEeCcCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--eEeccCChhhEEEcCCCcEEEeeccee
Confidence            999999999999999999997754  4889999999999999999999976  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +.......  .....+||+.|+|||++.+..|+.++|||||||+||||++|+.||........                .
T Consensus       490 ~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~----------------~  551 (674)
T 3pfq_A          490 KENIWDGV--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL----------------F  551 (674)
T ss_dssp             EECCCTTC--CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----------------H
T ss_pred             eccccCCc--ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHH----------------H
Confidence            86432222  23457899999999999999999999999999999999999999976432111                1


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCH-----HHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLM-----SDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~-----~eil~~  356 (431)
                      ..++...+  .++...+.++.+||.+||+.||.+||++     .+|++|
T Consensus       552 ~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          552 QSIMEHNV--AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHSSCC--CCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHhCCC--CCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            11111111  1233455788999999999999999997     777765

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.9e-45  Score=342.87  Aligned_cols=258  Identities=21%  Similarity=0.306  Sum_probs=203.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      .++|++.+.||+|+||.||+|.+..+++.      ||+|++.....  ...+.+.+|+.++++++||||+++++++.+  
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   78 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRT   78 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGG
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcE------EEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCC
Confidence            46789999999999999999998766543      99999876532  344668899999999999999999998854  


Q ss_pred             CCeeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCC---CCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAE---RPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      ....++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.+   .+|+||||||+|||++.++.+||+
T Consensus        79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~  158 (279)
T 2w5a_A           79 NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLG  158 (279)
T ss_dssp             GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEEC
T ss_pred             CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEe
Confidence            57889999999999999999753  2345899999999999999999999854   239999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++.......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||........   ..       
T Consensus       159 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~-------  226 (279)
T 2w5a_A          159 DFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG-------  226 (279)
T ss_dssp             CCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HH-------
T ss_pred             cCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHH---HH-------
Confidence            9999876543221  12235689999999999999999999999999999999999999976532110   00       


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP  359 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~  359 (431)
                         .+....    ....+...+.++.+++.+||+.||.+||++.+|++++..
T Consensus       227 ---~i~~~~----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          227 ---KIREGK----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             ---HHHHTC----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             ---HHhhcc----cccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence               000000    011222345788999999999999999999999988753

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-45  Score=351.23  Aligned_cols=274  Identities=25%  Similarity=0.301  Sum_probs=198.4

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-----HHHHHHHHHHHhcCCCCceeeee
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-----HREWLTEVNFLGQLRHPNLVKLI  147 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~  147 (431)
                      +....++|++.+.||+|+||.||+|.+..++.      .||+|++.......     ...+.+|+.++++++||||++++
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   78 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQ------IVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLL   78 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCS------EEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCc------EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEE
Confidence            34456789999999999999999999876544      39999987543221     23578999999999999999999


Q ss_pred             cEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          148 GYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       148 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      +++.+.+..++||||+++ +|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        79 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~kl~  154 (346)
T 1ua2_A           79 DAFGHKSNISLVFDFMET-DLEVIIKDNS-LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLA  154 (346)
T ss_dssp             EEECCTTCCEEEEECCSE-EHHHHHTTCC-SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEEeeCCceEEEEEcCCC-CHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCC--EECCCCCHHHEEEcCCCCEEEE
Confidence            999999999999999965 8988886543 35788888999999999999999977  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RP  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~  304 (431)
                      |||+++.......  ......||+.|+|||++.+. .++.++|||||||++|||++|..||...........+...  .+
T Consensus       155 Dfg~a~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~  232 (346)
T 1ua2_A          155 DFGLAKSFGSPNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP  232 (346)
T ss_dssp             CCGGGSTTTSCCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             ecccceeccCCcc--cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999987543221  23346799999999998764 5899999999999999999999999765432211110000  00


Q ss_pred             hh---hccchhhhhcCcccc-----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          305 KL---NDKRKMLQIIDPRLE-----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       305 ~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ..   .......+.+.....     .......+.++.+||.+||+.||.+|||+.|++++-.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~  294 (346)
T 1ua2_A          233 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY  294 (346)
T ss_dssp             CTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGG
T ss_pred             ChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChh
Confidence            00   000000000000000     0011234578999999999999999999999998743

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.5e-44  Score=342.23  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=206.6

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .+.|++.+.||+|+||.||+|.+..++.      .||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   94 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQK------VVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK   94 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCC------EEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCc------EEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCe
Confidence            3568899999999999999999876554      399999876532 345778899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++..   .++++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++...
T Consensus        95 ~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           95 LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEK--KIHRDIKAANVLLSEHGEVKLADFGVAGQL  169 (303)
T ss_dssp             EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChheEEECCCCCEEEeecccceec
Confidence            9999999999999999854   35899999999999999999999976  999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........             +...
T Consensus       170 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~  234 (303)
T 3a7i_A          170 TDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL-------------IPKN  234 (303)
T ss_dssp             BTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHHS
T ss_pred             Ccccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH-------------hhcC
Confidence            43221  12345799999999999999999999999999999999999999976432111100             0000


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ..+.+    ....+..+.+|+.+||+.||.+|||+.+++++..
T Consensus       235 ~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          235 NPPTL----EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             CCCCC----CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHH
T ss_pred             CCCCC----ccccCHHHHHHHHHHcCCChhhCcCHHHHhhChh
Confidence            11111    1223467889999999999999999999998754

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.5e-44  Score=345.50  Aligned_cols=256  Identities=25%  Similarity=0.364  Sum_probs=199.1

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------hhHHHHHHHHHHHhcCCCCceee
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------QGHREWLTEVNFLGQLRHPNLVK  145 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~  145 (431)
                      ..+.++|++.+.||+|+||.||+|.+..++..      ||+|++.....        .....+.+|+.+|++++||||++
T Consensus         6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~   79 (322)
T 2ycf_A            6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKK------VAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK   79 (322)
T ss_dssp             HHHHHHEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECC---------------CHHHHHHHHHHCCCTTBCC
T ss_pred             hhhhhceeEeeEEecCCCEEEEEEEEcCCCcE------EEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCce
Confidence            34667899999999999999999999876554      99999875432        12234789999999999999999


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc--
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT--  223 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~--  223 (431)
                      +++++...+ .++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.  
T Consensus        80 ~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~~  154 (322)
T 2ycf_A           80 IKNFFDAED-YYIVLELMEGGELFDKVVGNK--RLKEATCKLYFYQMLLAVQYLHENG--IIHRDLKPENVLLSSQEEDC  154 (322)
T ss_dssp             EEEEEESSS-EEEEEECCTTEETHHHHSTTC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSSSC
T ss_pred             EeeEEcCCc-eEEEEecCCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCCHHHEEEecCCCCC
Confidence            999987654 899999999999999986543  5889999999999999999999876  999999999999987654  


Q ss_pred             -EEEecccCCccCCCCCCcceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhh
Q 014079          224 -AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       224 -~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~  299 (431)
                       +||+|||+++......   ......||+.|+|||++.   ...++.++|||||||++|+|++|..||.........  .
T Consensus       155 ~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~  229 (322)
T 2ycf_A          155 LIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL--K  229 (322)
T ss_dssp             CEEECCCTTCEECCCCH---HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCH--H
T ss_pred             eEEEccCccceeccccc---ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHH--H
Confidence             9999999998754321   223356999999999874   467899999999999999999999999765432211  0


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...    .      .. ............+..+.+|+.+||+.||.+||++.+++++
T Consensus       230 ~~~----~------~~-~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          230 DQI----T------SG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             HHH----H------HT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHH----H------hC-ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            000    0      00 0000001112235688999999999999999999999965

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=346.56  Aligned_cols=255  Identities=27%  Similarity=0.390  Sum_probs=198.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEe-
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCE-  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  152 (431)
                      ...++|++.+.||+|+||.||+|.+..++.      .||+|++.... .....+.+|+.+++++ +||||+++++++.. 
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   93 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQ------LAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK   93 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCC------eEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence            346789999999999999999999876544      39999987543 2346788999999999 79999999999987 


Q ss_pred             -----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 -----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           .+..++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+
T Consensus        94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--ivH~dlkp~NIl~~~~~~~kl~  171 (326)
T 2x7f_A           94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK--VIHRDIKGQNVLLTENAEVKLV  171 (326)
T ss_dssp             C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEEC
T ss_pred             cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCcHHHEEEcCCCCEEEe
Confidence                 468899999999999999998765557899999999999999999999976  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      |||++........  ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||...........    
T Consensus       172 Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----  245 (326)
T 2x7f_A          172 DFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----  245 (326)
T ss_dssp             CCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----
T ss_pred             eCcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----
Confidence            9999876533211  123357999999999987     56789999999999999999999999975432111100    


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                               +.....+.+   .....+..+.+||.+||..||.+||++.+++++
T Consensus       246 ---------~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          246 ---------IPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ---------HHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---------hhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                     000000111   111234678899999999999999999999975

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.8e-44  Score=348.71  Aligned_cols=265  Identities=23%  Similarity=0.274  Sum_probs=194.8

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++....  ......+.+|+.+++.++||||+++++++...+
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   97 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQK   97 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCce------EEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccc
Confidence            46899999999999999999998776553      9999987542  234466889999999999999999999998765


Q ss_pred             ------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          155 ------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       155 ------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                            ..|+||||+. ++|.+++..    .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        98 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~--ivH~Dlkp~NIl~~~~~~~kl~D  170 (371)
T 2xrw_A           98 SLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  170 (371)
T ss_dssp             STTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCC--eecccCCHHHEEEcCCCCEEEEE
Confidence                  7899999995 578888842    4788999999999999999999976  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh----hh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA----RP  304 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~----~~  304 (431)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+...    .+
T Consensus       171 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  247 (371)
T 2xrw_A          171 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP  247 (371)
T ss_dssp             CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCH
T ss_pred             eeccccccccc---ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99998643221   223467999999999999999999999999999999999999999765432111000000    00


Q ss_pred             h----h--------hc-----cchhhhhcCcc---ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 K----L--------ND-----KRKMLQIIDPR---LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~----~--------~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .    +        ..     ...+.......   .........+..+.+|+.+||+.||.+|||+.|++++-
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence            0    0        00     00000000000   01112234477899999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=341.49  Aligned_cols=255  Identities=25%  Similarity=0.368  Sum_probs=200.9

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ...++|++.+.||+|+||.||+|.+..++.      .||+|++....  ....+.+|+.+++.++||||+++++++.+.+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   97 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQ------IVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNT   97 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCC------EEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETT
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCC------EEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCC
Confidence            345789999999999999999999876554      39999987653  3467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+.+++|.+++.... ..+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++..
T Consensus        98 ~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  174 (314)
T 3com_A           98 DLWIVMEYCGAGSVSDIIRLRN-KTLTEDEIATILQSTLKGLEYLHFMR--KIHRDIKAGNILLNTEGHAKLADFGVAGQ  174 (314)
T ss_dssp             EEEEEEECCTTEEHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEEeecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--CcCCCcCHHHEEECCCCCEEEeecccchh
Confidence            9999999999999999986432 35899999999999999999999877  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........             +..
T Consensus       175 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~  239 (314)
T 3com_A          175 LTDTMA--KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-------------IPT  239 (314)
T ss_dssp             CBTTBS--CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH-------------HHH
T ss_pred             hhhhcc--ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH-------------Hhc
Confidence            533211  22345799999999999999999999999999999999999999976432111000             000


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...+.+  ..+...+..+.+|+.+||+.||.+|||+.+++++-
T Consensus       240 ~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~  280 (314)
T 3com_A          240 NPPPTF--RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHP  280 (314)
T ss_dssp             SCCCCC--SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSH
T ss_pred             CCCccc--CCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence            000000  11222346788999999999999999999998753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-44  Score=340.30  Aligned_cols=254  Identities=22%  Similarity=0.273  Sum_probs=188.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hH-HHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GH-REWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+..+++.      ||+|++...... .. ..+.++...++.++||||+++++++.+.+
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~   79 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQI------MAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG   79 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeE------EEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccC
Confidence            46799999999999999999998766554      999998765322 22 23445555688899999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          155 HRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      ..++||||++ ++|.+++..  .....+++..++.++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||+
T Consensus        80 ~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T 3fme_A           80 DVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGI  156 (290)
T ss_dssp             SEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC--CCCCCCSGGGCEECTTCCEEBCCC--
T ss_pred             CEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC--eecCCCCHHHEEECCCCCEEEeecCC
Confidence            9999999996 588887754  2345689999999999999999999985 6  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYV----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      +........   .....||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........           
T Consensus       157 ~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-----------  222 (290)
T 3fme_A          157 SGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ-----------  222 (290)
T ss_dssp             ----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH-----------
T ss_pred             ccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH-----------
Confidence            976543221   2234699999999996    5667899999999999999999999999754321110           


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                          +...+............+.++.+|+.+||+.||++|||+.+++++-
T Consensus       223 ----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp  268 (290)
T 3fme_A          223 ----LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHP  268 (290)
T ss_dssp             ----HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             ----HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCc
Confidence                1111111111111123456789999999999999999999999853

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.1e-44  Score=351.43  Aligned_cols=208  Identities=25%  Similarity=0.299  Sum_probs=177.1

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CC-----ceee
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HP-----NLVK  145 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~  145 (431)
                      ..+.+.++|++.+.||+|+||+||+|.+..++..      ||+|+++... .....+..|+.+++.++ |+     +|++
T Consensus        48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~  120 (382)
T 2vx3_A           48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEW------VAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVH  120 (382)
T ss_dssp             TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred             cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcE------EEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence            3445568899999999999999999998876554      9999997542 33456778888888875 44     4999


Q ss_pred             eecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC--CCCc
Q 014079          146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYT  223 (431)
Q Consensus       146 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~--~~~~  223 (431)
                      +++++...+..++||||+. ++|.+++.......+++..+..++.|++.||.|||++..+|+||||||+||||+  .++.
T Consensus       121 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~  199 (382)
T 2vx3_A          121 LKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA  199 (382)
T ss_dssp             EEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred             eeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence            9999999999999999994 699999987765678999999999999999999997556699999999999994  4788


Q ss_pred             EEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCC
Q 014079          224 AKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRP  292 (431)
Q Consensus       224 ~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  292 (431)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       200 ~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          200 IKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             EEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             EEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999875332     2245799999999999999999999999999999999999999987543

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.8e-44  Score=349.50  Aligned_cols=269  Identities=24%  Similarity=0.304  Sum_probs=203.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeC--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCED--  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--  153 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++..... .....+.+|+++|++++||||+++++++...  
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~   99 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI   99 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSST
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeE------EEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCc
Confidence            46899999999999999999998776554      99999875432 3346788999999999999999999999765  


Q ss_pred             ---CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          154 ---DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       154 ---~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                         ...++||||+. ++|.+++...   .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||
T Consensus       100 ~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIl~~~~~~~kl~Dfg  173 (364)
T 3qyz_A          100 EQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG  173 (364)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             cccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCChHhEEECCCCCEEEEeCc
Confidence               36899999995 6999988653   4889999999999999999999976  9999999999999999999999999


Q ss_pred             CCccCCCCCCc-ceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          231 LAKAGPQGDET-HVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       231 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      +++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.........
T Consensus       174 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  253 (364)
T 3qyz_A          174 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  253 (364)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCH
T ss_pred             ceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99865432211 11234579999999998765 45899999999999999999999999876543322111100000000


Q ss_pred             -----------cchhhhhcCccc--cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          309 -----------KRKMLQIIDPRL--ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       309 -----------~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                                 ............  ........+.++.+|+.+||+.||.+|||+.|++++-
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  315 (364)
T 3qyz_A          254 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHP  315 (364)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred             HHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence                       000000000000  0011122356789999999999999999999999764

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=6e-44  Score=342.88  Aligned_cols=266  Identities=21%  Similarity=0.301  Sum_probs=205.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEc-CCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC------ceeeeec
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP------NLVKLIG  148 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~  148 (431)
                      +.++|++.+.||+|+||.||+|.+. .++.      .||+|+++... .....+.+|+.+++.++|+      +|+++++
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~   84 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGR------HVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLE   84 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTE------EEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEE
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCc------EEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeec
Confidence            4578999999999999999999883 3333      49999987542 3446678899999888655      5999999


Q ss_pred             EEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC--------
Q 014079          149 YCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--------  220 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~--------  220 (431)
                      ++.+.+..++||||+ +++|.+++......++++..++.++.|++.||+|||+.+  |+||||||+|||++.        
T Consensus        85 ~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlkp~Nil~~~~~~~~~~~  161 (339)
T 1z57_A           85 WFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK--LTHTDLKPENILFVQSDYTEAYN  161 (339)
T ss_dssp             EEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESCCCEEEEEC
T ss_pred             ccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCHHHEEEeccccccccC
Confidence            999999999999999 999999998877667899999999999999999999976  999999999999987        


Q ss_pred             -----------CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          221 -----------DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       221 -----------~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                                 ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||..
T Consensus       162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence                       668999999999864332     2245799999999999999999999999999999999999999976


Q ss_pred             CCCcccchhhhhhhhhhhcc-------------------------chhhhhcCccc-cCcccHHHHHHHHHHHHHhhhcC
Q 014079          290 TRPSKEQSLVDWARPKLNDK-------------------------RKMLQIIDPRL-ENQYSVRAAQKACSLAYYCLSQN  343 (431)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~d  343 (431)
                      .........+..........                         ........+.. ........+.++.+|+.+||+.|
T Consensus       237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d  316 (339)
T 1z57_A          237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD  316 (339)
T ss_dssp             SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence            54322111111100000000                         00000000000 00112345688999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 014079          344 PKARPLMSDVVET  356 (431)
Q Consensus       344 P~~RPt~~eil~~  356 (431)
                      |.+|||+.|++++
T Consensus       317 P~~Rpt~~ell~h  329 (339)
T 1z57_A          317 PAKRITLREALKH  329 (339)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             cccccCHHHHhcC
Confidence            9999999999976

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-44  Score=354.67  Aligned_cols=267  Identities=21%  Similarity=0.279  Sum_probs=197.2

Q ss_pred             HHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           74 ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        74 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +...++|++.+.||+|+||.||+|.+..++..      ||+|++.....    ...+|+.+|+.++||||++++++|...
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~------vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~   72 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKR------FALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTT   72 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCE------EEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCE------EEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeec
Confidence            45668899999999999999999998776553      99998865432    123699999999999999999998543


Q ss_pred             --------------------------------------CeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHH
Q 014079          154 --------------------------------------DHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAA  193 (431)
Q Consensus       154 --------------------------------------~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~  193 (431)
                                                            ..+++||||++ ++|.+.+..  .....+++..+..++.|++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~  151 (383)
T 3eb0_A           73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLF  151 (383)
T ss_dssp             -------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHH
T ss_pred             CcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHH
Confidence                                                  34889999996 588877754  3345689999999999999


Q ss_pred             HHHHHhHhCCCCeeeccCCCCCEEEC-CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhH
Q 014079          194 KGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVY  271 (431)
Q Consensus       194 ~~l~~LH~~~~~ivHrDlkp~NILl~-~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diw  271 (431)
                      .||.|||+.+  |+||||||+|||++ .++.+||+|||+++.......   .....||+.|+|||++.+. .++.++|||
T Consensus       152 ~aL~~LH~~g--i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  226 (383)
T 3eb0_A          152 RAVGFIHSLG--ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLW  226 (383)
T ss_dssp             HHHHHHHTTT--EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHHHHHCc--CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhh
Confidence            9999999866  99999999999997 688999999999986543322   2345789999999998765 599999999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhhhhccc---------hhhhhcCccccCcccHHHHHHHHHHHHHhh
Q 014079          272 SFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDKR---------KMLQIIDPRLENQYSVRAAQKACSLAYYCL  340 (431)
Q Consensus       272 slG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl  340 (431)
                      ||||++|||++|+.||.+.........+...  .+......         .........+...++...+.++.+|+.+||
T Consensus       227 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  306 (383)
T 3eb0_A          227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL  306 (383)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred             hHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence            9999999999999999875432211111000  00000000         000000011111122334577899999999


Q ss_pred             hcCCCCCCCHHHHHHH
Q 014079          341 SQNPKARPLMSDVVET  356 (431)
Q Consensus       341 ~~dP~~RPt~~eil~~  356 (431)
                      +.||.+|||+.|+++|
T Consensus       307 ~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          307 RYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CSSGGGSCCHHHHHTS
T ss_pred             cCChhhCCCHHHHhcC
Confidence            9999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=9.7e-45  Score=353.66  Aligned_cols=254  Identities=13%  Similarity=0.047  Sum_probs=182.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHH---HHHhcCCCCceeeee----
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEV---NFLGQLRHPNLVKLI----  147 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~----  147 (431)
                      ..|++.+.||+|+||.||+|.+..++.      .||+|++.....   .....+.+|+   .+|+. +||||++++    
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~  134 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLE------DFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLL  134 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTE------EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBC
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCc------eeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEE
Confidence            458889999999999999999876655      399999987643   2334566774   55555 799988755    


Q ss_pred             ---cEEEeC-----------------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHH------HHHHHHHHHHHHHhHh
Q 014079          148 ---GYCCED-----------------DHRLLVYEFMFRGSLENHLFRKATVPLSWATR------MMIAFGAAKGLAFLHN  201 (431)
Q Consensus       148 ---~~~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~------~~i~~~i~~~l~~LH~  201 (431)
                         +++...                 ..+|+||||++ ++|.+++..... .+.+..+      +.++.|++.||+|||+
T Consensus       135 ~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~  212 (371)
T 3q60_A          135 LPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQS  212 (371)
T ss_dssp             CCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             eeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHH
Confidence               454433                 33799999997 899999976422 2344445      6777999999999998


Q ss_pred             CCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHH
Q 014079          202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLE  279 (431)
Q Consensus       202 ~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~e  279 (431)
                      .+  |+||||||+||||+.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++|||||||++||
T Consensus       213 ~~--ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~e  285 (371)
T 3q60_A          213 KG--LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYR  285 (371)
T ss_dssp             TT--EEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHH
T ss_pred             CC--CccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHH
Confidence            77  99999999999999999999999999986432     1224567799999999987  789999999999999999


Q ss_pred             HHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          280 LLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       280 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      |++|+.||....+........         ..........+........+..+.+||.+||+.||++|||+.+++++
T Consensus       286 lltg~~Pf~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          286 VWCLFLPFGLVTPGIKGSWKR---------PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             HHHSSCSTTBCCTTCTTCCCB---------CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             HHhCCCCCCCcCcccccchhh---------hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            999999998764322111000         00000011111111112345788999999999999999999999864

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-44  Score=342.78  Aligned_cols=264  Identities=26%  Similarity=0.385  Sum_probs=187.1

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..++|++.+.||+|+||.||+|.+..++.      .||+|++..... ....++.+|+.++++++||||+++++++...+
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   86 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKE------KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKD   86 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----C------EEEEECCC----------------CCCCCCCTTBCCEEEEEESSS
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCc------EEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecC
Confidence            35789999999999999999998765443      399999876432 33456889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhh------CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          155 HRLLVYEFMFRGSLENHLFR------KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~------~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ..++||||+++++|.+++..      .....+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~kl~d  164 (303)
T 2vwi_A           87 ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG--QIHRDVKAGNILLGEDGSVQIAD  164 (303)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTCCEEECC
T ss_pred             CcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCCCCChhhEEEcCCCCEEEEe
Confidence            99999999999999999864      12345899999999999999999999876  99999999999999999999999


Q ss_pred             ccCCccCCCCCC---cceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          229 FGLAKAGPQGDE---THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       229 FG~a~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      ||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||..............   
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---  241 (303)
T 2vwi_A          165 FGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ---  241 (303)
T ss_dssp             CHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT---
T ss_pred             ccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc---
Confidence            999876543221   112234579999999999876 5789999999999999999999999977543221111000   


Q ss_pred             hhhccchhh-hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          305 KLNDKRKML-QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       305 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ....... ...+...    ....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       242 --~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          242 --NDPPSLETGVQDKEM----LKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             --SSCCCTTC-----CC----CCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             --cCCCccccccccchh----hhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              0000000 0001111    11234678899999999999999999999975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=9.2e-45  Score=343.41  Aligned_cols=255  Identities=23%  Similarity=0.374  Sum_probs=199.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ..++|++.+.||+|+||.||+|.+..++.      .||+|++..........+.+|+.+++.++||||+++++++.+.+.
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   90 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGA------LAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK   90 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCC------EEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-C
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCc------EEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCe
Confidence            45789999999999999999999986554      399999887666667789999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           91 LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKR--IIHRDLKAGNVLMTLEGDIRLADFGVSAKN  167 (302)
T ss_dssp             EEEEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred             EEEEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCC--cccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence            999999999999999886643 35899999999999999999999876  999999999999999999999999987531


Q ss_pred             CCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      ...  ........||+.|+|||++.     +..++.++||||||+++|+|++|+.||..........  .          
T Consensus       168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~----------  233 (302)
T 2j7t_A          168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL--K----------  233 (302)
T ss_dssp             HHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH--H----------
T ss_pred             ccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH--H----------
Confidence            110  01122356899999999884     6678999999999999999999999997643211100  0          


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       +.....+.  ...+...+..+.+|+.+||+.||.+|||+.+++++
T Consensus       234 -~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          234 -IAKSDPPT--LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -HHHSCCCC--CSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -HhccCCcc--cCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             00000000  01122335678899999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=351.86  Aligned_cols=259  Identities=27%  Similarity=0.355  Sum_probs=201.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcC-CCCceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQL-RHPNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  152 (431)
                      ++|++.+.||+|+||.||+|.+..+..   .+..||+|++++...    .....+.+|+.+|+++ +||||+++++++.+
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHD---TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTT---TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCC---CCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            579999999999999999999843111   123499999875432    2334566899999999 69999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus       131 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~--ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          131 ETKLHLILDYINGGELFTHLSQRE--RFTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CceEEEEeecCCCCCHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999999997654  4889999999999999999999876  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      +....... ......+||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+.  ..      
T Consensus       207 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~------  277 (355)
T 1vzo_A          207 KEFVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RR------  277 (355)
T ss_dssp             EECCGGGG-GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HH------
T ss_pred             eecccCCC-CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHH--HH------
Confidence            86533221 12234679999999999986  357899999999999999999999997543322111110  00      


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHHHh
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVETLE  358 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~L~  358 (431)
                       +.. ..+    .++...+..+.+||.+||+.||.+||     ++.+++++..
T Consensus       278 -~~~-~~~----~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~  324 (355)
T 1vzo_A          278 -ILK-SEP----PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF  324 (355)
T ss_dssp             -HHH-CCC----CCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred             -Hhc-cCC----CCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcc
Confidence             000 011    12233456788999999999999999     9999998764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-44  Score=346.81  Aligned_cols=270  Identities=22%  Similarity=0.298  Sum_probs=201.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  152 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++.....  .....+.+|+.+|+.++||||+++++++..   
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   90 (351)
T 3mi9_A           17 SKYEKLAKIGQGTFGEVFKARHRKTGQ------KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   90 (351)
T ss_dssp             GGEEEEEECSSCSTTSEEEEEETTTCC------EEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--
T ss_pred             cceeEEEEEecCCCcEEEEEEECCCCC------EEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccc
Confidence            679999999999999999999876554      399998865432  224567899999999999999999999987   


Q ss_pred             -----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 -----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           .+..++||||+. ++|.+.+.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--ivH~Dlkp~NIl~~~~~~~kl~  166 (351)
T 3mi9_A           91 PYNRCKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLA  166 (351)
T ss_dssp             ------CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEEC
T ss_pred             ccccCCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeCCCCCHHHEEEcCCCCEEEc
Confidence                 456899999996 57777775543 35899999999999999999999976  9999999999999999999999


Q ss_pred             cccCCccCCCCCC--cceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          228 DFGLAKAGPQGDE--THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       228 DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      |||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       167 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  246 (351)
T 3mi9_A          167 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  246 (351)
T ss_dssp             CCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             cchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            9999986543221  122234678999999998876 4689999999999999999999999987543222111111000


Q ss_pred             hhh-----cc--chhhhhcC--ccccCcccHH-----HHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 KLN-----DK--RKMLQIID--PRLENQYSVR-----AAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~~~-----~~--~~~~~~~~--~~~~~~~~~~-----~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...     ..  ......+.  ..........     .+..+.+||.+||+.||++|||+.|++++-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp  313 (351)
T 3mi9_A          247 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  313 (351)
T ss_dssp             CCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCC
Confidence            000     00  00000000  0000001111     145688999999999999999999999874

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.4e-44  Score=334.34  Aligned_cols=249  Identities=24%  Similarity=0.334  Sum_probs=195.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .++|++.+.||+|+||.||+|.+..++.      .||+|++.....   .....+.+|+.+++.++||||+++++++.+.
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   83 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGH------KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP   83 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCc------eEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            3679999999999999999999875544      399999865422   2345788999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+||+|||++.
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~~l~dfg~~~  159 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICKHG--RVEEMEARRLFQQILSAVDYCHRHM--VVHRDLKPENVLLDAHMNAKIADFGLSN  159 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHC--SSCCCCCGGGEEECTTSCEEECCCCGGG
T ss_pred             CeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCChhhEEECCCCCEEEeeccccc
Confidence            99999999999999999997654  4788999999999999999999877  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........   ...          +
T Consensus       160 ~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~---~~~----------~  223 (276)
T 2h6d_A          160 MMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTL---FKK----------I  223 (276)
T ss_dssp             CCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH---HHH----------H
T ss_pred             ccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHH---HHH----------h
Confidence            754332   1233568999999999988765 6899999999999999999999975421110   000          0


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ... ..    ..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus       224 ~~~-~~----~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          224 RGG-VF----YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHC-CC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             hcC-cc----cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            000 00    1112234678899999999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-43  Score=335.21  Aligned_cols=255  Identities=24%  Similarity=0.325  Sum_probs=204.2

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---------hhHHHHHHHHHHHhcCC-CCcee
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---------QGHREWLTEVNFLGQLR-HPNLV  144 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv  144 (431)
                      .+.++|++.+.||+|+||.||+|.+..++..      ||+|++.....         ...+.+.+|+.+++++. ||||+
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~   87 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII   87 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBC
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCce------EEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEe
Confidence            3457899999999999999999999876553      99999865431         12356789999999996 99999


Q ss_pred             eeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          145 KLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       145 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      ++++++.+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+|+||||+|||++.++.+
T Consensus        88 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dl~p~Nil~~~~~~~  163 (298)
T 1phk_A           88 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNI  163 (298)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCE
T ss_pred             eeeeeeccCCeEEEEEeccCCCcHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCcceEEEcCCCcE
Confidence            99999999999999999999999999997653  5889999999999999999999877  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccc------cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM------TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      ||+|||++........   .....||+.|+|||++.      ...++.++||||||+++|+|++|+.||...........
T Consensus       164 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  240 (298)
T 1phk_A          164 KLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM  240 (298)
T ss_dssp             EECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEecccchhhcCCCcc---cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH
Confidence            9999999987543322   23457999999999885      45688999999999999999999999976432111000


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +.             .. ............+..+.+|+.+||+.||.+|||+.+++++
T Consensus       241 ~~-------------~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          241 IM-------------SG-NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HH-------------HT-CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             Hh-------------cC-CcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            00             00 0001111112345788999999999999999999999875

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-44  Score=351.96  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=186.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++....  ......+.+|+.+|+.++||||+++++++...
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~  100 (367)
T 2fst_X           27 VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA  100 (367)
T ss_dssp             EETTEEEEEECC----CCEEEEEETTTTEE------EEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCceEEeeEEeecCCeEEEEEEECCCCCE------EEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC
Confidence            347899999999999999999998776554      9999987642  23456788999999999999999999998754


Q ss_pred             ------CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 ------DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                            ...|+|+|++ +++|.+++..   ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus       101 ~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g--ivH~Dlkp~NIll~~~~~~kL~  174 (367)
T 2fst_X          101 RSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKIL  174 (367)
T ss_dssp             SSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEEC
T ss_pred             CccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--eeeCCCCHhhEEECCCCCEEEe
Confidence                  5679999999 8999998855   35899999999999999999999977  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~  304 (431)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.........+....  +
T Consensus       175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p  249 (367)
T 2fst_X          175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP  249 (367)
T ss_dssp             C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred             ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            99999864322     234579999999999887 689999999999999999999999997754322111110000  0


Q ss_pred             h------hhc--cchhhhhcCccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 K------LND--KRKMLQIIDPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~------~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .      +..  .......+.......   .....+..+.+||.+||+.||.+|||+.+++++-
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp  313 (367)
T 2fst_X          250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHA  313 (367)
T ss_dssp             CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcCh
Confidence            0      000  000000000000000   0112346789999999999999999999999863

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.3e-44  Score=349.69  Aligned_cols=274  Identities=23%  Similarity=0.304  Sum_probs=199.1

Q ss_pred             CHHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-----------hhHHHHHHHHHHHhc
Q 014079           69 SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-----------QGHREWLTEVNFLGQ  137 (431)
Q Consensus        69 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~E~~~l~~  137 (431)
                      ...++..+.++|++.+.||+|+||.||+|.+..+.       .||+|++.....           ...+.+.+|+.++++
T Consensus        13 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   85 (362)
T 3pg1_A           13 LIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGI-------PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNH   85 (362)
T ss_dssp             HHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSC-------EEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhccceEEeEEeccCCCEEEEEEECCCCC-------eEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHh
Confidence            35577888999999999999999999999886543       389998855321           123678899999999


Q ss_pred             CCCCceeeeecEEEeC-----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCC
Q 014079          138 LRHPNLVKLIGYCCED-----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFK  212 (431)
Q Consensus       138 l~h~niv~l~~~~~~~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlk  212 (431)
                      ++||||+++++++...     ...|+||||+. ++|.+++... ...+++..++.++.|++.||.|||+.+  |+|||||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~--ivH~Dlk  161 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAG--VVHRDLH  161 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCC
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc--CEecCCC
Confidence            9999999999998543     36799999996 6888888654 346899999999999999999999976  9999999


Q ss_pred             CCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Q 014079          213 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTR  291 (431)
Q Consensus       213 p~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  291 (431)
                      |+|||++.++.+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus       162 p~NIl~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  238 (362)
T 3pg1_A          162 PGNILLADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST  238 (362)
T ss_dssp             GGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             hHHEEEcCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999997533222   2234579999999999877 679999999999999999999999998654


Q ss_pred             Ccccchhhhhh--hhhhhc-----cchhhhhcCcc-------ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          292 PSKEQSLVDWA--RPKLND-----KRKMLQIIDPR-------LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       292 ~~~~~~~~~~~--~~~~~~-----~~~~~~~~~~~-------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+...  .+....     .......+...       .........+..+.+|+.+||+.||.+|||+.|++++
T Consensus       239 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          239 FYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            22211111000  000000     00000000000       0001122335678999999999999999999999976

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=3.9e-44  Score=346.05  Aligned_cols=266  Identities=19%  Similarity=0.254  Sum_probs=204.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-----------------HHHHHHHHHHHhcCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-----------------HREWLTEVNFLGQLR  139 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~  139 (431)
                      .++|++.+.||+|+||.||+|.+ . +.      .||+|++.......                 ...+.+|+.++++++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~-~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  101 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-D-NK------FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK  101 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-T-TE------EEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-C-Cc------eEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence            46899999999999999999998 3 22      49999986542211                 177889999999999


Q ss_pred             CCceeeeecEEEeCCeeEEEEEecCCCChHHh------hhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCC
Q 014079          140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENH------LFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFK  212 (431)
Q Consensus       140 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlk  212 (431)
                      ||||+++++++.+.+..++||||+++++|.++      +.......+++..++.++.|++.||.|||+ .+  |+|||||
T Consensus       102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~--i~H~dl~  179 (348)
T 2pml_X          102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVK  179 (348)
T ss_dssp             CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC--EECCCCC
T ss_pred             CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC--EeecCCC
Confidence            99999999999999999999999999999999      655445679999999999999999999998 66  9999999


Q ss_pred             CCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccC-CCCc-chhhHHHHHHHHHHHhCCCCCCCC
Q 014079          213 TSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTA-RSDVYSFGVVLLELLTGRKSVDKT  290 (431)
Q Consensus       213 p~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~pf~~~  290 (431)
                      |+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|||++|+.||...
T Consensus       180 p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          180 PSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             hHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999865332    23446799999999999877 6766 999999999999999999999865


Q ss_pred             CCcccc-hhhhhhhhhhhcc-chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          291 RPSKEQ-SLVDWARPKLNDK-RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       291 ~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...... ..+.......... ...................+..+.+|+.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          256 ISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             SCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            442111 0000000000000 00000000000000113345788999999999999999999999975

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=3.7e-44  Score=372.98  Aligned_cols=262  Identities=24%  Similarity=0.366  Sum_probs=206.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ..++|++.+.||+|+||.||+|.+......   ...||+|.+..... ...+.+.+|+.+|++++||||+++++++. .+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~---~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENP---AMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSC---CEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCc---cEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            346799999999999999999998654321   23499999876432 33467899999999999999999999985 56


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRK-FSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTT-TTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccccchHhEEEeCCCCEEEEecCCCee
Confidence            7899999999999999997643 45899999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ....... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+......   ...          +.
T Consensus       541 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~---~~~----------i~  606 (656)
T 2j0j_A          541 MEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV---IGR----------IE  606 (656)
T ss_dssp             CCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHH----------HH
T ss_pred             cCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHH---HHH----------HH
Confidence            6443221 2223457889999999999999999999999999999997 9999976432111   100          00


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .    ......+..++..+.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       607 ~----~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          607 N----GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             H----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c----CCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence            0    00111223345788999999999999999999999999998754

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.8e-44  Score=355.96  Aligned_cols=263  Identities=24%  Similarity=0.317  Sum_probs=194.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC----
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED----  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----  153 (431)
                      .+|++.++||+|+||.||+|.+..++.      .||||++.....    .+.+|+++|+.++|||||+++++|...    
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~------~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGE------LVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCc------EEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            468899999999999999999976554      399998865421    234699999999999999999998642    


Q ss_pred             --CeeEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEEec
Q 014079          154 --DHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSD  228 (431)
Q Consensus       154 --~~~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl~D  228 (431)
                        ..+++||||+++ +|.+.+..  .....+++..++.++.||+.||.|||+.+  |+||||||+||||+.+ +.+||+|
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~NILl~~~~~~~kl~D  200 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCD  200 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC--ccccCCChhhEEEeCCCCeEEecc
Confidence              236799999964 67666543  23456899999999999999999999866  9999999999999965 6789999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+...... .
T Consensus       201 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~-p  276 (420)
T 1j1b_A          201 FGSAKQLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT-P  276 (420)
T ss_dssp             CTTCEECCTTCC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS-C
T ss_pred             chhhhhcccCCC---ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-C
Confidence            999987543322   2345789999999998765 7999999999999999999999999875432211111000000 0


Q ss_pred             ccchhhhh-------cCccc-----cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQI-------IDPRL-----ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~-------~~~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ....+..+       .-+.+     ...+....+.++.+||.+||+.||.+|||+.|+++|-
T Consensus       277 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp  338 (420)
T 1j1b_A          277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHS  338 (420)
T ss_dssp             CHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             CHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCH
Confidence            00000000       00000     0011223457899999999999999999999999763

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=6.4e-44  Score=339.63  Aligned_cols=255  Identities=22%  Similarity=0.330  Sum_probs=196.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCC--CCceeeeecEEE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLR--HPNLVKLIGYCC  151 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  151 (431)
                      ..++|++.+.||+|+||.||++.+.++.       .||+|++.....  .....+.+|+.++++++  |+||+++++++.
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~-------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~   98 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNEKKQ-------IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI   98 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECTTCC-------EEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcCCCc-------EEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence            3467999999999999999999876532       399999865432  34567889999999997  599999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      +.+..++||| +.+++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||+++ +.+||+|||+
T Consensus        99 ~~~~~~lv~e-~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~dlkp~NIl~~~-~~~kL~Dfg~  172 (313)
T 3cek_A           99 TDQYIYMVME-CGNIDLNSWLKKKK--SIDPWERKSYWKNMLEAVHTIHQHG--IVHSDLKPANFLIVD-GMLKLIDFGI  172 (313)
T ss_dssp             CSSEEEEEEC-CCSEEHHHHHHHCS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEEET-TEEEECCCSS
T ss_pred             cCCEEEEEEe-cCCCcHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceecCCCcccEEEEC-CeEEEeeccc
Confidence            9999999999 55899999997754  5788899999999999999999876  999999999999964 8999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccccc-----------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMT-----------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      +................||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......      
T Consensus       173 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~------  246 (313)
T 3cek_A          173 ANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI------  246 (313)
T ss_dssp             SCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH------
T ss_pred             cccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH------
Confidence            987544333223334579999999999875           478899999999999999999999997543211      


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                               ..+...+++.....++...+.++.+|+.+||+.||.+||++.+++++-.
T Consensus       247 ---------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~  295 (313)
T 3cek_A          247 ---------SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  295 (313)
T ss_dssp             ---------HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---------HHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCcc
Confidence                     0111122222222222223467889999999999999999999997643

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=9.4e-44  Score=350.74  Aligned_cols=274  Identities=22%  Similarity=0.327  Sum_probs=185.4

Q ss_pred             HhcCCCc-cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           76 ITKSFRS-DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        76 ~~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      +.+.|.+ .++||+|+||.||+|.+.++.    .+..||+|++......  ..+.+|+.+|++++||||+++++++..  
T Consensus        18 ~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~----~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~   91 (405)
T 3rgf_A           18 VEDLFEYEGCKVGRGTYGHVYKAKRKDGK----DDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHA   91 (405)
T ss_dssp             HHHHEECSSCCCC-----EEEEEEESSSS----CCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETT
T ss_pred             hhhhhhhcCcEeeecCCeEEEEEEEccCC----CCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCC
Confidence            4456766 457999999999999976421    1224999999765432  467899999999999999999999964  


Q ss_pred             CCeeEEEEEecCCCChHHhhhhC-------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE----CCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRK-------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL----DSD  221 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl----~~~  221 (431)
                      ....++||||+. ++|.+++...       ....+++..++.++.||+.||.|||+.+  |+||||||+||||    +.+
T Consensus        92 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~--ivH~Dlkp~NIll~~~~~~~  168 (405)
T 3rgf_A           92 DRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW--VLHRDLKPANILVMGEGPER  168 (405)
T ss_dssp             TTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECCSSTTT
T ss_pred             CCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--EeCCCcCHHHeEEecCCCCC
Confidence            678999999995 6888877531       2235899999999999999999999977  9999999999999    677


Q ss_pred             CcEEEecccCCccCCCCCCc-ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc---
Q 014079          222 YTAKLSDFGLAKAGPQGDET-HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ---  296 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~---  296 (431)
                      +.+||+|||+++........ ......+||+.|+|||++.+. .++.++|||||||++|||++|+.||.........   
T Consensus       169 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~  248 (405)
T 3rgf_A          169 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNP  248 (405)
T ss_dssp             TCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CC
T ss_pred             CcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccccccccc
Confidence            99999999999875432211 223346799999999999874 5999999999999999999999999765432100   


Q ss_pred             ---hhhhhh-----hhh------h---hccchhhhhcCc-cccCc--------ccHHHHHHHHHHHHHhhhcCCCCCCCH
Q 014079          297 ---SLVDWA-----RPK------L---NDKRKMLQIIDP-RLENQ--------YSVRAAQKACSLAYYCLSQNPKARPLM  350 (431)
Q Consensus       297 ---~~~~~~-----~~~------~---~~~~~~~~~~~~-~~~~~--------~~~~~~~~~~~li~~cl~~dP~~RPt~  350 (431)
                         ..+...     .+.      +   .....+...+.. .....        .....+..+.+||.+||+.||.+|||+
T Consensus       249 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta  328 (405)
T 3rgf_A          249 YHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS  328 (405)
T ss_dssp             CCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCH
T ss_pred             chHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCH
Confidence               000000     000      0   000000000000 00000        000114578899999999999999999


Q ss_pred             HHHHHHHh
Q 014079          351 SDVVETLE  358 (431)
Q Consensus       351 ~eil~~L~  358 (431)
                      .|+++|-.
T Consensus       329 ~e~L~hp~  336 (405)
T 3rgf_A          329 EQAMQDPY  336 (405)
T ss_dssp             HHHHTSGG
T ss_pred             HHHhcChh
Confidence            99998754

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.3e-44  Score=341.21  Aligned_cols=269  Identities=23%  Similarity=0.341  Sum_probs=196.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEE----
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCC----  151 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----  151 (431)
                      +.++|++.+.||+|+||.||+|.+..+++.      ||+|++........+.+.+|++++++++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   82 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKR------VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS   82 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEE------EEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeE------EEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence            357899999999999999999999876553      9999987766566678899999999999999999999873    


Q ss_pred             ----------eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-C
Q 014079          152 ----------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-S  220 (431)
Q Consensus       152 ----------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-~  220 (431)
                                +....++||||+. ++|.+++..   .++++..++.++.|++.||+|||+.+  |+||||||+|||++ .
T Consensus        83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~  156 (320)
T 2i6l_A           83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSAN--VLHRDLKPANLFINTE  156 (320)
T ss_dssp             BCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETT
T ss_pred             ccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCC--EecCCCCHHHEEEcCC
Confidence                      4467899999996 699999854   35888999999999999999999876  99999999999997 5


Q ss_pred             CCcEEEecccCCccCCCCCC-cceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          221 DYTAKLSDFGLAKAGPQGDE-THVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      ++.+||+|||+++....... ........+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........
T Consensus       157 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  236 (320)
T 2i6l_A          157 DLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQL  236 (320)
T ss_dssp             TTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             CCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            67999999999987543211 112233568999999998875 6799999999999999999999999987543221111


Q ss_pred             hhhhhhhhhc--cchhhh--------hcC-ccc-cCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          299 VDWARPKLND--KRKMLQ--------IID-PRL-ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       299 ~~~~~~~~~~--~~~~~~--------~~~-~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +....+....  ...+..        ... +.. ........+.++.+|+.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          237 ILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             HHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            1100000000  000000        000 000 001112345789999999999999999999999975

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.2e-44  Score=346.97  Aligned_cols=264  Identities=19%  Similarity=0.240  Sum_probs=202.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-----------CCceee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-----------HPNLVK  145 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~  145 (431)
                      .++|++.+.||+|+||.||+|.+..++..      ||+|++.... .....+.+|+.++++++           |+||++
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~   90 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTH------VAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILK   90 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCC
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcE------EEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHH
Confidence            35799999999999999999998766553      9999997543 33456788999999886           899999


Q ss_pred             eecEEEeCC----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEEC-
Q 014079          146 LIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLD-  219 (431)
Q Consensus       146 l~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~-  219 (431)
                      +++++...+    ..++||||+ +++|.+++.......+++..++.++.|++.||.|||+. +  |+||||||+||||+ 
T Consensus        91 ~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~--ivH~Dikp~NIll~~  167 (373)
T 1q8y_A           91 LLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEI  167 (373)
T ss_dssp             CCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEE
T ss_pred             HHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC--EEecCCChHHeEEec
Confidence            999998654    789999999 99999999876666789999999999999999999986 6  99999999999994 


Q ss_pred             -----CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcc
Q 014079          220 -----SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSK  294 (431)
Q Consensus       220 -----~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~  294 (431)
                           ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.......
T Consensus       168 ~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  242 (373)
T 1q8y_A          168 VDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS  242 (373)
T ss_dssp             EETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence                 4458999999999865332     223579999999999999999999999999999999999999998654321


Q ss_pred             cc---hhhhhhhhhhh------------------ccch-----------hhhhcCccccCcccHHHHHHHHHHHHHhhhc
Q 014079          295 EQ---SLVDWARPKLN------------------DKRK-----------MLQIIDPRLENQYSVRAAQKACSLAYYCLSQ  342 (431)
Q Consensus       295 ~~---~~~~~~~~~~~------------------~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  342 (431)
                      ..   .........+.                  ....           +...+..  ...++...+.++.+||.+||+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~  320 (373)
T 1q8y_A          243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTE--KYKFSKDEAKEISDFLSPMLQL  320 (373)
T ss_dssp             --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHH--TTCCCHHHHHHHHHHHGGGGCS
T ss_pred             cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhh--cccCCcchHHHHHHHHHHHhcc
Confidence            11   00000000000                  0000           0000000  1124567788999999999999


Q ss_pred             CCCCCCCHHHHHHHH
Q 014079          343 NPKARPLMSDVVETL  357 (431)
Q Consensus       343 dP~~RPt~~eil~~L  357 (431)
                      ||.+|||+.|++++-
T Consensus       321 dP~~Rpt~~ell~hp  335 (373)
T 1q8y_A          321 DPRKRADAGGLVNHP  335 (373)
T ss_dssp             STTTCBCHHHHHTCG
T ss_pred             CccccCCHHHHhhCh
Confidence            999999999999864

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=344.13  Aligned_cols=259  Identities=22%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|++.+.||+|+||.||+|.+...         +++|++.....  ...+.+.+|+.++++++||||+++++++.+.+
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~~---------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  102 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHGE---------VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP  102 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESSS---------EEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcCe---------EEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence            46789999999999999999987642         89998865422  22345678999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++ ++.+||+|||+++.
T Consensus       103 ~~~iv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~--i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~  178 (319)
T 2y4i_B          103 HLAIITSLCKGRTLYSVVRDAK-IVLDVNKTRQIAQEIVKGMGYLHAKG--ILHKDLKSKNVFYD-NGKVVITDFGLFSI  178 (319)
T ss_dssp             CEEEECBCCCSEEHHHHTTSSC-CCCCSHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred             ceEEEeecccCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence            9999999999999999996643 35888999999999999999999976  99999999999998 67999999999875


Q ss_pred             CCCCC---CcceeecccCCccccCcccccc---------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh
Q 014079          235 GPQGD---ETHVSTRVMGTYGYAAPEYVMT---------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA  302 (431)
Q Consensus       235 ~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  302 (431)
                      .....   .........||+.|+|||++.+         ..++.++|||||||++|||++|+.||...........    
T Consensus       179 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----  254 (319)
T 2y4i_B          179 SGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ----  254 (319)
T ss_dssp             ---------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHH----
T ss_pred             cccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----
Confidence            43211   1112223568999999999864         4578999999999999999999999976432111100    


Q ss_pred             hhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          303 RPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                               +.....+.+.   ....+.++.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       255 ---------~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          255 ---------MGTGMKPNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ---------HHTTCCCCCC---CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ---------hccCCCCCCC---cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                     0000111110   1123356889999999999999999999999999887654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.3e-43  Score=333.43  Aligned_cols=256  Identities=21%  Similarity=0.348  Sum_probs=194.5

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe---
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  152 (431)
                      +.++|++.+.||+|+||.||+|.+..++.      .||+|++.... .....+.+|+.++++++||||+++++++.+   
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   76 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSR------YYAIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRN   76 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCC
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCe------EEEEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcc
Confidence            56789999999999999999999876554      39999986532 345678899999999999999999998865   


Q ss_pred             ----------CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          153 ----------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       153 ----------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                                .+..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.+  |+||||||+|||++.++
T Consensus        77 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dlkp~Nil~~~~~  153 (303)
T 1zy4_A           77 FVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSEN-LNQQRDEYWRLFRQILEALSYIHSQG--IIHRDLKPMNIFIDESR  153 (303)
T ss_dssp             CCC------CEEEEEEEEECCCSCBHHHHHHHSC-GGGCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTS
T ss_pred             hhhhhcccccCCceEEEEecCCCCCHHHhhhccc-cccchHHHHHHHHHHHHHHHHHHhCC--eecccCCHHhEEEcCCC
Confidence                      456799999999999999997643 35788889999999999999999976  99999999999999999


Q ss_pred             cEEEecccCCccCCCCCC------------cceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          223 TAKLSDFGLAKAGPQGDE------------THVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                      .+||+|||++........            ........||+.|+|||++.+. .++.++|||||||++|+|++   ||..
T Consensus       154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~  230 (303)
T 1zy4_A          154 NVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST  230 (303)
T ss_dssp             CEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             CEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence            999999999986542210            1122345799999999998764 78999999999999999998   5532


Q ss_pred             CCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          290 TRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ...  ......          .+ ......+...+....+..+.+++.+||+.||.+|||+.+++++-
T Consensus       231 ~~~--~~~~~~----------~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~  285 (303)
T 1zy4_A          231 GME--RVNILK----------KL-RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG  285 (303)
T ss_dssp             HHH--HHHHHH----------HH-HSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred             chh--HHHHHH----------hc-cccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence            100  000000          00 00111222233344556788999999999999999999999763

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=7.1e-44  Score=344.92  Aligned_cols=270  Identities=23%  Similarity=0.301  Sum_probs=201.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeC-
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCED-  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-  153 (431)
                      +.++|++.+.||+|+||.||+|.+..++..      ||+|++..... .....+.+|+.++++++||||+++++++... 
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   82 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEI------VAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDS   82 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcE------EEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccc
Confidence            457899999999999999999998866553      99999875432 3345688999999999999999999988764 


Q ss_pred             ----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecc
Q 014079          154 ----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDF  229 (431)
Q Consensus       154 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DF  229 (431)
                          ...++||||+. ++|.+++...   .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+||
T Consensus        83 ~~~~~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~~--ivH~Dlkp~Nil~~~~~~~kl~Df  156 (353)
T 2b9h_A           83 FENFNEVYIIQELMQ-TDLHRVISTQ---MLSDDHIQYFIYQTLRAVKVLHGSN--VIHRDLKPSNLLINSNCDLKVCDF  156 (353)
T ss_dssp             STTCCCEEEEECCCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCC
T ss_pred             cCccceEEEEEeccC-ccHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHHCC--eecCCCCHHHeEEcCCCcEEEEec
Confidence                67899999995 6999988663   4889999999999999999999876  999999999999999999999999


Q ss_pred             cCCccCCCCCCcc--------eeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          230 GLAKAGPQGDETH--------VSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       230 G~a~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      |+++.........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus       157 g~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~  236 (353)
T 2b9h_A          157 GLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF  236 (353)
T ss_dssp             TTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             ccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence            9998654322111        1223578999999998765 678999999999999999999999998654221111000


Q ss_pred             hhhhhhh--------ccchhhhhcC---c---cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          301 WARPKLN--------DKRKMLQIID---P---RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       301 ~~~~~~~--------~~~~~~~~~~---~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .......        ......+.+.   .   ..........+.++.+|+.+||+.||.+|||+.+++++-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  307 (353)
T 2b9h_A          237 GIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHP  307 (353)
T ss_dssp             HHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred             HHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCc
Confidence            0000000        0000000000   0   000011123457889999999999999999999999863

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-43  Score=338.82  Aligned_cols=269  Identities=25%  Similarity=0.330  Sum_probs=201.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEc-CCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcC---CCCceeeeecE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQL---RHPNLVKLIGY  149 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~  149 (431)
                      ..++|++.+.||+|+||.||+|.+. .++.      .||+|++......  ....+.+|+.+++.+   +||||++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   82 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGR------FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDV   82 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTE------EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCE------EEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeee
Confidence            3578999999999999999999985 3333      3899988653221  122455677776666   89999999999


Q ss_pred             EE-----eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcE
Q 014079          150 CC-----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       150 ~~-----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~  224 (431)
                      +.     .....++||||+. ++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g--i~H~dlkp~Nili~~~~~~  159 (326)
T 1blx_A           83 CTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQI  159 (326)
T ss_dssp             EEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCE
T ss_pred             eeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCHHHeEEcCCCCE
Confidence            87     5567899999996 69999998776666899999999999999999999976  9999999999999999999


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--  302 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--  302 (431)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...  
T Consensus       160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~  236 (326)
T 1blx_A          160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG  236 (326)
T ss_dssp             EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            999999998653221   223467999999999999999999999999999999999999999865432211111000  


Q ss_pred             hhhhhcc-------chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          303 RPKLNDK-------RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       303 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+.....       ..............+....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0000000       00000000000111222345788899999999999999999999965

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.1e-43  Score=340.22  Aligned_cols=267  Identities=19%  Similarity=0.277  Sum_probs=204.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc------eeeeecE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN------LVKLIGY  149 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~  149 (431)
                      +.++|++.+.||+|+||.||+|.+.....     ..||+|+++... .....+.+|+.+++.++|++      ++.++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~   90 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGK-----SQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDW   90 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTT-----EEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEE
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCc-----eEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeee
Confidence            45789999999999999999999865431     249999997542 34456778999999987655      9999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEE-----------
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILL-----------  218 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl-----------  218 (431)
                      +...+..++||||+ +++|.+++......++++..++.++.|++.||.|||+.+  |+||||||+|||+           
T Consensus        91 ~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~--ivH~Dlkp~NIll~~~~~~~~~~~  167 (355)
T 2eu9_A           91 FNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ--LTHTDLKPENILFVNSEFETLYNE  167 (355)
T ss_dssp             EEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEESCCCEEEEECC
T ss_pred             eeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEEEecccccccccc
Confidence            99999999999999 788888887766567899999999999999999999866  9999999999999           


Q ss_pred             --------CCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Q 014079          219 --------DSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKT  290 (431)
Q Consensus       219 --------~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  290 (431)
                              +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (355)
T 2eu9_A          168 HKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTH  242 (355)
T ss_dssp             C-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    56789999999999864332     23357999999999999999999999999999999999999999865


Q ss_pred             CCcccchhhhhhhhhhhc-----c--------------------chhhhhcCc-cccCcccHHHHHHHHHHHHHhhhcCC
Q 014079          291 RPSKEQSLVDWARPKLND-----K--------------------RKMLQIIDP-RLENQYSVRAAQKACSLAYYCLSQNP  344 (431)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~-----~--------------------~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP  344 (431)
                      ........+.........     .                    ........+ ..........+..+.+|+.+||+.||
T Consensus       243 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  322 (355)
T 2eu9_A          243 ENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDP  322 (355)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSST
T ss_pred             CHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCCh
Confidence            432211111100000000     0                    000000000 00001123446689999999999999


Q ss_pred             CCCCCHHHHHHH
Q 014079          345 KARPLMSDVVET  356 (431)
Q Consensus       345 ~~RPt~~eil~~  356 (431)
                      .+|||+.|++++
T Consensus       323 ~~Rpt~~e~l~h  334 (355)
T 2eu9_A          323 AQRITLAEALLH  334 (355)
T ss_dssp             TTSCCHHHHTTS
T ss_pred             hhCcCHHHHhcC
Confidence            999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.4e-43  Score=345.46  Aligned_cols=264  Identities=24%  Similarity=0.341  Sum_probs=199.4

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|.+.+.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.+++.++||||+++++++...
T Consensus        40 l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  113 (371)
T 4exu_A           40 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEK------VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA  113 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             ccccEEEEeEEecCCCeEEEEEEECCCCCE------EEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence            457899999999999999999998876554      99999876432  2346788999999999999999999999887


Q ss_pred             Cee------EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 DHR------LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ~~~------~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      +..      ++||||+. ++|.+++..    .+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+||+
T Consensus       114 ~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~--ivH~Dikp~NIll~~~~~~kL~  186 (371)
T 4exu_A          114 SSLRNFYDFYLVMPFMQ-TDLQKIMGM----EFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKIL  186 (371)
T ss_dssp             SSSTTCCCCEEEEECCC-EEHHHHTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCcccceeEEEEEcccc-ccHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCcCHHHeEECCCCCEEEE
Confidence            765      99999995 788888732    4899999999999999999999976  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~  304 (431)
                      |||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....  +
T Consensus       187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~  261 (371)
T 4exu_A          187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP  261 (371)
T ss_dssp             STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            99999864322     234678999999999887 789999999999999999999999997654222111100000  0


Q ss_pred             ------hhhc--cchhhhhcCccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 ------KLND--KRKMLQIIDPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ------~~~~--~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                            .+..  .......+.......   .....+..+.+||.+||+.||.+|||+.|++++-
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  325 (371)
T 4exu_A          262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  325 (371)
T ss_dssp             CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCc
Confidence                  0000  000000000000000   1123357899999999999999999999999763

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-43  Score=331.02  Aligned_cols=256  Identities=27%  Similarity=0.353  Sum_probs=204.1

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEE
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYC  150 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~  150 (431)
                      ...+.++|++.+.||+|+||.||+|.+..++.      .||+|++.....  .....+.+|++++++++||||+++++++
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~------~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   90 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQ------EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL   90 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCc------EEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEE
Confidence            45667899999999999999999999876544      399999865432  3457788999999999999999999999


Q ss_pred             EeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---CcEEEe
Q 014079          151 CEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---YTAKLS  227 (431)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---~~~kl~  227 (431)
                      .+.+..++||||+++++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++.+   +.+||+
T Consensus        91 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~--i~H~dl~p~NIlv~~~~~~~~~kL~  166 (287)
T 2wei_A           91 EDSSSFYIVGELYTGGELFDEIIKRK--RFSEHDAARIIKQVFSGITYMHKHN--IVHRDLKPENILLESKEKDCDIKII  166 (287)
T ss_dssp             ECSSEEEEEECCCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             eCCCeEEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeccCCChhhEEEecCCCcccEEEe
Confidence            99999999999999999999887654  4789999999999999999999876  9999999999999764   479999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........+       .
T Consensus       167 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------~  235 (287)
T 2wei_A          167 DFGLSTCFQQNTK---MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV-------E  235 (287)
T ss_dssp             STTGGGTBCCCSS---CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-------H
T ss_pred             ccCcceeecCCCc---cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH-------H
Confidence            9999976543221   123458999999998765 5899999999999999999999999764321110000       0


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..       ............+.++.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~-------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          236 TG-------KYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HC-------CCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cC-------CCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence            00       0000001112335678899999999999999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1e-43  Score=341.72  Aligned_cols=257  Identities=21%  Similarity=0.257  Sum_probs=176.8

Q ss_pred             HhcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           76 ITKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        76 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      +.++|.+. ++||+|+||.||+|.+..++.      .||+|++.... .   ...+....++.+.||||+++++++..  
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~------~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~   95 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQ------KCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMH   95 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCC------EEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhcc
Confidence            45778885 469999999999999986654      39999986542 1   11222334566789999999999976  


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEe
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLS  227 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~  227 (431)
                        ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.   ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~--ivH~dlkp~NIll~~~~~~~~~kl~  173 (336)
T 3fhr_A           96 HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN--IAHRDVKPENLLYTSKEKDAVLKLT  173 (336)
T ss_dssp             TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEESCSSTTCCEEEC
T ss_pred             CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--eecCCCCHHHEEEEecCCCceEEEe
Confidence              455899999999999999998876667999999999999999999999976  999999999999976   4569999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++.....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............       
T Consensus       174 Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-------  242 (336)
T 3fhr_A          174 DFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK-------  242 (336)
T ss_dssp             CCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--------------------
T ss_pred             ccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH-------
Confidence            99999764322    1234568999999999988899999999999999999999999997654322110000       


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         .........+........+.++.+|+.+||+.||.+|||+.+++++-.
T Consensus       243 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  290 (336)
T 3fhr_A          243 ---RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPW  290 (336)
T ss_dssp             -----------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHH
T ss_pred             ---HhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence               000000001111111234578899999999999999999999998654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.8e-44  Score=349.18  Aligned_cols=264  Identities=23%  Similarity=0.324  Sum_probs=192.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe-
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH-  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-  155 (431)
                      ..+|++.++||+|+||.||+|.+..+..       +|+|.+.....    ...+|+++|+.++||||++++++|...+. 
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-------~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~  107 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-------VAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDK  107 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEE-------EEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCe-------EEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence            4579999999999999999999877654       66766544321    12369999999999999999999965443 


Q ss_pred             -----eEEEEEecCCCChHHhhh-hCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-CCCcEEEec
Q 014079          156 -----RLLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSD  228 (431)
Q Consensus       156 -----~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-~~~~~kl~D  228 (431)
                           +++||||+.++.+..... ......+++..++.++.|++.||.|||+.+  |+||||||+||||+ .++.+||+|
T Consensus       108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~--ivHrDlkp~Nill~~~~~~~kL~D  185 (394)
T 4e7w_A          108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLID  185 (394)
T ss_dssp             SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEECC
T ss_pred             CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ccCCCCCHHHEEEcCCCCcEEEee
Confidence                 789999996654433332 122346889999999999999999999976  99999999999999 789999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPK  305 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~  305 (431)
                      ||+++.......   .....||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+...  .+.
T Consensus       186 FG~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~  262 (394)
T 4e7w_A          186 FGSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPS  262 (394)
T ss_dssp             CTTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             CCCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            999987543322   2345789999999998765 5999999999999999999999999875432211111000  000


Q ss_pred             hhccc---------hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKR---------KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....         .+..+....+...+....+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          263 REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            00000         0000000000111122345789999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.2e-43  Score=336.87  Aligned_cols=256  Identities=24%  Similarity=0.339  Sum_probs=180.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHH-HHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVN-FLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..++..      ||+|++..... ....++..|+. +++.++||||+++++++.+.+.
T Consensus        22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~   95 (327)
T 3aln_A           22 EDLKDLGEIGRGAYGSVNKMVHKPSGQI------MAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD   95 (327)
T ss_dssp             CSEEC-CEEEECSSEEEEEEEETTTTEE------EEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred             HHhhehheeccCCCEEEEEEEEcCCCCE------EEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence            6788999999999999999999766553      99999876532 23345566666 7788899999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhh---CCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          156 RLLVYEFMFRGSLENHLFR---KATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~---~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      .++||||+. ++|.+++..   .....+++..+..++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||+
T Consensus        96 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~--ivH~dlkp~NIll~~~~~~kl~Dfg~  172 (327)
T 3aln_A           96 CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGI  172 (327)
T ss_dssp             EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS--CCCSCCCGGGEEEETTTEEEECCCSS
T ss_pred             eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC--EeECCCCHHHEEEcCCCCEEEccCCC
Confidence            999999996 488877753   2345689999999999999999999986 6  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccc----ccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYV----MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.........  .        
T Consensus       173 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~--~--------  239 (327)
T 3aln_A          173 SGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ--L--------  239 (327)
T ss_dssp             SCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-----------------
T ss_pred             ceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH--H--------
Confidence            98654322   12234699999999998    4667899999999999999999999999764321110  0        


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                        ........+.+........+..+.+|+.+||+.||.+|||+.+|+++-
T Consensus       240 --~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          240 --TQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             --CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             --HHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence              000000011111111123456889999999999999999999998753

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.4e-43  Score=341.09  Aligned_cols=272  Identities=23%  Similarity=0.289  Sum_probs=189.8

Q ss_pred             HHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           73 LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        73 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .....++|++.+.||+|+||.||+|.+..++.      .||+|++.... .....+.+|++.+..++||||+++++++..
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~   90 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGM------SVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYT   90 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCC------EEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCC------EEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhc
Confidence            44556789999999999999999999876554      39999886543 223456678888899999999999999976


Q ss_pred             CCe-------eEEEEEecCCCChHHhhhh--CCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-CC
Q 014079          153 DDH-------RLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-DY  222 (431)
Q Consensus       153 ~~~-------~~lv~e~~~~gsL~~~l~~--~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-~~  222 (431)
                      .+.       .++||||+.+ +|.+.+..  .....+++..+..++.|++.||.|||.+.++|+||||||+||||+. ++
T Consensus        91 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           91 LGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             ECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT
T ss_pred             cccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC
Confidence            443       7899999965 55554432  2344688899999999999999999933344999999999999997 89


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhh
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDW  301 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  301 (431)
                      .+||+|||+++.......   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~  246 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP---NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVR  246 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC---CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cEEEeeCCCceecCCCCC---cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHH
Confidence            999999999987544322   2345789999999998765 489999999999999999999999987543222111100


Q ss_pred             hhhhhhccchhhhhcCcc----------------ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          302 ARPKLNDKRKMLQIIDPR----------------LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      ..  ..........+++.                .........+.++.+|+.+||+.||.+|||+.|+++|-
T Consensus       247 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  316 (360)
T 3e3p_A          247 VL--GCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHP  316 (360)
T ss_dssp             HH--CCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSG
T ss_pred             Hc--CCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCc
Confidence            00  00000000000000                00011122467899999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=336.94  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=198.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      .++|.+.+.||+|+||.||+|.+..++..      ||+|++.....  .....+.+|+.+++.++||||+++++++...+
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~------vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   96 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEK------VAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPAS   96 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCE------EEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccc
Confidence            46799999999999999999998776554      99999876432  23467889999999999999999999998765


Q ss_pred             e------eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          155 H------RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       155 ~------~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      .      .++||||+. ++|.+++..    .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|
T Consensus        97 ~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~~--ivH~dlkp~NIl~~~~~~~kl~D  169 (353)
T 3coi_A           97 SLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSAG--VVHRDLKPGNLAVNEDCELKILD  169 (353)
T ss_dssp             SGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSSCCGGGEEECTTCCEEECS
T ss_pred             ccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC--cccCCCCHHHEeECCCCcEEEee
Confidence            4      499999995 688887732    4889999999999999999999976  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--h-
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--P-  304 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~-  304 (431)
                      ||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+....  + 
T Consensus       170 fg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~  244 (353)
T 3coi_A          170 FGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG  244 (353)
T ss_dssp             TTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCC
T ss_pred             cccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            9999864322     233578999999999887 688999999999999999999999997654321111000000  0 


Q ss_pred             -----hhhcc--chhhhhcCcccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 -----KLNDK--RKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 -----~~~~~--~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                           .+...  ......+.....   .......+.++.+|+.+||+.||++|||+.+++++-
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  307 (353)
T 3coi_A          245 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP  307 (353)
T ss_dssp             HHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSG
T ss_pred             HHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence                 00000  000000000000   111224467899999999999999999999999763

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=335.01  Aligned_cols=248  Identities=25%  Similarity=0.425  Sum_probs=192.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcC----CCC
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQL----RHP  141 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~  141 (431)
                      +.+.+.++|++.+.||+|+||.||+|.+..++.      .||+|++......      ....+.+|+.++.++    +||
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~   98 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRL------QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP   98 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCC------EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCS
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCe------EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCC
Confidence            345677899999999999999999998876544      4999999765432      122355789999888    899


Q ss_pred             ceeeeecEEEeCCeeEEEEEe-cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-
Q 014079          142 NLVKLIGYCCEDDHRLLVYEF-MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-  219 (431)
Q Consensus       142 niv~l~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-  219 (431)
                      ||+++++++.+.+..++|||+ +.+++|.+++....  ++++..++.++.|++.||.|||+.+  |+||||||+|||++ 
T Consensus        99 ~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~  174 (312)
T 2iwi_A           99 GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKG--PLGEGPSRCFFGQVVAAIQHCHSRG--VVHRDIKDENILIDL  174 (312)
T ss_dssp             SBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHHT--EECCCCSGGGEEEET
T ss_pred             CeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeecCCChhhEEEeC
Confidence            999999999999999999999 78999999997754  5889999999999999999999876  99999999999999 


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLT-ARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||++.......    .....||+.|+|||++.+..+. .++||||||+++|+|++|+.||....     ..
T Consensus       175 ~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~  245 (312)
T 2iwi_A          175 RRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EI  245 (312)
T ss_dssp             TTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred             CCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HH
Confidence            78999999999998754332    2345699999999999877764 58999999999999999999996421     00


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .       .          ..  ..++...+..+.+|+.+||+.||++|||+.+++++-
T Consensus       246 ~-------~----------~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~  285 (312)
T 2iwi_A          246 L-------E----------AE--LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDP  285 (312)
T ss_dssp             H-------H----------TC--CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHST
T ss_pred             h-------h----------hc--cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence            0       0          00  011223346788999999999999999999999764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=3.9e-43  Score=335.36  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=200.4

Q ss_pred             HHHHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCC--CC
Q 014079           70 LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLR--HP  141 (431)
Q Consensus        70 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~  141 (431)
                      ..+.+.+.++|++.+.||+|+||.||+|.+..++.      .||+|++......      ....+.+|+.++++++  |+
T Consensus        35 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           35 GKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             -----CCTTTEEEEEECSSSSSCEEEEEEETTTTE------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             ccccCCccCceEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            34455667889999999999999999999876654      4999998765321      1234667999999996  59


Q ss_pred             ceeeeecEEEeCCeeEEEEEecCC-CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-
Q 014079          142 NLVKLIGYCCEDDHRLLVYEFMFR-GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-  219 (431)
Q Consensus       142 niv~l~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-  219 (431)
                      ||+++++++.+.+..++|||++.+ ++|.+++....  .+++..++.++.|++.||.|||+.+  |+||||||+|||++ 
T Consensus       109 ~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~--ivH~Dlkp~NIll~~  184 (320)
T 3a99_A          109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDL  184 (320)
T ss_dssp             SBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEET
T ss_pred             CceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--cEeCCCCHHHEEEeC
Confidence            999999999999999999999976 89999997654  5788999999999999999999876  99999999999999 


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++......    .....||+.|+|||++.+..+ +.++|||||||++|||++|+.||.....     .
T Consensus       185 ~~~~~kL~Dfg~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----~  255 (320)
T 3a99_A          185 NRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----I  255 (320)
T ss_dssp             TTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----H
T ss_pred             CCCCEEEeeCcccccccccc----ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----h
Confidence            78999999999998754322    233569999999999987776 6789999999999999999999964210     0


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .       ..        ...    .....+.++.+|+.+||+.||++|||+.+|+++-
T Consensus       256 ~-------~~--------~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp  295 (320)
T 3a99_A          256 I-------RG--------QVF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHP  295 (320)
T ss_dssp             H-------HC--------CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred             h-------cc--------ccc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCH
Confidence            0       00        000    1112346788999999999999999999999753

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.9e-42  Score=344.22  Aligned_cols=254  Identities=24%  Similarity=0.301  Sum_probs=186.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      .+.|.+.++||+|+||+||.+...++       ..||||++...   ....+.+|+.+|+++ +|||||++++++.+.+.
T Consensus        14 ~~~~~~~~~LG~G~~g~V~~~~~~~g-------~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   83 (434)
T 2rio_A           14 KNLVVSEKILGYGSSGTVVFQGSFQG-------RPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRF   83 (434)
T ss_dssp             SSCEEEEEEEEECSTTCEEEEEESSS-------SEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred             hheeeccCeEeeCCCeEEEEEEEECC-------eEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCe
Confidence            34566778999999999987644433       24999988654   234577899999876 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCc-----CHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC---------
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPL-----SWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD---------  221 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~-----~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~---------  221 (431)
                      .|+||||+. |+|.+++........     .+..++.++.|++.||+|||+.+  |+||||||+||||+.+         
T Consensus        84 ~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDLkp~NILl~~~~~~~~~~~~  160 (434)
T 2rio_A           84 LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK--IIHRDLKPQNILVSTSSRFTADQQT  160 (434)
T ss_dssp             EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEECCHHHHSCCTT
T ss_pred             EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC--ccccCCChHhEEEecCccccccccc
Confidence            999999994 699999976543221     22234679999999999999976  9999999999999654         


Q ss_pred             ----CcEEEecccCCccCCCCCCcc--eeecccCCccccCcccccc-------CCCCcchhhHHHHHHHHHHHh-CCCCC
Q 014079          222 ----YTAKLSDFGLAKAGPQGDETH--VSTRVMGTYGYAAPEYVMT-------GHLTARSDVYSFGVVLLELLT-GRKSV  287 (431)
Q Consensus       222 ----~~~kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~pf  287 (431)
                          +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.||
T Consensus       161 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf  240 (434)
T 2rio_A          161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF  240 (434)
T ss_dssp             CCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCC
Confidence                489999999998765432211  1234579999999999875       678999999999999999999 99999


Q ss_pred             CCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          288 DKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ....... .....       ...     ..+.+........+.++.+|+.+||+.||.+|||+.+|+++
T Consensus       241 ~~~~~~~-~~i~~-------~~~-----~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          241 GDKYSRE-SNIIR-------GIF-----SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             CSTTTHH-HHHHH-------TCC-----CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCchhhH-HHHhc-------CCC-----CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            7543211 00000       000     00111112234667899999999999999999999999874

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.2e-42  Score=326.79  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=179.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hH-HHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GH-REWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+..++.      .||+|++...... .. +.+.++..+++.++||||+++++++.+.+.
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~   98 (318)
T 2dyl_A           25 NDLENLGEMGSGTCGQVWKMRFRKTGH------VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD   98 (318)
T ss_dssp             GGEEEEEEC------CEEEEEETTTCC------EEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             ccccccceeeecCCeeEEEEEEecCCe------EEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence            568889999999999999999976544      3999998765432 22 234445567888899999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-CCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .++||||+ ++.+..+.... ...+++..++.++.|++.||.|||+. +  |+||||||+|||++.++.+||+|||++..
T Consensus        99 ~~lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~--i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  174 (318)
T 2dyl_A           99 VFIAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGR  174 (318)
T ss_dssp             EEEEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred             EEEEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCC--EEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence            99999999 66666555432 34689999999999999999999983 6  99999999999999999999999999976


Q ss_pred             CCCCCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhcc
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDK  309 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  309 (431)
                      .....   ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||........  ...         
T Consensus       175 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~---------  240 (318)
T 2dyl_A          175 LVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE--VLT---------  240 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHH---------
T ss_pred             ccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH--HHH---------
Confidence            53322   123356999999999984     56789999999999999999999999976432111  000         


Q ss_pred             chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+.....+.+.  .....+.++.+|+.+||+.||.+||++.+|+++
T Consensus       241 -~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          241 -KVLQEEPPLLP--GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -HHHHSCCCCCC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -HHhccCCCCCC--ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             00000001111  011234678899999999999999999999975

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=339.85  Aligned_cols=250  Identities=25%  Similarity=0.317  Sum_probs=183.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  156 (431)
                      .+|.+.++||+|+||+||.....++       ..||||++......   .+.+|+++|+++ +|||||++++++.+.+..
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~-------~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~   93 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDN-------RDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQ   93 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSS-------SEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEE
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCC-------eEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEE
Confidence            4588889999999999764433333       24999998765433   245799999999 799999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-----CCcEEEecccC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-----DYTAKLSDFGL  231 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFG~  231 (431)
                      |+||||+. |+|.+++..... .+.....+.++.|++.||.|||+.+  |+||||||+||||+.     ...+||+|||+
T Consensus        94 ~lv~E~~~-g~L~~~l~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~  169 (432)
T 3p23_A           94 YIAIELCA-ATLQEYVEQKDF-AHLGLEPITLLQQTTSGLAHLHSLN--IVHRDLKPHNILISMPNAHGKIKAMISDFGL  169 (432)
T ss_dssp             EEEEECCS-EEHHHHHHSSSC-CCCSSCHHHHHHHHHHHHHHHHHTT--CCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred             EEEEECCC-CCHHHHHHhcCC-CccchhHHHHHHHHHHHHHHHHHCc--CEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence            99999995 699999976543 3344455688999999999999977  999999999999953     23588999999


Q ss_pred             CccCCCCCCc-ceeecccCCccccCccccc---cCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhh
Q 014079          232 AKAGPQGDET-HVSTRVMGTYGYAAPEYVM---TGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       232 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      ++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||...........        
T Consensus       170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~--------  241 (432)
T 3p23_A          170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANIL--------  241 (432)
T ss_dssp             EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHH--------
T ss_pred             eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHH--------
Confidence            9875433221 2233467999999999987   4677889999999999999999 9999964322111000        


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            ....... ........+..+.+||.+||+.||.+|||+.+|++|
T Consensus       242 ------~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          242 ------LGACSLD-CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             ------TTCCCCT-TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ------hccCCcc-ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                  0000000 001122345678899999999999999999999964

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=4.1e-41  Score=316.16  Aligned_cols=237  Identities=15%  Similarity=0.119  Sum_probs=185.6

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||.||+|.+..+++.      ||+|++.....   .....+.+|+.++.+++||||+++++++.+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~------vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  102 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQ------VALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT  102 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEE------EEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCce------EEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE
Confidence            446799999999999999999999775553      99999986543   234678899999999999999999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..|+||||++|++|.+++...    ........++.|++.||.|||+.+  |+||||||+||||+.++.+||+++|  
T Consensus       103 ~~~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~g--ivH~Dikp~NIll~~~g~~kl~~~~--  174 (286)
T 3uqc_A          103 RAGGLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAG--VALSIDHPSRVRVSIDGDVVLAYPA--  174 (286)
T ss_dssp             TTEEEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCSGGGEEEETTSCEEECSCC--
T ss_pred             CCcEEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCC--CccCCCCcccEEEcCCCCEEEEecc--
Confidence            99999999999999999999542    244467789999999999999976  9999999999999999999998543  


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                                          |++       .++.++|||||||++|||++|+.||.............   ......   
T Consensus       175 --------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~---~~~~~~---  221 (286)
T 3uqc_A          175 --------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE---RDTAGQ---  221 (286)
T ss_dssp             --------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC---BCTTSC---
T ss_pred             --------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH---HHhccC---
Confidence                                333       36889999999999999999999998754322110000   000000   


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCC
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND  365 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~  365 (431)
                           ...........+.++.+|+.+||+.||.+| |+.|+++.|+.+.....
T Consensus       222 -----~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          222 -----PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             -----BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             -----CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                 000011122345678999999999999999 99999999998776543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=4.3e-41  Score=318.12  Aligned_cols=235  Identities=19%  Similarity=0.264  Sum_probs=182.0

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHH-hcCCCCceeeeecEEEe--
Q 014079           77 TKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFL-GQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~--  152 (431)
                      .++|.+. ++||+|+||.||+|.+..++.      .||+|++...     ..+.+|+.++ +.++||||+++++++..  
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~------~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~   84 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQE------KFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY   84 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCc------EEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhc
Confidence            4556666 789999999999999876654      3999998653     3566788887 56689999999999987  


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEe
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLS  227 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~  227 (431)
                        ....++||||+++++|.+++.......+++..++.++.|++.||.|||+.+  |+||||||+|||++.   ++.+||+
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           85 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCHHHEEEecCCCCCcEEEe
Confidence              678899999999999999998876667999999999999999999999977  999999999999998   7899999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||++....                        +..++.++|||||||++|||++|+.||.............       
T Consensus       163 Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~-------  211 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------  211 (299)
T ss_dssp             CCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC-------
T ss_pred             ccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH-------
Confidence            999986421                        2456789999999999999999999997643221100000       


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                         .........+........+.++.+|+.+||+.||.+|||+.|++++-.
T Consensus       212 ---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~  259 (299)
T 3m2w_A          212 ---TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  259 (299)
T ss_dssp             ---CSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             ---HHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChh
Confidence               000000000000011234578899999999999999999999998644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.8e-41  Score=348.03  Aligned_cols=263  Identities=25%  Similarity=0.315  Sum_probs=197.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      ..++|++.+.||+|+||.||+|.+..++.      .||+|++.... ......+.+|+.+|++++||||+++++++..  
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~------~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGE------QVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTC------CEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCc------EEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            34789999999999999999998876544      39999987652 2345678899999999999999999998765  


Q ss_pred             ----CCeeEEEEEecCCCChHHhhhhCC-CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCc---E
Q 014079          153 ----DDHRLLVYEFMFRGSLENHLFRKA-TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYT---A  224 (431)
Q Consensus       153 ----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~---~  224 (431)
                          .+..++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.   +
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g--IVHrDLKP~NILl~~~g~~~~v  163 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR--IIHRDLKPENIVLQPGPQRLIH  163 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT--BCCCCCCSTTEEEECCSSSCEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC--CccCCCCHHHeEeecCCCceeE
Confidence                677899999999999999997643 235788889999999999999999976  999999999999987664   9


Q ss_pred             EEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          225 KLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      ||+|||++........   .....||+.|+|||++.+..++.++|||||||++|+|++|..||......     ..|...
T Consensus       164 KL~DFG~a~~~~~~~~---~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~~~~~~  235 (676)
T 3qa8_A          164 KIIDLGYAKELDQGEL---CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----VQWHGK  235 (676)
T ss_dssp             EECSCCCCCBTTSCCC---CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----HHSSTT
T ss_pred             EEcccccccccccccc---cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----hhhhhh
Confidence            9999999987544322   23467999999999999999999999999999999999999999753211     001000


Q ss_pred             hhh----------ccchhhhhc-CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHH
Q 014079          305 KLN----------DKRKMLQII-DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVV  354 (431)
Q Consensus       305 ~~~----------~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil  354 (431)
                      ...          .......+. ............+..+.+|+.+||+.||++|||+.+++
T Consensus       236 i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL  296 (676)
T 3qa8_A          236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNP  296 (676)
T ss_dssp             CC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCC
T ss_pred             hhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHh
Confidence            000          000000000 00111223445678999999999999999999998843

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=6.7e-41  Score=351.22  Aligned_cols=243  Identities=24%  Similarity=0.367  Sum_probs=193.6

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcC-CceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDE-NVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      .+.++|++.+.||+|+||.||+|.+.. ++.      .||||++..... .....+.+|+.+|++++||||+++++++.+
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~------~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~  150 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGR------PVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH  150 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTE------EEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCc------EEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEee
Confidence            345789999999999999999999864 333      499998865432 344568899999999999999999999988


Q ss_pred             CCe-----eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 DDH-----RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 ~~~-----~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      .+.     .||||||++|++|.+++..    .+++..++.++.||+.||.|||+.+  ||||||||+||||+.+ .+||+
T Consensus       151 ~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~g--iiHrDlkp~NIll~~~-~~kl~  223 (681)
T 2pzi_A          151 TDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIG--LVYNDLKPENIMLTEE-QLKLI  223 (681)
T ss_dssp             ECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSS-CEEEC
T ss_pred             cCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCC--CeecccChHHeEEeCC-cEEEE
Confidence            766     7999999999999987743    5899999999999999999999977  9999999999999986 99999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++.....      ....||+.|+|||++.++ ++.++|||||||++|+|++|..||.......           +.
T Consensus       224 DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~  285 (681)
T 2pzi_A          224 DLGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LP  285 (681)
T ss_dssp             CCTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CC
T ss_pred             ecccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------cc
Confidence            99999875432      335799999999988765 4889999999999999999988876421100           00


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-HHHHHHHHhhhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-MSDVVETLEPLQ  361 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-~~eil~~L~~l~  361 (431)
                                   ........+..+.+||.+||+.||.+||+ +.++.+.|..+.
T Consensus       286 -------------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -------------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                         00111223467889999999999999995 556666665543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.1e-41  Score=331.26  Aligned_cols=242  Identities=18%  Similarity=0.155  Sum_probs=181.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCC-Cceeee-------
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRH-PNLVKL-------  146 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l-------  146 (431)
                      ..|...++||+|+||+||+|.+..++.      .||||++.....   ...+.+.+|+.+++.++| .|+..+       
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~------~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~  151 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGE------SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI  151 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBC
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCC------ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccc
Confidence            457788899999999999999876654      499999874332   224678899999999987 322111       


Q ss_pred             --------------ecEEEe-----CCeeEEEEEecCCCChHHhhh-----hCCCCCcCHHHHHHHHHHHHHHHHHhHhC
Q 014079          147 --------------IGYCCE-----DDHRLLVYEFMFRGSLENHLF-----RKATVPLSWATRMMIAFGAAKGLAFLHNA  202 (431)
Q Consensus       147 --------------~~~~~~-----~~~~~lv~e~~~~gsL~~~l~-----~~~~~~~~~~~~~~i~~~i~~~l~~LH~~  202 (431)
                                    +.++..     ...++++|+++ +++|.+++.     .....++++..++.++.|++.||+|||+.
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~  230 (413)
T 3dzo_A          152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY  230 (413)
T ss_dssp             CCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             cchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence                          111111     22457777766 789999885     23344678889999999999999999987


Q ss_pred             CCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCcccc----------ccCCCCcchhhHH
Q 014079          203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV----------MTGHLTARSDVYS  272 (431)
Q Consensus       203 ~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diws  272 (431)
                      +  ||||||||+||||+.++.+||+|||+++.....     ....+| +.|+|||++          .+..++.++||||
T Consensus       231 ~--iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwS  302 (413)
T 3dzo_A          231 G--LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWT  302 (413)
T ss_dssp             T--EECSCCCGGGEEECTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHH
T ss_pred             C--cccCCcccceEEEecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHH
Confidence            7  999999999999999999999999998764321     344578 999999999          5556888999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHH
Q 014079          273 FGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSD  352 (431)
Q Consensus       273 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~e  352 (431)
                      |||++|||++|+.||.........                ..++...  .    ..+..+.+|+.+||+.||++||++.+
T Consensus       303 lGvil~elltg~~Pf~~~~~~~~~----------------~~~~~~~--~----~~~~~~~~li~~~l~~dP~~Rpt~~~  360 (413)
T 3dzo_A          303 LGLAIYWIWCADLPNTDDAALGGS----------------EWIFRSC--K----NIPQPVRALLEGFLRYPKEDRLLPLQ  360 (413)
T ss_dssp             HHHHHHHHHHSSCCCCTTGGGSCS----------------GGGGSSC--C----CCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             HHHHHHHHHHCCCCCCCcchhhhH----------------HHHHhhc--c----cCCHHHHHHHHHHccCChhhCcCHHH
Confidence            999999999999999764321110                0111100  0    12367899999999999999999998


Q ss_pred             HHHH
Q 014079          353 VVET  356 (431)
Q Consensus       353 il~~  356 (431)
                      ++++
T Consensus       361 ~l~~  364 (413)
T 3dzo_A          361 AMET  364 (413)
T ss_dssp             HTTS
T ss_pred             HHhC
Confidence            8764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=1.8e-40  Score=319.01  Aligned_cols=242  Identities=21%  Similarity=0.238  Sum_probs=182.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------hhHHHHHHHHHHHhcCC---------
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------QGHREWLTEVNFLGQLR---------  139 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~---------  139 (431)
                      .++|++.+.||+|+||.||+|.+.+  .      .||+|++.....        ...+.+.+|+.+|+.++         
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~--~------~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~   90 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADH--T------PVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNR   90 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETT--E------EEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSB
T ss_pred             cccchheeeecccCceEEEEEEeCC--c------eEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhcccccc
Confidence            3568899999999999999998832  2      499999876532        23467888999988886         


Q ss_pred             CCceeee-----------------ecEEEe-------------CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHH
Q 014079          140 HPNLVKL-----------------IGYCCE-------------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIA  189 (431)
Q Consensus       140 h~niv~l-----------------~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~  189 (431)
                      |||||++                 +++|.+             .+..|+||||+++|+|.+.+.+   ..+++..++.++
T Consensus        91 h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~  167 (336)
T 2vuw_A           91 TEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSIL  167 (336)
T ss_dssp             CCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHH
T ss_pred             CCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHH
Confidence            5555554                 444443             7889999999999987776644   357899999999


Q ss_pred             HHHHHHHHHhH-hCCCCeeeccCCCCCEEECCCC--------------------cEEEecccCCccCCCCCCcceeeccc
Q 014079          190 FGAAKGLAFLH-NAERPVIYRDFKTSNILLDSDY--------------------TAKLSDFGLAKAGPQGDETHVSTRVM  248 (431)
Q Consensus       190 ~~i~~~l~~LH-~~~~~ivHrDlkp~NILl~~~~--------------------~~kl~DFG~a~~~~~~~~~~~~~~~~  248 (431)
                      .||+.||.||| +.+  |+||||||+||||+.++                    .+||+|||+++.....       ..+
T Consensus       168 ~qi~~aL~~lH~~~~--ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~  238 (336)
T 2vuw_A          168 HQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG-------IVV  238 (336)
T ss_dssp             HHHHHHHHHHHHHHC--CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT-------EEE
T ss_pred             HHHHHHHHHHHHhCC--EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC-------cEE
Confidence            99999999999 877  99999999999999887                    8999999999864321       246


Q ss_pred             CCccccCccccccCCCCcchhhHHHHHH-HHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh--hcCccccCccc
Q 014079          249 GTYGYAAPEYVMTGHLTARSDVYSFGVV-LLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ--IIDPRLENQYS  325 (431)
Q Consensus       249 gt~~y~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  325 (431)
                      ||+.|+|||++.+.. +.++|||||+++ .+++++|..||...         .|....   ...+..  ...........
T Consensus       239 gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~---------~~~~~~---~~~~~~~~~~~~~~~~~~~  305 (336)
T 2vuw_A          239 FCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNV---------LWLHYL---TDKMLKQMTFKTKCNTPAM  305 (336)
T ss_dssp             CCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHH---------HHHHHH---HHHHHHTCCCSSCCCSHHH
T ss_pred             EeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcch---------hhhhHH---HHhhhhhhccCcccchhhh
Confidence            999999999998766 899999998777 77888899888421         010000   000110  01111222334


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCCCCHHHHH-HH
Q 014079          326 VRAAQKACSLAYYCLSQNPKARPLMSDVV-ET  356 (431)
Q Consensus       326 ~~~~~~~~~li~~cl~~dP~~RPt~~eil-~~  356 (431)
                      ...+.++.+||.+||+.|     |+.|++ +|
T Consensus       306 ~~~s~~~~dli~~~L~~d-----sa~e~l~~H  332 (336)
T 2vuw_A          306 KQIKRKIQEFHRTMLNFS-----SATDLLCQH  332 (336)
T ss_dssp             HHHHHHHHHHHHHGGGSS-----SHHHHHHHC
T ss_pred             hhcCHHHHHHHHHHhccC-----CHHHHHhcC
Confidence            567889999999999977     999998 64

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.8e-34  Score=294.89  Aligned_cols=185  Identities=17%  Similarity=0.058  Sum_probs=126.6

Q ss_pred             ecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----------hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           86 LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----------QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        86 lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      ++.|++|.+..++..-      -+..|++|++.+...          ...++|.+|+++|+++ .|+||+++++++++++
T Consensus       242 ~~~~~~~~h~~~rr~~------fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~  315 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYF------FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQ  315 (569)
T ss_dssp             -C--------CCEEEE------ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSS
T ss_pred             cccCCccccccccccc------ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECC
Confidence            4555555554433221      223499999876421          2345689999999999 6999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..||||||++|++|.++|.+.+  +++..   .|+.||+.||+|||+++  ||||||||+||||+.+|.+||+|||+|+.
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~~~--~l~~~---~I~~QIl~AL~ylH~~G--IIHRDIKPeNILL~~dg~vKL~DFGlAr~  388 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAAGE--EIDRE---KILGSLLRSLAALEKQG--FWHDDVRPWNVMVDARQHARLIDFGSIVT  388 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHTTC--CCCHH---HHHHHHHHHHHHHHHTT--CEESCCCGGGEEECTTSCEEECCCTTEES
T ss_pred             EEEEEEecCCCCcHHHHHHhCC--CCCHH---HHHHHHHHHHHHHHHCC--ceeccCchHhEEECCCCCEEEeecccCee
Confidence            9999999999999999997754  45554   47889999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCC
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKS  286 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  286 (431)
                      ......  .....+||+.|||||++.+ .+..++|+|++|++++++.++..+
T Consensus       389 ~~~~~~--~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          389 TPQDCS--WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCCCc--cccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            543322  2344689999999998875 467789999999998887665443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=4.5e-30  Score=261.03  Aligned_cols=185  Identities=17%  Similarity=0.215  Sum_probs=142.4

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--------hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--------GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      ...++||+|+||.||+|.....        .+++|........        ..+.+.+|+++|++++||||+++..++..
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~~~--------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~  410 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYLDF--------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD  410 (540)
T ss_dssp             ---------CCEEEEEEECSSC--------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE
T ss_pred             CCCCEEeeCCCEEEEEEEECCC--------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe
Confidence            4456899999999999954432        3777765332211        13457899999999999999977666667


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      .+..||||||++|++|.+++..          ++.++.|++.||.|||+.+  |+||||||+|||++.  .+||+|||++
T Consensus       411 ~~~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~g--IiHrDiKp~NILl~~--~~kL~DFGla  476 (540)
T 3en9_A          411 LDNKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKND--VIHNDLTTSNFIFDK--DLYIIDFGLG  476 (540)
T ss_dssp             TTTTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTT--EECTTCCTTSEEESS--SEEECCCTTC
T ss_pred             CCccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCc--CccCCCCHHHEEECC--eEEEEECccC
Confidence            8888999999999999999965          4578999999999999877  999999999999998  9999999999


Q ss_pred             ccCCCCCCcc-----eeecccCCccccCcccccc--CCCCcchhhHHHHHHHHHHHhCCCCC
Q 014079          233 KAGPQGDETH-----VSTRVMGTYGYAAPEYVMT--GHLTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       233 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      +.........     ......||+.|||||++..  ..|+..+|+|+..+-..+.+.++.+|
T Consensus       477 ~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          477 KISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            8764432111     1234679999999999987  67888899999999999988877665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=1.7e-25  Score=209.02  Aligned_cols=146  Identities=15%  Similarity=0.090  Sum_probs=115.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc------------------hhHHHHHHHHHHHhcCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL------------------QGHREWLTEVNFLGQLR  139 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~  139 (431)
                      ..|.+.+.||+|+||.||+|.+ .++.      .||+|+++....                  .....+.+|+.+|++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~------~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFG------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTE------EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCC------EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            4566679999999999999998 4333      399999864321                  12456889999999999


Q ss_pred             CCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       140 h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                        | +++++++.. +..|+||||++|++|.+ +..      .  ....++.|++.||.|||+.+  |+||||||+|||++
T Consensus       163 --~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~--~~~~i~~qi~~~l~~lH~~g--iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 --G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------E--NPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVS  227 (282)
T ss_dssp             --T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------S--CHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEE
T ss_pred             --C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------h--hHHHHHHHHHHHHHHHHHCC--CEeCCCCHHHEEEE
Confidence              5 777776544 56799999999999998 521      1  23358999999999999877  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCcccccc
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT  261 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  261 (431)
                       ++.+||+|||+++.               +..|+|||++..
T Consensus       228 -~~~vkl~DFG~a~~---------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE---------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE---------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE---------------CCCCCHHHHHHH
Confidence             99999999999863               345789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=4.5e-21  Score=176.74  Aligned_cols=138  Identities=17%  Similarity=0.095  Sum_probs=102.2

Q ss_pred             CCccceecccCcEEEEEEEEc-CCceeccccceeEEEEccccCch------------------------hHHHHHHHHHH
Q 014079           80 FRSDYILGEGGFGTVYKGYID-ENVRVGLKSLPVAVKVLNKEGLQ------------------------GHREWLTEVNF  134 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~-~~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~  134 (431)
                      |.+.+.||+|+||.||+|.+. ++..     ..||||+++.....                        ....+.+|+.+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~-----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~  123 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKP-----VAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN  123 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEE-----EEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcE-----eeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence            567889999999999999883 3321     12899986543111                        01357789999


Q ss_pred             HhcCCCCce--eeeecEEEeCCeeEEEEEecCC-C----ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhH-hCCCCe
Q 014079          135 LGQLRHPNL--VKLIGYCCEDDHRLLVYEFMFR-G----SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH-NAERPV  206 (431)
Q Consensus       135 l~~l~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH-~~~~~i  206 (431)
                      |..+.|+++  +.++++    +..+|||||+.+ |    +|.++...     .++.....++.|++.+|.||| ..+  |
T Consensus       124 l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~g--i  192 (258)
T 1zth_A          124 LERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAE--L  192 (258)
T ss_dssp             HHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSC--E
T ss_pred             HHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCC--E
Confidence            999988764  333332    356899999942 3    77776532     123455678899999999999 876  9


Q ss_pred             eeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          207 IYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       207 vHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +||||||+|||++.  .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999999753

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.74  E-value=6.6e-19  Score=169.04  Aligned_cols=143  Identities=13%  Similarity=0.080  Sum_probs=98.1

Q ss_pred             HHHHhcC---CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--------------hhHHH--------
Q 014079           73 LETITKS---FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--------------QGHRE--------  127 (431)
Q Consensus        73 ~~~~~~~---y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--------------~~~~~--------  127 (431)
                      +.++.++   |++...||.|+||.||+|.+.++.       .||||+++....              .....        
T Consensus        87 L~~L~~rg~iY~I~~~IG~Gk~a~VY~a~d~~G~-------~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~  159 (397)
T 4gyi_A           87 LHTHAARKDVYSVGSRIGVGKESDIMIVADEKGK-------QKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLA  159 (397)
T ss_dssp             HHHHHHTTSCSEEEEEEEECSSEEEEEEECTTCC-------EEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHH
T ss_pred             HHHHHHCCCEEEecCEeeeCCceEEEEEECCCCC-------EEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHH
Confidence            3444444   889999999999999999886543       389998753211              00111        


Q ss_pred             HHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCee
Q 014079          128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVI  207 (431)
Q Consensus       128 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~iv  207 (431)
                      ..+|...|.++.+.++.-..-+..  ...+|||||++|++|.++...      +  ....++.|++.+|.|||.++  ||
T Consensus       160 A~kE~~nL~rL~~~gv~vp~p~~~--~~~~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~~g--IV  227 (397)
T 4gyi_A          160 AIKEFAFMKALYEEGFPVPEPIAQ--SRHTIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAKHG--LI  227 (397)
T ss_dssp             HHHHHHHHHHHHHTTCSCCCEEEE--ETTEEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHHTT--EE
T ss_pred             HHHHHHHHHHHHhcCCCCCeeeec--cCceEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHHCC--Cc
Confidence            134566666664443321111111  223799999999998775421      1  12356789999999999877  99


Q ss_pred             eccCCCCCEEECCCC----------cEEEecccCCcc
Q 014079          208 YRDFKTSNILLDSDY----------TAKLSDFGLAKA  234 (431)
Q Consensus       208 HrDlkp~NILl~~~~----------~~kl~DFG~a~~  234 (431)
                      ||||||.|||+++++          .+.|+||+-+..
T Consensus       228 HrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          228 HGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999999999998876          389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.47  E-value=1.4e-13  Score=126.72  Aligned_cols=144  Identities=13%  Similarity=0.036  Sum_probs=110.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCED  153 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  153 (431)
                      .....|++...++.|+.+.||++...+ .       .+++|+...........+.+|+.+|+.+. +..+.++++++.+.
T Consensus        11 ~~l~~~~~~~~~~g~s~~~v~~~~~~~-~-------~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~   82 (263)
T 3tm0_A           11 KLIEKYRCVKDTEGMSPAKVYKLVGEN-E-------NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD   82 (263)
T ss_dssp             HHHTTSEEEECCSCCSSSEEEEEECSS-C-------EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET
T ss_pred             HHhccceeEeeccCCCCCeEEEEECCC-C-------cEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC
Confidence            444678888889999999999987542 2       38999986532122335778999999885 67788999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC------------------------------
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE------------------------------  203 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~------------------------------  203 (431)
                      +..|+||||++|.+|.+.+..       ......++.+++.+|..||+..                              
T Consensus        83 ~~~~lv~e~i~G~~l~~~~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (263)
T 3tm0_A           83 GWSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDC  155 (263)
T ss_dssp             TEEEEEEECCSSEEHHHHCCT-------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSG
T ss_pred             CceEEEEEecCCeehhhccCC-------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccc
Confidence            999999999999999886421       1122356778899999999710                              


Q ss_pred             ---------------------------CCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          204 ---------------------------RPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       204 ---------------------------~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                                                 ..++|+|++|.|||++.+..+.|+||+.+.
T Consensus       156 ~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          156 ENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                       338999999999999876566799998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.25  E-value=5.2e-12  Score=115.62  Aligned_cols=135  Identities=15%  Similarity=0.013  Sum_probs=95.2

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc--eeeeecEEEeCCeeE
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN--LVKLIGYCCEDDHRL  157 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~  157 (431)
                      |.+..+.+.|..+.||++...++.       .+++|+.....   ...+.+|+.+++.+.+.+  +.++++++...+..+
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~-------~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~   91 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRP-------VLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW   91 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSC-------CEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred             CceEecccCCCCceEEEEecCCCC-------eEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence            444333345666999998654332       38899876542   234668899988886444  566888888888899


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC----------------------------------
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE----------------------------------  203 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~----------------------------------  203 (431)
                      +||||++|.+|.  ...     ...   ..++.+++..|..||+..                                  
T Consensus        92 ~v~e~i~G~~l~--~~~-----~~~---~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (264)
T 1nd4_A           92 LLLGEVPGQDLL--SSH-----LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEE  161 (264)
T ss_dssp             EEEECCSSEETT--TSC-----CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGG
T ss_pred             EEEEecCCcccC--cCc-----CCH---hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhh
Confidence            999999998884  211     111   245667777788888632                                  


Q ss_pred             ----------------------CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 ----------------------RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ----------------------~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                                            ..++|+|++|.|||++.++.+.|+|||.+..
T Consensus       162 ~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          162 HQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             GTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                  1299999999999998776667999998643

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.20  E-value=4.3e-11  Score=115.20  Aligned_cols=141  Identities=16%  Similarity=0.203  Sum_probs=103.5

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEEEEcc--ccC-chhHHHHHHHHHHHhcCC--CCceeeeecEEEeC---
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLN--KEG-LQGHREWLTEVNFLGQLR--HPNLVKLIGYCCED---  153 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---  153 (431)
                      ..+.|+.|.++.||+....++        .+++|+..  ... ......+.+|+.+|+.|.  +..+++++.++.+.   
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~~--------~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~  113 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPGQ--------TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVI  113 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSSC--------EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTT
T ss_pred             eEEEcCCcccceEEEEEECCc--------eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCcc
Confidence            355789999999999876542        37888776  322 122346778999999887  45688888888776   


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC-------------------------------
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA-------------------------------  202 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~-------------------------------  202 (431)
                      +..|+||||++|.++.+...    ..++...+..++.+++..|..||..                               
T Consensus       114 g~~~~vme~v~G~~l~~~~~----~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (359)
T 3dxp_A          114 GRAFYIMEFVSGRVLWDQSL----PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLS  189 (359)
T ss_dssp             SSCEEEEECCCCBCCCCTTC----TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEecCCeecCCCcc----ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhc
Confidence            45899999999988754221    1356777778889999999999973                               


Q ss_pred             -------------------------CCCeeeccCCCCCEEECCCCc--EEEecccCCcc
Q 014079          203 -------------------------ERPVIYRDFKTSNILLDSDYT--AKLSDFGLAKA  234 (431)
Q Consensus       203 -------------------------~~~ivHrDlkp~NILl~~~~~--~kl~DFG~a~~  234 (431)
                                               ...++|+|+++.|||++.++.  +.|+||+.+..
T Consensus       190 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          190 ETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                     135999999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=5.2e-11  Score=111.88  Aligned_cols=182  Identities=19%  Similarity=0.216  Sum_probs=116.3

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCc--eeeeecEEEeCC---ee
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPN--LVKLIGYCCEDD---HR  156 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~  156 (431)
                      .+.++.|....||+..           ..+++|+....  .....+.+|+.+|+.+. +..  +.+++......+   ..
T Consensus        25 i~~~~~G~~n~v~~v~-----------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~   91 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMS   91 (304)
T ss_dssp             CCEEEECSSEEEEEST-----------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCS
T ss_pred             eEecCCCCcceEEEEC-----------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcc
Confidence            3468999999999853           13888886543  33466788999998874 322  344444433333   34


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC---------------------------------
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE---------------------------------  203 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------  203 (431)
                      |+||++++|.+|.+....    .++...+..++.+++..|..||+..                                 
T Consensus        92 ~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           92 FAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             eEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            899999999988754321    2455566667777777777777511                                 


Q ss_pred             -----------------------CCeeeccCCCCCEEECC--CCcEEEecccCCccCCCCCCcceeecccCCccc---cC
Q 014079          204 -----------------------RPVIYRDFKTSNILLDS--DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY---AA  255 (431)
Q Consensus       204 -----------------------~~ivHrDlkp~NILl~~--~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y---~a  255 (431)
                                             ..++|+|++|.|||++.  +..+.|+||+.+........      ......+   ..
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~  241 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYG  241 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCC
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccC
Confidence                                   23899999999999998  55678999998865322100      0000011   12


Q ss_pred             cccccc-----CC---------CCcchhhHHHHHHHHHHHhCCCCC
Q 014079          256 PEYVMT-----GH---------LTARSDVYSFGVVLLELLTGRKSV  287 (431)
Q Consensus       256 PE~~~~-----~~---------~~~~~DiwslG~il~ell~g~~pf  287 (431)
                      |+....     +.         .....+.|+++.++|.+.+|..+|
T Consensus       242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence            221110     01         112368999999999999998665

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.69  E-value=8.7e-08  Score=87.98  Aligned_cols=135  Identities=19%  Similarity=0.092  Sum_probs=92.4

Q ss_pred             eecccCcE-EEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEEe
Q 014079           85 ILGEGGFG-TVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        85 ~lg~G~~g-~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      .+..|..| .||+.....+..      .+++|+....   ....+.+|..+|+.+. +--|.++++++.+.+..++|||+
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~------~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~  101 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAP------ELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTA  101 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCC------CEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             EccCCCcCCeEEEEEecCCCe------EEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEe
Confidence            34555554 689877654433      3788876543   3456778999988875 33367888899999999999999


Q ss_pred             cCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC---------------------------------------
Q 014079          163 MFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE---------------------------------------  203 (431)
Q Consensus       163 ~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------------------  203 (431)
                      ++|.++.+......      .....+..+++..|..||...                                       
T Consensus       102 l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (272)
T 4gkh_A          102 IPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWP  175 (272)
T ss_dssp             CCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCC
T ss_pred             eCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchH
Confidence            99988877553211      112234445555555555321                                       


Q ss_pred             -----------------CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 -----------------RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 -----------------~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                                       ..++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       176 ~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          176 VEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                             1279999999999999877777999987653

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.60  E-value=3.7e-07  Score=85.55  Aligned_cols=135  Identities=19%  Similarity=0.114  Sum_probs=87.2

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC---ceeeeecEEE-eCCeeEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP---NLVKLIGYCC-EDDHRLL  158 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~l  158 (431)
                      .+.++.|....||+.   + .       .+++|+....  .....+.+|+++|+.|.+.   .|.+++.+.. ..+..++
T Consensus        24 v~~l~~G~~n~v~~v---g-~-------~~VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~   90 (306)
T 3tdw_A           24 VESLGEGFRNYAILV---N-G-------DWVFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFV   90 (306)
T ss_dssp             EEEEEECSSEEEEEE---T-T-------TEEEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEE
T ss_pred             eeecCCCcceeEEEE---C-C-------EEEEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEE
Confidence            346888998999987   1 1       3888885332  2345688999999999742   3556666664 3456789


Q ss_pred             EEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-------------------------------------
Q 014079          159 VYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-------------------------------------  201 (431)
Q Consensus       159 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-------------------------------------  201 (431)
                      ||||++|.+|.+....    .++......++.++...|..||+                                     
T Consensus        91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~  166 (306)
T 3tdw_A           91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE  166 (306)
T ss_dssp             EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred             EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence            9999999888763211    11222223333333333333332                                     


Q ss_pred             ---------------------CCCCeeeccCCCCCEEECC---CCc-EEEecccCCcc
Q 014079          202 ---------------------AERPVIYRDFKTSNILLDS---DYT-AKLSDFGLAKA  234 (431)
Q Consensus       202 ---------------------~~~~ivHrDlkp~NILl~~---~~~-~kl~DFG~a~~  234 (431)
                                           ....++|+|+++.|||++.   ++. +.|+||+.+..
T Consensus       167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                 2234799999999999987   455 48999997754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.41  E-value=3.8e-07  Score=87.31  Aligned_cols=83  Identities=2%  Similarity=-0.103  Sum_probs=52.7

Q ss_pred             cee-cccCcEEEEEEEEc---CCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCC-C--CceeeeecEEEeC
Q 014079           84 YIL-GEGGFGTVYKGYID---ENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLR-H--PNLVKLIGYCCED  153 (431)
Q Consensus        84 ~~l-g~G~~g~V~~~~~~---~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~  153 (431)
                      +.| +.|....+|+....   ++..   .+..+++|+.....   ......+.+|+.+|+.|. +  -.+.+++.++.+.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~---~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~  102 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRS---IQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG  102 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEE---EEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred             EECCCCCccceEEEEEEecccCCCC---CCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence            457 88889999987654   1000   01237888765432   111234567888888774 2  3467777777655


Q ss_pred             ---CeeEEEEEecCCCChH
Q 014079          154 ---DHRLLVYEFMFRGSLE  169 (431)
Q Consensus       154 ---~~~~lv~e~~~~gsL~  169 (431)
                         +..++||||++|.+|.
T Consensus       103 ~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          103 DVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTTSSCEEEEECCCCBCCC
T ss_pred             CccCCceEEEEecCCCChh
Confidence               3568999999887764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.28  E-value=2.4e-06  Score=83.05  Aligned_cols=76  Identities=16%  Similarity=0.096  Sum_probs=47.1

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-------hhHHHHHHHHHHHhcCCC--C-ceeeeecEEEe
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-------QGHREWLTEVNFLGQLRH--P-NLVKLIGYCCE  152 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~-niv~l~~~~~~  152 (431)
                      .+.||.|.++.||++....+..      .+++|.......       .....+..|.++|+.+..  + .+.+++.+  +
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~------~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d  106 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDR------ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  106 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----C------EEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEECCCCceEEEEEEEECCCCc------EEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c
Confidence            4579999999999997543222      388887543211       122345678888887742  3 34455543  4


Q ss_pred             CCeeEEEEEecCCC
Q 014079          153 DDHRLLVYEFMFRG  166 (431)
Q Consensus       153 ~~~~~lv~e~~~~g  166 (431)
                      .+..++|||++++.
T Consensus       107 ~~~~~lvmE~l~g~  120 (397)
T 2olc_A          107 TEMAVTVMEDLSHL  120 (397)
T ss_dssp             TTTTEEEECCCTTS
T ss_pred             CCccEEEEEeCCCc
Confidence            55678999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.25  E-value=5.8e-06  Score=78.29  Aligned_cols=32  Identities=19%  Similarity=0.211  Sum_probs=27.7

Q ss_pred             CCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       203 ~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ...++|+|+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            35599999999999998888999999997643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.97  E-value=4e-05  Score=71.67  Aligned_cols=75  Identities=17%  Similarity=0.154  Sum_probs=57.5

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC---CCceeeeecEEEeCCeeEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---HPNLVKLIGYCCEDDHRLLV  159 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  159 (431)
                      .+.|+.|.+..+|+....+ .       .+++|+....   ....+..|...|+.|.   ...+++++.+....+..++|
T Consensus        41 ~~~l~gG~~n~~y~v~~~~-~-------~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lv  109 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDEV-Q-------TVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLL  109 (312)
T ss_dssp             EEEECCSSSSEEEEEESSS-C-------EEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEE
T ss_pred             eEEeCCccceeeeEEEECC-C-------eEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEE
Confidence            4568999999999987532 2       3788886543   3456778988888884   35688888888888889999


Q ss_pred             EEecCCCCh
Q 014079          160 YEFMFRGSL  168 (431)
Q Consensus       160 ~e~~~~gsL  168 (431)
                      |||++|..+
T Consensus       110 me~l~G~~~  118 (312)
T 3jr1_A          110 LEALNKSKN  118 (312)
T ss_dssp             EECCCCCCC
T ss_pred             EEeccCCCC
Confidence            999998865

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.81  E-value=9.7e-05  Score=68.19  Aligned_cols=78  Identities=15%  Similarity=0.106  Sum_probs=53.4

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC---CceeeeecEEEeCCee
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH---PNLVKLIGYCCEDDHR  156 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~~~~~  156 (431)
                      ....+.+|.|..+.||+....++..       |.+|+...........+..|+..|+.|.-   --+.+++++.    ..
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~DG~~-------~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~   85 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELADGTP-------LFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DR   85 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTSCE-------EEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TT
T ss_pred             eEEEEecCCCCCeEEEEEEECCCCE-------EEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----Cc
Confidence            4445679999999999999877643       88898765443333456789998888742   1244445432    34


Q ss_pred             EEEEEecCCCCh
Q 014079          157 LLVYEFMFRGSL  168 (431)
Q Consensus       157 ~lv~e~~~~gsL  168 (431)
                      ++||||++++..
T Consensus        86 ~lv~e~l~~~~~   97 (288)
T 3f7w_A           86 TLAMEWVDERPP   97 (288)
T ss_dssp             EEEEECCCCCCC
T ss_pred             eEEEEeecccCC
Confidence            789999977643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.76  E-value=0.00012  Score=71.65  Aligned_cols=77  Identities=17%  Similarity=0.226  Sum_probs=46.7

Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceeecccC--CccccCccccccC---CCCcchhhHHHHHHHH
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMG--TYGYAAPEYVMTG---HLTARSDVYSFGVVLL  278 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~---~~~~~~DiwslG~il~  278 (431)
                      ..++|+|+++.|||++.++ +.|+||+.+........  . .....  ...|++|+.....   .-....++..+...+|
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~D--l-a~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFD--I-GAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHH--H-HHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHH--H-HHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            4599999999999998876 99999998875321100  0 00000  1235666544311   1122355567788888


Q ss_pred             HHHhCC
Q 014079          279 ELLTGR  284 (431)
Q Consensus       279 ell~g~  284 (431)
                      +.+.+.
T Consensus       308 ~~y~~~  313 (420)
T 2pyw_A          308 NLFNKR  313 (420)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            877653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=0.00021  Score=66.93  Aligned_cols=156  Identities=13%  Similarity=0.109  Sum_probs=83.7

Q ss_pred             cCHHHHHHHhcCCCcc-----ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc
Q 014079           68 FSLFELETITKSFRSD-----YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN  142 (431)
Q Consensus        68 ~~~~~~~~~~~~y~~~-----~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n  142 (431)
                      ++..++..+...|.+.     +.|+.|....+|+....++        .+++|+.....  ....+..|+.+++.|...+
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g--------~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g   76 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKG   76 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--------CEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc--------cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCC
Confidence            3445556666666552     3466788889999876543        28889887531  1123445777766663111


Q ss_pred             --eeeeec------EEEeCCeeEEEEEecCCCChHH--------------hhhhC--C-CCC----c---CHHHHHHH--
Q 014079          143 --LVKLIG------YCCEDDHRLLVYEFMFRGSLEN--------------HLFRK--A-TVP----L---SWATRMMI--  188 (431)
Q Consensus       143 --iv~l~~------~~~~~~~~~lv~e~~~~gsL~~--------------~l~~~--~-~~~----~---~~~~~~~i--  188 (431)
                        +.+++.      +....+..+++|+|++|..+..              .++..  . ..+    .   .|...+.-  
T Consensus        77 ~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~  156 (322)
T 2ppq_A           77 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  156 (322)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             CCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHH
Confidence              233332      1223466789999998865421              01110  0 000    1   12211000  


Q ss_pred             ----------HHHHHHHHHHhHh-----CCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          189 ----------AFGAAKGLAFLHN-----AERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       189 ----------~~~i~~~l~~LH~-----~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                                ...+...+++++.     ....++|+|+.+.|||++.++.+.|+||+.+.
T Consensus       157 ~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          157 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence                      0113334555542     12349999999999999887666899998764

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.56  E-value=0.00039  Score=60.44  Aligned_cols=102  Identities=15%  Similarity=0.070  Sum_probs=66.4

Q ss_pred             CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCcceee
Q 014079          166 GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST  245 (431)
Q Consensus       166 gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~  245 (431)
                      -+|.++|...+ .|+.+.++|.+++|.+..|.-+-.... -..+=+.|..|+|..+|.+.+.+ ..+.            
T Consensus        33 vSL~eIL~~~~-~PlsEEqaWALc~Qc~~~L~~~~~~~~-~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           33 LSLEEILRLYN-QPINEEQAWAVCYQCCGSLRAAARRRQ-PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTC-CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             ccHHHHHHHcC-CCcCHHHHHHHHHHHHHHHHhhhhccc-CCceecCCcceEEecCCceeccc-cccc------------
Confidence            37899887664 489999999999999998877621111 12333456899999999988764 2111            


Q ss_pred             cccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCC
Q 014079          246 RVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK  285 (431)
Q Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  285 (431)
                        .....+.+||... ...+.+.=|||||++||..+--..
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence              0122467888653 345678899999999999987443

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.54  E-value=0.00018  Score=66.84  Aligned_cols=71  Identities=7%  Similarity=0.069  Sum_probs=43.1

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  161 (431)
                      .+.|+.|....+|+.   .         .+++|+....... .....+|+.+++.+...++ .+++++  +.+.-++|+|
T Consensus        23 i~~l~gG~tN~~~~~---~---------~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e   87 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA---G---------DLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTR   87 (301)
T ss_dssp             CEEEESCSSEEEEEE---T---------TEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEE
T ss_pred             eeEcCCcccccccee---e---------eEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEe
Confidence            567899999999998   1         2888887653211 1112357777776642222 455544  3444578999


Q ss_pred             ec-CCCCh
Q 014079          162 FM-FRGSL  168 (431)
Q Consensus       162 ~~-~~gsL  168 (431)
                      |+ +|.+|
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66555

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.39  E-value=0.0008  Score=63.29  Aligned_cols=31  Identities=29%  Similarity=0.345  Sum_probs=27.0

Q ss_pred             CCeeeccCCCCCEEECCC----CcEEEecccCCcc
Q 014079          204 RPVIYRDFKTSNILLDSD----YTAKLSDFGLAKA  234 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~----~~~kl~DFG~a~~  234 (431)
                      ..++|+|+.+.|||++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999874    6899999998865

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.38  E-value=0.0003  Score=68.90  Aligned_cols=80  Identities=14%  Similarity=0.062  Sum_probs=48.7

Q ss_pred             cceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCeeEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  160 (431)
                      .+.|+.|-...||++...++.. .......+++|+.....  ....+.+|+.+++.|...+ ..++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            3468888889999997653210 00011248888874421  1245567988888875333 3566665532    3899


Q ss_pred             EecCCCCh
Q 014079          161 EFMFRGSL  168 (431)
Q Consensus       161 e~~~~gsL  168 (431)
                      ||++|.+|
T Consensus       152 e~l~G~~l  159 (429)
T 1nw1_A          152 EYIPSRPL  159 (429)
T ss_dssp             CCCCEEEC
T ss_pred             EEeCCccc
Confidence            99986544

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.36  E-value=0.00049  Score=66.04  Aligned_cols=146  Identities=18%  Similarity=0.178  Sum_probs=79.5

Q ss_pred             ceecccCcEEEEEEEEcCCc-eeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENV-RVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~-~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      +.|..|-...+|++...++. ........+++|+.... ......+.+|.++++.|. +.-..++++.+.+    .+|||
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            45777888889998764310 00011234888886432 233456678999988875 3223566666543    29999


Q ss_pred             ecCCCChHHh--------------h---hhCC---CCCcC--HHHHHHHHHHHH-------------------HHHHHh-
Q 014079          162 FMFRGSLENH--------------L---FRKA---TVPLS--WATRMMIAFGAA-------------------KGLAFL-  199 (431)
Q Consensus       162 ~~~~gsL~~~--------------l---~~~~---~~~~~--~~~~~~i~~~i~-------------------~~l~~L-  199 (431)
                      |++|.+|...              |   +...   ..+..  +..+..+..++.                   ..+..| 
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            9988765321              0   1110   11111  233333333221                   112333 


Q ss_pred             ---HhC--CCCeeeccCCCCCEEECCC----CcEEEecccCCcc
Q 014079          200 ---HNA--ERPVIYRDFKTSNILLDSD----YTAKLSDFGLAKA  234 (431)
Q Consensus       200 ---H~~--~~~ivHrDlkp~NILl~~~----~~~kl~DFG~a~~  234 (431)
                         ...  ...++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence               221  2348999999999999876    7899999987753

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.26  E-value=0.0024  Score=59.73  Aligned_cols=76  Identities=16%  Similarity=0.091  Sum_probs=46.4

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCC--ceeeeecE-----EEeCCee
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHP--NLVKLIGY-----CCEDDHR  156 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~-----~~~~~~~  156 (431)
                      ..|+ |....||+....++.       .+++|+..... .....+..|..+++.|...  .+++++..     ....+..
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~-------~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~  102 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRR-------RFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFY  102 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCC-------CEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEE
T ss_pred             Eeec-CcccceEEEEcCCCC-------EEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEE
Confidence            3466 777899987654332       38899886432 1234566677777776421  23444432     2235567


Q ss_pred             EEEEEecCCCCh
Q 014079          157 LLVYEFMFRGSL  168 (431)
Q Consensus       157 ~lv~e~~~~gsL  168 (431)
                      +++|+|++|.++
T Consensus       103 ~~l~~~i~G~~~  114 (328)
T 1zyl_A          103 FAVFPSVGGRQF  114 (328)
T ss_dssp             EEEEECCCCEEC
T ss_pred             EEEEEecCCCCC
Confidence            899999987553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.08  E-value=0.0019  Score=63.61  Aligned_cols=74  Identities=15%  Similarity=0.045  Sum_probs=44.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCce-eeeecEEEeCCeeEEEEEe
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNL-VKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~  162 (431)
                      +.|+.|-...+|++...+...      .+++|+..... ...-+..+|..+++.|...++ .++++.+.  +  .+||||
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~------~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~  182 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQA------KYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEF  182 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTE------EEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEEC
T ss_pred             EEcCCCeEeEEEEEEECCCCc------eEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEe
Confidence            468888889999987754212      37888875431 111112478888888864444 56666662  2  359999


Q ss_pred             cCCCCh
Q 014079          163 MFRGSL  168 (431)
Q Consensus       163 ~~~gsL  168 (431)
                      ++|.+|
T Consensus       183 I~G~~l  188 (458)
T 2qg7_A          183 MDGYAL  188 (458)
T ss_dssp             CCSEEC
T ss_pred             eCCccC
Confidence            987655

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.93  E-value=0.0042  Score=58.58  Aligned_cols=31  Identities=13%  Similarity=0.202  Sum_probs=27.1

Q ss_pred             CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3499999999999999888899999987654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.86  E-value=0.0018  Score=61.92  Aligned_cols=80  Identities=10%  Similarity=0.101  Sum_probs=42.3

Q ss_pred             ceecccCcEEEEEEEEcCCce--eccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCeeEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVR--VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~--~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  160 (431)
                      +.|+.|....+|+....++..  .......+++|+..... ....+...|..+++.+...+ +.++++.+  .  -++||
T Consensus        39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~  113 (369)
T 3c5i_A           39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE  113 (369)
T ss_dssp             EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred             EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence            457788888999987643100  00001248888875432 11112346777777775333 44666543  2  37899


Q ss_pred             EecCCCCh
Q 014079          161 EFMFRGSL  168 (431)
Q Consensus       161 e~~~~gsL  168 (431)
                      ||++|.++
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99987654

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.60  E-value=0.027  Score=54.61  Aligned_cols=80  Identities=14%  Similarity=0.058  Sum_probs=45.5

Q ss_pred             ceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      +.|..|-...+|+....+... .......+++++..... ....+..+|..+++.+. +.-..++++.+  .  -++|||
T Consensus        76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e  150 (424)
T 3mes_A           76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE  150 (424)
T ss_dssp             EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred             EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence            457778888999988753110 00112348888865432 11112346888877774 22244555433  2  278999


Q ss_pred             ecCCCCh
Q 014079          162 FMFRGSL  168 (431)
Q Consensus       162 ~~~~gsL  168 (431)
                      |++|.+|
T Consensus       151 fI~G~~l  157 (424)
T 3mes_A          151 FIDGEPL  157 (424)
T ss_dssp             CCCSEEC
T ss_pred             EeCCccC
Confidence            9988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=91.77  E-value=0.7  Score=39.90  Aligned_cols=116  Identities=9%  Similarity=0.103  Sum_probs=78.8

Q ss_pred             CCCceeeeecEEEeCCeeEEEEEecCCC-ChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEE
Q 014079          139 RHPNLVKLIGYCCEDDHRLLVYEFMFRG-SLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNIL  217 (431)
Q Consensus       139 ~h~niv~l~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NIL  217 (431)
                      .||+++.. .+-.+.+.+.+.++.-..+ ++.. +.     .++...+++++..|+....+++.    -+|-=|.|+||+
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik-----~~~~~eKlr~l~ni~~l~~~~~~----r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK-----SFTKNEKLRYLLNIKNLEEVNRT----RYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG-----GSCHHHHHHHHHHGGGGGGGGGS----SEECCCSGGGEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH-----hcCHHHHHHHHHHHHHHHHHhcC----ceEEEEecceEE
Confidence            58888866 5666777777777654423 3333 32     36778888899888877655552    588999999999


Q ss_pred             ECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCC
Q 014079          218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK  289 (431)
Q Consensus       218 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  289 (431)
                      ++.++.+++.=-|+-..                   ++|.     .++...=.-.+=|++..+++++..|+.
T Consensus       112 f~~~~~p~i~~RGik~~-------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQNV-------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             ECTTSCEEESCCEETTT-------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EcCCCCEEEEEccCccC-------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            99999999987665332                   1221     122223344677889999999988853

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.66  E-value=1.8  Score=37.40  Aligned_cols=115  Identities=10%  Similarity=0.066  Sum_probs=76.4

Q ss_pred             CCCceeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHH-HhHhCCCCeeeccCCCCCEE
Q 014079          139 RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA-FLHNAERPVIYRDFKTSNIL  217 (431)
Q Consensus       139 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~-~LH~~~~~ivHrDlkp~NIL  217 (431)
                      .||++  -..+-.+++.+.+.++.-+++.=...+.     .++...+++++..|+.... +++  .  -+|-=|.|+||+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~--~--r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA--R--RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS--S--SEECCCCGGGEE
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh--C--ceeEEEeCceEE
Confidence            57777  3444567788878777654443333342     2577788888888776555 444  3  688999999999


Q ss_pred             ECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCC
Q 014079          218 LDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVD  288 (431)
Q Consensus       218 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~  288 (431)
                      ++.++.++|.=.|+-..                   ++|.-     ++..-=+-.+=|++..++.++..|+
T Consensus       117 f~~~~~p~i~hRGi~~~-------------------lpP~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKES-------------------LPPDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETTT-------------------BSSCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCccc-------------------CCCCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999987775332                   23321     1222223456788888999888774

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.57  E-value=0.14  Score=50.18  Aligned_cols=62  Identities=11%  Similarity=0.191  Sum_probs=17.0

Q ss_pred             ccceecccCcEEEEEEEEcCCceeccccceeEE------EEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           82 SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAV------KVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        82 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vav------K~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.+.||   ||.||+|.+...      ..+||+      |..+....  .....+.+|..+++.++|||+++.+++...
T Consensus       146 l~~~lG---fG~v~~g~~~~~------~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~  215 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYKK------HMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH  215 (463)
T ss_dssp             STTTSS---BCCC---------------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred             ccccCC---chhhhccccccc------CCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence            345666   999999988642      224677      65543222  223467889999999999999999887653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=84.09  E-value=0.49  Score=45.39  Aligned_cols=29  Identities=28%  Similarity=0.320  Sum_probs=24.5

Q ss_pred             eeeccCCCCCEEE------CCCCcEEEecccCCcc
Q 014079          206 VIYRDFKTSNILL------DSDYTAKLSDFGLAKA  234 (431)
Q Consensus       206 ivHrDlkp~NILl------~~~~~~kl~DFG~a~~  234 (431)
                      ++|+|+.+.|||+      +++..+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            5799999999999      4567899999988753

>1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3

Probab=80.61  E-value=3.6  Score=37.95  Aligned_cols=78  Identities=17%  Similarity=0.148  Sum_probs=42.8

Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCe--ee-ccCCCCCEEECCCCc-EEEeccc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPV--IY-RDFKTSNILLDSDYT-AKLSDFG  230 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~i--vH-rDlkp~NILl~~~~~-~kl~DFG  230 (431)
                      .+.++|+|.+|..|.+.-.......+.......+  +-+-+++++..+.-+.  +. .--.++|||++.++. +.++|-+
T Consensus       156 ~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~L--G~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~IDhn  233 (342)
T 1cja_A          156 ANILLMELVRGITLNKLTTTSAPEVLTKSTMQQL--GSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDSK  233 (342)
T ss_dssp             SEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHH--HHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSCC
T ss_pred             cceehhhhcCCCccccchhhhhhhhcCHHHHHhh--chhheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEcCC
Confidence            4669999998777665322110001222222221  1234466665433222  11 124788999977554 8999998


Q ss_pred             CCcc
Q 014079          231 LAKA  234 (431)
Q Consensus       231 ~a~~  234 (431)
                      ++..
T Consensus       234 ~af~  237 (342)
T 1cja_A          234 IIPL  237 (342)
T ss_dssp             CCCC
T ss_pred             cccc
Confidence            8854

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	431
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-77
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-69
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	7e-69
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-69
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-68
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-68
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-68
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-67
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-67
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-66
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-66
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-66
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	7e-66
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-65
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	5e-65
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	8e-64
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-63
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-62
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-62
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-62
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-62
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	4e-62
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-61
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	9e-61
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-60
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-58
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-57
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-57
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-55
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-54
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-53
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	6e-51
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-50
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	4e-50
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-49
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-49
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-49
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	6e-49
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-48
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-47
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-47
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-46
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-45
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-45
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-45
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-44
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-44
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-43
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-42
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-42
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	8e-41
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-37
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-35
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	5e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	4e-34
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	7e-30
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-16

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  240 bits (614), Expect = 1e-77
 Identities = 80/290 (27%), Positives = 127/290 (43%), Gaps = 34/290 (11%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNF 134
                    +G G FGTVYKG    +V         AVK+LN      Q  + +  EV  
Sbjct: 7   DGQITVGQRIGSGSFGTVYKGKWHGDV---------AVKMLNVTAPTPQQLQAFKNEVGV 57

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           L + RH N++  +GY        +V ++    SL +HL    T        + IA   A+
Sbjct: 58  LRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHIIET-KFEMIKLIDIARQTAQ 115

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+ +LH   + +I+RD K++NI L  D T K+ DFGLA    +   +H   ++ G+  + 
Sbjct: 116 GMDYLHA--KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 255 APEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK 311
           APE +        + +SDVY+FG+VL EL+TG+       P    +  D     +   R 
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIFMV--GRG 225

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
            L     ++ +       +    L   CL +    RPL   ++ ++E L 
Sbjct: 226 YLSPDLSKVRSNCP----KAMKRLMAECLKKKRDERPLFPQILASIELLA 271

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 1e-69
 Identities = 73/284 (25%), Positives = 123/284 (43%), Gaps = 32/284 (11%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           R        LG G FG V+ GY + + +V       AVK L +        +L E N + 
Sbjct: 12  RETLKLVERLGAGQFGEVWMGYYNGHTKV-------AVKSLKQGS-MSPDAFLAEANLMK 63

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           QL+H  LV+L       +   ++ E+M  GSL + L   + + L+    + +A   A+G+
Sbjct: 64  QLQHQRLVRLYA-VVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           AF+   ER  I+RD + +NIL+    + K++DFGLA+     +E            + AP
Sbjct: 123 AFIE--ERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKWTAP 179

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +  G  T +SDV+SFG++L E++T  +       + E                ++Q +
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----------------VIQNL 223

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           +            ++   L   C  + P+ RP    +   LE  
Sbjct: 224 ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  218 bits (555), Expect = 7e-69
 Identities = 72/298 (24%), Positives = 133/298 (44%), Gaps = 30/298 (10%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
           R+D      LG G +G VY+G   +       SL VAVK L ++ ++   E+L E   + 
Sbjct: 16  RTDITMKHKLGGGQYGEVYEGVWKKY------SLTVAVKTLKEDTMEV-EEFLKEAAVMK 68

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           +++HPNLV+L+G C  +    ++ EFM  G+L ++L       +S    + +A   +  +
Sbjct: 69  EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 128

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +L   ++  I+RD    N L+  ++  K++DFGL++    GD             + AP
Sbjct: 129 EYLE--KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAP 185

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +     + +SDV++FGV+L E+ T   S                     D  ++ +++
Sbjct: 186 ESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG----------------IDLSQVYELL 229

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSL 374
           +     +      +K   L   C   NP  RP  +++ +  E +   +   +E+   L
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  218 bits (556), Expect = 9e-69
 Identities = 70/311 (22%), Positives = 131/311 (42%), Gaps = 35/311 (11%)

Query: 63  THVIAFSLFELETITKSF-----RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVA 113
             +  F+  +     + F      S      ++G G FG V  G++      G + + VA
Sbjct: 2   IFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLP---GKREIFVA 58

Query: 114 VKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHL 172
           +K L      +  R++L+E + +GQ  HPN++ L G   +    +++ EFM  GSL+   
Sbjct: 59  IKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD-SF 117

Query: 173 FRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA 232
            R+     +    + +  G A G+ +L +     ++RD    NIL++S+   K+SDFGL+
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLAD--MNYVHRDLAARNILVNSNLVCKVSDFGLS 175

Query: 233 KAGPQGDETHVSTRV---MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDK 289
           +           T          + APE +     T+ SDV+S+G+V+ E+++  +    
Sbjct: 176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE---- 231

Query: 290 TRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL 349
            RP  + +  D           ++  I+        +        L   C  ++   RP 
Sbjct: 232 -RPYWDMTNQD-----------VINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPK 279

Query: 350 MSDVVETLEPL 360
              +V TL+ +
Sbjct: 280 FGQIVNTLDKM 290

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (549), Expect = 3e-68
 Identities = 66/286 (23%), Positives = 115/286 (40%), Gaps = 38/286 (13%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
             +      +G+G FG V  G          +   VAVK +  +     + +L E + + 
Sbjct: 6   MKELKLLQTIGKGEFGDVMLGD--------YRGNKVAVKCIKNDATA--QAFLAEASVMT 55

Query: 137 QLRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           QLRH NLV+L+G   E+   L +V E+M +GSL ++L  +    L     +  +    + 
Sbjct: 56  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           + +L       ++RD    N+L+  D  AK+SDFGL K      +T           + A
Sbjct: 116 MEYLE--GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTA 168

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE +     + +SDV+SFG++L E+ +  +      P     L D          ++ + 
Sbjct: 169 PEALREKKFSTKSDVWSFGILLWEIYSFGR-----VPYPRIPLKDVV-------PRVEKG 216

Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
                 +            +   C   +   RP    + E LE ++
Sbjct: 217 YKMDAPDGCP----PAVYEVMKNCWHLDAAMRPSFLQLREQLEHIK 258

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 7e-68
 Identities = 73/289 (25%), Positives = 128/289 (44%), Gaps = 23/289 (7%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFLGQ 137
                 ++G G FG VYKG +  +   G K +PVA+K L     +  R ++L E   +GQ
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSS--GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQ 65

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
             H N+++L G   +    +++ E+M  G+  +   R+     S    + +  G A G+ 
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGA-LDKFLREKDGEFSVLQLVGMLRGIAAGMK 124

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTRVMGTYGYAAP 256
           +L N     ++RD    NIL++S+   K+SDFGL++      + T+ ++       + AP
Sbjct: 125 YLAN--MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +     T+ SDV+SFG+V+ E++T  +       + E                +++ I
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKAI 226

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAND 365
           +        +        L   C  Q    RP  +D+V  L+ L  A D
Sbjct: 227 NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (546), Expect = 7e-68
 Identities = 74/285 (25%), Positives = 125/285 (43%), Gaps = 32/285 (11%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
            S+      +G G FG V+ GY        L    VA+K + + G     +++ E   + 
Sbjct: 4   PSELTFVQEIGSGQFGLVHLGYW-------LNKDKVAIKTIRE-GAMSEEDFIEEAEVMM 55

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
           +L HP LV+L G C E     LV+EFM  G L ++  R      +  T + +     +G+
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY-LRTQRGLFAAETLLGMCLDVCEGM 114

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
           A+L   E  VI+RD    N L+  +   K+SDFG+ +     D+   ST       +A+P
Sbjct: 115 AYLE--EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASP 171

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E       +++SDV+SFGV++ E+ +  K   + R + E          + D     ++ 
Sbjct: 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEV---------VEDISTGFRLY 222

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
            PRL +            +  +C  + P+ RP  S ++  L  + 
Sbjct: 223 KPRLAS-------THVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (550), Expect = 7e-68
 Identities = 79/299 (26%), Positives = 130/299 (43%), Gaps = 27/299 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNFLGQLRHPNL 143
           ++G G FG VY G + +N     K +  AVK LN+    G   ++LTE   +    HPN+
Sbjct: 34  VIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNV 90

Query: 144 VKLIGYCCEDD-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA 202
           + L+G C   +   L+V  +M  G L N +  + T   +    +      AKG+ FL + 
Sbjct: 91  LSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLAS- 148

Query: 203 ERPVIYRDFKTSNILLDSDYTAKLSDFGLAK--AGPQGDETHVSTRVMGTYGYAAPEYVM 260
            +  ++RD    N +LD  +T K++DFGLA+     + D  H  T       + A E + 
Sbjct: 149 -KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQ 207

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
           T   T +SDV+SFGV+L EL+T         P  + +  D     L  +R    ++ P  
Sbjct: 208 TQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQGRR----LLQPEY 258

Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDGGNEISSSLT-ANL 378
                         +   C     + RP  S++V  +  +     G + +  + T  N+
Sbjct: 259 -------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNV 310

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-67
 Identities = 59/282 (20%), Positives = 110/282 (39%), Gaps = 32/282 (11%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLG 136
             D      LG G FG V  G              VA+K++ +       E++ E   + 
Sbjct: 3   PKDLTFLKELGTGQFGVVKYGKWRGQY-------DVAIKMIKEGS-MSEDEFIEEAKVMM 54

Query: 137 QLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGL 196
            L H  LV+L G C +     ++ E+M  G L N+L             + +     + +
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAM 113

Query: 197 AFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAP 256
            +L +  +  ++RD    N L++     K+SDFGL++     DE   S        ++ P
Sbjct: 114 EYLES--KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-DEYTSSVGSKFPVRWSPP 170

Query: 257 EYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII 316
           E +M    +++SD+++FGV++ E+ +  K   +   + E                  + I
Sbjct: 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHI 214

Query: 317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
              L       A++K  ++ Y C  +    RP    ++  + 
Sbjct: 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNIL 256

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (543), Expect = 7e-67
 Identities = 73/307 (23%), Positives = 122/307 (39%), Gaps = 42/307 (13%)

Query: 83  DYIL----GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFLGQ 137
             +L    G+G FG V++G          +   VAVK+ +    +   RE   E+     
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--------WRGEEVAVKIFSSREERSWFRE--AEIYQTVM 53

Query: 138 LRHPNLVKLIGYCCEDD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           LRH N++  I    +D+       LV ++   GSL ++L R     ++    + +A   A
Sbjct: 54  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTA 110

Query: 194 KGLAFLHN------AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET--HVST 245
            GLA LH        +  + +RD K+ NIL+  + T  ++D GLA       +T      
Sbjct: 111 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 170

Query: 246 RVMGTYGYAAPEYVMT------GHLTARSDVYSFGVVLLELLTGRK----SVDKTRPSKE 295
             +GT  Y APE +             R+D+Y+ G+V  E+           D   P  +
Sbjct: 171 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 230

Query: 296 QSLVDWARPKLNDKRKMLQIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVV 354
               D +  ++       Q + P + N++ S  A +    +   C   N  AR     + 
Sbjct: 231 LVPSDPSVEEMRKVV-CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

Query: 355 ETLEPLQ 361
           +TL  L 
Sbjct: 290 KTLSQLS 296

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 2e-66
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 45/305 (14%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFL 135
           R +     +LG G FG V         + G  S+ VAVK+L ++     RE  ++E+  +
Sbjct: 36  RENLEFGKVLGSGAFGKVMNATAYGISKTG-VSIQVAVKMLKEKADSSEREALMSELKMM 94

Query: 136 GQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK------------------- 175
            QL  H N+V L+G C       L++E+   G L N+L  K                   
Sbjct: 95  TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 154

Query: 176 --ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
                 L++   +  A+  AKG+ FL    +  ++RD    N+L+      K+ DFGLA+
Sbjct: 155 EEDLNVLTFEDLLCFAYQVAKGMEFLE--FKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPS 293
                    V         + APE +  G  T +SDV+S+G++L E+ +   +       
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN------- 265

Query: 294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDV 353
                     P +       ++I    +      A ++   +   C + + + RP   ++
Sbjct: 266 --------PYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

Query: 354 VETLE 358
              L 
Sbjct: 318 TSFLG 322

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (540), Expect = 4e-66
 Identities = 67/310 (21%), Positives = 117/310 (37%), Gaps = 40/310 (12%)

Query: 73  LETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTE 131
           +E     F     LG G  G V+K     +  V      +A K+++ E     R   + E
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLV------MARKLIHLEIKPAIRNQIIRE 54

Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFG 191
           +  L +   P +V   G    D    +  E M  GSL+  L +     +       ++  
Sbjct: 55  LQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIA 112

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
             KGL +L   +  +++RD K SNIL++S    KL DFG++          ++   +GT 
Sbjct: 113 VIKGLTYLRE-KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFVGTR 167

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK-------------------------- 285
            Y +PE +   H + +SD++S G+ L+E+  GR                           
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETP 227

Query: 286 SVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 345
              +T      S    +RP +     +  I++       S   + +       CL +NP 
Sbjct: 228 PRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPA 287

Query: 346 ARPLMSDVVE 355
            R  +  ++ 
Sbjct: 288 ERADLKQLMV 297

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  210 bits (536), Expect = 6e-66
 Identities = 71/315 (22%), Positives = 121/315 (38%), Gaps = 42/315 (13%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-E 127
            L  LE    +      +GEG FG V++      +     ++ VAVK+L +E     + +
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTM-VAVKMLKEEASADMQAD 62

Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK------------ 175
           +  E   + +  +PN+VKL+G C       L++E+M  G L   L               
Sbjct: 63  FQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 176 ----------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK 225
                        PLS A ++ IA   A G+A+L   ER  ++RD  T N L+  +   K
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS--ERKFVHRDLATRNCLVGENMVVK 180

Query: 226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRK 285
           ++DFGL++     D             +  PE +     T  SDV+++GVVL E+ +   
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL 240

Query: 286 SVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPK 345
                               +  +  +  + D  +          +  +L   C S+ P 
Sbjct: 241 QPY---------------YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPA 284

Query: 346 ARPLMSDVVETLEPL 360
            RP    +   L+ +
Sbjct: 285 DRPSFCSIHRILQRM 299

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  211 bits (537), Expect = 7e-66
 Identities = 74/300 (24%), Positives = 113/300 (37%), Gaps = 40/300 (13%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFL 135
           R+       LG G FG V +      ++    ++ VAVK+L        RE  ++E+  L
Sbjct: 22  RNRLSFGKTLGAGAFGKVVEATAYGLIKSD-AAMTVAVKMLKPSAHLTEREALMSELKVL 80

Query: 136 GQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK----------------ATV 178
             L  H N+V L+G C      L++ E+   G L N L RK                  +
Sbjct: 81  SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 179 PLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQG 238
            L     +  ++  AKG+AFL    +  I+RD    NILL      K+ DFGLA+     
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLA--SKNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198

Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
               V         + APE +     T  SDV+S+G+ L EL +   S     P   +  
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK-- 256

Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
                          ++I           A  +   +   C   +P  RP    +V+ +E
Sbjct: 257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE 303

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 4e-65
 Identities = 72/283 (25%), Positives = 119/283 (42%), Gaps = 28/283 (9%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ 137
           +S R +  LG+G FG V+ G  +   RV       A+K L   G      +L E   + +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWNGTTRV-------AIKTLKP-GTMSPEAFLQEAQVMKK 68

Query: 138 LRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLA 197
           LRH  LV+L     E+    +V E+M +GSL + L  +    L     + +A   A G+A
Sbjct: 69  LRHEKLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMA 127

Query: 198 FLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE 257
           ++       ++RD + +NIL+  +   K++DFGLA+     +E            + APE
Sbjct: 128 YVER--MNYVHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTAPE 184

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
             + G  T +SDV+SFG++L EL T  +       ++E                +L  ++
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVE 228

Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                       +    L   C  + P+ RP    +   LE  
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (529), Expect = 5e-65
 Identities = 69/279 (24%), Positives = 121/279 (43%), Gaps = 26/279 (9%)

Query: 82  SDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFLGQLRH 140
           +D  LG G FG+V +G      R+  K + VA+KVL +   +   E  + E   + QL +
Sbjct: 13  ADIELGCGNFGSVRQGV----YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P +V+LIG  C+ +  +LV E    G L   L  K    +  +    +    + G+ +L 
Sbjct: 69  PYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKRE-EIPVSNVAELLHQVSMGMKYLE 126

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYGYAAPEYV 259
              +  ++RD    N+LL + + AK+SDFGL+KA G         +       + APE +
Sbjct: 127 E--KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECI 184

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                ++RSDV+S+GV + E L+  +     +P K+    +           ++  I+  
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQ-----KPYKKMKGPE-----------VMAFIEQG 228

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
              +       +  +L   C     + RP    V + + 
Sbjct: 229 KRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR 267

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 8e-64
 Identities = 72/289 (24%), Positives = 122/289 (42%), Gaps = 30/289 (10%)

Query: 83  DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRH 140
           D  LG G FGTV KGY     ++      VAVK+L  E        E L E N + QL +
Sbjct: 12  DKELGSGNFGTVKKGY----YQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN 67

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P +V++IG  CE +  +LV E    G L  +L +     +     + +    + G+ +L 
Sbjct: 68  PYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLE 124

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA-GPQGDETHVSTRVMGTYGYAAPEYV 259
                 ++RD    N+LL + + AK+SDFGL+KA     +     T       + APE +
Sbjct: 125 E--SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 260 MTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR 319
                +++SDV+SFGV++ E  +  +     +P +     +           +  +++  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQ-----KPYRGMKGSE-----------VTAMLEKG 226

Query: 320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP--LQCANDG 366
                     ++   L   C + + + RP  + V   L        N+G
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  204 bits (519), Expect = 3e-63
 Identities = 75/292 (25%), Positives = 115/292 (39%), Gaps = 38/292 (13%)

Query: 70  LFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW- 128
           LF  +   K F     +G G FG VY      N  V      VA+K ++  G Q + +W 
Sbjct: 7   LFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQ 60

Query: 129 --LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             + EV FL +LRHPN ++  G    +    LV E+    + +     K   PL      
Sbjct: 61  DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK--PLQEVEIA 118

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            +  GA +GLA+LH     +I+RD K  NILL      KL DFG A           +  
Sbjct: 119 AVTHGALQGLAYLH--SHNMIHRDVKAGNILLSEPGLVKLGDFGSAS------IMAPANS 170

Query: 247 VMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
            +GT  + APE ++    G    + DV+S G+  +EL   +                   
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP----------------PL 214

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
             +N    +  I         S   ++   +    CL + P+ RP    +++
Sbjct: 215 FNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 1e-62
 Identities = 61/285 (21%), Positives = 121/285 (42%), Gaps = 29/285 (10%)

Query: 82  SDY----ILGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFL 135
           +++    +LG G FGTVYKG +I E  +V +    VA+K L +    + ++E L E   +
Sbjct: 9   TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP---VAIKELREATSPKANKEILDEAYVM 65

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
             + +P++ +L+   C      L+ + M  G L +++       +     +      AKG
Sbjct: 66  ASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKD-NIGSQYLLNWCVQIAKG 123

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           + +L +  R +++RD    N+L+ +    K++DFGLAK     ++ + +        + A
Sbjct: 124 MNYLED--RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
            E ++    T +SDV+S+GV + EL+T         P+ E                +  I
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI 225

Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
           ++                 +   C   +  +RP   +++     +
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (514), Expect = 1e-62
 Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 31/275 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG+G FG VYK    E   +       A KV++ +  +   +++ E++ L    HPN+VK
Sbjct: 20  LGDGAFGKVYKAQNKETSVL------AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L+     +++  ++ EF   G+++  +      PL+ +   ++       L +LH  +  
Sbjct: 74  LLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLH--DNK 130

Query: 206 VIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT---- 261
           +I+RD K  NIL   D   KL+DFG++    +  +       +GT  + APE VM     
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSK 188

Query: 262 -GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
                 ++DV+S G+ L+E+           P  E + +         +   L       
Sbjct: 189 DRPYDYKADVWSLGITLIEMAEIE------PPHHELNPMRVLLKIAKSEPPTLAQPS--- 239

Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                 R +         CL +N  AR   S +++
Sbjct: 240 ------RWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-62
 Identities = 76/288 (26%), Positives = 120/288 (41%), Gaps = 26/288 (9%)

Query: 78  KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
           K  R    LG+G FG V +G  D       K++ VAVK L  + L   +   +++ EVN 
Sbjct: 8   KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           +  L H NL++L G         +V E    GSL + L +         T    A   A+
Sbjct: 65  MHSLDHRNLIRLYG-VVLTPPMKMVTELAPLGSLLDRLRKHQG-HFLLGTLSRYAVQVAE 122

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV-STRVMGTYGY 253
           G+ +L    +  I+RD    N+LL +    K+ DFGL +A PQ D+ +V        + +
Sbjct: 123 GMGYLE--SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180

Query: 254 AAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
            APE + T   +  SD + FGV L E+ T  +      P    +          +  ++ 
Sbjct: 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGERL- 234

Query: 314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
               PR E+       Q   ++   C +  P+ RP    + + L   Q
Sbjct: 235 ----PRPED-----CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 3e-62
 Identities = 67/283 (23%), Positives = 105/283 (37%), Gaps = 35/283 (12%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQ 137
            + D  +G G F TVYKG   E          VA   L    L     + +  E   L  
Sbjct: 11  LKFDIEIGRGSFKTVYKGLDTETTVE------VAWCELQDRKLTKSERQRFKEEAEMLKG 64

Query: 138 LRHPNLVKLIGYCCE----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
           L+HPN+V+               +LV E M  G+L+ +L R     +             
Sbjct: 65  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQIL 122

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYG 252
           KGL FLH    P+I+RD K  NI +     + K+ D GLA           +  V+GT  
Sbjct: 123 KGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178

Query: 253 YAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM 312
           + APE +         DVY+FG+ +LE+ T      + + + +                 
Sbjct: 179 FMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------Y 222

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
            ++        +   A  +   +   C+ QN   R  + D++ 
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-62
 Identities = 65/282 (23%), Positives = 107/282 (37%), Gaps = 31/282 (10%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNF 134
           F  D+     LGEG +G V                 VAVK+++ +      E    E+  
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICI 56

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
              L H N+VK  G+  E + + L  E+   G L + +     + +              
Sbjct: 57  NKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMA 114

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
           G+ +LH     + +RD K  N+LLD     K+SDFGLA      +   +  ++ GT  Y 
Sbjct: 115 GVVYLH--GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172

Query: 255 APEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML 313
           APE +          DV+S G+VL  +L G    D+   S ++                 
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE---------------YS 217

Query: 314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
              + +       +      +L +  L +NP AR  + D+ +
Sbjct: 218 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 69/291 (23%), Positives = 129/291 (44%), Gaps = 32/291 (10%)

Query: 81  RSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR-EWLTEVNFL 135
           R        LG+G FG VY+G + + V        VA+K +N+      R E+L E + +
Sbjct: 19  REKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 77

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLF--------RKATVPLSWATRMM 187
            +    ++V+L+G   +    L++ E M RG L+++L              P S +  + 
Sbjct: 78  KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
           +A   A G+A+L+      ++RD    N ++  D+T K+ DFG+ +   + D      + 
Sbjct: 138 MAGEIADGMAYLN--ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKG 195

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
           +    + +PE +  G  T  SDV+SFGVVL E+ T  +                    L+
Sbjct: 196 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------QPYQGLS 240

Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
           +++ +  +++  L ++           L   C   NPK RP   +++ +++
Sbjct: 241 NEQVLRFVMEGGLLDKPD-NCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-61
 Identities = 66/297 (22%), Positives = 121/297 (40%), Gaps = 41/297 (13%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL 138
            +   ++GEG FG V K  I ++       +  A+K + +      HR++  E+  L +L
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 139 -RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATV--------------PLSWA 183
             HPN++ L+G C    +  L  E+   G+L + L +   +               LS  
Sbjct: 68  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHV 243
             +  A   A+G+ +L   ++  I+RD    NIL+  +Y AK++DFGL++      +   
Sbjct: 128 QLLHFAADVARGMDYLS--QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK-- 183

Query: 244 STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR 303
            T       + A E +     T  SDV+S+GV+L E+++   +     P    +  +   
Sbjct: 184 -TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGT-----PYCGMTCAELY- 236

Query: 304 PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                  K+ Q                +   L   C  + P  RP  + ++ +L  +
Sbjct: 237 ------EKLPQGYRLEKPLNCD----DEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (500), Expect = 9e-61
 Identities = 68/285 (23%), Positives = 116/285 (40%), Gaps = 29/285 (10%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLTEVNFL 135
           R        +GEG FG V++G         L    VA+K          RE +L E   +
Sbjct: 6   RERIELGRCIGEGQFGDVHQGIYMSPENPALA---VAIKTCKNCTSDSVREKFLQEALTM 62

Query: 136 GQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
            Q  HP++VKLIG    ++   ++ E    G L + L  +    L  A+ ++ A+  +  
Sbjct: 63  RQFDHPHIVKLIG-VITENPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTA 120

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           LA+L    +  ++RD    N+L+ S+   KL DFGL++        + +++      + A
Sbjct: 121 LAYLE--SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-YYKASKGKLPIKWMA 177

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI 315
           PE +     T+ SDV+ FGV + E+L         +P +     D      N +R     
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGV-----KPFQGVKNNDVIGRIENGER----- 227

Query: 316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
               +             SL   C + +P  RP  +++   L  +
Sbjct: 228 --LPMPPNCP----PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 1e-60
 Identities = 67/281 (23%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 82  SDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNF 134
            D+     LG+G FG VY     ++  +      +A+KVL K  L       +   EV  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEI 59

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
              LRHPN+++L GY  +     L+ E+   G++   L + +                A 
Sbjct: 60  QSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELAN 117

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
            L++ H   + VI+RD K  N+LL S    K++DFG +   P        T + GT  Y 
Sbjct: 118 ALSYCH--SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYL 171

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
            PE +       + D++S GV+  E L G+       P +  +  +  +     +     
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRVEFTFPD 225

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
            +     +            L    L  NP  RP++ +V+E
Sbjct: 226 FVTEGARD------------LISRLLKHNPSQRPMLREVLE 254

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (498), Expect = 2e-60
 Identities = 62/285 (21%), Positives = 114/285 (40%), Gaps = 34/285 (11%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQ 137
           +   Y +G G +G   K     + ++      +  K L+   +     +  ++EVN L +
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 138 LRHPNLVKLIGYCCE--DDHRLLVYEFMFRGSLENHLFR--KATVPLSWATRMMIAFGAA 193
           L+HPN+V+      +  +    +V E+   G L + + +  K    L     + +     
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLT 119

Query: 194 KGLAFLH---NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             L   H   +    V++RD K +N+ LD     KL DFGLA+      +T  +   +GT
Sbjct: 120 LALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI--LNHDTSFAKAFVGT 177

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR 310
             Y +PE +       +SD++S G +L EL           P    S  + A        
Sbjct: 178 PYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALM------PPFTAFSQKELA-------G 224

Query: 311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           K+ +    R+  +YS     +   +    L+     RP + +++E
Sbjct: 225 KIREGKFRRIPYRYS----DELNEIITRMLNLKDYHRPSVEEILE 265

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (485), Expect = 3e-58
 Identities = 58/287 (20%), Positives = 113/287 (39%), Gaps = 28/287 (9%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           S+  +    K +     +G+G  GTVY        +       VA++ +N +        
Sbjct: 11  SIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE------VAIRQMNLQQQPKKELI 64

Query: 129 LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMI 188
           + E+  + + ++PN+V  +      D   +V E++  GSL + +       +       +
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAV 121

Query: 189 AFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVM 248
                + L FLH     VI+RD K+ NILL  D + KL+DFG         E    + ++
Sbjct: 122 CRECLQALEFLH--SNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMV 177

Query: 249 GTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND 308
           GT  + APE V       + D++S G++ +E++ G        P   ++ +        +
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE------PPYLNENPLRALYLIATN 231

Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
               LQ  +         + +         CL  + + R    ++++
Sbjct: 232 GTPELQNPE---------KLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 78/305 (25%), Positives = 118/305 (38%), Gaps = 39/305 (12%)

Query: 81  RSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-HREWLTEVNFL 135
           R        LG G FG V +      +        VAVK+L +      HR  ++E+  L
Sbjct: 12  RDRLKLGKPLGRGAFGQVIEAD-AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKIL 70

Query: 136 GQ-LRHPNLVKLIGYCCEDDHRL-LVYEFMFRGSLENHLFRK--------------ATVP 179
                H N+V L+G C +    L ++ EF   G+L  +L  K                  
Sbjct: 71  IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           L+    +  +F  AKG+ FL    R  I+RD    NILL      K+ DFGLA+   +  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA--SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 188

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
           +            + APE +     T +SDV+SFGV+L E+ +   S     P     + 
Sbjct: 189 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS-----PYPGVKID 243

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
           +    +L +  +       R  +  +     +       C    P  RP  S++VE L  
Sbjct: 244 EEFCRRLKEGTR------MRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSELVEHLGN 293

Query: 360 LQCAN 364
           L  AN
Sbjct: 294 LLQAN 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (478), Expect = 3e-57
 Identities = 69/301 (22%), Positives = 122/301 (40%), Gaps = 39/301 (12%)

Query: 81  RSDYI----LGEGGFGTVYKG-YIDENVRVGLKSLPVAVKVLNKEGLQGH-REWLTEVNF 134
           R   +    LGEG FG V     I  +     +   VAVK+L  +  +    + ++E+  
Sbjct: 12  RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEM 71

Query: 135 LGQL-RHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK--------------ATVP 179
           +  + +H N++ L+G C +D    ++ E+  +G+L  +L  +                  
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 180 LSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGD 239
           LS    +  A+  A+G+ +L    +  I+RD    N+L+  D   K++DFGLA+     D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLA--SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
               +T       + APE +     T +SDV+SFGV+L E+ T   S     P +E    
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE---- 245

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEP 359
                       + +++              +   +   C    P  RP    +VE L+ 
Sbjct: 246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR 293

Query: 360 L 360
           +
Sbjct: 294 I 294

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 4e-55
 Identities = 57/280 (20%), Positives = 98/280 (35%), Gaps = 31/280 (11%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHP 141
           ILGEG F TV         R        A+K+L K  +           E + + +L HP
Sbjct: 15  ILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
             VKL     +D+       +   G L  ++ +                     L +LH 
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLH- 125

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             + +I+RD K  NILL+ D   +++DFG AK      +   +   +GT  Y +PE +  
Sbjct: 126 -GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE 321
                 SD+++ G ++ +L+ G        P +  +     +  +  +    +   P   
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGL------PPFRAGNEYLIFQKIIKLEYDFPEKFFP--- 235

Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ 361
                    KA  L    L  +   R    ++        
Sbjct: 236 ---------KARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  181 bits (461), Expect = 4e-54
 Identities = 60/284 (21%), Positives = 99/284 (34%), Gaps = 28/284 (9%)

Query: 74  ETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           + +   +     LG G FG V++                A K +             E+ 
Sbjct: 22  DHVLDHYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPHESDKETVRKEIQ 75

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            +  LRHP LV L     +D+  +++YEFM  G L   +  +    +S    +       
Sbjct: 76  TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVC 134

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDY--TAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           KGL  +H  E   ++ D K  NI+  +      KL DFGL       D         GT 
Sbjct: 135 KGLCHMH--ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTA 189

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK 311
            +AAPE      +   +D++S GV+   LL+G        P   ++  +  R   +    
Sbjct: 190 EFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL------SPFGGENDDETLRNVKSCDWN 243

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           M       +        ++         L  +P  R  +   +E
Sbjct: 244 MDDSAFSGI--------SEDGKDFIRKLLLADPNTRMTIHQALE 279

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  179 bits (455), Expect = 3e-53
 Identities = 60/272 (22%), Positives = 109/272 (40%), Gaps = 28/272 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G FG V++       RV         K +N            E++ + QL HP L+ 
Sbjct: 37  LGSGAFGVVHRCVEKATGRV------FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
           L     +    +L+ EF+  G L + +  +    +S A  +     A +GL  +H  E  
Sbjct: 91  LHDAFEDKYEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMH--EHS 147

Query: 206 VIYRDFKTSNILLDS--DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           +++ D K  NI+ ++    + K+ DFGLA    + +   +      T  +AAPE V    
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAAPEIVDREP 204

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQ 323
           +   +D+++ GV+   LL+G        P        +A     +  + ++  D   +  
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGL------SP--------FAGEDDLETLQNVKRCDWEFDED 250

Query: 324 YSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                + +A       L + P+ R  + D +E
Sbjct: 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (436), Expect = 6e-51
 Identities = 62/288 (21%), Positives = 111/288 (38%), Gaps = 31/288 (10%)

Query: 72  ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE-WLT 130
           + E I   +    +LG G F  V         ++      VA+K + K+ L+G       
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKL------VAIKCIAKKALEGKEGSMEN 56

Query: 131 EVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAF 190
           E+  L +++HPN+V L        H  L+ + +  G L + +  K     +      + F
Sbjct: 57  EIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIF 114

Query: 191 GAAKGLAFLHNAERPVIYRDFKTSNILL---DSDYTAKLSDFGLAKAGPQGDETHVSTRV 247
                + +LH  +  +++RD K  N+L    D D    +SDFGL+K     D   V +  
Sbjct: 115 QVLDAVKYLH--DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPGSVLSTA 169

Query: 248 MGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN 307
            GT GY APE +     +   D +S GV+   LL G        P  +++        L 
Sbjct: 170 CGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY------PPFYDENDAKLFEQILK 223

Query: 308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
            + +        +        +  A     + + ++P+ R      ++
Sbjct: 224 AEYEFDSPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  169 bits (429), Expect = 3e-50
 Identities = 70/300 (23%), Positives = 119/300 (39%), Gaps = 34/300 (11%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG---HREWLTE 131
            ++  +    ILG GG   V+        R       VAVKVL  +  +    +  +  E
Sbjct: 4   HLSDRYELGEILGFGGMSEVHLARDLRLHR------DVAVKVLRADLARDPSFYLRFRRE 57

Query: 132 VNFLGQLRHPNLVKLIGYCCEDDHRL----LVYEFMFRGSLENHLFRKATVPLSWATRMM 187
                 L HP +V +      +        +V E++   +L + +  +   P++    + 
Sbjct: 58  AQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIE 115

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVSTR 246
           +   A + L F H  +  +I+RD K +NI++ +    K+ DFG+A+     G+    +  
Sbjct: 116 VIADACQALNFSH--QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAA 173

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL 306
           V+GT  Y +PE      + ARSDVYS G VL E+LTG        P    S V  A   +
Sbjct: 174 VIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------PPFTGDSPVSVAYQHV 227

Query: 307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG 366
            +           L        +    ++    L++NP+ R       E    L   ++G
Sbjct: 228 REDPIPPSARHEGL--------SADLDAVVLKALAKNPENRY--QTAAEMRADLVRVHNG 277

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (431), Expect = 4e-50
 Identities = 50/284 (17%), Positives = 104/284 (36%), Gaps = 33/284 (11%)

Query: 78  KSFRSDYI----LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVN 133
           K     Y+    LG G FG V++     + +          K +  +G         E++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKGTD-QVLVKKEIS 53

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            L   RH N++ L       +  ++++EF+    +   +   +   L+    +       
Sbjct: 54  ILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERI-NTSAFELNEREIVSYVHQVC 112

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSD--YTAKLSDFGLAKAGPQGDETHVSTRVMGTY 251
           + L FLH     + + D +  NI+  +    T K+ +FG A+    GD   +   +    
Sbjct: 113 EALQFLH--SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTAP 167

Query: 252 GYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK 311
            Y APE      ++  +D++S G ++  LL+G        P   ++        +N +  
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------NPFLAETNQQIIENIMNAEYT 221

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
             +     +        + +A       L +  K+R   S+ ++
Sbjct: 222 FDEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEALQ 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 2e-49
 Identities = 68/268 (25%), Positives = 104/268 (38%), Gaps = 34/268 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLG-QLRH 140
           +LG+G FG V+     +  +        A+K L K+ +    +    + E   L     H
Sbjct: 9   MLGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 141 PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLH 200
           P L  +       ++   V E++  G L  H+       LS AT    A     GL FLH
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--YAAEIILGLQFLH 120

Query: 201 NAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVM 260
              + ++YRD K  NILLD D   K++DFG+ K    GD         GT  Y APE ++
Sbjct: 121 --SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT--NTFCGTPDYIAPEILL 176

Query: 261 TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRL 320
                   D +SFGV+L E+L G+       P   Q   +       D     + ++   
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQ------SPFHGQDEEELFHSIRMDNPFYPRWLEKEA 230

Query: 321 ENQYSVRAAQKACSLAYYCLSQNPKARP 348
           ++            L      + P+ R 
Sbjct: 231 KD------------LLVKLFVREPEKRL 246

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 68/296 (22%), Positives = 109/296 (36%), Gaps = 47/296 (15%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---------QGHR 126
           F  +Y    ILG G    V +       +        AVK+++  G          +   
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELRE 54

Query: 127 EWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATR 185
             L EV+ L ++  HPN+++L      +    LV++ M +G L ++L  K  V LS    
Sbjct: 55  ATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKET 112

Query: 186 MMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVST 245
             I     + +  LH  +  +++RD K  NILLD D   KL+DFG +    Q D      
Sbjct: 113 RKIMRALLEVICALH--KLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLR 167

Query: 246 RVMGTYGYAAPEYVMTGHL------TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
            V GT  Y APE +               D++S GV++  LL G        P   +  +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQM 221

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
              R  ++   +                 +     L    L   P+ R    + + 
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEALA 269

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (428), Expect = 2e-49
 Identities = 69/304 (22%), Positives = 122/304 (40%), Gaps = 28/304 (9%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE- 127
            +F+   +   + +   +GEG +G V   Y + N         VA+K ++    Q + + 
Sbjct: 2   QVFD---VGPRYTNLSYIGEGAYGMVCSAYDNVNKVR------VAIKKISPFEHQTYCQR 52

Query: 128 WLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRK-ATVPLSWATRM 186
            L E+  L + RH N++ +           +   ++    +   L++   T  LS     
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHIC 112

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK-AGPQGDETHVST 245
              +   +GL ++H     V++RD K SN+LL++    K+ DFGLA+ A P  D T   T
Sbjct: 113 YFLYQILRGLKYIH--SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 170

Query: 246 RVMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGR-------------KSVDKTR 291
             + T  Y APE ++      +S D++S G +L E+L+ R               +    
Sbjct: 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 230

Query: 292 PSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS 351
              ++ L      K  +    L   +    N+    A  KA  L    L+ NP  R  + 
Sbjct: 231 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVE 290

Query: 352 DVVE 355
             + 
Sbjct: 291 QALA 294

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 64/297 (21%), Positives = 108/297 (36%), Gaps = 37/297 (12%)

Query: 69  SLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW 128
           ++F  E +   + +   LG G F  V K                A K + K   +  R  
Sbjct: 1   TVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQ------YAAKFIKKRRTKSSRRG 54

Query: 129 ------LTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
                   EV+ L +++HPN++ L          +L+ E +  G L + L  K    L+ 
Sbjct: 55  VSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE--SLTE 112

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD----YTAKLSDFGLAKAGPQG 238
                       G+ +LH     + + D K  NI+L          K+ DFGLA     G
Sbjct: 113 EEATEFLKQILNGVYYLH--SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 170

Query: 239 DETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSL 298
           +E      + GT  + APE V    L   +D++S GV+   LL+G               
Sbjct: 171 NEF---KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK------ 221

Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                    +    +  ++   E++Y    +  A       L ++PK R  + D ++
Sbjct: 222 --------QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (427), Expect = 6e-49
 Identities = 69/276 (25%), Positives = 108/276 (39%), Gaps = 36/276 (13%)

Query: 80  FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVN--- 133
           F    I+G GGFG VY     +  ++       A+K L+K+ +   QG    L E     
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 134 FLGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAA 193
            +     P +V +       D    + + M  G L  HL +      S A     A    
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEII 117

Query: 194 KGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGY 253
            GL  +H   R V+YRD K +NILLD     ++SD GLA    +          +GT+GY
Sbjct: 118 LGLEHMH--NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVGTHGY 171

Query: 254 AAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM 312
            APE +  G    + +D +S G +L +LL G     + +   +  +            +M
Sbjct: 172 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID-----------RM 220

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
              +   L + +S     +  SL    L ++   R 
Sbjct: 221 TLTMAVELPDSFS----PELRSLLEGLLQRDVNRRL 252

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (417), Expect = 3e-48
 Identities = 65/287 (22%), Positives = 108/287 (37%), Gaps = 28/287 (9%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-----HREWLTEVNFLGQLR 139
            LGEG F TVYK       ++      VA+K +            +R  L E+  L +L 
Sbjct: 5   FLGEGQFATVYKARDKNTNQI------VAIKKIKLGHRSEAKDGINRTALREIKLLQELS 58

Query: 140 HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
           HPN++ L+       +  LV++FM              + L+ +          +GL +L
Sbjct: 59  HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYL 116

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +  +++RD K +N+LLD +   KL+DFGLAK+   G      T  + T  Y APE +
Sbjct: 117 H--QHWILHRDLKPNNLLLDENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELL 172

Query: 260 MTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV----------DWARPKLND 308
               +     D+++ G +L ELL     +       + + +           W       
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 232

Query: 309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                +       +     A      L       NP AR   +  ++
Sbjct: 233 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 1e-47
 Identities = 52/281 (18%), Positives = 95/281 (33%), Gaps = 29/281 (10%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +G G FG +Y G              VA+K+   +    H +   E      ++    + 
Sbjct: 15  IGSGSFGDIYLGTDIAAGE------EVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIP 66

Query: 146 LIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERP 205
            I +C  +    ++   +   SLE  LF   +   S  T +++A      + ++H   + 
Sbjct: 67  TIRWCGAEGDYNVMVMELLGPSLE-DLFNFCSRKFSLKTVLLLADQMISRIEYIH--SKN 123

Query: 206 VIYRDFKTSNIL---LDSDYTAKLSDFGLAKAGPQGDET-----HVSTRVMGTYGYAAPE 257
            I+RD K  N L           + DFGLAK               +  + GT  YA+  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 258 YVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
             +    + R D+ S G VL+    G       + + ++   +          K +    
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYE------RISEKKMSTPI 237

Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE 358
             L   Y      +  +   +C S     +P  S + +   
Sbjct: 238 EVLCKGYP----SEFATYLNFCRSLRFDDKPDYSYLRQLFR 274

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  162 bits (410), Expect = 4e-47
 Identities = 66/274 (24%), Positives = 106/274 (38%), Gaps = 40/274 (14%)

Query: 82  SDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE---WLTEVNF 134
            D+     LG G FG V+      N R        A+KVL KE +   ++      E   
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLM 57

Query: 135 LGQLRHPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAK 194
           L  + HP ++++ G   +     ++ +++  G L + L +    P   A           
Sbjct: 58  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAE--VCL 115

Query: 195 GLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYA 254
            L +LH   + +IYRD K  NILLD +   K++DFG AK  P    T       GT  Y 
Sbjct: 116 ALEYLH--SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYI 168

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ 314
           APE V T       D +SFG+++ E+L G        P  + + +      LN + +   
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELRFPP 222

Query: 315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
             +                 L    ++++   R 
Sbjct: 223 FFNE------------DVKDLLSRLITRDLSQRL 244

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  159 bits (402), Expect = 3e-46
 Identities = 54/283 (19%), Positives = 106/283 (37%), Gaps = 25/283 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           +GEG +G VYK   +            A+K +  E          + E++ L +L+H N+
Sbjct: 10  IGEGTYGVVYKAQNNYGETF-------ALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL          +LV+E + +   +     +    L   T          G+A+ H  +
Sbjct: 63  VKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG--GLESVTAKSFLLQLLNGIAYCH--D 118

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           R V++RD K  N+L++ +   K++DFGLA+A       +    ++  +  A    + +  
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT-HEIVTLWYRAPDVLMGSKK 177

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV----------DWAR-PKLNDKRKM 312
            +   D++S G +  E++ G         + +   +          +W    +L      
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN 237

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
             + +P     +     +    L    L  +P  R      +E
Sbjct: 238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 1e-45
 Identities = 61/283 (21%), Positives = 111/283 (39%), Gaps = 23/283 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           +GEG +G VYK        V      VA+K +  +          + E++ L +L HPN+
Sbjct: 10  IGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           VKL+     ++   LV+EF+ +  L+  +   A   +         F   +GLAF H   
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD-LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--S 120

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
             V++RD K  N+L++++   KL+DFGLA+A         +  V+  +  A    +   +
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKE-----------QSLVDWARPKLNDKRKM 312
            +   D++S G +  E++T R          +             +V      + D +  
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                 +  ++      +   SL    L  +P  R      + 
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 67/290 (23%), Positives = 111/290 (38%), Gaps = 32/290 (11%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQL---RH 140
           +GEG +G V+K    +N         VA+K +  +  +       + EV  L  L    H
Sbjct: 15  IGEGAYGKVFKARDLKN-----GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69

Query: 141 PNLVKLIGYCC-----EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           PN+V+L   C       +    LV+E + +     +L +     +   T   + F   +G
Sbjct: 70  PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMFQLLRG 128

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAA 255
           L FLH     V++RD K  NIL+ S    KL+DFGLA+           T V+ T  Y A
Sbjct: 129 LDFLH--SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY---SFQMALTSVVVTLWYRA 183

Query: 256 PEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV----------DWARPK 305
           PE ++        D++S G +  E+   +     +    +   +          DW R  
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR-D 242

Query: 306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           +   R+       +   ++     +    L   CL+ NP  R      + 
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  156 bits (396), Expect = 3e-45
 Identities = 48/288 (16%), Positives = 91/288 (31%), Gaps = 37/288 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           +GEG FG +++G    N +       VA+K   +       +   E      L     + 
Sbjct: 13  IGEGSFGVIFEGTNLLNNQ------QVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIP 64

Query: 146 LIGYCCEDD-HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAER 204
            + Y  ++  H +LV + +  G     L        S  T  M A      +  +H  E+
Sbjct: 65  NVYYFGQEGLHNVLVIDLL--GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIH--EK 120

Query: 205 PVIYRDFKTSNILLDSDYT-----AKLSDFGLAK-----AGPQGDETHVSTRVMGTYGYA 254
            ++YRD K  N L+    +       + DFG+ K        Q         + GT  Y 
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYM 180

Query: 255 APEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPKLNDKRKM 312
           +    +    + R D+ + G V +  L G       + +  +   +    + +    R++
Sbjct: 181 SINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL 360
                                   +Y  +    A P    +      +
Sbjct: 241 CAGFPEEFYK------------YMHYARNLAFDATPDYDYLQGLFSKV 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 8e-45
 Identities = 74/267 (27%), Positives = 102/267 (38%), Gaps = 33/267 (12%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHP 141
           +LG+G FG V         R        A+K+L KE +    E    +TE   L   RHP
Sbjct: 12  LLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            L  L       D    V E+   G L  HL R+     +              L +LH 
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLH- 122

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
             R V+YRD K  N++LD D   K++DFGL K G     T       GT  Y APE +  
Sbjct: 123 -SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM--KTFCGTPEYLAPEVLED 179

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE 321
                  D +  GVV+ E++ GR       P   Q         L ++ +  + + P   
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIRFPRTLSP--- 230

Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARP 348
                    +A SL    L ++PK R 
Sbjct: 231 ---------EAKSLLAGLLKKDPKQRL 248

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-44
 Identities = 54/296 (18%), Positives = 101/296 (34%), Gaps = 39/296 (13%)

Query: 73  LETITKSFRSDY-----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE 127
           L+    +   DY     +LG G  G V + +              A+K+L         +
Sbjct: 2   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQD-----CPK 50

Query: 128 WLTEVNFLGQL-RHPNLVKLIGYC----CEDDHRLLVYEFMFRGSLENHLFRKATVPLSW 182
              EV    +  + P++V+++             L+V E +  G L + +  +     + 
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTE 110

Query: 183 ATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLAKAGPQGD 239
                I     + + +LH     + +RD K  N+L  S   +   KL+DFG AK     +
Sbjct: 111 REASEIMKSIGEAIQYLH--SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168

Query: 240 ETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV 299
                     T  Y APE +         D++S GV++  LL G        P      +
Sbjct: 169 SLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY------PPFYSNHGL 219

Query: 300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                     +  +++      N      +++   L    L   P  R  +++ + 
Sbjct: 220 AI----SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 3e-44
 Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 35/297 (11%)

Query: 79  SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQL 138
           S+    ++G G FG VY+  + ++  +      VA+K + ++    +RE    +  + +L
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKVLQDKRFKNRE----LQIMRKL 70

Query: 139 RHPNLVKLIGYCCEDD------HRLLVYEFMFRGSLENHL-FRKATVPLSWATRMMIAFG 191
            H N+V+L  +           +  LV +++          + +A   L      +  + 
Sbjct: 71  DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ 130

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
             + LA++H     + +RD K  N+LLD D    KL DFG AK   +G+     + +   
Sbjct: 131 LFRSLAYIH--SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSR 186

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR------------KSVDKTRPSKEQSL 298
           Y  A          T+  DV+S G VL ELL G+              + K   +  +  
Sbjct: 187 YYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246

Query: 299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
           +    P   +  K  QI        +  R   +A +L    L   P AR    +   
Sbjct: 247 IREMNPNYTEF-KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA 302

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-43
 Identities = 60/290 (20%), Positives = 105/290 (36%), Gaps = 51/290 (17%)

Query: 80  FRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHRE------WL 129
             S Y    +LG GGFG+VY G    +        PVA+K + K+ +    E        
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVP 55

Query: 130 TEVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMM 187
            EV  L ++      +++L+ +    D  +L+ E             +    L       
Sbjct: 56  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG-ALQEELARS 114

Query: 188 IAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDETHVSTR 246
             +   + +   H     V++RD K  NIL+D +    KL DFG         +  V T 
Sbjct: 115 FFWQVLEAVRHCH--NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL----LKDTVYTD 168

Query: 247 VMGTYGYAAPEYVMTGHLTARS-DVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK 305
             GT  Y+ PE++       RS  V+S G++L +++ G        P +    +   +  
Sbjct: 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEHDEEIIRGQVF 222

Query: 306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
              +      +    ++            L  +CL+  P  RP   ++  
Sbjct: 223 FRQR------VSSECQH------------LIRWCLALRPSDRPTFEEIQN 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-42
 Identities = 57/311 (18%), Positives = 113/311 (36%), Gaps = 37/311 (11%)

Query: 68  FSLFELETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL- 122
           F   E+       R+ Y     +G G +G V                 VA+K L +    
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAK------VAIKKLYRPFQS 57

Query: 123 -QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYEFM----FRGSLENHLFRKAT 177
               +    E+  L  +RH N++ L+     D+      +F     F G+    L +   
Sbjct: 58  ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHE- 116

Query: 178 VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 237
             L       + +   KGL ++H     +I+RD K  N+ ++ D   K+ DFGLA+    
Sbjct: 117 -KLGEDRIQFLVYQMLKGLRYIH--AAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-- 171

Query: 238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR------------- 284
             ++ ++  V+  +  A    +     T   D++S G ++ E++TG+             
Sbjct: 172 --DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLK 229

Query: 285 KSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNP 344
           + +  T     + +      +  +  K L  ++ +        A+  A +L    L  + 
Sbjct: 230 EIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289

Query: 345 KARPLMSDVVE 355
           + R    + + 
Sbjct: 290 EQRVTAGEALA 300

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 61/284 (21%), Positives = 103/284 (36%), Gaps = 25/284 (8%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNL 143
           +GEG +GTV+K    E   +      VA+K +  +          L E+  L +L+H N+
Sbjct: 10  IGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 144 VKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE 203
           V+L      D    LV+EF  +   +        +           F   KGL F H+  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKS--FLFQLLKGLGFCHS-- 119

Query: 204 RPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGH 263
           R V++RD K  N+L++ +   KL++FGLA+A       + S  V+  +            
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLFGAKL 178

Query: 264 LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ-----------SLVDWAR-PKLNDKRK 311
            +   D++S G +  EL    + +       +Q           +   W    KL D + 
Sbjct: 179 YSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKP 238

Query: 312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                          +       L    L  NP  R    + ++
Sbjct: 239 YPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 8e-41
 Identities = 62/297 (20%), Positives = 110/297 (37%), Gaps = 37/297 (12%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG--HREWLTEVNFLGQLRHPNL 143
           +G+G FG V+K    +  +       VA+K +  E  +       L E+  L  L+H N+
Sbjct: 18  IGQGTFGEVFKARHRKTGQK------VALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 144 VKLIGYCCE--------DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKG 195
           V LI  C               LV++F                 LS   R+M       G
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQ--MLLNG 129

Query: 196 LAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVS--TRVMGTYGY 253
           L ++H     +++RD K +N+L+  D   KL+DFGLA+A      +  +  T  + T  Y
Sbjct: 130 LYYIH--RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 187

Query: 254 AAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLV----------DWA 302
             PE ++         D++  G ++ E+ T    +       + +L+           W 
Sbjct: 188 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 247

Query: 303 RPKLNDKRKMLQIIDPR----LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVE 355
                +  + L+++  +     +   +      A  L    L  +P  R    D + 
Sbjct: 248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  143 bits (360), Expect = 1e-39
 Identities = 58/267 (21%), Positives = 96/267 (35%), Gaps = 36/267 (13%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREW---LTEVNFLGQLRHP 141
            LG G FG V      E+          A+K+L+K+ +   ++    L E   L  +  P
Sbjct: 48  TLGTGSFGRVMLVKHKESGNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            LVKL     ++ +  +V E++  G + +HL R      S       A        +LH 
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLH- 158

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT 261
               +IYRD K  N+L+D     +++DFG AK       T     + GT    APE +++
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILS 212

Query: 262 GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLE 321
                  D ++ GV++ E+  G        P      +      ++ K +          
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGY------PPFFADQPIQIYEKIVSGKVRFPSHFSS--- 263

Query: 322 NQYSVRAAQKACSLAYYCLSQNPKARP 348
                        L    L  +   R 
Sbjct: 264 ---------DLKDLLRNLLQVDLTKRF 281

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 3e-37
 Identities = 72/271 (26%), Positives = 105/271 (38%), Gaps = 29/271 (10%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRH 140
           +LG G +G V+          G      A+KVL K  +    +      TE   L  +R 
Sbjct: 31  VLGTGAYGKVFLVRKISGHDTGKL---YAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87

Query: 141 -PNLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFL 199
            P LV L      +    L+ +++  G L  HL ++           +        L  L
Sbjct: 88  SPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE--IVLALEHL 145

Query: 200 HNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYV 259
           H  +  +IYRD K  NILLDS+    L+DFGL+K     DET  +    GT  Y AP+ V
Sbjct: 146 H--KLGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYMAPDIV 202

Query: 260 MTGH--LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID 317
             G        D +S GV++ ELLTG        P        +      + +  +    
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGA------SP--------FTVDGEKNSQAEISRRI 248

Query: 318 PRLENQYSVRAAQKACSLAYYCLSQNPKARP 348
            + E  Y    +  A  L    L ++PK R 
Sbjct: 249 LKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  131 bits (331), Expect = 1e-35
 Identities = 56/314 (17%), Positives = 113/314 (35%), Gaps = 48/314 (15%)

Query: 71  FELETITKSFRSDY----ILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHR 126
           +E   +    + DY     LG G +  V++     N         V VK+L     +   
Sbjct: 24  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEK------VVVKILKPVKKK--- 74

Query: 127 EWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRL--LVYEFMFRGSLENHLFRKATVPLSWA 183
           +   E+  L  LR  PN++ L     +   R   LV+E +     +          L+  
Sbjct: 75  KIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDY 129

Query: 184 TRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKLSDFGLAKAGPQGDETH 242
                 +   K L + H     +++RD K  N+++D +    +L D+GLA+    G E  
Sbjct: 130 DIRFYMYEILKALDYCH--SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY- 186

Query: 243 VSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ----- 296
                + +  +  PE ++         D++S G +L  ++  ++       + +Q     
Sbjct: 187 --NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244

Query: 297 ------SLVDWAR-------PKLND--KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLS 341
                  L D+         P+ ND   R   +  +  + ++     + +A       L 
Sbjct: 245 KVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLR 304

Query: 342 QNPKARPLMSDVVE 355
            + ++R    + +E
Sbjct: 305 YDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 5e-35
 Identities = 63/313 (20%), Positives = 118/313 (37%), Gaps = 48/313 (15%)

Query: 75  TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEV 132
           T+ K +++   +G G  G V   Y     R       VA+K L++        +    E+
Sbjct: 14  TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYREL 67

Query: 133 NFLGQLRHPNLVKLIGYCC------EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRM 186
             +  + H N++ L+          E     LV E M     +                 
Sbjct: 68  VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-----DHERMS 122

Query: 187 MIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDETHVSTR 246
            + +    G+  LH     +I+RD K SNI++ SD T K+ DFGLA+       + + T 
Sbjct: 123 YLLYQMLCGIKHLH--SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTP 177

Query: 247 VMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR----------------KSVDKT 290
            + T  Y APE ++        D++S G ++ E++  +                + +   
Sbjct: 178 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 237

Query: 291 RPSKEQSLVDWARPKLNDKRKMLQIIDPRL--------ENQYSVRAAQKACSLAYYCLSQ 342
            P   + L    R  + ++ K   +  P+L        +++++   A +A  L    L  
Sbjct: 238 CPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI 297

Query: 343 NPKARPLMSDVVE 355
           +P  R  + D ++
Sbjct: 298 DPAKRISVDDALQ 310

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 4e-34
 Identities = 55/312 (17%), Positives = 116/312 (37%), Gaps = 38/312 (12%)

Query: 62  YTHVIAFSLFELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG 121
           Y   +  +++E   + + +++   +G G +G+V   +  +          VAVK L++  
Sbjct: 5   YRQELNKTIWE---VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPF 55

Query: 122 L--QGHREWLTEVNFLGQLRHPNLVKLIGYC-----CEDDHRLLVYEFMFRGSLENHLFR 174
                 +    E+  L  ++H N++ L+         E+ + + +   +    L N +  
Sbjct: 56  QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC 115

Query: 175 KATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA 234
           +    L+      + +   +GL ++H     +I+RD K SN+ ++ D   K+ DFGLA  
Sbjct: 116 Q---KLTDDHVQFLIYQILRGLKYIH--SADIIHRDLKPSNLAVNEDCELKILDFGLA-- 168

Query: 235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR---------- 284
             +  +  ++  V   +  A    +   H     D++S G ++ ELLTGR          
Sbjct: 169 --RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226

Query: 285 ---KSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLS 341
                +        + L   +     +  + L  +         + A   A  L    L 
Sbjct: 227 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLV 286

Query: 342 QNPKARPLMSDV 353
            +   R   +  
Sbjct: 287 LDSDKRITAAQA 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  117 bits (292), Expect = 7e-30
 Identities = 50/315 (15%), Positives = 98/315 (31%), Gaps = 53/315 (16%)

Query: 86  LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVK 145
           LG G F TV+      N         VA+K++  + +        E+  L ++   +  K
Sbjct: 21  LGWGHFSTVWLAKDMVNNTH------VAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73

Query: 146 LIGYCCEDDHRLL-VYEFMFRGSLENHLF-------------RKATVPLSWATRMMIAFG 191
                     +LL  +       +   +              +     +       I+  
Sbjct: 74  EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQ 133

Query: 192 AAKGLAFLHNAERPVIYRDFKTSNILLDS-DYTAKLSDFGLAKAGPQGDETHVSTRVMGT 250
              GL ++H     +I+ D K  N+L++  D    L    +A  G         T  + T
Sbjct: 134 LLLGLDYMHR-RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT 192

Query: 251 YGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR---------------------KSVDK 289
             Y +PE ++       +D++S   ++ EL+TG                        +  
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG 252

Query: 290 TRPSKEQSLVDWARPKLNDKRKMLQIIDPRL---------ENQYSVRAAQKACSLAYYCL 340
             PS       + R   N +  +  I   +          + ++S   A++        L
Sbjct: 253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 312

Query: 341 SQNPKARPLMSDVVE 355
             +P+ R     +V 
Sbjct: 313 QLDPRKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.0 bits (186), Expect = 1e-16
 Identities = 23/152 (15%), Positives = 49/152 (32%), Gaps = 11/152 (7%)

Query: 85  ILGEGGFGTVYKGYIDENVRVGLKSLPVAV---KVLNKEGLQGHREWLTEVNFLGQLRHP 141
           ++GEG    V+  Y ++     +K   V     K + ++   G   +        +    
Sbjct: 7   LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66

Query: 142 NLVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN 201
            L KL G           Y +     L   +  K    +       +     + +A  + 
Sbjct: 67  ALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFY- 120

Query: 202 AERPVIYRDFKTSNILLDSDYTAKLSDFGLAK 233
             R +++ D    N+L+  +    + DF  + 
Sbjct: 121 -HRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	431
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.82
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.18
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.89
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.21
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.0
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.0

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-58  Score=424.03  Aligned_cols=255  Identities=25%  Similarity=0.322  Sum_probs=206.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||+||+|.+..+++.      ||+|++...... ..+.+.+|+++|++++|||||++++++.+++.
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~   77 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEA------VAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNI   77 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCE------EEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCce
Confidence            35799999999999999999999876553      999998765432 34568899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .||||||+++|+|.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.++.+||+|||+|+..
T Consensus        78 ~~ivmEy~~gg~L~~~l~~~~--~l~e~~~~~i~~qi~~al~ylH~~~--IiHrDiKp~NILl~~~~~~KL~DFG~a~~~  153 (271)
T d1nvra_          78 QYLFLEYCSGGELFDRIEPDI--GMPEPDAQRFFHQLMAGVVYLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVF  153 (271)
T ss_dssp             EEEEEECCTTEEGGGGSBTTT--BCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEeccCCCcHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHHcC--CccCcccHHHEEECCCCCEEEccchhheee
Confidence            999999999999999996543  6899999999999999999999876  999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ............+||+.|||||++.+..+ +.++|||||||++|||++|+.||........... .              
T Consensus       154 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~-~--------------  218 (271)
T d1nvra_         154 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS-D--------------  218 (271)
T ss_dssp             EETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH-H--------------
T ss_pred             ccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH-H--------------
Confidence            54444444456789999999999988876 5789999999999999999999976543221110 0              


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..............+.++.+|+.+||+.||++|||+.|+++|
T Consensus       219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         219 WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            000011111112345678899999999999999999999875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=423.18  Aligned_cols=261  Identities=29%  Similarity=0.426  Sum_probs=205.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC--chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG--LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|.++.         .||||+++...  ....+.|.+|+.+|++++|||||++++++. .+.
T Consensus         8 ~~~~~~~~lG~G~fg~Vy~~~~~~---------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~   77 (276)
T d1uwha_           8 GQITVGQRIGSGSFGTVYKGKWHG---------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQ   77 (276)
T ss_dssp             TCCCCCSEEEECSSCEEEEEESSS---------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSS
T ss_pred             ccEEEEEEEeeCCCcEEEEEEECC---------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccE
Confidence            578999999999999999997643         29999987543  345577899999999999999999999875 457


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +++|||||++|+|.+++.... .++++..++.++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+|+..
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKS--IIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCC--EeccccCHHHEEEcCCCCEEEccccceeec
Confidence            899999999999999997654 35899999999999999999999866  999999999999999999999999999876


Q ss_pred             CCCCCcceeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .............||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+...........            
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~------------  222 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV------------  222 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH------------
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHH------------
Confidence            55444444456789999999999864   358999999999999999999999998754322111110            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      ............+..+++++.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus       223 ~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             HHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            000000011122334557899999999999999999999999999988764

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-57  Score=421.44  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=210.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||+||+|.+..++.      .||+|+++.......+.+.+|+.+|++++|||||+++++|.+++.+|
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~------~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   93 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQ------EVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELW   93 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCC------EEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCC------EEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEE
Confidence            579999999999999999999877654      39999988766566678999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +|||||+||+|.+++...   ++++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++....
T Consensus        94 ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~  168 (293)
T d1yhwa1          94 VVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQ--VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  168 (293)
T ss_dssp             EEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCC--CcccCCcHHHeEECCCCcEeeccchhheeecc
Confidence            999999999999988653   4899999999999999999999876  99999999999999999999999999987643


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ...  .....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+..........             ...  
T Consensus       169 ~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~-------------~~~--  231 (293)
T d1yhwa1         169 EQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI-------------ATN--  231 (293)
T ss_dssp             TTC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-------------HHH--
T ss_pred             ccc--cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHH-------------HhC--
Confidence            322  234567999999999999999999999999999999999999999764322111000             000  


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .......+...+.++.+||.+||+.||++|||+.|+++|
T Consensus       232 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         232 GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            001111223445788999999999999999999999876

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-57  Score=423.17  Aligned_cols=259  Identities=24%  Similarity=0.391  Sum_probs=217.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||+||+|.+..++..      ||||+++.+. ...++|.+|+++|++++|||||+++++|.+.+..+
T Consensus        17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          17 TDITMKHKLGGGQYGEVYEGVWKKYSLT------VAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             GGEEEEEETTTTTTSSEEEEEEGGGTEE------EEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCCCeE------EEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            5688889999999999999999876553      9999997654 34577999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++|+|.+++.......+++..++.++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+|+....
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN--FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC--cccCccccCeEEECCCCcEEEccccceeecCC
Confidence            9999999999999998877778999999999999999999999866  99999999999999999999999999987644


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ... .......||+.|+|||++.++.|+.++|||||||++|||++|..||.......                .+.+.+.
T Consensus       168 ~~~-~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~----------------~~~~~i~  230 (287)
T d1opja_         168 DTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS----------------QVYELLE  230 (287)
T ss_dssp             SSS-EEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH----------------HHHHHHH
T ss_pred             CCc-eeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH----------------HHHHHHh
Confidence            322 22334568999999999999999999999999999999999877765432211                1112222


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .......+..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       231 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             cCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            222223344456789999999999999999999999999987654

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-57  Score=415.62  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=207.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.+..++..      ||+|++.+...   .....+.+|+++|++++|||||++++++.+++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~   79 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFI------LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDAT   79 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcE------EEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECC
Confidence            4689999999999999999999876554      99999875432   23467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+|||||++|+|.+++....  ++++..+..++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+|+.
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~~~--~l~e~~~~~i~~qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~~kl~DFG~a~~  155 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQKLS--KFDEQRTATYITELANALSYCHSKR--VIHRDIKPENLLLGSAGELKIADFGWSVH  155 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEECCCCSCSC
T ss_pred             EEEEEEeecCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHCC--eeeeeeccccceecCCCCEeecccceeee
Confidence            9999999999999999997654  4889999999999999999999976  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....    ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........                .
T Consensus       156 ~~~~~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~----------------~  215 (263)
T d2j4za1         156 APSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK----------------R  215 (263)
T ss_dssp             CCCCC----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----------------H
T ss_pred             cCCCc----ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHH----------------H
Confidence            54332    234679999999999999999999999999999999999999997643211111                0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +....  ..++...++++.+|+.+||+.||++|||+.|+++|
T Consensus       216 i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         216 ISRVE--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHTTC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHcCC--CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence            11111  11222345788999999999999999999999975

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-57  Score=414.82  Aligned_cols=256  Identities=27%  Similarity=0.419  Sum_probs=199.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||+||+|.+.++.       .||||+++... ...++|.+|++++++++|||||++++++.+++..+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKD-------KVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   76 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTE-------EEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCC-------EEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceE
Confidence            46888899999999999999987643       39999997654 34577999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++....
T Consensus        77 lv~E~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qia~gl~~lH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          77 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEAC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCTTCSGGGEEECGGGCEEECSCC-------
T ss_pred             EEEEecCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHhhhccc--eeecccchhheeecCCCCeEecccchheeccC
Confidence            9999999999999986643 45889999999999999999999876  99999999999999999999999999987544


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+++ .+||.......   ...              .+
T Consensus       154 ~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~---~~~--------------~i  215 (263)
T d1sm2a_         154 DQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVE--------------DI  215 (263)
T ss_dssp             ------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH---HHH--------------HH
T ss_pred             CCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH---HHH--------------HH
Confidence            3322 22345799999999999999999999999999999999995 44444322111   111              11


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ........+..++.++.+|+.+||+.||++|||++||+++|+++++
T Consensus       216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence            1111111223345788999999999999999999999999998865

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-56  Score=420.32  Aligned_cols=262  Identities=24%  Similarity=0.419  Sum_probs=202.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.++||+|+||+||+|.+..++..   ...||||.+..... ...++|.+|+++|++++|||||++++++.+.+.+
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~  102 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKR---EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV  102 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---C---CEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCE---EEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            4678889999999999999998654321   22489998876533 3456799999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++|||||++|+|.+++.... ..+++..++.++.|++.||.|||+.+  ||||||||+||||+.++.+||+|||+++...
T Consensus       103 ~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         103 MIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMN--YVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             EEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCC--CccCccccceEEECCCCcEEECCcccceEcc
Confidence            99999999999999887643 35899999999999999999999866  9999999999999999999999999998754


Q ss_pred             CCCCcce---eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          237 QGDETHV---STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       237 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .......   .....||+.|+|||++.++.|+.++|||||||++|||+| |+.||.+......                 
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~-----------------  242 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDV-----------------  242 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH-----------------
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHH-----------------
Confidence            4322211   122468999999999999999999999999999999998 8999976532211                 


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      ...+........+..++..+.+|+.+||+.||++|||+.||++.|+++..
T Consensus       243 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         243 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11111111122233456788999999999999999999999999998764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-57  Score=416.63  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=195.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe--C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE--D  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~  153 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||+|++.....  ...+.+.+|+++|++++|||||++++++.+  .
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   77 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKI------LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN   77 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC---
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCE------EEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCC
Confidence            5689999999999999999999876554      99999876543  234568899999999999999999999865  4


Q ss_pred             CeeEEEEEecCCCChHHhhhhC--CCCCcCHHHHHHHHHHHHHHHHHhHhCC---CCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 DHRLLVYEFMFRGSLENHLFRK--ATVPLSWATRMMIAFGAAKGLAFLHNAE---RPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~~i~~~l~~LH~~~---~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      +.+|+|||||++|+|.+++.+.  ....+++..++.++.|++.||.|||+.+   .+||||||||+||||+.++.+||+|
T Consensus        78 ~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~D  157 (269)
T d2java1          78 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGD  157 (269)
T ss_dssp             -CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECC
T ss_pred             CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEee
Confidence            5689999999999999998642  3456899999999999999999999743   3499999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      ||+++......  .......||+.|+|||++.+..|+.++|||||||++|||++|+.||........   ..        
T Consensus       158 FG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~---~~--------  224 (269)
T d2java1         158 FGLARILNHDT--SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL---AG--------  224 (269)
T ss_dssp             HHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH---HH--------
T ss_pred             ccceeecccCC--CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHH---HH--------
Confidence            99998754322  223456899999999999999999999999999999999999999976432111   00        


Q ss_pred             cchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 KRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           .+..... ...+...++++.+|+.+||+.||.+|||+.||++|
T Consensus       225 -----~i~~~~~-~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         225 -----KIREGKF-RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----HHHHTCC-CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----HHHcCCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                 0111111 11223345788999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=417.95  Aligned_cols=252  Identities=25%  Similarity=0.394  Sum_probs=208.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      +.|++.+.||+|+||+||+|.+..++..      ||+|+++.......+.+.+|+++|++++|||||++++++.+++.+|
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   85 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVL------AAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLW   85 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeE------EEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEE
Confidence            4688999999999999999999876554      9999998766666678899999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      ||||||++|+|.+++.+.. .++++..+..++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||+|+....
T Consensus        86 lvmEy~~~g~L~~~~~~~~-~~l~e~~~~~i~~qi~~gL~ylH~~~--ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~  162 (288)
T d2jfla1          86 ILIEFCAGGAVDAVMLELE-RPLTESQIQVVCKQTLDALNYLHDNK--IIHRDLKAGNILFTLDGDIKLADFGVSAKNTR  162 (288)
T ss_dssp             EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEECHH
T ss_pred             EEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--EEEeecChhheeECCCCCEEEEechhhhccCC
Confidence            9999999999999886543 35899999999999999999999876  99999999999999999999999999975322


Q ss_pred             CCCcceeecccCCccccCccccc-----cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVM-----TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      .  .......+||+.|+|||++.     +..|+.++|||||||++|||++|+.||.+........               
T Consensus       163 ~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~---------------  225 (288)
T d2jfla1         163 T--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL---------------  225 (288)
T ss_dssp             H--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH---------------
T ss_pred             C--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH---------------
Confidence            1  11223467999999999984     4568999999999999999999999997654322111               


Q ss_pred             hhhcCc-cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDP-RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+... ......+...+.++.+||.+||+.||.+|||+.|+++|
T Consensus       226 -~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         226 -KIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -HHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             11100 00111223455788999999999999999999999875

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-56  Score=409.70  Aligned_cols=249  Identities=27%  Similarity=0.394  Sum_probs=198.9

Q ss_pred             CCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe----C
Q 014079           80 FRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE----D  153 (431)
Q Consensus        80 y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~  153 (431)
                      |++.+.||+|+||+||+|.+..++.      .||+|++.....  ...+.+.+|+++|++++|||||++++++.+    .
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~------~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   84 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTV------EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK   84 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCC------EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCe------EEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccC
Confidence            3566789999999999999987654      399998876532  344678899999999999999999999875    3


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC-CCCcEEEecccCC
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD-SDYTAKLSDFGLA  232 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~-~~~~~kl~DFG~a  232 (431)
                      ..+|+||||+++|+|.+++.+..  .+++..++.++.||+.||+|||+.+.+|+||||||+||||+ +++.+||+|||++
T Consensus        85 ~~~~ivmE~~~~g~L~~~l~~~~--~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla  162 (270)
T d1t4ha_          85 KCIVLVTELMTSGTLKTYLKRFK--VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA  162 (270)
T ss_dssp             EEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred             CEEEEEEeCCCCCcHHHHHhccc--cccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence            56799999999999999997654  57889999999999999999998666699999999999996 5789999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      +.....    .....+||+.|+|||++.+ .|+.++|||||||++|||++|+.||.........  ..            
T Consensus       163 ~~~~~~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~--~~------------  223 (270)
T d1t4ha_         163 TLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI--YR------------  223 (270)
T ss_dssp             GGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH--HH------------
T ss_pred             eeccCC----ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHH--HH------------
Confidence            864322    2335689999999998865 6999999999999999999999999754322111  00            


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+........++...++++.+||.+||+.||++|||+.|+++|
T Consensus       224 -~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         224 -RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             -HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -HHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCC
Confidence             0011111111222334678899999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-56  Score=414.11  Aligned_cols=258  Identities=27%  Similarity=0.436  Sum_probs=209.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.++++.       .||||+++... ...+.|.+|+.+|++++|||||++++++.+ +..+
T Consensus        13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          13 ETLKLVERLGAGQFGEVWMGYYNGHT-------KVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTE-------EEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEeEEEecCCCcEEEEEEECCCC-------EEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            57888999999999999999987543       39999997654 345679999999999999999999998754 5679


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++|+|.+++......++++..++.++.||+.||.|||+.+  |+||||||+||||+.++.+||+|||+|+....
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~--ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~  161 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN--YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCccchhheeeecccceeeccccceEEccC
Confidence            9999999999999887665556899999999999999999999866  99999999999999999999999999987654


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      ... .......||+.|+|||++.++.++.++|||||||++|||+||..|+........  ..              ..+.
T Consensus       162 ~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~--~~--------------~~i~  224 (272)
T d1qpca_         162 NEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE--VI--------------QNLE  224 (272)
T ss_dssp             SCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH--HH--------------HHHH
T ss_pred             Ccc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH--HH--------------HHHH
Confidence            322 223346799999999999999999999999999999999997665543322110  11              1111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .......+..++.++.+|+.+||+.||++|||+.+|++.|+.+-.+
T Consensus       225 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         225 RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            1111122334557889999999999999999999999999876543

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-56  Score=424.37  Aligned_cols=262  Identities=25%  Similarity=0.426  Sum_probs=211.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.++||+|+||+||+|.+....+.. ....||+|++..... .....+.+|+.+|.++ +|||||++++++.+.+.
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGISKTG-VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCSSSS-CEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCCccc-ceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            57889999999999999999987543221 123489998865432 3345788999999998 89999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCC---------------------CCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKAT---------------------VPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTS  214 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~  214 (431)
                      +|+|||||++|+|.++|.....                     ..+++..++.++.|++.||+|||+.+  ||||||||+
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--IiHRDlKp~  193 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--CVHRDLAAR  193 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--EEETTCSGG
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCchh
Confidence            9999999999999999976432                     35889999999999999999999876  999999999


Q ss_pred             CEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCc
Q 014079          215 NILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPS  293 (431)
Q Consensus       215 NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~  293 (431)
                      |||++.++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||++|||++ |+.||.+....
T Consensus       194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~  273 (325)
T d1rjba_         194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD  273 (325)
T ss_dssp             GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred             ccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987655444444445678999999999999999999999999999999998 89999765432


Q ss_pred             ccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHh
Q 014079          294 KEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLE  358 (431)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~  358 (431)
                      ..                +.+++........+..+++++.+||.+||+.||++|||+.||+++|.
T Consensus       274 ~~----------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         274 AN----------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HH----------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HH----------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            21                11112122222333445678999999999999999999999999985

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=424.62  Aligned_cols=266  Identities=23%  Similarity=0.321  Sum_probs=207.1

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||+||+|.+..++..      ||+|+++.... .....+.+|+.+|++++|||||+++++|.+.+.
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~   78 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLV------MARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE   78 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEE------EEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcE------EEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            46799999999999999999999876654      99999876533 334678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      +|+||||++||+|.+++.+.+  .+++..+..++.|++.||.|||+ ++  |+||||||+||||+.++.+||+|||+|+.
T Consensus        79 ~~iVmEy~~gg~L~~~l~~~~--~l~~~~~~~~~~qil~aL~yLH~~~~--IiHRDiKP~NILl~~~~~vkl~DFGla~~  154 (322)
T d1s9ja_          79 ISICMEHMDGGSLDQVLKKAG--RIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEEECCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHHHC--CCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred             EEEEEEcCCCCcHHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHHhCC--EEccccCHHHeeECCCCCEEEeeCCCccc
Confidence            999999999999999997754  48899999999999999999997 36  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-h----------
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA-R----------  303 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~----------  303 (431)
                      ....    .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||............... .          
T Consensus       155 ~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (322)
T d1s9ja_         155 LIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRP  230 (322)
T ss_dssp             HHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------
T ss_pred             cCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccc
Confidence            4221    223468999999999999999999999999999999999999999765432211000000 0          


Q ss_pred             ---------------hhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          304 ---------------PKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       304 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                                     +..........+.............+.++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         231 RTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ---------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                           00000000000000000000111234688999999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-56  Score=417.81  Aligned_cols=251  Identities=23%  Similarity=0.309  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||||++.+...   ...+.+.+|+++|++++|||||++++++.+++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   81 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSRE------YAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDE   81 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSS
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECC
Confidence            5699999999999999999999876553      99999876432   23467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++||+|.+++...+  .+++..+..++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+|+.
T Consensus        82 ~~~ivmEy~~gg~L~~~~~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~NIll~~~~~vkl~DFG~a~~  157 (288)
T d1uu3a_          82 KLYFGLSYAKNGELLKYIRKIG--SFDETCTRFYTAEIVSALEYLHGKG--IIHRDLKPENILLNEDMHIQITDFGTAKV  157 (288)
T ss_dssp             EEEEEECCCTTEEHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEEccCCCCHHHhhhccC--CCCHHHHHHHHHHHHHHHHhhcccc--EEcCcCCccccccCCCceEEeccccccee
Confidence            9999999999999999987654  5889999999999999999999977  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.........                ..
T Consensus       158 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~----------------~~  221 (288)
T d1uu3a_         158 LSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF----------------QK  221 (288)
T ss_dssp             CC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----------------HH
T ss_pred             cccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHH----------------HH
Confidence            65444443445578999999999999999999999999999999999999999764321111                01


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +....+  .++...++++.+||.+||+.||.+|||++|++.+
T Consensus       222 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         222 IIKLEY--DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HHTTCC--CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             HHcCCC--CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence            111111  1222345788999999999999999999997654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-55  Score=402.97  Aligned_cols=254  Identities=23%  Similarity=0.394  Sum_probs=210.7

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||+||+|.++++.       .||||++++... ..++|.+|+.++++++|||||+++++|.+++.++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~-------~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~   75 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQY-------DVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   75 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTE-------EEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCC-------EEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceE
Confidence            57889999999999999999986543       399999987653 4568999999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++|+|.+++..... .+++..++.++.|++.||.|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus        76 iv~Ey~~~g~l~~~~~~~~~-~~~~~~~~~i~~qi~~gl~~LH~~~--iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          76 IITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAMEYLESKQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EEEECCTTEEHHHHHHSGGG-CCCHHHHHHHHHHHHHHHHHHHHTT--BCCSCCSGGGEEECTTCCEEECCCSSCCBCSS
T ss_pred             EEEEccCCCcHHHhhhcccc-CCcHHHHHHHHHHHHHHHHHHhhcC--cccccccceeEEEcCCCcEEECcchhheeccC
Confidence            99999999999998765433 5788999999999999999999866  99999999999999999999999999987554


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhc
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQII  316 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (431)
                      .... ......||+.|+|||++.+..|+.++|||||||++|||+| |+.||...........                 +
T Consensus       153 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~-----------------i  214 (258)
T d1k2pa_         153 DEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH-----------------I  214 (258)
T ss_dssp             SSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH-----------------H
T ss_pred             CCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHH-----------------H
Confidence            3322 2334679999999999999999999999999999999998 8999976542211111                 1


Q ss_pred             CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          317 DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ........+...+.++.+||.+||+.||++|||+.+|+++|.++
T Consensus       215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            11111122334457889999999999999999999999998653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=410.24  Aligned_cols=259  Identities=27%  Similarity=0.386  Sum_probs=207.2

Q ss_pred             cCCCccce-ecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYI-LGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~-lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|.+.+. ||+|+||.||+|.++...    ++..||||+++.... ...++|.+|+++|++++|||||++++++.+ +.
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~----~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~   82 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRK----KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EA   82 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC-------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCC----CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-Ce
Confidence            34566664 999999999999875432    123599999976543 345779999999999999999999999865 56


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +||||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+++..
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~-~~l~~~~~~~i~~qi~~gL~ylH~~~--iiHrDlKp~Nill~~~~~~Kl~DFGla~~~  159 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKR-EEIPVSNVAELLHQVSMGMKYLEEKN--FVHRDLAARNVLLVNRHYAKISDFGLSKAL  159 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCT-TTSCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCcHHHHhhccc-cCCCHHHHHHHHHHHHHHHHHHHhCC--eecCcCchhheeeccCCceeeccchhhhcc
Confidence            899999999999999885543 36899999999999999999999866  999999999999999999999999999876


Q ss_pred             CCCCCc-ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          236 PQGDET-HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       236 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ...... .......||+.|+|||++.++.++.++|||||||++|||++ |+.||.........                 
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~-----------------  222 (285)
T d1u59a_         160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVM-----------------  222 (285)
T ss_dssp             TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHH-----------------
T ss_pred             cccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHH-----------------
Confidence            543322 22234578999999999999999999999999999999998 99999765432111                 


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      ..+........+..++.++.+|+.+||+.||++|||+.+|++.|+.+.
T Consensus       223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~  270 (285)
T d1u59a_         223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY  270 (285)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            111111112233445678999999999999999999999999988654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=409.78  Aligned_cols=265  Identities=27%  Similarity=0.435  Sum_probs=205.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ..|++.++||+|+||.||+|.++.+..  .....||||+++.... ....+|.+|+++|++++|||||++++++.+.+..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~--~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~   84 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSG--KKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM   84 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC-----CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCC--EEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCce
Confidence            457888999999999999999876432  1223599999876533 3345689999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+  |+||||||+||||+.++.+||+|||+++...
T Consensus        85 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~--iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          85 MIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccc--cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999999999886654 36899999999999999999999976  9999999999999999999999999998754


Q ss_pred             CCCC-cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDE-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .... ........||+.|+|||++.++.++.++|||||||++|||++|..||.......                .+...
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~----------------~~~~~  225 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH----------------EVMKA  225 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH----------------HHHHH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHH----------------HHHHH
Confidence            4322 222334568999999999999999999999999999999999766654432211                11111


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      +........+..++.++.+|+.+||+.||++|||+.||++.|+.+...
T Consensus       226 i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         226 INDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            222222233344567899999999999999999999999999987654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=5.9e-55  Score=418.03  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=211.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      -++|++.+.||+|+||.||+|.+..++..      ||||++........+.+.+|+.+|++++|||||++++++.+++.+
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~------vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNN------FAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEE------EEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCE------EEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            45799999999999999999999876554      999999887666667889999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC--CCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS--DYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~--~~~~kl~DFG~a~~  234 (431)
                      |||||||+||+|.+++.... .++++..+..++.||+.||.|||+.+  ||||||||+||||+.  ++.+||+|||+++.
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcC--CeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999999999999986543 35899999999999999999999977  999999999999964  57899999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....   ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.........+.             .
T Consensus       176 ~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~-------------~  239 (350)
T d1koaa2         176 LDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK-------------S  239 (350)
T ss_dssp             CCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------H
T ss_pred             ccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-------------h
Confidence            64432   2334679999999999999999999999999999999999999997653211111000             0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       .+..+........++++.+||.+||+.||++|||+.|+++|
T Consensus       240 -~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         240 -CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -TCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -CCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             01111112223345788999999999999999999999986

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-55  Score=415.80  Aligned_cols=255  Identities=23%  Similarity=0.359  Sum_probs=194.1

Q ss_pred             HHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           75 TITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        75 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      .+.+.|++.+.||+|+||+||+|.+..+++.      ||||++.+.... ....+.+|+.+|++++|||||++++++.++
T Consensus         6 di~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~   79 (307)
T d1a06a_           6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKL------VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG   79 (307)
T ss_dssp             CGGGTEEEEEESBSGGGGGEEEEEETTTCCE------EEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             CCccceEEEEEEeeccCeEEEEEEECCCCCE------EEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence            3567899999999999999999999876554      999999765433 234577999999999999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC---CCCcEEEeccc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD---SDYTAKLSDFG  230 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~---~~~~~kl~DFG  230 (431)
                      +.+|||||||+||+|.+++....  .+++..+..++.||+.||+|||+.+  ||||||||+|||+.   +++.+||+|||
T Consensus        80 ~~~~lvmE~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~al~ylH~~~--iiHrDiKp~Nil~~~~~~~~~vkl~DFG  155 (307)
T d1a06a_          80 GHLYLIMQLVSGGELFDRIVEKG--FYTERDASRLIFQVLDAVKYLHDLG--IVHRDLKPENLLYYSLDEDSKIMISDFG  155 (307)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCS--CCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEESSSSTTCCEEECCC-
T ss_pred             CEEEEEEeccCCCcHHHhhhccc--CCCHHHHHHHHHHHHHHHHhhhhce--eeeEEecccceeecccCCCceEEEeccc
Confidence            99999999999999999997644  5899999999999999999999876  99999999999994   57899999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      +++......   .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.      .   
T Consensus       156 ~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~---  223 (307)
T d1a06a_         156 LSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQIL------K---  223 (307)
T ss_dssp             --------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------T---
T ss_pred             eeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHh------c---
Confidence            998654332   2334679999999999999999999999999999999999999997643211110000      0   


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           ....+........++++.+|+.+||+.||++|||+.|+++|
T Consensus       224 -----~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         224 -----AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             -----TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             -----cCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                 01111112223455788999999999999999999999986

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-55  Score=404.01  Aligned_cols=251  Identities=28%  Similarity=0.409  Sum_probs=199.8

Q ss_pred             ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeEEEEE
Q 014079           84 YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRLLVYE  161 (431)
Q Consensus        84 ~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  161 (431)
                      +.||+|+||+||+|.+.....    ...||||+++....  ...+++.+|+++|++++|||||+++++|.+ +..+||||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~----~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE   87 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKV----VKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVME   87 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSS----EEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCc----CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEE
Confidence            469999999999998764321    12499999875432  234679999999999999999999999865 56789999


Q ss_pred             ecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCCc
Q 014079          162 FMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDET  241 (431)
Q Consensus       162 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~~  241 (431)
                      |+++|+|.+++....  ++++..++.++.||+.||+|||+.+  ||||||||+||||+.++.+||+|||+++........
T Consensus        88 ~~~~g~L~~~l~~~~--~l~~~~~~~i~~qi~~gl~ylH~~~--iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          88 MAELGPLNKYLQQNR--HVKDKNIIELVHQVSMGMKYLEESN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             CCTTEEHHHHHHHCT--TCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             cCCCCcHHHHHhhcc--CCCHHHHHHHHHHHHHHHhhHHhCC--cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            999999999997654  5899999999999999999999876  999999999999999999999999999876543322


Q ss_pred             c-eeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCcc
Q 014079          242 H-VSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDPR  319 (431)
Q Consensus       242 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  319 (431)
                      . ......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......                 ...+...
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~-----------------~~~i~~~  226 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEV-----------------TAMLEKG  226 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH-----------------HHHHHTT
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHH-----------------HHHHHcC
Confidence            2 2234579999999999999999999999999999999998 8999976532111                 1111111


Q ss_pred             ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          320 LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       320 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      .....+..++.++.+|+.+||+.||++|||+.+|++.|+..
T Consensus       227 ~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCH
Confidence            11223334567899999999999999999999999888754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-55  Score=412.99  Aligned_cols=247  Identities=29%  Similarity=0.430  Sum_probs=203.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      +.|+..+.||+|+||+||+|.+..++..      ||||++......   ..+.+.+|+++|++++|||||++++++.+++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   88 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEV------VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREH   88 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcE------EEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECC
Confidence            4589999999999999999999877654      999998765432   3356889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..|+|||||.+|+|..++....  ++++..++.++.||+.||.|||+.+  ||||||||+||||+.++.+||+|||+++.
T Consensus        89 ~~~iv~E~~~~g~l~~~~~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHrDiKp~NILl~~~~~~Kl~DFG~a~~  164 (309)
T d1u5ra_          89 TAWLVMEYCLGSASDLLEVHKK--PLQEVEIAAVTHGALQGLAYLHSHN--MIHRDVKAGNILLSEPGLVKLGDFGSASI  164 (309)
T ss_dssp             EEEEEEECCSEEHHHHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCSGGGEEEETTTEEEECCCTTCBS
T ss_pred             EEEEEEEecCCCchHHHHHhCC--CCCHHHHHHHHHHHHHHHHHHHhCC--EeccCCCcceEEECCCCCEEEeecccccc
Confidence            9999999999999987765543  5899999999999999999999976  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCcccccc---CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccch
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMT---GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRK  311 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  311 (431)
                      ...      .....||+.|||||++.+   +.|+.++|||||||++|||++|+.||.+......                
T Consensus       165 ~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~----------------  222 (309)
T d1u5ra_         165 MAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA----------------  222 (309)
T ss_dssp             SSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH----------------
T ss_pred             cCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH----------------
Confidence            432      223579999999999864   4689999999999999999999999976432111                


Q ss_pred             hhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      +..+.........+...++++.+||.+||+.||.+|||+.|+++|
T Consensus       223 ~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         223 LYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence            011111111111122345788999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=9.3e-55  Score=416.97  Aligned_cols=254  Identities=23%  Similarity=0.293  Sum_probs=211.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+.|++.+.||+|+||.||+|.+..++..      ||||+++.........+.+|+.+|++++|||||+++++|.+++.+
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~  101 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRV------FVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM  101 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCE------EEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            35799999999999999999998776554      999999877666667788999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC--CCCcEEEecccCCcc
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD--SDYTAKLSDFGLAKA  234 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~--~~~~~kl~DFG~a~~  234 (431)
                      |||||||+||+|.+++.... .++++..++.++.||+.||.|||+.+  ||||||||+||||+  .++.+||+|||+|+.
T Consensus       102 ~ivmE~~~gg~L~~~~~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~--iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         102 VLILEFLSGGELFDRIAAED-YKMSEAEVINYMRQACEGLKHMHEHS--IVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEEECCCCCBHHHHTTCTT-CCBCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEEcCCCChHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--eeecccccccccccccCCCeEEEeeccccee
Confidence            99999999999999876543 46899999999999999999999876  99999999999998  578999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      .....   ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.              
T Consensus       179 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~--------------  241 (352)
T d1koba_         179 LNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK--------------  241 (352)
T ss_dssp             CCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH--------------
T ss_pred             cCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--------------
Confidence            65432   2344679999999999999999999999999999999999999997643221111000              


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..+..+........+.++.+||.+||++||.+|||+.|+++|
T Consensus       242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             hCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            001111222223455788999999999999999999999986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-54  Score=406.79  Aligned_cols=254  Identities=24%  Similarity=0.329  Sum_probs=209.0

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc------hhHHHHHHHHHHHhcCCCCceeeeecE
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL------QGHREWLTEVNFLGQLRHPNLVKLIGY  149 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~  149 (431)
                      +.++|++.+.||+|+||+||+|.+..++..      ||||++++...      ...+.+.+|+.+|++++|||||+++++
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~------~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   81 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQ------YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEV   81 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCE------EEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            457899999999999999999999776553      99999875432      235678999999999999999999999


Q ss_pred             EEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC----cEE
Q 014079          150 CCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY----TAK  225 (431)
Q Consensus       150 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~----~~k  225 (431)
                      |.+.+.+|||||||++|+|.+++....  .+++..++.++.|++.||+|||+.+  |+||||||+|||++.++    .+|
T Consensus        82 ~~~~~~~~iv~E~~~gg~L~~~i~~~~--~l~~~~~~~~~~qi~~al~yLH~~~--ivHrDiKp~Nill~~~~~~~~~vk  157 (293)
T d1jksa_          82 YENKTDVILILELVAGGELFDFLAEKE--SLTEEEATEFLKQILNGVYYLHSLQ--IAHFDLKPENIMLLDRNVPKPRIK  157 (293)
T ss_dssp             EECSSEEEEEEECCCSCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSSSSCCEE
T ss_pred             EEECCEEEEEEEcCCCccccchhcccc--ccchhHHHHHHHHHHHHHHhhhhcc--eeecccccceEEEecCCCcccceE
Confidence            999999999999999999999997754  5899999999999999999999877  99999999999998876    599


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.     
T Consensus       158 l~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~-----  229 (293)
T d1jksa_         158 IIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS-----  229 (293)
T ss_dssp             ECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-----
T ss_pred             ecchhhhhhcCCCc---cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH-----
Confidence            99999998764432   2234679999999999999999999999999999999999999997643221110000     


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                              . ....+........+.++.+||.+||+.||++|||+.|+++|
T Consensus       230 --------~-~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         230 --------A-VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             --------T-TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------h-cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    0 01111111222345788999999999999999999999875

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=403.83  Aligned_cols=259  Identities=27%  Similarity=0.417  Sum_probs=206.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      ++|++.+.||+|+||.||+|.++++.       .||||+++... ...+.|.+|+.+|++++|||||++++++. .+..+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~-------~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~   87 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTT-------RVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIY   87 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTE-------EEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCE
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCC-------EEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeE
Confidence            57999999999999999999987653       39999997654 34577999999999999999999999985 45689


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+++|+|..++.......+++..++.++.|++.||+|||+.+  |+||||||+||||+.++++||+|||+++....
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~--ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~  165 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN--YVHRDLRAANILVGENLVCKVADFGLARLIED  165 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh--eecccccceEEEECCCCcEEEcccchhhhccC
Confidence            9999999999999987765556899999999999999999999876  99999999999999999999999999987543


Q ss_pred             CCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcC
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIID  317 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (431)
                      .... ......||+.|+|||++.++.++.++|||||||++|||++|..||........                +...+.
T Consensus       166 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~----------------~~~~i~  228 (285)
T d1fmka3         166 NEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVE  228 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHH
T ss_pred             CCce-eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHH----------------HHHHHH
Confidence            3322 23345799999999999999999999999999999999997666654322111                111111


Q ss_pred             ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcC
Q 014079          318 PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCAN  364 (431)
Q Consensus       318 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~  364 (431)
                      .......+..++.++.+||.+||+.||++||++.+|++.|+......
T Consensus       229 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         229 RGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             TTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             hcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            11122233445678999999999999999999999999998766543

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=408.47  Aligned_cols=249  Identities=29%  Similarity=0.368  Sum_probs=208.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+..+++.      ||+|++++...   ...+.+.+|+.+|++++|||||+++++|.+.+
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~------~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   78 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRY------YAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHD   78 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSS
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCE------EEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccc
Confidence            5689999999999999999998876554      99999976532   34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+|||||+||+|.+++....  .+++..++.++.|++.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+.
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~~~--~~~e~~~~~~~~qil~al~ylH~~~--iiHRDlKP~NILl~~~g~vkl~DFG~a~~  154 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSRER--VFTEERARFYGAEIVSALEYLHSRD--VVYRDIKLENLMLDKDGHIKITDFGLCKE  154 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             ccccceeccCCCchhhhhhccc--CCcHHHHHHHHHHHhhhhhhhhhcC--ccccccCHHHeEecCCCCEEEeecccccc
Confidence            9999999999999999997765  4788889999999999999999977  99999999999999999999999999986


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ......  .....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+........                .
T Consensus       155 ~~~~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~----------------~  216 (337)
T d1o6la_         155 GISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE----------------L  216 (337)
T ss_dssp             SCCTTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cccCCc--ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH----------------H
Confidence            543222  2345789999999999999999999999999999999999999998754211110                0


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                      +....  ..++...+.++.+||.+||++||.+|++     +.|+++|
T Consensus       217 i~~~~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         217 ILMEE--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HhcCC--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence            11111  1123344578899999999999999994     8888875

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=407.27  Aligned_cols=262  Identities=24%  Similarity=0.372  Sum_probs=206.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC-chhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG-LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      .+|++.++||+|+||+||+|.+..++..  ...+||+|.++... ....+++.+|+.+|++++|||||+++++|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEK--VKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCE--EEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            3589999999999999999998755432  11248999886542 34567899999999999999999999999765 56


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++++||+.+++|.+++.... ..+++..++.++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||+++...
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~--iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTS-SSCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccc-cCCCHHHHHHHHHHHHHHHHHHHHcC--cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            78889999999999887653 46899999999999999999999976  9999999999999999999999999998765


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ............||+.|+|||++.++.|+.++|||||||++|||+| |..||.........                 ..
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-----------------~~  225 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-----------------SI  225 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-----------------HH
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-----------------HH
Confidence            5444444445679999999999999999999999999999999998 78888765322211                 11


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      +........+..++.++.+|+.+||+.||++|||+.||+++|+.+..
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            11111112233455788999999999999999999999999987653

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=398.59  Aligned_cols=261  Identities=24%  Similarity=0.366  Sum_probs=200.3

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+..+...   ...||||.++..... ..+.+.+|+.+|++++|||||++++++. .+..
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~---~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~   82 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSPENP---ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   82 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC--C---CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecCCce---eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence            5789999999999999999998654321   224899988754333 3467899999999999999999999985 5678


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      |+||||+++|+|.+++.... .++++..++.++.|++.||.|||+.+  ||||||||+|||++.++.+||+|||+++...
T Consensus        83 ~iv~E~~~~g~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          83 WIIMELCTLGELRSFLQVRK-YSLDLASLILYAYQLSTALAYLESKR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEEEECCTTEEHHHHHHHTT-TTSCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEEEeccCCcHHhhhhccC-CCCCHHHHHHHHHHHHHHhhhhcccC--eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999999876543 46899999999999999999999976  9999999999999999999999999998754


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      .... .......||+.|+|||++.++.|+.++|||||||++|||++ |..||...........+                
T Consensus       160 ~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----------------  222 (273)
T d1mp8a_         160 DSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----------------  222 (273)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----------------
T ss_pred             CCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----------------
Confidence            3322 22334568999999999999999999999999999999998 89999765432211111                


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .. ......+..+++++.+||.+||+.||++|||+.||+++|+.+...
T Consensus       223 ~~-~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         223 EN-GERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             HT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             Hc-CCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            00 111122334567899999999999999999999999999887543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-54  Score=396.82  Aligned_cols=251  Identities=26%  Similarity=0.426  Sum_probs=200.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEe-CCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-DDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.+++.        .||||+++++.  ..+.+.+|+++|++++|||||++++++.+ .+.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~~~--------~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYRGN--------KVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTE--------EEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             HHeEEeEEEecCCCeEEEEEEECCe--------EEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            4578889999999999999988532        39999997653  44678999999999999999999999865 4668


Q ss_pred             EEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCC
Q 014079          157 LLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGP  236 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~  236 (431)
                      ++||||+++|+|.+++.......+++..++.++.||+.||.|||+.+  |+||||||+|||++.++.+||+|||+++...
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~--ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~  154 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS  154 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTSCEEECCCCC-----
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc--eeccccchHhheecCCCCEeecccccceecC
Confidence            99999999999999997765556899999999999999999999866  9999999999999999999999999998643


Q ss_pred             CCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchhhhh
Q 014079          237 QGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQI  315 (431)
Q Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (431)
                      ..     .....+|+.|+|||++.++.++.++|||||||++|||++ |+.||........   .              ..
T Consensus       155 ~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~---~--------------~~  212 (262)
T d1byga_         155 ST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---V--------------PR  212 (262)
T ss_dssp             ------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH---H--------------HH
T ss_pred             CC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH---H--------------HH
Confidence            32     223468999999999999999999999999999999998 6777765432211   1              11


Q ss_pred             cCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          316 IDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      +......+.+...+.++.+|+.+||+.||.+|||+.+|+++|+.++.
T Consensus       213 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         213 VEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence            11112223334455788999999999999999999999999998864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-54  Score=404.73  Aligned_cols=267  Identities=27%  Similarity=0.373  Sum_probs=202.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeC-C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCED-D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-~  154 (431)
                      ++|++.+.||+|+||.||+|.+...... .....||||+++.... ...+.+.+|..++.++ +|+|||.+++++.+. .
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~-~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKT-ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSS-SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcc-cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            6799999999999999999998654321 1223599999876533 3446678888888877 589999999988765 4


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      .+++|||||++|+|.+++....              ...+++..++.++.|++.||.|||+.+  ||||||||+||||+.
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~--ivHrDlKp~NILl~~  169 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK--CIHRDLAARNILLSE  169 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC--CcCCcCCccceeECC
Confidence            6899999999999999996542              235889999999999999999999976  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccchhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~~  299 (431)
                      ++.+||+|||+|+...............||+.|+|||++.++.++.++|||||||++|||++| ..||........    
T Consensus       170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~----  245 (299)
T d1ywna1         170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----  245 (299)
T ss_dssp             GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH----
T ss_pred             CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHH----
Confidence            999999999999876544443334456799999999999999999999999999999999996 457765432211    


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                  +...+........+...++++.+|+.+||+.||++|||+.||+++|+.+.++
T Consensus       246 ------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq~  297 (299)
T d1ywna1         246 ------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  297 (299)
T ss_dssp             ------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                        1111111111122333457889999999999999999999999999987644

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.7e-53  Score=402.58  Aligned_cols=246  Identities=26%  Similarity=0.371  Sum_probs=205.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||+||+|.++.+++.      ||||++++...   ...+.+.+|+.+|++++|||||++++++.+.+
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~------vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~   77 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRY------YAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ   77 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSS
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCE------EEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCC
Confidence            4689999999999999999999876554      99999875422   34567889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      .+|+||||++||+|..++....  .+++.....++.||+.||+|||+.+  ||||||||+||||+.+|.+||+|||+|+.
T Consensus        78 ~~~ivmE~~~gg~l~~~~~~~~--~~~~~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NILl~~~g~vkL~DFG~a~~  153 (316)
T d1fota_          78 QIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHSKD--IIYRDLKPENILLDKNGHIKITDFGFAKY  153 (316)
T ss_dssp             EEEEEECCCCSCBHHHHHHHTS--SCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             eeeeEeeecCCccccccccccc--cccccHHHHHHHHHHHhhhhhccCc--EEccccCchheeEcCCCCEEEecCccceE
Confidence            9999999999999999987765  4677888889999999999999866  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.......                ..
T Consensus       154 ~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~  212 (316)
T d1fota_         154 VPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY----------------EK  212 (316)
T ss_dssp             CSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH----------------HH
T ss_pred             eccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHH----------------HH
Confidence            5432     23468999999999999999999999999999999999999999764321111                11


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +....  ..++...+.++.+++.+||++||.+|+     |++++++|
T Consensus       213 i~~~~--~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         213 ILNAE--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHcCC--CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            11111  112223456788999999999999996     89999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.3e-53  Score=401.66  Aligned_cols=265  Identities=25%  Similarity=0.374  Sum_probs=211.2

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch-hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ-GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||+||+|.++.... ...+..||||+++..... ..+++.+|+.+|++++||||+++++++.+.+.
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLP-YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSST-TSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCcc-CCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            4679999999999999999999764211 012235999999765433 34679999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC----------------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA----------------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKT  213 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp  213 (431)
                      .++||||+++|+|.+++....                      ...+++..++.++.|++.||+|||+.+  ||||||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~--ivHrDlKp  168 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK--FVHRDLAT  168 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSG
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC--eEeeEEcc
Confidence            999999999999999986432                      234788999999999999999999876  99999999


Q ss_pred             CCEEECCCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCC
Q 014079          214 SNILLDSDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR-KSVDKTRP  292 (431)
Q Consensus       214 ~NILl~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~  292 (431)
                      +||||+.++.+||+|||+++...............||+.|+|||++.+..|+.++|||||||++|||++|. .||.....
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~  248 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  248 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCH
Confidence            99999999999999999998654443333444567999999999999999999999999999999999986 56765432


Q ss_pred             cccchhhhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          293 SKEQSLVDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                      .....                .+.+.. ....+..++.++.+|+.+||+.||++|||+.||++.|+++.
T Consensus       249 ~e~~~----------------~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         249 EEVIY----------------YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHH----------------HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHH----------------HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            21111                111111 11223344578899999999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-53  Score=393.96  Aligned_cols=262  Identities=25%  Similarity=0.346  Sum_probs=203.9

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHHHHHHHHHhcCCCCceeeeecEEEe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREWLTEVNFLGQLRHPNLVKLIGYCCE  152 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~  152 (431)
                      +.++|++.+.||+|+||+||+|.+..+++.      ||||++++....   ....+.+|+++|+.++|||||++++++..
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~   78 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRD------VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA   78 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCE------EEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeee
Confidence            357799999999999999999999876654      999999765432   34568899999999999999999999987


Q ss_pred             CC----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          153 DD----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       153 ~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      .+    .+||||||++|++|.+++....  ++++..++.++.|++.||+|||+.+  ||||||||+||||+.++..+|+|
T Consensus        79 ~~~~~~~~~lvmE~~~g~~L~~~~~~~~--~l~~~~~~~i~~qi~~al~~lH~~~--iiHrDiKP~NIll~~~~~~~l~d  154 (277)
T d1o6ya_          79 ETPAGPLPYIVMEYVDGVTLRDIVHTEG--PMTPKRAIEVIADACQALNFSHQNG--IIHRDVKPANIMISATNAVKVMD  154 (277)
T ss_dssp             ECSSSEEEEEEEECCCEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTSCEEECC
T ss_pred             ccCCCceEEEEEECCCCCEehhhhcccC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccCccccCcccccCccccceeeh
Confidence            54    3789999999999999887654  5889999999999999999999876  99999999999999999999999


Q ss_pred             ccCCccCCCCCC-cceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          229 FGLAKAGPQGDE-THVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       229 FG~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ||.+........ .......+||+.|+|||++.+..|+.++|||||||++|||++|+.||............      +.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~------~~  228 (277)
T d1o6ya_         155 FGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH------VR  228 (277)
T ss_dssp             CTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HH
T ss_pred             hhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHH------Hh
Confidence            999876433222 22334467999999999999999999999999999999999999999764322111000      00


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-CHHHHHHHHhhhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-LMSDVVETLEPLQ  361 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-t~~eil~~L~~l~  361 (431)
                      .        ++..........+.++.+||.+||++||.+|| |++++++.|.+++
T Consensus       229 ~--------~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         229 E--------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             C--------CCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             c--------CCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            0        00111111223457889999999999999999 8999999888764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-53  Score=395.22  Aligned_cols=260  Identities=28%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccC---chhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEG---LQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+.....   ....||||++++..   ....++|.+|+.+|++++|||||++++++.+ .
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~---~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~   83 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSG---KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P   83 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTS---CEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCC---cEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence            568999999999999999998754322   12358999987643   2345678999999999999999999999965 4


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+++|+|.+++.... .++++..++.++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||+++.
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~--iiHrDikp~NIll~~~~~vkl~DfGl~~~  160 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKR--FIHRDLAARNLLLATRDLVKIGDFGLMRA  160 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCC--EeeeeecHHHhccccccceeeccchhhhh
Confidence            6789999999999999887643 35899999999999999999999966  99999999999999999999999999997


Q ss_pred             CCCCCCcce-eecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhhhhhhhhhhccchh
Q 014079          235 GPQGDETHV-STRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLVDWARPKLNDKRKM  312 (431)
Q Consensus       235 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  312 (431)
                      ......... .....||..|+|||++.+..++.++|||||||++|||++ |+.||.+......                +
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~----------------~  224 (273)
T d1u46a_         161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----------------L  224 (273)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----------------H
T ss_pred             cccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHH----------------H
Confidence            655433322 233568889999999999999999999999999999998 8999976432211                1


Q ss_pred             hhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhh
Q 014079          313 LQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPL  360 (431)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l  360 (431)
                      ..+.......+.+..++..+.+|+.+||+.||++|||+.+|++.|.+.
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            111112222222334457889999999999999999999999998764

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=398.15  Aligned_cols=267  Identities=24%  Similarity=0.388  Sum_probs=211.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCce-eccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVR-VGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.+....+ ...+...||||+++++.. ....++.+|+..+.++ +|||||+++++|.+++
T Consensus        13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~   92 (299)
T d1fgka_          13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG   92 (299)
T ss_dssp             GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCC
Confidence            578889999999999999998765432 223344699999977644 3456788999999888 7999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCC--------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC
Q 014079          155 HRLLVYEFMFRGSLENHLFRKA--------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS  220 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~--------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~  220 (431)
                      ..++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.+  ||||||||+|||++.
T Consensus        93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~--ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK--CIHRDLAARNVLVTE  170 (299)
T ss_dssp             SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECT
T ss_pred             eEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC--EEeeeecccceeecC
Confidence            9999999999999999997543              235899999999999999999999977  999999999999999


Q ss_pred             CCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHh-CCCCCCCCCCcccchhh
Q 014079          221 DYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLT-GRKSVDKTRPSKEQSLV  299 (431)
Q Consensus       221 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~pf~~~~~~~~~~~~  299 (431)
                      ++.+||+|||+++...............||+.|+|||++.++.|+.++|||||||++|||++ |..||.......     
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-----  245 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-----  245 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-----
Confidence            99999999999987655444444455679999999999999999999999999999999998 788886543211     


Q ss_pred             hhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          300 DWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                  +...+........+...++++.+||.+||+.||.+|||+.||++.|+++.+.
T Consensus       246 ------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         246 ------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             ------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence                        1111111122222334457899999999999999999999999999987643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-53  Score=398.66  Aligned_cols=252  Identities=19%  Similarity=0.267  Sum_probs=208.3

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      +-++|++.+.||+|+||+||+|.+..++..      ||+|+++.... +...+.+|+++|++++|||||+++++|.+++.
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~------~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~   75 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKT------YMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEE   75 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcE------EEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            346799999999999999999999877654      99999987643 34567899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC--CcEEEecccCCc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD--YTAKLSDFGLAK  233 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~--~~~kl~DFG~a~  233 (431)
                      +|||||||+||+|.+++.... .++++..+..++.||+.||.|||+.+  |+||||||+|||++.+  +.+||+|||+++
T Consensus        76 ~~lvmE~~~gg~L~~~i~~~~-~~l~e~~~~~i~~qi~~al~yLH~~~--iiHrDlKp~NIll~~~~~~~ikl~DFG~~~  152 (321)
T d1tkia_          76 LVMIFEFISGLDIFERINTSA-FELNEREIVSYVHQVCEALQFLHSHN--IGHFDIRPENIIYQTRRSSTIKIIEFGQAR  152 (321)
T ss_dssp             EEEEECCCCCCBHHHHHTSSS-CCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEESSSSCCCEEECCCTTCE
T ss_pred             EEEEEecCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHcC--CCcccccccceeecCCCceEEEEcccchhh
Confidence            999999999999999996643 35899999999999999999999877  9999999999999854  589999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      ......   ......||+.|+|||.+.+..|+.++|||||||++|+|++|+.||........                +.
T Consensus       153 ~~~~~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~----------------~~  213 (321)
T d1tkia_         153 QLKPGD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI----------------IE  213 (321)
T ss_dssp             ECCTTC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH----------------HH
T ss_pred             ccccCC---cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH----------------HH
Confidence            754332   23346799999999999999999999999999999999999999976532111                11


Q ss_pred             hhcCcc--ccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          314 QIIDPR--LENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       314 ~~~~~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .+....  +........+.++.+||.+||+.||.+|||+.|+++|
T Consensus       214 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         214 NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            111111  1111112345788999999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-53  Score=400.93  Aligned_cols=254  Identities=20%  Similarity=0.263  Sum_probs=202.4

Q ss_pred             hcCCCcc-ceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhc-CCCCceeeeecEEEe--
Q 014079           77 TKSFRSD-YILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQ-LRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~--  152 (431)
                      .++|.+. ++||+|+||+||+|.+..+++.      ||||++++.     ..+.+|+.++.+ ++|||||+++++|.+  
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~   78 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEK------FALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLY   78 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCE------EEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecc
Confidence            4578776 4699999999999998776554      999998653     356689998765 489999999999876  


Q ss_pred             --CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEe
Q 014079          153 --DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLS  227 (431)
Q Consensus       153 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~  227 (431)
                        ...+|+|||||+||+|.+++...+...+++..+..++.||+.||+|||+.+  |+||||||+|||++.   ++.+||+
T Consensus        79 ~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~--iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          79 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN--IAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC--Ccccccccccccccccccccccccc
Confidence              467899999999999999998766667999999999999999999999877  999999999999975   5679999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      |||+++.......   ....+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.........+.       
T Consensus       157 DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~-------  226 (335)
T d2ozaa1         157 DFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK-------  226 (335)
T ss_dssp             CCTTCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------------
T ss_pred             ccceeeeccCCCc---cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH-------
Confidence            9999987544332   234679999999999999999999999999999999999999997654322111000       


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                         .........+........++++.+||.+||+.||++|||+.|+++|
T Consensus       227 ---~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         227 ---TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             ----CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence               0000001111122234556889999999999999999999999986

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.5e-53  Score=403.63  Aligned_cols=246  Identities=24%  Similarity=0.331  Sum_probs=206.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++|++.+.||+|+||.||+|.++.++..      ||||++.+...   ...+.+.+|+++|+.++|||||++++++.+..
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~------~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~  114 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNH------YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCE------EEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccc
Confidence            4799999999999999999999876554      99999875432   33467889999999999999999999999999


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                      ..++||||+.+|+|.+++....  .+++..+..++.||+.||.|||+.+  ||||||||+||||+.+|.+||+|||+|+.
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~~~--~l~e~~~~~i~~qi~~aL~yLH~~~--iiHRDIKP~NILl~~~g~ikL~DFG~a~~  190 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRRIG--RFSEPHARFYAAQIVLTFEYLHSLD--LIYRDLKPENLLIDQQGYIQVTDFGFAKR  190 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccccccccccccchhhhHhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--EecCcCCHHHcccCCCCCEEeeeceeeee
Confidence            9999999999999999997765  4889999999999999999999877  99999999999999999999999999987


Q ss_pred             CCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhh
Q 014079          235 GPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQ  314 (431)
Q Consensus       235 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (431)
                      ....     .....||+.|||||++.+..|+.++|||||||++|||++|+.||.+........                .
T Consensus       191 ~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~----------------~  249 (350)
T d1rdqe_         191 VKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE----------------K  249 (350)
T ss_dssp             CSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----------------H
T ss_pred             cccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHH----------------H
Confidence            5432     234679999999999999999999999999999999999999997643211111                1


Q ss_pred             hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          315 IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                      +.....  ..+...+.++.+||.+||+.||.+|+     |+.+|++|
T Consensus       250 i~~~~~--~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         250 IVSGKV--RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHCCC--CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HhcCCC--CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence            111110  11223457889999999999999994     89999875

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=395.80  Aligned_cols=266  Identities=26%  Similarity=0.397  Sum_probs=214.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||.||+|.+....+. .....||||+++.... .....+.+|+.+++++ +|||||++++++.+.+.
T Consensus        23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          23 NRLSFGKTLGAGAFGKVVEATAYGLIKS-DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESSSST-TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHeEEeeEEeecCCeEEEEEEEeccccC-CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            6788899999999999999987542111 1233599999976543 3445788999999999 69999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCC----------------CCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEEC
Q 014079          156 RLLVYEFMFRGSLENHLFRKA----------------TVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLD  219 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~----------------~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~  219 (431)
                      .++|||||++|+|.+++....                ...+++..++.++.||+.||+|||+.+  ||||||||+|||++
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~--ivHrDLKp~NIl~~  179 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN--CIHRDLAARNILLT  179 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEEE
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC--eeeccccccccccc
Confidence            999999999999999997643                235889999999999999999999977  99999999999999


Q ss_pred             CCCcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhC-CCCCCCCCCcccchh
Q 014079          220 SDYTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTG-RKSVDKTRPSKEQSL  298 (431)
Q Consensus       220 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~pf~~~~~~~~~~~  298 (431)
                      .++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+++ .+||........   
T Consensus       180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~---  256 (311)
T d1t46a_         180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK---  256 (311)
T ss_dssp             TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH---
T ss_pred             ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHH---
Confidence            9999999999999987655554455567899999999999999999999999999999999994 555544322111   


Q ss_pred             hhhhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          299 VDWARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                                   +.+++........+...+.++.+||.+||+.||++|||+.+|++.|++...
T Consensus       257 -------------~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         257 -------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             -------------HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence                         111222222222233445789999999999999999999999999987543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.9e-52  Score=401.64  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=201.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---hHHHH---HHHHHHHhcCCCCceeeeecEEE
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---GHREW---LTEVNFLGQLRHPNLVKLIGYCC  151 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~~---~~E~~~l~~l~h~niv~l~~~~~  151 (431)
                      ++|++.++||+|+||.||+|.+..++..      ||||++.+....   ....+   .+|+.+++.++|||||+++++|.
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~------vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~   77 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKM------YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH   77 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCE------EEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCE------EEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEE
Confidence            5699999999999999999999876554      999998654321   12223   34577888889999999999999


Q ss_pred             eCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccC
Q 014079          152 EDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGL  231 (431)
Q Consensus       152 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~  231 (431)
                      +.+.+|+||||++||+|.+++....  .+++..+..++.||+.||.|||+.+  ||||||||+||||+.+|.+||+|||+
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~~~--~~~e~~~~~~~~qi~~aL~ylH~~~--iiHrDlKP~NILl~~~g~iKl~DFGl  153 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQHG--VFSEADMRFYAAEIILGLEHMHNRF--VVYRDLKPANILLDEHGHVRISDLGL  153 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECSSSCEEECCCTT
T ss_pred             ECCEEEEEEEecCCCcHHHHHHhcc--cccHHHHHHHHHHHHHHHHHHHHCC--ccceeeccceeEEcCCCcEEEeeece
Confidence            9999999999999999999997754  4788899999999999999999877  99999999999999999999999999


Q ss_pred             CccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          232 AKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       232 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      |+......    ....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||.............          
T Consensus       154 a~~~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~----------  219 (364)
T d1omwa3         154 ACDFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----------  219 (364)
T ss_dssp             CEECSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH----------
T ss_pred             eeecCCCc----ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH----------
Confidence            98754332    234679999999999875 568999999999999999999999997654322211111          


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCC-----HHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPL-----MSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt-----~~eil~~  356 (431)
                         ....  .....+...+.++.+||.+||+.||++|||     ++|+++|
T Consensus       220 ---~~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         220 ---MTLT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             ---HSSS--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             ---hccc--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence               0000  011122234578899999999999999999     6888875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=395.75  Aligned_cols=260  Identities=24%  Similarity=0.399  Sum_probs=206.8

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcC-CCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQL-RHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.++||+|+||.||+|.+++++..    ..||||.++.... ...+.+.+|+++|.++ +|||||++++++.+.+.
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~----~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~   85 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLR----MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY   85 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEE----EEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeE----EEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCe
Confidence            5688899999999999999998765432    1378888754422 3445789999999999 79999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhC--------------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC
Q 014079          156 RLLVYEFMFRGSLENHLFRK--------------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD  221 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~--------------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~  221 (431)
                      +++||||+++|+|.++|...              ....+++..++.++.|++.||.|||+.+  ||||||||+|||++.+
T Consensus        86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~--iiHrDlkp~NIL~~~~  163 (309)
T d1fvra_          86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ--FIHRDLAARNILVGEN  163 (309)
T ss_dssp             EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECGG
T ss_pred             eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC--ccccccccceEEEcCC
Confidence            99999999999999999653              2356899999999999999999999976  9999999999999999


Q ss_pred             CcEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcccchhhh
Q 014079          222 YTAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR-KSVDKTRPSKEQSLVD  300 (431)
Q Consensus       222 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~  300 (431)
                      +.+||+|||+++.......   .....||..|+|||.+.++.|+.++|||||||++|||++|. .||.......      
T Consensus       164 ~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~------  234 (309)
T d1fvra_         164 YVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------  234 (309)
T ss_dssp             GCEEECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------
T ss_pred             CceEEcccccccccccccc---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH------
Confidence            9999999999976433222   22356899999999999999999999999999999999976 4665432111      


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                                 +...+........+..+++++.+||.+||+.||++|||+.||+++|+++...
T Consensus       235 -----------~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         235 -----------LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             -----------HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             -----------HHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                       1111111111222334557899999999999999999999999999988754

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.2e-52  Score=386.53  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=206.4

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch---------hHHHHHHHHHHHhcCC-CCceeee
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ---------GHREWLTEVNFLGQLR-HPNLVKL  146 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~-h~niv~l  146 (431)
                      .++|++.+.||+|+||+||+|++..+++.      ||||++++....         ..+.+.+|+.+|++++ |||||++
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~------~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~   75 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKE------YAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQL   75 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCE------EEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEE
Confidence            36799999999999999999998776654      999998764321         1235789999999997 9999999


Q ss_pred             ecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEE
Q 014079          147 IGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKL  226 (431)
Q Consensus       147 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl  226 (431)
                      ++++.+++..||||||+++|+|.+++..+.  ++++..++.++.||+.||+|||+.+  |+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--ivHrDlkp~Nill~~~~~~kl  151 (277)
T d1phka_          76 KDTYETNTFFFLVFDLMKKGELFDYLTEKV--TLSEKETRKIMRALLEVICALHKLN--IVHRDLKPENILLDDDMNIKL  151 (277)
T ss_dssp             EEEEECSSEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEECTTCCEEE
T ss_pred             EeecccCcceEEEEEcCCCchHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcC--CcccccccceEEEcCCCCeEE
Confidence            999999999999999999999999997654  5899999999999999999999877  999999999999999999999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCcccccc------CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMT------GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD  300 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~  300 (431)
                      +|||+++.......   .....||+.|+|||++.+      ..++.++|||||||++|||++|+.||.+.........+.
T Consensus       152 ~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~  228 (277)
T d1phka_         152 TDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  228 (277)
T ss_dssp             CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             ccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHH
Confidence            99999987654322   234679999999999864      347889999999999999999999998654221110000


Q ss_pred             hhhhhhhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 WARPKLNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                            ..        ...+........++++.+|+.+||+.||++|||+.||++|
T Consensus       229 ------~~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         229 ------SG--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ------HT--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ------hC--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                  00        0111112223456789999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=390.59  Aligned_cols=262  Identities=26%  Similarity=0.417  Sum_probs=205.9

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEcccc-CchhHHHHHHHHHHHhcCCCCceeeeecEEEe-CCeeEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKE-GLQGHREWLTEVNFLGQLRHPNLVKLIGYCCE-DDHRLLVY  160 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~  160 (431)
                      .++||+|+||+||+|.+.++..   +...||||++++. .....++|.+|+++|++++|||||++++++.+ ++..++||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~---~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~  108 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDG---KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL  108 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC-------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred             ceEEeecCCeEEEEEEEECCCC---EEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence            4689999999999999865432   2235899998754 33455779999999999999999999999876 46889999


Q ss_pred             EecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCCCCC
Q 014079          161 EFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQGDE  240 (431)
Q Consensus       161 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~~~~  240 (431)
                      |||++++|.+++.... ...++..++.++.|++.||.|||+.+  |+||||||+||||++++.+||+|||+++.......
T Consensus       109 E~~~~g~l~~~~~~~~-~~~~~~~~~~i~~qia~gL~~lH~~~--iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         109 PYMKHGDLRNFIRNET-HNPTVKDLIGFGLQVAKGMKFLASKK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             ECCTTCBHHHHHHCTT-CCCBHHHHHHHHHHHHHHHHHHHHTT--CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             EEeecCchhhhhcccc-ccchHHHHHHHHHHHHHhhhhhcccC--cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            9999999999886543 35778889999999999999999866  99999999999999999999999999987654332


Q ss_pred             c--ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhhhhcCc
Q 014079          241 T--HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKMLQIIDP  318 (431)
Q Consensus       241 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (431)
                      .  .......||+.|+|||.+.++.++.++||||||+++|||++|+.||........  ...+.             .. 
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~i-------------~~-  249 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVYL-------------LQ-  249 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHH-------------HT-
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHHH-------------Hc-
Confidence            2  122335789999999999999999999999999999999998888765432111  11110             00 


Q ss_pred             cccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhcCCC
Q 014079          319 RLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCANDG  366 (431)
Q Consensus       319 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~~~~  366 (431)
                      ......+..+++++.+|+.+||+.||++||++.||+++|+.+......
T Consensus       250 g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            001112223457889999999999999999999999999998765444

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-52  Score=396.95  Aligned_cols=249  Identities=27%  Similarity=0.423  Sum_probs=204.1

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc---hhHHHHHHHHHHHh-cCCCCceeeeecEEEeC
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL---QGHREWLTEVNFLG-QLRHPNLVKLIGYCCED  153 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~  153 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||||++++...   ...+.+..|..++. .++|||||++++++.++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~------vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~   75 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQF------FAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   75 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCE------EEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC
Confidence            4689999999999999999999877664      99999976422   23455677777765 68999999999999999


Q ss_pred             CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          154 DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       154 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                      +.+||||||+++|+|.+++....  .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++
T Consensus        76 ~~~yivmEy~~~g~L~~~i~~~~--~~~e~~~~~~~~qi~~al~ylH~~~--iiHrDikp~NiL~~~~~~~kl~DFG~a~  151 (320)
T d1xjda_          76 ENLFFVMEYLNGGDLMYHIQSCH--KFDLSRATFYAAEIILGLQFLHSKG--IVYRDLKLDNILLDKDGHIKIADFGMCK  151 (320)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHS--SCCHHHHHHHHHHHHHHHHHHHHTT--CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred             CceeEEEeecCCCcHHHHhhccC--CCCHHHHHHHHHHHHHHHHHHHhCC--eeeccCcccceeecCCCceeccccchhh
Confidence            99999999999999999997655  4788889999999999999999977  9999999999999999999999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccchhh
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKRKML  313 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  313 (431)
                      .......  ......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+.             
T Consensus       152 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-------------  216 (320)
T d1xjda_         152 ENMLGDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-------------  216 (320)
T ss_dssp             CCCCTTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-------------
T ss_pred             hcccccc--cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-------------
Confidence            6543322  2344689999999999999999999999999999999999999997653221111100             


Q ss_pred             hhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHH-HHHHH
Q 014079          314 QIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMS-DVVET  356 (431)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~-eil~~  356 (431)
                       ...+    .++...+.++.+||.+||+.||.+||++. ++++|
T Consensus       217 -~~~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         217 -MDNP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             -HCCC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             -cCCC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence             0011    12223457889999999999999999996 78653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-52  Score=388.57  Aligned_cols=268  Identities=24%  Similarity=0.333  Sum_probs=201.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|.+..++..      ||+|+++.....  ....+.+|+++|++++|||||++++++.+.+.
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~   75 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEV------VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENK   75 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCE------EEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccc
Confidence            4789999999999999999999776554      999998765322  24678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      +|+||||+. +.+.+++.......+++..+..++.|++.||.|||+.+  ||||||||+|||++.++.+||+|||+|+..
T Consensus        76 ~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~--IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~  152 (298)
T d1gz8a_          76 LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR--VLHRDLKPQNLLINTEGAIKLADFGLARAF  152 (298)
T ss_dssp             EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECSTTHHHHH
T ss_pred             eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC--EEccccCchheeecccCcceeccCCcceec
Confidence            999999995 55666665555567999999999999999999999876  999999999999999999999999999765


Q ss_pred             CCCCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hh------hh
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RP------KL  306 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~------~~  306 (431)
                      .....  ......||+.|+|||++.... ++.++|||||||++|+|++|+.||.+.........+...  .+      ..
T Consensus       153 ~~~~~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  230 (298)
T d1gz8a_         153 GVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV  230 (298)
T ss_dssp             CCCSB--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             cCCcc--cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccc
Confidence            33222  223457999999999887665 578999999999999999999999765422211100000  00      00


Q ss_pred             hccchhhhhcCccccC---cccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          307 NDKRKMLQIIDPRLEN---QYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ................   ......+.++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            0000000000000000   0112345788999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=389.06  Aligned_cols=264  Identities=25%  Similarity=0.393  Sum_probs=210.6

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDHR  156 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  156 (431)
                      ++|++.+.||+|+||.||+|.++.... ......||||+++.... .....+.+|+.++++++|||||++++++...+..
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~-~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~   98 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVVK-DEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT   98 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEET-TEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCccc-CCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence            678899999999999999998753211 11223599999976533 3345688999999999999999999999999999


Q ss_pred             EEEEEecCCCChHHhhhhC--------CCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          157 LLVYEFMFRGSLENHLFRK--------ATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       157 ~lv~e~~~~gsL~~~l~~~--------~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                      ++||||+++|+|.+++...        ....+++..+..++.|++.||.|||+.+  |+||||||+||||+.++++||+|
T Consensus        99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~--ivHrDlk~~NiLld~~~~~Kl~D  176 (308)
T d1p4oa_          99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK--FVHRDLAARNCMVAEDFTVKIGD  176 (308)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT--CBCSCCSGGGEEECTTCCEEECC
T ss_pred             eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC--eeeceEcCCceeecCCceEEEee
Confidence            9999999999999988642        2235788999999999999999999866  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCC-CCCCCCCCcccchhhhhhhhhhh
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGR-KSVDKTRPSKEQSLVDWARPKLN  307 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~pf~~~~~~~~~~~~~~~~~~~~  307 (431)
                      ||+++...............||+.|+|||.+.++.++.++|||||||++|||++|. .||.........           
T Consensus       177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~-----------  245 (308)
T d1p4oa_         177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL-----------  245 (308)
T ss_dssp             TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH-----------
T ss_pred             cccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH-----------
Confidence            99998754443333334457899999999999999999999999999999999985 667553221111           


Q ss_pred             ccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhh
Q 014079          308 DKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQ  361 (431)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~  361 (431)
                           ..+.+.. ....+..++..+.+||.+||+.||++|||+.+|+++|++..
T Consensus       246 -----~~i~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~  293 (308)
T d1p4oa_         246 -----RFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM  293 (308)
T ss_dssp             -----HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGS
T ss_pred             -----HHHHhCC-CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence                 1111111 11122334578999999999999999999999999998653

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-52  Score=391.02  Aligned_cols=262  Identities=25%  Similarity=0.296  Sum_probs=194.7

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchh-----HHHHHHHHHHHhcCCCCceeeeecEEEeCCeeE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQG-----HREWLTEVNFLGQLRHPNLVKLIGYCCEDDHRL  157 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  157 (431)
                      .++||+|+||+||+|.+..+++.      ||||+++......     .+.+.+|+.+|++++|||||++++++.+++.+|
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~   76 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQI------VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS   76 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSE------EEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred             ceEeccCcCeEEEEEEECCCCcE------EEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCcee
Confidence            46899999999999998776543      9999987653321     235789999999999999999999999999999


Q ss_pred             EEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccCCC
Q 014079          158 LVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ  237 (431)
Q Consensus       158 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~~~  237 (431)
                      +||||+.++++..+....  ..+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+||+|||+++....
T Consensus        77 ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~--iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~  152 (299)
T d1ua2a_          77 LVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQHW--ILHRDLKPNNLLLDENGVLKLADFGLAKSFGS  152 (299)
T ss_dssp             EEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECCCGGGSTTTS
T ss_pred             ehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhccc--eecccCCcceEEecCCCccccccCccccccCC
Confidence            999999888777666443  35777888899999999999999977  99999999999999999999999999987544


Q ss_pred             CCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhh---hhccch
Q 014079          238 GDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPK---LNDKRK  311 (431)
Q Consensus       238 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~---~~~~~~  311 (431)
                      ...  .....+||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...........+...  .+.   ......
T Consensus       153 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~  230 (299)
T d1ua2a_         153 PNR--AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS  230 (299)
T ss_dssp             CCC--CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred             Ccc--cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhc
Confidence            322  2234679999999998875 46899999999999999999999999765432211111000  000   000000


Q ss_pred             hhhhcC-cccc----CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQIID-PRLE----NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~~-~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ...... ....    .......++++.+|+.+||+.||++|||+.|+++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            000000 0000    00111235789999999999999999999999975

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=387.41  Aligned_cols=273  Identities=26%  Similarity=0.363  Sum_probs=202.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHH--HHHHHHhcCCCCceeeeecEEEeCC
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWL--TEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~--~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ...|.+.+.||+|+||.||+|++.+  .      .||||+++...   ..++.  .|+..+.+++|||||++++++.+.+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~~g--~------~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~   70 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKWRG--E------EVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDN   70 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEETT--E------EEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEECC--E------EEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC
Confidence            4568888999999999999998743  2      49999987543   23333  4555566789999999999998764


Q ss_pred             ----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhC------CCCeeeccCCCCCEEECCCCcE
Q 014079          155 ----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNA------ERPVIYRDFKTSNILLDSDYTA  224 (431)
Q Consensus       155 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~------~~~ivHrDlkp~NILl~~~~~~  224 (431)
                          .+|+||||+++|+|.+++.+.   ++++..++.++.|++.||+|||+.      .++||||||||+||||+.++.+
T Consensus        71 ~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~  147 (303)
T d1vjya_          71 GTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTC  147 (303)
T ss_dssp             SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCE
T ss_pred             CcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCe
Confidence                579999999999999999764   489999999999999999999974      3469999999999999999999


Q ss_pred             EEecccCCccCCCCCCcc--eeecccCCccccCccccccCC------CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 014079          225 KLSDFGLAKAGPQGDETH--VSTRVMGTYGYAAPEYVMTGH------LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ  296 (431)
Q Consensus       225 kl~DFG~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  296 (431)
                      ||+|||+++.........  ......||+.|+|||++.+..      ++.++|||||||+||||++|..||.........
T Consensus       148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~  227 (303)
T d1vjya_         148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP  227 (303)
T ss_dssp             EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred             EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence            999999998754433221  223467999999999987643      677899999999999999999888654332211


Q ss_pred             hhhh-hhhhhhhc--cchhhhhcCccccCcc-cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          297 SLVD-WARPKLND--KRKMLQIIDPRLENQY-SVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       297 ~~~~-~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                      .... ...+....  ........++.+.... ..+....+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            0000 00000000  0001111222222222 345667899999999999999999999999999988754

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=380.42  Aligned_cols=242  Identities=24%  Similarity=0.405  Sum_probs=197.3

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch------hHHHHHHHHHHHhcCC--CCceeeeec
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ------GHREWLTEVNFLGQLR--HPNLVKLIG  148 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~--h~niv~l~~  148 (431)
                      .++|++.++||+|+||+||+|.+..++.      .||||++++....      ...++.+|+.+|++++  |||||++++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~------~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~   76 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL------PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD   76 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCC------EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCC------EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEE
Confidence            4689999999999999999999987654      3999998754321      1233668999999987  899999999


Q ss_pred             EEEeCCeeEEEEEecCC-CChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCC-CcEEE
Q 014079          149 YCCEDDHRLLVYEFMFR-GSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSD-YTAKL  226 (431)
Q Consensus       149 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~-~~~kl  226 (431)
                      ++.+.+..++||||+.+ +++.+++....  .+++..+..++.|++.||+|||+.+  |+||||||+|||++.+ +.+||
T Consensus        77 ~~~~~~~~~lv~e~~~~~~~l~~~~~~~~--~l~e~~~~~~~~qi~~al~~lH~~~--iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          77 WFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHNCG--VLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHC--SCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCSGGGEEEETTTTEEEE
T ss_pred             EEeeCCeEEEEEEeccCcchHHHHHhccC--CCCHHHHHHHHHHHHHHHHHHHHCC--CccccCcccceEEecCCCeEEE
Confidence            99999999999999976 57888876654  5889999999999999999999876  9999999999999854 79999


Q ss_pred             ecccCCccCCCCCCcceeecccCCccccCccccccCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          227 SDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHL-TARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       227 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|||+++.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||....     ...      
T Consensus       153 ~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i~------  217 (273)
T d1xwsa_         153 IDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII------  217 (273)
T ss_dssp             CCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH------
T ss_pred             Cccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HHh------
Confidence            999999865332    2334679999999999987765 567999999999999999999996421     000      


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                       ..        ...    ++...+.++.+||.+||+.||++|||+.|+++|
T Consensus       218 -~~--------~~~----~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         218 -RG--------QVF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -HC--------CCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -hc--------ccC----CCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence             00        001    111234788999999999999999999999975

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=381.19  Aligned_cols=268  Identities=24%  Similarity=0.315  Sum_probs=198.0

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCC-ceeccccceeEEEEccccCch--hHHHHHHHHHHHhcC---CCCceeeeecEE
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDEN-VRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQL---RHPNLVKLIGYC  150 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l---~h~niv~l~~~~  150 (431)
                      .++|++.+.||+|+||+||+|.+..+ ++.      ||||+++.....  ....+.+|+.+|+.|   +||||++++++|
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~   79 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRF------VALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVC   79 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEE------EEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEE------EEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeee
Confidence            46899999999999999999998643 333      899998654221  123455677776665   799999999998


Q ss_pred             Ee-----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEE
Q 014079          151 CE-----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAK  225 (431)
Q Consensus       151 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~k  225 (431)
                      ..     ....+++|||+.++.+.... ......+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+|
T Consensus        80 ~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~--ivHrDiKp~NILi~~~~~~k  156 (305)
T d1blxa_          80 TVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHR--VVHRDLKPQNILVTSSGQIK  156 (305)
T ss_dssp             EEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEE
T ss_pred             cccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCC--EEecCCCccEEEEcCCCCee
Confidence            63     34679999999777665444 334456899999999999999999999977  99999999999999999999


Q ss_pred             EecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          226 LSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       226 l~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      |+|||+++.....   .......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.........+......
T Consensus       157 l~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~  233 (305)
T d1blxa_         157 LADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL  233 (305)
T ss_dssp             ECSCCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ecchhhhhhhccc---ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCC
Confidence            9999998864322   2334578999999999999999999999999999999999999999865432221111100000


Q ss_pred             -----hhcc----chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 -----LNDK----RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 -----~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                           ....    ..............+....++.+.+|+.+||+.||++|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                 0000    00000000011111223345788899999999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-50  Score=376.87  Aligned_cols=266  Identities=21%  Similarity=0.299  Sum_probs=199.4

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCch--hHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQ--GHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|.++++.       .||||+++.....  ..+.+.+|+.+|++++|||||++++++.+.+.
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~-------~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~   74 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGE-------TFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKR   74 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSC-------EEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCC-------EEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCc
Confidence            57999999999999999999986542       4999998765332  24678899999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .+++|||+.++.+..+....  ..+++..+..++.|++.||+|||+.+  ||||||||+||||+.++.+||+|||++...
T Consensus        75 ~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~--IvHrDiKp~NIll~~~~~~kl~DfG~a~~~  150 (286)
T d1ob3a_          75 LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRR--VLHRDLKPQNLLINREGELKIADFGLARAF  150 (286)
T ss_dssp             EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTSCEEECCTTHHHHH
T ss_pred             eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCc--EEecCCCCceeeEcCCCCEEecccccceec
Confidence            99999999777666665443  45899999999999999999999977  999999999999999999999999999764


Q ss_pred             CCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh--hhh---hhcc
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA--RPK---LNDK  309 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~--~~~---~~~~  309 (431)
                      .....  ......|++.|+|||.+.+. .++.++|||||||++|||++|+.||.+.........+...  .+.   ....
T Consensus       151 ~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  228 (286)
T d1ob3a_         151 GIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV  228 (286)
T ss_dssp             CC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred             ccCcc--ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccch
Confidence            33221  22334689999999998764 5689999999999999999999999765432211111000  000   0000


Q ss_pred             chhhh------hcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          310 RKMLQ------IIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       310 ~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....      ...+..........+..+.+|+.+||+.||++|||++|+++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             GGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000      001111111223345788999999999999999999999865

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=376.78  Aligned_cols=268  Identities=22%  Similarity=0.319  Sum_probs=198.7

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||+||+|.+..+++.      ||||++++...  ...+.+.+|+++|++++|||||+++++|...
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~   89 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAK------VAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPD   89 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCE------EEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCE------EEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccC
Confidence            457899999999999999999999876554      99999976432  3346788999999999999999999999866


Q ss_pred             C------eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          154 D------HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       154 ~------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                      +      .+|+||||+ +.+|..++...   .+++..++.++.||+.||.|||+++  |+||||||+|||++.++.+||+
T Consensus        90 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~~--IiHrDiKp~NIL~~~~~~~kl~  163 (346)
T d1cm8a_          90 ETLDDFTDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAG--IIHRDLKPGNLAVNEDCELKIL  163 (346)
T ss_dssp             SSTTTCCCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEEC
T ss_pred             ccccccceEEEEEecc-cccHHHHHHhc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCcchhhcccccccccc
Confidence            5      469999999 77888777543   4899999999999999999999977  9999999999999999999999


Q ss_pred             cccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhh
Q 014079          228 DFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKL  306 (431)
Q Consensus       228 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~  306 (431)
                      |||+++.....     .+...||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.................
T Consensus       164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~  238 (346)
T d1cm8a_         164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP  238 (346)
T ss_dssp             CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred             cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence            99999875432     2346799999999998764 57899999999999999999999997754322111110000000


Q ss_pred             --------h--ccchhhhhc---CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH--Hhhh
Q 014079          307 --------N--DKRKMLQII---DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET--LEPL  360 (431)
Q Consensus       307 --------~--~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~--L~~l  360 (431)
                              .  ........+   ............+..+.+||.+||+.||.+|||+.|+++|  ++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence                    0  000000000   0000011122345678899999999999999999999987  5444

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2e-48  Score=364.68  Aligned_cols=265  Identities=18%  Similarity=0.212  Sum_probs=208.5

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCC-CceeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRH-PNLVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||+||+|++..+++.      ||||++....  ....+.+|+++++.++| +|++.+++++.+...
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~------vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~   75 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQ------VAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH   75 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEE------EEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCE------EEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCc
Confidence            46899999999999999999998876554      9999886543  22346678899999875 899999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC-----CCcEEEeccc
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS-----DYTAKLSDFG  230 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~-----~~~~kl~DFG  230 (431)
                      .++||||+ +++|.+++.... ..++......++.|++.||+|||+.+  ||||||||+||||+.     ++.+||+|||
T Consensus        76 ~~~vme~~-~~~l~~~~~~~~-~~~~~~~~~~i~~q~~~~l~~lH~~g--iiHrDiKp~Nili~~~~~~~~~~vkl~DFG  151 (293)
T d1csna_          76 NVLVIDLL-GPSLEDLLDLCG-RKFSVKTVAMAAKQMLARVQSIHEKS--LVYRDIKPDNFLIGRPNSKNANMIYVVDFG  151 (293)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred             cEEEEEec-CCCHHHHHHhhc-cchhhHHHHHHHHHHHHHHHHHHHCC--ceeccCCccceeecCcccccCCceEEcccc
Confidence            99999999 899999886654 36899999999999999999999876  999999999999964     5789999999


Q ss_pred             CCccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh
Q 014079          231 LAKAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK  305 (431)
Q Consensus       231 ~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~  305 (431)
                      +|+........     .......||+.|||||++.+..++.++|||||||++|||++|+.||.+............... 
T Consensus       152 ~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~-  230 (293)
T d1csna_         152 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE-  230 (293)
T ss_dssp             TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHH-
T ss_pred             eeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHh-
Confidence            99875433211     122346799999999999999999999999999999999999999986554333221111000 


Q ss_pred             hhccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhhc
Q 014079          306 LNDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQCA  363 (431)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~~  363 (431)
                         ..   .   ..........+++++.+++..|+..+|++||++..+.+.|+++...
T Consensus       231 ---~~---~---~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~  279 (293)
T d1csna_         231 ---KK---Q---STPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLER  279 (293)
T ss_dssp             ---HH---H---HSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ---cc---C---CCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHH
Confidence               00   0   0000011122346788999999999999999999999988876544

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.8e-48  Score=366.43  Aligned_cols=263  Identities=20%  Similarity=0.235  Sum_probs=200.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-eeeeecEEEeCCe
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-LVKLIGYCCEDDH  155 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~  155 (431)
                      .++|++.+.||+|+||.||+|.+..+++.      ||||++.....  ..++..|+++++.++|+| |+.+.+++.+.+.
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~------vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEE------VAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEE------EEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCE------EEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            35799999999999999999998776553      99998776532  235778999999998766 5555666778888


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECC---CCcEEEecccCC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDS---DYTAKLSDFGLA  232 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~---~~~~kl~DFG~a  232 (431)
                      .++||||+ +++|.+.+.... ..+++..++.++.|++.||+|||+.+  ||||||||+|||++.   +..+||+|||+|
T Consensus        78 ~~ivme~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~--iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a  153 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKN--FIHRDVKPDNFLMGLGKKGNLVYIIDFGLA  153 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTT--EECSCCCGGGEEECCGGGTTCEEECCCSSC
T ss_pred             EEEEEEEc-CCchhhhhhhcc-CCCcHHHHHHHHHHHHHHHHHHHHCC--eeeccCCHhhccccccCCCceeeeeccCcc
Confidence            99999999 677777665543 35899999999999999999999977  999999999999864   457999999999


Q ss_pred             ccCCCCCCc-----ceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhh-hhhh
Q 014079          233 KAGPQGDET-----HVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWA-RPKL  306 (431)
Q Consensus       233 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~-~~~~  306 (431)
                      +........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............... ....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ckia_         154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM  233 (299)
T ss_dssp             EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred             eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence            876443221     1233468999999999999999999999999999999999999999775443322211110 0000


Q ss_pred             hccchhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHHhhhhh
Q 014079          307 NDKRKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETLEPLQC  362 (431)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L~~l~~  362 (431)
                      .          . ........++.++.+++.+||+.||++||++.+|.+.|+.+..
T Consensus       234 ~----------~-~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         234 S----------T-PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             H----------S-CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             C----------C-ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            0          0 0001112344778999999999999999999999988887644

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-49  Score=376.52  Aligned_cols=270  Identities=23%  Similarity=0.320  Sum_probs=198.2

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc-hhHHHHHHHHHHHhcCCCCceeeeecEEEeCC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL-QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD  154 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  154 (431)
                      ++.+|++.+.||+|+||+||+|.+..++..      ||||++++... ...+.+.+|+.+|++++||||+++++++....
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~   79 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVR------VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT   79 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSE------EEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcE------EEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence            346799999999999999999998776554      99999976543 34567889999999999999999999987653


Q ss_pred             ----eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEeccc
Q 014079          155 ----HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFG  230 (431)
Q Consensus       155 ----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG  230 (431)
                          ..+++++++.+|+|.+++...   .+++..+..++.|++.||+|||+++  ||||||||+||||+.++.+||+|||
T Consensus        80 ~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~--iiHRDIKp~NILl~~~~~~kl~DfG  154 (345)
T d1pmea_          80 IEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSAN--VLHRDLKPSNLLLNTTCDLKICDFG  154 (345)
T ss_dssp             TTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CcCCCCCcceEEECCCCCEEEcccC
Confidence                234445566699999999654   4899999999999999999999977  9999999999999999999999999


Q ss_pred             CCccCCCCCCc-ceeecccCCccccCccccc-cCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhc
Q 014079          231 LAKAGPQGDET-HVSTRVMGTYGYAAPEYVM-TGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLND  308 (431)
Q Consensus       231 ~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  308 (431)
                      +++........ ......+||+.|+|||++. +..++.++||||+||++|||++|+.||.....................
T Consensus       155 ~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~  234 (345)
T d1pmea_         155 LARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ  234 (345)
T ss_dssp             TCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred             ceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCCh
Confidence            99865433221 1233467999999999985 456789999999999999999999999765432211111000000000


Q ss_pred             c----------chhhhhcCcccc---CcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          309 K----------RKMLQIIDPRLE---NQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       309 ~----------~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .          ............   .......+.++.+|+.+||+.||.+|||+.|+++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            0          000000000000   00111234678999999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-49  Score=377.39  Aligned_cols=263  Identities=25%  Similarity=0.315  Sum_probs=194.2

Q ss_pred             CCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCceeeeecEEEeC-----
Q 014079           79 SFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPNLVKLIGYCCED-----  153 (431)
Q Consensus        79 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  153 (431)
                      .|+..++||+|+||+||+|++..+++.      ||||++.+....    +.+|+++|++++|||||+++++|...     
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGEL------VAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCE------EEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCE------EEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            578888999999999999999876554      999998765322    23799999999999999999998643     


Q ss_pred             -CeeEEEEEecCCCChHHhhh-hCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEeccc
Q 014079          154 -DHRLLVYEFMFRGSLENHLF-RKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFG  230 (431)
Q Consensus       154 -~~~~lv~e~~~~gsL~~~l~-~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG  230 (431)
                       .++|||||||+++.+..+.. ......+++..+..++.||+.||+|||+++  |+||||||+||||+.++ .+||+|||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~--IiHrDiKp~NILl~~~~~~~kl~DFG  168 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG--ICHRDIKPQNLLLDPDTAVLKLCDFG  168 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT--EECCCCCGGGEEECTTTCCEEECCCT
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcccCCCcceEEEecCCCceeEeccc
Confidence             35789999997654444332 234456899999999999999999999866  99999999999999775 89999999


Q ss_pred             CCccCCCCCCcceeecccCCccccCcccccc-CCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhh--hhhh
Q 014079          231 LAKAGPQGDETHVSTRVMGTYGYAAPEYVMT-GHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWAR--PKLN  307 (431)
Q Consensus       231 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~--~~~~  307 (431)
                      +++......   ......||+.|+|||++.+ ..|+.++|||||||++|||++|+.||...........+....  +...
T Consensus       169 ~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         169 SAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             chhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            998754432   2234679999999998875 578999999999999999999999997654322111110000  0000


Q ss_pred             cc---------chhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          308 DK---------RKMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       308 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      ..         ..........+........+.++.+|+.+||+.||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00         00000000000111122345788999999999999999999999976

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=371.29  Aligned_cols=270  Identities=21%  Similarity=0.271  Sum_probs=196.0

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe---
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE---  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---  152 (431)
                      ++|++.+.||+|+||+||+|.+..+++.      ||||++.....  ....++.+|+.+|++++||||+++++++..   
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~   83 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQK------VALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS   83 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCE------EEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccc
Confidence            6799999999999999999999766554      99999865432  234668899999999999999999998865   


Q ss_pred             -----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEe
Q 014079          153 -----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLS  227 (431)
Q Consensus       153 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~  227 (431)
                           .+..|+||||+.++.+......  ...++...+..++.|++.||.|||+.+  |+||||||+||||+.++.+||+
T Consensus        84 ~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~--ivHrDlKp~NILl~~~~~~kl~  159 (318)
T d3blha1          84 PYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK--ILHRDMKAANVLITRDGVLKLA  159 (318)
T ss_dssp             -------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCCGGGEEECTTSCEEEC
T ss_pred             cccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCC--EEecCcCchheeecCCCcEEee
Confidence                 3468999999977766655433  335788888999999999999999876  9999999999999999999999


Q ss_pred             cccCCccCCCCCCc--ceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhh
Q 014079          228 DFGLAKAGPQGDET--HVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARP  304 (431)
Q Consensus       228 DFG~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  304 (431)
                      |||+++........  ......+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.........+.....
T Consensus       160 dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~  239 (318)
T d3blha1         160 DFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCG  239 (318)
T ss_dssp             CCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            99999765433221  122335799999999998765 689999999999999999999999976543222111111000


Q ss_pred             hhhcc-------chhhhhcCc--cccCcc-----cHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHHH
Q 014079          305 KLNDK-------RKMLQIIDP--RLENQY-----SVRAAQKACSLAYYCLSQNPKARPLMSDVVETL  357 (431)
Q Consensus       305 ~~~~~-------~~~~~~~~~--~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~L  357 (431)
                      .....       ......+..  ......     .......+++||.+||+.||++|||+.|+++|=
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hp  306 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD  306 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSG
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcCh
Confidence            00000       000000000  000000     111245778999999999999999999999873

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.2e-48  Score=368.11  Aligned_cols=260  Identities=18%  Similarity=0.271  Sum_probs=199.5

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeC--C
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCED--D  154 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~  154 (431)
                      ++|++.+.||+|+||+||+|++..+++.      ||||+++...   .+++.+|+.+|++++ ||||++++++|...  .
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~------vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~  105 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEK------VVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSR  105 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCE------EEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCC
Confidence            5799999999999999999999876664      9999997643   456789999999996 99999999999744  5


Q ss_pred             eeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC-cEEEecccCCc
Q 014079          155 HRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY-TAKLSDFGLAK  233 (431)
Q Consensus       155 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~-~~kl~DFG~a~  233 (431)
                      .+++||||+.+++|..+.     ..+++..+..++.||+.||.|||+++  ||||||||+||||+.++ .+||+|||+|+
T Consensus       106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~g--IvHrDiKp~NILi~~~~~~vkl~DFG~a~  178 (328)
T d3bqca1         106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMG--IMHRDVKPHNVMIDHEHRKLRLIDWGLAE  178 (328)
T ss_dssp             SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEEETTTTEEEECCGGGCE
T ss_pred             ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcc--cccccccccceEEcCCCCeeeecccccce
Confidence            689999999999998764     24889999999999999999999977  99999999999998654 69999999998


Q ss_pred             cCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh-----------h
Q 014079          234 AGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD-----------W  301 (431)
Q Consensus       234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~-----------~  301 (431)
                      .......   ....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.............           +
T Consensus       179 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~  255 (328)
T d3bqca1         179 FYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY  255 (328)
T ss_dssp             ECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred             eccCCCc---ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhh
Confidence            7544322   2346799999999998765 57999999999999999999999997655432211000           0


Q ss_pred             hh-hhhhccchhhhhcC--------ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          302 AR-PKLNDKRKMLQIID--------PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       302 ~~-~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .. ..............        ...........+.++.+||.+||+.||++|||++|+++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00 00000000000000        001111122345788999999999999999999999975

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=362.23  Aligned_cols=267  Identities=22%  Similarity=0.272  Sum_probs=205.2

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeCCe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDDH  155 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  155 (431)
                      ++|++.+.||+|+||+||+|++..++..      ||||+++....  .....+.+|+.+|+.++||||+++++++.+...
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~------vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   75 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEI------VALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKK   75 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCE------EEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcE------EEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccc
Confidence            5799999999999999999999877654      99999865432  345778999999999999999999999999999


Q ss_pred             eEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCCccC
Q 014079          156 RLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAG  235 (431)
Q Consensus       156 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~~  235 (431)
                      .++|++++.+++|..++....  .+++..+..++.|++.||+|||+.+  ||||||||+|||++.++.+||+|||.++..
T Consensus        76 ~~iv~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~q~~~aL~~lH~~~--IvHrDiKP~NIli~~~~~~kl~DFG~a~~~  151 (292)
T d1unla_          76 LTLVFEFCDQDLKKYFDSCNG--DLDPEIVKSFLFQLLKGLGFCHSRN--VLHRDLKPQNLLINRNGELKLANFGLARAF  151 (292)
T ss_dssp             EEEEEECCSEEHHHHHHHTTT--CCCHHHHHHHHHHHHHHHHHHHHTT--EECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eeEEeeecccccccccccccc--ccchhHHHHHHHHHHHHHHHhhcCC--EeeecccCcccccccCCceeeeecchhhcc
Confidence            999999999999888776543  5788899999999999999999876  999999999999999999999999999875


Q ss_pred             CCCCCcceeecccCCccccCccccccCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCCcccch-hhhh--hhhhhhccch
Q 014079          236 PQGDETHVSTRVMGTYGYAAPEYVMTGH-LTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQS-LVDW--ARPKLNDKRK  311 (431)
Q Consensus       236 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~-~~~~--~~~~~~~~~~  311 (431)
                      .....  ......+++.|+|||++.+.. ++.++|||||||++|||++|+.||.......... .+..  ..+.......
T Consensus       152 ~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (292)
T d1unla_         152 GIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS  229 (292)
T ss_dssp             CSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred             cCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhh
Confidence            44332  223346788999999887665 6899999999999999999999975543322110 0000  0000000000


Q ss_pred             hhhhc---------CccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          312 MLQII---------DPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       312 ~~~~~---------~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                      .....         ............+..+.+|+.+||+.||.+|||++|+++|
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            00000         0000111223345688999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=368.30  Aligned_cols=257  Identities=28%  Similarity=0.356  Sum_probs=201.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc----hhHHHHHHHHHHHhcCCC-CceeeeecEEEe
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL----QGHREWLTEVNFLGQLRH-PNLVKLIGYCCE  152 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~  152 (431)
                      ++|++.+.||+|+||+||+|.+..+..   .+..||+|++++...    ...+.+.+|+++|++++| |||+++++++.+
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~---~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~  100 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHD---TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  100 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTT---TTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCC---CCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence            569999999999999999998744211   123499999875432    234567789999999976 899999999999


Q ss_pred             CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEecccCC
Q 014079          153 DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSDFGLA  232 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a  232 (431)
                      ....++||||+.+|+|.+++.....  +.+.....++.|++.||.|||+.+  |+||||||+||||+.++.+||+|||++
T Consensus       101 ~~~~~~v~e~~~~~~L~~~i~~~~~--~~e~~~~~~~~Qi~~al~~lH~~~--ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         101 ETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVLALEHLHKLG--IIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             TTEEEEEECCCCSCBHHHHHHHHSC--CCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             CCceeeeeecccccHHHHHHHhccc--ccHHHHHHHHHHHHHHHHHhhcCC--EEeccCCccceeecCCCCEEEeeccch
Confidence            9999999999999999999977654  567888889999999999999977  999999999999999999999999999


Q ss_pred             ccCCCCCCcceeecccCCccccCccccccC--CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhhhhccc
Q 014079          233 KAGPQGDETHVSTRVMGTYGYAAPEYVMTG--HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPKLNDKR  310 (431)
Q Consensus       233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  310 (431)
                      +........ ......|++.|+|||.+.+.  .++.++|||||||+||||++|+.||...........+...        
T Consensus       177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~--------  247 (322)
T d1vzoa_         177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR--------  247 (322)
T ss_dssp             EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHH--------
T ss_pred             hhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh--------
Confidence            865433222 23346799999999998764  4788999999999999999999999776543322111100        


Q ss_pred             hhhhhcCccccCcccHHHHHHHHHHHHHhhhcCCCCCC-----CHHHHHHH
Q 014079          311 KMLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARP-----LMSDVVET  356 (431)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----t~~eil~~  356 (431)
                          ....  ....+...+.++.+|+.+||++||.+||     |++|+++|
T Consensus       248 ----~~~~--~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         248 ----ILKS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             ----HHHC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             ----cccC--CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence                0000  1112234567899999999999999999     47888875

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=367.66  Aligned_cols=264  Identities=23%  Similarity=0.278  Sum_probs=192.7

Q ss_pred             hcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEe--
Q 014079           77 TKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCE--  152 (431)
Q Consensus        77 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--  152 (431)
                      .++|++.++||+|+||+||+|.+..++..      ||||++.+...  .....+.+|+.+|++++|||||+++++|..  
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~------vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~   89 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRN------VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQK   89 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEE------EEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCE------EEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccc
Confidence            46799999999999999999999876554      99999976532  334568899999999999999999999964  


Q ss_pred             ----CCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          153 ----DDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       153 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                          ...+|+||||+.++ |.+.+.    ..+++..+..++.|++.||.|||+.+  |+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~iv~Ey~~~~-l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~g--iiHrDlKP~Nil~~~~~~~kl~d  162 (355)
T d2b1pa1          90 TLEEFQDVYLVMELMDAN-LCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAG--IIHRDLKPSNIVVKSDCTLKILD  162 (355)
T ss_dssp             STTTCCEEEEEEECCSEE-HHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT--CCCSCCCGGGEEECTTCCEEECC
T ss_pred             ccccCceeEEEEeccchH-HHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcc--cccccCCccccccccccceeeec
Confidence                36789999999655 444442    24788999999999999999999977  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhh--------
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVD--------  300 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--------  300 (431)
                      ||+++......   .....+||+.|+|||++.+..++.++||||+||++|+|++|+.||.+.........+.        
T Consensus       163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~  239 (355)
T d2b1pa1         163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP  239 (355)
T ss_dssp             CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred             hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence            99988644322   2344679999999999999999999999999999999999999997654221111000        


Q ss_pred             --hhh--hh----hhc-----cchhhhhcC---ccccCcccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          301 --WAR--PK----LND-----KRKMLQIID---PRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       301 --~~~--~~----~~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        |..  ..    ...     .........   ...........+.++.+|+.+||..||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence              000  00    000     000000110   011122234567899999999999999999999999977

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-47  Score=366.14  Aligned_cols=265  Identities=23%  Similarity=0.325  Sum_probs=196.8

Q ss_pred             HhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc--hhHHHHHHHHHHHhcCCCCceeeeecEEEeC
Q 014079           76 ITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL--QGHREWLTEVNFLGQLRHPNLVKLIGYCCED  153 (431)
Q Consensus        76 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  153 (431)
                      +.++|++.+.||+|+||+||+|++..++..      ||||++.+...  ...+.+.+|+++|++++|||||++++++...
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~------vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~   89 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLR------VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   89 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEE------EEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCE------EEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeec
Confidence            357899999999999999999998876654      99999976532  3445788999999999999999999998643


Q ss_pred             -----CeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCCcEEEec
Q 014079          154 -----DHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDYTAKLSD  228 (431)
Q Consensus       154 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~~~kl~D  228 (431)
                           ...+++|+|+.+|+|.+++..+   .+++..+..++.||+.||+|||+.+  |+||||||+|||++.++.+|++|
T Consensus        90 ~~~~~~~~~~i~~~~~gg~L~~~~~~~---~l~e~~~~~i~~qil~aL~~LH~~g--iiHrDiKp~NILi~~~~~~kl~d  164 (348)
T d2gfsa1          90 RSLEEFNDVYLVTHLMGADLNNIVKCQ---KLTDDHVQFLIYQILRGLKYIHSAD--IIHRDLKPSNLAVNEDCELKILD  164 (348)
T ss_dssp             SSTTTCCCCEEEEECCSEEHHHHHTTC---CCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccccCceEEEEEeecCCchhhhcccc---cccHHHHHHHHHHHHHHHHHHHhCC--CcccccCCccccccccccccccc
Confidence                 3346667778899999998543   5899999999999999999999876  99999999999999999999999


Q ss_pred             ccCCccCCCCCCcceeecccCCccccCccccccC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccchhhhhhhhh--
Q 014079          229 FGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTG-HLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQSLVDWARPK--  305 (431)
Q Consensus       229 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~--  305 (431)
                      ||++.....     ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.........+......  
T Consensus       165 fg~a~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~  239 (348)
T d2gfsa1         165 FGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  239 (348)
T ss_dssp             C----CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cchhcccCc-----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            999876432     22346799999999987765 4688999999999999999999999765432221111000000  


Q ss_pred             --hhc------cchhhhhcCccccCc---ccHHHHHHHHHHHHHhhhcCCCCCCCHHHHHHH
Q 014079          306 --LND------KRKMLQIIDPRLENQ---YSVRAAQKACSLAYYCLSQNPKARPLMSDVVET  356 (431)
Q Consensus       306 --~~~------~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~dP~~RPt~~eil~~  356 (431)
                        ...      ...............   .....+.++.+||.+||+.||.+|||+.|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         240 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence              000      000000000000000   011235678999999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.9e-42  Score=333.96  Aligned_cols=265  Identities=18%  Similarity=0.216  Sum_probs=191.9

Q ss_pred             cCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-----------CCceeee
Q 014079           78 KSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-----------HPNLVKL  146 (431)
Q Consensus        78 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l  146 (431)
                      .+|++.++||+|+||+||+|++..++..      ||||+++++.. ..+.+.+|+++++.++           |+||+++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~------vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~   85 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTH------VAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   85 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEE------EEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCE------EEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEE
Confidence            3599999999999999999999876654      99999987642 2456778999888875           5789999


Q ss_pred             ecEEEe--CCeeEEEEEecCCCC-hHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHh-CCCCeeeccCCCCCEEECCCC
Q 014079          147 IGYCCE--DDHRLLVYEFMFRGS-LENHLFRKATVPLSWATRMMIAFGAAKGLAFLHN-AERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       147 ~~~~~~--~~~~~lv~e~~~~gs-L~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~-~~~~ivHrDlkp~NILl~~~~  222 (431)
                      ++++..  ....+++|+++..+. ............+++..+..++.|++.||+|||+ .+  |+||||||+||||+.++
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~--IvHrDlKp~NIll~~~~  163 (362)
T d1q8ya_          86 LDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVD  163 (362)
T ss_dssp             CEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC--EECSCCSGGGEEEEEEE
T ss_pred             EEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC--cccccCChhHeeeeccC
Confidence            998864  355667777764443 3344444555568889999999999999999997 55  99999999999998665


Q ss_pred             ------cEEEecccCCccCCCCCCcceeecccCCccccCccccccCCCCcchhhHHHHHHHHHHHhCCCCCCCCCCcccc
Q 014079          223 ------TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLELLTGRKSVDKTRPSKEQ  296 (431)
Q Consensus       223 ------~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~  296 (431)
                            .++|+|||.+......     ....+||+.|+|||++.+..|+.++|||||||++++|++|+.||.........
T Consensus       164 ~~~~~~~~kl~dfg~s~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~  238 (362)
T d1q8ya_         164 SPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  238 (362)
T ss_dssp             TTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             cccccceeeEeecccccccccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCcccccc
Confidence                  3999999999764322     23467999999999999999999999999999999999999999764332111


Q ss_pred             hhhhhhhhhh-----------hccchhhhhcC---------c----------cccCcccHHHHHHHHHHHHHhhhcCCCC
Q 014079          297 SLVDWARPKL-----------NDKRKMLQIID---------P----------RLENQYSVRAAQKACSLAYYCLSQNPKA  346 (431)
Q Consensus       297 ~~~~~~~~~~-----------~~~~~~~~~~~---------~----------~~~~~~~~~~~~~~~~li~~cl~~dP~~  346 (431)
                      .........+           ..........+         .          ..........+.++.+|+.+||+.||.+
T Consensus       239 ~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~  318 (362)
T d1q8ya_         239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  318 (362)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             chhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhH
Confidence            1000000000           00000000000         0          0012234667889999999999999999


Q ss_pred             CCCHHHHHHH
Q 014079          347 RPLMSDVVET  356 (431)
Q Consensus       347 RPt~~eil~~  356 (431)
                      |||++|+++|
T Consensus       319 Rpta~e~L~H  328 (362)
T d1q8ya_         319 RADAGGLVNH  328 (362)
T ss_dssp             CBCHHHHHTC
T ss_pred             CcCHHHHhcC
Confidence            9999999986

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=1.2e-25  Score=195.82  Aligned_cols=164  Identities=13%  Similarity=0.083  Sum_probs=116.8

Q ss_pred             CccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCc------------------hhHHHHHHHHHHHhcCCCCc
Q 014079           81 RSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGL------------------QGHREWLTEVNFLGQLRHPN  142 (431)
Q Consensus        81 ~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~n  142 (431)
                      .+.+.||+|+||+||+|.+.++.       .||||+++....                  .......+|...+.++.|.+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~-------~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~   75 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFG-------ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLA   75 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTE-------EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSS
T ss_pred             hhCCEeeeCcceEEEEEECCCCC-------EEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCC
Confidence            45778999999999999886543       389998653211                  01123457889999999999


Q ss_pred             eeeeecEEEeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCCCCeeeccCCCCCEEECCCC
Q 014079          143 LVKLIGYCCEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAERPVIYRDFKTSNILLDSDY  222 (431)
Q Consensus       143 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~~~ivHrDlkp~NILl~~~~  222 (431)
                      ++..+++.    ..+++|||+++..+.++         +......++.|++.+|.|||+.+  |+||||||+|||++++ 
T Consensus        76 v~~~~~~~----~~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~g--iiHrDiKP~NILv~~~-  139 (191)
T d1zara2          76 VPKVYAWE----GNAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHRG--IVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             SCCEEEEE----TTEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHTT--EECSCCSTTSEEEETT-
T ss_pred             cceEEEec----CCEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhCC--EEEccCChhheeeeCC-
Confidence            99887653    23799999987665442         22234568899999999999977  9999999999999865 


Q ss_pred             cEEEecccCCccCCCCCCcceeecccCCccccCcc-----ccccCCCCcchhhHHHHHHH
Q 014079          223 TAKLSDFGLAKAGPQGDETHVSTRVMGTYGYAAPE-----YVMTGHLTARSDVYSFGVVL  277 (431)
Q Consensus       223 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslG~il  277 (431)
                      .++|+|||+|.........          .|....     .+....|+.++|+||+.--+
T Consensus       140 ~~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 GIWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             EEEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CEEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            5899999999764332211          111110     01246788899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.82  E-value=6.2e-09  Score=93.03  Aligned_cols=148  Identities=15%  Similarity=0.074  Sum_probs=97.3

Q ss_pred             HHHHHhcCCCccceecccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEE
Q 014079           72 ELETITKSFRSDYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYC  150 (431)
Q Consensus        72 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~  150 (431)
                      ++...-..|+..+..+.++.+.||+....++        .+.+|+...........+.+|...++.+. +--+.+++.+.
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~--------~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~   79 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGENE--------NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE   79 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECSSC--------EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeCCC--------eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE
Confidence            4566667777776655555678998764332        27788776543333344667888877764 33367778888


Q ss_pred             EeCCeeEEEEEecCCCChHHhhhhCCCCCcCHHHHHHHHHHHHHHHHHhHhCC---------------------------
Q 014079          151 CEDDHRLLVYEFMFRGSLENHLFRKATVPLSWATRMMIAFGAAKGLAFLHNAE---------------------------  203 (431)
Q Consensus       151 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~~i~~~l~~LH~~~---------------------------  203 (431)
                      .+++..++||++++|.++.+......    .   ...++.+++..+..||+..                           
T Consensus        80 ~~~~~~~lv~~~l~G~~~~~~~~~~~----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (263)
T d1j7la_          80 RHDGWSNLLMSEADGVLCSEEYEDEQ----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLAD  152 (263)
T ss_dssp             EETTEEEEEEECCSSEEHHHHTTTCS----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSC
T ss_pred             ecCCceEEEEEecccccccccccccc----c---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhh
Confidence            88899999999999988866542211    1   1112334444444454311                           


Q ss_pred             ------------------------------CCeeeccCCCCCEEECCCCcEEEecccCCcc
Q 014079          204 ------------------------------RPVIYRDFKTSNILLDSDYTAKLSDFGLAKA  234 (431)
Q Consensus       204 ------------------------------~~ivHrDlkp~NILl~~~~~~kl~DFG~a~~  234 (431)
                                                    ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         153 VDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             hhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                          1278999999999999876667999987653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.18  E-value=2.9e-06  Score=74.68  Aligned_cols=75  Identities=16%  Similarity=0.031  Sum_probs=50.5

Q ss_pred             ecccC-cEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC--CCceeeeecEEEeCCeeEEEEEe
Q 014079           86 LGEGG-FGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR--HPNLVKLIGYCCEDDHRLLVYEF  162 (431)
Q Consensus        86 lg~G~-~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~  162 (431)
                      +..|. -+.||+....++..       +++|........   .+..|+..|+.+.  .-.+.+++.+..+++..++||++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~-------~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~   87 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPV-------LFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   87 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCC-------EEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             cCCcccCCeEEEEEeCCCCE-------EEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEe
Confidence            44444 36789887655432       777876554322   3456777777664  23367778888888899999999


Q ss_pred             cCCCChHH
Q 014079          163 MFRGSLEN  170 (431)
Q Consensus       163 ~~~gsL~~  170 (431)
                      ++|.++.+
T Consensus        88 i~G~~~~~   95 (255)
T d1nd4a_          88 VPGQDLLS   95 (255)
T ss_dssp             CSSEETTT
T ss_pred             eecccccc
Confidence            98877643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.89  E-value=2.7e-05  Score=73.05  Aligned_cols=78  Identities=17%  Similarity=0.125  Sum_probs=46.7

Q ss_pred             cceecccCcEEEEEEEEcCCceeccccceeEEEEccc------cCc-hhHHHHHHHHHHHhcCC-C--CceeeeecEEEe
Q 014079           83 DYILGEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNK------EGL-QGHREWLTEVNFLGQLR-H--PNLVKLIGYCCE  152 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~------~~~-~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~  152 (431)
                      .+.||.|....||++...++.+      .+++|....      ... ....+...|.+.|+.+. +  ..+.+++.+  +
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~------svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d  102 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDR------ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D  102 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----C------EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E
T ss_pred             EEEeCCCceEeEEEEEeCCCCe------EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c
Confidence            3468999999999998765543      277785432      111 12233456777777653 2  345555544  5


Q ss_pred             CCeeEEEEEecCCCCh
Q 014079          153 DDHRLLVYEFMFRGSL  168 (431)
Q Consensus       153 ~~~~~lv~e~~~~gsL  168 (431)
                      .+..++|||++.+..+
T Consensus       103 ~~~~~lvmE~L~~~~~  118 (392)
T d2pula1         103 TEMAVTVMEDLSHLKI  118 (392)
T ss_dssp             TTTTEEEECCCTTSEE
T ss_pred             CCCCEEEEeccCCccc
Confidence            5667899999976543

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.21  E-value=0.00026  Score=63.91  Aligned_cols=156  Identities=15%  Similarity=0.050  Sum_probs=82.3

Q ss_pred             cCHHHHHHHhcCCCcccee-----cccCcEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCC---
Q 014079           68 FSLFELETITKSFRSDYIL-----GEGGFGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR---  139 (431)
Q Consensus        68 ~~~~~~~~~~~~y~~~~~l-----g~G~~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---  139 (431)
                      .+..+++.+..+|.+.++.     ..|---+.|+....++        .+++|+.....  ...++..|+++|..|.   
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g--------~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g   72 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD--------PLILTLYEKRV--EKNDLPFFLGLMQHLAAKG   72 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC--------CEEEEEECC-----CCHHHHHHHHHHHHHHTT
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC--------cEEEEEcCCCC--CHHHHHHHHHHHHhhhhcc
Confidence            3566788888888875543     4565678899876654        28999986532  1223444666666653   


Q ss_pred             --CCceeeeec---EEEeCCeeEEEEEecCCCChHHh--------------hhh---CCC----CCcCHH----------
Q 014079          140 --HPNLVKLIG---YCCEDDHRLLVYEFMFRGSLENH--------------LFR---KAT----VPLSWA----------  183 (431)
Q Consensus       140 --h~niv~l~~---~~~~~~~~~lv~e~~~~gsL~~~--------------l~~---~~~----~~~~~~----------  183 (431)
                        .|..+...+   +.........++.++.+......              ++.   ...    ......          
T Consensus        73 ~pvp~pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  152 (316)
T d2ppqa1          73 LSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSE  152 (316)
T ss_dssp             CCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHG
T ss_pred             ccccccceecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHH
Confidence              232222211   22334556777777765433210              000   000    000000          


Q ss_pred             --------HHHHHHHHHHHHHHHhHh--CCCCeeeccCCCCCEEECCCCcEEEecccCCc
Q 014079          184 --------TRMMIAFGAAKGLAFLHN--AERPVIYRDFKTSNILLDSDYTAKLSDFGLAK  233 (431)
Q Consensus       184 --------~~~~i~~~i~~~l~~LH~--~~~~ivHrDlkp~NILl~~~~~~kl~DFG~a~  233 (431)
                              .....+..+...+.-.+.  ...++||+|+.++||+++.+...-|+||+.+.
T Consensus       153 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         153 ERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             GGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HhhhhcchhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence                    011111122222222221  23459999999999999988777899999774

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.00  E-value=0.00075  Score=62.92  Aligned_cols=81  Identities=14%  Similarity=0.035  Sum_probs=51.2

Q ss_pred             cceecccCcEEEEEEEEcCCcee-ccccceeEEEEccccCchhHHHHHHHHHHHhcCC-CCceeeeecEEEeCCeeEEEE
Q 014079           83 DYILGEGGFGTVYKGYIDENVRV-GLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLR-HPNLVKLIGYCCEDDHRLLVY  160 (431)
Q Consensus        83 ~~~lg~G~~g~V~~~~~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  160 (431)
                      .+.|+.|-.-.+|++...++... ......|.+++....  .......+|..+++.+. +.-..++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            34688888899999987654321 112233667766532  22344567888888885 4334577777642    6899


Q ss_pred             EecCCCChH
Q 014079          161 EFMFRGSLE  169 (431)
Q Consensus       161 e~~~~gsL~  169 (431)
                      ||++|.+|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999876543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.00  E-value=0.0018  Score=58.44  Aligned_cols=69  Identities=17%  Similarity=0.073  Sum_probs=44.0

Q ss_pred             cEEEEEEEEcCCceeccccceeEEEEccccCchhHHHHHHHHHHHhcCCCCc-----eeeee--cEEEeCCeeEEEEEec
Q 014079           91 FGTVYKGYIDENVRVGLKSLPVAVKVLNKEGLQGHREWLTEVNFLGQLRHPN-----LVKLI--GYCCEDDHRLLVYEFM  163 (431)
Q Consensus        91 ~g~V~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv~l~--~~~~~~~~~~lv~e~~  163 (431)
                      --.||++...++.       .|++|+.+... ...+++..|...|..|...+     .+..-  ..+...+..+.+++++
T Consensus        35 EN~vy~v~~~dg~-------~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~  106 (325)
T d1zyla1          35 ENRVYQFQDEDRR-------RFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  106 (325)
T ss_dssp             SSEEEEECCTTCC-------CEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             cceeEEEEcCCCC-------EEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeec
Confidence            3579998876654       38899986542 34566778888887774222     12211  2334567788999999


Q ss_pred             CCCC
Q 014079          164 FRGS  167 (431)
Q Consensus       164 ~~gs  167 (431)
                      .|..
T Consensus       107 ~G~~  110 (325)
T d1zyla1         107 GGRQ  110 (325)
T ss_dssp             CCEE
T ss_pred             CCcC
Confidence            7654